PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Slomski, A				Slomski, Anita			Some Men With Localized Prostate Cancer Regret Surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 4	2022	327	1					26	26		10.1001/jama.2021.22982	http://dx.doi.org/10.1001/jama.2021.22982			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YF7YT	34982130				2022-12-28	WOS:000742019000004
J	Voelker, R				Voelker, Rebecca			Lighting the Way for Improved Detection of Ovarian Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	2	2	2	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 4	2022	327	1					27	27		10.1001/jama.2021.23423	http://dx.doi.org/10.1001/jama.2021.23423			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YF7YT	34982136				2022-12-28	WOS:000742019000009
J	Slomski, A				Slomski, Anita			An Increase in Adolescent Cannabis Vaping Is Reported	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 4	2022	327	1					26	26		10.1001/jama.2021.23317	http://dx.doi.org/10.1001/jama.2021.23317			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YF7YT	34982130				2022-12-28	WOS:000742019000005
J	Voelker, R				Voelker, Rebecca			A Treatment Advance for Patients With Posttransplant CMV	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	2	2	2	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 4	2022	327	1					27	27		10.1001/jama.2021.22960	http://dx.doi.org/10.1001/jama.2021.22960			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YF7YT	34982136				2022-12-28	WOS:000742019000010
J	Kim, M; Jeong, J; Lu, HZ; Lee, TK; Eickemeyer, FT; Liu, YH; Choi, IW; Choi, SJ; Jo, Y; Kim, HB; Mo, SI; Kim, YK; Lee, H; An, NG; Cho, S; Tress, WR; Zakeeruddin, SM; Hagfeldt, A; Kim, JY; Gratzel, M; Kim, DS				Kim, Minjin; Jeong, Jaeki; Lu, Haizhou; Lee, Tae Kyung; Eickemeyer, Felix T.; Liu, Yuhang; Choi, In Woo; Choi, Seung Ju; Jo, Yimhyun; Kim, Hak-Beom; Mo, Sung-In; Kim, Young-Ki; Lee, Heunjeong; An, Na Gyeong; Cho, Shinuk; Tress, Wolfgang R.; Zakeeruddin, Shaik M.; Hagfeldt, Anders; Kim, Jin Young; Gratzel, Michael; Kim, Dong Suk			Conformal quantum dot-SnO2 layers as electron transporters for efficient perovskite solar cells	SCIENCE			English	Article							PERFORMANCE; VOLTAGE; MODULE; BINDER; SIZE	Improvements to perovskite solar cells (PSCs) have focused on increasing their power conversion efficiency (PCE) and operational stability and maintaining high performance upon scale-up to module sizes. We report that replacing the commonly used mesoporous-titanium dioxide electron transport layer (ETL) with a thin layer of polyacrylic acid-stabilized tin(IV) oxide quantum dots (paa-QD-SnO2) on the compact-titanium dioxide enhanced light capture and largely suppressed nonradiative recombination at the ETL-perovskite interface. The use of paa-QD-SnO2 as electron-selective contact enabled PSCs (0.08 square centimeters) with a PCE of 25.7% (certified 25.4%) and high operational stability and facilitated the scale-up of the PSCs to larger areas. PCEs of 23.3, 21.7, and 20.6% were achieved for PSCs with active areas of 1, 20, and 64 square centimeters, respectively.	[Kim, Minjin; Choi, In Woo; Choi, Seung Ju; Jo, Yimhyun; Kim, Hak-Beom; Mo, Sung-In; Kim, Dong Suk] Korea Inst Energy Res, Ulsan Adv Energy Technol R&D Ctr, Ulsan 44776, South Korea; [Jeong, Jaeki; Lu, Haizhou; Eickemeyer, Felix T.; Liu, Yuhang; Zakeeruddin, Shaik M.; Gratzel, Michael] Ecole Polytech Fed Lausanne EPFL, Lab Photon & Interfaces, Inst Chem Sci & Engn, CH-1015 Lausanne, Switzerland; [Lee, Tae Kyung] Korea Inst Energy Res KIER, Photovolta Res Dept, Daejeon 34129, South Korea; [Kim, Young-Ki] Ulsan Natl Inst Sci & Technol UNIST, Cent Res Facil UCRF, Ulsan 44919, South Korea; [Lee, Heunjeong; Cho, Shinuk] Univ Ulsan, Dept Phys, Ulsan 44610, South Korea; [Lee, Heunjeong; Cho, Shinuk] Univ Ulsan, Energy Harvest Storage Res Ctr, Ulsan 44610, South Korea; [An, Na Gyeong; Kim, Jin Young] Ulsan Natl Inst Sci & Technol UNIST, Sch Energy & Chem Engn, Dept Energy Engn, Ulsan 44919, South Korea; [Tress, Wolfgang R.] Zurich Univ Appl Sci, Inst Computat Phys, Novel Semicond Devices Grp, CH-8401 Winterthur, Switzerland; [Hagfeldt, Anders] Uppsala Univ, Dept Chem, Angstrom Lab, S-75120 Uppsala, Sweden	Korea Institute of Energy Research (KIER); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Korea Institute of Energy Research (KIER); Ulsan National Institute of Science & Technology (UNIST); University of Ulsan; University of Ulsan; Ulsan National Institute of Science & Technology (UNIST); Zurich University of Applied Sciences; Uppsala University	Kim, DS (corresponding author), Korea Inst Energy Res, Ulsan Adv Energy Technol R&D Ctr, Ulsan 44776, South Korea.; Gratzel, M (corresponding author), Ecole Polytech Fed Lausanne EPFL, Lab Photon & Interfaces, Inst Chem Sci & Engn, CH-1015 Lausanne, Switzerland.	michael.graetzel@epfl.ch; kimds@kier.re.kr	Liu, Yuhang/HCH-1949-2022; Kim, Jin Young/E-6152-2010; kim, hak-beom/HGU-1087-2022; Liu, Yuhang/AAV-9702-2020; Tress, Wolfgang/B-7171-2017	Liu, Yuhang/0000-0001-6500-3278; Kim, Jin Young/0000-0002-6595-4468; Choi, Seung Ju/0000-0001-7836-3440; An, Na Gyeong/0000-0003-3099-2736; Tress, Wolfgang/0000-0002-4010-239X	Development Program of the Korea Institute of Energy Research (KIER) [C1-2401, C1-2402]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2020R1A6A1A03038697]; NRF - Ministry of Science, ICT, and Future Planning [2020M1A2A2080746, 2020M1A2A208075011]; European Union [881603, 764047]	Development Program of the Korea Institute of Energy Research (KIER); Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education(National Research Foundation of Korea); NRF - Ministry of Science, ICT, and Future Planning; European Union(European Commission)	This work was support by Development Program of the Korea Institute of Energy Research (KIER) (C1-2401 and C1-2402); Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2020R1A6A1A03038697); and the NRF funded by the Ministry of Science, ICT, and Future Planning (2020M1A2A2080746 and 2020M1A2A208075011). M.G. acknowledges financial support from the European Union's Horizon 2020 research and innovation program under grants 881603 and 764047.	Anaraki EH, 2016, ENERG ENVIRON SCI, V9, P3128, DOI 10.1039/c6ee02390h; Bi EB, 2019, JOULE, V3, P2748, DOI 10.1016/j.joule.2019.07.030; Bu TL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07099-9; Caprioglio P, 2019, ADV ENERGY MATER, V9, DOI 10.1002/aenm.201901631; Chen RH, 2019, J AM CHEM SOC, V141, P541, DOI 10.1021/jacs.8b11001; Das A, 2014, J MATER CHEM C, V2, P164, DOI 10.1039/c3tc31728e; Das A., 2014, J MATER CHEM C, V2, P164; Deng YH, 2018, NAT ENERGY, V3, P560, DOI 10.1038/s41560-018-0153-9; Di Giacomo F, 2018, SOL ENERG MAT SOL C, V181, P53, DOI 10.1016/j.solmat.2017.11.010; Eperon GE, 2014, ENERG ENVIRON SCI, V7, P982, DOI 10.1039/c3ee43822h; Fu GS, 2017, SOL ENERG MAT SOL C, V165, P36, DOI 10.1016/j.solmat.2017.01.013; GREEN MA, 1982, SOL CELLS, V7, P337, DOI 10.1016/0379-6787(82)90057-6; Hou Y, 2020, SCIENCE, V367, P1135, DOI 10.1126/science.aaz3691; Hu B, 2019, J POWER SOURCES, V416, P125, DOI 10.1016/j.jpowsour.2019.01.068; Jeon NJ, 2015, NATURE, V517, P476, DOI 10.1038/nature14133; Jeong J, 2021, NATURE, V592, P381, DOI 10.1038/s41586-021-03406-5; Jeong M, 2020, SCIENCE, V369, P1615, DOI 10.1126/science.abb7167; Ji J, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101013; Jiang Q, 2019, NAT PHOTONICS, V13, P460, DOI 10.1038/s41566-019-0398-2; Jiang Q, 2018, SMALL, V14, DOI 10.1002/smll.201801154; Jiang Q, 2017, NAT ENERGY, V2, P1, DOI [10.1038/nenergy.2016.177, 10.1038/NENERGY.2016.177]; Kim M, 2020, SUSTAIN ENERG FUELS, V4, P3753, DOI 10.1039/d0se00382d; Kim M, 2019, JOULE, V3, P2179, DOI 10.1016/j.joule.2019.06.014; Kirchartz T, 2020, ADV ENERGY MATER, V10, DOI 10.1002/aenm.201904134; Leijtens Tomas, 2013, Nature Communications, V4, DOI 10.1038/ncomms3885; Li PW, 2018, NANO ENERGY, V46, P203, DOI 10.1016/j.nanoen.2018.01.049; Lu HZ, 2020, SCIENCE, V370, P74, DOI 10.1126/science.abb8985; Lu HZ, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101359; Manzoor S, 2017, IEEE PHOT SPEC CONF, P1228; Min H, 2019, SCIENCE, V366, P749, DOI 10.1126/science.aay7044; Parikh P, 2019, CHEM MATER, V31, P2535, DOI 10.1021/acs.chemmater.8b05020; Pettersson LAA, 1999, J APPL PHYS, V86, P487, DOI 10.1063/1.370757; Priyadarshi A, 2016, ENERG ENVIRON SCI, V9, P3687, DOI 10.1039/c6ee02693a; Prochowicz D, 2019, J MATER CHEM A, V7, P8218, DOI 10.1039/c9ta00272c; Rau U, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.085303; ROSS RT, 1967, J CHEM PHYS, V46, P4590, DOI 10.1063/1.1840606; Shin SS, 2017, SCIENCE, V356, P167, DOI 10.1126/science.aam6620; Shin SS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8410; Tait JG, 2016, J MATER CHEM A, V4, P3792, DOI 10.1039/c6ta00739b; Tavakoli MM, 2018, ADV ENERGY MATER, V8, DOI 10.1002/aenm.201800794; Tavakoli MM, 2018, NANO LETT, V18, P2428, DOI 10.1021/acs.nanolett.7b05469; Tress W, 2015, ADV ENERGY MATER, V5, DOI 10.1002/aenm.201400812; Turren-Cruz SH, 2018, SCIENCE, V362, P449, DOI 10.1126/science.aat3583; Wang YB, 2019, SCIENCE, V365, P687, DOI 10.1126/science.aax8018; Wei LM, 2017, J MATER CHEM A, V5, P22156, DOI 10.1039/c7ta05195f; WURFEL P, 1982, J PHYS C SOLID STATE, V15, P3967, DOI 10.1088/0022-3719/15/18/012; Yang D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05760-x; Yang G, 2021, NAT PHOTONICS, V15, P681, DOI 10.1038/s41566-021-00829-4; Yoo JJ, 2021, NATURE, V590, DOI 10.1038/s41586-021-03285-w; Zhang FY, 2020, ADV ENERGY MATER, V10, DOI 10.1002/aenm.201903252; Zhang Y, 2020, ACS ENERGY LETT, V5, P360, DOI 10.1021/acsenergylett.9b02348	51	221	221	423	779	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2022	375	6578					302	+		10.1126/science.abh1885	http://dx.doi.org/10.1126/science.abh1885			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YK2FS	35050659	Green Submitted			2022-12-28	WOS:000745036100030
J	Schroeder, KM; Lyons, SK; Smith, FA				Schroeder, Katlin M.; Lyons, S. Kathleen; Smith, Felisa A.			Response to Comment on "The influence of juvenile dinosaurs on community structure and diversity"	SCIENCE			English	Editorial Material								The analysis of dinosaur ecology hinges on the appropriate reconstruction and analysis of dinosaur biodiversity. Benson et al. question the data used in our analysis and our subsequent interpretation of the results. We address these concerns and show that their reanalysis is flawed. Indeed, when occurrences are filtered to include only valid taxa, their revised dataset strengthens our earlier conclusions.	[Schroeder, Katlin M.; Smith, Felisa A.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Lyons, S. Kathleen] Univ Nebraska, Sch Biol Sci, Lincoln, NE USA	University of New Mexico; University of Nebraska System; University of Nebraska Lincoln	Schroeder, KM (corresponding author), Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA.	maguire@unm.edu		Lyons, S. Kathleen/0000-0001-5112-2508; Smith, Felisa/0000-0001-6262-436X				Behrensmeyer A.K., 1980, FOSSILS MAKING VERTE; Benson R. B. J., 2022, SCIENCE, V375; Benson RBJ, 2018, PALAEONTOLOGY, V61, P13, DOI 10.1111/pala.12329; Chin K, 2007, PALAIOS, V22, P554, DOI 10.2110/palo.2006.p06-087r; Clauss M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068714; Cullen TM, 2016, BMC ECOL, V16, DOI 10.1186/s12898-016-0106-8; Evans DC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2749; Holtz TR, 2021, CAN J EARTH SCI, V58, P778, DOI 10.1139/cjes-2020-0174; Hummel J., 2011, BIOL SAUROPOD DINOSA; Ibrahim N, 2020, ZOOKEYS, P1, DOI 10.3897/zookeys.928.47517; Lockley MG, 2021, EARTH-SCI REV, V220, DOI 10.1016/j.earscirev.2021.103715; Lyons S. K., 2015, ANIMAL BODY SIZE LIN, P116; Palmqvist P, 2008, PALAEOGEOGR PALAEOCL, V266, P95, DOI 10.1016/j.palaeo.2008.03.015; Schroeder K, 2021, SCIENCE, V371, P941, DOI 10.1126/science.abd9220; Smits PD, 2015, P NATL ACAD SCI USA, V112, P13015, DOI 10.1073/pnas.1510482112	15	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2022	375	6578								10.1126/science.abj7383	http://dx.doi.org/10.1126/science.abj7383			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YK2FS	35050650				2022-12-28	WOS:000745036100002
J	Findlay, S; Nelson, K; Logan, I				Findlay, Simon; Nelson, Katharine; Logan, Ian			A tropical electrocardiogram wave	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Findlay, Simon] Newcastle Univ, Northern Inst Canc Res, Fac Med Sci, Newcastle Upon Tyne, Tyne & Wear, England; [Nelson, Katharine] Newcastle Tyne Hosp NHS Fdn Trust, Dept Cardiol, Royal Victoria Infirm, Newcastle Upon Tyne, Tyne & Wear, England; [Logan, Ian] Newcastle Tyne Hosp NHS Fdn Trust, Freeman Hosp, Dept Nephrol, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Newcastle Freeman Hospital; Newcastle Upon Tyne Hospitals NHS Foundation Trust	Findlay, S (corresponding author), Newcastle Univ, Northern Inst Canc Res, Fac Med Sci, Newcastle Upon Tyne, Tyne & Wear, England.	simon.findlay1@nhs.net						Renal Association clinical practice guideline, 2020, TREATMENT ACUTE HYPE	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 19	2022	376								e065769	10.1136/bmj-2021-065769	http://dx.doi.org/10.1136/bmj-2021-065769			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YL6WC	35046054				2022-12-28	WOS:000746028500006
J	Oliver, D				Oliver, David			David Oliver: Solutions for the workforce crisis exist, so let's act now	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						Gillian Keegan MP., 2021, BIGG VIS BOOST SOC C; Health Foundation King's Fund Nuffield Trust, 2019, CLOSING GAP KEY AREA; NHS England,, 2021, 202223 PRIOR OP PLAN; Nuffield Trust, 2020, UNDERSTANDING IMPACT; Nuffield Trust,, 2021, ONG WORKF CRIS SOC C; Oliver David, 2022, BMJ, V376, pn3139, DOI 10.1136/bmj.n3139	6	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 12	2022	376								o23	10.1136/bmj.o23	http://dx.doi.org/10.1136/bmj.o23			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YP6JI	35022184	Bronze			2022-12-28	WOS:000748728200012
J	Caillard, S; Thaunat, O; Benotmane, I; Masset, C; Blancho, G				Caillard, Sophie; Thaunat, Olivier; Benotmane, Ilies; Masset, Christophe; Blancho, Gilles			Antibody Response to a Fourth Messenger RNA COVID-19 Vaccine Dose in Kidney Transplant Recipients: A Case Series	ANNALS OF INTERNAL MEDICINE			English	Letter									[Caillard, Sophie; Benotmane, Ilies] Univ Hosp Strasbourg, Dept Nephrol & Transplantat, INSERM Unit 1109, Strasbourg, France; [Thaunat, Olivier] Claude Bernard Lyon 1 Univ, Hosp Civils Lyon, Dept Transplantat Nephrol & Clin Immunol, INSERM Unit 1111, Lyon, France; [Masset, Christophe; Blancho, Gilles] Nantes Univ, Ctr Hosp Univ Nantes, Ctr Rech Transplantat & Immunol, Inst Transplantat Urol Nephrol,UMR 1064,INSERM, Nantes, France	CHU Strasbourg; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes	Caillard, S (corresponding author), Hop Univ Strasbourg, Dept Nephrol & Transplantat, 1 Pl Hop, F-67091 Strasbourg, France.	Sophie.caillard@chru-strasbourg.fr	Benotmane, Ilies/AAE-6895-2021	Benotmane, Ilies/0000-0001-9113-2479; Blancho, Gilles/0000-0003-0356-5069; caillard, sophie/0000-0002-0525-4291				Benotmane I, 2021, JAMA-J AM MED ASSOC, V326, P1063, DOI 10.1001/jama.2021.12339; Boyarsky BJ, 2021, JAMA-J AM MED ASSOC, V325, P2204, DOI 10.1001/jama.2021.7489; Kamar N, 2021, NEW ENGL J MED, V385, P661, DOI 10.1056/NEJMc2108861; O'Brien Meagan P, 2021, medRxiv, DOI 10.1101/2021.06.14.21258567; Planas D, 2021, NATURE, V596, P276, DOI 10.1038/s41586-021-03777-9	5	44	44	2	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR	2022	175	3					455	+		10.7326/L21-0598	http://dx.doi.org/10.7326/L21-0598		JAN 2022	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0O4EB	35007148	Green Published			2022-12-28	WOS:000783479300017
J	Christie, B				Christie, Bryan			Sixty seconds on ... lockdown injuries	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 7	2022	376								o32	10.1136/bmj.o32	http://dx.doi.org/10.1136/bmj.o32			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YP9GN	34996763				2022-12-28	WOS:000748927300010
J	O'Dowd, A				O'Dowd, Adrian			Drive to boost medical workforce numbers continues to stall	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2021, NHS VACANCY STAT ENG; [Anonymous], 2022, NHS WORKFORCE STAT S; NHS Digital, 2021, GEN PRACT WORKF	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 7	2022	376								o26	10.1136/bmj.o26	http://dx.doi.org/10.1136/bmj.o26			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YP9GN	34996814				2022-12-28	WOS:000748927300002
J	Scheinker, D; Milstein, A; Schulman, K				Scheinker, David; Milstein, Arnold; Schulman, Kevin			The Dysfunctional Health Benefits Market and Implications for US Employers and Employees	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Scheinker, David; Milstein, Arnold] Stanford Univ, Clin Excellence Res Ctr, Stanford, CA 94305 USA; [Schulman, Kevin] Stanford Univ, Dept Med, Stanford, CA 94305 USA	Stanford University; Stanford University	Schulman, K (corresponding author), Clin Excellence Res Ctr, 453 Quarry Rd,CAM Bldg,Ste 117B, Palo Alto, CA 94304 USA.	Kevin.Schulman@Stanford.edu						[Anonymous], 2020, EMPLOYER HLTH BENEFI; Arnold D., 2020, WHO PAYS HLTH CARE C; Dieleman JL, 2017, JAMA-J AM MED ASSOC, V318, P1668, DOI 10.1001/jama.2017.15927; Kliff, 2021, NEW YORK TIMES; Martin AB, 2021, HEALTH AFFAIR, V40, P14, DOI 10.1377/hlthaff.2020.02022; Whaley CM., 2020, NATIONWIDE EVALUATIO	6	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 25	2022	327	4					323	324		10.1001/jama.2021.23258	http://dx.doi.org/10.1001/jama.2021.23258		JAN 2022	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YV9PW	34994781				2022-12-28	WOS:000739989000004
J	Sleakowsld, LM				Sleakowsld, Lisa Michelle			Scenes From a Mammogram	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								In this narrative medicine essay, a pediatrician describes her dreary routine visit to the local breast imaging center for her annual screening mammogram.	[Sleakowsld, Lisa Michelle] Univ Nebraska Med Ctr, Dept Pediat, Omaha, NE USA; [Sleakowsld, Lisa Michelle] Childrens Hosp & Med Ctr, 8200 Dodge St, Omaha, NE 68114 USA	University of Nebraska System; University of Nebraska Medical Center	Sleakowsld, LM (corresponding author), Childrens Hosp & Med Ctr, 8200 Dodge St, Omaha, NE 68114 USA.	lsieczkowski@childrensomaha.org							0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 4	2022	327	1					35	35		10.1001/jama.2021.23000	http://dx.doi.org/10.1001/jama.2021.23000			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YF7YT	34982116				2022-12-28	WOS:000742019000014
J	Geng, EH				Geng, Elvin H.			The Doctor's Oldest Tool	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																			0	1	1	1	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 6	2022	386	1					7	9		10.1056/NEJMp2115832	http://dx.doi.org/10.1056/NEJMp2115832		JAN 2022	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YC1QX	34979072	Bronze			2022-12-28	WOS:000736921200001
J	Gewin, V				Gewin, Virginia			THE QUEST TO RESTORE SCIENTIFIC INTEGRITY	NATURE			English	Editorial Material																		Dillon L, 2018, AM J PUBLIC HEALTH, V108, pS89, DOI 10.2105/AJPH.2018.304360; Fredrickson L., 2019, SHEEP CLOSET EROSION; Fredrickson L, 2018, AM J PUBLIC HEALTH, V108, pS95, DOI 10.2105/AJPH.2018.304396; Pace RM, 2017, ECOL EVOL, V7, P8730, DOI 10.1002/ece3.3406	4	0	0	1	5	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 20	2022	601	7893					471	473		10.1038/d41586-022-00105-7	http://dx.doi.org/10.1038/d41586-022-00105-7			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YI0DC	35039651				2022-12-28	WOS:000743527000006
J	Kuehn, BM				Kuehn, Bridget M.			Global HIV Suppression Rates Fall Short of Targets	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 18	2022	327	3					209	209						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YV9PQ	35040878				2022-12-28	WOS:000753055100008
J	Mahase, E				Mahase, Elisabeth			Covid-19: Severe complications during pregnancy are more common in unvaccinated women, study finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Iacobucci G, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n2862; Mahase E, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3391; Stock SJ, 2022, NAT MED, V28, P504, DOI 10.1038/s41591-021-01666-2	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 17	2022	376								o117	10.1136/bmj.o117	http://dx.doi.org/10.1136/bmj.o117			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YP6HX	35039319	Bronze			2022-12-28	WOS:000748724000001
J	Bates, N				Bates, Nancy			Who gets counted and how	SCIENCE			English	Editorial Material									[Bates, Nancy] US Census Bur, Suitland, MD 20746 USA			batesnancy5@gmail.com						Adhikari L, 2021, ENV CHALLENGES, V11; [Anonymous], 2021, EXPRESS TRIBUNE; Hayder H, 2021, PROPAKISTANI; Khattak R. H, 2021, BRAZ J BIOL, V20, P83; Michel S, 2015, CAPRA FALCONERI ERRA; Rashid W, 2020, ANIMALS-BASEL, V10, DOI 10.3390/ani10040597	6	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2022	375	6577					152	153		10.1126/science.abn1911	http://dx.doi.org/10.1126/science.abn1911			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YG3OI	35025631				2022-12-28	WOS:000742401600021
J	[Anonymous]				[Anonymous]			Molten iron in Earth-like exoplanet cores	SCIENCE			English	Editorial Material														Zhang, Youjun/0000-0001-5340-4170	National Natural Science Foundation of China [42074098]; National Science Foundation [EAR-1901801]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation(National Science Foundation (NSF))	We thank P. Driscoll for the helpful comments. Y.Z. is supported by the National Natural Science Foundation of China (42074098), and J.-F.L. is supported by the Geophysics Program of the National Science Foundation (EAR-1901801).	Anzellini S, 2013, SCIENCE, V340, P464, DOI 10.1126/science.1233514; Bonati I, 2021, J GEOPHYS RES-PLANET, V126, DOI 10.1029/2020JE006724; Driscoll P, 2011, ICARUS, V213, P12, DOI 10.1016/j.icarus.2011.02.010; Duffy T., 2015, TREATISE GEOPHYS, V2, P149; Foley BJ, 2016, GEOCHEM GEOPHY GEOSY, V17, P1885, DOI 10.1002/2015GC006210; Hemingway DJ, 2021, J GEOPHYS RES-PLANET, V126, DOI 10.1029/2020JE006663; Hirose K, 2021, NAT REV EARTH ENV, V2, P645, DOI 10.1038/s43017-021-00203-6; Kraus RG, 2022, SCIENCE, V375, P202, DOI 10.1126/science.abm1472; Li J, 2020, GEOPHYS RES LETT, V47, DOI 10.1029/2020GL087758; Mayor M, 2014, NATURE, V513, P328, DOI 10.1038/nature13780; Stahler SC, 2021, SCIENCE, V373, P443, DOI 10.1126/science.abi7730; Turneaure SJ, 2020, PHYS REV LETT, V125, DOI 10.1103/PhysRevLett.125.215702; Unterborn CT, 2019, J GEOPHYS RES-PLANET, V124, P1704, DOI 10.1029/2018JE005844; Zhang YJ, 2020, PHYS REV LETT, V125, DOI 10.1103/PhysRevLett.125.078501	14	1	1	10	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2022	375	6577					146	147		10.1126/science.abn2051	http://dx.doi.org/10.1126/science.abn2051			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YG3OI	35025656				2022-12-28	WOS:000742401600017
J	Bero, L				Bero, Lisa			Stamp out fake clinical data by working together	NATURE			English	Editorial Material									[Bero, Lisa] Univ Colorado, Ctr Bioeth & Humanities, Anschutz Med Campus, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Bero, L (corresponding author), Univ Colorado, Ctr Bioeth & Humanities, Anschutz Med Campus, Aurora, CO 80045 USA.	lisa.bero@cuanschutz.edu						Carlisle JB, 2021, ANAESTHESIA, V76, P472, DOI 10.1111/anae.15263; Popp M, 2021, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD015017.pub2, 10.1002/14651858.CD015017]	2	1	1	0	2	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 13	2022	601	7892					167	167						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YE9KY	35017708				2022-12-28	WOS:000741438200003
J	Maharajh, S; Teelucksingh, S				Maharajh, Sandeep; Teelucksingh, Surujpal			Hyperpigmentation in Vitamin B-12 Deficiency	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Hyperpigmentation in Vitamin B-12 Deficiency A 59-year-old man presented with fatigue and hyperpigmentation on his palms and soles. Physical examination showed a smooth tongue with areas of darkening. Laboratory tests showed pancytopenia, a low vitamin B-12 level, and an elevated intrinsic factor antibody level, findings consistent with vitamin B-12 deficiency due to autoimmune gastritis.	[Maharajh, Sandeep; Teelucksingh, Surujpal] Univ West Indies, St Augustine, Trinidad Tobago	University West Indies Mona Jamaica; University West Indies Saint Augustine	Maharajh, S (corresponding author), Univ West Indies, St Augustine, Trinidad Tobago.	sk_maharajh@hotmail.com		Maharajh, Sandeep/0000-0001-7554-326X					0	0	0	1	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 13	2022	386	2					172	172		10.1056/NEJMicm2113099	http://dx.doi.org/10.1056/NEJMicm2113099			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YF2NZ	35020987				2022-12-28	WOS:000741651400014
J	Yang, C; Liu, HW; Liu, Y; Wang, JD; Qiu, D; Wang, SS; Wang, Y; He, QM; Li, XL; Li, P; Tang, Y; Wang, J; Xie, XC; Valles, JM; Xiong, J; Li, YR				Yang, Chao; Liu, Haiwen; Liu, Yi; Wang, Jiandong; Qiu, Dong; Wang, Sishuang; Wang, Yang; He, Qianmei; Li, Xiuli; Li, Peng; Tang, Yue; Wang, Jian; Xie, X. C.; Valles, James M., Jr.; Xiong, Jie; Li, Yanrong			Signatures of a strange metal in a bosonic system	NATURE			English	Article							SUPERCONDUCTOR-INSULATOR TRANSITION; QUANTUM CRITICALITY; TEMPERATURE; STATE; FLUCTUATIONS; DISSIPATION; TRANSPORT; SCATTERING; PSEUDOGAP; VISCOSITY	Fermi liquid theory forms the basis for our understanding of the majority of metals: their resistivity arises from the scattering of well defined quasiparticles at a rate where, in the low-temperature limit, the inverse of the characteristic time scale is proportional to the square of the temperature. However, various quantum materials(1-15)-notably high-temperature superconductors(1-10)-exhibit strange-metallic behaviour with a linear scattering rate in temperature, deviating from this central paradigm. Here we show the unexpected signatures of strange metallicity in a bosonic system for which the quasiparticle concept does not apply. Our nanopatterned YBa2Cu3O7-delta (YBCO) film arrays reveal linear-in-temperature and linear-in-magnetic field resistance over extended temperature and magnetic field ranges. Notably, below the onset temperature at which Cooper pairs form, the low-field magnetoresistance oscillates with a period dictated by the superconducting flux quantum, h/2e (e, electron charge; h, Planck's constant). Simultaneously, the Hall coefficient drops and vanishes within the measurement resolution with decreasing temperature, indicating that Cooper pairs instead of single electrons dominate the transport process. Moreover, the characteristic time scale tau in this bosonic system follows a scale-invariant relation without an intrinsic energy scale: h/tau approximate to a(k(B)T + gamma mu B-B), where h is the reduced Planck's constant, a is of order unity(7,8,11,12), k(B) is Boltzmann's constant, T is temperature, mu(B) is the Bohr magneton and gamma approximate to 2. By extending the reach of strange-metal phenomenology to a bosonic system, our results suggest that there is a fundamental principle governing their transport that transcends particle statistics.	[Yang, Chao; Wang, Jiandong; Qiu, Dong; Wang, Sishuang; Wang, Yang; He, Qianmei; Li, Xiuli; Li, Peng; Xiong, Jie; Li, Yanrong] Univ Elect Sci & Technol China, State Key Lab Elect Thin Films & Integrated Devic, Chengdu, Peoples R China; [Liu, Haiwen] Beijing Normal Univ, Ctr Adv Quantum Studies, Dept Phys, Beijing, Peoples R China; [Liu, Yi; Tang, Yue; Wang, Jian; Xie, X. C.] Peking Univ, Sch Phys, Int Ctr Quantum Mat, Beijing, Peoples R China; [Wang, Jian] Beijing Acad Quantum Informat Sci, Beijing, Peoples R China; [Valles, James M., Jr.] Brown Univ, Dept Phys, Providence, RI 02912 USA; [Li, Yanrong] Sichuan Univ, Chengdu, Peoples R China	University of Electronic Science & Technology of China; Beijing Normal University; Peking University; Brown University; Sichuan University	Xiong, J (corresponding author), Univ Elect Sci & Technol China, State Key Lab Elect Thin Films & Integrated Devic, Chengdu, Peoples R China.; Valles, JM (corresponding author), Brown Univ, Dept Phys, Providence, RI 02912 USA.	james_valles_jr@brown.edu; jiexiong@uestc.edu.cn	Yang, Chao/AAF-3799-2022; Yang, Chao/AFI-4937-2022; Liu, Haiwen/F-2518-2014	Liu, Haiwen/0000-0002-0007-3117	National Natural Science Foundation of China [51722204, 51972041, U20A20244, 11888101, 12022407, 11774008, 12074056]; National Basic Research Program of China [2021YFA0718800, 2017YFA0303300, 2018YFA0305604, 2017YFA0304600]; Beijing Natural Science Foundation [Z180010]; China National Postdoctoral Program for Innovative Talents [BX2021054]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Beijing Natural Science Foundation(Beijing Natural Science Foundation); China National Postdoctoral Program for Innovative Talents	We thank C.M. Varma, H.Yao, A.Lucas and J.M. Kosterlitz for discussions. This work was supported by the National Natural Science Foundation of China (grants 51722204, 51972041, U20A20244, 11888101, 12022407, 11774008 and 12074056), the National Basic Research Program of China (grants 2021YFA0718800, 2017YFA0303300, 2018YFA0305604 and 2017YFA0304600), Beijing Natural Science Foundation (Z180010) and the China National Postdoctoral Program for Innovative Talents (BX2021054).	Aji V, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.067003; Anderson P.W., 1998, THEORY SUPERCONDUCTI; Ayres J, 2021, NATURE, V595, P661, DOI 10.1038/s41586-021-03622-z; Bollinger AT, 2011, NATURE, V472, P458, DOI 10.1038/nature09998; Bottcher CGL, 2018, NAT PHYS, V14, P1138, DOI 10.1038/s41567-018-0259-9; Boyd C, 2019, PHYS REV B, V100, DOI 10.1103/PhysRevB.100.155139; Breznay NP, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700612; Bruin JAN, 2013, SCIENCE, V339, P804, DOI 10.1126/science.1227612; Cao C, 2011, SCIENCE, V331, P58, DOI 10.1126/science.1195219; Cao Y, 2020, PHYS REV LETT, V124, DOI 10.1103/PhysRevLett.124.076801; CHAKRAVARTY S, 1987, PHYS REV B, V35, P7256, DOI 10.1103/PhysRevB.35.7256; Chakravarty S, 2010, UNDERSTANDING QUANTU; Chowdhury D, 2018, PHYS REV X, V8, DOI 10.1103/PhysRevX.8.031024; Custers J, 2003, NATURE, V424, P524, DOI 10.1038/nature01774; Daou R, 2009, NAT PHYS, V5, P31, DOI [10.1038/nphys1109, 10.1038/NPHYS1109]; Davison RA, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.245116; Doiron-Leyraud N, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.214531; Doniach S, 2003, BRAZ J PHYS, V33, P740, DOI 10.1590/S0103-97332003000400021; ECKERN U, 1984, PHYS REV B, V30, P6419, DOI 10.1103/PhysRevB.30.6419; Faulkner T, 2010, SCIENCE, V329, P1043, DOI 10.1126/science.1189134; FISHER MPA, 1989, PHYS REV B, V40, P546, DOI 10.1063/1.38820; Garcia-Barriocanal J, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.024509; Gegenwart P, 2008, NAT PHYS, V4, P186, DOI 10.1038/nphys892; Giraldo-Gallo P, 2018, SCIENCE, V361, P479, DOI 10.1126/science.aan3178; Glatz A, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.104510; Greene RL, 2020, ANNU REV CONDEN MA P, V11, P213, DOI 10.1146/annurev-conmatphys-031119-050558; Grissonnanche G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4280; Han Z, 2014, NAT PHYS, V10, P380, DOI [10.1038/NPHYS2929, 10.1038/nphys2929]; Hartnoll SA, 2018, HOLOGRAPHIC QUANTUM MATTER; Hartnoll SA, 2015, NAT PHYS, V11, P54, DOI [10.1038/NPHYS3174, 10.1038/nphys3174]; Hartnoll SA, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.241601; Hayes IM, 2021, NAT PHYS, V17, DOI 10.1038/s41567-020-0982-x; Hayes IM, 2016, NAT PHYS, V12, P916, DOI [10.1038/NPHYS3773, 10.1038/nphys3773]; JAEGER HM, 1989, PHYS REV B, V40, P182, DOI 10.1103/PhysRevB.40.182; Jin K, 2011, NATURE, V476, P73, DOI 10.1038/nature10308; KAMPF A, 1987, PHYS REV B, V36, P3651, DOI 10.1103/PhysRevB.36.3651; Kapitulnik A, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.125322; Kapitulnik A, 2019, REV MOD PHYS, V91, DOI 10.1103/RevModPhys.91.011002; Keimer B, 2015, NATURE, V518, P179, DOI 10.1038/nature14165; Kovtun PK, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.111601; Legros A, 2019, NAT PHYS, V15, P142, DOI 10.1038/s41567-018-0334-2; Lindner NH, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.054512; Liu Y, 2020, NANO LETT, V20, P5728, DOI 10.1021/acs.nanolett.0c01356; Maksimovic N, 2020, PHYS REV X, V10, DOI 10.1103/PhysRevX.10.041062; Mason N, 1999, PHYS REV LETT, V82, P5341, DOI 10.1103/PhysRevLett.82.5341; Patel AA, 2019, PHYS REV LETT, V123, DOI 10.1103/PhysRevLett.123.066601; Patel AA, 2018, PHYS REV X, V8, DOI 10.1103/PhysRevX.8.021049; Phillips P, 2003, SCIENCE, V302, P243, DOI 10.1126/science.1088253; Prochaska L, 2020, SCIENCE, V367, P285, DOI 10.1126/science.aag1595; Rullier-Albenque F, 2008, EPL-EUROPHYS LETT, V81, DOI 10.1209/0295-5075/81/37008; Saito Y, 2015, SCIENCE, V350, P409, DOI 10.1126/science.1259440; Segawa K, 2001, PHYS REV LETT, V86, P4907, DOI 10.1103/PhysRevLett.86.4907; Shen B, 2020, NATURE, V579, P51, DOI 10.1038/s41586-020-2052-z; Stewart MD, 2007, SCIENCE, V318, P1273, DOI 10.1126/science.1149587; Taillefer L, 2010, ANNU REV CONDEN MA P, V1, P51, DOI 10.1146/annurev-conmatphys-070909-104117; Tikhonov KS, 2020, ANN PHYS-NEW YORK, V417, DOI 10.1016/j.aop.2020.168138; Tomita T, 2015, SCIENCE, V349, P506, DOI 10.1126/science.1262054; Varma CM, 2020, REV MOD PHYS, V92, DOI 10.1103/RevModPhys.92.031001; VARMA CM, 1989, PHYS REV LETT, V63, P1996, DOI 10.1103/PhysRevLett.63.1996; Wang F., 2021, NAT COMMUN, V12; Wen LY, 2017, NAT NANOTECHNOL, V12, P244, DOI [10.1038/nnano.2016.257, 10.1038/NNANO.2016.257]; Yang C, 2019, SCIENCE, V366, P1505, DOI 10.1126/science.aax5798; Zaanen J, 2004, NATURE, V430, P512, DOI 10.1038/430512a; Zaanen J., 2015, HOLOGRAPHIC DUALITY; Zaanen J, 2019, SCIPOST PHYS, V6, DOI 10.21468/SciPostPhys.6.5.061; Zaanen J, 2016, SCIENCE, V351, P1026, DOI 10.1126/science.aaf2487; Zhu LJ, 2016, PHYS REV B, V94, DOI 10.1103/PhysRevB.94.235156	67	4	4	39	150	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 13	2022	601	7892					205	+		10.1038/s41586-021-04239-y	http://dx.doi.org/10.1038/s41586-021-04239-y			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YF9MG	35022592	Green Submitted			2022-12-28	WOS:000742123100010
J	Iacobucci, G				Iacobucci, Gareth			One in five doctors feels overwhelmed daily by covid and winter pressures, RCP reports	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 12	2022	376								o86	10.1136/bmj.o86	http://dx.doi.org/10.1136/bmj.o86			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YP6JI	35022229	Bronze			2022-12-28	WOS:000748728200002
J	Monroe, JG; Srikant, T; Carbonell-Bejerano, P; Becker, C; Lensink, M; Exposito-Alonso, M; Klein, M; Hildebrandt, J; Neumann, M; Kliebenstein, D; Weng, ML; Imbert, E; Agren, J; Rutter, MT; Fenster, CB; Weigel, D				Monroe, J. Grey; Srikant, Thanvi; Carbonell-Bejerano, Pablo; Becker, Claude; Lensink, Mariele; Exposito-Alonso, Moises; Klein, Marie; Hildebrandt, Julia; Neumann, Manuela; Kliebenstein, Daniel; Weng, Mao-Lun; Imbert, Eric; Agren, Jon; Rutter, Matthew T.; Fenster, Charles B.; Weigel, Detlef			Mutation bias reflects natural selection in Arabidopsis thaliana	NATURE			English	Article							DNA MISMATCH REPAIR; CHROMATIN ORGANIZATION; MOLECULAR-SPECTRUM; NONRANDOM MUTATION; HUMAN GENOME; EVOLUTION; RATES; GENES; REVEAL; MODEL	Since the first half of the twentieth century, evolutionary theory has been dominated by the idea that mutations occur randomly with respect to their consequences(1). Here we test this assumption with large surveys of de novo mutations in the plant Arabidopsis thaliana. In contrast to expectations, we find that mutations occur less often in functionally constrained regions of the genome-mutation frequency is reduced by half inside gene bodies and by two-thirds in essential genes. With independent genomic mutation datasets, including from the largest Arabidopsis mutation accumulation experiment conducted to date, we demonstrate that epigenomic and physical features explain over 90% of variance in the genome-wide pattern of mutation bias surrounding genes. Observed mutation frequencies around genes in turn accurately predict patterns of genetic polymorphisms in natural Arabidopsis accessions (r = 0.96). That mutation bias is the primary force behind patterns of sequence evolution around genes in natural accessions is supported by analyses of allele frequencies. Finally, we find that genes subject to stronger purifying selection have a lower mutation rate. We conclude that epigenome-associated mutation bias2 reduces the occurrence of deleterious mutations in Arabidopsis, challenging the prevailing paradigm that mutation is a directionless force in evolution.	[Monroe, J. Grey; Srikant, Thanvi; Carbonell-Bejerano, Pablo; Becker, Claude; Klein, Marie; Hildebrandt, Julia; Neumann, Manuela; Weigel, Detlef] Max Planck Inst Biol Tubingen, Dept Mol Biol, Tubingen, Germany; [Monroe, J. Grey; Lensink, Mariele; Klein, Marie; Kliebenstein, Daniel] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Exposito-Alonso, Moises] Carnegie Inst Sci, Dept Plant Biol, 290 Panama St, Stanford, CA 94305 USA; [Exposito-Alonso, Moises] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Weng, Mao-Lun] Westfield State Univ, Dept Biol, Westfield, MA USA; [Imbert, Eric] Univ Montpellier, ISEM, Montpellier, France; [Agren, Jon] Uppsala Univ, Dept Ecol & Genet, EBC, Uppsala, Sweden; [Rutter, Matthew T.] Coll Charleston, Dept Biol, Charleston, SC 29401 USA; [Fenster, Charles B.] South Dakota State Univ, Oak Lake Field Stn, Brookings, SD 57007 USA; [Becker, Claude] Ludwig Maximilians Univ Munchen, Fac Biol, Martinsried, Germany	University of California System; University of California Davis; Carnegie Institution for Science; Stanford University; Massachusetts System of Public Higher Education; Westfield State University; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Uppsala University; College of Charleston; South Dakota State University; University of Munich	Monroe, JG; Weigel, D (corresponding author), Max Planck Inst Biol Tubingen, Dept Mol Biol, Tubingen, Germany.; Monroe, JG (corresponding author), Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA.	gmonroe@ucdavis.edu; weigel@weigelworld.org	Weigel, Detlef/C-1418-2008; Becker, Claude/H-9011-2019; Weigel, Detlef/AAR-3312-2021; Weigel, Detlef/GSJ-0799-2022; Carbonell-Bejerano, Pablo/L-6699-2017	Weigel, Detlef/0000-0002-2114-7963; Becker, Claude/0000-0003-3406-4670; Weigel, Detlef/0000-0002-2114-7963; Agren, Jon/0000-0001-9573-2463; Kliebenstein, Daniel/0000-0001-5759-3175; Neumann, Manuela/0000-0003-2778-3028; Srikant, Thanvi/0000-0003-1390-3236; Exposito-Alonso, Moises/0000-0001-5711-0700; Carbonell-Bejerano, Pablo/0000-0002-7266-9665	Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	Open access funding provided by Max Planck Society.	Alonso-Blanco C, 2016, CELL, V166, P481, DOI 10.1016/j.cell.2016.05.063; Arndt PF, 2005, J MOL EVOL, V60, P748, DOI 10.1007/s00239-004-0222-5; Baggs EL, 2020, PLANT CELL, V32, P2158, DOI 10.1105/tpc.19.00903; Belfield EJ, 2021, GENOME RES, V31, P40, DOI [10.1101/gr.259853.119, 10.1101/gr.259853.119.]; Belfield EJ, 2018, GENOME RES, V28, P66, DOI 10.1101/gr.219303.116; Bobiwash K, 2013, HEREDITY, V111, P338, DOI 10.1038/hdy.2013.57; Bomblies K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000890; Cao J, 2011, NAT GENET, V43, P956, DOI 10.1038/ng.911; Chen XZ, 2013, MOL BIOL EVOL, V30, P1559, DOI 10.1093/molbev/mst060; Chen XS, 2012, SCIENCE, V335, P1235, DOI 10.1126/science.1217580; Choi J, 2020, MOL CELL, V77, P310, DOI 10.1016/j.molcel.2019.10.011; Chong SY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14595-4; Elango N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000015; Evans LM, 2014, NAT GENET, V46, P1089, DOI 10.1038/ng.3075; Exposito-Alonso M, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007155; Eyre-Walker A, 2007, NAT REV GENET, V8, P610, DOI 10.1038/nrg2146; Fang J, 2018, P NATL ACAD SCI USA, V115, P9598, DOI 10.1073/pnas.1806355115; Frigola J, 2017, NAT GENET, V49, P1684, DOI 10.1038/ng.3991; Fryxell KJ, 2005, MOL BIOL EVOL, V22, P650, DOI 10.1093/molbev/msi043; Fryxell KJ, 2000, MOL BIOL EVOL, V17, P1371, DOI 10.1093/oxfordjournals.molbev.a026420; Futuyma D.J., 1986, EVOL BIOL, V2nd ed.; Gossmann TI, 2010, MOL BIOL EVOL, V27, P1822, DOI 10.1093/molbev/msq079; Ha K, 2017, NPJ GENOM MED, V2, DOI 10.1038/s41525-017-0010-y; Halldorsson BV, 2019, SCIENCE, V363, P364, DOI 10.1126/science.aau1043; Haller BC, 2019, MOL BIOL EVOL, V36, P632, DOI 10.1093/molbev/msy228; Haudry A, 2013, NAT GENET, V45, P891, DOI 10.1038/ng.2684; Henderson IR, 2005, DEVELOPMENT, V132, P3597, DOI 10.1242/dev.01924; Herbette M, 2017, DNA REPAIR, V57, P139, DOI 10.1016/j.dnarep.2017.07.007; Hodgkinson A, 2011, NAT REV GENET, V12, P756, DOI 10.1038/nrg3098; Hodgkinson A, 2010, GENOME BIOL EVOL, V2, P547, DOI 10.1093/gbe/evq039; Huang WC, 2012, BIOINFORMATICS, V28, P593, DOI 10.1093/bioinformatics/btr708; Huang YP, 2018, DNA REPAIR, V71, P82, DOI 10.1016/j.dnarep.2018.08.010; Huang YP, 2018, J BIOL CHEM, V293, P7811, DOI 10.1074/jbc.RA118.002839; Hung S, 2019, ELIFE, V8, DOI 10.7554/eLife.40760; Johri P, 2020, GENETICS, V215, P173, DOI 10.1534/genetics.119.303002; Kawakatsu T, 2016, CELL, V166, P492, DOI 10.1016/j.cell.2016.06.044; Keightley PD, 2003, EVOLUTION, V57, P683, DOI 10.1111/j.0014-3820.2003.tb01561.x; Knief U., 2021, BEHAV RES METHODS, V53, P2576, DOI [10.3758/s13428-021-01587-5, DOI 10.3758/s13428-021-01587-5]; Lee H, 2012, P NATL ACAD SCI USA, V109, pE2774, DOI 10.1073/pnas.1210309109; Li C, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15185-0; Li F, 2013, CELL, V153, P590, DOI 10.1016/j.cell.2013.03.025; Lim B, 2017, CANCER RES, V77, P2822, DOI 10.1158/0008-5472.CAN-16-3033; Liu Y, 2018, NUCLEIC ACIDS RES, V46, pD1157, DOI 10.1093/nar/gkx919; Lloyd JP, 2015, PLANT CELL, V27, P2133, DOI 10.1105/tpc.15.00051; Lloyd J, 2012, PLANT PHYSIOL, V158, P1115, DOI 10.1104/pp.111.192393; Long HA, 2018, NAT ECOL EVOL, V2, P237, DOI 10.1038/s41559-017-0425-y; Lynch M, 2016, NAT REV GENET, V17, P704, DOI 10.1038/nrg.2016.104; Lynch M, 2010, TRENDS GENET, V26, P345, DOI 10.1016/j.tig.2010.05.003; Heredia-Genestar JM, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16296-4; Martincorena I, 2013, BIOESSAYS, V35, P123, DOI 10.1002/bies.201200150; Martincorena I, 2012, NATURE, V485, P95, DOI 10.1038/nature10995; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Mergner J, 2020, NATURE, V579, P409, DOI 10.1038/s41586-020-2094-2; Mi HY, 2019, NUCLEIC ACIDS RES, V47, pD419, DOI 10.1093/nar/gky1038; Monroe JG, 2018, ELIFE, V7, DOI 10.7554/eLife.41038; Moore L, 2021, NATURE, V597, P381, DOI 10.1038/s41586-021-03822-7; Moore RC, 2003, P NATL ACAD SCI USA, V100, P15682, DOI 10.1073/pnas.2535513100; Mugal CF, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r58; O'Hara RB, 2010, METHODS ECOL EVOL, V1, P118, DOI 10.1111/j.2041-210X.2010.00021.x; Ossowski S, 2010, SCIENCE, V327, P92, DOI 10.1126/science.1180677; Platt A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000843; Pockrandt C, 2020, BIOINFORMATICS, V36, P3687, DOI 10.1093/bioinformatics/btaa222; Polak P, 2015, NATURE, V518, P360, DOI 10.1038/nature14221; Quadrana L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11385-5; Rand DM, 1996, MOL BIOL EVOL, V13, P735, DOI 10.1093/oxfordjournals.molbev.a025634; Sabarinathan R, 2016, NATURE, V532, P264, DOI 10.1038/nature17661; Salzberg AC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173723; Schuster-Bockler B, 2012, NATURE, V488, P504, DOI 10.1038/nature11273; Sedlazeck FJ, 2013, BIOINFORMATICS, V29, P2790, DOI 10.1093/bioinformatics/btt468; Shaw FH, 2002, EVOLUTION, V56, P453, DOI 10.1111/j.0014-3820.2002.tb01358.x; Shilatifard A, 2012, ANNU REV BIOCHEM, V81, P65, DOI 10.1146/annurev-biochem-051710-134100; Stoletzki N, 2011, MOL BIOL EVOL, V28, P1371, DOI 10.1093/molbev/msq320; Supek F, 2019, DNA REPAIR, V81, DOI 10.1016/j.dnarep.2019.102647; Supek F, 2017, CELL, V170, P534, DOI 10.1016/j.cell.2017.07.003; Supek F, 2015, NATURE, V521, P81, DOI 10.1038/nature14173; TAJIMA F, 1989, GENETICS, V123, P585; Wang L, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000191; Wang Y, 2012, J BIOL CHEM, V287, P4386, DOI 10.1074/jbc.M111.329417; Watson JM, 2016, P NATL ACAD SCI USA, V113, P12226, DOI 10.1073/pnas.1609686113; Weng ML, 2021, EVOLUTION, V75, P330, DOI 10.1111/evo.14152; Weng ML, 2019, GENETICS, V211, P703, DOI 10.1534/genetics.118.301721; WOLFE KH, 1989, NATURE, V337, P283, DOI 10.1038/337283a0; Xia B, 2020, CELL, V180, P248, DOI 10.1016/j.cell.2019.12.015; Yazdi PG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136574; Youk J, 2020, BMC GENOMICS, V21, DOI 10.1186/s12864-020-6674-1; Zheng CL, 2014, CELL REP, V9, P1228, DOI 10.1016/j.celrep.2014.10.031	88	48	47	42	125	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 3	2022	602	7895					101	+		10.1038/s41586-021-04269-6	http://dx.doi.org/10.1038/s41586-021-04269-6		JAN 2022	25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YS1FH	35022609	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000741978700002
J	Wang, ZQ; Koirala, B; Hernandez, Y; Zimmerman, M; Park, S; Perlin, DS; Brady, SF				Wang, Zongqiang; Koirala, Bimal; Hernandez, Yozen; Zimmerman, Matthew; Park, Steven; Perlin, David S.; Brady, Sean F.			A naturally inspired antibiotic to target multidrug-resistant pathogens	NATURE			English	Article							ACINETOBACTER-BAUMANNII; LIPOCALIN NGAL; LIPOPOLYSACCHARIDE; DISCOVERY; COLISTIN; MARKER	Gram-negative bacteria are responsible for an increasing number of deaths caused by antibiotic-resistant infections(1,2). The bacterial natural product colistin is considered the last line of defence against a number of Gram-negative pathogens. The recent global spread of the plasmid-borne mobilized colistin-resistance gene mcr-1 (phosphoethanolamine transferase) threatens the usefulness of colistin(3). Bacteria-derived antibiotics often appear in nature as collections of similar structures that are encoded by evolutionarily related biosynthetic gene clusters. This structural diversity is, at least in part, expected to be a response to the development of natural resistance, which often mechanistically mimics clinical resistance. Here we propose that a solution to mcr-1-mediated resistance might have evolved among naturally occurring colistin congeners. Bioinformatic analysis of sequenced bacterial genomes identified a biosynthetic gene cluster that was predicted to encode a structurally divergent colistin congener. Chemical synthesis of this structure produced macolacin, which is active against Gram-negative pathogens expressing mcr-1 and intrinsically resistant pathogens with chromosomally encoded phosphoethanolamine transferase genes. These Gram-negative bacteria include extensively drug-resistant Acinetobacter baumannii and intrinsically colistin-resistant Neisseria gonorrhoeae, which, owing to a lack of effective treatment options, are considered among the highest level threat pathogens(4). In a mouse neutropenic infection model, a biphenyl analogue of macolacin proved to be effective against extensively drug-resistant A. baumannii with colistin-resistance, thus providing a naturally inspired and easily produced therapeutic lead for overcoming colistin-resistant pathogens.	[Wang, Zongqiang; Koirala, Bimal; Hernandez, Yozen; Brady, Sean F.] Rockefeller Univ, Lab Genetically Encoded Small Mol, 1230 York Ave, New York, NY 10021 USA; [Zimmerman, Matthew; Park, Steven; Perlin, David S.] Hackensack Meridian Hlth, Ctr Discovery & Innovat, Nutley, NJ USA	Rockefeller University	Brady, SF (corresponding author), Rockefeller Univ, Lab Genetically Encoded Small Mol, 1230 York Ave, New York, NY 10021 USA.	sbrady@rockefeller.edu	Koirala, Bimal/J-3161-2018	Koirala, Bimal/0000-0003-1806-7935; Hernandez, Yozen/0000-0003-3349-8856; wang, zongqiang/0000-0001-7121-0396	National Institutes of Health [1U19AI142731, 5R35GM122559]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the Y. Doi (pMQ124-mcr-1 and pMQ124xlab-mcr-1) and J. M. Boll (E. cloacae 13047-ophoP/Q and E. cloacae13047-ophoP/Q+phoP/Q) laboratories for providing strains and plasmids. We thank the CDC and FDA Antibiotic Resistance (AR) Isolate Bank for providing A. baumannii resistant strains (0282, 0286, 0287, 0295, 0296 and 0301). We thank the Comparative Bioscience Center at the Rockefeller University for their help with the animal studies. This work was supported by the National Institutes of Health (1U19AI142731 and 5R35GM122559).	Aitolo GL, 2021, CURR MICROBIOL, V78, P867, DOI 10.1007/s00284-021-02353-8; Biswas S, 2012, EXPERT REV ANTI-INFE, V10, P917, DOI [10.1586/eri.12.78, 10.1586/ERI.12.78]; Blin K, 2019, NUCLEIC ACIDS RES, V47, pW81, DOI 10.1093/nar/gkz310; Blin K, 2019, NUCLEIC ACIDS RES, V47, pD625, DOI 10.1093/nar/gky1060; Bojkovic J, 2016, J BACTERIOL, V198, P731, DOI 10.1128/JB.00639-15; Bolignano D, 2008, AM J KIDNEY DIS, V52, P595, DOI 10.1053/j.ajkd.2008.01.020; CARMICHAEL J, 1987, CANCER RES, V47, P936; Chu J, 2020, J AM CHEM SOC, V142, P14158, DOI 10.1021/jacs.0c04376; Chu J, 2019, J AM CHEM SOC, V141, P15737, DOI 10.1021/jacs.9b07317; Chu J, 2016, NAT CHEM BIOL, V12, P1004, DOI 10.1038/nchembio.2207; Devarajan P, 2008, SCAND J CLIN LAB INV, V68, P89, DOI 10.1080/00365510802150158; Guidance regarding agency interpretation of, 2019, FED REGISTER, V84, P724, DOI DOI 10.15620/CDC:82532; Hameed F, 2019, REV SOC BRAS MED TRO, V52, DOI 10.1590/0037-8682-0237-2019; Imai Y, 2019, NATURE, V576, P459, DOI 10.1038/s41586-019-1791-1; Jeannot K, 2017, INT J ANTIMICROB AG, V49, P526, DOI 10.1016/j.ijantimicag.2016.11.029; Kang KN, 2019, MOL MICROBIOL, V111, P1604, DOI 10.1111/mmi.14240; Li J, 2019, ADV EXP MED BIOL, V1145, pV; Ling ZR, 2020, J ANTIMICROB CHEMOTH, V75, P3087, DOI 10.1093/jac/dkaa205; Liu YY, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.00580-17; Liu YY, 2016, LANCET INFECT DIS, V16, P161, DOI 10.1016/S1473-3099(15)00424-7; Lucas DD, 2018, ANTIMICROB AGENTS CH, V62, DOI [10.1128/AAC.02442-17, 10.1128/aac.02442-17]; Lutgring JD, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01415-17; McClerren AL, 2005, BIOCHEMISTRY-US, V44, P16574, DOI 10.1021/bi0518186; Moffatt JH, 2010, ANTIMICROB AGENTS CH, V54, P4971, DOI 10.1128/AAC.00834-10; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Rabanal F, 2017, NAT PROD REP, V34, P886, DOI 10.1039/c7np00023e; Richie DL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160918; Rutledge PJ, 2015, NAT REV MICROBIOL, V13, P509, DOI 10.1038/nrmicro3496; Sakura N, 2004, B CHEM SOC JPN, V77, P1915, DOI 10.1246/bcsj.77.1915; Schwarz S, 2016, J ANTIMICROB CHEMOTH, V71, P2066, DOI 10.1093/jac/dkw274; Stachelhaus T, 1999, CHEM BIOL, V6, P493, DOI 10.1016/S1074-5521(99)80082-9; Sussmuth RD, 2017, ANGEW CHEM INT EDIT, V56, P3770, DOI 10.1002/anie.201609079; Tacconelli E, 2018, LANCET INFECT DIS, V18, P318, DOI [10.1016/S1473-3099(17)30753-3, 10.1016/s1473-3099(17)30753-3]; Testing E. C. O. A. S, 2016, REC MIC DET COL POL; Tian GB, 2017, LANCET INFECT DIS, V17, P577, DOI 10.1016/S1473-3099(17)30266-9; Tomm HA, 2019, J IND MICROBIOL BIOT, V46, P1381, DOI 10.1007/s10295-019-02198-y; Tsubery H, 2001, PEPTIDES, V22, P1675, DOI 10.1016/S0196-9781(01)00503-4; Ventola C Lee, 2015, P T, V40, P277; Wang J, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.01146; Wei JR, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00199-17; Wikler M. A., 2006, CLSI NCCLS, V26, pM7	41	18	18	91	181	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 27	2022	601	7894					606	+		10.1038/s41586-021-04264-x	http://dx.doi.org/10.1038/s41586-021-04264-x		JAN 2022	21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YQ8HX	34987225				2022-12-28	WOS:000739283800003
J	McGrew, S; Taylor, HA				McGrew, Susanna; Taylor, Holly A.			Adolescents, Parents, and Covid-19 Vaccination - Who Should Decide?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[McGrew, Susanna; Taylor, Holly A.] NIH, Dept Bioeth, Clin Ctr, Bldg 10, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	McGrew, S (corresponding author), NIH, Dept Bioeth, Clin Ctr, Bldg 10, Bethesda, MD 20892 USA.			McGrew, Susanna/0000-0002-8086-3417; Taylor, Holly/0000-0001-6811-9356				Coleman DL, 2013, PEDIATRICS, V131, P786, DOI 10.1542/peds.2012-2470; Hamel L., 2021, KFF COVID 19 VACCINE; McDermott, 2021, LOOK PARENTAL CONSEN; Olick RS, 2021, PUBLIC HEALTH REP, DOI 10.1177/00333549211048784; Steinberg L, 2013, J MED PHILOS, V38, P256, DOI 10.1093/jmp/jht017	5	3	3	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 13	2022	386	2								10.1056/NEJMp2116771	http://dx.doi.org/10.1056/NEJMp2116771		DEC 2021	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YF2NZ	34965336	Bronze			2022-12-28	WOS:000735531800001
J	Middleton, J; Lopes, H				Middleton, John; Lopes, Henrique			With covid-19, single measures aren't enough Single magic bullets for covid-19 do not exist, say John Middleton and Henrique Lopes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Middleton, John] Assoc Sch Publ Hlth European Reg, Brussels, Belgium; [Lopes, Henrique] Catholic Univ Portugal, Hlth Sci Inst, Publ Hlth Unit, Lisbon, Portugal	Universidade Catolica Portuguesa	Middleton, J (corresponding author), Assoc Sch Publ Hlth European Reg, Brussels, Belgium.			Lopes, Henrique/0000-0002-7586-401X				BBC, 2021, BBC; Christie B, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n3144; Hassan F, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n3074; Johns Hopkins University, COVID19 DATA EXPLORE; Rae M, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n3095; Reicher S, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n3150	6	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 29	2021	375								n3157	10.1136/bmj.n3157	http://dx.doi.org/10.1136/bmj.n3157			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YH4NO	34965930	Bronze			2022-12-28	WOS:000743145900004
J	Stein, KC; Morales-Polanco, F; van der Lienden, J; Rainbolt, TK; Frydman, J				Stein, Kevin C.; Morales-Polanco, Fabian; van der Lienden, Joris; Rainbolt, T. Kelly; Frydman, Judith			Ageing exacerbates ribosome pausing to disrupt cotranslational proteostasis	NATURE			English	Article							QUALITY-CONTROL; LIFE-SPAN; MESSENGER-RNA; TRANSLATION ELONGATION; PROTEIN; AGGREGATION; UBIQUITINATION; DEGRADATION; PATHWAY; COMPLEX	Ageing is accompanied by a decline in cellular proteostasis, which underlies many age-related protein misfolding diseases(1,2). Yet, how ageing impairs proteostasis remains unclear. As nascent polypeptides represent a substantial burden on the proteostasis network(3), we hypothesized that altered translational efficiency during ageing could help to drive the collapse of proteostasis. Here we show that ageing alters the kinetics of translation elongation in both Caenorhabditis elegans and Saccharomyces cerevisiae. Ribosome pausing was exacerbated at specific positions in aged yeast and worms, including polybasic stretches, leading to increased ribosome collisions known to trigger ribosome-associated quality control (RQC)(4-6). Notably, aged yeast cells exhibited impaired clearance and increased aggregation of RQC substrates, indicating that ageing overwhelms this pathway. Indeed, long-lived yeast mutants reduced age-dependent ribosome pausing, and extended lifespan correlated with greater flux through the RQC pathway. Further linking altered translation to proteostasis collapse, we found that nascent polypeptides exhibiting age-dependent ribosome pausing in C. elegans were strongly enriched among age-dependent protein aggregates. Notably, ageing increased the pausing and aggregation of many components of proteostasis, which could initiate a cycle of proteostasis collapse. We propose that increased ribosome pausing, leading to RQC overload and nascent polypeptide aggregation, critically contributes to proteostasis impairment and systemic decline during ageing.	[Stein, Kevin C.; Morales-Polanco, Fabian; van der Lienden, Joris; Rainbolt, T. Kelly; Frydman, Judith] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Frydman, Judith] Stanford Univ, Dept Genet, Stanford, CA 94305 USA	Stanford University; Stanford University	Frydman, J (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.; Frydman, J (corresponding author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.	jfrydman@stanford.edu		van der Lienden, Joris C.J./0000-0002-7012-2471; , judith/0000-0003-2302-6943	NIH/NIA [T32AG047126]; Pew Trusts in the Biomedical Sciences postdoctoral Award [00034104]; NIH/NIGMS National Research Service Award [F32GM120947]; NIH [GM056433, AG054407]	NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Pew Trusts in the Biomedical Sciences postdoctoral Award; NIH/NIGMS National Research Service Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank R. Aviner and M. Aguilar-Rangel for comments on the manuscript; members of the Frydman Laboratory for discussions and advice; J. Chartron, P. Dolan and K. Dalton for technical input; and J. Lim and J. Arribere for C. elegans expertise. YTM1 and HAT2performed at the UCSF Center for Advanced Technology. K.C.S. was supported as a Glenn Foundation for Medical Research Postdoctoral Fellow and by NIH/NIA grant (T32AG047126). F.M.-P. was supported by The Pew Trusts in the Biomedical Sciences postdoctoral Award (00034104), and T.K.R was supported by the NIH/NIGMS National Research Service Award (F32GM120947). This work was supported by NIH grants GM056433 and AG054407 (to J.F.). J.F. is a CZ Biohub Investigator.	Anisimova AS, 2020, P NATL ACAD SCI USA, V117, P15581, DOI 10.1073/pnas.2001788117; Balchin D, 2016, SCIENCE, V353, DOI 10.1126/science.aac4354; Barros GC, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100586; Ben-Zvi A, 2009, P NATL ACAD SCI USA, V106, P14914, DOI 10.1073/pnas.0902882106; Bengtson MH, 2010, NATURE, V467, P470, DOI 10.1038/nature09371; Brandman O, 2016, NAT STRUCT MOL BIOL, V23, P7, DOI 10.1038/nsmb.3147; Brandman O, 2012, CELL, V151, P1042, DOI 10.1016/j.cell.2012.10.044; BRENNER S, 1974, GENETICS, V77, P71; Buhr F, 2016, MOL CELL, V61, P341, DOI 10.1016/j.molcel.2016.01.008; Burtner CR, 2009, CELL CYCLE, V8, P1256, DOI 10.4161/cc.8.8.8287; Chartron JW, 2016, NATURE, V536, P224, DOI 10.1038/nature19309; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Choe YJ, 2016, NATURE, V531, P191, DOI 10.1038/nature16973; Choi J, 2018, ANNU REV BIOCHEM, V87, P421, DOI 10.1146/annurev-biochem-060815-014818; Ciryam P, 2013, CELL REP, V5, P781, DOI 10.1016/j.celrep.2013.09.043; Collart MA, 2020, NUCLEIC ACIDS RES, V48, P1043, DOI 10.1093/nar/gkz763; David DC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000450; Dey KK, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2489-3; Dimitrova LN, 2009, J BIOL CHEM, V284, P10343, DOI 10.1074/jbc.M808840200; Duttler S, 2013, MOL CELL, V50, P379, DOI 10.1016/j.molcel.2013.03.010; Fabrizio P, 2001, SCIENCE, V292, P288, DOI 10.1126/science.1059497; Gamble CE, 2016, CELL, V166, P679, DOI 10.1016/j.cell.2016.05.070; Gingold H, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.14; Guydosh NR, 2014, CELL, V156, P950, DOI 10.1016/j.cell.2014.02.006; Han Px, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107610; Hansen M, 2007, AGING CELL, V6, P95, DOI 10.1111/j.1474-9726.2006.00267.x; Hu Z, 2018, ELIFE, V7, DOI 10.7554/eLife.35551; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hughes AL, 2012, NATURE, V492, P261, DOI 10.1038/nature11654; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Ikeuchi K, 2019, EMBO J, V38, DOI 10.15252/embj.2018100276; Ingolia NT, 2012, NAT PROTOC, V7, P1534, DOI 10.1038/nprot.2012.086; Ishimura R, 2014, SCIENCE, V345, P455, DOI 10.1126/science.1249749; Jahn TR, 2008, ARCH BIOCHEM BIOPHYS, V469, P100, DOI 10.1016/j.abb.2007.05.015; Juszkiewicz S, 2020, MOL CELL, V79, P603, DOI 10.1016/j.molcel.2020.06.006; Juszkiewicz S, 2018, MOL CELL, V72, P469, DOI 10.1016/j.molcel.2018.08.037; Juszkiewicz S, 2017, MOL CELL, V65, P743, DOI 10.1016/j.molcel.2016.11.039; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kim SJ, 2015, SCIENCE, V348, P444, DOI 10.1126/science.aaa3974; Koplin A, 2010, J CELL BIOL, V189, P57, DOI 10.1083/jcb.200910074; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Matsuo Y, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00188-1; McCormick MA, 2015, CELL METAB, V22, P895, DOI 10.1016/j.cmet.2015.09.008; Meydan S, 2020, MOL CELL, V79, P588, DOI 10.1016/j.molcel.2020.06.010; Narayan V, 2016, CELL SYST, V3, P144, DOI 10.1016/j.cels.2016.06.011; Nedialkova DD, 2015, CELL, V161, P1606, DOI 10.1016/j.cell.2015.05.022; Pan KZ, 2007, AGING CELL, V6, P111, DOI 10.1111/j.1474-9726.2006.00266.x; Pechmann S, 2014, NAT STRUCT MOL BIOL, V21, P1100, DOI 10.1038/nsmb.2919; Pechmann S, 2013, MOL CELL, V49, P411, DOI 10.1016/j.molcel.2013.01.020; Pechmann S, 2013, NAT STRUCT MOL BIOL, V20, P237, DOI 10.1038/nsmb.2466; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Reis-Rodrigues P, 2012, AGING CELL, V11, P120, DOI 10.1111/j.1474-9726.2011.00765.x; Schuller AP, 2017, MOL CELL, V66, P194, DOI 10.1016/j.molcel.2017.03.003; Shao SC, 2015, MOL CELL, V57, P433, DOI 10.1016/j.molcel.2014.12.015; Shao SC, 2014, MOL CELL, V55, P880, DOI 10.1016/j.molcel.2014.07.006; Shao S, 2013, MOL CELL, V50, P637, DOI 10.1016/j.molcel.2013.04.015; Shen PS, 2015, SCIENCE, V347, P75, DOI 10.1126/science.1259724; Simms CL, 2017, MOL CELL, V68, P361, DOI 10.1016/j.molcel.2017.08.019; Sitron CS, 2020, ANNU REV BIOCHEM, V89, P417, DOI 10.1146/annurev-biochem-013118-110729; Sitron CS, 2019, NAT STRUCT MOL BIOL, V26, P450, DOI 10.1038/s41594-019-0230-1; Steffen KK, 2016, CELL METAB, V23, P1004, DOI 10.1016/j.cmet.2016.05.013; Stein KC, 2019, MOL CELL, V75, P1117, DOI 10.1016/j.molcel.2019.06.036; Stein KC, 2019, J BIOL CHEM, V294, P2076, DOI 10.1074/jbc.REV118.002814; Sundaramoorthy E, 2017, MOL CELL, V65, P751, DOI 10.1016/j.molcel.2016.12.026; Taylor RC, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004440; Tsuboi T, 2012, MOL CELL, V46, P518, DOI 10.1016/j.molcel.2012.03.013; Walther DM, 2015, CELL, V161, P919, DOI 10.1016/j.cell.2015.03.032; Willmund F, 2013, CELL, V152, P196, DOI 10.1016/j.cell.2012.12.001; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wu CCC, 2020, CELL, V182, P404, DOI 10.1016/j.cell.2020.06.006; Yofe I, 2016, NAT METHODS, V13, P371, DOI [10.1038/NMETH.3795, 10.1038/nmeth.3795]; Yonashiro R, 2016, ELIFE, V5, DOI 10.7554/eLife.11794; Young DJ, 2015, CELL, V162, P872, DOI 10.1016/j.cell.2015.07.041; Yu CH, 2015, MOL CELL, V59, P744, DOI 10.1016/j.molcel.2015.07.018; Zhang G, 2009, NAT STRUCT MOL BIOL, V16, P274, DOI 10.1038/nsmb.1554	78	11	12	9	46	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 27	2022	601	7894					637	+		10.1038/s41586-021-04295-4	http://dx.doi.org/10.1038/s41586-021-04295-4		JAN 2022	25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YQ8HX	35046576	Green Accepted			2022-12-28	WOS:000744417900003
J	Qaseem, A; Etxeandia-Ikobaltzeta, I; Lin, JS; Fitterman, N; Shamliyan, T; Wilt, TJ				Qaseem, Amir; Etxeandia-Ikobaltzeta, Itziar; Lin, Jennifer S.; Fitterman, Nick; Shamliyan, Tatyana; Wilt, Timothy J.		Amer Coll Phys	Colonoscopy for Diagnostic Evaluation and Interventions to Prevent Recurrence After Acute Left-Sided Colonic Diverticulitis: A Clinical Guideline From the American College of Physicians	ANNALS OF INTERNAL MEDICINE			English	Article							UNCOMPLICATED DIVERTICULITIS; COLORECTAL-CANCER; CT DIAGNOSIS; ROUTINE COLONOSCOPY; SURGERY; RISK; MULTICENTER; MESALAZINE; MANAGEMENT; DISEASE	Description: The American College of Physicians (ACP) developed this guideline to provide clinical recommendations on the role of colonoscopy for diagnostic evaluation of colorectal cancer (CRC) after a presumed diagnosis of acute left-sided colonic diverticulitis and on the role of pharmacologic, nonpharmacologic, and elective surgical interventions to prevent recurrence after initial treatment of acute complicated and uncomplicated left-sided colonic diverticulitis. This guideline is based on the current best available evidence about benefits and harms, taken in the context of costs and patient values and preferences. Methods: The ACP Clinical Guidelines Committee (CGC) based these recommendations on a systematic review on the role of colonoscopy after acute left-sided colonic diverticulitis and pharmacologic, nonpharmacologic, and elective surgical interventions after initial treatment. The systematic review evaluated outcomes rated by the CGC as critical or important. This guideline was developed using the GRADE (Grading of Recommendations Assessment, Development and Evaluation) method. Target Audience and Patient Population: The target audience is all clinicians, and the target patient population is adults with recent episodes of acute left-sided colonic diverticulitis. Recommendation 1: ACP suggests that clinicians refer patients for a colonoscopy after an initial episode of complicated left-sided colonic diverticulitis in patients who have not had recent colonoscopy (conditional recommendation; low-certainty evidence). Recommendation 2: ACP recommends against clinicians using mesalamine to prevent recurrent diverticulitis (strong recommendation; high-certainty evidence). Recommendation 3: ACP suggests that clinicians discuss elective surgery to prevent recurrent diverticulitis after initial treatment in patients who have either uncomplicated diverticulitis that is persistent or recurs frequently or complicated diverticulitis (conditional recommendation; low-certainty evidence). The informed decision whether or not to undergo surgery should be personalized based on a discussion of potential benefits, harms, costs, and patient's preferences.	[Qaseem, Amir; Etxeandia-Ikobaltzeta, Itziar; Shamliyan, Tatyana] Amer Coll Physicians, 190 N Independence Mall West, Philadelphia, PA 19106 USA; [Lin, Jennifer S.] Kaiser Permanente Northwest, Portland, OR USA; [Fitterman, Nick] Northwell Hlth, Huntington, NY USA; [Wilt, Timothy J.] Minneapolis VA Ctr Care Delivery & Outcomes Res, Minneapolis, MN USA	American College of Physicians; Kaiser Permanente; Northwell Health	Qaseem, A (corresponding author), Amer Coll Physicians, 190 N Independence Mall West, Philadelphia, PA 19106 USA.	aqaseem@acponline.org	ETXEANDIA-IKOBALTZETA, ITZIAR/AAG-3519-2022; ETXEANDIA-IKOBALTZETA, ITZIAR/AFK-4845-2022	ETXEANDIA-IKOBALTZETA, ITZIAR/0000-0001-6606-649X; ETXEANDIA-IKOBALTZETA, ITZIAR/0000-0001-6606-649X; Qaseem, Amir/0000-0001-6866-7985	ACP operating budget	ACP operating budget	Financial support for the development of this guideline comes exclusively from the ACP operating budget.	Abdulazeez Z, 2020, ANN ROY COLL SURG, V102, P744, DOI 10.1308/rcsann.2020.0181; Alcantar DC, 2019, CUREUS, V11, DOI 10.7759/cureus.5666; Anderson JC, 2015, CLIN TRANSL GASTROEN, V6, DOI 10.1038/ctg.2015.5; Andrade P, 2017, DIGEST SURG, V34, P197, DOI 10.1159/000449259; Aquina CT, 2019, BRIT J SURG, V106, P467, DOI 10.1002/bjs.10982; Arnold MH, 2020, MED J AUSTRALIA, V212, P434, DOI 10.5694/mja2.50526; Balk EM, 2022, ANN INTERN MED, V175, P388, DOI 10.7326/M21-1646; BALTHAZAR EJ, 1990, AM J ROENTGENOL, V154, P281, DOI 10.2214/ajr.154.2.2105015; Bhakta A, 2016, SURG ENDOSC, V30, P1629, DOI 10.1007/s00464-015-4393-5; Bharucha AE, 2015, AM J GASTROENTEROL, V110, P1588, DOI 10.1038/ajg.2015.302; Bolkenstein HE, 2019, BRIT J SURG, V106, P448, DOI 10.1002/bjs.11024; Bolkenstein HE, 2019, ANN SURG, V269, P612, DOI 10.1097/SLA.0000000000003033; Bordeianou L, 2019, ANN SURG, V270, P1124, DOI 10.1097/SLA.0000000000002859; Brar MS, 2013, DIS COLON RECTUM, V56, P1259, DOI 10.1097/DCR.0b013e3182a26bfd; Cohan JN, 2021, J SURG RES, V261, P159, DOI 10.1016/j.jss.2020.12.019; Daniels L, 2015, SURG ENDOSC, V29, P2605, DOI 10.1007/s00464-014-3977-9; Drummond M, 2005, INT J TECHNOL ASSESS, V21, P165, DOI 10.1017/S0266462305050221; Elmi A, 2013, AM J ROENTGENOL, V200, P1269, DOI 10.2214/AJR.12.9539; Feingold D, 2014, DIS COLON RECTUM, V57, P284, DOI 10.1097/DCR.0000000000000075; Festa V, 2017, EUR REV MED PHARMACO, V21, P1397; Franco Diana L, 2017, Gastroenterol Hepatol (N Y), V13, P476; Garrison LP, 2018, VALUE HEALTH, V21, P161, DOI 10.1016/j.jval.2017.12.009; Hassab TH, 2021, SURGERY, V169, P1323, DOI 10.1016/j.surg.2020.12.024; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Horesh N, 2016, TECH COLOPROCTOL, V20, P383, DOI 10.1007/s10151-016-1478-7; Husereau D, 2013, INT J TECHNOL ASSESS, V29, P117, DOI 10.1017/S0266462313000160; Ilyas MIM, 2017, COLORECTAL DIS, V19, P260, DOI 10.1111/codi.13461; Imaeda Hiroyuki, 2018, Inflamm Intest Dis, V3, P61, DOI 10.1159/000492178; Khoury T, 2020, J GASTROINTEST CANC, V51, P48, DOI 10.1007/s12029-019-00202-3; Kohler L, 1999, SURG ENDOSC-ULTRAS, V13, P430, DOI 10.1007/s004649901007; Kruis W, 2017, ALIMENT PHARM THER, V46, P282, DOI 10.1111/apt.14152; Kvasnovsky CL, 2017, INFLAMMOPHARMACOLOGY, V25, P499, DOI 10.1007/s10787-017-0363-y; Lahat A, 2007, ENDOSCOPY, V39, P521, DOI 10.1055/s-2007-966399; Lanas A, 2013, DIGEST LIVER DIS, V45, P104, DOI 10.1016/j.dld.2012.09.006; Lau KC, 2011, DIS COLON RECTUM, V54, P1265, DOI 10.1097/DCR.0b013e31822899a2; Lecleire S, 2014, UNITED EUR GASTROENT, V2, P301, DOI 10.1177/2050640614541765; Lidor AO, 2010, J GASTROINTEST SURG, V14, P1867, DOI 10.1007/s11605-010-1344-2; Masoomi H, 2011, WORLD J SURG, V35, P2143, DOI 10.1007/s00268-011-1117-4; Meireles LC, 2015, EUR J GASTROEN HEPAT, V27, P1429, DOI 10.1097/MEG.0000000000000474; Mensch A, 2018, PHARMACOECONOMICS, V36, P987, DOI 10.1007/s40273-018-0651-4; Meyer J, 2018, WORLD J CLIN ONCOL, V9, P119, DOI 10.5306/wjco.v9.i6.119; Meyer J, 2019, CLIN GASTROENTEROL H, V17, P1448, DOI 10.1016/j.cgh.2018.07.031; Mizuki A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43236-0; Moghadamyeghaneh Z, 2015, AM J SURG, V210, P838, DOI 10.1016/j.amjsurg.2015.04.010; O'Donohoe N, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-56641-2; Papageorge CM, 2016, J GASTROINTEST SURG, V20, P1376, DOI 10.1007/s11605-016-3150-y; Parente F, 2013, INT J COLORECTAL DIS, V28, P1423, DOI 10.1007/s00384-013-1722-9; Parmelli E, 2017, INT J TECHNOL ASSESS, V33, P176, DOI 10.1017/S0266462317000447; Peery AF, 2021, GASTROENTEROLOGY, V160, P906, DOI 10.1053/j.gastro.2020.09.059; Perez NP, 2021, J GASTROINTEST SURG, V25, P1297, DOI 10.1007/s11605-020-04762-9; Pessaux P, 2004, WORLD J SURG, V28, P92, DOI 10.1007/s00268-003-7146-x; Qaseem A, 2019, ANN INTERN MED, V171, P643, DOI 10.7326/M19-0642; Qaseem A, 2019, ANN INTERN MED, V171, P354, DOI 10.7326/M18-3279; Qaseem A, 2019, ANN INTERN MED, V170, P863, DOI 10.7326/M18-3290; Ramphal W, 2018, DIGEST DIS, V36, P362, DOI 10.1159/000489926; Ramsey S, 2005, VALUE HEALTH, V8, P521, DOI 10.1111/j.1524-4733.2005.00045.x; Raskin JB, 2014, GASTROENTEROLOGY, V147, P793, DOI 10.1053/j.gastro.2014.07.004; Ressurreicao J, 2013, ACUTE DIVERTICULITIS; Richards RJ, 2002, DIGEST DIS SCI, V47, P1903, DOI 10.1023/A:1019624101225; Russ AJ, 2010, GASTROENTEROLOGY, V138, P2267, DOI 10.1053/j.gastro.2010.02.048; Sai VF, 2012, RADIOLOGY, V263, P383, DOI 10.1148/radiol.12111869; Sallinen V, 2014, SURG ENDOSC, V28, P961, DOI 10.1007/s00464-013-3257-0; Sanchez SDS, 2014, J GASTROEN HEPATOL, V29, P106; Sanders GD, 2016, JAMA-J AM MED ASSOC, V316, P1093, DOI 10.1001/jama.2016.12195; Santos A, 2021, JAMA SURG, V156, P129, DOI 10.1001/jamasurg.2020.5151; Schout PJC, 2012, DIGEST SURG, V29, P408, DOI 10.1159/000345332; Schunemann H, HDB GRADING QUALITY; Schunemann HJ, 2017, J CLIN EPIDEMIOL, V81, P101, DOI 10.1016/j.jclinepi.2016.09.009; Seoane-Urgorri A, 2018, REV ESP ENFERM DIG, V110, P571, DOI [10.17235/reed.2018.5524/2017, 10.17235/reed.2018.5524/2018]; Sheer AJ, 2011, DIS COLON RECTUM, V54, P1430, DOI 10.1097/DCR.0b013e31822c4e85; Silva-Velazco J, 2016, SURG ENDOSC, V30, P3541, DOI 10.1007/s00464-015-4651-6; Simianu VV, 2015, AM J SURG, V209, P913, DOI 10.1016/j.amjsurg.2014.12.027; Singh S, 2020, CUREUS, V12, DOI 10.7759/cureus.12027; Sterne JAC, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i4919; Stollman N, 2015, GASTROENTEROLOGY, V149, P1944, DOI 10.1053/j.gastro.2015.10.003; Stollman N, 2013, J CLIN GASTROENTEROL, V47, P621, DOI 10.1097/MCG.0b013e31828003f6; Studniarek A, 2019, AM SURGEON, V85, P1381; Suhardja TS, 2017, INT J COLORECTAL DIS, V32, P485, DOI 10.1007/s00384-016-2749-5; Takeda Pharmaceutical Company, PENTASA MES; Torney MVU, 2020, JAMA SURG, V155, P600, DOI 10.1001/jamasurg.2020.0757; Tsilimparis N, 2010, DEUT MED WOCHENSCHR, V135, P1743, DOI 10.1055/s-0030-1263305; Tursi A, 2002, DIGEST LIVER DIS, V34, P510, DOI 10.1016/S1590-8658(02)80110-4; Tursi A, 2007, INT J COLORECTAL DIS, V22, P1103, DOI 10.1007/s00384-007-0299-6; Valizadeh N, 2018, AM SURGEON, V84, P1781; van de Wall BJM, 2017, LANCET GASTROENTEROL, V2, P13, DOI 10.1016/S2468-1253(16)30109-1; Varma S, 2019, J SURG RES, V234, P224, DOI 10.1016/j.jss.2018.09.043; Warner Chilcott Deutschland GmbH, DELZICOL MES; Warner Chilcott Deutschland GmbH, ASACOL MES; Wilkins T, 2013, AM FAM PHYSICIAN, V87, P612; Willke RJ, 2018, VALUE HEALTH, V21, P155, DOI 10.1016/j.jval.2017.12.011; You H, 2019, MED J AUSTRALIA, V211, P421, DOI 10.5694/mja2.50276; You K, 2018, BRIT J SURG, V105, P971, DOI 10.1002/bjs.10868	92	3	3	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR	2022	175	3					416	+		10.7326/M21-2711	http://dx.doi.org/10.7326/M21-2711		JAN 2022	18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0O5UF	35038270				2022-12-28	WOS:000745535700001
J	Eduardo-Santos, A				Eduardo-Santos, Anderson			No need to hide	SCIENCE			English	Editorial Material									[Eduardo-Santos, Anderson] Univ Sao Paulo, Ribeirao Preto, Brazil	Universidade de Sao Paulo	Eduardo-Santos, A (corresponding author), Univ Sao Paulo, Ribeirao Preto, Brazil.	SciCareerEditor@aaas.org							0	0	0	1	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2022	375	6577					234	234						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YG3OI	35025647				2022-12-28	WOS:000742401600040
J	Iacobucci, G				Iacobucci, Gareth			Covid-19: Pressures in north east England are making services unsafe, MPs are warned	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		NHS England, URG EM CAR DAIL SIT	1	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 14	2022	376								o99	10.1136/bmj.o99	http://dx.doi.org/10.1136/bmj.o99			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZE9IM	35031536	Bronze			2022-12-28	WOS:000759190400011
J	Looi, MK				Looi, Mun-Keat			Sixty seconds on ... covid-19 and sex	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Delcea C, 2021, SEXOLOGIES, V30, pE49, DOI 10.1016/j.sexol.2020.12.001; Kusuma AHW, 2021, AFR J UROL, V27, DOI 10.1186/s12301-021-00227-w; Prem Kumar P., 2022, NIKKEI ASIA 0103; Subramanian S., 2022, WORLDS LARGEST CONDO	4	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 14	2022	376								o104	10.1136/bmj.o104	http://dx.doi.org/10.1136/bmj.o104			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZE9IM	35031561	Bronze			2022-12-28	WOS:000759190400002
J	Wang, ZY				Wang, Zuoyue			An antiquated language, reimagined	SCIENCE			English	Editorial Material									[Wang, Zuoyue] Calif State Polytech Univ Pomona, Dept Hist, Pomona, CA 91768 USA	California State University System; California State Polytechnic University Pomona	Wang, ZY (corresponding author), Calif State Polytech Univ Pomona, Dept Hist, Pomona, CA 91768 USA.	zywang@cpp.edu						Mullaney TS, 2017, STUD WEATHERH EAST, P1	1	0	0	2	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2022	375	6577					151	151		10.1126/science.abn0932	http://dx.doi.org/10.1126/science.abn0932			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YG3OI	35025658				2022-12-28	WOS:000742401600020
J	Kotz, M; Levermann, A; Wenz, L				Kotz, Maximilian; Levermann, Anders; Wenz, Leonie			The effect of rainfall changes on economic production	NATURE			English	Article							WATER SCARCITY; GROWTH; TEMPERATURE; GAUGE	Macro-economic assessments of climate impacts lack an analysis of the distribution of daily rainfall, which can resolve both complex societal impact channels and anthropogenically forced changes(1-6). Here, using a global panel of subnational economic output for 1,554 regions worldwide over the past 40 years, we show that economic growth rates are reduced by increases in the number of wet days and in extreme daily rainfall, in addition to responding nonlinearly to the total annual and to the standardized monthly deviations of rainfall. Furthermore, high-income nations and the services and manufacturing sectors are most strongly hindered by both measures of daily rainfall, complementing previous work that emphasized the beneficial effects of additional total annual rainfall in low-income, agriculturally dependent economies(4,7). By assessing the distribution of rainfall at multiple timescales and the effects on different sectors, we uncover channels through which climatic conditions can affect the economy. These results suggest that anthropogenic intensification of daily rainfall extremes(8-10) will have negative global economic consequences that require further assessment by those who wish to evaluate the costs of anthropogenic climate change.	[Kotz, Maximilian; Levermann, Anders; Wenz, Leonie] Potsdam Inst Climate Impact Res, Res Dept Complex Sci, Potsdam, Germany; [Kotz, Maximilian; Levermann, Anders] Potsdam Univ, Inst Phys, Potsdam, Germany; [Levermann, Anders] Columbia Univ, Lamont Doherty Earth Observ, New York, NY USA; [Wenz, Leonie] Mercator Res Inst Global Commons & Climate Change, Berlin, Germany	Potsdam Institut fur Klimafolgenforschung; University of Potsdam; Columbia University	Wenz, L (corresponding author), Potsdam Inst Climate Impact Res, Res Dept Complex Sci, Potsdam, Germany.; Wenz, L (corresponding author), Mercator Res Inst Global Commons & Climate Change, Berlin, Germany.	leonie.wenz@pik-potsdam.de	Levermann, Anders/G-4666-2011	Levermann, Anders/0000-0003-4432-4704; Wenz, Leonie/0000-0002-8500-1568; Kotz, Maximilian/0000-0003-2564-5043	Volkswagen Foundation; Horizon 2020 Framework Programme of the European Union [820712]	Volkswagen Foundation(Volkswagen); Horizon 2020 Framework Programme of the European Union	We acknowledge funding from the Volkswagen Foundation and from the Horizon 2020 Framework Programme of the European Union (grant agreement number 820712). We thank M. Kalkuhl and S. Lange for discussions regarding economic and climate data, respectively.	Ali S., 2012, CLIMATE CHANGE EC GR, DOI [10.2139/ssrn.2018233, DOI 10.2139/SSRN.2018233]; Auffhammer M, 2013, REV ENV ECON POLICY, V7, P181, DOI 10.1093/reep/ret016; Bador M, 2020, ENVIRON RES LETT, V15, DOI 10.1088/1748-9326/ab6a22; Barrios S, 2010, REV ECON STAT, V92, P350, DOI 10.1162/rest.2010.11212; Beck HE, 2019, HYDROL EARTH SYST SC, V23, P207, DOI 10.5194/hess-23-207-2019; Beck HE, 2017, HYDROL EARTH SYST SC, V21, P589, DOI 10.5194/hess-21-589-2017; Burke M, 2015, NATURE, V527, P235, DOI 10.1038/nature15725; Chadwick R, 2016, NAT CLIM CHANGE, V6, P177, DOI [10.1038/NCLIMATE2805, 10.1038/nclimate2805]; Damania R, 2020, J ENVIRON ECON MANAG, V102, DOI 10.1016/j.jeem.2020.102335; Damania R, 2020, OXFORD REV ECON POL, V36, P24, DOI 10.1093/oxrep/grz027; Davenport FV, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2017524118; Dell M, 2012, AM ECON J-MACROECON, V4, P66, DOI 10.1257/mac.4.3.66; Desbureaux S, 2019, WORLD DEV, V114, P13, DOI 10.1016/j.worlddev.2018.09.026; Feng X, 2013, NAT CLIM CHANGE, V3, P811, DOI [10.1038/nclimate1907, 10.1038/NCLIMATE1907]; Fischer EM, 2016, NAT CLIM CHANGE, V6, P986, DOI [10.1038/nclimate3110, 10.1038/NCLIMATE3110]; Garrick DE, 2017, SCIENCE, V358, P1003, DOI 10.1126/science.aao4942; Goldewijk KK, 2011, GLOBAL ECOL BIOGEOGR, V20, P73, DOI 10.1111/j.1466-8238.2010.00587.x; Hidalgo CA, 2007, SCIENCE, V317, P482, DOI 10.1126/science.1144581; Holtermann L, 2020, GLOBAL ENVIRON CHANG, V65, DOI 10.1016/j.gloenvcha.2020.102167; Hsiang SM, 2013, SCIENCE, V341, P1212, DOI 10.1126/science.1235367; Kalkuhl M., 2021, Zenodo, DOI 10.5281/zenodo.4681306; Kalkuhl M, 2020, J ENVIRON ECON MANAG, V103, DOI 10.1016/j.jeem.2020.102360; Kikstra JS, 2021, ENVIRON RES LETT, V16, DOI 10.1088/1748-9326/ac1d0b; Kotz M, 2021, NAT CLIM CHANGE, V11, P319, DOI 10.1038/s41558-020-00985-5; Krichene H, 2021, WORLD DEV, V144, DOI 10.1016/j.worlddev.2021.105475; Lehmann J, 2018, GEOPHYS RES LETT, V45, P13468, DOI 10.1029/2018GL079439; Liang XZ, 2017, P NATL ACAD SCI USA, V114, pE2285, DOI 10.1073/pnas.1615922114; Loayza NV, 2012, WORLD DEV, V40, P1317, DOI 10.1016/j.worlddev.2012.03.002; Madakumbura GD, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-24262-x; Marvel K, 2013, P NATL ACAD SCI USA, V110, P19301, DOI 10.1073/pnas.1314382110; Min SK, 2011, NATURE, V470, P378, DOI 10.1038/nature09763; Moore FC, 2015, NAT CLIM CHANGE, V5, P127, DOI [10.1038/nclimate2481, 10.1038/NCLIMATE2481]; Myhre G, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52277-4; Sangkhaphan S, 2020, ECONOMIES, V8, DOI 10.3390/economies8010001; Sheffield J, 2006, J CLIMATE, V19, P3088, DOI 10.1175/JCLI3790.1; Swain DL, 2018, NAT CLIM CHANGE, V8, P427, DOI 10.1038/s41558-018-0140-y; Willner SN, 2018, NAT CLIM CHANGE, V8, P594, DOI 10.1038/s41558-018-0173-2; Zhang WX, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abf8021	38	17	17	38	86	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 13	2022	601	7892					223	+		10.1038/s41586-021-04283-8	http://dx.doi.org/10.1038/s41586-021-04283-8			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YF9MG	35022593				2022-12-28	WOS:000742123100013
J	Giglio, ME; Magalski, GR; Doan, YP; Bowman, S				Giglio, Marisa E.; Magalski, Gabrielle R.; Doan, Yen P.; Bowman, Sydney			Abortion Training in Medical Education - Implications of the Supreme Court's Upcoming Decision	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Giglio, Marisa E.; Doan, Yen P.] Penn State Coll Med, Hershey, PA 17033 USA; [Magalski, Gabrielle R.] Univ Queensland, Ochsner Clin Sch, New Orleans, LA USA; [Bowman, Sydney] Univ Texas Med Branch, Galveston, TX 77555 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Ochsner Health System; University of Queensland; University of Texas System; University of Texas Medical Branch Galveston	Giglio, ME (corresponding author), Penn State Coll Med, Hershey, PA 17033 USA.			Giglio, Marisa/0000-0002-6368-9701				Jones RK, 2017, AM J PUBLIC HEALTH, V107, P1904, DOI 10.2105/AJPH.2017.304042; Landy U, 2021, CONTRACEPTION, V103, P305, DOI 10.1016/j.contraception.2020.12.009; Schreiber CA, 2018, NEW ENGL J MED, V378, P2161, DOI 10.1056/NEJMoa1715726; Steinauer JE, 2018, AM J OBSTET GYNECOL, V219, DOI 10.1016/j.ajog.2018.04.011; Zeldovich VB, 2020, OBSTET GYNECOL, V135, P1296, DOI 10.1097/AOG.0000000000003876	5	2	2	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 24	2022	386	8					707	709		10.1056/NEJMp2117368	http://dx.doi.org/10.1056/NEJMp2117368		JAN 2022	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ZF7PI	35021003	Bronze			2022-12-28	WOS:000741666100001
J	Vidal, CM; Lane, CS; Asrat, A; Barfod, DN; Mark, DF; Tomlinson, EL; Tadesse, AZ; Yirgu, G; Deino, A; Hutchison, W; Mounier, A; Oppenheimer, C				Vidal, Celine M.; Lane, Christine S.; Asrat, Asfawossen; Barfod, Dan N.; Mark, Darren F.; Tomlinson, Emma L.; Tadesse, Amdemichael Zafu; Yirgu, Gezahegn; Deino, Alan; Hutchison, William; Mounier, Aurelien; Oppenheimer, Clive			Age of the oldest known Homo sapiens from eastern Africa	NATURE			English	Article							MAIN ETHIOPIAN RIFT; CANYON SANIDINE STANDARD; K-40 DECAY CONSTANTS; MIDDLE STONE-AGE; KIBISH FORMATION; JOINT DETERMINATION; IMPROVED ACCURACY; HOMININ FOSSILS; KONSO FORMATION; OMO I	Efforts to date the oldest modern human fossils in eastern Africa, from Omo-Kibish(1-3) and Herto(4,5) in Ethiopia, have drawn on a variety of chronometric evidence, including Ar-40/Ar-39 ages of stratigraphically associated tuffs. The ages that are generally reported for these fossils are around 197 thousand years (kyr) for the Kibish Omo I-3,I-6,I-7, and around 160-155 kyr for the Herto hominins(5,8). However, the stratigraphic relationships and tephra correlations that underpin these estimates have been challenged(6,8). Here we report geochemical analyses that link the Kamoya's Hominid Site (KHS) Tuff(9), which conclusively overlies the member of the Omo-Kibish Formation that contains Omo I, with a major explosive eruption of Shala volcano in the Main Ethiopian Rift. By dating the proximal deposits of this eruption, we obtain a new minimum age for the Omo fossils of 233 +/- 22 kyr. Contrary to previous arguments(6,8), we also show that the KHS Tuff does not correlate with another widespread tephra layer, the Waidedo Vitric Tuff, and therefore cannot anchor a minimum age for the Herto fossils. Shifting the age of the oldest known Homo sapiens fossils in eastern Africa to before around 200 thousand years ago is consistent with independent evidence for greater antiquity of the modern human lineage(10).	[Vidal, Celine M.; Lane, Christine S.; Oppenheimer, Clive] Univ Cambridge, Dept Geog, Cambridge, England; [Vidal, Celine M.] Univ Cambridge, Fitzwilliam Coll, Cambridge, England; [Asrat, Asfawossen; Yirgu, Gezahegn] Addis Ababa Univ, Sch Earth Sci, Addis Ababa, Ethiopia; [Asrat, Asfawossen] Botswana Int Univ Sci & Technol, Dept Min & Geol Engn, Palapye, Botswana; [Barfod, Dan N.; Mark, Darren F.] Univ Glasgow, SUERC, NEIF Argon Isotopes, Glasgow, Lanark, Scotland; [Tomlinson, Emma L.] Univ Dublin, Trinity Coll Dublin, Dublin, Ireland; [Tadesse, Amdemichael Zafu] Univ Libre Bruxelles, Dept Geosci Environm & Soc, Brussels, Belgium; [Deino, Alan] Berkeley Geochronol Ctr, Berkeley, CA USA; [Hutchison, William] Univ St Andrews, Sch Earth & Environm Sci, St Andrews, Fife, Scotland; [Mounier, Aurelien] MNHN CNRS UPVD, UMR 7194, Hist Nat Homme Prehist HNHP, Musee Homme, Paris, France; [Mounier, Aurelien] Univ Cambridge, Dept Archaeol, Leverhulme Ctr Human Evolutionary Studies, Cambridge, England; [Oppenheimer, Clive] McDonald Inst Archaeol Res, Cambridge, England	University of Cambridge; University of Cambridge; Addis Ababa University; Scottish Universities Research & Reactor Center; University of Glasgow; Trinity College Dublin; Universite Libre de Bruxelles; Berkeley Geochronolgy Center; University of St Andrews; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); University of Cambridge; University of Cambridge	Vidal, CM (corresponding author), Univ Cambridge, Dept Geog, Cambridge, England.; Vidal, CM (corresponding author), Univ Cambridge, Fitzwilliam Coll, Cambridge, England.	cv325@cam.ac.uk	Tomlinson, Emma/A-9350-2011; Tomlinson, Emma/GLU-8745-2022	Tomlinson, Emma/0000-0002-0646-6640; Tomlinson, Emma/0000-0002-0646-6640; Lane, Christine/0000-0001-9206-3903; Asrat, Asfawossen/0000-0002-6312-8082; Tadesse, Amdemichael/0000-0002-0542-0165; Mounier, Aurelien/0000-0001-9713-7246	Leverhulme Trust ('Nature and impacts of Middle Pleistocene volcanism in the Ethiopian Rift', 2016-21); Cambridge-Africa ALBORADA Research Fund ('Volcanic tie-lines between records of past climates and early modern humans in Ethiopia, 2019-21'); NIGFSC through the UK Natural Environment Research Council [IP-1683-1116]; SFI [13/RC/2092]	Leverhulme Trust ('Nature and impacts of Middle Pleistocene volcanism in the Ethiopian Rift', 2016-21); Cambridge-Africa ALBORADA Research Fund ('Volcanic tie-lines between records of past climates and early modern humans in Ethiopia, 2019-21'); NIGFSC through the UK Natural Environment Research Council; SFI(Science Foundation Ireland)	This study was supported by the Leverhulme Trust ('Nature and impacts of Middle Pleistocene volcanism in the Ethiopian Rift', 2016-21) and the Cambridge-Africa ALBORADA Research Fund ('Volcanic tie-lines between records of past climates and early modern humans in Ethiopia, 2019-21'). Ar-Ar dating was supported by grant NIGFSC IP-1683-1116 through the UK Natural Environment Research Council. The iCRAG LA-ICP-MS facility at Trinity College Dublin is supported by SFI award 13/RC/2092. We acknowledge the local and regional authorities in Ethiopia for facilitating fieldwork and sample export, including the School of Earth Sciences Addis Ababa University, the Oromiya Regional State, the Ngangatom Woreda Local Administration and the FDRE Ministry of Mines, Petroleum and Natural Gas. We are grateful to Y. Beyene for assistance in accessing the Konso tephra localities; Ethioder and their drivers for logistical support; and field assistants Alex in Omo-Kibish and Demelash in Konso. We thank D. Colby for facilitating access to the Corbetti sample and A. Piermattei, I. Buisman and J. Day for assistance with sample preparation and microprobe analyses in Cambridge. The manuscript has benefited from comments by W. Hart and C. Feibel, and we are grateful to them for their input.	Abbott PM, 2020, J QUATERNARY SCI, V35, P1, DOI 10.1002/jqs.3184; Bergstrom A, 2021, NATURE, V590, P229, DOI 10.1038/s41586-021-03244-5; Blockley SPE, 2005, QUATERNARY SCI REV, V24, P1952, DOI 10.1016/j.quascirev.2004.12.008; Brown FH, 2008, J HUM EVOL, V55, P366, DOI 10.1016/j.jhevol.2008.05.009; Brown FH, 2012, J HUM EVOL, V63, P577, DOI 10.1016/j.jhevol.2012.05.014; BUTZER KW, 1969, NATURE, V222, P1138, DOI 10.1038/2221138a0; Clark JD, 2003, NATURE, V423, P747, DOI 10.1038/nature01670; DAY MH, 1969, NATURE, V222, P1135, DOI 10.1038/2221135a0; Faupl P, 2003, NATURE, V426, P621, DOI 10.1038/426621a; Fleagle JG, 2008, J HUM EVOL, V55, P360, DOI 10.1016/j.jhevol.2008.05.007; Fontijn K, 2018, J VOLCANOL GEOTH RES, V356, P90, DOI 10.1016/j.jvolgeores.2018.02.001; Hart WK, 2003, NATURE, V426, P622, DOI 10.1038/426622a; Hutchison W, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13192; Katoh S, 2000, QUATERNARY SCI REV, V19, P1305, DOI 10.1016/S0277-3791(99)00099-2; Kroon D., 1998, ARCTIC, V160, P181, DOI DOI 10.2973/ODP.PROC.SR.160.071.1998(CHAPTER14)160; Kuiper KF, 2008, SCIENCE, V320, P500, DOI 10.1126/science.1154339; Lahr MM, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0241; Lane CS, 2017, QUAT GEOCHRONOL, V40, P1, DOI 10.1016/j.quageo.2017.04.003; Lane CS, 2014, J ARCHAEOL SCI, V42, P42, DOI 10.1016/j.jas.2013.10.033; LAURY RL, 1975, GEOL SOC AM BULL, V86, P999, DOI 10.1130/0016-7606(1975)86<999:GOMSAA>2.0.CO;2; Lowe DJ, 2017, QUATERNARY SCI REV, V175, P1, DOI 10.1016/j.quascirev.2017.08.003; Lowe DJ, 2011, QUAT GEOCHRONOL, V6, P107, DOI 10.1016/j.quageo.2010.08.003; McDougall I, 2005, NATURE, V433, P733, DOI 10.1038/nature03258; McDougall I, 2008, J HUM EVOL, V55, P409, DOI 10.1016/j.jhevol.2008.05.012; Mohr P., 1980, B VOLCANOL, V43, P173, DOI [10. 1007/BF02597619, DOI 10.1007/BF02597619, 10.1007/BF02597619]; Morgan LE, 2008, GEOLOGY, V36, P967, DOI 10.1130/G25213A.1; Mounier A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11213-w; Nagaoka S, 2005, PALAEOGEOGR PALAEOCL, V216, P333, DOI 10.1016/j.palaeo.2004.11.008; Quade J, 2008, GEOL SOC AM SPEC PAP, V446, P1, DOI 10.1130/2008.2446(01); Renne PR, 2011, GEOCHIM COSMOCHIM AC, V75, P5097, DOI 10.1016/j.gca.2011.06.021; Renne PR, 2010, GEOCHIM COSMOCHIM AC, V74, P5349, DOI 10.1016/j.gca.2010.06.017; Richter D, 2017, NATURE, V546, P293, DOI 10.1038/nature22335; Roberts HM, 2021, QUATERNARY SCI REV, V266, DOI 10.1016/j.quascirev.2021.107025; ROSSIGNOLSTRICK M, 1985, PALAEOGEOGR PALAEOCL, V49, P237, DOI 10.1016/0031-0182(85)90056-2; Sahle Y., 2019, MODERN HUMAN ORIGINS, P73; Sehlebusch CM, 2017, SCIENCE, V358, P652, DOI 10.1126/science.aao6266; Stringer C, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0237; Tomlinson EL, 2010, CHEM GEOL, V279, P73, DOI 10.1016/j.chemgeo.2010.09.013; White TD, 2003, NATURE, V423, P742, DOI 10.1038/nature01669	39	15	15	10	18	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 27	2022	601	7894					579	+		10.1038/s41586-021-04275-8	http://dx.doi.org/10.1038/s41586-021-04275-8		JAN 2022	10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YQ8HX	35022610	Green Published, Green Accepted, hybrid, Green Submitted			2022-12-28	WOS:000741978700010
J	Gao, TA; Chen, YY				Gao, Torahito A.; Chen, Yvonne Y.			T cells to fix a broken heart	SCIENCE			English	Editorial Material							FIBROBLAST ACTIVATION PROTEIN; THERAPY		[Gao, Torahito A.; Chen, Yvonne Y.] Univ Calif Los Angeles UCLA, Dept Chem & Biomol Engn, Los Angeles, CA 90095 USA; [Chen, Yvonne Y.] UCLA, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Chen, Yvonne Y.] UCLA, Parker Inst, Canc Immunotherapy Ctr, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Chen, YY (corresponding author), Univ Calif Los Angeles UCLA, Dept Chem & Biomol Engn, Los Angeles, CA 90095 USA.; Chen, YY (corresponding author), UCLA, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.; Chen, YY (corresponding author), UCLA, Parker Inst, Canc Immunotherapy Ctr, Los Angeles, CA 90095 USA.	yvchen@ucla.edu		Gao, Torahito/0000-0003-4333-5305				Aghajanian H, 2019, NATURE, V573, P430, DOI 10.1038/s41586-019-1546-z; Bainbridge P, 2013, J WOUND CARE, V22, P407; David RM, 2017, TOXICOL SCI, V155, P315, DOI 10.1093/toxsci/kfw220; Hong MH, 2020, CANCER CELL, V38, P473, DOI 10.1016/j.ccell.2020.07.005; Jafarzadeh L, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00702; Kakarla S, 2013, MOL THER, V21, P1611, DOI 10.1038/mt.2013.110; Koff WC, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abd1525; Nawaz W, 2021, BLOOD CANCER J, V11, DOI 10.1038/s41408-021-00508-1; O'Leary MC, 2019, CLIN CANCER RES, V25, P1142, DOI 10.1158/1078-0432.CCR-18-2035; Rafiq S, 2020, NAT REV CLIN ONCOL, V17, P147, DOI 10.1038/s41571-019-0297-y; Rurik J. G, SCIENCE, V375, P91; Seif M, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02711; Tran E, 2013, J EXP MED, V210, P1125, DOI 10.1084/jem.20130110; Travers JG, 2016, CIRC RES, V118, P1021, DOI 10.1161/CIRCRESAHA.115.306565; Wang LCS, 2014, CANCER IMMUNOL RES, V2, P154, DOI 10.1158/2326-6066.CIR-13-0027	15	1	2	4	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 7	2022	375	6576					23	24		10.1126/science.abn0851	http://dx.doi.org/10.1126/science.abn0851			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YD3FW	34990255				2022-12-28	WOS:000740261400024
J	Park, JJH; Detry, MA; Murthy, S; Guyatt, G; Mills, EJ				Park, Jay J. H.; Detry, Michelle A.; Murthy, Srinivas; Guyatt, Gordon; Mills, Edward J.			How to Use and Interpret the Results of a Platform Trial Users' Guide to the Medical Literature	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							ADAPTIVE DESIGNS; CLINICAL-TRIALS; RANDOMIZED-TRIALS; CHECKLIST	Platform trials are a type of randomized clinical trial that allow simultaneous comparison of multiple intervention groups against a single control group that serves as a common control based on a prespecified interim analysis plan. The platform trial design enables introduction of new interventions after the trial is initiated to evaluate multiple interventions in an ongoing manner using a single overarching protocol called a master (or core) protocol. When multiple treatment candidates are available, rapid scientific therapeutic discoveries may be made. Platform trials have important potential advantages in creating an efficient trial infrastructure that can help address critical clinical questions as the evidence evolves. Platform trials have recently been used in investigations of evolving therapies for patients with COVID-19. The purpose of this Users' Guide to the Medical Literature is to describe fundamental concepts of platform trials and master protocols and review issues in the conduct and interpretation of these studies. This Users' Guide is intended to help clinicians and readers understand articles reporting on interventions evaluated using platform trial designs.	[Park, Jay J. H.] Univ British Columbia, Dept Med, Div Expt Med, Vancouver, BC, Canada; [Detry, Michelle A.] Berry Consultants LLC, Austin, TX USA; [Murthy, Srinivas] Univ British Columbia, Fac Med, Dept Pediat, Vancouver, BC, Canada; [Guyatt, Gordon; Mills, Edward J.] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada; [Mills, Edward J.] Cytel Inc, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; McMaster University	Mills, EJ (corresponding author), 802-777 W Broadway, Vancouver, BC V5Z 1J5, Canada.	millsej@mcmaster.ca		Murthy, Srinivas/0000-0002-9476-839X				Angus DC, 2020, JAMA-J AM MED ASSOC, V324, P1317, DOI 10.1001/jama.2020.17022; Angus DC, 2020, ANN AM THORAC SOC, V17, P879, DOI 10.1513/AnnalsATS.202003-192SD; Angus DC, 2019, NAT REV DRUG DISCOV, V18, P797, DOI 10.1038/s41573-019-0034-3; Barker AD, 2009, CLIN PHARMACOL THER, V86, P97, DOI 10.1038/clpt.2009.68; Bauer P, 2016, STAT MED, V35, P325, DOI 10.1002/sim.6472; Berry SM, 2015, JAMA-J AM MED ASSOC, V313, P1619, DOI 10.1001/jama.2015.2316; Berry SM, 1999, J AM STAT ASSOC, V94, P661, DOI 10.2307/2669973; Bhatt DL, 2016, NEW ENGL J MED, V375, P65, DOI 10.1056/NEJMra1510061; Biswas A, 2016, STAT METHODS MED RES, V25, P81, DOI 10.1177/0962280212441424; Committee for Proprietary Medicinal Products, 2001, ICH TOP E 10 CHOIC C, P30; Cook D., 2015, USERSGUIDES MEDICAL; Dean NE, 2020, NEW ENGL J MED, V382, P1366, DOI 10.1056/NEJMsb1905390; Detry MA, STANDARDS DESIGN CON; Dimairo M, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m115; Dimairo M, 2020, TRIALS, V21, DOI 10.1186/s13063-020-04334-x; Dron L, 2019, CONT CLIN TRIAL COMM, V16, DOI 10.1016/j.conctc.2019.100446; FDA, 2019, FDA GUID AD DES CLIN; Greenland S, 2016, EUR J EPIDEMIOL, V31, P337, DOI 10.1007/s10654-016-0149-3; He WL, 2012, DRUG INF J, V46, P160, DOI 10.1177/0092861512436580; Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]; Hummel J., 2015, Clinical Investigation, V5, P401; James ND, 2016, JAMA ONCOL, V2, P348, DOI 10.1001/jamaoncol.2015.4350; Lee KM, 2020, BMC MED RES METHODOL, V20, DOI 10.1186/s12874-020-01043-6; Lewis RJ, 2018, JAMA-J AM MED ASSOC, V320, P2208, DOI 10.1001/jama.2018.16916; Mayer C, 2019, STAT BIOPHARM RES, V11, P325, DOI 10.1080/19466315.2018.1560359; McGlothlin AE, 2018, JAMA-J AM MED ASSOC, V320, P2365, DOI 10.1001/jama.2018.17977; Orkin AM, 2021, JAMA-J AM MED ASSOC, V326, P257, DOI 10.1001/jama.2021.9941; Park JJH, 2020, J CLIN EPIDEMIOL, V125, P1, DOI 10.1016/j.jclinepi.2020.04.025; Park JJH, 2020, CA-CANCER J CLIN, V70, P125, DOI 10.3322/caac.21600; Park JJH, 2019, TRIALS, V20, DOI 10.1186/s13063-019-3664-1; Park JJH, 2018, CLIN EPIDEMIOL, V10, P343, DOI 10.2147/CLEP.S156708; Parmar MKB, 2014, LANCET, V384, P283, DOI 10.1016/S0140-6736(14)61122-3; Quintana M, 2017, JAMA-J AM MED ASSOC, V318, P1605, DOI 10.1001/jama.2017.15574; Reis G, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.6468; REMAP-CAP, CURR PROT DOC; Saville BR, 2016, CLIN TRIALS, V13, P358, DOI 10.1177/1740774515626362; Saville BR, 2014, CLIN TRIALS, V11, P485, DOI 10.1177/1740774514531352; Schiavone F, 2019, TRIALS, V20, DOI 10.1186/s13063-019-3216-8; Siden EG, 2019, CONT CLIN TRIAL COMM, V15, DOI 10.1016/j.conctc.2019.100406; Sterne JAC, 2020, JAMA-J AM MED ASSOC, V324, P1330, DOI 10.1001/jama.2020.17023; Sterne JAC, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l4898; Sydes MR, 2018, ANN ONCOL, V29, P1235, DOI 10.1093/annonc/mdy072; Sydes MR, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-168; Thorlund K, 2020, CLIN EPIDEMIOL, V12, P457, DOI 10.2147/CLEP.S242097; Thorlund K, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k698; Viele K, 2020, CLIN TRIALS, V17, P52, DOI 10.1177/1740774519877836; Viele K, 2016, JAMA-J AM MED ASSOC, V315, P1646, DOI 10.1001/jama.2016.2628; Viele K, 2014, PHARM STAT, V13, P41, DOI 10.1002/pst.1589; Woodcock J, 2017, NEW ENGL J MED, V377, P62, DOI 10.1056/NEJMra1510062; Yu LM, 2021, LANCET, V398, P843, DOI 10.1016/S0140-6736(21)01744-X	50	6	6	2	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 4	2022	327	1					67	74		10.1001/jama.2021.22507	http://dx.doi.org/10.1001/jama.2021.22507			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YF7YT	34982138				2022-12-28	WOS:000742019000020
J	[Anonymous]				[Anonymous]			The Centennial Year (Reprinted from JAMA, vol 133, pg 32, 1947)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 4	2022	327	1					88	88		10.1001/jama.2021.16793	http://dx.doi.org/10.1001/jama.2021.16793			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YF7YT	34982127				2022-12-28	WOS:000742019000033
J	Mannar, D; Saville, JW; Zhu, X; Srivastava, SS; Berezuk, AM; Tuttle, KS; Marquez, AC; Sekirov, I; Subramaniam, S				Mannar, Dhiraj; Saville, James W.; Zhu, Xing; Srivastava, Shanti S.; Berezuk, Alison M.; Tuttle, Katharine S.; Marquez, Ana Citlali; Sekirov, Inna; Subramaniam, Sriram			SARS-CoV-2 Omicron variant: Antibody evasion and cryo-EM structure of spike protein-ACE2 complex	SCIENCE			English	Article							VISUALIZATION; DOMAIN; ACE2	The newly reported Omicron variant is poised to replace Delta as the most prevalent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant across the world. Cryo-electron microscopy (cryo-EM) structural analysis of the Omicron variant spike protein in complex with human angioten-sinconverting enzyme 2 (ACE2) reveals new salt bridges and hydrogen bonds formed by mutated residues arginine-493, serine-496, and arginine-498 in the receptor binding domain with ACE2. These interactions appear to compensate for other Omicron mutations such as the substitution of asparagine for lysine at position 417 (K417N) that are known to reduce ACE2 binding affinity, resulting in similar biochemical ACE2 binding affinities for the Delta and Omicron variants. Neutralization assays show that pseudoviruses that display the Omicron spike protein exhibit increased antibody evasion. The increase in antibody evasion and the retention of strong interactions at the ACE2 interface thus represent important molecular features that likely contribute to the rapid spread of the Omicron variant.	[Mannar, Dhiraj; Saville, James W.; Zhu, Xing; Srivastava, Shanti S.; Berezuk, Alison M.; Tuttle, Katharine S.; Subramaniam, Sriram] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC, Canada; [Marquez, Ana Citlali; Sekirov, Inna] BC Ctr Dis Control Publ Hlth Lab, Vancouver, BC, Canada; [Sekirov, Inna] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC, Canada; [Subramaniam, Sriram] Gandeeva Therapeut Inc, Vancouver, BC, Canada	University of British Columbia; University of British Columbia	Subramaniam, S (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC, Canada.; Subramaniam, S (corresponding author), Gandeeva Therapeut Inc, Vancouver, BC, Canada.	sriram.subramaniam@ubc.ca	Tuttle, Katharine/HDN-7517-2022	Mannar, Dhiraj/0000-0002-7154-8677; Zhu, Xing/0000-0003-4839-4857; Subramaniam, Sriram/0000-0003-4231-4115; Tuttle, Katharine Susanne/0000-0002-9788-1830; Saville, James/0000-0001-8813-721X; Srivastava, Shanti Swaroop/0000-0002-4208-6127	Canada Excellence Research Chair Award; VGH Foundation; Genome BC, Canada; Tai Hung Fai Charitable Foundation; CIHR Frederick Banting and Charles Best Canada Graduate Scholarship Master's Award (CGS-M); CIHR Frederick Banting and Charles Best Canada Graduate Scholarships Doctoral Award (CGS D); University of British Columbia President's Academic Excellence Initiative PhD Award	Canada Excellence Research Chair Award; VGH Foundation; Genome BC, Canada; Tai Hung Fai Charitable Foundation; CIHR Frederick Banting and Charles Best Canada Graduate Scholarship Master's Award (CGS-M)(Canadian Institutes of Health Research (CIHR)); CIHR Frederick Banting and Charles Best Canada Graduate Scholarships Doctoral Award (CGS D)(Canadian Institutes of Health Research (CIHR)); University of British Columbia President's Academic Excellence Initiative PhD Award	This work was supported by awards to S.S. from a Canada Excellence Research Chair Award; the VGH Foundation; Genome BC, Canada; and the Tai Hung Fai Charitable Foundation. D.M. is supported by a CIHR Frederick Banting and Charles Best Canada Graduate Scholarship Master's Award (CGS-M). J.W. S. is supported by a CIHR Frederick Banting and Charles Best Canada Graduate Scholarships Doctoral Award (CGS D) and a University of British Columbia President's Academic Excellence Initiative PhD Award.	Barton MI, 2021, ELIFE, V10, DOI 10.7554/eLife.70658; Cameroni E., 2021, NATURE, DOI [10.1038/s41586-021-04386-2 Medline, DOI 10.1038/S41586-021-04386-2MEDLINE]; Cameroni E, 2022, NATURE, V602, P664, DOI [10.1038/s41586-021-04386-2, 10.1101/2021.12.12.472269]; Cathcart AL, 2021, DUAL FUNCTION MONOCL, DOI [10.1101/2021.03.09.434607, DOI 10.1101/2021.03.09.434607, 10.1101/2021.03.09. 434607]; Chi XY, 2020, SCIENCE, V369, P650, DOI 10.1126/science.abc6952; Elbe S, 2017, GLOB CHALL, V1, P33, DOI 10.1002/gch2.1018; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gobeil SMC, 2021, SCIENCE, V373, P641, DOI [10.1126/science.abi6226, 10.1101/2021.03.11.435037]; Goddard TD, 2018, PROTEIN SCI, V27, P14, DOI 10.1002/pro.3235; Hastie KM, 2021, SCIENCE, V374, P472, DOI 10.1126/science.abh2315; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Krammer F, 2020, NATURE, V586, P516, DOI 10.1038/s41586-020-2798-3; Laffeber C, 2021, J MOL BIOL, V433, DOI 10.1016/j.jmb.2021.167058; Li W, 2020, P NATL ACAD SCI USA, V117, P29832, DOI 10.1073/pnas.2010197117; Li W, 2020, CELL, V183, P429, DOI 10.1016/j.cell.2020.09.007; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Liu HL, 2021, CELL RES, V31, P720, DOI 10.1038/s41422-021-00496-8; Liu L., 2021, NATURE, DOI [10.1038/s41586-021-04388-0 Medline, DOI 10.1038/S41586-021-04388-0MEDLINE]; Liu LH, 2022, NATURE, V602, P676, DOI 10.1038/s41586-021-04388-0; Liu LH, 2020, NATURE, V584, P450, DOI 10.1038/s41586-020-2571-7; Liu L, 2022, IEEE T KNOWL DATA EN, V34, P2293, DOI [10.1109/TKDE.2020.3004939, 10.1101/2020.06.17.153486]; Mannar D., 2021, BIORXIV2021121747317, DOI [10.1101/2021.12.17.473178, DOI 10.1101/2021.12.17.473178]; Mannar D, 2021, CELL REP, V37, DOI 10.1016/j.celrep.2021.110156; McCallum M., 2021, PREPRINT, DOI [10.1101/2021.12.28.474380, DOI 10.1101/2021.12.28.474380]; McCallum M., 2021, BIORXIV2021201220284, DOI [10.1101/2021.12.28.474380, DOI 10.1101/2021.12.28.474380]; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Piccoli L, 2020, CELL, V183, P1024, DOI 10.1016/j.cell.2020.09.037; Pinto D, 2020, NATURE, V583, P290, DOI 10.1038/s41586-020-2349-y; Planas D., 2021, NATURE, DOI [10.1038/s41586-021-04389-z Medline, DOI 10.1038/S41586-021-04389-ZMEDLINE]; Planas D, 2021, NAT MED, V27, P917, DOI 10.1038/s41591-021-01318-5; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Roessler A, 2021, NEW ENGL J MED, DOI [10.1101/2021.12.08.21267491, DOI 10.1101/2021.12.08.21267491]; Rossler A., 2012, MEDRXIV2021201220082, V2021, DOI [10.1101/2021.12.08.21267491, DOI 10.1101/2021.12.08.21267491]; Saville J. W., 2021, BIORXIV2021200920024, V2021, DOI [10.1101/2021.09.02.458774, DOI 10.1101/2021.09.02.458774]; Starr TN, 2020, CELL, V182, P1295, DOI 10.1016/j.cell.2020.08.012; Tian F, 2021, ELIFE, V10, DOI 10.7554/eLife.69091; Tortorici MA, 2020, SCIENCE, V370, P950, DOI 10.1126/science.abe3354; VanBlargan LA, INFECTIOUS SARS COV, DOI [10.1101/2021.12.15.472828, DOI 10.1101/2021.12.15.472828]; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Wei CS, 2021, J GENET GENOMICS, V48, P1111, DOI 10.1016/j.jgg.2021.12.003; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1126/science.abb2507, 10.1101/2020.02.11.944462]; Zahradnik J, 2021, NAT MICROBIOL, V6, P1188, DOI 10.1038/s41564-021-00954-4; Zhang J, 2021, SCIENCE, V374, P1353, DOI [10.1126/science.abl9463, 10.1101/2021.08.17.456689]; Zhang J, 2021, SCIENCE, V372, P525, DOI 10.1126/science.abf2303; Zhu X, 2021, PLOS BIOL, V19, DOI 10.1371/journal.pbio.3001237	45	165	170	46	104	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 18	2022	375	6582					760	+		10.1126/science.abn7760	http://dx.doi.org/10.1126/science.abn7760			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZD4AQ	35050643				2022-12-28	WOS:000758142600044
J	Oliver, D				Oliver, David			David Oliver: The social care white paper provides few solutions to an urgent crisis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						Cabinet Office Department of Health and Social Care, 2021, 10 DOWN STREET BUILD; Department of health and Social Care, 2021, PEOPL HEART CAR AD S; Health Foundation King's Fund Nuffield Trust, 2019, CLOSING GAP KEY AREA; Rocks S, 2021, HLTH SOCIAL CARE FUN	4	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 19	2022	376								o107	10.1136/bmj.o107	http://dx.doi.org/10.1136/bmj.o107			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YL6WC	35046081	Bronze			2022-12-28	WOS:000746028500010
J	Torjesen, I				Torjesen, Ingrid			Covid-19: Intensive care units asked to take extra patients as hospitals struggle to find beds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Anandaciva S, 2020, CRITICAL CARE SERVIC	1	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 17	2022	376								o125	10.1136/bmj.o125	http://dx.doi.org/10.1136/bmj.o125			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YP6HX	35039321	Bronze			2022-12-28	WOS:000748724000003
J	Gandhi, RT; Malani, PN; del Rio, C				Gandhi, Rajesh T.; Malani, Preeti N.; del Rio, Carlos			COVID-19 Therapeutics for Nonhospitalized Patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Gandhi, Rajesh T.] Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Malani, Preeti N.] Univ Michigan Hlth Syst, Dept Internal Med, Div Infect Dis, Ann Arbor, MI USA; [del Rio, Carlos] Emory Univ, Sch Med, Dept Med, Georgia Grady Hlth Syst,Div Infect Dis, Atlanta, GA USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Michigan System; University of Michigan; Emory University	Gandhi, RT (corresponding author), Massachusetts Gen Hosp, Cox 548, Boston, MA 02114 USA.	rgandhi@mgh.harvard.edu	del Rio, Carlos/B-3763-2012	del Rio, Carlos/0000-0002-0153-3517	Harvard University Center for AIDS Research [NIAID 5P30AI060354]; AIDS Clinical Trials Group (NIH/NIAID) [UM1 AI069412-09]	Harvard University Center for AIDS Research; AIDS Clinical Trials Group (NIH/NIAID)	Dr Gandhi receives funding from the Harvard University Center for AIDS Research (NIAID 5P30AI060354) and AIDS Clinical Trials Group (NIH/NIAID UM1 AI069412-09).	Bernal AJ, 2022, NEW ENGL J MED, V386, P509, DOI 10.1056/NEJMoa2116044; Gandhi RT, 2020, NEW ENGL J MED, V383, P1757, DOI 10.1056/NEJMcp2009249; Gottlieb RL, 2022, NEW ENGL J MED, V386, P305, DOI 10.1056/NEJMoa2116846; Gupta A, 2021, NEW ENGL J MED, V385, P1941, DOI 10.1056/NEJMoa2107934; Infectious Disease Society of America, IDSA GUID TREATM MAN; National Institutes of Health, COR DIS 2019 COVID 1; Owen DR, 2021, SCIENCE, V374, P1586, DOI 10.1126/science.abl4784; Planas D., CONSIDERABLE ESCAPE, DOI [10.1101/2021.12.14.472630, DOI 10.1101/2021.12.14.472630]; US Food and Drug Administration, FACT SHEET HEALTHC P; Zhou ST, 2021, J INFECT DIS, V224, P415, DOI 10.1093/infdis/jiab247	10	22	23	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 15	2022	327	7					617	618		10.1001/jama.2022.0335	http://dx.doi.org/10.1001/jama.2022.0335		JAN 2022	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZD5SM	35029659				2022-12-28	WOS:000742417400001
J	Kitagawa, M; Wu, PP; Balkunde, R; Cunniff, P; Jackson, D				Kitagawa, Munenori; Wu, Peipei; Balkunde, Rachappa; Cunniff, Patrick; Jackson, David			An RNA exosome subunit mediates cell-to-cell trafficking of a homeobox mRNA via plasmodesmata	SCIENCE			English	Article							HOMEODOMAIN PROTEIN; ARABIDOPSIS; SHOOT; MOVEMENT; MULTIPLE; NUCLEAR; GROWTH; DOMAIN; GENES; RRP44	Messenger RNAs (mRNAs) function as mobile signals for cell-to-cell communication in multicellular organisms. The KNOTTED1 (KN1) homeodomain family transcription factors act non-cell autonomously to control stem cell maintenance in plants through cell-to-cell movement of their proteins and mRNAs through plasmodesmata; however, the mechanism of mRNA movement is largely unknown. We show that cell-to-cell movement of a KN1 mRNA requires ribosomal RNA-processing protein 44A (AtRRP44A), a subunit of the RNA exosome that processes or degrades diverse RNAs in eukaryotes. AtRRP44A can interact with plasmodesmata and mediates the cell-to-cell trafficking of KN1 mRNA, and genetic analysis indicates that AtRRP44A is required for the developmental functions of SHOOT MERISTEMLESS, an Arabidopsis KN1 homolog. Our findings suggest that AtRRP44A promotes mRNA trafficking through plasmodesmata to control stem cell-dependent processes in plants.	[Kitagawa, Munenori; Wu, Peipei; Balkunde, Rachappa; Cunniff, Patrick; Jackson, David] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Jackson, David] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan 430070, Peoples R China; [Balkunde, Rachappa] Bayer Crop Sci LLC, Chesterfield, MO 63017 USA	Cold Spring Harbor Laboratory; Huazhong Agricultural University	Jackson, D (corresponding author), Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA.	jacksond@cshl.edu		Cunniff, Patrick/0000-0002-7761-6810; Kitagawa, Munenori/0000-0002-2766-3889; Balkunde, Rachappa/0000-0002-6059-9532	National Science Foundation [IOS-1930101]; Next-Generation BioGreen 21 Program (System & Synthetic Agro-biotech Center), Rural Development Administration, Republic of Korea [PJ01322602]; Cold Spring Harbor Laboratory's Undergraduate Research Program	National Science Foundation(National Science Foundation (NSF)); Next-Generation BioGreen 21 Program (System & Synthetic Agro-biotech Center), Rural Development Administration, Republic of Korea; Cold Spring Harbor Laboratory's Undergraduate Research Program	This research is supported by the National Science Foundation (IOS-1930101) and the Next-Generation BioGreen 21 Program (System & Synthetic Agro-biotech Center, project no. PJ01322602), Rural Development Administration, Republic of Korea. P.C. was supported by the Cold Spring Harbor Laboratory's Undergraduate Research Program.	Balkunde R, 2017, PLANT J, V90, P435, DOI 10.1111/tpj.13504; Bayer EM, 2006, PROTEOMICS, V6, P301, DOI 10.1002/pmic.200500046; Brunkard JO, 2017, CURR OPIN PLANT BIOL, V35, P76, DOI 10.1016/j.pbi.2016.11.007; Chekanova JA, 2007, CELL, V131, P1340, DOI 10.1016/j.cell.2007.10.056; Chen J., 1994, MAIZE HDB, P526, DOI [10.1007/978-1-4612-2694-9_85, DOI 10.1007/978-1-4612-2694-9_85]; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Davis AM, 2009, PLANT METHODS, V5, DOI 10.1186/1746-4811-5-3; Dubnau J, 1996, NATURE, V379, P694, DOI 10.1038/379694a0; Dziembowski A, 2007, NAT STRUCT MOL BIOL, V14, P15, DOI 10.1038/nsmb1184; Fekih R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068529; Fernandez-Calvino L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018880; Ghate TH, 2017, PLANT MOL BIOL, V93, P563, DOI 10.1007/s11103-016-0582-4; Haimovich G, 2017, P NATL ACAD SCI USA, V114, pE9873, DOI 10.1073/pnas.1706365114; JACKSON D, 1994, DEVELOPMENT, V120, P405; Kanrar S, 2006, PLANTA, V224, P1163, DOI 10.1007/s00425-006-0298-9; Kilchert C, 2020, METHODS MOL BIOL, V2062, P215, DOI 10.1007/978-1-4939-9822-7_11; Kilchert C, 2016, NAT REV MOL CELL BIO, V17, P227, DOI 10.1038/nrm.2015.15; Kim G, 2014, SCIENCE, V345, P808, DOI 10.1126/science.1253122; Kim JY, 2005, GENE DEV, V19, P788, DOI 10.1101/gad.332805; Kim JY, 2003, DEVELOPMENT, V130, P4351, DOI 10.1242/dev.00618; Kitagawa M, 2017, PLANTS-BASEL, V6, DOI 10.3390/plants6010012; Kumakura N, 2016, PLANT BIOTECHNOL-NAR, V33, P77, DOI 10.5511/plantbiotechnology.16.0316a; Kumakura N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079219; Lange H, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004564; Li ZP, 2021, CELL MOL LIFE SCI, V78, P799, DOI 10.1007/s00018-020-03622-8; Lionnet T, 2011, NAT METHODS, V8, P165, DOI 10.1038/NMETH.1551; Liu L, 2018, CELL REP, V23, P1879, DOI 10.1016/j.celrep.2018.04.033; Long JA, 1996, NATURE, V379, P66, DOI 10.1038/379066a0; Lorentzen E, 2008, MOL CELL, V29, P717, DOI 10.1016/j.molcel.2008.02.018; Lu KJ, 2012, RNA BIOL, V9, P653, DOI 10.4161/rna.19965; LUCAS WJ, 1995, SCIENCE, V270, P1980, DOI 10.1126/science.270.5244.1980; Luo KR, 2018, PLANT PHYSIOL, V177, P604, DOI 10.1104/pp.18.00107; Makino DL, 2013, NATURE, V495, P70, DOI 10.1038/nature11870; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; Notaguchi M, 2012, J INTEGR PLANT BIOL, V54, P760, DOI 10.1111/j.1744-7909.2012.01155.x; OHKURA H, 1988, EMBO J, V7, P1465, DOI 10.1002/j.1460-2075.1988.tb02964.x; OPPENHEIMER DG, 1991, CELL, V67, P483, DOI 10.1016/0092-8674(91)90523-2; Sambade A, 2008, TRAFFIC, V9, P2073, DOI 10.1111/j.1600-0854.2008.00824.x; Snee MJ, 2016, GENETICS, V203, P749, DOI 10.1534/genetics.116.187930; Tomecki R, 2014, NUCLEIC ACIDS RES, V42, P1270, DOI 10.1093/nar/gkt930; Winter N, 2007, PLANT CELL, V19, P3001, DOI 10.1105/tpc.107.044354; Wu G, 2007, P NATL ACAD SCI USA, V104, P18813, DOI 10.1073/pnas.0705082104; Xu F., 2015, BIO-PROTOCOL, V5, P1520, DOI [10.21769/BioProtoc.1520, DOI 10.21769/BIOPROTOC.1520]; Xu XM, 2011, SCIENCE, V333, P1141, DOI 10.1126/science.1205727; Yang L, 2019, CURR BIOL, V29, P2465, DOI 10.1016/j.cub.2019.06.042; Zavaliev R, 2015, METHODS MOL BIOL, V1217, P105, DOI 10.1007/978-1-4939-1523-1_7; Zhang WP, 2010, P NATL ACAD SCI USA, V107, P15981, DOI 10.1073/pnas.1007060107; Zinder JC, 2017, GENE DEV, V31, P88, DOI 10.1101/gad.294769.116	48	3	3	19	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2022	375	6577					177	+		10.1126/science.abm0840	http://dx.doi.org/10.1126/science.abm0840			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YG3OI	35025667				2022-12-28	WOS:000742401600030
J	Augst, C				Augst, Charlotte			If we are going to learn to live with covid, then we need to listen to people living with ill health	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 13	2022	376								o49	10.1136/bmj.o49	http://dx.doi.org/10.1136/bmj.o49			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZE9IW	35027363	Bronze			2022-12-28	WOS:000759191400012
J	Hayes, KN; Brown, KA; Cheung, AM; Kim, SA; Juurlink, DN; Cadarette, SM				Hayes, Kaleen N.; Brown, Kevin A.; Cheung, Angela M.; Kim, Sandra A.; Juurlink, David N.; Cadarette, Suzanne M.			Comparative Fracture Risk During Osteoporosis Drug Holidays After Long-Term Risedronate Versus Alendronate Therapy A Propensity Score-Matched Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							IDENTIFYING PATIENTS; ADMINISTRATIVE DATA; BISPHOSPHONATES; VALIDATION; CARE; INTERVENTION; MANAGEMENT; BONE	Background: An osteoporosis drug holiday is recommended for most patients after 3 to 5 years of therapy. Risedronate has a shorter half-life than alendronate, and thus the residual length of fracture protection may be shorter. Objective: To examine the comparative risks of drug holidays after long-term (>= 3 years) risedronate versus alendronate therapy. Design: Population-based, matched, cohort study. Setting: Province-wide health care administrative databases providing comprehensive coverage to Ontario residents aged 65 years or older between November 2000 and March 2020. Patients: Persons aged 66 years drug holiday were matched 1:1 on propensity score to those who had long-term alendronate therapy and a drug holiday. Measurements: The primary outcome was hip fracture within 3 years after a 120-day ascertainment period. Secondary analyses included shorter follow-up and sex-specific estimates. Cox proportional hazards models were used to estimate hazard ratios (HRs) for fracture risk between groups. Results: A total of 25077 propensity score-matched pairs were eligible (mean age, 81 years; 81% women). Hip fracture rates were higher among risedronate than alendronate drug holidays (12.4 and 10.6 events, respectively, per 1000 patient-years; HR, 1.18 [95% CI, 1.04 to 1.34]; 915 total hip fractures). The association was attenuated when any fracture was included as the outcome (HR, 1.07 [CI, 1.00 to 1.16]) and with shorter drug holidays (1 year: HR, 1.03 [CI, 0.85 to 1.24]; 2 years: HR, 1.14 [CI, 0.96 to 1.32]). Limitation: Analyses were limited to health care administrative data (potential unmeasured confounding), and some secondary analyses contained few events. Conclusion: Drug holidays after long-term therapy with risedronate were associated with a small increase in risk for hip fracture compared with alendronate drug holidays. Future research should examine how best to mitigate this risk.	[Hayes, Kaleen N.] Brown Univ, Sch Publ Hlth, 121 South Main St,Box G-5121-8, Providence, RI 02903 USA; [Hayes, Kaleen N.; Cheung, Angela M.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Brown, Kevin A.; Juurlink, David N.] Univ Toronto, Dalla Lana Sch Publ Hlth, ICES, Toronto, ON, Canada; [Brown, Kevin A.] Publ Hlth Ontario, Toronto, ON, Canada; [Cheung, Angela M.; Kim, Sandra A.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Cheung, Angela M.] Univ Hlth Network, Toronto, ON, Canada; [Kim, Sandra A.] Womens Coll Hosp, Ctr Osteoporosis & Bone Hlth, Toronto, ON, Canada; [Juurlink, David N.] Sunnybrook Res Inst, Toronto, ON, Canada; [Cadarette, Suzanne M.] Univ Toronto, Leslie & Fac Pharm, Toronto, ON, Canada; [Cadarette, Suzanne M.] ICES, Toronto, ON, Canada; [Cadarette, Suzanne M.] Univ N Carolina, Eshelman Sch Pharm, Chapel Hill, NC 27515 USA	Brown University; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; University of North Carolina; University of North Carolina Chapel Hill	Hayes, KN (corresponding author), Brown Univ, Sch Publ Hlth, 121 South Main St,Box G-5121-8, Providence, RI 02903 USA.; Hayes, KN (corresponding author), Brown Univ, Sch Publ Hlth, 121 South Main St,Box G-S121-8, Providence, RI 02903 USA.	kaley_hayes@brown.edu		Cheung, Angela M./0000-0001-8332-0744; Hayes, Kaleen/0000-0002-1122-0071; Brown, Kevin Antoine/0000-0002-1483-2188	Canadian Institutes of Health Research [PJT-16913, GSD-16412]; Drug Safety and Effectiveness CrossDisciplinary Training program; Ontario Drug Policy Research Network; Tier 1 Canada Research Chair in Musculoskeletal and Postmenopausal Health; ICES - Ontario Ministry of Health; Leslie Dan Faculty of Pharmacy	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Drug Safety and Effectiveness CrossDisciplinary Training program; Ontario Drug Policy Research Network; Tier 1 Canada Research Chair in Musculoskeletal and Postmenopausal Health; ICES - Ontario Ministry of Health; Leslie Dan Faculty of Pharmacy	By a Canadian Institutes of Health Research Project Grant (PJT-16913). Dr. Hayes was supported by a Canadian Institutes of Health Research Doctoral Research Award (GSD-16412), the Drug Safety and Effectiveness CrossDisciplinary Training program, and the Ontario Drug Policy Research Network during this project. Dr. Cheung is supported by a Tier 1 Canada Research Chair in Musculoskeletal and Postmenopausal Health. This study was supported by ICES, which is funded by an annual grant from the Ontario Ministry of Health. All analyses were completed at the ICES University of Toronto site, supported by the Leslie Dan Faculty of Pharmacy. Parts of this material are based on data and information compiled and provided by the Ministry of Health, the Canadian Institute for Health Information, Cancer Care Ontario, and IQVIA Solutions.	Adler RA, 2016, J BONE MINER RES, V31, P16, DOI 10.1002/jbmr.2708; Allergan Pharma Co, 2017, PROD MON ACTONEL ACT; Alzahrani K, 2010, CAN J SURG, V53, P294; Amiche MA, 2016, OSTEOPOROSIS INT, V27, P1989, DOI 10.1007/s00198-015-3476-4; Amiche MA, 2018, J BONE MINER RES, V33, P419, DOI 10.1002/jbmr.3318; Austin PC, 2013, STAT MED, V32, P2837, DOI 10.1002/sim.5705; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Benchimol EI, 2014, J CLIN EPIDEMIOL, V67, P887, DOI 10.1016/j.jclinepi.2014.02.019; Black DM, 2020, NEW ENGL J MED, V383, P743, DOI 10.1056/NEJMoa1916525; Black DM, 2006, JAMA-J AM MED ASSOC, V296, P2927, DOI 10.1001/jama.296.24.2927; Cadarette SM, 2008, ANN INTERN MED, V148, P637, DOI 10.7326/0003-4819-148-9-200805060-00003; Cadarette Suzanne M, 2013, CMAJ Open, V1, pE97, DOI 10.9778/cmajo.20130036; Curtis JR, 2009, OSTEOPOROSIS INT, V20, P973, DOI 10.1007/s00198-008-0772-2; Curtis JR, 2020, MED CARE, V58, P419, DOI 10.1097/MLR.0000000000001294; Eastell R, 2019, J CLIN ENDOCR METAB, V104, P1595, DOI 10.1210/jc.2019-00221; Fink HA, 2019, AHRQ PUBLICATION, V19; Gershon AS, 2009, CAN RESPIR J, V16, P183, DOI 10.1155/2009/963098; Hayes KN, 2021, OSTEOPOROSIS INT, V32, P1413, DOI 10.1007/s00198-020-05794-2; Hayes KN, 2019, OSTEOPOROSIS INT, V30, P2311, DOI 10.1007/s00198-019-05061-z; LIN DY, 1993, BIOMETRIKA, V80, P557, DOI 10.2307/2337177; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; Lipscombe L, 2018, CAN J DIABETES, V42, pS88, DOI 10.1016/j.jcjd.2017.10.034; Lix LM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-301; Marshall D, 1996, BRIT MED J, V312, P1254, DOI 10.1136/bmj.312.7041.1254; Martin D, 2018, LANCET, V391, P1718, DOI 10.1016/S0140-6736(18)30181-8; Mathur MB, 2018, EPIDEMIOLOGY, V29, pE45, DOI 10.1097/EDE.0000000000000864; Nancollas GH, 2006, BONE, V38, P617, DOI 10.1016/j.bone.2005.05.003; Naylor KE, 2019, OSTEOPOROSIS INT, V30, P917, DOI 10.1007/s00198-018-04823-5; Naylor KE, 2018, OSTEOPOROSIS INT, V29, P1407, DOI 10.1007/s00198-018-4460-6; O'Donnell S, 2013, ARCH OSTEOPOROS, V8, DOI 10.1007/s11657-013-0143-2; Ontario Ministry of Health, 2021, GET COV PRESCR DRUGS; Papadimitriou N, 2017, LANCET PUBLIC HEALTH, V2, pE239, DOI 10.1016/S2468-2667(17)30046-4; Papaioannou A, 2010, CAN MED ASSOC J, V182, P1864, DOI 10.1503/cmaj.100771; Rosenbaum PR, 2020, ANNU REV STAT APPL, V7, P143, DOI 10.1146/annurev-statistics-031219-041058; Russell RGG, 2008, OSTEOPOROSIS INT, V19, P733, DOI 10.1007/s00198-007-0540-8; Schilcher J, 2015, ACTA ORTHOP, V86, P100, DOI 10.3109/17453674.2015.1004149; Schultz SE, 2013, CHRON DIS INJ CAN, V33, P160; Solling AS, 2021, OSTEOPOROSIS INT, V32, P1557, DOI 10.1007/s00198-021-05835-4; Statistics Canada, 2017, CENS PROF 2016 CENS; Tu Karen, 2007, Open Med, V1, pe18; VanderWeele TJ, 2017, ANN INTERN MED, V167, P268, DOI 10.7326/M16-2607; Watts NB, 2008, OSTEOPOROSIS INT, V19, P365, DOI 10.1007/s00198-007-0460-7; Wells G, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004523.pub3; Wells GA, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001155.pub2; Widdifield J, 2013, ARTHRIT CARE RES, V65, P1582, DOI 10.1002/acr.22031	45	4	4	1	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR	2022	175	3					335	+		10.7326/M21-2512	http://dx.doi.org/10.7326/M21-2512		JAN 2022	12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0O5UF	35007149				2022-12-28	WOS:000743552700001
J	Robinson, A				Robinson, Andrew			The Red Sea Scrolls	SCIENCE			English	Book Review												andrew@andrew-robinson.org						TALLET P, 2022, THE RED SEA SCROLLS	1	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 7	2022	375	6576					34	34		10.1126/science.abl9126	http://dx.doi.org/10.1126/science.abl9126			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YD3FW	34990232				2022-12-28	WOS:000740261400031
J	Yasuhara, M; Deutsch, CA				Yasuhara, Moriaki; Deutsch, Curtis A.			Paleobiology provides glimpses of future ocean	SCIENCE			English	Editorial Material							CLIMATE-CHANGE		[Yasuhara, Moriaki] Univ Hong Kong, Sch Biol Sci, Area Ecol & Biodivers, Swire Inst Marine Sci, Kadoorie Biol Sci Bldg,Pokfulam Rd, Hong Kong, Peoples R China; [Yasuhara, Moriaki] Univ Hong Kong, State Key Lab Marine Pollut, Kadoorie Biol Sci Bldg,Pokfulam Rd, Hong Kong, Peoples R China; [Deutsch, Curtis A.] Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA; [Deutsch, Curtis A.] Princeton Univ, High Meadows Environm Inst, Princeton, NJ 08544 USA	University of Hong Kong; University of Hong Kong; Princeton University; Princeton University	Yasuhara, M (corresponding author), Univ Hong Kong, Sch Biol Sci, Area Ecol & Biodivers, Swire Inst Marine Sci, Kadoorie Biol Sci Bldg,Pokfulam Rd, Hong Kong, Peoples R China.; Yasuhara, M (corresponding author), Univ Hong Kong, State Key Lab Marine Pollut, Kadoorie Biol Sci Bldg,Pokfulam Rd, Hong Kong, Peoples R China.	yasuhara@hku.hk						Alexander L.V., 2013, CLIM CHANG 2013 PHYS; Baxter JM, 2016, EXPLAINING OCEAN WAR; Chaudhary C, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2015094118; Chavez FP, 2008, PROG OCEANOGR, V79, P95, DOI 10.1016/j.pocean.2008.10.012; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Howard EM, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aay3188; Hunt G, 2006, P NATL ACAD SCI USA, V103, P1347, DOI 10.1073/pnas.0510550103; Kiessling W, 2012, P NATL ACAD SCI USA, V109, P21378, DOI 10.1073/pnas.1214037110; Lefevre S, 2017, GLOBAL CHANGE BIOL, V23, P3449, DOI 10.1111/gcb.13652; Pinsky ML, 2020, ANNU REV MAR SCI, V12, P153, DOI 10.1146/annurev-marine-010419-010916; Portner HO, 2010, J EXP BIOL, V213, P881, DOI 10.1242/jeb.037523; Salvatteci R, 2022, SCIENCE, V375, P101, DOI 10.1126/science.abj0270; Verberk WCEP, 2021, BIOL REV, V96, P247, DOI 10.1111/brv.12653; Yasuhara M, 2020, P NATL ACAD SCI USA, V117, P12891, DOI 10.1073/pnas.1916923117	14	5	5	4	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 7	2022	375	6576					25	26		10.1126/science.abn2384	http://dx.doi.org/10.1126/science.abn2384			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YD3FW	34990227				2022-12-28	WOS:000740261400025
J	Rogers, E; Cusnir, M				Rogers, Everett; Cusnir, Mike			Gingival Infiltration in Acute Monocytic Leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Rogers, Everett; Cusnir, Mike] Mt Sinai Med Ctr, Miami, FL 33140 USA	Mount Sinai Medical Center	Cusnir, M (corresponding author), Mt Sinai Med Ctr, Miami, FL 33140 USA.	mike.cusnir@msmc.com							0	0	0	1	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 6	2022	386	1					79	79		10.1056/NEJMicm2113297	http://dx.doi.org/10.1056/NEJMicm2113297			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YC1QX	34986288				2022-12-28	WOS:000739473800013
J	Batchinsky, A; Roberts, T; Cancio, L				Batchinsky, Andriy; Roberts, Teryn; Cancio, Leopoldo			Extracorporeal Carbon Dioxide Removal vs Standard Care Ventilation Effect on 90-Day Mortality in Patients With Acute Hypoxemic Respiratory Failure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							MECHANICAL VENTILATION		[Batchinsky, Andriy; Roberts, Teryn] Geneva Fdn, Autonomous Reanimat & Evacuat AREVA Res Program, 2509 Kennedy Cir,Bldg 125, San Antonio, TX 78235 USA; [Cancio, Leopoldo] Inst Surg Res, US Army Burn Unit, Ft Sam Houston, TX USA		Batchinsky, A (corresponding author), Geneva Fdn, Autonomous Reanimat & Evacuat AREVA Res Program, 2509 Kennedy Cir,Bldg 125, San Antonio, TX 78235 USA.	abatchinsky@genevausa.org						Batchinsky AI, 2011, CRIT CARE MED, V39, P1382, DOI 10.1097/CCM.0b013e31820eda45; Bein T, 2013, INTENS CARE MED, V39, P847, DOI 10.1007/s00134-012-2787-6; Dembinski R, 2007, CRIT CARE MED, V35, P2359, DOI 10.1097/01.CCM.0000281857.87354.A5; McNamee JJ, 2021, JAMA-J AM MED ASSOC, V326, P1013, DOI 10.1001/jama.2021.13374	4	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 4	2022	327	1					82	83						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YF7YT	34982125				2022-12-28	WOS:000742019000036
J	Gulpen, AJW; Teijink, JAW				Gulpen, Anouk J. W.; Teijink, Joep A. W.			Pectoralis minor muscle causes venous thoracic outlet syndrome: visualised using venography	LANCET			English	Editorial Material									[Gulpen, Anouk J. W.] Elkerliek Hosp, Dept Internal Med, NL-5707 HA Helmond, Netherlands; [Teijink, Joep A. W.] Catharina Hosp, Dept Vasc Surg, Eindhoven, Netherlands	Catharina Hospital	Gulpen, AJW (corresponding author), Elkerliek Hosp, Dept Internal Med, NL-5707 HA Helmond, Netherlands.	anoukgulpen@gmail.com							0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN	2022	399	10320					E1	E1						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YD7YG	34998504				2022-12-28	WOS:000740652500001
J	Liu, LH; Iketani, S; Guo, YC; Chan, JFW; Wang, M; Liu, LY; Luo, Y; Chu, H; Huang, YM; Nair, MS; Yu, J; Chik, KKH; Yuen, TTT; Yoon, C; To, KKW; Chen, HL; Yin, MT; Sobieszczyk, ME; Huang, YX; Wang, HH; Sheng, ZZ; Yuen, KY; Ho, DD				Liu, Lihong; Iketani, Sho; Guo, Yicheng; Chan, Jasper F-W; Wang, Maple; Liu, Liyuan; Luo, Yang; Chu, Hin; Huang, Yiming; Nair, Manoj S.; Yu, Jian; Chik, Kenn K-H; Yuen, Terrence T-T; Yoon, Chaemin; To, Kelvin K-W; Chen, Honglin; Yin, Michael T.; Sobieszczyk, Magdalena E.; Huang, Yaoxing; Wang, Harris H.; Sheng, Zizhang; Yuen, Kwok-Yung; Ho, David D.			Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2	NATURE			English	Article								The B.1.1.529/Omicron variant of SARS-CoV-2 was only recently detected in southern Africa, but its subsequent spread has been extensive, both regionally and globally(1). It is expected to become dominant in the coming weeks(2), probably due to enhanced transmissibility. A striking feature of this variant is the large number of spike mutations(3) that pose a threat to the efficacy of current COVID-19 vaccines and antibody therapies(4). This concern is amplified by the findings of our study. Here we found that B.1.1.529 is markedly resistant to neutralization by serum not only from patients who recovered from COVID-19, but also from individuals who were vaccinated with one of the four widely used COVID-19 vaccines. Even serum from individuals who were vaccinated and received a booster dose of mRNA-based vaccines exhibited substantially diminished neutralizing activity against B.1.1.529. By evaluating a panel of monoclonal antibodies against all known epitope clusters on the spike protein, we noted that the activity of 17 out of the 19 antibodies tested were either abolished or impaired, including ones that are currently authorized or approved for use in patients. Moreover, we also identified four new spike mutations (S371L, N440K, G446S and Q493R) that confer greater antibody resistance on B.1.1.529. The Omicron variant presents a serious threat to many existing COVID-19 vaccines and therapies, compelling the development of new interventions that anticipate the evolutionary trajectory of SARS-CoV-2.	[Liu, Lihong; Iketani, Sho; Guo, Yicheng; Wang, Maple; Luo, Yang; Nair, Manoj S.; Yu, Jian; Yin, Michael T.; Sobieszczyk, Magdalena E.; Huang, Yaoxing; Sheng, Zizhang; Ho, David D.] Columbia Univ, Aaron Diamond AIDS Res Ctr, Vagelos Coll Phys & Surg, New York, NY 10032 USA; [Iketani, Sho; Ho, David D.] Columbia Univ, Dept Microbiol & Immunol, Vagelos Coll Phys & Surg, New York, NY 10032 USA; [Chan, Jasper F-W; Chu, Hin; Yuen, Terrence T-T; Yoon, Chaemin; To, Kelvin K-W; Chen, Honglin; Yuen, Kwok-Yung] Univ Hong Kong, State Key Lab Emerging Infect Dis, Carol Yu Ctr Infect, Dept Microbiol,Li Ka Shing Fac Med, Hong Kong, Peoples R China; [Chan, Jasper F-W; Chu, Hin; Chik, Kenn K-H; To, Kelvin K-W; Chen, Honglin; Yuen, Kwok-Yung] Ctr Virol Vaccinol & Therapeut, Hong Kong, Peoples R China; [Liu, Liyuan; Huang, Yiming; Wang, Harris H.] Columbia Univ, Dept Syst Biol, Vagelos Coll Phys & Surg, New York, NY USA; [Yin, Michael T.; Sobieszczyk, Magdalena E.; Ho, David D.] Columbia Univ, Dept Med, Div Infect Dis, Vagelos Coll Phys & Surg, New York, NY 10032 USA	Columbia University; Columbia University; University of Hong Kong; Columbia University; Columbia University	Ho, DD (corresponding author), Columbia Univ, Aaron Diamond AIDS Res Ctr, Vagelos Coll Phys & Surg, New York, NY 10032 USA.; Ho, DD (corresponding author), Columbia Univ, Dept Microbiol & Immunol, Vagelos Coll Phys & Surg, New York, NY 10032 USA.; Ho, DD (corresponding author), Columbia Univ, Dept Med, Div Infect Dis, Vagelos Coll Phys & Surg, New York, NY 10032 USA.	dh2994@cumc.columbia.edu	Sheng, Zizhang/AFR-8049-2022; liu, li/HGC-0900-2022; CHU, HIN/ABU-1193-2022; Nair, Manoj/B-4389-2009; Chan, Jasper F. W./D-8007-2013	Sheng, Zizhang/0000-0002-3253-3309; CHU, HIN/0000-0003-2855-9837; Nair, Manoj/0000-0002-5994-3957; Chan, Jasper F. W./0000-0001-6336-6657; Iketani, Sho/0000-0002-3733-9556; Guo, Yicheng/0000-0001-5357-660X; Huang, Yiming/0000-0003-1932-2803	Gates Foundation; JPB Foundation; Health@InnoHK; National Science Foundation [MCB-2032259]	Gates Foundation(Bill & Melinda Gates Foundation); JPB Foundation; Health@InnoHK; National Science Foundation(National Science Foundation (NSF))	We thank the staff at Regeneron Pharmaceuticals, B. Zhang and P. Kwong (NIAID), and B. Dekosky (MIT) for antibodies. This study was supported by funding from the Gates Foundation, the JPB Foundation, A. and P. Cherng, S. Yin, C. Ludwig, D. and R. Wu, Health@InnoHK and the National Science Foundation (MCB-2032259).	Abu-Raddad LJ, 2021, NEW ENGL J MED, V385, P187, DOI 10.1056/NEJMc2104974; Amanat F, 2021, CELL, V184, P3936, DOI 10.1016/j.cell.2021.06.005; Annavajhala MK, 2021, NATURE, V597, P703, DOI [10.1038/s41586-021-03908-2, 10.1101/2021.02.23.21252259]; Banach BB, 2021, CELL REP, V37, DOI [10.1016/j.celrep.2021.109771, 10.1101/2020.12.31.424987]; Barnes CO, 2020, NATURE, V588, P682, DOI 10.1038/s41586-020-2852-1; Baym M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128036; Bernal JL, 2021, NEW ENGL J MED, V385, P585, DOI 10.1056/NEJMoa2108891; Cameroni E, 2022, NATURE, V602, P664, DOI [10.1038/s41586-021-04386-2, 10.1101/2021.12.12.472269]; Cerutti G, 2021, CELL REP, V37, DOI [10.1016/j.celrep.2021.109928, 10.1101/2021.06.29.450397]; Cerutti G, 2021, CELL HOST MICROBE, V29, P819, DOI 10.1016/j.chom.2021.03.005; Chu H, 2020, LANCET MICROBE, V1, pE14, DOI 10.1016/S2666-5247(20)30004-5; Cromer D, 2022, LANCET MICROBE, V3, pE52, DOI 10.1016/S2666-5247(21)00267-6; Davies NG, 2021, SCIENCE, V372, P149, DOI 10.1126/science.abg3055; Doria-Rose N. A, BOOSTER MRNA 1273 VA, DOI [10.1101/2021.12.15.21267805(2021), DOI 10.1101/2021.12.15.21267805(2021)]; Faria NR, 2021, SCIENCE, V372, P815, DOI [10.1126/science.abh2644Article, 10.1126/science.abh2644, 10.1101/2021.02.26.21252554]; Garcia-Beltran W. F, CELL, DOI [10.1016/j.cell.2021.12.033(2022, DOI 10.1016/J.CELL.2021.12.033(2022]; Grabowski F., OMICRON STRAIN SPREA, DOI [10.1101/2021.12.08.21267494(2021, DOI 10.1101/2021.12.08.21267494(2021]; Hacisuleyman E, 2021, NEW ENGL J MED, V384, P2212, DOI [10.1056/NEJMc2107808, 10.1056/NEJMoa2105000]; Hadfield J, 2018, BIOINFORMATICS, V34, P4121, DOI 10.1093/bioinformatics/bty407; Hansen J, 2020, SCIENCE, V369, P1010, DOI 10.1126/science.abd0827; Jones BE, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abf1906; Ju B, 2020, NATURE, V584, P115, DOI 10.1038/s41586-020-2380-z; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li DP, 2021, CELL, V184, P4203, DOI 10.1016/j.cell.2021.06.021; Liu L, ISOLATION COMP ANAL, DOI [10.1101/2021.12.11.472236(2021, DOI 10.1101/2021.12.11.472236(2021]; Liu LH, 2020, NATURE, V584, P450, DOI 10.1038/s41586-020-2571-7; Madhi SA, 2021, NEW ENGL J MED, V384, P1885, DOI 10.1056/NEJMoa2102214; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Mlcochova P, 2021, NATURE, V599, P114, DOI 10.1038/s41586-021-03944-y; Pinto D, 2020, NATURE, V583, P290, DOI 10.1038/s41586-020-2349-y; Planas D, NATURE, DOI [10.1038/s41586-021-04389-z(2021, DOI 10.1038/S41586-021-04389-Z(2021]; Pulliam JRC., 2021, INCREASED RISK SARS, DOI [10.1101/2021.11.11.21266068, 10.1101/2021.11.11.21266068:2021.11.11.21266068, DOI 10.1101/2021.11.11.21266068:2021.11.11.21266068]; Rappazzo CG, 2021, SCIENCE, V371, P823, DOI 10.1126/science.abf4830; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Sadoff J, 2021, NEW ENGL J MED, V384, P2187, DOI 10.1056/NEJMoa2101544; Schmidt F, NEW ENGL J MED, DOI [10.1056/NEJMc2119641(2021, DOI 10.1056/NEJMC2119641(2021]; Scott L, 2021, SCIENCE, V374, P1454, DOI 10.1126/science.abn4543; Shi R, 2020, NATURE, V584, P120, DOI 10.1038/s41586-020-2381-y; Shu YL, 2017, EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.13.30494; Starr TN, 2021, CELL REP MED, V2, DOI 10.1016/j.xcrm.2021.100255; Tegally H, 2021, NATURE, V592, P438, DOI 10.1038/s41586-021-03402-9; Tortorici MA, 2021, NATURE, V597, P103, DOI 10.1038/s41586-021-03817-4; Uriu K, 2021, NEW ENGL J MED, V385, DOI 10.1056/NEJMc2114706; Wang PF, 2021, NATURE, V593, P130, DOI 10.1038/s41586-021-03398-2; Wroughton L., 2021, WASHINGTON POST 1214; Zhang WJ, 2021, JAMA-J AM MED ASSOC, V325, P1324, DOI 10.1001/jama.2021.1612; Zost SJ, 2020, NATURE, V584, P443, DOI 10.1038/s41586-020-2548-6	48	338	339	63	117	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 24	2022	602	7898					676	+		10.1038/s41586-021-04388-0	http://dx.doi.org/10.1038/s41586-021-04388-0		DEC 2021	19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZG7GF	35016198	Green Submitted, Bronze			2022-12-28	WOS:000756560800005
J	Planas, D; Saunders, N; Maes, P; Guivel-Benhassine, F; Planchais, C; Buchrieser, J; Bolland, WH; Porrot, F; Staropoli, I; Lemoine, F; Pere, H; Veyer, D; Puech, J; Rodary, J; Baela, G; Dellicour, S; Raymenants, J; Gorissen, S; Geenen, C; Vanmechelen, B; Wawina-Bokalanga, T; Marti-Carrerasi, J; Cuypers, L; Seve, A; Hocqueloux, L; Prazuck, T; Rey, F; Simon-Lorriere, E; Bruel, T; Mouquet, H; Andre, E; Schwartz, O				Planas, Delphine; Saunders, Nell; Maes, Piet; Guivel-Benhassine, Florence; Planchais, Cyril; Buchrieser, Julian; Bolland, William-Henry; Porrot, Francoise; Staropoli, Isabelle; Lemoine, Frederic; Pere, Helene; Veyer, David; Puech, Julien; Rodary, Julien; Baela, Guy; Dellicour, Simon; Raymenants, Joren; Gorissen, Sarah; Geenen, Caspar; Vanmechelen, Bert; Wawina-Bokalanga, Tony; Marti-Carrerasi, Joan; Cuypers, Lize; Seve, Aymeric; Hocqueloux, Laurent; Prazuck, Thierry; Rey, Felix; Simon-Lorriere, Etienne; Bruel, Timothee; Mouquet, Hugo; Andre, Emmanuel; Schwartz, Olivier			Considerable escape of SARS-CoV-2 Omicron to antibody neutralization	NATURE			English	Article							EFFICIENT GENERATION	The SARS-CoV-2 Omicron variant was first identified in November 2021 in Botswana and South Africa(1-3). It has since spread to many countries and is expected to rapidly become dominant worldwide. The lineage is characterized by the presence of around 32 mutations in spike-located mostly in the N-terminal domain and the receptor-binding domain-that may enhance viral fitness and enable antibody evasion. Here we isolated an infectious Omicron virus in Belgium from a traveller returning from Egypt. We examined its sensitivity to nine monoclonal antibodies that have been clinically approved or are in development(4), and to antibodies present in 115 serum samples from COVID-19 vaccine recipients or individuals who have recovered from COVID-19. Omicron was completely or partially resistant to neutralization by all monoclonal antibodies tested. Sera from recipients of the Pfizer or AstraZeneca vaccine, sampled five months after complete vaccination, barely inhibited Omicron. Sera from COVID-19-convalescent patients collected 6 or 12 months after symptoms displayed low or no neutralizing activity against Omicron. Administration of a booster Pfizer dose as well as vaccination of previously infected individuals generated an anti-Omicron neutralizing response, with titres 6-fold to 23-fold lower against Omicron compared with those against Delta. Thus, Omicron escapes most therapeutic monoclonal antibodies and, to a large extent, vaccine-elicited antibodies. However, Omicron is neutralized by antibodies generated by a booster vaccine dose.	[Planas, Delphine; Saunders, Nell; Guivel-Benhassine, Florence; Buchrieser, Julian; Bolland, William-Henry; Porrot, Francoise; Staropoli, Isabelle; Bruel, Timothee; Schwartz, Olivier] Univ Paris, Inst Pasteur, Virus & Immun Unit, CNRS UMR3569, Paris, France; [Planas, Delphine; Bruel, Timothee; Schwartz, Olivier] Vaccine Res Inst, Creteil, France; [Saunders, Nell; Bolland, William-Henry] Univ Paris, Ecole Doctorate BioSPC 562, Paris, France; [Maes, Piet; Baela, Guy; Dellicour, Simon; Vanmechelen, Bert; Wawina-Bokalanga, Tony; Marti-Carrerasi, Joan] Katholieke Univ Leuven, Dept Microbiol, Lab Clin & Epidemiol Virol Immunol & Transplantat, Rega Inst, Leuven, Belgium; [Planchais, Cyril; Mouquet, Hugo] Univ Paris, Inst Pasteur, Humorat Immunol Lab, INSERM U1222, Paris, France; [Lemoine, Frederic] Univ Paris, Inst Pasteur, Hub Bioinformat & Biostat, CNRS USR 3756, Paris, France; [Pere, Helene; Veyer, David; Puech, Julien; Rodary, Julien] Hop Europeen Georges Pompidou, Lab Virot, Serv Microbiot, Paris, France; [Pere, Helene; Veyer, David] Sorbonne Univ, Funct Genom Solid Tumors FunGeST, Ctr Rech Cordetier, INSERM,Univ Paris, Paris, France; [Dellicour, Simon] Univ Libre Bruxelles, Spatial Epidemiol Lab SpELL, Brussels, Belgium; [Raymenants, Joren; Gorissen, Sarah; Geenen, Caspar; Andre, Emmanuel] Katholieke Univ Leuven, Lab Clin Microbiol, Dept Microbiol Immunol & Transplantat, Leuven, Belgium; [Cuypers, Lize; Andre, Emmanuel] Univ Hosp Leuven, Natl Reference Ctr Resp Pathogens, Dept Lab Med, Leuven, Belgium; [Seve, Aymeric; Hocqueloux, Laurent; Prazuck, Thierry] CHR Orleans, Serv Malad Infect, Orleans, France; [Rey, Felix] Univ Paris, Inst Pasteur, Struct Virol Unit, CNRS UMR3569, Paris, France; [Simon-Lorriere, Etienne] Univ Paris, Inst Pasteur, G5 Evolutionary Genom RNA Viruses, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; KU Leuven; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Universite Libre de Bruxelles; KU Leuven; KU Leuven; University Hospital Leuven; Centre Hospitalier Regional d'Orleans; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite	Bruel, T; Schwartz, O (corresponding author), Univ Paris, Inst Pasteur, Virus & Immun Unit, CNRS UMR3569, Paris, France.; Bruel, T; Schwartz, O (corresponding author), Vaccine Res Inst, Creteil, France.; Mouquet, H (corresponding author), Univ Paris, Inst Pasteur, Humorat Immunol Lab, INSERM U1222, Paris, France.; Andre, E (corresponding author), Katholieke Univ Leuven, Lab Clin Microbiol, Dept Microbiol Immunol & Transplantat, Leuven, Belgium.; Andre, E (corresponding author), Univ Hosp Leuven, Natl Reference Ctr Resp Pathogens, Dept Lab Med, Leuven, Belgium.	timothee.bruet@pasteur.fr; hugo.mouquet@pasteur.fr; emmanuel.andre@uzleuven.be; olivier.schwartz@pasteur.fr	Mouquet, Hugo/M-2750-2014; Bruel, Timothée/AAI-4632-2020; Vanmechelen, Bert/AAF-4991-2019; Vanmechelen, Bert/E-7680-2018; Maes, Piet/P-7782-2017	Mouquet, Hugo/0000-0002-4230-610X; Vanmechelen, Bert/0000-0002-8350-4356; Vanmechelen, Bert/0000-0002-8350-4356; Wawina Bokalanga, Tony/0000-0001-6659-0267; Maes, Piet/0000-0002-4571-5232; Planas, Delphine/0000-0002-2509-9954; Andre, Emmanuel/0000-0001-8321-3770; Saunders, Nell/0000-0002-0872-1529; Geenen, Caspar/0000-0002-2778-6344; Buchrieser, Julian/0000-0003-4790-7577	Institut Pasteur; Region ile de France (DIM1Health); Urgence COVID-19 Fundraising Campaign of Institut Pasteur; Fondation pour la Recherche Medicale (FRM); ANRS; Vaccine Research Institute [ANR-10-LABX-77]; Labex IBEID [ANR-10-LABX-62-IBEID]; ANR/FRM Flash Covid PROTEO-SARS-CoV-2; IDISCOVR; Region Ile-de-France program DIM1-Health; Vaccine Research Institute; Milieu Interieur Program [ANR-10-LABX-69-01]; INSERM; REACTing; EU (RECOVER); Fondation de France [00106077]; INCEPTION program (Investissements d'Avenir grant) [ANR-16-CONV-0005]; French Government's Investissement d'Avenir programme, Laboratoire d'Excellence 'Integrative Biology of Emerging Infectious Diseases' [ANR-10-LABX-62-IBEID]; Internal Funds KU Leuven [C14/18/094]; Research Foundation-Flanders (Fonds voor Wetenschappelijk Onderzoek-Vlaanderen) [G0E1420N, G098321N]; COVID-19 research grant of 'Fonds Wetenschappelijk Onderzoek'/Research Foundation-Flanders [G0H4420N]; Fonds National de la Recherche Scientifique (FNRS, Belgium); European Union [874850];  [ANR-10-INSB-04-01]	Institut Pasteur(European Commission); Region ile de France (DIM1Health); Urgence COVID-19 Fundraising Campaign of Institut Pasteur; Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); ANRS(ANRSFrench National Research Agency (ANR)); Vaccine Research Institute; Labex IBEID; ANR/FRM Flash Covid PROTEO-SARS-CoV-2; IDISCOVR; Region Ile-de-France program DIM1-Health; Vaccine Research Institute; Milieu Interieur Program; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); REACTing; EU (RECOVER); Fondation de France(Fondation de France); INCEPTION program (Investissements d'Avenir grant)(French National Research Agency (ANR)); French Government's Investissement d'Avenir programme, Laboratoire d'Excellence 'Integrative Biology of Emerging Infectious Diseases'(French National Research Agency (ANR)); Internal Funds KU Leuven; Research Foundation-Flanders (Fonds voor Wetenschappelijk Onderzoek-Vlaanderen)(FWO); COVID-19 research grant of 'Fonds Wetenschappelijk Onderzoek'/Research Foundation-Flanders(FWO); Fonds National de la Recherche Scientifique (FNRS, Belgium)(Fonds de la Recherche Scientifique - FNRS); European Union(European Commission); 	We thank the staff at the European Health Emergency Preparedness and Response Authority (HERA) for their support; S. Cole for his help in initiating the collaboration between Institut Pasteur and KU Leuven through the HERA network; A. Baidaliuk and F. Gambaro for their help with the sequencing data analysis; the patients who participated to this study; the members of the Virus and Immunity Unit and other teams for discussions and help; N. Aulner and the staff at the UtechS Photonic BioImaging (UPBI) core facility (Institut Pasteur)-a member of the France BioImaging network-for image acquisition and analysis; the members of the KU Leuven University authorities, and J. Arnout, B. Lambrecht, C. Van Geet and L. Sels for their support; L. Belec, N. Robillard and M. Saliba for their help with sequencing; and F. Peira, V. Legros and L. Courtellemont for their help with the cohorts. The Opera system was co-funded by Institut Pasteur and the Region ile de France (DIM1Health). Work in the O.S. laboratory is funded by Institut Pasteur, Urgence COVID-19 Fundraising Campaign of Institut Pasteur, Fondation pour la Recherche Medicale (FRM), ANRS, the Vaccine Research Institute (ANR-10-LABX-77), Labex IBEID (ANR-10-LABX-62-IBEID), ANR/FRM Flash Covid PROTEO-SARS-CoV-2 and IDISCOVR. Work in the UPBI is funded by grant ANR-10-INSB-04-01 and Region Ile-de-France program DIM1-Health. D.P. is supported by the Vaccine Research Institute. The H.M. laboratory is funded by the Institut Pasteur, the Milieu Interieur Program (ANR-10-LABX-69-01), the INSERM, REACTing, EU (RECOVER) and Fondation de France (00106077) grants. The E.S.-L. laboratory is funded by Institut Pasteur, the INCEPTION program (Investissements d'Avenir grant ANR-16-CONV-0005) and the French Government's Investissement d'Avenir programme, Laboratoire d'Excellence 'Integrative Biology of Emerging Infectious Diseases' (grant no. ANR-10-LABX-62-IBEID). G.B. acknowledges support from the Internal Funds KU Leuven under grant agreement C14/18/094, and the Research Foundation-Flanders (Fonds voor Wetenschappelijk Onderzoek-Vlaanderen, G0E1420N, G098321N). P.M. acknowledges support from a COVID-19 research grant of 'Fonds Wetenschappelijk Onderzoek'/Research Foundation-Flanders (grant no. G0H4420N). S.D. is supported by the Fonds National de la Recherche Scientifique (FNRS, Belgium) and also acknowledges support from the Research Foundation-Flanders (Fonds voor Wetenschappelijk Onderzoek-Vlaanderen, G098321N) and from the European Union Horizon 2020 project MOOD (grant no. 874850). The funders of this study had no role in study design, data collection, analysis and interpretation, or writing of the article.	Aggarwal A., 2021, SARS COV 2 OMICRON E, DOI [10.1101/2021.12.14.21267772, DOI 10.1101/2021.12.14.21267772]; [Anonymous], 2021, CLASSIFICATION OMICR; Barda N, 2021, LANCET, V398, P2093, DOI 10.1016/S0140-6736(21)02249-2; Barnes CO, 2020, NATURE, V588, P682, DOI 10.1038/s41586-020-2852-1; Buchrieser J, 2020, EMBO J, V39, DOI 10.15252/embj.2020106267; Cai YF, 2020, SCIENCE, V369, P1586, DOI [10.1126/science.abd4251, 10.1101/2020.05.16.099317]; Cameroni E, 2022, NATURE, V602, P664, DOI [10.1038/s41586-021-04386-2, 10.1101/2021.12.12.472269]; Cao YL, 2022, NATURE, V602, P657, DOI 10.1038/s41586-021-04385-3; Cele S, 2022, NATURE, V602, P654, DOI 10.1038/s41586-021-04387-1; Dejnirattisai W, 2022, LANCET, V399, P234, DOI 10.1016/S0140-6736(21)02844-0; Gaebler C, 2021, NATURE, V591, P639, DOI [10.1038/s41586-021-03207-w, 10.1101/2020.11.03.367391]; Gagne M, 2022, CELL, V185, P113, DOI 10.1016/j.cell.2021.12.002; Gallais F, 2021, EBIOMEDICINE, V71, DOI 10.1016/j.ebiom.2021.103561; Grabowski F., OMICRON STRAIN SPREA, DOI [10.1101/2021.12.08.21267494, DOI 10.1101/2021.12.08.21267494]; Hadfield J, 2018, BIOINFORMATICS, V34, P4121, DOI 10.1093/bioinformatics/bty407; Hansen J, 2020, SCIENCE, V369, P1010, DOI 10.1126/science.abd0827; Jones BE, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abf1906; Karim SSA, 2021, LANCET, V398, P2126, DOI 10.1016/S0140-6736(21)02758-6; Kim C, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20602-5; Krammer F, 2021, NEW ENGL J MED, V384, P1372, DOI 10.1056/NEJMc2101667; Liu JY, 2021, NATURE, V596, P273, DOI 10.1038/s41586-021-03693-y; Liu LH, 2020, NATURE, V584, P450, DOI 10.1038/s41586-020-2571-7; Lorin V, 2015, J IMMUNOL METHODS, V422, P102, DOI 10.1016/j.jim.2015.04.010; Lucas C, 2021, NATURE, V600, P523, DOI 10.1038/s41586-021-04085-y; McCallum M, 2021, SCIENCE, V373, P648, DOI 10.1126/science.abi7994; Pinto D, 2020, NATURE, V583, P290, DOI 10.1038/s41586-020-2349-y; Planas D, 2021, NAT MED, V27, P917, DOI [DOI 10.1038/s41591-021-01318-5, 10.1038/s41591-021- 01318-5]; Planas D, 2021, NATURE, V596, P276, DOI 10.1038/s41586-021-03777-9; Plante JA, 2021, CELL HOST MICROBE, V29, P508, DOI 10.1016/j.chom.2021.02.020; Pulliam JRC., 2021, INCREASED RISK SARS, DOI [10.1101/2021.11.11.21266068, 10.1101/2021.11.11.21266068:2021.11.11.21266068, DOI 10.1101/2021.11.11.21266068:2021.11.11.21266068]; Rajah MM, 2021, EMBO J, V40, DOI 10.15252/embj.2021108944; Rappazzo CG, 2021, SCIENCE, V371, P823, DOI 10.1126/science.abf4830; Redd Andrew D, 2021, bioRxiv, DOI 10.1101/2021.12.06.471446; Shi R, 2020, NATURE, V584, P120, DOI 10.1038/s41586-020-2381-y; Starr TN, 2021, SCIENCE, V371, P850, DOI 10.1126/science.abf9302; Taylor PC, 2021, NAT REV IMMUNOL, V21, P382, DOI 10.1038/s41577-021-00542-x; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Tzou PL, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12091006; Van Cleemput J, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-26884-7; Viana R, 2022, NATURE, V603, P679, DOI 10.1038/s41586-022-04411-y; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Wang ZJ, 2021, NATURE, V595, P426, DOI 10.1038/s41586-021-03696-9; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1126/science.abb2507, 10.1101/2020.02.11.944462]; Zost SJ, 2020, NATURE, V584, P443, DOI 10.1038/s41586-020-2548-6	44	424	433	55	91	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 24	2022	602	7898					671	+		10.1038/s41586-021-04389-z	http://dx.doi.org/10.1038/s41586-021-04389-z		DEC 2021	16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZG7GF	35016199	Green Submitted, Green Accepted, Bronze, Green Published			2022-12-28	WOS:000756560800001
J	Mudd, PA; Minervina, AA; Pogorelyy, MV; Turner, JS; Kim, W; Kalaidina, E; Petersen, J; Schmitz, AJ; Lei, TT; Haile, A; Kirk, AM; Mettelman, RC; Crawford, JC; Nguyen, THO; Rowntree, LC; Rosati, E; Richards, KA; Sant, AJ; Klebert, MK; Suessen, T; Middleton, WD; Wolf, J; Teefey, SA; O'Halloran, JA; Presti, RM; Kedzierska, K; Rossjohn, J; Thomas, PG; Ellebedy, AH				Mudd, Philip A.; Minervina, Anastasia A.; Pogorelyy, Mikhail, V; Turner, Jackson S.; Kim, Wooseob; Kalaidina, Elizaveta; Petersen, Jan; Schmitz, Aaron J.; Lei, Tingting; Haile, Alem; Kirk, Allison M.; Mettelman, Robert C.; Crawford, Jeremy Chase; Nguyen, Thi H. O.; Rowntree, Louise C.; Rosati, Elisa; Richards, Katherine A.; Sant, Andrea J.; Klebert, Michael K.; Suessen, Teresa; Middleton, William D.; Wolf, Joshua; Teefey, Sharlene A.; O'Halloran, Jane A.; Presti, Rachel M.; Kedzierska, Katherine; Rossjohn, Jamie; Thomas, Paul G.; Ellebedy, Ali H.		SJTRC Study Team	SARS-CoV-2 mRNA vaccination elicits a robust and persistent T follicular helper cell response in humans	CELL			English	Article							MEMORY B; IMMUNITY	SARS-CoV-2 mRNA vaccines induce robust anti-spike (S) antibody and CD4(+) T cell responses. It is not yet clear whether vaccine-induced follicular helper CD4(+) T (T-FH) cell responses contribute to this outstanding immunogenicity. Using fine-needle aspiration of draining axillary lymph nodes from individuals who received the BNT162b2 mRNA vaccine, we evaluated the T cell receptor sequences and phenotype of lymph node T-FH . Mining of the responding T-FH T cell receptor repertoire revealed a strikingly immunodominant HLA-DPB1*04-restricted response to S167-180 in individuals with this allele, which is among the most common HLA alleles in humans. Paired blood and lymph node specimens show that while circulating S-specific T-FH cells peak one week after the second immunization, S-specific T-FH persist at nearly constant frequencies for at least six months. Collectively, our results underscore the key role that robust T-FH cell responses play in establishing long-term immunity by this efficacious human vaccine.	[Mudd, Philip A.] Washington Univ, Dept Emergency Med, Sch Med, St Louis, MO 63110 USA; [Mudd, Philip A.; Presti, Rachel M.; Ellebedy, Ali H.] Washington Univ, Ctr Vaccines & Immun Microbial Pathogens, Sch Med, St Louis, MO 63110 USA; [Minervina, Anastasia A.; Pogorelyy, Mikhail, V; Kirk, Allison M.; Mettelman, Robert C.; Crawford, Jeremy Chase; Thomas, Paul G.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Turner, Jackson S.; Kim, Wooseob; Schmitz, Aaron J.; Lei, Tingting; Ellebedy, Ali H.] Washington Univ, Dept Pathol & Immunol, Sch Med, St Louis, MO 63110 USA; [Kalaidina, Elizaveta] Washington Univ, Dept Internal Med, Div Allergy & Immunol, Sch Med, St Louis, MO 63110 USA; [Petersen, Jan; Rossjohn, Jamie] Monash Univ, Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic 3800, Australia; [Petersen, Jan; Rossjohn, Jamie] Monash Univ, Biomed Discovery Inst, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Haile, Alem; Klebert, Michael K.; Presti, Rachel M.] Washington Univ, Clin Trials Unit, Sch Med, St Louis, MO 63110 USA; [Nguyen, Thi H. O.; Rowntree, Louise C.; Kedzierska, Katherine] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia; [Rosati, Elisa] Christian Albrecht Univ Kiel, Inst Clin Mol Biol, D-24105 Kiel, Germany; [Richards, Katherine A.; Sant, Andrea J.] Univ Rochester, David H Smith Ctr Vaccine Biol & Immunol, Dept Microbiol & Immunol, Med Ctr, Rochester, NY 14642 USA; [Suessen, Teresa; Middleton, William D.; Teefey, Sharlene A.] Washington Univ, Mallinckrodt Inst Radiol, Sch Med, St Louis, MO 63110 USA; [Wolf, Joshua] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA; [O'Halloran, Jane A.; Presti, Rachel M.] Washington Univ, Dept Internal Med, Div Infect Dis, Sch Med, St Louis, MO 63110 USA; [Rossjohn, Jamie] Cardiff Univ, Sch Med, Inst Infect & Immun, Heath Pk, Cardiff CF14 4XN, Wales; [Presti, Rachel M.; Ellebedy, Ali H.] Washington Univ, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, Sch Med, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); St Jude Children's Research Hospital; Washington University (WUSTL); Washington University (WUSTL); Monash University; Monash University; Washington University (WUSTL); University of Melbourne; University of Kiel; University of Rochester; Washington University (WUSTL); St Jude Children's Research Hospital; Washington University (WUSTL); Cardiff University; Washington University (WUSTL)	Mudd, PA (corresponding author), Washington Univ, Dept Emergency Med, Sch Med, St Louis, MO 63110 USA.; Mudd, PA; Ellebedy, AH (corresponding author), Washington Univ, Ctr Vaccines & Immun Microbial Pathogens, Sch Med, St Louis, MO 63110 USA.; Thomas, PG (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA.; Ellebedy, AH (corresponding author), Washington Univ, Dept Pathol & Immunol, Sch Med, St Louis, MO 63110 USA.; Ellebedy, AH (corresponding author), Washington Univ, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, Sch Med, St Louis, MO 63110 USA.	pmudd@wustl.edu; paul.thomas@stjude.org; ellebedy@wustl.edu	Rowntree, Louise/HHZ-1437-2022; Crawford, Jeremy Chase/G-5711-2013; Wolf, Joshua/ADO-0221-2022; Lin, Chun-Yang/AAH-1897-2020; Pogorelyy, Mikhail V/H-9610-2014; Hijano, Diego/N-2665-2018	Crawford, Jeremy Chase/0000-0003-4096-6048; Lin, Chun-Yang/0000-0002-3064-0178; Pogorelyy, Mikhail V/0000-0003-0773-1204; Kirk, Allison/0000-0002-4286-3678; Schmitz, Aaron/0000-0002-8077-6751; Mudd, Philip/0000-0002-3860-5473; Kim, Wooseob/0000-0002-9199-1000; Hijano, Diego/0000-0002-2903-666X; Rowntree, Louise/0000-0002-0649-5089	Washington University Institute for Clinical and Translational Sciences grant from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH) [UL1TR002345]; Australian Research Council Laureate Fellowship; NHMRC Leadership Investigator Fellowship [1173871]; NHMRC Emerging Leadership Level 1 Investigator Fellowship [1194036]; ALSAC at St. Jude; Center for Influenza Vaccine Research for High-Risk Populations (CIVR-HRP) [75N93019C00052]; St. Jude Center of Excellence for Influenza Research and Surveillance [HHSN272201400006C]; St. Jude Center of Excellence for Influenza Research and Response (P.G.T.) [75N93021C00016, U01AI150747, U01AI144616-02S1, R01AI136514]; NIAID [U01AI150747, U01AI141990]; NIAID Centers of Excellence for Influenza Research and Surveillance contracts [HHSN272201400006C, HHSN272201400008C]; NIAID Collaborative Influenza Vaccine Innovation Centers [75N93019C00051]	Washington University Institute for Clinical and Translational Sciences grant from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH); Australian Research Council Laureate Fellowship(Australian Research Council); NHMRC Leadership Investigator Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Emerging Leadership Level 1 Investigator Fellowship(National Health and Medical Research Council (NHMRC) of Australia); ALSAC at St. Jude; Center for Influenza Vaccine Research for High-Risk Populations (CIVR-HRP); St. Jude Center of Excellence for Influenza Research and Surveillance; St. Jude Center of Excellence for Influenza Research and Response (P.G.T.); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID Centers of Excellence for Influenza Research and Surveillance contracts; NIAID Collaborative Influenza Vaccine Innovation Centers	The authors would like to thank the study participants for their invaluable contri-bution to this work. We also thank Greig Lennon from St. Jude Immunology flow core for his help with FACS, Hartwell Center at St. Jude Children's Research Hospital for high-throughput sequencing, and Carmen Llerna for assistance in HLA-DP4 protein purification. This study was funded in part by the Washing-ton University Institute for Clinical and Translational Sciences grant UL1TR002345 from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH) (P.A.M.) . J.R. is supported by an Australian Research Council Laureate Fellowship. K.K. was supported by the NHMRC Leadership Investigator Fellowship (#1173871) , and T.H.O.N. was supported by the NHMRC Emerging Leadership Level 1 Investigator Fellowship (#1194036) . This work was funded by ALSAC at St. Jude; the Center for Influenza Vaccine Research for High-Risk Populations (CIVR-HRP) contract number 75N93019C00052 (P.G.T. and K.K.) ; the St. Jude Center of Excellence for Influenza Research and Surveillance (P.G.T.) contract number HHSN272201400006C; and the St. Jude Center of Excellence for Influenza Research and Response (P.G.T.) contract numbers 75N93021C00016, U01AI150747, U01AI144616-02S1, and R01AI136514 (P.G.T.) . The Ellebedy laboratory was supported by NIAID grants U01AI141990 and U01AI150747, NIAID Centers of Excellence for Influenza Research and Surveillance contracts HHSN272201400006C and HHSN272201400008C, and by NIAID Collaborative Influenza Vaccine Innovation Centers contract 75N93019C00051. The contents of this publication are solely the responsibility of the authors and do not neces-sarily represent the official views of the NIAID or NIH.	Al Kaabi N, 2021, JAMA-J AM MED ASSOC, V326, P35, DOI 10.1001/jama.2021.8565; Anderson EJ, 2020, NEW ENGL J MED, V383, P2427, DOI 10.1056/NEJMoa2028436; Andreano E, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2103154118; Arungundram S, 2009, J AM CHEM SOC, V131, P17394, DOI 10.1021/ja907358k; Bacher P, 2020, IMMUNITY, V53, P1258, DOI 10.1016/j.immuni.2020.11.016; Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389; Bolotin DA, 2015, NAT METHODS, V12, P380, DOI 10.1038/nmeth.3364; Brenna E, 2020, CELL REP, V30, P137, DOI 10.1016/j.celrep.2019.12.016; Chen RTE, 2021, NAT MED, V27, DOI 10.1038/s41591-021-01294-w; Corbett Kizzmekia S, 2021, bioRxiv, DOI 10.1101/2021.04.20.440647; Crotty S, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a032102; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Dash P, 2017, NATURE, V547, P89, DOI 10.1038/nature22383; Dykema AG, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI146922; Egorov ES, 2015, J IMMUNOL, V194, P6155, DOI 10.4049/jimmunol.1500215; Glanville J, 2017, NATURE, V547, P94, DOI 10.1038/nature22976; Good-Jacobson KL, 2014, P NATL ACAD SCI USA, V111, P9585, DOI 10.1073/pnas.1402485111; Jackson LA, 2020, NEW ENGL J MED, V383, P1920, DOI 10.1056/NEJMoa2022483; Jensen KK, 2018, IMMUNOLOGY, V154, P394, DOI 10.1111/imm.12889; Kamar N, 2021, NEW ENGL J MED, V385, P661, DOI 10.1056/NEJMc2108861; Khoury DS, 2021, NAT MED, V27, P1205, DOI 10.1038/s41591-021-01377-8; Kim Wooseob, 2021, bioRxiv, DOI 10.1101/2021.10.31.466651; Logunov DY, 2021, LANCET, V397, P671, DOI 10.1016/S0140-6736(21)00234-8; Loyal L, 2021, SCIENCE, V374, P171, DOI 10.1126/science.abh1823; Meckiff BJ, 2020, CELL, V183, P1340, DOI 10.1016/j.cell.2020.10.001; Minervina A.A., 2021, CONVERGENT EPITOPESP, DOI [10.1101/2021.07.12.21260227, DOI 10.1101/2021.07.12.21260227]; Minervina AA, 2021, ELIFE, V10, DOI 10.7554/eLife.63502; Minervina AA, 2020, ELIFE, V9, DOI 10.7554/eLife.53704; Niehrs A, 2019, NAT IMMUNOL, V20, P1129, DOI 10.1038/s41590-019-0448-4; Nolan Sean, 2020, Res Sq, DOI 10.21203/rs.3.rs-51964/v1; Painter MM, 2021, IMMUNITY, V54, P2133, DOI 10.1016/j.immuni.2021.08.001; Peng YC, 2020, NAT IMMUNOL, V21, P1336, DOI [10.1038/s41590-020-0782-6, 10.1101/2020.06.05.134551]; Pogorelyy MV, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000314; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Qi H, 2016, NAT REV IMMUNOL, V16, P612, DOI 10.1038/nri.2016.94; Ripperger TJ, 2021, ANNU REV IMMUNOL, V39, P345, DOI 10.1146/annurev-immunol-093019-125603; Sacha JB, 2010, NAT PROTOC, V5, P239, DOI 10.1038/nprot.2009.227; Sadoff J, 2021, NEW ENGL J MED, V384, P2187, DOI 10.1056/NEJMoa2101544; Scally SW, 2013, J EXP MED, V210, P2569, DOI 10.1084/jem.20131241; Shomuradova AS, 2020, IMMUNITY, V53, P1245, DOI 10.1016/j.immuni.2020.11.004; Shugay M, 2014, NAT METHODS, V11, P653, DOI [10.1038/NMETH.2960, 10.1038/nmeth.2960]; Tarke A, 2021, CELL REP MED, V2, DOI 10.1016/j.xcrm.2021.100204; Touizer E, 2021, LANCET HIV, V8, pE317, DOI 10.1016/S2352-3018(21)00099-0; Tubo NJ, 2013, CELL, V153, P785, DOI 10.1016/j.cell.2013.04.007; Turner JS, 2021, NATURE, V596, P109, DOI 10.1038/s41586-021-03738-2; Turner JS, 2020, NATURE, V586, P127, DOI 10.1038/s41586-020-2711-0; Ueno H, 2015, NAT IMMUNOL, V16, P142, DOI 10.1038/ni.3054; Verbeke R, 2021, J CONTROL RELEASE, V333, P511, DOI 10.1016/j.jconrel.2021.03.043; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Voysey M, 2021, LANCET, V397, P99, DOI 10.1016/S0140-6736(20)32661-1; Walsh EE, 2020, NEW ENGL J MED, V383, P2439, DOI 10.1056/NEJMoa2027906; Wang GC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003647; Wang PF, 2021, NATURE, V593, P130, DOI 10.1038/s41586-021-03398-2; Weisel FJ, 2016, IMMUNITY, V44, P116, DOI 10.1016/j.immuni.2015.12.004; Widge AT, 2021, NEW ENGL J MED, V384, P80, DOI 10.1056/NEJMc2032195; Wu K, 2021, NEW ENGL J MED, V384, P1468, DOI 10.1056/NEJMc2102179	56	57	57	15	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 17	2022	185	4					603	+		10.1016/j.cell.2021.12.026	http://dx.doi.org/10.1016/j.cell.2021.12.026			27	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ZS1XX	35026152	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000768265900004
J	Fawcett, C				Fawcett, Christine			Kids attend to saliva sharing to infer social relationships Saliva sharing suggests "thick," intimate bonds	SCIENCE			English	Article							INFANTS USE		[Fawcett, Christine] Uppsala Univ, Dept Psychol, Uppsala Child & Baby Lab, Uppsala, Sweden; [Fawcett, Christine] Stockholm Univ, Dept Psychol, Stockholm, Sweden	Uppsala University; Stockholm University	Fawcett, C (corresponding author), Uppsala Univ, Dept Psychol, Uppsala Child & Baby Lab, Uppsala, Sweden.; Fawcett, C (corresponding author), Stockholm Univ, Dept Psychol, Stockholm, Sweden.	christine.fawcett@psyk.uu.se						Case TI, 2006, EVOL HUM BEHAV, V27, P357, DOI 10.1016/j.evolhumbehav.2006.03.003; Curtis V, 2001, PERSPECT BIOL MED, V44, P17, DOI 10.1353/pbm.2001.0001; Fawcett C, 2017, J EXP CHILD PSYCHOL, V160, P127, DOI 10.1016/j.jecp.2017.03.014; Fawcett C, 2013, DEVELOPMENTAL SCI, V16, P841, DOI 10.1111/desc.12074; Fiske AP, 2009, EUR J SOC PSYCHOL, V39, P1294, DOI 10.1002/ejsp.697; Gredeback G, 2010, COGNITION, V114, P197, DOI 10.1016/j.cognition.2009.09.004; Hirschfeld L.A., 1998, RACE MAKING COGNITIO; Johnson SC, 2007, PSYCHOL SCI, V18, P501, DOI 10.1111/j.1467-9280.2007.01929.x; Liberman Z, 2014, J EXP PSYCHOL GEN, V143, P966, DOI 10.1037/a0034481; Thomas AJ, 2022, SCIENCE, V375, P311, DOI 10.1126/science.abh1054; THOMAS L N, 2008, GEOPHYS MONOGR SER, V177, P17, DOI [DOI 10.1029/177GM04, 10.1029/177GM04]; van den Berg L, 2021, DEVELOPMENTAL SCI, V24, DOI 10.1111/desc.13036; Wellman H.M., 1992, CHILDS THEORY MIND; Ziv T, 2017, CHILD DEV, V88, P1930, DOI 10.1111/cdev.12674	14	0	0	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2022	375	6578					260	261		10.1126/science.abn5157	http://dx.doi.org/10.1126/science.abn5157			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YK2FS	35050653				2022-12-28	WOS:000745036100011
J	Newman, L				Newman, Lenore			Eating to Extinction	SCIENCE			English	Book Review									[Newman, Lenore] Univ Fraser Valley, Food & Agr Inst, Abbotsford, BC, Canada	University of Fraser Valley	Newman, L (corresponding author), Univ Fraser Valley, Food & Agr Inst, Abbotsford, BC, Canada.	lenore.newman@ufv.ca						SALADINO D, 2022, EATING TO EXTINCTION	1	0	0	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2022	375	6578					273	273		10.1126/science.abn1066	http://dx.doi.org/10.1126/science.abn1066			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YK2FS	35050663				2022-12-28	WOS:000745036100018
J	Schriber, EA; Paley, DW; Bolotovsky, R; Rosenberg, DJ; Sierra, RG; Aquila, A; Mendez, D; Poitevin, F; Blaschke, JP; Bhowmick, A; Kelly, RP; Hunter, M; Hayes, B; Popple, DC; Yeung, M; Pareja-Rivera, C; Lisova, S; Tono, K; Sugahara, M; Owada, S; Kuykendall, T; Yao, KY; Schuck, PJ; Solis-Ibarra, D; Sauter, NK; Brewster, AS; Hohman, JN				Schriber, Elyse A.; Paley, Daniel W.; Bolotovsky, Robert; Rosenberg, Daniel J.; Sierra, Raymond G.; Aquila, Andrew; Mendez, Derek; Poitevin, Frederic; Blaschke, Johannes P.; Bhowmick, Asmit; Kelly, Ryan P.; Hunter, Mark; Hayes, Brandon; Popple, Derek C.; Yeung, Matthew; Pareja-Rivera, Carina; Lisova, Stella; Tono, Kensuke; Sugahara, Michihiro; Owada, Shigeki; Kuykendall, Tevye; Yao, Kaiyuan; Schuck, P. James; Solis-Ibarra, Diego; Sauter, Nicholas K.; Brewster, Aaron S.; Hohman, J. Nathan			Chemical crystallography by serial femtosecond X-ray diffraction	NATURE			English	Article							ALGORITHMS; TOOL	Inorganic-organic hybrid materials represent a large share of newly reported structures, owing to their simple synthetic routes and customizable properties(1). This proliferation has led to a characterization bottleneck: many hybrid materials are obligate microcrystals with low symmetry and severe radiation sensitivity, interfering with the standard techniques of single-crystal X-ray diffraction(2,3) and electron microdiffraction(4-11). Here we demonstrate small-molecule serial femtosecond X-ray crystallography (smSFX) for the determination of material crystal structures from microcrystals. We subjected microcrystalline suspensions to X-ray free-electron laser radiation(12,13) and obtained thousands of randomly oriented diffraction patterns. We determined unit cells by aggregating spot-finding results into high-resolution powder diffractograms. After indexing the sparse serial patterns by a graph theory approach(14), the resulting datasets can be solved and refined using standard tools for single-crystal diffraction data(15-17). We describe the ab initio structure solutions of mithrene (AgSePh)(18-20), thiorene (AgSPh) and tethrene (AgTePh), of which the latter two were previously unknown structures. In thiorene, we identify a geometric change in the silver-silver bonding network that is linked to its divergent optoelectronic properties(20). We demonstrate that smSFX can be applied as a general technique for structure determination of beam-sensitive microcrystalline materials at near-ambient temperature and pressure.	[Schriber, Elyse A.; Kelly, Ryan P.; Hohman, J. Nathan] Univ Connecticut, Inst Mat Sci, Storrs, CT 06269 USA; [Schriber, Elyse A.; Kelly, Ryan P.; Hohman, J. Nathan] Univ Connecticut, Dept Chem, U-60, Storrs, CT 06269 USA; [Paley, Daniel W.; Bolotovsky, Robert; Rosenberg, Daniel J.; Mendez, Derek; Bhowmick, Asmit; Sauter, Nicholas K.; Brewster, Aaron S.] Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging Div, Berkeley, CA 94720 USA; [Rosenberg, Daniel J.] Univ Calif Berkeley, Grad Grp Biophys, Berkeley, CA 94720 USA; [Sierra, Raymond G.; Aquila, Andrew; Poitevin, Frederic; Hunter, Mark; Hayes, Brandon] SLAC Natl Accelerator Lab, Linac Coherent Light Source, Menlo Pk, CA USA; [Blaschke, Johannes P.; Popple, Derek C.] Lawrence Berkeley Natl Lab, Natl Energy Res Sci Comp Ctr, Berkeley, CA USA; [Popple, Derek C.] Univ Calif Berkeley, Coll Chem, Berkeley, CA 94720 USA; [Yeung, Matthew] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Pareja-Rivera, Carina; Solis-Ibarra, Diego] Univ Nacl Autonoma Mexico, Inst Invest Mat, Coyoacan, Mexico; [Lisova, Stella] Arizona State Univ, Dept Phys, Tempe, AZ 85287 USA; [Tono, Kensuke; Owada, Shigeki] Japan Synchrotron Radiat Res Inst, SPring 8, Sayo, Japan; [Sugahara, Michihiro] RIKEN SPring 8 Ctr, Sayo, Japan; [Kuykendall, Tevye] Lawrence Berkeley Natl Lab, Mol Foundry, Berkeley, CA USA; [Yao, Kaiyuan; Schuck, P. James] Columbia Univ, Dept Mech Engn, New York, NY 10027 USA	University of Connecticut; University of Connecticut; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Massachusetts Institute of Technology (MIT); Universidad Nacional Autonoma de Mexico; Arizona State University; Arizona State University-Tempe; Japan Synchrotron Radiation Research Institute; RIKEN; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Columbia University	Hohman, JN (corresponding author), Univ Connecticut, Inst Mat Sci, Storrs, CT 06269 USA.; Hohman, JN (corresponding author), Univ Connecticut, Dept Chem, U-60, Storrs, CT 06269 USA.; Sauter, NK; Brewster, AS (corresponding author), Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging Div, Berkeley, CA 94720 USA.	nksauter@lbl.gov; asbrewster@lbl.gov; james.hohman@uconn.edu	Pareja-Rivera, Carina/AAX-7515-2021	Pareja-Rivera, Carina/0000-0002-2764-0513; Poitevin, Frederic/0000-0002-3181-8652; Schriber, Elyse/0000-0002-8935-2955; Aquila, Andrew/0000-0003-0358-2774	NIH [GM117126]; DOE-BER IDAT [DE-AC02-05CH11231]; NIGMS ALS-ENABLE [P30 GM124169, S10OD018483]; Exascale Computing Project, Department of Energy (DOE) Office of Science [17-SC-20-SC]; National Nuclear Security Administration [17-SC-20-SC]; DOE ICDI grant [DE-SC0022215]; PAPIIT [IN216020]; CONACYT [CB-A1-S-8729]; Programmable Quantum Materials, an Energy Frontier Research Center - US Department of Energy (DOE), Office of Science, Basic Energy Sciences (BES) [DE-SC0019443]; US DOE, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; Office of Science, Office of Basic Energy Sciences, of the US DOE [DE-AC02-05CH11231]; National Energy Research Scientific Computing Center (NERSC), a US DOE, Office of Science User Facility located at Lawrence Berkeley National Laboratory [DE-AC02-05CH11231]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOE-BER IDAT; NIGMS ALS-ENABLE; Exascale Computing Project, Department of Energy (DOE) Office of Science(United States Department of Energy (DOE)); National Nuclear Security Administration(National Nuclear Security Administration); DOE ICDI grant(United States Department of Energy (DOE)); PAPIIT(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)); CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Programmable Quantum Materials, an Energy Frontier Research Center - US Department of Energy (DOE), Office of Science, Basic Energy Sciences (BES)(United States Department of Energy (DOE)); US DOE, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Office of Science, Office of Basic Energy Sciences, of the US DOE(United States Department of Energy (DOE)); National Energy Research Scientific Computing Center (NERSC), a US DOE, Office of Science User Facility located at Lawrence Berkeley National Laboratory	We thank the SACLA and LCLS technical staff for their invaluable support. We are also grateful for the computational support from the SACLA HPC system. XFEL experiments were carried out at SACLA with the approval of the Japan Synchrotron Radiation Research Institute (JASRI) (proposal number 2019A8074). Research was supported by the NIH grant GM117126 to N.K.S. D.J.R. was supported by DOE-BER IDAT DE-AC02-05CH11231 and NIGMS ALS-ENABLE (P30 GM124169 and S10OD018483). D.M., J.P.B. and N.K.S. were supported by the Exascale Computing Project (grant 17-SC-20-SC), a collaborative effort of the Department of Energy (DOE) Office of Science and the National Nuclear Security Administration. E.A.S., A.S.B. and J.N.H. were supported by DOE ICDI grant DE-SC0022215. C.P.-R. and D.S-I. were supported by PAPIIT IN216020 and CONACYT's CB-A1-S-8729. P.J.S. and K.Y. acknowledge support by Programmable Quantum Materials, an Energy Frontier Research Center funded by the US Department of Energy (DOE), Office of Science, Basic Energy Sciences (BES), under award DE-SC0019443. Use of the Linac Coherent Light Source (LCLS), SLAC National Accelerator Laboratory, is supported by the US DOE, Office of Science, Office of Basic Energy Sciences under contract no. DE-AC02-76SF00515. Work was performed at the Molecular Foundry and was supported by the Office of Science, Office of Basic Energy Sciences, of the US DOE under contract no. DE-AC02-05CH11231. This research used resources of the National Energy Research Scientific Computing Center (NERSC), a US DOE, Office of Science User Facility located at Lawrence Berkeley National Laboratory, operated under contract no. DE-AC02-05CH11231. B.H.Toby is acknowledged for assistance with GSAS-II.	Brewster AS, 2019, ACTA CRYSTALLOGR D, V75, P959, DOI 10.1107/S2059798319012877; Brewster AS, 2018, ACTA CRYSTALLOGR D, V74, P877, DOI 10.1107/S2059798318009191; Brewster AS, 2015, ACTA CRYSTALLOGR D, V71, P357, DOI 10.1107/S1399004714026145; Bucker R, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14793-0; Chapman HN, 2011, NATURE, V470, P73, DOI 10.1038/nature09750; Chatterjee R, 2019, J SYNCHROTRON RADIAT, V26, P1716, DOI 10.1107/S1600577519007550; Christensen J, 2019, IUCRJ, V6, P703, DOI 10.1107/S2052252519006948; Coelho AA, 2003, J APPL CRYSTALLOGR, V36, P86, DOI 10.1107/S0021889802019878; Coelho AA, 2018, J APPL CRYSTALLOGR, V51, P210, DOI 10.1107/S1600576718000183; Cole JC, 2019, STRUCT DYN-US, V6, DOI 10.1063/1.5116878; Cuthbert HL, 2002, Z ANORG ALLG CHEM, V628, P2483, DOI 10.1002/1521-3749(200211)628:11<2483::AID-ZAAC2483>3.0.CO;2-U; DANCE IG, 1991, INORG CHEM, V30, P183, DOI 10.1021/ic00002a008; David WIF, 2006, J APPL CRYSTALLOGR, V39, P910, DOI 10.1107/S0021889806042117; Dejoie C, 2020, J APPL CRYSTALLOGR, V53, P824, DOI 10.1107/S160057672000521X; Dejoie C, 2015, IUCRJ, V2, P361, DOI 10.1107/S2052252515006740; DePonte DP, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/19/195505; Dolomanov OV, 2009, J APPL CRYSTALLOGR, V42, P339, DOI 10.1107/S0021889808042726; Groom CR, 2016, ACTA CRYSTALLOGR B, V72, P171, DOI 10.1107/S2052520616003954; Grosse-Kunstleve RW, 2002, J APPL CRYSTALLOGR, V35, P126, DOI 10.1107/S0021889801017824; Hattne J, 2014, NAT METHODS, V11, P545, DOI [10.1038/NMETH.2887, 10.1038/nmeth.2887]; Jaramillo DE, 2020, NAT MATER, V19, P517, DOI 10.1038/s41563-019-0597-8; Jones CG, 2018, ACS CENTRAL SCI, V4, P1587, DOI 10.1021/acscentsci.8b00760; Kameshima T, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4867668; Kolb U, 2011, CRYST RES TECHNOL, V46, P542, DOI 10.1002/crat.201100036; Leonarski F, 2018, NAT METHODS, V15, P799, DOI 10.1038/s41592-018-0143-7; Liang MN, 2015, J SYNCHROTRON RADIAT, V22, P514, DOI 10.1107/S160057751500449X; Maserati L, 2021, MATER HORIZ, V8, DOI 10.1039/c9mh01917k; Meng G., 2021, CRYSTALS, V11, P263; Ozaki Y, 2020, NPJ COMPUT MATER, V6, DOI 10.1038/s41524-020-0330-9; Paritmongkol W, 2021, J AM CHEM SOC, V143, P20256, DOI 10.1021/jacs.1c09106; Raccuglia P, 2016, NATURE, V533, P73, DOI 10.1038/nature17439; Samkian AE, 2021, ANGEW CHEM INT EDIT, V60, P2493, DOI 10.1002/anie.202012213; Schmidbaur H, 2015, ANGEW CHEM INT EDIT, V54, P746, DOI 10.1002/anie.201405936; Schriber EA, 2018, ACS APPL NANO MATER, V1, P3498, DOI 10.1021/acsanm.8b00662; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Sheldrick GM, 2015, ACTA CRYSTALLOGR A, V71, P3, DOI 10.1107/S2053273314026370; Smeets S, 2018, J APPL CRYSTALLOGR, V51, P1262, DOI 10.1107/S1600576718009500; Spek A., 1990, ACTA CRYSTALLOGR A, V46, pc34, DOI DOI 10.1107/S0108767390099780; Toby BH, 2013, J APPL CRYSTALLOGR, V46, P544, DOI 10.1107/S0021889813003531; Tono K, 2015, J SYNCHROTRON RADIAT, V22, P532, DOI 10.1107/S1600577515004464; Trang B, 2018, J AM CHEM SOC, V140, P13892, DOI 10.1021/jacs.8b08878; Wang B, 2019, IUCRJ, V6, P854, DOI 10.1107/S2052252519007681; Wang B, 2018, CHEM-EUR J, V24, P17429, DOI 10.1002/chem.201804133; Weierstall U, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0337; Wiedorn MO, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06156-7; Winter G, 2018, ACTA CRYSTALLOGR D, V74, P85, DOI 10.1107/S2059798317017235; WOLFF PMD, 1972, J APPL CRYSTALLOGR, V5, P243; Yao KY, 2021, ACS NANO, V15, P4085, DOI 10.1021/acsnano.0c08096; Zhu DL, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4736725	49	9	8	24	52	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 20	2022	601	7893					360	+		10.1038/s41586-021-04218-3	http://dx.doi.org/10.1038/s41586-021-04218-3			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YJ6UI	35046599	Green Published, hybrid			2022-12-28	WOS:000744666700027
J	Xu, LG; Wang, XX; Wang, WW; Sun, MZ; Choi, WJ; Kim, JY; Hao, CL; Li, S; Qu, AH; Lu, MR; Wu, XL; Colombari, FM; Gomes, WR; Blanco, AL; de Moura, AF; Guo, X; Kuang, H; Kotov, NA; Xu, CL				Xu, Liguang; Wang, Xiuxiu; Wang, Weiwei; Sun, Maozhong; Choi, Won Jin; Kim, Ji-Young; Hao, Changlong; Li, Si; Qu, Aihua; Lu, Meiru; Wu, Xiaoling; Colombari, Felippe M.; Gomes, Weverson R.; Blanco, Asdrubal L.; de Moura, Andre F.; Guo, Xiao; Kuang, Hua; Kotov, Nicholas A.; Xu, Chuanlai			Enantiomer-dependent immunological response to chiral nanoparticles	NATURE			English	Article							SURFACE; ACTIVATION	Chirality is a unifying structural metric of biological and abiological forms of matter. Over the past decade, considerable clarity has been achieved in understanding the chemistry and physics of chiral inorganic nanoparticles(1-4); however, little is known about their effects on complex biochemical networks(5,6). Intermolecular interactions of biological molecules and inorganic nanoparticles show some commonalities(7-9), but these structures differ in scale, in geometry and in the dynamics of chiral shapes, which can both impede and strengthen their mirror-asymmetric complexes. Here we show that achiral and left- and right-handed gold biomimetic nanoparticles show different in vitro and in vivo immune responses. We use irradiation with circularly polarized light (CPL) to synthesize nanoparticles with controllable nanometre-scale chirality and optical anisotropy factors (g-factors) of up to 0.4. We find that binding of nanoparticles to two proteins from the family of adhesion G-protein-coupled receptors (AGPCRs)-namely cluster-of-differentiation 97 (CD97) and epidermal-growth-factor-like-module receptor 1 (EMR1)-results in the opening of mechanosensitive potassium-efflux channels, the production of immune signalling complexes known as inflammasomes, and the maturation of mouse bone-marrow-derived dendritic cells. Both in vivo and in vitro immune responses depend monotonically on the g-factors of the nanoparticles, indicating that nanoscale chirality can be used to regulate the maturation of immune cells. Finally, left-handed nanoparticles show substantially higher (1,258-fold) efficiency compared with their right-handed counterparts as adjuvants for vaccination against the H9N2 influenza virus, opening a path to the use of nanoscale chirality in immunology.	[Xu, Liguang; Wang, Xiuxiu; Wang, Weiwei; Sun, Maozhong; Hao, Changlong; Qu, Aihua; Lu, Meiru; Wu, Xiaoling; Guo, Xiao; Kuang, Hua; Xu, Chuanlai] Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi, Jiangsu, Peoples R China; [Xu, Liguang; Wang, Xiuxiu; Wang, Weiwei; Sun, Maozhong; Hao, Changlong; Qu, Aihua; Lu, Meiru; Wu, Xiaoling; Guo, Xiao; Kuang, Hua; Xu, Chuanlai] Jiangnan Univ, Sch Food Sci & Technol, Int Joint Res Lab Biointerface & Biodetect, Wuxi, Jiangsu, Peoples R China; [Choi, Won Jin; Kotov, Nicholas A.] Univ Michigan, Dept Mat Sci & Engn, Ann Arbor, MI 48109 USA; [Kim, Ji-Young; Kotov, Nicholas A.] Univ Michigan, Dept Chem Engn, Biointerface Inst, Ann Arbor, MI 48109 USA; [Li, Si; Kuang, Hua] Jiangnan Univ, Sch Chem & Mat Engn, Key Lab Synthet & Biol Colloids, Minist Educ, Wuxi, Jiangsu, Peoples R China; [Colombari, Felippe M.] Brazilian Ctr Res Energy & Mat, Brazilian Nanotechnol Natl Lab, Campinas, SP, Brazil; [Gomes, Weverson R.; Blanco, Asdrubal L.; de Moura, Andre F.] Univ Fed Sao Carlos, Dept Chem, Sao Carlos, SP, Brazil; [Kuang, Hua] Jiangnan Univ, Sci Ctr Future Foods, Wuxi, Jiangsu, Peoples R China	Jiangnan University; Jiangnan University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Jiangnan University; Universidade Federal de Sao Carlos; Jiangnan University	Kuang, H; Xu, CL (corresponding author), Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi, Jiangsu, Peoples R China.; Kuang, H; Xu, CL (corresponding author), Jiangnan Univ, Sch Food Sci & Technol, Int Joint Res Lab Biointerface & Biodetect, Wuxi, Jiangsu, Peoples R China.; Kotov, NA (corresponding author), Univ Michigan, Dept Mat Sci & Engn, Ann Arbor, MI 48109 USA.; Kotov, NA (corresponding author), Univ Michigan, Dept Chem Engn, Biointerface Inst, Ann Arbor, MI 48109 USA.; Kuang, H (corresponding author), Jiangnan Univ, Sch Chem & Mat Engn, Key Lab Synthet & Biol Colloids, Minist Educ, Wuxi, Jiangsu, Peoples R China.; Kuang, H (corresponding author), Jiangnan Univ, Sci Ctr Future Foods, Wuxi, Jiangsu, Peoples R China.	kuangh@jiangnan.edu.cn; kotov@umich.edu; xcl@jiangnan.edu.cn	Colombari, Felippe Mariano/O-5013-2018	Colombari, Felippe Mariano/0000-0002-5431-1301; CHOI, WON JIN/0000-0001-6303-8899; Kim, Ji-Young/0000-0001-5631-957X	National Natural Science Foundation of China [21925402, 32071400, 21977038, 92156003]; Natural Science Foundation of Jiangsu Province [BK20212014]; Young Elite Scientist Sponsorship Program by China Association for Science and Technology (CAST) [2019QNRC001]; US National Science Foundation (NSF) [1463474, 1566460]; Brazilian Ministerio da Educacao (MEC)/Tutorial Education Programme (PET); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [311353/2019-3]; Brazilian funding agency Coordenacao de Aperfeicoamento de Pessoal de Nivel Superio (CAPES); Brazilian funding agency CNPq; Brazilian funding agency Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2012/15147-4, 2013/07296-2]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Young Elite Scientist Sponsorship Program by China Association for Science and Technology (CAST); US National Science Foundation (NSF)(National Science Foundation (NSF)); Brazilian Ministerio da Educacao (MEC)/Tutorial Education Programme (PET)(German Research Foundation (DFG)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian funding agency Coordenacao de Aperfeicoamento de Pessoal de Nivel Superio (CAPES); Brazilian funding agency CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian funding agency Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was financially supported by the National Natural Science Foundation of China (21925402, 32071400, 21977038, 92156003), Natural Science Foundation of Jiangsu Province (BK20212014), and Young Elite Scientist Sponsorship Program by China Association for Science and Technology (CAST) (2019QNRC001). N.A.K thanks the US National Science Foundation (NSF) (grants 1463474 and 1566460) for support. A.F.M. thanks the Brazilian Ministerio da EducacAo (MEC)/Tutorial Education Programme (PET) for a fellowship and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) for a research fellowship (311353/2019-3). We thank the Brazilian funding agencies CoordenacAo de Aperfeicoamento de Pessoal de Nivel Superio (CAPES), CNPq, and FundacAo de Amparo a Pesquisa do Estado de SAo Paulo (FAPESP) (processes 2012/15147-4 and 2013/07296-2) for financial support; and the high-performance computer (HPC) resources provided by the SDumont supercomputer at the National Laboratory for Scientific Computing (Laboratorio Nacional de ComputacAo Cientifica (LNCC)/Ministerio da Ciencia, Tecnologia e Inovacoes (MCTI), Brazil; http://sdumont.lncc.br) and by the Cloud@UFSCar.	Cagno V, 2018, NAT MATER, V17, P195, DOI 10.1038/NMAT5053; Chen L, 2014, NANO LETT, V14, P7201, DOI 10.1021/nl504126u; Chen W, 2009, NANO LETT, V9, P2153, DOI 10.1021/nl900726s; Cobb M. H., 2002, MOL BIOL CELL, V6th, P589; Copeland L. O., 1999, PRINCIPLES SEED SCI, P59; Del Pino P, 2014, MATER HORIZ, V1, P301, DOI 10.1039/c3mh00106g; Ferguson SM, 2012, NAT REV MOL CELL BIO, V13, P75, DOI 10.1038/nrm3266; Galic M, 2012, NAT CELL BIOL, V14, P874, DOI 10.1038/ncb2533; Gerard VA, 2011, CHEM COMMUN, V47, P7383, DOI 10.1039/c1cc11083g; Geva M, 2003, J AM CHEM SOC, V125, P696, DOI 10.1021/ja027942j; Gonzalez-Rubio G, 2017, SCIENCE, V358, P640, DOI 10.1126/science.aan8478; Guerrero-Martinez A, 2011, NANO TODAY, V6, P381, DOI 10.1016/j.nantod.2011.06.003; Im SW, 2020, ADV MATER, V32, DOI 10.1002/adma.201905758; JOHNSON PB, 1972, PHYS REV B, V6, P4370, DOI 10.1103/PhysRevB.6.4370; Karst J, 2019, ACS NANO, V13, P8659, DOI 10.1021/acsnano.9b04046; Kefauver JM, 2020, NATURE, V587, P567, DOI 10.1038/s41586-020-2933-1; Kim JY, 2019, J AM CHEM SOC, V141, P11739, DOI 10.1021/jacs.9b00700; Kotov NA, 2010, SCIENCE, V330, P188, DOI 10.1126/science.1190094; Kuznetsova VA, 2017, CHIRALITY, V29, P403, DOI 10.1002/chir.22713; Langenhan T, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003825; Lee HE, 2018, NATURE, V556, P360, DOI 10.1038/s41586-018-0034-1; Ma W, 2017, CHEM REV, V117, P8041, DOI 10.1021/acs.chemrev.6b00755; Ma W, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3689; Mahmoudi M, 2011, CHEM REV, V111, P3407, DOI 10.1021/cr1003166; Molotsky T, 2010, J PHYS CHEM C, V114, P15951, DOI 10.1021/jp911968x; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Naur P, 2007, P NATL ACAD SCI USA, V104, P14116, DOI 10.1073/pnas.0703718104; Ohta S, 2016, SCIENCE, V351, P841, DOI 10.1126/science.aad4925; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Ou ZH, 2020, NAT MATER, V19, P450, DOI 10.1038/s41563-019-0514-1; Pellegrini M, 2016, SCI REP-UK, V6, DOI 10.1038/srep34986; Ranade SS, 2015, NEURON, V87, P1162, DOI 10.1016/j.neuron.2015.08.032; Richards DM, 2016, P NATL ACAD SCI USA, V113, P6113, DOI 10.1073/pnas.1521974113; Saito K, 2018, NANO LETT, V18, P3209, DOI 10.1021/acs.nanolett.8b00929; Singh G, 2014, SCIENCE, V345, P1149, DOI 10.1126/science.1254132; Sun MZ, 2018, NAT CHEM, V10, P821, DOI 10.1038/s41557-018-0083-y; Walkey CD, 2012, J AM CHEM SOC, V134, P2139, DOI 10.1021/ja2084338; Wang DG, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aau6584; Wang J, 2018, NAT NANOTECHNOL, V13, P1078, DOI 10.1038/s41565-018-0274-0; Wang XY, 2017, ACS NANO, V11, P4606, DOI 10.1021/acsnano.7b00200; Xia YF, 2018, NAT MATER, V17, P187, DOI 10.1038/NMAT5057; Yeom J, 2018, SCIENCE, V359, P309, DOI 10.1126/science.aao7172; Yeom J, 2015, NAT MATER, V14, P66, DOI [10.1038/NMAT4125, 10.1038/nmat4125]; Zhang QZ, 2018, NAT NANOTECHNOL, V13, P1182, DOI 10.1038/s41565-018-0254-4; Zhang QF, 2019, SCIENCE, V365, P1475, DOI 10.1126/science.aax5415; Zheng GC, 2018, ANGEW CHEM INT EDIT, V57, P16452, DOI 10.1002/anie.201810693	47	66	65	155	358	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 20	2022	601	7893					366	+		10.1038/s41586-021-04243-2	http://dx.doi.org/10.1038/s41586-021-04243-2			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YJ6UI	35046606				2022-12-28	WOS:000744666700028
J	Jayedi, A; Soltani, S; Motlagh, SZT; Emadi, A; Shahinfar, H; Moosavi, H; Shab-Bidar, S				Jayedi, Ahmad; Soltani, Sepideh; Motlagh, Sheida Zeraat-talab; Emadi, Alireza; Shahinfar, Hosein; Moosavi, Hanieh; Shab-Bidar, Sakineh			Anthropometric and adiposity indicators and risk of type 2 diabetes: systematic review and dose-response meta-analysis of cohort studies	BMJ-BRITISH MEDICAL JOURNAL			English	Review							BODY-MASS INDEX; TO-HEIGHT RATIO; OBESITY; WEIGHT; BIAS; ASSOCIATIONS; OVERWEIGHT; MORTALITY; DURATION; QUALITY	OBJECTIVE To present a comprehensive review of the association between measures of body weight, waist, and fat, and different ratios of these measures, and the risk of type 2 diabetes. DESIGN Systematic review and dose-response meta-analysis of cohort studies. DATA SOURCES PubMed, Scopus, and Web of Science up to 1 May 2021. REVIEW METHODS Cohort studies looking at the association between general or central adiposity and body fat content and the risk of type 2 diabetes in the general adult population were included. Two of the authors extracted the data in duplicate. Random effects dose-response meta-analyses were performed to estimate the degree of the associations. Curvilinear associations were modelled with a one stage weighted mixed effects meta-analysis. RESULTS 216 cohort studies with 2.3 million individuals with type 2 diabetes among 26 million participants were identified. Relative risks were 1.72 (95% confidence interval 1.65 to 1.81; n=182 studies) for an increase in body mass index of 5 units, 1.61 (1.52 to 1.70; n=78) for a 10 cm larger waist circumference, 1.63 (1.50 to 1.78; n=34) for an increase in waist-to-hip ratio of 0.1 units, 1.73 (1.51 to 1.98; n=25) for an increase in waist-to-height ratio of 0.1 units, 1.42 (1.27 to 1.58; n=9) for an increase in visceral adiposity index of 1 unit, 2.05 (1.41 to 2.98; n=6) Shab-Bidar2 for a 10% higher percentage body fat, 1.09 (1.05 to 1.13, n=5) for an increase in body shape index of 0.005 units, 2.55 (1.59 to 4.10, n=4) for a 10% higher body adiposity index, and 1.11 (0.98 to 1.27; n=14) for a 10 cm larger hip circumference. A strong positive linear association was found between body mass index and the risk of type 2 diabetes. Positive linear or monotonic associations were also found in all regions and ethnicities, without marked deviation from linearity at a specific cut-off value. Indices of central fatness, independent of overall adiposity, also had positive linear or monotonic associations with the risk of type 2 diabetes. Positive linear or monotonic associations were also found for total and visceral fat mass, although the number of studies was small. CONCLUSIONS A higher body mass index was associated with a greater risk of developing type 2 diabetes. A larger waist circumference, independent of overall adiposity, was strongly and linearly associated with the risk of type 2 diabetes. SYSTEMATIC REVIEW REGISTRATION PROSPERO CRD42021255338.	[Jayedi, Ahmad] Semnan Univ Med Sci, Social Determinant Hlth Res Ctr, Semnan, Iran; [Jayedi, Ahmad; Motlagh, Sheida Zeraat-talab; Moosavi, Hanieh; Shab-Bidar, Sakineh] Univ Tehran Med Sci, Sch Nutr Sci & Dietet, Dept Community Nutr, Tehran, Iran; [Soltani, Sepideh] Shahid Sadoughi Univ Med Sci, Yazd Cardiovasc Res Ctr, Yazd, Iran; [Emadi, Alireza] Semnan Univ Med Sci, Food Safety Res Ctr salt, Semnan, Iran; [Shahinfar, Hosein] Iran Univ Med Sci, Sch Publ Hlth, Dept Nutr, Tehran, Iran	Semnan University of Medical Sciences; Tehran University of Medical Sciences; Semnan University of Medical Sciences; Iran University of Medical Sciences	Shab-Bidar, S (corresponding author), Univ Tehran Med Sci, Sch Nutr Sci & Dietet, Dept Community Nutr, Tehran, Iran.	s_shabbidar@tums.ac.ir	; Shab-Bidar, Sakineh/H-9525-2017	jayedi, ahmad/0000-0003-4231-3147; Shab-Bidar, Sakineh/0000-0002-0167-7174				Abdullah A, 2010, DIABETES RES CLIN PR, V89, P309, DOI 10.1016/j.diabres.2010.04.012; ANDRES R, 1985, ANN INTERN MED, V103, P1030, DOI 10.7326/0003-4819-103-6-1030; Ashwell M, 2012, OBES REV, V13, P275, DOI 10.1111/j.1467-789X.2011.00952.x; Aune D, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2156; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bender R, 1999, JAMA-J AM MED ASSOC, V281, P1498, DOI 10.1001/jama.281.16.1498; Bergman RN, 2011, OBESITY, V19, P1083, DOI 10.1038/oby.2011.38; Brown P, 2006, BRIT MED J, V333, P804, DOI 10.1136/bmj.38987.492014.94; Caleyachetty R, 2021, LANCET DIABETES ENDO, V9, P419, DOI 10.1016/S2213-8587(21)00088-7; Cawley J, 2015, ECON HUM BIOL, V19, P27, DOI 10.1016/j.ehb.2015.07.001; Cheng L, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00094; Chiolero A, 2007, OBES REV, V8, P373, DOI 10.1111/j.1467-789X.2007.00375.x; Crippa A, 2019, STAT METHODS MED RES, V28, P1579, DOI 10.1177/0962280218773122; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Di Angelantonio E, 2016, LANCET, V388, P776, DOI 10.1016/S0140-6736(16)30175-1; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ezzati M, 2017, LANCET, V390, P2627, DOI 10.1016/S0140-6736(17)32129-3; Felber JP, 2002, INT J OBESITY, V26, pS39, DOI 10.1038/sj.ijo.0802126; GREENLAND S, 1992, AM J EPIDEMIOL, V135, P1301, DOI 10.1093/oxfordjournals.aje.a116237; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1294, DOI 10.1016/j.jclinepi.2011.03.017; Hamling J, 2008, STAT MED, V27, P954, DOI 10.1002/sim.3013; Harrell FE, 2015, SPRINGER SER STAT, DOI 10.1007/978-3-319-19425-7; Hartemink N, 2006, AM J EPIDEMIOL, V163, P1042, DOI 10.1093/aje/kwj141; Higgins J., 2022, COCHRANE HDB SYSTEMA, DOI DOI 10.1002/9781119536604; Higgins JPT, 2008, INT J EPIDEMIOL, V37, P1158, DOI 10.1093/ije/dyn204; Hu Y, 2014, OBESITY, V22, P2267, DOI 10.1002/oby.20851; Ioannidis JPA, 2008, BMJ-BRIT MED J, V336, P1413, DOI 10.1136/bmj.a117; Jayedi A, 2018, OBES REV, V19, P654, DOI 10.1111/obr.12656; Jayedi A, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3324; Jayedi A, 2020, EUR J CLIN NUTR, V74, P1263, DOI 10.1038/s41430-020-0610-y; Kodama S, 2012, AM J EPIDEMIOL, V176, P959, DOI 10.1093/aje/kws172; Kyrgiou M, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j477; Maukonen M, 2018, SCAND J PUBLIC HEALT, V46, P565, DOI 10.1177/1403494818761971; Neuenschwander M, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003347; Orsini N, 2021, STATA J, V21, P320, DOI 10.1177/1536867X211025798; Orsini N, 2012, AM J EPIDEMIOL, V175, P66, DOI 10.1093/aje/kwr265; Page MJ, 2021, BMJ-BRIT MED J, V372, DOI [10.1136/bmj.n71, 10.1016/j.ijsu.2021.105906]; Peters JL, 2008, J CLIN EPIDEMIOL, V61, P991, DOI 10.1016/j.jclinepi.2007.11.010; Rucker G, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-79; Schnemann H., 2013, GRADE HDB HDB GRADIN; Schunemann HJ, 2019, J CLIN EPIDEMIOL, V111, P105, DOI 10.1016/j.jclinepi.2018.01.012; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Sterne JA., 2019, COCHRANE HDB SYSTEMA, DOI DOI 10.1002/9781119536604.CH25; Sterne JAC, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i4919; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Stevens J, 1998, NEW ENGL J MED, V338, P1, DOI 10.1056/NEJM199801013380101; Symons MJ, 2002, J CLIN EPIDEMIOL, V55, P893, DOI 10.1016/S0895-4356(02)00443-2; Tremmel M, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14040435; Wannamethee SG, 1999, DIABETES CARE, V22, P1266, DOI 10.2337/diacare.22.8.1266; Wells G., 2013, NEWCASTLE OTTAWA SCA; WHO, 2004, LANCET, V363, P902; Willett W., 2012, NUTR EPIDEMIOLOGY, DOI [10.1093/acprof:oso/9780199754038.001.0001, DOI 10.1093/ACPROF:OSO/9780199754038.001.0001]; Xu H, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.00603; Yang JJ, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.2696; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690; Zheng Y, 2018, NAT REV ENDOCRINOL, V14, P88, DOI 10.1038/nrendo.2017.151	56	8	8	2	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 18	2022	376								e067516	10.1136/bmj-2021-067516	http://dx.doi.org/10.1136/bmj-2021-067516			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YL6XO	35042741	hybrid, Green Published			2022-12-28	WOS:000746032600001
J	Rubin, R				Rubin, Rita			Regulation of 3D Printing at Health Care Facilities	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 18	2022	327	3					210	210						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YV9PQ	35040899				2022-12-28	WOS:000753055100004
J	Johnson, AG; Wein, T; Mayer, ML; Duncan-Lowey, B; Yirmiya, E; Oppenheimer-Shaanan, Y; Amitai, G; Sorek, R; Kranzusch, PJ				Johnson, Alex G.; Wein, Tanita; Mayer, Megan L.; Duncan-Lowey, Brianna; Yirmiya, Erez; Oppenheimer-Shaanan, Yaara; Amitai, Gil; Sorek, Rotem; Kranzusch, Philip J.			Bacterial gasdermins reveal an ancient mechanism of cell death	SCIENCE			English	Article							SEQUENCE ALIGNMENT; MODEL; PYROPTOSIS	Gasdermin proteins form large membrane pores in human cells that release immune cytokines and induce lytic cell death. Gasdermin pore formation is triggered by caspase-mediated cleavage during inflammasome signaling and is critical for defense against pathogens and cancer. We discovered gasdermin homologs encoded in bacteria that defended against phages and executed cell death. Structures of bacterial gasdermins revealed a conserved pore-forming domain that was stabilized in the inactive state with a buried lipid modification. Bacterial gasdermins were activated by dedicated caspase-like proteases that catalyzed site-specific cleavage and the removal of an inhibitory C-terminal peptide. Release of autoinhibition induced the assembly of large and heterogeneous pores that disrupted membrane integrity. Thus, pyroptosis is an ancient form of regulated cell death shared between bacteria and animals.	[Johnson, Alex G.; Duncan-Lowey, Brianna; Kranzusch, Philip J.] Harvard Med Sch, Dept Microbiol, Boston, MA 02115 USA; [Johnson, Alex G.; Duncan-Lowey, Brianna; Kranzusch, Philip J.] Dana Farber Canc Inst, Dept Canc Immunol & Virol, Boston, MA 02115 USA; [Wein, Tanita; Yirmiya, Erez; Oppenheimer-Shaanan, Yaara; Amitai, Gil; Sorek, Rotem] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; [Mayer, Megan L.] Harvard Med Sch, Harvard Ctr Cryoelectron Microscopy, Boston, MA 02115 USA; [Kranzusch, Philip J.] Dana Farber Canc Inst, Parker Inst Canc Immunotherapy, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Weizmann Institute of Science; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute	Kranzusch, PJ (corresponding author), Harvard Med Sch, Dept Microbiol, Boston, MA 02115 USA.; Kranzusch, PJ (corresponding author), Dana Farber Canc Inst, Dept Canc Immunol & Virol, Boston, MA 02115 USA.; Sorek, R (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.; Kranzusch, PJ (corresponding author), Dana Farber Canc Inst, Parker Inst Canc Immunotherapy, Boston, MA 02115 USA.	rotem.sorek@weizmann.ac.il; philip_kranzusch@dfci.harvard.edu	Oppenheimer-Shaanan, Yaara/AGM-2041-2022; Wein, Tanita/GRS-2427-2022	Yirmiya, Erez/0000-0002-1907-9244; Duncan-Lowey, Brianna/0000-0001-9078-503X; Oppenheimer shaanan, Yaara/0000-0002-7005-3074; Wein, Tanita/0000-0002-4561-9654; Johnson, Alexander/0000-0002-4040-9797	Pew Biomedical Scholars Program; Burroughs Wellcome Fund PATH award; Mathers Foundation; Parker Institute for Cancer Immunotherapy; European Research Council [ERC-CoG 681203]; Israel Science Foundation [ISF 296/21]; Ernest and Bonnie Beutler Research Program of Excellence in Genomic Medicine; Minerva Foundation; Federal German Ministry for Education and Research; Knell Family Center for Microbiology; Weizmann Institute Sustainability and Energy Research Initiative; Dr. Barry Sherman Institute for Medicinal Chemistry; National Institute of Health Cancer Immunology training grant [T32CA207021]; Life Science Research Foundation postdoctoral fellowship of the Open Philanthropy Project; Minerva Foundation postdoctoral fellowship; Herchel Smith Graduate Research Fellowship; Yotam project	Pew Biomedical Scholars Program; Burroughs Wellcome Fund PATH award(Burroughs Wellcome Fund); Mathers Foundation; Parker Institute for Cancer Immunotherapy; European Research Council(European Research Council (ERC)European Commission); Israel Science Foundation(Israel Science Foundation); Ernest and Bonnie Beutler Research Program of Excellence in Genomic Medicine; Minerva Foundation; Federal German Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); Knell Family Center for Microbiology; Weizmann Institute Sustainability and Energy Research Initiative; Dr. Barry Sherman Institute for Medicinal Chemistry; National Institute of Health Cancer Immunology training grant; Life Science Research Foundation postdoctoral fellowship of the Open Philanthropy Project; Minerva Foundation postdoctoral fellowship; Herchel Smith Graduate Research Fellowship; Yotam project	This study was supported by the Pew Biomedical Scholars Program (P.J.K.), the Burroughs Wellcome Fund PATH award (P.J.K.), the Mathers Foundation (P.J.K.), the Parker Institute for Cancer Immunotherapy (P.J.K.), European Research Council grant ERC-CoG 681203 (R.S.), Israel Science Foundation grant ISF 296/21 (R.S.), the Ernest and Bonnie Beutler Research Program of Excellence in Genomic Medicine (R.S.), the Minerva Foundation and Federal German Ministry for Education and Research (R.S.), the Knell Family Center for Microbiology (R.S.), the Yotam project and the Weizmann Institute Sustainability and Energy Research Initiative (R.S.), the Dr. Barry Sherman Institute for Medicinal Chemistry (R.S.), National Institute of Health Cancer Immunology training grant T32CA207021 (A.G.J.), a Life Science Research Foundation postdoctoral fellowship of the Open Philanthropy Project (A.G. J.), a Minerva Foundation postdoctoral fellowship (T.W.), and a Herchel Smith Graduate Research Fellowship (B.D.-L.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Broz P, 2020, NAT REV IMMUNOL, V20, P143, DOI 10.1038/s41577-019-0228-2; Chen IMA, 2019, NUCLEIC ACIDS RES, V47, pD666, DOI 10.1093/nar/gky901; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Clave C., FUNGAL GASDERMIN LIK, P1, DOI [10.1101/2021.06.03.446900, DOI 10.1101/2021.06.03.446900]; Clave C., 2021, BIORXIV; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Daskalov A, 2020, P NATL ACAD SCI USA, V117, P18600, DOI 10.1073/pnas.2004876117; Ding JJ, 2016, NATURE, V535, P111, DOI 10.1038/nature18590; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hansen JM, 2021, CELL, V184, P3178, DOI 10.1016/j.cell.2021.04.036; He WT, 2015, CELL RES, V25, P1285, DOI 10.1038/cr.2015.139; Humphries F, 2020, SCIENCE, V369, P1633, DOI 10.1126/science.abb9818; Jiang S, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd2591; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kall L, 2008, BIOINFORMATICS, V24, pI42, DOI 10.1093/bioinformatics/btn294; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Katoh K, 2019, BRIEF BIOINFORM, V20, P1160, DOI 10.1093/bib/bbx108; Kaur G, 2020, ELIFE, V9, DOI 10.7554/eLife.52696; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kummel D, 2006, P NATL ACAD SCI USA, V103, P12701, DOI 10.1073/pnas.0603513103; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Letunic I, 2019, NUCLEIC ACIDS RES, V47, pW256, DOI 10.1093/nar/gkz239; Lieberman J, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aav1447; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Liu X, 2016, NATURE, V535, P153, DOI 10.1038/nature18629; Liu ZH, 2019, IMMUNITY, V51, P43, DOI 10.1016/j.immuni.2019.04.017; Mastronarde DN, 1997, J STRUCT BIOL, V120, P343, DOI 10.1006/jsbi.1997.3919; Mazzocco Amanda, 2009, V501, P81, DOI 10.1007/978-1-60327-164-6_9; Millman A, 2020, NAT MICROBIOL, V5, P1608, DOI 10.1038/s41564-020-0777-y; Minh BQ, 2020, MOL BIOL EVOL, V37, P1530, DOI 10.1093/molbev/msaa015; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Pei JM, 2014, METHODS MOL BIOL, V1079, P263, DOI 10.1007/978-1-62703-646-7_17; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Ruan JB, 2018, NATURE, V557, P62, DOI 10.1038/s41586-018-0058-6; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schorb M, 2019, NAT METHODS, V16, P471, DOI 10.1038/s41592-019-0396-9; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Shi M, 2020, CURR OPIN CELL BIOL, V63, P194, DOI 10.1016/j.ceb.2020.03.002; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Steinegger M, 2017, NAT BIOTECHNOL, V35, P1026, DOI 10.1038/nbt.3988; Wagner T, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0437-z; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Wheeler DL, 2008, NUCLEIC ACIDS RES, V36, pD13, DOI 10.1093/nar/gkm1000; Xia SY, 2021, NATURE, V593, P607, DOI 10.1038/s41586-021-03478-3; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zimmermann L, 2018, J MOL BIOL, V430, P2237, DOI 10.1016/j.jmb.2017.12.007	48	23	39	33	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2022	375	6577					221	+		10.1126/science.abj8432	http://dx.doi.org/10.1126/science.abj8432			41	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YG3OI	35025633	Green Accepted, Green Submitted			2022-12-28	WOS:000742401600038
J	van der Valk, J				van der Valk, Jan			Fetal bovine serum-a cell culture dilemma	SCIENCE			English	Editorial Material							MAMMALIAN-CELLS		[van der Valk, Jan] Univ Utrecht, 3Rs Ctr, Utrecht, Netherlands	Utrecht University	van der Valk, J (corresponding author), Univ Utrecht, 3Rs Ctr, Utrecht, Netherlands.	j.vandervalk@uu.nl						Barosova H, 2021, TOXICOL IN VITRO, V75, DOI 10.1016/j.tiv.2021.105178; Bieback K, 2019, CYTOTHERAPY, V21, P911, DOI 10.1016/j.jcyt.2019.06.006; Bryan N, 2011, BIOSCIENCE REP, V31, P199, DOI 10.1042/BSR20100064; Cimino M, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/6597815; EMA, 2013, GUID US BOV SER MAN; Harrison RG, 1907, ANAT REC, V1, P116, DOI 10.1002/ar.1090010503; Landauer K, 2014, METHODS MOL BIOL, V1104, P89, DOI 10.1007/978-1-62703-733-4_7; Lau AJ, 2014, TOXICOL APPL PHARM, V277, P221, DOI 10.1016/j.taap.2014.03.023; OECD, 2017, GUID DOC GOOD IN VIT; Oleaga C, 2019, ADV FUNCT MATER, V29, DOI 10.1002/adfm.201805792; PUCK TT, 1958, J EXP MED, V108, P945, DOI 10.1084/jem.108.6.945; Sinacore MS, 2000, MOL BIOTECHNOL, V15, P249, DOI 10.1385/MB:15:3:249; US Department of Health and Human Services (HHS) Food and Drug Administration Center for Biologics Evaluation and Research, 2010, GUID IND CHAR QUAL C; van der Valk J, 2010, TOXICOL IN VITRO, V24, P1053, DOI 10.1016/j.tiv.2010.03.016; Wei ZY, 2016, SCI REP-UK, V6, DOI 10.1038/srep31175	15	6	6	16	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2022	375	6577					143	144		10.1126/science.abm1317	http://dx.doi.org/10.1126/science.abm1317			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YG3OI	35025663				2022-12-28	WOS:000742401600015
J	Hamilton, I				Hamilton, Ian			The UK tinkers around the edges of drug policy but it still needs national reform	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material						Local trials can attempt to minimise the harm from illegal drugs; but what the UK really needs is an; overhaul of its drug policy; says Ian Hamilton			[Hamilton, Ian] Univ York, York, N Yorkshire, England	University of York - UK	Hamilton, I (corresponding author), Univ York, York, N Yorkshire, England.							ABC News, 2022, ABC NEWS; [Anonymous], 2021, REV DRUGS 2; [Anonymous], 2021, LARG EV INCR FUND DR; [Anonymous], 2020, IND REV DRUGS PROF D; [Anonymous], 2021, HARM HOPE 10 YEAR DR; Checkpoint, DURH CONST; Diver T., 2022, TELEGRAPH; Eastwood N., NUMBERS BLACK WHITE; Hamilton F., 2022, TIMES 0108; Rimi A, 2022, INDEPENDENT	10	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 10	2022	376								o52	10.1136/bmj.o52	http://dx.doi.org/10.1136/bmj.o52			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YP6IZ	35012939	Bronze			2022-12-28	WOS:000748727200007
J	Mahase, E				Mahase, Elisabeth			Covid-19: Positive lateral flow tests will no longer require PCR confirmation, government announces	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2021, ASYMPTOMATIC TESTING	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 6	2022	376								o14	10.1136/bmj.o14	http://dx.doi.org/10.1136/bmj.o14			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YG5VA	34992094	Bronze			2022-12-28	WOS:000742554700005
J	Hahn, EE; Munoz-Plaza, CE; Pounds, D; Lyons, LJ; Lee, JS; Shen, E; Hong, BD; La Cava, S; Brasfield, FM; Durna, LN; Kwan, KW; Beard, DB; Ferreira, A; Padmanabhan, A; Gould, MK				Hahn, Erin E.; Munoz-Plaza, Corrine E.; Pounds, Dana; Lyons, Lindsay Joe; Lee, Janet S.; Shen, Ernest; Hong, Benjamin D.; La Cava, Shannon; Brasfield, Farah M.; Durna, Lara N.; Kwan, Karen W.; Beard, David B.; Ferreira, Alexander; Padmanabhan, Aswini; Gould, Michael K.			Effect of a Community-Based Medical Oncology Depression Screening Program on Behavioral Health Referrals Among Patients With Breast Cancer A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PSYCHOSOCIAL DISTRESS; IMPLEMENTATION-RESEARCH; MANAGEMENT; CARE; INTERVENTIONS; ADHERENCE; VALIDITY; SOCIETY; SCIENCE; ANXIETY	IMPORTANCE Implementation of guideline-recommended depression screening in medical oncology remains challenging. Evidence suggests that multicomponent care pathways with algorithm-based referral and management are effective, yet implementation of sustainable programs remains limited and implementation-science guided approaches are understudied. OBJECTIVE To evaluate the effectiveness of an implementation-strategy guided depression screening program for patients with breast cancer in a community setting. DESIGN, SETTING, AND PARTICIPANTS A pragmatic cluster randomized clinical trial conducted within Kaiser Permanente Southern California (KPSC). The trial included 6 medical centers and 1436 patients diagnosed with new primary breast cancer who had a consultation with medical oncology between October 1, 2017, through September 30, 2018. Patients were followed up through study end date of May 31, 2019. INTERVENTIONS Six medical centers in Southern California participated and were randomized 1:1 to tailored implementation strategies (intervention, 3 sites, n = 744 patients) or education-only (control, 3 sites, n = 692 patients) groups. The program consisted of screening with the 9-item Patient Health Questionnaire (PHQ-9) and algorithm-based scoring and referral to behavioral health services based on low, moderate, or high score. Clinical teams at tailored intervention sites received program education, audit, and feedback of performance data and implementation facilitation, and clinical workflows were adapted to suit local context. Education-only controls sites received program education. MAIN OUTCOMES AND MEASURES The primary outcome was percent of eligible patients screened and referred (based on PHQ-9 score) at intervention vs control groups measured at the patient level. Secondary outcomes included outpatient health care utilization for behavioral health, primary care, oncology, urgent care, and emergency department. RESULTS All 1436 eligible patients were randomized at the center level (mean age, 61.5 years; 99% women; 18% Asian, 17% Black, 26% Hispanic, and 37% White) and were followed up to the end of the study, insurance disenrollment, or death. Groups were similar in demographic and tumor characteristics. For the primary outcome, 7.9%(59 of 744) of patients at tailored sites were referred compared with 0.1% (1 of 692) at education-only sites (difference, 7.8%; 95% CI, 5.8%-9.8%). Referrals to a behavioral health clinician were completed by 44 of 59 patients treated at the intervention sites (75%) intervention sites vs 1 of 1 patient at the education-only sites (100%). In adjusted models patients at tailored sites had significantly fewer outpatient visits in medical oncology (rate ratio, 0.86; 95% CI, 0.86-0.89; P=.001), and no significant difference in utilization of primary care, urgent care, and emergency department visits. CONCLUSIONS AND RELEVANCE Among patients with breast cancer treated in community-based oncology practices, tailored strategies for implementation of routine depression screening compared with an education-only control group resulted in a greater proportion of referrals to behavioral care. Further research is needed to understand the clinical benefit and cost-effectiveness of this program.	[Hahn, Erin E.; Munoz-Plaza, Corrine E.; Pounds, Dana; Lyons, Lindsay Joe; Lee, Janet S.; Shen, Ernest; Hong, Benjamin D.] Kaiser Permanente Southern Calif, Dept Res & Evaluat, 100 S Los Robles Ave, Pasadena, CA 91101 USA; [Hahn, Erin E.; Gould, Michael K.] Kaiser Permanente Bernard J Tyson Sch Med, Dept Hlth Syst Sci, Pasadena, CA USA; [Pounds, Dana] Southern Calif Permanente Med Grp, Performance Assessment Team, Pasadena, CA USA; [La Cava, Shannon] Canc Support Community, Los Angeles, CA USA; [Brasfield, Farah M.] Southern Calif Permanente Med Grp, Dept Med Oncol, Anaheim, CA USA; [Durna, Lara N.] Southern Calif Permanente Med Grp, Dept Med Oncol, South Bay, CA USA; [Kwan, Karen W.] Southern Calif Permanente Med Grp, Dept Med Oncol, Los Angeles, CA USA; [Beard, David B.] Southern Calif Permanente Med Grp, Dept Med Oncol, Woodland Hills, CA USA; [Ferreira, Alexander] Southern Calif Permanente Med Grp, Dept Med Oncol, West Los Angeles, CA USA; [Padmanabhan, Aswini] Southern Calif Permanente Med Grp, Dept Med Oncol, Baldwin Pk, CA USA	Kaiser Permanente; Kaiser Permanente; Permanente Medical Groups; Permanente Medical Groups; Permanente Medical Groups; Permanente Medical Groups; Permanente Medical Groups; Permanente Medical Groups; Permanente Medical Groups	Hahn, EE (corresponding author), Kaiser Permanente Southern Calif, Dept Res & Evaluat, 100 S Los Robles Ave, Pasadena, CA 91101 USA.	erin.e.hahn@kp.org			Regents of the University of California, Research Grants Program Office, California Breast Cancer Research Program [22OB-0029]	Regents of the University of California, Research Grants Program Office, California Breast Cancer Research Program	This project was supported by grant 22OB-0029 from the Regents of the University of California, Research Grants Program Office, California Breast Cancer Research Program.	American College of Surgeons Commission on Cancer, 2016, CANC PROGRAM STANDAR, P56; Andersen BL, 2014, J CLIN ONCOL, V32, P1605, DOI 10.1200/JCO.2013.52.4611; Berta W, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0323-0; Burgess C, 2005, BRIT MED J, V330, P702, DOI 10.1136/bmj.38343.670868.D3; Carlson LE, 2012, J CLIN ONCOL, V30, P1160, DOI 10.1200/JCO.2011.39.5509; Curran GM, 2012, MED CARE, V50, P217, DOI 10.1097/MLR.0b013e3182408812; Damschroder LJ, 2011, PSYCHOL ADDICT BEHAV, V25, P194, DOI 10.1037/a0022284; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; Donner A, 1996, J CLIN EPIDEMIOL, V49, P435, DOI 10.1016/0895-4356(95)00511-0; Donovan KA, 2020, EPIDEMIOL PSYCH SCI, V29, DOI 10.1017/S2045796019000799; Dudgeon D, 2012, PSYCHO-ONCOLOGY, V21, P357, DOI 10.1002/pon.1918; Ehlers SL, 2019, TRANSL BEHAV MED, V9, P282, DOI 10.1093/tbm/iby123; Fitch MI, 2018, SUPPORT CARE CANCER, V26, P4011, DOI 10.1007/s00520-018-4278-y; Fradgley EA, 2020, SUPPORT CARE CANCER, V28, P249, DOI 10.1007/s00520-019-04801-5; Hintze J., 2014, PASS 13 POWER ANAL S; Ivers NM, 2014, J GEN INTERN MED, V29, P1534, DOI 10.1007/s11606-014-2913-y; Jacobsen PB, 2019, TRANSL BEHAV MED, V9, P292, DOI 10.1093/tbm/ibz022; Koebnick Corinna, 2012, Perm J, V16, P37; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lazenby M, 2015, J ONCOL PRACT, V11, pE413, DOI 10.1200/JOP.2014.002816; Liang WH, 2020, LANCET ONCOL, V21, P335, DOI 10.1016/S1470-2045(20)30096-6; Loudon K, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2147; McCarter K, 2020, CURR OPIN SUPPORT PA, V14, P220, DOI 10.1097/SPC.0000000000000513; McCarter K, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-017959; Mehnert A, 2018, PSYCHO-ONCOLOGY, V27, P75, DOI 10.1002/pon.4464; Mitchell AJ, 2012, CANCER-AM CANCER SOC, V118, P6260, DOI 10.1002/cncr.27648; Mitchell AJ, 2010, J NATL COMPR CANC NE, V8, P487, DOI 10.6004/jnccn.2010.0035; National Academies of Sciences Engineering and Medicine, 2018, LONG TERM SURV CAR C, DOI 10.17226/11993; Nekhlyudov L, 2020, J CANCER SURVIV, V14, P601, DOI 10.1007/s11764-020-00884-w; O'Connor E, 2016, AHRQ PUBLICATION; Pilevarzadeh M, 2019, BREAST CANCER RES TR, V176, P519, DOI 10.1007/s10549-019-05271-3; Pirl WF, 2014, CANCER-AM CANCER SOC, V120, P2946, DOI 10.1002/cncr.28750; Powell BJ, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0209-1; Riba MB, 2019, J NATL COMPR CANC NE, V17, P1229, DOI 10.6004/jnccn.2019.0048; Smith AB, 2009, PSYCHO-ONCOLOGY, V18, P195, DOI 10.1002/pon.1423; Smith Sophia K, 2018, Am Soc Clin Oncol Educ Book, V38, P813, DOI 10.1200/EDBK_201307; Stanton AL, 2006, J CLIN ONCOL, V24, P5132, DOI 10.1200/JCO.2006.06.8775; Suppli NP, 2014, J CLIN ONCOL, V32, P3831, DOI 10.1200/JCO.2013.54.0419; Thorpe KE, 2009, J CLIN EPIDEMIOL, V62, P464, DOI [10.1503/cmaj.090523, 10.1016/j.jclinepi.2008.12.011]; Zebrack B, 2017, J NATL COMPR CANC NE, V15, P903, DOI 10.6004/jnccn.2017.0120; Zebrack B, 2015, J CLIN ONCOL, V33, P1165, DOI 10.1200/JCO.2014.57.4020	41	2	2	7	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 4	2022	327	1					41	49		10.1001/jama.2021.22596	http://dx.doi.org/10.1001/jama.2021.22596			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YF7YT	34982119	Green Published			2022-12-28	WOS:000742019000017
J	Prete, A; Subramanian, A; Bancos, I; Chortis, V; Tsagarakis, S; Lang, K; Macech, M; Delivanis, DA; Pupovac, ID; Reimondo, G; Marina, LV; Deutschbein, T; Balomenaki, M; O'Reilly, MW; Gilligan, LC; Jenkinson, C; Bednarczuk, T; Zhang, CD; Dusek, T; Diamantopoulos, A; Asia, M; Kondracka, A; Li, DF; Masjkur, JR; Quinkler, M; Ueland, GA; Dennedy, MC; Beuschlein, F; Tabarin, A; Fassnacht, M; Ivovic, M; Terzolo, M; Kastelan, D; Young, WF; Manolopoulos, KN; Ambroziak, U; Vassiliadi, DA; Taylor, AE; Sitch, AJ; Nirantharakumar, K; Arlt, W				Prete, Alessandro; Subramanian, Anuradhaa; Bancos, Irina; Chortis, Vasileios; Tsagarakis, Stylianos; Lang, Katharina; Macech, Magdalena; Delivanis, Danae A.; Pupovac, Ivana D.; Reimondo, Giuseppe; Marina, Ljiljana, V; Deutschbein, Timo; Balomenaki, Maria; O'Reilly, Michael W.; Gilligan, Lorna C.; Jenkinson, Carl; Bednarczuk, Tomasz; Zhang, Catherine D.; Dusek, Tina; Diamantopoulos, Aristidis; Asia, Miriam; Kondracka, Agnieszka; Li, Dingfeng; Masjkur, Jimmy R.; Quinkler, Marcus; Ueland, Grethe A.; Dennedy, M. Conall; Beuschlein, Felix; Tabarin, Antoine; Fassnacht, Martin; Ivovic, Miomira; Terzolo, Massimo; Kastelan, Darko; Young, William F., Jr.; Manolopoulos, Konstantinos N.; Ambroziak, Urszula; Vassiliadi, Dimitra A.; Taylor, Angela E.; Sitch, Alice J.; Nirantharakumar, Krishnarajah; Arlt, Wiebke		ENSAT EURINE-ACT Investigators	Cardiometabolic Disease Burden and Steroid Excretion in Benign Adrenal Tumors A Cross-Sectional Multicenter Study	ANNALS OF INTERNAL MEDICINE			English	Article							CUSHINGS-SYNDROME; SUBCLINICAL HYPERCORTISOLISM; PRIMARY ALDOSTERONISM; INCIDENTALOMAS; DIAGNOSIS; SOCIETY; PREVALENCE; MANAGEMENT; HYPERTENSION; ASSOCIATION	Background: Benign adrenal tumors are commonly discovered on cross-sectional imaging. Mild autonomous cortisol secretion (MACS) is regularly diagnosed, but its effect on cardiometabolic disease in affected persons is ill defined. Objective: To determine cardiometabolic disease burden and steroid excretion in persons with benign adrenal tumors with and without MACS. Design: Cross-sectional study. Setting: 14 endocrine secondary and tertiary care centers (recruitment from 2011 to 2016). Participants: 1305 prospectively recruited persons with benign adrenal tumors. Measurements: Cortisol excess was defined by clinical assessment and the 1-mg overnight dexamethasone-suppression test (serum cortisol: <50 nmol/L, nonfunctioning adrenal tumor [NFAT]; 50 to 138 nmol/L, possible MACS [MACS-1]; >138 nmol/L and absence of typical clinical Cushing syndrome [CS] features, definitive MACS [MACS-2]). Net steroid production was assessed by multisteroid profiling of 24-hour urine by tandem mass spectrometry. Results: Of the 1305 participants, 49.7% had NFAT (n= 649; 64.1% women), 34.6% had MACS-1 (n = 451; 67.2% women), 10.7% had MACS-2 (n= 140; 73.6% women), and 5.0% had CS (n= 65; 86.2% women). Prevalence and severity of hypertension were higher in MACS-2 and CS than NFAT (adjusted prevalence ratios [aPRs] for hypertension: MACS-2, 1.15 [95% CI, 1.04 to 1.27], and CS, 1.37 [CI, 1.16 to 1.62]; aPRs for use of >= 3 antihypertensives: MACS-2, 1.31 [CI, 1.02 to 1.68], and CS, 2.22 [CI, 1.62 to 3.05]). Type 2 diabetes was more prevalent in CS than NFAT (aPR, 1.62 [CI, 1.08 to 2.42]) and more likely to require insulin therapy for MACS-2 (aPR, 1.89 [CI, 1.01 to 3.52]) and CS (aPR, 3.06 [CI, 1.60 to 5.85]). Urinary multisteroid profiling revealed an increase in glucocorticoid excretion from NFAT over MACS-1 and MACS-2 to CS, whereas androgen excretion decreased. Limitations: Cross-sectional design; possible selection bias. Conclusion: A cardiometabolic risk condition, MACS predominantly affects women and warrants regular assessment for hypertension and type 2 diabetes.	[Prete, Alessandro; Chortis, Vasileios; Lang, Katharina; Nirantharakumar, Krishnarajah] Univ Birmingham, Inst Metab & Syst Res, Ctr Endocrinol Diabet & Metab, Birmingham Hlth Partners, Birmingham, W Midlands, England; [Prete, Alessandro; Chortis, Vasileios; Lang, Katharina; Asia, Miriam] Univ Hosp Birmingham NHS Fdn Trust, Dept Endocrinol, Queen Elizabeth Hosp, Birmingham, W Midlands, England; [Subramanian, Anuradhaa; Sitch, Alice J.; Nirantharakumar, Krishnarajah] Univ Birmingham, Inst Appl Hlth Res, Birmingham, W Midlands, England; [Bancos, Irina; O'Reilly, Michael W.; Gilligan, Lorna C.; Jenkinson, Carl; Manolopoulos, Konstantinos N.; Taylor, Angela E.] Univ Birmingham, Inst Metab & Syst Res, Birmingham, W Midlands, England; [Bancos, Irina; Delivanis, Danae A.; Zhang, Catherine D.; Li, Dingfeng; Young, William F., Jr.] Mayo Clin, Div Endocrinol Diabet Metab & Nutr, Dept Internal Med, Rochester, MN USA; [Tsagarakis, Stylianos; Balomenaki, Maria; Diamantopoulos, Aristidis; Vassiliadi, Dimitra A.] Evangelismos Med Ctr, Dept Endocrinol Diabet & Metab, Athens, Greece; [Macech, Magdalena; Bednarczuk, Tomasz; Kondracka, Agnieszka; Ambroziak, Urszula] Med Univ Warsaw, Dept Internal Med & Endocrinol, Warsaw, Poland; [Pupovac, Ivana D.; Dusek, Tina; Kastelan, Darko] Univ Hosp Ctr Zagreb, Dept Endocrinol, Zagreb, Croatia; [Reimondo, Giuseppe; Terzolo, Massimo] Univ Turin, San Luigi Hosp, Div Internal Med, Turin, Italy; [Marina, Ljiljana, V; Ivovic, Miomira] Univ Belgrade, Univ Clin Ctr Serbia, Dept Obes Reprod & Metab Disorders, Fac Med,Clin Endocrinol Diabet & Metab Dis, Belgrade, Serbia; [Deutschbein, Timo; Fassnacht, Martin] Univ Wurzburg, Univ Hosp Wurzburg, Dept Internal Med 1, Div Endocrinol & Diabet, Wurzburg, Germany; [Deutschbein, Timo] Medicover Oldenburg MVZ, Oldenburg, Germany; [O'Reilly, Michael W.] Univ Med & Hlth Sci, Dept Med, Royal Coll Surg Ireland, Dublin, Ireland; [Asia, Miriam] Univ Hosp Birmingham NHS Fdn Trust, Birmingham Hlth Partners, Ctr Endocrinol Diabet & Metab, Queen Elizabeth Hosp, Birmingham, W Midlands, England; [Masjkur, Jimmy R.] Tech Univ Dresden, Dept Med 3, Dresden, Germany; [Masjkur, Jimmy R.] Tech Univ Dresden, Inst Clin Chem & Lab Med, Dresden, Germany; [Quinkler, Marcus] Endocrinol Charlottenburg, Berlin, Germany; [Ueland, Grethe A.] Haukeland Hosp, Dept Endocrinol, Bergen, Norway; [Dennedy, M. Conall] Univ Hosp Galway, Dept Endocrinol, Galway, Ireland; [Beuschlein, Felix] Univ Spital Zurich USZ, Klin Endokrinol Diabetol & Klin Ernahrung, Zurich, Switzerland; [Beuschlein, Felix] Univ Zurich UZH, Zurich, Switzerland; [Beuschlein, Felix] Ludwig Maximilians Univ Munchen, Med Klin & Poliklin 4, Munich, Germany; [Tabarin, Antoine] Hop Haut Leveque, Serv Endocrinol, Ctr Hosp Univ Bordeaux, Pessac, France; [Sitch, Alice J.; Arlt, Wiebke] Univ Birmingham, NIHR Birmingham Biomed Res Ctr, Birmingham, W Midlands, England; [Sitch, Alice J.; Arlt, Wiebke] Univ Hosp Birmingham NHS Fdn Trust, Birmingham, W Midlands, England; [Arlt, Wiebke] Univ Birmingham, Inst Metab & Syst Res,Univ Hosp Birmingham NHS Fd, Birmingham Hlth Partners,Dept Endocrinol, Ctr Endocrinol Diabet & Metab,Queen Elizabeth Hos, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham; University of Birmingham; University of Birmingham; Mayo Clinic; Evangelismos Hospital; Medical University of Warsaw; University of Zagreb; University of Turin; Clinical Centre of Serbia; University of Belgrade; University of Wurzburg; Royal College of Surgeons - Ireland; University of Birmingham; Technische Universitat Dresden; Technische Universitat Dresden; University of Bergen; Haukeland University Hospital; Ollscoil na Gaillimhe-University of Galway; University of Zurich; University of Munich; CHU Bordeaux; University of Birmingham; University of Birmingham; University of Birmingham	Arlt, W (corresponding author), Univ Birmingham, Coll Med & Dent Sci, Inst Metab & Syst Res, Birmingham B15 2TT, W Midlands, England.	w.arlt@bham.ac.uk	Masjkur, Jimmy/CAF-9054-2022; Vassiliadi, Dimitra/ABF-8100-2021; Sitch, Alice/L-9121-2019; Bednarczuk, Tomasz/AFQ-8418-2022	Sitch, Alice/0000-0001-7727-4497; REIMONDO, Giuseppe Matteo/0000-0001-9489-2094; Prete, Alessandro/0000-0002-4821-0336; Riester, Anna/0000-0003-3231-7435; Ambroziak, Urszula/0000-0002-8778-1959; Kondracka, Agnieszka/0000-0002-2708-4641; Taylor, Angela, E/0000-0002-5835-5643	Diabetes UK (Sir George Alberti Research Training Fellowship) [18/0005782]; European Commission [259735]; European Union [633983]; U.K. Medical Research Council [G0801473]; Claire Khan Trust Fund at University Hospitals Birmingham Charities; Mayo Clinic Foundation for Medical Education and Research; Wellcome Trust [WT101671, WT209492/Z/17/Z]; Academy of Medical Sciences; National Institute of Diabetes and Digestive and Kidney Diseases of the U.S. National Institutes of Health [K23DK121888]; NIHR Birmingham Biomedical Research Centre at the University Hospitals Birmingham NHS Foundation Trust and the University of Birmingham [BRC-1215-20009]; Clinical Research Priority Program of the University of Zurich; Deutsche Forschungsgemeinschaft [314061271, CRC/Transregio 205]	Diabetes UK (Sir George Alberti Research Training Fellowship)(Diabetes UK); European Commission(European CommissionEuropean Commission Joint Research Centre); European Union(European Commission); U.K. Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Claire Khan Trust Fund at University Hospitals Birmingham Charities; Mayo Clinic Foundation for Medical Education and Research; Wellcome Trust(Wellcome Trust); Academy of Medical Sciences(Academy of Medical Sciences (AMS)); National Institute of Diabetes and Digestive and Kidney Diseases of the U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIHR Birmingham Biomedical Research Centre at the University Hospitals Birmingham NHS Foundation Trust and the University of Birmingham; Clinical Research Priority Program of the University of Zurich; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Diabetes UK (Sir George Alberti Research Training Fellowship 18/0005782 [Dr. Prete]), by the European Commission under the 7th Framework Programme (FP7/2007-2013, grant agreement 259735, ENSATCANCER [Drs. Arlt, Fassnacht, and Beuschlein]), and under the European Union's Horizon 2020 Research and Innovation Program under grant agreement no. 633983 (ENSAT-HT) (Drs. Arlt and Beuschlein). This work was also supported by the U.K. Medical Research Council (strategic biomarker grant G0801473 [Dr. Arlt]), the Claire Khan Trust Fund at University Hospitals Birmingham Charities (project grant [Dr. Arlt]), the Mayo Clinic Foundation for Medical Education and Research (Mayo scholarship [Dr. Bancos]), the Wellcome Trust (clinical research training fellowship WT101671 [Dr. Chortis] and investigator award WT209492/Z/17/Z [Dr. Arlt]), and the Academy of Medical Sciences (starter grant for clinical lecturers [Dr. Chortis]). This research was partly supported by the National Institute of Diabetes and Digestive and Kidney Diseases of the U.S. National Institutes of Health under award K23DK121888 (Dr. Bancos). Drs. Arlt and Sitch receive support from the NIHR Birmingham Biomedical Research Centre at the University Hospitals Birmingham NHS Foundation Trust and the University of Birmingham (grant reference number BRC-1215-20009). Dr. Beuschlein receives funding from the Clinical Research Priority Program of the University of Zurich for CRPP HYRENE (Clinical Research Priority Program HYpertension REsearch NEtwork). Support for this study also came in part from the Deutsche Forschungsgemeinschaft (project number 314061271; CRC/Transregio 205) (Drs. Fassnacht and Beuschlein).	Amer Diabet Assoc, 2021, DIABETES CARE, V44, pS15, DOI 10.2337/dc21-S002; Arnett DK, 2019, CIRCULATION, V140, pE596, DOI [10.1161/CIR.0000000000000678, 10.1161/CIR.0000000000000677, 10.1016/j.jacc.2019.03.009, 10.1016/j.jacc.2019.03.010]; Bancos I, 2020, LANCET DIABETES ENDO, V8, P773, DOI 10.1016/S2213-8587(20)30218-7; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Bouys L, 2021, ENDOCRINE, V71, P595, DOI 10.1007/s12020-021-02645-w; Calhoun DA, 2008, HYPERTENSION, V51, P1403, DOI 10.1161/HYPERTENSIONAHA.108.189141; Chiodini L, 2005, EUR J ENDOCRINOL, V153, P837, DOI 10.1530/eje.1.02045; Cole TJ, 2000, STAT MED, V19, P3109, DOI 10.1002/1097-0258(20001130)19:22<3109::AID-SIM558>3.0.CO;2-F; Di Dalmazi G, 2020, J CLIN ENDOCR METAB, V105, pE2770, DOI 10.1210/clinem/dgaa270; Di Dalmazi G, 2014, LANCET DIABETES ENDO, V2, P396, DOI 10.1016/S2213-8587(13)70211-0; Elhassan YS, 2019, ANN INTERN MED, V171, P107, DOI 10.7326/M18-3630; Fassnacht M, 2016, EUR J ENDOCRINOL, V175, pG1, DOI 10.1530/EJE-16-0467; Funder JW, 2008, J CLIN ENDOCR METAB, V93, P3266, DOI 10.1210/jc.2008-0104; Funder JW, 2016, J CLIN ENDOCR METAB, V101, P1889, DOI 10.1210/jc.2015-4061; Iniguez-Ariza Nicole M, 2018, Mayo Clin Proc Innov Qual Outcomes, V2, P30, DOI 10.1016/j.mayocpiqo.2017.11.002; Invitti C, 1999, J CLIN ENDOCR METAB, V84, P440, DOI 10.1210/jc.84.2.440; Kasperlik-Zatuska AA, 2008, HORM METAB RES, V40, P338, DOI 10.1055/s-2008-1073167; Kjellbom A, 2021, ANN INTERN MED, V174, P1041, DOI 10.7326/M20-7946; Mancini T, 2004, CLIN ENDOCRINOL, V61, P768, DOI 10.1111/j.1365-2265.2004.02168.x; Mantero F, 2000, J CLIN ENDOCR METAB, V85, P637, DOI 10.1210/jc.85.2.637; Nieman LK, 2008, J CLIN ENDOCR METAB, V93, P1526, DOI 10.1210/jc.2008-0125; Nieman LK, 2015, EUR J ENDOCRINOL, V173, pM33, DOI 10.1530/EJE-15-0464; Oki K, 2012, EXP CLIN ENDOCR DIAB, V120, P244, DOI 10.1055/s-0032-1301896; Olsen H, 2012, ENDOCRINE, V42, P164, DOI 10.1007/s12020-012-9622-2; Petramala L, 2020, ENDOCRINE, V70, P150, DOI 10.1007/s12020-020-02297-2; Raverot V, 2016, ANN ENDOCRINOL-PARIS, V77, P620, DOI 10.1016/j.ando.2016.05.002; Reimondo G, 2020, J CLIN ENDOCR METAB, V105, DOI 10.1210/clinem/dgz284; Singh S, 2020, J CLIN ENDOCR METAB, V105, pE3307, DOI 10.1210/clinem/dgaa410; Song JH, 2008, AM J ROENTGENOL, V190, P1163, DOI 10.2214/AJR.07.2799; Vassiliadi DA, 2011, CLIN ENDOCRINOL, V74, P438, DOI 10.1111/j.1365-2265.2010.03963.x	30	15	15	2	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR	2022	175	3					325	+		10.7326/M21-1737	http://dx.doi.org/10.7326/M21-1737		JAN 2022	20	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0O5UF	34978855				2022-12-28	WOS:000745985300001
J	Horton, R				Horton, Richard			Offline: The origins story-towards a Deep Ecology	LANCET			English	Editorial Material												richard.horton@lancet.com							0	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN	2022	399	10320					129	129						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YD7YG	34998494	Green Published			2022-12-28	WOS:000740652500009
J	Lau, D; Saxinger, L				Lau, Darren; Saxinger, Lynora			In uninfected household contacts of patients with COVID-19, REGEN-COV reduced symptomatic COVID-19 at 28 d	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Lau, Darren; Saxinger, Lynora] Univ Alberta, Edmonton, AB, Canada	University of Alberta	Lau, D (corresponding author), Univ Alberta, Edmonton, AB, Canada.							Regeneron Pharmaceuticals, 2021, REG ANN NEW US GOV A	1	0	0	8	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN	2022	175	1					JC5	JC5		10.7326/J21-0008	http://dx.doi.org/10.7326/J21-0008			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0Y3LO	34978854				2022-12-28	WOS:000790293700015
J	Saul, H; Gursul, D; Cassidy, S; Smeeth, L; Perkins, A				Saul, Helen; Gursul, Deniz; Cassidy, Samantha; Smeeth, Liam; Perkins, Alexander			Statins do not commonly cause muscle pain and stiffness	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Saul, Helen; Gursul, Deniz; Cassidy, Samantha] NIHR Ctr Engagement & Disseminat, Twickenham, England; [Smeeth, Liam] London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London, England; [Perkins, Alexander] London Sch Hyg & Trop Med, Dept Med Stat, London, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Saul, H (corresponding author), NIHR Ctr Engagement & Disseminat, Twickenham, England.	NIHRAlerts@nihr.ac.uk	Smeeth, Liam/X-5862-2018	Smeeth, Liam/0000-0002-9168-6022; Perkins, Alexander/0000-0002-9817-2390				Davis JW, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-043714; Khunti K, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.5554; Wood FA, 2020, NEW ENGL J MED, V383, P2182, DOI 10.1056/NEJMc2031173	3	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 29	2021	375								n3060	10.1136/bmj.n3060	http://dx.doi.org/10.1136/bmj.n3060			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YH4NO	34965931				2022-12-28	WOS:000743145900003
J	Li, SQ; Driver, T; Rosenberger, P; Champenois, EG; Duris, J; Al-Haddad, A; Averbukh, V; Barnard, JCT; Berrah, N; Bostedt, C; Bucksbaum, PH; Coffee, RN; DiMauro, LF; Fang, L; Garratt, D; Gatton, A; Guo, ZH; Hartmann, G; Haxton, D; Helml, W; Huang, ZR; LaForge, AC; Kamalov, A; Knurr, J; Lin, MF; Lutman, AA; MacArthur, JP; Marangos, JP; Nantel, M; Natan, A; Obaid, R; O'Neal, JT; Shivaram, NH; Schori, A; Walter, P; Li Wang, A; Wolf, TJA; Zhang, Z; Kling, MF; Marinelli, A; Cryan, JP				Li, Siqi; Driver, Taran; Rosenberger, Philipp; Champenois, Elio G.; Duris, Joseph; Al-Haddad, Andre; Averbukh, Vitali; Barnard, Jonathan C. T.; Berrah, Nora; Bostedt, Christoph; Bucksbaum, Philip H.; Coffee, Ryan N.; DiMauro, Louis F.; Fang, Li; Garratt, Douglas; Gatton, Averell; Guo, Zhaoheng; Hartmann, Gregor; Haxton, Daniel; Helml, Wolfram; Huang, Zhirong; LaForge, Aaron C.; Kamalov, Andrei; Knurr, Jonas; Lin, Ming-Fu; Lutman, Alberto A.; MacArthur, James P.; Marangos, Jon P.; Nantel, Megan; Natan, Adi; Obaid, Razib; O'Neal, Jordan T.; Shivaram, Niranjan H.; Schori, Aviad; Walter, Peter; Li Wang, Anna; Wolf, Thomas J. A.; Zhang, Zhen; Kling, Matthias F.; Marinelli, Agostino; Cryan, James P.			Attosecond coherent electron motion in Auger-Meitner decay	SCIENCE			English	Article							REAL-TIME OBSERVATION; CHARGE MIGRATION; O 1S; EXCITATION; DYNAMICS; SPECTRA	In quantum systems, coherent superpositions of electronic states evolve on ultrafast time scales (few femtoseconds to attoseconds; 1 attosecond = 0.001 femtoseconds = 10(-18) seconds), leading to a time-dependent charge density. Here we performed time-resolved measurements using attosecond soft x-ray pulses produced by a free-electron laser, to track the evolution of a coherent core-hole excitation in nitric oxide. Using an additional circularly polarized infrared laser pulse, we created a clock to time-resolve the electron dynamics and demonstrated control of the coherent electron motion by tuning the photon energy of the x-ray pulse. Core-excited states offer a fundamental test bed for studying coherent electron dynamics in highly excited and strongly correlated matter.	[Li, Siqi; Driver, Taran; Rosenberger, Philipp; Duris, Joseph; Coffee, Ryan N.; Gatton, Averell; Guo, Zhaoheng; Huang, Zhirong; Kamalov, Andrei; Lin, Ming-Fu; Lutman, Alberto A.; MacArthur, James P.; Nantel, Megan; Obaid, Razib; Shivaram, Niranjan H.; Walter, Peter; Wolf, Thomas J. A.; Zhang, Zhen; Kling, Matthias F.; Marinelli, Agostino; Cryan, James P.] SLAC Natl Accelerator Lab, Menlo Pk, CA 94025 USA; [Li, Siqi; Bucksbaum, Philip H.; Huang, Zhirong; Kamalov, Andrei; MacArthur, James P.; Nantel, Megan; O'Neal, Jordan T.] Stanford Univ, Dept Phys, Stanford, CA 94305 USA; [Driver, Taran; Rosenberger, Philipp; Champenois, Elio G.; Bucksbaum, Philip H.; Coffee, Ryan N.; Kamalov, Andrei; Knurr, Jonas; Natan, Adi; O'Neal, Jordan T.; Schori, Aviad; Li Wang, Anna; Wolf, Thomas J. A.; Kling, Matthias F.; Marinelli, Agostino; Cryan, James P.] SLAC Natl Accelerator Lab, Stanford Pulse Inst, Menlo Pk, CA 94025 USA; [Driver, Taran; Averbukh, Vitali; Barnard, Jonathan C. T.; Garratt, Douglas; Marangos, Jon P.] Imperial Coll London, Dept Phys, Blackett Lab, London, England; [Rosenberger, Philipp; Kling, Matthias F.] Max Planck Inst Quantum Opt, Garching, Germany; [Rosenberger, Philipp; Kling, Matthias F.] Ludwig Maximilians Univ Munchen, Phys Dept, Garching, Germany; [Al-Haddad, Andre; Bostedt, Christoph] Paul Scherrer Inst, Villigen, Switzerland; [Berrah, Nora; LaForge, Aaron C.; Obaid, Razib] Univ Connecticut, Phys Dept, Storrs, CT USA; [Bostedt, Christoph] Ecole Polytech Fed Lausanne, LUXS Lab Ultrafast Xray Sci, Lausanne, Switzerland; [Bucksbaum, Philip H.; Guo, Zhaoheng; Li Wang, Anna] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [DiMauro, Louis F.; Fang, Li] Ohio State Univ, Dept Phys, 174 W 18th Ave, Columbus, OH 43210 USA; [Fang, Li] Univ Cent Florida, Dept Phys, Orlando, FL USA; [Hartmann, Gregor] Univ Kassel, Inst Phys, Kassel, Germany; [Hartmann, Gregor] Univ Kassel, CINSaT, Kassel, Germany; [Haxton, Daniel] KLA Corp, Milpitas, CA USA; [Helml, Wolfram] TU Dortmund Univ, Dept Phys, Dortmund, Germany; [Shivaram, Niranjan H.] Purdue Univ, Dept Phys & Astron, W Lafayette, IN 47907 USA; [Shivaram, Niranjan H.] Purdue Univ, Purdue Quantum Sci & Engn Inst, W Lafayette, IN 47907 USA	Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Imperial College London; Max Planck Society; University of Munich; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; University of Connecticut; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Stanford University; University System of Ohio; Ohio State University; State University System of Florida; University of Central Florida; Universitat Kassel; Universitat Kassel; KLA Corporation; Dortmund University of Technology; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Marinelli, A; Cryan, JP (corresponding author), SLAC Natl Accelerator Lab, Menlo Pk, CA 94025 USA.; Marinelli, A; Cryan, JP (corresponding author), SLAC Natl Accelerator Lab, Stanford Pulse Inst, Menlo Pk, CA 94025 USA.	marinelli@slac.stanford.edu; jcryan@slac.stanford.edu	Wolf, Thomas/AAQ-5838-2020; Kling, Matthias Friedrich/AHH-0080-2022; Helml, Wolfram/D-1005-2017; Averbukh, Vitali/L-2535-2014	Wolf, Thomas/0000-0002-0641-1279; Kling, Matthias Friedrich/0000-0002-1710-0775; Lutman, Alberto/0000-0001-5791-9198; Helml, Wolfram/0000-0003-1537-2993; Nantel, Megan/0000-0002-9684-3314; Averbukh, Vitali/0000-0001-7999-0075; Bucksbaum, Philip/0000-0003-1258-5571; Wang, Anna/0000-0001-7515-0626; Cryan, James/0000-0002-7776-0919; Li, Siqi/0000-0002-1262-6292; Rosenberger, Philipp/0000-0002-4271-3557	US Department of Energy (DOE), BES Scientific User Facilities Division Field Work Proposal [100317]; Laboratory Directed Research and Development Program; US DOE, Office of Science, Office of Basic Energy Sciences (BES), Chemical Sciences, Geosciences, and Biosciences Division (CSGB); DOE Laboratory Directed Research and Development program at SLAC National Accelerator Laboratory [DE-AC02-76SF00515]; German Research Foundation [KL-1439/10]; Fellow program of the Max Planck Society; UK EPSRC [EP/R019509/1, EP/T006943/1, EP/I032517/1]; Chemical Sciences, Geosciences and Biosciences Division, US DOE, Office of Science, BES [DE-SC0012376]; Swiss National Science Foundation; National Center of Competence in Research-Molecular Ultrafast Science and Technology NCCR-MUST; NSF [1605042]; DOE [DE-FG02-04ER15614]; German BMBF [05K19PE1]; US DOE, Office of Science, BES [DE-AC02-76SF00515]	US Department of Energy (DOE), BES Scientific User Facilities Division Field Work Proposal(United States Department of Energy (DOE)); Laboratory Directed Research and Development Program; US DOE, Office of Science, Office of Basic Energy Sciences (BES), Chemical Sciences, Geosciences, and Biosciences Division (CSGB)(United States Department of Energy (DOE)); DOE Laboratory Directed Research and Development program at SLAC National Accelerator Laboratory; German Research Foundation(German Research Foundation (DFG)); Fellow program of the Max Planck Society; UK EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Chemical Sciences, Geosciences and Biosciences Division, US DOE, Office of Science, BES(United States Department of Energy (DOE)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Center of Competence in Research-Molecular Ultrafast Science and Technology NCCR-MUST; NSF(National Science Foundation (NSF)); DOE(United States Department of Energy (DOE)); German BMBF(Federal Ministry of Education & Research (BMBF)); US DOE, Office of Science, BES(United States Department of Energy (DOE))	S.L., Z. Z., and A.M. acknowledge support from US Department of Energy (DOE), BES Scientific User Facilities Division Field Work Proposal 100317; J.D. and A. M. were supported by the Laboratory Directed Research and Development Program in support of the Panofsky fellowship. The contributions from T.D., P.H.B., A.K., A.N., J.T.O., T.J.A.W., A.L.W., and J.P.C. were supported by the US DOE, Office of Science, Office of Basic Energy Sciences (BES), Chemical Sciences, Geosciences, and Biosciences Division (CSGB); E.G.C. was supported by the DOE Laboratory Directed Research and Development program at SLAC National Accelerator Laboratory, under contract DE-AC02-76SF00515. P.R. and M.F.K. acknowledge support by the German Research Foundation via KL-1439/10, and the Fellow program of the Max Planck Society. V.A, J.C.T.B., D.G., and J.P.Mar. gratefully acknowledge funding support from UK EPSRC grants EP/R019509/1, EP/T006943/1, and EP/I032517/1. N.B., R.O., and A.C.L. acknowledge the Chemical Sciences, Geosciences and Biosciences Division, US DOE, Office of Science, BES, grant DE-SC0012376. C.B. acknowledges the Swiss National Science Foundation and the National Center of Competence in Research-Molecular Ultrafast Science and Technology NCCR-MUST. L.F.D. and L.F. acknowledge support from NSF grant 1605042 and DOE DE-FG02-04ER15614. W.H. thanks the German BMBF for funding of the project "SpeAR_XFEL" under contract 05K19PE1. Use of the Linac Coherent Light Source (LCLS), SLAC National Accelerator Laboratory, is supported by the US DOE, Office of Science, BES, under Contract DE-AC02-76SF00515.	ALEKSANDROV EB, 1964, OPT SPEKTROSK+, V17, P957; Ammosov M. V., 1986, Soviet Physics - JETP, V64, P1191; BONIFACIO R, 1984, AIP CONF PROC, P236, DOI 10.1063/1.34640; Bradley D. J., 1971, Optics Communications, V2, P391, DOI 10.1016/0030-4018(71)90252-5; Calegari F, 2014, SCIENCE, V346, P336, DOI 10.1126/science.1254061; CEDERBAUM LS, 1986, ADV CHEM PHYS, V65, P115, DOI 10.1002/9780470142899.ch3; Cederbaum LS, 1999, CHEM PHYS LETT, V307, P205, DOI 10.1016/S0009-2614(99)00508-4; Dahlstrom JM, 2013, CHEM PHYS, V414, P53, DOI 10.1016/j.chemphys.2012.01.017; Dahlstrom JM, 2012, J PHYS B-AT MOL OPT, V45, DOI 10.1088/0953-4075/45/18/183001; Demekhin PV, 2010, J PHYS B-AT MOL OPT, V43, DOI 10.1088/0953-4075/43/16/165103; Despre V, 2018, PHYS REV LETT, V121, DOI 10.1103/PhysRevLett.121.203002; Drescher M, 2002, NATURE, V419, P803, DOI 10.1038/nature01143; Driver T., 2022, ZENODO, DOI [10.5281/zenodo.5711217, DOI 10.5281/ZENODO.5711217]; Duris J, 2020, NAT PHOTONICS, V14, P30, DOI 10.1038/s41566-019-0549-5; Eckle P, 2008, SCIENCE, V322, P1525, DOI 10.1126/science.1163439; FANO U, 1961, PHYS REV, V124, P1866, DOI 10.1103/PhysRev.124.1866; FORRESTER AT, 1955, PHYS REV, V99, P1691, DOI 10.1103/PhysRev.99.1691; Glownia JM, 2010, OPT EXPRESS, V18, P17620, DOI 10.1364/OE.18.017620; Goulielmakis E, 2010, NATURE, V466, P739, DOI 10.1038/nature09212; HADEISHI T, 1965, PHYS REV LETT, V14, P891, DOI 10.1103/PhysRevLett.14.891; Hartmann N, 2018, NAT PHOTONICS, V12, P215, DOI 10.1038/s41566-018-0107-6; Haynes DC, 2021, NAT PHYS, V17, P512, DOI 10.1038/s41567-020-01111-0; Itatani J, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.173903; Kazansky AK, 2009, J PHYS B-AT MOL OPT, V42, DOI 10.1088/0953-4075/42/24/245601; Kraus PM, 2015, SCIENCE, V350, P790, DOI 10.1126/science.aab2160; Kuleff AI, 2014, J PHYS B-AT MOL OPT, V47, DOI 10.1088/0953-4075/47/12/124002; Lepine F, 2014, NAT PHOTONICS, V8, P195, DOI 10.1038/nphoton.2014.25; Li S, 2018, AIP ADV, V8, DOI 10.1063/1.5046192; Marciniak A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08131-8; Mauritsson J, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.053001; Puttner R, 1999, PHYS REV A, V59, P3415, DOI 10.1103/PhysRevA.59.3415; Serov VV, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.063414; Smirnova O, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.253001; Storn R, 1997, J GLOBAL OPTIM, V11, P341, DOI 10.1023/A:1008202821328; TSUCHIYA Y, 1984, IEEE J QUANTUM ELECT, V20, P1516, DOI 10.1109/JQE.1984.1072316; Uiberacker M, 2007, NATURE, V446, P627, DOI 10.1038/nature05648; Vacher M, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.083001; Verhoef AJ, 2011, LASER PHYS, V21, P1270, DOI 10.1134/S1054660X11130263; Wang H, 2003, CHEM PHYS, V289, P31, DOI 10.1016/S0301-0104(02)00792-9; Wickenhauser M, 2006, J MOD OPTIC, V53, P247, DOI 10.1080/09500340500259870; Wickenhauser M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.023002; Zholents AA, 2005, PHYS REV SPEC TOP-AC, V8, DOI 10.1103/PhysRevSTAB.8.040701	42	11	11	6	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2022	375	6578					285	+		10.1126/science.abj2096	http://dx.doi.org/10.1126/science.abj2096			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YK2FS	34990213	Green Submitted			2022-12-28	WOS:000745036100027
J	Zhu, RH; del Rio-Salgado, JM; Garcia-Ojalvo, J; Elowitz, MB				Zhu, Ronghui; del Rio-Salgado, Jesus M.; Garcia-Ojalvo, Jordi; Elowitz, Michael B.			Synthetic multistability in mammalian cells	SCIENCE			English	Article							ZINC-FINGER PROTEINS; POSITIVE-FEEDBACK; GENE-EXPRESSION; TRANSCRIPTIONAL REGULATION; SWITCH; ULTRASENSITIVITY; DYNAMICS; MEMORY; PLURIPOTENCY; COMMITMENT	In multicellular organisms, gene regulatory circuits generate thousands of molecularly distinct, mitotically heritable states through the property of multistability. Designing synthetic muftistable circuits would provide insight into natural cell fate control circuit architectures and would allow engineering of mufticellular programs that require interactions among distinct cell types. We created MultiFate, a naturally inspired, synthetic circuit that supports long-term, controllable, and expandable multistability in mammalian cells. MultiFate uses engineered zinc finger transcription factors that transcriptionally self-activate as homodimers and mutually inhibit one another through heterodimerization. Using a model-based design, we engineered MuftiFate circuits that generate as many as seven states, each stable for at least 18 days. MultiFate permits controlled state switching and modulation of state stability through external inputs and can be expanded with additional transcription factors. These results provide a foundation for engineering multicellular behaviors in mammalian cells.	[Zhu, Ronghui; del Rio-Salgado, Jesus M.; Elowitz, Michael B.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Garcia-Ojalvo, Jordi] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Barcelona 08003, Spain; [Elowitz, Michael B.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA	California Institute of Technology; Pompeu Fabra University; California Institute of Technology; Howard Hughes Medical Institute	Elowitz, MB (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.; Elowitz, MB (corresponding author), CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA.	melowitz@caltech.edu	Garcia-Ojalvo, Jordi/A-4574-2009	Garcia-Ojalvo, Jordi/0000-0002-3716-7520; Zhu, Ronghui/0000-0001-8171-482X; Elowitz, Michael/0000-0002-1221-0967	DARPA [HR0011-17-2-0008]; Allen Discovery Center program; Allen Discovery Center program, a Paul G. Allen Frontiers Group advised program of the Paul G. Allen Family Foundation [UWSC10142]; Spanish Ministry of Science and Innovation; FEDER [PGC2018-101251-B-I00]; "Maria de Maeztu" Programme for Units of Excellence in RD [CEX2018-000792-M]; Generalitat de Catalunya (ICREA Academia program)	DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Allen Discovery Center program; Allen Discovery Center program, a Paul G. Allen Frontiers Group advised program of the Paul G. Allen Family Foundation; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); FEDER(European Commission); "Maria de Maeztu" Programme for Units of Excellence in RD; Generalitat de Catalunya (ICREA Academia program)(ICREA)	Supported by DARPA (HR0011-17-2-0008, M.B.E.); the Allen Discovery Center program, a Paul G. Allen Frontiers Group advised program of the Paul G. Allen Family Foundation (UWSC10142, M.B.E.); the Spanish Ministry of Science and Innovation and FEDER (PGC2018-101251-B-I00, J.G.-O.); "Maria de Maeztu" Programme for Units of Excellence in R&D (CEX2018-000792-M, J.G.-O.); and the Generalitat de Catalunya (ICREA Academia program, J.G.-O.). M.B.E. is a Howard Hughes Medical Institute investigator.	Ajo-Franklin CM, 2007, GENE DEV, V21, P2271, DOI 10.1101/gad.1586107; Aksoy I, 2013, EMBO J, V32, P938, DOI 10.1038/emboj.2013.31; Arendt D, 2016, NAT REV GENET, V17, P744, DOI 10.1038/nrg.2016.127; Balleza E, 2018, NAT METHODS, V15, P47, DOI [10.1038/NMETH.4509, 10.1038/nmeth.4509]; Bashor CJ, 2019, SCIENCE, V364, P593, DOI 10.1126/science.aau8287; Beerli RR, 1998, P NATL ACAD SCI USA, V95, P14628, DOI 10.1073/pnas.95.25.14628; Bennett MR, 2007, BIOPHYS J, V92, P3501, DOI 10.1529/biophysj.106.095638; Bessonnard S, 2014, DEVELOPMENT, V141, P3637, DOI 10.1242/dev.109678; Bhattacharya A, 2011, CELL, V147, P881, DOI 10.1016/j.cell.2011.08.055; Bintu L, 2005, CURR OPIN GENET DEV, V15, P125, DOI 10.1016/j.gde.2005.02.006; Buchler NE, 2008, J MOL BIOL, V384, P1106, DOI 10.1016/j.jmb.2008.09.079; Buder T, 2017, BIOINFORM BIOL INSIG, V11, DOI 10.1177/1177932217712241; Burrill DR, 2012, GENE DEV, V26, P1486, DOI 10.1101/gad.189035.112; Chassin H, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09974-5; Clackson T, 1998, P NATL ACAD SCI USA, V95, P10437, DOI 10.1073/pnas.95.18.10437; Donahue PS, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14147-5; Eden E, 2011, SCIENCE, V331, P764, DOI 10.1126/science.1199784; Elrod-Erickson M, 1998, STRUCTURE, V6, P451, DOI 10.1016/S0969-2126(98)00047-1; Ferrell JE, 2014, TRENDS BIOCHEM SCI, V39, P612, DOI 10.1016/j.tibs.2014.10.002; Ferrell JE, 2014, TRENDS BIOCHEM SCI, V39, P556, DOI 10.1016/j.tibs.2014.09.003; Frieda KL, 2017, NATURE, V541, P107, DOI 10.1038/nature20777; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gerety SS, 2013, DEVELOPMENT, V140, P2235, DOI 10.1242/dev.091520; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; Gonzalez J, 2017, GENETICS, V207, P975, DOI 10.1534/genetics.117.300290; Gunne-Braden A, 2020, CELL STEM CELL, V26, P693, DOI 10.1016/j.stem.2020.03.005; He L, 2019, ELIFE, V8, DOI 10.7554/eLife.46181; Hosokawa H, 2018, IMMUNITY, V48, P1119, DOI 10.1016/j.immuni.2018.04.024; Hsu C, 2016, CELL REP, V16, P1204, DOI 10.1016/j.celrep.2016.06.072; Huang S, 2006, COMPUTATIONAL SYSTEM, P293; Huang S, 2007, DEV BIOL, V305, P695, DOI 10.1016/j.ydbio.2007.02.036; Israni D.V., 2021, BIORXIV, V2021, P432371, DOI [10.1101/2021.02.22.432371, DOI 10.1101/2021.02.22.432371]; Iwamoto M, 2010, CHEM BIOL, V17, P981, DOI 10.1016/j.chembiol.2010.07.009; Khalil AS, 2012, CELL, V150, P647, DOI 10.1016/j.cell.2012.05.045; Kramer BP, 2004, NAT BIOTECHNOL, V22, P867, DOI 10.1038/nbt980; Kueh HY, 2013, SCIENCE, V341, P670, DOI 10.1126/science.1240831; Laslo P, 2006, CELL, V126, P755, DOI 10.1016/j.cell.2006.06.052; Lebar T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6007; Liu Q, 1997, P NATL ACAD SCI USA, V94, P5525, DOI 10.1073/pnas.94.11.5525; Loh KM, 2016, CELL, V166, P451, DOI 10.1016/j.cell.2016.06.011; Lohmueller JJ, 2012, NUCLEIC ACIDS RES, V40, P5180, DOI 10.1093/nar/gks142; Ma Y, 2022, CELL, V185, P12; Miller JA, 2003, MOL CELL BIOL, V23, P1623, DOI 10.1128/MCB.23.5.1623-1632.2003; Mirny LA, 2010, P NATL ACAD SCI USA, V107, P22534, DOI 10.1073/pnas.0913805107; Miyamoto T, 2002, DEV CELL, V3, P137, DOI 10.1016/S1534-5807(02)00201-0; MIYAZAKI J, 1989, GENE, V79, P269; Moraga I, 2017, ELIFE, V6, DOI 10.7554/eLife.22882; Morsut L, 2016, CELL, V164, P780, DOI 10.1016/j.cell.2016.01.012; Muldoon JJ, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abe9375; NEUHOLD LA, 1993, CELL, V74, P1033, DOI 10.1016/0092-8674(93)90725-6; Notta F, 2016, SCIENCE, V351, P139, DOI 10.1126/science.aab2116; Pan X, 2017, APPL MICROBIOL BIOT, V101, P8101, DOI 10.1007/s00253-017-8531-y; Paulous S, 2003, NUCLEIC ACIDS RES, V31, P722, DOI 10.1093/nar/gkf695; Polach KJ, 1996, J MOL BIOL, V258, P800, DOI 10.1006/jmbi.1996.0288; Pougach K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5868; Ramon S., 1995, HISTOLOGY NERVOUS SY; Santos-Moreno J, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16574-1; Schlosshauer M, 2004, PROTEIN SCI, V13, P1660, DOI 10.1110/ps.03517304; Schwalb B, 2016, SCIENCE, V352, P1225, DOI 10.1126/science.aad9841; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Schwarz KA, 2017, NAT CHEM BIOL, V13, P202, DOI [10.1038/nchembio.2253, 10.1038/NCHEMBIO.2253]; Sokolik C, 2015, CELL SYST, V1, P117, DOI 10.1016/j.cels.2015.08.001; Stapornwongkul KS, 2020, SCIENCE, V370, P321, DOI 10.1126/science.abb8205; Stefanovic S, 2009, J CELL BIOL, V186, P665, DOI 10.1083/jcb.200901040; Strogatz S.H., 2014, NONLINEAR DYNAMICS C; Subach OM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028674; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; THAYER MJ, 1989, CELL, V58, P241, DOI 10.1016/0092-8674(89)90838-6; Toda S, 2020, SCIENCE, V370, P327, DOI 10.1126/science.abc0033; Wu FQ, 2017, ELIFE, V6, DOI 10.7554/eLife.23702; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089; Yao G, 2008, NAT CELL BIOL, V10, P476, DOI 10.1038/ncb1711; ZITZEWITZ JA, 1995, BIOCHEMISTRY-US, V34, P12812, DOI 10.1021/bi00039a042	74	9	9	12	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2022	375	6578					284	+	eabg9765	10.1126/science.abg9765	http://dx.doi.org/10.1126/science.abg9765			91	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YK2FS	35050677	Green Accepted, Green Submitted			2022-12-28	WOS:000745036100026
J	Coombes, R; Davies, M				Coombes, Rebecca; Davies, Madlen			Facebook versus The BMJ: when fact checking goes wrong	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												rcoombes@bmj.com						[Anonymous], Issue a correction or dispute a rating; [Anonymous], 2018, POYNT TOP FUND SOURC; [Anonymous], 2021, TWITTER; Coombes R., BMJ, V2021; Godlee F., 2021, BMJ; International FactChecking Network, 2020, IFCNS COD PRINC TRAN; Kaplan H, 2021, FACEBOOK; Legum J., 2020, POPULAR INFORM FEB; Miller D, 2021, LEAD STORIES NOV; Thacker P, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n2635	10	9	9	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 19	2022	376								o95	10.1136/bmj.o95	http://dx.doi.org/10.1136/bmj.o95			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YL6WC	35045953	Bronze			2022-12-28	WOS:000746028500007
J	Di Domizio, J; Gulen, MF; Saidoune, F; Thacker, VV; Yatim, A; Sharma, K; Nass, T; Guenova, E; Schaller, M; Conrad, C; Goepfert, C; de Leval, L; von Garnier, C; Berezowska, S; Dubois, A; Gilliet, M; Ablasser, A				Di Domizio, Jeremy; Gulen, Muhammet F.; Saidoune, Fanny; Thacker, Vivek V.; Yatim, Ahmad; Sharma, Kunal; Nass, Theo; Guenova, Emmanuella; Schaller, Martin; Conrad, Curdin; Goepfert, Christine; de Leval, Laurence; von Garnier, Christophe; Berezowska, Sabina; Dubois, Anaelle; Gilliet, Michel; Ablasser, Andrea			The cGAS-STING pathway drives type I IFN immunopathology in COVID-19	NATURE			English	Article							SINGLE-CENTER; INFECTION; INTERFERON; IDENTIFICATION	COVID-19, which is caused by infection with SARS-CoV-2, is characterized by lung pathology and extrapulmonary complications(1,2). Type I interferons (IFNs) have an essential role in the pathogenesis of COVID-19 (refs (3-5)). Although rapid induction of type I IFNs limits virus propagation, a sustained increase in the levels of type I IFNs in the late phase of the infection is associated with aberrant inflammation and poor clinical outcome(5-17). Here we show that the cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) pathway, which controls immunity to cytosolic DNA, is a critical driver of aberrant type I IFN responses in COVID-19 (ref. (18)). Profiling COVID-19 skin manifestations, we uncover a STING-dependent type I IFN signature that is primarily mediated by macrophages adjacent to areas of endothelial cell damage. Moreover, cGAS-STING activity was detected in lung samples from patients with COVID-19 with prominent tissue destruction, and was associated with type I IFN responses. A lung-on-chip model revealed that, in addition to macrophages, infection with SARS-CoV-2 activates cGAS-STING signalling in endothelial cells through mitochondrial DNA release, which leads to cell death and type I IFN production. In mice, pharmacological inhibition of STING reduces severe lung inflammation induced by SARS-CoV-2 and improves disease outcome. Collectively, our study establishes a mechanistic basis of pathological type I IFN responses in COVID-19 and reveals a principle for the development of host-directed therapeutics. The cGAS-STING pathway has a central role in the pathogenesis of severe COVID-19 by driving the increase in type I interferons that occurs in the later stages of SARS-CoV-2 infection.	[Di Domizio, Jeremy; Saidoune, Fanny; Yatim, Ahmad; Guenova, Emmanuella; Conrad, Curdin; Gilliet, Michel] CHUV Univ Hosp, Dept Dermatol, Lausanne, Switzerland; [Gulen, Muhammet F.; Thacker, Vivek V.; Sharma, Kunal; Nass, Theo; Gilliet, Michel] Univ Lausanne UNIL, Lausanne, Switzerland; [Gulen, Muhammet F.; Thacker, Vivek V.; Sharma, Kunal; Nass, Theo; Ablasser, Andrea] Swiss Fed Inst Technol Lausanne EPFL, Global Hlth Inst, Lausanne, Switzerland; [Schaller, Martin] Eberhard Karls Univ Tubingen, Univ Dept Dermatol, Tubingen, Germany; [Goepfert, Christine] Univ Bern, Inst Anim Pathol, COMPATH, Bern, Switzerland; [Goepfert, Christine] Swiss Fed Inst Technol Lausanne EPFL, Histol Core Facil, Lausanne, Switzerland; [de Leval, Laurence; Berezowska, Sabina] CHUV Univ Hosp, Inst Pathol, Lausanne, Switzerland; [de Leval, Laurence; von Garnier, Christophe; Berezowska, Sabina] Univ Lausanne UNIL, Lausanne, Switzerland; [von Garnier, Christophe] CHUV Univ Hosp, Div Pulmonol, Lausanne, Switzerland; [Dubois, Anaelle] Swiss Fed Inst Technol Lausanne EPFL, Biol Elect Microscopy Facil, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Bern; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Gilliet, M (corresponding author), CHUV Univ Hosp, Dept Dermatol, Lausanne, Switzerland.; Gilliet, M (corresponding author), Univ Lausanne UNIL, Lausanne, Switzerland.; Ablasser, A (corresponding author), Swiss Fed Inst Technol Lausanne EPFL, Global Hlth Inst, Lausanne, Switzerland.	michel.gilliet@chuv.ch; andrea.ablasser@epfl.ch	Guenova, Emmanuella/G-7441-2017; Thacker, Vivek V/AAX-5119-2020	Guenova, Emmanuella/0000-0001-5478-8735; Thacker, Vivek V/0000-0002-1681-627X; DI DOMIZIO, Jeremy/0000-0002-6281-3918; Sharma, Kunal/0000-0001-8086-3436; Nass, Theo/0000-0002-5934-2895; Conrad, Curdin/0000-0002-2547-3440	COVID-19 National Research Program [NRP-78, 4078P0_198470]; Leenaards Foundation; Fondation Acteria; European Union [804933]; Novartis Foundation for Medical-Biological Research [20C240]	COVID-19 National Research Program; Leenaards Foundation; Fondation Acteria; European Union(European Commission); Novartis Foundation for Medical-Biological Research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank the Genomic Technologies Facility (GTF) at University of Lausanne (UNIL) and the Immune Landscape Laboratory (Oncology department, CHUV) for accessing the NanoString platform; A. Joncic and I. Surbeck for technical assistance with the histological analysis; B. Fehrenbacher for technical assistance with transmission electron microscopy studies of COVID-19 skin samples; J. Blanc and G. Knott for technical assistance with serial block scanning electron microscopy of LoC devices and data analysis and volumetric reconstruction; R. Hamelin, F. Armand and M. Pavlou for technical assistance for the proteomic analysis studies in the LoC devices; F. Signorino-Gelo for LoC device fabrication; and N. Samson for help with BioRender. This work was supported by the COVID-19 National Research Program (NRP-78) to M.G. and A.A. (4078P0_198470) with additional support by the Leenaards Foundation to M.G. and A.A. and the Fondation Acteria and European Union's Horizon 2020 Research and Innovation program grant agreement (grant no. 804933, ImAgine) to A.A. V.V.T. received support from the Novartis Foundation for Medical-Biological Research (grant no. 20C240).	Ablasser A, 2019, SCIENCE, V363, P1055, DOI 10.1126/science.aat8657; Asano T, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abl4348; Bao LN, 2020, NATURE, V583, P830, DOI 10.1038/s41586-020-2312-y; Berezowska S, 2021, DIAGNOSTICS, V11, DOI 10.3390/diagnostics11081357; Bonaventura A, 2021, NAT REV IMMUNOL, V21, P319, DOI 10.1038/s41577-021-00536-9; Channappanavar R, 2016, CELL HOST MICROBE, V19, P181, DOI 10.1016/j.chom.2016.01.007; Chua RL, 2020, NAT BIOTECHNOL, V38, P970, DOI 10.1038/s41587-020-0602-4; Conde JN, 2020, MBIO, V11, DOI 10.1128/mBio.03185-20; Dorfer V, 2014, J PROTEOME RES, V13, P3679, DOI 10.1021/pr500202e; Farber DL, 2021, NATURE, V593, P506, DOI 10.1038/d41586-021-01396-y; Freeman EE, 2020, J AM ACAD DERMATOL, V83, P1118, DOI 10.1016/j.jaad.2020.06.1016; Galani IE, 2021, NAT IMMUNOL, V22, P32, DOI 10.1038/s41590-020-00840-x; Gibellini L, 2020, EMBO MOL MED, V12, DOI 10.15252/emmm.202013001; Golden JW, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.142032; Goshua George, 2020, Lancet Haematol, V7, pe575, DOI 10.1016/S2352-3026(20)30216-7; Gupta A, 2020, NAT MED, V26, P1017, DOI 10.1038/s41591-020-0968-3; Haag SM, 2018, NATURE, V559, P269, DOI 10.1038/s41586-018-0287-8; Hadjadj J, 2020, SCIENCE, V369, P718, DOI 10.1126/science.abc6027; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Israelow B, 2020, J EXP MED, V217, DOI [10.1101/2020.05.27.118893, 10.1084/jem.20201241]; Kim J, 2019, SCIENCE, V366, P1531, DOI 10.1126/science.aav4011; KLIPPERAURBACH Y, 1995, MED HYPOTHESES, V45, P486, DOI 10.1016/0306-9877(95)90228-7; Kong AT, 2017, NAT METHODS, V14, P513, DOI [10.1038/NMETH.4256, 10.1038/nmeth.4256]; Lee JS, 2020, NAT REV IMMUNOL, V20, P585, DOI 10.1038/s41577-020-00429-3; Lee JS, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd1554; Liao MF, 2020, NAT MED, V26, P842, DOI 10.1038/s41591-020-0901-9; Liu SQ, 2015, SCIENCE, V347, P1217, DOI 10.1126/science.aaa2630; Liu Y, 2014, NEW ENGL J MED, V371, P507, DOI 10.1056/NEJMoa1312625; Lucas C, 2020, NATURE, V584, P463, DOI 10.1038/s41586-020-2588-y; Mazaleuskaya L, 2012, VIRUSES-BASEL, V4, P901, DOI 10.3390/v4050901; McCray PB, 2007, J VIROL, V81, P813, DOI 10.1128/JVI.02012-06; Munoz-Fontela C, 2020, NATURE, V586, P509, DOI 10.1038/s41586-020-2787-6; Neufeldt CJ, 2022, COMMUN BIOL, V5, DOI 10.1038/s42003-021-02983-5; Nienhold R, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18854-2; Park A, 2020, CELL HOST MICROBE, V27, P870, DOI 10.1016/j.chom.2020.05.008; Perkins JR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-296; Plubell DL, 2017, MOL CELL PROTEOMICS, V16, P873, DOI 10.1074/mcp.M116.065524; Prantner D, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.382986; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schulte-Schrepping J, 2020, CELL, V182, P1419, DOI 10.1016/j.cell.2020.08.001; Stukalov A, 2021, NATURE, V594, P246, DOI 10.1038/s41586-021-03493-4; Tai YC, 2006, ANN STAT, V34, P2387, DOI 10.1214/009053606000000759; Teuwen LA, 2020, NAT REV IMMUNOL, V20, P389, DOI 10.1038/s41577-020-0343-0; Thacker VV, 2021, EMBO REP, V22, DOI 10.15252/embr.202152744; van der Made CI, 2020, JAMA-J AM MED ASSOC, V324, P663, DOI 10.1001/jama.2020.13719; Varga Z, 2020, LANCET, V395, P1417, DOI 10.1016/S0140-6736(20)30937-5; Wang N, 2020, CELL HOST MICROBE, V28, P455, DOI 10.1016/j.chom.2020.07.005; Wilk AJ, 2020, NAT MED, V26, P1070, DOI [10.1038/s41591-020-0944-y, 10.1101/2020.04.17.20069930]; Winkler ES, 2020, NAT IMMUNOL, V21, P1327, DOI 10.1038/s41590-020-0778-2; Wolfel R, 2020, NATURE, V588, pE35, DOI 10.1038/s41586-020-2984-3; Xia SM, 2019, J IMMUNOL RES, V2019, DOI 10.1155/2019/5370706; Xie JZ, 2018, CELL HOST MICROBE, V23, P297, DOI 10.1016/j.chom.2018.01.006; Yang DM, 2021, MILITARY MED RES, V8, DOI [10.1186/s40779-021-00340-5, 10.1101/2021.02.10.430677]; Zhang Q, 2020, SCIENCE, V370, DOI 10.1126/science.abd4570; Zhou Z, 2020, CELL HOST MICROBE, V27, P883, DOI 10.1016/j.chom.2020.04.017	57	73	73	26	52	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 3	2022	603	7899					145	+		10.1038/s41586-022-04421-w	http://dx.doi.org/10.1038/s41586-022-04421-w		JAN 2022	27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZL3UV	35045565	Green Published, hybrid			2022-12-28	WOS:000760256600001
J	Shepherd, A				Shepherd, Alison			THE BIG PICTURE Covid-19: Brazilian artist celebrates life in death	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Taylor Luke, 2022, BMJ, V376, po133, DOI 10.1136/bmj.o133	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 19	2022	376								o129	10.1136/bmj.o129	http://dx.doi.org/10.1136/bmj.o129			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YL6WC	35046011	Bronze			2022-12-28	WOS:000746028500002
J	Funatomi, H; Kuriyama, A				Funatomi, Hiroyuki; Kuriyama, Akira			Lisfranc Injury	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Funatomi, Hiroyuki; Kuriyama, Akira] Kurashiki Cent Hosp, Okayama, Japan	Kurashiki Central Hospital	Funatomi, H (corresponding author), Kurashiki Cent Hosp, Okayama, Japan.	ak13568@kchnet.or.jp							0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 20	2022	386	3								10.1056/NEJMicm2034535	http://dx.doi.org/10.1056/NEJMicm2034535		JAN 2022	1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YK1UG	35029849				2022-12-28	WOS:000742768000001
J	Dyer, C				Dyer, Clare			Covid-19: Government's use of VIP lane for awarding PPE contracts was unlawful, says judge	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 13	2022	376								o96	10.1136/bmj.o96	http://dx.doi.org/10.1136/bmj.o96			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZE9IW	35027367	Bronze			2022-12-28	WOS:000759191400005
J	Gardner, RJ; Hermansen, E; Pachitariu, M; Burak, Y; Baas, NA; Dunn, BA; Moser, MB; Moser, EI				Gardner, Richard J.; Hermansen, Erik; Pachitariu, Marius; Burak, Yoram; Baas, Nils A.; Dunn, Benjamin A.; Moser, May-Britt; Moser, Edvard, I			Toroidal topology of population activity in grid cells	NATURE			English	Article							PATH-INTEGRATION; ATTRACTOR DYNAMICS; COGNITIVE MAP; DIRECTION; MODEL; REPRESENTATION; ORIENTATION; HIPPOCAMPUS; INHIBITION; MECHANISMS	The medial entorhinal cortex is part of a neural system for mapping the position of an individual within a physical environment(1). Grid cells, a key component of this system, fire in a characteristic hexagonal pattern of locations(2), and are organized in modules(3) that collectively form a population code for the animal's allocentric position(1). The invariance of the correlation structure of this population code across environments(4,5) and behavioural states(6,7), independent of specific sensory inputs, has pointed to intrinsic, recurrently connected continuous attractor networks (CANs) as a possible substrate of the grid pattern(1,8-11). However, whether grid cell networks show continuous attractor dynamics, and how they interface with inputs from the environment, has remained unclear owing to the small samples of cells obtained so far. Here, using simultaneous recordings from many hundreds of grid cells and subsequent topological data analysis, we show that the joint activity of grid cells from an individual module resides on a toroidal manifold, as expected in a two-dimensional CAN. Positions on the torus correspond to positions of the moving animal in the environment. Individual cells are preferentially active at singular positions on the torus. Their positions are maintained between environments and from wakefulness to sleep, as predicted by CAN models for grid cells but not by alternative feedforward models(12). This demonstration of network dynamics on a toroidal manifold provides a population-level visualization of CAN dynamics in grid cells.	[Gardner, Richard J.; Dunn, Benjamin A.; Moser, May-Britt; Moser, Edvard, I] Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, Trondheim, Norway; [Gardner, Richard J.; Dunn, Benjamin A.; Moser, May-Britt; Moser, Edvard, I] Norwegian Univ Sci & Technol, Ctr Neural Computat, Trondheim, Norway; [Hermansen, Erik; Baas, Nils A.; Dunn, Benjamin A.] Norwegian Univ Sci & Technol, Dept Math Sci, Trondheim, Norway; [Pachitariu, Marius] HHMI Janelia Res Campus, Ashburn, VA USA; [Burak, Yoram] Hebrew Univ Jerusalem, Edmond & Lily Safra Ctr Brain Sci, Jerusalem, Israel; [Burak, Yoram] Hebrew Univ Jerusalem, Racah Inst Phys, Jerusalem, Israel	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Hebrew University of Jerusalem; Hebrew University of Jerusalem	Gardner, RJ; Dunn, BA; Moser, EI (corresponding author), Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, Trondheim, Norway.; Gardner, RJ; Dunn, BA; Moser, EI (corresponding author), Norwegian Univ Sci & Technol, Ctr Neural Computat, Trondheim, Norway.; Baas, NA; Dunn, BA (corresponding author), Norwegian Univ Sci & Technol, Dept Math Sci, Trondheim, Norway.	richard.gardner@ntnu.no; nils.baas@ntnu.no; benjamin.dunn@ntnu.no; edvard.moser@ntnu.no			European Research Council [951319]; RCN FRIPRO grant [286225]; Centre of Excellence grant; National Infrastructure grant; Research Council of Norway (Centre of Neural Computation) [223262, 295721]; Kavli Foundation; Department of Mathematical Sciences at the Norwegian University of Science and Technology; Israel Science Foundation [1745/18]; Gatsby Charitable Foundation	European Research Council(European Research Council (ERC)European Commission); RCN FRIPRO grant; Centre of Excellence grant; National Infrastructure grant; Research Council of Norway (Centre of Neural Computation)(Research Council of Norway); Kavli Foundation; Department of Mathematical Sciences at the Norwegian University of Science and Technology; Israel Science Foundation(Israel Science Foundation); Gatsby Charitable Foundation	We thank M. P. Witter for help with evaluation of recording locations, and A. M. Amundsgard, K. Haugen, K. Jenssen, E. Krakvik, I. Ulsaker-Janke and H. Waade for technical assistance. The work was supported by a Synergy Grant to E.I.M. and Y.B. from the European Research Council (`KILONEURONS', grant agreement no. 951319); an RCN FRIPRO grant to E.I.M. (grant no. 286225); a Centre of Excellence grant to M.-B.M. and E.I.M. and a National Infrastructure grant to E.I.M. and M.-B.M. from the Research Council of Norway (Centre of Neural Computation, grant number 223262; NORBRAIN, grant number 295721); the Kavli Foundation (M.-B.M. and E.I.M.); the Department of Mathematical Sciences at the Norwegian University of Science and Technology (B.A.D., E.H. and N.A.B.); a direct contribution to M.-B.M. and E.I.M. from the Ministry of Education and Research of Norway; and grants to Y.B. from the Israel Science Foundation (grant no. 1745/18) and the Gatsby Charitable Foundation. Some of the computations were performed on resources provided by the NTNU IDUN/EPIC computing cluster.	Aksay E, 2007, NAT NEUROSCI, V10, P494, DOI 10.1038/nn1877; AMARI SI, 1977, BIOL CYBERN, V27, P77, DOI 10.1007/BF00337259; Baas Nils A., 2017, Current Opinion in Systems Biology, V1, P32, DOI 10.1016/j.coisb.2016.12.002; Barry C, 2007, NAT NEUROSCI, V10, P682, DOI 10.1038/nn1905; Bauer Ulrich, 2021, J APPL COMPUT TOPOL, P1, DOI [DOI 10.1007/S41468-021-00071-5, 10.1007/s41468-021-00071-5]; Bellman R., 1957, DYNAMIC PROGRAMMING; BENYISHAI R, 1995, P NATL ACAD SCI USA, V92, P3844, DOI 10.1073/pnas.92.9.3844; Boccara CN, 2019, SCIENCE, V363, P1443, DOI 10.1126/science.aav4837; Burak Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000291; Butler WN, 2019, SCIENCE, V363, P1447, DOI 10.1126/science.aav5297; Chaudhuri R, 2019, NAT NEUROSCI, V22, P1512, DOI 10.1038/s41593-019-0460-x; Compte A, 2000, CEREB CORTEX, V10, P910, DOI 10.1093/cercor/10.9.910; Couey JJ, 2013, NAT NEUROSCI, V16, P318, DOI 10.1038/nn.3310; Csordas DE, 2020, J NEUROSCI, V40, P4512, DOI 10.1523/JNEUROSCI.2569-19.2020; D'Albis T, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005782; Dabaghian Y, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002581; Darshan R., 2021, LEARNING REPRESENT C, DOI [10.1101/2021.06.01.446635(2021, DOI 10.1101/2021.06.01.446635(2021]; de Silva V, 2011, DISCRETE COMPUT GEOM, V45, P737, DOI 10.1007/s00454-011-9344-x; Donato F, 2017, SCIENCE, V355, DOI 10.1126/science.aai8178; Dordek Y, 2016, ELIFE, V5, DOI 10.7554/eLife.10094; Finkelstein A, 2015, NATURE, V517, P159, DOI 10.1038/nature14031; Fuhs MC, 2006, J NEUROSCI, V26, P4266, DOI 10.1523/JNEUROSCI.4353-05.2006; Fyhn M, 2007, NATURE, V446, P190, DOI 10.1038/nature05601; Gardner RJ, 2019, NAT NEUROSCI, V22, P598, DOI 10.1038/s41593-019-0360-0; Ginosar G, 2021, NATURE, V596, P404, DOI 10.1038/s41586-021-03783-x; Giusti C, 2015, P NATL ACAD SCI USA, V112, P13455, DOI 10.1073/pnas.1506407112; Gray CM, 1995, J NEUROSCI METH, V63, P43, DOI 10.1016/0165-0270(95)00085-2; Green J, 2017, NATURE, V546, P101, DOI 10.1038/nature22343; Guanella A, 2007, INT J NEURAL SYST, V17, P231, DOI 10.1142/S0129065707001093; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hardcastle K, 2017, NEURON, V94, P375, DOI 10.1016/j.neuron.2017.03.025; Hatcher A, 2002, ALGEBRAIC TOPOLOGY; James Melville, 2020, Arxiv, DOI arXiv:1802.03426; Jun JJ, 2017, NATURE, V551, P232, DOI 10.1038/nature24636; Kang L, 2021, FRONT COMPUT NEUROSC, V15, DOI 10.3389/fncom.2021.616748; Kim SS, 2017, SCIENCE, V356, P849, DOI 10.1126/science.aal4835; Kloke J., 2009, TOPOLOGICAL DENOISIN; Kobak D, 2021, NAT BIOTECHNOL, V39, DOI 10.1038/s41587-020-00809-z; Koyluoglu OO, 2017, ELIFE, V6, DOI 10.7554/eLife.22225; Kropff E, 2008, HIPPOCAMPUS, V18, P1256, DOI 10.1002/hipo.20520; Krupic J, 2015, NATURE, V518, P232, DOI 10.1038/nature14153; Langston RF, 2010, SCIENCE, V328, P1576, DOI 10.1126/science.1188210; Latuske P, 2015, J NEUROSCI, V35, P10963, DOI 10.1523/JNEUROSCI.0276-15.2015; Ledergerber D, 2021, CELL REP, V35, DOI 10.1016/j.celrep.2021.109175; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; LUKASHIN AV, 1993, BIOL CYBERN, V69, P517, DOI 10.1007/BF01185423; Machens CK, 2005, SCIENCE, V307, P1121, DOI 10.1126/science.1104171; McNaughton BL, 1996, J EXP BIOL, V199, P173; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Meehan S., 2021, UNIFORM MANIFOLD APP; Monsalve-Mercado MM, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.038101; Montgomery SM, 2008, J NEUROSCI, V28, P6731, DOI 10.1523/JNEUROSCI.1227-08.2008; Newman EL, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00193; Perea J. A., 2020, TOPOLOGICAL DATA ANA, P435; Peyrache A, 2015, NAT NEUROSCI, V18, P569, DOI 10.1038/nn.3968; Redish AD, 1996, NETWORK-COMP NEURAL, V7, P671, DOI 10.1088/0954-898X/7/4/004; Romani S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000869; Rubin A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12724-2; Rybakken E, 2019, NEURAL COMPUT, V31, P68, DOI 10.1162/neco_a_01150; Samsonovich A, 1997, J NEUROSCI, V17, P5900; Santos Pata, 2020, GRID CELLS; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Seelig JD, 2015, NATURE, V521, P186, DOI 10.1038/nature14446; Seung HS, 1996, P NATL ACAD SCI USA, V93, P13339, DOI 10.1073/pnas.93.23.13339; Si BL, 2012, BIOL CYBERN, V106, P483, DOI 10.1007/s00422-012-0513-7; Singh G, 2008, J VISION, V8, DOI 10.1167/8.8.11; Sjalander M., 2020, EPIC ENERGY EFFICIEN; Skaggs W E, 1995, Adv Neural Inf Process Syst, V7, P173; Skaggs W.E., 1992, ADV NEURAL INFORM PR, V5, P1030, DOI DOI 10.5555/2987061.2987188; Sorscher B., 2020, NEUROSCIENCE PREPRIN, DOI [10.1101/2020.12.29.424583, DOI 10.1101/2020.12.29.424583]; Spivak DI, 2009, METRIC REALIZATION F; Spreemann G, 2018, PHYS REV E, V97, DOI 10.1103/PhysRevE.97.032313; Stachenfeld KL, 2017, NAT NEUROSCI, V20, P1643, DOI 10.1038/nn.4650; Steinmetz NA, 2021, SCIENCE, V372, P258, DOI 10.1126/science.abf4588; Stensola H, 2012, NATURE, V492, P72, DOI 10.1038/nature11649; Stensola T, 2015, NATURE, V518, P207, DOI 10.1038/nature14151; Stepanyuk A, 2015, BIOL INSPIR COGN ARC, V13, P48, DOI 10.1016/j.bica.2015.06.006; Sussillo D, 2013, NEURAL COMPUT, V25, P626, DOI 10.1162/NECO_a_00409; TAUBE JS, 1990, J NEUROSCI, V10, P420; The GUDHI Project, 2021, SEISM WAV AN REAL TI; Tralie C., 2018, J OPEN SOURCE SOFTWA, V3, P925, DOI [10.21105/joss.00925, DOI 10.21105/JOSS.00925]; Trettel SG, 2019, NAT NEUROSCI, V22, P609, DOI 10.1038/s41593-019-0359-6; Tsodyks M, 1995, INTERNATIONAL JOURNAL OF NEURAL SYSTEMS, SUPPLEMENTARY ISSUE, 1995, P81; Wang XJ, 2008, NEURON, V60, P215, DOI 10.1016/j.neuron.2008.09.034; Weber SN, 2018, ELIFE, V7, DOI 10.7554/eLife.34560; Wills TJ, 2010, SCIENCE, V328, P1573, DOI 10.1126/science.1188224; Wimmer K, 2014, NAT NEUROSCI, V17, P431, DOI 10.1038/nn.3645; Yoganarasimha D, 2006, J NEUROSCI, V26, P622, DOI 10.1523/JNEUROSCI.3885-05.2006; Yoon KJ, 2013, NAT NEUROSCI, V16, P1077, DOI 10.1038/nn.3450; Zhang K, 1996, J NEUROSCI, V16, P2112	91	24	24	16	32	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 3	2022	602	7895					123	+		10.1038/s41586-021-04268-7	http://dx.doi.org/10.1038/s41586-021-04268-7		JAN 2022	26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YS1FH	35022611	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000741978700006
J	Suran, M				Suran, Melissa			Preparing Hospitals' Medical Oxygen Delivery Systems for a Respiratory "Twindemic"	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item; Early Access								This Medical News feature examines the challenges that hospitals face as they prepare for a spike in severe cases of COVID-19 and other respiratory illnesses that require supplemental oxygen.											0	2	2	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.												10.1001/jama.2021.23392	http://dx.doi.org/10.1001/jama.2021.23392		JAN 2022	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YG3TV	35019960	Bronze			2022-12-28	WOS:000742416400002
J	Kraft, B; Jehmlich, N; Larsen, M; Bristow, LA; Konneke, M; Thamdrup, B; Canfield, DE				Kraft, Beate; Jehmlich, Nico; Larsen, Morten; Bristow, Laura A.; Konneke, Martin; Thamdrup, Bo; Canfield, Donald E.			Oxygen and nitrogen production by an ammonia-oxidizing archaeon	SCIENCE			English	Article							NITRIC-OXIDE; OXIDATION; KINETICS; PHYSIOLOGY; DENITRIFICATION; NITRIFICATION; INHIBITORS; DIVERSITY; MECHANISM; BACTERIA	Ammonia-oxidizing archaea (AOA) are one of the most abundant groups of microbes in the world's oceans and are key players in the nitrogen cycle. Their energy metabolism-the oxidation of ammonia to nitrite-requires oxygen. Nevertheless, AOA are abundant in environments where oxygen is undetectable. By carrying out incubations for which oxygen concentrations were resolved to the nanomolar range, we show that after oxygen depletion, Nitrosopumilus maritimus produces dinitrogen and oxygen, which is used for ammonia oxidation. The pathway is not completely resolved but likely has nitric oxide and nitrous oxide as key intermediates. N. maritimus joins a handful of organisms known to produce oxygen in the dark. On the basis of this ability, we reevaluate the role of N. maritimus in oxygen- depleted marine environments.	[Kraft, Beate; Larsen, Morten; Bristow, Laura A.; Thamdrup, Bo; Canfield, Donald E.] Univ Southern Denmark, Dept Biol, Nordcee, Odense, Denmark; [Jehmlich, Nico] UFZ GmbH, Dept Mol Syst Biol, Helmholtz Ctr Environm Res, Leipzig, Germany; [Konneke, Martin] Univ Bremen, Ctr Marine Environm Sci MARUM, Marine Archaea Grp, Bremen, Germany; [Konneke, Martin] Univ Bremen, Dept Geosci, Bremen, Germany; [Konneke, Martin] Carl von Ossietzky Univ Oldenburg, Inst Chem & Biol Marine Environm ICBM, Oldenburg, Germany; [Canfield, Donald E.] China Natl Petr Corp, Key Lab Petr Geochem, Res Inst Petr Explorat & Dev, Beijing 100083, Peoples R China; [Canfield, Donald E.] Univ Southern Denmark, Danish Inst Adv Study, Odense, Denmark	University of Southern Denmark; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); University of Bremen; University of Bremen; Carl von Ossietzky Universitat Oldenburg; China National Petroleum Corporation; University of Southern Denmark	Kraft, B (corresponding author), Univ Southern Denmark, Dept Biol, Nordcee, Odense, Denmark.	bkraft@biology.sdu.dk	Jehmlich, Nico/D-9041-2015; Canfield, Don/C-1735-2012; Koenneke, Martin/E-6893-2013	Jehmlich, Nico/0000-0002-5638-6868; Bristow, Laura/0000-0003-4865-070X; Kraft, Beate/0000-0003-0310-5206; Canfield, Don/0000-0001-7602-8366; Koenneke, Martin/0000-0001-6770-414X	Villum Foundation, Denmark (Villum Young Investigator Grant) [25491, 16518]; Independent Research Fund Denmark [14181-00025]; Heisenberg Program of the Deutsche Forschungsgemeinschaft awarded [KO 3651/6-1]	Villum Foundation, Denmark (Villum Young Investigator Grant); Independent Research Fund Denmark; Heisenberg Program of the Deutsche Forschungsgemeinschaft awarded(German Research Foundation (DFG))	This work was supported by the Villum Foundation, Denmark (Villum Young Investigator Grant 25491 to B.K. and Villum Investigator Grant 16518 to D.E.C.); the Independent Research Fund Denmark (grant 14181-00025 to D.E.C.); and the Heisenberg Program of the Deutsche Forschungsgemeinschaft awarded (KO 3651/6-1) to M.K.	Amend JP, 2001, FEMS MICROBIOL REV, V25, P175, DOI 10.1016/S0168-6445(00)00062-0; Arciero DM, 2002, BIOCHEMISTRY-US, V41, P1703, DOI 10.1021/bi015908w; Bayer B, 2019, ENVIRON MICROBIOL, V21, P4062, DOI 10.1111/1462-2920.14755; BEDARD C, 1989, MICROBIOL REV, V53, P68; Beman JM, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00263; BENDSCHNEIDER K, 1952, J MAR RES, V11, P87; Berg C, 2015, ISME J, V9, P1319, DOI 10.1038/ismej.2014.218; BONNER FT, 1986, INORG CHEM, V25, P1858, DOI 10.1021/ic00231a029; BOWER CE, 1980, CAN J FISH AQUAT SCI, V37, P794, DOI 10.1139/f80-106; Bristow LA, 2017, NAT GEOSCI, V10, P24, DOI [10.1038/ngeo2847, 10.1038/NGEO2847]; Dalsgaard T, 2012, LIMNOL OCEANOGR, V57, P1331, DOI 10.4319/lo.2012.57.5.1331; De Brabandere L, 2012, J MICROBIOL METH, V88, P147, DOI 10.1016/j.mimet.2011.11.001; DuMond JF, 2011, ANTIOXID REDOX SIGN, V14, P1637, DOI 10.1089/ars.2010.3838; Ettwig KF, 2012, BBA-BIOENERGETICS, V1817, pS155, DOI [10.3389/fmicb.2012.00273, 10.1016/j.bbabio.2012.06.406]; Ettwig KF, 2010, NATURE, V464, P543, DOI 10.1038/nature08883; Fernandes AT, 2010, FEBS J, V277, P3176, DOI 10.1111/j.1742-4658.2010.07725.x; Gong XZ, 2016, APPL ENVIRON MICROB, V82, P1412, DOI 10.1128/AEM.03669-15; HOOPER AB, 1973, J BACTERIOL, V115, P480, DOI 10.1128/JB.115.2.480-485.1973; Hughes MN, 2008, METHOD ENZYMOL, V436, P3, DOI 10.1016/S0076-6879(08)36001-7; Jensen MM, 2008, LIMNOL OCEANOGR, V53, P23, DOI 10.4319/lo.2008.53.1.0023; Ji QX, 2018, GLOBAL BIOGEOCHEM CY, V32, P1790, DOI 10.1029/2018GB005887; Kim JG, 2016, P NATL ACAD SCI USA, V113, P7888, DOI 10.1073/pnas.1605501113; King SB, 1999, METHOD ENZYMOL, V301, P211; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Lam P, 2011, ANNU REV MAR SCI, V3, P317, DOI 10.1146/annurev-marine-120709-142814; Lehner P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128125; Liu SR, 2017, ENVIRON SCI TECHNOL, V51, P13122, DOI 10.1021/acs.est.7b02360; Loscher CR, 2012, BIOGEOSCIENCES, V9, P2419, DOI 10.5194/bg-9-2419-2012; Martens-Habbena W, 2015, ENVIRON MICROBIOL, V17, P2261, DOI 10.1111/1462-2920.12677; Martens-Habbena W, 2009, NATURE, V461, P976, DOI 10.1038/nature08465; Miranda KM, 2005, J AM CHEM SOC, V127, P722, DOI 10.1021/ja045480z; Molina V, 2010, ENVIRON MICROBIOL, V12, P2450, DOI 10.1111/j.1462-2920.2010.02218.x; Nakagawa H, 2013, J INORG BIOCHEM, V118, P187, DOI 10.1016/j.jinorgbio.2012.10.004; REVSBECH NP, 1989, LIMNOL OCEANOGR, V34, P474, DOI 10.4319/lo.1989.34.2.0474; Santoro AE, 2021, GLOBAL BIOGEOCHEM CY, V35, DOI 10.1029/2020GB006716; Santoro AE, 2011, SCIENCE, V333, P1282, DOI 10.1126/science.1208239; Schleper C, 2010, ADV MICROB PHYSIOL, V57, P1, DOI 10.1016/B978-0-12-381045-8.00001-1; Shafirovich V, 2002, P NATL ACAD SCI USA, V99, P7340, DOI 10.1073/pnas.112202099; Sollai M, 2019, GEOBIOLOGY, V17, P91, DOI 10.1111/gbi.12316; Spott O, 2011, SOIL BIOL BIOCHEM, V43, P1995, DOI 10.1016/j.soilbio.2011.06.014; Stahl DA, 2012, ANNU REV MICROBIOL, V66, P83, DOI 10.1146/annurev-micro-092611-150128; Stewart FJ, 2012, ENVIRON MICROBIOL, V14, P23, DOI 10.1111/j.1462-2920.2010.02400.x; Stieglmeier M, 2014, ISME J, V8, P1135, DOI 10.1038/ismej.2013.220; Tiano L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105399; Walker CB, 2010, P NATL ACAD SCI USA, V107, P8818, DOI 10.1073/pnas.0913533107; Widdel F., 1992, PROKARYOTES, DOI 10.1007/978-1-4757-2191-1_2; WILSON MT, 1994, J BIOL CHEM, V269, P24114; WINK DA, 1993, CHEM RES TOXICOL, V6, P23, DOI 10.1021/tx00031a003; ZAMORA R, 1995, BIOCHEM J, V312, P333, DOI 10.1042/bj3120333	49	23	23	56	170	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 7	2022	375	6576					97	+	eabe6733	10.1126/science.abe6733	http://dx.doi.org/10.1126/science.abe6733			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YD3FW	34990242				2022-12-28	WOS:000740261400047
J	Pulla, P				Pulla, Priyanka			How covid-19 vaccines exposed India's adverse events reporting system	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												priyanka@gmail.com			Thakur Family Foundation	Thakur Family Foundation	I have read and understood the BMJ policy on declaration of interests and declare the following interests: Reporting for this story was supported by a grant from the Thakur Family Foundation. The foundation exerts no editorial influence on the work.	[Anonymous], 2017, NATL FAMILY HLTH SUR; GOV.UK, 2021, COR VACC WEEKL SUMM; GOV.UK, JCVI ADV COV 19 VACC; Government of Canada, 2021, COVID 19 VACC SAF WE; Hindu Bureau, 2021, HINDU; Joshi J, 2018, INDIAN J PEDIATR, V85, P139, DOI 10.1007/s12098-017-2532-9; Ministry of Health & Family Welfare, 2021, ANSW RAJ SABH UNST Q; Pulla P, 2021, LIVEMINT 0527; Sarkar Mohammad Abdullah, 2021, Ann Glob Health, V87, P124, DOI 10.5334/aogh.3530; WHO, 2021, GUIDANCE CLIN CASE M; Wise J, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n954; World Health Organization, 2020, MON RESP ADV EV SPEC	12	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 7	2022	376								n3146	10.1136/bmj.n3146	http://dx.doi.org/10.1136/bmj.n3146			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YP9GN	34996761	Bronze			2022-12-28	WOS:000748927300006
J	Chou, KT; Lee, DYD; Chiou, JG; Galera-Laporta, L; Ly, S; Garcia-Ojalvo, J; Suel, GM				Chou, Kwang-Tao; Lee, Dong-Yeon D.; Chiou, Jian-Geng; Galera-Laporta, Leticia; Ly, San; Garcia-Ojalvo, Jordi; Suel, Gurol M.			A segmentation clock patterns cellular differentiation in a bacterial biofilm	CELL			English	Article							WAVE-FRONT MODEL; BACILLUS-SUBTILIS; ZEBRAFISH SOMITOGENESIS; VERTEBRATE SEGMENTATION; GLUTAMINE-SYNTHETASE; TRANSCRIPTION FACTOR; PRESOMITIC MESODERM; SIGNALING PATHWAY; GENE-EXPRESSION; SPORULATION	Contrary to multicellular organisms that display segmentation during development, communities of unicellular organisms are believed to be devoid of such sophisticated patterning. Unexpectedly, we find that the gene expression underlying the nitrogen stress response of a developing Bacillus subtilis biofilm becomes organized into a ring-like pattern. Mathematical modeling and genetic probing of the underlying circuit indicate that this patterning is generated by a clock and wavefront mechanism, similar to that driving vertebrate somitogenesis. We experimentally validated this hypothesis by showing that predicted nutrient conditions can even lead to multiple concentric rings, resembling segments. We additionally confirmed that this patterning mechanism is driven by cell-autonomous oscillations. Importantly, we show that the clock and wavefront process also spatially patterns sporulation within the biofilm. Together, these findings reveal a biofilm segmentation clock that organizes cellular differentiation in space and time, thereby challenging the paradigm that such patterning mechanisms are exclusive to plant and animal development.	[Chou, Kwang-Tao; Chiou, Jian-Geng; Galera-Laporta, Leticia; Ly, San; Suel, Gurol M.] Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, La Jolla, CA 92093 USA; [Lee, Dong-Yeon D.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Garcia-Ojalvo, Jordi] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Barcelona 08003, Spain; [Suel, Gurol M.] Univ Calif San Diego, San Diego Ctr Syst Biol, La Jolla, CA 92093 USA; [Suel, Gurol M.] Univ Calif San Diego, Ctr Microbiome Innovat, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Stanford University; Pompeu Fabra University; University of California System; University of California San Diego; University of California System; University of California San Diego	Suel, GM (corresponding author), Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, La Jolla, CA 92093 USA.; Suel, GM (corresponding author), Univ Calif San Diego, San Diego Ctr Syst Biol, La Jolla, CA 92093 USA.; Suel, GM (corresponding author), Univ Calif San Diego, Ctr Microbiome Innovat, La Jolla, CA 92093 USA.	gsuel@ucsd.edu	Garcia-Ojalvo, Jordi/A-4574-2009	Garcia-Ojalvo, Jordi/0000-0002-3716-7520; Galera-Laporta, Leticia/0000-0002-2453-896X; Chou, Todd/0000-0003-2011-7137	National Institutes of Health [T32GM127235]; Spanish Ministry of Science, Innovation and Universities; FEDER [PGC2018-101251-B-I00, CEX2018-000792-M]; Generalitat de Catalunya (ICREA Academia program); National Institute of General Medical Sciences [R01 GM121888, R35 GM139645]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Ministry of Science, Innovation and Universities(Spanish Government); FEDER(European Commission); Generalitat de Catalunya (ICREA Academia program)(ICREA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge Munehiro Asally, Tolga Cagatay, and Katherine Suel for helpful discussions. K.-T.C. acknowledges support from National Institutes of Health grant T32GM127235. J.G.-O. acknowledges support from the Spanish Ministry of Science, Innovation and Universities and FEDER (Project PGC2018-101251-B-I00 and CEX2018-000792-M), and from the Generalitat de Catalunya (ICREA Academia program). G.M.S. acknowledges support for this research from National Institute of General Medical Sciences grants R01 GM121888 and R35 GM139645. G.M.S. is a Howard Hughes Medical Institute -Simons Foundation Faculty Scholar.	Aulehla A, 2008, NAT CELL BIOL, V10, P186, DOI 10.1038/ncb1679; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Belitsky BR, 2000, J BACTERIOL, V182, P5939, DOI 10.1128/JB.182.21.5939-5947.2000; Billings N, 2015, REP PROG PHYS, V78, DOI 10.1088/0034-4885/78/3/036601; Cao YXL, 2016, CELL, V165, P620, DOI 10.1016/j.cell.2016.03.006; COOKE J, 1976, J THEOR BIOL, V58, P455, DOI 10.1016/S0022-5193(76)80131-2; Cotterell J, 2015, CELL SYST, V1, P257, DOI 10.1016/j.cels.2015.10.002; DAWES IW, 1970, J BACTERIOL, V103, P529, DOI 10.1128/JB.103.3.529-535.1970; DEUEL TF, 1974, J BIOL CHEM, V249, P257; Gunka K, 2012, MOL MICROBIOL, V85, P213, DOI 10.1111/j.1365-2958.2012.08105.x; Henry CA, 2002, DEVELOPMENT, V129, P3693; Holley SA, 2000, GENE DEV, V14, P1678; Hubaud A, 2017, CELL, V171, P668, DOI 10.1016/j.cell.2017.08.043; Irving SE, 2021, NAT REV MICROBIOL, V19, P256, DOI 10.1038/s41579-020-00470-y; KAROW ML, 1995, P NATL ACAD SCI USA, V92, P2012, DOI 10.1073/pnas.92.6.2012; Kuchina A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002273; Lauschke VM, 2013, NATURE, V493, P101, DOI 10.1038/nature11804; Lewis J, 2003, CURR BIOL, V13, P1398, DOI 10.1016/S0960-9822(03)00534-7; Liu JT, 2015, NATURE, V523, P550, DOI 10.1038/nature14660; LONDONOVALLEJO JA, 1995, GENE DEV, V9, P503, DOI 10.1101/gad.9.4.503; Masamizu Y, 2006, P NATL ACAD SCI USA, V103, P1313, DOI 10.1073/pnas.0508658103; Meinhardt H, 2008, CURR TOP DEV BIOL, V81, P1, DOI 10.1016/S0070-2153(07)81001-5; Mirouze N, 2015, MICROBIOLOGYOPEN, V4, P423, DOI 10.1002/mbo3.249; Murray PJ, 2011, J THEOR BIOL, V283, P227, DOI 10.1016/j.jtbi.2011.05.004; Nadezhdin E, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14431-9; NAKANO MM, 1995, J BACTERIOL, V177, P573, DOI 10.1128/jb.177.3.573-579.1995; Oates AC, 2002, DEVELOPMENT, V129, P2929; Oates AC, 2012, DEVELOPMENT, V139, P625, DOI 10.1242/dev.063735; Pais-de-Azevedo Tomas, 2018, F1000Res, V7, P97, DOI 10.12688/f1000research.12369.1; Palmeirim I, 1997, CELL, V91, P639, DOI 10.1016/S0092-8674(00)80451-1; Pourquie O, 2003, SCIENCE, V301, P328, DOI 10.1126/science.1085887; Prindle A, 2015, NATURE, V527, P59, DOI 10.1038/nature15709; Richmond DL, 2012, CURR OPIN GENET DEV, V22, P600, DOI 10.1016/j.gde.2012.10.003; Sawada A, 2000, DEVELOPMENT, V127, P1691; SCHAEFFER P, 1965, P NATL ACAD SCI USA, V54, P704, DOI 10.1073/pnas.54.3.704; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shih NP, 2015, DEVELOPMENT, V142, P1785, DOI 10.1242/dev.119057; Sonenshein AL, 2007, NAT REV MICROBIOL, V5, P917, DOI 10.1038/nrmicro1772; Soroldoni D, 2014, SCIENCE, V345, P222, DOI 10.1126/science.1253089; Srinivasan S, 2018, BIOPHYS J, V114, P1490, DOI 10.1016/j.bpj.2018.02.002; Stewart PS, 2008, NAT REV MICROBIOL, V6, P199, DOI 10.1038/nrmicro1838; STJOHNSTON D, 1992, CELL, V68, P201; Suel GM, 2006, NATURE, V440, P545, DOI 10.1038/nature04588; Tsiairis CD, 2016, CELL, V164, P656, DOI 10.1016/j.cell.2016.01.028; Veening JW, 2008, ANNU REV MICROBIOL, V62, P193, DOI 10.1146/annurev.micro.62.081307.163002; Vlamakis H, 2013, NAT REV MICROBIOL, V11, P157, DOI 10.1038/nrmicro2960; Volker U, 1999, J BACTERIOL, V181, P3942; Wang JD, 2009, NAT REV MICROBIOL, V7, P822, DOI 10.1038/nrmicro2202; Webb AB, 2016, ELIFE, V5, DOI 10.7554/eLife.08438; Wray LV, 2007, J BACTERIOL, V189, P20, DOI 10.1128/JB.01238-06; Wray LV, 2001, CELL, V107, P427, DOI 10.1016/S0092-8674(01)00572-4	52	7	7	19	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 6	2022	185	1					145	+		10.1016/j.cell.2021.12.001	http://dx.doi.org/10.1016/j.cell.2021.12.001			27	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	YG3GE	34995513				2022-12-28	WOS:000742379900002
J	Ngai, J				Ngai, John			BRAIN 2.0: Transforming neuroscience	CELL			English	Editorial Material								The NIH BRAIN Initiative is entering a new phase. Three large new projects-a comprehensive human brain cell atlas, a whole mammalian brain microconnectivity map, and tools for precision access to brain cell types-promise to transform neuroscience research and the treatment of human brain disorders.	[Ngai, John] NIH, BRAIN Initiat, Bldg 10, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Ngai, J (corresponding author), NIH, BRAIN Initiat, Bldg 10, Bethesda, MD 20892 USA.	john.ngai@nih.gov						ACD BRAIN Initiative Working Group 2.0, 2019, BRAIN IN 2 0 CELLS C; Bargmann C., 2014, BRAIN 2025 NIH BRAIN; Berg J, 2021, NATURE, V598, P151, DOI 10.1038/s41586-021-03813-8; Brittin CA, 2021, NATURE, V591, P105, DOI 10.1038/s41586-021-03284-x; Callaway EM, 2021, NATURE, V598, P86, DOI 10.1038/s41586-021-03950-0; David KK, 2020, NEURON, V108, P1020, DOI 10.1016/j.neuron.2020.11.020; Ecker JR, 2017, NEURON, V96, P542, DOI 10.1016/j.neuron.2017.10.007; Koroshetz W, 2018, J NEUROSCI, V38, P6427, DOI 10.1523/JNEUROSCI.3174-17.2018; Mich JK, 2021, CELL REP, V34, DOI 10.1016/j.celrep.2021.108754; 2021, FUNCTIONAL CONNECTOM, DOI [10.1101/2021.07.28.454025, DOI 10.1101/2021.07.28.454025]; Kumar SR, 2020, NAT METHODS, V17, P541, DOI 10.1038/s41592-020-0799-7; Richardson RR, 2021, NEURON, V109, P3361, DOI 10.1016/j.neuron.2021.10.021; Scheffer LK, 2020, ELIFE, V9, DOI 10.7554/eLife.57443; Shapson-Coe A., 2021, CONNECTOMIC STUDY PE, DOI [10.1101/2021.05.29.446289, DOI 10.1101/2021.05.29.446289]; Zhu DQ, 2021, TRENDS MOL MED, V27, P524, DOI 10.1016/j.molmed.2021.03.010	15	6	6	16	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 6	2022	185	1					4	8		10.1016/j.cell.2021.11.037	http://dx.doi.org/10.1016/j.cell.2021.11.037			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	YL5FO	34995517				2022-12-28	WOS:000745916700002
J	Nuzzo, JB; Gostin, LO				Nuzzo, Jennifer B.; Gostin, Lawrence O.			The First 2 Years of COVID-19 Lessons to Improve Preparedness for the Next Pandemic	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Nuzzo, Jennifer B.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Gostin, Lawrence O.] Georgetown Univ, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Georgetown University	Gostin, LO (corresponding author), Georgetown Univ, ONeill Inst Natl & Global Hlth Law, Law Ctr, 500 First St NW,Off 810, Washington, DC 20001 USA.	gostin@georgetown.edu						[Anonymous], Billions committed, millions delivered: the mixed record of vaccine donations and diplomacy; [Anonymous], Disparities in COVID-19-associated hospitalizations; [Anonymous], Joint statement on dose donations of COVID-19 vaccines to African countries; Jackson J., GLOBAL EC EFFECTS CO; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Nuzzo JB, 2020, JAMA-J AM MED ASSOC, V324, P1391, DOI 10.1001/jama.2020.17395; Sepulveda ER, 2021, SSM-POPUL HLTH, V16, DOI 10.1016/j.ssmph.2021.100904; Simmons-Duffin S., NPR; World Health Organization, TRUE DEATH TOLL COVI	9	15	15	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 18	2022	327	3					217	218		10.1001/jama.2021.24394	http://dx.doi.org/10.1001/jama.2021.24394		JAN 2022	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YV9PQ	34989763	Bronze			2022-12-28	WOS:000739988300005
J	Larsen, J; Raisen, CL; Ba, XL; Sadgrove, NJ; Padilla-Gonzalez, GF; Simmonds, MSJ; Loncaric, I; Kerschner, H; Apfalter, P; Hartl, R; Deplano, A; Vandendriessche, S; Bolfikova, BC; Hulva, P; Arendrup, MC; Hare, RK; Barnadas, C; Stegger, M; Sieber, RN; Skov, RL; Petersen, A; Angen, O; Rasmussen, SL; Espinosa-Gongora, C; Aarestrup, FM; Lindholm, LJ; Nykasenoja, SM; Laurent, F; Becker, K; Walther, B; Kehrenberg, C; Cuny, C; Layer, F; Werner, G; Witte, W; Stamm, I; Moroni, P; Jorgensen, HJ; de Lencastre, H; Cercenado, E; Garcia-Garrote, F; Borjesson, S; Haeggman, S; Perreten, V; Teale, CJ; Waller, AS; Pichon, B; Curran, MD; Ellington, MJ; Welch, JJ; Peacock, SJ; Seilly, DJ; Morgan, FJE; Parkhill, J; Hadjirin, NF; Lindsay, JA; Holden, MTG; Edwards, GF; Foster, G; Paterson, GK; Didelot, X; Holmes, MA; Harrison, EM; Larsen, AR				Larsen, Jesper; Raisen, Claire L.; Ba, Xiaoliang; Sadgrove, Nicholas J.; Padilla-Gonzalez, Guillermo F.; Simmonds, Monique S. J.; Loncaric, Igor; Kerschner, Heidrun; Apfalter, Petra; Hartl, Rainer; Deplano, Ariane; Vandendriessche, Stien; Bolfikova, Barbora Cerna; Hulva, Pavel; Arendrup, Maiken C.; Hare, Rasmus K.; Barnadas, Celine; Stegger, Marc; Sieber, Raphael N.; Skov, Robert L.; Petersen, Andreas; Angen, Oystein; Rasmussen, Sophie L.; Espinosa-Gongora, Carmen; Aarestrup, Frank M.; Lindholm, Laura J.; Nykasenoja, Suvi M.; Laurent, Frederic; Becker, Karsten; Walther, Birgit; Kehrenberg, Corinna; Cuny, Christiane; Layer, Franziska; Werner, Guido; Witte, Wolfgang; Stamm, Ivonne; Moroni, Paolo; Jorgensen, Hannah J.; de Lencastre, Herminia; Cercenado, Emilia; Garcia-Garrote, Fernando; Borjesson, Stefan; Haeggman, Sara; Perreten, Vincent; Teale, Christopher J.; Waller, Andrew S.; Pichon, Bruno; Curran, Martin D.; Ellington, Matthew J.; Welch, John J.; Peacock, Sharon J.; Seilly, David J.; Morgan, Fiona J. E.; Parkhill, Julian; Hadjirin, Nazreen F.; Lindsay, Jodi A.; Holden, Matthew T. G.; Edwards, Giles F.; Foster, Geoffrey; Paterson, Gavin K.; Didelot, Xavier; Holmes, Mark A.; Harrison, Ewan M.; Larsen, Anders R.			Emergence of methicillin resistance predates the clinical use of antibiotics	NATURE			English	Article							STAPHYLOCOCCAL COMPLEMENT INHIBITOR; MECA HOMOLOG; AUREUS; HEDGEHOG; TRANSMISSION; RESERVOIR; STRAINS; MRSA; EPIDEMIOLOGY; PHYLOGENIES	The discovery of antibiotics more than 80 years ago has led to considerable improvements in human and animal health. Although antibiotic resistance in environmental bacteria is ancient, resistance in human pathogens is thought to be a modern phenomenon that is driven by the clinical use of antibiotics(1). Here we show that particular lineages of methicillin-resistant Staphylococcus aureus-a notorious human pathogen-appeared in European hedgehogs in the pre-antibiotic era. Subsequently, these lineages spread within the local hedgehog populations and between hedgehogs and secondary hosts, including livestock and humans. We also demonstrate that the hedgehog dermatophyte Trichophyton erinacei produces two beta-lactam antibiotics that provide a natural selective environment in which methicillin-resistant S. aureus isolates have an advantage over susceptible isolates. Together, these results suggest that methicillin resistance emerged in the pre-antibiotic era as a co-evolutionary adaptation of S. aureus to the colonization of dermatophyte-infected hedgehogs. The evolution of clinically relevant antibiotic-resistance genes in wild animals and the connectivity of natural, agricultural and human ecosystems demonstrate that the use of a One Health approach is critical for our understanding and management of antibiotic resistance, which is one of the biggest threats to global health, food security and development.	[Larsen, Jesper; Arendrup, Maiken C.; Hare, Rasmus K.; Barnadas, Celine; Stegger, Marc; Sieber, Raphael N.; Petersen, Andreas; Angen, Oystein; Larsen, Anders R.] Statens Serum Inst, Dept Bacteria Parasites & Fungi, Copenhagen, Denmark; [Raisen, Claire L.; Ba, Xiaoliang; Seilly, David J.; Morgan, Fiona J. E.; Parkhill, Julian; Hadjirin, Nazreen F.; Holmes, Mark A.] Univ Cambridge, Dept Vet Med, Cambridge, England; [Sadgrove, Nicholas J.; Padilla-Gonzalez, Guillermo F.; Simmonds, Monique S. J.] Royal Bot Gardens, Richmond, Surrey, England; [Loncaric, Igor] Univ Vet Med, Inst Microbiol, Vienna, Austria; [Kerschner, Heidrun; Apfalter, Petra; Hartl, Rainer] Ordensklinikum Linz Elisabethinen, Inst Hyg Microbiol & Trop Med, Natl Reference Ctr Antimicrobial Resistance & Nos, Linz, Austria; [Deplano, Ariane; Vandendriessche, Stien] Univ Libre Bruxelles, Natl Reference Ctr Staphylococcus Aureus, Dept Microbiol, Hop Erasme, Brussels, Belgium; [Bolfikova, Barbora Cerna] Czech Univ Life Sci Prague, Fac Trop AgriSci, Dept Anim Sci & Food Proc, Prague, Czech Republic; [Hulva, Pavel] Charles Univ Prague, Dept Zool, Prague, Czech Republic; [Hulva, Pavel] Univ Ostrava, Dept Biol & Ecol, Ostrava, Czech Republic; [Barnadas, Celine] European Ctr Dis Prevent & Control ECDC, European Programme Publ Hlth Microbiol Training E, Stockholm, Sweden; [Skov, Robert L.] Statens Serum Inst, Infect Dis Preparedness, Copenhagen, Denmark; [Rasmussen, Sophie L.] Aalborg Univ, Dept Chem & Biosci, Aalborg, Denmark; [Rasmussen, Sophie L.] Univ Oxford, Dept Zool, Wildlife Conservat Res Unit WildCRU, Tubney, England; [Espinosa-Gongora, Carmen] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet & Anim Sci, Frederiksberg, Denmark; [Aarestrup, Frank M.] Tech Univ Denmark, Natl Food Inst, Lyngby, Denmark; [Lindholm, Laura J.] Finnish Inst Hlth & Welf, Dept Hlth Secur, Expert Microbiol Unit, Helsinki, Finland; [Nykasenoja, Suvi M.] Finnish Food Author, Microbiol Unit, Helsinki, Finland; [Laurent, Frederic] Univ Lyon, Hosp Civils Lyon, Bacteriol Dept, Lyon, France; [Laurent, Frederic] Univ Lyon, Hosp Civils Lyon, French Natl Reference Ctr Staphylococci, Lyon, France; [Becker, Karsten] Univ Med Greifswald, Friedrich Loeffler Inst Med Microbiol, Greifswald, Germany; [Walther, Birgit] Free Univ Berlin, Inst Microbiol & Epizoot, Vet Fac, Berlin, Germany; [Kehrenberg, Corinna] Justus Liebig Univ Giessen, Inst Vet Food Sci, Giessen, Germany; [Cuny, Christiane; Layer, Franziska; Werner, Guido; Witte, Wolfgang] Robert Koch Inst, Natl Reference Ctr Staphylococci & Enterococci, Dept Infect Dis, Div Nosocomial Pathogens & Antibiot Resistances, Wernigerode, Germany; [Stamm, Ivonne] Vet Med Lab GmbH, Kornwestheim, Germany; [Moroni, Paolo] Univ Milan, Dipartimento Med Vet, Lodi, Italy; [Jorgensen, Hannah J.] Norwegian Vet Inst, As, Norway; [de Lencastre, Herminia] ITQB NOVA, Lab Mol Genet, Oeiras, Portugal; [de Lencastre, Herminia] Rockefeller Univ, Lab Microbiol & Infect Dis, 1230 York Ave, New York, NY 10021 USA; [Cercenado, Emilia; Garcia-Garrote, Fernando] Hosp Univ Lucus Augusti, Serv Microbiol, Lugo, Spain; [Borjesson, Stefan] Natl Vet Inst SVA, Dept Anim Hlth & Antimicrobial Strategies, Uppsala, Sweden; [Borjesson, Stefan; Haeggman, Sara] Publ Hlth Agcy Sweden, Dept Microbiol, Solna, Sweden; [Perreten, Vincent] Univ Bern, Inst Vet Bacteriol, Bern, Switzerland; [Teale, Christopher J.] Anim & Plant Hlth Agcy, Dept Bacteriol, Weybridge, Surrey, England; [Waller, Andrew S.] Anim Hlth Trust, Newmarket, Suffolk, England; [Pichon, Bruno; Ellington, Matthew J.] UK Hlth Secur Agcy, Antimicrobial Resistance & Healthcare Associated, London, England; [Curran, Martin D.; Ellington, Matthew J.] Addenbrookes Hosp, Clin Microbiol & Publ Hlth Lab, UK Hlth Secur Agcy, Cambridge, England; [Welch, John J.] Univ Cambridge, Dept Genet, Cambridge, England; [Peacock, Sharon J.; Harrison, Ewan M.] Univ Cambridge, Dept Med, Cambridge, England; [Lindsay, Jodi A.] St Georges Univ London, Inst Infect & Immun, London, England; [Holden, Matthew T. G.] Univ St Andrews, Sch Med, St Andrews, Fife, Scotland; [Edwards, Giles F.] Stobhill Hosp, Scottish MRSA Reference Lab, NHS Greater Glasgow & Clyde, Glasgow, Scotland; [Foster, Geoffrey] SRUC Vet Serv, Inverness, Scotland; [Paterson, Gavin K.] Univ Edinburgh, Royal Dick Sch Vet Studies, Easter Bush, England; [Paterson, Gavin K.] Univ Edinburgh, Roslin Inst, Easter Bush, England; [Didelot, Xavier] Univ Warwick, Sch Life Sci, Warwick, England; [Didelot, Xavier] Univ Warwick, Dept Stat, Warwick, England; [Harrison, Ewan M.] Wellcome Sanger Inst, Hinxton, England; [Harrison, Ewan M.] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Vandendriessche, Stien] Ghent Univ Hosp, Lab Med Microbiol, Ghent, Belgium; [Walther, Birgit] Robert Koch Inst, Adv Light & Electron Microscopy ZBS 4, Berlin, Germany; [Moroni, Paolo] Cornell Univ, Anim Hlth Diagnost Ctr, Qual Milk Prod Serv, Ithaca, NY USA; [Garcia-Garrote, Fernando] Complejo Asistencial Univ Salamanca, Serv Microbiol, Salamanca, Spain; [Waller, Andrew S.] Intervacc AB, Stockholm, Sweden; [Waller, Andrew S.] Swedish Univ Agr Sci, Dept Biomed Sci & Vet Publ Hlth, Uppsala, Sweden; [Morgan, Fiona J. E.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England	Statens Serum Institut; University of Cambridge; Royal Botanic Gardens, Kew; University of Veterinary Medicine Vienna; Ordensklinikum Linz Elisabethinen; Universite Libre de Bruxelles; Czech University of Life Sciences Prague; Charles University Prague; University of Ostrava; European Centre for Disease Prevention & Control; Statens Serum Institut; Aalborg University; University of Oxford; University of Copenhagen; Technical University of Denmark; Finnish Food Authority; CHU Lyon; CHU Lyon; Friedrich Loeffler Institute; Greifswald Medical School; Free University of Berlin; Justus Liebig University Giessen; Robert Koch Institute; University of Milan; Norwegian Veterinary Institute; Rockefeller University; Hospital Universitario Lucus Augusti-Lugo; National Veterinary Institute SVA; Public Health Agency of Sweden; University of Bern; Animal & Plant Health Agency UK; Animal Health Trust; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; University of Cambridge; St Georges University London; University of St Andrews; University of Edinburgh; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Warwick; University of Warwick; Wellcome Trust Sanger Institute; University of Cambridge; Ghent University; Ghent University Hospital; Robert Koch Institute; Cornell University; Swedish University of Agricultural Sciences; University of Cambridge	Larsen, J (corresponding author), Statens Serum Inst, Dept Bacteria Parasites & Fungi, Copenhagen, Denmark.	jrl@ssi.dk	Sadgrove, Nicholas/CAG-7780-2022; Kehrenberg, Corinna/GSI-9835-2022; Holden, Matthew TG/K-6449-2014; LAURENT, Frederic/AGM-0706-2022; Lindsay, Jodi/ABH-8205-2020; Rasmussen, Sophie Lund/AAS-6739-2020; Harrison, Ewan/I-5003-2013; Padilla-Gonzalez, Guillermo/G-2636-2012	Holden, Matthew TG/0000-0002-4958-2166; Lindsay, Jodi/0000-0002-5219-1625; Rasmussen, Sophie Lund/0000-0002-2975-678X; Stegger, Marc/0000-0003-0321-1180; Petersen, Andreas/0000-0002-6864-0624; Hartl, Rainer/0000-0002-9007-6089; Aarestrup, Frank/0000-0002-7116-2723; Harrison, Ewan/0000-0003-2720-0507; Ba, Xiaoliang/0000-0002-3882-3585; Layer, Franziska/0000-0002-4613-6478; Jorgensen, Hannah Joan/0000-0002-1788-9219; Padilla-Gonzalez, Guillermo/0000-0002-8300-6891; Sieber, Raphael/0000-0002-0372-128X; Sadgrove, Nicholas/0000-0001-7593-1289; Espinosa-Gongora, Carmen/0000-0002-9536-0548; Foster, Geoffrey/0000-0002-5527-758X; Larsen, Jesper/0000-0003-0582-0457	Czech University of Life Sciences Prague [IGA 20213106]; National Institute for Health Research (NIHR) Health Protection Research Unit in Genomics and Enabling Data [NIHR200892]; Medical Research Council [G1001787/1, MR/N002660/1, MR/P007201/1]; Economic and Social Research Council [ES/S000186/1]; UK Research and Innovation (UKRI) Fellowship [MR/S00291X/1]	Czech University of Life Sciences Prague; National Institute for Health Research (NIHR) Health Protection Research Unit in Genomics and Enabling Data; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); UK Research and Innovation (UKRI) Fellowship	We thank M. Ganoti, F. Attila-Zoltan, M. Dugar, Z. Pokorna, D. Madsen, S. M. Gamborg, R. Molina-Lopez, C. Rodrigues, T. Vieira, J. Viricel, A. Fingar, K. South, G. Prince, H. Gasser, S. Sebright, N. Ennew, C. Catchpole, E. Acton, N. Acton, K. Horrey and P. Loague for providing hedgehog samples; A. Medina, L. R. H. Kildevang, P. T. Hansen, and S. M. Johansson for technical assistance during the analysis of hedgehog samples; A. E. Henius for help with Figs. 1, 4 and Extended Data Fig. 8; and V. Bortolaia for reading the manuscript. This work is dedicated to V. R. Simpson, who passed away during the study. B.C.B. was supported by a grant from the Czech University of Life Sciences Prague (no. IGA 20213106). X.D. was funded by a grant from the National Institute for Health Research (NIHR) Health Protection Research Unit in Genomics and Enabling Data (no. NIHR200892). M.A.H. was supported by grants from the Medical Research Council (nos. G1001787/1, MR/N002660/1 and MR/P007201/1) and the Economic and Social Research Council (no. ES/S000186/1). E.M.H. was supported by a UK Research and Innovation (UKRI) Fellowship (no. MR/S00291X/1). We acknowledge Eurostat for the provision of maps, which are licensed under the Creative Commons Attribution 4.0 International (CC BY 4.0) licence, and administrative boundaries, which are copyright of EuroGeographics.	Adusumilli R, 2017, METHODS MOL BIOL, V1550, P339, DOI 10.1007/978-1-4939-6747-6_23; Allen HK, 2009, ISME J, V3, P243, DOI 10.1038/ismej.2008.86; [Anonymous], 2017, GLOBAL PRIORITY LIST; Arndt D, 2016, NUCLEIC ACIDS RES, V44, pW16, DOI 10.1093/nar/gkw387; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bengtsson B, 2017, VET MICROBIOL, V207, P103, DOI 10.1016/j.vetmic.2017.06.004; Bortolaia V, 2020, J ANTIMICROB CHEMOTH, V75, P3491, DOI 10.1093/jac/dkaa345; BROCKIE R E, 1975, New Zealand Journal of Zoology, V2, P445; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Clausen PTLC, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2336-6; Coll F, 2020, LANCET MICROBE, V1, pE328, DOI 10.1016/S2666-5247(20)30149-X; D'Costa VM, 2011, NATURE, V477, P457, DOI 10.1038/nature10388; Danish Integrated Antimicrobial Resistance Monitoring and Research Programme,, 2020, DANMAP 2019 US ANT A; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; Delcher AL, 2002, NUCLEIC ACIDS RES, V30, P2478, DOI 10.1093/nar/30.11.2478; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Didelot X, 2021, MOL BIOL EVOL, V38, P307, DOI 10.1093/molbev/msaa193; Didelot X, 2018, NUCLEIC ACIDS RES, V46, DOI 10.1093/nar/gky783; Didelot X, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004041; Dube F, 2021, BMC MICROBIOL, V21, DOI 10.1186/s12866-021-02260-9; ENGLISH MP, 1962, BRIT MED J, P149, DOI 10.1136/bmj.1.5272.149; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Eriksson J, 2013, VET MICROBIOL, V163, P110, DOI 10.1016/j.vetmic.2012.12.006; European Centre for Disease Prevention and Control European Medicines Agency., 2009, BACT CHALL TIM REACT; Forsberg KJ, 2014, NATURE, V509, P612, DOI 10.1038/nature13377; Forsberg KJ, 2012, SCIENCE, V337, P1107, DOI 10.1126/science.1220761; Garcia-Alvarez L, 2011, LANCET INFECT DIS, V11, P595, DOI 10.1016/S1473-3099(11)70126-8; Gomez P, 2016, J ANTIMICROB CHEMOTH, V71, P53, DOI 10.1093/jac/dkv314; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hansen JE, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02733; Harkins CP, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1252-9; Harrison EM, 2013, EMBO MOL MED, V5, P509, DOI 10.1002/emmm.201202413; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Holden MTG, 2013, GENOME RES, V23, P653, DOI 10.1101/gr.147710.112; JEVONS MP, 1961, BRIT MED J, V1, P124, DOI 10.1136/bmj.1.5219.124-a; Kim C, 2012, J BIOL CHEM, V287, P36854, DOI 10.1074/jbc.M112.395962; KITANO K, 1976, J FERMENT TECHNOL, V54, P705; Kurz S., 2004, GENOME BIOL, V5; Le Barzic C, 2021, J FUNGI, V7, DOI 10.3390/jof7020074; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Loncaric I, 2019, VET MICROBIOL, V230, P138, DOI 10.1016/j.vetmic.2019.02.014; MARPLES MJ, 1960, NATURE, V188, P867, DOI 10.1038/188867b0; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Morris P, 1969, Sabouraudia, V7, P122; Nubel U, 2008, P NATL ACAD SCI USA, V105, P14130, DOI 10.1073/pnas.0804178105; Pantucek R, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.01746-17; Paterson GK, 2014, TRENDS MICROBIOL, V22, P42, DOI 10.1016/j.tim.2013.11.003; Petersen A, 2013, CLIN MICROBIOL INFEC, V19, pE16, DOI 10.1111/1469-0691.12036; Plummer M., 2006, R NEWS, V6, P7, DOI DOI 10.1159/000323281; Price LB, 2012, MBIO, V3, DOI 10.1128/mBio.00305-11; Rasmussen SL, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227205; Rasmussen SL, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222031; Richardson EJ, 2018, NAT ECOL EVOL, V2, P1468, DOI 10.1038/s41559-018-0617-0; Rooijakkers SHM, 2007, J IMMUNOL, V179, P2989, DOI 10.4049/jimmunol.179.5.2989; Sahl JW, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000074; SMITH JMB, 1965, J HYG-CAMB, V63, P285, DOI 10.1017/S0022172400045162; SMITH JMB, 1964, NATURE, V201, P844, DOI 10.1038/201844a0; SMITH JMB, 1965, J HYG-CAMB, V63, P293, DOI 10.1017/S0022172400045174; Strauss L, 2017, P NATL ACAD SCI USA, V114, pE10596, DOI 10.1073/pnas.1702472114; Tahlan K, 2013, J ANTIBIOT, V66, P401, DOI 10.1038/ja.2013.24; Ullan RV, 2007, CHEM BIOL, V14, P329, DOI 10.1016/j.chembiol.2007.01.012; van den Berg MA, 2008, NAT BIOTECHNOL, V26, P1161, DOI 10.1038/nbt.1498; van Wamel WJB, 2006, J BACTERIOL, V188, P1310, DOI 10.1128/JB.188.4.1310-1315.2006; Veterinary Medicines Directorate,, 2020, UK VET ANT RES SAL S; Viana D, 2010, MOL MICROBIOL, V77, P1583, DOI 10.1111/j.1365-2958.2010.07312.x; Volz EM, 2017, VIRUS EVOL, V3, DOI 10.1093/ve/vex025; Wang MX, 2016, NAT BIOTECHNOL, V34, P828, DOI 10.1038/nbt.3597	68	36	36	80	240	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 3	2022	602	7895					135	+		10.1038/s41586-021-04265-w	http://dx.doi.org/10.1038/s41586-021-04265-w		JAN 2022	28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YS1FH	34987223	Green Published, Green Accepted, hybrid, Green Submitted			2022-12-28	WOS:000739283800005
J	Shepherd, A				Shepherd, Alison			Vaccines wasted as Africa waits	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 5	2022	376								n3163	10.1136/bmj.n3163	http://dx.doi.org/10.1136/bmj.n3163			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YI8XS	34987049	Bronze			2022-12-28	WOS:000744126400007
J	Nagpaul, C				Nagpaul, Chaand			2022-the year of recovery?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 4	2022	376								o2	10.1136/bmj.o2	http://dx.doi.org/10.1136/bmj.o2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YD7MV	34983815	Bronze			2022-12-28	WOS:000740622800009
J	Kamoi, K; Uchimaru, K; Tojo, A; Watanabe, T; Ohno-Matsui, K				Kamoi, Koju; Uchimaru, Kaoru; Tojo, Arinobu; Watanabe, Toshiki; Ohno-Matsui, Kyoko			HTLV-1 uveitis and Graves' disease presenting with sudden onset of blurred vision	LANCET			English	Editorial Material									[Kamoi, Koju; Ohno-Matsui, Kyoko] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Ophthalmol & Visual Sci, Tokyo 1138519, Japan; [Kamoi, Koju; Uchimaru, Kaoru; Tojo, Arinobu; Watanabe, Toshiki] Univ Tokyo, Res Hosp, Inst Med Sci, Dept Haematol & Oncol, Tokyo, Japan; [Uchimaru, Kaoru] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Lab Tumour Cell Biol, Tokyo, Japan; [Watanabe, Toshiki] St Marianna Univ, Dept Pract Management Med Informat, Grad Sch Med, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); University of Tokyo; University of Tokyo; Saint Marianna University	Kamoi, K (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Ophthalmol & Visual Sci, Tokyo 1138519, Japan.	koju.oph@tmd.ac.jp							0	3	3	7	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 1	2022	399	10319					60	60						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YA3YW	34973718				2022-12-28	WOS:000738273800021
J	Marchalik, D; Melnick, E				Marchalik, Daniel; Melnick, Edward			Do Androids Dream of Electric Sheep?	LANCET			English	Book Review									[Marchalik, Daniel] Georgetown Univ, Sch Med, Off Phys Wellbeing & Literature & Med Track, Washington, DC 20007 USA; [Melnick, Edward] Yale Sch Med, Dept Emergency Med, New Haven, CT USA	Georgetown University; Yale University	Marchalik, D (corresponding author), Georgetown Univ, Sch Med, Off Phys Wellbeing & Literature & Med Track, Washington, DC 20007 USA.	dan.marchalik@gmail.com						DICK PK, DO ANDROIDS DREAM EL	1	0	0	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN	2022	399	10321					231	231						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YL7AZ	35033216				2022-12-28	WOS:000746041700013
J	Boulware, LE; Corbie, G; Aguilar-Gaxiola, S; Wilkins, CH; Ruiz, R; Vitale, A; Egede, LE				Boulware, L. Ebony; Corbie, Giselle; Aguilar-Gaxiola, Sergio; Wilkins, Consuelo H.; Ruiz, Raquel; Vitale, Alfred; Egede, Leonard E.			Combating Structural Inequities - Diversity, Equity, and Inclusion in Clinical and Translational Research	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Y	[Boulware, L. Ebony] Duke Univ, Sch Med, Durham, NC 27706 USA; [Corbie, Giselle] Univ N Carolina, Sch Med, Chapel Hill, NC USA; [Aguilar-Gaxiola, Sergio] North Carolina Univ Davis, Sch Med, Sacramento, CA USA; [Wilkins, Consuelo H.] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Ruiz, Raquel; Vitale, Alfred] Univ Rochester, Med Ctr, Rochester, NY 14642 USA; [Egede, Leonard E.] Med Coll Wisconsin, Milwaukee, WI 53226 USA	Duke University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Vanderbilt University; University of Rochester; Medical College of Wisconsin	Boulware, LE (corresponding author), Duke Univ, Sch Med, Durham, NC 27706 USA.			Ruiz, Raquel/0000-0003-2275-0059; Vitale, Alfred/0000-0001-9675-3573				Anderson, 2015, RACE GAP SCI KNOWLED; Andriole DA, 2017, ACAD MED, V92, P1440, DOI 10.1097/ACM.0000000000001871; Association of American Medical Colleges, 2020, 2020 US MED SCH FAC; Association of American Medical Colleges, 2021, DIVERSITY INCLUSION; Knepper TC, 2018, NATURE, V557, P157, DOI 10.1038/d41586-018-05049-5	5	14	14	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 20	2022	386	3					201	203		10.1056/NEJMp2112233	http://dx.doi.org/10.1056/NEJMp2112233		JAN 2022	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YK1UG	35029847				2022-12-28	WOS:000742767900001
J	Fricke, EC; Ordonez, A; Rogers, HS; Svenning, JC				Fricke, Evan C.; Ordonez, Alejandro; Rogers, Haldre S.; Svenning, Jens-Christian			The effects of defaunation on plants' capacity to track climate change	SCIENCE			English	Article							ENDOZOOCHOROUS SEED DISPERSAL; DISTANCE; NETWORKS; PATTERNS; SHADOW; MIGRATION; FRAMEWORK; DEER	Half of all plant species rely on animals to disperse their seeds. Seed dispersal interactions lost through defaunation and gained during novel community assembly influence whether plants can adapt to climate change through migration. We develop trait-based models to predict pairwise interactions and dispersal function for fleshy-fruited plants globally. Using interactions with introduced species as an observable proxy for interactions in future novel seed dispersal networks, we find strong potential to forecast their assembly and functioning. We conservatively estimate that mammal and bird defaunation has already reduced the capacity of plants to track climate change by 60% globally. This strong reduction in the ability of plants to adapt to climate change through range shifts shows a synergy between defaunation and climate change that undermines vegetation resilience.	[Fricke, Evan C.] Univ Maryland, Natl Socioenvironm Synth Ctr, Annapolis, MD 21401 USA; [Fricke, Evan C.] Rice Univ, Dept BioSci, Houston, TX 77005 USA; [Ordonez, Alejandro; Svenning, Jens-Christian] Aarhus Univ, Ctr Biodivers Dynam Changing World BIOCHANGE, Dept Biol, Ny Munkegade 114, DK-8000 Aarhus C, Denmark; [Rogers, Haldre S.] Iowa State Univ, Dept Ecol & Evolutionary Biol, Ames, IA 50011 USA	Rice University; Aarhus University; Iowa State University	Fricke, EC (corresponding author), Univ Maryland, Natl Socioenvironm Synth Ctr, Annapolis, MD 21401 USA.; Fricke, EC (corresponding author), Rice Univ, Dept BioSci, Houston, TX 77005 USA.	evancfricke@gmail.com	; Svenning, Jens-Christian/C-8977-2012; Ordonez, Alejandro/I-7950-2013	Rogers, Haldre/0000-0003-4763-5006; Svenning, Jens-Christian/0000-0002-3415-0862; Ordonez, Alejandro/0000-0003-2873-4551; Fricke, Evan/0000-0002-0520-4200	National SocioEnvironmental Synthesis Center postdoctoral fellowship under National Science Foundation [DBI-1639145]; VILLUM Investigator project "Biodiversity Dynamics in a Changing World" - VILLUM FONDEN grant [16549]; AUFF starting grant [AUFF-F-2018-7-8]	National SocioEnvironmental Synthesis Center postdoctoral fellowship under National Science Foundation; VILLUM Investigator project "Biodiversity Dynamics in a Changing World" - VILLUM FONDEN grant; AUFF starting grant	This work was supported by a National SocioEnvironmental Synthesis Center postdoctoral fellowship under funding from the National Science Foundation award number DBI-1639145 to E.C.F., the VILLUM Investigator project "Biodiversity Dynamics in a Changing World", funded by VILLUM FONDEN grant 16549 to J.-C.S., and an AUFF starting grant number AUFF-F-2018-7-8 to A.O.	Abedi-Lartey M, 2016, GLOB ECOL CONSERV, V7, P12, DOI 10.1016/j.gecco.2016.03.005; Alexander JM, 2018, GLOBAL CHANGE BIOL, V24, P563, DOI 10.1111/gcb.13976; Andermann T, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abb2313; Anderson JT, 2011, P ROY SOC B-BIOL SCI, V278, P3329, DOI 10.1098/rspb.2011.0155; Baldwin JW, 2020, ECOLOGY, V101, DOI 10.1002/ecy.2937; Bartomeus I, 2016, FUNCT ECOL, V30, P1894, DOI 10.1111/1365-2435.12666; Bender IMA, 2018, ECOGRAPHY, V41, P1910, DOI 10.1111/ecog.03396; Berti E, 2020, GLOBAL ECOL BIOGEOGR, V29, P2131, DOI 10.1111/geb.13182; Brose U, 2019, NAT ECOL EVOL, V3, P919, DOI 10.1038/s41559-019-0899-x; Bruggeman J, 2009, NUCLEIC ACIDS RES, V37, pW179, DOI 10.1093/nar/gkp370; Bullock JM, 2017, J ECOL, V105, P6, DOI 10.1111/1365-2745.12666; Bunney K, 2017, BIOTROPICA, V49, P395, DOI 10.1111/btp.12423; Campos-Arceiz A, 2012, BIOTROPICA, V44, P220, DOI 10.1111/j.1744-7429.2011.00784.x; Carpenter JK, 2019, ROY SOC OPEN SCI, V6, DOI 10.1098/rsos.190397; Chen SC, 2019, ECOL LETT, V22, P954, DOI 10.1111/ele.13255; Cooke RSC, 2019, GLOBAL ECOL BIOGEOGR, V28, P484, DOI 10.1111/geb.12869; CORLETT RT, 1994, J TROP ECOL, V10, P445, DOI 10.1017/S0266467400008129; Dinerstein E, 2017, BIOSCIENCE, V67, P534, DOI 10.1093/biosci/bix014; Donoso I, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2016.2664; Doughty CE, 2016, ECOGRAPHY, V39, P194, DOI 10.1111/ecog.01587; Duncan RP, 2013, P NATL ACAD SCI USA, V110, P6436, DOI 10.1073/pnas.1216511110; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Falcon W, 2020, BIOL REV, V95, P142, DOI 10.1111/brv.12558; Faurby S, 2018, ECOLOGY, V99, P2626, DOI 10.1002/ecy.2443; Franco LM, 2019, REV CHIL HIST NAT, V92, DOI 10.1186/s40693-019-0088-y; Fricke E. C., 2021, **DATA OBJECT**, DOI 10.5281/zenodo.5565123; Fricke EC, 2020, NATURE, V585, P74, DOI 10.1038/s41586-020-2640-y; Gelmi-Candusso TA, 2019, ECOL EVOL, V9, P8965, DOI 10.1002/ece3.5422; Gilman SE, 2010, TRENDS ECOL EVOL, V25, P325, DOI 10.1016/j.tree.2010.03.002; Gonzalez-Varo JP, 2021, NATURE, V595, P75, DOI 10.1038/s41586-021-03665-2; Greenwell B., 2020, Gbm: Generalized Boosted Regression Models. R Package Version, 2.1.8; Harvey E, 2017, J APPL ECOL, V54, P371, DOI 10.1111/1365-2664.12769; Hickey JR, 1999, OIKOS, V87, P499, DOI 10.2307/3546814; Hirt MR, 2018, TRENDS ECOL EVOL, V33, P701, DOI 10.1016/j.tree.2018.07.003; HUNTLEY B, 1989, J BIOGEOGR, V16, P5, DOI 10.2307/2845307; JANZEN DH, 1982, SCIENCE, V215, P19, DOI 10.1126/science.215.4528.19; Jordano P, 2016, FUNCT ECOL, V30, P1883, DOI 10.1111/1365-2435.12763; Jordano P, 2014, SEEDS: THE ECOLOGY OF REGENERATION IN PLANT COMMUNITIES, 3RD EDITION, P18, DOI 10.1079/9781780641836.0018; Kattge J, 2020, GLOBAL CHANGE BIOL, V26, P119, DOI 10.1111/gcb.14904; Koike S, 2011, OIKOS, V120, P280, DOI 10.1111/j.1600-0706.2010.18626.x; Laliberte E., 2014, FD MEASURING FUNCTIO; Laliberte E, 2010, ECOLOGY, V91, P299, DOI 10.1890/08-2244.1; Lehouck V, 2009, J VEG SCI, V20, P1110, DOI 10.1111/j.1654-1103.2009.01109.x; Lenz J, 2011, P ROY SOC B-BIOL SCI, V278, P2257, DOI 10.1098/rspb.2010.2383; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004; McConkey KR, 2007, J TROP ECOL, V23, P269, DOI 10.1017/S0266467407003999; McConkey KR, 2012, BIOL CONSERV, V146, P1, DOI 10.1016/j.biocon.2011.09.018; McGuire JL, 2016, P NATL ACAD SCI USA, V113, P7195, DOI 10.1073/pnas.1602817113; Mise Y, 2016, ECOL RES, V31, P881, DOI 10.1007/s11284-016-1397-0; Mokany K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4971; Morales-Castilla I, 2015, TRENDS ECOL EVOL, V30, P347, DOI 10.1016/j.tree.2015.03.014; Nakabayashi M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217590; Nakamoto A, 2009, ECOL RES, V24, P405, DOI 10.1007/s11284-008-0516-y; Nakashima Y, 2009, TROPICS, V18, P221; Naniwadekar R, 2019, ACTA OECOL, V101, DOI 10.1016/j.actao.2019.103482; Nield AP, 2019, POPUL ECOL, V61, P333, DOI 10.1002/1438-390X.12006; O'Connor S. J., 2006, THESIS; Ordonez A, 2016, NAT CLIM CHANGE, V6, P1104, DOI [10.1038/nclimate3127, 10.1038/NCLIMATE3127]; Pearse IS, 2013, ECOL LETT, V16, P1088, DOI 10.1111/ele.12143; Pellerin M, 2016, BASIC APPL ECOL, V17, P321, DOI 10.1016/j.baae.2016.01.005; Phiphatsuwannachai S, 2018, BIOTROPICA, V50, P106, DOI 10.1111/btp.12499; Pichler M, 2020, METHODS ECOL EVOL, V11, P281, DOI 10.1111/2041-210X.13329; Pires MM, 2018, ECOGRAPHY, V41, P153, DOI 10.1111/ecog.03163; Razafindratsima OH, 2014, AM J PRIMATOL, V76, P84, DOI 10.1002/ajp.22199; Rehm E, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2018.2007; Ripple WJ, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400103; Rogers H. S., 2021, 462022 BIORXIV, DOI 10.12.462022; Rogers HS, 2021, ANNU REV ECOL EVOL S, V52, P641, DOI 10.1146/annurev-ecolsys-012221-111742; Rojas-Nossa SV, 2016, OIKOS, V125, P1044, DOI 10.1111/oik.02685; Sato H, 2018, INT J PRIMATOL, V39, P377, DOI 10.1007/s10764-018-0057-3; Schleuning M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13965; Schurr F. M., 2018, LONG DISTANCE SEED D, V38, P204; Schurr FM, 2010, ANNU PLANT REV, V38, P204, DOI 10.1002/9781444314557.ch6; Sekar N, 2015, ECOLOGY, V96, P2093, DOI 10.1890/14-1543.1; Sinnott-Armstrong MA, 2021, ECOL LETT, V24, P1387, DOI 10.1111/ele.13753; Steyaert Sam M. J. G., 2009, Ekologia (Bratislava), V28, P191, DOI 10.4149/ekol_2009_02_191; Sun C, 1997, OECOLOGIA, V112, P94, DOI 10.1007/s004420050288; Thibault M, 2018, ECOL EVOL, V8, P9259, DOI 10.1002/ece3.4140; Tori WP, 2016, ORNITOL NEOTROP, V27, P145; Tsuji Y, 2016, ZOOL SCI, V33, P352, DOI 10.2108/zs160017; Tsuji Y, 2016, AM J PRIMATOL, V78, P185, DOI 10.1002/ajp.22490; Tucker MA, 2018, SCIENCE, V359, P466, DOI 10.1126/science.aam9712; Urban MC, 2016, SCIENCE, V353, P1113, DOI 10.1126/science.aad8466; Valido A, 2019, FRONT ECOL EVOL, V7, DOI 10.3389/fevo.2019.00049; Vazquez DP, 2009, ANN BOT-LONDON, V103, P1445, DOI 10.1093/aob/mcp057; Vellend M, 2003, ECOLOGY, V84, P1067, DOI 10.1890/0012-9658(2003)084[1067:DOTSBD]2.0.CO;2; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; Wehncke EV, 2003, J ECOL, V91, P677, DOI 10.1046/j.1365-2745.2003.00798.x; Yoshikawa T, 2019, OIKOS, V128, P836, DOI 10.1111/oik.05827	90	29	29	46	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2022	375	6577					210	+		10.1126/science.abk3510	http://dx.doi.org/10.1126/science.abk3510			51	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YG3OI	35025640				2022-12-28	WOS:000742401600036
J	Yang, Y; Arseni, D; Zhang, WJ; Huang, M; Lovestam, S; Schweighauser, M; Kotecha, A; Murzin, AG; Peak-Chew, SY; Macdonald, J; Lavenir, I; Garringer, HJ; Gelpi, E; Newell, KL; Kovacs, GG; Vidal, R; Ghetti, B; Ryskeldi-Falcon, B; Scheres, SHW; Goedert, M				Yang, Yang; Arseni, Diana; Zhang, Wenjuan; Huang, Melissa; Lovestam, Sofia; Schweighauser, Manuel; Kotecha, Abhay; Murzin, Alexey G.; Peak-Chew, Sew Y.; Macdonald, Jennifer; Lavenir, Isabelle; Garringer, Holly J.; Gelpi, Ellen; Newell, Kathy L.; Kovacs, Gabor G.; Vidal, Ruben; Ghetti, Bernardino; Ryskeldi-Falcon, Benjamin; Scheres, Sjors H. W.; Goedert, Michel			Cryo-EM structures of amyloid-b 42 filaments from human brains	SCIENCE			English	Review							ATOMIC-RESOLUTION STRUCTURE; PAIRED HELICAL FILAMENTS; BEAM-INDUCED MOTION; ALZHEIMERS-DISEASE; A-BETA; FIBRIL STRUCTURE; SENILE PLAQUES; TAU-PROTEINS; TRANSMISSION; REFINEMENT	Filament assembly of amyloid-b peptides ending at residue 42 (A beta 42) is a central event in Alzheimer's disease. Here, we report the cryo-electron microscopy (cryo-EM) structures of A beta 42 filaments from human brains. Two structurally related S-shaped protofilament folds give rise to two types of filaments. Type I filaments were found mostly in the brains of individuals with sporadic Alzheimer's disease, and type II filaments were found in individuals with familial Alzheimer's disease and other conditions. The structures of A beta 42 filaments from the brain differ from those of filaments assembled in vitro. By contrast, in App(NL-F) knock-in mice, A beta 42 deposits were made of type II filaments. Knowledge of A beta 42 filament structures from human brains may lead to the development of inhibitors of assembly and improved imaging agents.	[Yang, Yang; Arseni, Diana; Zhang, Wenjuan; Huang, Melissa; Lovestam, Sofia; Kotecha, Abhay; Murzin, Alexey G.; Peak-Chew, Sew Y.; Macdonald, Jennifer; Lavenir, Isabelle; Ryskeldi-Falcon, Benjamin; Scheres, Sjors H. W.; Goedert, Michel] MRC, Lab Mol Biol, Cambridge, England; [Schweighauser, Manuel] Thermo Fisher Sci, Eindhoven, Netherlands; [Garringer, Holly J.; Newell, Kathy L.; Vidal, Ruben; Ghetti, Bernardino] Indiana Univ, Dept Pathol & Lab Med, Indianapolis, IN 46204 USA; [Gelpi, Ellen; Kovacs, Gabor G.] Med Univ, Inst Neurol, Vienna, Austria; [Kovacs, Gabor G.] Univ Toronto, Tanz Ctr, Toronto, ON, Canada; [Kovacs, Gabor G.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Zhang, Wenjuan] UCL, Inst Prion Dis, MRC, Prion Unit, London, England	MRC Laboratory Molecular Biology; Thermo Fisher Scientific; Indiana University System; Indiana University-Purdue University Indianapolis; University of Toronto; University of Toronto; University of London; University College London	Ryskeldi-Falcon, B; Scheres, SHW; Goedert, M (corresponding author), MRC, Lab Mol Biol, Cambridge, England.; Ghetti, B (corresponding author), Indiana Univ, Dept Pathol & Lab Med, Indianapolis, IN 46204 USA.	bghetti@iupui.edu; btalcon@mrc-lmb.cam.ac.uk; scheres@mrc-lmb.cam.ac.uk; mg@mrc-lmb.cam.ac.uk	Kovacs, Gabor/A-7468-2013	Kovacs, Gabor/0000-0003-3841-5511; Lovestam, Sofia/0000-0002-2152-1476; Zhang, Wenjuan/0000-0002-3011-9956; Kotecha, Abhay/0000-0002-4480-5439; Ryskeldi-Falcon, Benjamin/0000-0002-8176-2618; Arseni, Diana/0000-0001-7585-288X; Yang, Yang/0000-0003-2238-6437; Huang, Melissa/0000-0002-0698-6996	UK Medical Research Council [MC_UP_1201/25, MC_UP_A025_1013, MC_U105184291]; Alzheimer's Research UK [ARUK-RS2019-001]; Rainwater Charitable Foundation; US National Institutes of Health [P30-AG010133, UO1-NS110437, RF1AG071177]; Department of Pathology and Laboratory Medicine, Indiana University School of Medicine; Safra Foundation; Rossy Foundation	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); Rainwater Charitable Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Pathology and Laboratory Medicine, Indiana University School of Medicine; Safra Foundation; Rossy Foundation	This work was supported by the UK Medical Research Council (MC_UP_1201/25, to B.R.-F.; MC_UP_A025_1013, to S.H.W.S.; and MC_U105184291, to M.G.); Alzheimer's Research UK (ARUK-RS2019-001, to B.R.-F.); the Rainwater Charitable Foundation (to M.G.); the US National Institutes of Health (P30-AG010133, UO1-NS110437, and RF1AG071177, to B.G. and R.V.); and the Department of Pathology and Laboratory Medicine, Indiana University School of Medicine (to B.G., K.L.N., and R.V.). W.Z. was supported by a foundation that prefers to remain anonymous. G.G.K. was supported by the Safra Foundation and the Rossy Foundation.	Afonine PV, 2018, ACTA CRYSTALLOGR D, V74, P531, DOI 10.1107/S2059798318006551; [Anonymous], [No title captured], DOI 10.5281/zenodo.4090925; Attems J, 2005, ACTA NEUROPATHOL, V110, P222, DOI 10.1007/s00401-005-1064-y; Brown A, 2015, ACTA CRYSTALLOGR D, V71, P136, DOI 10.1107/S1399004714021683; Casanal A, 2020, PROTEIN SCI, V29, P1069, DOI 10.1002/pro.3791; Chen CD, 2021, ACTA NEUROPATHOL, V142, P689, DOI 10.1007/s00401-021-02342-y; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; CITRON M, 1994, P NATL ACAD SCI USA, V91, P11993, DOI 10.1073/pnas.91.25.11993; Colvin MT, 2016, J AM CHEM SOC, V138, P9663, DOI 10.1021/jacs.6b05129; de la Vega MP, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abc6184; Falcon B, 2018, ACTA NEUROPATHOL, V136, P699, DOI 10.1007/s00401-018-1914-z; Farlow JL, 2016, JAMA NEUROL, V73, P68, DOI 10.1001/jamaneurol.2015.3266; Fitzpatrick AWP, 2017, NATURE, V547, P185, DOI 10.1038/nature23002; Frontzek K, 2016, SWISS MED WKLY, V146, DOI 10.4414/smw.2016.14287; Ghosh U, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2023089118; GOEDERT M, 1992, NEURON, V8, P159, DOI 10.1016/0896-6273(92)90117-V; GREENBERG SG, 1990, P NATL ACAD SCI USA, V87, P5827, DOI 10.1073/pnas.87.15.5827; Gremer L, 2017, SCIENCE, V358, P116, DOI 10.1126/science.aao2825; Guardia-Laguarta C, 2010, J NEUROPATH EXP NEUR, V69, P53, DOI 10.1097/NEN.0b013e3181c6b84d; Guntert A, 2006, NEUROSCIENCE, V143, P461, DOI 10.1016/j.neuroscience.2006.08.027; Haass C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006270; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; He SD, 2017, J STRUCT BIOL, V198, P163, DOI 10.1016/j.jsb.2017.02.003; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Jaunmuktane Z, 2018, ACTA NEUROPATHOL, V135, P671, DOI 10.1007/s00401-018-1822-2; Jaunmuktane Z, 2015, NATURE, V525, P247, DOI 10.1038/nature15369; Kakuda N, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0477-x; Klotz S, 2021, NEUROPATHOLOGY, V41, P72, DOI 10.1111/neup.12708; Kollmer M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12683-8; Lau HHC, 2021, ACTA NEUROPATHOL, V142, P17, DOI 10.1007/s00401-020-02201-2; Lichtenthaler SF, 2002, P NATL ACAD SCI USA, V99, P1365, DOI 10.1073/pnas.032395699; Long JM, 2019, CELL, V179, P312, DOI 10.1016/j.cell.2019.09.001; Lovestam S, 2021, FEBS OPEN BIO, V11, P999, DOI 10.1002/2211-5463.13110; Lu JX, 2013, CELL, V154, P1257, DOI 10.1016/j.cell.2013.08.035; Maarouf CL, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-20; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Murray ME, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt254; MURRELL J, 1991, SCIENCE, V254, P97, DOI 10.1126/science.1925564; Nakane T, 2020, ZENODO; Nakane T., 2020, atom2svg, version 200213, DOI 10.5281/zenodo.4090925; NASLUND J, 1994, P NATL ACAD SCI USA, V91, P8378, DOI 10.1073/pnas.91.18.8378; Pettersen EF, 2021, PROTEIN SCI, V30, P70, DOI 10.1002/pro.3943; Rasmussen J, 2017, P NATL ACAD SCI USA, V114, P13018, DOI 10.1073/pnas.1713215114; Sawaya MR, 2021, CELL, V184, P4857, DOI 10.1016/j.cell.2021.08.013; Scheres SHW, 2020, ACTA CRYSTALLOGR D, V76, P94, DOI 10.1107/S2059798319016577; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Schutz AK, 2015, ANGEW CHEM INT EDIT, V54, P331, DOI 10.1002/anie.201408598; Schweighauser M, 2020, NATURE, V585, P464, DOI 10.1038/s41586-020-2317-6; Shi Y, 2021, NATURE, V598, P359, DOI 10.1038/s41586-021-03911-7; Spina S, 2008, BRAIN, V131, P72, DOI 10.1093/brain/awm280; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; Tarutani A, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0532-2; Thal DR, 2015, ACTA NEUROPATHOL, V129, P167, DOI 10.1007/s00401-014-1375-y; Thal DR, 2002, NEUROLOGY, V58, P1791, DOI 10.1212/WNL.58.12.1791; Vassar R, 2014, J NEUROCHEM, V130, P4, DOI 10.1111/jnc.12715; Walti MA, 2016, P NATL ACAD SCI USA, V113, pE4976, DOI 10.1073/pnas.1600749113; Warmack RA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11183-z; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Xiao YL, 2015, NAT STRUCT MOL BIOL, V22, P499, DOI 10.1038/nsmb.2991; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zhang WJ, 2019, ELIFE, V8, DOI 10.7554/eLife.43584; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zivanov J, 2020, IUCRJ, V7, P253, DOI 10.1107/S2052252520000081; Zivanov J, 2019, IUCRJ, V6, P5, DOI 10.1107/S205225251801463X; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	67	56	55	57	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2022	375	6577					167	+		10.1126/science.abm7285	http://dx.doi.org/10.1126/science.abm7285			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YG3OI	35025654	Green Submitted, Green Accepted			2022-12-28	WOS:000742401600028
J	Marblestone, A; Gamick, A; Kalil, T; Martin, C; Cvitkovic, M; Rodrigues, SG				Marblestone, Adam; Gamick, Anastasia; Kalil, Tom; Martin, Cheryl; Cvitkovic, Milan; Rodrigues, Samuel G.			Unblock research bottlenecks with non-profit start-ups	NATURE			English	Editorial Material						Research management; Institutions			[Marblestone, Adam; Gamick, Anastasia] Astera Inst, Berkeley, CA 94705 USA; [Kalil, Tom] Schmidt Futures, New York, NY USA; [Martin, Cheryl] Harwich Partners, Harwich, MA USA; [Cvitkovic, Milan] Convergent Res, Arlington, MA USA; [Rodrigues, Samuel G.] Francis Crick Inst, Appl Biotechnol Lab, London, England	Francis Crick Institute	Marblestone, A (corresponding author), Astera Inst, Berkeley, CA 94705 USA.	adam@convergentresearch.org; sam.rodriques@crick.ac.uk						Collins FS, 2021, SCIENCE, V373, P165, DOI 10.1126/science.abj8547; Dugan RE, 2013, HARVARD BUS REV, V91, P74; Prabhakar A., 2021, UNLOCK POTENTIAL ADV; Rubin GM, 2019, ELIFE, V8, DOI 10.7554/eLife.44826	4	3	3	0	0	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 13	2022	601	7892					188	190		10.1038/d41586-022-00018-5	http://dx.doi.org/10.1038/d41586-022-00018-5			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YE9KY	35017702				2022-12-28	WOS:000741438200016
J	de Latour, RP; Kulasekararaj, A; Iacobelli, S; Terwel, SR; Cook, R; Griffin, M; Halkes, CJM; Recher, C; Barraco, F; Forcade, E; Vallejo, JC; Drexler, B; Mear, JB; Smith, AE; Angelucci, E; Raymakers, RAP; de Groot, MR; Daguindau, E; Nur, E; Barcellini, W; Russell, NH; Terriou, L; Iori, AP; La Rocca, U; Sureda, A; Sanchez-Ortega, I; Xicoy, B; Jarque, I; Cavenagh, J; de Fontbrune, FS; Marotta, S; Munir, T; Tjon, JML; Tavitian, S; Praire, A; Clement, L; Rabian, F; Marano, L; Hill, A; Palmisani, E; Muus, P; Cacace, F; Frieri, C; Van Lint, MT; Passweg, JR; Marsh, JCW; Socie, G; Mufti, GJ; Dufour, C; Risitano, AM				de Latour, R. Peffault; Kulasekararaj, A.; Iacobelli, S.; Terwel, S. R.; Cook, R.; Griffin, M.; Halkes, C. J. M.; Recher, C.; Barraco, F.; Forcade, E.; Vallejo, J-C; Drexler, B.; Mear, J-B; Smith, A. E.; Angelucci, E.; Raymakers, R. A. P.; de Groot, M. R.; Daguindau, E.; Nur, E.; Barcellini, W.; Russell, N. H.; Terriou, L.; Iori, A-P; La Rocca, U.; Sureda, A.; Sanchez-Ortega, I; Xicoy, B.; Jarque, I; Cavenagh, J.; de Fontbrune, F. Sicre; Marotta, S.; Munir, T.; Tjon, J. M. L.; Tavitian, S.; Praire, A.; Clement, L.; Rabian, F.; Marano, L.; Hill, A.; Palmisani, E.; Muus, P.; Cacace, F.; Frieri, C.; Van Lint, M-T; Passweg, J. R.; Marsh, J. C. W.; Socie, G.; Mufti, G. J.; Dufour, C.; Risitano, A. M.		European Soc Blood Marrow Transpla	Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ANTITHYMOCYTE GLOBULIN; SOMATIC MUTATIONS; ANTILYMPHOCYTE GLOBULIN; DOSE CYCLOPHOSPHAMIDE; CYCLOSPORINE; HEMATOPOIESIS; THERAPY; HORSE	BACKGROUND A single-group, phase 1-2 study indicated that eltrombopag improved the efficacy of standard immunosuppressive therapy that entailed horse antithymocyte globulin (ATG) plus cyclosporine in patients with severe aplastic anemia. METHODS In this prospective, investigator-led, open-label, multicenter, randomized, phase 3 trial, we compared the efficacy and safety of horse ATG plus cyclosporine with or without eltrombopag as front-line therapy in previously untreated patients with severe aplastic anemia. The primary end point was a hematologic complete response at 3 months. RESULTS Patients were assigned to receive immunosuppressive therapy (Group A, 101 patients) or immunosuppressive therapy plus eltrombopag (Group B, 96 patients). The percentage of patients who had a complete response at 3 months was 10% in Group A and 22% in Group B (odds ratio, 3.2; 95% confidence interval [CI], 1.3 to 7.8; P=0.01). At 6 months, the overall response rate (the percentage of patients who had a complete or partial response) was 41% in Group A and 68% in Group B. The median times to the first response were 8.8 months (Group A) and 3.0 months (Group B). The incidence of severe adverse events was similar in the two groups. With a median follow-up of 24 months, a karyotypic abnormality that was classified as myelodysplastic syndrome developed in 1 patient (Group A) and 2 patients (Group B); event-free survival was 34% and 46%, respectively. Somatic mutations were detected in 29% (Group A) and 31% (Group B) of the patients at baseline; these percentages increased to 66% and 55%, respectively, at 6 months, without affecting the hematologic response and 2-year outcome. CONCLUSIONS The addition of eltrombopag to standard immunosuppressive therapy improved the rate, rapidity, and strength of hematologic response among previously untreated patients with severe aplastic anemia, without additional toxic effects.	[de Latour, R. Peffault; de Fontbrune, F. Sicre; Frieri, C.; Socie, G.] St Louis Hosp, French Reference Ctr Aplast Anemia & Paroxysmal N, Paris, France; [de Latour, R. Peffault; de Fontbrune, F. Sicre; Frieri, C.; Socie, G.] Univ Paris, Paris, France; [Rabian, F.] St Louis Hosp, Adolescent & Young Adult Hematol Unit, Paris, France; [Recher, C.; Tavitian, S.] CHU Toulouse, Inst Univ Canc Toulouse Oncopole, Hematol Dept, Toulouse, France; [Barraco, F.; Praire, A.] Ctr Hosp Univ Lyon Sud, Lyon, France; [Forcade, E.; Clement, L.] CHU Bordeaux, Hop Haut Leveque, Pessac, France; [Mear, J-B] Rennes Univ Hosp, Dept Clin Hematol, Rennes, France; [Daguindau, E.] Hop Jean Minjoz, Serv Hematol, Besancon, France; [Terriou, L.] Hop Claude Huriez, Lille, France; [de Latour, R. Peffault; Kulasekararaj, A.; Iacobelli, S.; Terwel, S. R.; Sanchez-Ortega, I; Frieri, C.; Dufour, C.; Risitano, A. M.] European Soc Blood & Marrow Transplantat, Clin Study Unit, Leiden, Netherlands; [Halkes, C. J. M.; Tjon, J. M. L.] Leiden Univ, Dept Hematol, Med Ctr, Leiden, Netherlands; [Raymakers, R. A. P.] Univ Med Ctr Utrecht, Dept Hematol, Utrecht, Netherlands; [de Groot, M. R.] Univ Med Ctr Groningen, Dept Hematol, Groningen, Netherlands; [Nur, E.] Univ Amsterdam, Acad Med Ctr, Dept Clin Hematol, Med Ctr, Amsterdam, Netherlands; [Kulasekararaj, A.; Cook, R.; Smith, A. E.; Muus, P.; Marsh, J. C. W.; Mufti, G. J.] Kings Coll Hosp NHS Fdn Trust, Dept Haematol Med, London, England; [Cavenagh, J.] Barts Hlth NHS Trust, St Bartholomews Hosp, London, England; [Griffin, M.; Munir, T.; Hill, A.; Muus, P.] St James Univ Hosp, Dept Haematol, Leeds, W Yorkshire, England; [Russell, N. H.] Nottingham Univ Hosp, Ctr Clin Haematol, Nottingham, England; [Iacobelli, S.] Univ Tor Vergata, Dept Biol, Rome, Italy; [Iori, A-P; La Rocca, U.] Sapienza Univ, Dept Translat & Precis Med, Div Hematol, Rome, Italy; [Angelucci, E.; Van Lint, M-T] IRCCS Osped Policlin San Martino, Ematol & Ctr Trapianti, Genoa, Italy; [Palmisani, E.; Dufour, C.] IRCCS Ist Giannina Gaslini, Hematol Unit, Genoa, Italy; [Barcellini, W.] Fdn IRCCS Ca Granda, Unita Operat Complessa Fisiopatol Anemie, Osped Maggiore Policlin, Unita Operat Complessa Ematol, Milan, Italy; [Marotta, S.; Marano, L.; Cacace, F.; Frieri, C.; Risitano, A. M.] Univ Naples Federico II, Dept Clin Med & Surg, Naples, Italy; [Marano, L.; Frieri, C.; Risitano, A. M.] Azienda Osped Rilievo Nazl San Giuseppe Moscati, Ematol & Trapianto Emopoiet, Avellino, Italy; [Vallejo, J-C] Univ Hosp Donostia, San Sebastian, Spain; [Sureda, A.] Hosp Duran I Reynals, Catalan Inst Oncol, Bellvitge Hosp, Dept Hematol, Lhospitalet De Llobregat, Spain; [Xicoy, B.] Hosp Badalona Germans Trias & Pujol, Josep Carreras Leukemia Res Inst, Inst Catala Oncol, Barcelona, Spain; [Jarque, I] Hosp Univ & Politecn La Fe, Serv Hematol & Hemoterapia, Valencia, Spain; [Drexler, B.; Passweg, J. R.] Univ Hosp Basel, Dept Hematol, Basel, Switzerland	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU de Toulouse; CHU Lyon; CHU Bordeaux; CHU Rennes; Universite de Rennes; Universite de Franche-Comte; CHU Besancon; Universite de Lille - ISITE; CHU Lille; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Utrecht University; Utrecht University Medical Center; University of Groningen; University of Amsterdam; Academic Medical Center Amsterdam; King's College Hospital NHS Foundation Trust; Barts Health NHS Trust; University of London; Queen Mary University London; Saint James's University Hospital; Nottingham University Hospital NHS Trust; University of Nottingham; University of Rome Tor Vergata; Sapienza University Rome; University of Genoa; IRCCS Istituto Giannina Gaslini; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Naples Federico II; San Giuseppe Moscati Hospital; University Hospital Donostia; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; Hospital Duran i Reynals; Catalan Institute of Oncology; Hospital Germans Trias i Pujol; Institut de Recerca Contra la Leucemia Josep Carreras (IJC); Hospital Universitari i Politecnic La Fe; University of Basel	de Latour, RP (corresponding author), Univ Paris, St Louis Hosp, French Reference Ctr Aplast Anemia & Paroxysmal N, 1 Ave Claude Vellefaux, F-75010 Paris, France.; Risitano, AM (corresponding author), Azienda Osped Rilievo Nazl San Giuseppe Moscati, I-83100 Avellino, Italy.	regis.peffaultdelatour@aphp.fr; amrisita@unina.it	Angelucci, Emanuele/AAC-1855-2021	Halkes, Constantijn/0000-0001-6573-0045; Nur, Erfan/0000-0002-7069-930X; La Rocca, Ursula/0000-0002-1990-9973	Novartis; Pfizer; Alexion Pharma; Cancer Research UK [A22324]; Bloodwise UK [10024, 14017]	Novartis(Novartis); Pfizer(Pfizer); Alexion Pharma; Cancer Research UK(Cancer Research UK); Bloodwise UK	Supported by Novartis, Pfizer, a grant from Alexion Pharma, a grant (A22324) from Cancer Research UK, and grants (10024 and 14017) from Bloodwise UK (previously called Leukaemia and Lymphoma Research).	Alvarado LJ, 2019, BLOOD, V133, P2043, DOI 10.1182/blood-2018-11-884486; [Anonymous], 2009, COMMON TERMINOLOGY C; CAMITTA BM, 1988, LANCET, V1, P303; Desmond R, 2014, BLOOD, V123, P1818, DOI 10.1182/blood-2013-10-534743; Frick M, 2019, J CLIN ONCOL, V37, P375, DOI 10.1200/JCO.2018.79.2184; FRICKHOFEN N, 1991, NEW ENGL J MED, V324, P1297, DOI 10.1056/NEJM199105093241901; Ghanima W, 2019, HAEMATOLOGICA, V104, P1112, DOI 10.3324/haematol.2018.212845; Gibson CJ, 2017, BLOOD, V130, P91, DOI 10.1182/blood-2017-01-764951; GLUCKMAN E, 1978, EXP HEMATOL, V6, P679; Kojima S, 2000, BLOOD, V96, P2049; Kulasekararaj AG, 2014, BLOOD, V124, P2698, DOI 10.1182/blood-2014-05-574889; Lengline E, 2018, HAEMATOLOGICA, V103, P212, DOI 10.3324/haematol.2017.176339; Luzzatto L, 1997, CELL, V88, P1, DOI 10.1016/S0092-8674(00)81850-4; Luzzatto L, 2018, BRIT J HAEMATOL, V182, P758, DOI 10.1111/bjh.15443; Marsh JCW, 2014, BLOOD, V123, P1774, DOI 10.1182/blood-2014-02-553404; Olnes MJ, 2012, NEW ENGL J MED, V367, P11, DOI 10.1056/NEJMoa1200931; Rosenfeld S, 2003, JAMA-J AM MED ASSOC, V289, P1130, DOI 10.1001/jama.289.9.1130; ROSENFELD SJ, 1995, BLOOD, V85, P3058, DOI 10.1182/blood.V85.11.3058.bloodjournal85113058; Scheinberg P, 2006, BRIT J HAEMATOL, V133, P606, DOI 10.1111/j.1365-2141.2006.06085.x; Scheinberg P, 2014, BLOOD, V124, P2820, DOI 10.1182/blood-2014-05-573642; Scheinberg P, 2012, BLOOD, V119, P345, DOI 10.1182/blood-2011-05-352328; Scheinberg P, 2011, NEW ENGL J MED, V365, P430, DOI 10.1056/NEJMoa1103975; Scheinberg P, 2009, HAEMATOL-HEMATOL J, V94, P348, DOI 10.3324/haematol.13829; Scheinberg P, 2009, BRIT J HAEMATOL, V144, P206, DOI 10.1111/j.1365-2141.2008.07450.x; Socie G, 2000, SEMIN HEMATOL, V37, P91; SPECK B, 1977, LANCET, V2, P1145; Tichelli A, 2011, BLOOD, V117, P4434, DOI 10.1182/blood-2010-08-304071; Tisdale JF, 2000, LANCET, V356, P1554, DOI 10.1016/S0140-6736(00)03126-3; Townsley DM, 2017, NEW ENGL J MED, V376, P1540, DOI 10.1056/NEJMoa1613878; Yoshizato T, 2015, NEW ENGL J MED, V373, P35, DOI 10.1056/NEJMoa1414799; YOUNG N, 1988, BLOOD, V72, P1861; Young NS, 2018, NEW ENGL J MED, V379, P1643, DOI 10.1056/NEJMra1413485; Zhao X, 2018, EXP HEMATOL, V58, P39, DOI 10.1016/j.exphem.2017.09.006	33	21	21	6	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 6	2022	386	1					11	23		10.1056/NEJMoa2109965	http://dx.doi.org/10.1056/NEJMoa2109965			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YC1QX	34986284	Green Published			2022-12-28	WOS:000739473800007
J	Boden, WE; Kaski, JC; Al-Lamee, R; Weintraub, WS				Boden, William E.; Kaski, Juan Carlos; Al-Lamee, Rasha; Weintraub, William S.			What constitutes an appropriate empirical trial of antianginal therapy in patients with stable angina before referral for revascularisation?	LANCET			English	Editorial Material							PERCUTANEOUS CORONARY INTERVENTION; OPTIMAL MEDICAL THERAPY; OUTCOMES; SYNTAX; PCI		[Boden, William E.] Boston Univ, Sch Med, VA Boston Healthcare Syst, Boston, MA 02130 USA; [Kaski, Juan Carlos] St Georges Univ London, Mol & Clin Sci Res Inst, London, England; [Al-Lamee, Rasha] Imperial Coll London, Natl Heart & Lung Inst, London, England; [Weintraub, William S.] Georgetown Univ, Sch Med, MedStar Hlth Res Inst, Washington, DC USA	Boston University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; St Georges University London; Imperial College London; Georgetown University; MedStar Health Research Institute	Boden, WE (corresponding author), Boston Univ, Sch Med, VA Boston Healthcare Syst, Boston, MA 02130 USA.	william.boden@va.gov						Aggarwal R, 2020, AM HEART J, V228, P44, DOI 10.1016/j.ahj.2020.05.016; Al-Lamee R, 2018, LANCET, V391, P31, DOI 10.1016/S0140-6736(17)32714-9; Bari D Study Grp, 2009, NEW ENGL J MED, V360, P2503, DOI 10.1056/NEJMoa0805796; Ben-Yehuda O, 2016, CATHETER CARDIO INTE, V88, P1017, DOI 10.1002/ccd.26365; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Boden WE, 2021, J AM COLL CARDIOL, V78, P39, DOI 10.1016/j.jacc.2021.04.088; Crea F, 2019, EUR HEART J, V40, P2455, DOI 10.1093/eurheartj/ehy857; Ferrari R, 2018, NAT REV CARDIOL, V15, P120, DOI 10.1038/nrcardio.2017.131; Fihn SD, 2014, J AM COLL CARDIOL, V64, P1929, DOI 10.1016/j.jacc.2014.07.017; Foley M, 2021, J AM HEART ASSOC, V10, DOI 10.1161/JAHA.120.017381; Iqbal J, 2015, CIRCULATION, V131, P1269, DOI 10.1161/CIRCULATIONAHA.114.013042; Kawashima H, 2021, J AM COLL CARDIOL, V78, P27, DOI 10.1016/j.jacc.2021.04.087; Knuuti J, 2020, EUR HEART J, V41, P407, DOI 10.1093/eurheartj/ehz425; Libby P, 2019, ARTERIOSCL THROM VAS, V39, P538, DOI 10.1161/ATVBAHA.118.310958; Maron DJ, 2020, NEW ENGL J MED, V382, P1395, DOI 10.1056/NEJMoa1915922; Mesnier J, 2021, CIRCULATION, V144, P512, DOI 10.1161/CIRCULATIONAHA.121.054567; Palmer SC, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.m4573; Rajkumar CA, 2019, CIRC-CARDIOVASC QUAL, V12, DOI 10.1161/CIRCOUTCOMES.119.006265; ROSE G, 1968, BRIT J PREV SOC MED, V22, P12; Soares A, 2021, J AM HEART ASSOC, V10, DOI 10.1161/JAHA.120.019114; SPERTUS JA, 1995, J AM COLL CARDIOL, V25, P333, DOI 10.1016/0735-1097(94)00397-9; Spertus JA, 2020, NEW ENGL J MED, V382, P1408, DOI 10.1056/NEJMoa1916370; Weintraub WS, 2008, NEW ENGL J MED, V359, P677, DOI 10.1056/NEJMoa072771; Weintraub WS, 2008, CIRC-CARDIOVASC QUAL, V1, P12, DOI 10.1161/CIRCOUTCOMES.108.798462	24	2	2	3	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB	2022	399	10325					691	694		10.1016/S0140-6736(21)02045-6	http://dx.doi.org/10.1016/S0140-6736(21)02045-6			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YY1RO	35033221				2022-12-28	WOS:000754571600027
J	Benson, RBJ; Brown, CM; Campione, NE; Cullen, TM; Evans, DC; Zanno, LE				Benson, Roger B. J.; Brown, Caleb M.; Campione, Nicolas E.; Cullen, Thomas M.; Evans, David C.; Zanno, Lindsay E.			Comment on "The influence of juvenile dinosaurs on community structure and diversity"	SCIENCE			English	Editorial Material								Schroeder et al. (Reports, 26 February 2021, p. 941) reported a size gap among predatory dinosaur species. We argue that the supporting dataset is skewed toward Late Cretaceous North America and that the gap was likely absent during other intervals in most geographic regions. We urge broader consideration of this hypothesis, with quantitative evaluation of preservational and dataset biases.	[Benson, Roger B. J.] Univ Oxford, Dept Earth Sci, Oxford, England; [Brown, Caleb M.] Royal Tyrrell Museum Palaeontol, Drumheller, AB, Canada; [Campione, Nicolas E.] Univ New England, Sch Environm & Rural Sci, Armidale, NSW, Australia; [Cullen, Thomas M.] Carleton Univ, Dept Earth Sci, Ottawa, ON, Canada; [Cullen, Thomas M.; Zanno, Lindsay E.] Nagaunee Integrat Res Ctr, Field Museum Nat Hist, Chicago, IL USA; [Evans, David C.] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada; [Evans, David C.] Royal Ontario Museum, Toronto, ON, Canada; [Zanno, Lindsay E.] North Carolina Museum Nat Sci, Paleontol, Raleigh, NC USA; [Zanno, Lindsay E.] North Carolina State Univ, Dept Biol Sci, Raleigh, NC USA	University of Oxford; University of New England; Carleton University; Field Museum of Natural History (Chicago); University of Toronto; Royal Ontario Museum; University of North Carolina; North Carolina State University	Benson, RBJ (corresponding author), Univ Oxford, Dept Earth Sci, Oxford, England.	roger.benson@earth.ox.ac.uk	; Campione, Nicolas/R-6862-2018	Cullen, Thomas/0000-0002-4261-1323; Campione, Nicolas/0000-0002-4205-9794; Brown, Caleb/0000-0001-6463-8677; Zanno, Lindsay/0000-0002-1654-1990; Benson, Roger/0000-0001-8244-6177	Natural Sciences and Engineering Research Council of Canada Discovery Grant (NSERC) [RGPIN-2018-06788]	Natural Sciences and Engineering Research Council of Canada Discovery Grant (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	We thank K. Schroeder for discussions and for sharing the unpublished global dataset from (1). D.C.E. thanks Natural Sciences and Engineering Research Council of Canada Discovery Grant (NSERC Grant File Number: RGPIN-2018-06788).	Alroy J, 1998, SCIENCE, V280, P731, DOI 10.1126/science.280.5364.731; BEHRENSMEYER AK, 1979, PALEOBIOLOGY, V5, P12, DOI 10.1017/S0094837300006254; Belli PR, 2017, BIOL LETTERS, V13, DOI 10.1098/rsbl.2017.0092; Benson RBJ, 2018, ANNU REV ECOL EVOL S, V49, P379, DOI 10.1146/annurev-ecolsys-110617-062231; Brown CM, 2013, PALAEOGEOGR PALAEOCL, V372, P108, DOI 10.1016/j.palaeo.2012.06.027; Close RA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15381; Codron D, 2012, BIOL LETTERS, V8, P620, DOI 10.1098/rsbl.2012.0240; Evans DC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2749; Fiorillo Anthony R., 1998, Historical Biology, V13, P1; Foth C, 2016, PEERJ, V4, DOI 10.7717/peerj.1589; Fowler DW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188426; Frederickson JA, 2020, PALAEOGEOGR PALAEOCL, V552, DOI 10.1016/j.palaeo.2020.109780; Ratsimbaholison NO, 2016, ACTA PALAEONTOL POL, V61, P281, DOI 10.4202/app.00132.2014; Sander PM, 2008, SCIENCE, V322, P200, DOI 10.1126/science.1160904; Schroeder K, 2021, SCIENCE, V371, P941, DOI 10.1126/science.abd9220	15	1	1	2	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2022	375	6578								10.1126/science.abj5976	http://dx.doi.org/10.1126/science.abj5976			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YK2FS	35050649	Green Submitted			2022-12-28	WOS:000745036100001
J	Morgenstern, M; Goerbig, M				Morgenstern, Markus; Goerbig, Mark			Many-particle electron states in graphene	SCIENCE			English	Editorial Material							SKYRMIONS	Scanning tunneling microscopy probes ground state competition in a magnetic field	[Morgenstern, Markus] Rhein Westfal TH Aachen, Inst Phys B 2, D-52074 Aachen, Germany; [Morgenstern, Markus] Rhein Westfal TH Aachen, JARA FIT, D-52074 Aachen, Germany; [Goerbig, Mark] Univ Paris Saclay, CNRS, Lab Phys Solides, Bat 510, F-91405 Orsay, France	RWTH Aachen University; RWTH Aachen University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Morgenstern, M (corresponding author), Rhein Westfal TH Aachen, Inst Phys B 2, D-52074 Aachen, Germany.; Morgenstern, M (corresponding author), Rhein Westfal TH Aachen, JARA FIT, D-52074 Aachen, Germany.	mmorgens@physik.rwth-aachen.de			German Research Foundation [Mo 858/15-1]; Agence Nationale de la Recherche [ANR-17-CE30-0029]	German Research Foundation(German Research Foundation (DFG)); Agence Nationale de la Recherche(French National Research Agency (ANR))	The authors acknowledge M. Pratzer for the figure outline and the German Research Foundation (Mo 858/15-1) and the Agence Nationale de la Recherche (ANR-17-CE30-0029) for financial support.	Atteia J, 2021, PHYS REV B, V103, DOI 10.1103/PhysRevB.103.035403; Balents L, 2020, NAT PHYS, V16, P725, DOI 10.1038/s41567-020-0906-9; BARRETT SE, 1995, PHYS REV LETT, V74, P5112, DOI 10.1103/PhysRevLett.74.5112; Bode M, 2003, REP PROG PHYS, V66, P523, DOI 10.1088/0034-4885/66/4/203; Goerbig MO, 2011, REV MOD PHYS, V83, P1193, DOI 10.1103/RevModPhys.83.1193; Lian YL, 2017, PHYS REV B, V95, DOI 10.1103/PhysRevB.95.245428; Liu X., SCIENCE, V375, P321; Murthy G, 2003, REV MOD PHYS, V75, P1101, DOI 10.1103/RevModPhys.75.1101; Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233; Papic Z, 2018, PHYS REV X, V8, DOI 10.1103/PhysRevX.8.011037; Reznikov M, 1999, NATURE, V399, P238, DOI 10.1038/20384	13	0	0	11	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2022	375	6578					263	264		10.1126/science.abn2049	http://dx.doi.org/10.1126/science.abn2049			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YK2FS	35050651				2022-12-28	WOS:000745036100013
J	Khatri, A				Khatri, Akanksha			Message to mayors: cities need nature	NATURE			English	Editorial Material									[Khatri, Akanksha] World Econ Forum, Nat & Biodivers, Cologny, Switzerland		Khatri, A (corresponding author), World Econ Forum, Nat & Biodivers, Cologny, Switzerland.	khatri@weforum.org							0	4	4	2	7	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 20	2022	601	7893					299	299		10.1038/d41586-022-00102-w	http://dx.doi.org/10.1038/d41586-022-00102-w			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YI0DC	35039649				2022-12-28	WOS:000743527000001
J	Costa, ML; Achten, J; Ooms, A; Png, ME; Cook, JA; Lamb, SE; Hedley, H; Dias, J				Costa, Matthew L.; Achten, Juul; Ooms, Alexander; Png, May Ee; Cook, Jonathan A.; Lamb, Sarah E.; Hedley, Helen; Dias, Joseph		DRAFFT2 Collaborators	Surgical fixation with K-wires versus casting in adults with fracture of distal radius: DRAFFT2 multicentre randomised clinical trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DISABILITY	OBJECTIVE assess wrist function, quality of life, and complications in adult patients with a dorsally displaced fracture of the distal radius, treated with either a moulded cast or surgical fixation with K-wires. DESIGN Multicentre randomised clinical superiority trial, SETTING 36 hospitals in the UK National Health Service (NHS). PARTICIPANTS 500 adults aged 16 or over with a dorsally displaced fracture of the distal radius, randomised after manipulation of their fracture (255 to moulded cast; 245 to surgical fixation). INTERVENTIONS Manipulation and moulded cast was compared with manipulation and surgical fixation with K-wires plus cast. Details of the application of the cast and the insertion of the K-wires were at the discretion of the treating surgeon, according to their normal clinical practice. MAIN OUTCOME MEASURES The primary outcome measure was the Patient Rated Wrist Evaluation (PRWE) score at 12 months (five questions about pain and 10 about function and disability; overall score out of 100 (best score=0 and worst score=100)). Secondary outcomes were PRWE score at three and six months, quality of life, and complications, including the need for surgery due to loss of fracture position in the first six weeks. RESULTS The mean age of participants was 60 years and 417 (83%) were women; 395 (79%) completed follow-up. No statistically significant difference in the PRWE score was seen at 12 months (cast group (n=200), mean 21.2 (SD 23.1); K-wire group (n=195), mean 20.7 (22.3); adjusted mean difference -0.34 (95% confidence interval -4.33 to 3.66), P=0.87). No difference was seen at earlier time points. In the cast group, 33 (13%) of participants needed surgical fixation for loss of fracture position in the first six weeks compared with one revision surgery in the K-wire group (odds ratio 0.02, 95% confidence interval 0.001 to 0.10). CONCLUSIONS Among patients with a dorsally displaced distal radius fracture that needed manipulation, surgical fixation with K-wires did not improve patients' wrist function at 12 months compared with a cast. TRIAL REGISTRATION ISRCTN registry ISRCTN11980540.	[Costa, Matthew L.; Achten, Juul] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Orthopaed, Trauma Unit,Oxford Trauma & Emergency Care, Oxford, England; [Ooms, Alexander; Cook, Jonathan A.] Univ Oxford, Nuffield Dept Orthopaed, Ctr Stat Med, Botnar Res Ctr,Oxford Clinical Trials Res Unit, Oxford, England; [Png, May Ee] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Radcliffe Primary Care Bldg, Oxford, England; [Lamb, Sarah E.] Univ Exeter, Coll Med & Hlth, South Cloisters, Exeter, Devon, England; [Hedley, Helen] Univ Hosp Coventry & Warwickshire NHS Trust, Univ Hosp Coventry & Warwickshire, Dept Trauma & Orthopaed, Coventry, W Midlands, England; [Dias, Joseph] Univ Leicester, Dept Hlth Sci, George Davies Ctr, Leicester, Leics, England	University of Oxford; University of Oxford; University of Oxford; University of Exeter; University of Warwick; University of Leicester	Costa, ML (corresponding author), Univ Oxford, John Radcliffe Hosp, Nuffield Dept Orthopaed, Trauma Unit,Oxford Trauma & Emergency Care, Oxford, England.	Matthew.costa@ndorms.ox.ac.uk	Cook, Jonathan/D-3648-2015; Png, May Ee/AAG-4902-2019	Cook, Jonathan/0000-0002-4156-6989; Png, May Ee/0000-0001-5876-9363; Lamb, Sarah/0000-0003-4349-7195; Dakin, Helen/0000-0003-3255-748X; Peach, Chris/0000-0002-2516-4760; Achten, Juul/0000-0002-8857-5743; Costa, Matthew/0000-0003-3644-1388; Whitehouse, Michael/0000-0003-2436-9024	UK National Institute for Health Research (NIHR) Health Technology Assessment (HTA) Programme [15/27/01]; NIHR Oxford Biomedical Research Centre	UK National Institute for Health Research (NIHR) Health Technology Assessment (HTA) Programme; NIHR Oxford Biomedical Research Centre(National Institute for Health Research (NIHR))	This project was funded by the UK National Institute for Health Research (NIHR) Health Technology Assessment (HTA) Programme (project number 15/27/01) and was supported by NIHR Oxford Biomedical Research Centre. The funder was not involved in the design of the study. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health. The University of Oxford acted as sponsor for the trial and was responsible for all elements of governance.	Achten J, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-028474; Barrett JA, 1999, J CLIN EPIDEMIOL, V52, P243, DOI 10.1016/S0895-4356(98)00167-X; Chen NC, 2007, J BONE JOINT SURG AM, V89A, P2051, DOI 10.2106/JBJS.G.00020; Cook JA, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-2; Costa ML, 2016, BONE JOINT J, V98B, P410, DOI 10.1302/0301-620X.98B3.36730; Costa ML, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4807; Handoll HHG, 2003, BMC MUSCULOSKEL DIS, V4, DOI 10.1186/1471-2474-4-27; Herdman M, 2011, QUAL LIFE RES, V20, P1727, DOI 10.1007/s11136-011-9903-x; Karantana A, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006080.pub3; MacDermid J, 2007, PATIENT RATED WRIST; MacDermid JC, 1998, J ORTHOP TRAUMA, V12, P577, DOI 10.1097/00005131-199811000-00009; MacDermid JC, 2003, BMC MUSCULOSKEL DIS, V4, DOI 10.1186/1471-2474-4-24; MacDermid JC, 2000, J HAND SURG-AM, V25A, P330, DOI 10.1053/jhsu.2000.jhsu25a0330; National Institute for Health and Care Excellence, 2016, FRACT NONC ASS MAN; Ooms AG, 2020, BONE JOINT OPEN, V1, P245, DOI 10.1302/2633-1462.16.BJO-2020-0044.R1	15	2	2	3	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 19	2022	376								e068041	10.1136/bmj-2021-068041	http://dx.doi.org/10.1136/bmj-2021-068041			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YL6WC	35045969	Green Published, hybrid			2022-12-28	WOS:000746028500008
J	Huang, XY; Akdim, O; Douthwaite, M; Wang, K; Zhao, L; Lewis, RJ; Pattisson, S; Daniel, IT; Miedziak, PJ; Shaw, G; Morgan, DJ; Althahban, SM; Davies, TE; He, Q; Wang, F; Fu, JL; Bethell, D; McIntosh, S; Kiely, CJ; Hutchings, GJ				Huang, Xiaoyang; Akdim, Ouardia; Douthwaite, Mark; Wang, Kai; Zhao, Liang; Lewis, Richard J.; Pattisson, Samuel; Daniel, Isaac T.; Miedziak, Peter J.; Shaw, Greg; Morgan, David J.; Althahban, Sultan M.; Davies, Thomas E.; He, Qian; Wang, Fei; Fu, Jile; Bethell, Donald; McIntosh, Steven; Kiely, Christopher J.; Hutchings, Graham J.			Au-Pd separation enhances bimetallic catalysis of alcohol oxidation	NATURE			English	Article; Early Access							SELECTIVE AEROBIC OXIDATION; OXYGEN REDUCTION REACTION; BASE-FREE OXIDATION; 2,5-FURANDICARBOXYLIC ACID; AQUEOUS-PHASE; SUPPORTED AU; GOLD; HMF; NANOPARTICLES; CARBON	In oxidation reactions catalysed by supported metal nanoparticles with oxygen as the terminal oxidant, the rate of the oxygen reduction can be a limiting factor. This is exemplified by the oxidative dehydrogenation of alcohols, an important class of reactions with modern commercial applications(1-3). Supported gold nanoparticles are highly active for the dehydrogenation of the alcohol to an aldehyde(4) but are less effective for oxygen reduction(5,6). By contrast, supported palladium nanoparticles offer high efficacy for oxygen reduction(5,6). This imbalance can be overcome by alloying gold with palladium, which gives enhanced activity to both reactions(7,8,9); however, the electrochemical potential of the alloy is a compromise between that of the two metals, meaning that although the oxygen reduction can be improved in the alloy, the dehydrogenation activity is often limited. Here we show that by separating the gold and palladium components in bimetallic carbon-supported catalysts, we can almost double the reaction rate compared with that achieved with the corresponding alloy catalyst. We demonstrate this using physical mixtures of carbon-supported monometallic gold and palladium catalysts and a bimetallic catalyst comprising separated gold and palladium regions. Furthermore, we demonstrate electrochemically that this enhancement is attributable to the coupling of separate redox processes occurring at isolated gold and palladium sites. The discovery of this catalytic effect-a cooperative redox enhancement-offers an approach to the design of multicomponent heterogeneous catalysts.	[Huang, Xiaoyang; Akdim, Ouardia; Douthwaite, Mark; Wang, Kai; Zhao, Liang; Lewis, Richard J.; Pattisson, Samuel; Daniel, Isaac T.; Miedziak, Peter J.; Shaw, Greg; Morgan, David J.; Davies, Thomas E.; He, Qian; Wang, Fei; Fu, Jile; Bethell, Donald; Hutchings, Graham J.] Cardiff Univ, Sch Chem, Cardiff Catalysis Inst, Max Planck Cardiff Ctr Fundamentals Heterogeneous, Cardiff, Wales; [Miedziak, Peter J.] Univ South Wares, Sch Appl Sci, Pontypridd, M Glam, Wales; [Althahban, Sultan M.; Kiely, Christopher J.] Lehigh Univ, Dept Mat Sci & Engn, Bethlehem, PA 18015 USA; [Althahban, Sultan M.] Jazan Univ, Dept Mech Engn, Jazan, Saudi Arabia; [He, Qian] Natl Univ Singapore, Fac Engn, Dept Mat Sci & Engn, Singapore, Singapore; [McIntosh, Steven; Kiely, Christopher J.] Lehigh Univ, Dept Chem & Biomol Engn, Bethlehem, PA 18015 USA	Cardiff University; Lehigh University; Jazan University; National University of Singapore; Lehigh University	Hutchings, GJ (corresponding author), Cardiff Univ, Sch Chem, Cardiff Catalysis Inst, Max Planck Cardiff Ctr Fundamentals Heterogeneous, Cardiff, Wales.	hutch@cardiff.ac.uk	Huang, Xiaoyang/AAE-2890-2022; Douthwaite, Mark/U-2290-2017	Huang, Xiaoyang/0000-0002-7221-2075; Pattisson, Samuel/0000-0002-6520-2194; Althahban, sultan/0000-0003-2228-1184; Shaw, Greg/0000-0002-3119-0631; Daniel, Isaac T./0000-0002-3103-6415; Wang, Fei/0000-0002-3798-3974; Wang, Kai/0000-0002-1918-4781; Zhao, Liang/0000-0002-4956-9447; Lewis, Richard/0000-0001-9990-7064; Douthwaite, Mark/0000-0002-9162-3363	National Science Foundation Major Research Instrumentation programme [MRI/DMR-1040229]; Saudi Arabian government; Cardiff University School of Chemistry; National Research Foundation (NRF) Singapore [NRF-NRFF11-2019-0002]; Chinese Scholarship Council (CSC); UCL [PR16195]; Cardiff University; Max Planck Centre for Fundamental Heterogeneous Catalysis (FUNCAT)	National Science Foundation Major Research Instrumentation programme(National Science Foundation (NSF)); Saudi Arabian government; Cardiff University School of Chemistry; National Research Foundation (NRF) Singapore(National Research Foundation, Singapore); Chinese Scholarship Council (CSC)(China Scholarship Council); UCL; Cardiff University; Max Planck Centre for Fundamental Heterogeneous Catalysis (FUNCAT)	We thank L. Kang and R. Wang from University College London and Cardiff University for access and assistance with the electron microscopy; and the Diamond Light Source for access to beamline E01 (proposal number EM18909). C.J.K. acknowledges funding from the National Science Foundation Major Research Instrumentation programme (GR# MRI/DMR-1040229). S.M.A. thanks the Saudi Arabian government for his PhD scholarship. X.H. and Q.H. thank Cardiff University School of Chemistry for financial support. Q.H. also acknowledges the support by National Research Foundation (NRF) Singapore, under its NRF Fellowship (NRF-NRFF11-2019-0002). K.W. and L.Z. thank the Chinese Scholarship Council (CSC) for financial support. XPS data collection was performed at the EPSRC National Facility for XPS ('HarwellXPS'), operated by Cardiff University and UCL, under contract number PR16195. We thank Cardiff University and the Max Planck Centre for Fundamental Heterogeneous Catalysis (FUNCAT) for financial support.	Abad A, 2005, ANGEW CHEM INT EDIT, V44, P4066, DOI 10.1002/anie.200500382; Artz J, 2015, CHEMSUSCHEM, V8, P3832, DOI 10.1002/cssc.201501106; Bonincontro D, 2019, GREEN CHEM, V21, P4090, DOI 10.1039/c9gc01283d; Chadderdon DJ, 2014, GREEN CHEM, V16, P3778, DOI 10.1039/c4gc00401a; Chen H, 2018, APPL CATAL A-GEN, V555, P98, DOI 10.1016/j.apcata.2018.01.023; Ciriminna R, 2015, ORG PROCESS RES DEV, V19, P1554, DOI 10.1021/acs.oprd.5b00204; Davis SE, 2013, GREEN CHEM, V15, P17, DOI 10.1039/c2gc36441g; Enache DI, 2006, SCIENCE, V311, P362, DOI 10.1126/science.1120560; Ferraz CP, 2020, CATALYSTS, V10, DOI 10.3390/catal10010075; Gao F, 2012, CHEM SOC REV, V41, P8009, DOI 10.1039/c2cs35160a; Golberg D, 2010, ACS NANO, V4, P2979, DOI 10.1021/nn1006495; Gui ZY, 2016, CHEMCATCHEM, V8, P3636, DOI 10.1002/cctc.201600852; Han SM, 2021, ACCOUNTS CHEM RES, V54, P379, DOI 10.1021/acs.accounts.0c00642; Han XW, 2016, GREEN CHEM, V18, P1597, DOI 10.1039/c5gc02114f; Han YF, 2007, J PHYS CHEM C, V111, P8410, DOI 10.1021/jp072934g; Hutchings GJ, 2013, ACCOUNTS CHEM RES, V46, P1759, DOI 10.1021/ar300356m; Kerdi F, 2015, APPL CATAL A-GEN, V506, P206, DOI 10.1016/j.apcata.2015.09.002; Kulkarni A, 2018, CHEM REV, V118, P2302, DOI 10.1021/acs.chemrev.7b00488; Liu YQ, 2019, ACS CATAL, V9, P8306, DOI 10.1021/acscatal.9b02115; MACKAY AL, 1962, ACTA CRYSTALLOGR, V15, P916, DOI 10.1107/S0365110X6200239X; Mallat T, 2004, CHEM REV, V104, P3037, DOI 10.1021/cr0200116; Masoud N, 2018, APPL CATAL A-GEN, V561, P150, DOI 10.1016/j.apcata.2018.05.027; Megias-Sayago C, 2020, CHEMCATCHEM, V12, P1177, DOI 10.1002/cctc.201901742; Megias-Sayago C, 2018, ACS CATAL, V8, P11154, DOI 10.1021/acscatal.8b02522; Mishra DK, 2017, GREEN CHEM, V19, P1619, DOI 10.1039/c7gc00027h; Norskov JK, 2004, J PHYS CHEM B, V108, P17886, DOI 10.1021/jp047349j; Parmeggiani C, 2017, GREEN CHEM, V19, P2030, DOI 10.1039/c7gc00406k; Pelaez M, 2012, APPL CATAL B-ENVIRON, V125, P331, DOI 10.1016/j.apcatb.2012.05.036; Rass HA, 2015, CHEMSUSCHEM, V8, P1206, DOI 10.1002/cssc.201403390; Ringeisen BR, 2006, ENVIRON SCI TECHNOL, V40, P2629, DOI 10.1021/es052254w; Schade O, 2020, CATALYSTS, V10, DOI 10.3390/catal10030342; Schade OR, 2018, GREEN CHEM, V20, P3530, DOI 10.1039/c8gc01340c; Sheldon RA, 2002, ACCOUNTS CHEM RES, V35, P774, DOI 10.1021/ar010075n; Siyo B, 2014, APPL CATAL A-GEN, V478, P107, DOI 10.1016/j.apcata.2014.03.020; Suo YG, 2007, ANGEW CHEM INT EDIT, V46, P2862, DOI 10.1002/anie.200604332; Trindell JA, 2020, CHEMELECTROCHEM, V7, P3824, DOI 10.1002/celc.202000971; Villa A, 2013, CHEMSUSCHEM, V6, P609, DOI 10.1002/cssc.201200778; Wan XY, 2014, ACS CATAL, V4, P2175, DOI 10.1021/cs5003096; Wang AQ, 2013, J CATAL, V308, P258, DOI 10.1016/j.jcat.2013.08.023; Wang D, 2008, J PHYS CHEM C, V112, P8617, DOI 10.1021/jp800805e; Yang J, 2019, CATAL SCI TECHNOL, V9, P6659, DOI 10.1039/c9cy01298b; Yu K, 2018, J CATAL, V365, P292, DOI 10.1016/j.jcat.2018.06.025; Zhou CM, 2015, CHEMCATCHEM, V7, P2853, DOI 10.1002/cctc.201500352; Zhu XJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09421-5; Zhu YL, 2015, CHEM MATER, V27, P3048, DOI 10.1021/acs.chemmater.5b00450; Zope BN, 2010, SCIENCE, V330, P74, DOI 10.1126/science.1195055	46	31	30	123	256	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature											s41586-022-04397-7	10.1038/s41586-022-04397-7	http://dx.doi.org/10.1038/s41586-022-04397-7		JAN 2022	18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZL0HP	35038718				2022-12-28	WOS:000763361600001
J	Li, XH; Straub, J; Medeiros, TC; Mehra, C; den Brave, F; Peker, E; Atanassov, I; Stillger, K; Michaelis, JB; Burbridge, E; Adrain, C; Munch, C; Riemer, J; Becker, T; Pernas, LF				Li, Xianhe; Straub, Julian; Medeiros, Tania Catarina; Mehra, Chahat; den Brave, Fabian; Peker, Esra; Atanassov, Ilian; Stillger, Katharina; Michaelis, Jonas Benjamin; Burbridge, Emma; Adrain, Colin; Munch, Christian; Riemer, Jan; Becker, Thomas; Pernas, Lena F.			Mitochondria shed their outer membrane in response to infection-induced stress	SCIENCE			English	Review							TOXOPLASMA-GONDII; PROTEIN IMPORT; TRANSPORT; PARKIN; TRANSLOCATION; COMPARTMENTS; BIOGENESIS; CONTACT; FISSION; PATHWAY	The outer mitochondrial membrane (OMM) is essential for cellular homeostasis. Yet little is known of the mechanisms that remodel it during natural stresses. We found that large "SPOTs" (structures positive for OMM) emerge during Toxoplasma gondii infection in mammalian cells. SPOTs mediated the depletion of the OMM proteins mitofusin 1 and 2, which restrict parasite growth. The formation of SPOTs depended on the parasite effector TgMAF1 and the host mitochondrial import receptor TOM70, which is required for optimal parasite proliferation. TOM70 enabled TgMAF1 to interact with the host OMM translocase SAM50. The ablation of SAM50 or the overexpression of an OMM-targeted protein promoted OMM remodeling independently of infection. Thus, Toxoplasma hijacks the formation of SPOTs, a cellular response to OMM stress, to promote its growth.	[Li, Xianhe; Straub, Julian; Medeiros, Tania Catarina; Mehra, Chahat; Atanassov, Ilian; Pernas, Lena F.] Max Planck Inst Biol Ageing, Cologne, Germany; [den Brave, Fabian; Becker, Thomas] Univ Bonn, Med Fac, Inst Biochem & Mol Biol, Bonn, Germany; [Peker, Esra; Stillger, Katharina; Riemer, Jan] Univ Cologne, Inst Biochem, Cologne, Germany; [Michaelis, Jonas Benjamin; Munch, Christian] Goethe Univ, Fac Med, Inst Biochem 2, Frankfurt, Germany; [Burbridge, Emma; Adrain, Colin] Queens Univ Belfast, Patrick G Johnston Ctr Canc Res, Belfast, Antrim, North Ireland; [Burbridge, Emma; Adrain, Colin] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Riemer, Jan; Pernas, Lena F.] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany	Max Planck Society; University of Bonn; University of Cologne; Goethe University Frankfurt; Queens University Belfast; Instituto Gulbenkian de Ciencia; University of Cologne	Pernas, LF (corresponding author), Max Planck Inst Biol Ageing, Cologne, Germany.; Pernas, LF (corresponding author), Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany.	pernas@age.mpg.de	; Atanassov, Ilian/L-2464-2016	Riemer, Jan/0000-0002-7574-8457; Straub, Julian/0000-0003-4544-6332; Michaelis, Jonas Benjamin/0000-0001-9548-2337; Stillger, Katharina/0000-0001-5811-6389; Munch, Christian/0000-0003-3832-090X; den Brave, Fabian/0000-0001-6955-4616; Atanassov, Ilian/0000-0001-8259-2545; XIANHE, LI/0000-0003-1099-518X; Mehra, Chahat/0000-0003-3338-1527	European Research Council [ERC-StG-2019 852457]; Deutsche Forschungsgemeinschaft [SFB 1218, 269925409, 411422114-GRK 255, 04679/2-2, 269424439]; BONFOR program of the Univeristy Hospital Bonn; Chinese Research Council; IMPRS	European Research Council(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BONFOR program of the Univeristy Hospital Bonn; Chinese Research Council; IMPRS	This work was supported by the European Research Council ERC-StG-2019 852457 (to L.F.P.); Deutsche Forschungsgemeinschaft SFB 1218 Project ID 269925409 (to L.F.P. and T.B.); Project ID 411422114-GRK 2550 (to L.F.P.); BE 4679/2-2 Project ID 269424439 (to T.B.); BONFOR program of the Univeristy Hospital Bonn (to F.d.B.); Chinese Research Council (to X.L.); and IMPRS (to C.M.).	AUGUST DA, 1985, CANCER-AM CANCER SOC, V55, P1490, DOI 10.1002/1097-0142(19850401)55:7<1490::AID-CNCR2820550712>3.0.CO;2-N; Backes S, 2021, CELL REP, V35, DOI 10.1016/j.celrep.2021.108936; Backes S, 2018, J CELL BIOL, V217, P1369, DOI 10.1083/jcb.201708044; Becker T, 2011, J CELL BIOL, V194, P387, DOI 10.1083/jcb.201102044; Blank ML, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2013336118; Blank ML, 2018, MOL MICROBIOL, V108, P519, DOI 10.1111/mmi.13947; Bomer U, 1997, J BIOL CHEM, V272, P30439, DOI 10.1074/jbc.272.48.30439; Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048; Chen WW, 2017, NAT PROTOC, V12, P2215, DOI 10.1038/nprot.2017.104; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dabir DV, 2013, DEV CELL, V25, P81, DOI 10.1016/j.devcel.2013.03.006; Denison SR, 2003, ONCOGENE, V22, P8370, DOI 10.1038/sj.onc.1207072; Derre I, 2007, PLOS PATHOG, V3, P1446, DOI 10.1371/journal.ppat.0030155; Dumoux M, 2016, BBA-MOL CELL BIOL L, V1861, P895, DOI 10.1016/j.bbalip.2016.01.018; EILERS M, 1986, NATURE, V322, P228, DOI 10.1038/322228a0; English AM, 2020, J CELL BIOL, V219, DOI 10.1083/jcb.202002144; Fan ACY, 2006, J BIOL CHEM, V281, P33313, DOI 10.1074/jbc.M605250200; Hughes AL, 2016, ELIFE, V5, DOI 10.7554/eLife.13943; Iqbal A., 2021, Flaski. Zenodo, DOI 10.5281/zenodo.4890981; Ishihara N, 2009, NAT CELL BIOL, V11, P958, DOI 10.1038/ncb1907; Kelly FD, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00183-17, 10.1128/msphere.00183-17]; Doan KN, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107567; Li XP, 2021, METHODS MOL BIOL, V2261, P13, DOI 10.1007/978-1-0716-1186-9_2; Lopez-Domenech G, 2018, EMBO J, V37, P321, DOI 10.15252/embj.201696380; Lundmark R, 2009, J CELL SCI, V122, P5, DOI 10.1242/jcs.037135; MacKenzie JA, 2007, BBA-MOL BASIS DIS, V1772, P509, DOI 10.1016/j.bbadis.2006.12.002; Martensson CU, 2019, NATURE, V569, P679, DOI 10.1038/s41586-019-1227-y; Matheoud D, 2016, CELL, V166, P314, DOI 10.1016/j.cell.2016.05.039; McLelland GL, 2014, EMBO J, V33, P282, DOI 10.1002/embj.201385902; Medeiros TC, 2021, CURR OPIN MICROBIOL, V63, P189, DOI 10.1016/j.mib.2021.07.014; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Mueller B, 2008, P NATL ACAD SCI USA, V105, P12325, DOI 10.1073/pnas.0805371105; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Murschall L. M., BIOPROTOC, V11, pe4057; Nahar S, 2020, J BIOCHEM, V167, P279, DOI 10.1093/jb/mvz104; Neuspiel M, 2008, CURR BIOL, V18, P102, DOI 10.1016/j.cub.2007.12.038; Ott C, 2012, MOL CELL BIOL, V32, P1173, DOI 10.1128/MCB.06388-11; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Pernas L, 2021, J CELL SCI, V134, DOI 10.1242/jcs.252023; Pernas L, 2018, CELL METAB, V27, P886, DOI 10.1016/j.cmet.2018.02.018; Pernas L, 2016, ANNU REV PHYSIOL, V78, P505, DOI 10.1146/annurev-physiol-021115-105011; Pernas L, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001845; Priesnitz C, 2020, METHOD CELL BIOL, V155, P45, DOI 10.1016/bs.mcb.2019.11.006; R Core Team, 2021, R LANG ENV STAT COMP; Rath S, 2021, NUCLEIC ACIDS RES, V49, pD1541, DOI 10.1093/nar/gkaa1011; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rudel T, 2010, NAT REV MICROBIOL, V8, P693, DOI 10.1038/nrmicro2421; Schuler M.H., 2020, AMINO ACIDS PROMOTE, DOI [10.1101/2020. 12.23.424218, DOI 10.1101/2020.12.23.424218]; Schuler MH, 2021, MOL CELL, V81, P3786, DOI 10.1016/j.molcel.2021.08.021; Scorrano L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09253-3; Seth RB, 2006, CELL RES, V16, P141, DOI 10.1038/sj.cr.7310019; Shaw MK, 2000, PARASITOLOGY, V121, P35, DOI 10.1017/S0031182099006071; Sinai AP, 1997, J CELL SCI, V110, P2117; Song JY, 2021, NAT REV MOL CELL BIO, V22, P54, DOI 10.1038/s41580-020-00300-2; Soubannier V, 2012, CURR BIOL, V22, P135, DOI 10.1016/j.cub.2011.11.057; Suzuki M, 2014, CELL HOST MICROBE, V16, P581, DOI 10.1016/j.chom.2014.09.015; Tiku V, 2020, TRENDS CELL BIOL, V30, P263, DOI [10.1016/j.tcb.2020.01.006, 10.1016/j.tcb.2020.07.001]; Todkar K, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21984-w; Viana MP, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2021.102119; Xu F, 2021, CELL RES, V31, P141, DOI 10.1038/s41422-020-00416-2; Yamamoto H, 2009, J BIOL CHEM, V284, P31635, DOI 10.1074/jbc.M109.041756	62	7	8	15	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2022	375	6577					159	+		10.1126/science.abi4343	http://dx.doi.org/10.1126/science.abi4343			45	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YG3OI	35025629				2022-12-28	WOS:000742401600025
J	Rayner, KJ; Rasheed, A				Rayner, Katey J.; Rasheed, Adil			The scent of atherosclerosis	SCIENCE			English	Editorial Material									[Rayner, Katey J.; Rasheed, Adil] Univ Ottawa Heart Inst, Ottawa, ON, Canada; [Rayner, Katey J.; Rasheed, Adil] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada	University of Ottawa; University of Ottawa Heart Institute; University of Ottawa	Rayner, KJ (corresponding author), Univ Ottawa Heart Inst, Ottawa, ON, Canada.; Rayner, KJ (corresponding author), Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada.	krayner@ottawaheart.ca		Rasheed, Adil/0000-0002-3204-6674	University of Ottawa Cardiac Endowment Fund; Canadian Institutes for Health Research	University of Ottawa Cardiac Endowment Fund; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	A.R. is supported by the University of Ottawa Cardiac Endowment Fund,and K.J.R. is supported by the Canadian Institutes for Health Research.	Grebe A, 2018, CIRC RES, V122, P1722, DOI 10.1161/CIRCRESAHA.118.311362; Janfaza S, 2019, BIOL METHODS PROTOC, V4, DOI 10.1093/biomethods/bpz014; Libby P, 2021, NATURE, V592, P524, DOI 10.1038/s41586-021-03392-8; Malnic B, 2004, P NATL ACAD SCI USA, V101, P2584, DOI 10.1073/pnas.0307882100; McArdle S, 2019, CIRC RES, V125, P1038, DOI 10.1161/CIRCRESAHA.119.315175; Moore KJ, 2013, NAT REV IMMUNOL, V13, P709, DOI 10.1038/nri3520; Orecchioni M, 2022, SCIENCE, V375, P214, DOI 10.1126/science.abg3067; Rasheed A, 2021, ENDOCR REV, V42, P407, DOI 10.1210/endrev/bnab004; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Trimmer C, 2019, P NATL ACAD SCI USA, V116, P9475, DOI 10.1073/pnas.1804106115; Zernecke A, 2020, CIRC RES, V127, P402, DOI 10.1161/CIRCRESAHA.120.316903	11	0	0	7	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2022	375	6577					145	146		10.1126/science.abn4708	http://dx.doi.org/10.1126/science.abn4708			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YG3OI	35025639				2022-12-28	WOS:000742401600016
J	Reid, T; Gibert, J				Reid, Tahira; Gibert, James			Inclusion in human-machine interactions	SCIENCE			English	Editorial Material									[Reid, Tahira; Gibert, James] Purdue Univ, Sch Mech Engn, 585 Purdue Mall, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Reid, T (corresponding author), Purdue Univ, Sch Mech Engn, 585 Purdue Mall, W Lafayette, IN 47907 USA.	tahira@purdue.edu						Allyn, 2020, NPR; Bhuyan J, 2020, TECHTRENDS, V64, P899, DOI 10.1007/s11528-020-00502-7; Bushwick S, 2021, SCI AM; Floridi L, 2020, SCI ENG ETHICS, V26, P1771, DOI 10.1007/s11948-020-00213-5; Foster C, 2013, EUR J DEV RES, V25, P333, DOI 10.1057/ejdr.2013.7; Grother P., 2019, FACE RECOGNITION V 3, DOI 10.6028/nist.ir.8280; Hambling D, 2021, NEW SCI; Howard A, 2018, SCI ENG ETHICS, V24, P1521, DOI 10.1007/s11948-017-9975-2; Ishak Z, 2012, PROCD SOC BEHV, V65, P793, DOI 10.1016/j.sbspro.2012.11.201; Salgado L, 2015, LECT NOTES COMPUT SC, V9169, P60, DOI 10.1007/978-3-319-20901-2_6; Selyukh Alina, 2016, NPR; Stern Howard, 2020, HOWARD STERN SH 0616; Syme S. L., 2004, PREV CHRONIC DIS, V1; Vascik Parker D., 2018, Journal of Air Transportation, V26, P133, DOI 10.2514/1.D0120; Wiggers K., 2020, VENTUREBEAT 0909	15	1	1	10	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2022	375	6577					149	150		10.1126/science.abf2618	http://dx.doi.org/10.1126/science.abf2618			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YG3OI	35025666				2022-12-28	WOS:000742401600019
J	Tanne, JH				Tanne, Janice Hopkins			Covid-19: US cases and hospital admissions climb to record levels as Biden promises more tests	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		American Red Cross, NAT BLOOD CRIS; [Anonymous], 2022, PBS NEWSHOUR; [Anonymous], 2022, CNBC; Karaian J., 2022, NEW YORK TIMES; Nirappil F., 2022, WASH POST; Shumaker L., 2022, REUTERS 0111; Yancey-Bragg N, 2022, USA TODAY	7	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 12	2022	376								o76	10.1136/bmj.o76	http://dx.doi.org/10.1136/bmj.o76			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YP6JI	35022227	Bronze			2022-12-28	WOS:000748728200003
J	Goldenberg, NA; Kittelson, JM; Abshire, TC; Bonaca, M; Casella, JF; Dale, RA; Halperin, JL; Hamblin, F; Kessler, CM; Manco-Johnson, MJ; Sidonio, RF; Spyropoulos, AC; Steg, PG; Turpie, AGG; Schulman, S				Goldenberg, Neil A.; Kittelson, John M.; Abshire, Thomas C.; Bonaca, Marc; Casella, James F.; Dale, Rita A.; Halperin, Jonathan L.; Hamblin, Frances; Kessler, Craig M.; Manco-Johnson, Marilyn J.; Sidonio, Robert F.; Spyropoulos, Alex C.; Steg, P. Gabriel; Turpie, Alexander G. G.; Schulman, Sam		Kids-DOTT Trial Investigat	Effect of Anticoagulant Therapy for 6 Weeks vs 3 Months on Recurrence and Bleeding Events in Patients Younger Than 21 Years of Age With Provoked Venous Thromboembolism The Kids-DOTT Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ANTITHROMBOTIC THERAPY; PULMONARY-EMBOLISM; THROMBOSIS; DURATION; CHILDREN; SAFETY; POINT; RISK; RACE	IMPORTANCE Among patients younger than 21 years of age, the optimal duration of anticoagulant therapy for venous thromboembolism is unknown. OBJECTIVE To test the hypothesis that a 6-week duration of anticoagulant therapy for provoked venous thromboembolism is noninferior to a conventional 3-month therapy duration in patients younger than 21 years of age. DESIGN, SETTING, AND PARTICIPANTS Randomized clinical trial involving 417 patients younger than 21 years of age with acute, provoked venous thromboembolism enrolled at 42 centers in 5 countries from 2008-2021. The main exclusions were severe anticoagulant deficiencies or prior venous thromboembolism. Patients without persistent antiphospholipid antibodies and whose thrombi were resolved or not completely occlusive upon repeat imaging at 6 weeks after diagnosis underwent randomization. The final visit for the primary end points occurred in January 2021. INTERVENTIONS Total duration for anticoagulant therapy of 6 weeks (n = 207) vs 3 months (n = 210) for provoked venous thromboembolism. MAIN OUTCOMES AND MEASURES The primary efficacy and safety end points were centrally adjudicated symptomatic recurrent venous thromboembolism and clinically relevant bleeding events within 1 year blinded to treatment group. The primary analysis was noninferiority in the per-protocol population. The noninferiority boundary incorporated a bivariate trade-off that induded an absolute increase of 0% in symptomatic recurrent venous thromboembolism with an absolute risk reduction of 4% in clinically relevant bleeding events (1 of 3 points on the bivariate noninferiority boundary curve). RESULTS Among 417 randomized patients, 297 (median age, 8.3 [range, 0.04-20.9] years; 49% female) met criteria for the primary per-protocol population analysis. The Kaplan-Meier estimate for the 1-year cumulative incidence of the primary efficacy outcome was 0.66% (95% CI, 0%-1.95%) in the 6-week anticoagulant therapy group and 0.70% (95% CI, 0%-2.07%) in the 3-month anticoagulant therapy group, and for the primary safety outcome, the incidence was 0.65% (95% CI, 0%1.91%) and 0.70% (95% CI, 0%-2.06%). Based on absolute risk differences in recurrent venous thromboembolism and clinically relevant bleeding events between groups, noninferiority was demonstrated. Adverse events occurred in 26% of patients in the 6-week anticoagulant therapy group and in 32% of patients in the 3-month anticoagulant therapy group; the most common adverse event was fever (1.9% and 3.4%, respectively). CONCLUSIONS AND RELEVANCE Among patients younger than 21 years of age with provoked venous thromboembolism, anticoagulant therapy for 6 weeks compared with 3 months met noninferiority criteria based on the trade-off between recurrent venous thromboembolism risk and bleeding risk.	[Goldenberg, Neil A.; Hamblin, Frances] Johns Hopkins All Childrens Hosp, Inst Clin & Translat Res, Canc & Blood Disorder Inst, St Petersburg, FL USA; [Goldenberg, Neil A.; Hamblin, Frances] Johns Hopkins All Childrens Hosp, Inst Heart, St Petersburg, FL USA; [Goldenberg, Neil A.; Casella, James F.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD USA; [Goldenberg, Neil A.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD USA; [Kittelson, John M.] Univ Colorado, Sch Publ Hlth, Dept Biostat, Anschutz Med Campus, Aurora, CO USA; [Goldenberg, Neil A.; Bonaca, Marc; Dale, Rita A.] CPC Clin Res, Aurora, CO USA; [Abshire, Thomas C.] Med Coll Wisconsin, Dept Pediat & Med, Milwaukee, WI USA; [Abshire, Thomas C.] Med Coll Wisconsin, Versiti Blood Res Inst, Milwaukee, WI USA; [Abshire, Thomas C.] Med Coll Wisconsin, Clin & Translat Sci Inst, Milwaukee, WI USA; [Bonaca, Marc] Univ Colorado, Sch Med, Div Cardiol, Anschutz Med Campus, Aurora, CO USA; [Halperin, Jonathan L.] Icahn Sch Med Mt Sinai, Cardiovasc Inst, New York, NY 10029 USA; [Kessler, Craig M.] Georgetown Univ, Lombardi Canc Ctr, Dept Med, Sch Med, Washington, DC USA; [Manco-Johnson, Marilyn J.] Univ Colorado, Dept Pediat, Sch Med, Childrens Hosp Colorado,Hemophilia & Thrombosis C, Anschutz Med Campus, Aurora, CO USA; [Sidonio, Robert F.] Emory Univ, Sch Med, Childrens Healthcare Atlanta, Dept Pediat, Atlanta, GA USA; [Spyropoulos, Alex C.] Northwell & Feinstein Inst Med Res, Dept Med, Zucker Sch Med Hofstra, Manhasset, NY USA; [Spyropoulos, Alex C.; Schulman, Sam] IM Sechenov First Moscow State Med Univ, Dept Obstet & Gynecol, Moscow, Russia; [Steg, P. Gabriel] Univ Paris, Hop Bichat, AP HP, French Alliance Cardiovasc Trials & INSERM, F-1148 Paris, France; [Turpie, Alexander G. G.; Schulman, Sam] McMaster Univ, Dept Med, Thrombosis & Atherosclerosis Res Inst, Hamilton, ON, Canada	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; University of Colorado System; University of Colorado Anschutz Medical Campus; Icahn School of Medicine at Mount Sinai; Georgetown University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Healthcare of Atlanta (CHOA); Emory University; Sechenov First Moscow State Medical University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; McMaster University	Goldenberg, NA (corresponding author), Johns Hopkins All Childrens Hosp, Inst Clin & Translat Res, 600 Fifth St S,Ste 3200, St Petersburg, FL 33701 USA.	neil@jhmi.edu	Chan, Anthony K. C./AAR-8892-2021	Chan, Anthony K. C./0000-0003-1551-3995; Ahuja, Sanjay/0000-0002-0178-7947; Kumar, Riten/0000-0001-8004-4190	National Heart, Lung, and Blood Institute [1U01HL130048, 1K23HL084055]; Bridge Award from the American Society of Hematology; Thrombosis Studies Award from the Hemophilia and Thrombosis Research Society of North America; Eisai Inc; Johns Hopkins All Children's Foundation	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Bridge Award from the American Society of Hematology; Thrombosis Studies Award from the Hemophilia and Thrombosis Research Society of North America; Eisai Inc(Eisai Co Ltd); Johns Hopkins All Children's Foundation	This work was funded by grants 1U01HL130048 and 1K23HL084055 from the National Heart, Lung, and Blood Institute; the Bridge Award from the American Society of Hematology; the Thrombosis Studies Award from the Hemophilia and Thrombosis Research Society of North America; an investigator-initiated studies award from Eisai Inc; and an institutional research award from the Johns Hopkins All Children's Foundation.	Aujesky D, 2007, J CLIN EPIDEMIOL, V60, P410, DOI 10.1016/j.jclinepi.2006.06.023; BARRITT DW, 1960, LANCET, V1, P1309; Chi G, 2017, J THROMB HAEMOST, V15, P1913, DOI 10.1111/jth.13783; Emerson SS, 2007, STAT MED, V26, P5047, DOI 10.1002/sim.2901; Fay MP, 2015, BIOMETRICS, V71, P146, DOI 10.1111/biom.12231; Goldenberg NA, 2015, J THROMB HAEMOST, V13, P1597, DOI 10.1111/jth.13038; Goldenberg NA, 2010, CONTEMP CLIN TRIALS, V31, P131, DOI 10.1016/j.cct.2009.11.006; Halton J, 2021, LANCET HAEMATOL, V8, pE22, DOI 10.1016/S2352-3026(20)30368-9; Hu JX, 2020, STAT MED, V39, P3823, DOI 10.1002/sim.8696; Kahn SR, 2008, ANN INTERN MED, V149, P698, DOI 10.7326/0003-4819-149-10-200811180-00004; Kearon C, 2016, CHEST, V149, P315, DOI 10.1016/j.chest.2015.11.026; Kittelson JM, 2013, J THROMB HAEMOST, V11, P1443, DOI 10.1111/jth.12324; Kittelson JM, 2016, THROMB HAEMOSTASIS, V116, P544, DOI 10.1160/TH15-12-1000; Male C, 2020, LANCET HAEMATOL, V7, pE18, DOI 10.1016/S2352-3026(19)30219-4; Mitchell LG, 2011, J THROMB HAEMOST, V9, P1856, DOI 10.1111/j.1538-7836.2011.04433.x; Monagle P, 2008, CHEST, V133, p887S, DOI 10.1378/chest.08-0762; Monagle P, 2018, BLOOD ADV, V2, P3292, DOI 10.1182/bloodadvances.2018024786; Monagle P, 2012, CHEST, V141, pE737S, DOI 10.1378/chest.11-2308; Prandoni P, 1996, ANN INTERN MED, V125, P1, DOI 10.7326/0003-4819-125-1-199607010-00001; Revel-Vilk S, 2012, J Thromb Haemost, V10, P2182; SCHULMAN S, 1995, NEW ENGL J MED, V332, P1661, DOI 10.1056/NEJM199506223322501; Spyropoulos AC, 2012, J THROMB HAEMOST, V10, P2621, DOI 10.1111/jth.12005; White RH, 2009, THROMB RES, V123, pS11, DOI 10.1016/S0049-3848(09)70136-7	23	15	15	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 11	2022	327	2					129	137		10.1001/jama.2021.23182	http://dx.doi.org/10.1001/jama.2021.23182			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YH8QV	35015038	Green Published			2022-12-28	WOS:000743426500014
J	Borio, LL; Bright, RA; Emanuel, EJ				Borio, Luciana L.; Bright, Rick A.; Emanuel, Ezekiel J.			A National Strategy for COVID-19 Medical Countermeasures Vaccines and Therapeutics	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Borio, Luciana L.] Council Foreign Relat, New York, NY USA; [Bright, Rick A.] Rockefeller Fdn, New York, NY USA; [Emanuel, Ezekiel J.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Emanuel, Ezekiel J.] Univ Penn, Wharton Sch, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Emanuel, EJ (corresponding author), Univ Penn, Perelman Sch Med, Med Eth & Hlth Policy, 423 Guardian Dr,Blockley Hall Ste 1412, Philadelphia, PA 19104 USA.	zemanuel@upenn.edu						Abbott B., WALL STR J; Cohen MS, 2021, NEW ENGL J MED, V384, P289, DOI 10.1056/NEJMe2034495; Feuerstein A., INEXPENSIVE STEROIDS; Lovelace B., MODERNA SHARES RISE; McNeil DG, NEW YORK TIMES; Merck & Co. Inc, MERCK RIDG INV OR AN; Our World in Data, 2021, DAIL NEW CONF COVID; Pfizer Inc, PFIZ NOV COVID 19 OR	8	8	8	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 18	2022	327	3					215	216		10.1001/jama.2021.24165	http://dx.doi.org/10.1001/jama.2021.24165		JAN 2022	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YV9PQ	34989782	Bronze			2022-12-28	WOS:000739988300002
J	Varadarajan, SG; Hunyara, JL; Hamilton, NR; Kolodkin, AL; Huberman, AD				Varadarajan, Supraja G.; Hunyara, John L.; Hamilton, Natalie R.; Kolodkin, Alex L.; Huberman, Andrew D.			Central nervous system regeneration	CELL			English	Review							SPINAL-CORD-INJURY; RETINAL GANGLION-CELLS; LEUCINE-ZIPPER KINASE; PROMOTES AXON REGENERATION; OPTIC-NERVE; WALLERIAN DEGENERATION; FUNCTIONAL RECOVERY; GROWTH CONE; ADULT CNS; NEURONAL SURVIVAL	Neurons of the mammalian central nervous system fail to regenerate. Substantial progress has been made toward identifying the cellular and molecular mechanisms that underlie regenerative failure and how altering those pathways can promote cell survival and/or axon regeneration. Here, we summarize those findings while comparing the regenerative process in the central versus the peripheral nervous system. We also highlight studies that advance our understanding of the mechanisms underlying neural degeneration in response to injury, as many of these mechanisms represent primary targets for restoring functional neural circuits.	[Varadarajan, Supraja G.; Huberman, Andrew D.] Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA; [Hunyara, John L.; Hamilton, Natalie R.; Kolodkin, Alex L.] Johns Hopkins Univ, Solomon H Snyder Dept Neurosci, Sch Med, Baltimore, MD 21205 USA; [Huberman, Andrew D.] Stanford Univ, Dept Ophthalmol, Stanford, CA 94305 USA	Stanford University; Johns Hopkins University; Stanford University	Huberman, AD (corresponding author), Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA.; Kolodkin, AL (corresponding author), Johns Hopkins Univ, Solomon H Snyder Dept Neurosci, Sch Med, Baltimore, MD 21205 USA.; Huberman, AD (corresponding author), Stanford Univ, Dept Ophthalmol, Stanford, CA 94305 USA.	kolodkin@jhmi.edu; adh1@stanford.edu		Varadarajan, Supraja/0000-0001-9666-3295; Kolodkin, Alex/0000-0001-7562-5513; Hunyara, John/0000-0002-7885-6525	Gilbert Family Foundation Vision Restoration Initiative; National Science Foundation Graduate Research Fellowship Program (NSF GRFP); Knights Templar Eye Foundation;  [EY027713]	Gilbert Family Foundation Vision Restoration Initiative; National Science Foundation Graduate Research Fellowship Program (NSF GRFP)(National Science Foundation (NSF)NSF - Office of the Director (OD)); Knights Templar Eye Foundation; 	We thank Roman Giger, Jeffrey Goldberg, and Zhigang He for helpful comments on this manuscript. All illustrations were drawn by Natalie Hamilton. Work in the authors' laboratories is supported by EY027713 to A.L.K. and A.D.H., The Gilbert Family Foundation Vision Restoration Initiative to A.D.H., National Sci-ence Foundation Graduate Research Fellowship Program (NSF GRFP) to N.R.H., and Knights Templar Eye Foundation Career Starter Grant to S.G.V.	Adams KL, 2018, NAT NEUROSCI, V21, P9, DOI 10.1038/s41593-017-0033-9; Ambacher KK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046885; AMBROS V, 1984, SCIENCE, V226, P409, DOI 10.1126/science.6494891; Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Andrews MR, 2009, J NEUROSCI, V29, P5546, DOI 10.1523/JNEUROSCI.0759-09.2009; Barritt AW, 2006, J NEUROSCI, V26, P10856, DOI 10.1523/JNEUROSCI.2980-06.2006; Bashaw GJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001941; Beck KD, 2010, BRAIN, V133, P433, DOI 10.1093/brain/awp322; Bei FF, 2016, CELL, V164, P219, DOI 10.1016/j.cell.2015.11.036; Bellver-Landete V, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08446-0; BISBY MA, 1990, BRAIN RES, V530, P117, DOI 10.1016/0006-8993(90)90666-Y; Bradke F, 2012, NAT REV NEUROSCI, V13, P183, DOI 10.1038/nrn3176; Bray ER, 2019, NEURON, V103, P642, DOI 10.1016/j.neuron.2019.05.044; Bray ER, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0093-17.2017; BROWN MC, 1991, NEURON, V6, P359, DOI 10.1016/0896-6273(91)90245-U; Bundesen LQ, 2003, J NEUROSCI, V23, P7789; Ceto S, 2020, CELL STEM CELL, V27, P430, DOI 10.1016/j.stem.2020.07.007; Chandran V, 2016, NEURON, V89, P956, DOI 10.1016/j.neuron.2016.01.034; Chang KC, 2021, ENEURO, V8, DOI 10.1523/ENEURO.0358-20.2020; Chedotal A, 2019, NAT REV NEUROSCI, V20, P380, DOI 10.1038/s41583-019-0168-7; Collyer E, 2014, EXP NEUROL, V261, P451, DOI 10.1016/j.expneurol.2014.07.014; Conta AC, 2004, J COMP NEUROL, V479, P347, DOI 10.1002/cne.20319; Crair MC, 2016, J NEUROSCI, V36, P10707, DOI 10.1523/JNEUROSCI.1711-16.2016; Cui Q, 2015, NEUROSCIENCE, V284, P845, DOI 10.1016/j.neuroscience.2014.11.002; Cummings BJ, 2005, P NATL ACAD SCI USA, V102, P14069, DOI 10.1073/pnas.0507063102; DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034; de Lima S, 2012, P NATL ACAD SCI USA, V109, P9149, DOI 10.1073/pnas.1119449109; Dougherty SE, 2020, EXP NEUROL, V323, DOI 10.1016/j.expneurol.2019.113089; Duan HM, 2015, P NATL ACAD SCI USA, V112, P13360, DOI 10.1073/pnas.1510176112; Duan X, 2015, NEURON, V85, P1244, DOI 10.1016/j.neuron.2015.02.017; Duffy P, 2012, P NATL ACAD SCI USA, V109, P5063, DOI 10.1073/pnas.1113953109; Evans TA, 2014, EXP NEUROL, V254, P109, DOI 10.1016/j.expneurol.2014.01.013; Fernandes KA, 2018, EXP EYE RES, V171, P54, DOI 10.1016/j.exer.2018.03.007; Figley MD, 2021, NEURON, V109, DOI 10.1016/j.neuron.2021.02.009; Filbin MT, 2003, NAT REV NEUROSCI, V4, P703, DOI 10.1038/nrn1195; Fischer D, 2017, EXP NEUROL, V296, P83, DOI 10.1016/j.expneurol.2017.07.008; Fouad K, 2001, CURR BIOL, V11, P1766, DOI 10.1016/S0960-9822(01)00535-8; GEORGE R, 1994, EXP NEUROL, V129, P225, DOI 10.1006/exnr.1994.1164; Gerdts J, 2015, SCIENCE, V348, P453, DOI 10.1126/science.1258366; Giger RJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001867; Gilley J, 2017, CELL REP, V21, P10, DOI 10.1016/j.celrep.2017.09.027; Goldberg JL, 2002, NEURON, V33, P689, DOI 10.1016/S0896-6273(02)00602-5; Greenhalgh AD, 2020, NAT REV NEUROSCI, V21, P139, DOI 10.1038/s41583-020-0263-9; Guo XZ, 2021, CELL, V184, P4299, DOI 10.1016/j.cell.2021.06.031; Guttenplan KA, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107776; Hains BC, 2003, J COMP NEUROL, V462, P328, DOI 10.1002/cne.10733; Harel NY, 2006, NAT REV NEUROSCI, V7, P603, DOI 10.1038/nrn1957; Hassannejad Z, 2018, IRAN J BASIC MED SCI, V21, P546, DOI 10.22038/IJBMS.2018.24239.6052; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; He ZG, 2016, NEURON, V90, P437, DOI 10.1016/j.neuron.2016.04.022; Hertz NT, 2019, NEURON, V103, P412, DOI 10.1016/j.neuron.2019.05.030; Hoffman PN, 2010, EXP NEUROL, V223, P11, DOI 10.1016/j.expneurol.2009.09.006; HOLLANDER H, 1985, EXP BRAIN RES, V59, P633; Hollis ER, 2016, NAT NEUROSCI, V19, P697, DOI 10.1038/nn.4282; Hollis ER, 2009, EXP NEUROL, V215, P53, DOI 10.1016/j.expneurol.2008.09.014; Hou YJ, 2019, NAT REV NEUROL, V15, P565, DOI 10.1038/s41582-019-0244-7; Jessen KR, 2016, J PHYSIOL-LONDON, V594, P3521, DOI 10.1113/JP270874; Jin D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9074; Jin YJ, 2016, NEURON, V91, P748, DOI 10.1016/j.neuron.2016.07.024; Joly S, 2014, EUR J NEUROSCI, V40, P3021, DOI 10.1111/ejn.12677; Kadoya K, 2016, NAT MED, V22, P479, DOI 10.1038/nm.4066; Kadoya K, 2009, NEURON, V64, P165, DOI 10.1016/j.neuron.2009.09.016; Kalinski AL, 2020, ELIFE, V9, DOI 10.7554/eLife.60223; Kang H, 2014, J NEUROSCI, V34, P6323, DOI 10.1523/JNEUROSCI.4673-13.2014; Kang H, 2013, J NEUROSCI, V33, P19480, DOI 10.1523/JNEUROSCI.4067-13.2013; Kerschensteiner M, 2005, NAT MED, V11, P572, DOI 10.1038/nm1229; Knoferle J, 2010, P NATL ACAD SCI USA, V107, P6064, DOI 10.1073/pnas.0909794107; Koeberle PD, 2010, NEUROSCIENCE, V169, P495, DOI 10.1016/j.neuroscience.2010.04.079; Kuhlmann T, 2002, J NEUROSCI RES, V67, P185, DOI 10.1002/jnr.10104; Kumamaru H, 2019, CELL REP, V26, P2329, DOI 10.1016/j.celrep.2019.01.099; Lee H, 2010, P NATL ACAD SCI USA, V107, P3340, DOI 10.1073/pnas.0905437106; Leibinger M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.310; Li C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14242; Li SY, 2008, CELL MOL NEUROBIOL, V28, P1095, DOI 10.1007/s10571-008-9286-x; Li Y, 2020, NATURE, V587, P613, DOI 10.1038/s41586-020-2795-6; Li YQ, 2017, P NATL ACAD SCI USA, V114, pE209, DOI 10.1073/pnas.1616811114; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Lilley BN, 2019, J COMP NEUROL, V527, P282, DOI 10.1002/cne.24507; Lim JHA, 2016, NAT NEUROSCI, V19, P1073, DOI 10.1038/nn.4340; Liu K, 2010, NAT NEUROSCI, V13, P1075, DOI 10.1038/nn.2603; Lu YC, 2020, NATURE, V588, P124, DOI 10.1038/s41586-020-2975-4; Luo XT, 2013, EXP NEUROL, V247, P653, DOI 10.1016/j.expneurol.2013.03.001; Lutz AB, 2017, P NATL ACAD SCI USA, V114, pE8072, DOI 10.1073/pnas.1710566114; Ma M, 2013, NEUROBIOL DIS, V60, P61, DOI 10.1016/j.nbd.2013.08.010; Mahar M, 2018, NAT REV NEUROSCI, V19, P323, DOI 10.1038/s41583-018-0001-8; Massey JM, 2006, J NEUROSCI, V26, P4406, DOI 10.1523/JNEUROSCI.5467-05.2006; Meyer-Franke A, 1998, NEURON, V21, P681, DOI 10.1016/S0896-6273(00)80586-3; Miller GM, 2015, EXP NEUROL, V274, P115, DOI 10.1016/j.expneurol.2015.08.015; Moon LDF, 2001, NAT NEUROSCI, V4, P465, DOI 10.1038/87415; Moore DL, 2009, SCIENCE, V326, P298, DOI 10.1126/science.1175737; Morenilla-Palao C, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz8797; Mothe AJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10987-7; Muller LPD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093274; Muir E, 2019, EXP NEUROL, V321, DOI 10.1016/j.expneurol.2019.113032; Nathan FM, 2020, MOL THER, V28, P1902, DOI 10.1016/j.ymthe.2020.04.010; Nawabi H, 2015, NEURON, V88, P704, DOI 10.1016/j.neuron.2015.10.005; Neumann S, 2002, NEURON, V34, P885, DOI 10.1016/S0896-6273(02)00702-X; Neumann S, 1999, NEURON, V23, P83, DOI 10.1016/S0896-6273(00)80755-2; Norsworthy MW, 2017, NEURON, V94, P1112, DOI 10.1016/j.neuron.2017.05.035; Osterloh JM, 2012, SCIENCE, V337, P481, DOI 10.1126/science.1223899; Overman JJ, 2012, P NATL ACAD SCI USA, V109, pE2230, DOI 10.1073/pnas.1204386109; Park JY, 2013, NEURAL REGEN RES, V8, P3401, DOI 10.3969/j.issn.1673-5374.2013.36.005; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Pasterkamp RJ, 2001, EUR J NEUROSCI, V13, P457, DOI 10.1046/j.0953-816X.2000.01398.x; Pernet V, 2014, TRENDS NEUROSCI, V37, P381, DOI 10.1016/j.tins.2014.05.002; Pernet V, 2013, NEUROBIOL DIS, V51, P202, DOI 10.1016/j.nbd.2012.11.011; PERRY VH, 1990, EUR J NEUROSCI, V2, P408, DOI 10.1111/j.1460-9568.1990.tb00433.x; Petros TJ, 2008, ANNU REV NEUROSCI, V31, P295, DOI 10.1146/annurev.neuro.31.060407.125609; Poplawski GHD, 2020, NATURE, V581, P77, DOI 10.1038/s41586-020-2200-5; Renthal W, 2020, NEURON, V108, P128, DOI 10.1016/j.neuron.2020.07.026; Ribas VT, 2017, MOL NEUROBIOL, V54, P72, DOI 10.1007/s12035-015-9676-2; Rosenzweig ES, 2019, NAT NEUROSCI, V22, P1269, DOI 10.1038/s41593-019-0424-1; Ruschel J, 2015, SCIENCE, V348, P347, DOI 10.1126/science.aaa2958; Sasaki Y, 2016, ELIFE, V5, DOI 10.7554/eLife.19749; Schwab ME, 1996, PHYSIOL REV, V76, P319, DOI 10.1152/physrev.1996.76.2.319; Shin JE, 2012, NEURON, V74, P1015, DOI 10.1016/j.neuron.2012.04.028; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Simon DJ, 2021, DEV CELL, V56, P976, DOI 10.1016/j.devcel.2021.03.011; Simon DJ, 2016, CELL, V164, P1031, DOI 10.1016/j.cell.2016.01.032; SON YJ, 1995, NEURON, V14, P125, DOI 10.1016/0896-6273(95)90246-5; Stern S, 2021, NEURON, V109, P3436, DOI 10.1016/j.neuron.2021.08.014; Steward O, 2017, EXP NEUROL, V287, P374, DOI 10.1016/j.expneurol.2016.06.029; Sun F, 2011, NATURE, V480, P372, DOI 10.1038/nature10594; Symonds ACE, 2007, EUR J NEUROSCI, V25, P744, DOI 10.1111/j.1460-9568.2007.05321.x; Terenzio M, 2018, SCIENCE, V359, P1416, DOI 10.1126/science.aan1053; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Tian WL, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-0776-9; Tom VJ, 2004, J NEUROSCI, V24, P6531, DOI 10.1523/JNEUROSCI.0994-04.2004; Trakhtenberg EF, 2018, EXP NEUROL, V300, P22, DOI 10.1016/j.expneurol.2017.10.025; Tran AP, 2022, CELL TISSUE RES, V387, P319, DOI 10.1007/s00441-021-03477-w; Tran NM, 2019, NEURON, V104, P1039, DOI 10.1016/j.neuron.2019.11.006; Ueno M, 2020, CEREB CORTEX, V30, P5702, DOI 10.1093/cercor/bhaa142; Vargas ME, 2007, ANNU REV NEUROSCI, V30, P153, DOI 10.1146/annurev.neuro.30.051606.094354; Vargas ME, 2010, P NATL ACAD SCI USA, V107, P11993, DOI 10.1073/pnas.1001948107; Venugopalan P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10472; Wang JT, 2015, P NATL ACAD SCI USA, V112, P10093, DOI 10.1073/pnas.1508337112; Wang XW, 2018, CELL REP, V24, P2540, DOI 10.1016/j.celrep.2018.07.105; Watkins TA, 2013, P NATL ACAD SCI USA, V110, P4039, DOI 10.1073/pnas.1211074110; Welsbie DS, 2017, NEURON, V94, P1142, DOI 10.1016/j.neuron.2017.06.008; Welsbie DS, 2013, P NATL ACAD SCI USA, V110, P4045, DOI 10.1073/pnas.1211284110; Weng YL, 2017, NEURON, V94, P337, DOI 10.1016/j.neuron.2017.03.034; Williams PR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6683; Zhang YL, 2019, NEURON, V103, P39, DOI 10.1016/j.neuron.2019.04.033; Zhang ZY, 1996, J COMP NEUROL, V371, P485; Zhou X, 2020, NAT NEUROSCI, V23, P337, DOI 10.1038/s41593-020-0597-7	145	15	15	24	56	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 6	2022	185	1					77	94		10.1016/j.cell.2021.10.029	http://dx.doi.org/10.1016/j.cell.2021.10.029			18	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	YL5FO	34995518				2022-12-28	WOS:000745916700006
J	Feinmann, J				Feinmann, Jane			The BMJ appeal 2021-22: "Without this team there would have been many more deaths"-the MSF workers dealing with mass casualty incidents in Afghanistan	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jane@janefeinmann.com						O'Dowd A, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5324	1	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 5	2022	376								n3101	10.1136/bmj.n3101	http://dx.doi.org/10.1136/bmj.n3101			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YI8XS	34987060				2022-12-28	WOS:000744126400001
J	Mahase, E				Mahase, Elisabeth			Omicron: South Africa says fourth wave peak has passed as it lifts curfew	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Department of Health (South Africa), 2021, CAB APPR CHANG COV 1; Dyer O, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n3104; Jassat W, LANCET; Mahase E, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n3151	4	5	5	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 5	2022	376								o7	10.1136/bmj.o7	http://dx.doi.org/10.1136/bmj.o7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YI8XS	34987026	Bronze			2022-12-28	WOS:000744126400008
J	Bates, ER				Bates, Eric R.			In HFpEF, adding empagliflozin to usual care reduced a composite of CV death or HF hospitalization at a median 26 mo	ANNALS OF INTERNAL MEDICINE			English	Editorial Material								Question: In patients with chronic heart failure (HF) and preserved ejection fraction (pEF), does adding empagliflozin to usual therapy improve major HF outcomes? Design: Randomized placebo-controlled trial (EMPEROR-Preserved [Empagliflozin Outcome Trial in Patients with Chronic Heart Failure with Preserved Ejection Fraction]). Blinding: Treatment allocation concealed; blinded (patients, investigators, other staff involved in trial conduct and analysis, and clinical event adjudication committee).* Setting: 622 centers in 23 countries. Patients: 5988 patients aged >= 18 years (mean age, 72 y; 55% men; 33% with left ventricular EF [LVEF] >= 60%; 49% with diabetes; mean estimated glomerular filtration rate, 61 mL/min/1.73 m(2)) who had chronic HF (New York Heart Association class II to IV), LVEF >40%, and N-terminal pro-Btype natriuretic peptide level >300 pg/mL (>900 pg/mL in patients with atrial fibrillation). Key exclusions: conditions that could affect patient safety or independently affect clinical course. Interventions: Empagliflozin, 10 mg/d (n = 2997), or placebo (n = 2991), added to usual therapy.	[Bates, Eric R.] Univ Michigan, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Bates, ER (corresponding author), Univ Michigan, Ann Arbor, MI 48109 USA.							Kosiborod, 2021, 12 SEP 2021 HEART FA; McMurray JJV, 2019, NEW ENGL J MED, V381, P1995, DOI 10.1056/NEJMoa1911303; Packer M, 2020, NEW ENGL J MED, V383, P1413, DOI 10.1056/NEJMoa2022190; Redfield MM, 2016, NEW ENGL J MED, V375, P1868, DOI 10.1056/NEJMcp1511175; Zelniker TA, 2019, LANCET, V393, P31, DOI 10.1016/S0140-6736(18)32590-X	5	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN	2022	175	1					JC4	JC4		10.7326/J21-0006	http://dx.doi.org/10.7326/J21-0006		JAN 2022	1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0Y3LO	34978853				2022-12-28	WOS:000742139400001
J	Heliotis, I; Whatling, R; Desai, S; Visavadia, M				Heliotis, Isabelle; Whatling, Rosemary; Desai, Shinal; Visavadia, Medona			Primary herpetic gingivostomatitis in children	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ACYCLOVIR		[Heliotis, Isabelle; Whatling, Rosemary] Royal London Dent Hosp, London, England; [Desai, Shinal] Birmingham Dent Hosp, Birmingham, W Midlands, England; [Visavadia, Medona] Watford Hlth Ctr, Watford, England	University of Birmingham	Heliotis, I (corresponding author), Royal London Dent Hosp, London, England.	Isabelle.heliotis@nhs.net						Amir J, 1997, BRIT MED J, V314, P1800, DOI 10.1136/bmj.314.7097.1800; [Anonymous], 2009, DIARRHOEA VOMITING C; Brookes ZLS, 2020, J DENT, V103, DOI 10.1016/j.jdent.2020.103497; Cammarata-Scalisi F, 2020, CANCERS, V12, DOI 10.3390/cancers12061634; Georgiou A, CONT ORAL MED, V1st, DOI [10.1007/978-3-319-72303-7_25, DOI 10.1007/978-3-319-72303-7_25]; Goldman RD, 2016, CAN FAM PHYSICIAN, V62, P403; National Institute for Health and Care Excellence, 2016, HERP SIMPL OR; Odell E. W., 2017, CAWSONS ESSENTIALS O; Padmini Chiyadu, 2014, ISRN Hematol, V2014, P895721, DOI 10.1155/2014/895721; Scully C., 2014, SCULLYS MEDICAL PROB, V7th ed.; Stoopler ET, 2014, MED CLIN N AM, V98, P1323, DOI 10.1016/j.mcna.2014.08.006; Thomas E, 2007, BRIT DENT J, V203, P33, DOI 10.1038/bdj.2007.585; Welbury W, 2012, PAEDIAT DENTISTRY, V4th	13	1	1	3	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 31	2021	375								e065540	10.1136/bmj-2021-065540	http://dx.doi.org/10.1136/bmj-2021-065540			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YD6KP	34972691				2022-12-28	WOS:000740549300002
J	Akey, CW; Singh, D; Ouch, C; Echeverria, I; Nudelman, I; Varberg, JM; Yu, ZL; Fang, F; Shi, Y; Wang, JJ; Salzberg, D; Song, KK; Xu, C; Gumbart, JC; Suslov, S; Unruh, J; Jaspersen, SL; Chait, BT; Sali, A; Fernandez-Martinez, J; Ludtke, SJ; Villa, E; Rout, MP				Akey, Christopher W.; Singh, Digvijay; Ouch, Christna; Echeverria, Ignacia; Nudelman, Ilona; Varberg, Joseph M.; Yu, Zulin; Fang, Fei; Shi, Yi; Wang, Junjie; Salzberg, Daniel; Song, Kangkang; Xu, Chen; Gumbart, James C.; Suslov, Sergey; Unruh, Jay; Jaspersen, Sue L.; Chait, Brian T.; Sali, Andrej; Fernandez-Martinez, Javier; Ludtke, Steven J.; Villa, Elizabeth; Rout, Michael P.			Comprehensive structure and functional adaptations of the yeast nuclear pore complex	CELL			English	Article							MOLECULAR ARCHITECTURE; INNER RING; INTEGRATIVE STRUCTURE; MEMBRANE-PROTEINS; HEPTAMERIC MODULE; BASKET PROTEINS; IMPORTIN-BETA; CRYO-EM; TRANSPORT; DOMAIN	Nuclear pore complexes (NPCs) mediate the nucleocytoplasmic transport of macromolecules. Here we provide a structure of the isolated yeast NPC in which the inner ring is resolved by cryo-EM at sub-nanometer resolution to show how flexible connectors tie together different structural and functional layers. These connectors may be targets for phosphorylation and regulated disassembly in cells with an open mitosis. Moreover, some nucleoporin pairs and transport factors have similar interaction motifs, which suggests an evolutionary and mechanistic link between assembly and transport. We provide evidence for three major NPC variants that may foreshadow functional specializations at the nuclear periphery. Cryo-electron tomography extended these studies, providing a model of the in situ NPC with a radially expanded inner ring. Our comprehensive model reveals features of the nuclear basket and central transporter, suggests a role for the lumenal Pom152 ring in restricting dilation, and highlights structural plasticity that may be required for transport.	[Akey, Christopher W.; Ouch, Christna] Boston Univ, Dept Physiol & Biophys, Sch Med, 700 Albany St, Boston, MA 02118 USA; [Singh, Digvijay; Suslov, Sergey; Villa, Elizabeth] Univ Calif San Diego, Div Biol Sci, Sect Mol Biol, La Jolla, CA 92093 USA; [Ouch, Christna; Song, Kangkang; Xu, Chen] Univ Massachusetts, Dept Biochem & Mol Pharmacol, Med Sch, 364 Plantat St, Worcester, MA 01605 USA; [Echeverria, Ignacia; Salzberg, Daniel; Sali, Andrej] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Nudelman, Ilona; Fernandez-Martinez, Javier; Rout, Michael P.] Rockefeller Univ, Lab Cellular & Struct Biol, New York, NY 10065 USA; [Fang, Fei; Shi, Yi] Univ Pittsburgh, Dept Cell Biol, Pittsburgh, PA USA; [Wang, Junjie; Chait, Brian T.] Rockefeller Univ, Lab Mass Spectrometry & Gaseous Ion Chem, 1230 York Ave, New York, NY 10021 USA; [Gumbart, James C.] Georgia Inst Technol, Sch Phys, Atlanta, GA 30332 USA; [Varberg, Joseph M.; Yu, Zulin; Unruh, Jay; Jaspersen, Sue L.] Stowers Inst Med Res, Kansas City, MO USA; [Jaspersen, Sue L.] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66103 USA; [Ludtke, Steven J.] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, 1 Baylor Plaza, Houston, TX 77030 USA; [Echeverria, Ignacia] Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Sali, Andrej] Univ Calif San Francisco, Quantitat Biosci Inst, San Francisco, CA 94158 USA; [Sali, Andrej] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Villa, Elizabeth] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Fernandez-Martinez, Javier] Basque Fdn Sci, Ikerbasque, Bilbao 48013, Spain; [Fernandez-Martinez, Javier] Univ Basque Country, Inst Biofis, UPV EHU, CSIC, Leioa 48940, Spain	Boston University; University of California System; University of California San Diego; University of Massachusetts System; University of Massachusetts Worcester; University of California System; University of California San Francisco; Rockefeller University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Rockefeller University; University System of Georgia; Georgia Institute of Technology; Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center; Baylor College of Medicine; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Diego; Basque Foundation for Science; Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika	Villa, E (corresponding author), Univ Calif San Diego, Div Biol Sci, Sect Mol Biol, La Jolla, CA 92093 USA.; Fernandez-Martinez, J; Rout, MP (corresponding author), Rockefeller Univ, Lab Cellular & Struct Biol, New York, NY 10065 USA.; Ludtke, SJ (corresponding author), Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, 1 Baylor Plaza, Houston, TX 77030 USA.; Villa, E (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA.; Fernandez-Martinez, J (corresponding author), Basque Fdn Sci, Ikerbasque, Bilbao 48013, Spain.; Fernandez-Martinez, J (corresponding author), Univ Basque Country, Inst Biofis, UPV EHU, CSIC, Leioa 48940, Spain.	cakey@bu.edu; jfernandez@rockefeller.edu; sludtke@bcm.edu; evilla@ucsd.edu; rout@rockefeller.edu	Fernandez-Martinez, Javier/HGC-9122-2022; Fernandez-Martinez, Javier/ABD-9112-2020; Fang, Fei/AHD-3579-2022; Wang, Junjie/K-7509-2014; Shi, Yi/P-7972-2018; Villa, Elizabeth/D-1811-2010	Fernandez-Martinez, Javier/0000-0003-0567-498X; Fang, Fei/0000-0003-0829-9871; Ouch, Christna/0000-0003-4116-1217; Wang, Junjie/0000-0002-0587-2209; Singh, Digvijay/0000-0002-7411-4436; Shi, Yi/0000-0002-2761-8324; Villa, Elizabeth/0000-0003-4677-9809	Damon Runyon Postdoctoral Fellowship [DRG-2364-19]; Ruth L. Kirschstein NRSA Postdoctoral Fellowship [F32 GM133096]; NIH [P41 GM109824, R01 GM112108, R01 GM117212, R01 GM45377, P01 GM121203, R01 GM080139, DP2 GM123494, NSF-1818129]; Pew Scholars Program [MRI DBI 1920374]; Stowers Institute for Medical Research; University of California San Diego	Damon Runyon Postdoctoral Fellowship; Ruth L. Kirschstein NRSA Postdoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Scholars Program; Stowers Institute for Medical Research; University of California San Diego(University of California System)	We thank members of the Chait, Villa, and Rout laboratories for technical and intellectual support. D.S. is supported by a Damon Runyon Postdoctoral Fellowship (DRG-2364-19). J.M.V. was funded by an Ruth L. Kirschstein NRSA Postdoctoral Fellowship (F32 GM133096). This work was supported by NIH P41 GM109824 (B.T.C., M.P.R., and A.S.), NIH R01 GM112108 and R01 GM117212 (M.P.R.), NIH R01 GM45377 (C.W.A.), NIH P01 GM121203 and NIH R01 GM080139 (S.J.L.), NIH DP2 GM123494 (E.V.), NSF-1818129 (J.F.-M.), the Pew Scholars Program (E.V.), NSF MRI DBI 1920374 (E.V.),and the Stowers Institute for Medical Research (S.L.J.). E.V. is an investigator of the Howard Hughes Medical Institute. We acknowledge the use of the UC San Diego cryo-EM facility, which was built and equipped with funds from the University of California San Diego and an initial gift from Agouron Institute.	Afonine PV, 2018, ACTA CRYSTALLOGR D, V74, P531, DOI 10.1107/S2059798318006551; AKEY CW, 1993, J CELL BIOL, V122, P1, DOI 10.1083/jcb.122.1.1; Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Alber F, 2007, NATURE, V450, P683, DOI 10.1038/nature06404; Allegretti M, 2020, NATURE, V586, P796, DOI 10.1038/s41586-020-2670-5; Amlacher S, 2011, CELL, V146, P277, DOI 10.1016/j.cell.2011.06.039; Andersen KR, 2013, ELIFE, V2, DOI 10.7554/eLife.00745; Antonin W, 2011, NUCLEUS-AUSTIN, V2, P87, DOI 10.4161/nucl.2.2.14637; Beck M, 2018, CURR OPIN STRUC BIOL, V52, P32, DOI 10.1016/j.sbi.2018.07.012; Bhardwaj A, 2010, BIOCHEMISTRY-US, V49, P5042, DOI 10.1021/bi100292y; Bonomi M, 2019, STRUCTURE, V27, P175, DOI 10.1016/j.str.2018.09.011; Bui KH, 2013, CELL, V155, P1233, DOI 10.1016/j.cell.2013.10.055; Casanal A, 2020, PROTEIN SCI, V29, P1069, DOI 10.1002/pro.3791; Chen M, 2019, NAT METHODS, V16, P1161, DOI 10.1038/s41592-019-0591-8; Chen ZL, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11337-z; Chen ZA, 2019, NAT PROTOC, V14, P171, DOI 10.1038/s41596-018-0089-3; Chug H, 2015, SCIENCE, V350, P106, DOI 10.1126/science.aac7420; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; D'Angelo MA, 2018, NUCLEUS-PHILA, V9, P142, DOI 10.1080/19491034.2017.1395542; De Souza CPC, 2004, CURR BIOL, V14, P1973, DOI 10.1016/j.cub.2004.10.050; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Devos D, 2004, PLOS BIOL, V2, P2085, DOI 10.1371/journal.pbio.0020380; Devos D, 2006, P NATL ACAD SCI USA, V103, P2172, DOI 10.1073/pnas.0506345103; Drin G, 2007, NAT STRUCT MOL BIOL, V14, P138, DOI 10.1038/nsmb1194; Eibauer M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8532; Elosegui-Artola A, 2017, CELL, V171, P1397, DOI 10.1016/j.cell.2017.10.008; Feldherr C, 1998, J CELL SCI, V111, P1889; FELDHERR CM, 1994, EXP CELL RES, V215, P206, DOI 10.1006/excr.1994.1333; Fernandez-Martinez J, 2021, TRENDS BIOCHEM SCI, V46, P595, DOI 10.1016/j.tibs.2021.01.003; Fernandez-Martinez J, 2016, CELL, V167, P1215, DOI 10.1016/j.cell.2016.10.028; Fernandez-Martinez J, 2012, J CELL BIOL, V196, P419, DOI 10.1083/jcb.201109008; Field Mark C, 2019, F1000Res, V8, DOI 10.12688/f1000research.16402.1; Field MC, 2011, J CELL BIOL, V193, P963, DOI 10.1083/jcb.201102042; Fischer J, 2015, NAT STRUCT MOL BIOL, V22, P774, DOI 10.1038/nsmb.3084; Flemming D, 2012, J STRUCT BIOL, V177, P99, DOI 10.1016/j.jsb.2011.11.008; Fridy PC, 2014, NAT METHODS, V11, P1253, DOI [10.1038/NMETH.3170, 10.1038/nmeth.3170]; Gaik M, 2015, J CELL BIOL, V208, P283, DOI 10.1083/jcb.201411003; Hampoelz B, 2019, ANNU REV BIOPHYS, V48, P515, DOI 10.1146/annurev-biophys-052118-115308; Hao Q, 2018, CELL DISCOV, V4, DOI 10.1038/s41421-018-0057-7; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Huang GXY, 2020, CELL RES, V30, P520, DOI 10.1038/s41422-020-0319-4; Jacchetti E, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-81920-2; Juhlen R, 2018, HISTOCHEM CELL BIOL, V150, P593, DOI 10.1007/s00418-018-1748-8; Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2; Kassianidou E, 2019, EXP CELL RES, V377, P86, DOI 10.1016/j.yexcr.2019.02.009; Kelley K, 2015, NAT STRUCT MOL BIOL, V22, P425, DOI 10.1038/nsmb.2998; Kim SJ, 2018, NATURE, V555, P475, DOI 10.1038/nature26003; Kim SJ, 2014, MOL CELL PROTEOMICS, V13, P2911, DOI 10.1074/mcp.M114.040915; Knockenhauer KE, 2016, CELL, V164, P1162, DOI 10.1016/j.cell.2016.01.034; Kosinski J, 2016, SCIENCE, V352, P363, DOI 10.1126/science.aaf0643; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Kuhn TM, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8111414; Kutay U, 2021, TRENDS CELL BIOL, V31, P1019, DOI 10.1016/j.tcb.2021.06.011; Laurell E, 2011, CELL, V144, P539, DOI 10.1016/j.cell.2011.01.012; Lin DH, 2016, SCIENCE, V352, DOI 10.1126/science.aaf1015; Linder MI, 2017, DEV CELL, V43, P141, DOI 10.1016/j.devcel.2017.08.020; Liu YT, 2019, NATURE, V570, P257, DOI 10.1038/s41586-019-1248-6; Lutzmann M, 2002, EMBO J, V21, P387, DOI 10.1093/emboj/21.3.387; Mahamid J, 2016, SCIENCE, V351, P969, DOI 10.1126/science.aad8857; Mansfeld J, 2006, MOL CELL, V22, P93, DOI 10.1016/j.molcel.2006.02.015; Marelli M, 2001, J CELL BIOL, V153, P709, DOI 10.1083/jcb.153.4.709; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Meszaros N, 2015, DEV CELL, V33, P285, DOI 10.1016/j.devcel.2015.02.017; Mitrousis G, 2008, J BIOL CHEM, V283, P7877, DOI 10.1074/jbc.M709093200; Mosalaganti S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04739-y; Nakane T, 2018, ELIFE, V7, DOI [10.7554/elife.36861, 10.7554/eLife.36861]; Niepel M, 2013, MOL BIOL CELL, V24, P3920, DOI 10.1091/mbc.E13-07-0412; Ori A, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.4; Osmani AH, 2006, MOL BIOL CELL, V17, P4946, DOI 10.1091/mbc.E06-07-0657; Paci G, 2021, J CELL SCI, V134, DOI 10.1242/jcs.247874; Penczek PA, 2020, IUCRJ, V7, P995, DOI 10.1107/S2052252520011574; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pintilie GD, 2010, J STRUCT BIOL, V170, P427, DOI 10.1016/j.jsb.2010.03.007; Ptak C, 2014, CURR OPIN CELL BIOL, V28, P46, DOI 10.1016/j.ceb.2014.02.001; Pulupa J, 2020, ELIFE, V9, DOI 10.7554/eLife.60654; Romes EM, 2012, J BIOL CHEM, V287, P15862, DOI 10.1074/jbc.M111.336172; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Rout MP, 2019, CELL, V177, P1384, DOI 10.1016/j.cell.2019.05.016; ROUT MP, 1993, J CELL BIOL, V123, P771, DOI 10.1083/jcb.123.4.771; Russel D, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001244; Sali A, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100743; Saltzberg DJ, 2021, PROTEIN SCI, V30, P250, DOI 10.1002/pro.3995; Saltzberg DJ, 2019, PROG BIOPHYS MOL BIO, V147, P92, DOI 10.1016/j.pbiomolbio.2019.09.003; Sampathkumar P, 2013, STRUCTURE, V21, P560, DOI 10.1016/j.str.2013.02.005; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schuller AP, 2021, NATURE, V598, P667, DOI 10.1038/s41586-021-03985-3; Shi Y, 2014, MOL CELL PROTEOMICS, V13, P2927, DOI 10.1074/mcp.M114.041673; Simon DN, 2014, ADV EXP MED BIOL, V773, P285, DOI 10.1007/978-1-4899-8032-8_13; Smoyer CJ, 2016, J CELL BIOL, V215, P575, DOI 10.1083/jcb.201607043; Strambio-de-Castillia C, 1999, J CELL BIOL, V144, P839, DOI 10.1083/jcb.144.5.839; Strambio-De-Castillia C, 2010, NAT REV MOL CELL BIO, V11, P490, DOI 10.1038/nrm2928; Stuwe T, 2015, SCIENCE, V350, P56, DOI 10.1126/science.aac9176; Stuwe T, 2014, P NATL ACAD SCI USA, V111, P2530, DOI 10.1073/pnas.1311081111; Summer MC, 2022, CSH PERSPECT BIOL, V14, DOI 10.1101/cshperspect.a039438; SWENDSEN RH, 1986, PHYS REV LETT, V57, P2607, DOI 10.1103/PhysRevLett.57.2607; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Trabuco LG, 2008, STRUCTURE, V16, P673, DOI 10.1016/j.str.2008.03.005; Upla P, 2017, STRUCTURE, V25, P434, DOI 10.1016/j.str.2017.01.006; Viswanath S, 2017, BIOPHYS J, V113, P2344, DOI 10.1016/j.bpj.2017.10.005; Vollmer B, 2012, EMBO J, V31, P4072, DOI 10.1038/emboj.2012.256; von Appen A, 2015, NATURE, V526, P140, DOI 10.1038/nature15381; Wagner FR, 2020, NAT PROTOC, V15, P2041, DOI 10.1038/s41596-020-0320-x; WOZNIAK RW, 1994, J CELL BIOL, V125, P31, DOI 10.1083/jcb.125.1.31; Xiang YF, 2021, CELL SYST, V12, P220, DOI 10.1016/j.cels.2021.01.003; Xiang YF, 2020, SCIENCE, V370, P1479, DOI 10.1126/science.abe4747; Yamada J, 2010, MOL CELL PROTEOMICS, V9, P2205, DOI 10.1074/mcp.M000035-MCP201; Yang B, 2012, NAT METHODS, V9, P904, DOI 10.1038/nmeth.2099; Yang Q, 1998, MOL CELL, V1, P223, DOI 10.1016/S1097-2765(00)80023-4; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zhang YQ, 2020, CELL RES, V30, P532, DOI 10.1038/s41422-020-0320-y; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zimmerli CE, 2021, SCIENCE, V374, P1341, DOI 10.1126/science.abd9776	112	27	27	17	56	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 20	2022	185	2					361	+		10.1016/j.cell.2021.12.015	http://dx.doi.org/10.1016/j.cell.2021.12.015			44	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	YN7KG	34982960	hybrid, Green Submitted, Green Accepted, Green Published			2022-12-28	WOS:000747432800001
J	Sablerolles, RSG; Rietdijk, WJR; Goorhuis, A; Postma, DF; Visser, LG; Geers, D; Schmitz, KS; Garrido, HMG; Koopmans, MPG; Dalm, VASH; Kootstra, NA; Huckriede, ALW; Lafeber, M; van Baarle, D; GeurtsvanKessel, CH; de Vries, RD; van der Kuy, PHM				Sablerolles, Roos S. G.; Rietdijk, Wim J. R.; Goorhuis, Abraham; Postma, Douwe F.; Visser, Leo G.; Geers, Daryl; Schmitz, Katharina S.; Garrido, Hannah M. Garcia; Koopmans, Marion P. G.; Dalm, Virgil A. S. H.; Kootstra, Neeltje A.; Huckriede, Anke L. W.; Lafeber, Melvin; van Baarle, Debbie; GeurtsvanKessel, Corine H.; de Vries, Rory D.; van der Kuy, P. Hugo M.		SWITCH Res Grp	Immunogenicity and Reactogenicity of Vaccine Boosters after Ad26.COV2.S Priming	NEW ENGLAND JOURNAL OF MEDICINE			English	Article								BACKGROUND The Ad26.COV2.S vaccine, which was approved as a single-shot immunization regimen, has been shown to be effective against severe coronavirus disease 2019. However, this vaccine induces lower severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S)-specific antibody levels than those induced by messenger RNA (mRNA)-based vaccines. The immunogenicity and reactogenicity of a homologous or heterologous booster in persons who have received an Ad26. COV2.S priming dose are unclear. METHODS In this single-blind, multicenter, randomized, controlled trial involving health care workers who had received a priming dose of Ad26.COV2.S vaccine, we assessed immunogenicity and reactogenicity 28 days after a homologous or heterologous booster vaccination. The participants were assigned to receive no booster, an Ad26. COV2.S booster, an mRNA-1273 booster, or a BNT162b2 booster. The primary end point was the level of S-specific binding antibodies, and the secondary end points were the levels of neutralizing antibodies, S-specific T-cell responses, and reactogenicity. A post hoc analysis was performed to compare mRNA-1273 boosting with BNT162b2 boosting. RESULTS Homologous or heterologous booster vaccination in 434 participants resulted in higher levels of S-specific binding antibodies, neutralizing antibodies, and T-cell responses than a single Ad26.COV2.S vaccination. The increase in binding antibodies was significantly larger with heterologous regimens that included mRNA-based vaccines than with the homologous booster. The mRNA-1273 booster was most immunogenic and was associated with higher reactogenicity than the BNT162b2 and Ad26.COV2.S boosters. Local and systemic reactions were generally mild to moderate in the first 2 days after booster administration. CONCLUSIONS The Ad26.COV2.S and mRNA boosters had an acceptable safety profile and were immunogenic in health care workers who had received a priming dose of Ad26. COV2.S vaccine. The strongest responses occurred after boosting with mRNA-based vaccines. Boosting with any available vaccine was better than not boosting.	[Sablerolles, Roos S. G.; Lafeber, Melvin] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Sablerolles, Roos S. G.; Rietdijk, Wim J. R.; van der Kuy, P. Hugo M.] Erasmus MC, Dept Hosp Pharm, Rotterdam, Netherlands; [Geers, Daryl; Schmitz, Katharina S.; Koopmans, Marion P. G.; GeurtsvanKessel, Corine H.; de Vries, Rory D.] Erasmus MC, Dept Virosci, Rotterdam, Netherlands; [Dalm, Virgil A. S. H.] Erasmus MC, Div Allergy & Clin Immunol, Dept Internal Med, Rotterdam, Netherlands; [Dalm, Virgil A. S. H.] Erasmus MC, Dept Immunol, Rotterdam, Netherlands; [Goorhuis, Abraham; Garrido, Hannah M. Garcia] Univ Amsterdam, Amsterdam Inst Infect & Immun, Med Ctr, Dept Infect Dis,Ctr Trop Med & Travel Med, Amsterdam, Netherlands; [Kootstra, Neeltje A.] Univ Amsterdam, Amsterdam Inst Infect & Immun, Med Ctr, Dept Expt Immunol, Amsterdam, Netherlands; [Postma, Douwe F.] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med & Infect Dis, Groningen, Netherlands; [Huckriede, Anke L. W.; van Baarle, Debbie] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol & Infect Prevent, Groningen, Netherlands; [Visser, Leo G.] Leiden Univ, Dept Infect Dis, Med Ctr, Leiden, Netherlands; [van Baarle, Debbie] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, Bilthoven, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Amsterdam; University of Amsterdam; University of Groningen; University of Groningen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Netherlands National Institute for Public Health & the Environment	van der Kuy, PHM (corresponding author), Erasmus MC, Dept Hosp Pharm, Dr Molewaterpl 40, NL-3015 GD Rotterdam, Netherlands.	h.vanderkuy@erasmusmc.nl	de Vries, Rory D/L-2264-2015; Huckriede, Anke/P-3558-2019	de Vries, Rory D/0000-0003-2817-0127; Huckriede, Anke/0000-0002-2646-5143; Goorhuis, Abraham/0000-0001-7423-6217	Netherlands Organization for Health Research and Development ZonMw [10430072110001]	Netherlands Organization for Health Research and Development ZonMw(Netherlands Organization for Health Research and Development)	Supported by a grant (10430072110001) from the Netherlands Organization for Health Research and Development ZonMw.	Alter G, 2021, NATURE, V596, P268, DOI 10.1038/s41586-021-03681-2; Anderson EJ, 2020, NEW ENGL J MED, V383, P2427, DOI 10.1056/NEJMoa2028436; Atmar Robert L, 2021, medRxiv, DOI 10.1101/2021.10.10.21264827; Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389; Barouch DH, 2021, NEW ENGL J MED, V385, P951, DOI 10.1056/NEJMc2108829; Borobia AM, 2021, LANCET, V398, P121, DOI 10.1016/S0140-6736(21)01420-3; Collier AY, 2021, NEW ENGL J MED, V385, P2010, DOI 10.1056/NEJMc2115596; Duarte-Salles T, 2021, LANCET, V398, P94, DOI 10.1016/S0140-6736(21)01442-2; Food and Drug Administration, 2007, GUID IND; Geers D, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abj1750; GeurtsvanKessel CH., 2021, DIVERGENT SARS COV 2, DOI [10.1101/2021.12.27.21268416v1, DOI 10.1101/2021.12.27.21268416V1]; Goel RR, 2021, SCIENCE, V374, P1214, DOI 10.1126/science.abm0829; Hacisuleyman E, 2021, NEW ENGL J MED, V384, P2212, DOI [10.1056/NEJMc2107808, 10.1056/NEJMoa2105000]; He Q, 2021, EMERG MICROBES INFEC, V10, P629, DOI 10.1080/22221751.2021.1902245; Hillus D, 2021, LANCET RESP MED, V9, P1255, DOI 10.1016/S2213-2600(21)00357-X; Khoury DS, 2021, NAT MED, V27, P1205, DOI 10.1038/s41591-021-01377-8; Krammer F, 2021, NAT MED, V27, P1147, DOI 10.1038/s41591-021-01432-4; Krause PR, 2021, NEW ENGL J MED, V385, P179, DOI 10.1056/NEJMsr2105280; Leuzinger K, 2021, J CLIN MICROBIOL, V59, DOI 10.1128/JCM.01381-21; Liu XX, 2021, LANCET, V398, P856, DOI 10.1016/S0140-6736(21)01694-9; Mahmoud SA., 2021, EVALUATION SEROLOGIC, DOI [10.1101/2021.04.27.21256205v1, DOI 10.1101/2021.04.27.21256205V1]; Mlcochova P, 2021, NATURE, V599, P114, DOI 10.1038/s41586-021-03944-y; Planas D, 2021, NATURE, V596, P276, DOI 10.1038/s41586-021-03777-9; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Ramasamy MN, 2020, LANCET, V396, P1979, DOI 10.1016/S0140-6736(20)32466-1; Sablerolles RSG, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.753319; Sadoff J., 2021, DURABILITY ANTIBODY, DOI [10.1101/2021.08.25.21262569v1, DOI 10.1101/2021.08.25.21262569V1]; Sadoff J, 2021, NEW ENGL J MED, V384, P2187, DOI 10.1056/NEJMoa2101544; Sanders JSF, 2022, TRANSPLANTATION, V106, P821, DOI 10.1097/TP.0000000000003983; Shaw RH, 2021, LANCET, V397, P2043, DOI [10.1016/S0140-6736(21)01158-2, 10.1016/S0140-6736(21)01115-6]; Spencer AJ, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23173-1; Stephenson KE, 2021, JAMA-J AM MED ASSOC, V325, P1535, DOI 10.1001/jama.2021.3645; Tan AT, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI152379; van Gils MJ., 2021, 4 SARS COV 2 VACCINE, DOI [10.1101/2021.09.27.21264163v1, DOI 10.1101/2021.09.27.21264163V1]; Voysey M, 2021, LANCET, V397, P881, DOI 10.1016/S0140-6736(21)00432-3; Voysey M, 2021, LANCET, V397, P99, DOI 10.1016/S0140-6736(20)32661-1; Walsh EE, 2020, NEW ENGL J MED, V383, P2439, DOI 10.1056/NEJMoa2027906	37	33	35	2	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 10	2022	386	10					951	963		10.1056/NEJMoa2116747	http://dx.doi.org/10.1056/NEJMoa2116747		JAN 2022	13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZP3BU	35045226	Green Published, Bronze			2022-12-28	WOS:000744206500001
J	Mafi, JN; Craff, M; Vangala, S; Pu, T; Skinner, D; Tabatabai-Yazdi, C; Nelson, A; Reid, R; Agniel, D; Tseng, CH; Sarkisian, C; Damberg, CL; Kahn, KL				Mafi, John N.; Craff, Melody; Vangala, Sitaram; Pu, Thomas; Skinner, Dale; Tabatabai-Yazdi, Cyrus; Nelson, Anikia; Reid, Rachel; Agniel, Denis; Tseng, Chi-Hong; Sarkisian, Catherine; Damberg, Cheryl L.; Kahn, Katherine L.			Trends in US Ambulatory Care Patterns During the COVID-19 Pandemic, 2019-2021	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							UNITED-STATES; VISITS; DISPARITIES; IMPACT	IMPORTANCE Following reductions in US ambulatory care early in the pandemic, it remains unclear whether care consistently returned to expected rates across insurance types and services. OBJECTIVE To assess whether patients with Medicaid or Medicare-Medicaid dual eligibility had significantly lower than expected return to use of ambulatory care rates than patients with commercial, Medicare Advantage, or Medicare fee-for-service insurance. DESIGN, SETTING, AND PARTICIPANTS In this retrospective cohort study examining ambulatory care service patterns from January 1, 2019, through February 28, 2021, claims data from multiple US payers were combined using the Milliman Medlnsight research database. Using a difference-in-differences design, the extent to which utilization during the pandemic differed from expected rates had the pandemic not occurred was estimated. Changes in utilization rates between January and February 2020 and each subsequent 2-month time frame during the pandemic were compared with the changes in the corresponding months from the year prior. Age- and sex-adjusted Poisson regression models of monthly utilization counts were used, offsetting for total patient-months and stratifying by service and insurance type. EXPOSURES Patients with Medicaid or Medicare-Medicaid dual eligibility compared with patients with commercial, Medicare Advantage, or Medicare fee-for-service insurance, respectively. MAIN OUTCOMES AND MEASURES Utilization rates per 100 people for 6 services: emergency department, office and urgent care, behavioral health, screening colonoscopies, screening mammograms, and contraception counseling or HIV screening. RESULTS More than 14.5 million US adults were induded (mean age, 52.7 years; 54.9% women). In the March-April 2020 time frame, the combined use of 6 ambulatory services declined to 67.0% (95% CI, 66.9%-67.1%) of expected rates, but returned to 96.7% (95% CI, 96.6%-96.8%) of expected rates by the November-December 2020 time frame. During the second COVID-19 wave in the January-February 2021 time frame, overall utilization again declined to 86.2% (95% CI, 86.1%-86.3%) of expected rates, with colonoscopy remaining at 65.0% (95% CI, 64.1%-65.9%) and mammography at 79.2% (95% CI, 78.5%-79.8%) of expected rates. By the January-February 2021 time frame, overall utilization returned to expected rates as follows: patients with Medicaid at 78.4% (95% CI. 78.2%-78.7%), Medicare-Medicaid dual eligibility at 73.3% (95% CI. 72.8%-73.8%). commercial at 90.7% (95% CI. 90.5%-90.9%), Medicare Advantage at 83.2% (95% CI. 81.7%-82.2%), and Medicare fee-for-service at 82.0% (95% CI, 81.7%-82.2%; P < .001; comparing return to expected utilization rates among patients with Medicaid and Medicare-Medicaid dual eligibility, respectively, with each of the other insurance types). CONCLUSIONS AND RELEVANCE Between March 2020 and February 2021, aggregate use of 6 ambulatory care services increased after the preceding decrease in utilization that followed the onset of the COVID-19 pandemic. However, the rate of increase in use of these ambulatory care services was significantly lower for participants with Medicaid or Medicare-Medicaid dual eligibility than for those insured by commercial, Medicare Advantage, or Medicare fee-for-service.	[Mafi, John N.; Vangala, Sitaram; Tseng, Chi-Hong; Sarkisian, Catherine; Kahn, Katherine L.] Univ Calif Los Angeles, David Geffen Sch Med, Div Gen Internal Med & Hlth Serv Res, 1100 Glendon Ave,908, Los Angeles, CA 90024 USA; [Mafi, John N.; Reid, Rachel; Agniel, Denis; Damberg, Cheryl L.; Kahn, Katherine L.] RAND Corp, RAND Hlth, Santa Monica, CA USA; [Craff, Melody; Pu, Thomas; Skinner, Dale; Nelson, Anikia] Milliman MedInsight, Seattle, WA USA; [Tabatabai-Yazdi, Cyrus] Univ Calif Los Angeles, Sch Comp Sci, Los Angeles, CA USA; [Reid, Rachel] Harvard Med Sch, Brigham & Womens Hosp, Div Gen Internal Med, Boston, MA 02115 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; RAND Corporation; University of California System; University of California Los Angeles; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Mafi, JN (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Gen Internal Med & Hlth Serv Res, 1100 Glendon Ave,908, Los Angeles, CA 90024 USA.	jmafi@mednet.ucla.edu			National Institute on Aging K76 Career Development Award	National Institute on Aging K76 Career Development Award	This work was supported by the National Institute on Aging K76 Career Development Award. UCLA paid Milliman to provide the data and perform descriptive cohort analyses provided by Drs Craff and Nelson and Messrs Pu and Skinner. UCLA also paid Mr Tabatabai-Yazdi to perform data analysis and data visualization. All statistical analyses were completed at UCLA.	[Anonymous], MILLIMAN MEDINSIGHT; [Anonymous], Overview of Medicare and Medicaid state telehealth policies; [Anonymous], MEDICARE TELEMEDICIN; [Anonymous], 2006, WHO WHAT WHY NPI; [Anonymous], Coding scenario: coding for telehealth visits; [Anonymous], NEW YORK TIMES; Becker NV, 2021, JAMA-HEALTH FORUM, V2, DOI 10.1001/jamahealthforum.2021.1408; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bray MJC, 2021, JAMA PSYCHIAT, V78, P444, DOI 10.1001/jamapsychiatry.2020.3938; Cox C., HAVE HLTH SPENDING U; Czeisler ME, 2020, MMWR-MORBID MORTAL W, V69, P1250, DOI 10.15585/mmwr.mm6936a4; Findling Mary G, 2020, JAMA Health Forum, V1, pe201463, DOI 10.1001/jamahealthforum.2020.1463; Fronstin P, MANY AM HAVE LOST J; Godwin J, 2021, INQUIRY-J HEALTH CAR, V58, DOI 10.1177/0046958021991276; Hartnett KP, 2020, MMWR-MORBID MORTAL W, V69, P699, DOI 10.15585/mmwr.mm6923e1; Health Resources & Services Administration, WOM PREV SERV GUID; Khorrami P, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.9463; Maddox KEJ, 2019, JAMA INTERN MED, V179, P769, DOI 10.1001/jamainternmed.2019.0117; Maringe C, 2020, LANCET ONCOL, V21, P1023, DOI 10.1016/S1470-2045(20)30388-0; Martin K, IMPACT COVID 19 USE; Mehrotra A, WHAT IMPACT HAS COVI; Mehrotra A, TELEMEDICINE WHAT SH; Nolen LST, HEALTH AFFAIR, DOI [10.1377/forefront.20200828.661111/full, DOI 10.1377/FOREFRONT.20200828.661111/FULL]; Parikh-Patel A, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000009125; Patel SY, 2021, JAMA INTERN MED, V181, P388, DOI 10.1001/jamainternmed.2020.5928; Rodriguez JA, 2021, AM J MANAG CARE, V27, P21, DOI 10.37765/ajmc.2021.88573; Saloner B, 2014, NEW ENGL J MED, V370, P1177, DOI 10.1056/NEJMp1316370; Schmidt AL, 2020, CANCER CELL, V38, P769, DOI 10.1016/j.ccell.2020.10.023; Telemedicine, MED; US Preventive Services Task Force, GRADE B REC SERV; Uscher-Pines L, 2021, JAMA-J AM MED ASSOC, V325, P1106, DOI 10.1001/jama.2021.0282; Whaley CM, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.24984; Woolf SH, 2021, JAMA-J AM MED ASSOC, V325, P1786, DOI 10.1001/jama.2021.5199; Woolf SH, 2020, JAMA-J AM MED ASSOC, V324, P510, DOI 10.1001/jama.2020.11787; Yabroff KR, 2020, JNCI-J NATL CANCER I, V112, P671, DOI 10.1093/jnci/djaa048; Yang J, 2020, GEN HOSP PSYCHIAT, V67, P100, DOI 10.1016/j.genhosppsych.2020.09.004	36	10	10	5	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 18	2022	327	3					237	247		10.1001/jama.2021.24294	http://dx.doi.org/10.1001/jama.2021.24294			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YV9PQ	35040886	Bronze, Green Published			2022-12-28	WOS:000753055100018
J	Kraus, RG; Hemley, RJ; Ali, SJ; Belof, JL; Benedict, LX; Bernier, J; Braun, D; Cohen, RE; Collins, GW; Coppari, F; Desjarlais, MP; Fratanduono, D; Hamel, S; Krygier, A; Lazicki, A; Mcnaney, J; Millot, M; Myint, PC; Newman, MG; Rygg, JR; Sterbentz, DM; Stewart, ST; Stixrude, L; Swift, DC; Wehrenberg, C; Eggert, JH				Kraus, Richard G.; Hemley, Russell J.; Ali, Suzanne J.; Belof, Jonathan L.; Benedict, Lorin X.; Bernier, Joel; Braun, Dave; Cohen, R. E.; Collins, Gilbert W.; Coppari, Federica; Desjarlais, Michael P.; Fratanduono, Dayne; Hamel, Sebastien; Krygier, Andy; Lazicki, Amy; Mcnaney, James; Millot, Marius; Myint, Philip C.; Newman, Matthew G.; Rygg, James R.; Sterbentz, Dane M.; Stewart, Sarah T.; Stixrude, Lars; Swift, Damian C.; Wehrenberg, Chris; Eggert, Jon H.			Measuring the melting curve of iron at super-Earth core conditions	SCIENCE			English	Article							THERMOPHYSICAL PROPERTIES; GRUNEISEN-PARAMETER; LIQUID-IRON; STABILITY; KINETICS; PLANETS; ROCKY; PHASE; LIMIT; HEAT	The discovery of more than 4500 extrasolar planets has created a need for modeling their interior structure and dynamics. Given the prominence of iron in planetary interiors, we require accurate and precise physical properties at extreme pressure and temperature. A first-order property of iron is its melting point, which is still debated for the conditions of Earth's interior. We used high-energy lasers at the National Ignition Facility and in situ x-ray diffraction to determine the melting point of iron up to 1000 gigapascals, three times the pressure of Earth's inner core. We used this melting curve to determine the length of dynamo action during core solidification to the hexagonal close-packed (hcp) structure. We find that terrestrial exoplanets with four to six times Earth's mass have the longest dynamos, which provide important shielding against cosmic radiation.	[Kraus, Richard G.; Ali, Suzanne J.; Belof, Jonathan L.; Benedict, Lorin X.; Bernier, Joel; Braun, Dave; Coppari, Federica; Fratanduono, Dayne; Hamel, Sebastien; Krygier, Andy; Lazicki, Amy; Mcnaney, James; Millot, Marius; Myint, Philip C.; Sterbentz, Dane M.; Swift, Damian C.; Wehrenberg, Chris; Eggert, Jon H.] Lawrence Livermore Natl Lab, Livermore, CA 94550 USA; [Hemley, Russell J.] Univ Illinois, Dept Phys, Chicago, IL 60607 USA; [Hemley, Russell J.] Univ Illinois, Dept Chem, Chicago, IL 60607 USA; [Hemley, Russell J.] Univ Illinois, Dept Earth & Environm Sci, Chicago, IL 60607 USA; [Cohen, R. E.] Carnegie Inst Sci, Earth & Planets Lab, Washington, DC 20015 USA; [Collins, Gilbert W.; Rygg, James R.] Univ Rochester, Dept Mech Engn, Rochester, NY 14627 USA; [Collins, Gilbert W.; Rygg, James R.] Univ Rochester, Dept Phys & Astron, Rochester, NY 14627 USA; [Collins, Gilbert W.; Rygg, James R.] Univ Rochester, Lab Laser Energet, Rochester, NY 14627 USA; [Desjarlais, Michael P.] Sandia Natl Labs, Albuquerque, NM 87123 USA; [Newman, Matthew G.] CALTECH, Div Engn & Appl Sci, Pasadena, CA 91125 USA; [Stewart, Sarah T.] Univ Calif Davis, Dept Earth & Planetary Sci, Davis, CA 95616 USA; [Stixrude, Lars] Univ Calif Los Angeles, Dept Earth Planetary & Space Sci, Los Angeles, CA 90095 USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Carnegie Institution for Science; University of Rochester; University of Rochester; University of Rochester; United States Department of Energy (DOE); Sandia National Laboratories; California Institute of Technology; University of California System; University of California Davis; University of California System; University of California Los Angeles	Kraus, RG (corresponding author), Lawrence Livermore Natl Lab, Livermore, CA 94550 USA.	kraus4@llnl.gov	MILLOT, Marius/GOE-5797-2022	Belof, Jonathan/0000-0001-6551-7439; Millot, Marius/0000-0003-4414-3532; Coppari, Federica/0000-0003-1592-3898; Kraus, Richard/0000-0003-3088-1892; Rygg, James Ryan/0000-0002-0605-7847; Myint, Philip/0000-0003-4383-5350; Ali, Suzanne Jihad/0000-0003-1823-3788; Bernier, Joel/0000-0001-5418-8094; Stewart, Sarah/0000-0001-9606-1593	US Department of Energy by Lawrence Livermore National Laboratory [DE-AC52-07NA27344]; US Department of Energy's National Nuclear Security Administration (DOE/NNSA) [DE-NA0003525]; Center for Matter under Extreme Conditions - DOE/NNSA [DE-NA0003842]; NSF Physics Frontier Center [PHY-2020249]; Gauss Centre for Supercomputing e.V.; NSF [EAR-1901813]; Carnegie Institution for Science	US Department of Energy by Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); US Department of Energy's National Nuclear Security Administration (DOE/NNSA); Center for Matter under Extreme Conditions - DOE/NNSA; NSF Physics Frontier Center(National Science Foundation (NSF)); Gauss Centre for Supercomputing e.V.; NSF(National Science Foundation (NSF)); Carnegie Institution for Science	This work was performed under the auspices of the US Department of Energy by Lawrence Livermore National Laboratory under contract DE-AC52-07NA27344. Sandia National Laboratories is a multi-mission laboratory managed and operated by National Technology and Engineering Solutions of Sandia, a wholly owned subsidiary of Honeywell International, for the US Department of Energy's National Nuclear Security Administration (DOE/NNSA) under contract DE-NA0003525. R.J.H. acknowledges support from DOE/NNSA (DE-NA0003975, CDAC). S.T.S. was supported by the Center for Matter under Extreme Conditions, funded by DOE/NNSA under award DE-NA0003842. G.W.C. and J.R.R. recognize support from NSF Physics Frontier Center award PHY-2020249. R.E.C. gratefully acknowledges the Gauss Centre for Supercomputing e.V. (www.gauss-centre.eu) for funding this project by providing computing time on the GCS Supercomputer SuperMUC-NG at Leibniz Supercomputing Centre (LRZ, www.lrz.de) and support from NSF grant EAR-1901813 and the Carnegie Institution for Science.	Ahrens TJ., 1972, MOON PLANETS, V4, P214, DOI [10.1007/BF00562927, DOI 10.1007/BF00562927]; Ali SJ, 2020, J APPL PHYS, V128, DOI 10.1063/5.0029723; Anderson OL, 1998, PHYS EARTH PLANET IN, V109, P179, DOI 10.1016/S0031-9201(98)00123-X; ANDERSON WW, 1994, J GEOPHYS RES-SOL EA, V99, P4273, DOI 10.1029/93JB03158; [Anonymous], 2002, STAT PHYS CRYSTALS L; Anzellini S, 2013, SCIENCE, V340, P464, DOI 10.1126/science.1233514; Asay J. R., 1993, HIGH PRESSURE SHOCK; Avrami M, 1939, J CHEM PHYS, V7, P1103, DOI 10.1063/1.1750380; Avrami M, 1940, J CHEM PHYS, V8, P212, DOI [10.1063/1.1750631, DOI 10.1063/1.1750631]; Ayers S., 2013, SPIE OPTICS PHOTONIC; Barrios MA, 2013, HIGH ENERG DENS PHYS, V9, P626, DOI 10.1016/j.hedp.2013.05.018; Belonoshko AB, 2003, NATURE, V424, P1032, DOI 10.1038/nature01954; BEUTL M, 1994, INT J THERMOPHYS, V15, P1323, DOI 10.1007/BF01458840; Bono RK, 2019, NAT GEOSCI, V12, P143, DOI 10.1038/s41561-018-0288-0; Boujibar A, 2020, J GEOPHYS RES-PLANET, V125, DOI 10.1029/2019JE006124; Brown JM, 2000, J APPL PHYS, V88, P5496, DOI 10.1063/1.1319320; Cao H, 2014, GEOPHYS RES LETT, V41, P4127, DOI 10.1002/2014GL060196; Carter PJ, 2020, J GEOPHYS RES-PLANET, V125, DOI 10.1029/2019JE006042; Celliers PM, 2004, REV SCI INSTRUM, V75, P4916, DOI 10.1063/1.1807008; Chase M. W., 1998, NIST JANAF THERMOCHE, V9; Coppari F, 2019, REV SCI INSTRUM, V90, DOI 10.1063/1.5111878; Davies EJ, 2020, J GEOPHYS RES-PLANET, V125, DOI 10.1029/2019JE006227; Dehant V, 2007, SPACE SCI REV, V129, P279, DOI 10.1007/s11214-007-9163-9; DESAI PD, 1986, J PHYS CHEM REF DATA, V15, P967, DOI 10.1063/1.555761; Desjarlais MP, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.062145; Dewaele A, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.215504; Dolan DH, 2007, NAT PHYS, V3, P339, DOI 10.1038/nphys562; Duffy T. S., 1992, HIGH PRESSURE RES AP, P353; DZIEWONSKI AM, 1981, PHYS EARTH PLANET IN, V25, P297, DOI 10.1016/0031-9201(81)90046-7; Elkins-Tanton L., 2013, Eos, Transactions American Geophysical Union, V94, P149; Fischer RA, 2015, AM MINERAL, V100, P2718, DOI 10.2138/am-2015-5191; Gaidos E, 2010, ASTROPHYS J, V718, P596, DOI 10.1088/0004-637X/718/2/596; Hemley RJ, 2001, INT GEOL REV, V43, P1; Hicks DG, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.025502; HIXSON RS, 1990, PHYS REV B, V42, P6485, DOI 10.1103/PhysRevB.42.6485; Johnson WA, 1939, T AM I MIN MET ENG, V135, P416; Kirsch LE, 2019, J APPL PHYS, V125, DOI 10.1063/1.5091722; Kolmogorov A.N., 1937, B ACAD SCI USSR MATH, V1, P355; Kono Y, 2015, PHYS EARTH PLANET IN, V241, P57, DOI 10.1016/j.pepi.2015.02.006; Kraus RG, 2021, PHYS REV LETT, V126, DOI 10.1103/PhysRevLett.126.255701; Kraus RG, 2012, J GEOPHYS RES-PLANET, V117, DOI 10.1029/2012JE004082; Kraus RG, 2015, NAT GEOSCI, V8, P269, DOI 10.1038/NGEO2369; Laio A, 2000, SCIENCE, V287, P1027, DOI 10.1126/science.287.5455.1027; Lay T, 2008, NAT GEOSCI, V1, P25, DOI 10.1038/ngeo.2007.44; Li J, 2020, GEOPHYS RES LETT, V47, DOI 10.1029/2020GL087758; Luo W, 2010, P NATL ACAD SCI USA, V107, P9962, DOI 10.1073/pnas.1004076107; Michel DT, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.155007; Morard G, 2011, HIGH ENERG DENS PHYS, V7, P141, DOI 10.1016/j.hedp.2011.02.001; Myint PC, 2020, AIP ADV, V10, DOI 10.1063/5.0032973; Myint PC, 2018, PHYS REV LETT, V121, DOI 10.1103/PhysRevLett.121.155701; Nguyen JH, 2004, NATURE, V427, P339, DOI 10.1038/nature02248; Raymond S.N., 2014, PROTOSTARS PLANETS, VVI, P595, DOI DOI 10.2458/AZU_UAPRESS_9780816531240-CH026; Rigg PA, 2014, J APPL PHYS, V116, DOI 10.1063/1.4890714; Rygg JR, 2020, REV SCI INSTRUM, V91, DOI 10.1063/1.5129698; Sadigh B, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2017809118; Samanta A, 2018, J CHEM PHYS, V149, DOI 10.1063/1.5028268; Shanker J, 2007, PHYSICA B, V387, P409, DOI 10.1016/j.physb.2006.04.026; Sinmyo R, 2019, EARTH PLANET SC LETT, V510, P45, DOI 10.1016/j.epsl.2019.01.006; Smith RF, 2018, NAT ASTRON, V2, P452, DOI 10.1038/s41550-018-0437-9; Stewart ST, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035947; Stixrude L, 2014, PHILOS T R SOC A, V372, DOI 10.1098/rsta.2013.0076; Stixrude L, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.055505; Sugita S, 2012, AIP CONF PROC, V1426, DOI 10.1063/1.3686422; Sun DY, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.024108; Sun G, 2018, NAT MATER, V17, P881, DOI 10.1038/s41563-018-0174-6; Tateno S, 2015, EARTH PLANET SC LETT, V418, P11, DOI 10.1016/j.epsl.2015.02.008; Turneaure SJ, 2020, PHYS REV LETT, V125, DOI 10.1103/PhysRevLett.125.215702; Valencia D, 2006, ICARUS, V181, P545, DOI 10.1016/j.icarus.2005.11.021; van Summeren J, 2013, J GEOPHYS RES-PLANET, V118, P938, DOI 10.1002/jgre.20077; Wang J, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.174114; Xu F, 2021, EARTH PLANET SC LETT, V563, DOI 10.1016/j.epsl.2021.116884; YOO CS, 1993, PHYS REV LETT, V70, P3931, DOI 10.1103/PhysRevLett.70.3931; Zhang WJ, 2015, PHYS EARTH PLANET IN, V244, P69, DOI 10.1016/j.pepi.2014.10.011	75	7	7	15	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2022	375	6577					202	+		10.1126/science.abm1472	http://dx.doi.org/10.1126/science.abm1472			51	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YG3OI	35025665				2022-12-28	WOS:000742401600034
J	Overstreet, C; Asenbaum, P; Curti, J; Kim, M; Kasevich, MA				Overstreet, Chris; Asenbaum, Peter; Curti, Joseph; Kim, Minjeong; Kasevich, Mark A.			Observation of a gravitational Aharonov-Bohm effect	SCIENCE			English	Article							GRAVITY; INTERFERENCE	Gravity curves space and time. This can lead to proper time differences between freely falling, nonlocal trajectories. A spatial superposition of a massive particle is predicted to be sensitive to this effect. We measure the gravitational phase shift induced in a matter-wave interferometer by a kilogram-scale source mass close to one of the wave packets. Deflections of each interferometer arm due to the source mass are independently measured. The phase shift deviates from the deflection-induced phase contribution, as predicted by quantum mechanics. In addition, the observed scaling of the phase shift is consistent with Heisenberg's error-disturbance relation. These results show that gravity creates Aharonov-Bohm phase shifts analogous to those produced by electromagnetic interactions.	[Overstreet, Chris; Asenbaum, Peter; Curti, Joseph; Kim, Minjeong; Kasevich, Mark A.] Stanford Univ, Dept Phys, Stanford, CA 94305 USA; [Asenbaum, Peter] Austrian Acad Sci, Inst Quantum Opt & Quantum Informat IQOQI Vienna, Boltzmanngasse 3, A-1090 Vienna, Austria	Stanford University; Austrian Academy of Sciences	Kasevich, MA (corresponding author), Stanford Univ, Dept Phys, Stanford, CA 94305 USA.	kasevich@stanford.edu		Asenbaum, Peter/0000-0002-3126-2164; Curti, Joseph/0000-0001-5006-123X; Kim, Minjeong/0000-0002-5283-7457; Overstreet, Chris/0000-0002-1430-9581	Defense Threat Reduction Agency; Office of Naval Research; Vannevar Bush Faculty Fellowship program; Kwanjeong Educational Foundation	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Office of Naval Research(Office of Naval Research); Vannevar Bush Faculty Fellowship program; Kwanjeong Educational Foundation	We acknowledge funding from the Defense Threat Reduction Agency, the Office of Naval Research, and the Vannevar Bush Faculty Fellowship program. M. K. acknowledges funding from the Kwanjeong Educational Foundation.	Abe M, 2021, QUANTUM SCI TECHNOL, V6, DOI 10.1088/2058-9565/abf719; AHARONOV Y, 1961, PHYS REV, V123, P1511, DOI 10.1103/PhysRev.123.1511; AHARONOV Y, 1959, PHYS REV, V115, P485, DOI 10.1103/PhysRev.115.485; Antoine C, 2003, J OPT B-QUANTUM S O, V5, pS199, DOI 10.1088/1464-4266/5/2/380; Arvanitaki A, 2018, PHYS REV D, V97, DOI 10.1103/PhysRevD.97.075020; Asenbaum P, 2020, PHYS REV LETT, V125, DOI 10.1103/PhysRevLett.125.191101; Asenbaum P, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.183602; AUDRETSCH J, 1983, J PHYS A-MATH GEN, V16, P2457, DOI 10.1088/0305-4470/16/11/017; Batelaan H, 2009, PHYS TODAY, V62, P38, DOI 10.1063/1.3226854; Busch P, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.160405; Carraz O, 2014, MICROGRAVITY SCI TEC, V26, P139, DOI 10.1007/s12217-014-9385-x; CHAMBERS RG, 1960, PHYS REV LETT, V5, P3, DOI 10.1103/PhysRevLett.5.3; COLELLA R, 1975, PHYS REV LETT, V34, P1472, DOI 10.1103/PhysRevLett.34.1472; Gillot J, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.030401; Hohensee MA, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.230404; Kim M, 2020, OPT LETT, V45, P6555, DOI 10.1364/OL.404430; Marletto C, 2020, PHYS REV LETT, V125, DOI 10.1103/PhysRevLett.125.040401; Muller H, 2014, ATOM INTERFEROMETRY, P389; Neyman J, 1933, PHILOS T R SOC LOND, V231, P289, DOI 10.1098/rsta.1933.0009; Overstreet C., HARVARD DATAVERSE, V2, DOI [10.7910/DVN/O9IS7Y, DOI 10.7910/DVN/O9IS7Y]; Overstreet C, 2020, ATOM INTERFEROMETRIC; Overstreet C, 2021, AM J PHYS, V89, P324, DOI 10.1119/10.0002638; POUND RV, 1960, PHYS REV LETT, V4, P337, DOI 10.1103/PhysRevLett.4.337; Rosi G, 2014, NATURE, V510, P518, DOI 10.1038/nature13433; Roura A, 2020, PHYS REV X, V10, DOI 10.1103/PhysRevX.10.021014; STOREY P, 1994, J PHYS II, V4, P1999, DOI 10.1051/jp2:1994103; VESSOT RFC, 1980, PHYS REV LETT, V45, P2081, DOI 10.1103/PhysRevLett.45.2081; Will CM, 2014, LIVING REV RELATIV, V17, DOI 10.12942/lrr-2014-4; Wolf P, 2011, CLASSICAL QUANT GRAV, V28, DOI 10.1088/0264-9381/28/14/145017; Xu V, 2019, SCIENCE, V366, P745, DOI 10.1126/science.aay6428	30	10	10	6	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2022	375	6577					226	+		10.1126/science.abl7152	http://dx.doi.org/10.1126/science.abl7152			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YG3OI	35025635				2022-12-28	WOS:000742401600039
J	Pigati, JS; Springer, KB; Bennett, MR; Bustos, D; Urban, TM; Holliday, VT; Reynolds, SC; Odess, D				Pigati, Jeffrey S.; Springer, Kathleen B.; Bennett, Matthew R.; Bustos, David; Urban, Thomas M.; Holliday, Vance T.; Reynolds, Sally C.; Odess, Daniel			Response to Comment on "Evidence of humans in North America during the Last Glacial Maximum"	SCIENCE			English	Editorial Material								Madsen et al. question the reliability of calibrated radiocarbon ages associated with human footprints discovered recently in White Sands National Park, New Mexico, USA. On the basis of the geologic, hydrologic, stratigraphic, and chronologic evidence, we maintain that the ages are robust and conclude that the footprints date to between similar to 23,000 and 21,000 years ago.	[Pigati, Jeffrey S.; Springer, Kathleen B.] US Geol Survey, Denver Fed Ctr, Box 25046,MS 980, Denver, CO 80225 USA; [Bennett, Matthew R.; Reynolds, Sally C.] Bournemouth Univ, Inst Studies Landscapes & Human Evolut, Poole BH12 5BB, Dorset, England; [Bustos, David] Natl Pk Serv, White Sands Natl Pk, Holloman Afb, NM 88330 USA; [Urban, Thomas M.] Cornell Univ, Dept Class, Ithaca, NY 14853 USA; [Urban, Thomas M.] Cornell Univ, Cornell Tree Ring Lab, Ithaca, NY 14853 USA; [Holliday, Vance T.] Univ Arizona, Sch Anthropol, Tucson, AZ 85721 USA; [Odess, Daniel] Natl Pk Serv, Cultural Resources Directorate, Washington, DC 20240 USA	United States Department of the Interior; United States Geological Survey; Bournemouth University; United States Department of the Interior; Cornell University; Cornell University; University of Arizona; United States Department of the Interior	Bennett, MR (corresponding author), Bournemouth Univ, Inst Studies Landscapes & Human Evolut, Poole BH12 5BB, Dorset, England.	mbennett@bournemouth.ac.uk		Odess, Daniel/0000-0003-2391-8175; Bustos, David/0000-0002-0309-7632; Reynolds, Sally/0000-0001-6313-6405; Pigati, Jeffrey/0000-0001-5843-6219				Allen B.D., 2009, N M GEOL, V31, P9; Belcher W. R., 2018, US GEOLOGICAL SURVEY, DOI [10.3133/sir20185151, DOI 10.3133/SIR20185151]; Bennett MR, 2021, SCIENCE, V373, P1528, DOI 10.1126/science.abg7586; Madsen D. B., 2021, SCIENCE, V374; Mamer E.A., 2014, NEW MEXICO BUREAU GE, V562, P71; Rhodes EJ, 2011, ANNU REV EARTH PL SC, V39, P461, DOI [10.1146/annurev-earth-040610-133425, 10.1146/annurev-earth-040610-13425]; RIGGS AC, 1984, SCIENCE, V224, P58, DOI 10.1126/science.224.4644.58; Zhou AF, 2009, RADIOCARBON, V51, P529, DOI 10.1017/S0033822200055909	8	2	2	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2022	375	6577								10.1126/science.abm6987	http://dx.doi.org/10.1126/science.abm6987			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YG3OI	35025662				2022-12-28	WOS:000742401600002
J	Dyer, C				Dyer, Clare			Surgeon who put his initials on patients' livers is struck off medical register	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Dyer C, 2021, BMJ-BRIT MED J, V374, DOI 10.1136/bmj.n1941	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 12	2022	376								o75	10.1136/bmj.o75	http://dx.doi.org/10.1136/bmj.o75			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YP6JI	35022200				2022-12-28	WOS:000748728200015
J	Bundy, JD; Mills, KT; Anderson, AH; Yang, W; Chen, J; He, J				Bundy, Joshua D.; Mills, Katherine T.; Anderson, Amanda H.; Yang, Wei; Chen, Jing; He, Jiang		CRIC Study Investigators	Prediction of End-Stage Kidney Disease Using Estimated Glomerular Filtration Rate With and Without Race A Prospective Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							RENAL-INSUFFICIENCY COHORT; CLINICAL-PRACTICE GUIDELINE; RISK; PROGRESSION; INCLUSION; EQUATIONS; FAILURE; TIME; GFR	Background: New estimated glomerular filtration rate (eGFR) equations removed race adjustment, but the impact of its removal on prediction of end-stage kidney disease (ESKD) is unknown. Objective: To compare the ESKD prediction performance of different eGFR equations. Design: Observational, prospective cohort study. Setting: 7 U.S. clinical centers. Participants: 3873 participants with chronic kidney disease (CKD) from the CRIC (Chronic Renal Insufficiency Cohort) Study contributing 13 902 two-year risk periods. Measurements: ESKD was defined as initiation of dialysis or transplantation. eGFR was calculated using 5 Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equations based on serum creatinine and/or cystatin C, with or without race adjustment. The predicted 2-year risk for ESKD was calculated using the 4-variable Kidney Failure Risk Equation (KFRE). We evaluated the prediction performance of eGFR equations and the KFRE score using discrimination and calibration analyses. Results: During a maximum 16 years of follow-up, 856 participants developed ESKD. Across all eGFR equations, the KFRE score was superior for predicting 2-year incidence of ESKD compared with eGFR alone (area under the curve ranges, 0.945 to 0.954 vs. 0.900 to 0.927). Prediction performance of KFRE scores using different eGFR equations was similar, but the creatinine equation without race adjustment improved calibration among Black participants. Among all participants, compared with an eGFR less than 20 mL/min/1.73 m(2), a KFRE score greater than 20% had similar specificity for predicting 2-year ESKD risk (ranges, 0.94 to 0.97 vs. 0.95 to 0.98) but higher sensitivity (ranges, 0.68 to 0.78 vs. 0.42 to 0.66). Limitation: Data are solely from the United States. Conclusion: The KFRE score better predicts 2-year risk for ESKD compared with eGFR alone, regardless of race adjustment. The creatinine equation with age and sex may improve calibration among Black patients. A KFRE score greater than 20% showed high specificity and sensitivity for predicting 2-year risk for ESKD.	[Bundy, Joshua D.; Mills, Katherine T.] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, Translat Sci Inst, New Orleans, LA 70118 USA; [Anderson, Amanda H.; Chen, Jing; He, Jiang] Tulane Univ, Dept Epidemiol, Sch Publ Hlth & Trop Med, 1440 Canal St,Suite 2000, New Orleans, LA 70118 USA; [Anderson, Amanda H.; Chen, Jing; He, Jiang] Tulane Univ, Translat Sci Inst, New Orleans, LA 70118 USA; [Anderson, Amanda H.; Yang, Wei] Univ Penn, Perelman Sch Med, Dept Biostat Epidemiol & Informat, Philadelphia, PA 19104 USA; [Chen, Jing; He, Jiang] Tulane Univ, Dept Med, Sch Med, New Orleans, LA 70118 USA	Tulane University; Tulane University; Tulane University; University of Pennsylvania; Pennsylvania Medicine; Tulane University	He, J (corresponding author), Tulane Univ, Dept Epidemiol, Sch Publ Hlth & Trop Med, 1440 Canal St,Suite 2000, New Orleans, LA 70118 USA.	jbundy1@tulane.edu	He, Jiang/AAF-5303-2020	He, Jiang/0000-0002-8286-9652; Mills, Katherine/0000-0002-4278-5788	National Institute of Diabetes and Digestive and Kidney Diseases [U01DK060990, U01DK060984, U01DK061022, U01DK061021, U01DK061028, U01DK060980, U01DK060963, U01DK060902, U24DK060990]; Perelman School of Medicine at the University of Pennsylvania Clinical and Translational Science Award [NIH/NCATS UL1TR000003]; Johns Hopkins University [UL1 TR-000424]; University of Maryland [GCRC M01 RR-16500]; Clinical and Translational Science Collaborative of Cleveland; National Center for Advancing Translational Sciences component of the National Institutes of Health; National Institutes of Health Roadmap for Medical Research [UL1TR000439]; Michigan Institute for Clinical and Health Research [UL1TR000433]; University of Illinois at Chicago [CTSA UL1RR029879]; Tulane Center of Biomedical Research Excellence for Clinical and Translational Research in Cardiometabolic Diseases [P20 GM109036]; Kaiser Permanente [NIH/NCRR UCSFCTSI UL1 RR-024131]; Department of InternalMedicine, University of New Mexico School of Medicine [NM R01DK119199]; National Institutes of Health/Eunice Kennedy Shriver National Institute of Child Health and Human Development career development grant [K12HD043451]	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Perelman School of Medicine at the University of Pennsylvania Clinical and Translational Science Award; Johns Hopkins University(Johns Hopkins University); University of Maryland; Clinical and Translational Science Collaborative of Cleveland(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Center for Advancing Translational Sciences component of the National Institutes of Health; National Institutes of Health Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michigan Institute for Clinical and Health Research; University of Illinois at Chicago; Tulane Center of Biomedical Research Excellence for Clinical and Translational Research in Cardiometabolic Diseases; Kaiser Permanente; Department of InternalMedicine, University of New Mexico School of Medicine; National Institutes of Health/Eunice Kennedy Shriver National Institute of Child Health and Human Development career development grant	By a cooperative agreement from the National Institute of Diabetes and Digestive and Kidney Diseases (grant U01DK060990, U01DK060984, U01DK061022, U01DK061021, U01DK061028, U01DK060980, U01DK060963, U01DK060902, and U24DK060990). In part by the Perelman School of Medicine at the University of Pennsylvania Clinical and Translational Science Award (grant NIH/NCATS UL1TR000003); Johns Hopkins University (grant UL1 TR-000424); University of Maryland (grant GCRC M01 RR-16500); Clinical and Translational Science Collaborative of Cleveland; National Center for Advancing Translational Sciences component of the National Institutes of Health and National Institutes of Health Roadmap for Medical Research (grant UL1TR000439); Michigan Institute for Clinical and Health Research (grant UL1TR000433); University of Illinois at Chicago (grant CTSA UL1RR029879); Tulane Center of Biomedical Research Excellence for Clinical and Translational Research in Cardiometabolic Diseases (grant P20 GM109036); Kaiser Permanente (grant NIH/NCRR UCSFCTSI UL1 RR-024131); andDepartment of InternalMedicine, University of New Mexico School of Medicine (grant NM R01DK119199). Dr. Bundy was supported by the National Institutes of Health/Eunice Kennedy Shriver National Institute of Child Health and Human Development career development grant (grant K12HD043451).	Anderson AH, 2012, AM J KIDNEY DIS, V60, P250, DOI 10.1053/j.ajkd.2012.04.012; Blanche P, 2013, STAT MED, V32, P5381, DOI 10.1002/sim.5958; Braun L, 2021, SOC SCI MED, V268, DOI 10.1016/j.socscimed.2020.113548; Chadban SJ, 2020, TRANSPLANTATION, V104, pS11, DOI 10.1097/TP.0000000000003136; Coresh J, 2014, JAMA-J AM MED ASSOC, V311, P2518, DOI 10.1001/jama.2014.6634; Delgado C, 2021, J AM SOC NEPHROL, V32, P2994, DOI 10.1681/ASN.2021070988; Delgado C, 2021, J AM SOC NEPHROL, V32, P1305, DOI 10.1681/ASN.2021010039; Denker M, 2015, CLIN J AM SOC NEPHRO, V10, P2073, DOI 10.2215/CJN.04260415; Diao JA, 2021, NEW ENGL J MED, V384, P396, DOI 10.1056/NEJMp2028243; Duggal V, 2021, J AM SOC NEPHROL, V32, P1454, DOI 10.1681/ASN.2020121780; Grams ME, 2015, AM J KIDNEY DIS, V65, P394, DOI 10.1053/j.ajkd.2014.07.026; Hsu C, 2021, NEW ENGL J MED, V385, P1750, DOI 10.1056/NEJMoa2103753; Inker LA, 2021, NEW ENGL J MED, V385, P1737, DOI 10.1056/NEJMoa2102953; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Kattan Michael W, 2018, Diagn Progn Res, V2, P7, DOI 10.1186/s41512-018-0029-2; Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group, 2013, KIDNEY INT S, V3, P1, DOI [DOI 10.1038/KISUP.2012.73, 10.1038/kisup.2012.48]; Lash JP, 2009, CLIN J AM SOC NEPHRO, V4, P1302, DOI 10.2215/CJN.00070109; Levey AS, 2020, CLIN J AM SOC NEPHRO, V15, P1203, DOI 10.2215/CJN.12791019; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Levey AS, 2012, LANCET, V379, P165, DOI 10.1016/S0140-6736(11)60178-5; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lok CE, 2020, AM J KIDNEY DIS, V75, pS1, DOI 10.1053/j.ajkd.2019.12.001; Major RW, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002955; Mills KT, 2015, KIDNEY INT, V88, P950, DOI 10.1038/ki.2015.230; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Sumida K, 2020, ANN INTERN MED, V173, P426, DOI 10.7326/M20-0529; Tangri N, 2017, NEPHROL DIAL TRANSPL, V32, P748, DOI 10.1093/ndt/gfx067; Tangri N, 2016, JAMA-J AM MED ASSOC, V315, P164, DOI 10.1001/jama.2015.18202; Tangri N, 2011, JAMA-J AM MED ASSOC, V305, P1553, DOI 10.1001/jama.2011.451; Vyas DA, 2020, NEW ENGL J MED, V383, P874, DOI 10.1056/NEJMms2004740	31	7	7	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR	2022	175	3					305	+		10.7326/M21-2928	http://dx.doi.org/10.7326/M21-2928		JAN 2022	17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0O5UF	35007146	Green Accepted			2022-12-28	WOS:000743251900001
J	Salvatteci, R; Schneider, RR; Galbraith, E; Field, D; Blanz, T; Bauersachs, T; Crosta, X; Martinez, P; Echevin, V; Scholz, F; Bertrand, A				Salvatteci, Renato; Schneider, Ralph R.; Galbraith, Eric; Field, David; Blanz, Thomas; Bauersachs, Thorsten; Crosta, Xavier; Martinez, Philippe; Echevin, Vincent; Scholz, Florian; Bertrand, Arnaud			Smaller fish species in a warm and oxygen-poor Humboldt Current system	SCIENCE			English	Article							TETRAETHER LIPIDS; CLIMATE-CHANGE; OCEAN; PERU; TEMPERATURE; PRODUCTIVITY; LIMITATION; EVOLUTION; SEDIMENTS; PACIFIC	Climate change is expected to result in smaller fish size, but the influence of fishing has made it difficult to substantiate the theorized link between size and ocean warming and deoxygenation. We reconstructed the fish community and oceanographic conditions of the most recent global warm period (last interglacial; 130 to 116 thousand years before present) by using sediments from the northern Humboldt Current system off the coast of Peru, a hotspot of small pelagic fish productivity. In contrast to the present-day anchovy-dominated state, the last interglacial was characterized by considerably smaller (mesopelagic and goby-like) fishes and very low anchovy abundance. These small fish species are more difficult to harvest and are less palatable than anchovies, indicating that our rapidly warming world poses a threat to the global fish supply.	[Salvatteci, Renato] Univ Kiel, Ctr Ocean & Soc, Kiel, Germany; [Schneider, Ralph R.; Blanz, Thomas; Bauersachs, Thorsten] Univ Kiel, Inst Geosci, Kiel, Germany; [Galbraith, Eric] McGill Univ, Earth & Planetary Sci, Montreal, PQ, Canada; [Galbraith, Eric] Univ Autonoma Barcelona, Inst Ciencia & Tecnol Ambientals ICTA UAB, Barcelona 08193, Spain; [Field, David] Hawaii Pacific Univ, Coll Nat Sci, Kaneohe, HI USA; [Crosta, Xavier; Martinez, Philippe] Univ Bordeaux, EPHE, CNRS, UMR EPOC 5805, Pessac, France; [Echevin, Vincent] Sorbonne Univ, LOCEAN IPSL, CNRS, IRD,MNHN, 4 Pl Jussieu, F-75252 Paris, France; [Scholz, Florian] GEOMAR Helmholtz Ctr Ocean Res Kiel, Kiel, Germany; [Bertrand, Arnaud] Univ Montpellier, IRD, IFREMER, CNRS,MARBEC, Sete, France	University of Kiel; University of Kiel; McGill University; Autonomous University of Barcelona; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Salvatteci, R (corresponding author), Univ Kiel, Ctr Ocean & Soc, Kiel, Germany.	rsalvatteci@kms.uni-kiel.de	Bauersachs, Thorsten/AFY-5641-2022; Bertrand, Arnaud/E-4251-2010; Florian, Scholz/C-5056-2012	Bertrand, Arnaud/0000-0003-4723-179X; ECHEVIN, Vincent/0000-0003-3859-840X; Crosta, Xavier/0000-0002-8005-9939; Scholz, Florian/0000-0001-8653-0448; Salvatteci, Renato/0000-0002-7399-6465	Deutsche Forschungsgemeinschaft (DFG) [754]; Federal Ministry of Education and Research of Germany; European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme [682602]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Federal Ministry of Education and Research of Germany(Federal Ministry of Education & Research (BMBF)); European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme(European Research Council (ERC))	Collaborative Research Project 754 "Climate-Biogeochemistry interactions in the Tropical Ocean" (www.sfb754.de/) is supported by the Deutsche Forschungsgemeinschaft (DFG), and Project Humboldt Tipping Point (https://humboldt-tipping.org/en) is sponsored by the Federal Ministry of Education and Research of Germany. F.S. wishes to thank the DFG for funding through Emmy Noether Nachwuchsforschergruppe ICONOX. This project has received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (grant agreement No 682602).	Arguelles J, 2008, PROG OCEANOGR, V79, P308, DOI 10.1016/j.pocean.2008.10.003; Blanz T, 2005, GEOCHIM COSMOCHIM AC, V69, P3589, DOI 10.1016/j.gca.2005.02.026; Castillo R, 2019, FISH OCEANOGR, V28, P389, DOI 10.1111/fog.12419; Cheung William W. L., 2018, FAO Fisheries and Aquaculture Technical Paper, V627, P63; Cheung WWL, 2013, NAT CLIM CHANGE, V3, P254, DOI 10.1038/NCLIMATE1691; Contreras S, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045728; Cornejo R, 2006, MAR BIOL, V149, P1519, DOI 10.1007/s00227-006-0319-z; Crosta X, 2020, MAR MICROPALEONTOL, V157, DOI 10.1016/j.marmicro.2020.101861; Crosta X, 2007, DEV MARINE GEOL, V1, P327, DOI 10.1016/S1572-5480(07)01013-5; Daufresne M, 2009, P NATL ACAD SCI USA, V106, P12788, DOI 10.1073/pnas.0902080106; Deutsch C, 2020, NATURE, V585, P557, DOI 10.1038/s41586-020-2721-y; Doering K, 2016, PALEOCEANOGRAPHY, V31, P1453, DOI 10.1002/2016PA002936; dos Santos RAL, 2013, PALEOCEANOGRAPHY, V28, P377, DOI 10.1002/palo.20035; Echevin V, 2020, BIOGEOSCIENCES, V17, P3317, DOI 10.5194/bg-17-3317-2020; Etourneau J, 2010, EARTH PLANET SC LETT, V297, P103, DOI 10.1016/j.epsl.2010.06.010; FAO, 2020, STAT WORLDS FOR 2020, DOI [10.4060/ca9229en, 10.4060/ca9229-n, DOI 10.4060/CA9229-N]; Filardo A, 2019, DEV PALEO FORAGE FIS; Ghanbarifardi M, 2020, J APPL ICHTHYOL, V36, P713, DOI 10.1111/jai.14071; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Hopmans EC, 2000, RAPID COMMUN MASS SP, V14, P585, DOI 10.1002/(SICI)1097-0231(20000415)14:7<585::AID-RCM913>3.3.CO;2-E; Hunt G, 2006, P NATL ACAD SCI USA, V103, P1347, DOI 10.1073/pnas.0510550103; Kim JH, 2010, GEOCHIM COSMOCHIM AC, V74, P4639, DOI 10.1016/j.gca.2010.05.027; Leduc G, 2010, QUATERNARY SCI REV, V29, P989, DOI 10.1016/j.quascirev.2010.01.004; Lisiecki LE, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2004PA001071; Liu XL, 2012, RAPID COMMUN MASS SP, V26, P2295, DOI 10.1002/rcm.6355; Mollier-Vogel E, 2019, GLOBAL PLANET CHANGE, V172, P365, DOI 10.1016/j.gloplacha.2018.10.020; Muller PJ, 1998, GEOCHIM COSMOCHIM AC, V62, P1757, DOI 10.1016/S0016-7037(98)00097-0; MULLER PJ, 1993, DEEP-SEA RES PT I, V40, P425, DOI 10.1016/0967-0637(93)90140-X; Oliveros-Ramos R., 2021, FAO FISHERIES AQUACU, P237; Pauly D, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abc6050; Penven P, 2006, OCEAN MODEL, V12, P157, DOI 10.1016/j.ocemod.2005.05.002; Portner HO, 2007, SCIENCE, V315, P95, DOI 10.1126/science.1135471; Rein B, 2007, DEV QUATER SCI, V7, P305; Risien CM, 2008, J PHYS OCEANOGR, V38, P2379, DOI 10.1175/2008JPO3881.1; Rubalcaba JG, 2020, P NATL ACAD SCI USA, V117, P31963, DOI 10.1073/pnas.2003292117; Salvanes AGV, 2011, MAR ECOL PROG SER, V425, P193, DOI 10.3354/meps08998; Salvatteci R, 2016, QUATERNARY SCI REV, V131, P102, DOI 10.1016/j.quascirev.2015.10.044; Salvatteci R., 2021, Paleoceanographic proxies obtained from core M77/2-024-5 off Peru, DOI 10.5281/zenodo.5613922; Salvatteci R, 2021, PALEOCEANOGRAPHIC PR; Salvatteci R, 2019, PROG OCEANOGR, V176, DOI 10.1016/j.pocean.2019.05.006; Salvatteci R, 2019, GEOPHYS RES LETT, V46, P281, DOI 10.1029/2018GL080634; Salvatteci R, 2018, GLOBAL CHANGE BIOL, V24, P1055, DOI 10.1111/gcb.13991; Salvatteci R, 2014, MAR GEOL, V357, P72, DOI 10.1016/j.margeo.2014.07.008; Salvatteci R, 2012, PALEOBIOLOGY, V38, P52, DOI 10.1666/10045.1; Sandoval-Huerta ER, 2019, MOL PHYLOGENET EVOL, V130, P269, DOI 10.1016/j.ympev.2018.10.020; Scholz F, 2014, NAT GEOSCI, V7, P433, DOI [10.1038/NGEO2162, 10.1038/ngeo2162]; Schouten S, 2002, EARTH PLANET SC LETT, V204, P265, DOI 10.1016/S0012-821X(02)00979-2; Shchepetkin AF, 2009, J COMPUT PHYS, V228, P8985, DOI 10.1016/j.jcp.2009.09.002; Tercerie S., 2019, OSTEOBASE; Watt J, 1997, ICES COOP RES REP, P1; Wefer G., 1990, P OCEAN DRILLING PRO, V112, DOI [10.2973/odp.proc.sr.112.164.1990, DOI 10.2973/ODP.PROC.SR.112.164.1990]; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Yasuhara M, 2020, OCEANOGRAPHY, V33, P16, DOI 10.5670/oceanog.2020.225	53	6	6	6	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 7	2022	375	6576					101	+	eabj0270	10.1126/science.abj0270	http://dx.doi.org/10.1126/science.abj0270			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YD3FW	34990239	Green Submitted, Green Accepted			2022-12-28	WOS:000740261400048
J	Sheather, J				Sheather, Julian			The cold water cut through my numbness	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		[Anonymous], NEW SCI; Buijze GA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225749; Peretti D, 2015, NATURE, V518, P236, DOI 10.1038/nature14142; van Tulleken Christoffer, 2018, BMJ Case Rep, V2018, DOI 10.1136/bcr-2018-225007	4	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 7	2022	376								o40	10.1136/bmj.o40	http://dx.doi.org/10.1136/bmj.o40			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YP9GN	34996764	Bronze			2022-12-28	WOS:000748927300011
J	Wang, CS; Kavalali, ET; Monteggia, LM				Wang, Camille S.; Kavalali, Ege T.; Monteggia, Lisa M.			BDNF signaling in context: From synaptic regulation to psychiatric disorders	CELL			English	Review							LONG-TERM POTENTIATION; NONSELECTIVE CATIONIC CURRENT; FACTOR VAL66MET POLYMORPHISM; RAPID ANTIDEPRESSANT ACTION; NEUROTROPHIC FACTOR; TRKB RECEPTORS; MESSENGER-RNA; HIPPOCAMPAL NEUROGENESIS; NEUROTRANSMITTER RELEASE; TREATMENT INCREASES	Brain-derived neurotrophic factor (BDNF) is a neuropeptide that plays numerous important roles in synaptic development and plasticity. While its importance in fundamental physiology is well established, studies of BDNF often produce conflicting and unclear results, and the scope of existing research makes the prospect of setting future directions daunting. In this review, we examine the importance of spatial and temporal factors on BDNF activity, particularly in processes such as synaptogenesis, Hebbian plasticity, homeostatic plasticity, and the treatment of psychiatric disorders. Understanding the fundamental physiology of when, where, and how BDNF acts and new approaches to control BDNF signaling in time and space can contribute to improved therapeutics and patient outcomes.	[Wang, Camille S.; Kavalali, Ege T.; Monteggia, Lisa M.] Vanderbilt Univ, Vanderbilt Brain Inst, Nashville, TN 37232 USA; [Wang, Camille S.; Kavalali, Ege T.; Monteggia, Lisa M.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37240 USA	Vanderbilt University; Vanderbilt University	Monteggia, LM (corresponding author), Vanderbilt Univ, Vanderbilt Brain Inst, Nashville, TN 37232 USA.; Monteggia, LM (corresponding author), Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37240 USA.	lisa.monteggia@vanderbilt.edu		Monteggia, Lisa/0000-0003-0018-501X; Wang, Camille/0000-0002-2178-5754	National Institute of Mental Health [MH081060, MH070727, MH66198]	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank current and former members of Kavalali and Monteggia laboratories for numerous invaluable discussions. We acknowledge that the field of BDNF is vast, and we apologize that we were unable to cite many important papers due to space limitations. This work was supported by National Institute of Mental Health grants MH081060 and MH070727 (L.M.M.) and MH66198 (E.T.K.) .	Adachi M, 2008, BIOL PSYCHIAT, V63, P642, DOI 10.1016/j.biopsych.2007.09.019; Adachi M, 2017, NEUROPSYCHOPHARMACOL, V42, P886, DOI 10.1038/npp.2016.201; Alonso M, 2004, LEARN MEMORY, V11, P172, DOI 10.1101/lm.67804; Alonso P, 2008, BIOL PSYCHIAT, V63, P619, DOI 10.1016/j.biopsych.2007.06.020; Amaral MD, 2007, J NEUROPHYSIOL, V98, P2476, DOI 10.1152/jn.00797.2007; Amaral MD, 2007, J NEUROSCI, V27, P5179, DOI 10.1523/JNEUROSCI.5499-06.2007; American Psychiatric Association, 2013, DSM 5 TASK FORCE DIA, V5th, DOI DOI 10.1176/APPI.BOOKS.9780890425596; An JJ, 2008, CELL, V134, P175, DOI 10.1016/j.cell.2008.05.045; Aruga J, 2003, GENE, V315, P87, DOI 10.1016/S0378-1119(03)00715-7; Autry AE, 2012, PHARMACOL REV, V64, P238, DOI 10.1124/pr.111.005108; Autry AE, 2011, NATURE, V475, P91, DOI 10.1038/nature10130; Balkowiec A, 2002, J NEUROSCI, V22, P10399; BARDE YA, 1978, NATURE, V274, P818, DOI 10.1038/274818a0; Baydyuk M, 2015, J NEUROSCI, V35, P4676, DOI 10.1523/JNEUROSCI.2695-14.2015; Berman RM, 2000, BIOL PSYCHIAT, V47, P351, DOI 10.1016/S0006-3223(99)00230-9; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Bjorkholm C, 2016, NEUROPHARMACOLOGY, V102, P72, DOI 10.1016/j.neuropharm.2015.10.034; Boltaev U, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aal1670; Casarotto PC, 2021, CELL, V184, P1299, DOI 10.1016/j.cell.2021.01.034; Cheng Q, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00075; Chhatwal JP, 2006, NAT NEUROSCI, V9, P870, DOI 10.1038/nn1718; COHEN S, 1956, P NATL ACAD SCI USA, V42, P571, DOI 10.1073/pnas.42.9.571; Crawford DC, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14436; Dean C, 2009, NAT NEUROSCI, V12, P767, DOI 10.1038/nn.2315; Desai NS, 1999, LEARN MEMORY, V6, P284; Dieni S, 2012, J CELL BIOL, V196, P775, DOI 10.1083/jcb.201201038; Du J, 2000, J CELL BIOL, V150, P1423, DOI 10.1083/jcb.150.6.1423; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Figurov A, 1996, NATURE, V381, P706, DOI 10.1038/381706a0; Frerking M, 1998, J NEUROPHYSIOL, V80, P3383, DOI 10.1152/jn.1998.80.6.3383; FRISEN J, 1993, P NATL ACAD SCI USA, V90, P4971, DOI 10.1073/pnas.90.11.4971; Fukumoto T, 2001, PSYCHOPHARMACOLOGY, V158, P100, DOI 10.1007/s002130100871; Fumagalli F, 2012, INT J NEUROPSYCHOPH, V15, P235, DOI 10.1017/S1461145711000150; Gideons ES, 2017, ELIFE, V6, DOI 10.7554/eLife.25480; Gideons ES, 2014, P NATL ACAD SCI USA, V111, P8649, DOI 10.1073/pnas.1323920111; Gruart A, 2007, LEARN MEMORY, V14, P54, DOI 10.1101/lm.428307; Hall J, 2000, NAT NEUROSCI, V3, P533, DOI 10.1038/75698; Harward SC, 2016, NATURE, V538, P99, DOI 10.1038/nature19766; Heldt SA, 2007, MOL PSYCHIATR, V12, P656, DOI 10.1038/sj.mp.4001957; Hildebrand ME, 2016, CELL REP, V17, P2753, DOI 10.1016/j.celrep.2016.11.024; Holick KA, 2008, NEUROPSYCHOPHARMACOL, V33, P406, DOI 10.1038/sj.npp.1301399; Hong EJ, 2008, NEURON, V60, P610, DOI 10.1016/j.neuron.2008.09.024; Horch HW, 2002, NAT NEUROSCI, V5, P1177, DOI 10.1038/nn927; Horvath PM, 2021, CELL REP, V36, DOI 10.1016/j.celrep.2021.109467; HYMAN C, 1991, NATURE, V350, P230, DOI 10.1038/350230a0; IP NY, 1992, P NATL ACAD SCI USA, V89, P3060, DOI 10.1073/pnas.89.7.3060; Jakawich SK, 2010, NEURON, V68, P1143, DOI 10.1016/j.neuron.2010.11.034; Jang SW, 2010, P NATL ACAD SCI USA, V107, P2687, DOI 10.1073/pnas.0913572107; Ji YY, 2010, NAT NEUROSCI, V13, P302, DOI 10.1038/nn.2505; Jing DQ, 2017, NEUROPHARMACOLOGY, V112, P84, DOI 10.1016/j.neuropharm.2016.06.030; Jovanovic JN, 2000, NAT NEUROSCI, V3, P323, DOI 10.1038/73888; Kang Heather, 2020, Brain Neurosci Adv, V4, p2398212820957847, DOI 10.1177/2398212820957847; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; Kang HJ, 1996, LEARN MEMORY, V3, P188, DOI 10.1101/lm.3.2-3.188; Kavalaii ET, 2012, AM J PSYCHIAT, V169, P1150, DOI 10.1176/appi.ajp.2012.12040531; Kavalali ET, 2020, NEURON, V106, P715, DOI 10.1016/j.neuron.2020.05.015; Kim JW, 2021, NAT NEUROSCI, V24, P1100, DOI 10.1038/s41593-021-00868-8; KOKAIA Z, 1994, EUR J NEUROSCI, V6, P587, DOI 10.1111/j.1460-9568.1994.tb00303.x; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; Kowianski P, 2018, CELL MOL NEUROBIOL, V38, P579, DOI 10.1007/s10571-017-0510-4; Lahteinen S, 2003, NEUROSCIENCE, V122, P1081, DOI 10.1016/j.neuroscience.2003.08.037; Laje G, 2012, BIOL PSYCHIAT, V72, pE27, DOI 10.1016/j.biopsych.2012.05.031; Lang SB, 2007, J NEUROSCI, V27, P1097, DOI 10.1523/JNEUROSCI.3590-06.2007; Lemtiri-Chlieh F, 2010, J NEUROPHYSIOL, V104, P1923, DOI 10.1152/jn.00472.2010; LEVINE ES, 1995, P NATL ACAD SCI USA, V92, P8074, DOI 10.1073/pnas.92.17.8074; Lewis DA, 2002, ANNU REV NEUROSCI, V25, P409, DOI 10.1146/annurev.neuro.25.112701.142754; Li HS, 1999, NEURON, V24, P261, DOI 10.1016/S0896-6273(00)80838-7; Li YX, 1998, J NEUROSCI, V18, P10231; Li YX, 1998, P NATL ACAD SCI USA, V95, P10884, DOI 10.1073/pnas.95.18.10884; Lin PY, 2021, CELL REP, V36, DOI 10.1016/j.celrep.2021.109513; Lin PY, 2018, CELL REP, V24, P1550, DOI 10.1016/j.celrep.2018.07.020; Linkovski O, 2019, J CLIN PSYCHOPHARM, V39, P91, DOI 10.1097/JCP.0000000000000994; Lipska BK, 2001, EUR J NEUROSCI, V14, P135, DOI 10.1046/j.1460-9568.2001.01633.x; Lituma PJ, 2021, ELIFE, V10, DOI 10.7554/eLife.66612; Liu CY, 2016, TRANSL NEURODEGENER, V5, DOI 10.1186/s40035-015-0048-7; Liu IYC, 2004, J NEUROSCI, V24, P7958, DOI 10.1523/JNEUROSCI.1948-04.2004; LOHOF AM, 1993, NATURE, V363, P350, DOI 10.1038/363350a0; Lowe D., 2017, SCIENCE; Lu B, 2003, LEARN MEMORY, V10, P86, DOI 10.1101/lm.54603; Luikart BW, 2005, J NEUROSCI, V25, P3774, DOI 10.1523/JNEUROSCI.0041-05.2005; Ma ZZ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01709-8; MAISONPIERRE PC, 1990, SCIENCE, V247, P1446, DOI 10.1126/science.2321006; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Massa SM, 2010, J CLIN INVEST, V120, P1774, DOI 10.1172/JCI41356; Matsumoto T, 2008, NAT NEUROSCI, V11, P131, DOI 10.1038/nn2038; Maya-Vetencourt JF, 2008, SCIENCE, V320, P385, DOI 10.1126/science.1150516; Maynard KR, 2015, BIOL PSYCHIAT, V77, p308S; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; McIntyre RS, 2020, LANCET, V396, P1841, DOI 10.1016/S0140-6736(20)31544-0; Meyer-Franke A, 1998, NEURON, V21, P681, DOI 10.1016/S0896-6273(00)80586-3; Minichiello L, 1999, NEURON, V24, P401, DOI 10.1016/S0896-6273(00)80853-3; Minichiello L, 2009, NAT REV NEUROSCI, V10, P850, DOI 10.1038/nrn2738; Monteggia LM, 2013, BIOL PSYCHIAT, V73, P1199, DOI 10.1016/j.biopsych.2012.09.006; Monteggia LM, 2004, P NATL ACAD SCI USA, V101, P10827, DOI 10.1073/pnas.0402141101; Morris RGM, 2003, PHILOS T ROY SOC B, V358, P643, DOI 10.1098/rstb.2002.1230; Mossner R, 2005, INT J NEUROPSYCHOPH, V8, P133, DOI 10.1017/S146114570400495X; NIBUYA M, 1995, J NEUROSCI, V15, P7539; Nosyreva E, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00094; Nosyreva E, 2013, J NEUROSCI, V33, P6990, DOI 10.1523/JNEUROSCI.4998-12.2013; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Parikh V, 2004, NEUROSCI LETT, V356, P135, DOI 10.1016/j.neulet.2003.10.079; Park H, 2013, NAT REV NEUROSCI, V14, P7, DOI 10.1038/nrn3379; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Rantamaki T, 2007, NEUROPSYCHOPHARMACOL, V32, P2152, DOI 10.1038/sj.npp.1301345; Real E, 2009, BIOL PSYCHIAT, V66, P674, DOI 10.1016/j.biopsych.2009.05.017; Reimers JM, 2014, EUR J NEUROSCI, V39, P1159, DOI 10.1111/ejn.12422; Rutherford LC, 1998, NEURON, V21, P521, DOI 10.1016/S0896-6273(00)80563-2; Rutherford LC, 1997, J NEUROSCI, V17, P4527; Saarelainen T, 2003, J NEUROSCI, V23, P349; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Schmid DA, 2012, J NEUROSCI, V32, P1803, DOI 10.1523/JNEUROSCI.0865-11.2012; Shimojo M, 2015, CELL REP, V11, P1054, DOI 10.1016/j.celrep.2015.04.032; Shinoda Yo, 2014, Front Synaptic Neurosci, V6, P27, DOI 10.3389/fnsyn.2014.00027; Shirayama Y, 2002, J NEUROSCI, V22, P3251, DOI 10.1523/JNEUROSCI.22-08-03251.2002; Shmelkov SV, 2010, NAT MED, V16, P598, DOI 10.1038/nm.2125; Siuciak JA, 1997, PHARMACOL BIOCHEM BE, V56, P131, DOI 10.1016/S0091-3057(96)00169-4; Snigdha S, 2011, J MOL NEUROSCI, V43, P337, DOI 10.1007/s12031-010-9447-5; Song M, 2015, DEV CELL, V33, P690, DOI 10.1016/j.devcel.2015.04.009; Sudhof TC, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011353; Suzuki K, 2021, CELL REP, V37, DOI 10.1016/j.celrep.2021.109918; TIMMUSK T, 1993, NEURON, V10, P475, DOI 10.1016/0896-6273(93)90335-O; Ting Jonathan T, 2008, Curr Chem Genomics, V2, P62; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Tyler WJ, 2001, J NEUROSCI, V21, P4249, DOI 10.1523/JNEUROSCI.21-12-04249.2001; Vaswani M, 2003, PROG NEURO-PSYCHOPH, V27, P85, DOI 10.1016/S0278-5846(02)00338-X; Vicario-Abejon C, 2002, NAT REV NEUROSCI, V3, P965, DOI 10.1038/nrn988; Wang HL, 2011, J NEUROSCI, V31, P17764, DOI 10.1523/JNEUROSCI.3964-11.2011; Wardle RA, 2003, J NEUROSCI, V23, P8722; Xu HY, 2002, NEUROSCI LETT, V321, P65, DOI 10.1016/S0304-3940(02)00034-4; Yang JM, 2009, NAT NEUROSCI, V12, P113, DOI 10.1038/nn.2244; Yasuda S, 2009, MOL PSYCHIATR, V14, P51, DOI 10.1038/sj.mp.4002099; Zakharenko SS, 2003, NEURON, V39, P975, DOI 10.1016/S0896-6273(03)00543-9; Zarate CA, 2006, ARCH GEN PSYCHIAT, V63, P856, DOI 10.1001/archpsyc.63.8.856; Zhang JC, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyu077	136	24	24	26	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 6	2022	185	1					62	76		10.1016/j.cell.2021.12.003	http://dx.doi.org/10.1016/j.cell.2021.12.003			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology	YL5FO	34963057				2022-12-28	WOS:000745916700005
J	Sharma, V; Kumar, A				Sharma, Vinod; Kumar, Akash			Carcinoma in breastplate	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Sharma, Vinod; Kumar, Akash] Natl Canc Inst, Jhajjar, India	All India Institute of Medical Sciences (AIIMS) New Delhi; National Cancer Institute-India (NCI-India)	Sharma, V (corresponding author), Natl Canc Inst, Jhajjar, India.	vinod_mbbs4u@yahoo.co.in		Sharma, Vinod/0000-0002-8960-5449					0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 30	2021	385	27					2562	2562		10.1056/NEJMicm2111669	http://dx.doi.org/10.1056/NEJMicm2111669			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	XW2YE	34965340				2022-12-28	WOS:000735490500013
J	Becu, M; Doeller, CF				Becu, Marcia; Doeller, Christian F.			Dark and Magical Places: The Neuroscience of Navigation	SCIENCE			English	Book Review									[Becu, Marcia; Doeller, Christian F.] Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, Ctr Neural Computat, Egil & Pauline Braathen & Fred Kavli Ctr Cort Mic, Trondheim, Norway; [Becu, Marcia; Doeller, Christian F.] Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, KG Jebsen Ctr Alzheimers Dis, Trondheim, Norway; [Becu, Marcia; Doeller, Christian F.] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany; [Doeller, Christian F.] Univ Leipzig, Wilhelm Wundt Inst Psychol, Leipzig, Germany	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Max Planck Society; Leipzig University	Becu, M (corresponding author), Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, Ctr Neural Computat, Egil & Pauline Braathen & Fred Kavli Ctr Cort Mic, Trondheim, Norway.; Becu, M (corresponding author), Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, KG Jebsen Ctr Alzheimers Dis, Trondheim, Norway.; Becu, M (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany.	marcia.becu@ntnu.no						KEMP C, 2022, DARK MAGICAL PLACES	1	0	0	3	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2022	375	6578					274	274		10.1126/science.abn0862	http://dx.doi.org/10.1126/science.abn0862			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YK2FS	35050654				2022-12-28	WOS:000745036100019
J	Alvarez-Dominguez, JR; Melton, DA				Alvarez-Dominguez, Juan R.; Melton, Douglas A.			Cell maturation: Hallmarks, triggers, and manipulation	CELL			English	Review							RETINAL-PIGMENT EPITHELIUM; STEM-CELLS; METABOLIC MATURATION; BETA-CELLS; CARDIAC DIFFERENTIATION; ELECTRICAL-STIMULATION; MOLECULAR-MECHANISMS; SYNAPTIC PLASTICITY; INSULIN-SECRETION; CARDIOMYOCYTES	How cells become specialized, or "mature,"is important for cell and developmental biology. While maturity is usually deemed a terminal fate, it may be more helpful to consider maturation not as a switch but as a dynamic continuum of adaptive phenotypic states set by genetic and environment programing. The hallmarks of maturity comprise changes in anatomy (form, gene circuitry, and interconnectivity) and physiology (function, rhythms, and proliferation) that confer adaptive behavior. We discuss efforts to harness their chemical (nutrients, oxygen, and growth factors) and physical (mechanical, spatial, and electrical) triggers in vitro and in vivo and how maturation strategies may support disease research and regenerative medicine.	[Alvarez-Dominguez, Juan R.] Univ Penn, Dept Cell & Dev Biol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Melton, Douglas A.] Harvard Univ, Harvard Stem Cell Inst, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA	University of Pennsylvania; Pennsylvania Medicine; Harvard University	Alvarez-Dominguez, JR (corresponding author), Univ Penn, Dept Cell & Dev Biol, Perelman Sch Med, Philadelphia, PA 19104 USA.; Melton, DA (corresponding author), Harvard Univ, Harvard Stem Cell Inst, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.	juan.alvarez@pennmedicine.upen.edu; dmelton@harvard.edu			Howard Hughes Medical Institute; NIH [1K01DK129442-01]; Human Islet Research Network [U24DK104162-07]; Harvard Stem Cell Institute; Helmsley Charitable Trust; Juvenile Diabetes Research Foundation; JPB Foundation	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Islet Research Network; Harvard Stem Cell Institute; Helmsley Charitable Trust; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); JPB Foundation	We thank Harvey Lodish, Katie Villa, Jose Rivera-Feliciano, and members of our laboratories for helpful discussions and feedback on this manuscript and Tom DiCesare for help with the illustrations. This work was supported by the Howard Hughes Medical Institute and by grants from the NIH (1K01DK129442-01) and Human Islet Research Network (U24DK104162-07) to J.R.A.-D. and from the Harvard Stem Cell Institute, Helmsley Charitable Trust, Juvenile Diabetes Research Foundation, and the JPB Foundation to D.A.M. We apologize to colleagues whose work could not be referenced or discussed due to space limitations.	Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; Aguayo-Mazzucato C, 2011, DIABETOLOGIA, V54, P583, DOI 10.1007/s00125-010-2026-z; Aguayo-Mazzucato C, 2015, J CLIN ENDOCR METAB, V100, P3651, DOI 10.1210/jc.2015-2632; Aguayo-Mazzucato C, 2013, DIABETES, V62, P1569, DOI 10.2337/db12-0849; Alvarez-Dominguez JR, 2020, CELL STEM CELL, V26, P108, DOI 10.1016/j.stem.2019.11.011; An XU, 2008, BRIT J HAEMATOL, V141, P367, DOI 10.1111/j.1365-2141.2008.07091.x; Artner I, 2010, DIABETES, V59, P2530, DOI 10.2337/db10-0190; Avior Y, 2015, HEPATOLOGY, V62, P265, DOI 10.1002/hep.27803; Baeyens L, 2016, DIABETES OBES METAB, V18, P63, DOI 10.1111/dom.12716; Bass J, 2016, SCIENCE, V354, P994, DOI 10.1126/science.aah4965; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Bechmann LP, 2012, J HEPATOL, V56, P952, DOI 10.1016/j.jhep.2011.08.025; Bedont JL, 2020, ANNU REV CELL DEV BI, V36, P469, DOI 10.1146/annurev-cellbio-100818-125454; Berger DR, 2015, HEPATOLOGY, V61, P1370, DOI 10.1002/hep.27621; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Bertrand S, 1998, J NEUROPHYSIOL, V79, P342, DOI 10.1152/jn.1998.79.1.342; Bertrand SS, 2013, CURR PHARM DESIGN, V19, P4498, DOI 10.2174/1381612811319240014; Bideyan L, 2021, GENE DEV, V35, P635, DOI 10.1101/gad.348340.121; Brennan MD, 2014, LAB CHIP, V14, P4305, DOI 10.1039/c4lc00853g; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Chattergoon NN, 2012, FASEB J, V26, P397, DOI 10.1096/fj.10-179895; Chaudhuri O, 2020, NATURE, V584, P535, DOI 10.1038/s41586-020-2612-2; Cho CS, 2014, P NATL ACAD SCI USA, V111, P12043, DOI 10.1073/pnas.1401100111; Chong DC, 2011, DEV DYNAM, V240, P2153, DOI 10.1002/dvdy.22706; Correia C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08713-4; Takano APC, 2013, MOL CELL ENDOCRINOL, V376, P43, DOI 10.1016/j.mce.2013.05.024; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Davis-Dusenbery BN, 2014, DEVELOPMENT, V141, P491, DOI 10.1242/dev.097410; Delaunay J, 2007, BLOOD REV, V21, P1, DOI 10.1016/j.blre.2006.03.005; Discher DE, 2000, CURR OPIN HEMATOL, V7, P117, DOI 10.1097/00062752-200003000-00008; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Duan XJ, 2013, NANO TODAY, V8, P351, DOI 10.1016/j.nantod.2013.05.001; Dunn KK, 2019, BIOTECHNOL J, V14, DOI 10.1002/biot.201800725; Dvir T, 2011, NAT NANOTECHNOL, V6, P13, DOI 10.1038/NNANO.2010.246; ELGSAETER A, 1986, SCIENCE, V234, P1217, DOI 10.1126/science.3775380; Eng G, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10312; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Esch MB, 2011, ANNU REV BIOMED ENG, V13, P55, DOI [10.1146/annurev-bioeng-071910-124629, 10.1146/annurev-biocng-071910-124629]; Fajans SS, 2001, NEW ENGL J MED, V345, P971, DOI 10.1056/NEJMra002168; Feaster TK, 2015, CIRC RES, V117, P995, DOI 10.1161/CIRCRESAHA.115.307580; Feiner R, 2018, NAT REV MATER, V3, DOI 10.1038/natrevmats.2017.76; Feridaooni HA, 2015, J MOL CELL CARDIOL, V83, P62, DOI 10.1016/j.yjmcc.2014.12.004; Friedman CE, 2018, CELL STEM CELL, V23, P586, DOI 10.1016/j.stem.2018.09.009; Garbern JC, 2020, CIRCULATION, V141, P285, DOI 10.1161/CIRCULATIONAHA.119.044205; Garg P, 2018, AM J NEPHROL, V47, P3, DOI 10.1159/000481633; Gentillon C, 2019, J MOL CELL CARDIOL, V132, P120, DOI 10.1016/j.yjmcc.2019.05.003; GRANIT R, 1963, J PHYSIOL-LONDON, V168, P911, DOI 10.1113/jphysiol.1963.sp007230; Grillner S, 2003, NAT REV NEUROSCI, V4, P573, DOI 10.1038/nrn1137; Guo R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06433-3; Hang WJ, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01121; Hattersley AT, 2018, PEDIATR DIABETES, V19, P47, DOI 10.1111/pedi.12772; Helman A, 2020, CELL METAB, V31, P1004, DOI 10.1016/j.cmet.2020.04.004; Henslee EA, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02161-4; Herrup K, 2007, NAT REV NEUROSCI, V8, P368, DOI 10.1038/nrn2124; Hinckley CA, 2005, J NEUROPHYSIOL, V93, P1439, DOI 10.1152/jn.00647.2004; Hofer M, 2021, NAT REV MATER, V6, P402, DOI 10.1038/s41578-021-00279-y; Homan KA, 2019, NAT METHODS, V16, P255, DOI 10.1038/s41592-019-0325-y; Hrvatin S, 2014, P NATL ACAD SCI USA, V111, P3038, DOI 10.1073/pnas.1400709111; Hu DJ, 2018, CIRC RES, V123, P1066, DOI 10.1161/CIRCRESAHA.118.313249; Huang C, 2018, DEV CELL, V45, P347, DOI 10.1016/j.devcel.2018.03.013; Huh D, 2011, TRENDS CELL BIOL, V21, P745, DOI 10.1016/j.tcb.2011.09.005; Humphrey JD, 2014, NAT REV MOL CELL BIO, V15, P802, DOI 10.1038/nrm3896; Ichimura K, 2017, J CELL SCI, V130, P132, DOI 10.1242/jcs.187815; Jaafar R, 2019, J CLIN INVEST, V129, P4124, DOI 10.1172/JCI127021; Jacovetti C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9084; Jakesova M, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav5265; Kamiya A, 2001, FEBS LETT, V492, P90, DOI 10.1016/S0014-5793(01)02140-8; Kanning KC, 2010, ANNU REV NEUROSCI, V33, P409, DOI 10.1146/annurev.neuro.051508.135722; Karbassi E, 2020, NAT REV CARDIOL, V17, P341, DOI 10.1038/s41569-019-0331-x; Kataoka K, 2002, J BIOL CHEM, V277, P49903, DOI 10.1074/jbc.M206796200; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kidambi S, 2009, P NATL ACAD SCI USA, V106, P15714, DOI 10.1073/pnas.0906820106; Kim DH, 2010, P NATL ACAD SCI USA, V107, P565, DOI 10.1073/pnas.0906504107; Kirkby LA, 2013, NEURON, V80, P1129, DOI 10.1016/j.neuron.2013.10.030; Kojima N, 2014, ORGANOGENESIS, V10, P225, DOI 10.4161/org.28351; Kook H, 2003, J CLIN INVEST, V112, P863, DOI 10.1172/JCI200319137; Kuhn V, 2017, ANTIOXID REDOX SIGN, V26, P718, DOI 10.1089/ars.2016.6954; Laflamme MA, 2011, NATURE, V473, P326, DOI 10.1038/nature10147; Lakkaraju A, 2020, PROG RETIN EYE RES, V78, DOI 10.1016/j.preteyeres.2020.100846; Lancaster MA, 2014, SCIENCE, V345, DOI 10.1126/science.1247125; LARSEN FL, 1981, NATURE, V294, P667, DOI 10.1038/294667a0; Lee DS, 2015, CELL REP, V12, P1960, DOI 10.1016/j.celrep.2015.08.042; Lee HP, 2017, NAT MATER, V16, P1243, DOI [10.1038/NMAT4993, 10.1038/nmat4993]; Lee YK, 2010, MOL ENDOCRINOL, V24, P1728, DOI 10.1210/me.2010-0032; Leppik L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24892-0; Li Q, 2019, NANO LETT, V19, P5781, DOI 10.1021/acs.nanolett.9b02512; Little MH, 2019, GENE DEV, V33, P1319, DOI 10.1101/gad.329573.119; Liu J, 2015, NAT NANOTECHNOL, V10, P629, DOI [10.1038/NNANO.2015.115, 10.1038/nnano.2015.115]; Marian AJ, 2017, CIRC RES, V121, P749, DOI 10.1161/CIRCRESAHA.117.311059; Marlier Q, 2020, CELL MOL LIFE SCI, V77, P4553, DOI 10.1007/s00018-020-03548-1; Martewicz S, 2017, STEM CELL RES, V25, P107, DOI 10.1016/j.scr.2017.10.011; May-Simera HL, 2018, CELL REP, V22, P189, DOI 10.1016/j.celrep.2017.12.038; McCain ML, 2011, PFLUG ARCH EUR J PHY, V462, P89, DOI 10.1007/s00424-011-0951-4; Meehan CF, 2010, J NEUROPHYSIOL, V103, P2599, DOI 10.1152/jn.00668.2009; Mills RJ, 2017, P NATL ACAD SCI USA, V114, pE8372, DOI 10.1073/pnas.1707316114; Mohamed TMA, 2018, CELL, V173, P104, DOI 10.1016/j.cell.2018.02.014; Mohandas N, 2008, BLOOD, V112, P3939, DOI 10.1182/blood-2008-07-161166; Mohanty JG, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00084; Moroni L, 2018, NAT REV MATER, V3, P21, DOI 10.1038/s41578-018-0006-y; Mortola JP, 2002, RESP PHYSIOL NEUROBI, V131, P91, DOI 10.1016/S1569-9048(02)00040-X; Nakano H, 2017, ELIFE, V6, DOI [10.7554/e.Life.29330, 10.7554/eLife.29330]; Noy A, 2011, ADV MATER, V23, P807, DOI 10.1002/adma.201003751; Nunes SS, 2013, NAT METHODS, V10, P781, DOI [10.1038/NMETH.2524, 10.1038/nmeth.2524]; O'Neill JS, 2011, NATURE, V469, P498, DOI 10.1038/nature09702; Olbrot M, 2002, P NATL ACAD SCI USA, V99, P6737, DOI 10.1073/pnas.102168499; Panda S, 2016, SCIENCE, V354, P1008, DOI 10.1126/science.aah4967; Parikh SS, 2017, CIRC RES, V121, P1323, DOI 10.1161/CIRCRESAHA.117.311920; Pipatpolkai T, 2020, NAT REV ENDOCRINOL, V16, P378, DOI 10.1038/s41574-020-0351-y; Politis PK, 2008, CELL CYCLE, V7, P691, DOI 10.4161/cc.7.6.5550; Porat S, 2011, CELL METAB, V13, P440, DOI 10.1016/j.cmet.2011.02.012; Prentki M, 2013, CELL METAB, V18, P162, DOI 10.1016/j.cmet.2013.05.018; Puente BN, 2014, CELL, V157, P565, DOI 10.1016/j.cell.2014.03.032; Radisic M, 2004, P NATL ACAD SCI USA, V101, P18129, DOI 10.1073/pnas.0407817101; Rao C, 2013, BIOMATERIALS, V34, P2399, DOI 10.1016/j.biomaterials.2012.11.055; Rekling JC, 2000, PHYSIOL REV, V80, P767, DOI 10.1152/physrev.2000.80.2.767; Renoux C, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43200-y; Ribeiro AJS, 2015, P NATL ACAD SCI USA, V112, P12705, DOI 10.1073/pnas.1508073112; Rizzolo LJ, 2011, PROG RETIN EYE RES, V30, P296, DOI 10.1016/j.preteyeres.2011.06.002; Roberts JN, 2016, ACS NANO, V10, P6667, DOI 10.1021/acsnano.6b01765; Rog-Zielinska EA, 2015, CELL DEATH DIFFER, V22, P1106, DOI 10.1038/cdd.2014.181; Ronaldson-Bouchard K, 2018, NATURE, V556, P239, DOI 10.1038/s41586-018-0016-3; Rorsman P, 2018, PHYSIOL REV, V98, P117, DOI 10.1152/physrev.00008.2017; Ruan JL, 2016, CIRCULATION, V134, P1557, DOI 10.1161/CIRCULATIONAHA.114.014998; Rubio-Cabezas O, 2013, HORM RES PAEDIAT, V80, P137, DOI 10.1159/000354219; Rutter J, 2002, ANNU REV BIOCHEM, V71, P307, DOI 10.1146/annurev.biochem.71.090501.142857; Sarikhani M, 2020, STEM CELL REP, V15, P498, DOI 10.1016/j.stemcr.2020.06.012; Sasai Y, 2013, NATURE, V493, P318, DOI 10.1038/nature11859; Scott RP, 2015, J CELL BIOL, V209, P199, DOI 10.1083/jcb.201410017; Sharma A, 2020, CELL STEM CELL, V26, P309, DOI 10.1016/j.stem.2020.02.011; Sheydina A, 2011, CLIN SCI, V121, P315, DOI 10.1042/CS20110115; Shin DH, 2013, COMPR PHYSIOL, V3, P799, DOI 10.1002/cphy.c120022; Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354; Siedner S, 2003, J PHYSIOL-LONDON, V548, P493, DOI 10.1113/JPHYSIOL.2002.036509; Sinturel F, 2021, GENE DEV, V35, P329, DOI 10.1101/gad.346460.120; Smith Q, 2018, CELL REP, V24, P895, DOI [10.1016/j.celrep.2018.06.083, 10.1016/j.celrep.2018.08.005]; Spach MS, 2004, HEART RHYTHM, V1, P500, DOI 10.1016/j.hrthm.2004.06.010; Sparrrow JR, 2010, CURR MOL MED, V10, P802; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Stolovich-Rain M, 2015, DEV CELL, V32, P535, DOI 10.1016/j.devcel.2015.01.002; Storm T, 2020, J CELL SCI, V133, DOI 10.1242/jcs.238279; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Stuck BJ, 2008, J BIOL CHEM, V283, P32562, DOI 10.1074/jbc.M801904200; Tian BZ, 2019, CHEM REV, V119, P9136, DOI 10.1021/acs.chemrev.8b00795; Tian BZ, 2012, NAT MATER, V11, P986, DOI [10.1038/NMAT3404, 10.1038/nmat3404]; Tilles AW, 2001, BIOTECHNOL BIOENG, V73, P379, DOI 10.1002/bit.1071; Trefts E, 2017, CURR BIOL, V27, pR1147, DOI 10.1016/j.cub.2017.09.019; Vegas AJ, 2016, NAT MED, V22, P306, DOI 10.1038/nm.4030; Velasco S, 2020, ANNU REV NEUROSCI, V43, P375, DOI 10.1146/annurev-neuro-070918-050154; Velazco-Cruz L, 2019, STEM CELL REP, V12, P351, DOI 10.1016/j.stemcr.2018.12.012; Veres A, 2019, NATURE, V569, P368, DOI 10.1038/s41586-019-1168-5; VONDERMARK K, 1977, NATURE, V267, P531, DOI 10.1038/267531a0; Wang DS, 2020, CELL, V180, P1198, DOI 10.1016/j.cell.2020.02.048; Wang H, 2007, DIABETOLOGIA, V50, P348, DOI 10.1007/s00125-006-0490-2; Weir GC, 2001, DIABETES, V50, pS154, DOI 10.2337/diabetes.50.2007.S154; Werley CA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172671; Yang K, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2101258118; Yoshihara E, 2016, CELL METAB, V23, P622, DOI 10.1016/j.cmet.2016.03.005; Zhang C, 2005, MOL CELL BIOL, V25, P4969, DOI 10.1128/MCB.25.12.4969-4976.2005; Zhu SY, 2014, NATURE, V508, P93, DOI 10.1038/nature13020; Ziman AP, 2010, J MOL CELL CARDIOL, V48, P379, DOI 10.1016/j.yjmcc.2009.09.016	164	10	10	11	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 20	2022	185	2					235	249		10.1016/j.cell.2021.12.012	http://dx.doi.org/10.1016/j.cell.2021.12.012			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	YL8YE	34995481				2022-12-28	WOS:000746172100006
J	Finfer, S; Micallef, S; Hammond, N; Navarra, L; Bellomo, R; Billot, L; Delaney, A; Gallagher, M; Gattas, D; Li, Q; Biostat, M; Mackie, D; Mysore, J; Saxena, M; Taylor, C; Young, P; Myburgh, J				Finfer, Simon; Micallef, Sharon; Hammond, Naomi; Navarra, Leanlove; Bellomo, Rinaldo; Billot, Laurent; Delaney, Anthony; Gallagher, Martin; Gattas, David; Li, Qiang; Biostat, M.; Mackie, Diane; Mysore, Jayanthi; Saxena, Manoj; Taylor, Colman; Young, Paul; Myburgh, John		PLUS Study Investigators; Australian New Zealand Intensive C	Balanced Multielectrolyte Solution versus Saline in Critically Ill Adults	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PLASMA-LYTE 148; RANDOMIZED CONTROLLED-TRIAL; CARE FLUID THERAPY; HYDROXYETHYL STARCH; KIDNEY INJURY; RESUSCITATION; PROTOCOL; ALBUMIN; PLUS; DEFINITIONS	BACKGROUND Whether the use of balanced multielectrolyte solution (BMES) in preference to 0.9% sodium chloride solution (saline) in critically ill patients reduces the risk of acute kidney injury or death is uncertain. METHODS In a double-blind, randomized, controlled trial, we assigned critically ill patients to receive BMES (Plasma-Lyte 148) or saline as fluid therapy in the intensive care unit (ICU) for 90 days. The primary outcome was death from any cause within 90 days after randomization. Secondary outcomes were receipt of new renal-replacement therapy and the maximum increase in the creatinine level during ICU stay. RESULTS A total of 5037 patients were recruited from 53 ICUs in Australia and New Zealand - 2515 patients were assigned to the BMES group and 2522 to the saline group. Death within 90 days after randomization occurred in 530 of 2433 patients (21.8%) in the BMES group and in 530 of 2413 patients (22.0%) in the saline group, for a difference of -0.15 percentage points (95% confidence interval [CI], -3.60 to 3.30; P=0.90). New renal-replacement therapy was initiated in 306 of 2403 patients (12.7%) in the BMES group and in 310 of 2394 patients (12.9%) in the saline group, for a difference of -0.20 percentage points (95% CI, -2.96 to 2.56). The mean (+/- SD) maximum increase in serum creatinine level was 36.6 +/- 94.0 mu mol per liter (0.41 +/- 1.06 mg per deciliter) in the BMES group and 36.1 +/- 90.2 mu mol per liter (0.41 +/- 1.02 mg per deciliter) in the saline group, for a difference of 0.5 mu mol per liter (95% CI, -4.7 to 5.3) (0.01 mg per deciliter [95% CI, -0.05 to 0.06]). The number of adverse and serious adverse events did not differ meaningfully between the groups. CONCLUSIONS We found no evidence that the risk of death or acute kidney injury among critically ill adults in the ICU was lower with the use of BMES than with saline.	[Finfer, Simon; Micallef, Sharon; Hammond, Naomi; Billot, Laurent; Delaney, Anthony; Gallagher, Martin; Li, Qiang; Mysore, Jayanthi; Saxena, Manoj; Taylor, Colman; Myburgh, John] George Inst Global Hlth, Sydney, NSW, Australia; [Finfer, Simon; Micallef, Sharon; Hammond, Naomi; Billot, Laurent; Delaney, Anthony; Gallagher, Martin; Li, Qiang; Mysore, Jayanthi; Saxena, Manoj; Taylor, Colman; Myburgh, John] Univ New South Wales, Sydney, NSW, Australia; [Hammond, Naomi; Delaney, Anthony] Royal North Shore Hosp, Malcolm Fisher Dept Intens Care, St Leonards, NSW, Australia; [Delaney, Anthony] Northern Clin Sch, Camperdown, NSW, Australia; [Gattas, David] Cent Clin Sch, Camperdown, NSW, Australia; [Gattas, David] Univ Sydney, Royal Prince Alfred Hosp, Intens Care Unit, Camperdown, NSW, Australia; [Biostat, M.; Myburgh, John] St George Hosp, Dept Intens Care, Kogarah, NSW, Australia; [Saxena, Manoj] Bankstown Hosp, Intens Care Unit, Sydney, NSW, Australia; [Bellomo, Rinaldo] Austin Hosp, Intens Care Unit, Heidelberg, Vic, Australia; [Bellomo, Rinaldo] Royal Melbourne Hosp, Dept Intens Care, Melbourne, Vic, Australia; [Bellomo, Rinaldo; Young, Paul] Univ Melbourne, Dept Crit Care, Melbourne, Vic, Australia; [Bellomo, Rinaldo; Young, Paul] Monash Univ, Sch Publ Hlth & Prevent Med, Australian & New Zealand Intens Care Res Ctr, Melbourne, Vic, Australia; [Finfer, Simon] Imperial Coll London, Sch Publ Hlth, London, England; [Navarra, Leanlove; Mackie, Diane; Young, Paul] Med Res Inst New Zealand, Wellington, New Zealand; [Navarra, Leanlove; Young, Paul] Wellington Reg Hosp, Dept Intens Care, Wellington, New Zealand	George Institute for Global Health; University of Sydney; University of New South Wales Sydney; Royal North Shore Hospital; University of Sydney; St George Hospital; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Royal Melbourne Hospital; University of Melbourne; Monash University; Imperial College London; Medical Research Institute Of New Zealand	Finfer, S (corresponding author), George Inst Global Hlth, 1 King St, Newtown, NSW 2042, Australia.	sfinfer@georgeinstitute.org.au	; Presneill, Jeffrey/B-4894-2012	Delaney, Anthony/0000-0002-1015-7146; Gallagher, Martin/0000-0001-9187-6187; Billot, Laurent/0000-0002-4975-9793; Saxena, Manoj/0000-0002-0385-6731; Micallef, Sharon/0000-0002-8496-2324; Presneill, Jeffrey/0000-0001-7177-7667; Young, Paul/0000-0002-3428-3083; Venkatesh, Bala/0000-0002-3234-5244; Finfer, Simon/0000-0002-2785-5864; Bellomo, Rinaldo/0000-0002-1650-8939; Myburgh, John/0000-0003-4088-7016; Thompson, Kelly/0000-0003-2304-8931; Hammond, Naomi/0000-0002-6559-7747	National Health and Medical Research Council of Australia [177267]; Health Research Council of New Zealand [16/009]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Health Research Council of New Zealand(Health Research Council of New Zealand)	Supported by project grants from the National Health and Medical Research Council of Australia (177267) and the Health Research Council of New Zealand (16/009); by Practitioner Fellowships from the National Health and Medical Research Council of Australia (to Drs. Finfer and Bellomo); by a National Health and Medical Research Council of Australia Leadership Fellowship (to Dr. Myburgh); by a National Health and Medical Research Council of Australia Emerging Leader Investigator Grant (to Dr. Hammond); and by a Health Research Council of New Zealand Clinical Practitioner Research Fellowship (to Dr. Young). The Medical Research Institute of New Zealand received Independent Research Organization funding from the Health Research Council of New Zealand. Baxter Healthcare and its subsidiary manufactured, supplied, and distributed the concealed trial fluids. Disclosure forms provided by the authors are available with the full text of this article at NEJM.org. A data sharing statement provided by the authors is available with the full text of this article at NEJM.org.	Billot L, 2021, CRIT CARE RESUSC, V23, P24; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Brown RM, 2019, AM J RESP CRIT CARE, V200, P1487, DOI 10.1164/rccm.201903-0557OC; Finfer S, 2004, NEW ENGL J MED, V350, P2247; Finfer S, 2010, CRIT CARE, V14, DOI 10.1186/cc9293; Hammond NE, 2015, INTENS CARE MED, V41, P1611, DOI 10.1007/s00134-015-3878-y; Hammond NE, 2019, CRIT CARE RESUSC, V21, P284; Hammond NE, 2017, CRIT CARE RESUSC, V19, P239; Hammond NE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176292; Hammond NE., 2022, NEJM EVID, V1, DOI [10.1056/EVIDoa2100010, DOI 10.1056/EVIDOA2100010]; Hernan MA, 2017, NEW ENGL J MED, V377, P1391, DOI 10.1056/NEJMsm1605385; Iguchi N, 2018, CRIT CARE RESUSC, V20, P48; Kellum JA, 2004, CHEST, V125, P243, DOI 10.1378/chest.125.1.243; Kellum JA, 2018, NAT REV NEPHROL, V14, P358, DOI 10.1038/s41581-018-0008-4; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Liu C, 2019, AM J EMERG MED, V37, P2072, DOI 10.1016/j.ajem.2019.02.045; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Myburgh J, 2018, NEW ENGL J MED, V378, P862, DOI 10.1056/NEJMe1800449; Myburgh JA, 2012, NEW ENGL J MED, V367, P1901, DOI 10.1056/NEJMoa1209759; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Perner A, 2012, NEW ENGL J MED, V367, P124, DOI 10.1056/NEJMoa1204242; Raghunathan K, 2014, CRIT CARE MED, V42, P1585, DOI 10.1097/CCM.0000000000000305; Ramanan M, 2021, INTENS CARE MED, V47, P1248, DOI 10.1007/s00134-021-06480-5; Reeve R, 2018, STAT METHODS MED RES, V27, P451, DOI 10.1177/0962280216631583; Roquilly A, 2013, CRIT CARE, V17, DOI 10.1186/cc12686; Self WH, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.24596; Semler MW, 2018, NEW ENGL J MED, V378, P829, DOI 10.1056/NEJMoa1711584; Shaw AD, 2012, ANN SURG, V255, P821, DOI 10.1097/SLA.0b013e31825074f5; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Young P, 2015, JAMA-J AM MED ASSOC, V314, P1701, DOI 10.1001/jama.2015.12334; Yunos NM, 2012, JAMA-J AM MED ASSOC, V308, P1566, DOI 10.1001/jama.2012.13356; Yunos NM, 2011, CRIT CARE MED, V39, P2419, DOI 10.1097/CCM.0b013e31822571e5; Yunos NM, 2010, CRIT CARE, V14, DOI 10.1186/cc9052; Zampieri FG, 2021, JAMA-J AM MED ASSOC, V326, P818, DOI 10.1001/jama.2021.11684	34	32	32	3	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 3	2022	386	9					815	826		10.1056/NEJMoa2114464	http://dx.doi.org/10.1056/NEJMoa2114464		JAN 2022	12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZK5CH	35041780	Bronze			2022-12-28	WOS:000743650000001
J	Waters, A				Waters, Adele			Covid-19: Reassess effects of mandatory vaccination on staffing, urge unions	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Department of Health and Social Care, 2021, IMP STAT MAK VACC CO; England NHS Improvement NHS., 2022, VACC COND DEPL VCOD; Rimmer A, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n2733; Torjesen Ingrid, 2022, BMJ, V376, po60, DOI 10.1136/bmj.o60	4	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 18	2022	376								o139	10.1136/bmj.o139	http://dx.doi.org/10.1136/bmj.o139			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YP6OA	35042696	Bronze			2022-12-28	WOS:000748741800001
J	Harrison, D				Harrison, Dominic			What is driving all cause excess mortality?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Harrison, Dominic] Blackburn Darwen Borough Council, Blackburn, Lancs, England		Harrison, D (corresponding author), Blackburn Darwen Borough Council, Blackburn, Lancs, England.							[Anonymous], 2022, GUARDIAN; Hiam L, 2017, J ROY SOC MED, V110, P131, DOI 10.1177/0141076817693600; Mcdonald Stuart, THESIS; Office for National Statistics, CORONAVIRUS COVID 19	4	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 14	2022	376								o100	10.1136/bmj.o100	http://dx.doi.org/10.1136/bmj.o100			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZE9IM	35031539	hybrid			2022-12-28	WOS:000759190400012
J	Willem, M; Fandrich, M				Willem, Michael; Faendrich, Marcus			A molecular view of human amyloid-beta folds	SCIENCE			English	Editorial Material							ALZHEIMERS; OLIGOMERS		[Willem, Michael] Ludwig Maximilians Univ Munchen, Fac Med, Biomed Ctr BMC, Div Metab Biochem, Munich, Germany; [Faendrich, Marcus] Ulm Univ, Inst Prot Biochem, Ulm, Germany	University of Munich; Ulm University	Willem, M (corresponding author), Ludwig Maximilians Univ Munchen, Fac Med, Biomed Ctr BMC, Div Metab Biochem, Munich, Germany.	mwillem@med.uni-muenchen.de; marcus.faendrich@uni-ulm.de			German Research Council [FA456/24-1]	German Research Council(German Research Foundation (DFG))	M.F. is supported by the German Research Council (FA456/24-1).	Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; Arndt JW, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24501-0; Arseni D, NATURE, DOI [10.1038/s41586-021-04199-3 (2021), DOI 10.1038/S41586-021-04199-3(2021)]; Bansal A, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21129-z; Colvin MT, 2015, J AM CHEM SOC, V137, P7509, DOI 10.1021/jacs.5b03997; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Kollmer M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12683-8; Scheltens P, 2016, LANCET, V388, P505, DOI 10.1016/S0140-6736(15)01124-1; Scheres SHW, 2020, CURR OPIN STRUC BIOL, V64, P17, DOI 10.1016/j.sbi.2020.05.011; Schonfelder J, 2021, AMYLOID, V28, P243, DOI 10.1080/13506129.2021.1960501; Sintini I, 2021, CURR OPIN NEUROL, V34, P525, DOI 10.1097/WCO.0000000000000947; Thal DR, 2015, ACTA NEUROPATHOL, V129, P167, DOI 10.1007/s00401-014-1375-y; Walti MA, 2016, P NATL ACAD SCI USA, V113, pE4976, DOI 10.1073/pnas.1600749113; Xiao YL, 2015, NAT STRUCT MOL BIOL, V22, P499, DOI 10.1038/nsmb.2991; Yang Y, 2022, SCIENCE, V375, P167, DOI 10.1126/science.abm7285	15	2	2	8	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2022	375	6577					147	148		10.1126/science.abn5428	http://dx.doi.org/10.1126/science.abn5428			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YG3OI	35025652				2022-12-28	WOS:000742401600018
J	Chua, KP; Conti, RM; Becker, NV				Chua, Kao-Ping; Conti, Rena M.; Becker, Nora V.			US Insurer Spending on Ivermectin Prescriptions for COVID-19	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Chua, Kao-Ping] Univ Michigan, Sch Med, Susan B Meister Child Hlth Evaluat & Res Ctr, 300 N Ingalls St,SPC 5456,Room 6E18, Ann Arbor, MI 48109 USA; [Conti, Rena M.] Boston Univ, Questrom Sch Business, Dept Markets Publ Policy & Law, Boston, MA USA; [Becker, Nora V.] Univ Michigan, Sch Med, Div Gen Med, Ann Arbor, MI USA	University of Michigan System; University of Michigan; Boston University; University of Michigan System; University of Michigan	Chua, KP (corresponding author), Univ Michigan, Sch Med, Susan B Meister Child Hlth Evaluat & Res Ctr, 300 N Ingalls St,SPC 5456,Room 6E18, Ann Arbor, MI 48109 USA.	chuak@med.umich.edu						Centers for Disease Control and Prevention, 2021, RAP INCR IV PRESCR R; Chernew ME, 2007, HEALTH AFFAIR, V26, pW195, DOI 10.1377/hlthaff.26.2.w195; Lopez-Medina E, 2021, JAMA-J AM MED ASSOC, V325, P1426, DOI 10.1001/jama.2021.3071; Schwartz AL, 2014, JAMA INTERN MED, V174, P1067, DOI 10.1001/jamainternmed.2014.1541; The IQVIA Institute, 2021, US MED US	5	5	5	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 8	2022	327	6					584	587		10.1001/jama.2021.24352	http://dx.doi.org/10.1001/jama.2021.24352		JAN 2022	5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZD5RT	35024763	Bronze, Green Published			2022-12-28	WOS:000742416300002
J	Weinstein, DF				Weinstein, Debra F.			Reengineering GME in a Pandemic - Looking Back, and Forward	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Weinstein, Debra F.] Univ Michigan, Sch Med, Ann Arbor, MI 48109 USA; [Weinstein, Debra F.] Univ Michigan, Michigan Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Weinstein, DF (corresponding author), Univ Michigan, Sch Med, Ann Arbor, MI 48109 USA.; Weinstein, DF (corresponding author), Univ Michigan, Michigan Med, Ann Arbor, MI 48109 USA.							Accreditation Council for Graduate Medical Education, 2021, SPONS I EM CAT; American Board of Medical Specialties, 2020, ABMS ACGME JOINT PRI; Coalition for Physician Accountability's Work Group on Medical Students in the Class of 2022 Moving Across Institutions for Interviews for Postgraduate Training, 2021, REC 2021 22 RES SEAS; Dennis Bradley, 2020, J Grad Med Educ, V12, P272, DOI 10.4300/JGME-D-20-00290.1; Massachusetts General Hospital, 2020, MASS GEN COVID URG R	5	2	2	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 13	2022	386	2					97	100		10.1056/NEJMp2116760	http://dx.doi.org/10.1056/NEJMp2116760		JAN 2022	4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YF2NZ	34995028				2022-12-28	WOS:000740348000001
J	Borchert, MJ; Devlin, JA; Erlewein, SR; Fleck, M; Harrington, JA; Higuchi, T; Latacz, BM; Voelksen, F; Wursten, EJ; Abbass, F; Bohman, MA; Mooser, AH; Popper, D; Wiesinger, M; Will, C; Blaum, K; Matsuda, Y; Ospelkaus, C; Quint, W; Walz, J; Yamazaki, Y; Smorra, C; Ulmer, S				Borchert, M. J.; Devlin, J. A.; Erlewein, S. R.; Fleck, M.; Harrington, J. A.; Higuchi, T.; Latacz, B. M.; Voelksen, F.; Wursten, E. J.; Abbass, F.; Bohman, M. A.; Mooser, A. H.; Popper, D.; Wiesinger, M.; Will, C.; Blaum, K.; Matsuda, Y.; Ospelkaus, C.; Quint, W.; Walz, J.; Yamazaki, Y.; Smorra, C.; Ulmer, S.			A 16-parts-per-trillion measurement of the antiproton-to-proton charge-mass ratio	NATURE			English	Article							PENNING TRAP; ELECTRON; CPT; CONSTRAINTS; MATTER; TESTS; ION	The standard model of particle physics is both incredibly successful and glaringly incomplete. Among the questions left open isthe striking imbalance of matter and antimatter in the observable universe(1), which inspires experiments to compare the fundamental properties of matter/antimatter conjugates with high precision(2-5). Our experiments deal with direct investigations of the fundamental properties of protons and antiprotons, performing spectroscopy in advanced cryogenic Penning trap systems(6). For instance, we previously compared the proton/antiproton magnetic moments with 1.5 parts per billion fractional precision(7,8), which improved upon previous best measurements(9) by a factor of greaterthan 3,000. Here we report on a new comparison of the proton/antiproton charge-to-mass ratios with a fractional uncertainty of 16 parts per trillion. Our result is based on the combination of four independent long-term studies, recorded in a total time span of 1.5 years. We use different measurement methods and experimental set-ups incorporating different systematic effects. The final result, -(q/m)(p)/(q/m)((p) over bar) =1.000000000003(16), is consistent with the fundamental charge-parity-time reversal invariance, and improvesthe precision of our previous best measurement' by a factor of4.3. The measurement teststhe standard model at an energy scale of 1.96 x 10(-27) gigaelectronvolts (confidence level 0.68), and improves ten coefficients ofthe standard model extension(10). Our cyclotron clock study also constrains hypothetical interactions mediating violations ofthe clock weak equivalence principle (WEPcc) for antimatterto less than 1.8 x 10(-7), and enablesthe first differential test ofthe WEP CC using antiprotons(11). From this interpretation we constrain the differential WEPcc-violating coefficient to less than 0.030.	[Borchert, M. J.; Devlin, J. A.; Erlewein, S. R.; Fleck, M.; Harrington, J. A.; Higuchi, T.; Latacz, B. M.; Voelksen, F.; Wursten, E. J.; Bohman, M. A.; Wiesinger, M.; Yamazaki, Y.; Smorra, C.; Ulmer, S.] RIKEN, Ulmer Fundamental Symmetries Lab, Saitama, Japan; [Borchert, M. J.; Ospelkaus, C.] Leibniz Univ Hannover, Inst Quantenopt, Hannover, Germany; [Borchert, M. J.; Ospelkaus, C.] Phys Tech Bundesanstalt, Braunschweig, Germany; [Devlin, J. A.; Erlewein, S. R.; Wursten, E. J.] CERN, Meyrin, Switzerland; [Erlewein, S. R.; Harrington, J. A.; Wursten, E. J.; Bohman, M. A.; Mooser, A. H.; Wiesinger, M.; Will, C.; Blaum, K.] Max Planck Inst Kernphys, Heidelberg, Germany; [Fleck, M.; Higuchi, T.; Matsuda, Y.] Univ Tokyo, Grad Sch Arts & Sci, Tokyo, Japan; [Voelksen, F.; Quint, W.] GSI Helmholtzzentrum Schwerionenforsch, Darmstadt, Germany; [Abbass, F.; Popper, D.; Walz, J.; Smorra, C.] Johannes Gutenberg Univ Mainz, Inst Phys, Mainz, Germany; [Walz, J.] Johannes Gutenberg Univ Mainz, Helmholtz Inst Mainz, Mainz, Germany	RIKEN; Leibniz University Hannover; Physikalisch-Technische Bundesanstalt (PTB); European Organization for Nuclear Research (CERN); Max Planck Society; University of Tokyo; Helmholtz Association; GSI Helmholtz-Center for Heavy Ion Research; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Ulmer, S (corresponding author), RIKEN, Ulmer Fundamental Symmetries Lab, Saitama, Japan.	stefan.ulmer@cern.ch	Higuchi, Takashi/C-4571-2017; Matsuda, Yasuyuki/C-3007-2008; Ulmer, Stefan/AAC-8087-2022	Higuchi, Takashi/0000-0003-3281-4669; Matsuda, Yasuyuki/0000-0002-9847-3791; Ulmer, Stefan/0000-0002-4185-4147; Smorra, Christian/0000-0001-5584-7960; Will, Christian/0000-0003-4622-7799; Wursten, Elise/0000-0002-2413-2214; Devlin, Jack/0000-0002-4448-5471; Fleck, Markus/0000-0003-4114-1902; Latacz, Barbara/0000-0003-2320-1713	RIKEN; RIKEN EEE pioneering project; RIKEN SPDR; JRA programme; Max Planck Society; European Union [FunI-832848, STEP-852818]; CRC 1227 'DQ-mat' [DFG 274200144]; Cluster of Excellence 'Quantum Frontiers' [DFG 390837967]; CERN fellowship programme; Helmholtz-Gemeinschaft; Max Planck, RIKEN, PTB Center for Time, Constants, and Fundamental Symmetries (C-TCFS);  [AVA-721559]	RIKEN; RIKEN EEE pioneering project; RIKEN SPDR; JRA programme; Max Planck Society(Max Planck SocietyFoundation CELLEX); European Union(European Commission); CRC 1227 'DQ-mat'; Cluster of Excellence 'Quantum Frontiers'; CERN fellowship programme; Helmholtz-Gemeinschaft(Helmholtz Association); Max Planck, RIKEN, PTB Center for Time, Constants, and Fundamental Symmetries (C-TCFS); 	We acknowledge technical support by CERN, especially the Antiproton Decelerator operation group, CERN's cryolab team and engineering department, and all other CERN groups that provide support to Antiproton Decelerator experiments. We acknowledge Y.Ding for comments in the discussion of the updated SME limits. We acknowledge financial support by RIKEN, the RIKEN EEE pioneering project funding, the RIKEN SPDR and JRA programme, the Max Planck Society, the European Union (FunI-832848, STEP-852818), CRC 1227 'DQ-mat'(DFG 274200144), the Cluster of Excellence 'Quantum Frontiers' (DFG 390837967), AVA-721559, the CERN fellowship programme and the Helmholtz-Gemeinschaft. This work was supported by the Max Planck, RIKEN, PTB Center for Time, Constants, and Fundamental Symmetries (C-TCFS).	Ahmadi M, 2018, NATURE, V557, P71, DOI 10.1038/s41586-018-0017-2; BASE Collaboration, 2019, CERNSPSC2019047 BASE; Bertsche WA, 2018, PHILOS T R SOC A, V376, DOI 10.1098/rsta.2017.0265; Bluhm R, 1998, PHYS REV D, V57, P3932, DOI 10.1103/PhysRevD.57.3932; BROWN LS, 1986, REV MOD PHYS, V58, P233, DOI 10.1103/RevModPhys.58.233; Chardin Gabriel, 2018, Hyperfine Interactions, V239, DOI 10.1007/s10751-018-1521-3; Charlton M., 2020, TESTING FUNDAMENTAL; CORNELL EA, 1990, PHYS REV A, V41, P312, DOI 10.1103/PhysRevA.41.312; D'Urso B, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.043001; Devlin JA, 2019, PHYS REV APPL, V12, DOI 10.1103/PhysRevApplied.12.044012; Dine M, 2004, REV MOD PHYS, V76, P1, DOI 10.1103/RevModPhys.76.1; Ding YH, 2020, PHYS REV D, V102, DOI 10.1103/PhysRevD.102.056009; DiSciacca J, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.130801; Edwards BR, 2018, PHYS LETT B, V786, P319, DOI 10.1016/j.physletb.2018.10.011; Gabrielse G, 1999, PHYS REV LETT, V82, P3198, DOI 10.1103/PhysRevLett.82.3198; GABRIELSE G, 1989, INT J MASS SPECTROM, V88, P319, DOI 10.1016/0168-1176(89)85027-X; Heiss F, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.033001; Hoaglin D. C, 2000, UNDERSTANDING ROBUST; Hori M, 2016, SCIENCE, V354, P610, DOI 10.1126/science.aaf6702; HUGHES RJ, 1990, PHYS REV D, V41, P2367, DOI 10.1103/PhysRevD.41.2367; HUGHES RJ, 1991, PHYS REV LETT, V66, P854, DOI 10.1103/PhysRevLett.66.854; Jentschura UD, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.163003; KENYON IR, 1990, PHYS LETT B, V237, P274, DOI 10.1016/0370-2693(90)91443-F; Ketter J, 2014, INT J MASS SPECTROM, V358, P1, DOI 10.1016/j.ijms.2013.10.005; Kortunov IV, 2021, NAT PHYS, V17, P569, DOI 10.1038/s41567-020-01150-7; Kostelecky VA, 2011, REV MOD PHYS, V83, DOI 10.1103/RevModPhys.83.11; KOSTELECKY VA, 1991, NUCL PHYS B, V359, P545; Kramida A., 2020, NIST ATOMIC SPECTRA, DOI 10.18434/T4W30F; Lehnert R, 2016, SYMMETRY-BASEL, V8, DOI 10.3390/sym8110114; LUDERS G, 1957, ANN PHYS-NEW YORK, V2, P1, DOI 10.1016/0003-4916(57)90032-5; LYKKE KR, 1991, PHYS REV A, V43, P6104, DOI 10.1103/PhysRevA.43.6104; Nagahama H, 2016, REV SCI INSTRUM, V87, DOI 10.1063/1.4967493; Natarayan V., 1993, THESIS MIT; Parthey CG, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.203001; Patra S, 2020, SCIENCE, V369, P1238, DOI 10.1126/science.aba0453; Perez P, 2012, CLASSICAL QUANT GRAV, V29, DOI 10.1088/0264-9381/29/18/184008; Rao CR, 1992, BREAKTHROUGHS STAT, P235, DOI DOI 10.1007/978-1-4612-0919-5; Rau S, 2020, NATURE, V585, P43, DOI 10.1038/s41586-020-2628-7; S uper-K amiokande collaboration, 2017, PHYS REV D, V95; Sahoo BK, 2020, PHYS REV A, V102, DOI 10.1103/PhysRevA.102.022820; Scampoli P, 2014, MOD PHYS LETT A, V29, DOI 10.1142/S0217732314300171; Schneider G, 2017, SCIENCE, V358, P1081, DOI 10.1126/science.aan0207; SCHWINGENHEUER B, 1995, PHYS REV LETT, V74, P4376, DOI 10.1103/PhysRevLett.74.4376; Sellner S, 2017, NEW J PHYS, V19, DOI 10.1088/1367-2630/aa7e73; Smorra C, 2017, NATURE, V550, P371, DOI 10.1038/nature24048; Smorra C, 2015, EUR PHYS J-SPEC TOP, V224, P3055, DOI 10.1140/epjst/e2015-02607-4; Smorra C, 2015, INT J MASS SPECTROM, V389, P10, DOI 10.1016/j.ijms.2015.08.007; Smorra C, 2021, TECHNICAL DESIGN REP; Tchernin C, 2020, ASTRON ASTROPHYS, V644, DOI 10.1051/0004-6361/201937028; Thompson JK, 2004, NATURE, V430, P58, DOI 10.1038/nature02682; Tsujikawa S, 2013, CLASSICAL QUANT GRAV, V30, DOI 10.1088/0264-9381/30/21/214003; Ulmer S, 2015, NATURE, V524, P196, DOI 10.1038/nature14861; VANDYCK RS, 1987, PHYS REV LETT, V59, P26, DOI 10.1103/PhysRevLett.59.26; Wang YJ, 2006, FISH RES, V77, P220, DOI 10.1016/j.fishres.2005.08.011; Weinberg S., 2008, COSMOLOGY; WINELAND DJ, 1975, J APPL PHYS, V46, P919, DOI 10.1063/1.321602	57	3	3	3	14	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 6	2022	601	7891					53	+		10.1038/s41586-021-04203-w	http://dx.doi.org/10.1038/s41586-021-04203-w			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YD5HH	34987217				2022-12-28	WOS:000740442700001
J	Combes, AJ; Samad, B; Tsui, J; Chew, NW; Yan, P; Reeder, GC; Kushnoor, D; Shen, AL; Davidson, B; Barczak, AJ; Adkisson, M; Edwards, A; Naser, M; Barry, KC; Courau, T; Hammoudi, T; Arguello, RJ; Rao, AA; Olshen, AB; Cai, C; Zhan, J; Davis, KC; Kelley, RK; Chapman, JS; Atreya, CE; Patel, A; Daud, AI; Ha, P; Diaz, AA; Kratz, JR; Collisson, EA; Fragiadakis, GK; Erle, DJ; Boissonnas, A; Asthana, S; Chan, V; Krummel, MF				Combes, Alexis J.; Samad, Bushra; Tsui, Jessica; Chew, Nayvin W.; Yan, Peter; Reeder, Gabriella C.; Kushnoor, Divyashree; Shen, Alan; Davidson, Brittany; Barczak, Andrea J.; Adkisson, Michael; Edwards, Austin; Naser, Mohammad; Barry, Kevin C.; Courau, Tristan; Hammoudi, Taymour; Arguello, Rafael J.; Rao, Arjun Arkal; Olshen, Adam B.; Cai, Cathy; Zhan, Jenny; Davis, Katelyn C.; Kelley, Robin K.; Chapman, Jocelyn S.; Atreya, Chloe E.; Patel, Amar; Daud, Adil, I; Ha, Patrick; Diaz, Aaron A.; Kratz, Johannes R.; Collisson, Eric A.; Fragiadakis, Gabriela K.; Erle, David J.; Boissonnas, Alexandre; Asthana, Saurabh; Chan, Vincent; Krummel, Matthew F.		Immunoprofiler Consortium	Discovering dominant tumor immune archetypes in a pan-cancer census	CELL			English	Article							SINGLE-CELL; T-CELLS; GENE-EXPRESSION; LANDSCAPE; MICROENVIRONMENT; REVEALS; IMMUNOTHERAPY; FEATURES; THERAPY; MACROPHAGES	Cancers display significant heterogeneity with respect to tissue of origin, driver mutations, and other features of the surrounding tissue. It is likely that individual tumors engage common patterns of the immune system-here "archetypes"-creating prototypical non-destructive tumor immune microenvironments (TMEs) and modulating tumor-targeting. To discover the dominant immune system archetypes, the University of California, San Francisco (UCSF) Immunoprofiler Initiative (IPI) processed 364 individual tumors across 12 cancer types using standardized protocols. Computational clustering of flow cytometry and transcriptomic data obtained from cell sub-compartments uncovered dominant patterns of immune composition across cancers. These archetypes were profound insofar as they also differentiated tumors based upon unique immune and tumor gene expression patterns. They also partitioned well-established classifications of tumor biology. The IPI resource provides a template for understanding cancer immunity as a collection of dominant patterns of immune organization and provides a rational path forward to learn how to modulate these to improve therapy.	[Combes, Alexis J.; Samad, Bushra; Tsui, Jessica; Chew, Nayvin W.; Yan, Peter; Reeder, Gabriella C.; Kushnoor, Divyashree; Shen, Alan; Edwards, Austin; Naser, Mohammad; Courau, Tristan; Hammoudi, Taymour; Rao, Arjun Arkal; Cai, Cathy; Zhan, Jenny; Davis, Katelyn C.; Krummel, Matthew F.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Combes, Alexis J.; Samad, Bushra; Tsui, Jessica; Chew, Nayvin W.; Yan, Peter; Reeder, Gabriella C.; Kushnoor, Divyashree; Shen, Alan; Davidson, Brittany; Edwards, Austin; Naser, Mohammad; Courau, Tristan; Hammoudi, Taymour; Rao, Arjun Arkal; Cai, Cathy; Zhan, Jenny; Davis, Katelyn C.; Kratz, Johannes R.; Fragiadakis, Gabriela K.; Erle, David J.; Chan, Vincent; Krummel, Matthew F.] Univ Calif San Francisco, ImmunoX Initiat, San Francisco, CA 94143 USA; [Combes, Alexis J.; Samad, Bushra; Tsui, Jessica; Chew, Nayvin W.; Yan, Peter; Reeder, Gabriella C.; Kushnoor, Divyashree; Shen, Alan; Davidson, Brittany; Barczak, Andrea J.; Adkisson, Michael; Edwards, Austin; Naser, Mohammad; Courau, Tristan; Hammoudi, Taymour; Rao, Arjun Arkal; Olshen, Adam B.; Cai, Cathy; Zhan, Jenny; Davis, Katelyn C.; Chapman, Jocelyn S.; Atreya, Chloe E.; Patel, Amar; Collisson, Eric A.; Fragiadakis, Gabriela K.; Erle, David J.; Asthana, Saurabh; Chan, Vincent; Krummel, Matthew F.] Univ Calif San Francisco, UCSF Immunoprofiler Initiat, San Francisco, CA 94143 USA; [Combes, Alexis J.; Samad, Bushra; Tsui, Jessica; Chew, Nayvin W.; Yan, Peter; Reeder, Gabriella C.; Kushnoor, Divyashree; Shen, Alan; Davidson, Brittany; Barczak, Andrea J.; Adkisson, Michael; Edwards, Austin; Naser, Mohammad; Courau, Tristan; Hammoudi, Taymour; Rao, Arjun Arkal; Cai, Cathy; Zhan, Jenny; Davis, Katelyn C.; Fragiadakis, Gabriela K.; Erle, David J.] Univ Calif San Francisco, UCSF CoLabs, San Francisco, CA 94143 USA; [Barry, Kevin C.] Fred Hutchinson Canc Res Ctr, Publ Hlth Sci Div, Translat Res Program, 1124 Columbia St, Seattle, WA 98104 USA; [Arguello, Rafael J.] Aix Marseille Univ, Ctr Immunol Marseille Luminy, CIML, CNRS,INSERM, Marseille, France; [Olshen, Adam B.; Kelley, Robin K.; Atreya, Chloe E.; Collisson, Eric A.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Olshen, Adam B.; Asthana, Saurabh] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Chapman, Jocelyn S.] Univ Calif San Francisco, Dept Obstet, San Francisco, CA 94143 USA; [Chapman, Jocelyn S.] Univ Calif San Francisco, Dept Gynecol, San Francisco, CA 94143 USA; [Chapman, Jocelyn S.] Univ Calif San Francisco, Dept Reprod Sci, Med, San Francisco, CA 94143 USA; [Atreya, Chloe E.; Patel, Amar; Daud, Adil, I; Collisson, Eric A.] Univ Calif San Francisco, Div Hematol & Oncol, Dept Med, San Francisco, CA 94143 USA; [Daud, Adil, I] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA; [Ha, Patrick] Univ Calif San Francisco, Dept Otolaryngol, San Francisco, CA 94143 USA; [Diaz, Aaron A.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Kratz, Johannes R.] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA; [Fragiadakis, Gabriela K.] Univ Calif San Francisco, Div Rheumatol, Dept Med, San Francisco, CA 94143 USA; [Erle, David J.] Univ Calif San Francisco, Dept Med, Lung Biol Ctr, San Francisco, CA 94143 USA; [Erle, David J.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Boissonnas, Alexandre] Sorbonne Univ, INSERM, CNRS, Ctr Immunol & Malad Infect CIMI, Paris, France; [Chan, Vincent] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Fred Hutchinson Cancer Center; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of California System; University of California San Francisco	Combes, AJ; Krummel, MF (corresponding author), Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA.; Combes, AJ; Krummel, MF (corresponding author), Univ Calif San Francisco, ImmunoX Initiat, San Francisco, CA 94143 USA.; Combes, AJ; Krummel, MF (corresponding author), Univ Calif San Francisco, UCSF Immunoprofiler Initiat, San Francisco, CA 94143 USA.; Combes, AJ (corresponding author), Univ Calif San Francisco, UCSF CoLabs, San Francisco, CA 94143 USA.	alexis.combes@ucsf.edu; matthew.krummel@ucsf.edu	Boissonnas, Alexandre/A-2801-2016	Boissonnas, Alexandre/0000-0002-7770-7210; Yan, Peter/0000-0002-6024-8548; Rao, Arjun/0000-0003-4480-3190; Courau, Tristan/0000-0003-1819-9516; Reeder, Gabriella/0000-0001-7286-4615; Davidson, Brittany/0000-0003-3538-2822; Carnevale, Julia/0000-0001-9410-7148; Tsui, Jessica/0000-0002-1336-6760; Combes, Alexis/0000-0002-9110-6542; Samad, Bushra/0000-0002-2893-0897; Arguello, Rafael J/0000-0001-9785-3883	AbbVie; Amgen; Bristol-Myers Squibb; Pfizer; NIH [R01CA197363, U01CA217864]; NCI [R01 CA178015, CA222862, CA227807, CA239604, CA230263, U24 (CA210974), U54 (CA224081), P30 (P30CA082103)]	AbbVie(AbbVie); Amgen(Amgen); Bristol-Myers Squibb(Bristol-Myers Squibb); Pfizer(Pfizer); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank all members of the Krummel lab, University of California, San Fran-cisco (UCSF) ImmunoX, UCSF CoLabs, and the UCSF Immunoprofiler Con-sortium for discussion and guidance while developing this study. We would like to thank Dr. Nicholas Kuhn for scientific discussion. We would like to thank Dr. Kenneth Hu for editing the manuscript. We would like to particularly thank Isabelle Tingin, Garry Shumakher, Elizabeth Edmiston, and Meghan Zubradt for their constant support and help during this study. We would like to thank Dr. Ana Catharina Silva for her help in designing the graphical abstract. Finally,we thank all patients and their families, for placing their trust in us. Acquisition and analysis of certain human samples described in this study was partially funded by contributions from AbbVie, Amgen, Bristol-Myers Squibb, and Pfizer as part of the UCSF Immunoprofiler Initiative. Further support came from the NIH (R01CA197363 and U01CA217864 to M.F.K.) , NCI (R01 CA178015, CA222862, CA227807, CA239604, and CA230263 to E.A.C.) , U24 (CA210974 to E.A.C.) , U54 (CA224081 to E.A.C.) , and P30 (P30CA082103 to A.B.O.) .	Angelo M, 2014, NAT MED, V20, P436, DOI 10.1038/nm.3488; [Anonymous], 2017, P 12 BIANNUAL C ITAL, DOI [10.1145/3125571.3125585, DOI 10.1145/3125571.3125585, DOI 10.1093/sysbio/syy032]; Aran D, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1349-1; Arguello RJ, 2020, CELL METAB, V32, DOI 10.1016/j.cmet.2020.11.007; Asp M, 2019, CELL, V179, P1647, DOI 10.1016/j.cell.2019.11.025; Azizi E, 2018, CELL, V174, P1293, DOI 10.1016/j.cell.2018.05.060; Bagaev A, 2021, CANCER CELL, V39, P845, DOI 10.1016/j.ccell.2021.04.014; Barry KC, 2018, NAT MED, V24, P1178, DOI 10.1038/s41591-018-0085-8; Beltra JC, 2020, IMMUNITY, V52, P825, DOI 10.1016/j.immuni.2020.04.014; Bengsch B, 2018, IMMUNITY, V48, P1029, DOI 10.1016/j.immuni.2018.04.026; Berger AC, 2018, CANCER CELL, V33, P690, DOI 10.1016/j.ccell.2018.03.014; Bindea G, 2013, IMMUNITY, V39, P782, DOI 10.1016/j.immuni.2013.10.003; Binnewies M, 2019, CELL, V177, P556, DOI 10.1016/j.cell.2019.02.005; Binnewies M, 2018, NAT MED, V24, P541, DOI 10.1038/s41591-018-0014-x; Biswas SK, 2013, SEMIN IMMUNOPATHOL, V35, P585, DOI 10.1007/s00281-013-0367-7; Blank CU, 2019, NAT REV IMMUNOL, V19, P665, DOI 10.1038/s41577-019-0221-9; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Bottcher JP, 2018, CELL, V172, P1022, DOI 10.1016/j.cell.2018.01.004; Borcherding N, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-020-01625-6; Bosteels C, 2020, IMMUNITY, V52, P1039, DOI 10.1016/j.immuni.2020.04.005; Brown SD, 2014, GENOME RES, V24, P743, DOI 10.1101/gr.165985.113; Broz ML, 2014, CANCER CELL, V26, P638, DOI 10.1016/j.ccell.2014.09.007; Cassetta L, 2019, CANCER CELL, V35, P588, DOI 10.1016/j.ccell.2019.02.009; Chen BB, 2018, METHODS MOL BIOL, V1711, P243, DOI 10.1007/978-1-4939-7493-1_12; Chen DS, 2017, NATURE, V541, P321, DOI 10.1038/nature21349; Chen J, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-02064-6; Cheng SJ, 2021, CELL, V184, P792, DOI 10.1016/j.cell.2021.01.010; Coffelt SB, 2015, NATURE, V522, P345, DOI 10.1038/nature14282; Combes A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00695-1; Combes AJ, 2021, NATURE, V591, P124, DOI 10.1038/s41586-021-03234-7; Davidson-Pilon C., 2020, CAMDAVIDSONPILONLIFE, DOI [10.5281/zenodo.4136578, DOI 10.5281/ZENODO.4136578]; DAVIES DL, 1979, IEEE T PATTERN ANAL, V1, P224, DOI 10.1109/TPAMI.1979.4766909; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dominguez D, 2016, CELL RES, V26, P946, DOI 10.1038/cr.2016.84; Duan QQ, 2020, TRENDS CANCER, V6, P605, DOI 10.1016/j.trecan.2020.02.022; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Ephrem A, 2013, EUR J IMMUNOL, V43, P2421, DOI 10.1002/eji.201343451; Etzerodt A, 2020, J EXP MED, V217, DOI 10.1084/jem.20191869; Gajewski TF, 2013, CURR OPIN IMMUNOL, V25, P268, DOI 10.1016/j.coi.2013.02.009; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Galon J, 2019, NAT REV DRUG DISCOV, V18, P197, DOI 10.1038/s41573-018-0007-y; Gentles AJ, 2015, NAT MED, V21, P938, DOI 10.1038/nm.3909; Gerlach C, 2016, IMMUNITY, V45, P1270, DOI 10.1016/j.immuni.2016.10.018; Ghosh M, 2021, CANCER CELL, V39, P494, DOI 10.1016/j.ccell.2021.01.003; Goldman MJ, 2020, NAT BIOTECHNOL, V38, P675, DOI 10.1038/s41587-020-0546-8; Goodman AM, 2017, MOL CANCER THER, V16, P2598, DOI 10.1158/1535-7163.MCT-17-0386; Goswami S, 2020, NAT MED, V26, P39, DOI 10.1038/s41591-019-0694-x; Gotwals P, 2017, NAT REV CANCER, V17, P286, DOI 10.1038/nrc.2017.17; Grunwald BT, 2021, CELL, V184, P5577, DOI 10.1016/j.cell.2021.09.022; Gubin MM, 2018, CELL, V175, P1014, DOI 10.1016/j.cell.2018.09.030; Gueguen P, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abd5778; Hafemeister C, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1874-1; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hegde PS, 2016, CLIN CANCER RES, V22, P1865, DOI 10.1158/1078-0432.CCR-15-1507; Hu KH, 2020, NAT METHODS, V17, P833, DOI 10.1038/s41592-020-0880-2; Hugo W, 2016, CELL, V165, P35, DOI 10.1016/j.cell.2016.02.065; Iwai Y, 2005, INT IMMUNOL, V17, P133, DOI 10.1093/intimm/dxh194; James Melville, 2020, Arxiv, DOI arXiv:1802.03426; Keren L, 2018, CELL, V174, P1373, DOI 10.1016/j.cell.2018.08.039; Khan O, 2019, NATURE, V571, P211, DOI 10.1038/s41586-019-1325-x; Kinker G.S., 2019, PAN CANC SINGLE CELL, DOI [10.1101/807552, DOI 10.1101/807552]; Kinker GS, 2020, NAT GENET, V52, P1208, DOI 10.1038/s41588-020-00726-6; Korsunsky I, 2019, NAT METHODS, V16, P1289, DOI 10.1038/s41592-019-0619-0; Kumar BV, 2017, CELL REP, V20, P2921, DOI 10.1016/j.celrep.2017.08.078; Lavin Y, 2017, CELL, V169, P750, DOI 10.1016/j.cell.2017.04.014; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Lawrence MS, 2015, NATURE, V517, P576, DOI 10.1038/nature14129; Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lopes N, 2021, NAT IMMUNOL, V22, P179, DOI 10.1038/s41590-020-00848-3; Loyher PL, 2018, J EXP MED, V215, P2536, DOI 10.1084/jem.20180534; Maier B, 2020, NATURE, V580, P257, DOI 10.1038/s41586-020-2134-y; Mandal R, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.89829; Mariathasan S, 2018, NATURE, V554, P544, DOI 10.1038/nature25501; Maynard A, 2020, CELL, V182, P1232, DOI 10.1016/j.cell.2020.07.017; McGinnis CS, 2019, CELL SYST, V8, P329, DOI 10.1016/j.cels.2019.03.003; Metzemaekers M, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01970; Michea Paula, 2018, Nat Immunol, V19, P885, DOI 10.1038/s41590-018-0145-8; Mlecnik B, 2016, IMMUNITY, V44, P698, DOI 10.1016/j.immuni.2016.02.025; Molgora M, 2020, CELL, V182, P886, DOI 10.1016/j.cell.2020.07.013; Mondini M, 2019, CANCER IMMUNOL RES, V7, P376, DOI 10.1158/2326-6066.CIR-18-0633; Mujal AM, 2019, SCIENCE, V364, P28, DOI 10.1126/science.aau8694; Mulder K, 2021, IMMUNITY, V54, P1883, DOI 10.1016/j.immuni.2021.07.007; Nagarsheth N, 2017, NAT REV IMMUNOL, V17, P559, DOI 10.1038/nri.2017.49; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/NMETH.3337, 10.1038/nmeth.3337]; Oh DY, 2020, CELL, V181, P1612, DOI 10.1016/j.cell.2020.05.017; Oliveira G, 2021, NATURE, V596, P119, DOI 10.1038/s41586-021-03704-y; Petitprez F, 2020, NATURE, V577, P556, DOI 10.1038/s41586-019-1906-8; Plitas G, 2016, IMMUNITY, V45, P1122, DOI 10.1016/j.immuni.2016.10.032; Quigley DA, 2018, CELL, V174, P758, DOI 10.1016/j.cell.2018.06.039; Reynolds G, 2021, SCIENCE, V371, P364, DOI 10.1126/science.aba6500; Richer MJ, 2016, J IMMUNOL, V197, P1009, DOI 10.4049/jimmunol.1600847; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Roberts EW, 2016, CANCER CELL, V30, P324, DOI 10.1016/j.ccell.2016.06.003; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rooney MS, 2015, CELL, V160, P48, DOI 10.1016/j.cell.2014.12.033; Salmon H, 2016, IMMUNITY, V44, P924, DOI 10.1016/j.immuni.2016.03.012; Sancho D, 2009, NATURE, V458, P899, DOI 10.1038/nature07750; Savas P, 2018, NAT MED, V24, P986, DOI 10.1038/s41591-018-0078-7; Scott AC, 2019, NATURE, V571, P270, DOI 10.1038/s41586-019-1324-y; Slyper M, 2020, NAT MED, V26, P792, DOI 10.1038/s41591-020-0844-1; Spranger S, 2016, P NATL ACAD SCI USA, V113, pE7759, DOI 10.1073/pnas.1609376113; Spranger S, 2016, TRENDS IMMUNOL, V37, P349, DOI 10.1016/j.it.2016.04.008; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Thorsson V, 2018, IMMUNITY, V48, P812, DOI [10.1016/j.immuni.2018.03.023, 10.1016/j.immuni.2019.08.004]; van Galen P, 2019, CELL, V176, P1265, DOI 10.1016/j.cell.2019.01.031; Vargas FA, 2018, CANCER CELL, V33, P649, DOI 10.1016/j.ccell.2018.02.010; Varn FS, 2017, CANCER RES, V77, P1271, DOI 10.1158/0008-5472.CAN-16-2490; Virtanen P, 2020, NAT METHODS, V17, P261, DOI 10.1038/s41592-019-0686-2; Vivian J, 2017, NAT BIOTECHNOL, V35, P314, DOI 10.1038/nbt.3772; Wellenstein MD, 2019, NATURE, V572, P538, DOI 10.1038/s41586-019-1450-6; Wiley CD, 2017, AGING CELL, V16, P1043, DOI 10.1111/acel.12632; Wolf FA, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-017-1382-0; Zaretsky AG, 2017, CELL REP, V18, P1906, DOI 10.1016/j.celrep.2017.01.067; Zemmour D, 2018, NAT IMMUNOL, V19, P291, DOI 10.1038/s41590-018-0051-0; Zhang L, 2020, CELL, V181, P442, DOI 10.1016/j.cell.2020.03.048; Zhang QM, 2019, CELL, V179, P829, DOI 10.1016/j.cell.2019.10.003; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001; Zilionis R, 2019, IMMUNITY, V50, P1317, DOI 10.1016/j.immuni.2019.03.009	120	13	13	18	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 6	2022	185	1					184	+		10.1016/j.cell.2021.12.004	http://dx.doi.org/10.1016/j.cell.2021.12.004			40	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	YN0XD	34963056				2022-12-28	WOS:000746989500001
J	Fiedorczuk, K; Chen, J				Fiedorczuk, Karol; Chen, Jue			Mechanism of CFTR correction by type I folding correctors	CELL			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS; ENDOPLASMIC-RETICULUM; CONFORMATIONAL MATURATION; DIRECT BINDING; MEMBRANE; DOMAIN; PROTEIN; VX-809; PHOSPHORYLATION	Small molecule chaperones have been exploited as therapeutics for the hundreds of diseases caused by protein misfolding. The most successful examples are the CFTR correctors, which transformed cystic fibrosis therapy. These molecules revert folding defects of the Delta F508 mutant and are widely used to treat patients. To investigate the molecular mechanism of their action, we determined cryo-electron microscopy structures of CFTR in complex with the FDA-approved correctors lumacaftor or tezacaftor. Both drugs insert into a hydrophobic pocket in the first transmembrane domain (TMD1), linking together four helices that are thermo-dynamically unstable. Mutating residues at the binding site rendered Delta F508-CFTR insensitive to lumacaftor and tezacaftor, underscoring the functional significance of the structural discovery. These results support a mechanism in which the correctors stabilize TMD1 at an early stage of biogenesis, prevent its premature degradation, and thereby allosterically rescuing many disease-causing mutations.	[Fiedorczuk, Karol; Chen, Jue] Rockefeller Univ, Lab Membrane Biol & Biophys, New York, NY 10065 USA; [Chen, Jue] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Rockefeller University; Howard Hughes Medical Institute	Chen, J (corresponding author), Rockefeller Univ, Lab Membrane Biol & Biophys, New York, NY 10065 USA.; Chen, J (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	juechen@rockefeller.edu			Howard Hughes Medical Institute; Cystic Fibrosis Foundation Therapeutics	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Cystic Fibrosis Foundation Therapeutics(Italian Cystic Fibrosis Research Foundation)	We thank M. Ebrahim and J. Sotiris at Rockefeller's Evelyn Gruss Lipper CryoElectron Microscopy Resource Center for assistance in electron microscopy data collection, F. Glickman of the Rockefeller High-Throughput and Spectroscopy Resource Center for help with the SPA experiments, and P. Banerjee at the Frits and Rita Markus Bio-Imaging Resource Center at The Rockefeller University for assistance in confocal microscopy data collection, Donna Tallent for proofreading the manuscript. We also thank reviewers of Biophysics Colab, R. Gaudet, T.C. Hwang, P. Vergani, and anonymous reviewers of Cell for their comments. This work is supported by the Howard Hughes Medical Institute (to J.C.) and the Cystic Fibrosis Foundation Therapeutics (to J.C. and K.F.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Amaral MD, 2004, J MOL NEUROSCI, V23, P41, DOI 10.1385/JMN:23:1-2:041; Baroni D, 2014, EUR BIOPHYS J BIOPHY, V43, P341, DOI 10.1007/s00249-014-0956-y; Berg J., 2019, BIOCHEMISTRY-US, V9th ed; Carlson Eric, 2005, V301, P185; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; CHENG SH, 1991, CELL, V66, P1027, DOI 10.1016/0092-8674(91)90446-6; Csanady L, 2019, PHYSIOL REV, V99, P707, DOI 10.1152/physrev.00007.2018; Cui LY, 2007, J MOL BIOL, V365, P981, DOI 10.1016/j.jmb.2006.10.086; Cutting GR, 2015, NAT REV GENET, V16, P45, DOI 10.1038/nrg3849; Davies JC, 2013, AM J RESP CRIT CARE, V187, P1219, DOI 10.1164/rccm.201301-0153OC; Du K, 2009, MOL BIOL CELL, V20, P1903, DOI 10.1091/mbc.E08-09-0950; Eckford PDW, 2014, CHEM BIOL, V21, P666, DOI 10.1016/j.chembiol.2014.02.021; Eckford PDW, 2012, J BIOL CHEM, V287, P36639, DOI 10.1074/jbc.M112.393637; Edelheit O, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-61; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ERIKSSON AE, 1992, SCIENCE, V255, P178, DOI 10.1126/science.1553543; Farinha CM, 2017, CELL MOL LIFE SCI, V74, P39, DOI 10.1007/s00018-016-2387-7; Farinha CM, 2013, CHEM BIOL, V20, P943, DOI 10.1016/j.chembiol.2013.06.004; Goehring A, 2014, NAT PROTOC, V9, P2574, DOI 10.1038/nprot.2014.173; Habib AR, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43652-2; He LH, 2013, FASEB J, V27, P536, DOI 10.1096/fj.12-216119; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Hessa T, 2007, NATURE, V450, P1026, DOI 10.1038/nature06387; Hudson RP, 2017, MOL PHARMACOL, V92, P124, DOI 10.1124/mol.117.108373; Jih KY, 2013, P NATL ACAD SCI USA, V110, P4404, DOI 10.1073/pnas.1215982110; Joh NH, 2009, J AM CHEM SOC, V131, P10846, DOI 10.1021/ja904711k; Johnson ZL, 2017, CELL, V168, P1075, DOI 10.1016/j.cell.2017.01.041; Kleizen B, 2005, MOL CELL, V20, P277, DOI 10.1016/j.molcel.2005.09.007; Kleizen B, 2021, J MOL BIOL, V433, DOI 10.1016/j.jmb.2021.166955; Krainer G, 2020, J BIOL CHEM, V295, P1985, DOI 10.1074/jbc.AC119.011360; Krainer G, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0153-0; Laselva O, 2019, FASEB BIOADV, V1, P661, DOI 10.1096/fba.2019-00039; Laselva O, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00719; Liu FY, 2019, SCIENCE, V364, P1184, DOI 10.1126/science.aaw7611; Liu FY, 2017, CELL, V169, P85, DOI 10.1016/j.cell.2017.02.024; Liu XL, 2011, PHARM RES-DORDR, V28, P962, DOI 10.1007/s11095-010-0303-7; Loo TW, 2017, BIOCHEM PHARMACOL, V136, P24, DOI 10.1016/j.bcp.2017.03.020; Loo TW, 2013, BIOCHEM PHARMACOL, V86, P612, DOI 10.1016/j.bcp.2013.06.028; Lukacs GL, 2012, TRENDS MOL MED, V18, P81, DOI 10.1016/j.molmed.2011.10.003; LUKACS GL, 1994, EMBO J, V13, P6076, DOI 10.1002/j.1460-2075.1994.tb06954.x; Meng X, 2017, J BIOL CHEM, V292, P3706, DOI 10.1074/jbc.M116.751537; Moniz S, 2013, ACS CHEM BIOL, V8, P432, DOI 10.1021/cb300484r; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; Okiyoneda T, 2013, NAT CHEM BIOL, V9, P444, DOI [10.1038/NCHEMBIO.1253, 10.1038/nchembio.1253]; Patrick AE, 2011, MOL BIOL CELL, V22, P4461, DOI 10.1091/mbc.E11-05-0396; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; Pedemonte N, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aay9669; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ren HY, 2013, MOL BIOL CELL, V24, P3016, DOI 10.1091/mbc.E13-05-0240; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Rosser MFN, 2008, MOL BIOL CELL, V19, P4570, DOI 10.1091/mbc.E08-04-0357; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; Shaikh TR, 2008, NAT PROTOC, V3, P1941, DOI 10.1038/nprot.2008.156; Sinha C, 2015, CHEMBIOCHEM, V16, P2017, DOI 10.1002/cbic.201500123; Skach WR, 2006, CELL, V127, P673, DOI 10.1016/j.cell.2006.11.002; Tector M, 1999, EMBO J, V18, P6290, DOI 10.1093/emboj/18.22.6290; Tran ML, 2020, MOLECULES, V25, DOI 10.3390/molecules25143145; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; Veit G, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.139983; Veit G, 2018, NAT MED, V24, P1732, DOI 10.1038/s41591-018-0200-x; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; Wang XQ, 2018, J MED CHEM, V61, P1436, DOI 10.1021/acs.jmedchem.7b01339; WARD CL, 1994, J BIOL CHEM, V269, P25710; WELSH MJ, 1993, CELL, V73, P1251, DOI 10.1016/0092-8674(93)90353-R; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zhang Z, 2018, P NATL ACAD SCI USA, V115, P12757, DOI 10.1073/pnas.1815287115; Zhang Z, 2017, CELL, V170, P483, DOI 10.1016/j.cell.2017.06.041; Zhang Z, 2016, CELL, V167, P1586, DOI 10.1016/j.cell.2016.11.014; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193	75	18	18	11	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 6	2022	185	1					158	+		10.1016/j.cell.2021.12.009	http://dx.doi.org/10.1016/j.cell.2021.12.009			23	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	YG3GE	34995514	Green Submitted, hybrid			2022-12-28	WOS:000742379900003
J	Janssens, J; Aibar, S; Taskiran, II; Ismail, JN; Gomez, AE; Aughey, G; Spanier, KI; De Rop, FV; Gonzalez-Blas, CB; Dionne, M; Grimes, K; Quan, XJ; Papasokrati, D; Hulselmans, G; Makhzami, S; De Waegeneer, M; Christiaens, V; Southall, T; Aerts, S				Janssens, Jasper; Aibar, Sara; Taskiran, Ibrahim Ihsan; Ismail, Joy N.; Gomez, Alicia Estacio; Aughey, Gabriel; Spanier, Katina, I; De Rop, Florian, V; Gonzalez-Blas, Carmen Bravo; Dionne, Marc; Grimes, Krista; Quan, Xiao Jiang; Papasokrati, Dafni; Hulselmans, Gert; Makhzami, Samira; De Waegeneer, Maxime; Christiaens, Valerie; Southall, Tony; Aerts, Stein			Decoding gene regulation in the fly brain	NATURE			English	Article							DROSOPHILA; CHROMATIN; RNA; EXPRESSION; DYNAMICS; RESOURCE; SUBTYPES; BINDING; MOUSE	The Drosophila brain is a frequently used model in neuroscience. Single-cell transcriptome analysis(1-6), three-dimensional morphological classification(7) and electron microscopy mapping of the connectome(8,9) have revealed an immense diversity of neuronal and glial cell types that underlie an array of functional and behavioural traits in the fly. The identities of these cell types are controlled by gene regulatory networks (GRNs), involving combinations of transcription factors that bind to genomic enhancers to regulate their target genes. Here, to characterize GRNs at the cell-type level in the fly brain, we profiled the chromatin accessibility of 240,919 single cells spanning 9 developmental timepoints and integrated these data with single-cell transcriptomes. We identify more than 95,000 regulatory regions that are used in different neuronal cell types, of which 70,000 are linked to developmental trajectories involving neurogenesis, reprogramming and maturation. For 40 cell types, uniquely accessible regions were associated with their expressed transcription factors and downstream target genes through a combination of motif discovery, network inference and deep learning, creating enhancer GRNs. The enhancer architectures revealed by DeepFlyBrain lead to a better understanding of neuronal regulatory diversity and can be used to design genetic driver lines for cell types at specific timepoints, facilitating their characterization and manipulation.	[Janssens, Jasper; Aibar, Sara; Taskiran, Ibrahim Ihsan; Ismail, Joy N.; Spanier, Katina, I; De Rop, Florian, V; Gonzalez-Blas, Carmen Bravo; Quan, Xiao Jiang; Papasokrati, Dafni; Hulselmans, Gert; Makhzami, Samira; De Waegeneer, Maxime; Christiaens, Valerie; Aerts, Stein] VIB Ctr Brain & Dis Res, Leuven, Belgium; [Janssens, Jasper; Aibar, Sara; Taskiran, Ibrahim Ihsan; Ismail, Joy N.; Spanier, Katina, I; De Rop, Florian, V; Gonzalez-Blas, Carmen Bravo; Quan, Xiao Jiang; Papasokrati, Dafni; Hulselmans, Gert; Makhzami, Samira; De Waegeneer, Maxime; Christiaens, Valerie; Aerts, Stein] Katholieke Univ Leuven, Dept Human Genet, Leuven, Belgium; [Gomez, Alicia Estacio; Aughey, Gabriel; Dionne, Marc; Grimes, Krista; Southall, Tony] Imperial Coll London, Dept Life Sci, London, England	Flanders Institute for Biotechnology (VIB); KU Leuven; Imperial College London	Aerts, S (corresponding author), VIB Ctr Brain & Dis Res, Leuven, Belgium.; Aerts, S (corresponding author), Katholieke Univ Leuven, Dept Human Genet, Leuven, Belgium.	stein.aerts@kuleuven.be	Aerts, Stein/A-1100-2009; Aibar, Sara/K-5717-2015	Aerts, Stein/0000-0002-8006-0315; Aibar, Sara/0000-0001-6104-7134; Dionne, Marc/0000-0002-8283-1750; Janssens, Jasper/0000-0001-9264-0782; De Rop, Florian/0000-0001-5241-924X; Aughey, Gabriel/0000-0001-5610-9345; Davie, Kristofer/0000-0003-2182-1249; Estacio Gomez, Alicia/0000-0001-6571-0757; Thienpont, Bernard/0000-0002-8772-6845; Spanier, Katina I/0000-0002-1375-4157	ERC Consolidator Grant [724226_cis-CONTROL]; Special Research Fund (BOF) KU Leuven [C14/18/092]; Research Foundation, Flanders (FWO) [1199518N, 11F1519N, 1S80920N, 1S75219N, G0C0417N, G094121N]	ERC Consolidator Grant(European Research Council (ERC)); Special Research Fund (BOF) KU Leuven; Research Foundation, Flanders (FWO)(FWO)	We thank the staff at the Janelia FlyLight Project for publicly providing images and reporter lines to assess enhancer activity on the CNS in Drosophila; F. Pinto-Teixeira for providing the ato-Gal4 and acj6/TfAP-2 RNAi lines; and the members of the Aerts laboratory for discussions and for reading the manuscript.This work is funded by the following grants to S. Aerts: ERC Consolidator Grant (724226_cis-CONTROL), by the Special Research Fund (BOF) KU Leuven (grant C14/18/092) and the FWO (grants G0C0417N, G094121N). J.J., C.B.G.-B., F.V.D.R. and D.P. are supported by a PhD fellowship of The Research Foundation, Flanders (FWO, 1199518N; 11F1519N; 1S80920N; 1S75219N). 10x Chromium was partially made available through VIB Tech Watch Funding. Imaging, FACS and single-cell analyses were supported by the light microscopy, FACS and single-cell expertise units at the VIB-KU Leuven Center for Brain and Disease Research. Computing was performed at the Vlaams Supercomputer Center (VSC). Stocks obtained from the Bloomington Drosophila Stock Center were used in this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000435; Aibar S, 2017, NAT METHODS, V14, P1083, DOI [10.1038/NMETH.4463, 10.1038/nmeth.4463]; Allen AM, 2020, ELIFE, V9, DOI 10.7554/eLife.54074; Anderson EL, 2008, P NATL ACAD SCI USA, V105, P14976, DOI [10.1073/pnas.0807297105, 10.1038/s41598-019-45839-z]; Aronesty E., 2011, EA UTILS COMMAND LIN; Atak ZK, 2021, GENOME RES, V31, DOI 10.1101/gr.260851.120; Aughey GN, 2021, G3-GENES GENOM GENET, V11, DOI 10.1093/g3journal/jkaa005; Avet-Rochex A, 2014, GENE EXPR PATTERNS, V16, P61, DOI 10.1016/j.gep.2014.09.001; Avsec Z, 2021, NAT GENET, V53, P354, DOI 10.1038/s41588-021-00782-6; Buenostro JD, 2015, NATURE, V523, P486, DOI 10.1038/nature14590; Cao JY, 2019, NATURE, V566, P496, DOI 10.1038/s41586-019-0969-x; Chen JF, 2016, PROC VLDB ENDOW, V9, P744, DOI 10.14778/2977797.2977801; Chen S, 2019, NAT BIOTECHNOL, V37, P1452, DOI 10.1038/s41587-019-0290-0; Corces MR, 2017, NAT METHODS, V14, P959, DOI [10.1038/NMETH.4396, 10.1038/nmeth.4396]; Costa M, 2016, NEURON, V91, P293, DOI 10.1016/j.neuron.2016.06.012; Crittenden JR, 2018, BIOL OPEN, V7, DOI 10.1242/bio.035618; Croset V, 2018, ELIFE, V7, DOI 10.7554/eLife.34550; Cusanovich DA, 2018, CELL, V174, P1309, DOI 10.1016/j.cell.2018.06.052; Cusanovich DA, 2018, NATURE, V555, P538, DOI 10.1038/nature25981; Davie K, 2018, CELL, V174, P982, DOI 10.1016/j.cell.2018.05.057; Davis CA, 2018, NUCLEIC ACIDS RES, V46, pD794, DOI 10.1093/nar/gkx1081; Davis FP, 2020, ELIFE, V9, DOI 10.7554/eLife.50901; De Rop F. V., HYDROP DROPLET BASED, DOI 10.1101/2021.06.04.447104(2021; Doe CQ, 2017, ANNU REV CELL DEV BI, V33, P219, DOI 10.1146/annurev-cellbio-111315-125210; Domcke S, 2020, SCIENCE, V370, P809, DOI 10.1126/science.aba7612; Estacio-Gomez A, 2020, BIOL OPEN, V9, DOI 10.1242/bio.052928; Frith MC, 2003, NUCLEIC ACIDS RES, V31, P3666, DOI 10.1093/nar/gkg540; Gonzalez-Blas CB, 2020, MOL SYST BIOL, V16, DOI 10.15252/msb.20209438; Gonzalez-Blas CB, 2019, NAT METHODS, V16, P397, DOI 10.1038/s41592-019-0367-1; Gramates LS, 2017, NUCLEIC ACIDS RES, V45, pD663, DOI 10.1093/nar/gkw1016; Granja JM, 2021, NAT GENET, V53, P403, DOI 10.1038/s41588-021-00790-6; Harris CR, 2020, NATURE, V585, P357, DOI 10.1038/s41586-020-2649-2; Herrmann C, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks543; Imrichova H, 2015, NUCLEIC ACIDS RES, V43, pW57, DOI 10.1093/nar/gkv395; Jacobs J, 2018, NAT GENET, V50, P1011, DOI 10.1038/s41588-018-0140-x; Jenett A, 2012, CELL REP, V2, P991, DOI 10.1016/j.celrep.2012.09.011; Kang HM, 2018, NAT BIOTECHNOL, V36, P89, DOI 10.1038/nbt.4042; Kaya-Okur HS, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09982-5; Kirilly D, 2009, NAT NEUROSCI, V12, P1497, DOI 10.1038/nn.2415; Komiyama T, 2003, CELL, V112, P157, DOI 10.1016/S0092-8674(03)00030-8; Konstantinides N., COMPREHENSIVE SERIES, DOI 10.1101/2021.06.13.448242(2021; Konstantinides N, 2018, CELL, V174, P622, DOI 10.1016/j.cell.2018.05.021; Korsunsky I, 2019, NAT METHODS, V16, P1289, DOI 10.1038/s41592-019-0619-0; Kudron MM, 2018, GENETICS, V208, P937, DOI 10.1534/genetics.117.300657; Kurmangaliyev YZ, 2020, NEURON, V108, DOI 10.1016/j.neuron.2020.10.006; Kurmangaliyev YZ, 2019, ELIFE, V8, DOI 10.7554/eLife.50822; Lake BB, 2018, NAT BIOTECHNOL, V36, P70, DOI 10.1038/nbt.4038; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li HJ, 2017, CELL, V171, P1206, DOI 10.1016/j.cell.2017.10.019; Lundberg SM, 2017, ADV NEUR IN, V30; Ma S, 2020, CELL, V183, P1103, DOI 10.1016/j.cell.2020.09.056; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; Marshall OJ, 2016, NAT PROTOC, V11, P1586, DOI 10.1038/nprot.2016.084; Marshall OJ, 2015, BIOINFORMATICS, V31, P3371, DOI 10.1093/bioinformatics/btv386; Masserdotti G, 2016, DEVELOPMENT, V143, P2494, DOI 10.1242/dev.092163; Minnoye L, 2020, GENOME RES, V30, DOI 10.1101/gr.260844.120; Minocha S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176002; Naidu VG, 2020, DEV BIOL, V464, P36, DOI 10.1016/j.ydbio.2020.05.005; Ozel MN, 2021, NATURE, V589, P88, DOI 10.1038/s41586-020-2879-3; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Preissl S, 2018, NAT NEUROSCI, V21, P432, DOI 10.1038/s41593-018-0079-3; Qiu XJ, 2017, NAT METHODS, V14, P979, DOI [10.1038/NMETH.4402, 10.1038/nmeth.4402]; Quang D, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw226; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Ravenscroft TA, 2020, J NEUROSCI, V40, P7999, DOI 10.1523/JNEUROSCI.0142-20.2020; Robie AA, 2017, CELL, V170, P393, DOI 10.1016/j.cell.2017.06.032; Scheffer LK, 2020, ELIFE, V9, DOI 10.7554/eLife.57443; Schilling T, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.169763; Seabold S., 2010, 9 PYTH SCI C, P6, DOI DOI 10.25080/MAJORA-92BF1922-011; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shih MFM, 2019, G3-GENES GENOM GENET, V9, P81, DOI 10.1534/g3.118.200726; Shrikumar, 2020, TECHNICAL NOTE TRANS; Shrikumar A, 2019, LEARNING IMPORTANT F; Southall TD, 2014, DEV CELL, V28, P685, DOI 10.1016/j.devcel.2014.01.030; Southall TD, 2013, DEV CELL, V26, P101, DOI 10.1016/j.devcel.2013.05.020; Stanescu DE, 2017, PHYSIOL GENOMICS, V49, P105, DOI 10.1152/physiolgenomics.00114.2016; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Trevino AE, 2020, SCIENCE, V367, P404, DOI 10.1126/science.aay1645; van de Sande B, 2020, NAT PROTOC, V15, P2247, DOI 10.1038/s41596-020-0336-2; Virtanen P, 2020, NAT METHODS, V17, P261, DOI 10.1038/s41592-019-0686-2; Wolf FA, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-017-1382-0; Yang JP, 2012, GENOME RES, V22, P2199, DOI 10.1101/gr.142125.112; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zheng ZH, 2018, CELL, V174, P730, DOI 10.1016/j.cell.2018.06.019; Zhu CX, 2019, NAT STRUCT MOL BIOL, V26, P1063, DOI 10.1038/s41594-019-0323-x	86	11	11	8	32	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 27	2022	601	7894					630	+		10.1038/s41586-021-04262-z	http://dx.doi.org/10.1038/s41586-021-04262-z		JAN 2022	43	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YQ8HX	34987221	Green Accepted, Green Submitted			2022-12-28	WOS:000739303000004
J	Morgan, M				Morgan, Matt			Matt Morgan: Your 1800 weeks of work	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Morgan, Matt] Univ Hosp Wales, Cardiff, Wales	Cardiff University	Morgan, M (corresponding author), Univ Hosp Wales, Cardiff, Wales.	mmorgan@bmj.com						Burkeman O., 2021, 4 THOUSAND WEEKS TIM	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 4	2022	376								n3140	10.1136/bmj.n3140	http://dx.doi.org/10.1136/bmj.n3140			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YD7MV	34983776	Bronze			2022-12-28	WOS:000740622800003
J	Slomski, A				Slomski, Anita			Belief in Having Had COVID-19 Linked With Long COVID Symptoms	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	1	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 4	2022	327	1					26	26		10.1001/jama.2021.23318	http://dx.doi.org/10.1001/jama.2021.23318			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YF7YT	34982129	Bronze			2022-12-28	WOS:000742019000006
J	Voelker, R				Voelker, Rebecca			Safer Water for Growing Produce	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 4	2022	327	1					27	27		10.1001/jama.2021.23422	http://dx.doi.org/10.1001/jama.2021.23422			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YF7YT	34982135				2022-12-28	WOS:000742019000008
J	Ferry, G				Ferry, Georgina			Sivaramakrishna Iyer Padmavati: trailblazing cardiologist in India	LANCET			English	Editorial Material												mgf@georginaferry.com							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 1	2022	399	10319					19	19						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YA3YW	34973711				2022-12-28	WOS:000738273800011
J	Horton, R				Horton, Richard			Offline: The incontestable moral value of health	LANCET			English	Editorial Material												richard.horton@lancet.com							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN	2022	399	10321					223	223						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YL7AZ	35033213	Bronze, Green Published			2022-12-28	WOS:000746041700007
J	Mahase, E				Mahase, Elisabeth			Omicron: NHS is on "war footing" as Nightingale hubs are announced in England	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Day M, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1860; Gov.uk, 2021, CAS UK; Oliver D, 2021, BMJ-BRIT MED J, V374, DOI 10.1136/bmj.n2013	3	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 30	2021	375								n3159	10.1136/bmj.n3159	http://dx.doi.org/10.1136/bmj.n3159			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YC3TX	34969669	Bronze			2022-12-28	WOS:000739618400004
J	Cele, S; Jackson, L; Khoury, DS; Khan, K; Moyo-Gwete, T; Tegally, H; San, JE; Cromer, D; Scheepers, C; Amoako, DG; Karim, F; Bernstein, M; Lustig, G; Archary, D; Smith, M; Ganga, Y; Jule, Z; Reedoy, K; Hwa, SH; Giandhari, J; Blackburn, JM; Gosnell, BI; Karim, SSA; Hanekom, W; von Gottberg, A; Bhiman, JN; Lessells, RJ; Moosa, MYS; Davenport, MP; de Oliveira, T; Moore, PL; Sigal, A				Cele, Sandile; Jackson, Laurelle; Khoury, David S.; Khan, Khadija; Moyo-Gwete, Thandeka; Tegally, Houriiyah; San, James Emmanuel; Cromer, Deborah; Scheepers, Cathrine; Amoako, Daniel G.; Karim, Farina; Bernstein, Mallory; Lustig, Gila; Archary, Derseree; Smith, Muneerah; Ganga, Yashica; Jule, Zesuliwe; Reedoy, Kajal; Hwa, Shi-Hsia; Giandhari, Jennifer; Blackburn, Jonathan M.; Gosnell, Bernadett, I; Karim, Salim S. Abdool; Hanekom, Willem; von Gottberg, Anne; Bhiman, Jinal N.; Lessells, Richard J.; Moosa, Mahomed-Yunus S.; Davenport, Miles P.; de Oliveira, Tulio; Moore, Penny L.; Sigal, Alex		NGS-SA; COMMIT-KZN Team	Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization	NATURE			English	Article								The emergence of the SARS-CoV-2 variant of concern Omicron (Pango lineage B.1.1.529), first identified in Botswana and South Africa, may compromise vaccine effectiveness and lead to re-infections(1). Here we investigated Omicron escape from neutralization by antibodies from South African individuals vaccinated with Pfizer BNT162b2. We used blood samples taken soon after vaccination from individuals who were vaccinated and previously infected with SARS-CoV-2 or vaccinated with no evidence of previous infection. We isolated and sequence-confirmed live Omicron virus from an infected person and observed that Omicron requires the angiotensin-converting enzyme 2 (ACE2) receptor to infect cells. We compared plasma neutralization of Omicron relative to an ancestral SARS-CoV-2 strain and found that neutralization of ancestral virus was much higher in infected and vaccinated individuals compared with the vaccinated-only participants. However, both groups showed a 22-fold reduction in vaccine-elicited neutralization by the Omicron variant. Participants who were vaccinated and had previously been infected exhibited residual neutralization of Omicron similar to the level of neutralization of the ancestral virus observed in the vaccination-only group. These data support the notion that reasonable protection against Omicron may be maintained using vaccination approaches.	[Cele, Sandile; Jackson, Laurelle; Khan, Khadija; Karim, Farina; Bernstein, Mallory; Ganga, Yashica; Jule, Zesuliwe; Reedoy, Kajal; Hwa, Shi-Hsia; Hanekom, Willem; Sigal, Alex] Africa Hlth Res Inst, Durban, South Africa; [Cele, Sandile; Khan, Khadija; Amoako, Daniel G.; Karim, Farina; Sigal, Alex] Univ KwaZulu Natal, Sch Lab Med & Med Sci, Durban, South Africa; [Khoury, David S.; Cromer, Deborah; Davenport, Miles P.] Univ New South Wales, Kirby Inst, Sydney, NSW, Australia; [Moyo-Gwete, Thandeka; Scheepers, Cathrine; Amoako, Daniel G.; von Gottberg, Anne; Bhiman, Jinal N.; Moore, Penny L.] Natl Hearth Lab Serv, Natl Inst Communicable Dis, Johannesburg, South Africa; [Moyo-Gwete, Thandeka; Scheepers, Cathrine; von Gottberg, Anne; Bhiman, Jinal N.; Moore, Penny L.] Univ Witwatersrand, Fac Hlth Sci, Sch Pathol, SA MRC Antibody Immun Res Unit, Johannesburg, South Africa; [Tegally, Houriiyah; San, James Emmanuel; Giandhari, Jennifer; Lessells, Richard J.; de Oliveira, Tulio] KwaZulu Natal Res Innovat & Sequencing Platform, Durban, South Africa; [Tegally, Houriiyah; de Oliveira, Tulio] Stellenbosch Univ, Ctr Epidem Response & Innovat, Sch Data Sci & Computat Thinking, Stellenbosch, South Africa; [Lustig, Gila; Archary, Derseree; Karim, Salim S. Abdool; Lessells, Richard J.; de Oliveira, Tulio; Moore, Penny L.] Ctr Aids Programme Res South Africa, Durban, South Africa; [Archary, Derseree] Univ KwaZulu Natal, Dept Med Microbiol, Durban, South Africa; [Smith, Muneerah; Blackburn, Jonathan M.] Univ Cape Town, Fac Hlth Sci, Dept Integrat Biomed Sci, Cape Town, South Africa; [Hwa, Shi-Hsia; Hanekom, Willem] UCL, Div Infect & Immun, London, England; [Blackburn, Jonathan M.; Moore, Penny L.] Univ Cape Town, Inst Infect Dis & Mol Med, Cape Town, South Africa; [Gosnell, Bernadett, I; Moosa, Mahomed-Yunus S.] Univ KwaZulu Natal, Nelson R Mandela Sch Clin Med, Dept Infect Dis, Durban, South Africa; [Karim, Salim S. Abdool] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [de Oliveira, Tulio] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Sigal, Alex] Max Planck Inst Infect Biol, Berlin, Germany	Africa Health Research Institute; University of Kwazulu Natal; University of New South Wales Sydney; Kirby Institute; National Institute for Communicable Diseases (NICD); University of Witwatersrand; Stellenbosch University; University of Kwazulu Natal; University of Cape Town; University of London; University College London; University of Cape Town; University of Kwazulu Natal; Columbia University; University of Washington; University of Washington Seattle; Max Planck Society	Sigal, A (corresponding author), Africa Hlth Res Inst, Durban, South Africa.; Sigal, A (corresponding author), Univ KwaZulu Natal, Sch Lab Med & Med Sci, Durban, South Africa.; Sigal, A (corresponding author), Max Planck Inst Infect Biol, Berlin, Germany.	arex.sigal@ahri.org	Scheepers, Cathrine/ABC-9229-2021	Jackson, Laurelle/0000-0003-3235-2468; Kloverpris, Henrik/0000-0002-2165-3313; von Gottberg, Anne/0000-0002-0243-7455; Davenport, Miles/0000-0002-4751-1831; de Oliveira, Tulio/0000-0002-3027-5254; Khoury, David/0000-0002-2663-1551; Wibmer, Constantinos Kurt/0000-0003-2329-2280	Bill and Melinda Gates award [INV-018944]; National Institutes of Health [R01 AI138546]; South African Medical Research Council; UK Foreign, Commonwealth and Development Office; Wellcome Trust [221003/Z/20/Z]; South African Research Chairs Initiative of the Department of Science and Innovation; NRF [98341]; NHMRC (Australia) Fellowship/Investigator grants; European and Developing Countries Clinical Trials Partnership (EDCTP) Senior Fellowship [TMA2017SF-1960]	Bill and Melinda Gates award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Foreign, Commonwealth and Development Office; Wellcome Trust(Wellcome Trust); South African Research Chairs Initiative of the Department of Science and Innovation; NRF; NHMRC (Australia) Fellowship/Investigator grants(National Health and Medical Research Council (NHMRC) of Australia); European and Developing Countries Clinical Trials Partnership (EDCTP) Senior Fellowship	This study was supported by the Bill and Melinda Gates award INV-018944 (A.S.), National Institutes of Health award R01 AI138546 (A.S.), and South African Medical Research Council awards (A.S., T.d.O. and P.L.M.) and the UK Foreign, Commonwealth and Development Office and Wellcome Trust (grant no. 221003/Z/20/Z to P.L.M.). P.L.M. is also supported by the South African Research Chairs Initiative of the Department of Science and Innovation and the NRF (grant no. 98341). D.S.K., D.C. and M.P.D. are supported by NHMRC (Australia) Fellowship/Investigator grants. D.A. was supported by the European and Developing Countries Clinical Trials Partnership (EDCTP) Senior Fellowship (grant no. TMA2017SF-1960). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah F, 2022, INT J INFECT DIS, V116, P38; Andreano E, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2103154118; Bernal JL, 2021, NEW ENGL J MED, V385, P585, DOI 10.1056/NEJMoa2108891; Cao YL, 2022, NATURE, V602, P657, DOI 10.1038/s41586-021-04385-3; Cele Sandile, 2021, medRxiv, DOI 10.1101/2021.09.14.21263564; Cele S, 2021, NATURE, V593, P142, DOI 10.1038/s41586-021-03471-w; Chemaitelly H, 2021, NEW ENGL J MED, V385, pE83, DOI 10.1056/NEJMoa2114114; Collie S, 2022, NEW ENGL J MED, V386, P494, DOI 10.1056/NEJMc2119270; Cromer D, 2022, LANCET MICROBE, V3, pE52, DOI 10.1016/S2666-5247(21)00267-6; Ebinger JE, 2021, NAT MED, V27, P981, DOI 10.1038/s41591-021-01325-6; Garcia-Beltran W. F., 2021, MRNA BASED COVID 19, DOI [10.1101/2021.12.14.21267615, DOI 10.1101/2021.12.14.21267615]; Garcia-Beltran WF, 2021, CELL, V184, P2372, DOI [10.1016/j.cell.2021.03.013, 10.1101/2021.02.14.21251704, 10.1016/j.cell.2021.04.006]; Goldberg Y, 2021, NEW ENGL J MED, V385, pE85, DOI 10.1056/NEJMoa2114228; Harvey WT, 2021, NAT REV MICROBIOL, V19, P409, DOI 10.1038/s41579-021-00573-0; Keeton R, 2021, CELL HOST MICROBE, V29, P1611, DOI 10.1016/j.chom.2021.10.003; Khoury DS, 2021, NAT MED, V27, P1205, DOI 10.1038/s41591-021-01377-8; Lu L, 2022, CLIN INFECT DIS, V75, pE822, DOI 10.1093/cid/ciab1041; Planas D, 2021, NAT MED, V27, P917, DOI [DOI 10.1038/s41591-021-01318-5, 10.1038/s41591-021- 01318-5]; Pulliam JRC., 2021, INCREASED RISK SARS, DOI [10.1101/2021.11.11.21266068, 10.1101/2021.11.11.21266068:2021.11.11.21266068, DOI 10.1101/2021.11.11.21266068:2021.11.11.21266068]; Roessler A, 2021, NEW ENGL J MED, DOI [10.1101/2021.12.08.21267491, DOI 10.1101/2021.12.08.21267491]; Sigal A, 2006, NATURE, V444, P643, DOI 10.1038/nature05316; Stamatatos L, 2021, SCIENCE, V372, P1413, DOI 10.1126/science.abg9175; Tao KM, 2021, NAT REV GENET, V22, P757, DOI 10.1038/s41576-021-00408-x; Tegally H, 2021, NATURE, V592, P438, DOI 10.1038/s41586-021-03402-9; Viana R, 2022, NATURE, V603, P679, DOI 10.1038/s41586-022-04411-y; Wang PF, 2021, NATURE, V593, P130, DOI 10.1038/s41586-021-03398-2; Weisblum Y, 2020, ELIFE, V9, DOI 10.7554/eLife.61312; Wibmer CK, 2021, NAT MED, V27, DOI [10.1038/s41591-021-01285-x, 10.1101/2021.01.18.427166]; Wilhelm A., 2021, REDUCED NEUTRALIZATI, DOI [10.1101/2021.12.07.21267432, DOI 10.15585/MMWR.MM7011A1EXTERNALICON, DOI 10.1101/2021.12.07.21267432]; Zhou DM, 2021, CELL, V184, P2348, DOI 10.1016/j.cell.2021.02.037	30	367	372	28	67	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 24	2022	602	7898					654	+		10.1038/s41586-021-04387-1	http://dx.doi.org/10.1038/s41586-021-04387-1		DEC 2021	14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZG7GF	35016196	Green Published, hybrid			2022-12-28	WOS:000756560800003
J	Jha, P; Deshmukh, Y; Tumbe, C; Suraweera, W; Bhowmick, A; Sharma, S; Novosad, P; Fu, SH; Newcombe, L; Gelband, H; Brown, P				Jha, Prabhat; Deshmukh, Yashwant; Tumbe, Chinmay; Suraweera, Wilson; Bhowmick, Aditi; Sharma, Sankalp; Novosad, Paul; Fu, Sze Hang; Newcombe, Leslie; Gelband, Hellen; Brown, Patrick			COVID mortality in India: National survey data and health facility deaths	SCIENCE			English	Article								India's national COVID death totals remain undetermined. Using an independent nationally representative survey of 0.14 million (M) adults, we compared COVID mortality during the 2020 and 2021 viral waves to expected all-cause mortality. COVID constituted 29% (95% confidence interval, 28 to 31%) of deaths from June 2020 to July 2021, corresponding to 3.2 M (3.1 to 3.4) deaths, of which 2.7 M (2.6 to 2.9) occurred in April to July 2021 (when COVID doubled all-cause mortality). A subsurvey of 57,000 adults showed similar temporal increases in mortality, with COVID and non-COVID deaths peaking similarly. Two government data sources found that, when compared to prepandemic periods, allcause mortality was 27% (23 to 32%) higher in 0.2 M health facilities and 26% (21 to 31%) higher in civil registration deaths in 10 states: both increases occurred mostly in 2021. The analyses find that India's cumulative COVID deaths by September 2021 were six to seven times higher than reported officially.	[Jha, Prabhat; Suraweera, Wilson; Fu, Sze Hang; Newcombe, Leslie; Gelband, Hellen; Brown, Patrick] Univ Toronto, Ctr Global Hlth Res, Unity Hlth Toronto, Toronto, ON, Canada; [Jha, Prabhat; Suraweera, Wilson; Fu, Sze Hang; Newcombe, Leslie; Gelband, Hellen; Brown, Patrick] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Deshmukh, Yashwant] Ctr Voting Opin & Trends Elect Res, Noida, Uttar Pradesh, India; [Tumbe, Chinmay] Indian Inst Management Ahmedabad, Dept Econ, Ahmadabad, Gujarat, India; [Bhowmick, Aditi; Sharma, Sankalp] Dev Data Lab, Washington, DC USA; [Novosad, Paul] Dartmouth Coll, Dept Econ, Hanover, NH 03755 USA	University of Toronto; University of Toronto; Indian Institute of Management (IIM System); Indian Institute of Management Ahmedabad; Dartmouth College	Jha, P (corresponding author), Univ Toronto, Ctr Global Hlth Res, Unity Hlth Toronto, Toronto, ON, Canada.; Jha, P (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.	prabhat.jha@utoronto.ca		Newcombe, Leslie/0000-0003-3153-4008; Jha, Prabhat/0000-0001-7067-8341; Deshmukh, Yashwant/0000-0002-4935-5115; Fu, Sze Hang/0000-0003-4890-9339; Sharma, Sankalp/0000-0002-3099-5796; Gelband, Hellen/0000-0002-8002-3135	Canadian Institutes of Health Research; Emergent Ventures	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Emergent Ventures	Canadian Institutes of Health Research; Emergent Ventures.	Acosta R. J., 2021, ALL CAUSE EXCESS MOR, DOI [10.1101/2021.08.22.21262432v1, DOI 10.1101/2021.08.22.21262432V1]; Anand A, 2021, 3 NEW ESTIMATES INDI; [Anonymous], 2021, COR APP; [Anonymous], 2021, INDIASPEND; Bamezai A., 2021, SURVEY EVIDENCE EXCE; Banaji M., 2021, MEDRXIV, DOI [10.1101/2021.09.30.21264376v1, DOI 10.1101/2021.09.30.21264376V1]; Brown P. E., 2020, MORTALITY COVID COLO, DOI [10.1101/2020.08.24.20181016v2, DOI 10.1101/2020.08.24.20181016V2]; Gerland P, 2014, ASIAN POPUL STUD, V10, P274, DOI 10.1080/17441730.2014.947059; Guilmoto C.Z., 2021, ESTIMATING DEATH TOL, DOI [10.1101/2021. 06.29.21257965v1, DOI 10.1101/2021.06.29.21257965V1]; Gupta A., 2021, HINDU; Health Management Information System, HLTH MAN INF SYST; Jha P, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-19; Keeter S., 2015, TELEPHONE WEB CHALLE; Leffler C. T., 2021, PRELIMINARY ANAL EXC, DOI [10.1101/2021.08.04.21261604v2, DOI 10.1101/2021.08.04.21261604V2]; Lewnard JA, 2022, LANCET INFECT DIS, V22, P463, DOI 10.1016/S1473-3099(21)00746-5; Madahar P, 2020, LANCET RESP MED, V9, P322, DOI 10.1016/S2213-2600(21)00080-1; Malani A., 2021, USING HOUSEHOLD ROST; Meh C, 2022, BJOG-INT J OBSTET GY, V129, P550, DOI 10.1111/1471-0528.16888; Menon GR, 2019, LANCET GLOB HEALTH, V7, pE1675, DOI 10.1016/S2214-109X(19)30451-6; Nepomuceno M. R., 2021, SENSITIVITY EXCESS M, DOI [10.1101/2021.07.20.21260869v1, DOI 10.1101/2021.07.20.21260869V1]; Novosad P., 2021, devdatalab/covid: DDL COVID repo, Zenodo, DOI 10.5281/zenodo.5796813; Office of the Registrar General & Census Commissioner India, 2020, SRS STAT REP 2018; Office of the Registrar General India, 2021, VIT STAT IND BAS CIV; Office of the Registrar General India, 2021, REP MED CERT CAUS DE; Pattabiraman C, 2021, WELLCOME OPEN RES, V6, P110, DOI 10.12688/ wellcomeopenres.16768.1; Population Reference Bureau, 2020, INT IND AV HOUS SIZ; Staff Reuters, 2021, REUTERS; Team CVoter, 2020, COVID 19 TRACK SURV; Team CVoter,, CVOT NEWS SERV; UN (United Nations Department of Economic and Social Affairs Population Division), 2019, STESASERA427 UN POP; Velumani A., 2021, SARS COV 2 SEROPREVA, DOI [10.1101/2021.03.19. 21253429v1, DOI 10.1101/2021.03.19.21253429V1]; Woolf SH, 2021, JAMA-J AM MED ASSOC, V325, P1786, DOI 10.1001/jama.2021.5199; World Health Organization, TRUE DEATH TOLL COVI	33	27	27	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 11	2022	375	6581					667	+		10.1126/science.abm5154	http://dx.doi.org/10.1126/science.abm5154			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YX2ZD	34990216				2022-12-28	WOS:000753975300039
J	Fontoura, L; D'Agata, S; Gamoyo, M; Barneche, DR; Luiz, OJ; Madin, EMP; Eggertsen, L; Maina, JM				Fontoura, Luisa; D'Agata, Stephanie; Gamoyo, Majambo; Barneche, Diego R.; Luiz, Osmar J.; Madin, Elizabeth M. P.; Eggertsen, Linda; Maina, Joseph M.			Protecting connectivity promotes successful biodiversity and fisheries conservation	SCIENCE			English	Article							LARVAL DISPERSAL; REEF; RECRUITMENT; FISH; PATTERNS; AREA; CONSEQUENCES; POPULATIONS; SIZE	The global decline of coral reefs has led to calls for strategies that reconcile biodiversity conservation and fisheries benefits. Still, considerable gaps in our understanding of the spatial ecology of ecosystem services remain. We combined spatial information on larval dispersal networks and estimates of human pressure to test the importance of connectivity for ecosystem service provision. We found that reefs receiving larvae from highly connected dispersal corridors were associated with high fish species richness. Generally, larval "sinks" contained twice as much fish biomass as "sources" and exhibited greater resilience to human pressure when protected. Despite their potential to support biodiversity persistence and sustainable fisheries, up to 70% of important dispersal corridors, sinks, and source reefs remain unprotected, emphasizing the need for increased protection of networks of well-connected reefs.	[Fontoura, Luisa; D'Agata, Stephanie; Maina, Joseph M.] Macquarie Univ, Dept Earth & Environm Sci, Sydney, NSW 2109, Australia; [D'Agata, Stephanie] Wildlife Conservat Soc, Marine Programs, Bronx, NY USA; [D'Agata, Stephanie] Univ La Reunion, Univ New Caledonia, ENTROPIE IRD, IFREMER, F-97400 St Denis, La Reunion, France; [D'Agata, Stephanie] IUEM, F-29280 Plouzane, France; [Gamoyo, Majambo] Coastal & Marine Resources Dev, Mombasa, Kenya; [Barneche, Diego R.] Australian Inst Marine Sci, Crawley, WA 6009, Australia; [Barneche, Diego R.] Univ Western Australia, Oceans Inst, Crawley, WA 6009, Australia; [Luiz, Osmar J.] Charles Darwin Univ, Res Inst Environm & Livelihoods, Darwin, NT, Australia; [Madin, Elizabeth M. P.] Univ Hawaii Manoa, Sch Ocean & Earth Sci & Technol, Hawaii Inst Marine Biol, Kaneohe, HI 96744 USA; [Eggertsen, Linda] Uppsala Univ, Dept Earth Sci, SE-62167 Visby, Sweden; [Maina, Joseph M.] Macquarie Univ, Ctr Environm Law, Sydney, NSW 2019, Australia	Macquarie University; Wildlife Conservation Society; Ifremer; University of La Reunion; Universite de Bretagne Occidentale; Institut Universitaire Europeen de la Mer (IUEM); Australian Institute of Marine Science; University of Western Australia; Charles Darwin University; University of Hawaii System; University of Hawaii Manoa; Uppsala University; Macquarie University	Maina, JM (corresponding author), Macquarie Univ, Dept Earth & Environm Sci, Sydney, NSW 2109, Australia.; Maina, JM (corresponding author), Macquarie Univ, Ctr Environm Law, Sydney, NSW 2019, Australia.	joseph.mbui@mq.edu.au		Luiz, Osmar/0000-0002-6995-6524; Fontoura, Luisa/0000-0003-3568-8565; Maina, Joseph/0000-0003-1268-6137; D'agata, Stephanie/0000-0001-6941-8489; Eggertsen, Linda/0000-0003-1222-2033; Barneche, Diego/0000-0002-4568-2362	Australian Government Research Training Program (RTP) Scholarship [2017002]; Laboratory of Excellence "Corail" (LIVELIHOOD project), France [EPHE IRD PD A02020]	Australian Government Research Training Program (RTP) Scholarship(Australian GovernmentDepartment of Industry, Innovation and Science); Laboratory of Excellence "Corail" (LIVELIHOOD project), France	L.F. was supported by an Australian Government Research Training Program (RTP) Scholarship (2017002). Funding for S.D. was provided by the Laboratory of Excellence "Corail" (LIVELIHOOD project, grant EPHE IRD PD A02020), France.	Adlandsvik B., 2009, ICES COOPERATIVE RES; Almany GR, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-017-0148; Andrello M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16039; [Anonymous], PROT PLAN WORLD DAT; [Anonymous], 2021, CONV BIOL DIV ZER DR; Ball I. R., 2009, SPATIAL CONSERVATION; Barcelo C, 2021, ICES J MAR SCI, V78, P1860, DOI 10.1093/icesjms/fsaa233; Barneche DR, 2019, GLOBAL ECOL BIOGEOGR, V28, P315, DOI 10.1111/geb.12851; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Boulanger E, 2020, ECOGRAPHY, V43, P1167, DOI 10.1111/ecog.05024; Brandl SJ, 2019, FRONT ECOL ENVIRON, V17, P445, DOI 10.1002/fee.2088; Brandl SJ, 2019, SCIENCE, V364, P1189, DOI 10.1126/science.aav3384; Brandl SJ, 2018, BIOL REV, V93, P1846, DOI 10.1111/brv.12423; Burkner PC, 2018, R J, V10, P395; Burgess SC, 2014, ECOL APPL, V24, P257, DOI 10.1890/13-0710.1; Chassot E, 2010, ECOL LETT, V13, P495, DOI 10.1111/j.1461-0248.2010.01443.x; Cinner JE, 2018, P NATL ACAD SCI USA, V115, pE6116, DOI 10.1073/pnas.1708001115; Cinner JE, 2016, NATURE, V535, P416, DOI 10.1038/nature18607; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; de Mitcheson Y. S., 2011, REEF FISH SPAWNING A; DeMitcheson YS, 2012, FISH FISH SER, V35, P1, DOI 10.1007/978-94-007-1980-4; DOHERTY PJ, 1987, B MAR SCI, V41, P411; Duffy JE, 2016, P NATL ACAD SCI USA, V113, P6230, DOI 10.1073/pnas.1524465113; FAO, 2011, FISH AQ COUNTR PROF; Ferry N, 2012, MERCATOR Q NEWSLETTE, V44, P29, DOI DOI 10.1016/J.OCEMOD.2018.07.009; Fontoura L., 2021, ZENODO, DOI [10.5281/zenodo. 5762799, DOI 10.5281/ZENODO.5762799]; Gaines SD, 2010, P NATL ACAD SCI USA, V107, P18286, DOI 10.1073/pnas.0906473107; Gelman A, 2019, AM STAT, V73, P307, DOI 10.1080/00031305.2018.1549100; Goatley CHR, 2021, CORAL REEFS, V40, P75, DOI 10.1007/s00338-020-02016-3; Goetze JS, 2021, GLOBAL CHANGE BIOL, V27, P3432, DOI 10.1111/gcb.15635; Goulet D, 1995, B MAR SCI, V57, P582; Graham NAJ, 2017, CURR BIOL, V27, P231, DOI 10.1016/j.cub.2016.10.062; Harrison HB, 2020, P NATL ACAD SCI USA, V117, P25595, DOI 10.1073/pnas.1920580117; Harrison HB, 2012, CURR BIOL, V22, P1023, DOI 10.1016/j.cub.2012.04.008; Heisig JP, 2019, EUR SOCIOL REV, V35, P258, DOI 10.1093/esr/jcy053; Hilty J., 2020, GUIDELINES CONSERVIN, DOI [10.2305/IUCN.CH.2020.PAG.30.en, DOI 10.2305/IUCN.CH.2020.PAG.30.EN]; Kulbicki M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081847; Le Port A, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.1300; Leis JM, 2010, ICHTHYOL RES, V57, P325, DOI 10.1007/s10228-010-0177-z; Lett C, 2008, ENVIRON MODELL SOFTW, V23, P1210, DOI 10.1016/j.envsoft.2008.02.005; Luiz OJ, 2013, P NATL ACAD SCI USA, V110, P16498, DOI 10.1073/pnas.1304074110; Magris RA, 2018, CONSERV LETT, V11, DOI 10.1111/conl.12439; Maina JM, 2020, CONSERV SCI PRACT, V2, DOI 10.1111/csp2.156; Marshall DJ, 2019, FRONT ECOL ENVIRON, V17, P407, DOI 10.1002/fee.2075; Maxwell SL, 2020, NATURE, V586, P217, DOI 10.1038/s41586-020-2773-z; McElreath R, 2016, TEXT STAT SCI, pXI; O'Connor MI, 2007, P NATL ACAD SCI USA, V104, P1266, DOI 10.1073/pnas.0603422104; Paris CB, 2007, MAR ECOL PROG SER, V347, P285, DOI 10.3354/meps06985; Parravicini V, 2013, ECOGRAPHY, V36, P1254, DOI 10.1111/j.1600-0587.2013.00291.x; Pauly D., 2000, SPECIES; Peliz A, 2007, J MARINE SYST, V68, P215, DOI 10.1016/j.jmarsys.2006.11.007; Pineda J, 2007, OCEANOGRAPHY, V20, P22, DOI 10.5670/oceanog.2007.27; Planes S, 2009, P NATL ACAD SCI USA, V106, P5693, DOI 10.1073/pnas.0808007106; R Core Team, 2021, R LANG ENV STAT COMP; Ramesh N, 2019, SCIENCE, V364, P1192, DOI 10.1126/science.aav3409; ROBERTSON DR, 1990, J EXP MAR BIOL ECOL, V144, P49; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; RUSSELL BC, 1977, AUST J MAR FRESH RES, V28, P521; Siegel DA, 2008, P NATL ACAD SCI USA, V105, P8974, DOI 10.1073/pnas.0802544105; Srinivasan M, 2006, CORAL REEFS, V25, P673, DOI 10.1007/s00338-006-0153-2; Treml EA, 2012, INTEGR COMP BIOL, V52, P525, DOI 10.1093/icb/ics101; Vehtari A, 2017, STAT COMPUT, V27, P1433, DOI 10.1007/s11222-016-9709-3; WALSH WJ, 1987, ENVIRON BIOL FISH, V18, P257, DOI 10.1007/BF00004879; Wessel P, 1996, J GEOPHYS RES-SOL EA, V101, P8741, DOI 10.1029/96JB00104; Woodhead AJ, 2019, FUNCT ECOL, V33, P1023, DOI 10.1111/1365-2435.13331	65	5	5	25	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2022	375	6578					336	+		10.1126/science.abg4351	http://dx.doi.org/10.1126/science.abg4351			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YK2FS	35050678				2022-12-28	WOS:000745036100037
J	Schutte, Z; Reines, AE				Schutte, Zachary; Reines, Amy E.			Black-hole-triggered star formation in the dwarf galaxy Henize 2-10	NATURE			English	Article							HOST GALAXIES; AGN; CLASSIFICATION; EMISSION; SPECTROSCOPY; ACCRETION; FEEDBACK; GAS	Black-hole-driven outflows have been observed in some dwarf galaxies with active galactic nuclei(1), and probably play a role in heating and expelling gas (thereby suppressing star formation), as they do in larger galaxies(2). The extent to which black-hole outflows can trigger star formation in dwarf galaxies is unclear, because work in this area has previously focused on massive galaxies and the observational evidence is scarce(3-5). Henize 2-10 is a dwarf starburst galaxy previously reported to have a central massive black hole(6-9), although that interpretation has been disputed because some aspects of the observational evidence are also consistent with a supernova remnant(10,11). At a distance of approximately 9 Mpc, it presents an opportunity to resolve the central region and to determine if there is evidence for a black-hole outflow influencing star formation. Here we report optical observations of Henize 2-10 with a linear resolution of a few parsecs. We find an approximately 150-pc-long ionized filament connecting the region of the black hole with a site of recent star formation. Spectroscopy reveals a sinusoid-like position-velocity structure that is well described by a simple precessing bipolar outflow. We conclude that this black-hole outflow triggered the star formation.	[Schutte, Zachary; Reines, Amy E.] Montana State Univ, Dept Phys, eXtreme Grav Inst, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman	Schutte, Z (corresponding author), Montana State Univ, Dept Phys, eXtreme Grav Inst, Bozeman, MT 59717 USA.	zachary.schutte@montana.edu		Reines, Amy/0000-0001-7158-614X	NASA through Space Telescope Science Institute [HST-GO-12584.006-A]; NASA through EPSCoR [80NSSC20M0231]; Montana Space Grant Consortium; NASA [NAS5-26555]	NASA through Space Telescope Science Institute(Space Telescope Science Institute); NASA through EPSCoR; Montana Space Grant Consortium; NASA(National Aeronautics & Space Administration (NASA))	We are grateful to M. Molina for useful discussions regarding shocks. We also thank M. Whittle and K. Johnson for their assistance with the HST/STIS proposal while A.E.R. was a graduate student at the University of Virginia, and for subsequent discussions. Support for Program number HST-GO-12584.006-A was provided by NASA through a grant from the Space Telescope Science Institute, which is operated by the Association of Universities for Research in Astronomy, Incorporated, under NASA contract NAS5-26555. A.E.R. also acknowledges support for this work provided by NASA through EPSCoR grant number 80NSSC20M0231. Z.S. acknowledges support for this project from the Montana Space Grant Consortium.	Allen MG, 2008, ASTROPHYS J SUPPL S, V178, P20, DOI 10.1086/589652; Baganoff FK, 2003, ASTROPHYS J, V591, P891, DOI 10.1086/375145; BALDWIN JA, 1981, PUBL ASTRON SOC PAC, V93, P5, DOI 10.1086/130766; Beck SC, 2018, ASTROPHYS J, V867, DOI 10.3847/1538-4357/aae481; Chandar R, 2003, ASTROPHYS J, V586, P939, DOI 10.1086/367956; Cielo S, 2018, ASTRON ASTROPHYS, V617, DOI 10.1051/0004-6361/201832582; Constantin A, 2009, ASTROPHYS J, V705, P1336, DOI 10.1088/0004-637X/705/2/1336; Cresci G, 2017, ASTRON ASTROPHYS, V604, DOI 10.1051/0004-6361/201730876; Dunn RJH, 2006, MON NOT R ASTRON SOC, V366, P758, DOI 10.1111/j.1365-2966.2005.09928.x; Fabian AC, 2012, ANNU REV ASTRON ASTR, V50, P455, DOI 10.1146/annurev-astro-081811-125521; Gaibler V, 2012, MON NOT R ASTRON SOC, V425, P438, DOI 10.1111/j.1365-2966.2012.21479.x; Gallagher R, 2019, MON NOT R ASTRON SOC, V485, P3409, DOI 10.1093/mnras/stz564; GOWER AC, 1982, ASTROPHYS J, V258, pL63, DOI 10.1086/183831; Greene JE, 2020, ANNU REV ASTRON ASTR, V58, P257, DOI 10.1146/annurev-astro-032620-021835; Hebbar PR, 2019, MON NOT R ASTRON SOC, V485, P5604, DOI 10.1093/mnras/stz553; Kauffmann G, 2003, MON NOT R ASTRON SOC, V346, P1055, DOI 10.1111/j.1365-2966.2003.07154.x; Kewley LJ, 2006, MON NOT R ASTRON SOC, V372, P961, DOI 10.1111/j.1365-2966.2006.10859.x; Kewley LJ, 2001, ASTROPHYS J, V556, P121, DOI 10.1086/321545; Kharb P, 2017, ASTROPHYS J, V846, DOI 10.3847/1538-4357/aa8321; KOBULNICKY HA, 1995, ASTRON J, V110, P116, DOI 10.1086/117500; Lee MG, 2015, ASTROPHYS J, V804, DOI 10.1088/0004-637X/804/1/63; Leitherer C, 1999, ASTROPHYS J SUPPL S, V123, P3, DOI 10.1086/313233; Maiolino R, 2017, NATURE, V544, P202, DOI 10.1038/nature21677; Manzano-King CM, 2019, ASTROPHYS J, V884, DOI 10.3847/1538-4357/ab4197; Martin-Hernandez NL, 2006, ASTRON ASTROPHYS, V455, P853, DOI 10.1051/0004-6361:20054302; MATHEWSON DS, 1980, ASTROPHYS J, V242, pL73, DOI 10.1086/183406; Molina M, 2021, ASTROPHYS J, V910, DOI 10.3847/1538-4357/abe120; Nawaz MA, 2016, MON NOT R ASTRON SOC, V458, P802, DOI 10.1093/mnras/stw330; Newville M., 2014, LMFIT NONLINEAR LEAS, DOI [10.5281/zenodo.11813, DOI 10.5281/ZENODO.11813]; Nguyen DD, 2014, ASTROPHYS J, V794, DOI 10.1088/0004-637X/794/1/34; Nixon C, 2013, ASTROPHYS J LETT, V765, DOI 10.1088/2041-8205/765/1/L7; Osterbrock D., 2006, ASTROPHYSICS GAS NEB; Penny SJ, 2018, MON NOT R ASTRON SOC, V476, P979, DOI 10.1093/mnras/sty202; Pringle JE, 1996, MON NOT R ASTRON SOC, V281, P357, DOI 10.1093/mnras/281.1.357; Reines AE, 2020, ASTROPHYS J, V888, DOI 10.3847/1538-4357/ab4999; Reines AE, 2016, ASTROPHYS J LETT, V830, DOI 10.3847/2041-8205/830/2/L35; Reines AE, 2012, ASTROPHYS J LETT, V750, DOI 10.1088/2041-8205/750/1/L24; Reines AE, 2011, NATURE, V470, P66, DOI 10.1038/nature09724; Santoro F, 2020, ASTRON ASTROPHYS, V644, DOI 10.1051/0004-6361/202039077; Silk J, 2013, ASTROPHYS J, V772, DOI 10.1088/0004-637X/772/2/112; Silk J, 2009, ASTROPHYS J, V700, P262, DOI 10.1088/0004-637X/700/1/262; Trump JR, 2011, ASTROPHYS J, V733, DOI 10.1088/0004-637X/733/1/60; Trump JR, 2011, ASTROPHYS J, V732, DOI 10.1088/0004-637X/732/1/23; VEILLEUX S, 1987, ASTROPHYS J SUPPL S, V63, P295, DOI 10.1086/191166	46	8	8	0	0	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 20	2022	601	7893					329	+		10.1038/s41586-021-04215-6	http://dx.doi.org/10.1038/s41586-021-04215-6			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YJ6UI	35046600	Green Published, Green Submitted			2022-12-28	WOS:000744666700021
J	Feinmann, J				Feinmann, Jane			The BMJ appeal 2021-22: "Doctors must raise their voices to advocate for those in Afghanistan"	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jane@janefeinmann.com						[Anonymous], 2021, UN NEWS; Parkin B.., 2021, FINANC TIMES; Unicef, DON PROT CHILD AFGH	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 14	2022	376								o78	10.1136/bmj.o78	http://dx.doi.org/10.1136/bmj.o78			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZE9IM	35031543				2022-12-28	WOS:000759190400016
J	Brusselle, GG; Koppelman, GH				Brusselle, Guy G.; Koppelman, Gerard H.			Biologic Therapies for Severe Asthma	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							SEVERE EOSINOPHILIC ASTHMA; QUALITY-OF-LIFE; DOUBLE-BLIND; MONOCLONAL-ANTIBODY; PRECISION MEDICINE; NASAL POLYPOSIS; MEPOLIZUMAB; PLACEBO; BENRALIZUMAB; EFFICACY	Biologic Therapies for Severe Asthma Patients with severe asthma are at increased risk for a decreased quality of life, fixed airway obstruction, hospitalization, and death. Biologics may be required to reduce the disease burden. This review discusses the mechanisms, efficacy, and safety of biologics for severe asthma.	[Brusselle, Guy G.] Ghent Univ Hosp, Dept Resp Med, Ghent, Belgium; [Brusselle, Guy G.] Erasmus MC, Dept Epidemiol & Resp Med, Rotterdam, Netherlands; [Koppelman, Gerard H.] Univ Groningen, Dept Pediat Pulmonol & Pediat Allergol, Beatrix Childrens Hosp, Univ Med Ctr Groningen, Groningen, Netherlands; [Koppelman, Gerard H.] Univ Groningen, Groningen Res Inst Asthma & COPD, Univ Med Ctr Groningen, Groningen, Netherlands	Ghent University; Ghent University Hospital; Erasmus University Rotterdam; Erasmus MC; University of Groningen; University of Groningen	Brusselle, GG (corresponding author), Ghent Univ Hosp, C Heymanslaan 10, B-9000 Ghent, Belgium.	guy.brusselle@ugent.be						Asthma GIf, 2022, GLOB STRAT ASTHM MAN; Bacharier LB, 2021, NEW ENGL J MED, V385, P2230, DOI 10.1056/NEJMoa2106567; Bachert C, 2016, JAMA-J AM MED ASSOC, V315, P469, DOI 10.1001/jama.2015.19330; Bel EH, 2014, NEW ENGL J MED, V371, P1189, DOI 10.1056/NEJMoa1403291; Bernstein JA, 2020, LANCET RESP MED, V8, P461, DOI 10.1016/S2213-2600(19)30372-8; Bleecker ER, 2020, AM J RESP CRIT CARE, V201, P276, DOI 10.1164/rccm.201904-0903SO; Bleecker ER, 2016, LANCET, V388, P2115, DOI 10.1016/S0140-6736(16)31324-1; BOUSQUET J, 1990, NEW ENGL J MED, V323, P1033, DOI 10.1056/NEJM199010113231505; Brightling CE, 2021, NEW ENGL J MED, V385, P1669, DOI 10.1056/NEJMoa2030880; Brusselle G, 2017, PULM PHARMACOL THER, V43, P39, DOI 10.1016/j.pupt.2017.01.011; Buhl R, 2022, J ALLER CL IMM-PRACT, V10, P422, DOI 10.1016/j.jaip.2021.10.059; Busse WW, 2019, LANCET RESP MED, V7, P46, DOI 10.1016/S2213-2600(18)30406-5; Casale TB, 2019, J ALLER CL IMM-PRACT, V7, P156, DOI 10.1016/j.jaip.2018.04.043; Castro M, 2018, NEW ENGL J MED, V378, P2486, DOI 10.1056/NEJMoa1804092; Castro M, 2020, ERJ OPEN RES, V6, DOI 10.1183/23120541.00204-2019; Castro M, 2015, LANCET RESP MED, V3, P355, DOI [10.1016/S2213-2600(15)00042-9, 10.1016/S2213-2600(15)00119-8]; Christiansen SC, 2019, NEW ENGL J MED, V381, P1046, DOI 10.1056/NEJMra1800345; Chung KF, 2014, EUR RESPIR J, V43, P343, DOI 10.1183/09031936.00202013; Chupp GL, 2017, LANCET RESP MED, V5, P390, DOI 10.1016/S2213-2600(17)30125-X; Clinical Research Pathways, 2021, DIV CLIN TRIALS; Corren J, 2021, J ALLER CL IMM-PRACT, V9, P1224, DOI 10.1016/j.jaip.2020.10.033; Criner GJ, 2019, NEW ENGL J MED, V381, P1023, DOI 10.1056/NEJMoa1905248; Diver S, 2021, LANCET RESP MED, V9, P1299, DOI 10.1016/S2213-2600(21)00226-5; Dupin C, 2020, CLIN EXP ALLERGY, V50, P789, DOI 10.1111/cea.13614; Eger K, 2021, J ALLER CL IMM-PRACT, V9, P2913, DOI 10.1016/j.jaip.2021.02.042; Eger K, 2021, J ALLER CL IMM-PRACT, V9, P1194, DOI 10.1016/j.jaip.2020.10.010; Fahy JV, 2015, NAT REV IMMUNOL, V15, P57, DOI 10.1038/nri3786; Fahy JV, 1997, AM J RESP CRIT CARE, V155, P1828, DOI 10.1164/ajrccm.155.6.9196082; FitzGerald JM, 2018, LANCET RESP MED, V6, P51, DOI 10.1016/S2213-2600(17)30344-2; FitzGerald JM, 2016, LANCET, V388, P2128, DOI [10.1016/s0140-6736(16)31322-8, 10.1016/S0140-6736(16)31322-8]; Frossing L, 2021, J ALLER CL IMM-PRACT, V9, P1267, DOI 10.1016/j.jaip.2020.09.051; Fu Z, 2021, J ASTHMA, V58, P1350, DOI 10.1080/02770903.2020.1789875; Gauvreau GM, 2020, EXPERT OPIN THER TAR, V24, P777, DOI 10.1080/14728222.2020.1783242; Global Initiative for Asthma, 2019, DIFF TO TREAT SEV AS; Gupta A, 2019, J ALLERGY CLIN IMMUN, V144, P1336, DOI 10.1016/j.jaci.2019.08.005; Haldar P, 2009, NEW ENGL J MED, V360, P973, DOI 10.1056/NEJMoa0808991; Hammad H, 2021, CELL, V184, P1469, DOI 10.1016/j.cell.2021.02.016; Hanania NA, 2013, AM J RESP CRIT CARE, V187, P804, DOI 10.1164/rccm.201208-1414OC; Harrison TW, 2021, LANCET RESP MED, V9, P260, DOI 10.1016/S2213-2600(20)30414-8; Harvey ES, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.02420-2019; Hearn AP, 2021, J ALLER CL IMM-PRACT, V9, P2093, DOI 10.1016/j.jaip.2021.01.008; Hinks TSC, 2021, EUR RESPIR J, V57, DOI 10.1183/13993003.00528-2020; Howarth P, 2020, J ALLERGY CLIN IMMUN, V145, P1713, DOI 10.1016/j.jaci.2020.02.002; Israel E, 2021, J ALLERGY CLIN IMMUN, V147, P1594, DOI 10.1016/j.jaci.2021.01.037; Israel E, 2017, NEW ENGL J MED, V377, P965, DOI 10.1056/NEJMra1608969; Kavanagh JE, 2021, CHEST, V159, P496, DOI 10.1016/j.chest.2020.08.2083; Kelsen SG, 2021, J ALLERGY CLIN IMMUN, V148, P790, DOI 10.1016/j.jaci.2021.03.044; Khatri S, 2019, J ALLERGY CLIN IMMUN, V143, P1742, DOI 10.1016/j.jaci.2018.09.033; Krings JG, 2019, J ALLER CL IMM-PRACT, V7, P1379, DOI 10.1016/j.jaip.2019.03.008; Laviolette M, 2013, J ALLERGY CLIN IMMUN, V132, P1086, DOI 10.1016/j.jaci.2013.05.020; Liu S, 2021, J ALLER CL IMM-PRACT, V9, P693, DOI 10.1016/j.jaip.2020.11.054; Lugogo NL, 2020, ANN ALLERG ASTHMA IM, V125, P171, DOI 10.1016/j.anai.2020.04.011; Manka LA, 2018, ANN ALLERG ASTHMA IM, V121, P406, DOI 10.1016/j.anai.2018.07.033; Maspero JF, 2021, ALLERGY, V76, P2621, DOI 10.1111/all.14872; Menzies-Gow A, 2021, NEW ENGL J MED, V384, P1800, DOI 10.1056/NEJMoa2034975; Menzies-Gow A, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.01633-2019; Menzies-Gow A, 2020, J ALLERGY CLIN IMMUN, V145, P757, DOI 10.1016/j.jaci.2019.12.006; Middleton PG, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.01208-2019; Nair P, 2017, NEW ENGL J MED, V376, P2448, DOI 10.1056/NEJMoa1703501; Nair P, 2009, NEW ENGL J MED, V360, P985, DOI 10.1056/NEJMoa0805435; NICE, 2013, OM TREAT SEV PERS AL; Oh SS, 2016, AM J RESP CRIT CARE, V193, P348, DOI 10.1164/rccm.201510-2045ED; Ortega HG, 2014, NEW ENGL J MED, V371, P1198, DOI 10.1056/NEJMoa1403290; Pavord ID, 2017, NEW ENGL J MED, V377, P1613, DOI 10.1056/NEJMoa1708208; Pavord ID, 2018, LANCET, V391, P350, DOI 10.1016/S0140-6736(17)30879-6; Pavord ID, 2012, LANCET, V380, P651, DOI 10.1016/S0140-6736(12)60988-X; Pepper AN, 2021, J ALLER CL IMM-PRACT, V9, P1081, DOI 10.1016/j.jaip.2020.10.048; Pfaller B, 2021, ALLERGY, V76, P71, DOI 10.1111/all.14282; Pijnenburg MW, 2020, LANCET RESP MED, V8, P1032, DOI 10.1016/S2213-2600(20)30399-4; Pilette C, 2018, LANCET RESP MED, V6, P581, DOI 10.1016/S2213-2600(18)30291-1; Porsbjerg CM, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.00260-2020; Rabe KF, 2018, NEW ENGL J MED, V378, P2475, DOI 10.1056/NEJMoa1804093; Samedy-Bates LA, 2019, CLIN PHARMACOL THER, V106, P1133, DOI 10.1002/cpt.1555; Settipane RA, 2019, ANN ALLERG ASTHMA IM, V123, P564, DOI 10.1016/j.anai.2019.08.462; Sverrild A, 2022, EUR RESPIR J, V59, DOI 10.1183/13993003.01296-2021; Taille C, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.02345-2019; Thaci D, 2016, LANCET, V387, P40, DOI 10.1016/S0140-6736(15)00388-8; Virchow JC, 2020, J ALLER CL IMM-PRACT, V8, P540, DOI 10.1016/j.jaip.2019.07.038; Wechsler ME, 2017, NEW ENGL J MED, V376, P1921, DOI 10.1056/NEJMoa1702079; Wechsler ME., 2020, CHEST, V14, P35450, DOI DOI 10.1016/j.chest.2020.11.060; Wechsler ME, 2021, NEW ENGL J MED, V385, P1656, DOI 10.1056/NEJMoa2024257; Wechsler ME, 2020, RESP RES, V21, DOI 10.1186/s12931-020-01503-z; Wenzel SE, 2021, AM J RESP CRIT CARE, V203, P809, DOI 10.1164/rccm.202009-3631CI; Williamson EJ, 2020, NATURE, V584, P430, DOI 10.1038/s41586-020-2521-4; Woodruff PG, 2009, AM J RESP CRIT CARE, V180, P388, DOI 10.1164/rccm.200903-0392OC; Yancey SW, 2019, ALLERGY ASTHMA CL IM, V15, DOI 10.1186/s13223-019-0366-x	86	50	51	34	46	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 13	2022	386	2					157	171		10.1056/NEJMra2032506	http://dx.doi.org/10.1056/NEJMra2032506			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YF2NZ	35020986	Green Published			2022-12-28	WOS:000741651400013
J	Andrews, N; Tessier, E; Stowe, J; Gower, C; Kirsebom, F; Simmons, R; Gallagher, E; Thelwall, S; Groves, N; Dabrera, G; Myers, R; Campbell, CNJ; Amirthalingam, G; Edmunds, M; Zambon, M; Brown, K; Hopkins, S; Chand, M; Ladhani, SN; Ramsay, M; Bernal, JL				Andrews, Nick; Tessier, Elise; Stowe, Julia; Gower, Charlotte; Kirsebom, Freja; Simmons, Ruth; Gallagher, Eileen; Thelwall, Simon; Groves, Natalie; Dabrera, Gavin; Myers, Richard; Campbell, Colin N. J.; Amirthalingam, Gayatri; Edmunds, Matt; Zambon, Maria; Brown, Kevin; Hopkins, Susan; Chand, Meera; Ladhani, Shamez N.; Ramsay, Mary; Bernal, Jamie Lopez			Duration of Protection against Mild and Severe Disease by Covid-19 Vaccines	NEW ENGLAND JOURNAL OF MEDICINE			English	Article								Background Vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (Covid-19), have been used since December 2020 in the United Kingdom. Real-world data have shown the vaccines to be highly effective against Covid-19 and related severe disease and death. Vaccine effectiveness may wane over time since the receipt of the second dose of the ChAdOx1-S (ChAdOx1 nCoV-19) and BNT162b2 vaccines. Methods We used a test-negative case-control design to estimate vaccine effectiveness against symptomatic Covid-19 and related hospitalization and death in England. Effectiveness of the ChAdOx1-S and BNT162b2 vaccines was assessed according to participant age and status with regard to coexisting conditions and over time since receipt of the second vaccine dose to investigate waning of effectiveness separately for the B.1.1.7 (alpha) and B.1.617.2 (delta) variants. Results Vaccine effectiveness against symptomatic Covid-19 with the delta variant peaked in the early weeks after receipt of the second dose and then decreased by 20 weeks to 44.3% (95% confidence interval [CI], 43.2 to 45.4) with the ChAdOx1-S vaccine and to 66.3% (95% CI, 65.7 to 66.9) with the BNT162b2 vaccine. Waning of vaccine effectiveness was greater in persons 65 years of age or older than in those 40 to 64 years of age. At 20 weeks or more after vaccination, vaccine effectiveness decreased less against both hospitalization, to 80.0% (95% CI, 76.8 to 82.7) with the ChAdOx1-S vaccine and 91.7% (95% CI, 90.2 to 93.0) with the BNT162b2 vaccine, and death, to 84.8% (95% CI, 76.2 to 90.3) and 91.9% (95% CI, 88.5 to 94.3), respectively. Greater waning in vaccine effectiveness against hospitalization was observed in persons 65 years of age or older in a clinically extremely vulnerable group and in persons 40 to 64 years of age with underlying medical conditions than in healthy adults. Conclusions We observed limited waning in vaccine effectiveness against Covid-19-related hospitalization and death at 20 weeks or more after vaccination with two doses of the ChAdOx1-S or BNT162b2 vaccine. Waning was greater in older adults and in those in a clinical risk group. Duration of Covid-19 Vaccine Protection in England A test-negative case-control study involving more than 6 million persons in England who received two doses of the ChAdOx1-S or BNT162b2 vaccine (interval, 3 to 12 weeks) showed high vaccine effectiveness against hospitalization and death from Covid-19 at 20 weeks or more after vaccination. Protection against infection waned. Waning was greater in older persons and those with underlying risk factors.	[Andrews, Nick; Tessier, Elise; Stowe, Julia; Gower, Charlotte; Kirsebom, Freja; Simmons, Ruth; Gallagher, Eileen; Thelwall, Simon; Groves, Natalie; Dabrera, Gavin; Myers, Richard; Campbell, Colin N. J.; Amirthalingam, Gayatri; Edmunds, Matt; Zambon, Maria; Brown, Kevin; Hopkins, Susan; Chand, Meera; Ladhani, Shamez N.; Ramsay, Mary; Bernal, Jamie Lopez] United Kingdom Hlth Secur Agcy, 61 Colindale Ave, London NW9 5EQ, England; [Andrews, Nick; Campbell, Colin N. J.; Amirthalingam, Gayatri; Brown, Kevin; Ramsay, Mary; Bernal, Jamie Lopez] London Sch Hyg & Trop Med, Hlth Protect Res Unit Vaccines & Munisat, Natl Inst Hlth Res NIHR, London, England; [Zambon, Maria; Bernal, Jamie Lopez] Imperial Coll London, NIHR Hlth Protect Res Unit Resp Infect, London, England; [Chand, Meera] Guys & St Thomas Hosp NHS Trust, London, England; [Ladhani, Shamez N.] St Georges Univ London, Paediat Infect Dis Res Grp, London, England; [Hopkins, Susan] Univ Oxford, Healthcare Associated Infect & Antimicrobial Resi, Oxford, England	University of London; London School of Hygiene & Tropical Medicine; Imperial College London; St Georges University London; University of Oxford	Bernal, JL (corresponding author), United Kingdom Hlth Secur Agcy, 61 Colindale Ave, London NW9 5EQ, England.	jamie.lopezbernal2@phe.gov.uk		Hopkins, Susan/0000-0001-5179-5702; Lopez Bernal, Jamie/0000-0002-1301-5653; Thelwall, Simon/0000-0002-0434-2724; Stowe, Julia/0000-0002-3999-6461; dabrera, gavin/0000-0003-4606-5945				Amirthalingam G, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-27410-5; Bernal JL, 2021, NEW ENGL J MED, V385, P585, DOI 10.1056/NEJMoa2108891; Bernal JL, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n1088; Chemaitelly H, 2021, NEW ENGL J MED, V385, pE83, DOI 10.1056/NEJMoa2114114; Falsey AR, 2021, NEW ENGL J MED, V385, P1627, DOI 10.1056/NEJMc2113468; Feng S, 2021, NAT MED, V27, P2032, DOI 10.1038/s41591-021-01540-1; Goldberg Y, 2021, NEW ENGL J MED, V385, pE85, DOI 10.1056/NEJMoa2114228; Hyams C, 2021, LANCET INFECT DIS, V21, P1539, DOI 10.1016/S1473-3099(21)00330-3; Ismail SA., 2021, EFFECTIVENESS BNT162; Israel A, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj-2021-067873; Khoury DS, 2021, NAT MED, V27, P1205, DOI 10.1038/s41591-021-01377-8; Longlune N, 2021, NEPHROL DIAL TRANSPL, V36, P1704, DOI 10.1093/ndt/gfab193; Mizrahi B, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-26672-3; Monin L, 2021, LANCET ONCOL, V22, P765, DOI 10.1016/S1470-2045(21)00213-8; Nanduri S, 2021, MMWR-MORBID MORTAL W, V70, P1163, DOI 10.15585/mmwr.mm7034e3; National Health Service, 2021, COVID 19 HIGH RISK S; Patalon T, 2022, JAMA INTERN MED, V182, P179, DOI 10.1001/jamainternmed.2021.7382; Pouwels KB, 2021, NAT MED, V27, P2127, DOI 10.1038/s41591-021-01548-7; Powell AA, 2021, EUROSURVEILLANCE, V26, DOI 10.2807/1560-7917.ES.2021.26.28.2100634; Pritchard E, 2021, NAT MED, V27, P1370, DOI 10.1038/s41591-021-01410-w; Public Health England, 2021, WEEKL NAT INFL COVID; Public Health England, SARS COV 2 VAR VAR I; Rosenberg ES, 2021, MMWR-MORBID MORTAL W, V70, P1150; Shrotri M, 2021, LANCET, V398, P385, DOI 10.1016/S0140-6736(21)01642-1; Tenforde MW, 2021, MMWR-MORBID MORTAL W, V70, P1156, DOI 10.15585/mmwr.mm7034e2; Thompson MG, 2021, NEW ENGL J MED, V385, P1355, DOI 10.1056/NEJMoa2110362; UK Health Security Agency, 2021, COVID 19 GREEN BOOK; UK Health Security Agency, 2021, EM DEP WEEKL B 2021; Vasileiou E, 2021, LANCET, V397, P1646, DOI 10.1016/S0140-6736(21)00677-2; Werbel WA, 2021, ANN INTERN MED, V174, P1330, DOI 10.7326/L21-0282; Whitaker HJ., 2021, PFIZER BIONTECH OXF; Wu K., 2021, MEDRXIV, DOI [10.1101/2021.05.05.21256716v1, 10.1101/2021.05.05.21256716]	32	171	173	14	28	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 27	2022	386	4					340	350		10.1056/NEJMoa2115481	http://dx.doi.org/10.1056/NEJMoa2115481		JAN 2022	11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YW6UB	35021002	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000741666000001
J	[Anonymous]				[Anonymous]			A Plea for Accuracy (Reprinted from JAMA, vol 78, pg 116, 1922)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		REILING J, 1922, JAMA-J AM MED ASSOC, V78, P116	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 11	2022	327	2					187	187		10.1001/jama.2021.21484	http://dx.doi.org/10.1001/jama.2021.21484			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YH8QV	35015047				2022-12-28	WOS:000743426500031
J	Iacobucci, G				Iacobucci, Gareth			Covid-19: Military drafted in to tackle staffing crisis in London hospitals	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		NHS England, URG EM CAR DAIL SIT	1	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 10	2022	376								o47	10.1136/bmj.o47	http://dx.doi.org/10.1136/bmj.o47			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YP6IZ	35012973	Bronze			2022-12-28	WOS:000748727200001
J	Tanne, JH				Tanne, Janice Hopkins			Covid-19: Former advisers urge Biden to adopt new pandemic strategy and learn to live with virus	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Borio LL, 2022, JAMA-J AM MED ASSOC, V327, P215, DOI 10.1001/jama.2021.24165; Emanuel EJ, 2022, JAMA-J AM MED ASSOC, V327, P211, DOI 10.1001/jama.2021.24282; Michaels D, 2022, JAMA-J AM MED ASSOC, V327, P213, DOI 10.1001/jama.2021.24168	3	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 10	2022	376								o56	10.1136/bmj.o56	http://dx.doi.org/10.1136/bmj.o56			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YP6IZ	35012963	Bronze			2022-12-28	WOS:000748727200006
J	Bikdeli, B; Talasaz, AH; Sharif-Kashani, B; Rashidi, F; Beigmohammadi, MT; Moghadam, KG; Rezaian, S; Dabbagh, A; Sezavar, SH; Farrokhpour, M; Bakhshandeh, H; Abedini, A; Aliannejad, R; Riahi, T; Yadollahzadeh, M; Lookzadeh, S; Rezaeifar, P; Matin, S; Tahamtan, O; Mohammadi, K; Zoghi, E; Rahmani, H; Hosseini, SH; Mousavian, SM; Abri, H; Sadeghipour, P; Baghizadeh, E; Rafiee, F; Jamalkhani, S; Amin, A; Mohebbi, B; Parhizgar, SE; Soleimanzadeh, M; Aghakouchakzadeh, M; Eslami, V; Payandemehr, P; Khalili, H; Talakoob, H; Tojari, T; Shafaghi, S; Ghazi, SF; Tabrizi, S; Kakavand, H; Kashefizadeh, A; Shahmirzaei, S; Najafi, A; Fathi, M; Jimenez, D; Gupta, A; Madhavan, MV; Sethi, SS; Parikh, SA; Monreal, M; Hadavand, N; Hajighasemi, A; Ansarin, K; Maleki, M; Sadeghian, S; Piazza, G; Kirtane, AJ; Van Tassell, BW; Stone, GW; Lip, GYH; Krumholz, HM; Goldhaber, SZ; Sadeghipour, P				Bikdeli, Behnood; Talasaz, Azita H.; Sharif-Kashani, Babak; Rashidi, Farid; Beigmohammadi, Mohammad Taghi; Moghadam, Keivan Gohari; Rezaian, Somaye; Dabbagh, Ali; Sezavar, Seyed Hashem; Farrokhpour, Mohsen; Bakhshandeh, Hooman; Abedini, Atefeh; Aliannejad, Rasoul; Riahi, Taghi; Yadollahzadeh, Mahdi; Lookzadeh, Somayeh; Rezaeifar, Parisa; Matin, Samira; Tahamtan, Ouria; Mohammadi, Keyhan; Zoghi, Elnaz; Rahmani, Hamid; Hosseini, Seyed Hossein; Mousavian, Seyed Masoud; Abri, Homa; Sadeghipour, Pardis; Baghizadeh, Elahe; Rafiee, Farnaz; Jamalkhani, Sepehr; Amin, Ahmad; Mohebbi, Bahram; Parhizgar, Seyed Ehsan; Soleimanzadeh, Mahshid; Aghakouchakzadeh, Maryam; Eslami, Vahid; Payandemehr, Pooya; Khalili, Hossein; Talakoob, Hamed; Tojari, Taranom; Shafaghi, Shadi; Ghazi, Samrand Fattah; Tabrizi, Sanaz; Kakavand, Hessam; Kashefizadeh, Alireza; Shahmirzaei, Shaghayegh; Najafi, Atabak; Fathi, Mohammad; Jimenez, David; Gupta, Aakriti; Madhavan, Mahesh, V; Sethi, Sanjum S.; Parikh, Sahil A.; Monreal, Manuel; Hadavand, Naser; Hajighasemi, Alireza; Ansarin, Khalil; Maleki, Majid; Sadeghian, Saeed; Piazza, Gregory; Kirtane, Ajay J.; Van Tassell, Benjamin W.; Stone, Gregg W.; Lip, Gregory Y. H.; Krumholz, Harlan M.; Goldhaber, Samuel Z.; Sadeghipour, Parham		INSPIRATION-S Investigators	Atorvastatin versus placebo in patients with covid-19 in intensive care: randomized controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							STATIN THERAPY; PREVENTION	OBJECTIVE To assess the effect of statin treatment versus placebo on clinical outcomes in patients with covid-19 admitted to the intensive care unit (ICU). DESIGN INSPIRATION/INSPIRATION-S was a multicenter, randomized controlled trial with a 2x2 factorial design. Results for the anticoagulation randomization have been reported previously. Results for the double blind randomization to atorvastatin versus placebo are reported here. SETTING 11 hospitals in Iran. PARTICIPANTS Adults aged >= 18 years with covid-19 admitted to the ICU. INTERVENTION Atorvastatin 20 mg orally once daily versus placebo, to be continued for 30 days from randomization irrespective of hospital discharge status. MAIN OUTCOME MEASURES The primary efficacy outcome was a composite of venous or arterial thrombosis, treatment with extracorporeal membrane oxygenation, or all cause mortality within 30 days from randomization. Prespecified safety outcomes included increase in liver enzyme levels more than three times the upper limit of normal and clinically diagnosed myopathy. A clinical events committee blinded to treatment assignment adjudicated the efficacy and safety outcomes. RESULTS Of 605 patients randomized between 29 July 2020 and 4 April 2021 for statin randomization in the INSPIRATION-S trial, 343 were co-randomized to intermediate dose versus standard dose prophylactic anticoagulation with heparin based regimens, whereas 262 were randomized after completion of the anticoagulation study. 587 of the 605 participants were included in the primary analysis of INSPIRATION-S, reported here: 290 were assigned to atorvastatin and 297 to placebo (median age 57 years (interquartile range 45-68 years); 256 (44%) women). The primary outcome occurred in 95 (33%) patients assigned to atorvastatin and 108 (36%) assigned to placebo (odds ratio 0.84, 95% confidence interval 0.58 to 1.21). Death occurred in 90 (31%) patients in the atorvastatin group and 103 (35%) in the placebo group (odds ratio 0.84, 95% confidence interval 0.58 to 1.22). Rates for venous thromboembolism were 2% (n=6) in the atorvastatin group and 3% (n=9) in the placebo group (odds ratio 0.71, 95% confidence interval 0.24 to 2.06). Myopathy was not clinically diagnosed in either group. Liver enzyme levels were increased in five (2%) patients assigned to atorvastatin and six (2%) assigned to placebo (odds ratio 0.85, 95% confidence interval 0.25 to 2.81). CONCLUSIONS In adults with covid-19 admitted to the ICU, atorvastatin was not associated with a significant reduction in the composite of venous or arterial thrombosis, treatment with extracorporeal membrane oxygenation, or all cause mortality compared with placebo. Treatment was, however, found to be safe. As the overall event rates were lower than expected, a clinically important treatment effect cannot be excluded. TRIAL REGISTRATION ClinicalTrials.gov NCT04486508.	[Sadeghipour, Parham] Rajaie Cardiovasc Med & Res Ctr, Tehran, Iran		Sadeghipour, P (corresponding author), Rajaie Cardiovasc Med & Res Ctr, Tehran, Iran.	bbikdeli@bwh.harvard.edu; psadeghipour@hotmail.com	rezaian, somaye/ABF-7429-2021; H Talasaz, Azita/GVT-1883-2022; aghakouchakzadeh, maryam/GLU-6605-2022; Kakavand, Hessam/GLU-2851-2022	H Talasaz, Azita/0000-0003-1839-3685; aghakouchakzadeh, maryam/0000-0003-0121-5989; Kakavand, Hessam/0000-0001-6719-4856; Farrokhzadeh, Fahimeh/0000-0003-4027-3401; Mazloomzadeh, Saeideh/0000-0001-6325-0662	Rajaie Cardiovascular Medical and Research Center	Rajaie Cardiovascular Medical and Research Center	The study was funded by the Rajaie Cardiovascular Medical and Research Center. Some study authors, including the senior author, are affiliated with the Rajaie Cardiovascular Medical and Research Center. Atorvastatin and matching placebo were provided by Sobhan Darou, which is not among the study sponsors. Neither the funder nor the company who donated the study drugs had any role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or the decision to submit the manuscript for publication.	Akhmerov A, 2020, CIRC RES, V126, P1443, DOI 10.1161/CIRCRESAHA.120.317055; Al-Samkari H, 2021, ANN INTERN MED, V174, P622, DOI 10.7326/M20-6739; Armstrong RA, 2020, ANAESTHESIA, V75, P1340, DOI 10.1111/anae.15201; Bassler D, 2008, J CLIN EPIDEMIOL, V61, P241, DOI 10.1016/j.jclinepi.2007.07.016; Bikdeli B, 2022, THROMB HAEMOSTASIS, V122, P131, DOI 10.1055/a-1485-2372; Bikdeli B, 2020, THROMB RES, V196, P382, DOI 10.1016/j.thromres.2020.09.027; Bikdeli B, 2020, THROMB HAEMOSTASIS, V120, P1004, DOI 10.1055/s-0040-1713152; Bikdeli B, 2020, J AM COLL CARDIOL, V75, P2950, DOI 10.1016/j.jacc.2020.04.031; Calfee CS, 2018, LANCET RESP MED, V6, P691, DOI 10.1016/S2213-2600(18)30177-2; Catanzaro M, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-0191-1; Cummings Matthew J, 2020, Lancet, V395, P1763, DOI [10.1101/2020.04.15.20067157, 10.1016/S0140-6736(20)31189-2]; Davoodi L, 2021, IJC HEART VASC, V36, DOI 10.1016/j.ijcha.2021.100875; DeDiego ML, 2014, J VIROL, V88, P913, DOI 10.1128/JVI.02576-13; Gallastegui N, 2021, CLIN APPL THROMB-HEM, V27, DOI 10.1177/1076029621996471; Ganjali S, 2020, METABOLISM, V113, DOI 10.1016/j.metabol.2020.154375; Glynn RJ, 2009, NEW ENGL J MED, V360, P1851, DOI 10.1056/NEJMoa0900241; Goligher EC, 2021, NEW ENGL J MED, V385, P777, DOI [10.1056/NEJMoa2103417, 10.1056/NEJMoa2100433]; Gupta A, 2020, NAT MED, V26, P1017, DOI 10.1038/s41591-020-0968-3; Hendren NS, 2021, CIRCULATION, V143, P135, DOI 10.1161/CIRCULATIONAHA.120.051936; Hothersall E, 2006, THORAX, V61, P729, DOI 10.1136/thx.2005.057976; Jimenez D, 2021, CHEST, V159, P1182, DOI 10.1016/j.chest.2020.11.005; Klok FA, 2020, THROMB RES, V191, P145, DOI [10.1016/j.thromres.2020.04.041, 10.1016/j.thromres.2020.04.013]; Kunutsor SK, 2017, LANCET HAEMATOL, V4, pE83, DOI 10.1016/S2352-3026(16)30184-3; Leentjens J, 2021, LANCET HAEMATOL, V8, DOI 10.1016/S2352-3026(21)00105-8; McAuley DF, 2014, NEW ENGL J MED, V371, P1695, DOI 10.1056/NEJMoa1403285; Merx MW, 2006, CURR OPIN CRIT CARE, V12, P309, DOI 10.1097/01.ccx.0000235207.00322.96; Middeldorp S, 2020, J THROMB HAEMOST, V18, P1995, DOI 10.1111/jth.14888; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Ramkumar S, 2016, ACTA CARDIOL SIN, V32, P631, DOI 10.6515/ACS20160611A; Sadeghipour P, 2021, JAMA-J AM MED ASSOC, V325, P1620, DOI 10.1001/jama.2021.4152; Sinha P, 2020, LANCET RESP MED, V8, P1209, DOI 10.1016/S2213-2600(20)30366-0; Sterne JAC, 2020, JAMA-J AM MED ASSOC, V324, P1330, DOI 10.1001/jama.2020.17023; Sviridov D, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.574508; Talasaz AH, 2021, J AM COLL CARDIOL, V78, P1635, DOI 10.1016/j.jacc.2021.08.021; Talasaz AH, 2021, J AM COLL CARDIOL, V77, P1903, DOI 10.1016/j.jacc.2021.02.035; Undas A, 2005, ARTERIOSCL THROM VAS, V25, P287, DOI 10.1161/01.ATV.0000151647.14923.ec; Violi F, 2013, CIRCULATION, V127, P251, DOI 10.1161/CIRCULATIONAHA.112.145334; Wiersinga WJ, 2020, JAMA-J AM MED ASSOC, V324, P782, DOI 10.1001/jama.2020.12839; Wise J, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2058; Wu KS, 2021, ANN MED, V53, P874, DOI 10.1080/07853890.2021.1933165	40	19	19	3	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 7	2022	376									10.1136/bmj-2021-068407	http://dx.doi.org/10.1136/bmj-2021-068407			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YP9GN	34996756	hybrid			2022-12-28	WOS:000748927300016
J	Gjorevski, N; Nikolaev, M; Brown, TE; Mitrofanova, O; Brandenberg, N; DelRio, FW; Yavitt, FM; Liberali, P; Anseth, KS; Lutolf, MP				Gjorevski, N.; Nikolaev, M.; Brown, T. E.; Mitrofanova, O.; Brandenberg, N.; DelRio, F. W.; Yavitt, F. M.; Liberali, P.; Anseth, K. S.; Lutolf, M. P.			Tissue geometry drives deterministic organoid patterning	SCIENCE			English	Article							INTESTINAL STEM-CELL; SELF-ORGANIZATION; CRYPT; YAP; YAP/TAZ; PROLIFERATION; MORPHOGENESIS; COORDINATE; EPITHELIUM; GRADIENTS	Epithelial organoids are stem cell-derived tissues that approximate aspects of real organs, and thus they have potential as powerful tools in basic and translational research. By definition, they self-organize, but the structures formed are often heterogeneous and irreproducible, which limits their use in the lab and clinic. We describe methodologies for spatially and temporally controlling organoid formation, thereby rendering a stochastic process more deterministic. Bioengineered stem cell microenvironments are used to specify the initial geometry of intestinal organoids, which in turn controls their patterning and crypt formation. We leveraged the reproducibility and predictability of the culture to identify the underlying mechanisms of epithelial patterning, which may contribute to reinforcing intestinal regionalization in vivo. By controlling organoid culture, we demonstrate how these structures can be used to answer questions not readily addressable with the standard, more variable, organoid models.	[Gjorevski, N.; Nikolaev, M.; Mitrofanova, O.; Brandenberg, N.; Lutolf, M. P.] Ecole Polytech Fed Lausanne EPFL, Lab Stem Cell Bioengn, Inst Bioengn, Sch Life Sci SV, Lausanne, Switzerland; [Gjorevski, N.; Nikolaev, M.; Mitrofanova, O.; Brandenberg, N.; Lutolf, M. P.] Ecole Polytech Fed Lausanne EPFL, Sch Engn STI, Lausanne, Switzerland; [Brown, T. E.; Yavitt, F. M.; Anseth, K. S.] Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80309 USA; [Brown, T. E.; Yavitt, F. M.; Anseth, K. S.] Univ Colorado, BioFrontiers Inst, Boulder, CO 80303 USA; [DelRio, F. W.] Sandia Natl Labs, Mat Phys & Chem Sci Ctr, Albuquerque, NM 87185 USA; [Liberali, P.] Friedrich Miescher Inst Biomed Res FMI, Basel, Switzerland; [Lutolf, M. P.] Ecole Polytech Fed Lausanne, Inst Chem Sci & Engn, Sch Basic Sci SB, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; United States Department of Energy (DOE); Sandia National Laboratories; Friedrich Miescher Institute for Biomedical Research; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Lutolf, MP (corresponding author), Ecole Polytech Fed Lausanne EPFL, Lab Stem Cell Bioengn, Inst Bioengn, Sch Life Sci SV, Lausanne, Switzerland.; Lutolf, MP (corresponding author), Ecole Polytech Fed Lausanne EPFL, Sch Engn STI, Lausanne, Switzerland.; Lutolf, MP (corresponding author), Ecole Polytech Fed Lausanne, Inst Chem Sci & Engn, Sch Basic Sci SB, Lausanne, Switzerland.	matthias.lutolf@epfl.ch		Aguado, Brian/0000-0002-4449-9806; Yavitt, Francis/0000-0002-9278-9082; Liberali, Prisca/0000-0003-0695-6081; Brown, Tobin/0000-0002-7852-7561	Swiss National Science Foundation (SNSF) [310030_179447]; EU [668294-2]; NIH [T32 GM-065103]; EMBO Long-Term Postdoctoral Fellowship; NSF GRFP; Center for Integrated Nanotechnologies, a US Department of Energy Office of Basic Energy Sciences; US Department of Energy National Nuclear Security Administration [DENA0003525]	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); EU(European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EMBO Long-Term Postdoctoral Fellowship(European Molecular Biology Organization (EMBO)); NSF GRFP(National Science Foundation (NSF)NSF - Office of the Director (OD)); Center for Integrated Nanotechnologies, a US Department of Energy Office of Basic Energy Sciences(United States Department of Energy (DOE)); US Department of Energy National Nuclear Security Administration(National Nuclear Security AdministrationUnited States Department of Energy (DOE))	This work was funded by support from the Swiss National Science Foundation (SNSF) research grant 310030_179447, the EU Horizon 2020 Project INTENS (#668294-2), the PHRT -PM/PH Research Project Proposal 2017, Ecole Polytechnique Federale de Lausanne (EPFL), and NIH (R01DK120921). N.G. was supported in part by an EMBO Long-Term Postdoctoral Fellowship. T.B. was supported by fellowships from the NSF GRFP and NIH (T32 GM-065103). F.D. was supported in part by the Center for Integrated Nanotechnologies, a US Department of Energy Office of Basic Energy Sciences user facility. Sandia National Laboratories is a multimission laboratory managed and operated by National Technology and Engineering Solutions of Sandia LLC, a wholly owned subsidiary of Honeywell International Inc., for the US Department of Energy National Nuclear Security Administration under contract DENA0003525.	[Anonymous], 2017, CELL STEM CELL, V20, P759, DOI 10.1016/j.stem.2017.05.014; Aragona M, 2013, CELL, V154, P1047, DOI 10.1016/j.cell.2013.07.042; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Clevers H, 2016, CELL, V165, P1586, DOI 10.1016/j.cell.2016.05.082; Clevers H, 2013, CELL, V154, P274, DOI 10.1016/j.cell.2013.07.004; DeForest CA, 2011, NAT CHEM, V3, P925, DOI [10.1038/NCHEM.1174, 10.1038/nchem.1174]; Drost J, 2018, NAT REV CANCER, V18, P407, DOI 10.1038/s41568-018-0007-6; Drost J, 2017, SCIENCE, V358, P234, DOI 10.1126/science.aao3130; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Fan FQ, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf2304; Farin HF, 2016, NATURE, V530, P340, DOI 10.1038/nature16937; Genander M, 2009, CELL, V139, P679, DOI 10.1016/j.cell.2009.08.048; Glorevski N, 2016, NATURE, V539, P560, DOI 10.1038/nature20168; Gregorieff A, 2015, NATURE, V526, P715, DOI 10.1038/nature15382; Guan YF, 2011, AM J PHYSIOL-CELL PH, V300, pC1404, DOI 10.1152/ajpcell.00270.2010; Holmberg J, 2006, CELL, V125, P1151, DOI 10.1016/j.cell.2006.04.030; Huch M, 2017, DEVELOPMENT, V144, P938, DOI 10.1242/dev.150201; Imajo M, 2015, NAT CELL BIOL, V17, P7, DOI 10.1038/ncb3084; Kiesslich R, 2012, GUT, V61, P1146, DOI 10.1136/gutjnl-2011-300695; Kim R, 2018, LAB CHIP, V18, P2202, DOI 10.1039/c8lc00332g; Lancaster MA, 2017, NAT BIOTECHNOL, V35, P659, DOI 10.1038/nbt.3906; Lancaster MA, 2014, SCIENCE, V345, DOI 10.1126/science.1247125; Legant WR, 2010, NAT METHODS, V7, P969, DOI 10.1038/NMETH.1531; Liu JJ, 2011, J CLIN GASTROENTEROL, V45, P240, DOI 10.1097/MCG.0b013e3181fbdb8a; Liu-Chittenden Y, 2012, GENE DEV, V26, P1300, DOI 10.1101/gad.192856.112; Lukonin I, 2020, NATURE, V586, P275, DOI 10.1038/s41586-020-2776-9; Marchiando Amanda M, 2011, Gastroenterology, V140, P1208, DOI 10.1053/j.gastro.2011.01.004; Marchiando AM, 2011, GASTROENTEROLOGY, V140, P1208, DOI 10.1053/j.gastro.2011.01.004; McKinnon DD, 2014, BIOMACROMOLECULES, V15, P2808, DOI 10.1021/bm500731b; Nelson CM, 2008, NAT PROTOC, V3, P674, DOI 10.1038/nprot.2008.35; Nelson CM, 2006, SCIENCE, V314, P298, DOI 10.1126/science.1131000; Nelson CM, 2009, BBA-MOL CELL RES, V1793, P903, DOI 10.1016/j.bbamcr.2008.12.014; Nikolaev M, 2020, NATURE, V585, P574, DOI 10.1038/s41586-020-2724-8; Panciera T, 2017, NAT REV MOL CELL BIO, V18, P758, DOI 10.1038/nrm.2017.87; Poling HM, 2018, NAT BIOMED ENG, V2, P429, DOI 10.1038/s41551-018-0243-9; Rosado-Olivieri EA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09404-6; Rossi G, 2018, NAT REV GENET, V19, P671, DOI 10.1038/s41576-018-0051-9; Sasai Y, 2013, NATURE, V493, P318, DOI 10.1038/nature11859; Sato T, 2013, SCIENCE, V340, P1190, DOI 10.1126/science.1234852; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Serra D, 2019, NATURE, V569, P66, DOI 10.1038/s41586-019-1146-y; Shyer AE, 2015, CELL, V161, P569, DOI 10.1016/j.cell.2015.03.041; Sneddon IN., 1965, INT J ENG SCI, V3, P47, DOI [10.1016/0020-7225(65)90019-4, DOI 10.1016/0020-7225(65)90019-4, 10.1016/0020-7225(65)90019-4.477, DOI 10.1016/0020-7225(65)90019-4.477]; Vlachogiannis G, 2018, SCIENCE, V359, P920, DOI 10.1126/science.aao2774; Wang FC, 2011, LAB INVEST, V91, P462, DOI 10.1038/labinvest.2010.182; Wang YL, 2018, CELL MOL GASTROENTER, V5, P113, DOI 10.1016/j.jcmgh.2017.10.007; Wang YL, 2017, BIOMATERIALS, V128, P44, DOI 10.1016/j.biomaterials.2017.03.005; Yin XL, 2014, NAT METHODS, V11, P106, DOI 10.1038/nmeth.2737; Yui S, 2018, CELL STEM CELL, V22, P35, DOI 10.1016/j.stem.2017.11.001; Zinner M, 2020, CURR OPIN CELL BIOL, V67, P37, DOI 10.1016/j.ceb.2020.07.004	51	52	53	61	152	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 7	2022	375	6576					40	+	eaaw9021	10.1126/science.aaw9021	http://dx.doi.org/10.1126/science.aaw9021			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YD3FW	34990240	Green Accepted			2022-12-28	WOS:000740261400034
J	Korde, A; Min, B; Kapaca, E; Knio, O; Nezam, I; Wang, ZY; Leisen, J; Yin, XY; Zhang, XY; Sholl, DS; Zou, XD; Willhammar, T; Jones, CW; Nair, S				Korde, Akshay; Min, Byunghyun; Kapaca, Elina; Knio, Omar; Nezam, Iman; Wang, Ziyuan; Leisen, Johannes; Yin, Xinyang; Zhang, Xueyi; Sholl, David S.; Zou, Xiaodong; Willhammar, Tom; Jones, Christopher W.; Nair, Sankar			Single-walled zeolitic nanotubes	SCIENCE			English	Article							IR SPECTROSCOPY; NANOSHEETS; PORE; MFI; ALUMINUM; ALKANE; FAMILY; BANDS	We report the synthesis and structure of single-walled aluminosilicate nanotubes with microporous zeolitic walls. This quasi-one-dimensional zeolite is assembled by a bolaform structure-directing agent (SDA) containing a central biphenyl group connected by C-10 alkyl chains to quinuclidinium end groups. High-resolution electron microscopy and diffraction, along with other supporting methods, revealed a unique wall structure that is a hybrid of characteristic building layers from two zeolite structure types, beta and MFI. This hybrid structure arises from minimization of strain energy during the formation of a curved nanotube wall. Nanotube formation involves the early appearance of a mesostructure due to self-assembly of the SDA molecules. The biphenyl core groups of the SDA molecules show evidence of p stacking, whereas the peripheral quinuclidinium groups direct the microporous wall structure.	[Korde, Akshay; Min, Byunghyun; Knio, Omar; Nezam, Iman; Wang, Ziyuan; Sholl, David S.; Jones, Christopher W.; Nair, Sankar] Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA; [Kapaca, Elina; Zou, Xiaodong; Willhammar, Tom] Stockholm Univ, Dept Mat & Environm Chem, S-10691 Stockholm, Sweden; [Leisen, Johannes; Jones, Christopher W.] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; [Yin, Xinyang; Zhang, Xueyi] Penn State Univ, Dept Chem Engn, University Pk, PA 16802 USA	University System of Georgia; Georgia Institute of Technology; Stockholm University; University System of Georgia; Georgia Institute of Technology; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Jones, CW; Nair, S (corresponding author), Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA.; Willhammar, T (corresponding author), Stockholm Univ, Dept Mat & Environm Chem, S-10691 Stockholm, Sweden.; Jones, CW (corresponding author), Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA.	tom.willhammar@mmk.su.se; cjones@chbe.gatech.edu	Wang, Zhiquan/HHS-6768-2022	Korde, Akshay/0000-0003-3811-5172; Wang, Ziyuan/0000-0003-4102-5020; Knio, Omar/0000-0002-7969-2569; leisen, johannes/0000-0003-0474-670X; Nezam, Iman/0000-0002-7759-8069	National Science Foundation [ECCS-1542174]; Swedish Research Council [2017-04321, 2019-05465]; US National Science Foundation [DMR-1420620]	National Science Foundation(National Science Foundation (NSF)); Swedish Research Council(Swedish Research CouncilEuropean Commission); US National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation (grant no. CBET-1534179 to S.N., C.W.J., D.S.S., A.K., B.M., and O.K.) and the Swedish Research Council (grant no. 2017-04321 to X. Zou and grant no. 2019-05465 to T.W.). PXRD and SEM characterizations were performed at the Georgia Tech Institute for Electronics and Nanotechnology, home to one of the 16 sites of the National Nanotechnology Coordinated Infrastructure (NNCI), which is supported by the National Science Foundation (grant no. ECCS-1542174). Materials characterization at Penn State University was performed at the Materials Characterization Laboratory, which is a partner in the National Nanotechnology Infrastructure Network (NNIN) and the Materials Research Facilities Network (MRFN), supported by the US National Science Foundation (award no. DMR-1420620).	Beyerlein RA, 1997, TOP CATAL, V4, P27, DOI 10.1023/A:1019188105794; Brown WM, 2013, COMPUT PHYS COMMUN, V184, P2785, DOI 10.1016/j.cpc.2013.08.002; Cejka J, 2007, CATAL REV, V49, P457, DOI 10.1080/01614940701583240; Choi M, 2009, NATURE, V461, P246, DOI 10.1038/nature08288; Cichocka MO, 2018, J APPL CRYSTALLOGR, V51, P1652, DOI 10.1107/S1600576718015145; Corma A, 2003, J CATAL, V216, P298, DOI 10.1016/S0021-9517(02)00132-X; COUDURIER G, 1982, J CHEM SOC CHEM COMM, P1413, DOI 10.1039/c39820001413; CRADWICK PD, 1972, NATURE-PHYS SCI, V240, P187, DOI 10.1038/physci240187a0; Cundy CS, 2003, CHEM REV, V103, P663, DOI 10.1021/cr020060i; Davis ME, 2002, NATURE, V417, P813, DOI 10.1038/nature00785; Eder F, 1997, J PHYS CHEM B, V101, P5414, DOI 10.1021/jp9706487; EMEIS CA, 1993, J CATAL, V141, P347, DOI 10.1006/jcat.1993.1145; Fan W, 2008, NAT MATER, V7, P984, DOI 10.1038/nmat2302; Feliczak-Guzik A, 2018, MICROPOR MESOPOR MAT, V259, P33, DOI 10.1016/j.micromeso.2017.09.030; Fogarty JC, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3407433; Gabrienko AA, 2018, J PHYS CHEM C, V122, P25386, DOI 10.1021/acs.jpcc.8b07429; Gallas JP, 2009, LANGMUIR, V25, P5825, DOI 10.1021/la802688w; Gren W, 2010, J PHYS CHEM C, V114, P9739, DOI 10.1021/jp909355e; JACOBS PA, 1981, ZEOLITES, V1, P161, DOI 10.1016/S0144-2449(81)80006-1; JANSEN JC, 1984, ZEOLITES, V4, P369, DOI 10.1016/0144-2449(84)90013-7; Kang DY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4342; Kang DY, 2010, ACS NANO, V4, P4897, DOI 10.1021/nn101211y; Kester PM, 2018, IND ENG CHEM RES, V57, P6673, DOI 10.1021/acs.iecr.8b00933; KLINOWSKI J, 1982, J CHEM SOC FARAD T 2, V78, P1025, DOI 10.1039/f29827801025; Knio O, 2019, CHEM MATER, V31, P353, DOI 10.1021/acs.chemmater.8b03290; Lesthaeghe D, 2008, J PHYS CHEM C, V112, P9186, DOI 10.1021/jp711550s; Margarit VJ, 2015, ANGEW CHEM INT EDIT, V54, P13724, DOI 10.1002/anie.201506822; Meyer JC, 2006, ULTRAMICROSCOPY, V106, P176, DOI 10.1016/j.ultramic.2005.07.008; Moller K, 2013, CHEM SOC REV, V42, P3689, DOI 10.1039/c3cs35488a; Na K, 2011, SCIENCE, V333, P328, DOI 10.1126/science.1204452; Na K, 2010, J AM CHEM SOC, V132, P4169, DOI 10.1021/ja908382n; Plimpton S., 2007, SANDIA NATL LAB, V18, P43; Pophale R, 2011, PHYS CHEM CHEM PHYS, V13, P12407, DOI 10.1039/c0cp02255a; Ravi M, 2020, NAT MATER, V19, P1047, DOI 10.1038/s41563-020-0751-3; Ravikovitch PI, 1995, LANGMUIR, V11, P4765, DOI 10.1021/la00012a030; Roth WJ, 2013, NAT CHEM, V5, P628, DOI [10.1038/NCHEM.1662, 10.1038/nchem.1662]; Schmidt JE, 2015, CHEM SCI, V6, P5955, DOI 10.1039/c5sc02325d; Senftle TP, 2016, NPJ COMPUT MATER, V2, DOI 10.1038/npjcompumats.2015.11; Seo Y, 2013, J AM CHEM SOC, V135, P8806, DOI [10.1021/ja403580J, 10.1021/ja403580j]; Serrano DP, 2013, CHEM SOC REV, V42, P4004, DOI 10.1039/c2cs35330j; Shen XF, 2018, ANGEW CHEM INT EDIT, V57, P724, DOI 10.1002/anie.201710748; Singh BK, 2014, CHEM MATER, V26, P7183, DOI 10.1021/cm503919h; Sun H, 1998, J PHYS CHEM B, V102, P7338, DOI 10.1021/jp980939v; Sun H, 2016, J MOL MODEL, V22, DOI 10.1007/s00894-016-2909-0; Taborda F, 2011, MICROPOR MESOPOR MAT, V143, P196, DOI 10.1016/j.micromeso.2011.02.030; Tao YS, 2006, CHEM REV, V106, P896, DOI 10.1021/cr040204o; Tomlinson S. R., 2013, INT J SPECTROSC, V2013, P1; Tomlinson SR, 2013, INT J SPECTROSC, DOI 10.1155/2013/961404; TREACY MMJ, 1988, NATURE, V332, P249, DOI 10.1038/332249a0; Verboekend D, 2011, CATAL SCI TECHNOL, V1, P879, DOI 10.1039/c1cy00150g; Wan W, CRYSTDIFF; Wan W, 2013, J APPL CRYSTALLOGR, V46, P1863, DOI 10.1107/S0021889813027714; Wang C, 2012, ACCOUNTS CHEM RES, V45, P608, DOI 10.1021/ar200226d; Xu DD, 2014, CHEM MATER, V26, P4612, DOI 10.1021/cm502027j; Xu DD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5262; Yoon JS, 2019, CATALYSTS, V9, DOI 10.3390/catal9110933; Zhang H, 2016, ANGEW CHEM INT EDIT, V55, P7184, DOI 10.1002/anie.201601135; Zhang XY, 2012, SCIENCE, V336, P1684, DOI 10.1126/science.1221111; Zhang YJ, 2020, ANGEW CHEM INT EDIT, V59, P50, DOI 10.1002/anie.201903364; Zhang YJ, 2019, CHEM-EUR J, V25, P738, DOI 10.1002/chem.201804841; Zhang YJ, 2018, CHEM MATER, V30, P1839, DOI 10.1021/acs.chemmater.8b00146	61	11	11	62	204	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 7	2022	375	6576					62	+	eabg3793	10.1126/science.abg3793	http://dx.doi.org/10.1126/science.abg3793			41	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YD3FW	34990247				2022-12-28	WOS:000740261400040
J	Martens-Habbena, W; Qin, W				Martens-Habbena, Willm; Qin, Wei			Archaeal nitrification without oxygen	SCIENCE			English	Editorial Material							AMMONIA-OXIDIZING ARCHAEA; NITRITE OXIDATION; NITROGEN		[Martens-Habbena, Willm] Univ Florida, Ft Lauderdale Res & Educ Ctr, Inst Food & Agr Sci, Dept Microbiol & Cell Sci, Davie, FL 33314 USA; [Qin, Wei] Univ Oklahoma, Dept Microbiol & Plant Biol, Norman, OK 73019 USA	State University System of Florida; University of Florida; University of Oklahoma System; University of Oklahoma - Norman	Martens-Habbena, W (corresponding author), Univ Florida, Ft Lauderdale Res & Educ Ctr, Inst Food & Agr Sci, Dept Microbiol & Cell Sci, Davie, FL 33314 USA.	w.martenshabbena@ufl.edu						Bristow LA, 2016, P NATL ACAD SCI USA, V113, P10601, DOI 10.1073/pnas.1600359113; Canfield DE, 2010, SCIENCE, V330, P192, DOI 10.1126/science.1186120; Jablonska J, 2021, NAT ECOL EVOL, V5, P442, DOI 10.1038/s41559-020-01386-9; Konneke M, 2014, P NATL ACAD SCI USA, V111, P8239, DOI 10.1073/pnas.1402028111; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Kraft B, SCIENCE, V375, P97; Martens-Habbena W, 2009, NATURE, V461, P976, DOI 10.1038/nature08465; Peng XF, 2015, GLOBAL BIOGEOCHEM CY, V29, P2034, DOI 10.1002/2015GB005278; Ren ML, 2019, ISME J, V13, P2150, DOI 10.1038/s41396-019-0418-8; Santoro AE, 2011, SCIENCE, V333, P1282, DOI 10.1126/science.1208239; Stein LY, 2021, ENVIRON SCI TECHNOL, V55, P797, DOI 10.1021/acs.est.0c06792; Sun X, 2021, ISME J, V15, P1317, DOI 10.1038/s41396-020-00852-3; Welte CU, 2016, ENV MICROBIOL REP, V8, P941, DOI 10.1111/1758-2229.12487; Yang YY, 2021, MOL BIOL EVOL, V38, P3637, DOI 10.1093/molbev/msab129; Zhang Y, 2020, P NATL ACAD SCI USA, V117, P4823, DOI 10.1073/pnas.1912367117	15	4	4	28	105	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 7	2022	375	6576					27	28		10.1126/science.abn0373	http://dx.doi.org/10.1126/science.abn0373			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YD3FW	34990251				2022-12-28	WOS:000740261400027
J	Mccay, L				Mccay, Layla			Omicron: Urgent action needed on NHS staffing crisis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Mccay, Layla] NHS Confederat, London, England		Mccay, L (corresponding author), NHS Confederat, London, England.							ANA Enterprise,, 2022, COR COVID 19 INF SUR	1	5	6	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 6	2022	376								o18	10.1136/bmj.o18	http://dx.doi.org/10.1136/bmj.o18			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YG5VA	34992087	Bronze			2022-12-28	WOS:000742554700004
J	Okeahialam, NA; Dworzynski, K; Jacklin, P; McClurg, D				Okeahialam, Nicola Adanna; Dworzynski, Katharina; Jacklin, Paul; McClurg, Doreen		Comm, G	Prevention and non-surgical management of pelvic floor dysfunction: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ICS JOINT REPORT; TERMINOLOGY		[Okeahialam, Nicola Adanna; Dworzynski, Katharina; Jacklin, Paul] Royal Coll Obstetricians & Gynaecologists, Natl Guideline Alliance, London, England; [Okeahialam, Nicola Adanna] Croydon Univ Hosp, Thornton Heath, England; [Okeahialam, Nicola Adanna] St Georges Univ, London, England; [McClurg, Doreen] Glasgow Caledonian Univ, Glasgow, Lanark, Scotland	Croydon University Hospital; St Georges University London; Glasgow Caledonian University	Okeahialam, NA (corresponding author), Royal Coll Obstetricians & Gynaecologists, Natl Guideline Alliance, London, England.; Okeahialam, NA (corresponding author), Croydon Univ Hosp, Thornton Heath, England.; Okeahialam, NA (corresponding author), St Georges Univ, London, England.	nicola.okeahialam@nhs.net		Okeahialam, Nicola/0000-0002-0786-2354	National Guideline Alliance at the Royal College of Obstetricians and Gynaecologists - NICE	National Guideline Alliance at the Royal College of Obstetricians and Gynaecologists - NICE	KD and PJ received support from the National Guideline Alliance at the Royal College of Obstetricians and Gynaecologists, which is commissioned and funded by NICE to develop clinical, public health, and social care guidelines and to write this BMJ summary. No authors received special funding from any other source to write this summary.	Bo K, 2017, INT UROGYNECOL J, V28, P191, DOI 10.1007/s00192-016-3123-4; First Do No Harm, 2020, REP IND MED MED DEV; Haylen BT, 2010, NEUROUROL URODYNAM, V29, P4, DOI 10.1002/nau.20798; National Institute for Health and Care Excellence, 2010, PH27 NAT I HLTH CAR; National Institute for Health and Care Excellence, 2021, NG12 NAT I HLTH CAR; National Institute for Health and Care Excellence, 2021, NG10123 NAT I HLTH C; National Institute for Health and Care Excellence, 2014, CG189 NAT I HLTH CAR; NICE, 2015, MED OPT SAF EFF US M; Royal College of Obstetricians and Gynaecologists, 2020, EACH BAB COUNTS 2019; The National Institute for Health and Care Excellence, 2018, STOP SMOK INT SERV N; UK Government, 2018, GUID EATW GUID; UK Government, 2020, GUID PHYS ACT GUID U; Wu JM, 2014, OBSTET GYNECOL, V123, P141, DOI 10.1097/AOG.0000000000000057	13	1	1	6	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 6	2022	376								n3049	10.1136/bmj.n3049	http://dx.doi.org/10.1136/bmj.n3049			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YG5VA	34992080				2022-12-28	WOS:000742554700006
J	Yu, XZ; Khakh, BS				Yu, Xinzhu; Khakh, Baljit S.			SnapShot: Astrocyte interactions	CELL			English	Editorial Material									[Yu, Xinzhu] Univ Illinois, Dept Mol & Integrat Physiol, 407 S Goodwin Ave, Urbana, IL 61801 USA; [Khakh, Baljit S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Yu, XZ (corresponding author), Univ Illinois, Dept Mol & Integrat Physiol, 407 S Goodwin Ave, Urbana, IL 61801 USA.				NIH [R35NS111583]; Brain Research Foundation [BRFSG-2021-12]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brain Research Foundation	B.S. K. thanks the NIH (R35NS111583), and X.Y. thanks the Brain Research Foundation (BRFSG-2021-12). Thanks to Drs. N. Allen, B. Deneen, and C. Murphy-Royal for comments on an earlier version.	Allen NJ, 2018, SCIENCE, V362, P181, DOI 10.1126/science.aat0473; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Clark IC, 2021, SCIENCE, V372, P360, DOI 10.1126/science.abf1230; Liddelow SA, 2020, TRENDS IMMUNOL, V41, P820, DOI 10.1016/j.it.2020.07.006; Simons M, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a020479; Yu XZ, 2020, NEURON, V108, DOI 10.1016/j.neuron.2020.09.021	6	0	0	15	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 6	2022	185	1					220	+		10.1016/j.cell.2021.09.029	http://dx.doi.org/10.1016/j.cell.2021.09.029			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	YN0XD	34995516				2022-12-28	WOS:000746989500004
J	Gahungu, N; Trueick, R; Coopes, M; Gabbay, E				Gahungu, Nestor; Trueick, Robert; Coopes, Martin; Gabbay, Eli			Paroxysmal atrial fibrillation	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RISK-FACTORS; STROKE; DIAGNOSIS; PREVALENCE; GUIDELINES; MANAGEMENT; MORTALITY; SEVERITY; ACCURACY; SYMPTOMS		[Gahungu, Nestor; Coopes, Martin; Gabbay, Eli] Univ Notre Dame Australia, Sch Med, Fremantle, WA, Australia; [Gahungu, Nestor; Trueick, Robert] Royal Perth Hosp, Dept Cardiol, Perth, Australia; [Gabbay, Eli] Bendat Resp Res & Dev Fund, SJOG Subiaco, Perth, WA, Australia	University of Notre Dame Australia; Royal Perth Hospital	Gahungu, N (corresponding author), Univ Notre Dame Australia, Sch Med, Fremantle, WA, Australia.	nestor.gahungu@gmail.com						Aguilar MI, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001927.pub2; Baber U, 2011, CIRC-ARRHYTHMIA ELEC, V4, P26, DOI 10.1161/CIRCEP.110.957100; Brieger D, 2018, HEART LUNG CIRC, V27, P1209, DOI 10.1016/j.hlc.2018.06.1043; Buch P, 2003, EUR RESPIR J, V21, P1012, DOI 10.1183/09031936.03.00051502; Bumgarner JM, 2018, J AM COLL CARDIOL, V71, P2381, DOI 10.1016/j.jacc.2018.03.003; Cadby G, 2015, CHEST, V148, P945, DOI 10.1378/chest.15-0229; Christophersen IE, 2016, AM HEART J, V178, P45, DOI 10.1016/j.ahj.2016.05.004; Chugh SS, 2014, CIRCULATION, V129, P837, DOI 10.1161/CIRCULATIONAHA.113.005119; Cooke G, 2006, J FAM PRACTICE, V55, P130; Doliwa PS, 2012, SCAND CARDIOVASC J, V46, P144, DOI 10.3109/14017431.2012.661873; Engdahl J, 2013, CIRCULATION, V127, P930, DOI 10.1161/CIRCULATIONAHA.112.126656; FLEGEL KM, 1987, LANCET, V1, P526; Freedman B, 2017, CIRCULATION, V135, P1851, DOI 10.1161/CIRCULATIONAHA.116.026693; Gahungu N, 2019, SLEEP MED, V57, P107, DOI 10.1016/j.sleep.2019.01.036; Ganesan AN, 2016, EUR HEART J, V37, P1591, DOI 10.1093/eurheartj/ehw007; Gladstone DJ, 2014, NEW ENGL J MED, V370, P2467, DOI 10.1056/NEJMoa1311376; Golwala H, 2016, AM HEART J, V174, P29, DOI 10.1016/j.ahj.2015.10.028; Heeringa J, 2006, EUR HEART J, V27, P949, DOI 10.1093/eurheartj/ehi825; Hindricks G, 2021, EUR HEART J, V42, P546, DOI 10.1093/eurheartj/ehaa945; Hobbs FDR, 2005, HEALTH TECHNOL ASSES, V9, P1, DOI 10.3310/hta9400; January CT, 2019, J AM COLL CARDIOL, V74, P104, DOI 10.1016/j.jacc.2019.01.011; Kirchhof P, 2016, EUR HEART J, V37, P2893, DOI 10.1093/eurheartj/ehw210; Krijthe BP, 2013, EUR HEART J, V34, P2746, DOI 10.1093/eurheartj/eht280; Levy S, 1999, CIRCULATION, V99, P3028, DOI 10.1161/01.CIR.99.23.3028; Lin HJ, 1996, STROKE, V27, P1760, DOI 10.1161/01.STR.27.10.1760; NICE, 2021, NICE GUID NG196; Orchard J, 2016, EUR J PREV CARDIOL, V23, P13, DOI 10.1177/2047487316670255; Ponamgi SP, 2021, BMJ-BRIT MED J, V373, DOI [10.1136/bmj.n379, 10.1136/bmj.mn379]; Psaty BM, 1997, CIRCULATION, V96, P2455; Quirino G, 2009, PACE, V32, P91, DOI 10.1111/j.1540-8159.2009.02181.x; Sanna T, 2014, NEW ENGL J MED, V370, P2478, DOI 10.1056/NEJMoa1313600; Schnabel RB, 2015, LANCET, V386, P154, DOI 10.1016/S0140-6736(14)61774-8; Sposato LA, 2015, LANCET NEUROL, V14, P377, DOI 10.1016/S1474-4422(15)70027-X; Stergiou GS, 2009, J HUM HYPERTENS, V23, P654, DOI 10.1038/jhh.2009.5; Stewart S, 2002, AM J MED, V113, P359, DOI 10.1016/S0002-9343(02)01236-6; Strickberger SA, 2005, HEART RHYTHM, V2, P125, DOI 10.1016/j.hrthm.2004.10.042; Svendsen JH, 2021, LANCET, V398, P1507, DOI 10.1016/S0140-6736(21)01698-6; Svennberg E, 2015, CIRCULATION, V131, P2176, DOI 10.1161/CIRCULATIONAHA.114.014343; Taggar JS, 2015, INT J CARDIOL, V184, P175, DOI 10.1016/j.ijcard.2015.02.014; Van Gelder IC, 2017, EUR HEART J, V38, P1339, DOI 10.1093/eurheartj/ehx042	40	2	2	3	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 30	2021	375								e058568	10.1136/bmj-2021-058568	http://dx.doi.org/10.1136/bmj-2021-058568			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YC3TX	34969661				2022-12-28	WOS:000739618400002
J	Muik, A; Lui, BG; Wallisch, AK; Bacher, M; Muhl, J; Reinholz, J; Ozhelvaci, O; Beckmann, N; Garcia, RDG; Poran, A; Shpyro, S; Finlayson, A; Cai, H; Yang, Q; Swanson, KA; Tureci, O; Sahin, U				Muik, Alexander; Lui, Bonny Gaby; Wallisch, Ann-Kathrin; Bacher, Maren; Muehl, Julia; Reinholz, Jonas; Ozhelvaci, Orkun; Beckmann, Nina; Garcia, Ramon de la Caridad Gueimil; Poran, Asaf; Shpyro, Svetlana; Finlayson, Andrew; Cai, Hui; Yang, Qi; Swanson, Kena A.; Tuereci, Oezlem; Sahin, Ugur			Neutralization of SARS-CoV-2 Omicron by BNT162b2 mRNA vaccine-elicited human sera	SCIENCE			English	Article							ANTIBODY	The globally circulating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant of concern Omicron (B.1.1.529) has a large number of mutations, especially in the spike protein, indicating that recognition by neutralizing antibodies may be compromised. We tested Wuhan (Wuhan-Hu-1 reference strain), Beta (B.1.351), Delta (B.1.617.2), or Omicron pseudoviruses with sera of 51 participants who received two or three doses of the messenger RNA (mRNA)-based COVID-19 vaccine BNT162b2. After two doses, Omicron-neutralizing titers were reduced >22-fold compared with Wuhan-neutralizing titers. One month after the third vaccine dose, Omicron-neutralizing titers were increased 23-fold relative to their levels after two doses and were similar to levels of Wuhan-neutralizing titers after two doses. The requirement of a third vaccine dose to effectively neutralize Omicron was confirmed with sera from a subset of participants using live SARS-CoV-2. These data suggest that three doses of the mRNA vaccine BNT162b2 may protect against Omicron-mediated COVID-19.	[Muik, Alexander; Lui, Bonny Gaby; Wallisch, Ann-Kathrin; Bacher, Maren; Muehl, Julia; Reinholz, Jonas; Ozhelvaci, Orkun; Beckmann, Nina; Garcia, Ramon de la Caridad Gueimil; Shpyro, Svetlana; Finlayson, Andrew; Tuereci, Oezlem; Sahin, Ugur] BioNTech, Goldgrube 12, D-55131 Mainz, Germany; [Poran, Asaf] BioNTech US, 40 Erie St, Cambridge, MA 02139 USA; [Cai, Hui; Yang, Qi; Swanson, Kena A.] Pfizer, 401 N Middletown Rd, Pearl River, NY 10960 USA; [Tuereci, Oezlem] HITRON Helmholtz Inst Translat Oncol Mainz DKFZ, Obere Zahlbacherstr 63, D-55131 Mainz, Germany; [Sahin, Ugur] Johannes Gutenberg Univ Mainz, TRON gGmbH Translat Oncol, Univ Med Ctr, Freiligrathstr 12, D-55131 Mainz, Germany	BioNTech SE; BioNTech SE; Pfizer; Johannes Gutenberg University of Mainz	Sahin, U (corresponding author), BioNTech, Goldgrube 12, D-55131 Mainz, Germany.; Sahin, U (corresponding author), Johannes Gutenberg Univ Mainz, TRON gGmbH Translat Oncol, Univ Med Ctr, Freiligrathstr 12, D-55131 Mainz, Germany.	ugur.sahin@biontech.de		Muik, Alexander/0000-0003-4561-2273; Wallisch, Ann-Kathrin/0000-0001-5450-3218	BioNTech; Pfizer	BioNTech; Pfizer(Pfizer)	This work was supported by BioNTech and Pfizer.	Abu-Raddad LJ, 2021, NEW ENGL J MED, V385, P187, DOI 10.1056/NEJMc2104974; Bertoletti A, 2021, CELL MOL IMMUNOL, V18, P2307, DOI 10.1038/s41423-021-00743-3; Case James Brett, 2020, bioRxiv, DOI 10.1101/2020.05.18.102038; Cele Sandile, 2021, medRxiv, DOI 10.1101/2021.12.08.21267417; Falsey AR, 2021, NEW ENGL J MED, V385, P1627, DOI 10.1056/NEJMc2113468; Ferguson N., 2021, 49 IMP COLL LOND, DOI [10.25561/93038, DOI 10.25561/93038]; Greaney AJ, 2021, CELL HOST MICROBE, V29, P44, DOI 10.1016/j.chom.2020.11.007; Grunau B, 2022, JAMA-J AM MED ASSOC, V327, P279, DOI 10.1001/jama.2021.21921; Harvey WT, 2021, NAT REV MICROBIOL, V19, P409, DOI 10.1038/s41579-021-00573-0; Khoury DS, 2021, NAT MED, V27, P1205, DOI 10.1038/s41591-021-01377-8; Kuzmina A, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2021.103467; Liu JY, 2021, NATURE, V596, P273, DOI 10.1038/s41586-021-03693-y; Liu Y, 2021, NEW ENGL J MED, V384, P1466, DOI 10.1056/NEJMc2102017; Mor O, 2022, J CLIN EPIDEMIOL, V142, P38, DOI 10.1016/j.jclinepi.2021.10.011; Muik A, 2021, SCIENCE, V371, P1152, DOI 10.1126/science.abg6105; Planas D, 2021, NATURE, V596, P276, DOI 10.1038/s41586-021-03777-9; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Premkumar L, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abc8413; Sahin U, 2021, NATURE, V595, P572, DOI 10.1038/s41586-021-03653-6; UK Health Security Agency, SARS COV 2 VAR CONC; Vogel AB, 2021, NATURE, V592, P283, DOI 10.1038/s41586-021-03275-y; Wang PF, 2021, NATURE, V593, P130, DOI 10.1038/s41586-021-03398-2; Wang Q, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2021.103393; WHO, 2021, SARS COV 2 DELT VAR; WHO Headquarters WHO Health Emergencies Programme., 2021, ENH READ OM B 1 1 52; WHO Technical Advisory Group on SARS-CoV-2 Virus Evolution (TAG-VE), CLASS OM B 1 1 529 S; Wilhelm A., 2021, MEDRXIV2021120721267, DOI [10.1101/2021.12.07.21267432, DOI 10.1101/2021.12.07.21267432]; World Health Organization, TRACK SARS COV 2 VAR	28	117	118	15	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 11	2022	375	6581					678	+		10.1126/science.abn7591	http://dx.doi.org/10.1126/science.abn7591			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YX2ZD	35040667				2022-12-28	WOS:000753975300041
J	Hoffmann, M; Kruger, N; Schulz, S; Cossmann, A; Rocha, C; Kempf, A; Nehlmeier, I; Graichen, L; Moldenhauer, AS; Winkler, MS; Lier, M; Dopfer-Jablonka, A; Jack, HM; Behrens, GMN; Pohlmann, S				Hoffmann, Markus; Krueger, Nadine; Schulz, Sebastian; Cossmann, Anne; Rocha, Cheila; Kempf, Amy; Nehlmeier, Inga; Graichen, Luise; Moldenhauer, Anna-Sophie; Winkler, Martin S.; Lier, Martin; Dopfer-Jablonka, Alexandra; Jaeck, Hans-Martin; Behrens, Georg M. N.; Poehlmann, Stefan			The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic	CELL			English	Article							SARS-COV-2; INFECTION	The rapid spread of the SARS-CoV-2 Omicron variant suggests that the virus might become globally dominant. Further, the high number of mutations in the viral spike protein raised concerns that the virus might evade antibodies induced by infection or vaccination. Here, we report that the Omicron spike was resistant against most therapeutic antibodies but remained susceptible to inhibition by sotrovimab. Similarly, the Omicron spike evaded neutralization by antibodies from convalescent patients or individuals vaccinated with the BioNTech-Pfizer vaccine (BNT162b2) with 12-to 44-fold higher efficiency than the spike of the Delta variant. Neutralization of the Omicron spike by antibodies induced upon heterologous ChAdOx1 (Astra Zeneca-Oxford)/BNT162b2 vaccination or vaccination with three doses of BNT162b2 was more efficient, but the Omicron spike still evaded neutralization more efficiently than the Delta spike. These findings indicate that most therapeutic antibodies will be ineffective against the Omicron variant and that double immunization with BNT162b2 might not adequately protect against severe disease induced by this variant.	[Hoffmann, Markus; Krueger, Nadine; Rocha, Cheila; Kempf, Amy; Nehlmeier, Inga; Graichen, Luise; Moldenhauer, Anna-Sophie; Poehlmann, Stefan] German Primate Ctr, Infect Biol Unit, Kellnerweg 3, D-37077 Gottingen, Germany; [Hoffmann, Markus; Kempf, Amy; Graichen, Luise; Poehlmann, Stefan] Georg August Univ Gottingen, Fac Biol & Psychol, Wilhelmspl 1, D-37073 Gottingen, Germany; [Schulz, Sebastian; Jaeck, Hans-Martin] Friedrich Alexander Univ Erlangen Nurnberg, Dept Internal Med 3, Div Mol Immunol, Gluckstr 6, D-91054 Erlangen, Germany; [Cossmann, Anne; Dopfer-Jablonka, Alexandra; Behrens, Georg M. N.] Hannover Med Sch, Dept Rheumatol & Immunol, Carl Neuberg Str 1, D-30625 Hannover, Germany; [Winkler, Martin S.; Lier, Martin] Georg August Univ Gottingen, Univ Gottingen Med Ctr, Dept Anesthesiol, Robert Koch Str 40, D-37075 Gottingen, Germany; [Dopfer-Jablonka, Alexandra; Behrens, Georg M. N.] German Ctr Infect Res DZIF, Partner Site Hannover Braunschweig, Hannover, Germany	Deutsches Primatenzentrum (DPZ); University of Gottingen; University of Erlangen Nuremberg; Hannover Medical School; University of Gottingen; German Center for Infection Research	Hoffmann, M; Pohlmann, S (corresponding author), German Primate Ctr, Infect Biol Unit, Kellnerweg 3, D-37077 Gottingen, Germany.; Hoffmann, M; Pohlmann, S (corresponding author), Georg August Univ Gottingen, Fac Biol & Psychol, Wilhelmspl 1, D-37073 Gottingen, Germany.	mhoffmann@dpz.eu; spoehlmann@dpz.eu	Krüger, Nadine/V-2282-2019; Behrens, Georg MN/Q-4486-2016; Hoffmann, Markus/J-7836-2018; Winkler, Martin Sebastian/AGZ-1086-2022; Pöhlmann, Stefan/H-2395-2011; Lencastre, Cheila/E-8776-2015	Krüger, Nadine/0000-0002-4413-8699; Hoffmann, Markus/0000-0003-4603-7696; Pöhlmann, Stefan/0000-0001-6086-9136; Cossmann, Anne/0000-0002-0029-8455; Lencastre, Cheila/0000-0002-0148-9405	BMBF [01KI2006D, 01KI20328A, 01KX2021, 01KI2074A, 01KI2043]; Ministry for Science and Culture of Lower Saxony [14-76103-184]; German Research Foundation (DFG) [PO 716/11-1, PO 716/14-1]; Sartorius AG, Lung research; Bavarian State Ministry for Science, and the Arts; Deutsche Forschungsgemeinschaft (DFG) [RTG1660, TRR130]; German Center for Infection Research [80018019238]; European Regional Development Fund (Defeat Corona) [ZW7-8515131]	BMBF(Federal Ministry of Education & Research (BMBF)); Ministry for Science and Culture of Lower Saxony; German Research Foundation (DFG)(German Research Foundation (DFG)); Sartorius AG, Lung research; Bavarian State Ministry for Science, and the Arts; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); German Center for Infection Research; European Regional Development Fund (Defeat Corona)	We thank R. Cattaneo, G. Herrler, A. Maisner, S. Ludwig, T. Pietschmann, Z. Qian, and G. Zimmer for providing reagents and L. ~Ci~cin-~Sain for discussion. We gratefully acknowledge the originating laboratories responsible for obtaining the specimens, as well as the submitting laboratories where the genome data were generated and shared via GISAID, on which this research is based. S.P. acknowledges funding by BMBF (01KI2006D, 01KI20328A, 01KX2021), the Ministry for Science and Culture of Lower Saxony (14-76103-184, MWK HZI COVID-19), and the German Research Foundation (DFG; PO 716/11-1, PO 716/14-1). N.K. received funding from BMBF (01KI2074A). M.S.W. received unrestricted funding from Sartorius AG, Lung research. H.-M.J. received funding from BMBF (01KI2043, NaFoUniMedCovid19-COVIM: 01KX2021), Bavarian State Ministry for Science, and the Arts and Deutsche Forschungsgemeinschaft (DFG) through the research training groups RTG1660 and TRR130. G.M.N.B. acknowledges funding by German Center for Infection Research (grant no 80018019238) and a European Regional Development Fund (Defeat Corona, ZW7-8515131, together with A.D.-J.).	Abbasi J, 2021, JAMA-J AM MED ASSOC, V326, P2460, DOI 10.1001/jama.2021.22619; Abdullah, 2021, TSHWANE DISTRICT OMI; Addetia Amin, 2020, medRxiv, DOI 10.1101/2020.08.13.20173161; Arora P, 2021, CELL MOL IMMUNOL, V18, P2673, DOI 10.1038/s41423-021-00779-5; Arora P, 2021, CELL REP, V37, DOI 10.1016/j.celrep.2021.109825; Bar-On YM, 2021, NEW ENGL J MED, V385, P2421, DOI 10.1056/NEJMoa2115926; Barros-Martins J, 2021, NAT MED, V27, P1525, DOI 10.1038/s41591-021-01449-9; Behrens GMN, 2021, LANCET, V398, P1041, DOI 10.1016/S0140-6736(21)01891-2; Bracken CJ, 2021, NAT CHEM BIOL, V17, P113, DOI 10.1038/s41589-020-00679-1; Brinkmann C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189073; Cai YF, 2020, SCIENCE, V369, P1586, DOI [10.1126/science.abd4251, 10.1101/2020.05.16.099317]; Chemaitelly H, 2021, NEW ENGL J MED, V385, pE83, DOI 10.1056/NEJMoa2114114; Company, 2021, COV OM SPREAD COMM J; Corbett KS, 2021, SCIENCE, V373, P1325, DOI 10.1126/science.abj0299; Dougan M, 2021, NEW ENGL J MED, V385, P1382, DOI 10.1056/NEJMoa2102685; Feng S, 2021, NAT MED, V27, P2032, DOI 10.1038/s41591-021-01540-1; Gilbert PB, 2022, SCIENCE, V375, P43, DOI 10.1126/science.abm3425; Graham Flora, 2021, Nature, DOI 10.1038/d41586-021-03610-3; Gu H., 2021, EMERG INFECT DIS, V28; Gupta A, 2021, NEW ENGL J MED, V385, P1941, DOI 10.1056/NEJMoa2107934; Hall VJ, 2021, LANCET, V397, P1459, DOI 10.1016/S0140-6736(21)00675-9; Hansen J, 2020, SCIENCE, V369, P1010, DOI 10.1126/science.abd0827; Harvey RA, 2021, JAMA INTERN MED, V181, P672, DOI 10.1001/jamainternmed.2021.0366; Haseltine W., 2021, UNDERSTANDING OMICRO; Hoffmann M, 2021, CELL REP, V35, DOI 10.1016/j.celrep.2021.109017; Hoffmann M, 2021, CELL, V184, P2384, DOI 10.1016/j.cell.2021.03.036; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Hoffmann M, 2020, MOL CELL, V78, P779, DOI 10.1016/j.molcel.2020.04.022; Hou Yixuan J, 2020, bioRxiv, DOI 10.1101/2020.09.28.317685; Jones BE, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abf1906; Kleine-Weber H, 2019, J VIROL, V93, DOI 10.1128/JVI.01381-18; Korber B, 2020, CELL, V182, P812, DOI 10.1016/j.cell.2020.06.043; Krammer F, 2021, LANCET, V397, P1421, DOI 10.1016/S0140-6736(21)00782-0; Kruger N, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms221910636; Kupferschmidt K, 2021, SCIENCE, V374, P1179, DOI 10.1126/science.acx9738; Liu Zhuoming, 2021, bioRxiv, DOI 10.1101/2020.11.06.372037; Lumley SF, 2021, NEW ENGL J MED, V384, P533, DOI 10.1056/NEJMoa2034545; McCallum M, 2021, CELL, V184, P2332, DOI [10.1016/j.cell.2021.03.028, 10.1101/2021.01.14.426475]; Meng B, 2021, CELL REP, V35, DOI 10.1016/j.celrep.2021.109292; Monteil V, 2020, CELL, V181, P905, DOI 10.1016/j.cell.2020.04.004; Pinto D, 2020, NATURE, V583, P290, DOI 10.1038/s41586-020-2349-y; Plante JA, 2021, NATURE, V592, P116, DOI 10.1038/s41586-020-2895-3; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Pulliam J.R.C., 2021, INCREASED RISK SARS, DOI [10.1101/2021.11.11.21266068, DOI 10.1101/2021.11.11.21266068, 10.1101/2021.11.11.21266068.]; Qiu Y, 2010, SCAND J IMMUNOL, V72, P425, DOI 10.1111/j.1365-3083.2010.02456.x; Rentsch MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025858; Riepler L, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9010013; Schmidt Fabian, 2020, J Exp Med, V217, DOI [10.1101/2020.06.08.140871, 10.1084/jem.20201181]; Shi R, 2020, NATURE, V584, P120, DOI 10.1038/s41586-020-2381-y; Sun SH, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-25903-x; Tao KM, 2021, NAT REV GENET, V22, P757, DOI 10.1038/s41576-021-00408-x; Torjesen I, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n3051; Voysey M, 2021, LANCET, V397, P99, DOI 10.1016/S0140-6736(20)32661-1; Weinreich DM, 2021, NEW ENGL J MED, V385, DOI 10.1056/NEJMoa2108163; Wheatley AK, 2021, CELL REP, V37, DOI 10.1016/j.celrep.2021.109822; Zhang LP, 2021, P NATL ACAD SCI USA, V118, DOI [10.1101/2021.02.05.429982, 10.1073/pnas.2109905118j1of7, 10.1073/pnas.2109905118]; Zhang YF, 2021, J VIROL, V95, DOI 10.1128/JVI.02477-20; Zhao JJ, 2020, CLIN INFECT DIS, V71, P2027, DOI 10.1093/cid/ciaa344; Zhou B, 2021, NATURE, V592, P122, DOI 10.1038/s41586-021-03361-1; Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2951-z, 10.1038/s41586-020-2012-7]	61	304	306	52	87	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 3	2022	185	3					447	+		10.1016/j.cell.2021.12.032	http://dx.doi.org/10.1016/j.cell.2021.12.032			22	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	YW7SP	35026151	Green Submitted, Bronze, Green Published			2022-12-28	WOS:000753615000007
J	Sun, K; Tan, DZ; Fang, XY; Xia, XT; Lin, DJ; Song, J; Lin, YH; Liu, ZJ; Gu, M; Yue, YZ; Qiu, JR				Sun, Ke; Tan, Dezhi; Fang, Xinyuan; Xia, Xintao; Lin, Dajun; Song, Juan; Lin, Yonghong; Liu, Zhaojun; Gu, Min; Yue, Yuanzheng; Qiu, Jianrong			Three-dimensional direct lithography of stable perovskite nanocrystals in glass	SCIENCE			English	Article							LIQUID-PHASE-SEPARATION; QUANTUM DOTS; HALIDE PEROVSKITES; ANION-EXCHANGE; CSPBX3; TRANSITION; BR; CL	Material composition engineering and device fabrication of perovskite nanocrystals (PNCs) in solution can introduce organic contamination and entail several synthetic, processing, and stabilization steps. We report three-dimensional (3D) direct lithography of PNCs with tunable composition and bandgap in glass. The halide ion distribution was controlled at the nanoscale with ultrafast laser-induced liquid nanophase separation. The PNCs exhibit notable stability against ultraviolet irradiation, organic solution, and high temperatures (up to 250 degrees C). Printed 3D structures in glass were used for optical storage, micro-light emitting diodes, and holographic displays. The proposed mechanisms of both PNC formation and composition tunability were verified.	[Sun, Ke; Xia, Xintao; Qiu, Jianrong] Zhejiang Univ, Coll Opt Sci & Engn, State Key Lab Modern Opt Instrumentat, Hangzhou, Peoples R China; [Tan, Dezhi] Zhejiang Lab, Hangzhou, Peoples R China; [Fang, Xinyuan; Lin, Dajun; Gu, Min] Univ Shanghai Sci & Technol, Inst Photon Chips, Shanghai, Peoples R China; [Fang, Xinyuan; Lin, Dajun; Gu, Min] Univ Shanghai Sci & Technol, Ctr Artificial Intelligence Nanophoton, Sch Opt Elect & Comp Engn, Shanghai, Peoples R China; [Song, Juan] Jiangsu Univ, Coll Mat Sci & Engn, Zhenjiang, Jiangsu, Peoples R China; [Lin, Yonghong; Liu, Zhaojun] Southern Univ Sci & Technol, Dept Elect & Elect Engn, Shenzhen 518055, Peoples R China; [Yue, Yuanzheng] Aalborg Univ, Dept Chem & Biosci, DK-9220 Aalborg, Denmark; [Qiu, Jianrong] Chinese Acad Sci, CAS Ctr Excellence Ultraintense Laser Sci, Shanghai 201800, Peoples R China	Zhejiang University; Zhejiang Laboratory; University of Shanghai for Science & Technology; University of Shanghai for Science & Technology; Jiangsu University; Southern University of Science & Technology; Aalborg University; Chinese Academy of Sciences	Qiu, JR (corresponding author), Zhejiang Univ, Coll Opt Sci & Engn, State Key Lab Modern Opt Instrumentat, Hangzhou, Peoples R China.; Tan, DZ (corresponding author), Zhejiang Lab, Hangzhou, Peoples R China.; Qiu, JR (corresponding author), Chinese Acad Sci, CAS Ctr Excellence Ultraintense Laser Sci, Shanghai 201800, Peoples R China.	wctdz@zju.edu.cn; qjr@zju.edu.cn	liu, zhao/GXV-6141-2022; Yue, Yuanzheng/H-1313-2011	sun, ke/0000-0003-3055-9457; Fang, Xinyuan/0000-0001-5904-2502; Song, Juan/0000-0002-7048-1423; Lin, Dajun/0000-0003-2097-2037; Yue, Yuanzheng/0000-0002-6048-5236; Xia, Xintao/0000-0001-8420-7292	National Natural Science Foundation of China [U20A20211, 51902286, 61775192, 61905215, 51772270, 62005164]; Shanghai Frontiers Science Center Program [2021-2025]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Frontiers Science Center Program	This work was financially supported by the National Natural Science Foundation of China (grant nos. U20A20211, 51902286, 61775192, 61905215, 51772270, and 62005164) and the Shanghai Frontiers Science Center Program 2021-2025	AASLAND S, 1994, NATURE, V369, P633, DOI 10.1038/369633a0; Akkerman QA, 2015, J AM CHEM SOC, V137, P10276, DOI 10.1021/jacs.5b05602; Allix M., 2019, SPRINGER HDB GLASS; Baranowski M, 2020, ADV ENERGY MATER, V10, DOI 10.1002/aenm.201903659; Batignani G, 2018, NAT COMMUN, V9, DOI [10.1038/s41467-018-04367-6, 10.1038/S41467-018-04367-6]; Brennan MC, 2020, TRENDS CHEM, V2, P282, DOI 10.1016/j.trechm.2020.01.010; Chiba T, 2018, NAT PHOTONICS, V12, P681, DOI 10.1038/s41566-018-0260-y; Choi JH, 2011, NAT PHOTONICS, V5, P763, DOI 10.1038/nphoton.2011.253; Draguta S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00284-2; Du JS, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abc4959; Efros AL, 2021, ACS NANO, V15, P6192, DOI 10.1021/acsnano.1c01399; Hassan Y, 2021, NATURE, V591, P72, DOI 10.1038/s41586-021-03217-8; He XX, 2017, ADV MATER, V29, DOI 10.1002/adma.201604510; Helmbrecht L, 2021, ADV MATER, V33, DOI 10.1002/adma.202005291; Henry L, 2020, NATURE, V584, P382, DOI 10.1038/s41586-020-2593-1; Hu T, 2021, LIGHT-SCI APPL, V10, DOI 10.1038/s41377-021-00498-6; Huang XJ, 2020, NAT PHOTONICS, V14, P82, DOI 10.1038/s41566-019-0538-8; JAMES PF, 1975, J MATER SCI, V10, P1802, DOI 10.1007/BF00554944; Jena AK, 2019, CHEM REV, V119, P3036, DOI 10.1021/acs.chemrev.8b00539; Karlsson M, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20582-6; Katayama Y, 2004, SCIENCE, V306, P848, DOI 10.1126/science.1102735; Kim KH, 2020, SCIENCE, V370, P978, DOI 10.1126/science.abb9385; Ko J, 2021, NANO LETT, V21, P2288, DOI 10.1021/acs.nanolett.1c00134; Komatsu T, 2015, J NON-CRYST SOLIDS, V428, P156, DOI 10.1016/j.jnoncrysol.2015.08.017; Kong XQ, 2018, NANOSCALE, V10, P8320, DOI 10.1039/c8nr01352g; Li XM, 2016, ADV FUNCT MATER, V26, P2435, DOI 10.1002/adfm.201600109; Lin CK, 2020, ACS NANO, V14, P3500, DOI 10.1021/acsnano.9b09685; Liu MM, 2021, NAT PHOTONICS, V15, P379, DOI 10.1038/s41566-021-00766-2; Liu XK, 2021, NAT MATER, V20, P10, DOI 10.1038/s41563-020-0784-7; Liu XF, 2018, PROG MATER SCI, V97, P38, DOI 10.1016/j.pmatsci.2018.02.006; Liu Y, 2019, ACS NANO, V13, P2042, DOI 10.1021/acsnano.8b08582; Liu ZJ, 2020, LIGHT-SCI APPL, V9, DOI 10.1038/s41377-020-0268-1; Llordes A, 2013, NATURE, V500, P323, DOI 10.1038/nature12398; McMeekin DP, 2016, SCIENCE, V351, P151, DOI 10.1126/science.aad5845; Motti SG, 2019, NAT PHOTONICS, V13, P532, DOI 10.1038/s41566-019-0435-1; Nedelcu G, 2015, NANO LETT, V15, P5635, DOI 10.1021/acs.nanolett.5b02404; Protesescu L, 2015, NANO LETT, V15, P3692, DOI 10.1021/nl5048779; Shi LF, 2019, ADV FUNCT MATER, V29, DOI 10.1002/adfm.201903648; Shi SC, 2021, SMALL METHODS, V5, DOI 10.1002/smtd.202000889; Tan DZ, 2021, LASER PHOTONICS REV, V15, DOI 10.1002/lpor.202000455; Tan DZ, 2021, ADV PHOTONICS, V3, DOI 10.1117/1.AP.3.2.024002; Wang GM, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500613; Wang HJ, 2018, ADV MATER TECHNOL-US, V3, DOI 10.1002/admt.201800150; Wang X, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08610-6; Wang YY, 2017, SCIENCE, V357, P385, DOI 10.1126/science.aan2958; Wei DZ, 2018, NAT PHOTONICS, V12, P596, DOI 10.1038/s41566-018-0240-2; Wei Y, 2019, CHEM SOC REV, V48, P310, DOI 10.1039/c8cs00740c; Xiao ZG, 2017, NANO LETT, V17, P6863, DOI 10.1021/acs.nanolett.7b03179; Xu HX, 2021, LIGHT-SCI APPL, V10, DOI 10.1038/s41377-021-00507-8; Xu JX, 2020, SCIENCE, V367, P1097, DOI 10.1126/science.aaz5074; Yang WJ, 2008, NAT PHOTONICS, V2, P99, DOI 10.1038/nphoton.2007.276; Yang Y, 2021, ADV MATER, V33, DOI 10.1002/adma.202100783; Yoon SJ, 2016, J PHYS CHEM LETT, V7, P1368, DOI 10.1021/acs.jpclett.6b00433; Yue YZ, 2004, J NON-CRYST SOLIDS, V345, P523, DOI 10.1016/j.jnoncrysol.2004.08.078; Zanotto ED, 2020, CERAM INT, V46, P24779, DOI 10.1016/j.ceramint.2020.06.305; Zhang CY, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01248-2; Zhang JY, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.033901; Zhao M, 2019, LIGHT-SCI APPL, V8, DOI 10.1038/s41377-019-0148-8; Zou C, 2020, NANO LETT, V20, P3710, DOI 10.1021/acs.nanolett.0c00701	59	44	47	166	394	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2022	375	6578					307	+		10.1126/science.abj2691	http://dx.doi.org/10.1126/science.abj2691			67	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YK2FS	35050658				2022-12-28	WOS:000745036100031
J	Guilliams, M; Bonnardel, J; Haest, B; Vanderborght, B; Wagner, C; Remmerie, A; Bujko, A; Martens, L; Thone, T; Browaeys, R; De Ponti, FF; Vanneste, B; Zwicker, C; Svedberg, FR; Vanhalewyn, T; Goncalves, A; Lippens, S; Devriendt, B; Cox, E; Ferrero, G; Wittamer, V; Willaert, A; Kaptein, SJF; Neyts, J; Dallmeier, K; Geldhof, P; Casaert, S; Deplancke, B; ten Dijke, P; Hoorens, A; Vanlander, A; Berrevoet, F; Van Nieuwenhove, Y; Saeys, Y; Saelens, W; Van Vlierberghe, H; Devisscher, L; Scott, CL				Guilliams, Martin; Bonnardel, Johnny; Haest, Birthe; Vanderborght, Bart; Wagner, Camille; Remmerie, Anneleen; Bujko, Anna; Martens, Liesbet; Thone, Tinne; Browaeys, Robin; De Ponti, Federico F.; Vanneste, Bavo; Zwicker, Christian; Svedberg, Freya R.; Vanhalewyn, Tineke; Goncalves, Amanda; Lippens, Saskia; Devriendt, Bert; Cox, Eric; Ferrero, Giuliano; Wittamer, Valerie; Willaert, Andy; Kaptein, Suzanne J. F.; Neyts, Johan; Dallmeier, Kai; Geldhof, Peter; Casaert, Stijn; Deplancke, Bart; ten Dijke, Peter; Hoorens, Anne; Vanlander, Aude; Berrevoet, Frederik; Van Nieuwenhove, Yves; Saeys, Yvan; Saelens, Wouter; Van Vlierberghe, Hans; Devisscher, Lindsey; Scott, Charlotte L.			Spatial proteogenomics reveals distinct and evolutionarily conserved hepatic macrophage niches	CELL			English	Article						hepatic cells	KUPFFER CELLS; SINGLE; STEATOHEPATITIS; VISUALIZATION; ENDOTHELIUM; FEATURES; LIGANDS; NETWORK; IMAGE	The liver is the largest solid organ in the body, yet it remains incompletely characterized. Here we present a spatial proteogenomic atlas of the healthy and obese human and murine liver combining single-cell CITEseq, single-nuclei sequencing, spatial transcriptomics, and spatial proteomics. By integrating these multiomic datasets, we provide validated strategies to reliably discriminate and localize all hepatic cells, including a population of lipid-associated macrophages (LAMs) at the bile ducts. We then align this atlas across seven species, revealing the conserved program of bona fide Kupffer cells and LAMs. We also uncover the respective spatially resolved cellular niches of these macrophages and the microenvironmental circuits driving their unique transcriptomic identities. We demonstrate that LAMs are induced by local lipid exposure, leading to their induction in steatotic regions of the murine and human liver, while Kupffer cell development crucially depends on their cross-talk with hepatic stellate cells via the evolutionarily conserved ALK1-BMP9/10 axis.	[Guilliams, Martin; Bonnardel, Johnny; Haest, Birthe; Wagner, Camille; Martens, Liesbet; Thone, Tinne; Vanneste, Bavo; Svedberg, Freya R.; Vanhalewyn, Tineke] VIB UGent Ctr Inflammat Res, Lab Myeloid Cell Biol Tissue Homeostasis & Regene, Technol Pk Zwijnaarde 71, B-9052 Ghent, Belgium; [Guilliams, Martin; Bonnardel, Johnny; Haest, Birthe; Wagner, Camille; Remmerie, Anneleen; Bujko, Anna; Martens, Liesbet; Thone, Tinne; De Ponti, Federico F.; Vanneste, Bavo; Zwicker, Christian; Svedberg, Freya R.; Vanhalewyn, Tineke; Goncalves, Amanda; Lippens, Saskia; Scott, Charlotte L.] Univ Ghent, Fac Sci, Dept Biomed Mol Biol, Ghent, Belgium; [Vanderborght, Bart; Van Vlierberghe, Hans] Univ Ghent, Liver Res Ctr, Dept Internal Med & Pediat, Hepatol Res Unit, Ghent, Belgium; [Vanderborght, Bart; Devisscher, Lindsey] Univ Ghent, Liver Res Ctr, Dept Basic & Appl Med Sci, Gut Liver Immunopharmacol Unit, Ghent, Belgium; [Remmerie, Anneleen; Bujko, Anna; Martens, Liesbet; Thone, Tinne; De Ponti, Federico F.; Vanneste, Bavo; Zwicker, Christian; Vanhalewyn, Tineke; Scott, Charlotte L.] VIB UGent Ctr Inflammat Res, Lab Myeloid Cell Biol Tissue Damage & Inflammat, Technol Pk Zwijnaarde 71, B-9052 Ghent, Belgium; [Browaeys, Robin; Saeys, Yvan] VIB UGent Ctr Inflammat Res, Data Min & Modelling Biomed, Technol Pk Zwijnaarde 71, B-9052 Ghent, Belgium; [Browaeys, Robin; Saeys, Yvan] Univ Ghent, Fac Sci, Dept Appl Math Comp Sci & Stat, Ghent, Belgium; [Goncalves, Amanda; Lippens, Saskia] VIB UGent Ctr Inflammat Res, VIB BioImaging Core, Technol Pk Zwijnaarde 71, B-9052 Ghent, Belgium; [Devriendt, Bert; Cox, Eric] Univ Ghent, Fac Vet Med, Dept Translat Physiol Infectiol & Publ Hlth, Lab Immunol, Ghent, Belgium; [Ferrero, Giuliano; Wittamer, Valerie] Univ Libre Bruxelles ULB, Inst Rech Interdisciplinaire Biol Humaine & Mol I, Brussels, Belgium; [Wittamer, Valerie] Univ Libre Bruxelles ULB, ULB Inst Neurosci UNI, Brussels, Belgium; [Wittamer, Valerie] Univ Libre Bruxelles ULB, WELBIO, Brussels, Belgium; [Willaert, Andy] Univ Ghent, Ctr Med Genet Ghent, Dept Biomol Med, Ghent, Belgium; [Kaptein, Suzanne J. F.; Neyts, Johan; Dallmeier, Kai] Katholieke Univ Leuven, Rega Inst, Dept Microbiol Immunol & Transplantat, Lab Virol & Chemotherapy Mol Vaccinol & Vaccine D, Leuven, Belgium; [Geldhof, Peter; Casaert, Stijn] Univ Ghent, Fac Vet Med, Dept Translat Physiol Infectiol & Publ Hlth, Lab Parasitol, Ghent, Belgium; [Deplancke, Bart; Saelens, Wouter] Ecole Polytech Fed Lausanne EPFL, Inst Bioengn, Lab Syst Biol & Genet, Sch Life Sci, Lausanne, Switzerland; [Deplancke, Bart; Saelens, Wouter] Swiss Inst Bioinformat SIB, Lausanne, Switzerland; [ten Dijke, Peter] Leiden Med Ctr, Oncode Inst, Dept Cell & Chem Biol, Leiden, Netherlands; [Hoorens, Anne] Ghent Univ Hosp, Dept Pathol, B-9000 Ghent, Belgium; [Vanlander, Aude; Berrevoet, Frederik] Ghent Univ Hosp, Dept Gen & Hepatopancreatobiliary Surg & Liver Tr, B-9000 Ghent, Belgium; [Van Nieuwenhove, Yves] Ghent Univ Hosp, Dept Human Struct & Repair, B-9000 Ghent, Belgium; [Van Vlierberghe, Hans] Ghent Univ Hosp, Dept Gastroenterol & Hepatol, B-9000 Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Ghent University; Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Universite Libre de Bruxelles; Universite Libre de Bruxelles; Universite Libre de Bruxelles; WELBIO; Ghent University; KU Leuven; Ghent University; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute of Bioinformatics; Leiden University; Leiden University Medical Center (LUMC); Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital	Guilliams, M (corresponding author), VIB UGent Ctr Inflammat Res, Lab Myeloid Cell Biol Tissue Homeostasis & Regene, Technol Pk Zwijnaarde 71, B-9052 Ghent, Belgium.; Guilliams, M; Scott, CL (corresponding author), Univ Ghent, Fac Sci, Dept Biomed Mol Biol, Ghent, Belgium.; Scott, CL (corresponding author), VIB UGent Ctr Inflammat Res, Lab Myeloid Cell Biol Tissue Damage & Inflammat, Technol Pk Zwijnaarde 71, B-9052 Ghent, Belgium.	martin.guilliams@ugent.be; charlotte.scott@ugent.be	Guilliams, Martin/N-7803-2013; Devisscher, Lindsey/AAD-5969-2021; Kaptein, Suzanne JF/O-4714-2019; NEYTS, Johan/U-8267-2017	Guilliams, Martin/0000-0003-3525-7570; Devisscher, Lindsey/0000-0003-4862-9580; Kaptein, Suzanne JF/0000-0002-7935-0219; Bujko, Anna/0000-0001-8693-9227; Cox, Eric/0000-0003-4281-2990; Browaeys, Robin/0000-0003-2934-5195; Goncalves, Amanda Maffioletti Mac Cord/0000-0003-2748-3033; Willaert, Andy/0000-0002-9543-1932; Van Vlierberghe, Hans/0000-0003-0647-9238; Vanneste, Bavo/0000-0002-4152-5634; Bonnardel, Johnny/0000-0003-2359-3438; Devriendt, Bert/0000-0002-3222-8769; Lippens, Saskia/0000-0002-8261-3462; NEYTS, Johan/0000-0002-0033-7514; Remmerie, Anneleen/0000-0001-5433-2316; Haest, Birthe/0000-0002-0156-7063	Chan Zuckerberg initiative; FWO SBO; ERC consolidator grant [KupfferCellNiche, 725924, BOF18-GOA-024]; ERC [851908]; FWO project grant [3G000519]; FWO PhD fellowship [1129521N, 1181318N, 11L2122N]; MSCA IF fellowships [MACtivate 101027317, LiverMacRegenCircuit 844301]; iPSC LiMics; MyeFattyLiver [851908]	Chan Zuckerberg initiative; FWO SBO; ERC consolidator grant(European Research Council (ERC)); ERC(European Research Council (ERC)European Commission); FWO project grant(FWO); FWO PhD fellowship(FWO); MSCA IF fellowships; iPSC LiMics; MyeFattyLiver	Funding: Chan Zuckerberg initiative; liver seed atlas grant (M.G. and C.L.S.), FWO SBO; iPSC LiMics (C.L.S., M.G., and Y.S.), ERC consolidator grant; KupfferCellNiche, 725924 (M.G.), GOA; BOF18-GOA-024 (M.G. and Y.S.), ERC starting grant; MyeFattyLiver, 851908 (C.L.S.), FWO project grant; 3G000519, (C.L.S. and M.G.), FWO PhD fellowship; 1129521N (B.H.), 1181318N (R.B.), 11L2122N (F.F.D.P.), MSCA IF fellowships; MACtivate 101027317 (C.Z.), LiverMacRegenCircuit 844301 (F.R.S.).	Aizarani N, 2019, NATURE, V572, P199, DOI 10.1038/s41586-019-1373-2; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Berg S, 2019, NAT METHODS, V16, P1226, DOI 10.1038/s41592-019-0582-9; Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738; Bittmann I, 2003, VIRCHOWS ARCH, V443, P541, DOI 10.1007/s00428-003-0861-8; Bleriot C, 2021, IMMUNITY, V54, P2101, DOI 10.1016/j.immuni.2021.08.006; Bonnardel J, 2019, IMMUNITY, V51, P638, DOI 10.1016/j.immuni.2019.08.017; Browaeys R, 2020, NAT METHODS, V17, P159, DOI 10.1038/s41592-019-0667-5; Chalasani N, 2008, J HEPATOL, V48, P829, DOI 10.1016/j.jhep.2008.01.016; Daemen S, 2021, CELL REP, V34, DOI 10.1016/j.celrep.2020.108626; De Simone G, 2021, IMMUNITY, V54, P2089, DOI 10.1016/j.immuni.2021.05.005; Desroches-Castan A, 2022, DEV DYNAM, V251, P178, DOI 10.1002/dvdy.395; Dobie R, 2019, CELL REP, V29, P1832, DOI 10.1016/j.celrep.2019.10.024; Eckert C, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00179; Ellett F, 2011, BLOOD, V117, pE49, DOI 10.1182/blood-2010-10-314120; Frankish A, 2019, NUCLEIC ACIDS RES, V47, pD766, DOI 10.1093/nar/gky955; Gans JD, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn301; Gayoso A, 2021, NAT METHODS, V18, P272, DOI 10.1038/s41592-020-01050-x; Gola A, 2021, NATURE, V589, P131, DOI 10.1038/s41586-020-2977-2; Goumans MJ, 2003, MOL CELL, V12, P817, DOI 10.1016/S1097-2765(03)00386-1; Gu ZG, 2014, BIOINFORMATICS, V30, P2811, DOI 10.1093/bioinformatics/btu393; Guilliams M, 2017, NAT REV IMMUNOL, V17, P451, DOI 10.1038/nri.2017.42; Haas JT, 2019, NAT METAB, V1, P604, DOI 10.1038/s42255-019-0076-1; Habib N, 2016, SCIENCE, V353, P925, DOI 10.1126/science.aad7038; Halpern KB, 2017, NATURE, V542, P352, DOI 10.1038/nature21065; Jaitin DA, 2019, CELL, V178, P686, DOI 10.1016/j.cell.2019.05.054; Jin HW, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23197-7; Johnson Pauline, 2009, Inflammation & Allergy Drug Targets, V8, P208; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Kleiner DE, 2016, CLIN LIVER DIS, V20, P293, DOI 10.1016/j.cld.2015.10.011; Komesli S, 1998, EUR J BIOCHEM, V254, P505, DOI 10.1046/j.1432-1327.1998.2540505.x; Korsunsky I, 2019, NAT METHODS, V16, P1289, DOI 10.1038/s41592-019-0619-0; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Liao MF, 2020, NAT MED, V26, P842, DOI 10.1038/s41591-020-0901-9; Liao YX, 2019, NUCLEIC ACIDS RES, V47, pW199, DOI 10.1093/nar/gkz401; Lindeboom RGH, 2021, TRENDS GENET, V37, P625, DOI 10.1016/j.tig.2021.03.007; Lopez R, 2018, NAT METHODS, V15, P1053, DOI 10.1038/s41592-018-0229-2; Lun Aaron T L, 2016, F1000Res, V5, P2122; Marcais G, 2011, BIOINFORMATICS, V27, P764, DOI 10.1093/bioinformatics/btr011; McCarthy DJ, 2017, BIOINFORMATICS, V33, P1179, DOI 10.1093/bioinformatics/btw777; MEERSCHAERT J, 1995, J IMMUNOL, V154, P4099; Pallett LJ, 2020, J EXP MED, V217, DOI 10.1084/jem.20200050; Park SO, 2008, BLOOD, V111, P633, DOI 10.1182/blood-2007-08-107359; Paszke A, 2019, ADV NEUR IN, V32; Pont F, 2019, NUCLEIC ACIDS RES, V47, DOI 10.1093/nar/gkz601; Ramachandran P, 2019, NATURE, V575, P512, DOI 10.1038/s41586-019-1631-3; Ranganath R., 2013, ARXIV14010118; Remmerie A, 2020, IMMUNITY, V53, P641, DOI 10.1016/j.immuni.2020.08.004; Rizzo G., 2020, SINGLE CELL TRANSCRI; Rodriguez JM, 2018, NUCLEIC ACIDS RES, V46, pD213, DOI 10.1093/nar/gkx997; Sakai M, 2019, IMMUNITY, V51, P655, DOI 10.1016/j.immuni.2019.09.002; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Scott CL, 2018, IMMUNITY, V49, P312, DOI 10.1016/j.immuni.2018.07.004; Scott CL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10321; Sharma A, 2020, CELL, V183, P377, DOI 10.1016/j.cell.2020.08.040; Sierro F, 2017, IMMUNITY, V47, P374, DOI 10.1016/j.immuni.2017.07.018; Stoeckius M, 2017, NAT METHODS, V14, P865, DOI [10.1038/nmeth.4380, 10.1038/NMETH.4380]; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wolf FA, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-017-1382-0; Yates AD, 2020, NUCLEIC ACIDS RES, V48, pD682, DOI 10.1093/nar/gkz966; Zhou X, 2018, CELL, V172, P744, DOI 10.1016/j.cell.2018.01.015	63	65	65	39	86	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 20	2022	185	2					379	+		10.1016/j.cell.2021.12.018	http://dx.doi.org/10.1016/j.cell.2021.12.018			56	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	YN7KG	35021063	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000747432800002
J	Brubacher, JR; Chan, H; Erdelyi, S; Staples, JA; Asbridge, M; Mann, RE				Brubacher, Jeffrey R.; Chan, Herbert; Erdelyi, Shannon; Staples, John A.; Asbridge, Mark; Mann, Robert E.			Cannabis Legalization and Detection of Tetrahydrocannabinol in Injured Drivers	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OLDER; TRENDS; RISK	BACKGROUND The effect of cannabis legalization in Canada (in October 2018) on the prevalence of injured drivers testing positive for tetrahydrocannabinol (THC) is unclear. METHODS We studied drivers treated after a motor vehicle collision in four British Columbia trauma centers, with data from January 2013 through March 2020. We included moderately injured drivers (those whose condition warranted blood tests as part of clinical assessment) for whom excess blood remained after clinical testing was complete. Blood was analyzed at the provincial toxicology center. The primary outcomes were a THC level greater than 0, a THC level of at least 2 ng per milliliter (Canadian legal limit), and a THC level of at least 5 ng per milliliter. The secondary outcomes were a THC level of at least 2.5 ng per milliliter plus a blood alcohol level of at least 0.05%; a blood alcohol level greater than 0; and a blood alcohol level of at least 0.08%. We calculated the prevalence of all outcomes before and after legalization. We obtained adjusted prevalence ratios using log-binomial regression to model the association between substance prevalence and legalization after adjustment for relevant covariates. RESULTS During the study period, 4339 drivers (3550 before legalization and 789 after legalization) met the inclusion criteria. Before legalization, a THC level greater than 0 was detected in 9.2% of drivers, a THC level of at least 2 ng per milliliter in 3.8%, and a THC level of at least 5 ng per milliliter in 1.1%. After legalization, the values were 17.9%, 8.6%, and 3.5%, respectively. After legalization, there was an increased prevalence of drivers with a THC level greater than 0 (adjusted prevalence ratio, 1.33; 95% confidence interval (CI), 1.05 to 1.68), a THC level of at least 2 ng per milliliter (adjusted prevalence ratio, 2.29; 95% CI, 1.52 to 3.45), and a THC level of at least 5 ng per milliliter (adjusted prevalence ratio, 2.05; 95% CI, 1.00 to 4.18). The largest increases in a THC level of at least 2 ng per milliliter were among drivers 50 years of age or older (adjusted prevalence ratio, 5.18; 95% CI, 2.49 to 10.78) and among male drivers (adjusted prevalence ratio, 2.44; 95% CI, 1.60 to 3.74). There were no significant changes in the prevalence of drivers testing positive for alcohol. CONCLUSIONS After cannabis legalization, the prevalence of moderately injured drivers with a THC level of at least 2 ng per milliliter in participating British Columbia trauma centers more than doubled. The increase was largest among older drivers and male drivers. (Funded by the Canadian Institutes of Health Research.)	[Brubacher, Jeffrey R.; Chan, Herbert; Erdelyi, Shannon; Staples, John A.] Univ British Columbia, Vancouver, BC, Canada; [Asbridge, Mark] Dalhousie Univ, Halifax, NS, Canada; [Mann, Robert E.] Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Mann, Robert E.] Univ Toronto, Toronto, ON, Canada	University of British Columbia; Dalhousie University; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto	Brubacher, JR (corresponding author), Univ British Columbia, Fac Med, Dept Emergency Med, 2775 Laurel St,11th Fl, Vancouver, BC V5Z 1M9, Canada.	jeff.brubacher@ubc.ca		Staples, John/0000-0003-1397-1503; Brubacher, Jeffrey/0000-0002-4866-4231	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Supported by the Canadian Institutes of Health Research.	Anderson DM, 2013, J LAW ECON, V56, P333, DOI 10.1086/668812; Anstey KJ, 2005, CLIN PSYCHOL REV, V25, P45, DOI 10.1016/j.cpr.2004.07.008; Asbridge M, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e536; Aydelotte JD, 2017, AM J PUBLIC HEALTH, V107, P1329, DOI 10.2105/AJPH.2017.303848; Beirness D., 2017, ALCOHOL DRUG USE DRI; Beirness D.J., 2018, ALCOHOL DRUG USE DRI; Brochu S, 2011, J DRUG ISSUES, V41, P95, DOI 10.1177/002204261104100105; Broyd SJ, 2016, BIOL PSYCHIAT, V79, P557, DOI 10.1016/j.biopsych.2015.12.002; Brubacher JR, 2019, ADDICTION, V114, P1616, DOI 10.1111/add.14663; Brubacher JR, 2018, ACCIDENT ANAL PREV, V118, P200, DOI 10.1016/j.aap.2018.02.018; Brubacher JR, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009278; Brubacher JR., 2021, 2021 NATL DRUG DRIVI; Brunet B, 2010, INT J LEGAL MED, V124, P543, DOI 10.1007/s00414-009-0403-2; Desrosiers NA, 2015, J ANAL TOXICOL, V39, P251, DOI 10.1093/jat/bkv012; Doroudgar S, 2017, TRAFFIC INJ PREV, V18, P41, DOI 10.1080/15389588.2016.1194980; Drummer OH, 2020, ACCIDENT ANAL PREV, V135, DOI 10.1016/j.aap.2019.105389; Drummer OH, 2013, INJURY PREV, V19, P284, DOI 10.1136/injuryprev-2012-040488; Dunn N., 2021, PILOT SENTINEL SURVE; Han BJH, 2020, JAMA INTERN MED, V180, P609, DOI 10.1001/jamainternmed.2019.7517; Hansen B, 2020, ECON INQ, V58, P547, DOI 10.1111/ecin.12751; Holland MG, 2011, FORENSIC SCI INT, V212, P247, DOI 10.1016/j.forsciint.2011.06.028; Kahan BC, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-20; Lane TJ, 2019, ADDICTION, V114, P847, DOI 10.1111/add.14536; Lemos NP, 2011, J ANAL TOXICOL, V35, P394, DOI 10.1093/anatox/35.7.394; Lloyd SL, 2018, GERONTOL GERIATR MED, V4, DOI 10.1177/2333721418781668; Lyman S, 2002, INJ PREV, V8, P116, DOI 10.1136/ip.8.2.116; Mann RE, 2010, TRAFFIC INJ PREV, V11, P115, DOI 10.1080/15389580903536704; Masud M, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09176-5; Nigatu YT., 2021, CAMH MONITOR E REPOR; Peacock A, 2018, ADDICTION, V113, P1905, DOI 10.1111/add.14234; Preusser DF, 1998, ACCIDENT ANAL PREV, V30, P151, DOI 10.1016/S0001-4575(97)00090-0; Rotermann M, 2020, HEALTH REP, V31, P11, DOI 10.25318/82-003-x202000200002-eng; Rotermann M, 2019, HEALTH REP, V30, P3, DOI 10.25318/82-003-x201900600001-eng; Santaella-Tenorio J, 2020, JAMA INTERN MED, V180, P1061, DOI 10.1001/jamainternmed.2020.1757; Staples JA, 2018, JAMA INTERN MED, V178, P569, DOI 10.1001/jamainternmed.2017.8298; Subbaraman MS, 2020, INT J DRUG POLICY, V75, DOI 10.1016/j.drugpo.2019.07.003; Tefft B., 2020, CANNABIS USE DRIVERS; Tefft BC, 2016, PREVALENCE MARIJUANA; Wong K., 2015, LEGALIZATION MARIJUA, V3	39	4	6	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 13	2022	386	2					148	156		10.1056/NEJMsa2109371	http://dx.doi.org/10.1056/NEJMsa2109371			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YF2NZ	35020985				2022-12-28	WOS:000741651400012
J	Looi, MK				Looi, Mun-Keat			The BMJ Interview: Rachel Levine on the greatest challenges in US health	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		Godlee F, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3703	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 13	2022	376								o8	10.1136/bmj.o8	http://dx.doi.org/10.1136/bmj.o8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZE9IW	35027425				2022-12-28	WOS:000759191400004
J	Videnovic, A; Babu, S; Zhao, B; Reda, HM; Linnoila, JJ				Videnovic, Aleksandar; Babu, Suma; Zhao, Brian; Reda, Haatem M.; Linnoila, Jenny J.			Case 1-2022: A 67-Year-Old Man with Motor Neuron Disease and Odd Behaviors during Sleep	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DISORDER	A Man with Motor Neuron Disease and Odd Behaviors during Sleep A 67-year-old man with progressive motor neuron disease was evaluated in the sleep clinic because of dream enactment, daytime sleepiness, and apnea detected on a sleep study. Four months earlier, he had fallen asleep while washing dishes; this resulted in a fall and unstable C1 spinal fracture. A diagnostic test was performed.	[Videnovic, Aleksandar; Babu, Suma; Reda, Haatem M.; Linnoila, Jenny J.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Zhao, Brian] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Videnovic, Aleksandar; Babu, Suma; Reda, Haatem M.; Linnoila, Jenny J.] Harvard Med Sch, Dept Neurol, Boston, MA 02115 USA; [Zhao, Brian] Harvard Med Sch, Dept Radiol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Videnovic, A (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA.			Babu, Suma/0000-0002-2648-7625				Abboud H, 2021, J NEUROL NEUROSUR PS, V92, P757, DOI 10.1136/jnnp-2020-325300; Albdewi MA, 2018, SLEEP BREATH, V22, P277, DOI 10.1007/s11325-017-1538-x; Antelmi E, 2021, SLEEP MED REV, V60, DOI 10.1016/j.smrv.2021.101515; Cabezudo-Garcia P, 2020, ACTA NEUROL SCAND, V141, P263, DOI 10.1111/ane.13207; Gadoth A, 2017, ANN NEUROL, V82, P79, DOI 10.1002/ana.24979; Gaig C, 2019, SLEEP, V42, DOI 10.1093/sleep/zsz133; Gresa-Arribas N, 2014, LANCET NEUROL, V13, P167, DOI 10.1016/S1474-4422(13)70282-5; Hogl B, 2018, NAT REV NEUROL, V14, P40, DOI 10.1038/nrneurol.2017.157; Honorat JA, 2017, NEUROL-NEUROIMMUNOL, V4, DOI 10.1212/NXI.0000000000000385; Irfan M, 2021, NEUROTHERAPEUTICS, V18, P124, DOI 10.1007/s13311-021-01011-y; Korotun M, 2021, CLIN GERIATR MED, V37, P483, DOI 10.1016/j.cger.2021.04.008; Landa J, 2020, ANN NEUROL, V88, P1023, DOI 10.1002/ana.25857; Werner J, 2021, NEUROL-NEUROIMMUNOL, V8, DOI 10.1212/NXI.0000000000000962	13	3	3	1	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 13	2022	386	2					173	180		10.1056/NEJMcpc2115844	http://dx.doi.org/10.1056/NEJMcpc2115844			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YF2NZ	35020988				2022-12-28	WOS:000741651400015
J	Mesic, A				Mesic, Anita			Drug resistant tuberculosis in Afghanistan: We must continue to put people at the centre of treatment	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material								In recent years, MSF has been able to improve patients' experiences of care for drug resistant tuberculosis, but the changing political situation threatens to derail this progress, writes Anita Mesic											0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 10	2022	376								o46	10.1136/bmj.o46	http://dx.doi.org/10.1136/bmj.o46			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YP6IZ	35012958	Bronze			2022-12-28	WOS:000748727200009
J	Bao, XY; Lithgow-Bertelloni, CR; Jackson, MG; Romanowicz, B				Bao, Xiyuan; Lithgow-Bertelloni, Carolina R.; Jackson, Matthew G.; Romanowicz, Barbara			On the relative temperatures of Earth's volcanic hotspots and mid-ocean ridges	SCIENCE			English	Article							OCEAN ISLAND BASALTS; UPPER-MANTLE; NORMAL-MODE; BENEATH; PLUMES; VELOCITY; CONVECTION; HELIUM; CONSTRAINTS; HETEROGENEITY	Volcanic hotspots are thought to be fed by hot, active upwellings from the deep mantle, with excess temperatures (T-ex) similar to 100 degrees to 300 degrees C higher than those of mid-ocean ridges. However, T-ex estimates are limited in geographical coverage and often inconsistent for individual hotspots. We infer the temperature of oceanic hotspots and ridges simultaneously by converting seismic velocity to temperature. We show that while similar to 45% of plume-fed hotspots are hot (T-ex >= 155 degrees C), similar to 15% are cold (T-ex <= 36 degrees C) and similar to 40% are not hot enough to actively upwell (50 degrees C <= T-ex <= 136 degrees C). Hot hotspots have an extremely high helium-3/helium-4 ratio and buoyancy flux, but cold hotspots do not. The latter may originate at upper mantle depths. Alternatively, the deep plumes that feed them may be entrained and cooled by small-scale convection.	[Bao, Xiyuan; Lithgow-Bertelloni, Carolina R.] Univ Calif Los Angeles, Dept Earth Planetary & Space Sci, Los Angeles, CA 90095 USA; [Jackson, Matthew G.] Univ Calif Santa Barbara, Dept Earth Sci, Santa Barbara, CA 93106 USA; [Romanowicz, Barbara] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA	University of California System; University of California Los Angeles; University of California System; University of California Santa Barbara; University of California System; University of California Berkeley	Bao, XY (corresponding author), Univ Calif Los Angeles, Dept Earth Planetary & Space Sci, Los Angeles, CA 90095 USA.	xiyuanbao@g.ucla.edu	Bao, Xiyuan/AEM-1758-2022; romanowicz, Barbara/H-6726-2017	Bao, Xiyuan/0000-0002-1363-3793; romanowicz, Barbara/0000-0002-6208-6044	NSF [EAR-1900633, EAR-1900652, EAR-1758198]; Louis B. and Martha B. Slichter Endowment for Geosciences	NSF(National Science Foundation (NSF)); Louis B. and Martha B. Slichter Endowment for Geosciences	This work was made possible by NSF grant EAR-1900633 to C.R.L.-B., EAR-1900652 to M.G.J., and EAR-1758198 to B.R. C.R.L.-B. was further supported by the Louis B. and Martha B. Slichter Endowment for Geosciences.	Agius MR, 2021, NATURE, V589, P562, DOI 10.1038/s41586-020-03139-x; Albers M, 1996, GEOPHYS RES LETT, V23, P3567, DOI 10.1029/96GL03311; Anderson DL, 2013, AUST J EARTH SCI, V60, P657, DOI 10.1080/08120099.2013.835283; Arnould M, 2020, EARTH PLANET SC LETT, V547, DOI 10.1016/j.epsl.2020.116439; Ballmer MD, 2015, GEOPHYS MONOGR SER, V208, P35; Bourdon E, 2001, MINER PETROL, V71, P127, DOI 10.1007/s007100170049; Cheng C, 2015, GEOPHYS MONOGR SER, V208, P19; Comaniciu D, 2002, IEEE T PATTERN ANAL, V24, P603, DOI 10.1109/34.1000236; Cottaar S., 2019, AGU FALL M ABSTR; Courtier A. M., EARTH PLANET SC LETT; Courtier AM, 2007, EARTH PLANET SC LETT, V264, P308, DOI 10.1016/j.epsl.2007.10.003; Courtillot V, 2003, EARTH PLANET SC LETT, V205, P295, DOI 10.1016/S0012-821X(02)01048-8; Dalton CA, 2014, SCIENCE, V344, P80, DOI 10.1126/science.1249466; Dannberg J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7960; Debayle E, 2016, GEOPHYS RES LETT, V43, P674, DOI 10.1002/2015GL067329; Delavault H, 2015, EARTH PLANET SC LETT, V426, P23, DOI 10.1016/j.epsl.2015.06.013; Doucelance R, 2003, GEOCHIM COSMOCHIM AC, V67, P3717, DOI 10.1016/S0016-7037(03)00161-3; DZIEWONSKI AM, 1981, PHYS EARTH PLANET IN, V25, P297, DOI 10.1016/0031-9201(81)90046-7; Fitton JG, 2020, J PETROL, V61, DOI 10.1093/petrology/egaa111; Forte AM, 2010, EARTH PLANET SC LETT, V295, P329, DOI 10.1016/j.epsl.2010.03.017; French SW, 2014, GEOPHYS J INT, V199, P1303, DOI 10.1093/gji/ggu334; French S, 2013, SCIENCE, V342, P227, DOI 10.1126/science.1241514; French SW, 2015, NATURE, V525, P95, DOI 10.1038/nature14876; Gale A, 2013, GEOCHEM GEOPHY GEOSY, V14, P489, DOI 10.1029/2012GC004334; Graham DW, 2002, REV MINERAL GEOCHEM, V47, P247, DOI 10.2138/rmg.2002.47.8; Guimaraes AR, 2020, EARTH PLANET SC LETT, V536, DOI 10.1016/j.epsl.2020.116147; Haroardottir S, 2018, CHEM GEOL, V480, P12, DOI 10.1016/j.chemgeo.2017.05.012; Herzberg C, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2006GC001390; Herzberg C, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2008GC002057; Herzberg C, 2000, GEOCHEM GEOPHY GEOSY, V1, DOI 10.1029/2000GC000089; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Ishii M, 1999, SCIENCE, V285, P1231, DOI 10.1126/science.285.5431.1231; Jackson MG, 2021, GEOCHEM GEOPHY GEOSY, V22, DOI 10.1029/2020GC009525; Jackson MG, 2017, NATURE, V542, P340, DOI 10.1038/nature21023; Jackson MG, 2020, P NATL ACAD SCI USA, V117, P30993, DOI 10.1073/pnas.2009663117; Jellinek AM, 2004, REV GEOPHYS, V42, DOI 10.1029/2003RG000144; Jones SM, 2014, EARTH PLANET SC LETT, V386, P86, DOI 10.1016/j.epsl.2013.09.029; Jones TD, 2020, PROG EARTH PLANET SC, V7, DOI 10.1186/s40645-020-00327-1; KENNETT BLN, 1995, GEOPHYS J INT, V122, P108, DOI 10.1111/j.1365-246X.1995.tb03540.x; Kim D, 2020, SCIENCE, V368, P1223, DOI 10.1126/science.aba8972; King SD, 2014, PHYS EARTH PLANET IN, V235, P66, DOI 10.1016/j.pepi.2014.07.006; King SD, 2000, SCIENCE, V290, P1137, DOI 10.1126/science.290.5494.1137; KLEIN EM, 1987, J GEOPHYS RES-SOLID, V92, P8089, DOI 10.1029/JB092iB08p08089; Li Z., 2019, AGU FALL M, V2019; Lithgow-Bertelloni C, 2001, J FLUID MECH, V434, P1; Liu X, 2021, GEOPHYS J INT, V225, P872, DOI 10.1093/gji/ggab012; Matthews S, 2021, GEOCHEM GEOPHY GEOSY, V22, DOI 10.1029/2020GC009157; MCKENZIE D, 1988, J PETROL, V29, P625, DOI 10.1093/petrology/29.3.625; Meschede M, 2015, GEOPHYS J INT, V200, P1076, DOI 10.1093/gji/ggu424; Minshull TA, 1998, GEOLOGY, V26, P115, DOI 10.1130/0091-7613(1998)026<0115:RPIOMH>2.3.CO;2; MORGAN WJ, 1971, NATURE, V230, P42, DOI 10.1038/230042a0; Mundl-Petermeier A, 2020, GEOCHIM COSMOCHIM AC, V271, P194, DOI 10.1016/j.gca.2019.12.020; Ngwa CN, 2017, LITHOS, V288, P326, DOI 10.1016/j.lithos.2017.06.028; Parnell-Turner R, 2014, NAT GEOSCI, V7, P914, DOI 10.1038/NGEO2281; Pertermann M, 2003, J PETROL, V44, P2173, DOI 10.1093/petrology/egg074; Pugh S, 2021, EARTH PLANET SC LETT, V561, DOI 10.1016/j.epsl.2021.116813; Putirka KD, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2005GC000915; Putirka K, 2008, GEOLOGY, V36, P283, DOI 10.1130/G24615A.1; Putirka K, 2018, AM MINERAL, V103, P1253, DOI 10.2138/am-2018-6192; Putirka KD, 2007, CHEM GEOL, V241, P177, DOI 10.1016/j.chemgeo.2007.01.014; Reyes J, 2019, GEOCHIM COSMOCHIM AC, V257, P311, DOI 10.1016/j.gca.2019.05.004; Ribe NM, 2020, EARTH PLANET SC LETT, V551, DOI 10.1016/j.epsl.2020.116570; RICHARDS MA, 1988, GEOPHYS J INT, V94, P367, DOI 10.1111/j.1365-246X.1988.tb02260.x; Rickers F, 2013, EARTH PLANET SC LETT, V367, P39, DOI 10.1016/j.epsl.2013.02.022; Ritsema J, 2011, GEOPHYS J INT, V184, P1223, DOI 10.1111/j.1365-246X.2010.04884.x; ROMANOWICZ B, 1995, J GEOPHYS RES-SOL EA, V100, P12375, DOI 10.1029/95JB00957; Rowley DB, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1601107; Samuel H, 2003, EARTH PLANET SC LETT, V207, P39, DOI 10.1016/S0012-821X(02)01125-1; Schaeffer AJ, 2013, GEOPHYS J INT, V194, P417, DOI 10.1093/gji/ggt095; Scott DW, 2015, WILEY SER PROBAB ST, P1, DOI 10.1002/9781118575574; Simmons NA, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2010JB007631; Sleep NH, 2007, GEOL SOC AM SPEC PAP, V430, P29, DOI 10.1130/2007.2430(02); Sobolev AV, 2007, SCIENCE, V316, P412, DOI 10.1126/science.1138113; Steinberger B, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2006GC001409; Steinberger B, 2019, GEOCHEM GEOPHY GEOSY, V20, P5896, DOI 10.1029/2019GC008490; Stixrude L, 2005, GEOPHYS J INT, V162, P610, DOI 10.1111/j.1365-246X.2005.02642.x; Stixrude L, 2011, GEOPHYS J INT, V184, P1180, DOI 10.1111/j.1365-246X.2010.04890.x; Stuart FM, 2003, NATURE, V424, P57, DOI 10.1038/nature01711; Styles E, 2011, EARTH PLANET SC LETT, V311, P351, DOI 10.1016/j.epsl.2011.09.012; SU WJ, 1992, NATURE, V360, P149, DOI 10.1038/360149a0; Torsvik TH, 2010, NATURE, V466, P352, DOI 10.1038/nature09216; Valbracht PJ, 1997, EARTH PLANET SC LETT, V150, P399, DOI 10.1016/S0012-821X(97)00094-0; Villagomez DR, 2014, NAT GEOSCI, V7, P151, DOI [10.1038/ngeo2062, 10.1038/NGEO2062]; Wei SQS, 2020, SCIENCE, V370, P983, DOI 10.1126/science.abd0312; White RS, 2001, J PETROL, V42, P1171, DOI 10.1093/petrology/42.6.1171; Williams CD, 2019, GEOCHEM GEOPHY GEOSY, V20, P4130, DOI 10.1029/2019GC008437; Xu WB, 2008, EARTH PLANET SC LETT, V275, P70, DOI 10.1016/j.epsl.2008.08.012; Yang AY, 2017, J GEOPHYS RES-SOL EA, V122, P191, DOI 10.1002/2016JB013284; ZHANG YS, 1994, PHYS EARTH PLANET IN, V84, P79, DOI 10.1016/0031-9201(94)90035-3	90	10	10	8	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 7	2022	375	6576					57	+	eabj8944	10.1126/science.abj8944	http://dx.doi.org/10.1126/science.abj8944			46	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YD3FW	34990241				2022-12-28	WOS:000740261400039
J	Schultz, P				Schultz, Peter			Richard Lerner (1938-2021)	SCIENCE			English	Biographical-Item									[Schultz, Peter] Scripps Res, La Jolla, CA 92037 USA	Scripps Research Institute	Schultz, P (corresponding author), Scripps Res, La Jolla, CA 92037 USA.	schultz@scripps.edu						LERNER RA, PUBLICATION LIST	1	0	0	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 7	2022	375	6576					30	30		10.1126/science.abn6377	http://dx.doi.org/10.1126/science.abn6377			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YD3FW	34990254				2022-12-28	WOS:000740261400029
J	Sun, CB				Sun, Chuan-bin			Free-Floating Cyst in the Vitreous	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Free-Floating Cyst in the Vitreous A healthy 18-year-old man presented to the eye clinic with a 1-day history of seeing a "floating ball" in his left eye when he blinked. Slit-lamp examination (shown in a video) revealed a spherical, brown-pigmented mass floating freely in the vitreous when the patient blinked. A diagnosis of iris pigment epithelium cyst was made.	[Sun, Chuan-bin] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Hangzhou, Peoples R China	Zhejiang University	Sun, CB (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Hangzhou, Peoples R China.	sunshine2012@zju.edu.cn	Sun, Chuanbin/ABJ-4306-2022	Sun, Chuan-bin/0000-0002-2767-6858					0	0	0	1	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 6	2022	386	1					E1	E1		10.1056/NEJMicm2112627	http://dx.doi.org/10.1056/NEJMicm2112627		JAN 2022	1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YC1QX	34979070				2022-12-28	WOS:000736921500001
J	Fousteri, G				Fousteri, Georgia			A mentor's journey	SCIENCE			English	Editorial Material									[Fousteri, Georgia] San Raffaele Diabet Res Inst, Milan, Italy		Fousteri, G (corresponding author), San Raffaele Diabet Res Inst, Milan, Italy.								0	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2022	375	6578					350	350						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0O5LX	35050672				2022-12-28	WOS:000783568700001
J	Kunze, C; Khalil, AS				Kunze, Colin; Khalil, Ahmad S.			One cell, many fates	SCIENCE			English	Editorial Material							CIRCUITS; SWITCH	A synthetic gene circuit enables programming of many stable states in mammalian cells	[Kunze, Colin; Khalil, Ahmad S.] Boston Univ, Biol Design Ctr, Boston, MA 02215 USA; [Kunze, Colin; Khalil, Ahmad S.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Khalil, Ahmad S.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA	Boston University; Boston University; Harvard University	Khalil, AS (corresponding author), Boston Univ, Biol Design Ctr, Boston, MA 02215 USA.; Khalil, AS (corresponding author), Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.; Khalil, AS (corresponding author), Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA.	khalil@bu.edu						Bashor CJ, 2019, SCIENCE, V364, P593, DOI 10.1126/science.aau8287; Burrill DR, 2012, GENE DEV, V26, P1486, DOI 10.1101/gad.189035.112; Elowitz M, 2010, NATURE, V468, P889, DOI 10.1038/468889a; Faucon PC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102873; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Khalil AS, 2012, CELL, V150, P647, DOI 10.1016/j.cell.2012.05.045; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Morsut L, 2016, CELL, V164, P780, DOI 10.1016/j.cell.2016.01.012; Santos-Moreno J, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16574-1; Stefanovic S, 2009, J CELL BIOL, V186, P665, DOI 10.1083/jcb.200901040; Toda S, 2018, SCIENCE, V361, P156, DOI 10.1126/science.aat0271; Waddington C H, 1957, STRATEGY GENES DISCU; Wu FQ, 2017, ELIFE, V6, DOI 10.7554/eLife.23702; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089; Zhu R., 2022, SCIENCE, V375	15	0	0	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2022	375	6578					262	263		10.1126/science.abn6548	http://dx.doi.org/10.1126/science.abn6548			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YK2FS	35050646				2022-12-28	WOS:000745036100012
J	Rosenthal, GG; Ryan, MJ				Rosenthal, Gil G.; Ryan, Michael J.			Sexual selection and the ascent of women: Mate choice research since Darwin	SCIENCE			English	Review							FEMALE CHOICE; MATING PREFERENCES; SOCIAL COMPETITION; SENSORY DRIVE; GOOD GENES; EVOLUTION; BEHAVIOR; SPECIATION; QUALITY; TRAITS	Darwin's theory of sexual selection fundamentally changed how we think about sex and evolution. The struggle over mating and fertilization is a powerful driver of diversification within and among species. Contemporaries dismissed Darwin's conjecture of a "taste for the beautiful" as favoring particular mates over others, but there is now overwhelming evidence for a primary role of both male and female mate choice in sexual selection. Darwin's misogyny precluded much analysis of the "taste"; an increasing focus on mate choice mechanisms before, during, and after mating reveals that these often evolve in response to selection pressures that have little to do with sexual selection on chosen traits. Where traits and preferences do coevolve, they can do so whether fitness effects on choosers are positive, neutral, or negative. The spectrum of selection on traits and preferences, and how traits and preferences respond to social effects, determine how sexual selection and mate choice influence broader-scale processes like reproductive isolation and population responses to environmental change.	[Rosenthal, Gil G.] Univ Padua, Dept Biol, Padua, Italy; [Rosenthal, Gil G.] Ctr Invest Cient Huastecas Aguazarca, Calnali, Hidalgo, Mexico; [Ryan, Michael J.] Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA; [Ryan, Michael J.] Smithsonian Trop Res Inst, Balboa, Panama	University of Padua; University of Texas System; University of Texas Austin; Smithsonian Institution; Smithsonian Tropical Research Institute	Rosenthal, GG (corresponding author), Univ Padua, Dept Biol, Padua, Italy.; Rosenthal, GG (corresponding author), Ctr Invest Cient Huastecas Aguazarca, Calnali, Hidalgo, Mexico.; Ryan, MJ (corresponding author), Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA.; Ryan, MJ (corresponding author), Smithsonian Trop Res Inst, Balboa, Panama.	gil.rosenthal@unipd.it; mryan@utexas.edu	Rosenthal, Gil/E-6924-2015	Rosenthal, Gil/0000-0003-0342-9024				Abbott R, 2013, J EVOLUTION BIOL, V26, P229, DOI 10.1111/j.1420-9101.2012.02599.x; Achorn AM, 2020, TRENDS ECOL EVOL, V35, P206, DOI 10.1016/j.tree.2019.11.007; Akre KL, 2010, CURR BIOL, V20, P502, DOI 10.1016/j.cub.2010.01.021; Andersson Malte, 1994; Andrade MCB, 1996, SCIENCE, V271, P70, DOI 10.1126/science.271.5245.70; Andreou D, 2017, BEHAV ECOL, V28, P953, DOI 10.1093/beheco/arx074; Bailey NW, 2012, P ROY SOC B-BIOL SCI, V279, P3589, DOI 10.1098/rspb.2012.0631; Beekman M, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0541; Berglund A, 1996, BIOL J LINN SOC, V58, P385, DOI 10.1111/j.1095-8312.1996.tb01442.x; Bilde T, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-33; Bilde T, 2009, SCIENCE, V324, P1705, DOI 10.1126/science.1171675; Bloch NI, 2018, NAT ECOL EVOL, V2, P1772, DOI 10.1038/s41559-018-0682-4; Bonisoli-Alquati A, 2011, HORM BEHAV, V59, P75, DOI 10.1016/j.yhbeh.2010.10.013; Broder E Dale, 2021, Biol Lett, V17, P20200733, DOI 10.1098/rsbl.2020.0733; Brooks R, 2000, NATURE, V406, P67, DOI 10.1038/35017552; Brouwer L, 2019, MOL ECOL, V28, P4864, DOI 10.1111/mec.15259; Burmeister SS, 2020, J EXP BIOL, V223, DOI 10.1242/jeb.214148; Byrne PG, 2021, EVOLUTION, V75, P529, DOI 10.1111/evo.14160; Cally JG, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10074-7; Cetinkaya H, 2006, J COMP PSYCHOL, V120, P427, DOI 10.1037/0735-7036.120.4.427; Chen C, 2020, SCIENCE, V367, P1377, DOI 10.1126/science.aaz5109; Coleman SW, 2004, NATURE, V428, P742, DOI 10.1038/nature02419; Cotton S, 2006, CURR BIOL, V16, pR755, DOI 10.1016/j.cub.2006.08.022; Cummings ME, 2018, CURR ZOOL, V64, P471, DOI 10.1093/cz/zoy043; Darwin C., 1871, P475; Davies AD, 2020, BEHAV ECOL, V31, P1279, DOI 10.1093/beheco/araa064; Del Giudice M, 2018, COGNITION, V179, P56, DOI 10.1016/j.cognition.2018.06.008; Desmond A., 2014, DARWINS SACRED CAUSE; Dong S, 2009, NEUROBIOL LEARN MEM, V92, P183, DOI 10.1016/j.nlm.2008.09.009; Dougherty LR, 2021, ECOL LETT, V24, P862, DOI 10.1111/ele.13679; Dunsworth H., 2021, MOST INTERESTING PRO, P144; DuPont E. M, 2008, EMBRYO PROJECT ENCY; Dyer KA, 2018, MOL ECOL, V27, P3655, DOI 10.1111/mec.14825; Eberhard W. G., 1996, FEMALE CONTROL SEXUA; ENDLER JA, 1992, AM NAT, V139, pS125, DOI 10.1086/285308; Firman RC, 2017, TRENDS ECOL EVOL, V32, P368, DOI 10.1016/j.tree.2017.02.010; Fisher R.A., 1930, GENETICAL THEORY NAT; Fuentes A., MOST INTERESTING PRO, V2021, P144; Galef B.G. Jr, 1988, P3; Ganna A, 2019, SCIENCE, V365, P882, DOI 10.1126/science.aat7693; Garcia CM, 2005, NATURE, V434, P501, DOI 10.1038/nature03363; Gavrilets S, 2000, NATURE, V403, P886, DOI 10.1038/35002564; Gould Stephen Jay, 1985, FLAMINGOS SMILE REFL; Gowaty PA, 2012, P NATL ACAD SCI USA, V109, P11740, DOI 10.1073/pnas.1207851109; Grosjean Y, 2011, NATURE, V478, P236, DOI 10.1038/nature10428; HEDRICK AV, 1993, ANIM BEHAV, V46, P193, DOI 10.1006/anbe.1993.1176; Hill SE, 2006, BIOL LETT-UK, V2, P203, DOI 10.1098/rsbl.2005.0423; Hoke KL, 2008, BIOL LETTERS, V4, P518, DOI 10.1098/rsbl.2008.0192; Hoke KL, 2007, P ROY SOC B-BIOL SCI, V274, P641, DOI 10.1098/rspb.2006.0038; Hoke KL, 2010, J EXP BIOL, V213, P3463, DOI 10.1242/jeb.043992; Hollis B, 2019, P NATL ACAD SCI USA, V116, P8437, DOI 10.1073/pnas.1821386116; Hrdy S. B, 2009, WOMAN NEVER EVOLVED; Hulse SV, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16389-0; Janicke T, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1500983; Jones BC, 2019, FRONT ECOL EVOL, V7, DOI 10.3389/fevo.2019.00390; Karpati Z, 2008, J EXP BIOL, V211, P2841, DOI 10.1242/jeb.017319; Kelley LA, 2014, BEHAV ECOL, V25, P450, DOI 10.1093/beheco/art118; Kelley LA, 2012, SCIENCE, V335, P335, DOI 10.1126/science.1212443; Kindsvater HK, 2013, BEHAV ECOL, V24, P691, DOI 10.1093/beheco/ars213; Kinsey A.C., 1998, SEXUAL BEHAV HUMAN F; Kinsey AC, 2003, AM J PUBLIC HEALTH, V93, P894, DOI 10.2105/AJPH.93.6.894; KIRKPATRICK M, 1991, NATURE, V350, P33, DOI 10.1038/350033a0; Kirkpatrick M, 1997, P NATL ACAD SCI USA, V94, P1282, DOI 10.1073/pnas.94.4.1282; KIRKPATRICK M, 1987, ANNU REV ECOL SYST, V18, P43, DOI 10.1146/annurev.es.18.110187.000355; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Lampert KP, 2010, CURR BIOL, V20, P1729, DOI 10.1016/j.cub.2010.08.029; Lea AM, 2015, SCIENCE, V349, P964, DOI 10.1126/science.aab2012; Lehmann GUC, 2016, ANIM BEHAV, V112, P267, DOI 10.1016/j.anbehav.2015.12.022; LEHRMAN DANIEL S., 1965, P355; Levitan DR, 1996, NATURE, V382, P153, DOI 10.1038/382153a0; Limbourg T, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.0835; Locatello L, 2015, BEHAV ECOL SOCIOBIOL, V69, P1119, DOI 10.1007/s00265-015-1924-y; Makowicz AM, 2020, EVOLUTION, V74, P1575, DOI 10.1111/evo.14018; Marie-Orleach L, 2021, EVOL LETT, V5, P101, DOI 10.1002/evl3.210; MARLER P, 1991, J PIAGET SY, P37; MAYNARD-SMITH J., 2003, ANIMAL SIGNALS; Mayr E., 1963, ANIMAL SPECIES EVOLU; Mead LS, 2004, TRENDS ECOL EVOL, V19, P264, DOI 10.1016/j.tree.2004.03.003; Mendelson TC, 2014, ECOL LETT, V17, P1053, DOI 10.1111/ele.12313; Muralidhar P, 2019, NATURE, V570, P376, DOI 10.1038/s41586-019-1271-7; Neff BD, 2009, J EVOLUTION BIOL, V22, P424, DOI 10.1111/j.1420-9101.2008.01646.x; Neff BD, 2005, MOL ECOL, V14, P19, DOI 10.1111/j.1365-294X.2004.02395.x; Passos C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101649; Patricelli GL, 2002, NATURE, V415, P279, DOI 10.1038/415279a; Pavlicev M, 2016, J EXP ZOOL PART B, V326, P326, DOI 10.1002/jez.b.22690; PENNEBAKER JW, 1979, PERS SOC PSYCHOL B, V5, P122, DOI 10.1177/014616727900500127; Pfaus JG, 2012, ARCH SEX BEHAV, V41, P31, DOI 10.1007/s10508-012-9935-5; Pfennig KS, 2007, SCIENCE, V318, P965, DOI 10.1126/science.1146035; Plath M, 2008, ANIM BEHAV, V75, P21, DOI 10.1016/j.anbehav.2007.05.013; Prokop ZM, 2012, EVOLUTION, V66, P2665, DOI 10.1111/j.1558-5646.2012.01654.x; Prum, 2017, EVOLUTION BEAUTY DAR; Prum RO, 2012, PHILOS T R SOC B, V367, P2253, DOI 10.1098/rstb.2011.0285; Rand AS, 1997, COPEIA, P447, DOI 10.2307/1447770; Rangassamy M, 2015, ANIM BEHAV, V103, P7, DOI 10.1016/j.anbehav.2015.02.007; Reber R, 2004, PERS SOC PSYCHOL REV, V8, P364, DOI 10.1207/s15327957pspr0804_3; Richards Evelleen, 2017, DARWIN MAKING SEXUAL; Roberts BH, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-81727-1; ROBERTSON JGM, 1990, ANIM BEHAV, V39, P639, DOI 10.1016/S0003-3472(05)80374-4; Rodriguez RL, 2020, Q REV BIOL, V95, P289, DOI 10.1086/711781; Rosenthal G, 2017, MATE CHOICE; Rosenthal GG, 2013, J EVOLUTION BIOL, V26, P252, DOI 10.1111/jeb.12004; Rosenthal GG, 2018, CURR ZOOL, V64, P485, DOI 10.1093/cz/zoy054; Ryan M.J., 1990, Oxford Surveys in Evolutionary Biology, V7, P157; Ryan M. J, 2018, TASTE BEAUTIFUL EVOL; Ryan MJ, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2008194118; Ryan MJ, 2019, AM NAT, V194, P125, DOI 10.1086/704103; Ryan MJ, 2013, ANNU REV ECOL EVOL S, V44, P437, DOI 10.1146/annurev-ecolsys-110512-135901; Ryan MJ, 2010, CURR ZOOL, V56, P343, DOI 10.1093/czoolo/56.3.343; RYAN MJ, 1992, AM NAT, V139, P21, DOI 10.1086/285311; RYAN MJ, 1990, NATURE, V343, P66, DOI 10.1038/343066a0; RYAN MJ, 1992, AM NAT, V139, P1370, DOI 10.1086/285391; RYAN MJ, 1992, AM NAT, V139, pS4, DOI 10.1086/285303; Schlupp I., 2021, MALE CHOICE FEMALE C; Schuett W, 2010, BIOL REV, V85, P217, DOI 10.1111/j.1469-185X.2009.00101.x; Seehausen O, 2008, NATURE, V455, P620, DOI 10.1038/nature07285; SEGER J, 1986, NATURE, V319, P771, DOI 10.1038/319771a0; Servedio MR, 2019, P NATL ACAD SCI USA, V116, P23225, DOI 10.1073/pnas.1904138116; Servedio MR, 2017, ANNU REV ECOL EVOL S, V48, P85, DOI 10.1146/annurev-ecolsys-110316-022905; Servedio MR, 2014, P NATL ACAD SCI USA, V111, P8113, DOI 10.1073/pnas.1316484111; Servedio MR, 2011, TRENDS ECOL EVOL, V26, P389, DOI 10.1016/j.tree.2011.04.005; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Simmons LW, 2020, PHILOS T R SOC B, V375, DOI 10.1098/rstb.2020.0060; Street SE, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19770-8; Suzuki K, 1997, APPL ENTOMOL ZOOL, V32, P235, DOI 10.1303/aez.32.235; Takayama S, 2005, ANNU REV PLANT BIOL, V56, P467, DOI 10.1146/annurev.arplant.56.032604.144249; Tang-Martinez Z, 2016, J SEX RES, V53, P532, DOI 10.1080/00224499.2016.1150938; Taylor RC, 2008, ANIM BEHAV, V76, P1089, DOI 10.1016/j.anbehav.2008.01.031; TURNER GF, 1995, P ROY SOC B-BIOL SCI, V260, P287, DOI 10.1098/rspb.1995.0093; Uyeda JC, 2009, EVOLUTION, V63, P583, DOI 10.1111/j.1558-5646.2008.00589.x; Verzijden MN, 2012, BEHAV ECOL, V23, P1133, DOI 10.1093/beheco/ars086; Verzijden MN, 2012, TRENDS ECOL EVOL, V27, P511, DOI 10.1016/j.tree.2012.05.007; Verzijden MN, 2005, EVOLUTION, V59, P2097; Walum H, 2018, NAT REV NEUROSCI, V19, P643, DOI 10.1038/s41583-018-0072-6; WARNER RR, 1975, SCIENCE, V190, P633, DOI 10.1126/science.1188360; WESTEBERHARD MJ, 1979, P AM PHILOS SOC, V123, P222; WESTEBERHARD MJ, 1983, Q REV BIOL, V58, P155, DOI 10.1086/413215; Wiley R. H., 2015, FUND IND; WILKINSON GS, 1994, P ROY SOC B-BIOL SCI, V255, P1, DOI 10.1098/rspb.1994.0001; Willis PM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034802; Yang YS, 2019, NATURE, V574, P99, DOI 10.1038/s41586-019-1599-z; Yeh DJ, 2019, AM NAT, V193, P81, DOI 10.1086/700958; Yeh DJ, 2018, EVOLUTION, V72, P1336, DOI 10.1111/evo.13500; Yeh DJ, 2015, EVOLUTION, V69, P1938, DOI 10.1111/evo.12688; Yorzinski JL, 2013, J EXP BIOL, V216, P3035, DOI 10.1242/jeb.087338; Zhu BC, 2021, J ANIM ECOL, V90, P1455, DOI 10.1111/1365-2656.13465	145	5	5	23	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2022	375	6578					281	+	eabi6308	10.1126/science.abi6308	http://dx.doi.org/10.1126/science.abi6308			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YK2FS	35050648				2022-12-28	WOS:000745036100024
J	Rana, N; Privitera, G; Kondolf, HC; Bulek, K; Lechuga, S; De Salvo, C; Corridoni, D; Antanaviciute, A; Maywald, RL; Hurtado, AM; Zhao, JJ; Huang, EH; Li, XX; Chan, ER; Simmons, A; Bamias, G; Abbott, DW; Heaney, JD; Ivanov, AI; Pizarro, TT				Rana, Nitish; Privitera, Giuseppe; Kondolf, Hannah C.; Bulek, Katarzyna; Lechuga, Susana; De Salvo, Carlo; Corridoni, Daniele; Antanaviciute, Agne; Maywald, Rebecca L.; Hurtado, Alexander M.; Zhao, Junjie; Huang, Emina H.; Li, Xiaoxia; Chan, E. Ricky; Simmons, Alison; Bamias, Giorgos; Abbott, Derek W.; Heaney, Jason D.; Ivanov, Andrei I.; Pizarro, Theresa T.			GSDMB is increased in IBD and regulates epithelial restitution/repair independent of pyroptosis	CELL			English	Article							FOCAL-ADHESION KINASE; MESENCHYMAL TRANSITION; CELL-PROLIFERATION; WOUND REPAIR; EXPRESSION; GENE; CANCER; PROTEIN; ASTHMA; GROWTH	Gasdermins are a family of structurally related proteins originally described for their role in pyroptosis. Gasdermin B (GSDMB) is currently the least studied, and while its association with genetic susceptibility to chronic mucosal inflammatory disorders is well established, little is known about its functional relevance during active disease states. Herein, we report increased GSDMB in inflammatory bowel disease, with single-cell analysis identifying epithelial specificity to inflamed colonocytes/crypt top colonocytes. Surprisingly, mechanistic experiments and transcriptome profiling reveal lack of inherent GSDMB-dependent pyroptosis in activated epithelial cells and organoids but instead point to increased proliferation and migration during in vitro wound closure, which arrests in GSDMB-deficient cells that display hyper-adhesiveness and enhanced formation of vinculin-based focal adhesions dependent on PDGF-A-mediated FAK phosphorylation. Importantly, carriage of disease-associated GSDMB SNPs confers functional defects, disrupting epithelial restitution/repair, which, altogether, establishes GSDMB as a critical factor for restoration of epithelial barrier function and the resolution of inflammation.	[Rana, Nitish; Privitera, Giuseppe; Kondolf, Hannah C.; De Salvo, Carlo; Hurtado, Alexander M.; Abbott, Derek W.; Pizarro, Theresa T.] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Rana, Nitish] Case Western Reserve Univ, Dept Physiol, Sch Med, Cleveland, OH 44106 USA; [Rana, Nitish] Case Western Reserve Univ, Dept Biophys, Sch Med, Cleveland, OH 44106 USA; [Chan, E. Ricky] Case Western Reserve Univ, Inst Computat Biol, Sch Med, Cleveland, OH 44106 USA; [Bulek, Katarzyna; Lechuga, Susana; Zhao, Junjie; Li, Xiaoxia; Ivanov, Andrei I.] Cleveland Clin Fdn, Learner Res Inst, Dept Inflammat & Immun, Cleveland, OH 44195 USA; [Huang, Emina H.] Cleveland Clin, Learner Res Inst, Dept Canc Biol, Cleveland, OH 44195 USA; [Huang, Emina H.] Cleveland Clin, Learner Res Inst, Dept Colon & Rectal Surg, Cleveland, OH 44195 USA; [Corridoni, Daniele; Antanaviciute, Agne; Simmons, Alison] Univ Oxford, John Radcliffe Hosp, MRC Weatherall Inst Mol Med, MRC Human Immunol Unit, Oxford, England; [Maywald, Rebecca L.; Heaney, Jason D.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Bamias, Giorgos] Ethnikon & Kapodistriakon Univ Athens, Laikon Hosp, Acad Dept Gastroenterol, Athens, Greece; [Huang, Emina H.] Univ Texas Southwestern Med Ctr Dallas, Dept Surg, Dallas, TX 75390 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; University of Oxford; Baylor College of Medicine; Laiko General Hospital; University of Texas System; University of Texas Southwestern Medical Center Dallas	Pizarro, TT (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA.	theresa.pizarro@case.edu		Privitera, Giuseppe/0000-0002-7020-5808; Lechuga, Susana/0000-0003-0614-1990; Hurtado, Alexander/0000-0003-0580-5927; De Salvo, Carlo/0000-0002-1523-1915; Kondolf, Hannah/0000-0002-6536-2868; Maywald, Rebecca/0000-0002-3737-1257; Simmons, Alison/0000-0003-3454-0710; Corridoni, Daniele/0000-0003-0251-2248	NIH [DK091222, DK042191, DK125293, DK108278, DK126702, AI141350, CA214300, DK237304]; MSTP [T32 GM007250]; Biorepository and Morphology/Imaging Cores of (Cleveland Digestive Diseases Research Core Center) [DK097948]; Office of Research Infrastructure (NIH-ORIP) [S10OD016164]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MSTP; Biorepository and Morphology/Imaging Cores of (Cleveland Digestive Diseases Research Core Center); Office of Research Infrastructure (NIH-ORIP)	This work was supported by the NIH: DK091222, DK042191, and DK125293 (to T.T.P.), DK108278 and DK126702 (to A.I.I.), AI141350 (to D.W.A.), CA214300 and DK237304 (to E.H.H.), an institutional MSTP T32 GM007250 (to H.C.K.), and the Biorepository and Morphology/Imaging Cores of DK097948 (Cleveland Digestive Diseases Research Core Center). We acknowledge Claudio Fiocchi, Gail West, Danian Che, and Blake Feldman for their supervisory and/or technical support; Asma Nusrat and Chithra Kannachazhath Muraleedharan for their technical assistance with organoid experimentation, and use of the Leica TCS SP8 confocal microscope in the Light Microscopy Imaging Core at CWRU, made available through the Office of Research Infrastructure (NIH-ORIP) shared instrumentation grant S10OD016164.	Bailey KM, 2008, J BIOL CHEM, V283, P13714, DOI 10.1074/jbc.M709329200; Bartolome RA, 2014, ONCOGENE, V33, P1658, DOI 10.1038/onc.2013.117; Bays JL, 2017, CELL MOL LIFE SCI, V74, P2999, DOI 10.1007/s00018-017-2511-3; Broz P, 2020, NAT REV IMMUNOL, V20, P143, DOI 10.1038/s41577-019-0228-2; Budden KF, 2017, NAT REV MICROBIOL, V15, P55, DOI 10.1038/nrmicro.2016.142; Bulek K, 2020, J CLIN INVEST, V130, P4218, DOI 10.1172/JCI138103; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Caliskan M, 2013, NEW ENGL J MED, V368, P1398, DOI 10.1056/NEJMoa1211592; Callahan MJ, 2008, CLIN CANCER RES, V14, P7667, DOI 10.1158/1078-0432.CCR-08-0479; Chao KL, 2017, P NATL ACAD SCI USA, V114, pE1128, DOI 10.1073/pnas.1616783114; Chen PH, 2013, BBA-PROTEINS PROTEOM, V1834, P2176, DOI 10.1016/j.bbapap.2012.10.015; Chen Q, 2019, J MOL CELL BIOL, V11, P496, DOI 10.1093/jmcb/mjy056; Corridoni D, 2020, NAT MED, V26, DOI 10.1038/s41591-020-1003-4; Cronstein BN, 2020, NAT REV RHEUMATOL, V16, P145, DOI 10.1038/s41584-020-0373-9; Das S, 2016, P NATL ACAD SCI USA, V113, P13132, DOI 10.1073/pnas.1610433113; Detjen KM, 2001, GUT, V49, P251, DOI 10.1136/gut.49.2.251; Ding JJ, 2016, NATURE, V535, P111, DOI 10.1038/nature18590; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Evavold CL, 2018, IMMUNITY, V48, P35, DOI 10.1016/j.immuni.2017.11.013; Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; Graham WV, 2019, NAT MED, V25, P690, DOI 10.1038/s41591-019-0393-7; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hansen JM, 2021, CELL, V184, P3178, DOI 10.1016/j.cell.2021.04.036; Herfarth HH, 2016, INFLAMM BOWEL DIS, V22, P224, DOI 10.1097/MIB.0000000000000589; Hu YL, 2014, SCI REP-UK, V4, DOI 10.1038/srep06024; Hunger-Glaser I, 2004, J CELL PHYSIOL, V200, P213, DOI 10.1002/jcp.20018; Ivanov A.I., 2019, J MOL NEUROSCI, V67, P564; JEFFES EWB, 1995, J INVEST DERMATOL, V104, P183, DOI 10.1111/1523-1747.ep12612745; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Leoni G, 2015, MUCOSAL IMMUNOL, V8, P959, DOI 10.1038/mi.2015.63; Li LS, 2020, CANCER MANAG RES, V12, P3033, DOI 10.2147/CMAR.S246948; Li XN, 2021, J ALLERGY CLIN IMMUN, V147, P894, DOI 10.1016/j.jaci.2020.07.030; Liu WM, 2019, ONCOL REP, V41, P1911, DOI 10.3892/or.2019.6957; Lopetuso LR, 2018, P NATL ACAD SCI USA, V115, pE9362, DOI 10.1073/pnas.1803613115; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Ma Z, 2020, AGING-US, V12, P7985, DOI 10.18632/aging.103117; McCloskey P, 1997, J BIOL CHEM, V272, P23285, DOI 10.1074/jbc.272.37.23285; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; Mehto S, 2019, MOL CELL, V73, P429, DOI 10.1016/j.molcel.2018.11.018; Miyoshi H, 2013, NAT PROTOC, V8, P2471, DOI 10.1038/nprot.2013.153; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Munir J, 2020, BIOCHEM BIOPH RES CO, V526, P91, DOI 10.1016/j.bbrc.2020.03.064; Noble CL, 2010, INFLAMM BOWEL DIS, V16, P1717, DOI 10.1002/ibd.21263; Odenwald MA, 2017, NAT REV GASTRO HEPAT, V14, P9, DOI 10.1038/nrgastro.2016.169; Parikh K, 2019, NATURE, V567, P49, DOI 10.1038/s41586-019-0992-y; Pasello M, 2018, J CELL COMMUN SIGNAL, V12, P55, DOI 10.1007/s12079-017-0445-z; Pastorelli L, 2010, P NATL ACAD SCI USA, V107, P8017, DOI 10.1073/pnas.0912678107; Pouillon L, 2020, NAT REV GASTRO HEPAT, V17, P365, DOI 10.1038/s41575-020-0293-9; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rashmi, 2021, PHARMACOL RES PERSPE, V9, DOI 10.1002/prp2.737; Reed M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12968-y; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rizzo P, 2017, AM J PATHOL, V187, P2441, DOI 10.1016/j.ajpath.2017.07.004; Rossi M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09754-1; Saeki N, 2009, GENE CHROMOSOME CANC, V48, P261, DOI 10.1002/gcc.20636; Sarvestani Samaneh K, 2018, Oncotarget, V9, P28717, DOI 10.18632/oncotarget.25617; Schaller MD, 2010, J CELL SCI, V123, P1007, DOI 10.1242/jcs.045112; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sean D, 2007, BIOINFORMATICS, V23, P1846, DOI 10.1093/bioinformatics/btm254; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Singh J, 2019, J MOL NEUROSCI, V67, P564, DOI 10.1007/s12031-019-1260-1; Stein MM, 2018, J ALLERGY CLIN IMMUN, V142, P749, DOI 10.1016/j.jaci.2017.12.974; Tang LP, 2020, CLIN TRANSL IMMUNOL, V9, DOI 10.1002/cti2.1186; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Uchiyama Y, 2010, P NATL ACAD SCI USA, V107, P9240, DOI 10.1073/pnas.0913748107; Winship A, 2017, INT J ONCOL, V50, P798, DOI 10.3892/ijo.2017.3848; Fan X, 2021, INT J CANCER, V148, P3060, DOI 10.1002/ijc.33494; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Yu JL, 2020, INT J BIOL MARKER, V35, P74, DOI 10.1177/1724600820905114; Yu JH, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-018-1263-9; Zhao XM, 2015, HUM MOL GENET, V24, P4615, DOI 10.1093/hmg/ddv192; Zhou WJ, 2011, CELL RES, V21, P609, DOI 10.1038/cr.2011.17; Zhou ZW, 2020, SCIENCE, V368, P965, DOI 10.1126/science.aaz7548	75	23	23	35	81	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 20	2022	185	2					283	+		10.1016/j.cell.2021.12.024	http://dx.doi.org/10.1016/j.cell.2021.12.024			34	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	YL8YE	35021065				2022-12-28	WOS:000746172100009
J	Rubin, R				Rubin, Rita			Developing Drugs for Life-threatening Genetic Diseases	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 18	2022	327	3					210	210						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YV9PQ	35040898				2022-12-28	WOS:000753055100006
J	Armstrong, K; Ritchie, C				Armstrong, Katrina; Ritchie, Christine			Research Participation in Marginalized Communities - Overcoming Barriers	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Armstrong, Katrina; Ritchie, Christine] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Armstrong, K (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.							[Anonymous], 2021, NEW ENGL J MED, V385, P1429, DOI 10.1056/NEJMe2114651; Artiga Samantha, 2021, RACIAL DIVERSITY COV; George S, 2014, AM J PUBLIC HEALTH, V104, pE16, DOI 10.2105/AJPH.2013.301706; Grumbach K, 2021, J CLIN TRANSL SCI, V5, DOI 10.1017/cts.2021.8	4	6	6	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 20	2022	386	3					203	205		10.1056/NEJMp2115621	http://dx.doi.org/10.1056/NEJMp2115621		JAN 2022	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YK1UG	35029846				2022-12-28	WOS:000742767800001
J	Aronson, JK				Aronson, Jeffrey K.			When I use a word .... Lexicographical anniversaries	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Aronson, Jeffrey K.] Univ Oxford, Ctr Evidence Based Med, Nuffield Dept Primary Care Hlth Sci, Oxford, England	University of Oxford	Aronson, JK (corresponding author), Univ Oxford, Ctr Evidence Based Med, Nuffield Dept Primary Care Hlth Sci, Oxford, England.			Aronson, Jeffrey/0000-0003-1139-655X				ANTHONY HS, 1966, J HIST IDEAS, V27, P593, DOI 10.2307/2708343; Aronson, 2000, BMJ, V321, P682, DOI 10.1136/bmj.321.7262.682; Aronson JK, 2022, BMJ-BRIT MED J, V376, DOI 10.1136/bmj.o39; Aronson JK., 2021, BMJ OPINION; ARRIGO AP, 1988, NATURE, V331, P192, DOI 10.1038/331192a0; GALLO R, 1988, NATURE, V333, P504, DOI 10.1038/333504a0; JOHNSTON SA, 1988, SCIENCE, V240, P1538, DOI 10.1126/science.2836954; Lyell John, 1871, Glasgow Med J, V3, P490; MEGENS AAHP, 1988, PSYCHOPHARMACOLOGY, V95, P493; Sterling P., 1988, HDB LIFE STRESS COGN, P629, DOI DOI 10.1016/0005-7967(90)90076-U	10	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 14	2022	376								o105	10.1136/bmj.o105	http://dx.doi.org/10.1136/bmj.o105			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZE9IM	35031548	Bronze			2022-12-28	WOS:000759190400015
J	Vijayan, T				Vijayan, Tara			Raining in Los Angeles	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Vijayan, Tara] Univ Calif Los Angeles, Div Infect Dis, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles	Vijayan, T (corresponding author), Univ Calif Los Angeles, Div Infect Dis, Los Angeles, CA 90024 USA.			Vijayan, Tara/0000-0003-1141-8261				[Anonymous], 2021, ABC7COM 1231; Batchlor E., 2021, ATLANTIC 0901; Johnson CY, 2021, WASHINGTON POST 1216; Martinez L, 2020, LAIST 1217; McGinley L, 2020, WASHINGTON POST; Nuriddin A, 2020, LANCET, V396, P949, DOI 10.1016/S0140-6736(20)32032-8; Vega PLA, 2022, ANGELES TIMES 0109; Vijayan T., 2021, BMJ OPINION; Vijayan T, 2021, CLIN INFECT DIS, V73, pE2970, DOI 10.1093/cid/ciaa1692; Webb BJ, 2021, OPEN FORUM INFECT DI, V8, DOI 10.1093/ofid/ofab331; Zimmer C, 2021, NEW YORK TIMES 1214	11	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 14	2022	376								o113	10.1136/bmj.o113	http://dx.doi.org/10.1136/bmj.o113			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZE9IM	35031589	Bronze			2022-12-28	WOS:000759190400013
J	[Anonymous]				[Anonymous]			Seven days in medicine: 5-11 January 2022	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Ayoubkhani D., 2022, PREV ONG SYMPT FOLL; GBD 2019 Dementia Forecasting Collaborators, 2022, Lancet Public Health, V7, pe105, DOI 10.1016/S2468-2667(21)00249-8; GBD 2019 Dementia Forecasting Collaborators, EST GLOB PREV DEM 20; Lipkind HS, 2022, MMWR-MORBID MORTAL W, V7, P26, DOI 10.15585/mmwr.mm7101e1; Veronesi G, 2022, OCCUP ENVIRON MED, V79, P192, DOI 10.1136/oemed-2021-107833	5	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 13	2022	376								o37	10.1136/bmj.o37	http://dx.doi.org/10.1136/bmj.o37			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZE9IW	35027343				2022-12-28	WOS:000759191400006
J	Gilani, A; Tierney, G				Gilani, Artaza; Tierney, Gillian			Chronic anal fissure in adults	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SITZ BATH; MANAGEMENT; METAANALYSIS		[Gilani, Artaza] UCL, Med Sch, UCL Res Dept Primary Care & Populat Hlth, Royal Free Hosp Campus, London NW3 2PF, England; [Tierney, Gillian] Royal Derby Hosp, Derby DE22 3NE, England; [Tierney, Gillian] Univ Nottingham, Nottingham NG7 2RD, England	University of London; University College London; University of Nottingham; University of Nottingham	Gilani, A (corresponding author), UCL, Med Sch, UCL Res Dept Primary Care & Populat Hlth, Royal Free Hosp Campus, London NW3 2PF, England.	artaza.gilani@ucl.ac.uk						Al-thoubaity F, 2020, ANN MED SURG, V57, P291, DOI 10.1016/j.amsu.2020.08.010; Beaty JS, 2016, CLIN COLON RECT SURG, V29, P30, DOI 10.1055/s-0035-1570390; Clinical Knowledge Summaries, 2017, ANAL FISSURE; Cross KLR, 2008, COLORECTAL DIS, V10, P1, DOI 10.1111/j.1463-1318.2008.01681.x; Ebinger SM, 2017, J GASTROENTEROL, V52, P663, DOI 10.1007/s00535-017-1335-0; Griffin N, 2004, Colorectal Dis, V6, P39, DOI 10.1111/j.1463-1318.2004.00576.x; Lang DSP, 2011, JPN J NURS SCI, V8, P115, DOI 10.1111/j.1742-7924.2011.00175.x; Malaty HM, 2016, DIGEST DIS SCI, V61, P861, DOI 10.1007/s10620-015-3930-3; Mapel DW, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-129; Mathur N, 2020, CURR OPIN GASTROEN, V36, P19, DOI 10.1097/MOG.0000000000000599; National Institute for Health and Care Excellence, 2013, EV SUMM CHRON AN FIS; Nelson RL, 2017, TECH COLOPROCTOL, V21, P605, DOI 10.1007/s10151-017-1664-2; Nevins EJ, 2020, TURK J SURG, V36, P347, DOI 10.47717/turkjsurg.2020.4895; Reynolds A, 2019, LANCET, V393, P434, DOI 10.1016/S0140-6736(18)31809-9; Schlichtemeier S, 2016, AUST PRESCR, V39, P14, DOI 10.18773/austprescr.2016.007; Scientific Advisory Committee on Nutrition, 2015, CARB HLTH; Stewart DB, 2017, DIS COLON RECTUM, V60, P7, DOI 10.1097/DCR.0000000000000735; Tejirian T, 2005, DIS COLON RECTUM, V48, P2336, DOI 10.1007/s10350-005-0085-x	18	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 12	2022	376								e066834	10.1136/bmj-2021-066834	http://dx.doi.org/10.1136/bmj-2021-066834			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YP6JI	35022226				2022-12-28	WOS:000748728200009
J	Kuehn, BM				Kuehn, Bridget M.			Younger Adults With Diabetes Miss Care, Disregard COVID-19 Precautions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 11	2022	327	2					116	116						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YH8QV	35015030	Bronze			2022-12-28	WOS:000743426500007
J	Courtin, J; Bitterman, Y; Muller, S; Hinz, J; Hagihara, KM; Muller, C; Luthi, A				Courtin, J.; Bitterman, Y.; Muller, S.; Hinz, J.; Hagihara, K. M.; Muller, C.; Luthi, A.			A neuronal mechanism for motivational control of behavior	SCIENCE			English	Article							BASOLATERAL AMYGDALA; REWARD; CIRCUITS; CORTEX; ACQUISITION; PERFORMANCE; ENCODES; LESIONS; MONKEY; FEAR	Acting to achieve goals depends on the ability to motivate specific behaviors based on their predicted consequences given an individual's internal state. However, the underlying neuronal mechanisms that encode and maintain such specific motivational control of behavior are poorly understood. Here, we used Ca2+ imaging and optogenetic manipulations in the basolateral amygdala of freely moving mice performing noncued, self-paced instrumental goal-directed actions to receive and consume rewards. We found that distinct neuronal activity patterns sequentially represent the entire action-consumption behavioral sequence. Whereas action-associated patterns integrated the identity, value, and expectancy of pursued goals, consumption-associated patterns reflected the identity and value of experienced outcomes. Thus, the interplay between these patterns allows the maintenance of specific motivational states necessary to adaptively direct behavior toward prospective rewards.	[Courtin, J.; Bitterman, Y.; Muller, S.; Hinz, J.; Hagihara, K. M.; Muller, C.; Luthi, A.] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; [Hinz, J.; Hagihara, K. M.; Luthi, A.] Univ Basel, CH-4000 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research; University of Basel	Courtin, J; Luthi, A (corresponding author), Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland.; Luthi, A (corresponding author), Univ Basel, CH-4000 Basel, Switzerland.	julien.courtin@fmi.ch; andreas.luthi@fmi.ch	bitterman, yael/GRS-6144-2022; Luthi, Andreas/D-7940-2016	Hinz, Julian/0000-0002-5432-6263; Courtin, Julien/0000-0002-6454-3245; Hagihara, Kenta M./0000-0003-0064-0852; bitterman, yael/0000-0002-4153-3888; Luthi, Andreas/0000-0002-1859-4252	European Research Council (ERC) under the European Union [669582]; SNSF Ambizione grant [PZ00P3_180057]	European Research Council (ERC) under the European Union(European Research Council (ERC)); SNSF Ambizione grant	This work was supported by the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program (grant no. 669582 to A.L.) and by SNSF Ambizione grant PZ00P3_180057 to J.C.	Ambroggi F, 2008, NEURON, V59, P648, DOI 10.1016/j.neuron.2008.07.004; Balleine BW, 2019, NEURON, V104, P47, DOI 10.1016/j.neuron.2019.09.024; Balleine BW, 2006, TRENDS NEUROSCI, V29, P272, DOI 10.1016/j.tins.2006.03.002; Balleine BW, 2003, J NEUROSCI, V23, P666, DOI 10.1523/JNEUROSCI.23-02-00666.2003; Bermudez MA, 2010, J NEUROPHYSIOL, V104, P3424, DOI 10.1152/jn.00540.2010; Chesworth R, 2017, AMYGDALA EMOTIONS SH, DOI [DOI 10.5772/67831, 10.5772/67831]; Corbit LH, 2013, J NEUROSCI, V33, P17682, DOI 10.1523/JNEUROSCI.3271-13.2013; Corder G, 2019, SCIENCE, V363, P276, DOI 10.1126/science.aap8586; Courtin J, 2014, NATURE, V505, P92, DOI 10.1038/nature12755; da Silva JA, 2018, NATURE, V554, P244, DOI 10.1038/nature25457; DICKINSON A, 1994, ANIM LEARN BEHAV, V22, P1, DOI 10.3758/BF03199951; Duvarci S, 2014, NEURON, V82, P966, DOI 10.1016/j.neuron.2014.04.042; Engelhard B, 2019, NATURE, V570, P509, DOI 10.1038/s41586-019-1261-9; Ferster C.B., 1957, SCHEDULES REINFORCEM, DOI 10.1037/10627-000; Fontanini A, 2009, J NEUROSCI, V29, P2486, DOI 10.1523/JNEUROSCI.3898-08.2009; Grace AA, 2007, TRENDS NEUROSCI, V30, P220, DOI 10.1016/j.tins.2007.03.003; Grundemann J, 2019, SCIENCE, V364, P254, DOI 10.1126/science.aav8736; Guizar-Sicairos M, 2008, OPT LETT, V33, P156, DOI 10.1364/OL.33.000156; Hart G, 2014, NEUROBIOL LEARN MEM, V108, P104, DOI 10.1016/j.nlm.2013.11.003; Hernadi I, 2015, NAT NEUROSCI, V18, P461, DOI 10.1038/nn.3925; Herry C, 2008, NATURE, V454, P600, DOI 10.1038/nature07166; Janak PH, 2015, NATURE, V517, P284, DOI 10.1038/nature14188; Johnson AW, 2009, J NEUROSCI, V29, P696, DOI 10.1523/JNEUROSCI.3758-08.2009; Karalis N, 2016, NAT NEUROSCI, V19, P605, DOI 10.1038/nn.4251; Kim J, 2017, NEURON, V93, P1464, DOI 10.1016/j.neuron.2017.02.034; Kim J, 2016, NAT NEUROSCI, V19, P1636, DOI 10.1038/nn.4414; Krabbe S, 2019, NAT NEUROSCI, V22, P1834, DOI 10.1038/s41593-019-0508-y; Kyriazi P, 2018, NEURON, V99, P1315, DOI 10.1016/j.neuron.2018.07.036; Lavi K, 2018, CELL REP, V24, P278, DOI 10.1016/j.celrep.2018.06.053; Lopes G, 2015, FRONT NEUROINFORM, V9, DOI 10.3389/fninf.2015.00007; Malvaez M, 2019, NAT NEUROSCI, V22, P762, DOI 10.1038/s41593-019-0374-7; Namburi P, 2015, NATURE, V520, P675, DOI 10.1038/nature14366; NISHIJO H, 1988, J NEUROSCI, V8, P3570; Niv Y, 2006, TRENDS COGN SCI, V10, P375, DOI 10.1016/j.tics.2006.06.010; Ostlund SB, 2008, J NEUROSCI, V28, P4398, DOI 10.1523/JNEUROSCI.5472-07.2008; Parkes SL, 2013, J NEUROSCI, V33, P8753, DOI 10.1523/JNEUROSCI.5071-12.2013; Paton JJ, 2006, NATURE, V439, P865, DOI 10.1038/nature04490; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Rhodes SEV, 2013, J NEUROSCI, V33, P3380, DOI 10.1523/JNEUROSCI.4374-12.2013; Roesch MR, 2010, J NEUROSCI, V30, P2464, DOI 10.1523/JNEUROSCI.5781-09.2010; Schoenbaum G, 1998, NAT NEUROSCI, V1, P155, DOI 10.1038/407; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; Servonnet A, 2020, J NEUROSCI, V40, P1732, DOI 10.1523/JNEUROSCI.2196-19.2020; Simmons DA, 2009, NEUROSCIENCE, V159, P1264, DOI 10.1016/j.neuroscience.2009.01.026; Stuber GD, 2011, NATURE, V475, P377, DOI 10.1038/nature10194; Tye KM, 2007, J NEUROSCI, V27, P3937, DOI 10.1523/JNEUROSCI.5281-06.2007; Yoshida K, 2019, NAT NEUROSCI, V22, P770, DOI 10.1038/s41593-019-0376-5; Zhang WJ, 2013, J NEUROSCI, V33, P722, DOI 10.1523/JNEUROSCI.2970-12.2013; Zhang X, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07679-9; Zhang XY, 2020, NEURON, V105, P1077, DOI 10.1016/j.neuron.2019.12.025; Zhou P, 2018, ELIFE, V7, DOI 10.7554/eLife.28728	51	4	4	9	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 7	2022	375	6576					42	+	eabg7277	10.1126/science.abg7277	http://dx.doi.org/10.1126/science.abg7277			42	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YD3FW	34990249				2022-12-28	WOS:000740261400036
J	Li, JX; Glover, JD; Zhang, HG; Peng, MF; Tan, JZ; Mallick, CB; Hou, D; Yang, YJ; Wu, SJ; Liu, Y; Peng, QQ; Zheng, SJC; Crosse, EI; Medvinsky, A; Anderson, RA; Brown, H; Yuan, ZY; Zhou, S; Xu, YQ; Kemp, JP; Ho, YYW; Loesch, DZ; Wang, LZ; Li, YX; Tang, SW; Wu, XL; Walters, RG; Lin, K; Meng, RG; Lv, J; Chernus, JM; Neiswanger, K; Feingold, E; Evans, DM; Medland, SE; Martin, NG; Weinberg, SM; Marazita, ML; Chen, G; Chen, ZM; Zhou, Y; Cheeseman, M; Wang, L; Jin, L; Headon, DJ; Wang, SJ				Li, Jinxi; Glover, James D.; Zhang, Haiguo; Peng, Meifang; Tan, Jingze; Mallick, Chandana Basu; Hou, Dan; Yang, Yajun; Wu, Sijie; Liu, Yu; Peng, Qianqian; Zheng, Shijie C.; Crosse, Edie, I; Medvinsky, Alexander; Anderson, Richard A.; Brown, Helen; Yuan, Ziyu; Zhou, Shen; Xu, Yanqing; Kemp, John P.; Ho, Yvonne Y. W.; Loesch, Danuta Z.; Wang, Lizhong; Li, Yingxiang; Tang, Senwei; Wu, Xiaoli; Walters, Robin G.; Lin, Kuang; Meng, Ruogu; Lv, Jun; Chernus, Jonathan M.; Neiswanger, Katherine; Feingold, Eleanor; Evans, David M.; Medland, Sarah E.; Martin, Nicholas G.; Weinberg, Seth M.; Marazita, Mary L.; Chen, Gang; Chen, Zhengming; Zhou, Yong; Cheeseman, Michael; Wang, Lan; Jin, Li; Headon, Denis J.; Wang, Sijia			Limb development genes underlie variation in human fingerprint patterns	CELL			English	Article							GENOME-WIDE ASSOCIATION; EXPRESSION PATTERNS; MOUSE LIMB; DERMATOGLYPHIC PATTERNS; PROTEIN RPGRIP1L; EPIDERMAL RIDGE; BETA-CATENIN; MODEL; CONSERVATION; MUTATIONS	Fingerprints are of long-standing practical and cultural interest, but little is known about the mechanisms that underlie their variation. Using genome-wide scans in Han Chinese cohorts, we identified 18 loci associated with fingerprint type across the digits, including a genetic basis for the long-recognized "pattern-block"correlations among the middle three digits. In particular, we identified a variant near EVI1 that alters regulatory activity and established a role for EVI1 in dermatoglyph patterning in mice. Dynamic EVI1 expression during human development supports its role in shaping the limbs and digits, rather than influencing skin patterning directly. Trans-ethnic meta-analysis identified 43 fingerprint-associated loci, with nearby genes being strongly enriched for general limb development pathways. We also found that fingerprint patterns were genetically correlated with hand proportions. Taken together, these findings support the key role of limb development genes in influencing the outcome of fingerprint patterning.	[Li, Jinxi; Wu, Sijie; Jin, Li] Fudan Univ, Collaborat Innovat Ctr Genet & Dev, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200438, Peoples R China; [Li, Jinxi; Wu, Sijie; Jin, Li] Fudan Univ, Human Phenome Inst, Shanghai 200438, Peoples R China; [Li, Jinxi; Peng, Meifang; Wu, Sijie; Liu, Yu; Peng, Qianqian; Zheng, Shijie C.; Jin, Li; Wang, Sijia] Chinese Acad Sci, Univ Chinese Acad Sci, Shanghai Inst Nutr & Hlth, CAS Key Lab Computat Biol, Shanghai 200031, Peoples R China; [Glover, James D.; Mallick, Chandana Basu; Brown, Helen; Cheeseman, Michael; Headon, Denis J.] Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland; [Glover, James D.; Mallick, Chandana Basu; Brown, Helen; Cheeseman, Michael; Headon, Denis J.] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh, Midlothian, Scotland; [Zhang, Haiguo; Peng, Meifang; Tan, Jingze; Yang, Yajun] Fudan Univ, Sch Life Sci, Dept Anthropol & Human Genet, Minist Educ,Key Lab Contemporary Anthropol, Shanghai 200438, Peoples R China; [Mallick, Chandana Basu] Banaras Hindu Univ, Ctr Genet Disorders, Inst Sci, Varanasi, Uttar Pradesh, India; [Hou, Dan; Wang, Lan] Chinese Acad Sci, Univ Chinese Acad Sci, Chinese Acad Sci Key Lab Tissue Microenvironm & T, Shanghai Inst Nutr & Hlth,Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [Crosse, Edie, I; Medvinsky, Alexander] Univ Edinburgh, Ctr Regenerat Med, Edinburgh, Midlothian, Scotland; [Anderson, Richard A.] Univ Edinburgh, MRC Ctr Reprod Hlth, Queens Med Res Inst, Edinburgh, Midlothian, Scotland; [Yuan, Ziyu] Fudan Taizhou Inst Hlth Sci, Taizhou 225326, Jiangsu, Peoples R China; [Zhou, Shen] Shanghai Foreign Language Sch, Shanghai 200083, Peoples R China; [Xu, Yanqing] Forest Ridge Sch Sacred Heart, Bellevue, WA 98006 USA; [Kemp, John P.; Evans, David M.] Univ Queensland, Univ Queensland Diamantina Inst, Brisbane, Qld, Australia; [Ho, Yvonne Y. W.; Medland, Sarah E.; Martin, Nicholas G.] QIMR Berghofer Med Rese Inst, Brisbane, Qld, Australia; [Loesch, Danuta Z.] La Trobe Univ, Psychol Dept, Melbourne, Vic, Australia; [Wang, Lizhong; Li, Yingxiang; Tang, Senwei; Wu, Xiaoli; Chen, Gang] WeGene, Shenzhen 518040, Guangdong, Peoples R China; [Walters, Robin G.; Lin, Kuang; Chen, Zhengming] Univ Oxford, Nuffield Dept Clin Med, Clin Trial Serv Unit, Oxford, England; [Walters, Robin G.; Lin, Kuang; Chen, Zhengming] Univ Oxford, Nuffield Dept Clin Med, Epidemiol Studies Unit, Oxford, England; [Walters, Robin G.; Chen, Zhengming] Univ Oxford, Med Res Council Populat Hlth Res Unit, Nuffield Dept Clin Med, Oxford, England; [Meng, Ruogu] Peking Univ, Ctr Data Sci Hlth & Med, Beijing 100191, Peoples R China; [Lv, Jun] Peking Univ Hlth Sci Ctr, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing 100191, Peoples R China; [Chernus, Jonathan M.; Feingold, Eleanor; Weinberg, Seth M.; Marazita, Mary L.] Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA 15261 USA; [Neiswanger, Katherine; Weinberg, Seth M.; Marazita, Mary L.] Univ Pittsburgh, Ctr Craniofacial & Dent Genet, Dept Oral & Craniofacial Sci, Pittsburgh, PA 15219 USA; [Evans, David M.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Evans, David M.] Univ Bristol, MRC Integrat Epidemiol Unit, Bristol, Avon, England; [Weinberg, Seth M.] Univ Pittsburgh, Dept Anthropol, Pittsburgh, PA 15260 USA; [Marazita, Mary L.] Univ Pittsburgh, Clin & Translat Sci, Pittsburgh, PA 15261 USA; [Marazita, Mary L.] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA 15261 USA; [Zhou, Yong] Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Clin Res Inst, Sch Med, Shanghai, Peoples R China; [Jin, Li] Chinese Acad Med Sci, Res Unit Dissecting Populat Genet & Developing Ne, Shanghai 200438, Peoples R China; [Wang, Sijia] Chinese Acad Sci, Ctr Excellence Anim Evolut & Genet, Kunming 650223, Yunnan, Peoples R China; [Peng, Meifang] Shanghai Jiao Tong Univ, State Key Lab Med Genom, Sch Med,Shanghai Peoples Hosp 9, Dept Mol Diagnost & Endocrinol,Core Lab Med Ctr C, Shanghai 200011, Peoples R China	Fudan University; Fudan University; Chinese Academy of Sciences; Shanghai Institute of Nutrition & Health, CAS; University of Chinese Academy of Sciences, CAS; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; Fudan University; Banaras Hindu University (BHU); Chinese Academy of Sciences; Shanghai Institute of Nutrition & Health, CAS; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; University of Edinburgh; University of Edinburgh; University of Queensland; La Trobe University; University of Oxford; University of Oxford; University of Oxford; Peking University; Peking University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Queensland; University of Bristol; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Shanghai Jiao Tong University; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Jiao Tong University	Jin, L (corresponding author), Fudan Univ, Collaborat Innovat Ctr Genet & Dev, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200438, Peoples R China.; Jin, L (corresponding author), Fudan Univ, Human Phenome Inst, Shanghai 200438, Peoples R China.; Jin, L; Wang, SJ (corresponding author), Chinese Acad Sci, Univ Chinese Acad Sci, Shanghai Inst Nutr & Hlth, CAS Key Lab Computat Biol, Shanghai 200031, Peoples R China.; Headon, DJ (corresponding author), Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland.; Headon, DJ (corresponding author), Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh, Midlothian, Scotland.; Jin, L (corresponding author), Chinese Acad Med Sci, Res Unit Dissecting Populat Genet & Developing Ne, Shanghai 200438, Peoples R China.; Wang, SJ (corresponding author), Chinese Acad Sci, Ctr Excellence Anim Evolut & Genet, Kunming 650223, Yunnan, Peoples R China.	lijin@fudan.edu.cn; denis.headon@roslin.ed.ac.uk; wangsijia@picb.ac.cn	Li, Jinxi/ACL-4148-2022; Evans, David/H-6325-2013	Li, Jinxi/0000-0002-1366-9593; Evans, David/0000-0003-0663-4621; Crosse, Edie/0000-0002-0477-7365; wang, lizhong/0000-0002-3571-8771; Glover, James/0000-0003-4678-5643; Weinberg, Seth/0000-0001-9467-4556	"Strategic Priority Research Program"of the Chinese Academy of Sciences [XDB38020400]; Science and Tecnology Commission of Shanghai Municipality; Ministry of Science and Technology of the People's Republic of China; Shanghai Municipal Science and Technology Major Project [2017SHZDZX01]; National Key Research and Development Project [2018YFC0910403]; Max Planck-CAS Paul Gerson Unna Independent Research Group Leadership Award; National Natural Science Foundation of China (NSFC) [31521003, 81622003, 81373082, 31771325]; China Postdoctoral Science Foundation [2019M651351]; National Science & Technology Basic Research Project [2015FY111700]; CAMS Innovation Fund for Medical Sciences [2019-I2M-5-066]; 111 Project [B13016]; Major Research Program of National Natural Science Foundation of China [91731303]; National Institute for Dental and Craniofacial Research (NIDCR) [R01-DE016148, R21-DE016930]; Biotechnology and Biological Sciences Research Council [BBS/E/D/10002071, BB/T007788/1]; MRC [G1100357, MR/N022556/1]; European Commission; Marie Sklodowska-Curie Actions Individual fellowship [706429]; Wellcome Trust/DBT India Alliance Early Career Fellowship [IA/E/18/1/504338]; Australian Research Council [A7960034, A79906588, A79801419, DP0212016, DP0343921]; Australian National Health and Medical Research Council (NHMRC) [241944, 339462, 389927, 389875, 389891, 389892, 389938, 443036, 442915, 442981, 496739, 552485, 552498]; UK Medical Research Council; Wellcome Trust [102215/2/13/2]; University of Bristol; Medical Research Council [MC_UU_12013/4, MC_UU_12013/3]; Australian Research Council Future Fellowship [FT130101709]; Hong Kong Kadoorie Charitable Foundation; UK Wellcome Trust [202922/Z/16/Z, 104085/Z/14/Z, 088158/Z/09/Z]; UK Medical Research Council [MC-PC-13049, MC-PC-14135]; British Heart Foundation; Cancer Research UK; NHMRC [SRF 1103623]	"Strategic Priority Research Program"of the Chinese Academy of Sciences(Chinese Academy of Sciences); Science and Tecnology Commission of Shanghai Municipality; Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); Shanghai Municipal Science and Technology Major Project; National Key Research and Development Project; Max Planck-CAS Paul Gerson Unna Independent Research Group Leadership Award; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Science & Technology Basic Research Project; CAMS Innovation Fund for Medical Sciences; 111 Project(Ministry of Education, China - 111 Project); Major Research Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institute for Dental and Craniofacial Research (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); Marie Sklodowska-Curie Actions Individual fellowship; Wellcome Trust/DBT India Alliance Early Career Fellowship(Wellcome Trust DBT India Alliance); Australian Research Council(Australian Research Council); Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); University of Bristol; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Australian Research Council Future Fellowship(Australian Research Council); Hong Kong Kadoorie Charitable Foundation; UK Wellcome Trust(Wellcome Trust); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	We would like to thank the participants of the TZL, NSPT, JD, CKB, WeGene, ALSPAC, QIMR, and Pittsburgh study who consented to participate in research, and the whole TZL, NSPT, and JD teams, which include interviewers, computer and laboratory technicians, clerical workers, research scientists, volunteers, managers, receptionists, and nurses. We also thank F.W. for her help with Figure 1A and W.S. for her help with graphic abstract. We thank Dida Biotech for performing the Luciferase assay experiments. This project was funded by the "Strategic Priority Research Program"of the Chinese Academy of Sciences (XDB38020400 to S. Wang) ; Science and Tecnology Commission of Shanghai Municipality; the Ministry of Science and Technology of the People's Republic of China; Shanghai Municipal Science and Technol-ogy Major Project (2017SHZDZX01 to L.J. and S. Wang) ; National Key Research and Development Project (2018YFC0910403 to S. Wang) ; Max Planck-CAS Paul Gerson Unna Independent Research Group Leadership Award (to S. Wang) ; National Natural Science Foundation of China (NSFC) (31521003 to L.J., 81622003 to L.W., 81373082 to J. Lv, and 31771325 to J.T.) ; China Postdoctoral Science Foundation (2019M651351 to J. Li) ; National Science & Technology Basic Research Project (2015FY111700 to L.J.) ; CAMS Innovation Fund for Medical Sciences (2019-I2M-5-066 to L.J.) ; The 111 Proj-ect (B13016 to L.J.) ; Major Research Program of National Natural Science Foundation of China (91731303 to J.T.) ; the National Institute for Dental and Craniofacial Research (NIDCR) (R01-DE016148 to M.L.M and S.M.W and R21-DE016930 to M.L.M) ; Biotechnology and Biological Sciences Research Council (BBS/E/D/10002071 and BB/T007788/1 to D.J.H.) ; MRC (G1100357 to R.A.A and MR/N022556/1 [MRC Centre for Reproductive Health] ; European Commission; Marie Sklodowska-Curie Actions Individual fellowship 706429; Wellcome Trust/DBT India Alliance Early Career Fellowship (IA/E/18/1/504338 to C.B.M) ; Australian Research Council (A7960034, A79906588, A79801419, DP0212016, and DP0343921 to S.E.M) ; Australian National Health and Medical Research Council (NHMRC) (241944, 339462, 389927, 389875, 389891, 389892, 389938, 443036, 442915, 442981, 496739, 552485, and 552498 to S.E.M) ; the UK Medical Research Council; the Well-come Trust (102215/2/13/2) ; the University of Bristol; Medical Research Coun-cil (MC_UU_12013/4 to D.M.E. and MC_UU_12013/3 to N.J.T.) ; Australian Research Council Future Fellowship (FT130101709 to D.M.E.) ; the Hong Kong Kadoorie Charitable Foundation; UK Wellcome Trust (202922/Z/16/Z, 104085/Z/14/Z, and 088158/Z/09/Z) ; UK Medical Research Council (MC-PC-13049 and MC-PC-14135) ; and core funding to the Clinical Trial Service Unit and Epidemiological Studies Unit at Oxford University from British Heart Foundation, UK MRC, and Cancer Research UK (to R.G.W. and Z.C.) . S.E.M. is supported by NHMRC (SRF 1103623) .	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Aguet F, 2017, NATURE, V550, P204, DOI 10.1038/nature24277; Aken BL, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw093; Ali S, 2016, GENOMICS, V108, P143, DOI 10.1016/j.ygeno.2016.08.003; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Andre T, 2010, J NEUROPHYSIOL, V103, P402, DOI 10.1152/jn.00901.2009; ARRIETA MI, 1991, AM J HUM BIOL, V3, P11, DOI 10.1002/ajhb.1310030104; Arts HH, 2007, NAT GENET, V39, P882, DOI 10.1038/ng2069; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Babler W J, 1991, Birth Defects Orig Artic Ser, V27, P95; BABLER WJ, 1987, COLLEGIUM ANTROPOL, V11, P297; Beccari L, 2021, DEV DYNAM, V250, P1280, DOI 10.1002/dvdy.303; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Bonnevie K, 1924, J GENET, V15, P1, DOI 10.1007/BF02983100; Boyd A, 2013, INT J EPIDEMIOL, V42, P111, DOI 10.1093/ije/dys064; Carlsen EO, 2015, AM J MED GENET A, V167, P1890, DOI 10.1002/ajmg.a.37079; Chaudhry AZ, 1997, DEV DYNAM, V208, P313; Chesterman ES, 2001, DEV DYNAM, V222, P459, DOI 10.1002/dvdy.1198; Cho EA, 1998, MECH DEVELOP, V77, P9; Choi SW, 2019, GIGASCIENCE, V8, DOI 10.1093/gigascience/giz082; Claes P, 2018, NAT GENET, V50, P414, DOI 10.1038/s41588-018-0057-4; Compagni A, 2003, DEV CELL, V5, P217, DOI 10.1016/S1534-5807(03)00198-9; Cummins H, 1969, AM J HUM GENET, V21, P516; Cummins H, 1926, AM J PHYS ANTHROPOL, V9, P471, DOI 10.1002/ajpa.1330090422; Davis CA, 2018, NUCLEIC ACIDS RES, V46, pD794, DOI 10.1093/nar/gkx1081; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Delous M, 2007, NAT GENET, V39, P875, DOI 10.1038/ng2039; Dickinson ME, 2016, NATURE, V537, P508, DOI 10.1038/nature19356; Dong YF, 2010, DEVELOPMENT, V137, P1461, DOI 10.1242/dev.042911; Dubail J, 2014, GENESIS, V52, P702, DOI 10.1002/dvg.22784; Eppig J.T., 2017, MOUSE GENOME INFORMA; Fatemifar G, 2013, HUM MOL GENET, V22, P3807, DOI 10.1093/hmg/ddt231; Feng WG, 2008, MOL CELL BIOL, V28, P315, DOI 10.1128/MCB.01168-07; Ferrer-Vaquer A, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-121; Fraser A, 2013, INT J EPIDEMIOL, V42, P97, DOI 10.1093/ije/dys066; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Galton F., 1892, FINGER PRINTS; Gao B, 2013, CURR OPIN GENET DEV, V23, P438, DOI 10.1016/j.gde.2013.05.003; Garzon-Alvarado DA, 2011, THEOR BIOL MED MODEL, V8, DOI 10.1186/1742-4682-8-24; Gerhardt C, 2015, J CELL BIOL, V210, P115, DOI 10.1083/jcb.201408060; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; GibsonBrown JJ, 1996, MECH DEVELOP, V56, P93, DOI 10.1016/0925-4773(96)00514-X; Glass C, 2014, BLOOD CELL MOL DIS, V53, P67, DOI 10.1016/j.bcmd.2014.01.002; Hamrick MW, 2001, J HUM EVOL, V40, P339, DOI 10.1006/jhev.2001.0467; Han B, 2011, AM J HUM GENET, V88, P586, DOI 10.1016/j.ajhg.2011.04.014; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Headon DJ, 1999, NAT GENET, V22, P370, DOI 10.1038/11943; Hill TP, 2006, DEVELOPMENT, V133, P1219, DOI 10.1242/dev.02298; HIRSCH W, 1973, J MENT DEFIC RES, V17, P58; Ho YYW, 2016, J INVEST DERMATOL, V136, P859, DOI 10.1016/j.jid.2015.10.062; Holmes GP, 1998, MECH DEVELOP, V79, P57, DOI 10.1016/S0925-4773(98)00174-9; HOLT SB, 1968, GENETICS DERMAL RIDG; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Hoyt PR, 1997, MECH DEVELOP, V65, P55, DOI 10.1016/S0925-4773(97)00057-9; Kamal N., 2014, INT RES J BIOL SCI, V3, P90; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Kargul B, 2001, J Clin Pediatr Dent, V26, P5; Karmakar B, 2011, ANTHROPOL ANZ, V68, P185, DOI 10.1127/0003-5548/2011/0083; Kawakami Y, 2004, DEVELOPMENT, V131, P4763, DOI 10.1242/dev.01331; Kawakami Y, 2009, DEVELOPMENT, V136, P585, DOI 10.1242/dev.027748; Kichaev G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004722; Kohl M, 2011, METHODS MOL BIOL, V696, P291, DOI 10.1007/978-1-60761-987-1_18; Kowalczyk-Quintas C, 2014, CYTOKINE GROWTH F R, V25, P195, DOI 10.1016/j.cytogfr.2014.01.004; Kucken M, 2007, FORENSIC SCI INT, V171, P85, DOI 10.1016/j.forsciint.2007.02.025; Lancman JJ, 2005, DEV DYNAM, V234, P948, DOI 10.1002/dvdy.20591; Lee SH, 2012, BIOINFORMATICS, V28, P2540, DOI 10.1093/bioinformatics/bts474; Lehoczky JA, 2004, EVOL DEV, V6, P423, DOI 10.1111/j.1525-142X.2004.04050.x; Lewandowski JP, 2015, DEV BIOL, V406, P92, DOI 10.1016/j.ydbio.2015.07.022; Li DY, 2014, DEV CELL, V29, P233, DOI 10.1016/j.devcel.2014.03.001; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Liu J, 2013, DEV BIOL, V375, P160, DOI 10.1016/j.ydbio.2012.12.018; Loesch D.Z., 1983, QUANTITATIVE DERMATO; LOESCH DZ, 1984, ANN HUM BIOL, V11, P113, DOI 10.1080/03014468400006961; Loh PR, 2015, NAT GENET, V47, P284, DOI 10.1038/ng.3190; Ma PC, 2019, CELL REP, V28, P541, DOI 10.1016/j.celrep.2019.06.017; Maceo A., 2002, J FORENSIC IDENTIF, V52, P35; Machado JF, 2010, TWIN RES HUM GENET, V13, P482, DOI 10.1375/twin.13.5.482; Mankoo BS, 1999, NATURE, V400, P69, DOI 10.1038/21892; Mariani FV, 2008, NATURE, V453, P401, DOI 10.1038/nature06876; MARTIN NG, 1982, ANN HUM BIOL, V9, P539, DOI 10.1080/03014468200006061; Matsuda T, 2001, MECH DEVELOP, V105, P153, DOI 10.1016/S0925-4773(01)00383-5; McCulloch DR, 2009, DEV CELL, V17, P687, DOI 10.1016/j.devcel.2009.09.008; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Medland SE, 2010, AM J HUM GENET, V86, P519, DOI 10.1016/j.ajhg.2010.02.017; Medland SE, 2007, PLOS GENET, V3, P1736, DOI 10.1371/journal.pgen.0030165; MENSER MA, 1969, LANCET, V1, P1076; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Monreal AW, 1999, NAT GENET, V22, P366, DOI 10.1038/11937; Mou C, 2006, P NATL ACAD SCI USA, V103, P9075, DOI 10.1073/pnas.0600825103; MULVIHIL.JJ, 1969, J PEDIATR, V75, P579, DOI 10.1016/S0022-3476(69)80453-1; Nagy AS, 2005, HOMO, V56, P51, DOI 10.1016/j.jchb.2004.10.003; Nandadasa S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08520-7; NOHNO T, 1993, DEV BIOL, V158, P254, DOI 10.1006/dbio.1993.1184; OKAJIMA M, 1975, J MED GENET, V12, P243, DOI 10.1136/jmg.12.3.243; Ota S, 2007, DEVELOPMENT, V134, P1583, DOI 10.1242/dev.000703; Painter KJ, 2012, INTERFACE FOCUS, V2, P433, DOI 10.1098/rsfs.2011.0122; Parkinson N, 2006, PLOS GENET, V2, P1556, DOI 10.1371/journal.pgen.0020149; PENROSE LS, 1973, J MED GENET, V10, P201, DOI 10.1136/jmg.10.3.201; PENROSE LS, 1965, NATURE, V205, P544, DOI 10.1038/205544a0; PENROSE LS, 1965, ANN HUM GENET, V29, P207, DOI 10.1111/j.1469-1809.1965.tb00515.x; Pierani A, 1999, CELL, V97, P903, DOI 10.1016/S0092-8674(00)80802-8; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Pruitt KD, 2014, NUCLEIC ACIDS RES, V42, pD756, DOI 10.1093/nar/gkt1114; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rao R, 2019, PRENATAL DIAG, V39, P200, DOI 10.1002/pd.5397; REED T, 1975, HUM HERED, V25, P263, DOI 10.1159/000152734; Robertson EJ, 2007, DEVELOPMENT, V134, P4335, DOI 10.1242/dev.012047; ROSNER F, 1969, LANCET, V2, P272; Saad K, 2017, GENE, V610, P71, DOI 10.1016/j.gene.2017.02.012; Scheibert J, 2009, SCIENCE, V323, P1503, DOI 10.1126/science.1166467; Sengupta M, 2004, ANN HUM BIOL, V31, P526, DOI 10.1080/03014460412331287164; Sheehan-Rooney K, 2010, DEV DYNAM, V239, P3481, DOI 10.1002/dvdy.22483; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Shima Y, 2002, DEV DYNAM, V223, P321, DOI 10.1002/dvdy.10054; Spielmann M, 2016, GENOME RES, V26, P183, DOI 10.1101/gr.199430.115; Srivastava AK, 1997, P NATL ACAD SCI USA, V94, P13069, DOI 10.1073/pnas.94.24.13069; Szenker-Ravi E, 2018, NATURE, V557, P564, DOI 10.1038/s41586-018-0118-y; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Tenenhaus M, 2005, COMPUT STAT DATA AN, V48, P159, DOI 10.1016/j.csda.2004.03.005; Towers M, 2009, DEVELOPMENT, V136, P179, DOI 10.1242/dev.024158; TSUGANE M, 1995, ANAT REC, V242, P225, DOI 10.1002/ar.1092420212; Turner SD, 2014, BIORXIV, DOI 10. 1101/005165 , 2014 .; van Kleffens M, 1998, MOL CELL ENDOCRINOL, V138, P151, DOI 10.1016/S0303-7207(98)00007-0; VERBOV, 1970, BRIT J DERMATOL, V83, P341, DOI 10.1111/j.1365-2133.1970.tb15713.x; Wang XF, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-223; Wang YL, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1519-9; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Weinberg SM, 2006, CLEFT PALATE-CRAN J, V43, P7, DOI 10.1597/04-122R1.1; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Yamaguchi TP, 1999, DEVELOPMENT, V126, P1211; Yamamoto S, 2019, DEV GROWTH DIFFER, V61, P228, DOI 10.1111/dgd.12601; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yum SM, 2020, P NATL ACAD SCI USA, V117, P31665, DOI 10.1073/pnas.2001055117; Zeng HQ, 2010, DEV BIOL, V339, P418, DOI 10.1016/j.ydbio.2010.01.003; Zhang HG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008783; Zhao JQ, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-6	138	6	7	18	49	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 6	2022	185	1					95	+		10.1016/j.cell.2021.12.008	http://dx.doi.org/10.1016/j.cell.2021.12.008			37	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	YL5FO	34995520	Bronze, Green Published			2022-12-28	WOS:000745916700007
J	Kaczynski, M; Mylonakis, E				Kaczynski, Matthew; Mylonakis, Eleftherios			80% of patients with COVID-19 have >= 1 long-term effect at 14 to 110 d after initial symptoms	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Kaczynski, Matthew; Mylonakis, Eleftherios] Brown Univ, Rhode Isl Hosp, Providence, RI 02912 USA; [Kaczynski, Matthew; Mylonakis, Eleftherios] Brown Univ, Miriam Hosp, Providence, RI 02912 USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Lifespan Health Rhode Island; Miriam Hospital	Kaczynski, M (corresponding author), Brown Univ, Rhode Isl Hosp, Providence, RI 02912 USA.; Kaczynski, M (corresponding author), Brown Univ, Miriam Hosp, Providence, RI 02912 USA.							Lerner AM, 2021, ANN INTERN MED, V174, P999, DOI 10.7326/M21-1043; Nalbandian A, 2021, NAT MED, V27, P601, DOI 10.1038/s41591-021-01283-z	2	0	0	3	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN	2022	175	1					JC10	JC10		10.7326/J21-0007	http://dx.doi.org/10.7326/J21-0007		JAN 2022	1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0Y3LO	34978852				2022-12-28	WOS:000742139200001
J	Ferro, LS; Fang, QL; Eshun-Wilson, L; Fernandes, J; Jack, A; Farrell, DP; Golcuk, M; Huijben, T; Costa, K; Gur, M; DiMaio, F; Nogales, E; Yildiz, A				Ferro, Luke S.; Fang, Qianglin; Eshun-Wilson, Lisa; Fernandes, Jonathan; Jack, Amanda; Farrell, Daniel P.; Golcuk, Mert; Huijben, Teun; Costa, Katelyn; Gur, Mert; DiMaio, Frank; Nogales, Eva; Yildiz, Ahmet			Structural and functional insight into regulation of kinesin-1 by microtubule-associated protein MAP7	SCIENCE			English	Article							TUBULIN; DYNEIN; PREDICTION; ENSCONSIN; DYNAMICS; MOTORS; HAND; CODE	Microtubule (MT)-associated protein 7 (MAP7) is a required cofactor for kinesin-1-driven transport of intracellular cargoes. Using cryo-electron microscopy and single-molecule imaging, we investigated how MAP7 binds MTs and facilitates kinesin-1 motility. The MT-binding domain (MTBD) of MAP7 bound MTs as an extended alpha helix between the protofilament ridge and the site of lateral contact. Unexpectedly, the MTBD partially overlapped with the binding site of kinesin-1 and inhibited its motility. However. by tethering kinesin-1 to the MT, the projection domain of MAP7 prevented dissociation of the motor and facilitated its binding to available neighboring sites. The inhibitory effect of the MTBD dominated as MTs became saturated with MAP7. Our results reveal biphasic regulation of kinesin-1 by MAP7 in the context of their competitive binding to MTs.	[Ferro, Luke S.; Fang, Qianglin; Eshun-Wilson, Lisa; Nogales, Eva; Yildiz, Ahmet] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Fernandes, Jonathan] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Jack, Amanda; Nogales, Eva; Yildiz, Ahmet] Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA; [Farrell, Daniel P.; DiMaio, Frank] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Golcuk, Mert; Gur, Mert] Istanbul Tech Univ, Dept Mech Engn, Istanbul, Turkey; [Huijben, Teun] Delft Univ Technol, Dept Imaging Phys, Delft, Netherlands; [Costa, Katelyn] Press West Illustrat, Boston, MA USA; [Nogales, Eva] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Nogales, Eva; Yildiz, Ahmet] Lawrence Berkeley Natl Lab, Mol Biophys & Integrat Bioimaging Div, Berkeley, CA 94720 USA; [Yildiz, Ahmet] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Fang, Qianglin] Sun Yat Sen Univ, Sch Publ Hlth, Shenzhen, Peoples R China	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Washington; University of Washington Seattle; Istanbul Technical University; Delft University of Technology; Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Sun Yat Sen University	Fang, QL; Nogales, E; Yildiz, A (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.; Nogales, E; Yildiz, A (corresponding author), Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA.; Nogales, E (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA.; Nogales, E; Yildiz, A (corresponding author), Lawrence Berkeley Natl Lab, Mol Biophys & Integrat Bioimaging Div, Berkeley, CA 94720 USA.; Yildiz, A (corresponding author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.; Fang, QL (corresponding author), Sun Yat Sen Univ, Sch Publ Hlth, Shenzhen, Peoples R China.	qfang168@berkeley.edu; enogales@lbl.gov; yildiz@berkeley.edu		Fang, Qianglin/0000-0003-1844-7313; Jack, Amanda/0000-0001-8709-1432; Huijben, Teun A.P.M./0000-0002-8984-2882; Golcuk, Mert/0000-0001-5476-8160; Fernandes, Jonathan/0000-0002-3422-1763; Ferro, Luke/0000-0001-5037-8464; Eshun-Wilson, Lisa/0000-0001-6988-1457; Farrell, Daniel/0000-0001-7024-7998	National Institute of General Medical Sciences [GM094522, GM123655-03, GM051487, GM127018]; National Science Foundation [MCB-1617028, MCB-1055017]; PRACE [2019215144]; Istanbul Technical University BAP [MGA-2021-42803]	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF)); PRACE; Istanbul Technical University BAP(Istanbul Technical University)	This work was supported by grants from the National Institute of General Medical Sciences (GM094522 (A.Y.), GM123655-03 (L.F.), GM051487 (E.N.), GM127018 (E.N.), and the National Science Foundation (MCB-1617028 and MCB-1055017, A.Y.), PRACE (2019215144, MG), and Istanbul Technical University BAP (MGA-2021-42803, MG). E.N. is a Howard Hughes Medical Institute Investigator.	Al-Bassam J, 2002, J CELL BIOL, V157, P1187, DOI 10.1083/jcb.200201048; Alushin GM, 2014, CELL, V157, P1117, DOI 10.1016/j.cell.2014.03.053; Barlan K, 2013, CURR BIOL, V23, P317, DOI 10.1016/j.cub.2013.01.008; Beckstein O, 2009, J MOL BIOL, V394, P160, DOI 10.1016/j.jmb.2009.09.009; Belyy V, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6544; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Bodakuntla S, 2019, TRENDS CELL BIOL, V29, P804, DOI 10.1016/j.tcb.2019.07.004; Canty JT, 2021, ANNU REV BIOPHYS, V50, P549, DOI 10.1146/annurev-biophys-111020-101511; Castoldi M, 2003, PROTEIN EXPRES PURIF, V32, P83, DOI 10.1016/S1046-5928(03)00218-3; Chaudhary AR, 2019, J BIOL CHEM, V294, P10160, DOI 10.1074/jbc.RA119.008052; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Cook AD, 2020, J STRUCT BIOL, V209, DOI 10.1016/j.jsb.2019.10.004; Debs GE, 2020, P NATL ACAD SCI USA, V117, P16976, DOI 10.1073/pnas.2001546117; DiMaio F, 2009, J MOL BIOL, V392, P181, DOI 10.1016/j.jmb.2009.07.008; Dixit R, 2008, SCIENCE, V319, P1086, DOI 10.1126/science.1152993; Durrant JD, 2011, J MOL GRAPH MODEL, V31, P5, DOI 10.1016/j.jmgm.2011.07.008; Ebneth A, 1998, J CELL BIOL, V143, P777, DOI 10.1083/jcb.143.3.777; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eshun-Wilson L, 2019, P NATL ACAD SCI USA, V116, P10366, DOI 10.1073/pnas.1900441116; Ferro LS, 2019, ELIFE, V8, DOI 10.7554/eLife.48629; Gallaud E, 2014, J CELL BIOL, V204, P1111, DOI 10.1083/jcb.201311094; Gigant B, 2013, NAT STRUCT MOL BIOL, V20, P1001, DOI 10.1038/nsmb.2624; Grigorieff N, 2016, METHOD ENZYMOL, V579, P191, DOI 10.1016/bs.mie.2016.04.013; Gumy LF, 2017, NEURON, V94, P347, DOI 10.1016/j.neuron.2017.03.046; Heymann JB, 2018, J STRUCT BIOL, V204, P90, DOI 10.1016/j.jsb.2018.07.003; Hooikaas PJ, 2019, J CELL BIOL, V218, P1298, DOI 10.1083/jcb.201808065; Ishihara T, 1999, NEURON, V24, P751, DOI 10.1016/S0896-6273(00)81127-7; Kellogg EH, 2018, SCIENCE, V360, P1242, DOI 10.1126/science.aat1780; Kellogg EH, 2017, J MOL BIOL, V429, P633, DOI 10.1016/j.jmb.2017.01.001; Korten T, 2016, IEEE T NANOBIOSCI, V15, P62, DOI 10.1109/TNB.2016.2520832; Liu JS, 2012, MOL CELL, V47, P707, DOI 10.1016/j.molcel.2012.06.025; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Monroy BY, 2020, DEV CELL, V53, P60, DOI 10.1016/j.devcel.2020.01.029; Monroy BY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03909-2; Phillips JC, 2020, J CHEM PHYS, V153, DOI 10.1063/5.0014475; Roll-Mecak A, 2020, DEV CELL, V54, P7, DOI 10.1016/j.devcel.2020.06.008; Schlager MA, 2014, EMBO J, V33, P1855, DOI 10.15252/embj.201488792; Schneider R, 2015, BIOPHYS J, V108, P2249, DOI 10.1016/j.bpj.2015.03.048; Shigematsu H, 2018, J CELL BIOL, V217, P4155, DOI 10.1083/jcb.201711182; Song YF, 2013, STRUCTURE, V21, P1735, DOI 10.1016/j.str.2013.08.005; Sung HH, 2008, DEV CELL, V15, P866, DOI 10.1016/j.devcel.2008.10.006; Tyka MD, 2011, J MOL BIOL, V405, P607, DOI 10.1016/j.jmb.2010.11.008; Tymanskyj SR, 2018, ELIFE, V7, DOI 10.7554/eLife.36374; Valenstein ML, 2016, CELL, V164, P911, DOI 10.1016/j.cell.2016.01.019; Verhey KJ, 2011, ANNU REV BIOPHYS, V40, P267, DOI 10.1146/annurev-biophys-042910-155310; Vossel KA, 2010, SCIENCE, V330, P198, DOI 10.1126/science.1194653; West LM, 2000, J ORG CHEM, V65, P445, DOI 10.1021/jo991296y; Yildiz A, 2004, SCIENCE, V303, P676, DOI 10.1126/science.1093753; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398; Yin J, 2005, P NATL ACAD SCI USA, V102, P15815, DOI 10.1073/pnas.0507705102; Zhang K, 2017, CELL, V169, P1303, DOI 10.1016/j.cell.2017.05.025; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zhang R, 2015, J STRUCT BIOL, V192, P245, DOI 10.1016/j.jsb.2015.09.015; Zhang R, 2015, CELL, V162, P849, DOI 10.1016/j.cell.2015.07.012; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	57	4	4	4	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2022	375	6578					326	+		10.1126/science.abf6154	http://dx.doi.org/10.1126/science.abf6154			42	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YK2FS	35050657	Green Accepted, Green Submitted			2022-12-28	WOS:000745036100035
J	Banskota, S; Raguram, A; Suh, S; Du, SW; Davis, JR; Choi, EH; Wang, X; Nielsen, SC; Newby, GA; Randolph, PB; Osborn, MJ; Musunuru, K; Palczewski, K; Liu, DR				Banskota, Samagya; Raguram, Aditya; Suh, Susie; Du, Samuel W.; Davis, Jessie R.; Choi, Elliot H.; Wang, Xiao; Nielsen, Sarah C.; Newby, Gregory A.; Randolph, Peyton B.; Osborn, Mark J.; Musunuru, Kiran; Palczewski, Krzysztof; Liu, David R.			Engineered virus-like particles for efficient in vivo delivery of therapeutic proteins	CELL			English	Article							LEBER CONGENITAL AMAUROSIS; LENTIVIRAL VECTOR; CAS9 PROTEIN; GENOMIC DNA; TARGET BASE; PCSK9; TRANSDUCTION; CHOLESTEROL; MICE; VARIANTS	Methods to deliver gene editing agents in vivo as ribonucleoproteins could offer safety advantages over nucleic acid delivery approaches. We report the development and application of engineered DNA-free virus-like particles (eVLPs) that efficiently package and deliver base editor or Cas9 ribonucleoproteins. By engineering VLPs to overcome cargo packaging, release, and localization bottlenecks, we developed fourth-generation eVLPs that mediate efficient base editing in several primary mouse and human cell types. Using different glycoproteins in eVLPs alters their cellular tropism. Single injections of eVLPs into mice support therapeutic levels of base editing in multiple tissues, reducing serum Pcsk9 levels 78% following 63% liver editing, and partially restoring visual function in a mouse model of genetic blindness. In vitro and in vivo off-target editing from eVLPs was virtually undetected, an improvement over AAV or plasmid delivery. These results establish eVLPs as promising vehicles for therapeutic macromolecule delivery that combine key advantages of both viral and nonviral delivery.	[Banskota, Samagya; Raguram, Aditya; Davis, Jessie R.; Newby, Gregory A.; Randolph, Peyton B.; Liu, David R.] Broad Inst MIT & Harvard, Merkin Inst Transformat Technol Healthcare, Cambridge, MA 02142 USA; [Banskota, Samagya; Raguram, Aditya; Davis, Jessie R.; Newby, Gregory A.; Randolph, Peyton B.; Liu, David R.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Banskota, Samagya; Raguram, Aditya; Davis, Jessie R.; Newby, Gregory A.; Randolph, Peyton B.; Liu, David R.] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Suh, Susie; Du, Samuel W.; Choi, Elliot H.; Palczewski, Krzysztof] Univ Calif Irvine, Dept Ophthalmol, Gavin Herbert Eye Inst, Ctr Translat Vis Res, Irvine, CA USA; [Suh, Susie; Choi, Elliot H.] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Du, Samuel W.; Palczewski, Krzysztof] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA USA; [Wang, Xiao; Musunuru, Kiran] Univ Penn, Perelman Sch Med, Cardiovasc Inst, Philadelphia, PA 19104 USA; [Wang, Xiao; Musunuru, Kiran] Univ Penn, Dept Med, Div Cardiovasc Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Wang, Xiao; Musunuru, Kiran] Univ Penn, Dept Genet, Perelman Sch Med, Philadelphia, PA 19104 USA; [Nielsen, Sarah C.; Osborn, Mark J.] Univ Minnesota, Dept Pediat, Div Blood & Marrow Transplant & Cellular Therapy, Minneapolis, MN 55455 USA; [Palczewski, Krzysztof] Univ Calif Irvine, Dept Chem, Irvine, CA 92717 USA; [Palczewski, Krzysztof] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Howard Hughes Medical Institute; University of California System; University of California Irvine; Case Western Reserve University; University of California System; University of California Irvine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California Irvine; University of California System; University of California Irvine	Liu, DR (corresponding author), Broad Inst MIT & Harvard, Merkin Inst Transformat Technol Healthcare, Cambridge, MA 02142 USA.; Liu, DR (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.; Liu, DR (corresponding author), Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA.	drliu@fas.harvard.edu	Liu, David R./HCH-3132-2022	Randolph, Peyton/0000-0001-6385-364X; Newby, Gregory A./0000-0001-7869-2615; Du, Samuel/0000-0002-9655-3659; Raguram, Aditya/0000-0002-5749-7308; Davis, Jessie/0000-0002-6911-0908	NIH [UG3AI150551, U01AI142756, R35GM118062, RM1HG009490, R01EY009339, T32GM095450, F30EY029136, T32GM007250, T32EY024236]; Bill and Melinda Gates Foundation; HHMI; NSF graduate research fellowship; Helen Hay Whitney postdoctoral fellowship; Saint Baldrick's Foundation Scholar Award; Kidz1stFund; Chambers Family Innovation Fund; Research to Prevent Blindness Stein Innovation Award	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); HHMI(Howard Hughes Medical Institute); NSF graduate research fellowship(National Science Foundation (NSF)); Helen Hay Whitney postdoctoral fellowship; Saint Baldrick's Foundation Scholar Award; Kidz1stFund; Chambers Family Innovation Fund; Research to Prevent Blindness Stein Innovation Award(Research to Prevent Blindness (RPB))	This work was supported by NIH UG3AI150551, U01AI142756, R35GM118062, RM1HG009490, and R01EY009339; the Bill and Melinda Gates Foundation; and HHMI. A.R. is supported by NIH T32GM095450 and an NSF graduate research fellowship. S.S. is supported by NIH F30EY029136, T32GM007250, and T32EY024236. S.W.D. acknowledges support from T32GM008620. G.A.N. is supported by a Helen Hay Whitney postdoctoral fellowship. M.J.O. is a recipient of a Saint Baldrick's Foundation Scholar Award. M.J.O and S.C.N. are supported by the Kidz1stFund and the Chambers Family Innovation Fund. P.B.R. is sup-ported by an NSF graduate research fellowship. K.P. is the Donald Bren Profes-sor and Irving H. Leopold Chair of Ophthalmology and acknowledges support from a Research to Prevent Blindness Stein Innovation Award and an unre-stricted grant to the Department of Ophthalmology. We thank P. Chen, B. MacDonald, and N. Pirete for helpful discussions; M. Howard for technical assis-tance; L. Zhang and R. Bronson for histopathological assessment; K. Cormier and C. Condon for assistance with digitization of H & E slides; D.S. Yun for elec-tron microscopy assistance; and B. Lash and F. Zhang for generous access to equipment. Some images in the graphical abstract and Figure 2C were created with BioRender.com .	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Akcakaya P, 2018, NATURE, V561, P416, DOI 10.1038/s41586-018-0500-9; Alanis-Lobato G, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2004832117; Anzalone AV, 2020, NAT BIOTECHNOL, V38, P824, DOI 10.1038/s41587-020-0561-9; Campbell LA, 2019, MOL THER, V27, P151, DOI 10.1016/j.ymthe.2018.10.002; Chandler RJ, 2017, HUM GENE THER, V28, P314, DOI 10.1089/hum.2017.009; Chen PJ, 2021, CELL, V184, P5635, DOI 10.1016/j.cell.2021.09.018; Choi JG, 2016, GENE THER, V23, P627, DOI 10.1038/gt.2016.27; Cideciyan AV, 2010, PROG RETIN EYE RES, V29, P398, DOI 10.1016/j.preteyeres.2010.04.002; Clement K, 2019, NAT BIOTECHNOL, V37, P224, DOI 10.1038/s41587-019-0032-3; Cohen J, 2005, NAT GENET, V37, P328, DOI 10.1038/ng0305-328c; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Cronin J, 2005, CURR GENE THER, V5, P387, DOI 10.2174/1566523054546224; David RM, 2017, TOXICOL SCI, V155, P315, DOI 10.1093/toxsci/kfw220; Davis KM, 2015, NAT CHEM BIOL, V11, P316, DOI [10.1038/NCHEMBIO.1793, 10.1038/nchembio.1793]; den Hollander AI, 2008, PROG RETIN EYE RES, V27, P391, DOI 10.1016/j.preteyeres.2008.05.003; Deverman BE, 2016, NAT BIOTECHNOL, V34, P204, DOI 10.1038/nbt.3440; Doman JL, 2020, NAT BIOTECHNOL, V38, P620, DOI 10.1038/s41587-020-0414-6; Doudna JA, 2020, NATURE, V578, P229, DOI 10.1038/s41586-020-1978-5; Feher A, 2006, J GEN VIROL, V87, P1321, DOI 10.1099/vir.0.81382-0; Fitzgerald K, 2014, LANCET, V383, P60, DOI 10.1016/S0140-6736(13)61914-5; Gaudelli NM, 2020, NAT BIOTECHNOL, V38, P892, DOI 10.1038/s41587-020-0491-6; Gaudelli NM, 2017, NATURE, V551, P464, DOI 10.1038/nature24644; Gee P, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14957-y; Giannoukos G, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4561-9; Golczak M, 2010, J BIOL CHEM, V285, P9667, DOI 10.1074/jbc.M109.063941; Hamilton JR, 2021, CELL REP, V35, DOI 10.1016/j.celrep.2021.109207; Hooper AJ, 2007, ATHEROSCLEROSIS, V193, P445, DOI 10.1016/j.atherosclerosis.2006.08.039; Huang TP, 2019, NAT BIOTECHNOL, V37, P626, DOI 10.1038/s41587-019-0134-y; Humbel M, 2021, GENE THER, V28, P75, DOI 10.1038/s41434-020-0172-6; Indikova I, 2020, NUCLEIC ACIDS RES, V48, P8178, DOI 10.1093/nar/gkaa561; Jang HK, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abg2661; Jo D.H., 2021, THERAPEUTIC ADENINE, DOI [10.1101/2021.01.07.425822, DOI 10.1101/2021.01.07.425822]; Johnson S, 2018, BIOLOGICALS, V52, P59, DOI 10.1016/j.biologicals.2017.12.005; Kaczmarczyk SJ, 2011, P NATL ACAD SCI USA, V108, P16998, DOI 10.1073/pnas.1101874108; Kato S, 2011, J NEUROSCI, V31, P17169, DOI 10.1523/JNEUROSCI.4005-11.2011; Koblan LW, 2021, NATURE, V589, P608, DOI 10.1038/s41586-020-03086-7; Koblan LW, 2018, NAT BIOTECHNOL, V36, P843, DOI 10.1038/nbt.4172; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Kosicki M, 2018, NAT BIOTECHNOL, V36, P765, DOI 10.1038/nbt.4192; Lazzarotto CR, 2020, NAT BIOTECHNOL, V38, P1317, DOI 10.1038/s41587-020-0555-7; Leibowitz ML, 2021, NAT GENET, V53, P895, DOI 10.1038/s41588-021-00838-7; LeibundGut-Landmann S, 2004, EUR J IMMUNOL, V34, P1513, DOI 10.1002/eji.200424964; Levy JM, 2020, NAT BIOMED ENG, V4, P97, DOI 10.1038/s41551-019-0501-5; Lyu P, 2021, CRISPR J, V4, P69, DOI 10.1089/crispr.2020.0095; Lyu P, 2019, NUCLEIC ACIDS RES, V47, DOI 10.1093/nar/gkz605; Mangeot PE, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-07845-z; Mangeot PE, 2011, MOL THER, V19, P1656, DOI 10.1038/mt.2011.138; Mercuri E, 2018, NEW ENGL J MED, V378, P625, DOI 10.1056/NEJMoa1710504; Meunier L, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01482; Milone MC, 2018, LEUKEMIA, V32, P1529, DOI 10.1038/s41375-018-0106-0; Musunuru K, 2021, NATURE, V593, P429, DOI 10.1038/s41586-021-03534-y; Newby GA, 2021, MOL THER, V29, P3107, DOI 10.1016/j.ymthe.2021.09.002; Newby GA, 2021, NATURE, V595, P295, DOI 10.1038/s41586-021-03609-w; Nishida K, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8729; Osborn MJ, 2020, J INVEST DERMATOL, V140, P338, DOI 10.1016/j.jid.2019.07.701; Pan D, 2002, MOL THER, V6, P19, DOI 10.1006/mthe.2002.0630; Pang JJ, 2005, MOL VIS, V11, P152; Parr-Brownlie LC, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00014; Puppo A, 2014, GENE THER, V21, P855, DOI 10.1038/gt.2014.57; Rao AS, 2018, CIRC-GENOM PRECIS ME, V11, DOI 10.1161/CIRCGEN.118.002162; Rees HA, 2018, NAT REV GENET, V19, P770, DOI 10.1038/s41576-018-0059-1; Rees HA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15790; Renner TM, 2020, J VIROL, V94, DOI 10.1128/JVI.01600-19; Richter MF, 2020, NAT BIOTECHNOL, V38, P883, DOI 10.1038/s41587-020-0453-z; Rothgangl T, 2021, NAT BIOTECHNOL, V39, P949, DOI 10.1038/s41587-021-00933-4; SERREZE DV, 1994, DIABETES, V43, P505, DOI 10.2337/diabetes.43.3.505; Sodi A, 2021, ORPHANET J RARE DIS, V16, DOI 10.1186/s13023-021-01868-4; Song YN, 2020, MOL THER-NUCL ACIDS, V21, P523, DOI 10.1016/j.omtn.2020.06.019; Stadtmauer EA, 2020, SCIENCE, V367, P1001, DOI 10.1126/science.aba7365; Suh S, 2021, NAT BIOMED ENG, V5, DOI 10.1038/s41551-020-00632-6; Swiech L, 2015, NAT BIOTECHNOL, V33, P102, DOI 10.1038/nbt.3055; Taylor AW, 2009, EYE, V23, P1885, DOI 10.1038/eye.2008.382; Thorne RG, 2006, P NATL ACAD SCI USA, V103, P5567, DOI 10.1073/pnas.0509425103; Tsai SQ, 2017, NAT METHODS, V14, P607, DOI [10.1038/NMETH.4278, 10.1038/nmeth.4278]; Turchiano G, 2021, CELL STEM CELL, V28, P1136, DOI 10.1016/j.stem.2021.02.002; Voelkel C, 2010, P NATL ACAD SCI USA, V107, P7805, DOI 10.1073/pnas.0914517107; Wang D, 2020, CELL, V181, P136, DOI 10.1016/j.cell.2020.03.023; Wang D, 2010, MOL GENET METAB, V99, P62, DOI 10.1016/j.ymgme.2009.08.002; Webber BR, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13007-6; Wei T, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17029-3; Wheeler JX, 2007, PROTEOM CLIN APPL, V1, P224, DOI 10.1002/prca.200600522; Wu DT, 2014, BIOMATERIALS, V35, P8416, DOI 10.1016/j.biomaterials.2014.06.006; Yao XG, 2021, J EXTRACELL VESICLES, V10, DOI 10.1002/jev2.12076; Yeh WH, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aay9101; Yeh WH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04580-3; Yu Y, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15887-5; Zeng J, 2020, NAT MED, V26, P535, DOI 10.1038/s41591-020-0790-y; Zhang W, 2015, AIMS BIOPHYS, V2, P343, DOI 10.3934/biophy.2015.3.343; Zhong ZL, 2019, MOL VIS, V25, P204	90	53	54	74	130	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 20	2022	185	2					250	+		10.1016/j.cell.2021.12.021	http://dx.doi.org/10.1016/j.cell.2021.12.021			33	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	YL8YE	35021064	Green Published, hybrid			2022-12-28	WOS:000746172100007
J	Madzik, MT; Asaad, S; Youssry, A; Joecker, B; Rudinger, KM; Nielsen, E; Young, KC; Proctor, TJ; Baczewski, AD; Laucht, A; Schmitt, V; Hudson, FE; Itoh, KM; Jakob, AM; Johnson, BC; Jamieson, DN; Dzurak, AS; Ferrie, C; Blume-Kohout, R; Morello, A				Madzik, Mateusz T.; Asaad, Serwan; Youssry, Akram; Joecker, Benjamin; Rudinger, Kenneth M.; Nielsen, Erik; Young, Kevin C.; Proctor, Timothy J.; Baczewski, Andrew D.; Laucht, Arne; Schmitt, Vivien; Hudson, Fay E.; Itoh, Kohei M.; Jakob, Alexander M.; Johnson, Brett C.; Jamieson, David N.; Dzurak, Andrew S.; Ferrie, Christopher; Blume-Kohout, Robin; Morello, Andrea			Precision tomography of a three-qubit donor quantum processor in silicon	NATURE			English	Article							ELECTRON-SPIN; NUCLEAR SPINS; QUBIT; ENTANGLEMENT; READOUT; GATE	Nuclear spins were among the first physical platforms to be considered for quantum information processing(1,2), because of their exceptional quantum coherence(3) and atomic-scale footprint. However, their full potential for quantum computing has not yet been realized, owing to the lack of methods with which to link nuclear qubits within a scalable device combined with multi-qubit operations with sufficient fidelity to sustain fault-tolerant quantum computation. Here we demonstrate universal quantum logic operations using a pair of ion-implanted P-31 donor nuclei in a silicon nanoelectronic device. A nuclear two-qubit controlled-Z gate is obtained by imparting a geometric phase to a shared electron spin(4), and used to prepare entangled Bell states with fidelities up to 94.2(2.7)%. The quantum operations are precisely characterized using gate set tomography (GST)(5), yielding one-qubit average gate fidelities up to 99.95(2)%, two-qubit average gate fidelity of 99.37(11)% and two-qubit preparation/measurement fidelities of 98.95(4)%. These three metrics indicate that nuclear spins in silicon are approaching the performance demanded in fault-tolerant quantum processors(6). We then demonstrate entanglement between the two nuclei and the shared electron by producing a Greenberger-Horne-Zeilinger three-qubit state with 92.5(1.0)% fidelity. Because electron spin qubits in semiconductors can be further coupled to other electrons(7-9) or physically shuttled across different locations(10,11), these results establish a viable route for scalable quantum information processing using donor nuclear and electron spins.	[Madzik, Mateusz T.; Asaad, Serwan; Joecker, Benjamin; Laucht, Arne; Schmitt, Vivien; Hudson, Fay E.; Dzurak, Andrew S.; Morello, Andrea] UNSW Sydney, Sch Elect Engn & Telecommun, Sydney, NSW, Australia; [Youssry, Akram; Laucht, Arne; Ferrie, Christopher] Univ Technol Sydney, Ctr Quantum Software & Informat, Ultimo, NSW, Australia; [Youssry, Akram] Ain Shams Univ, Fac Engn, Dept Elect & Commun Engn, Cairo, Egypt; [Rudinger, Kenneth M.; Nielsen, Erik; Blume-Kohout, Robin] Sandia Natl Labs, Quantum Performance Lab, POB 5800, Albuquerque, NM 87185 USA; [Young, Kevin C.; Proctor, Timothy J.] Sandia Natl Labs, Quantum Performance Lab, Livermore, CA USA; [Baczewski, Andrew D.] Sandia Natl Labs, Ctr Comp Res, POB 5800, Albuquerque, NM 87185 USA; [Itoh, Kohei M.] Keio Univ, Sch Fundamental Sci & Technol, Yokohama, Kanagawa, Japan; [Jakob, Alexander M.; Johnson, Brett C.; Jamieson, David N.] Univ Melbourne, Sch Phys, Melbourne, Vic, Australia; [Madzik, Mateusz T.] Delft Univ Technol, QuTech, Delft, Netherlands; [Asaad, Serwan] Univ Copenhagen, Ctr Quantum Devices, Niels Bohr Inst, Copenhagen, Denmark; [Schmitt, Vivien] Univ Grenoble Napes, IRIG PHELIQS, CEA, Grenoble INP, Grenoble, France	University of New South Wales Sydney; University of Technology Sydney; Egyptian Knowledge Bank (EKB); Ain Shams University; United States Department of Energy (DOE); Sandia National Laboratories; United States Department of Energy (DOE); Sandia National Laboratories; United States Department of Energy (DOE); Sandia National Laboratories; Keio University; University of Melbourne; Delft University of Technology; University of Copenhagen; Niels Bohr Institute; CEA; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble	Morello, A (corresponding author), UNSW Sydney, Sch Elect Engn & Telecommun, Sydney, NSW, Australia.	a.morello@unsw.edu.au	Morello, Andrea/B-6475-2008; SCHMITT, Vivien/A-3472-2016; Proctor, Timothy/AAF-7719-2019	Morello, Andrea/0000-0001-7445-699X; SCHMITT, Vivien/0000-0002-6495-1679; Baczewski, Andrew/0000-0001-8553-9934; Youssry, Akram/0000-0001-7301-5834; Madzik, Mateusz/0000-0003-4857-3257; Young, Kevin/0000-0002-4679-4542; Joecker, Benjamin/0000-0003-0263-5440; Proctor, Timothy/0000-0003-0219-8930; Asaad, Serwan/0000-0002-6407-4434; Jakob, Alexander Malwin/0000-0002-2794-404X; Rudinger, Kenneth/0000-0002-3038-4389	Australian Research Council [CE170100012]; US Army Research Office [W911NF-17-1-0200]; Australian Department of Industry, Innovation and Science [AUSMURI000002]; Australian National Fabrication Facility (ANFF); iHPC facility at the University of Technology Sydney (UTS); US Department of Energy, Office of Science, Office of Advanced Scientific Computing Research; US Department of Energy, Office of Science, National Quantum Information Science Research Centers (Quantum Systems Accelerator); US Department of Energy's National Nuclear Security Administration [DE-NA0003525]	Australian Research Council(Australian Research Council); US Army Research Office; Australian Department of Industry, Innovation and Science; Australian National Fabrication Facility (ANFF); iHPC facility at the University of Technology Sydney (UTS); US Department of Energy, Office of Science, Office of Advanced Scientific Computing Research(United States Department of Energy (DOE)); US Department of Energy, Office of Science, National Quantum Information Science Research Centers (Quantum Systems Accelerator)(United States Department of Energy (DOE)); US Department of Energy's National Nuclear Security Administration(National Nuclear Security Administration)	We acknowledge conversations with W.Huang, R.Rahman, S.Seritan and C.H. Yang and technical support from T.Botzem. The research was supported by the Australian Research Council (grant no. CE170100012), the US Army Research Office (contract no. W911NF-17-1-0200), and the Australian Department of Industry, Innovation and Science (grant no. AUSMURI000002). We acknowledge support from the Australian National Fabrication Facility (ANFF). This material is based upon work supported in part by the iHPC facility at the University of Technology Sydney (UTS), by the US Department of Energy, Office of Science, Office of Advanced Scientific Computing Research's Quantum Testbed Pathfinder and Early Career Research Programs, and by the US Department of Energy, Office of Science, National Quantum Information Science Research Centers (Quantum Systems Accelerator). Sandia National Laboratories is a multimission laboratory managed and operated by National Technology and Engineering Solutions of Sandia, LLC, a wholly owned subsidiary of Honeywell International, Inc., for the US Department of Energy's National Nuclear Security Administration under contract DE-NA0003525. All statements of fact, opinion or conclusions contained herein are those of the authors and should not be construed as representing the official views or policies of the US Department of Energy, or the US Government.	Adambukulam C, 2021, REV SCI INSTRUM, V92, DOI 10.1063/5.0055318; Akaike H., 1973, 2 INT S INF THEOR, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; ANANDAN J, 1992, NATURE, V360, P307, DOI 10.1038/360307a0; Asaad S, 2020, NATURE, V579, P205, DOI 10.1038/s41586-020-2057-7; Bhaskar MK, 2020, NATURE, V580, P60, DOI 10.1038/s41586-020-2103-5; Blume-Kohout R., 2021, TAXONOMY SMALL MARKO; Bourassa A, 2020, NAT MATER, V19, P1319, DOI 10.1038/s41563-020-00802-6; Bradley CE, 2019, PHYS REV X, V9, DOI 10.1103/PhysRevX.9.031045; Braginsky VB, 1996, REV MOD PHYS, V68, P1, DOI 10.1103/RevModPhys.68.1; Buonacorsi B, 2019, QUANTUM SCI TECHNOL, V4, DOI 10.1088/2058-9565/aaf3c4; Carignan-Dugas A, 2019, NEW J PHYS, V21, DOI 10.1088/1367-2630/ab1800; Dehollain JP, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/1/015202; Elzerman JM, 2004, NATURE, V430, P431, DOI 10.1039/nature02693; FEHER G, 1959, PHYS REV, V114, P1219, DOI 10.1103/PhysRev.114.1219; Filidou V, 2012, NAT PHYS, V8, P596, DOI [10.1038/NPHYS2353, 10.1038/nphys2353]; Fowler AG, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.032324; Gamble JK, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.235318; Gross J. A., 2021, HARDWARE EFFICIENT E; Gullans MJ, 2019, PHYS REV B, V100, DOI 10.1103/PhysRevB.100.085419; Harvey-Collard P, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01113-2; He Y, 2019, NATURE, V571, P371, DOI 10.1038/s41586-019-1381-2; Hensen B, 2020, NAT NANOTECHNOL, V15, P13, DOI 10.1038/s41565-019-0587-7; Hile SJ, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aaq1459; Hsueh YL, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.246406; Huang W, 2019, NATURE, V569, P532, DOI 10.1038/s41586-019-1197-0; Ivie JA, 2021, PHYS REV APPL, V16, DOI 10.1103/PhysRevApplied.16.054037; James DFV, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.052312; Joecker B, 2021, NEW J PHYS, V23, DOI 10.1088/1367-2630/ac0abf; Kalra R, 2016, REV SCI INSTRUM, V87, DOI 10.1063/1.4959153; Kane BE, 1998, NATURE, V393, P133, DOI 10.1038/30156; Kimmel S, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.011050; Madzik MT, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20424-5; Mehring M, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.153001; Mielke J, 2021, PRX QUANTUM, V2, DOI 10.1103/PRXQuantum.2.020347; Morello A, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.081307; Morello A, 2010, NATURE, V467, P687, DOI 10.1038/nature09392; Muhonen JT, 2015, J PHYS-CONDENS MAT, V27, DOI 10.1088/0953-8984/27/15/154205; Neumann P, 2008, SCIENCE, V320, P1326, DOI 10.1126/science.1157233; Nielsen E, 2021, QUANTUM-AUSTRIA, V5, DOI 10.22331/q-2021-10-05-557; Nielsen E, 2021, NEW J PHYS, V23, DOI 10.1088/1367-2630/ac20b9; Novais E, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.010502; Pica G, 2016, PHYS REV B, V93, DOI 10.1103/PhysRevB.93.035306; Pla JJ, 2013, NATURE, V496, P334, DOI 10.1038/nature12011; Pla JJ, 2012, NATURE, V489, P541, DOI 10.1038/nature11449; Pompili M, 2021, SCIENCE, V372, P259, DOI 10.1126/science.abg1919; Proctor T, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.130502; Sackett CA, 2000, NATURE, V404, P256, DOI 10.1038/35005011; Saeedi K, 2013, SCIENCE, V342, P830, DOI 10.1126/science.1239584; Steger M, 2011, J APPL PHYS, V109, DOI 10.1063/1.3577614; Tenberg SB, 2019, PHYS REV B, V99, DOI 10.1103/PhysRevB.99.205306; Tosi G, 2018, PHYS REV B, V98, DOI 10.1103/PhysRevB.98.075313; Tosi G, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00378-x; Vandersypen LMK, 2017, NPJ QUANTUM INFORM, V3, DOI 10.1038/s41534-017-0038-y; Vandersypen LMK, 2004, REV MOD PHYS, V76, P1037, DOI 10.1103/RevModPhys.76.1037; Waldherr G, 2014, NATURE, V506, P204, DOI 10.1038/nature12919; Wei KX, 2020, PHYS REV A, V101, DOI 10.1103/PhysRevA.101.032343; Wilks SS, 1938, ANN MATH STAT, V9, P60, DOI 10.1214/aoms/1177732360; Xue X, 2019, PHYS REV X, V9, DOI 10.1103/PhysRevX.9.021011; Xue X, 2022, NATURE, V601, P343, DOI 10.1038/s41586-021-04273-w; Yoneda J, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-24371-7; Zhong MJ, 2015, NATURE, V517, P177, DOI 10.1038/nature14025	67	34	34	23	34	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 20	2022	601	7893					348	+		10.1038/s41586-021-04292-7	http://dx.doi.org/10.1038/s41586-021-04292-7			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YJ6UI	35046601	Green Submitted			2022-12-28	WOS:000744666700025
J	Rubin, R				Rubin, Rita			Improving the Response to Foodborne Illness Outbreaks	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 18	2022	327	3					210	210						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YV9PQ	35040900				2022-12-28	WOS:000753055100005
J	Wagner, WE; Gold, SC				Wagner, Wendy E.; Gold, Steve C.			Legal obstacles to toxic chemical research	SCIENCE			English	Editorial Material									[Wagner, Wendy E.] Univ Texas Austin, Sch Law, Austin, TX 78712 USA; [Gold, Steve C.] Rutgers Law Sch, Newark, NJ USA	University of Texas System; University of Texas Austin; Rutgers State University Newark	Wagner, WE (corresponding author), Univ Texas Austin, Sch Law, Austin, TX 78712 USA.	wwagner@law.utexas.edu						Chibwe L, 2017, ENVIRON SCI TECH LET, V4, P32, DOI 10.1021/acs.estlett.6b00455; Coffin S, 2021, PLOS BIOL, V19, DOI 10.1371/journal.pbio.3000932; EPA, TSCA CBI REV STAT; EPA, 2021, EPAHQOPPT20200549000; EPA, 2009, 712F08001 EPA; European Chemicals Agency (ECHA), 2021, DISS CONF REACH REG; Hogue C., CHEM ENG NEWS, V99, P14; Llanos EJ, 2019, P NATL ACAD SCI USA, V116, P12660, DOI 10.1073/pnas.1816039116; Lundgren R.E, 2018, RISK COMMUNICATION H; Lyndon ML, 2011, RES HBK INTELLECT, P442; Richter L, 2021, SOCIOL PERSPECT, V64, P631, DOI 10.1177/0731121420964827; Stringer L, 2021, CHEM WATCH 0303; Wagner W, 2004, AM J LAW MED, V30, P119, DOI 10.1177/009885880403000202; Wang ZY, 2020, ENVIRON SCI TECHNOL, V54, P2575, DOI 10.1021/acs.est.9b06379; Washington JW, 2020, SCIENCE, V368, P1103, DOI 10.1126/science.aba7127	15	2	2	1	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2022	375	6577					138	141		10.1126/science.abl4383	http://dx.doi.org/10.1126/science.abl4383			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YG3OI	35025638				2022-12-28	WOS:000742401600013
J	Fan, WB; Dong, M				Fan, Weibin; Dong, Mei			Regulation of zeolite particle morphology	SCIENCE			English	Editorial Material							MFI		[Fan, Weibin; Dong, Mei] Chinese Acad Sci, Inst Coal Chem, State Key Lab Coal Convers, 27 South Taoyuan Rd, Taiyuan 030001, Peoples R China	Chinese Academy of Sciences; Institute of Coal Chemistry, CAS	Dong, M (corresponding author), Chinese Acad Sci, Inst Coal Chem, State Key Lab Coal Convers, 27 South Taoyuan Rd, Taiyuan 030001, Peoples R China.	mdong@sxicc.ac.cn						Chen LH, 2020, CHEM REV, V120, P11194, DOI 10.1021/acs.chemrev.0c00016; Choi M, 2009, NATURE, V461, P246, DOI 10.1038/nature08288; Fan W, 2008, NAT MATER, V7, P984, DOI 10.1038/nmat2302; Korde A, 2022, SCIENCE, V375, P62, DOI 10.1126/science.abg3793; Li SY, 2021, ACS APPL MATER INTER, V13, P58085, DOI 10.1021/acsami.1c15226; Moller K, 2011, SCIENCE, V333, P297, DOI 10.1126/science.1208528; Shen XF, 2018, CHEM-EUR J, V24, P8615, DOI 10.1002/chem.201800307; Shen XF, 2018, ANGEW CHEM INT EDIT, V57, P724, DOI 10.1002/anie.201710748; Sun MH, 2020, MATTER-US, V3, P1226, DOI 10.1016/j.matt.2020.07.016; Wang CF, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12285-4; Zhang Q, 2019, J AM CHEM SOC, V141, P3772, DOI 10.1021/jacs.8b11734	11	0	0	44	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 7	2022	375	6576					29	29		10.1126/science.abn2048	http://dx.doi.org/10.1126/science.abn2048			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YD3FW	34990234				2022-12-28	WOS:000740261400028
J	Mukherjee, B; Shaffer, A; Patel, PB; Yan, ZJ; Wilson, CC; Crepel, V; Fletcher, RJ; Zwierlein, M				Mukherjee, Biswaroop; Shaffer, Airlia; Patel, Parth B.; Yan, Zhenjie; Wilson, Cedric C.; Crepel, Valentin; Fletcher, Richard J.; Zwierlein, Martin			Crystallization of bosonic quantum Hall states in a rotating quantum gas	NATURE			English	Article							COLLECTIVE EXCITATIONS; SUPERFLUID HE-4; EDGE STATES; DYNAMICS; ROTON; ELECTRONS; LIQUID	The dominance of interactions over kinetic energy lies at the heart of strongly correlated quantum matter, from fractional quantum Hall liquids(1), to atoms in optical lattices(2) and twisted bilayergraphene(3). Crystalline phases often compete with correlated quantum liquids, and transitions between them occur when the energy cost of forming a density wave approaches zero. A prime example occurs for electrons in high-strength magnetic fields, where the instability of quantum Hall liquidstowards a Wigner crystal(4-9) is heralded by a roton-like softening of density modulations at the magnetic length(7,10-12). Remarkably, interacting bosons in a gauge field are also expected to form analogous liquid and crystalline states(13-)(21). However, combining interactions with strong synthetic magnetic fields has been a challenge for experiments on bosonic quantum gases(18,)(21). Here we study the purely interaction-driven dynamics of a Landau gauge Bose-Einstein condensate(22) in and near the lowest Landau level. We observe a spontaneous crystallization driven by condensation of magneto-rotons(7,10), excitations visible as density modulations at the magnetic length. Increasing the cloud density smoothly connects this behaviour to a quantum version of the Kelvin-Helmholtz hydrodynamic instability, driven by the sheared internal flow profile of the rapidly rotating condensate. At long times the condensate self-organizes into a persistent array of droplets separated by vortex streets, which are stabilized by a balance of interactions and effective magnetic forces.	[Mukherjee, Biswaroop; Shaffer, Airlia; Patel, Parth B.; Yan, Zhenjie; Wilson, Cedric C.; Crepel, Valentin; Fletcher, Richard J.; Zwierlein, Martin] MIT, Dept Phys, IMIT Harvard Ctr Ultracold Atoms, Elect Res Lab, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Zwierlein, M (corresponding author), MIT, Dept Phys, IMIT Harvard Ctr Ultracold Atoms, Elect Res Lab, Cambridge, MA 02139 USA.	zwierlei@mit.edu		/0000-0002-7155-5412; Fletcher, Richard/0000-0002-3650-2446; Wilson, Cedric/0000-0001-6586-7666	National Science Foundation (Center for Ultracold Atoms) [PHY-2012110]; Air Force Office of Scientific Research [FA9550-16-1-0324, FA9550-14-1-0035]; Office of Naval Research [N00014-17-1-2257]; DARPA A-PhI program through ARO [W911NF-19-1-0511]; Vannevar Bush Faculty Fellowship; NSF GRFP; Alexander von Humboldt Foundation	National Science Foundation (Center for Ultracold Atoms)(National Science Foundation (NSF)); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Office of Naval Research(Office of Naval Research); DARPA A-PhI program through ARO; Vannevar Bush Faculty Fellowship; NSF GRFP(National Science Foundation (NSF)NSF - Office of the Director (OD)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	We thank T. Pfau and his research group, J. Dunkel, A. Fetter, T. Senthil, T. Simula and W. Zwerger for discussions. This work was supported by the National Science Foundation (Center for Ultracold Atoms and grant no. PHY-2012110), Air Force Office of Scientific Research (FA9550-16-1-0324 and MURI Quantum Phases of Matter FA9550-14-1-0035), Office of Naval Research (N00014-17-1-2257), the DARPA A-PhI program through ARO grant W911NF-19-1-0511, and the Vannevar Bush Faculty Fellowship. A.S. acknowledges support from the NSF GRFP. M.Z. acknowledges funding from the Alexander von Humboldt Foundation.	Aftalion A, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.011603; Aidelsburger M, 2015, NAT PHYS, V11, P162, DOI 10.1038/NPHYS3171; Baggaley AW, 2018, PHYS REV A, V97, DOI 10.1103/PhysRevA.97.053608; Bao W, 2006, J COMPUT PHYS, V217, P612, DOI 10.1016/j.jcp.2006.01.020; Bloch I, 2008, REV MOD PHYS, V80, P885, DOI 10.1103/RevModPhys.80.885; Bretin V, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.050403; Bukov M, 2015, ADV PHYS, V64, P139, DOI 10.1080/00018732.2015.1055918; Cao Y, 2018, NATURE, V556, P43, DOI 10.1038/nature26160; Cerfon AJ, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.174801; Chalopin T, 2020, NAT PHYS, V16, P1017, DOI 10.1038/s41567-020-0942-5; Chandrasekhar S, 2013, HYDRODYNAMIC HYDROMA; Chomaz L, 2019, PHYS REV X, V9, DOI 10.1103/PhysRevX.9.021012; Cooper NR, 2008, ADV PHYS, V57, P539, DOI 10.1080/00018730802564122; Dalibard J, 2011, REV MOD PHYS, V83, DOI 10.1103/RevModPhys.83.1523; DAVIDSON RC, 1991, REV MOD PHYS, V63, P341, DOI 10.1103/RevModPhys.63.341; Feng L, 2018, NAT PHYS, V14, P269, DOI 10.1038/s41567-017-0011-x; Fetter A.L., 2003, QUANTUM THEORY MANY, Vthird; Finne AP, 2006, REP PROG PHYS, V69, P3157, DOI 10.1088/0034-4885/69/12/R03; Fletcher RJ, 2021, SCIENCE, V372, P1318, DOI 10.1126/science.aba7202; Galitski V, 2013, NATURE, V494, P49, DOI 10.1038/nature11841; GIRVIN SM, 1986, PHYS REV B, V33, P2481, DOI 10.1103/PhysRevB.33.2481; Goldman N, 2014, REP PROG PHYS, V77, DOI 10.1088/0034-4885/77/12/126401; Grass T, 2018, PHYS REV LETT, V121, DOI 10.1103/PhysRevLett.121.253403; Guo M, 2019, NATURE, V574, P386, DOI 10.1038/s41586-019-1569-5; Ha LC, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.055301; Hertkorn J, 2021, PHYS REV X, V11, DOI 10.1103/PhysRevX.11.011037; Ho TL, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.060403; Iordanskii S. V., 1980, Soviet Physics - Uspekhi, V23, P317, DOI 10.1070/PU1980v023n06ABEH004937; Jang JH, 2017, NAT PHYS, V13, P340, DOI [10.1038/NPHYS3979, 10.1038/nphys3979]; Ji SC, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.105301; JIANG HW, 1990, PHYS REV LETT, V65, P633, DOI 10.1103/PhysRevLett.65.633; Jotzu G, 2014, NATURE, V515, P237, DOI 10.1038/nature13915; Kukushkin IV, 2009, SCIENCE, V324, P1044, DOI 10.1126/science.1171472; Landau L.D., 1987, PHYS TODAY, V6; Leonard J, 2017, NATURE, V543, P87, DOI 10.1038/nature21067; Li JR, 2017, NATURE, V543, P91, DOI 10.1038/nature21431; Mancini M, 2015, SCIENCE, V349, P1510, DOI 10.1126/science.aaa8736; Martone GI, 2021, PHYS REV RES, V3, DOI 10.1103/PhysRevResearch.3.013143; Mottl R, 2012, SCIENCE, V336, P1570, DOI 10.1126/science.1220314; Nozierez P, 2004, J LOW TEMP PHYS, V137, P45, DOI 10.1023/B:JOLT.0000044234.82957.2f; Oktel MO, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.023618; PETRICH W, 1995, PHYS REV LETT, V74, P3352, DOI 10.1103/PhysRevLett.74.3352; Petter D, 2019, PHYS REV LETT, V122, DOI 10.1103/PhysRevLett.122.183401; PINCZUK A, 1993, PHYS REV LETT, V70, P3983, DOI 10.1103/PhysRevLett.70.3983; PITAEVSKII LP, 1984, JETP LETT+, V39, P511; Recati A, 2001, PHYS REV LETT, V86, P377, DOI 10.1103/PhysRevLett.86.377; Ronveaux A, 1995, HEUNS DIFFERENTIAL E; Schmidt JN, 2021, PHYS REV LETT, V126, DOI 10.1103/PhysRevLett.126.193002; Schweikhard V, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.040404; Senthil T, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.046801; Sinha S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.150401; Sinha S, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.190402; Stormer HL, 1999, REV MOD PHYS, V71, pS298, DOI 10.1103/RevModPhys.71.S298; Struck J, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.225304; Stuhl BK, 2015, SCIENCE, V349, P1514, DOI 10.1126/science.aaa8515; Tanzi L, 2019, NATURE, V574, P382, DOI 10.1038/s41586-019-1568-6; Wigner E, 1934, PHYS REV, V46, P1002, DOI 10.1103/PhysRev.46.1002; YOSHIOKA D, 1979, J PHYS SOC JPN, V47, P394, DOI 10.1143/JPSJ.47.394; Zhang ZD, 2020, NAT PHYS, V16, P652, DOI 10.1038/s41567-020-0839-3	63	4	4	6	21	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 6	2022	601	7891								10.1038/s41586-021-04170-2	http://dx.doi.org/10.1038/s41586-021-04170-2			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YD3GI	34987216	Green Submitted			2022-12-28	WOS:000740262600001
J	Perkel, JM				Perkel, Jeffrey M.			TERRA MAKES CLOUD-BASED 'OMICS' ACCESSIBLE	NATURE			English	Editorial Material						Computational biology and bioinformatics; Genomics; Software; Databases													0	2	2	2	4	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 6	2022	601	7891					154	155						2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YB0AX	34983991	Bronze			2022-12-28	WOS:000738686800014
J	Rasmussen, M; Reddy, M; Nolan, R; Camunas-Soler, J; Khodursky, A; Scheller, NM; Cantonwine, DE; Engelbrechtsen, L; Mi, JD; Dutta, A; Brundage, T; Siddiqui, F; Thao, M; Gee, EPS; La, J; Baruch-Gravett, C; Santillan, MK; Deb, S; Ame, SM; Ali, SM; Adkins, M; DePristo, MA; Lee, M; Namsaraev, E; Gybel-Brask, DJ; Skibsted, L; Litch, JA; Santillan, DA; Sazawal, S; Tribe, RM; Roberts, JM; Jain, M; Hogdall, E; Holzman, C; Quake, SR; Elovitz, MA; McElrath, TF				Rasmussen, Morten; Reddy, Mitsu; Nolan, Rory; Camunas-Soler, Joan; Khodursky, Arkady; Scheller, Nikolai M.; Cantonwine, David E.; Engelbrechtsen, Line; Mi, Jia Dai; Dutta, Arup; Brundage, Tiffany; Siddiqui, Farooq; Thao, Mainou; Gee, Elaine P. S.; La, Johnny; Baruch-Gravett, Courtney; Santillan, Mark K.; Deb, Saikat; Ame, Shaali M.; Ali, Said M.; Adkins, Melanie; DePristo, Mark A.; Lee, Manfred; Namsaraev, Eugeni; Gybel-Brask, Dorte Jensen; Skibsted, Lillian; Litch, James A.; Santillan, Donna A.; Sazawal, Sunil; Tribe, Rachel M.; Roberts, James M.; Jain, Maneesh; Hogdall, Estrid; Holzman, Claudia; Quake, Stephen R.; Elovitz, Michal A.; McElrath, Thomas F.			RNA profiles reveal signatures of future health and disease in pregnancy	NATURE			English	Article							GESTATIONAL-AGE; FETAL; EXPRESSION; KIDNEY; MOUSE; CELLS	Maternal morbidity and mortality continue to rise, and pre-eclampsia is a major driver of this burden(1). Yet the ability to assess underlying pathophysiology before clinical presentation to enable identification of pregnancies at risk remains elusive. Here we demonstrate the ability of plasma cell-free RNA (cfRNA) to reveal patterns of normal pregnancy progression and determine the risk of developing pre-eclampsia months before clinical presentation. Our results centre on comprehensive transcriptome data from eight independent prospectively collected cohorts comprising 1,840 racially diverse pregnancies and retrospective analysis of 2,539 banked plasma samples. The pre-eclampsia data include 524 samples (72 cases and 452 non-cases) from two diverse independent cohorts collected 14.5 weeks (s.d., 4.5 weeks) before delivery. We show that cfRNA signatures from a single blood draw can track pregnancy progression at the placental, maternal and fetal levels and can robustly predict pre-eclampsia, with a sensitivity of 75% and a positive predictive value of 32.3% (s.d., 3%), which is superior to the state-of-the-art method(2). cfRNA signatures of normal pregnancy progression and pre-eclampsia are independent of clinical factors, such as maternal age, body mass index and race, which cumulatively account for less than 1% of model variance. Further, the cfRNA signature for pre-eclampsia contains gene features linked to biological processes implicated in the underlying pathophysiology of pre-eclampsia.	[Rasmussen, Morten; Reddy, Mitsu; Nolan, Rory; Camunas-Soler, Joan; Khodursky, Arkady; Brundage, Tiffany; Siddiqui, Farooq; Thao, Mainou; Gee, Elaine P. S.; La, Johnny; Lee, Manfred; Namsaraev, Eugeni; Jain, Maneesh; Elovitz, Michal A.] Mirvie Inc, San Francisco, CA 94080 USA; [Scheller, Nikolai M.] Statens Serum Inst, Dept Epidemiol Res, Copenhagen, Denmark; [Cantonwine, David E.; McElrath, Thomas F.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Engelbrechtsen, Line] Herrev Univ Hosp, Dept Obstet & Gynecol, Herrev, Denmark; [Mi, Jia Dai; Tribe, Rachel M.] Kings Coll London, Fac Life Sci & Med, Sch Life Course Sci, Dept Women & Childrens Hlth, St Thomas Hosp Campus, London, England; [Dutta, Arup; Deb, Saikat; Sazawal, Sunil] Ctr Publ Hlth Kinet, New Delhi, India; [Baruch-Gravett, Courtney; Litch, James A.] Global Alliance Prevent Prematur & Stillbirth GAP, Lynnwood, WA USA; [Santillan, Mark K.; Santillan, Donna A.] Univ Iowa Hosp & Clin, Dept Obstet & Gynecol, Iowa City, IA 52242 USA; [Deb, Saikat; Ame, Shaali M.; Ali, Said M.] Publ Hlth Lab Ldc, Pemba, Zanzibar, Tanzania; [Adkins, Melanie; Holzman, Claudia] Michigan State Univ, E Lansing, MI 48824 USA; [DePristo, Mark A.] BigHat Biosci Inc, San Mateo, CA USA; [Gybel-Brask, Dorte Jensen; Skibsted, Lillian] Zealand Univ Hosp, Dept Obstet, Roskilde, Denmark; [Gybel-Brask, Dorte Jensen; Hogdall, Estrid] Herrev Univ Hosp, Dept Pathol, Herrev, Denmark; [Roberts, James M.] Univ Pittsburgh, Magee Womens Res Inst, Dept Obstet & Gynecol & Reprod Sci, Epidemiol & Clin & Translat Res, Pittsburgh, PA USA; [Quake, Stephen R.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Quake, Stephen R.] Chan Zuckerberg Biohub, Stanford, CA USA; [Quake, Stephen R.] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [Elovitz, Michal A.] Univ Penn, Sch Med, Dept Obstet & Gynecol, Maternal & Child Hlth Res Program, Philadelphia, PA 19104 USA	Statens Serum Institut; Harvard University; Brigham & Women's Hospital; University of London; King's College London; University of Iowa; Michigan State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Stanford University; Stanford University; University of Pennsylvania	Rasmussen, M; Elovitz, MA (corresponding author), Mirvie Inc, San Francisco, CA 94080 USA.; McElrath, TF (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.; Elovitz, MA (corresponding author), Univ Penn, Sch Med, Dept Obstet & Gynecol, Maternal & Child Hlth Res Program, Philadelphia, PA 19104 USA.	morten@mirvie.com; erovitz@pennmedicine.upenn.edu; tmcerrath@bwh.harvard.edu		Tribe, Rachel/0000-0003-3675-9978; Santillan, Mark/0000-0002-3991-8017; Mi, Jia Dai/0000-0001-5723-4252	Tommy's Charity [1060508]; National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) based at Guy's and St Thomas' National Health Service Foundation Trust; Rosetrees Trust [298582, M303-CD1]; NIHR Doctoral Research Fellowship [DRF-2013-06-171]; UI BioShare	Tommy's Charity; National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) based at Guy's and St Thomas' National Health Service Foundation Trust; Rosetrees Trust(Rosetrees Trust); NIHR Doctoral Research Fellowship; UI BioShare	We thank all women who donated blood samples and made this study possible. This research was conducted using specimens and data collected, stored and managed by INSIGHT, LIFECODES, The Women's Health Tissue, Pregnancy Outcomes and Community Health (POUCH), Prenatal Exposures and Preeclampsia Prevention (PEPP), Global Alliance to Prevent Prematurity and Stillbirth (GAPPS), Pemba Pregnancy and Newborn Discovery Cohort (PPNDC) and Roskilde biorepositories. We thank the Precia Group for introducing and coordinating with key study collaborators. Samples from the INSIGHT study were collected with support from Tommy's Charity (no. 1060508), the National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) based at Guy's and St Thomas' National Health Service Foundation Trust, the Rosetrees Trust (charity no. 298582) (M303-CD1) and an NIHR Doctoral Research Fellowship (DRF-2013-06-171) to N.L. Hezelgrave. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care. Research reported in this publication was supported by UI BioShare, the enterprise biospecimen management system supported by the University of Iowa's Carver College of Medicine, Holden Comprehensive Cancer Center and Institute for Clinical and Translational Science.	Alazami AM, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0792-0; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Carbone IF, 2020, MOL DIAGN THER, V24, P409, DOI 10.1007/s40291-020-00468-5; Challis JR, 2009, REPROD SCI, V16, P206, DOI 10.1177/1933719108329095; Chen X, 2019, HYPERTENS RES, V42, P970, DOI 10.1038/s41440-019-0224-8; Chez R A, 1976, Perspect Nephrol Hypertens, V5, P421; Cre A. S., 2017, FAST GENE SET ENRICH, DOI [10.18129/B9.BIOC.FGSEA, DOI 10.18129/B9.BIOC.FGSEA]; Cunningham P, 2009, J NUTR, V139, P636, DOI 10.3945/jn.108.098608; Delgado C, 2021, J AM SOC NEPHROL, V32, P1305, DOI 10.1681/ASN.2021010039; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Gao S, 2018, NAT CELL BIOL, V20, DOI 10.1038/s41556-018-0105-4; Gormley M, 2017, AM J OBSTET GYNECOL, V217, DOI 10.1016/j.ajog.2017.03.017; Grobman, AM J OBSTET GYNECOL, DOI [10.1016/j.ajog.2021.05.021(2021, DOI 10.1016/J.AJOG.2021.05.021(2021]; Kahn DA, 2010, P NATL ACAD SCI USA, V107, P9299, DOI 10.1073/pnas.1003909107; Khosrotehrani K, 2004, JAMA-J AM MED ASSOC, V292, P75, DOI 10.1001/jama.292.1.75; Korotkevich G., 2016, BIORXIV, DOI [10.1101/060012v3, DOI 10.1101/060012, 10.1101/060012]; Kramer AW, 2016, PLACENTA, V37, P19, DOI 10.1016/j.placenta.2015.11.004; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Malassine A, 2003, HUM REPROD UPDATE, V9, P531, DOI 10.1093/humupd/dmg043; Marinic M, 2020, PLOS GENET, V16, DOI 10.1371/journal.pgen.1008666; McCarthy FP, 2011, PLACENTA, V32, P413, DOI 10.1016/j.placenta.2011.03.010; Menon R, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.164038; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Munchel S, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aaz0131; Ngo TTM, 2018, SCIENCE, V360, P1133, DOI 10.1126/science.aar3819; Poon CE, 2013, HISTOCHEM CELL BIOL, V139, P583, DOI 10.1007/s00418-012-1052-y; Raghupathy R, 2008, FRONT BIOSCI-LANDMRK, V13, P985, DOI 10.2741/2737; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Ren, 2019, DISTINCT MOL PROCESS, DOI [10.1101/787796, DOI 10.1101/787796]; Rich-Edwards JW, 2014, EPIDEMIOL REV, V36, P57, DOI 10.1093/epirev/mxt006; Robillard PY, 2002, AM J REPROD IMMUNOL, V47, P104, DOI 10.1034/j.1600-0897.2002.1o043.x; Ryan D, 2018, EBIOMEDICINE, V27, P275, DOI 10.1016/j.ebiom.2017.12.016; Schumann S, 2015, HISTOCHEM CELL BIOL, V144, P571, DOI 10.1007/s00418-015-1361-z; Shi JW, 2020, INT J BIOL SCI, V16, P2220, DOI 10.7150/ijbs.45586; Skupski DW, 2017, OBSTET GYNECOL, V130, P433, DOI 10.1097/AOG.0000000000002137; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tan MY, 2018, ULTRASOUND OBST GYN, V52, P186, DOI 10.1002/uog.19112; Taylor H. S., ENDOTEXT; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Vyas DA, 2020, NEW ENGL J MED, V383, P874, DOI 10.1056/NEJMms2004740; Wang GQ, 2015, J LIPID RES, V56, P2238, DOI 10.1194/jlr.R056705; Zeller T, 2017, HYPERTENSION, V70, P743, DOI 10.1161/HYPERTENSIONAHA.117.09458	45	24	24	14	42	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 20	2022	601	7893					422	+		10.1038/s41586-021-04249-w	http://dx.doi.org/10.1038/s41586-021-04249-w		JAN 2022	17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YJ6UI	34987224	Green Published, hybrid			2022-12-28	WOS:000739303000005
J	Brown, K; Donato, AA				Brown, Krysta; Donato, Anthony A.			In persons at intermediate risk for CVD, polypills reduce a composite of CV events at 5 y	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Brown, Krysta; Donato, Anthony A.] Tower Hlth Reading Hosp, W Reading, PA 19611 USA		Brown, K (corresponding author), Tower Hlth Reading Hosp, W Reading, PA 19611 USA.							Teo K, 2018, AM J HYPERTENS, V31, P758, DOI 10.1093/ajh/hpy040; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419; Whelton Paul K, 2018, Hypertension, V71, pe13, DOI [10.1016/j.jash.2018.06.010, 10.1161/HYP.0000000000000065]; Williams B, 2018, J HYPERTENS, V36, P1953, DOI 10.1097/HJH.0000000000001940	4	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN	2022	175	1					JC2	JC3		10.7326/J21-0004	http://dx.doi.org/10.7326/J21-0004		JAN 2022	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0Y3LO	34978850				2022-12-28	WOS:000790293700009
J	Prasad, A				Prasad, Aarathi			Simukai Chigudu: elucidating the politics of global health	LANCET			English	Editorial Material																			0	0	0	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN	2022	399	10320					134	134						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YD7YG	34998497				2022-12-28	WOS:000740652500012
J	Bernson-Leung, ME; Rapalino, O; Walker, MA; Butler, WE				Bernson-Leung, Miya E.; Rapalino, Otto; Walker, Melissa A.; Butler, William E.			Case 40-2021: A 9-Year-Old Boy with Transient Weakness, Facial Droop, and Slurred Speech	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PEDIATRIC MOYAMOYA-DISEASE; MOVEMENT-DISORDERS; ISCHEMIC ATTACK; ACUTE STROKE; CHILDREN; REVASCULARIZATION	A Boy with Transient Weakness, Facial Droop, and Slurred Speech A 9-year-old boy was transferred to this hospital because of transient weakness, facial droop, and slurred speech that occurred after an episode of crying. The symptoms lasted approximately 2 minutes and then resolved. Two years earlier, the patient had been evaluated for episodes of shaking in the arms and legs. A diagnosis was made.	[Bernson-Leung, Miya E.] Harvard Med Sch, Dept Neurol, Boston Childrens Hosp, Boston, MA 02115 USA; [Bernson-Leung, Miya E.; Walker, Melissa A.] Harvard Med Sch, Dept Neurol, Boston, MA 02115 USA; [Rapalino, Otto] Harvard Med Sch, Dept Radiol, Boston, MA 02115 USA; [Butler, William E.] Harvard Med Sch, Dept Neurosurg, Boston, MA 02115 USA; [Rapalino, Otto] Massachusetts Gen Hosp, Dept Radiol, Boston, MA USA; [Walker, Melissa A.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Butler, William E.] Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Bernson-Leung, ME (corresponding author), Harvard Med Sch, Dept Neurol, Boston Childrens Hosp, Boston, MA 02115 USA.; Bernson-Leung, ME (corresponding author), Harvard Med Sch, Dept Neurol, Boston, MA 02115 USA.			Bernson-Leung, Miya/0000-0002-7766-2323				Adil MM, 2014, STROKE, V45, P887, DOI 10.1161/STROKEAHA.113.004526; Appireddy R, 2019, J CHILD NEUROL, V34, P517, DOI 10.1177/0883073819844854; Baik JS, 2010, MOVEMENT DISORD, V25, P1482, DOI 10.1002/mds.23130; Ferriero DM, 2019, STROKE, V50, pE51, DOI 10.1161/STR.0000000000000183; Ganesan V, 2010, DEV MED CHILD NEUROL, V52, P10, DOI 10.1111/j.1469-8749.2009.03527.x; Greene S, 2016, J CHILD NEUROL, V31, P646, DOI 10.1177/0883073815609152; Ha JY, 2019, KOREAN J RADIOL, V20, P985, DOI 10.3348/kjr.2018.0651; Huggins HE, 2020, J STROKE CEREBROVASC, V29, DOI 10.1016/j.jstrokecerebrovasdis.2020.104871; Ladner TR, 2015, STROKE, V46, P2328, DOI 10.1161/STROKEAHA.115.009961; Lee JY, 2014, CHILD NERV SYST, V30, P885, DOI 10.1007/s00381-013-2339-6; Lee S, 2017, J CHILD NEUROL, V32, P924, DOI 10.1177/0883073817718730; Lehman LL, 2016, STROKE, V47, P88, DOI 10.1161/STROKEAHA.115.009904; Liu JJ, 2017, NEUROSURG CLIN N AM, V28, P361, DOI 10.1016/j.nec.2017.02.004; Mackay MT, 2014, NEUROLOGY, V82, P1434, DOI 10.1212/WNL.0000000000000343; Mackay MT, 2011, ANN NEUROL, V69, P130, DOI 10.1002/ana.22224; Monagle P, 2012, CHEST, V141, pE737S, DOI 10.1378/chest.11-2308; Morshed RA, 2020, J CLIN NEUROSCI, V79, P137, DOI 10.1016/j.jocn.2020.07.016; Parray T, 2011, J NEUROSURG ANESTH, V23, P100, DOI 10.1097/ANA.0b013e3181f84fac; Quon JL, 2019, J NEUROSURG-PEDIATR, V23, P486, DOI 10.3171/2018.11.PEDS18498; Scott RM, 2009, NEW ENGL J MED, V360, P1226, DOI 10.1056/NEJMra0804622; TAGAWA T, 1987, STROKE, V18, P906, DOI 10.1161/01.STR.18.5.906	21	0	0	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 30	2021	385	27					2563	2572		10.1056/NEJMcpc2107358	http://dx.doi.org/10.1056/NEJMcpc2107358			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XW2YE	34965341				2022-12-28	WOS:000735490500014
J	Spudich, S; Nath, A				Spudich, Serena; Nath, Avindra			Nervous system consequences of COVID-19	SCIENCE			English	Editorial Material								Neurological symptoms highlight the need to understand pathophysiologic mechanisms	[Spudich, Serena] Yale Sch Med, New Haven, CT 06510 USA; [Nath, Avindra] NINDS, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA	Yale University; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Spudich, S (corresponding author), Yale Sch Med, New Haven, CT 06510 USA.	serena.spudich@yale.edu						Davis HE, 2021, ECLINICALMEDICINE, V38, DOI 10.1016/j.eclinm.2021.101019; Douaud G., 2021, MEDRXIV; Eden A, 2021, NEUROLOGY, V96, pE294, DOI 10.1212/WNL.0000000000010977; Franke C, 2021, BRAIN BEHAV IMMUN, V93, P415, DOI 10.1016/j.bbi.2020.12.022; Fullard JF, 2021, GENOME MED, V13, DOI 10.1186/s13073-021-00933-8; Heming M, 2021, IMMUNITY, V54, P164, DOI 10.1016/j.immuni.2020.12.011; Hosp JA, 2021, BRAIN, V144, P1263, DOI 10.1093/brain/awab009; Matschke J, 2020, LANCET NEUROL, V19, P919, DOI 10.1016/S1474-4422(20)30308-2; McAlpine LS, 2021, STROKE, V52, pe233, DOI 10.1161/STROKEAHA.120.031971; Merkler AE, 2020, JAMA NEUROL, V77, P1366, DOI 10.1001/jamaneurol.2020.2730; Perl DP, 2021, NEW ENGL J MED, V384, P481, DOI 10.1056/NEJMc2033369; Russell A. L.Ross, BRAIN COMMUN, V3; Teuwen LA, 2020, NAT REV IMMUNOL, V20, P389, DOI 10.1038/s41577-020-0343-0; VARATHARAJ A, 2020, LANCET PSYCHIAT, V7, P875, DOI [DOI 10.1016/S2215-0366(20)30287-X, 10.1016/S2215-0366(20)30287-X]	15	52	53	7	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2022	375	6578					267	269		10.1126/science.abm2052	http://dx.doi.org/10.1126/science.abm2052			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YK2FS	35050660				2022-12-28	WOS:000745036100016
J	Kelava, I; Chiaradia, I; Pellegrini, L; Kalinka, AT; Lancaster, MA				Kelava, Iva; Chiaradia, Ilaria; Pellegrini, Laura; Kalinka, Alex T.; Lancaster, Madeline A.			Androgens increase excitatory neurogenic potential in human brain organoids	NATURE			English	Article							SEXUAL-DIFFERENTIATION; HISTONE DEACETYLASE; PROGENITOR CELLS; TESTOSTERONE; GENE; METABOLISM; INHIBITOR; MUTATIONS; ESTRADIOL; APOPTOSIS	The biological basis of male-female brain differences has been difficult to elucidate in humans. The most notable morphological difference is size, with male individuals having on average a larger brain than female individuals(1,2), but a mechanistic understanding of how this difference arises remains unknown. Here we use brain organoids(3) to show that although sex chromosomal complement has no observable effect on neurogenesis, sex steroids-namely androgens-lead to increased proliferation of cortical progenitors and an increased neurogenic pool. Transcriptomic analysis and functional studies demonstrate downstream effects on histone deacetylase activity and the mTOR pathway. Finally, we show that androgens specifically increase the neurogenic output of excitatory neuronal progenitors, whereas inhibitory neuronal progenitors are not increased. These findings reveal a role for androgens in regulating the number of excitatory neurons and represent a step towards understanding the origin of sex-related brain differences in humans.	[Kelava, Iva; Chiaradia, Ilaria; Pellegrini, Laura; Lancaster, Madeline A.] Med Res Council Lab Mol Biol, Cambridge, England; [Kalinka, Alex T.] Univ Cambridge, Jeffrey Cheah Biomed Ctr, Milner Therapeut Inst, Cambridge, England; [Kelava, Iva] Wellcome Trust Genome Campus, Wellcome Sanger Inst, Hinxton, England	MRC Laboratory Molecular Biology; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Cambridge; Wellcome Trust Sanger Institute	Kelava, I; Lancaster, MA (corresponding author), Med Res Council Lab Mol Biol, Cambridge, England.	ik9@sanger.ac.uk; mlancast@mrc-lmb.cam.ac.uk		Pellegrini, Laura/0000-0002-8814-664X; Chiaradia, Ilaria/0000-0002-9529-4464; Lancaster, Madeline/0000-0003-2324-8853	Medical Research Council [MC_UP_1201/9]; European Research Council (ERC) [STG 757710]	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council (ERC)(European Research Council (ERC)European Commission)	We thank D. Srivastava, S. Munro and M. Hegde for comments; the MRC LMB Light Microscopy facility for help with microscopy and Bioinformatics (P. Freire-Pritchett) for help with RNA-seq analysis, as well as the CRUK Genomics facility for library preparation and sequencing; M. Mancini, M. Marcelli and E. Wilson for depositing their plasmids in Addgene; and the other members of the Lancaster laboratory and the MRC LMB Cell Biology division for discussions. Work in the Lancaster laboratory is supported by the Medical Research Council (MC_UP_1201/9) and the European Research Council (ERC STG 757710).	Abel KM, 2010, INT REV PSYCHIATR, V22, P417, DOI 10.3109/09540261.2010.515205; Abrahams BS, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-36; Alexeyenko A, 2012, NUCLEIC ACIDS RES, V40, pD821, DOI 10.1093/nar/gkr1062; Arnold AP, 2017, J NEUROSCI RES, V95, P291, DOI 10.1002/jnr.23884; Arnold AP, 2009, HORM BEHAV, V55, P570, DOI 10.1016/j.yhbeh.2009.03.011; Bagley JA, 2017, NAT METHODS, V14, P743, DOI 10.1038/nmeth.4304; Bahari-Javan S, 2017, P NATL ACAD SCI USA, V114, pE4686, DOI 10.1073/pnas.1613842114; Benito-Kwiecinski S, 2021, CELL, V184, P2084, DOI 10.1016/j.cell.2021.02.050; Boissinot M, 2012, LEUKEMIA RES, V36, P1304, DOI 10.1016/j.leukres.2012.07.002; Cao JY, 2019, NATURE, V566, P496, DOI 10.1038/s41586-019-0969-x; Choi YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043418; Davey Rachel A, 2016, Clin Biochem Rev, V37, P3; Dey A, 2016, ONCOGENE, V35, P4256, DOI 10.1038/onc.2015.491; Eliot L, 2021, NEUROSCI BIOBEHAV R, V125, P667, DOI 10.1016/j.neubiorev.2021.02.026; Fatemi SH, 2011, SCHIZOPHR RES, V128, P37, DOI 10.1016/j.schres.2010.12.025; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Fromer M, 2016, NAT NEUROSCI, V19, P1442, DOI 10.1038/nn.4399; Gerard D, 2020, BMC BIOINFORMATICS, V21, DOI 10.1186/s12859-020-3450-9; Giandomenico SL, 2021, NAT PROTOC, V16, P579, DOI 10.1038/s41596-020-00433-w; Giandomenico SL, 2019, NAT NEUROSCI, V22, P669, DOI 10.1038/s41593-019-0350-2; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Green T, 2019, NEUROPSYCHOPHARMACOL, V44, P9, DOI 10.1038/s41386-018-0153-2; Hackinger S, 2018, TRANSL PSYCHIAT, V8, DOI 10.1038/s41398-018-0304-6; Hines M, 2020, J NEUROSCI, V40, P37, DOI 10.1523/JNEUROSCI.0750-19.2019; Hines M, 2015, BIOL SEX DIFFER, V6, DOI 10.1186/s13293-015-0022-1; Iacopino F, 2008, INT J ONCOL, V32, P1293; Jeselsohn R, 2014, CLIN CANCER RES, V20, P1757, DOI 10.1158/1078-0432.CCR-13-2332; Kalinka A. T., 2020, IMPROVING SENSITIVIT, DOI 10.15.340737; Kielar M, 2014, NAT NEUROSCI, V17, P923, DOI 10.1038/nn.3729; Kim Woo-Yang, 2015, Commun Integr Biol, V8, pe994377, DOI 10.4161/19420889.2014.994377; Knickmeyer RC, 2014, CEREB CORTEX, V24, P2721, DOI 10.1093/cercor/bht125; Knickmeyer RC, 2006, EARLY HUM DEV, V82, P755, DOI 10.1016/j.earlhumdev.2006.09.014; Lancaster MA, 2017, NAT BIOTECHNOL, V35, P659, DOI 10.1038/nbt.3906; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Leek JT, 2012, BIOINFORMATICS, V28, P882, DOI 10.1093/bioinformatics/bts034; Li L, 2019, ISCIENCE, V20, P148, DOI 10.1016/j.isci.2019.09.015; Loomes R, 2017, J AM ACAD CHILD PSY, V56, P466, DOI 10.1016/j.jaac.2017.03.013; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Marin O, 2014, CURR OPIN NEUROBIOL, V26, P132, DOI 10.1016/j.conb.2014.01.015; Martinez-Cerdeno V, 2006, EUR J NEUROSCI, V24, P3475, DOI 10.1111/j.1460-9568.2006.05239.x; Mayer C, 2006, ONCOGENE, V25, P6384, DOI 10.1038/sj.onc.1209883; Mccarthy MM, 2008, PHYSIOL REV, V88, P91, DOI 10.1152/physrev.00010.2007; McCarthy MM, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0106; McCarthy MM, 2011, NAT NEUROSCI, V14, P677, DOI 10.1038/nn.2834; McManus JM, 2020, J STEROID BIOCHEM, V198, DOI 10.1016/j.jsbmb.2019.105572; Miller WL, 2011, ENDOCR REV, V32, P81, DOI 10.1210/er.2010-0013; Narayan S, 2009, J NEUROSCI RES, V87, P278, DOI 10.1002/jnr.21822; Noctor SC, 2008, J COMP NEUROL, V508, P28, DOI 10.1002/cne.21669; O'Shaughnessy PJ, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000002; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Pollen AA, 2015, CELL, V163, P55, DOI 10.1016/j.cell.2015.09.004; Qu YY, 2015, SCI REP-UK, V5, DOI 10.1038/srep07654; Quartier A, 2018, BIOL PSYCHIAT, V84, P239, DOI 10.1016/j.biopsych.2018.01.002; Rabinowicz T, 1999, J CHILD NEUROL, V14, P98, DOI 10.1177/088307389901400207; Raudvere U, 2019, NUCLEIC ACIDS RES, V47, pW191, DOI 10.1093/nar/gkz369; REYES FI, 1974, J CLIN ENDOCR METAB, V38, P612, DOI 10.1210/jcem-38-4-612; Ritchie SJ, 2018, CEREB CORTEX, V28, P2959, DOI 10.1093/cercor/bhy109; Ruigrok ANV, 2014, NEUROSCI BIOBEHAV R, V39, P34, DOI 10.1016/j.neubiorev.2013.12.004; Ryskalin L, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19082226; Saito A, 1999, P NATL ACAD SCI USA, V96, P4592, DOI 10.1073/pnas.96.8.4592; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shoskes JJ, 2016, TRANSL ANDROL UROL, V5, P834, DOI 10.21037/tau.2016.07.10; Sohal VS, 2019, MOL PSYCHIATR, V24, P1248, DOI 10.1038/s41380-019-0426-0; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Tang TX, 2019, NEURON, V101, P1117, DOI 10.1016/j.neuron.2019.01.007; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Udawela M, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.108; Voss MH, 2020, BRIT J CANCER, V123, P1590, DOI 10.1038/s41416-020-01041-x; Wallen K, 2005, FRONT NEUROENDOCRIN, V26, P7, DOI 10.1016/j.yfrne.2005.02.001; Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002; Woodson J. C., 1999, SEXUAL DIFFERENTIATI; Wright AS, 1996, J CLIN INVEST, V98, P2558, DOI 10.1172/JCI119074	73	7	7	19	57	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 3	2022	602	7895					112	+		10.1038/s41586-021-04330-4	http://dx.doi.org/10.1038/s41586-021-04330-4		JAN 2022	26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YS1FH	35046577	Green Accepted			2022-12-28	WOS:000744417900002
J	Balk, EM; Adam, GP; Bhuma, MR; Konnyu, KJ; Saldanha, IJ; Beland, MD; Shah, N				Balk, Ethan M.; Adam, Gaelen P.; Bhuma, Monika Reddy; Konnyu, Kristin J.; Saldanha, Ian J.; Beland, Michael D.; Shah, Nishit			Diagnostic Imaging and Medical Management of Acute Left-Sided Colonic Diverticulitis A Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Review							RANDOMIZED-CLINICAL-TRIAL; UNCOMPLICATED DIVERTICULITIS; OUTPATIENT TREATMENT; COMPUTED-TOMOGRAPHY; ANTIBIOTIC-TREATMENT; CT; MULTICENTER	Background: Clinicians need to better understand the value of computed tomography (CT) imaging and nonsurgical treatment options to manage acute left-sided colonic diverticulitis. Purpose: To evaluate CT imaging, outpatient treatment of uncomplicated diverticulitis, antibiotic treatment, and interventional radiology for patients with complicated diverticulitis. Data Sources: MEDLINE, Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews, Embase, CINAHL, and ClinicalTrials.gov from 1 January 1990 through 16 November 2020. Study Selection: Existing systematic reviews of CT imaging accuracy, as well as randomized trials and adjusted nonrandomized comparative studies reporting clinical or patient-centered outcomes. Data Extraction: 6 researchers extracted study data and risk of bias, which were verified by an independent researcher. The team assessed strength of evidence across studies. Data Synthesis: Based on moderate-strength evidence, CT imaging is highly accurate for diagnosing acute diverticulitis. For patients with uncomplicated acute diverticulitis, 6 studies provide low-strength evidence that initial outpatient and inpatient management have similar risks for recurrence or elective surgery, but they provide insufficient evidence regarding other outcomes. Also, for patients with uncomplicated acute diverticulitis, 5 studies comparing antibiotics versus no antibiotics provide low-strength evidence that does not support differences in risks for treatment failure, elective surgery, recurrence, posttreatment complications, and other outcomes. Evidence is insufficient to determine choice of antibiotic regimen (7 studies) or effect of percutaneous drainage (2 studies). Limitations: The evidence base is mostly of low strength. Studies did not adequately assess heterogeneity of treatment effect. Conclusion: Computed tomography imaging is accurate for diagnosing acute diverticulitis. For patients with uncomplicated diverticulitis, no differences in outcomes were found between outpatient and inpatient care. Avoidance of antibiotics for uncomplicated acute diverticulitis may be safe for most patients. The evidence is too sparse for other evaluated questions.	[Balk, Ethan M.; Adam, Gaelen P.; Bhuma, Monika Reddy; Konnyu, Kristin J.; Saldanha, Ian J.] Brown Univ, Brown Evidence Based Practice Ctr, Ctr Evidence Synth Hlth, Brown Sch Publ Hlth, Providence, RI 02912 USA; [Beland, Michael D.; Shah, Nishit] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA	Brown University; Brown University	Balk, EM (corresponding author), Brown Sch Publ Hlth, Box G-5121-8,121 South Main St, Providence, RI 02912 USA.	ethan_balk@brown.edu		Saldanha, Ian/0000-0002-2062-3382; Danko, Kristin/0000-0002-8476-0394; Balk, Ethan/0000-0002-4376-7290	AHRQ [HHSA290201500002I]; American College of Physicians	AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); American College of Physicians	By contract HHSA290201500002I/task order 13 from AHRQ. Additional funding for manuscript preparation was provided by the American College of Physicians.	Agency for Healthcare Research and Quality Effective Health Care Program, 2014, AHRQ PUBLICATION; Andeweg CS, 2014, SCAND J GASTROENTERO, V49, P775, DOI 10.3109/00365521.2014.908475; Andeweg CS, 2011, ANN SURG, V253, P940, DOI 10.1097/SLA.0b013e3182113614; Arevalo JM, 2007, REV ESP ENFERM DIG, V99, P320; Balk EM, 2020, COMP EFFECTIVENESS R, DOI [doi:10.23970/AHRQEP CCER233, DOI 10.23970/AHRQEPCCER233]; Balk EM, 2022, ANN INTERN MED, V175, P388, DOI 10.7326/M21-1646; Bassotti G, 2015, UNITED EUR GASTROENT, V3, P523, DOI 10.1177/2050640614563822; Berkman ND, 2015, J CLIN EPIDEMIOL, V68, P1312, DOI 10.1016/j.jclinepi.2014.11.023; Biondo S, 2014, ANN SURG, V259, P38, DOI 10.1097/SLA.0b013e3182965a11; Bolkenstein HE, 2018, INT J COLORECTAL DIS, V33, P863, DOI 10.1007/s00384-018-3055-1; Chabok A, 2012, BRIT J SURG, V99, P532, DOI 10.1002/bjs.8688; CHO KC, 1990, RADIOLOGY, V176, P111, DOI 10.1148/radiology.176.1.2191360; Daniels L, 2017, BRIT J SURG, V104, P52, DOI 10.1002/bjs.10309; Daniels L, 2014, EUR J CLIN MICROBIOL, V33, P1927, DOI 10.1007/s10096-014-2162-3; de Korte N, 2012, COLORECTAL DIS, V14, P325, DOI 10.1111/j.1463-1318.2011.02609.x; Deery SE, 2017, J GASTROINTEST SURG, V21, P1732, DOI 10.1007/s11605-017-3404-3; DORINGER E, 1990, ROFO FORTSCHR RONTG, V152, P76, DOI 10.1055/s-2008-1046821; Etzioni DA, 2010, DIS COLON RECTUM, V53, P861, DOI 10.1007/DCR.0b013e3181cdb243; Gaber CE, 2021, ANN INTERN MED, V174, P737, DOI 10.7326/M20-6315; Hansen O, 1999, LANGENBECK ARCH CHIR, V116, P1257; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Hjern F, 2007, SCAND J GASTROENTERO, V42, P41, DOI 10.1080/00365520600780650; Isacson D, 2019, BRIT J SURG, V106, P1542, DOI 10.1002/bjs.11239; Jaung R, 2021, CLIN GASTROENTEROL H, V19, P503, DOI 10.1016/j.cgh.2020.03.049; Joliat GR, 2017, INT J COLORECTAL DIS, V32, P1313, DOI 10.1007/s00384-017-2847-z; Juncadella AC, 2017, ANN INTERN MED, V166, pJC18, DOI 10.7326/ACPJC-2017-166-4-018; Jurowich CF, 2011, INT J COLORECTAL DIS, V26, P1609, DOI 10.1007/s00384-011-1280-y; KELLUM JM, 1992, CLIN THER, V14, P376; Kelly ME, 2015, ABDOM IMAGING, V40, P1853, DOI 10.1007/s00261-015-0349-4; Lambrichts DPV, 2019, BRIT J SURG, V106, P458, DOI 10.1002/bjs.11129; Lameris W, 2008, EUR RADIOL, V18, P2498, DOI 10.1007/s00330-008-1018-6; Lorente L, 2013, CIR ESPAN, V91, P504, DOI 10.1016/j.ciresp.2013.01.016; Mali J, 2019, WORLD J EMERG SURG, V14, DOI 10.1186/s13017-019-0250-5; Moya P, 2012, TECH COLOPROCTOL, V16, P301, DOI 10.1007/s10151-012-0847-0; Nally DM, 2019, DIGEST SURG, V36, P195, DOI 10.1159/000488216; National Heart Lung and Blood Institute; U.S. Department of Health and Human Services, STUD QUAL ASS TOOLS; Pradel JA, 1997, RADIOLOGY, V205, P503, DOI 10.1148/radiology.205.2.9356636; Rao PM, 1998, AM J ROENTGENOL, V170, P1445, DOI 10.2214/ajr.170.6.9609151; Ribas Y, 2010, INT J COLORECTAL DIS, V25, P1363, DOI 10.1007/s00384-010-0967-9; Ridgway PF, 2009, COLORECTAL DIS, V11, P941, DOI 10.1111/j.1463-1318.2008.01737.x; Salem TA, 2005, COLORECTAL DIS, V7, P460, DOI 10.1111/j.1463-1318.2005.00822.x; Scarpa CR, 2015, ANN COLOPROCTOL, V31, P52, DOI 10.3393/ac.2015.31.2.52; Schug-Pass C, 2010, INT J COLORECTAL DIS, V25, P751, DOI 10.1007/s00384-010-0899-4; Severi Carola, 2018, F1000Res, V7, DOI 10.12688/f1000research.14299.1; Soliman MF, 2004, ULTRASCHALL MED, V25, P342, DOI 10.1055/s-2004-813381; Stefansson T, 1997, ACTA RADIOL, V38, P313; Sterne JAC, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i4919; Tack D, 2005, RADIOLOGY, V237, P189, DOI 10.1148/radiol.2371041432; Unlu C, 2013, EUR J GASTROEN HEPAT, V25, P1038, DOI 10.1097/MEG.0b013e328361dd5b; van Dijk ST, 2020, BRIT J SURG, V107, P1062, DOI 10.1002/bjs.11465; van Dijk ST, 2018, AM J GASTROENTEROL, V113, P1045, DOI 10.1038/s41395-018-0030-y; van Dijk ST, 2019, DIS COLON RECTUM, V62, P608, DOI 10.1097/DCR.0000000000001361; Waqas S, 2014, AM J EMERG MED, V32, P36, DOI 10.1016/j.ajem.2013.09.019; Werner A, 2003, EUR RADIOL, V13, P2596, DOI 10.1007/s00330-003-1887-7	54	3	3	1	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR	2022	175	3					379	+		10.7326/M21-1645	http://dx.doi.org/10.7326/M21-1645		JAN 2022	10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0O5UF	35038271				2022-12-28	WOS:000745535400001
J	Qaseem, A; Etxeandia-Ikobaltzeta, I; Lin, JS; Fitterman, N; Shamliyan, T; Wilt, TJ				Qaseem, Amir; Etxeandia-Ikobaltzeta, Itziar; Lin, Jennifer S.; Fitterman, Nick; Shamliyan, Tatyana; Wilt, Timothy J.		Amer Coll Phys	Diagnosis and Management of Acute Left-Sided Colonic Diverticulitis: A Clinical Guideline From the American College of Physicians	ANNALS OF INTERNAL MEDICINE			English	Article							UNCOMPLICATED DIVERTICULITIS; OUTPATIENT TREATMENT; COMPUTED-TOMOGRAPHY; ANTIBIOTIC-TREATMENT; UNITED-STATES; CT; MILD; RISK; MULTICENTER; TRIAL	Description: The American College of Physicians (ACP) developed this guideline to provide clinical recommendations on the diagnosis and management of acute left-sided colonic diverticulitis in adults. This guideline is based on current best available evidence about benefits and harms, taken in the context of costs and patient values and preferences. Methods: The ACP Clinical Guidelines Committee (CGC) developed this guideline based on a systematic review on the use of computed tomography (CT) for the diagnosis of acute left-sided colonic diverticulitis and on management via hospitalization, antibiotic use, and interventional percutaneous abscess drainage. The systematic review evaluated outcomes that the CGC rated as critical or important. This guideline was developed using the GRADE ( Grading of Recommendations Assessment, Development and Evaluation) methodology. Target Audience and Patient Population: The target audience is all clinicians, and the target patient population is adults with suspected or known acute left-sided colonic diverticulitis. Recommendation 1: ACP suggests that clinicians use abdominal CT imaging when there is diagnostic uncertainty in a patient with suspected acute left-sided colonic diverticulitis (conditional recommendation; low-certainty evidence). Recommendation 2: ACP suggests that clinicians manage most patients with acute uncomplicated left-sided colonic diverticulitis in an outpatient setting (conditional recommendation; low-certainty evidence). Recommendation 3: ACP suggests that clinicians initially manage select patients with acute uncomplicated left-sided colonic diverticulitis without antibiotics (conditional recommendation; low-certainty evidence).	[Qaseem, Amir; Etxeandia-Ikobaltzeta, Itziar; Shamliyan, Tatyana] Amer Coll Physicians, 190 N Independence Mall West, Philadelphia, PA 19106 USA; [Lin, Jennifer S.] Kaiser Permanente Northwest, Portland, OR USA; [Fitterman, Nick] Northwell Hlth, Huntington, NY USA; [Wilt, Timothy J.] Minneapolis VA Ctr Care Delivery & Outcomes Res, Minneapolis, MN USA	American College of Physicians; Kaiser Permanente; Northwell Health	Qaseem, A (corresponding author), Amer Coll Physicians, 190 N Independence Mall West, Philadelphia, PA 19106 USA.	aqaseem@acponline.org	ETXEANDIA-IKOBALTZETA, ITZIAR/AAG-3519-2022; ETXEANDIA-IKOBALTZETA, ITZIAR/AFK-4845-2022	ETXEANDIA-IKOBALTZETA, ITZIAR/0000-0001-6606-649X; ETXEANDIA-IKOBALTZETA, ITZIAR/0000-0001-6606-649X; Qaseem, Amir/0000-0001-6866-7985	ACP operating budget	ACP operating budget	Financial support for the development of this guideline comes exclusively fromthe ACP operating budget.	Andeweg CS, 2014, SCAND J GASTROENTERO, V49, P775, DOI 10.3109/00365521.2014.908475; Andeweg CS, 2011, ANN SURG, V253, P940, DOI 10.1097/SLA.0b013e3182113614; Arevalo JM, 2007, REV ESP ENFERM DIG, V99, P320; Balasubramanian I, 2017, DIGEST SURG, V34, P151, DOI 10.1159/000450865; Balk EM, 2022, ANN INTERN MED, V175, P379, DOI 10.7326/M21-1645; Bharucha AE, 2015, AM J GASTROENTEROL, V110, P1588, DOI 10.1038/ajg.2015.302; Biondo S, 2014, ANN SURG, V259, P38, DOI 10.1097/SLA.0b013e3182965a11; Bolkenstein HE, 2018, INT J COLORECTAL DIS, V33, P863, DOI 10.1007/s00384-018-3055-1; Bollom A, 2017, DIGEST DIS SCI, V62, P2694, DOI 10.1007/s10620-017-4525-y; CDC, 2013, ANTIBIOTIC RESISTANC, DOI [DOI 10.15620/CDC:82532, 10.15620/cdc:82532]; Chabok A, 2012, BRIT J SURG, V99, P532, DOI 10.1002/bjs.8688; CHO KC, 1990, RADIOLOGY, V176, P111, DOI 10.1148/radiology.176.1.2191360; Daniels L, 2017, BRIT J SURG, V104, P52, DOI 10.1002/bjs.10309; de Korte N, 2012, COLORECTAL DIS, V14, P325, DOI 10.1111/j.1463-1318.2011.02609.x; DORINGER E, 1990, ROFO FORTSCHR RONTG, V152, P76, DOI 10.1055/s-2008-1046821; Drummond M, 2005, INT J TECHNOL ASSESS, V21, P165, DOI 10.1017/S0266462305050221; Etzioni DA, 2010, DIS COLON RECTUM, V53, P861, DOI 10.1007/DCR.0b013e3181cdb243; Gaber CE, 2021, ANN INTERN MED, V174, P737, DOI 10.7326/M20-6315; Garrison LP, 2018, VALUE HEALTH, V21, P161, DOI 10.1016/j.jval.2017.12.009; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Hjern F, 2007, SCAND J GASTROENTERO, V42, P41, DOI 10.1080/00365520600780650; HonorHealth, MUCH DOES CT SCAN CO; Husereau D, 2013, INT J TECHNOL ASSESS, V29, P117, DOI 10.1017/S0266462313000160; Imaeda Hiroyuki, 2018, Inflamm Intest Dis, V3, P61, DOI 10.1159/000492178; Isacson D, 2019, BRIT J SURG, V106, P1542, DOI 10.1002/bjs.11239; Isacson D, 2018, SCAND J GASTROENTERO, V53, P449, DOI 10.1080/00365521.2018.1448887; Jackson JD, 2014, INT J COLORECTAL DIS, V29, P775, DOI 10.1007/s00384-014-1900-4; Jaung R, 2021, CLIN GASTROENTEROL H, V19, P503, DOI 10.1016/j.cgh.2020.03.049; Jerjen F, 2021, J MED RADIAT SCI, V68, P310, DOI 10.1002/jmrs.458; Joliat GR, 2017, INT J COLORECTAL DIS, V32, P1313, DOI 10.1007/s00384-017-2847-z; Juncadella AC, 2017, ANN INTERN MED, V166, pJC18, DOI 10.7326/ACPJC-2017-166-4-018; Kaiser Permanente, RAD 2018; KELLUM JM, 1992, CLIN THER, V14, P376; Kelly ME, 2015, ABDOM IMAGING, V40, P1853, DOI 10.1007/s00261-015-0349-4; Kiewiet JJS, 2014, DIGEST LIVER DIS, V46, P119, DOI 10.1016/j.dld.2013.09.017; Kohler L, 1999, SURG ENDOSC-ULTRAS, V13, P430, DOI 10.1007/s004649901007; Lambrichts DPV, 2019, BRIT J SURG, V106, P458, DOI 10.1002/bjs.11129; Lameris W, 2008, EUR RADIOL, V18, P2498, DOI 10.1007/s00330-008-1018-6; Lameris W, 2010, DIS COLON RECTUM, V53, P896, DOI 10.1007/DCR.0b013e3181d98d86; Lorente L, 2013, CIR ESPAN, V91, P504, DOI 10.1016/j.ciresp.2013.01.016; Mali J, 2019, WORLD J EMERG SURG, V14, DOI 10.1186/s13017-019-0250-5; Mensch A, 2018, PHARMACOECONOMICS, V36, P987, DOI 10.1007/s40273-018-0651-4; Moya P, 2012, TECH COLOPROCTOL, V16, P301, DOI 10.1007/s10151-012-0847-0; Murphy CC, 2019, GASTROENTEROLOGY, V156, P958, DOI [10.1053/j.gastro.2018.08.063, 10.1053/j.gastro.2018.11.060]; Nally DM, 2019, DIGEST SURG, V36, P195, DOI 10.1159/000488216; Parmelli E, 2017, INT J TECHNOL ASSESS, V33, P176, DOI 10.1017/S0266462317000447; Peery AF, 2016, CLIN GASTROENTEROL H, V14, P980, DOI 10.1016/j.cgh.2016.01.020; Pradel JA, 1997, RADIOLOGY, V205, P503, DOI 10.1148/radiology.205.2.9356636; Qaseem A, 2019, ANN INTERN MED, V171, P643, DOI 10.7326/M19-0642; Qaseem A, 2019, ANN INTERN MED, V171, P354, DOI 10.7326/M18-3279; Qaseem A, 2019, ANN INTERN MED, V170, P863, DOI 10.7326/M18-3290; Ramsey S, 2005, VALUE HEALTH, V8, P521, DOI 10.1111/j.1524-4733.2005.00045.x; Rao PM, 1998, AM J ROENTGENOL, V170, P1445, DOI 10.2214/ajr.170.6.9609151; Ribas Y, 2010, INT J COLORECTAL DIS, V25, P1363, DOI 10.1007/s00384-010-0967-9; Ridgway PF, 2009, COLORECTAL DIS, V11, P941, DOI 10.1111/j.1463-1318.2008.01737.x; Rottier SJ, 2019, SURG INFECT, V20, P453, DOI 10.1089/sur.2018.289; Salem TA, 2005, COLORECTAL DIS, V7, P460, DOI 10.1111/j.1463-1318.2005.00822.x; Sanchez-Velazquez P, 2016, EUR J GASTROEN HEPAT, V28, P622, DOI 10.1097/MEG.0000000000000610; Sanders GD, 2016, JAMA-J AM MED ASSOC, V316, P1093, DOI 10.1001/jama.2016.12195; Scarpa CR, 2015, ANN COLOPROCTOL, V31, P52, DOI 10.3393/ac.2015.31.2.52; Schug-Pass C, 2010, INT J COLORECTAL DIS, V25, P751, DOI 10.1007/s00384-010-0899-4; Schunemann H, HDB GRADING QUALITY; Shahedi K, 2013, CLIN GASTROENTEROL H, V11, P1609, DOI 10.1016/j.cgh.2013.06.020; Soliman MF, 2004, ULTRASCHALL MED, V25, P342, DOI 10.1055/s-2004-813381; Stefansson T, 1997, ACTA RADIOL, V38, P313; Sterne JAC, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i4919; Strate LL, 2019, GASTROENTEROLOGY, V156, P1282, DOI 10.1053/j.gastro.2018.12.033; Swanson SM, 2018, ANN INTERN MED, V168, pITC65, DOI 10.7326/AITC201805010; Tack D, 2005, RADIOLOGY, V237, P189, DOI 10.1148/radiol.2371041432; Tsoukas S, 2018, AM J GASTROENTEROL, V113, pS103; Tursi A, 2019, MEDIAT INFLAMM, V2019, DOI 10.1155/2019/8328490; U.S. Centers for Medicare & Medicaid Services, PROC PRIC LOOK COMP; UMC Health System, PROC PRIC LOOK; Unlu C, 2013, EUR J GASTROEN HEPAT, V25, P1038, DOI 10.1097/MEG.0b013e328361dd5b; van Dijk ST, 2020, BRIT J SURG, V107, P1062, DOI 10.1002/bjs.11465; van Dijk ST, 2018, AM J GASTROENTEROL, V113, P1045, DOI 10.1038/s41395-018-0030-y; van Dijk ST, 2018, INT J COLORECTAL DIS, V33, P505, DOI 10.1007/s00384-018-3015-9; van Dijk ST, 2017, INT J COLORECTAL DIS, V32, P1693, DOI 10.1007/s00384-017-2919-0; van Dijk ST, 2018, SURG INFECT, V19, P362, DOI 10.1089/sur.2017.236; van Dijk ST, 2019, DIS COLON RECTUM, V62, P608, DOI 10.1097/DCR.0000000000001361; Waqas S, 2014, AM J EMERG MED, V32, P36, DOI 10.1016/j.ajem.2013.09.019; Weiss JB, 2020, ANN INTERN MED, V172, P508, DOI 10.7326/L20-0114; Werner A, 2003, EUR RADIOL, V13, P2596, DOI 10.1007/s00330-003-1887-7; Willke RJ, 2018, VALUE HEALTH, V21, P155, DOI 10.1016/j.jval.2017.12.011	84	5	5	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR	2022	175	3					399	+		10.7326/M21-2710	http://dx.doi.org/10.7326/M21-2710		JAN 2022	20	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0O5UF	35038273				2022-12-28	WOS:000747137200001
J	Karan, A				Karan, Abraar			What the face mask debacle can teach us about pandemic response	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material								Inconsistent messaging from US officials on the use of face masks has sowed public confusion and political divisiveness during the covid-19 pandemic, writes Abraar Karan	[Karan, Abraar] Stanford Univ, Stanford, CA 94305 USA	Stanford University	Karan, A (corresponding author), Stanford Univ, Stanford, CA 94305 USA.							Abaluck J, 2022, SCIENCE, V375, P160, DOI 10.1126/science.abi9069; Abutaleb Y., 2021, WASH POST; Alpert Reyes ELA, 2022, LOS ANGELES TIM 0105; Caldwell T, 2022, CNN HLTH; Dhillon R., 2020, HARVARD BUS REV; Fazio Marie, 2021, NEW YORK TIMES; Howard J, 2020, THE CNN; Karan A, 2020, VOX 0319; Lovelace B., 2021, CNBC; Lyu W, 2020, HEALTH AFFAIR, V39, P1419, DOI 10.1377/hlthaff.2020.00818; Simmons-Duffin s, 2022, NPR; Sun LH, 2022, WASH POST; Wallace-Wells D., 2022, INTELLIGENCER 0107	13	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 12	2022	376								o85	10.1136/bmj.o85	http://dx.doi.org/10.1136/bmj.o85			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YP6JI	35022183	Bronze			2022-12-28	WOS:000748728200011
J	Tuddenham, S; Hamill, MM; Ghanem, KG				Tuddenham, Susan; Hamill, Matthew M.; Ghanem, Khalil G.			Diagnosis and Treatment of Sexually Transmitted Infections A Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							HERPES-SIMPLEX-VIRUS; UPDATED EVIDENCE REPORT; MYCOPLASMA-GENITALIUM; CHLAMYDIA-TRACHOMATIS; TREPONEMA-PALLIDUM; CROSS-REACTIVITY; MEDIATED HYPERSENSITIVITY; GONOCOCCAL INFECTIONS; CLINICAL PRESENTATION; SYPHILIS	IMPORTANCE Approximately 1 in 5 adults in the US had a sexually transmitted infection (STI) in 2018. This review provides an update on the epidemiology, diagnosis, and treatment of gonorrhea, chlamydia, syphilis, Mycoplasma genitalium, trichomoniasis, and genital herpes. OBSERVATIONS From 2015 to 2019, the rates of gonorrhea, chlamydia, and syphilis increased in the US; from 1999 to 2016, while the rates of herpes simplex virus type 1 (HSV-1) and HSV-2 declined. Populations with higher rates of STIs include people younger than 25 years, sexual and gender minorities such as men and transgender women who have sex with men, and racial and ethnic minorities such as Black and Latinx people. Approximately 70% of infections with HSV and trichomoniasis and 53% to 100% of extragenital gonorrhea and chlamydia infections are asymptomatic or associated with few symptoms. STIs are associated with HIV acquisition and transmission and are the leading cause of tubal factor infertility in women. Nucleic acid amplification tests have high sensitivities (86.1%-100%) and specificities (97.1%-100%) for the diagnosis of gonorrhea, chlamydia, M genitalium, trichomoniasis, and symptomatic HSV-1 and HSV-2. Serology remains the recommended method to diagnose syphilis, typically using sequential testing to detect treponemal and nontreponemal (antiphospholipid) antibodies. Ceftriaxone, doxycycline, penicillin, moxifloxacin, and the nitroimidazoles, such as metronidazole, are effective treatments for gonorrhea, chlamydia, syphilis, M genitalium, and trichomoniasis, respectively, but antimicrobial resistance limits oral treatment options for gonorrhea and M genitalium. No cure is available for genital herpes. Effective STI prevention interventions include screening, contact tracing of sexual partners, and promoting effective barrier contraception. CONCLUSIONS AND RELEVANCE Approximately 1 in 5 adults in the US had an STI in 2018. Rates of gonorrhea, chlamydia, and syphilis in the US have increased, while rates of HSV-1 and HSV-2 have declined. Ceftriaxone, doxycycline, penicillin, moxifloxacin, and the nitroimidazoles are effective treatments for gonorrhea, chlamydia, syphilis, Mycoplasma genitalium, and trichomoniasis, respectively, but antimicrobial resistance limits oral therapies for gonorrhea and Mycoplasma genitalium, and no cure is available for genital herpes.	[Tuddenham, Susan; Hamill, Matthew M.; Ghanem, Khalil G.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA	Johns Hopkins University	Ghanem, KG (corresponding author), Johns Hopkins Univ, Bayview Med Ctr, 5200 Eastern Ave,MFL Ctr Tower 378, Baltimore, MD 21224 USA.	mdm608@northwestern.edu; kghanem@jhmi.edu		Hamill, Matthew M/0000-0002-1277-819X	National Institute of Allergy and Infectious Diseases [K23-AI125715]	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Dr Tuddenham is supported by grant K23-AI125715 from the National Institute of Allergy and Infectious Diseases.	Agyemang E, 2017, SEX TRANSM DIS, V44, P763, DOI 10.1097/OLQ.0000000000000689; Alhashimi M, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.01225-19; [Anonymous], 2020, Obstet Gynecol, V135, pe193, DOI 10.1097/AOG.0000000000003840; Arshad Zeeshaan, 2019, JMIR Public Health Surveill, V5, pe14216, DOI 10.2196/14216; Ayoub HH, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1285-x; Bernstein DI, 2013, CLIN INFECT DIS, V56, P344, DOI 10.1093/cid/cis891; BERNSTEIN DI, 1984, AM J MED, V77, P1055, DOI 10.1016/0002-9343(84)90188-8; Bolan RK, 2015, SEX TRANSM DIS, V42, P98, DOI 10.1097/OLQ.0000000000000216; Buitrago-Garcia D, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011399.pub2; Butler T, 2017, AM J TROP MED HYG, V96, P46, DOI 10.4269/ajtmh.16-0434; Cantor A, 2021, JAMA-J AM MED ASSOC, V326, P957, DOI 10.1001/jama.2021.10577; Centers for Disease Control and Prevention, 2021, SEX TRANSM DIS SURV; Centers for Disease Control and Prevention US Public Health Service, 2021, PREEXP PROPH PREV HI; Chan Philip A, 2016, Infect Dis Obstet Gynecol, V2016, P5758387, DOI 10.1155/2016/5758387; Chesson HW, 2021, SEX TRANSM DIS, V48, P215, DOI 10.1097/OLQ.0000000000001380; Clement ME, 2014, JAMA-J AM MED ASSOC, V312, P1905, DOI 10.1001/jama.2014.13259; Corey L, 2004, NEW ENGL J MED, V350, P11, DOI 10.1056/NEJMoa035144; COREY L, 1983, ANN INTERN MED, V98, P958, DOI 10.7326/0003-4819-98-6-958; de Vries HJC, 2019, CURR OPIN INFECT DIS, V32, P43, DOI [10.1097/qco.0000000000000519, 10.1097/QCO.0000000000000519]; Detels R, 2011, SEX TRANSM DIS, V38, P503, DOI 10.1097/OLQ.0b013e318206c288; Dionne-Odom J, 2018, CLIN INFECT DIS, V66, P796, DOI 10.1093/cid/cix853; Doernberg SB, 2020, CLIN INFECT DIS, V71, P2314, DOI 10.1093/cid/ciz1105; Dombrowski JC, 2021, CLIN INFECT DIS, V73, P824, DOI 10.1093/cid/ciab153; Durukan D, 2020, CLIN INFECT DIS, V71, P1461, DOI 10.1093/cid/ciz1031; Gaydos CA, 2019, J CLIN MICROBIOL, V57, DOI 10.1128/JCM.01125-19; Gayet-Ageron A, 2013, SEX TRANSM INFECT, V89, P251, DOI 10.1136/sextrans-2012-050622; Geisler WM, 2015, NEW ENGL J MED, V373, P2512, DOI 10.1056/NEJMoa1502599; Getman D, 2016, J CLIN MICROBIOL, V54, P2278, DOI 10.1128/JCM.01053-16; Ghanem KG, 2020, NEW ENGL J MED, V382, P845, DOI 10.1056/NEJMra1901593; Gnann JW, 2016, NEW ENGL J MED, V375, P1906, DOI 10.1056/NEJMc1611877; Harding AS, 2012, SEX TRANSM DIS, V39, P291, DOI 10.1097/OLQ.0b013e31824c0e62; He WH, 2020, ARCH GYNECOL OBSTET, V302, P553, DOI 10.1007/s00404-020-05664-6; Herbst de Cortina S., 2016, IN FECT DIS OBSTET G, V2016, P1, DOI [10.1155/2016/4386127, 10.5402/2011/279149]; Hollier Lisa M, 2015, BMJ Clin Evid, V2015; Kabapy AF, 2020, TRANSBOUND EMERG DIS, V67, P2372, DOI 10.1111/tbed.13621; Kirkcaldy RD, 2014, CLIN INFECT DIS, V59, P1083, DOI 10.1093/cid/ciu521; Kissinger P, 2018, LANCET INFECT DIS, V18, P1251, DOI [10.1016/S1473-3099(18)30423-7, 10.1016/s1473-3099(18)30423-7]; Kissinger P, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1055-0; Kreisel KM, 2021, SEX TRANSM DIS, V48, P208, DOI 10.1097/OLQ.0000000000001355; Lara-Torre E, 2003, AM J OBSTET GYNECOL, V188, P354, DOI 10.1067/mob.2003.8; Latimer RL, 2020, SEX TRANSM INFECT, V96, P10, DOI 10.1136/sextrans-2019-054058; Lau A, 2021, NEW ENGL J MED, V384, P2418, DOI 10.1056/NEJMoa2031631; LeGoff J, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-83; Lin JS, 2018, JAMA-J AM MED ASSOC, V320, P918, DOI 10.1001/jama.2018.7769; Lis R, 2015, CLIN INFECT DIS, V61, P418, DOI 10.1093/cid/civ312; Magaret AS, 2016, CLIN INFECT DIS, V62, P456, DOI 10.1093/cid/civ908; MAGNARELLI LA, 1987, J INFECT DIS, V156, P183, DOI 10.1093/infdis/156.1.183; Malekinejad M, 2021, SEX TRANSM DIS, V48, pE138, DOI 10.1097/OLQ.0000000000001403; Manhart LE, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00165-20; Martin ET, 2009, ARCH INTERN MED, V169, P1233, DOI 10.1001/archinternmed.2009.177; McQuillan Geraldine, 2018, NCHS Data Brief, P1; Molina JM, 2018, LANCET INFECT DIS, V18, P308, DOI [10.1016/S1473-3099(17)30725-9, 10.1016/s1473-3099(17)30725-9]; Muzny CA, 2013, SEX TRANSM INFECT, V89, P514, DOI 10.1136/sextrans-2012-050889; Nettleton WD, 2020, MMWR-MORBID MORTAL W, V69, P353, DOI 10.15585/mmwr.mm6912a5; Olaleye AO, 2020, EUR J OBSTET GYN R B, V255, P1, DOI 10.1016/j.ejogrb.2020.10.002; Ortiz DA, 2020, CLIN INFECT DIS, V71, pS43, DOI 10.1093/cid/ciaa307; Papp JR, 2014, MMWR RECOMM REP, V63, P1; Park IU, 2020, CLIN INFECT DIS, V71, pS13, DOI 10.1093/cid/ciaa349; Patel EU, 2018, CLIN INFECT DIS, V67, P211, DOI 10.1093/cid/ciy079; Petousis-Harris H, 2017, LANCET, V390, P1603, DOI 10.1016/S0140-6736(17)31449-6; Poncin Thibault, 2018, Euro Surveill, V23, DOI 10.2807/1560-7917.ES.2018.23.21.1800264; Ramchandani MS, 2020, SEX TRANSM DIS, V47, P296, DOI 10.1097/OLQ.0000000000001155; Read TRH, 2019, EMERG INFECT DIS, V25, P719, DOI 10.3201/eid2504.181258; RIVIERE GR, 1991, NEW ENGL J MED, V325, P539, DOI 10.1056/NEJM199108223250803; Romano A, 2018, J ALLER CL IMM-PRACT, V6, P1662, DOI 10.1016/j.jaip.2018.01.020; Romano A, 2016, J ALLERGY CLIN IMMUN, V138, P179, DOI 10.1016/j.jaci.2016.01.025; Ropper AH, 2019, NEW ENGL J MED, V381, P1358, DOI 10.1056/NEJMra1906228; Savaris RF, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010285.pub3; Sena AC, 2012, J INFECT DIS, V206, P357, DOI 10.1093/infdis/jis356; Shore R N, 1976, Cutis, V17, P745; Simons R, 2018, SEX TRANSM DIS, V45, P406, DOI 10.1097/OLQ.0000000000000772; Soni S, 2019, INT J STD AIDS, V30, P938, DOI 10.1177/0956462419825948; Stanberry LR, 2004, CLIN INFECT DIS, V39, P1433, DOI 10.1086/425307; Stoner BP, 2015, CLIN INFECT DIS, V61, pS865, DOI 10.1093/cid/civ756; Theel ES, 2020, CLIN INFECT DIS, V71, pS4, DOI 10.1093/cid/ciaa176; Towns JM, 2016, SEX TRANSM INFECT, V92, P110, DOI 10.1136/sextrans-2015-052219; Tronstein E, 2011, JAMA-J AM MED ASSOC, V305, P1441, DOI 10.1001/jama.2011.420; Tsevat DG, 2017, AM J OBSTET GYNECOL, V216, P1, DOI 10.1016/j.ajog.2016.08.008; Tucker JD, 2011, SEX TRANSM INFECT, V87, P4, DOI 10.1136/sti.2010.043042; Tuddenham S, 2020, CLIN INFECT DIS, V71, pS21, DOI 10.1093/cid/ciaa306; Unemo M, 2019, NAT REV DIS PRIMERS, V5, DOI [10.1038/s41572-019-0136-6, 10.1038/s41572-019-0128-6]; Whelan J, 2021, INFECT DIS THER, V10, P1887, DOI 10.1007/s40121-021-00481-z; Workowski KA, 2015, MMWR RECOMM REP, V64, P1, DOI 10.15585/mmwr.rr7004a1; Xiao L, 2019, SEX TRANSM DIS, V46, P18, DOI 10.1097/OLQ.0000000000000891	84	17	17	13	27	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 11	2022	327	2					161	172		10.1001/jama.2021.23487	http://dx.doi.org/10.1001/jama.2021.23487			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YH8QV	35015033				2022-12-28	WOS:000743426500017
J	Engel, M				Engel, Megan			The Complete Guide to Absolutely Everything (Abridged): Adventures in Math and Science	SCIENCE			English	Book Review									[Engel, Megan] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University	Engel, M (corresponding author), Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.	mcengel@seas.harvard.edu						RUTHERFORD A, 2022, COMPLETE GUIDE ABSOL	1	0	0	1	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 7	2022	375	6576					35	35		10.1126/science.abn0901	http://dx.doi.org/10.1126/science.abn0901			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YD3FW	34990243				2022-12-28	WOS:000740261400032
J	Arnold, C				Arnold, Carrie			SPURRED BY COVID, PUBLIC HEALTH GETS PRECISE	NATURE			English	News Item						Infection; Health care; Society	NEW-YORK-CITY											Alfonso YN, 2021, HEALTH AFFAIR, V40, P664, DOI 10.1377/hlthaff.2020.01084; [Anonymous], 1988, FUT PUBL HLTH; Greene SK, 2021, JMIR PUBLIC HLTH SUR, V7, P180, DOI 10.2196/25538; Greene SK, 2016, EMERG INFECT DIS, V22, P1808, DOI 10.3201/eid2210.160097; Latash J, 2020, MMWR-MORBID MORTAL W, V69, P815, DOI 10.15585/mmwr.mm6926a2; Myers KD, 2019, LANCET DIGIT HEALTH, V1, pE393, DOI 10.1016/S2589-7500(19)30150-5; Ritchie JB, 2021, HERED CANCER CLIN PR, V19, DOI 10.1186/s13053-021-00188-9	7	1	1	6	31	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 6	2022	601	7891					18	20		10.1038/d41586-021-03819-2	http://dx.doi.org/10.1038/d41586-021-03819-2			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YB0AX	34983989				2022-12-28	WOS:000738686800005
J	Gasbjerg, KS; Hagi-Pedersen, D; Lunn, TH; Laursen, CC; Holmqvist, M; Vinstrup, LO; Ammitzboell, M; Jakobsen, K; Jensen, MS; Pallesen, MJ; Bagger, J; Lindholm, P; Pedersen, NA; Schroder, HM; Lindberg-Larsen, M; Norskov, AK; Thybo, KH; Brorson, S; Overgaard, S; Jakobsen, JC; Mathiesen, O				Gasbjerg, Kasper Smidt; Hagi-Pedersen, Daniel; Lunn, Troels Haxholdt; Laursen, Christina Cleveland; Holmqvist, Majken; Vinstrup, Louise Orts; Ammitzboell, Mette; Jakobsen, Karina; Jensen, Mette Skov; Pallesen, Marie Johnk; Bagger, Jens; Lindholm, Peter; Pedersen, Niels Anker; Schroder, Henrik Morville; Lindberg-Larsen, Martin; Norskov, Anders Kehlet; Thybo, Kasper Hojgaard; Brorson, Stig; Overgaard, Soren; Jakobsen, Janus Christian; Mathiesen, Ole			Effect of dexamethasone as an analgesic adjuvant to multimodal pain treatment after total knee arthroplasty: randomised clinical trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							TOTAL JOINT ARTHROPLASTY; HIGH-DOSE DEXAMETHASONE; SYSTEMIC DEXAMETHASONE; NONOPIOID ANALGESICS; MORPHINE CONSUMPTION; CARDIAC-SURGERY; MAJOR SURGERY; OPIOID USE; GLUCOCORTICOIDS; PARACETAMOL	OBJECTIVE To investigate the effects of one and two doses of intravenous dexamethasone in patients after total knee arthroplasty. DESIGN Randomised, blinded, placebo controlled trial with follow-up at 90 days. SETTING Five Danish hospitals, September 2018 to March 2020. PARTICIPANTS 485 adult participants undergoing total knee arthroplasty. INTERVENTION A computer generated randomised sequence stratified for site was used to allocate participants to one of three groups: DX1 (dexamethasone (24 mg)+placebo); DX2 (dexamethasone (24 mg)+dexamethasone (24 mg)); or placebo (placebo+placebo). The intervention was given preoperatively and after 24 hours. Participants, investigators, and outcome assessors were blinded. All participants received paracetamol, ibuprofen, and local infiltration analgesia. MAIN OUTCOME MEASURES The primary outcome was total intravenous morphine consumption 0 to 48 hours postoperatively. Multiplicity adjusted threshold for statistical significance was P<0.017 and minimal important difference was 10 mg morphine. Secondary outcomes included postoperative pain. RESULTS 485 participants were randomised: 161 to DX1, 162 to DX2, and 162 to placebo. Data from 472 participants (97.3%) were included in the primary outcome analysis. The median (interquartile range) morphine consumptions at 0-48 hours were: DX1 37.9 mg (20.7 to 56.7); DX2 35.0 mg (20.6 to 52.0); and placebo 43.0 mg (28.7 to 64.0). Hodges-Lehmann median differences between groups were: -2.7 mg (98.3% confidence interval -9.3 to 3.7), P=0.30 between DX1 and DX2; 7.8 mg (0.7 to 14.7), P=0.008 between DX1 and placebo; and 10.7 mg (4.0 to 17.3), P<0.001 between DX2 and placebo. Postoperative pain was reduced at 24 hours with one dose, and at 48 hours with two doses, of dexamethasone. CONCLUSION Two doses of dexamethasone reduced morphine consumption during 48 hours after total knee arthroplasty and reduced postoperative pain. TRIAL REGISTRATION Clinicaltrials.gov NCT03506789.	[Gasbjerg, Kasper Smidt; Jakobsen, Karina; Jensen, Mette Skov] Naestved Hosp, Dept Anaesthesiol, Naestved, Denmark; [Gasbjerg, Kasper Smidt; Jakobsen, Karina; Jensen, Mette Skov] Slagelse Hosp, Dept Anaesthesiol, Naestved, Denmark; [Gasbjerg, Kasper Smidt; Jakobsen, Karina; Jensen, Mette Skov] Ringsted Hosp, Dept Anaesthesiol, Naestved, Denmark; [Hagi-Pedersen, Daniel; Lunn, Troels Haxholdt; Brorson, Stig; Overgaard, Soren; Mathiesen, Ole] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark; [Hagi-Pedersen, Daniel; Jakobsen, Janus Christian] Univ Southern Denmark, Fac Hlth Sci, Dept Reg Hlth Res, Odense, Denmark; [Hagi-Pedersen, Daniel] Naestved Hosp, Dept Anaesthesiol, Slagelse, Denmark; [Hagi-Pedersen, Daniel] Slagelse Hosp, Dept Anaesthesiol, Slagelse, Denmark; [Hagi-Pedersen, Daniel] Ringsted Hosp, Dept Anaesthesiol, Slagelse, Denmark; [Lunn, Troels Haxholdt; Laursen, Christina Cleveland; Vinstrup, Louise Orts] Univ Copenhagen, Bispebjerg & Frederiksberg Hosp, Dept Anaesthesia & Intens Care, Copenhagen, Denmark; [Laursen, Christina Cleveland; Vinstrup, Louise Orts] Univ Copenhagen, Bispebjerg & Frederiksberg Hosp, Copenhagen Ctr Translat Res, Copenhagen, Denmark; [Holmqvist, Majken; Thybo, Kasper Hojgaard; Mathiesen, Ole] Zealand Univ Hosp, Ctr Anaesthesiol Res, Dept Anaesthesiol, Koge, Denmark; [Ammitzboell, Mette; Pallesen, Marie Johnk; Bagger, Jens; Overgaard, Soren] Univ Copenhagen, Bispebjerg & Frederiksberg Hosp, Dept Orthopaed Surg & Traumatol, Copenhagen, Denmark; [Lindholm, Peter] Odense Univ Hosp, Dept Anaesthesiol & Intens Care, Odense, Denmark; [Pedersen, Niels Anker] Gildhoj Private Hosp, Dept Anaesthesia, Brondby, Denmark; [Schroder, Henrik Morville] Naestved Hosp, Dept Orthopaed Surg, Naestved, Denmark; [Schroder, Henrik Morville] Slagelse Hosp, Dept Orthopaed Surg, Naestved, Denmark; [Schroder, Henrik Morville] Ringsted Hosp, Dept Orthopaed Surg, Naestved, Denmark; [Lindberg-Larsen, Martin; Overgaard, Soren] Odense Univ Hosp, Dept Orthopaed Surg & Traumatol, Orthopaed Res Unit, Odense, Denmark; [Norskov, Anders Kehlet] Nordsjaelands Univ Hosp, Dept Anaesthesiol, Hillerod, Denmark; [Norskov, Anders Kehlet; Jakobsen, Janus Christian] Copenhagen Univ Hosp, Rigshosp, Copenhagen Trial Unit Ctr Clin Intervent Res, Capital Reg Denmark, Copenhagen, Denmark; [Brorson, Stig] Zealand Univ Hosp, Dept Orthopaed Surg, Koge, Denmark; [Lindberg-Larsen, Martin; Overgaard, Soren] Univ Southern Denmark, Dept Clin Res, Odense, Denmark	Naestved Hospital; University of Copenhagen; University of Southern Denmark; Naestved Hospital; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; Bispebjerg Hospital; University of Southern Denmark; Odense University Hospital; Naestved Hospital; University of Southern Denmark; Odense University Hospital; Rigshospitalet; University of Copenhagen; University of Southern Denmark	Mathiesen, O (corresponding author), Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark.; Mathiesen, O (corresponding author), Zealand Univ Hosp, Ctr Anaesthesiol Res, Dept Anaesthesiol, Koge, Denmark.	omat@regionsiaelland.dk	Hägi-Pedersen, Daniel/E-9653-2016; Jakobsen, Janus Christian/N-2419-2013; Brorson, Stig/AAD-9703-2020	Hägi-Pedersen, Daniel/0000-0001-8008-6614; Jakobsen, Janus Christian/0000-0002-3642-2120; Lindberg-Larsen, Martin/0000-0002-4483-677X; Norskov, Anders Kehlet/0000-0002-6908-7832; Brorson, Stig/0000-0001-5337-758X; Laursen, Christina Cleveland Westerdahl/0000-0002-9525-0920; Mathiesen, Ole/0000-0003-4544-0619; Vinstrup, Louise/0000-0002-3487-8845; Smidt Gasbjerg, Kasper/0000-0003-1484-483X	Naestved, Slagelse and Ringsted Hospitals' Research Fund; Department of Anaesthesiology, Naestved, Slagelse and Ringsted Hospitals, Denmark	Naestved, Slagelse and Ringsted Hospitals' Research Fund; Department of Anaesthesiology, Naestved, Slagelse and Ringsted Hospitals, Denmark	This study was funded by Naestved, Slagelse and Ringsted Hospitals' Research Fund, and received support from the Department of Anaesthesiology, Naestved, Slagelse and Ringsted Hospitals, Denmark. The funder of the study had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	Albrecht E, 2020, ACTA ANAESTH SCAND, V64, P6, DOI 10.1111/aas.13470; [Anonymous], 1995, ICH TOP E 2 CLIN SA; Chang CB, 2012, J BONE JOINT SURG BR, V94B, P1511, DOI 10.1302/0301-620X.94B11.29165; Cheng BLY, 2019, EUR J ORTHOP SURG TR, V29, P1473, DOI 10.1007/s00590-019-02469-5; Conroy RM, 2012, STATA J, V12, P182, DOI 10.1177/1536867X1201200202; Corcoran TB, 2021, NEW ENGL J MED, V384, P1731, DOI 10.1056/NEJMoa2028982; Dahl JB, 2014, ACTA ANAESTH SCAND, V58, P1165, DOI 10.1111/aas.12382; De Oliveira GS, 2011, ANESTHESIOLOGY, V115, P575, DOI 10.1097/ALN.0b013e31822a24c2; Dieleman JM, 2017, ANAESTHESIA, V72, P704, DOI 10.1111/anae.13853; Dieleman JM, 2012, JAMA-J AM MED ASSOC, V308, P1761, DOI 10.1001/jama.2012.14144; Doleman B, 2018, ANESTH ANALG, V126, P648, DOI 10.1213/ANE.0000000000002237; Fabritius ML, 2017, BRIT J ANAESTH, V119, P775, DOI 10.1093/bja/aex227; Fletcher D, 2014, BRIT J ANAESTH, V112, P991, DOI 10.1093/bja/aeu137; Gasbjerg KS, 2020, ACTA ANAESTH SCAND, V64, P839, DOI 10.1111/aas.13560; Gasbjerg KS, 2020, ACTA ANAESTH SCAND, V64, P267, DOI 10.1111/aas.13481; Gerbershagen HJ, 2013, ANESTHESIOLOGY, V118, P934, DOI 10.1097/ALN.0b013e31828866b3; Goesling J, 2016, PAIN, V157, P1259, DOI 10.1097/j.pain.0000000000000516; Inacio MCS, 2017, OSTEOARTHR CARTILAGE, V25, P1797, DOI 10.1016/j.joca.2017.07.022; Inacio MCS, 2017, CLIN ORTHOP RELAT R, V475, P2130, DOI 10.1007/s11999-017-5377-7; Jorgensen CC, 2017, BRIT J ANAESTH, V119, P267, DOI 10.1093/bja/aex190; Karlsen APH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173107; Koyuncu S, 2021, ANAESTHESIA, V76, P261, DOI 10.1111/anae.15118; Lex JR, 2021, J ARTHROPLASTY, V36, P1168, DOI 10.1016/j.arth.2020.10.010; Li DH, 2019, J KNEE SURG, V32, P171, DOI 10.1055/s-0038-1636506; Lunn TH, 2011, BRIT J ANAESTH, V106, P230, DOI 10.1093/bja/aeq333; Martinez V, 2017, BRIT J ANAESTH, V118, P22, DOI 10.1093/bja/aew391; Maund E, 2011, BRIT J ANAESTH, V106, P292, DOI 10.1093/bja/aeq406; Morales-Avalos R, 2021, J KNEE SURG, V34, P383, DOI 10.1055/s-0039-1696722; Myles PS, 2017, BRIT J ANAESTH, V118, P424, DOI 10.1093/bja/aew466; Myles PS, 2021, ANESTHESIOLOGY, V135, P895, DOI 10.1097/ALN.0000000000003898; Olsen MF, 2017, BMC MED, V15, DOI 10.1186/s12916-016-0775-3; Polderman JAW, 2019, ANAESTHESIA, V74, P929, DOI 10.1111/anae.14610; Romundstad L, 2007, ANESTHESIOLOGY, V107, P371, DOI 10.1097/01.anes.0000279487.27940.5c; Rupp M, 2020, CLIN ORTHOP RELAT R, V478, P1622, DOI 10.1097/CORR.0000000000001214; Thybo KH, 2019, JAMA-J AM MED ASSOC, V321, P562, DOI 10.1001/jama.2018.22039; Toner AJ, 2017, ANESTHESIOLOGY, V126, P234, DOI 10.1097/ALN.0000000000001466; Wainwright TW, 2020, ACTA ORTHOP, V91, P3, DOI 10.1080/17453674.2019.1683790; Wick EC, 2017, JAMA SURG, V152, P691, DOI 10.1001/jamasurg.2017.0898; Wu CL, 2019, ANESTH ANALG, V129, P567, DOI 10.1213/ANE.0000000000004194; Wu YG, 2018, BMC MUSCULOSKEL DIS, V19, DOI 10.1186/s12891-018-2359-1; Xu B, 2018, KNEE SURG SPORT TR A, V26, P1549, DOI 10.1007/s00167-017-4506-x; Xu H, 2018, J ARTHROPLASTY, V33, P3448, DOI 10.1016/j.arth.2018.06.031; Yu Y, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000015852; Zhao SZ, 2004, J PAIN SYMPTOM MANAG, V28, P35, DOI 10.1016/j.jpainsymman.2003.11.001	44	6	6	5	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 4	2022	376								e067325	10.1136/bmj-2021-067325	http://dx.doi.org/10.1136/bmj-2021-067325			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YD7MV	34983775	Green Published, hybrid			2022-12-28	WOS:000740622800007
J	Tweedy, DS				Tweedy, Damon S.			Race and Health - A Persistent American Dilemma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Tweedy, Damon S.] Duke Univ, Sch Med, Durham, NC 27710 USA	Duke University	Tweedy, DS (corresponding author), Duke Univ, Sch Med, Durham, NC 27710 USA.							Amutah BAC, 2021, NEW ENGL J MED, V384, P872, DOI 10.1056/NEJMms2025768; Ansell DA, 2015, NEW ENGL J MED, V372, P1087, DOI 10.1056/NEJMp1500832; Bassett MT, 2015, NEW ENGL J MED, V372, P1085, DOI 10.1056/NEJMp1500529; Geiger HJ, 1996, NEW ENGL J MED, V335, P815, DOI 10.1056/NEJM199609123351110; LUM CK, 1994, ACAD MED, V69, P239, DOI 10.1097/00001888-199403000-00021	5	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 30	2021	385	27							e98	10.1056/NEJMpv2117898	http://dx.doi.org/10.1056/NEJMpv2117898			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	XW2YE	34965345	Bronze			2022-12-28	WOS:000735490500002
J	Adam, D				Adam, David			THE EFFORT TO COUNT THE PANDEMIC'S GLOBAL DEATH TOLL	NATURE			English	News Item						SARS-CoV-2; Epidemiology; Research data; Computer science												Besson ESK, 2021, BMJ GLOB HEALTH, V6, DOI 10.1136/bmjgh-2020-004564; de Nicola G., 2022, ASTA WIRTSCHAFTS UND, V16, P5, DOI [DOI 10.1007/S11943-021-00297-W, 10.1007/s11943-021-00297-w]; Jha P, 2022, SCIENCE, V375, P667, DOI 10.1126/science.abm5154; Karlinsky A, 2021, ELIFE, V10, DOI 10.7554/eLife.69336; Karlinskya a, PREPRINT MEDRXIV, DOI [10.1101/2021.08.30.21262814(2021, DOI 10.1101/2021.08.30.21262814(2021]; Paget J, 2019, J GLOB HEALTH, V9, DOI 10.7189/jogh.09.020421; Simonsen L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001558; Subramanian a, 2021, 3 NEW ESTIMATES INDI; Warsame A, 2021, INT J INFECT DIS, V113, P190, DOI 10.1016/j.ijid.2021.09.049	9	50	50	3	6	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 20	2022	601	7893					312	315		10.1038/d41586-022-00104-8	http://dx.doi.org/10.1038/d41586-022-00104-8			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YI6PE	35042997				2022-12-28	WOS:000743967700013
J	Liu, XM; Li, JIA; Watanabe, K; Taniguchi, T; Hone, J; Halperin, BI; Kim, P; Dean, CR				Liu, Xiaomeng; Li, J. I. A.; Watanabe, Kenji; Taniguchi, Takashi; Hone, James; Halperin, Bertrand, I; Kim, Philip; Dean, Cory R.			Crossover between strongly coupled and weakly coupled exciton superfluids	SCIENCE			English	Article							HIGH-TEMPERATURE SUPERCONDUCTORS; BOSE-EINSTEIN CONDENSATION; BCS-BEC CROSSOVER; QUANTUM; PHASE; DEPENDENCE; FERMIONS; STATES	In fermionic systems, superconductivity and superfluidity occur through the condensation of fermion pairs. The nature of this condensate can be tuned by varying the pairing strength, which is challenging in electronic systems. We studied graphene double layers separated by an atomically thin insulator. Under applied magnetic field, electrons and holes couple across the barrier to form bound magneto-excitons whose pairing strength can be continuously tuned by varying the effective layer separation. Using temperature-dependent Coulomb drag and counterflow current measurements, we were able to tune the magneto-exciton condensate through the entire phase diagram from weak to strong coupling. Our results establish magneto-exciton condensates in graphene as a model platform to study the crossover between two bosonic quantum condensate phases in a solid-state system.	[Liu, Xiaomeng; Halperin, Bertrand, I; Kim, Philip] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Li, J. I. A.] Brown Univ, Dept Phys, Providence, RI 02912 USA; [Watanabe, Kenji] Natl Inst Mat Sci, Res Ctr Funct Mat, 1-1 Namiki, Tsukuba, Ibaraki 3050044, Japan; [Taniguchi, Takashi] Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton, 1-1 Namiki, Tsukuba, Ibaraki 3050044, Japan; [Hone, James] Columbia Univ, Dept Mech Engn, New York, NY 10027 USA; [Dean, Cory R.] Columbia Univ, Dept Phys, New York, NY 10027 USA	Harvard University; Brown University; National Institute for Materials Science; National Institute for Materials Science; Columbia University; Columbia University	Kim, P (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.; Dean, CR (corresponding author), Columbia Univ, Dept Phys, New York, NY 10027 USA.	pkim@physics.barrard.edu; cd2478@columbia.edu	Kim, Philip/N-1886-2013; Watanabe, Kenji/H-2825-2011; Hone, James/E-1879-2011	Kim, Philip/0000-0002-8255-0086; Watanabe, Kenji/0000-0003-3701-8119; Li, Jia/0000-0002-8431-2567; Liu, Xiaomeng/0000-0002-0039-7090; Hone, James/0000-0002-8084-3301	US Department of Energy (DOE), Office of Science, Basic Energy Sciences [DE-SC0019481]; DOE [DE-SC0012260]; DoD Vannevar Bush Faculty Fellowship [N00014-18-1-2877]; CREST, JST [JPMJCR15F3]; ARO MURI [W911NF-14-1-0247]; Center for Precision-Assembled Quantum Materials (PAQM), a Materials Science and Engineering Research Center (MRSEC) through NSF [DMR-2011738]; Science and Technology Center for Integrated Quantum Materials, NSF [DMR-1231319]; NSF [DMR-1644779]; state of Florida; NSF NNIN [ECS-00335765]; MEXT, Japan; JSPS	US Department of Energy (DOE), Office of Science, Basic Energy Sciences(United States Department of Energy (DOE)); DOE(United States Department of Energy (DOE)); DoD Vannevar Bush Faculty Fellowship; CREST, JST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); ARO MURI(MURI); Center for Precision-Assembled Quantum Materials (PAQM), a Materials Science and Engineering Research Center (MRSEC) through NSF; Science and Technology Center for Integrated Quantum Materials, NSF; NSF(National Science Foundation (NSF)); state of Florida; NSF NNIN(National Science Foundation (NSF)); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Supported by the US Department of Energy (DOE), Office of Science, Basic Energy Sciences, under award DE-SC0019481 (C.R.D.); DOE award DE-SC0012260 for device fabrication and measurement (X.L.); DoD Vannevar Bush Faculty Fellowship N00014-18-1-2877 (P.K.); and the Elemental Strategy Initiative conducted by the MEXT, Japan, A3 Foresight by JSPS and the CREST (JPMJCR15F3), JST (K.W. and T.T.). Sample preparation at Harvard was supported by ARO MURI (W911NF-14-1-0247). Sample fabrication at Columbia University was supported by the Center for Precision-Assembled Quantum Materials (PAQM), a Materials Science and Engineering Research Center (MRSEC) through NSF grant DMR-2011738. The theoretical analysis was supported in part by the Science and Technology Center for Integrated Quantum Materials, NSF grant DMR-1231319. A portion of this work was performed at the National High Magnetic Field Laboratory, which is supported by NSF Cooperative Agreement DMR-1644779 and the state of Florida. Nanofabrication at the Center for Nanoscale Systems at Harvard was supported by NSF NNIN award ECS-00335765.	Alicea J, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.256403; BARDEEN J, 1957, PHYS REV, V108, P1175, DOI 10.1103/PhysRev.108.1175; Bartenstein M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.203201; BEREZINSKII VL, 1972, SOV PHYS JETP-USSR, V34, P610; Bonesteel NE, 1996, PHYS REV LETT, V77, P3009, DOI 10.1103/PhysRevLett.77.3009; Bourdel T, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.050401; BREZIN E, 1976, PHYS REV B, V14, P3110, DOI 10.1103/PhysRevB.14.3110; Cao Y, 2018, NATURE, V556, P43, DOI 10.1038/nature26160; Chen QJ, 2005, PHYS REP, V412, P1, DOI 10.1016/j.physrep.2005.02.005; Son DT, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.031027; de Melo CARS, 2008, PHYS TODAY, V61, P45; Du LJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01988-1; EAGLES DM, 1969, PHYS REV, V186, P456, DOI 10.1103/PhysRev.186.456; Eisenstein JP, 2014, ANNU REV CONDEN MA P, V5, P159, DOI 10.1146/annurev-conmatphys-031113-133832; Eisenstein JP, 2004, NATURE, V432, P691, DOI 10.1038/nature03081; Girvin S. M, 2000, BOULDER SCH 2000 LEC; Girvin S. M., 2007, MULTICOMPONENT QUANT; Halperin B. I., 2020, FRACTIONAL QUANTUM H, P79; HALPERIN BI, 1993, PHYS REV B, V47, P7312, DOI 10.1103/PhysRevB.47.7312; JEROME D, 1967, PHYS REV, V158, P462, DOI 10.1103/PhysRev.158.462; KALLIN C, 1984, PHYS REV B, V30, P5655, DOI 10.1103/PhysRevB.30.5655; Kellogg M, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.036801; Kellogg M, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.126804; Kosterlitz JM, 1973, J PHYS C SOLID STATE, V6, P1181, DOI 10.1088/0022-3719/6/7/010; LAY TS, 1994, PHYS REV B, V50, P17725, DOI 10.1103/PhysRevB.50.17725; Leggett A., 2012, BEC BCS CROSSOVER SO; Leggett A. J., 1980, J PHYS C PARIS, V41, pC7, DOI [10.1051/jphyscol:1980704, DOI 10.1051/JPHYSCOL:1980704]; Li JIA, 2019, NAT PHYS, V15, P898, DOI 10.1038/s41567-019-0547-z; Li JIA, 2017, NAT PHYS, V13, P751, DOI [10.1038/NPHYS4140, 10.1038/nphys4140]; Littlewood PB, 2004, J PHYS-CONDENS MAT, V16, pS3597, DOI 10.1088/0953-8984/16/35/003; Liu X., 2021, HARVARD DATAVERSE, DOI [10.7910/DVN/4TLQYI, DOI 10.7910/DVN/4TLQYI]; Liu XM, 2019, NAT PHYS, V15, P893, DOI 10.1038/s41567-019-0546-0; Liu XM, 2017, NAT PHYS, V13, P746, DOI [10.1038/nphys4116, 10.1038/NPHYS4116]; Liu XM, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.056802; Moller G, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.176803; Moller G, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.125106; Murthy PA, 2018, SCIENCE, V359, P452, DOI 10.1126/science.aan5950; Nakagawa Y, 2021, SCIENCE, V372, P190, DOI 10.1126/science.abb9860; NOZIERES P, 1985, J LOW TEMP PHYS, V59, P195, DOI 10.1007/BF00683774; RANDERIA M, 1989, PHYS REV LETT, V62, P981, DOI 10.1103/PhysRevLett.62.981; Randeria M, 2014, ANNU REV CONDEN MA P, V5, P209, DOI 10.1146/annurev-conmatphys-031113-133829; Regal CA, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.040403; Ries MG, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.230401; Rinott S, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602372; Sodemann I, 2017, PHYS REV B, V95, DOI 10.1103/PhysRevB.95.085135; Su JJ, 2008, NAT PHYS, V4, P799, DOI 10.1038/nphys1055; Tallon JL, 2001, PHYSICA C, V349, P53, DOI 10.1016/S0921-4534(00)01524-0; Timusk T, 1999, REP PROG PHYS, V62, P61, DOI 10.1088/0034-4885/62/1/002; Tutuc E, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.036802; Wagner G., 2021, ARXIV210600690; Wang L, 2013, SCIENCE, V342, P614, DOI 10.1126/science.1244358; Zhu Z, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01693-5; Zwierlein MW, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.120403	55	5	5	16	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2022	375	6577					205	+		10.1126/science.abg1110	http://dx.doi.org/10.1126/science.abg1110			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YG3OI	35025642	Green Submitted			2022-12-28	WOS:000742401600035
J	Roura, A				Roura, Albert			Quantum probe of space-time curvature	SCIENCE			English	Editorial Material									[Roura, Albert] German Aerosp Ctr DLR, Inst Quantum Technol, Ulm, Germany	Helmholtz Association; German Aerospace Centre (DLR)	Roura, A (corresponding author), German Aerosp Ctr DLR, Inst Quantum Technol, Ulm, Germany.	albert.roura@dlr.de						AHARONOV Y, 1959, PHYS REV, V115, P485, DOI 10.1103/PhysRev.115.485; Asenbaum P, 2020, PHYS REV LETT, V125, DOI 10.1103/PhysRevLett.125.191101; Batelaan H, 2009, PHYS TODAY, V62, P38, DOI 10.1063/1.3226854; Bong K, 2019, NAT REV PHYS, V1, P731, DOI 10.1038/s42254-019-0117-4; Chou CW, 2010, SCIENCE, V329, P1630, DOI 10.1126/science.1192720; D'Amico G, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.253201; Hohensee MA, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.230404; Kovachy T, 2015, NATURE, V528, P530, DOI 10.1038/nature16155; Lee WT, 1998, PHYS REV LETT, V80, P3165, DOI 10.1103/PhysRevLett.80.3165; Overstreet C, 2022, SCIENCE, V375, P226, DOI 10.1126/science.abl7152; Peters A, 1999, NATURE, V400, P849, DOI 10.1038/23655; Rosi G, 2014, NATURE, V510, P518, DOI 10.1038/nature13433; Roura A, 2020, PHYS REV X, V10, DOI 10.1103/PhysRevX.10.021014; Roura A, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.160401; Schlippert D, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.203002	15	1	1	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2022	375	6577					142	143		10.1126/science.abm6854	http://dx.doi.org/10.1126/science.abm6854			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YG3OI	35025643				2022-12-28	WOS:000742401600014
J	Valdez, AC; Iftekhar, EN; Oliu-Barton, M; Bohm, R; Cuschieri, S; Czypionka, T; Dumpis, U; Giordano, G; Hanson, C; Hel, Z; Helova, A; Kickbusch, I; Klimek, P; Kojan, L; Kretzschmar, M; Krueger, T; Krutzinna, J; Lange, B; Lazarus, JV; Machado, H; McKee, M; Nagel, K; Perc, M; Petelos, E; Popivanov, N; Pradelski, B; Prainsack, B; Schroeder, K; Tsiodras, S; Wilmes, P; Wolff, G				Valdez, Andre Calero; Iftekhar, Emil N.; Oliu-Barton, Miquel; Bohm, Robert; Cuschieri, Sarah; Czypionka, Thomas; Dumpis, Uga; Giordano, Giulia; Hanson, Claudia; Hel, Zdenek; Helova, Anna; Kickbusch, Ilona; Klimek, Peter; Kojan, Lilian; Kretzschmar, Mirjam; Krueger, Tyll; Krutzinna, Jenny; Lange, Berit; Lazarus, Jeffrey, V; Machado, Helena; McKee, Martin; Nagel, Kai; Perc, Matjaz; Petelos, Elena; Popivanov, Nedyu; Pradelski, Bary; Prainsack, Barbara; Schroeder, Kay; Tsiodras, Sotirios; Wilmes, Paul; Wolff, Guntram			Europe must come together to confront omicron	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Valdez, Andre Calero; Kojan, Lilian] Rhein Westfal TH Aachen, Aachen, Germany; [Iftekhar, Emil N.] Max Planck Inst Dynam & Self Org, Gottingen, Germany; [Oliu-Barton, Miquel] Paris Dauphine Univ, Brussels, Belgium; [Oliu-Barton, Miquel; Wolff, Guntram] Bruegel, Brussels, Belgium; [Bohm, Robert] Univ Vienna, Copenhagen, Denmark; [Bohm, Robert] Univ Copenhagen, Copenhagen, Denmark; [Cuschieri, Sarah] Univ Malta, Fac Med & Surg, Msida, Malta; [Czypionka, Thomas] Inst Adv Studies Vienna, Vienna, Austria; [Czypionka, Thomas] London Sch Econ & Polit Sci, London, England; [Dumpis, Uga] Univ Latvia, Pauls Stradins Univ Hosp, Riga, Latvia; [Giordano, Giulia] Univ Trento, Trento, Italy; [Hanson, Claudia] Karolinska Inst, Solna, Sweden; [Hel, Zdenek] Univ Alabama Birmingham, Birmingham, AL USA; [Helova, Anna] Univ Alabama Birmingham, Sparkman Ctr Global Hlth, Sch Publ Hlth, Birmingham, AL USA; [Helova, Anna] Univ Alabama Birmingham, Dept Hlth Policy & Org, Sch Publ Hlth, Birmingham, AL USA; [Kickbusch, Ilona] Grad Inst Int & Dev Studies, Global Hlth Ctr, Geneva, Switzerland; [Klimek, Peter] Med Univ Vienna, Vienna, Austria; [Klimek, Peter] Complex Sci Hub Vienna, Vienna, Austria; [Kretzschmar, Mirjam] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Krueger, Tyll] Wroclaw Univ Sci & Technol, Wroclaw, Poland; [Krutzinna, Jenny] Univ Bergen, Bergen, Norway; [Lange, Berit] Helmholtz Ctr Infect Res, Braunschweig, Germany; [Lazarus, Jeffrey, V] Univ Barcelona, Hosp Clin, Barcelona Inst Global Hlth ISGlobal, Barcelona, Spain; [Machado, Helena] Univ Minho, Inst Social Sci, Braga, Portugal; [McKee, Martin] London Sch Hyg & Trop Med, London, England; [Nagel, Kai] TU Berlin, Berlin, Germany; [Perc, Matjaz] Univ Maribor, Maribor, Slovenia; [Perc, Matjaz] China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Petelos, Elena] Univ Crete, Iraklion, Greece; [Petelos, Elena] Maastricht Univ, Maastricht, Netherlands; [Popivanov, Nedyu] Bulgarian Acad Sci, Sofia, Bulgaria; [Popivanov, Nedyu] Sofia Univ, Sofia, Bulgaria; [Pradelski, Bary] CNRS, Grenoble, France; [Pradelski, Bary] Oxford Man Inst, Oxford, France; [Prainsack, Barbara] Univ Vienna, Vienna, Austria; [Schroeder, Kay] Zuyd Univ Appl Sci, Heerlen, Netherlands; [Tsiodras, Sotirios] Natl & Kapodistrian Univ Athens, Med Sch, Athens, Greece; [Wilmes, Paul] Univ Luxembourg, Esch Sur Alzette, Luxembourg; [Wolff, Guntram] Uni Libre Bruxelles, Brussels, Belgium	RWTH Aachen University; Max Planck Society; University of Copenhagen; University of Malta; University of London; London School Economics & Political Science; Pauls Stradins Clinical University Hospital; University of Latvia; University of Trento; Karolinska Institutet; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Medical University of Vienna; Utrecht University; Utrecht University Medical Center; Wroclaw University of Science & Technology; University of Bergen; Helmholtz Association; Helmholtz-Center for Infection Research; ISGlobal; University of Barcelona; Hospital Clinic de Barcelona; Universidade do Minho; University of London; London School of Hygiene & Tropical Medicine; Technical University of Berlin; University of Maribor; China Medical University Taiwan; China Medical University Hospital - Taiwan; University of Crete; Maastricht University; Bulgarian Academy of Sciences; University of Sofia; Centre National de la Recherche Scientifique (CNRS); University of Vienna; National & Kapodistrian University of Athens; University of Luxembourg; Universite Libre de Bruxelles	Valdez, AC (corresponding author), Rhein Westfal TH Aachen, Aachen, Germany.		Wolff, Guntram/AAY-9977-2021; Perc, Matjaz/A-5148-2009; MACHADO, HELENA/GVS-1123-2022; Czypionka, Thomas/AGG-9213-2022; Visan, Delia/GXW-3349-2022; Giordano, Giulia/L-5209-2015; Cuschieri, Sarah/Y-2881-2019; Calero Valdez, André/AAJ-3310-2021; Wilmes, Paul/B-1707-2017	Wolff, Guntram/0000-0003-2716-522X; Perc, Matjaz/0000-0002-3087-541X; Czypionka, Thomas/0000-0002-3381-1075; Giordano, Giulia/0000-0002-8600-1738; Cuschieri, Sarah/0000-0003-2012-9234; Calero Valdez, André/0000-0002-6214-1461; Nagel, Kai/0000-0003-2775-6898; Iftekhar, Emil Nafis/0000-0003-0188-500X; Prainsack, Barbara/0000-0002-6335-1532; Machado, Helena/0000-0001-8554-7619; Schroder, Kay Michael/0000-0002-5106-3656; Wilmes, Paul/0000-0002-6478-2924; Bohm, Robert/0000-0001-6806-0374	Ministry of Culture and Science of the German State of North Rhine-Westphalia; German Research Foundation (DFG) [BO 4466/2-1]; University of Malta; European Union's Horizon 2020 research and innovation programme [101016233]; National Research Programme project [VPP-COVID-2020/1-0008]; Strategic Grant MOSES at the University of Trento; National Institutes of Health, USA; European Research Council (ERC) under the European Union [724460, 863664]; European Union's Horizon 2020 research and innovation program [101003480]; Initiative and Networking Fund of the Helmholtz Association; German Federal Ministry of Education and Research [FKZ: 01KX2021]; Netherlands Organisation for Health Research and Development (ZonMw) [91216062]; University Paris-Dauphine and Bruegel; Slovenian Research Agency [P1-0403, J1-2457]; University of Crete; Bulgarian NSF [K-06-H52/4]; Luxembourg National Research Fund (FNR) as part of the COVID-19 Fast-Track research project CO-INFECTOMICS [COVID-19/2020-1/14729513]; Max Planck Society	Ministry of Culture and Science of the German State of North Rhine-Westphalia; German Research Foundation (DFG)(German Research Foundation (DFG)); University of Malta; European Union's Horizon 2020 research and innovation programme; National Research Programme project; Strategic Grant MOSES at the University of Trento; National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Research Council (ERC) under the European Union(European Research Council (ERC)); European Union's Horizon 2020 research and innovation program; Initiative and Networking Fund of the Helmholtz Association; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Netherlands Organisation for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); University Paris-Dauphine and Bruegel; Slovenian Research Agency(Slovenian Research Agency - Slovenia); University of Crete; Bulgarian NSF(National Science Fund of Bulgaria); Luxembourg National Research Fund (FNR) as part of the COVID-19 Fast-Track research project CO-INFECTOMICS; Max Planck Society(Max Planck SocietyFoundation CELLEX)	Digital Society research program funded by the Ministry of Culture and Science of the German State of North Rhine-Westphalia (ACV). The Max Planck Society (ENI). German Research Foundation (DFG) grant BO 4466/2-1 (RB). University of Malta (SC). European Union's Horizon 2020 research and innovation programme under grant agreement No 101016233 (PERISCOPE) (TC). National Research Programme project VPP-COVID-2020/1-0008 (UD). Strategic Grant MOSES at the University of Trento (GG). National Institutes of Health, USA (ZH). European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme, grant agreement no. 724460 (JK). European Union's Horizon 2020 research and innovation program under grant agreement No 101003480 Project CORESMA (BL). Initiative and Networking Fund of the Helmholtz Association (BL). German Federal Ministry of Education and Research, NaFOUniMedCovid19 FKZ: 01KX2021 (BL). Netherlands Organisation for Health Research and Development (ZonMw), 91216062 (MK). European Union's Horizon 2020 research and innovation program under grant agreement No 101003480 (Project CORESMA) (MK). University Paris-Dauphine and Bruegel (MOB). Slovenian Research Agency, Grant Nos. P1-0403 and J1-2457 (MP). University of Crete and from Maastricht University (EP). Bulgarian NSF under Grant N degrees..-06-..52/4 (NP). Luxembourg National Research Fund (FNR) as part of the COVID-19 Fast-Track research project CO-INFECTOMICS, COVID-19/2020-1/14729513 (PW). European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme, grant agreement no. 863664 (PW).	Ai JW, 2022, EMERG MICROBES INFEC, V11, P337, DOI 10.1080/22221751.2021.2022440; Anderson M, 2021, LANCET REG HEALTH-EU, V9, DOI 10.1016/j.lanepe.2021.100203; Anderson M, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1075; [Anonymous], NEWS ABC; [Anonymous], COVID BBC; Bernal JL, 2021, NEW ENGL J MED, V385, P585, DOI 10.1056/NEJMoa2108891; Cele Sandile, 2021, medRxiv, DOI 10.1101/2021.12.08.21267417; Christie B, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n3144; Cloete J., 2021, MEDRXIV, P1, DOI [10.1101/2021.12.21.21268108, DOI 10.1101/2021.12.21.21268108]; Ferguson N, REPORT 50 HOSPITALIS; Ferguson N, REPORT 49 GROWTH POP; Gardner B.J., 2021, ESTIMATES REDUCED VA, DOI [10.1101/2021.12.10.21267594, DOI 10.1101/2021.12.10.21267594]; Iacobucci G, 2022, BMJ-BRIT MED J, V376, DOI 10.1136/bmj.o3; Leicester J, FRANCE ALLOWS SOME C; Moloney C., 2022, GUARDIAN; Ngomti A., 2021, MEDRXIV, DOI 10.1101/2021.12.26.21268380; Priesemann V, 2021, LANCET, V397, P469, DOI 10.1016/S0140-6736(21)00150-1; Pulliam J.R.C., 2021, INCREASED RISK SARS, DOI [10.1101/2021.11.11.21266068, DOI 10.1101/2021.11.11.21266068, 10.1101/2021.11.11.21266068.]; Statens Serum Institut, RIS OM COP 2021; Torjesen I, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n3135	20	4	4	2	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 13	2022	376								o90	10.1136/bmj.o90	http://dx.doi.org/10.1136/bmj.o90			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZE9IW	35027352	Green Published, Bronze			2022-12-28	WOS:000759191400011
J	Olson, SM; Newhams, MM; Halasa, NB; Price, AM; Boom, JA; Sahni, LC; Pannaraj, PS; Irby, K; Walker, TC; Schwartz, SP; Maddux, AB; Mack, EH; Bradford, TT; Schuster, JE; Nofziger, RA; Cameron, MA; Chiotos, K; Cullimore, ML; Gertz, SJ; Levy, ER; Kong, M; Cvijanovich, NZ; Staat, MA; Kamidani, S; Chatani, BM; Bhumbra, SS; Bline, KE; Gaspers, MG; Hobbs, CV; Heidemann, SM; Maamari, M; Flori, HR; Hume, JR; Zinter, MS; Michelson, KN; Zambrano, LD; Campbell, AP; Patel, MM; Randolph, G				Olson, S. M.; Newhams, M. M.; Halasa, N. B.; Price, A. M.; Boom, J. A.; Sahni, L. C.; Pannaraj, P. S.; Irby, K.; Walker, T. C.; Schwartz, S. P.; Maddux, A. B.; Mack, E. H.; Bradford, T. T.; Schuster, J. E.; Nofziger, R. A.; Cameron, M. A.; Chiotos, K.; Cullimore, M. L.; Gertz, S. J.; Levy, E. R.; Kong, M.; Cvijanovich, N. Z.; Staat, M. A.; Kamidani, S.; Chatani, B. M.; Bhumbra, S. S.; Bline, K. E.; Gaspers, M. G.; Hobbs, C., V; Heidemann, S. M.; Maamari, M.; Flori, H. R.; Hume, J. R.; Zinter, M. S.; Michelson, K. N.; Zambrano, L. D.; Campbell, A. P.; Patel, M. M.; Randolph, G.		Overcoming Covid-19 Investigators	Effectiveness of BNT162b2 Vaccine against Critical Covid-19 in Adolescents	NEW ENGLAND JOURNAL OF MEDICINE			English	Article								Effectiveness of BNT162B2 Vaccine in Adolescents Investigators used a case-control, test-negative design to assess the effectiveness of the BNT162B2 vaccine in adolescents for the prevention of Covid-19-related hospitalization, ICU admission, or receipt of life support. Among 445 case patients and 777 controls, of the 180 patients admitted to an ICU, only 2 had been fully vaccinated; all 7 deaths occurred in unvaccinated patients. Background The increasing incidence of pediatric hospitalizations associated with coronavirus disease 2019 (Covid-19) caused by the B.1.617.2 (delta) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the United States has offered an opportunity to assess the real-world effectiveness of the BNT162b2 messenger RNA vaccine in adolescents between 12 and 18 years of age. Methods We used a case-control, test-negative design to assess vaccine effectiveness against Covid-19 resulting in hospitalization, admission to an intensive care unit (ICU), the use of life-supporting interventions (mechanical ventilation, vasopressors, and extracorporeal membrane oxygenation), or death. Between July 1 and October 25, 2021, we screened admission logs for eligible case patients with laboratory-confirmed Covid-19 at 31 hospitals in 23 states. We estimated vaccine effectiveness by comparing the odds of antecedent full vaccination (two doses of BNT162b2) in case patients as compared with two hospital-based control groups: patients who had Covid-19-like symptoms but negative results on testing for SARS-CoV-2 (test-negative) and patients who did not have Covid-19-like symptoms (syndrome-negative). Results A total of 445 case patients and 777 controls were enrolled. Overall, 17 case patients (4%) and 282 controls (36%) had been fully vaccinated. Of the case patients, 180 (40%) were admitted to the ICU, and 127 (29%) required life support; only 2 patients in the ICU had been fully vaccinated. The overall effectiveness of the BNT162b2 vaccine against hospitalization for Covid-19 was 94% (95% confidence interval [CI], 90 to 96); the effectiveness was 95% (95% CI, 91 to 97) among test-negative controls and 94% (95% CI, 89 to 96) among syndrome-negative controls. The effectiveness was 98% against ICU admission and 98% against Covid-19 resulting in the receipt of life support. All 7 deaths occurred in patients who were unvaccinated. Conclusions Among hospitalized adolescent patients, two doses of the BNT162b2 vaccine were highly effective against Covid-19-related hospitalization and ICU admission or the receipt of life support. (Funded by the Centers for Disease Control and Prevention.)	[Olson, S. M.; Price, A. M.; Zambrano, L. D.; Campbell, A. P.; Patel, M. M.] Ctr Dis Control & Prevent, Covid 19 Response Team, Atlanta, GA 30329 USA; [Kamidani, S.] Childrens Healthcare Atlanta, Ctr Childhood Infect & Vaccines, Atlanta, GA USA; [Kamidani, S.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA; [Newhams, M. M.; Randolph, G.] Boston Childrens Hosp, Dept Anesthesiol Crit Care & Pain Med, Boston, MA USA; [Randolph, G.] Harvard Med Sch, Dept Anaesthesia, Boston, MA 02115 USA; [Halasa, N. B.] Vanderbilt Univ, Med Ctr, Dept Pediat, Div Pediat Infect Dis, Nashville, TN 37232 USA; [Boom, J. A.; Sahni, L. C.] Texas Childrens Hosp, Baylor Coll Med, Immunizat Project, Dept Pediat, Houston, TX 77030 USA; [Maamari, M.] Univ Texas Southwestern, Childrens Med Ctr Dallas, Dept Pediat, Div Crit Care Med, Dallas, TX USA; [Pannaraj, P. S.] Univ Southern Calif, Childrens Hosp Los Angeles, Div Infect Dis, Los Angeles, CA 90007 USA; [Pannaraj, P. S.] Univ Southern Calif, Dept Pediat, Los Angeles, CA 90007 USA; [Pannaraj, P. S.] Univ Southern Calif, Dept Mol Microbiol & Immunol, Los Angeles, CA 90007 USA; [Cameron, M. A.] Univ Calif San Diego, Div Pediat Hosp Med, Rady Childrens Hosp, San Diego, CA USA; [Cvijanovich, N. Z.] UCSF Benioff Childrens Hosp Oakland, Div Crit Care Med, Oakland, CA USA; [Zinter, M. S.] Univ Calif San Francisco, Dept Pediat, Div Crit Care Med & Allergy, San Francisco, CA USA; [Zinter, M. S.] Univ Calif San Francisco, Dept Pediat, Div Immunol, San Francisco, CA USA; [Zinter, M. S.] Univ Calif San Francisco, Dept Pediat, Div Bone Marrow Transplant, San Francisco, CA USA; [Irby, K.] Arkansas Childrens Hosp, Dept Pediat, Sect Pediat Crit Care, 800 Marshall St, Little Rock, AR 72202 USA; [Walker, T. C.; Schwartz, S. P.] Univ N Carolina, Childrens Hosp, Dept Pediat, Chapel Hill, NC 27515 USA; [Maddux, A. B.] Univ Colorado, Sch Med, Sect Crit Care Med, Dept Pediat, Aurora, CO USA; [Maddux, A. B.] Childrens Hosp Colorado, Aurora, CO USA; [Mack, E. H.] Med Univ South Carolina, Div Pediat Crit Care Med, Charleston, SC 29425 USA; [Bradford, T. T.] Louisiana State Univ, Dept Pediat, Hlth Sci Ctr, Div Cardiol, New Orleans, LA USA; [Bradford, T. T.] Childrens Hosp New Orleans, New Orleans, LA USA; [Schuster, J. E.] Childrens Mercy Kansas City, Dept Pediat, Div Pedi Atr Infect Dis, Kansas City, MO USA; [Nofziger, R. A.] Akron Childrens Hosp, Div Crit Care Med, Dept Pediat, Akron, OH 44308 USA; [Staat, M. A.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA; [Bline, K. E.] Nationwide Childrens Hosp Columbus, Div Pediat Crit Care Med, Columbus, OH USA; [Chiotos, K.] Childrens Hosp Philadelphia, Dept Anesthesiol & Crit Care, Div Crit Care Med, Philadelphia, PA 19104 USA; [Cullimore, M. L.] Childrens Hosp & Med Ctr, Dept Pediat, Div Pediat Crit Care, Omaha, NE USA; [Gertz, S. J.] St Barnabas Hosp, Div Pediat Crit Care, Dept Pediat, Livingston, NJ USA; [Levy, E. R.] Mayo Clin, Dept Pediat & Adolescent Med, Div Pediat Infect Dis, Rochester, NY USA; [Levy, E. R.] Mayo Clin, Dept Pediat & Adolescent Med, Div Pediat Crit Care Med, Rochester, NY USA; [Hume, J. R.] Univ Minnesota, Masonic Childrens Hosp, Div Pediat Crit Carej, Minneapolis, MN USA; [Kong, M.] Univ Alabama Birmingham, Dept Pediat, Div Pediat Crit Care Med, Birmingham, AL USA; [Chatani, B. M.] UHlth Holtz Childrens Hosp, Dept Pediat, Div Pediat Infect Dis, Miami, FL USA; [Bhumbra, S. S.] Indiana Univ Sch Med, Dept Pediat, Ryan White Ctr Pediat Infect Dis & Global & Iealt, Indianapolis, IN 46202 USA; [Gaspers, M. G.] Univ Arizona, Diamond Childrens Banner Childrens Med Ctr, Tucson, AZ USA; [Hobbs, C., V] Univ Mississippi, Med Ctr, Dept Microbiol, Div Infect Dis,Dept Pediat, Jackson, MS 39216 USA; [Heidemann, S. M.] Cent Michigan Univ, Childrens Hosp Michigan, Dept Pediat, Detroit, MI USA; [Flori, H. R.] Mott Childrens Hosp, Dept Pediat, Div Pediat Crit Care Med, Ann Arbor, MI USA; [Flori, H. R.] Univ Michigan, Ann Arbor, MI 48109 USA; [Michelson, K. N.] Northwestern Univ, Dept Pediat, Div Crit Care Med, Feinberg Sch Med,Ann & Robert H Lurie Childrens H, Chicago, IL 60611 USA	Centers for Disease Control & Prevention - USA; Children's Healthcare of Atlanta (CHOA); Emory University; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Vanderbilt University; Baylor College of Medicine; University of Texas System; University of Texas Southwestern Medical Center Dallas; Children's Hospital Los Angeles; University of Southern California; University of Southern California; University of Southern California; Rady Childrens Hospital San Diego; University of California System; University of California San Diego; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Arkansas Children's Hospital; University of North Carolina; University of North Carolina Chapel Hill; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; Medical University of South Carolina; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Children's Hospital of New Orleans; Children's Mercy Hospital; Akron Children's Hospital; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Mayo Clinic; Mayo Clinic; University of Minnesota System; University of Minnesota Twin Cities; University of Alabama System; University of Alabama Birmingham; Indiana University System; Indiana University Bloomington; University of Arizona; University of Mississippi; University of Mississippi Medical Center; Central Michigan University; Children's Hospital of Michigan; University of Michigan System; University of Michigan; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center	Patel, MM (corresponding author), Ctr Dis Control & Prevent, Influenza Div, 1600 Clifton Rd NE,H24-7, Atlanta, GA 30329 USA.	aul3@cdc.gov	Bhumbra, Samina/AAX-8266-2020	Bhumbra, Samina/0000-0002-4036-0479; Olson, Samantha/0000-0003-0589-5766; Schwartz, Stephanie/0000-0003-4314-6117; Randolph, Adrienne/0000-0002-3084-3071; Hume, Janet/0000-0002-8891-6800; Hobbs, Charlotte/0000-0003-4829-0791	Centers for Disease Control and Prevention; Boston Children's Hospital	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Boston Children's Hospital	Supported by the Centers for Disease Control and Prevention under a contract with Boston Children's Hospital.	[Anonymous], 2021, COVID DATA TRACKER P; Centers for Disease Control and Prevention, 2021, COVID DAT TRACK VAR; Chua HY, 2020, EPIDEMIOLOGY, V31, P43, DOI 10.1097/EDE.0000000000001116; COVID-NET, 2021, LAB CONF COVID 19 AS; Dean NE, 2021, NEW ENGL J MED, V385, P1431, DOI 10.1056/NEJMe2113151; Delahoy MJ, 2021, MMWR-MORBID MORTAL W, V70, P1255, DOI 10.15585/mmwr.mm7036e2; Feldstein LR, 2021, JAMA-J AM MED ASSOC, V325, P1074, DOI 10.1001/jama.2021.2091; Feldstein LR, 2020, NEW ENGL J MED, V383, P334, DOI 10.1056/NEJMoa2021680; Ferdinands JM, 2014, J INFECT DIS, V210, P674, DOI 10.1093/infdis/jiu185; FIRTH D, 1993, BIOMETRIKA, V80, P27, DOI 10.1093/biomet/80.1.27; Frenck RW, 2021, NEW ENGL J MED, V385, P239, DOI 10.1056/NEJMoa2107456; Glatman-Freedman A, 2021, EMERG INFECT DIS, V27, P2919, DOI 10.3201/eid2711.211886; Halloran ME, 1997, AM J EPIDEMIOL, V146, P789; Lewnard JA, 2021, EPIDEMIOLOGY, V32, P508, DOI 10.1097/EDE.0000000000001366; Lewnard JA, 2018, AM J EPIDEMIOL, V187, P2686, DOI 10.1093/aje/kwy163; Lipsitch M, 2010, EPIDEMIOLOGY, V21, P383, DOI 10.1097/EDE.0b013e3181d61eeb; MALDONADO G, 1993, AM J EPIDEMIOL, V138, P923, DOI 10.1093/oxfordjournals.aje.a116813; Office of the Federal Register, CODE FEDERAL REGULAT; Olson SM, 2021, MMWR-MORBID MORTAL W, V70, P1483; Patel MM, 2020, JAMA-J AM MED ASSOC, V324, P1939, DOI 10.1001/jama.2020.19328; Reis B, 2021, NEW ENGL J MED, V385, P2101, DOI 10.1056/NEJMc2114290; Son MBF, 2021, NEW ENGL J MED, V385, P23, DOI 10.1056/NEJMoa2102605; Tartof SY, 2021, LANCET, V398, P1407, DOI 10.1016/S0140-6736(21)02183-8; Tenforde MW, 2021, MMWR-MORBID MORTAL W, V70, P1156, DOI 10.15585/mmwr.mm7034e2; Tenforde MW, 2022, CLIN INFECT DIS, V74, P1515, DOI [10.1093/cid/ciab687, 10.1101/2021.07.08.21259776]; Treanor JJ, 2016, NEW ENGL J MED, V375, P1261, DOI 10.1056/NEJMcp1512870; Tsabouri S, 2021, PEDIATR CLIN N AM, V68, P321, DOI 10.1016/j.pcl.2020.07.014; US Food and Drug Administration, 2022, COR COVID 19 UPD FDA; Woodruff RC, 2022, PEDIATRICS, V149, DOI 10.1542/peds.2021-053418; World Health Organization, 2021, INT GUID 0317	30	45	45	7	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 24	2022	386	8					713	723		10.1056/NEJMoa2117995	http://dx.doi.org/10.1056/NEJMoa2117995		JAN 2022	11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZF7PI	35021004	Green Published, Bronze			2022-12-28	WOS:000741666300001
J	Mahase, E				Mahase, Elisabeth			Covid-19: Omicron is "battering" the NHS and causing "untold suffering" for patients, say doctors	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Mahase E, 2022, BMJ-BRIT MED J, V376, DOI 10.1136/bmj.o13	1	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 10	2022	376								o45	10.1136/bmj.o45	http://dx.doi.org/10.1136/bmj.o45			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YP6IZ	35012961	Bronze			2022-12-28	WOS:000748727200005
J	Majeed, A				Majeed, Azeem			It's time for more targeted use of lateral flow tests for covid-19	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Majeed, Azeem] Imperial Coll London, Dept Primary Care & Publ Hlth, London, England	Imperial College London	Majeed, A (corresponding author), Imperial Coll London, Dept Primary Care & Publ Hlth, London, England.			Majeed, Azeem/0000-0002-2357-9858	NIHR Applied Research Collaboration NW London	NIHR Applied Research Collaboration NW London	AM is supported by the NIHR Applied Research Collaboration NW London. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care.	Johnson B., PM STATEMENT HOUSE C; Majeed A., QUESTIONS ANSWERS LA; Majeed A, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4654; Raffle AE, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n1058	4	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 7	2022	376								o28	10.1136/bmj.o28	http://dx.doi.org/10.1136/bmj.o28			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YP9GN	34996780	Bronze, Green Submitted			2022-12-28	WOS:000748927300009
J	Wise, J				Wise, Jacqui			Covid-19: Babies born during the pandemic show slight development delays	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		Deoni Sean Cl, 2022, medRxiv, DOI 10.1101/2021.08.10.21261846	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 7	2022	376								o29	10.1136/bmj.o29	http://dx.doi.org/10.1136/bmj.o29			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YP9GN	34996749	Bronze			2022-12-28	WOS:000748927300008
J	Crainiciuc, G; Palomino-Segura, M; Molina-Moreno, M; Sicilia, J; Aragones, DG; Li, JLY; Madurga, R; Adrover, JM; Aroca-Crevillen, A; Martin-Salamanca, S; del Valle, AS; Castillo, SD; Welch, HCE; Soehnlein, O; Graupera, M; Sanchez-Cabo, F; Zarbock, A; Smithgall, TE; Di Pilato, M; Mempel, TR; Tharaux, PL; Gonzalez, SF; Ayuso-Sacido, A; Ng, LG; Calvo, GF; Gonzalez-Diaz, I; Diaz-de-Maria, F; Hidalgo, A				Crainiciuc, Georgiana; Palomino-Segura, Miguel; Molina-Moreno, Miguel; Sicilia, Jon; Aragones, David G.; Li, Jackson Liang Yao; Madurga, Rodrigo; Adrover, Jose M.; Aroca-Crevillen, Alejandra; Martin-Salamanca, Sandra; Serrano del Valle, Alfonso; Castillo, Sandra D.; Welch, Heidi C. E.; Soehnlein, Oliver; Graupera, Mariona; Sanchez-Cabo, Fatima; Zarbock, Alexander; Smithgall, Thomas E.; Di Pilato, Mauro; Mempel, Thorsten R.; Tharaux, Pierre-Louis; Gonzalez, Santiago F.; Ayuso-Sacido, Angel; Ng, Lai Guan; Calvo, Gabriel F.; Gonzalez-Diaz, Ivan; Diaz-de-Maria, Fernando; Hidalgo, Andres			Behavioural immune landscapes of inflammation	NATURE			English	Article							FLUORESCENT PROTEIN; NEUTROPHIL; INHIBITION; MOUSE	Transcriptional and proteomic profiling of individual cells have revolutionized interpretation of biological phenomena by providing cellular landscapes of healthy and diseased tissues(1,2). These approaches, however, do not describe dynamic scenarios in which cells continuously change their biochemical properties and downstream `behavioural' outputs(3-5). Here we used 4D live imaging to record tens to hundreds of morpho-kinetic parameters describing the dynamics of individual leukocytes at sites of active inflammation. By analysing more than 100,000 reconstructions of cell shapes and tracks over time, we obtained behavioural descriptors of individual cells and used these high-dimensional datasets to build behavioural landscapes. These landscapes recognized leukocyte identities in the inflamed skin and trachea, and uncovered a continuum of neutrophil states inside blood vessels, including a large, sessile state that was embraced by the underlying endothelium and associated with pathogenic inflammation. Behavioural screening in 24 mouse mutants identified the kinase Fgr as a driver of this pathogenic state, and interference with Fgr protected mice from inflammatory injury. Thus, behavioural landscapes report distinct properties of dynamic environments at high cellular resolution.	[Crainiciuc, Georgiana; Palomino-Segura, Miguel; Sicilia, Jon; Li, Jackson Liang Yao; Adrover, Jose M.; Aroca-Crevillen, Alejandra; Martin-Salamanca, Sandra; Serrano del Valle, Alfonso; Hidalgo, Andres] Ctr Nacl Invest Cardiovasc Carlos III, Area Cell & Dev Biol, Madrid, Spain; [Molina-Moreno, Miguel; Gonzalez-Diaz, Ivan; Diaz-de-Maria, Fernando] Univ Carlos III Madrid, Dept Signal Proc & Commun, Madrid, Spain; [Sicilia, Jon; Sanchez-Cabo, Fatima] Ctr Nacl Invest Cardiovasc Carlos III, Bioinformat Unit, Madrid, Spain; [Aragones, David G.; Calvo, Gabriel F.] Univ Castilla La Mancha, Dept Math, Ciudad Real, Spain; [Aragones, David G.; Calvo, Gabriel F.] Univ Castilla La Mancha, MOLAB Math Oncol Lab, Ciudad Real, Spain; [Li, Jackson Liang Yao; Ng, Lai Guan] ASTAR, Biopolis, Singapore Immunol Network SIgN, Singapore, Singapore; [Madurga, Rodrigo; Ayuso-Sacido, Angel] Univ Francisco Vitoria, Fac Expt Sci, Madrid, Spain; [Madurga, Rodrigo; Ayuso-Sacido, Angel] Univ Francisco Vitoria, Fac Med, Madrid, Spain; [Castillo, Sandra D.; Graupera, Mariona] Josep Carreras Leukaemia Res Inst IJC, Endothelial Pathobiol & Microenviroment Grp, Barcelona 08916, Spain; [Castillo, Sandra D.; Graupera, Mariona] Inst Salud Carlos III, Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain; [Welch, Heidi C. E.] Babraham Inst, Signalling Programme, Cambridge, England; [Soehnlein, Oliver] Westfalische Wilhelms Univ, Inst Expt Pathol, Ctr Mol Biol Inflammat, Munster, Germany; [Zarbock, Alexander] Univ Hosp Munster, Dept Anesthesiol Intens Care & Pain Med, Munster, Germany; [Smithgall, Thomas E.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA USA; [Di Pilato, Mauro; Mempel, Thorsten R.] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Harvard Med Sch, Boston, MA 02114 USA; [Di Pilato, Mauro] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Tharaux, Pierre-Louis] Univ Paris, Paris Cardiovasc Ctr, Inserm, Paris, France; [Gonzalez, Santiago F.] Univ Svizzera Italiana, Inst Res Biomed, Bellinzona, Switzerland; [Ayuso-Sacido, Angel] Grp Hosp Vithas, Brain Tumor Lab, Fdn Vithas, Madrid, Spain; [Hidalgo, Andres] Yale Univ, Sch Med, Vasc Biol & Therapeut Program, New Haven, CT 06520 USA; [Hidalgo, Andres] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA	Centro Nacional de Investigaciones Cardiovasculares (CNIC); Universidad Carlos III de Madrid; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Universidad de Castilla-La Mancha; Universidad de Castilla-La Mancha; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Universidad Francisco de Vitoria; Universidad Francisco de Vitoria; Institut de Recerca Contra la Leucemia Josep Carreras (IJC); CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; Instituto de Salud Carlos III; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Munster; University of Munster; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Texas System; UTMD Anderson Cancer Center; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universita della Svizzera Italiana; Yale University; Yale University	Hidalgo, A (corresponding author), Ctr Nacl Invest Cardiovasc Carlos III, Area Cell & Dev Biol, Madrid, Spain.; Hidalgo, A (corresponding author), Yale Univ, Sch Med, Vasc Biol & Therapeut Program, New Haven, CT 06520 USA.; Hidalgo, A (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA.	ahidal.go@cnic.es	Sacido, Angel Ayuso/AAV-9331-2021; Ng, Lai Guan/E-5673-2011; Madurga, Rodrigo/ABG-3485-2021; Palomino-Segura, Miguel/FAE-7067-2022; Tharaux, Pierre-Louis/A-9155-2009; Adrover, Jose M/G-9741-2017; Díaz, Iván González/L-5103-2014; Molina-Moreno, Miguel/ABD-5447-2021; Castillo, Sandra D./AAA-7614-2020; Fernandez Calvo, Gabriel/T-6710-2018	Sacido, Angel Ayuso/0000-0003-3919-5880; Ng, Lai Guan/0000-0003-1905-3586; Madurga, Rodrigo/0000-0002-1381-2599; Tharaux, Pierre-Louis/0000-0002-6062-5905; Adrover, Jose M/0000-0002-1395-5477; Díaz, Iván González/0000-0003-4644-8479; Molina-Moreno, Miguel/0000-0002-3493-7470; Castillo, Sandra D./0000-0002-7007-3155; Fernandez Calvo, Gabriel/0000-0002-3623-236X; Palomino Segura, Miguel/0000-0003-1614-1222; Aragones, David/0000-0003-4035-0972; Serrano del Valle, Alfonso/0000-0001-9343-1050	Ministerio de Ciencia e Innovacion (MCIN) [RTI2018-095497-B-I00]; Fundacion La Caixa [HR17_00527]; Transatlantic Network of Excellence from the Leducq Foundation [TNE-18CVD04]; FET-OPEN from the European Commission [861878]; Federation of European Biochemical Societies; EMBO ALTF [1142-2020]; MICINN [PRE2019-089130]; La Caixa Foundation [CF/BQ/DR19/11740022]; A*STAR; Juan de la Cierva Fellowship from MICINN [JCI-2017-33136]; Marie Sklodowska-Curie fellowship [749731]; MCIN [SAF2017-89116R-P, RTI2018-102084-B-I00, TEC2017-84395-P]; la Fundacion La Caixa [HR18_00120]; NIH [AI163223]; SIgN from A*STAR; Junta de Comunidades de Castilla-La Mancha [SBPLY/19/180501/000211]; Leducq Foundation [TNE-18CVD04]; National Cancer Institute, NIH [CA233576]; Pro-CNIC Foundation;  [MCIN/AEI/10.13039/501100011033];  [PID2019-110895RB-I00]	Ministerio de Ciencia e Innovacion (MCIN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion La Caixa(La Caixa Foundation); Transatlantic Network of Excellence from the Leducq Foundation; FET-OPEN from the European Commission; Federation of European Biochemical Societies; EMBO ALTF; MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); La Caixa Foundation(La Caixa Foundation); A*STAR(Agency for Science Technology & Research (A*STAR)); Juan de la Cierva Fellowship from MICINN; Marie Sklodowska-Curie fellowship; MCIN; la Fundacion La Caixa; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SIgN from A*STAR(Agency for Science Technology & Research (A*STAR)); Junta de Comunidades de Castilla-La Mancha(Junta de Comunidades de Castilla-La Mancha); Leducq Foundation(Leducq Foundation); National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Pro-CNIC Foundation; ; 	We thank all members of the Hidalgo laboratory and M. Desco for discussion; P. Frenette for inspiring this study; C. C. Goh and E. Y. Kim for seeding imaging experiments; the electron microscopy unit from the faculty of Medicine of Universidad Autonoma de Madrid for help with experiments; E. Marin, L. Cabezuela, E. Santos, R. Mota and the animal facility at CNIC for animal husbandry, animal procedures and histology; J. Rossaint, M. Gunzer, J.A. Enriquez, A. Mocsai, R.W. Hendricks, G. Sabio, M. Sperandio, E. Hirsch and B. Walzog for the generous gift of mutant mice; and C. Torroja, D. Jimenez and M. Desco for technical advice. This study was supported by RTI2018-095497-B-I00 from Ministerio de Ciencia e Innovacion (MCIN), HR17_00527 from Fundacion La Caixa, Transatlantic Network of Excellence (TNE-18CVD04) from the Leducq Foundation, and FET-OPEN (no. 861878) from the European Commission to A.H. M.P-S. is supported by a Federation of European Biochemical Societies and the EMBO ALTF (no. 1142-2020) long-term fellowships. J.S. is supported by a fellowship (PRE2019-089130) from MICINN and A.A.-C. is supported by fellowship CF/BQ/DR19/11740022 from La Caixa Foundation. J.L.Y.L. was supported by A*STAR and a Juan de la Cierva JCI-2017-33136 Fellowship from MICINN. S.D.C. is a recipient of a Marie Sklodowska-Curie fellowship (749731). M.G. is supported by SAF2017-89116R-P from MCIN and HR18_00120 from la Fundacion La Caixa. T.R.M. is supported by grant NIH AI163223, L.G.N. is supported by SIgN core funding from A*STAR, and G.F.C. is supported by MCIN/AEI/10.13039/501100011033 (grant PID2019-110895RB-I00) and by Junta de Comunidades de Castilla-La Mancha (SBPLY/19/180501/000211). F.S.-C. is supported by MCIN (grant RTI2018-102084-B-I00), O.S. is supported by the Leducq Foundation (TNE-18CVD04), F.D.-d.-M. is supported by MCIN (TEC2017-84395-P), and T.E.S. is supported by the National Cancer Institute, NIH grant CA233576. The CNIC is supported by the MCIN and the Pro-CNIC Foundation.	Adrover JM, 2020, NAT IMMUNOL, V21, P135, DOI 10.1038/s41590-019-0571-2; Adrover JM, 2019, IMMUNITY, V50, P390, DOI 10.1016/j.immuni.2019.01.002; Amit I, 2011, NAT REV IMMUNOL, V11, P873, DOI 10.1038/nri3109; [Anonymous], 2006, P SIGGR COURS; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bauer CA, 2014, J CLIN INVEST, V124, P2425, DOI 10.1172/JCI66375; Boulch M, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abd4344; Cao HST, 2009, J CELL BIOCHEM, V107, P328, DOI 10.1002/jcb.22128; Devi S, 2013, J EXP MED, V210, P2321, DOI 10.1084/jem.20130056; Faust N, 2000, BLOOD, V96, P719; Garcia-Prieto J, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14780; Goh CC, 2018, EUR J IMMUNOL, V48, P1014, DOI 10.1002/eji.201747347; Goh CC, 2015, J INVEST DERMATOL, V135, P1181, DOI 10.1038/jid.2014.506; Hao Yuhan, 2021, Cell, V184, P3573, DOI 10.1016/j.cell.2021.04.048; Hasenberg A, 2015, NAT METHODS, V12, P445, DOI [10.1038/nmeth.3322, 10.1038/NMETH.3322]; Henique C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01885-7; Hidalgo A, 2009, NAT MED, V15, P384, DOI 10.1038/nm.1939; Hirahashi J, 2009, CIRCULATION, V120, P1255, DOI 10.1161/CIRCULATIONAHA.109.873695; Ivanovitch K, 2017, ELIFE, V6, DOI 10.7554/eLife.30668; Kwok I, 2020, IMMUNITY, V53, P303, DOI 10.1016/j.immuni.2020.06.005; Lammermann T, 2013, NATURE, V498, P371, DOI 10.1038/nature12175; Lelkes E, 2014, TRENDS IMMUNOL, V35, P379, DOI 10.1016/j.it.2014.05.005; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; LLOYD SP, 1982, IEEE T INFORM THEORY, V28, P129, DOI 10.1109/TIT.1982.1056489; McArdle S, 2019, CIRC RES, V125, P1038, DOI 10.1161/CIRCRESAHA.119.315175; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Mocsai A, 2015, CARDIOVASC RES, V107, P373, DOI 10.1093/cvr/cvv159; Ourselin S, 2016, MICCAI 2016, V9901; Palomino-Segura M, 2018, JOVE-J VIS EXP, DOI 10.3791/58355; Papalexi E, 2018, NAT REV IMMUNOL, V18, P35, DOI 10.1038/nri.2017.76; Sreeramkumar V, 2014, SCIENCE, V346, P1234, DOI 10.1126/science.1256478; Sumen C, 2004, IMMUNITY, V21, P315, DOI 10.1016/S1074-7613(04)00237-7; Venables W.N., 2002, MODERN APPL STAT S, VFourth; Weir MC, 2018, ACS CHEM BIOL, V13, P1551, DOI 10.1021/acschembio.8b00154; Woodfin A, 2011, NAT IMMUNOL, V12, P761, DOI 10.1038/ni.2062; Yamada KM, 2019, NAT REV MOL CELL BIO, V20, P738, DOI 10.1038/s41580-019-0172-9	36	16	16	17	51	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 20	2022	601	7893					415	+		10.1038/s41586-021-04263-y	http://dx.doi.org/10.1038/s41586-021-04263-y		JAN 2022	29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YJ6UI	34987220	Green Submitted			2022-12-28	WOS:000739283800002
J	Dyer, O				Dyer, Owen			Theranos founder who promised to revolutionise diagnostic testing is convicted of fraud	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Carreyrou J., 2015, WALL STR J; Diamandis EP, 2015, CLIN CHEM LAB MED, V53, P989, DOI 10.1515/cclm-2015-0356; Ioannidis JPA, 2015, JAMA-J AM MED ASSOC, V313, P663, DOI 10.1001/jama.2014.17662	3	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 5	2022	376								o11	10.1136/bmj.o11	http://dx.doi.org/10.1136/bmj.o11			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YI8XS	34987025				2022-12-28	WOS:000744126400006
J	Bannow, BS				Bannow, Bethany Samuelson			In acute PE, triage for home treatment using the Hestia rule vs. sPESI was noninferior for 30-d clinical outcomes	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							PULMONARY-EMBOLISM		[Bannow, Bethany Samuelson] Oregon Hlth & Sci Univ, Hemophilia Ctr, Portland, OR 97201 USA	Oregon Health & Science University	Bannow, BS (corresponding author), Oregon Hlth & Sci Univ, Hemophilia Ctr, Portland, OR 97201 USA.							Aujesky D, 2005, AM J RESP CRIT CARE, V172, P1041, DOI 10.1164/rccm.200506-862OC; Jimenez D, 2010, ARCH INTERN MED, V170, P1383, DOI 10.1001/archinternmed.2010.199; Zondag W, 2011, J THROMB HAEMOST, V9, P1500, DOI 10.1111/j.1538-7836.2011.04388.x	3	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN	2022	175	1					JC7	JC7		10.7326/J21-0010	http://dx.doi.org/10.7326/J21-0010		JAN 2022	1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0Y3LO	34978857				2022-12-28	WOS:000742139500001
J	Bastarache, L; Denny, JC; Roden, DM				Bastarache, Lisa; Denny, Joshua C.; Roden, Dan M.			Phenome-Wide Association Studies	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review								This Genomics and Precision Health article explores the concept of phenome-wide association studies, which use a data set to find phenotypic associations with genetic variations.	[Bastarache, Lisa] Vanderbilt Univ, Med Ctr, Dept Biomed Informat, Nashville, TN 37232 USA; [Denny, Joshua C.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37232 USA; [Denny, Joshua C.] NIH, All US Res Program, Bldg 10, Bethesda, MD 20892 USA; [Roden, Dan M.] Vanderbilt Univ, Div Clin Pharmacol, Med Ctr, 2215B Garland Ave,Room12858, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; National Institutes of Health (NIH) - USA; Vanderbilt University	Roden, DM (corresponding author), Vanderbilt Univ, Div Clin Pharmacol, Med Ctr, 2215B Garland Ave,Room12858, Nashville, TN 37232 USA.	dan.roden@vumc.org			National Institutes of Health (NIH) [P50 GM115305, U01 HG08672, U01HG011181]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported in part by grants from the National Institutes of Health (NIH): P50 GM115305, U01 HG08672, and U01HG011181.	Bush WS, 2016, NAT REV GENET, V17, P129, DOI 10.1038/nrg.2015.36; Denny JC, 2016, ANNU REV GENOM HUM G, V17, P353, DOI 10.1146/annurev-genom-090314-024956; Denny JC, 2013, NAT BIOTECHNOL, V31, P1102, DOI 10.1038/nbt.2749; Denny JC, 2010, BIOINFORMATICS, V26, P1205, DOI 10.1093/bioinformatics/btq126; Diogo D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06540-3; Taliun SAG, 2020, NAT GENET, V52, P550, DOI 10.1038/s41588-020-0622-5; Salem JE, 2019, JAMA CARDIOL, V4, P136, DOI 10.1001/jamacardio.2018.4615; Shekhar A, 2016, J CLIN INVEST, V126, P4444, DOI 10.1172/JCI87968; Unlu G, 2019, AM J HUM GENET, V104, P503, DOI 10.1016/j.ajhg.2019.01.017; Verma A, 2019, AM J HUM GENET, V104, P55, DOI 10.1016/j.ajhg.2018.11.006	10	5	6	4	22	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 4	2022	327	1					75	76		10.1001/jama.2021.20356	http://dx.doi.org/10.1001/jama.2021.20356			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YF7YT	34982132	Green Accepted			2022-12-28	WOS:000742019000021
J	Wallace, J; McWilliams, JM; Lollo, A; Eaton, J; Ndumele, CD				Wallace, Jacob; McWilliams, J. Michael; Lollo, Anthony; Eaton, Janet; Ndumele, Chima D.			Residual Confounding in Health Plan Performance Assessments: Evidence From Randomization in Medicaid	ANNALS OF INTERNAL MEDICINE			English	Article							READMISSIONS REDUCTION PROGRAM; SAFETY-NET HOSPITALS; UNINTENDED CONSEQUENCES; RISK; CARE; PAYMENT; ADJUSTMENT; INSURANCE; DISPARITIES; SYSTEMS	Background: Risk adjustment is used widely in payment systems and performance assessments, but the extent to which it distinguishes plan or provider effects from confounding due to patient differences is typically unknown. Objective: To assess the degree to which risk-adjusted measures of health plan performance adequately adjust for the variation across plans that arises because of differences in patient characteristics (residual confounding). Design: Comparison between plan performance estimates based on enrollees who made plan choices (observational population) and estimates based on enrollees assigned to plans (randomized population). Setting: Natural experiment in which more than two thirds of a state's Medicaid population in 1 region was randomly assigned to 1 of 5 plans. Participants: 137933 enrollees in 2013 to 2014, of whom 31.1% selected a plan and 68.9% were randomly assigned to 1 of the same 5 plans. Measurements: Annual total spending (that is, payments to providers), primary care use, dental care use, and avoidable emergency department visits, all scored as plan-specific deviations from the "average" plan performance within each population. Results: Enrollee characteristics were appreciably imbalanced across plans in the observational population, as expected, but were not in the randomized population. Annual total spending varied across plans more in the observational population (SD, $147 per enrollee) than in the randomized population (SD, $70 per enrollee) after accounting for baseline differences in the observational and randomized populations and for differences across plans. On average, a plan's spending score (its deviation from the "average" performance) in the observational population differed from its score in the randomized population by $67 per enrollee in absolute value (95% CI, $38 to $123), or 4.2% of mean spending per enrollee (P= 0.009, rejecting the null hypothesis that this difference would be expected from sampling error). The difference was reduced modestly by risk adjustment to $62 per enrollee (P= 0.012). Residual confounding was similarly substantial for most other performance measures. Further adjustment for social factors did not materially change estimates. Limitation: Potential heterogeneity in plan effects between the 2 populations. Conclusion: Residual confounding in risk-adjusted performance assessments can be substantial and should caution policymakers against assuming that risk adjustment isolates real differences in plan performance.	[Wallace, Jacob; Lollo, Anthony; Ndumele, Chima D.] Yale Sch Publ Hlth, New Haven, CT 06510 USA; [McWilliams, J. Michael] Harvard Med Sch, Dept Hlth Care Policy, Boston, MA 02115 USA; [McWilliams, J. Michael] Brigham & Womens Hosp, Div Gen Internal Med & Primary Care, 75 Francis St, Boston, MA 02115 USA; [Eaton, Janet] Yale Univ, Yale Sch Publ Hlth, New Haven, CT USA; [Eaton, Janet] Yale Univ, Tobin Ctr Econ Policy, New Haven, CT USA	Yale University; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Yale University; Yale University	Wallace, J (corresponding author), Yale Sch Publ Hlth, Dept Hlth Policy & Management, 60 Coll St, New Haven, CT 06510 USA.	jacob.wallace@yale.edu		Wallace, Jacob/0000-0003-4533-5253; Lollo, Anthony/0000-0002-2358-0138	Tobin Center for Economic Policy; Arnold Ventures	Tobin Center for Economic Policy; Arnold Ventures	By the Tobin Center for Economic Policy and a grant from Arnold Ventures.	Agency for Healthcare Research and Quality, PREV QUAL IND OV; Angrist JD, 2009, MOSTLY HARMLESS ECONOMETRICS: AN EMPIRICISTS COMPANION, P1; Angrist JD, 2010, J ECON PERSPECT, V24, P3, DOI 10.1257/jep.24.2.3; Barnett ML, 2019, NEW ENGL J MED, V380, P252, DOI 10.1056/NEJMsa1809010; Barnett ML, 2015, JAMA INTERN MED, V175, P1803, DOI 10.1001/jamainternmed.2015.4660; Bergquist SL, 2019, J HEALTH ECON, V66, P195, DOI 10.1016/j.jhealeco.2019.05.005; Buntin MB, 2017, NEW ENGL J MED, V376, P507, DOI 10.1056/NEJMp1700081; Centers for Medicare & Medicaid Services, MED AD COR SET MEAS; Centers for Medicare & Medicaid Services, 2020, HOSP READM RED PROGR; Chan AW, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e7586; Chatterjee P, 2019, HEALTH SERV RES, V54, P324, DOI 10.1111/1475-6773.13131; Chen LM, 2017, JAMA-J AM MED ASSOC, V318, P453, DOI 10.1001/jama.2017.9643; Chetty R, 2014, AM ECON REV, V104, P2593, DOI 10.1257/aer.104.9.2593; Cutler DM, 1998, Q J ECON, V113, P433, DOI 10.1162/003355398555649; DuGoff E, 2018, HOSP READMISSION RED, DOI [10.1377/hblog20140814.040725/full/, DOI 10.1377/HBLOG20140814.040725/FULL]; Dumville JC, 2006, CONTEMP CLIN TRIALS, V27, P1, DOI 10.1016/j.cct.2005.08.003; Ellis R.P., 2018, RISK ADJUSTMENT RISK, P55, DOI [10.1016/B978-0-12-811325-7.00003-8, DOI 10.1016/B978-0-12-811325-7.00003-8]; Finkelstein A, 2020, NEW ENGL J MED, V382, P152, DOI 10.1056/NEJMsa1906848; Finkelstein A, 2018, JAMA-J AM MED ASSOC, V320, P892, DOI 10.1001/jama.2018.12346; Finkelstein A, 2012, Q J ECON, V127, P1057, DOI 10.1093/qje/qjs020; Geruso M, 27762 NBER; Geruso M, 2020, J POLIT ECON, V128, P984, DOI 10.1086/704756; Geruso M, 2016, J HEALTH ECON, V47, P1, DOI 10.1016/j.jhealeco.2016.01.007; Gilman M, 2015, ANN INTERN MED, V163, P427, DOI 10.7326/M14-2813; Gilman M, 2015, HEALTH AFFAIR, V34, P398, DOI 10.1377/hlthaff.2014.1059; Glied S., 2016, HLTH AFFAIRS BLOG, DOI [10.1377/hblog20160715.055867, DOI 10.1377/HBLOG20160715.055867]; Gu Q, 2014, HEALTH SERV RES, V49, P818, DOI 10.1111/1475-6773.12150; Hughes JS, 2004, MED CARE, V42, P81, DOI 10.1097/01.mlr.0000102367.93252.70; Jacobson G, 2021, DOZEN FACTS MEDICARE; Jha AK, 2014, JAMA-J AM MED ASSOC, V312, P225, DOI 10.1001/jama.2014.7204; Johnston KJ, 2020, JAMA-J AM MED ASSOC, V323, P925, DOI 10.1001/jama.2019.22370; Johnston KJ, 2018, JAMA INTERN MED, V178, P1489, DOI 10.1001/jamainternmed.2018.4143; Joynt KE, 2013, NEW ENGL J MED, V368, P1175, DOI 10.1056/NEJMp1300122; Joynt KE, 2013, JAMA-J AM MED ASSOC, V309, P342, DOI 10.1001/jama.2012.94856; Kaiser Family Foundation, 2019, STAT HLTH FACTS 2017; Kind AJH, 2014, ANN INTERN MED, V161, P765, DOI 10.7326/M13-2946; Krueger AB, 1999, Q J ECON, V114, P497, DOI 10.1162/003355399556052; Lee I, 2018, HEALTH SERV RES, V53, P3592, DOI 10.1111/1475-6773.12811; Lipstein SH, 2014, ANN INTERN MED, V161, P594, DOI 10.7326/M14-1601; LUFT HS, 1988, HEALTH AFFAIR, V7, P97, DOI 10.1377/hlthaff.7.3.97; Maddox KEJ, 2019, HEALTH SERV RES, V54, P327, DOI 10.1111/1475-6773.13133; Maddox KEJ, 2018, NEW ENGL J MED, V378, P977, DOI 10.1056/NEJMp1715455; MANNING WG, 1987, AM ECON REV, V77, P251; Mansournia MA, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i189; McGuire TG, 2020, AM J HEALTH ECON, V6, P139, DOI 10.1086/706796; McWilliams JM, 2020, MILBANK Q, V98, P847, DOI 10.1111/1468-0009.12468; McWilliams JM, 2017, HEALTH AFFAIR, V36, P2085, DOI 10.1377/hlthaff.2017.0814; McWilliams JM, 2017, NEW ENGL J MED, V376, P807, DOI 10.1056/NEJMp1612779; McWilliams JM, 2020, HLTH AFFAIRS BLOG, DOI [10.1377/ hblog20201106.1578, DOI 10.1377/HBLOG20201106.1578]; Medi-Cal Managed Care Division California Departmen of Health Care Services, STAT COLL QUAL IMPR; MedPAC, 2014, C MED HLTH CAR DEL S, P21; National Academies of Sciences Engineering and Medicine, 2016, ACCOUNTING SOCIAL RI; O'Malley AJ, 2005, HEALTH SERV RES, V40, P2162, DOI 10.1111/j.1475-6773.2005.00470.x; Obermeyer Z, 2019, SCIENCE, V366, P447, DOI 10.1126/science.aax2342; Palmer JD, MEDICAID MANAGED CAR; Roberts ET, 2018, JAMA INTERN MED, V178, P1498, DOI 10.1001/jamainternmed.2018.4481; Roberts ET, 2018, ANN INTERN MED, V168, P255, DOI 10.7326/M17-1740; Rose S, 2019, AM STAT, V73, P152, DOI 10.1080/00031305.2018.1518269; Rose S, 2018, HEALTH SERV RES, V53, P3836, DOI 10.1111/1475-6773.12848; Rose S, 2016, HEALTH AFFAIR, V35, P440, DOI 10.1377/hlthaff.2015.1026; Ryan AM, 2013, NEW ENGL J MED, V369, P2472, DOI 10.1056/NEJMp1312654; Sussman JB, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2073; van Kleef RC, 2017, EUR J HEALTH ECON, V18, P1137, DOI 10.1007/s10198-016-0859-1; Wagner TH, 2016, HEALTH SERV RES, V51, P2002, DOI 10.1111/1475-6773.12454; Werner RM, 2008, JAMA-J AM MED ASSOC, V299, P2180, DOI 10.1001/jama.299.18.2180; Werner RM, 2005, JAMA-J AM MED ASSOC, V293, P1239, DOI 10.1001/jama.293.10.1239	67	3	3	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR	2022	175	3					314	+		10.7326/M21-0881	http://dx.doi.org/10.7326/M21-0881		JAN 2022	16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	0O5UF	34978862				2022-12-28	WOS:000742142800001
J	Okike, K; Chan, PH; Navarro, RA; Khatod, MX; Paxton, EW; Prentice, HA				Okike, Kanu; Chan, Priscilla H.; Navarro, Ronald A.; Khatod, Monti X.; Paxton, Elizabeth W.; Prentice, Heather A.			Hip Fracture Surgery Volumes Among Individuals 65 Years and Older During the COVID-19 Pandemic	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Okike, Kanu] Kaiser Permanente, Hawaii Permanente Med Grp, Honolulu, HI USA; [Chan, Priscilla H.; Paxton, Elizabeth W.; Prentice, Heather A.] Kaiser Permanente, Surg Outcomes & Anal Dept, San Diego, CA USA; [Navarro, Ronald A.] Kaiser Permanente, Southern Calif Permanente Med Grp, Pasadena, CA USA	Kaiser Permanente; Permanente Medical Groups; Kaiser Permanente; Kaiser Permanente; Permanente Medical Groups	Okike, K (corresponding author), Hawaii Permanente Med Grp, 3288 Moanalua Rd, Honolulu, HI 96821 USA.	okike@post.harvard.edu	Paxton, Elizabeth/GXH-9981-2022; Navarro, Ronald A/AAE-1422-2019	Navarro, Ronald A/0000-0003-1869-6440; Prentice, Heather/0000-0002-2200-6564				Best Jacob, 2021, OTA Int, V4, pe123, DOI 10.1097/OI9.0000000000000123; Inacio Maria C S, 2015, Perm J, V19, P29, DOI 10.7812/TPP/14-231; Kochera Andrew, 2002, Issue Brief (Public Policy Inst (Am Assoc Retired Pers)), P1; Morrison RS., HIP FRACTURE ADULTS; Stoker S, 2020, J ORTHOP TRAUMA, V34, pE336, DOI 10.1097/BOT.0000000000001860	5	2	2	1	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 25	2022	327	4					387	388		10.1001/jama.2021.23761	http://dx.doi.org/10.1001/jama.2021.23761		DEC 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YV9PW	34967845	Bronze, Green Published			2022-12-28	WOS:000737837900002
J	Tanne, JH				Tanne, Janice Hopkins			Covid-19: CDC shortens isolation period as US cases hit record high	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Abutaleb Y., 2021, WASH POST; [Anonymous], 2021, NEW YORK TIMES; Centers for Disease Control and Prevention, COV DAT TRACK VAR PR; Centers for Disease Control and Prevention, 2021, COV 19 COV DAT TRACK; Johns Hopkins University, 2021, TRACK HOM; Leonard B., 2021, POLITICO; Miller Z, 2021, ASS PRESS; Mueller B., 2021, NEW YORK TIMES; Yan H, 2021, CNN 1229	9	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 30	2021	375								n3161	10.1136/bmj.n3161	http://dx.doi.org/10.1136/bmj.n3161			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YC3TX	34969658	Bronze			2022-12-28	WOS:000739618400001
J	Siddle, KJ; Krasilnikova, LA; Moreno, GK; Schaffner, SF; Vostok, J; Fitzgerald, NA; Lemieux, JE; Barkas, N; Loreth, C; Specht, I; Tomkins-Tinch, CH; Paull, JS; Schaeffer, B; Taylor, BP; Loftness, B; Johnson, H; Schubert, PL; Shephard, HM; Doucette, M; Fink, T; Lang, AS; Baez, S; Beauchamp, J; Hennigan, S; Buzby, E; Ash, S; Brown, J; Clancy, S; Cofsky, S; Gagne, L; Hall, J; Harrington, R; Gionet, GL; DeRuff, KC; Vodzak, ME; Adams, GC; Dobbins, ST; Slack, SD; Reilly, SK; Anderson, LM; Cipicchio, MC; DeFelice, MT; Grimsby, JL; Anderson, SE; Blumenstiel, BS; Meldrim, JC; Rooke, HM; Vicente, G; Smith, NL; Messer, KS; Reagan, FL; Mandese, ZM; Lee, MD; Ray, MC; Fisher, ME; Ulcena, MA; Nolet, CM; English, SE; Larkin, KL; Vernest, K; Chaluvadi, S; Arvidson, D; Melchiono, M; Covell, T; Harik, V; Brock-Fisher, T; Dunn, M; Kearns, A; Hanage, WP; Bernard, C; Philippakis, A; Lennon, NJ; Gabriel, SB; Gallagher, GR; Smole, S; Madoff, LC; Brown, CM; Park, DJ; MacInnis, BL; Sabeti, PC				Siddle, Katherine J.; Krasilnikova, Lydia A.; Moreno, Gage K.; Schaffner, Stephen F.; Vostok, Johanna; Fitzgerald, Nicholas A.; Lemieux, Jacob E.; Barkas, Nikolaos; Loreth, Christine; Specht, Ivan; Tomkins-Tinch, Christopher H.; Paull, Jillian S.; Schaeffer, Beau; Taylor, Bradford P.; Loftness, Bryn; Johnson, Hillary; Schubert, Petra L.; Shephard, Hanna M.; Doucette, Matthew; Fink, Timelia; Lang, Andrew S.; Baez, Stephanie; Beauchamp, John; Hennigan, Scott; Buzby, Erika; Ash, Stephanie; Brown, Jessica; Clancy, Selina; Cofsky, Seana; Gagne, Luc; Hall, Joshua; Harrington, Rachel; Gionet, Gabrielle L.; DeRuff, Katherine C.; Vodzak, Megan E.; Adams, Gordon C.; Dobbins, Sabrina T.; Slack, Sarah D.; Reilly, Steven K.; Anderson, Lisa M.; Cipicchio, Michelle C.; DeFelice, Matthew T.; Grimsby, Jonna L.; Anderson, Scott E.; Blumenstiel, Brendan S.; Meldrim, James C.; Rooke, Heather M.; Vicente, Gina; Smith, Natasha L.; Messer, Katelyn S.; Reagan, Faye L.; Mandese, Zoe M.; Lee, Matthew D.; Ray, Marianne C.; Fisher, Marissa E.; Ulcena, Maesha A.; Nolet, Corey M.; English, Sean E.; Larkin, Katie L.; Vernest, Kyle; Chaluvadi, Sushma; Arvidson, Deirdre; Melchiono, Maurice; Covell, Theresa; Harik, Vaira; Brock-Fisher, Taylor; Dunn, Molly; Kearns, Amanda; Hanage, William P.; Bernard, Clare; Philippakis, Anthony; Lennon, Niall J.; Gabriel, Stacey B.; Gallagher, Glen R.; Smole, Sandra; Madoff, Lawrence C.; Brown, Catherine M.; Park, Daniel J.; MacInnis, Bronwyn L.; Sabeti, Pardis C.			Transmission from vaccinated individuals in a large SARS-CoV-2 Delta variant outbreak	CELL			English	Article								An outbreak of over 1,000 COVID-19 cases in Provincetown, Massachusetts (MA), in July 2021-the first large outbreak mostly in vaccinated individuals in the US-prompted a comprehensive public health response, motivating changes to national masking recommendations and raising questions about infection and transmission among vaccinated individuals. To address these questions, we combined viral genomic and epidemiological data from 467 individuals, including 40% of outbreak-associated cases. The Delta variant accounted for 99% of cases in this dataset; it was introduced from at least 40 sources, but 83% of cases derived from a single source, likely through transmission across multiple settings over a short time rather than a single event. Genomic and epidemiological data supported multiple transmissions of Delta from and between fully vaccinated individuals. However, despite its magnitude, the outbreak had limited onward impact in MA and the US overall, likely due to high vaccination rates and a robust public health response.	[Siddle, Katherine J.; Krasilnikova, Lydia A.; Moreno, Gage K.; Schaffner, Stephen F.; Fitzgerald, Nicholas A.; Lemieux, Jacob E.; Barkas, Nikolaos; Loreth, Christine; Specht, Ivan; Tomkins-Tinch, Christopher H.; Paull, Jillian S.; Loftness, Bryn; Gionet, Gabrielle L.; DeRuff, Katherine C.; Vodzak, Megan E.; Adams, Gordon C.; Dobbins, Sabrina T.; Slack, Sarah D.; Reilly, Steven K.; Anderson, Lisa M.; Cipicchio, Michelle C.; DeFelice, Matthew T.; Grimsby, Jonna L.; Anderson, Scott E.; Blumenstiel, Brendan S.; Meldrim, James C.; Rooke, Heather M.; Vicente, Gina; Smith, Natasha L.; Messer, Katelyn S.; Reagan, Faye L.; Mandese, Zoe M.; Lee, Matthew D.; Ray, Marianne C.; Fisher, Marissa E.; Ulcena, Maesha A.; Nolet, Corey M.; English, Sean E.; Larkin, Katie L.; Vernest, Kyle; Chaluvadi, Sushma; Bernard, Clare; Philippakis, Anthony; Lennon, Niall J.; Gabriel, Stacey B.; Park, Daniel J.; MacInnis, Bronwyn L.; Sabeti, Pardis C.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Krasilnikova, Lydia A.; Schaffner, Stephen F.; Tomkins-Tinch, Christopher H.; Sabeti, Pardis C.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Schaffner, Stephen F.; MacInnis, Bronwyn L.; Sabeti, Pardis C.] Harvard Univ, Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Vostok, Johanna; Johnson, Hillary; Schubert, Petra L.; Shephard, Hanna M.; Doucette, Matthew; Fink, Timelia; Lang, Andrew S.; Baez, Stephanie; Beauchamp, John; Hennigan, Scott; Buzby, Erika; Ash, Stephanie; Brown, Jessica; Clancy, Selina; Cofsky, Seana; Gagne, Luc; Hall, Joshua; Harrington, Rachel; Gallagher, Glen R.; Smole, Sandra; Madoff, Lawrence C.; Brown, Catherine M.] Massachusetts Dept Publ Hlth, Boston, MA 02199 USA; [Lemieux, Jacob E.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Specht, Ivan] Harvard Univ, Fac Arts & Sci, Cambridge, MA 02138 USA; [Paull, Jillian S.] Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA; [Schaeffer, Beau; Taylor, Bradford P.; Hanage, William P.] Harvard Univ, Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Schaeffer, Beau; Taylor, Bradford P.; Hanage, William P.] Harvard Univ, Ctr Communicable Dis Dynam, Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Shephard, Hanna M.] Council State & Terr Epidemiologists, Atlanta, GA 30345 USA; [Arvidson, Deirdre; Melchiono, Maurice; Covell, Theresa] Barnstable Cty Dept Hlth & Environm, Barnstable, MA 02630 USA; [Harik, Vaira] Barnstable Cty Dept Human Serv, Barnstable, MA 02630 USA; [Brock-Fisher, Taylor; Dunn, Molly; Kearns, Amanda] Commonwealth Massachusetts, Community Tracing Collaborat, Boston, MA 02199 USA; [Sabeti, Pardis C.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [MacInnis, Bronwyn L.; Sabeti, Pardis C.] Massachusetts Consortium Pathogen Readiness, Boston, MA 02115 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Harvard T.H. Chan School of Public Health; Massachusetts Department of Public Health; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Howard Hughes Medical Institute	Siddle, KJ; MacInnis, BL (corresponding author), Broad Inst Harvard & MIT, Cambridge, MA 02142 USA.; MacInnis, BL (corresponding author), Harvard Univ, Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA.; MacInnis, BL (corresponding author), Massachusetts Consortium Pathogen Readiness, Boston, MA 02115 USA.	kjsiddle@broadinstitute.org; bronwyn@broadinstitute.org	Hanage, Bill/CAF-1813-2022; Sabeti, Pardis/GQH-8610-2022	Schubert, Petra/0000-0002-6135-0173; Krasilnikova, Lydia/0000-0003-4163-706X; Lang, Andrew/0000-0002-9368-1751; Paull, Jillian/0000-0001-6624-3919; Brown, Jessica/0000-0001-6806-8499; Loftness, Bryn/0000-0003-4597-0783; Slack, Sarah/0000-0002-0559-3138; Schaffner, Stephen/0000-0001-6699-3568	Centers for Disease Control and Prevention [75D30121C10501, 75D30120C09605]; National Institute of Allergy and Infectious Diseases [U19AI110818, U01 AI151812]; Rockefeller Foundation [2021HTH013]; Bill and Melinda Gates Foundation [INV-002717]; Doris Duke Charitable Foundation; Howard Hughes Medical Institute; Merck KGaA Future Insight Prize; National Human Genome Research Institute [K99HG010669]	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Rockefeller Foundation; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Merck KGaA Future Insight Prize; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank Patricia Kludt and Meagan Burns from the Massachusetts Depart-ment of Public Health; Radhika Gharpure, Samira Sami, Rebecca T. Sabo, Noemi Hall, Anne Foreman, and Scott Laney from the CDC COVID-19 Response Team; the Barnstable County Department of Health and the Envi-ronment; the Community Tracing Collaborative; the Boston Public Health Commission; and all members of the local, regional, and national COVID-19 emergency response efforts. We also acknowledge all members of the Massa-chusetts Department of Public Health and Broad Institute SARS-CoV-2 genomic sequencing and surveillance efforts. We gratefully acknowledge the authors from the originating laboratories responsible for obtaining the specimens and the submitting laboratories where genetic sequence data were generated and shared via the GISAID Initiative, on which this research is based on (Table S1) . This work was sponsored by the Centers for Disease Control and Prevention COVID-19 baseline genomic surveillance contract sequencing (75D30121C10501 to Clinical Research Sequencing Platform, LLC) , a CDC Broad Agency Announcement (75D30120C09605 to B.L.M.) , Na-tional Institute of Allergy and Infectious Diseases (U19AI110818 and U01 AI151812 to P.C.S.) , the Rockefeller Foundation (2021HTH013 to B.L.M. and P.C.S.) , and the Bill and Melinda Gates Foundation (INV-002717 to B.L.M.) , as well as support from the Doris Duke Charitable Foundation (J.E.L.) , the Ho-ward Hughes Medical Institute and Merck KGaA Future Insight Prize (P.C.S.) , and the National Human Genome Research Institute (K99HG010669 to S.K.R.) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aksamentov I, 2021, J OPEN SOURCE SOFTW, V6, P3773, DOI [DOI 10.21105/JOSS.03773, 10.21105/joss.03773]; Brown CM, 2021, MMWR-MORBID MORTAL W, V70, P1059, DOI 10.15585/mmwr.mm7031e2; Campbell F, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2330-z; Center for Disease Control, 2021, INT PUBL HLTH REC FU; Chia PY, 2022, CLIN MICROBIOL INFEC, V28, DOI 10.1016/j.cmi.2021.11.010; Collier Ai-Ris Y, 2021, medRxiv, DOI 10.1101/2021.10.18.21265113; Cori A, 2013, AM J EPIDEMIOL, V178, P1505, DOI 10.1093/aje/kwt133; Earnest Rebecca, 2021, medRxiv, DOI 10.1101/2021.10.06.21264641; Elbe S, 2017, GLOB CHALL, V1, P33, DOI 10.1002/gch2.1018; Endo Akira, 2020, Wellcome Open Res, V5, P67, DOI [10.12688/wellcomeopenres.15842.3, 10.12688/wellcomeopenres.15842.1]; Gharpure R, 2022, EMERG INFECT DIS, V28, P35, DOI 10.3201/eid2801.212220; Hadfield J, 2018, BIOINFORMATICS, V34, P4121, DOI 10.1093/bioinformatics/bty407; Harvey WT, 2021, NAT REV MICROBIOL, V19, P409, DOI 10.1038/s41579-021-00573-0; Huddleston John, 2021, J Open Source Softw, V6, DOI 10.21105/joss.02906; Leonard AS, 2017, J VIROL, V91, DOI 10.1128/JVI.00171-17; Li QQ, 2020, CELL, V182, P1284, DOI 10.1016/j.cell.2020.07.012; Marks A, 2021, WHAT PROVINCETOWNS G; Massachusetts Department of Public Health, 2021, WEEKL COV 19 VACC RE; McCrone JT, 2018, CURR OPIN VIROL, V28, P20, DOI 10.1016/j.coviro.2017.10.008; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; R Development Core Team, 2009, R LANG ENV STAT COMP; Riemersma KK, 2021, SHEDDING INFECT SARS, DOI [10.1101/2021.07.31.21261387, DOI 10.1101/2021.07.31.21261387]; Sagulenko P, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vex042; Singanayagam A, 2022, LANCET INFECT DIS, V22, P183, DOI 10.1016/S1473-3099(21)00648-4; Turakhia Y, 2021, NAT GENET, V53, P809, DOI 10.1038/s41588-021-00862-7; Wilm A, 2012, NUCLEIC ACIDS RES, V40, P11189, DOI 10.1093/nar/gks918; Wohl S, 2016, ANNU REV VIROL, V3, P173, DOI 10.1146/annurev-virology-110615-035747; Zhang M, 2021, CHINA CDC WEEKLY, V3, P584, DOI 10.46234/ccdcw2021.148	29	11	11	1	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 3	2022	185	3					485	+		10.1016/j.cell.2021.12.027	http://dx.doi.org/10.1016/j.cell.2021.12.027			19	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	YW7SP	35051367	Green Published, hybrid			2022-12-28	WOS:000753615000010
J	Thomas, AJ; Woo, B; Nettle, D; Spelke, E; Saxe, R				Thomas, Ashley J.; Woo, Brandon; Nettle, Daniel; Spelke, Elizabeth; Saxe, Rebecca			Early concepts of intimacy: Young humans use saliva sharing to infer close relationships	SCIENCE			English	Article							PREVERBAL INFANTS; KINSHIP; PSYCHOLOGY; TODDLERS; SOCIETY	Across human societies, people form "thick" relationships characterized by strong attachments, obligations, and mutual responsiveness. People in thick relationships share food utensils, kiss, or engage in other distinctive interactions that involve sharing saliva. We found that children, toddlers, and infants infer that dyads who share saliva (as opposed to other positive social interactions) have a distinct relationship. Children expect saliva sharing to happen in nuclear families. Toddlers and infants expect that people who share saliva will respond to one another in distress. Parents confirm that saliva sharing is a valid cue of relationship thickness in their children's social environments. The ability to use distinctive interactions to infer categories of relationships thus emerges early in life, without explicit teaching; this enables young humans to rapidly identify close relationships, both within and beyond families.	[Thomas, Ashley J.; Woo, Brandon; Spelke, Elizabeth] Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA; [Thomas, Ashley J.; Saxe, Rebecca] MIT, Brain & Cognit Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Thomas, Ashley J.; Woo, Brandon; Spelke, Elizabeth; Saxe, Rebecca] Newcastle Univ, Populat Hlth Sci Inst, Newcastle Upon Tyne, Tyne & Wear, England; [Nettle, Daniel] NSF Ctr Brains Minds & Machines, Cambridge, MA USA	Harvard University; Massachusetts Institute of Technology (MIT); Newcastle University - UK	Thomas, AJ (corresponding author), Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA.; Thomas, AJ (corresponding author), MIT, Brain & Cognit Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Thomas, AJ (corresponding author), Newcastle Univ, Populat Hlth Sci Inst, Newcastle Upon Tyne, Tyne & Wear, England.	ajthomas@mit.edu		/0000-0003-2377-1791; Spelke, Elizabeth/0000-0002-6925-3618; Nettle, Daniel/0000-0001-9089-2599	NIH National Research Service Award [1F32HD096829]; Patrick J. McGovern Foundation; Guggenheim Foundation; Social Sciences and Humanities Research Council Doctoral Fellowship [752-2020-0474]; NSF Center for Brains Minds and Machines award [CCF-1231216]; Siegel Foundation award [S4881]	NIH National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Patrick J. McGovern Foundation; Guggenheim Foundation; Social Sciences and Humanities Research Council Doctoral Fellowship; NSF Center for Brains Minds and Machines award; Siegel Foundation award	NIH National Research Service Award 1F32HD096829 (A.J.T.); Patrick J. McGovern Foundation (R.S.); Guggenheim Foundation (R.S.); Social Sciences and Humanities Research Council Doctoral Fellowship 752-2020-0474 B.W.); NSF Center for Brains Minds and Machines award CCF-1231216 (E.S., A.J.T., B.W., R.S.); Siegel Foundation award S4881 (E.S.)	Alvarez HP, 2000, AM J PHYS ANTHROPOL, V113, P435, DOI 10.1002/1096-8644(200011)113:3<435::AID-AJPA11>3.0.CO;2-O; Bar-Haim Y, 2006, PSYCHOL SCI, V17, P159, DOI 10.1111/j.1467-9280.2006.01679.x; Burkner PC, 2017, J STAT SOFTW, V80, P1, DOI 10.18637/jss.v080.i01; Carey S., 2009, ORIGIN CONCEPTS; CARSTEN J, 1995, AM ETHNOL, V22, P223, DOI 10.1525/ae.1995.22.2.02a00010; Chmura D, 2013, POL J ECOL, V61, P431; Chuey A, 2021, FRONT PSYCHOL, V12, DOI 10.3389/fpsyg.2021.734398; CLARK MS, 1979, J PERS SOC PSYCHOL, V37, P12, DOI 10.1037/0022-3514.37.1.12; Cohen D, 2009, EUR J SOC PSYCHOL, V39, P1278, DOI 10.1002/ejsp.671; Cronk L, 2019, EVOL HUM BEHAV, V40, P281, DOI 10.1016/j.evolhumbehav.2018.12.004; Federal Communications Commission, 2018, BROADB DEPL REP; Fiske AP, 2009, EUR J SOC PSYCHOL, V39, P1294, DOI 10.1002/ejsp.697; FISKE AP, 1992, PSYCHOL REV, V99, P689, DOI 10.1037/0033-295X.99.4.689; Geraci A, 2011, DEVELOPMENTAL SCI, V14, P1012, DOI 10.1111/j.1467-7687.2011.01048.x; Hamlin JK, 2013, CURR DIR PSYCHOL SCI, V22, P186, DOI 10.1177/0963721412470687; Hartig F., 2019, DHARMA RESIDUAL DIAG; Hirschfeld LA, 2001, PERS SOC PSYCHOL REV, V5, P107, DOI 10.1207/S15327957PSPR0502_2; HIRSCHFELD LA, 1989, INT J BEHAV DEV, V12, P541, DOI 10.1177/016502548901200409; Hrdy SB, 2020, PHILOS T R SOC B, V375, DOI 10.1098/rstb.2019.0499; Hrdy SB, 2001, NAT HIST, V110, P50; Jones D, 2003, EVOL HUM BEHAV, V24, P303, DOI 10.1016/S1090-5138(03)00038-2; Kaufmann L, 2014, TOPOI-INT REV PHILOS, V33, P459, DOI 10.1007/s11245-014-9236-9; Kinzler KD, 2007, P NATL ACAD SCI USA, V104, P12577, DOI 10.1073/pnas.0705345104; Kominsky, 2020, SIMPLICITY VALIDITY, DOI [10.31234/osf.io/6j9p3, DOI 10.31234/OSF.IO/6J9P3]; Liberman Z, 2017, COGNITIVE SCI, V41, P622, DOI 10.1111/cogs.12403; Liberman Z, 2016, P NATL ACAD SCI USA, V113, P9480, DOI 10.1073/pnas.1605456113; Liu S, 2017, SCIENCE, V358, P1038, DOI 10.1126/science.aag2132; Margalit A., 2017, BETRAYAL; Miller L, 1998, EUR J SOC PSYCHOL, V28, P423, DOI 10.1002/(SICI)1099-0992(199805/06)28:3<423::AID-EJSP874>3.3.CO;2-M; MURDOCK GP, 1970, ETHNOLOGY, V9, P165, DOI 10.2307/3772782; Olson KR, 2008, COGNITION, V108, P222, DOI 10.1016/j.cognition.2007.12.003; Powell L.J., 2018, OPEN MIND, V2, P61, DOI DOI 10.1162/opmi_a_00018; Powell LJ, 2013, P NATL ACAD SCI USA, V110, pE3965, DOI 10.1073/pnas.1304326110; R Development Core Team, 2009, R LANG ENV STAT COMP; Rai TS, 2011, PSYCHOL REV, V118, P57, DOI 10.1037/a0021867; Rakich N., 2020, URBAN RURAL IS YOUR; Sahlins M. D., 1976, USE ABUSE BIOL ANTHR; Sahlins Marshall., 2017, STONE AGE EC; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Schneider D., 1984, CRITIQUE STUDY KINSH; Seyfarth RM, 2003, ANIMAL SOCIAL COMPLEXITY, P207; Silk JB, 2003, DAHL WS ENV, P37; Small, 2017, SOMEONE TO TALK TO; Sorokowska A, 2021, PERS SOC PSYCHOL B, V47, P1705, DOI 10.1177/0146167220988373; Spokes AC, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00440; Sumner JL, 2018, PS-POLIT SCI POLIT, V51, P396, DOI 10.1017/S1049096517002074; Thomas AJ, 2019, CURR BIOL, V29, P2183, DOI 10.1016/j.cub.2019.05.054; Thomsen L, 2013, NAVIGATING SOCIAL WO, P17, DOI [DOI 10.1093/ACPROF:OSO/9780199890712.003.0004, 10.1093/acprof:oso/9780199890712.003.0004]; Thomsen L, 2011, SCIENCE, V331, P477, DOI 10.1126/science.1199198; Ting F, 2019, P NATL ACAD SCI USA, V116, P6025, DOI 10.1073/pnas.1817849116; Woodward AL, 1998, COGNITION, V69, P1, DOI 10.1016/S0010-0277(98)00058-4	51	3	3	22	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2022	375	6578					311	+		10.1126/science.abh1054	http://dx.doi.org/10.1126/science.abh1054			42	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YK2FS	35050656	Green Submitted			2022-12-28	WOS:000745036100032
J	Farisenkov, SE; Kolomenskiy, D; Petrov, PN; Engels, T; Lapina, NA; Lehmann, FO; Onishi, R; Liu, H; Polilov, AA				Farisenkov, Sergey E.; Kolomenskiy, Dmitry; Petrov, Pyotr N.; Engels, Thomas; Lapina, Nadezhda A.; Lehmann, Fritz-Olaf; Onishi, Ryo; Liu, Hao; Polilov, Alexey A.			Novel flight style and light wings boost flight performance of tiny beetles	NATURE			English	Article							ROTATION; INSECTS; DESIGN	Flight speed is positively correlated with body size in animals(1). However, miniature featherwing beetles can fly at speeds and accelerations of insects three times their size(2). Here we show that this performance results from a reduced wing mass and a previously unknown type of wing-motion cycle. Our experiment combines three-dimensional reconstructions of morphology and kinematics in one of the smallest insects, the beetle Paratuposa placentis (body length 395 mu m). The flapping bristled wings follow a pronounced figure-of-eight loop that consists of subperpendicular up and down strokes followed by claps at stroke reversals above and below the body. The elytra act as inertial brakes that prevent excessive body oscillation. Computational analyses suggest functional decomposition of the wingbeat cycle into two power half strokes, which produce a large upward force, and two down-dragging recovery half strokes. In contrast to heavier membranous wings, the motion of bristled wings of the same size requires little inertial power. Muscle mechanical power requirements thus remain positive throughout the wingbeat cycle, making elastic energy storage obsolete. These adaptations help to explain how extremely small insects have preserved good aerial performance during miniaturization, one of the factors of their evolutionary success.	[Farisenkov, Sergey E.; Petrov, Pyotr N.; Lapina, Nadezhda A.; Polilov, Alexey A.] Lomonosov Moscow State Univ, Fac Biol, Dept Entomol, Moscow, Russia; [Kolomenskiy, Dmitry; Onishi, Ryo] Tokyo Inst Technol, GLobal Sci Informat & Comp Ctr, Tokyo, Japan; [Kolomenskiy, Dmitry] Skolkovo Inst Sci & Technol, Skoltech Ctr Design Mfg & Mat, Moscow, Russia; [Engels, Thomas; Lehmann, Fritz-Olaf] Univ Rostock, Inst Biol Sci, Dept Anim Physiol, Rostock, Germany; [Liu, Hao] Chiba Univ, Grad Sch Engn, Chiba, Japan; [Polilov, Alexey A.] Joint Russian Vietnamese Trop Res & Technol Ctr, Southern Branch, Ho Chi Minh City, Vietnam	Lomonosov Moscow State University; Tokyo Institute of Technology; Skolkovo Institute of Science & Technology; University of Rostock; Chiba University	Farisenkov, SE; Polilov, AA (corresponding author), Lomonosov Moscow State Univ, Fac Biol, Dept Entomol, Moscow, Russia.; Polilov, AA (corresponding author), Joint Russian Vietnamese Trop Res & Technol Ctr, Southern Branch, Ho Chi Minh City, Vietnam.	farisenkov@entomology.bio.msu.ru; polilov@gmail.com	Kolomenskiy, Dmitry/H-3825-2019; Lapina, Nadezhda/AAD-2488-2022; Polilov, Alexey/K-4599-2013; onishi, ryo/D-1109-2014	Kolomenskiy, Dmitry/0000-0003-0107-6894; Liu, Hao/0000-0002-8687-3237; Petrov, Pyotr/0000-0003-4093-9656; Engels, Thomas/0000-0002-9098-1054; Farisenkov, Sergey/0000-0003-2634-2204; Polilov, Alexey/0000-0002-6214-3627; Lapina, Nadezhda/0000-0001-8850-5297; onishi, ryo/0000-0001-9250-0712	Russian Science Foundation [19-14-00045]; JSPS KAKENHI [18K13693, 19H02060]; Deutsche Forschungsgemeinschaft [LE905/16-1, LE905/18-1];  [2183]	Russian Science Foundation(Russian Science Foundation (RSF)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); 	A.A.P. thanks R. D. Zhantiev for mentorship and for inspiring him to study miniature insects. We thank A. K. Tsaturyan for helpful discussions. The work of S.E.F., A.A.P., P.N.P. and N.A.L. was supported by the Russian Science Foundation (project number 19-14-00045, study of morphology, high-speed recording and reconstruction of kinematics). This study was performed using equipment of the shared research facilities of HPC computing resources at Lomonosov Moscow State University (A.A.P. and D.K., project no. 2183 `Computational fluid dynamics of the smallest insects'), TSUBAME3.0 supercomputer at the Tokyo Institute of Technology (D.K.) and HPC resources of IDRIS (T.E., allocation number A0102A01664 attributed by the Grand Equipement National de Calcul Intensif (GENCI)). The work of D.K. was supported by the JSPS KAKENHI (grant number 18K13693). H.L. was partially supported by the JSPS KAKENHI (grant number 19H02060). The contributions of F.-O.L. and T.E. were supported by grants from the Deutsche Forschungsgemeinschaft to F.-O.L. (LE905/16-1 and LE905/18-1). SEM studies were performed using the Shared Research Facility Electron microscopy in life sciences at Lomonosov Moscow State University (unique equipment `Three-dimensional electron microscopy and spectroscopy').	Atkins D. M., 1958, Canadian Entomologist, V90, P339; Bomphrey RJ, 2017, NATURE, V544, P92, DOI 10.1038/nature21727; Cheng X, 2019, PHYS FLUIDS, V31, DOI 10.1063/1.5121183; Cheng X, 2018, J FLUID MECH, V855, P646, DOI 10.1017/jfm.2018.668; Cheng X, 2016, SCI REP-UK, V6, DOI 10.1038/srep25706; Dickinson MH, 1999, SCIENCE, V284, P1954, DOI 10.1126/science.284.5422.1954; Dickinson MH, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0388; ELLINGTON CP, 1984, PHILOS T ROY SOC B, V305, P41, DOI 10.1098/rstb.1984.0051; Engels T, 2021, COMMUN COMPUT PHYS, V30, P1118, DOI 10.4208/cicp.OA-2020-0246; Farisenkov SE, 2020, P NATL ACAD SCI USA, V117, P24643, DOI 10.1073/pnas.2012404117; Ford MP, 2019, BIOINSPIR BIOMIM, V14, DOI 10.1088/1748-3190/ab1a00; Fukuda T., 2018, LIVING MACHINES HDB; HORRIDGE GA, 1956, NATURE, V178, P1334, DOI 10.1038/1781334a0; Kasoju VT, 2021, PHYS FLUIDS, V33, DOI 10.1063/5.0036018; Kasoju VT, 2018, FLUIDS, V3, DOI 10.3390/fluids3020044; Kolomenskiy D, 2020, EXP FLUIDS, V61, DOI 10.1007/s00348-020-03027-0; Lee SH, 2020, J FLUID MECH, V888, DOI 10.1017/jfm.2020.64; Lee SH, 2018, PHYS FLUIDS, V30, DOI 10.1063/1.5030693; Lyu YZ, 2019, PHYS REV E, V99, DOI 10.1103/PhysRevE.99.012419; Oh S, 2020, J FLUID MECH, V885, DOI 10.1017/jfm.2019.962; Polilov AA, 2019, ARTHROPOD STRUCT DEV, V48, P56, DOI 10.1016/j.asd.2019.01.003; Polilov AA, 2015, ANNU REV ENTOMOL, V60, P103, DOI 10.1146/annurev-ento-010814-020924; Sane SP, 2016, CURR OPIN NEUROBIOL, V41, P158, DOI 10.1016/j.conb.2016.09.008; Santhanakrishnan A, 2014, J EXP BIOL, V217, P3898, DOI 10.1242/jeb.084897; Sitorus PE, 2010, J BIONIC ENG, V7, P354, DOI 10.1016/S1672-6529(10)60267-3; Tennekes H., 2009, SIMPLE SCI FLIGHT IN; Vincent JFV, 2004, ARTHROPOD STRUCT DEV, V33, P187, DOI 10.1016/j.asd.2004.05.006; Walker JA, 2002, INTEGR COMP BIOL, V42, P232, DOI 10.1093/icb/42.2.232; WEISFOGH T, 1973, J EXP BIOL, V59, P169; Yavorskaya MI, 2019, ARTHROPOD STRUCT DEV, V48, P71, DOI 10.1016/j.asd.2019.01.002	30	12	13	19	55	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 3	2022	602	7895					96	+		10.1038/s41586-021-04303-7	http://dx.doi.org/10.1038/s41586-021-04303-7		JAN 2022	20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YS1FH	35046578	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000744417900001
J	Balk, EM; Adam, GP; Cao, WN; Mehta, S; Shah, N				Balk, Ethan M.; Adam, Gaelen P.; Cao, Wangnan; Mehta, Shivani; Shah, Nishit			Evaluation and Management After Acute Left-Sided Colonic Diverticulitis A Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Review							UNCOMPLICATED DIVERTICULITIS; EARLY COLONOSCOPY; ROUTINE COLONOSCOPY; CT DIAGNOSIS; MULTICENTER; MESALAZINE; SURGERY; DISEASE; RISK; SIGMOIDECTOMY	Background: The value of interventions used after acute colonic diverticulitis is unclear. Purpose: To evaluate postdiverticulitis colonoscopy and interventions to prevent recurrent diverticulitis. Data Sources: MEDLINE, Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews, Embase, CINAHL, and ClinicalTrials.gov from 1 January 1990 through 16 November 2020. Study Selection: Comparative studies of interventions of interest reporting critical or important outcomes, and larger single-group studies to evaluate prevalence of colonoscopy findings and harms. Data Extraction: 6 researchers extracted study data and risk of bias. The team assessed strength of evidence. Data Synthesis: 19 studies evaluated colonoscopy. Risk for prevalent colorectal cancer (CRC) compared with the general population is unclear. Based on low-strength evidence, long-term CRC diagnosis is similar with or without colonoscopy. High-strength evidence indicates that risk for prevalent CRC is higher among patients with complicated diverticulitis and colonoscopy complications are rare. Based on high-strength evidence, mesalamine does not reduce recurrence risk (6 randomized controlled trials [RCTs]). Evidence on other nonsurgical interventions is insufficient. For patients with prior complicated or smoldering or frequently recurrent diverticulitis, elective surgery is associated with reduced recurrence (3 studies; high strength). In 19 studies, serious surgical complications were uncommon. Limitations: Few RCTs provided evidence. Heterogeneity of treatment effect was not adequately assessed. Conclusion: It is unclear whether patients with recent acute diverticulitis are at increased risk for prevalent CRC, but those with complicated diverticulitis are at increased risk. Mesalamine is ineffective in preventing recurrence; other nonsurgical treatments have inadequate evidence. Elective surgery reduces recurrence in patients with prior complicated or smoldering or frequently recurrent diverticulitis, but it is unclear which of these patients may benefit most.	[Balk, Ethan M.; Adam, Gaelen P.; Cao, Wangnan; Mehta, Shivani] Brown Univ, Brown Evidence Based Practice Ctr, Ctr Evidence Synth Hlth, Brown Sch Publ Hlth, Providence, RI 02912 USA; [Shah, Nishit] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA	Brown University; Brown University	Balk, EM (corresponding author), Brown Sch Publ Hlth, Box G Sl 21-8,121 South Main St, Providence, RI 02912 USA.	ethan_balk@brown.edu		Balk, Ethan/0000-0002-4376-7290; Cao, Wangnan/0000-0002-6163-2760	AHRQ [HHSA290201500002I]; American College of Physicians	AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); American College of Physicians	By contract HHSA290201500002I/task order 13 from AHRQ. Additional funding for manuscript preparation was provided by the American College of Physicians.	Abdulazeez Z, 2020, ANN ROY COLL SURG, V102, P744, DOI 10.1308/rcsann.2020.0181; Agarwal AK, 2014, WORLD J GASTROENTERO, V20, P12509, DOI 10.3748/wjg.v20.i35.12509; Agency for Healthcare Research and Quality, 2014, AHRQ PUBL, V14-0005; Alcantar DC, 2019, CUREUS, V11, DOI 10.7759/cureus.5666; Andrade P, 2017, DIGEST SURG, V34, P197, DOI 10.1159/000449259; Aquina CT, 2019, BRIT J SURG, V106, P467, DOI 10.1002/bjs.10982; Balk EM, 2020, COMP EFFECTIVENESS R, DOI [doi:10.23970/AHRQEP CCER233, DOI 10.23970/AHRQEPCCER233]; Balk EM, 2022, ANN INTERN MED, V175, P379, DOI 10.7326/M21-1645; BALTHAZAR EJ, 1990, AM J ROENTGENOL, V154, P281, DOI 10.2214/ajr.154.2.2105015; Berkman ND, 2015, J CLIN EPIDEMIOL, V68, P1312, DOI 10.1016/j.jclinepi.2014.11.023; Bhakta A, 2016, SURG ENDOSC, V30, P1629, DOI 10.1007/s00464-015-4393-5; Bharucha AE, 2015, AM J GASTROENTEROL, V110, P1588, DOI 10.1038/ajg.2015.302; Bolkenstein HE, 2019, BRIT J SURG, V106, P448, DOI 10.1002/bjs.11024; Bolkenstein HE, 2019, ANN SURG, V269, P612, DOI 10.1097/SLA.0000000000003033; Bordeianou L, 2019, ANN SURG, V270, P1124, DOI 10.1097/SLA.0000000000002859; Brar MS, 2013, DIS COLON RECTUM, V56, P1259, DOI 10.1097/DCR.0b013e3182a26bfd; Carabotti M, 2017, NUTRIENTS, V9, DOI 10.3390/nu9020161; Daniels L, 2015, SURG ENDOSC, V29, P2605, DOI 10.1007/s00464-014-3977-9; Elmi A, 2013, AM J ROENTGENOL, V200, P1269, DOI 10.2214/AJR.12.9539; Festa V, 2017, EUR REV MED PHARMACO, V21, P1397; Garfinkle R, 2016, DIS COLON RECTUM, V59, P648, DOI 10.1097/DCR.0000000000000624; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Horesh N, 2016, TECH COLOPROCTOL, V20, P383, DOI 10.1007/s10151-016-1478-7; Ilyas MIM, 2017, COLORECTAL DIS, V19, P260, DOI 10.1111/codi.13461; Khoury T, 2020, J GASTROINTEST CANC, V51, P48, DOI 10.1007/s12029-019-00202-3; Kruis W, 2017, ALIMENT PHARM THER, V46, P282, DOI 10.1111/apt.14152; Kvasnovsky CL, 2017, INFLAMMOPHARMACOLOGY, V25, P499, DOI 10.1007/s10787-017-0363-y; Lahat A, 2007, ENDOSCOPY, V39, P521, DOI 10.1055/s-2007-966399; Lanas A, 2013, DIGEST LIVER DIS, V45, P104, DOI 10.1016/j.dld.2012.09.006; Lau KC, 2011, DIS COLON RECTUM, V54, P1265, DOI 10.1097/DCR.0b013e31822899a2; Lecleire S, 2014, UNITED EUR GASTROENT, V2, P301, DOI 10.1177/2050640614541765; Lidor AO, 2010, J GASTROINTEST SURG, V14, P1867, DOI 10.1007/s11605-010-1344-2; Masoomi H, 2011, WORLD J SURG, V35, P2143, DOI 10.1007/s00268-011-1117-4; Meireles LC, 2015, EUR J GASTROEN HEPAT, V27, P1429, DOI 10.1097/MEG.0000000000000474; Mizuki A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43236-0; Moghadamyeghaneh Z, 2015, AM J SURG, V210, P838, DOI 10.1016/j.amjsurg.2015.04.010; National Heart Lung and Blood Institute; U.S. Department of Health and Human Services, STUD QUAL ASS TOOLS; O'Donohoe N, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-56641-2; Papageorge CM, 2016, J GASTROINTEST SURG, V20, P1376, DOI 10.1007/s11605-016-3150-y; Parente F, 2013, INT J COLORECTAL DIS, V28, P1423, DOI 10.1007/s00384-013-1722-9; Perez NP, 2021, J GASTROINTEST SURG, V25, P1297, DOI 10.1007/s11605-020-04762-9; Pessaux P, 2004, WORLD J SURG, V28, P92, DOI 10.1007/s00268-003-7146-x; Ramphal W, 2018, DIGEST DIS, V36, P362, DOI 10.1159/000489926; Raskin JB, 2014, GASTROENTEROLOGY, V147, P793, DOI 10.1053/j.gastro.2014.07.004; Russ AJ, 2010, GASTROENTEROLOGY, V138, P2267, DOI 10.1053/j.gastro.2010.02.048; Sallinen V, 2014, SURG ENDOSC, V28, P961, DOI 10.1007/s00464-013-3257-0; Sanchez SDS, 2014, J GASTROEN HEPATOL, V29, P106; Santos A, 2021, JAMA SURG, V156, P129, DOI 10.1001/jamasurg.2020.5151; Schout PJC, 2012, DIGEST SURG, V29, P408, DOI 10.1159/000345332; Seoane-Urgorri A, 2018, REV ESP ENFERM DIG, V110, P571, DOI [10.17235/reed.2018.5524/2017, 10.17235/reed.2018.5524/2018]; Sharma PV, 2014, ANN SURG, V259, P263, DOI 10.1097/SLA.0000000000000294; Sheer AJ, 2011, DIS COLON RECTUM, V54, P1430, DOI 10.1097/DCR.0b013e31822c4e85; Silva-Velazco J, 2016, SURG ENDOSC, V30, P3541, DOI 10.1007/s00464-015-4651-6; Simianu VV, 2015, AM J SURG, V209, P913, DOI 10.1016/j.amjsurg.2014.12.027; Simianu VV, 2014, WORLD J GASTROENTERO, V20, P16609, DOI 10.3748/wjg.v20.i44.16609; Sterne JAC, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i4919; Stollman N, 2015, GASTROENTEROLOGY, V149, P1944, DOI 10.1053/j.gastro.2015.10.003; Stollman N, 2013, J CLIN GASTROENTEROL, V47, P621, DOI 10.1097/MCG.0b013e31828003f6; Stollman NH, 1999, AM J GASTROENTEROL, V94, P3110, DOI 10.1111/j.1572-0241.1999.01501.x; Studniarek A, 2019, AM SURGEON, V85, P1381; Suhardja TS, 2017, INT J COLORECTAL DIS, V32, P485, DOI 10.1007/s00384-016-2749-5; Sweeting MJ, 2004, STAT MED, V23, P1351, DOI 10.1002/sim.1761; Torney MVU, 2020, JAMA SURG, V155, P600, DOI 10.1001/jamasurg.2020.0757; Tsilimparis N, 2010, DEUT MED WOCHENSCHR, V135, P1743, DOI 10.1055/s-0030-1263305; Tursi A, 2002, DIGEST LIVER DIS, V34, P510, DOI 10.1016/S1590-8658(02)80110-4; Tursi A, 2007, INT J COLORECTAL DIS, V22, P1103, DOI 10.1007/s00384-007-0299-6; Valizadeh N, 2018, AM SURGEON, V84, P1781; van de Wall BJM, 2017, LANCET GASTROENTEROL, V2, P13, DOI 10.1016/S2468-1253(16)30109-1; Varma S, 2019, J SURG RES, V234, P224, DOI 10.1016/j.jss.2018.09.043; You K, 2018, BRIT J SURG, V105, P971, DOI 10.1002/bjs.10868	70	2	2	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR	2022	175	3					388	+		10.7326/M21-1646	http://dx.doi.org/10.7326/M21-1646		JAN 2022	12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0O5UF	35038269				2022-12-28	WOS:000745524900001
J	Gould, CA; McClain, KR; Reta, D; Kragskow, JGC; Marchiori, DA; Lachman, E; Choi, ES; Analytis, JG; Britt, RD; Chilton, NF; Harvey, BG; Long, JR				Gould, Colin A.; McClain, K. Randall; Reta, Daniel; Kragskow, Jon G. C.; Marchiori, David A.; Lachman, Ella; Choi, Eun-Sang; Analytis, James G.; Britt, R. David; Chilton, Nicholas F.; Harvey, Benjamin G.; Long, Jeffrey R.			Ultrahard magnetism from mixed-valence dilanthanide complexes with metal-metal bonding	SCIENCE			English	Article							BASIS-SETS; RELAXATION; DESIGN; ATOMS; IONS	Metal-metal bonding interactions can engender outstanding magnetic properties in bulk materials and molecules, and examples abound for the transition metals. Extending this paradigm to the lanthanides, herein we report mixed-valence dilanthanide complexes (Cp-iPr5)(2)Ln(2)I(3) (Ln is Gd, Tb, or Dy; Cp-iPr5, pentaisopropylcyclopentadienyl), which feature a singly occupied lanthanide-lanthanide sigma-bonding orbital of 5d(z2) parentage, as determined by structural, spectroscopic, and computational analyses. Valence delocalization, wherein the d electron is equally shared by the two lanthanide centers, imparts strong parallel alignment of the sigma-bonding and f electrons on both lanthanides according to Hund's rules. The combination of a well-isolated high-spin ground state and large magnetic anisotropy in (Cp-iPr5)(2)Dy2I3 gives rise to an enormous coercive magnetic field with a lower bound of 14 tesla at temperatures as high as 60 kelvin.	[Gould, Colin A.; Long, Jeffrey R.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [McClain, K. Randall; Harvey, Benjamin G.] US Navy, Res Dept, Weap Div, Chem Div,Naval Air Warfare Ctr, China Lake, CA 93555 USA; [Reta, Daniel; Kragskow, Jon G. C.; Chilton, Nicholas F.] Univ Manchester, Sch Nat Sci, Dept Chem, Manchester M13 9PL, Lancs, England; [Marchiori, David A.; Britt, R. David] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA; [Lachman, Ella; Analytis, James G.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Lachman, Ella; Analytis, James G.; Long, Jeffrey R.] Lawrence Berkeley Natl Lab, Mat Sci Div, Berkeley, CA 94720 USA; [Choi, Eun-Sang] Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32310 USA; [Long, Jeffrey R.] Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA; [Reta, Daniel] Euskal Herriko Unibertsitatea UPV EHU, Kimika Fak, PK 1072, Donostia San Sebastian 20080, Euskadi, Spain; [Reta, Daniel] Donostia Int Phys Ctr DIPC, PK 1072, Donostia San Sebastian 20080, Euskadi, Spain	University of California System; University of California Berkeley; United States Department of Defense; United States Navy; Naval Air Weapons Station China Lake (NAWS); University of Manchester; University of California System; University of California Davis; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; State University System of Florida; Florida State University; University of California System; University of California Berkeley; University of Basque Country	Long, JR (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.; Harvey, BG (corresponding author), US Navy, Res Dept, Weap Div, Chem Div,Naval Air Warfare Ctr, China Lake, CA 93555 USA.; Chilton, NF (corresponding author), Univ Manchester, Sch Nat Sci, Dept Chem, Manchester M13 9PL, Lancs, England.; Long, JR (corresponding author), Lawrence Berkeley Natl Lab, Mat Sci Div, Berkeley, CA 94720 USA.; Long, JR (corresponding author), Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA.	nicholas.chilton@manchester.ac.uk; benjamin.g.harvey.civ@us.navy.mil; jrlong@berkeley.edu	RETA, DANIEL/H-6853-2015	RETA, DANIEL/0000-0003-0000-9892; Gould, Colin/0000-0001-9539-1582; McClain, Kenneth/0000-0001-8072-8402; Choi, Eun Sang/0000-0001-9272-4134; Lachman, Ella/0000-0001-6967-890X; Marchiori, David/0000-0001-9738-3674	NSF [CHE-1800252, CHE-2102603, 1905397, DMR-1644779]; Naval Air Warfare Center Weapons Division (NAWCWD) NISE-219 program; ERC [2019-STG-851504]; Royal Society fellowship [URF191320]; University of Manchester; Computational Shared Facility at the University of Manchester; Gordon and Betty Moore Foundation's EPiQS Initiative [GBMF9067]; state of Florida	NSF(National Science Foundation (NSF)); Naval Air Warfare Center Weapons Division (NAWCWD) NISE-219 program; ERC(European Research Council (ERC)European Commission); Royal Society fellowship(Royal Society of London); University of Manchester; Computational Shared Facility at the University of Manchester; Gordon and Betty Moore Foundation's EPiQS Initiative; state of Florida	This work was funded by NSF grants CHE-1800252 and CHE-2102603 (C.A.G. and J.R.L.) and 1905397 (E.L. and J.G.A.); the Naval Air Warfare Center Weapons Division (NAWCWD) NISE-219 program (K.R.M. and B.G.H.); ERC grant 2019-STG-851504 (N.F.C.); and Royal Society fellowship URF191320 (N.F.C.). N.F.C. also thanks the University of Manchester and the Computational Shared Facility at the University of Manchester for support. J.G.A. and E.L. acknowledge support from the Gordon and Betty Moore Foundation's EPiQS Initiative through grant GBMF9067. A portion of this work was performed at the National High Magnetic Field Laboratory, which is supported by NSF cooperative agreement no. DMR-1644779 and the state of Florida.	Adamo C, 1999, J CHEM PHYS, V110, P6158, DOI 10.1063/1.478522; [Anonymous], 1993, MOL MAGNETISM, P212; [Anonymous], 1967, PROG INORG CHEM, DOI DOI 10.1002/9780470166093.CH7; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Benabderrahmane C., 2008, P 11 EUR PART ACC C; Berry JF, 2010, STRUCT BOND, V136, P1, DOI 10.1007/978-3-642-05243-9_1; Briganti M, 2021, J AM CHEM SOC, V143, P13633, DOI 10.1021/jacs.1c05068; Bruker AXS Inc, APEX3 SAINT SADABS X; Brunschwig BS, 2002, CHEM SOC REV, V31, P168, DOI 10.1039/b008034i; Chakarawet K, 2018, J AM CHEM SOC, V140, P2058, DOI 10.1021/jacs.7b13394; Chibotaru LF, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4739763; Chiesa A, 2020, PHYS REV B, V101, DOI 10.1103/PhysRevB.101.174402; Chilton NF, 2015, INORG CHEM, V54, P2097, DOI 10.1021/acs.inorgchem.5b00089; Chilton NF, 2015, CHEM COMMUN, V51, P101, DOI 10.1039/c4cc08312a; Chilton NF, 2013, J COMPUT CHEM, V34, P1164, DOI 10.1002/jcc.23234; Connelly SJ, 2013, ORGANOMETALLICS, V32, P7478, DOI 10.1021/om400970j; Cordero B, 2008, DALTON T, P2832, DOI 10.1039/b801115j; Cotton F., 1972, INORG CHIM ACTA, V6, P161, DOI [10.1016/S0020-1693(00)91778-X, DOI 10.1016/S0020-1693(00)91778-X]; Cotton F. A., 2005, MULTIPLE BONDS METAL; D'Alessandro DM, 2006, CHEM SOC REV, V35, P424, DOI 10.1039/b514590m; DANCOFF SM, 1950, PHYS REV, V78, P382, DOI 10.1103/PhysRev.78.382; de Graaf C., 2016, MAGNETIC INTERACTION; Demir S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01553-w; Dezember T, 1997, Z NATURFORSCH B, V52, P911; Dolomanov OV, 2009, J APPL CRYSTALLOGR, V42, P339, DOI 10.1107/S0021889808042726; Eisenhart RJ, 2015, ACCOUNTS CHEM RES, V48, P2885, DOI 10.1021/acs.accounts.5b00336; Evans P, 2019, J AM CHEM SOC, V141, P19935, DOI 10.1021/jacs.9b11515; Evans WJ, 2006, J COORD CHEM, V59, P1069, DOI 10.1080/00958970500512831; Fieser ME, 2015, J AM CHEM SOC, V137, P369, DOI 10.1021/ja510831n; Flack HD, 2003, HELV CHIM ACTA, V86, P905, DOI 10.1002/hlca.200390109; Galvan IF, 2019, J CHEM THEORY COMPUT, V15, P5925, DOI 10.1021/acs.jctc.9b00532; Gamelin DR, 1996, J AM CHEM SOC, V118, P8085, DOI 10.1021/ja9536633; Gatteschi D, 2006, MESOSCOPIC PHYS NANO, P1; Gould C. A., 2022, DRYAD, DOI 10.6078/D1RT4W; Grimme S, 2011, J COMPUT CHEM, V32, P1456, DOI 10.1002/jcc.21759; Grimme S, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3382344; Groom CR, 2016, ACTA CRYSTALLOGR B, V72, P171, DOI 10.1107/S2052520616003954; Gu L, 2021, PHYS REV B, V103, DOI 10.1103/PhysRevB.103.014401; Gu L, 2020, PHYS REV LETT, V125, DOI 10.1103/PhysRevLett.125.117203; Guo FS, 2018, SCIENCE, V362, P1400, DOI 10.1126/science.aav0652; HARDING C, 1994, J CHEM SOC CHEM COMM, P2499, DOI 10.1039/c39940002499; Iwahara N, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.174438; Kahn O., 1993, MOL MAGNETISM, P341; KANEKO YJ, 2000, P 16 INT WORKSH RAR, P83; KARAYIANIS N, 1970, J CHEM PHYS, V53, P2460, DOI 10.1063/1.1674348; Keller S, 2015, J CHEM PHYS, V143, DOI 10.1063/1.4939000; KRAATZ HB, 1995, COORDIN CHEM REV, V143, P35, DOI 10.1016/0010-8545(94)07005-5; KUTTERER R, 1977, J MAGN MAGN MATER, V4, P1, DOI 10.1016/0304-8853(77)90004-X; Lanotte L., 1996, MAGNETIC PROPERTIES; Ho LTA, 2018, PHYS REV B, V97, DOI 10.1103/PhysRevB.97.024427; Li Manni G, 2014, J CHEM THEORY COMPUT, V10, P3669, DOI 10.1021/ct500483t; Liu FP, 2019, ACCOUNTS CHEM RES, V52, P2981, DOI 10.1021/acs.accounts.9b00373; MacDonald MR, 2013, J AM CHEM SOC, V135, P9857, DOI 10.1021/ja403753j; McClain KR, 2018, CHEM SCI, V9, P8492, DOI 10.1039/c8sc03907k; Moehring SA, 2018, CHEM-EUR J, V24, P18059, DOI 10.1002/chem.201803807; NARASIMHAN KSVL, 1981, J APPL PHYS, V52, P2512, DOI 10.1063/1.328985; Neese F, 2018, WIRES COMPUT MOL SCI, V8, DOI 10.1002/wcms.1327; Neese F, 2012, WIRES COMPUT MOL SCI, V2, P73, DOI 10.1002/wcms.81; Pantazis DA, 2012, THEOR CHEM ACC, V131, DOI 10.1007/s00214-012-1292-x; Parsons S, 2003, ACTA CRYSTALLOGR D, V59, P1995, DOI 10.1107/S0907444903017657; Pfleiderer C, 2001, NATURE, V412, P58, DOI 10.1038/35083531; Powers IG, 2017, ACS CATAL, V7, P936, DOI 10.1021/acscatal.6b02692; Reta D, 2021, J AM CHEM SOC, V143, P5943, DOI 10.1021/jacs.1c01410; Reta D, 2019, PHYS CHEM CHEM PHYS, V21, P23567, DOI 10.1039/c9cp04301b; Robinson M.B., 1967, ADV INORG CHEM, V10, P247, DOI [10.1016/S0065-2792(08)60179-X, DOI 10.1016/S0065-2792(08)60179-X]; Roos BO, 2004, J PHYS CHEM A, V108, P2851, DOI 10.1021/jp031064+; Roos BO, 2005, J PHYS CHEM A, V109, P6575, DOI 10.1021/jp0581126; Ryabov ID, 1999, J MAGN RESON, V140, P141, DOI 10.1006/jmre/1999.1783; Sanchez RH, 2015, J AM CHEM SOC, V137, P13949, DOI 10.1021/jacs.5b08962; Sheldrick G. M., 2015, SHELXT SHELXL; Sheldrick GM, 2015, ACTA CRYSTALLOGR A, V71, P3, DOI 10.1107/S2053273314026370; STEVENS KWH, 1952, P PHYS SOC LOND A, V65, P209, DOI 10.1088/0370-1298/65/3/308; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; Tamm Ig., 1945, J PHYS USSR, V9, P449; Tao JM, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.146401; Weigend F, 2006, PHYS CHEM CHEM PHYS, V8, P1057, DOI 10.1039/b515623h; Weigend F, 2005, PHYS CHEM CHEM PHYS, V7, P3297, DOI 10.1039/b508541a	77	70	69	52	109	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2022	375	6577					198	+		10.1126/science.abl5470	http://dx.doi.org/10.1126/science.abl5470			130	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YG3OI	35025637				2022-12-28	WOS:000742401600033
J	Mayor, S				Mayor, Susan			Covid-19: Warning over transmission risk as self-isolation is cut to five days in England	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Department of Health and Social Care, 2022, SELF IS THOS COV 19; Torjesen I, 2022, BMJ-BRIT MED J, V376, DOI 10.1136/bmj.o89	2	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 14	2022	376								o111	10.1136/bmj.o111	http://dx.doi.org/10.1136/bmj.o111			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZE9IM	35031534	Bronze			2022-12-28	WOS:000759190400007
J	Zucker, C; Goodman, AA; Alves, J; Bialy, S; Foley, M; Speagle, JS; Grossschedl, J; Finkbeiner, DP; Burkert, A; Khimey, D; Swiggum, C				Zucker, Catherine; Goodman, Alyssa A.; Alves, Joao; Bialy, Shmuel; Foley, Michael; Speagle, Joshua S.; Grossschedl, Josefa; Finkbeiner, Douglas P.; Burkert, Andreas; Khimey, Diana; Swiggum, Cameren			Star formation near the Sun is driven by expansion of the Local Bubble	NATURE			English	Article							INTERSTELLAR-MEDIUM; SUPERNOVAE; KINEMATICS; EVOLUTION; STANDARD; ORIGIN; GAS	For decades we have known that the Sun lies within the Local Bubble, a cavity of low-density, high-temperature plasma surrounded by a shell of cold, neutral gas and dust(1-3). However, the precise shape and extent of this shell(4,5), the impetus and timescale for its formation(6,7), and its relationship to nearby star formation s have remained uncertain, largely due to low-resolution models of the local interstellar medium. Here we report an analysis of the three-dimensional positions, shapes and motions of dense gas and young stars within 200 pc of the Sun, using new spatial(9- 11) and dynamical constraints(12). We find that nearly all of the star-forming complexes in the solar vicinity lie on the surface of the Local Bubble and that their young stars show outward expansion mainly perpendicular to the bubble's surface. Tracebacks of these young stars' motions support a picture in which the origin of the Local Bubble was a burst of stellar birth and then death (supernovae) taking place near the bubble's centre beginning approximately 14 Myr ago. The expansion of the Local Bubble created by the supernovae swept up the ambient interstellar medium into an extended shell that has now fragmented and collapsed into the most prominent nearby molecular clouds, in turn providing robust observational support for the theory of supernova-driven star formation.	[Zucker, Catherine; Goodman, Alyssa A.; Bialy, Shmuel; Foley, Michael; Finkbeiner, Douglas P.; Khimey, Diana] Harvard & Smithsonian, Ctr Astrophys, Cambridge, MA 02138 USA; [Zucker, Catherine] Space Telescope Sci Inst, 3700 San Martin Dr, Baltimore, MD 21218 USA; [Alves, Joao; Grossschedl, Josefa; Swiggum, Cameren] Univ Vienna, Dept Astrophys, Vienna, Austria; [Bialy, Shmuel] Univ Maryland, Dept Astron, College Pk, MD 20742 USA; [Speagle, Joshua S.] Univ Toronto, Dept Stat Sci, Toronto, ON, Canada; [Speagle, Joshua S.] Univ Toronto, David A Dunlap Dept Astron & Astrophys, Toronto, ON, Canada; [Speagle, Joshua S.] Univ Toronto, Dunlap Inst Astron & Astrophys, Toronto, ON, Canada; [Finkbeiner, Douglas P.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Burkert, Andreas] Univ Observ Munich, Munich, Germany; [Burkert, Andreas] Max Planck Inst Extraterr Phys, Garching, Germany; [Swiggum, Cameren] Univ Wisconsin, Dept Astron, Madison, WI 53706 USA	Smithsonian Institution; Space Telescope Science Institute; University of Vienna; University System of Maryland; University of Maryland College Park; University of Toronto; University of Toronto; University of Toronto; Harvard University; University of Munich; Max Planck Society; University of Wisconsin System; University of Wisconsin Madison	Zucker, C (corresponding author), Harvard & Smithsonian, Ctr Astrophys, Cambridge, MA 02138 USA.; Zucker, C (corresponding author), Space Telescope Sci Inst, 3700 San Martin Dr, Baltimore, MD 21218 USA.	catherine.zucker@cfa.harvard.edu	ripert, marion/HHN-5115-2022; Goodman, Alyssa/A-6007-2010	Goodman, Alyssa/0000-0003-1312-0477; Foley, Michael/0000-0002-6747-2745; Swiggum, Cameren/0000-0001-9201-5995; Speagle, Joshua Shen/0000-0003-2573-9832; Bialy, Shmuel/0000-0002-0404-003X; Zucker, Catherine/0000-0002-2250-730X; Alves, Joao/0000-0002-4355-0921	NSF [OAC-1739657, CDSE:AAG-1908419, AST-1614941]; NASA ADAP [80NSSC21K0634]; Excellence Cluster ORIGINS - German Research Foundation (DFG) under Germany's Excellence Strategy [EXC-2094-390783311]; Data Science Research Centre; TURIS Research Platform of the University of Vienna; Austrian Research Promotion Agency (FFG) [873708]; NASA through the NASA Hubble Fellowship - Space Telescope Science Institute [HST-HF2-51498.001, NAS5-26555]	NSF(National Science Foundation (NSF)); NASA ADAP; Excellence Cluster ORIGINS - German Research Foundation (DFG) under Germany's Excellence Strategy(German Research Foundation (DFG)); Data Science Research Centre; TURIS Research Platform of the University of Vienna; Austrian Research Promotion Agency (FFG); NASA through the NASA Hubble Fellowship - Space Telescope Science Institute	The visualization, exploration and interpretation of data presented in this work were made possible using the glue visualization software, supported under NSF grant numbers OAC-1739657 and CDS&E:AAG-1908419. The interactive figures were made possible by the plot.ly python library. D.P.F. acknowledges support by NSF grant AST-1614941 'Exploring the Galaxy: 3-Dimensional Structure and Stellar Streams'. D.P.F., A.A.G. and C.Z. acknowledge support by NASA ADAP grant 80NSSC21K0634 'Knitting Together the Milky Way: An Integrated Model of the Galaxy's Stars, Gas, and Dust'. A.B. acknowledges support by the Excellence Cluster ORIGINS, which is funded by the German Research Foundation (DFG) under Germany's Excellence Strategy -EXC-2094-390783311. J.A. acknowledges support from the Data Science Research Centre and the TURIS Research Platform of the University of Vienna. J.G. acknowledges funding by the Austrian Research Promotion Agency (FFG) under project number 873708. C.Z. acknowledges that support for this work was provided by NASA through the NASA Hubble Fellowship grant number HST-HF2-51498.001 awarded by the Space Telescope Science Institute, which is operated by the Association of Universities for Research in Astronomy, Inc., for NASA, under contract NAS5-26555. C.Z., A.A.G., J.A. and S.B. acknowledge Interstellar Institute's program 'The Grand Cascade' and the Paris-Saclay University's Institut Pascal for hosting discussions that encouraged the development of the ideas behind this work.	Alves J, 2020, NATURE, V578, P237, DOI 10.1038/s41586-019-1874-z; Bialy S, 2021, ASTROPHYS J LETT, V919, DOI 10.3847/2041-8213/ac1f95; Bovy J, 2011, ANN APPL STAT, V5, P1657, DOI 10.1214/10-AOAS439; Breitschwerdt D, 2016, NATURE, V532, P73, DOI 10.1038/nature17424; COX DP, 1974, ASTROPHYS J, V189, pL105, DOI 10.1086/181476; COX DP, 1987, ANNU REV ASTRON ASTR, V25, P303; Dawson JR, 2013, PUBL ASTRON SOC AUST, V30, DOI 10.1017/pas.2013.002; Dehnen W, 1998, MON NOT R ASTRON SOC, V298, P387, DOI 10.1046/j.1365-8711.1998.01600.x; Dzib SA, 2018, ASTROPHYS J, V867, DOI 10.3847/1538-4357/aae687; El-Badry K, 2019, MON NOT R ASTRON SOC, V490, P1961, DOI 10.1093/mnras/stz2773; Fabricius C, 2021, ASTRON ASTROPHYS, V649, DOI 10.1051/0004-6361/202039834; Francis C, 2009, NEW ASTRON, V14, P615, DOI 10.1016/j.newast.2009.03.004; Frisch P., 2017, HDB SUPERNOVAE, P2253, DOI [10.1007/978-3-319-21846-5-13, DOI 10.1007/978-3-319-21846-5-13]; Fuchs B, 2006, MON NOT R ASTRON SOC, V373, P993, DOI 10.1111/j.1365-2966.2006.11044.x; Gagne J, 2018, ASTROPHYS J, V862, DOI 10.3847/1538-4357/aaca2e; Gagne J, 2018, ASTROPHYS J, V856, DOI 10.3847/1538-4357/aaae09; Galli PAB, 2021, ASTRON ASTROPHYS, V646, DOI 10.1051/0004-6361/202039395; Galli PAB, 2020, ASTRON ASTROPHYS, V643, DOI 10.1051/0004-6361/202038717; Galli PAB, 2020, ASTRON ASTROPHYS, V634, DOI 10.1051/0004-6361/201936708; Gontcharov GA, 2019, MON NOT R ASTRON SOC, V483, P299, DOI 10.1093/mnras/sty2978; Grasser N, 2021, ASTRON ASTROPHYS, V652, DOI 10.1051/0004-6361/202140438; Groschedl JE, 2021, ASTRON ASTROPHYS, V647, DOI 10.1051/0004-6361/202038913; Herczeg GJ, 2019, ASTROPHYS J, V878, DOI 10.3847/1538-4357/ab1d67; Inutsuka S, 2015, ASTRON ASTROPHYS, V580, DOI 10.1051/0004-6361/201425584; Kamdar H., STELLAR STREAMS GALA; KERR FJ, 1986, MON NOT R ASTRON SOC, V221, P1023, DOI 10.1093/mnras/221.4.1023; Kerr RMP, 2021, ASTROPHYS J, V917, DOI 10.3847/1538-4357/ac0251; Kim CG, 2017, ASTROPHYS J, V834, DOI 10.3847/1538-4357/834/1/25; Krolikowski DM, 2021, ASTRON J, V162, DOI 10.3847/1538-3881/ac0632; Lallement R, 2019, ASTRON ASTROPHYS, V625, DOI 10.1051/0004-6361/201834695; Lallement R, 2003, ASTRON ASTROPHYS, V411, P447, DOI 10.1051/0004-6361:20031214; Leike RH, 2020, ASTRON ASTROPHYS, V639, DOI 10.1051/0004-6361/202038169; Lindegren L, 2021, ASTRON ASTROPHYS, V649, DOI 10.1051/0004-6361/202039709; LUCKE PB, 1978, ASTRON ASTROPHYS, V64, P367; Maiz-Apellaniz J, 2001, ASTROPHYS J, V560, pL83, DOI 10.1086/324016; MCKEE CF, 1977, ASTROPHYS J, V218, P148, DOI 10.1086/155667; Ortiz-Leon GN, 2018, ASTROPHYS J, V865, DOI 10.3847/1538-4357/aada49; Pelgrims V, 2020, ASTRON ASTROPHYS, V636, DOI 10.1051/0004-6361/201937157; Perrot CA, 2003, ASTRON ASTROPHYS, V404, P519, DOI 10.1051/0004-6361:20030477; Price-Whelan AM, 2018, ASTRON J, V156, DOI 10.3847/1538-3881/aabc4f; Reid MJ, 2019, ASTROPHYS J, V885, DOI 10.3847/1538-4357/ab4a11; SALPETER EE, 1955, ASTROPHYS J, V121, P161, DOI 10.1086/145971; SANDERS WT, 1977, ASTROPHYS J, V217, pL87, DOI 10.1086/182545; Schonrich R, 2010, MON NOT R ASTRON SOC, V403, P1829, DOI 10.1111/j.1365-2966.2010.16253.x; Speagle JS, 2020, MON NOT R ASTRON SOC, V493, P3132, DOI 10.1093/mnras/staa278; VanderPlas J., 2012, 2012 Conference on Intelligent Data Understanding (CIDU 2012), P47, DOI 10.1109/CIDU.2012.6382200; Wang F, 2021, MON NOT R ASTRON SOC, V504, P199, DOI 10.1093/mnras/stab848; Welsh BY, 2010, ASTRON ASTROPHYS, V510, DOI 10.1051/0004-6361/200913202; Welsh BY, 1999, ASTRON ASTROPHYS, V352, P308; Zucker C, 2021, ASTROPHYS J, V919, DOI 10.3847/1538-4357/ac1f96	51	16	16	1	7	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 20	2022	601	7893					334	+		10.1038/s41586-021-04286-5	http://dx.doi.org/10.1038/s41586-021-04286-5		JAN 2022	15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YJ6UI	35022612	Green Submitted			2022-12-28	WOS:000741978700009
J	Hayes, KN; Brown, KA; Cheung, AM				Hayes, K. N.; Brown, K. A.; Cheung, A. M.			Summary for Patients: Fracture Risk During Osteoporosis Drug Holidays	ANNALS OF INTERNAL MEDICINE			English	Editorial Material																			0	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR	2022	175	3								10.7326/P21-0013	http://dx.doi.org/10.7326/P21-0013		JAN 2022	1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0X7BY	35007145				2022-12-28	WOS:000743247700001
J	Robertson, CT; Rukavina, M; Brown, EFC				Robertson, Christopher T.; Rukavina, Mark; Fuse Brown, Erin C.			New State Consumer Protections Against Medical Debt	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Robertson, Christopher T.] Boston Univ, Sch Law, Boston, MA 02215 USA; [Rukavina, Mark] Community Catalyst, Boston, MA USA; [Fuse Brown, Erin C.] Georgia State Univ, Coll Law, 85 Pk Pl NE,Ste 223, Atlanta, GA 30303 USA	Boston University; University System of Georgia; Georgia State University	Brown, EFC (corresponding author), Georgia State Univ, Coll Law, 85 Pk Pl NE,Ste 223, Atlanta, GA 30303 USA.	efusebrown@gsu.edu						Bennett N., WHO HAD MEDICAL DEBT; Collins Sara R., 2020, US HLTH INSURANCE CO; Fuse Brown E., 2021, APPEAL WEB DEBT SHOCKING TR; Hamel L., 2016, BURDEN MED DEBT RESU; Paturzo JGR, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.21926; Ramsey SD, 2016, J CLIN ONCOL, V34, P980, DOI 10.1200/JCO.2015.64.6620; Robertson CT., 2019, EXPOSED WHY OUR HLTH; Shen KL, 2020, WORLD J PEDIATR, V16, P232, DOI 10.1007/s12519-020-00362-4; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Yabroff KR, 2019, J GEN INTERN MED, V34, P1494, DOI 10.1007/s11606-019-05002-w	10	0	0	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 11	2022	327	2					121	122						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YH8QV	35015031				2022-12-28	WOS:000743426500010
J	Nolan, T				Nolan, Tom			Tom Nolan's research reviews-7 January 2022	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		Davidson GH, 2021, NEW ENGL J MED, V385, P2395, DOI 10.1056/NEJMc2116018; Lee CS, 2022, JAMA INTERN MED, V182, P134, DOI 10.1001/jamainternmed.2021.6990; Sabatine MS, 2021, LANCET, V398, P2247, DOI 10.1016/S0140-6736(21)02334-5; van Dalen JW, 2022, JAMA INTERN MED, V182, P142, DOI 10.1001/jamainternmed.2021.7009; Wan ES, 2021, JAMA-J AM MED ASSOC, V326, P2287, DOI 10.1001/jama.2021.20939	5	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 7	2022	376								o31	10.1136/bmj.o31	http://dx.doi.org/10.1136/bmj.o31			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YP9GN	34996823	Bronze			2022-12-28	WOS:000748927300014
J	Rurik, JG; Tombacz, I; Yadegari, A; Fernandez, POM; Shewale, SV; Li, L; Kimura, T; Soliman, OY; Papp, TE; Tam, YK; Mui, BL; Albelda, SM; Pure, E; June, CH; Aghajanian, H; Weissman, D; Parhiz, H; Epstein, JA				Rurik, Joel G.; Tombacz, Istvan; Yadegari, Amir; Fernandez, Pedro O. Mendez; Shewale, Swapnil, V; Li, Li; Kimura, Toru; Soliman, Ousamah Younoss; Papp, Tyler E.; Tam, Ying K.; Mui, Barbara L.; Albelda, Steven M.; Pure, Ellen; June, Carl H.; Aghajanian, Haig; Weissman, Drew; Parhiz, Hamideh; Epstein, Jonathan A.			CAR T cells produced in vivo to treat cardiac injury	SCIENCE			English	Article							MESSENGER-RNA; LIPID NANOPARTICLES; RECEPTOR; PROTEIN; PSEUDOURIDINE; EXPRESSION; FIBROSIS; DELIVERY	Fibrosis affects millions of people with cardiac disease. We developed a therapeutic approach to generate transient antifibrotic chimeric antigen receptor (CAR) T cells in vivo by delivering modified messenger RNA (mRNA) in T cell-targeted lipid nanoparticles (LNPs). The efficacy of these in vivo-reprogrammed CAR T cells was evaluated by injecting CD5-targeted LNPs into a mouse model of heart failure. Efficient delivery of modified mRNA encoding the CAR to T lymphocytes was observed, which produced transient, effective CAR T cells in vivo. Antifibrotic CAR T cells exhibited trogocytosis and retained the target antigen as they accumulated in the spleen. Treatment with modified mRNA-targeted LNPs reduced fibrosis and restored cardiac function after injury. In vivo generation of CAR T cells may hold promise as a therapeutic platform to treat various diseases.	[Rurik, Joel G.; Fernandez, Pedro O. Mendez; Li, Li; Aghajanian, Haig; Epstein, Jonathan A.] Univ Penn, Dept Cell & Dev Biol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Rurik, Joel G.; Fernandez, Pedro O. Mendez; Shewale, Swapnil, V; Li, Li; Aghajanian, Haig; Epstein, Jonathan A.] Univ Penn, Penn Cardiovasc Inst, Perelman Sch Med, Philadelphia, PA 19104 USA; [Rurik, Joel G.; Fernandez, Pedro O. Mendez; Aghajanian, Haig; Epstein, Jonathan A.] Univ Penn, Inst Regenerat Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Tombacz, Istvan; Yadegari, Amir; Kimura, Toru; Soliman, Ousamah Younoss; Papp, Tyler E.; Albelda, Steven M.; Weissman, Drew; Parhiz, Hamideh; Epstein, Jonathan A.] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Tam, Ying K.; Mui, Barbara L.] Acuitas Therapeut, Vancouver, BC V6T 1Z3, Canada; [Albelda, Steven M.; June, Carl H.] Univ Penn, Ctr Cellular Immunotherapies, Perelman Sch Med, Philadelphia, PA 19104 USA; [Pure, Ellen] Univ Penn, Sch Vet Med, Dept Biomed Sci, Philadelphia, PA 19104 USA; [Kimura, Toru] Osaka Int Canc Inst, Dept Gen Thorac Surg, Osaka, Japan	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Aghajanian, H; Epstein, JA (corresponding author), Univ Penn, Dept Cell & Dev Biol, Perelman Sch Med, Philadelphia, PA 19104 USA.; Aghajanian, H; Epstein, JA (corresponding author), Univ Penn, Penn Cardiovasc Inst, Perelman Sch Med, Philadelphia, PA 19104 USA.; Aghajanian, H; Epstein, JA (corresponding author), Univ Penn, Inst Regenerat Med, Perelman Sch Med, Philadelphia, PA 19104 USA.; Weissman, D; Parhiz, H; Epstein, JA (corresponding author), Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA.	haig@pennmedicine.upenn.edu; dreww@pennmedicine.upenn.edu; parhizh@pennmedicine.upenn.edu; epsteinj@upenn.edu		Mendez Fernandez, Pedro Obeth/0000-0003-4159-9366; Rurik, Joel/0000-0002-7156-4626; Tombacz, Istvan/0000-0001-6683-7223; Aghajanian, Haig/0000-0002-8317-0157; Kimura, Toru/0000-0003-4504-232X; Papp, Tyler/0000-0001-5116-0782; LI, LI/0000-0002-7844-6120	National Institutes of Health (NIH) [AI142596, HL134839, AI124429]; NIH [R35 HL140018]; Penn Center for AIDS Research (CFAR), an NIH [P30 AI 045008]; Cotswold Foundation; W.W. Smith endowed chair	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Penn Center for AIDS Research (CFAR), an NIH; Cotswold Foundation; W.W. Smith endowed chair	This research was supported by the National Institutes of Health (NIH grants AI142596, HL134839, and AI124429 to D.W. and grant NIH R35 HL140018 to J.A.E.), the Penn Center for AIDS Research (CFAR), an NIH-funded program (grant P30 AI 045008 to H.P.), the Cotswold Foundation (J.A.E.), and a W.W. Smith endowed chair to J.A.E.	Aghajanian H, 2019, NATURE, V573, P430, DOI 10.1038/s41586-019-1546-z; Akinc A, 2010, MOL THER, V18, P1357, DOI 10.1038/mt.2010.85; Andries O, 2015, J CONTROL RELEASE, V217, P337, DOI 10.1016/j.jconrel.2015.08.051; Baiersdorfer M, 2019, MOL THER-NUCL ACIDS, V15, P26, DOI 10.1016/j.omtn.2019.02.018; BOUMSELL L, 1980, J EXP MED, V152, P229, DOI 10.1084/jem.152.1.229; Gillmore JD, 2021, NEW ENGL J MED, V385, P493, DOI 10.1056/NEJMoa2107454; Gonzalez A, 2018, J AM COLL CARDIOL, V71, P1696, DOI 10.1016/j.jacc.2018.02.021; Hamieh M, 2019, NATURE, V568, P112, DOI 10.1038/s41586-019-1054-1; Henderson NC, 2020, NATURE, V587, P555, DOI 10.1038/s41586-020-2938-9; Joly E, 2003, NAT IMMUNOL, V4, P815, DOI 10.1038/ni0903-815; Kalos M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002842; Kariko K, 2005, IMMUNITY, V23, P165, DOI 10.1016/j.immuni.2005.06.008; Kariko K, 2008, MOL THER, V16, P1833, DOI 10.1038/mt.2008.200; Kaur H, 2016, CIRC RES, V118, P1906, DOI 10.1161/CIRCRESAHA.116.308643; Khalil H, 2017, J CLIN INVEST, V127, P3770, DOI 10.1172/JCI94753; Krienke Christina, 2021, Science, V371, P145, DOI 10.1126/science.aay3638; Maier MA, 2013, MOL THER, V21, P1570, DOI 10.1038/mt.2013.124; Martinez-Martin N, 2011, IMMUNITY, V35, P208, DOI 10.1016/j.immuni.2011.06.003; Moore-Morris T, 2014, J CLIN INVEST, V124, P2921, DOI 10.1172/JCI74783; Newick K, 2016, CANCER IMMUNOL RES, V4, P541, DOI 10.1158/2326-6066.CIR-15-0263; Pardi N, 2018, NAT REV DRUG DISCOV, V17, P261, DOI 10.1038/nrd.2017.243; Pardi N, 2015, J CONTROL RELEASE, V217, P345, DOI 10.1016/j.jconrel.2015.08.007; Parhiz H, 2018, J CONTROL RELEASE, V291, P106, DOI 10.1016/j.jconrel.2018.10.015; Pedram A, 2008, ENDOCRINOLOGY, V149, P3361, DOI 10.1210/en.2008-0133; Rizvi F, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-20903-3; Rurik JG, 2021, CIRC RES, V128, P1766, DOI 10.1161/CIRCRESAHA.121.318005; Schafer S, 2017, NATURE, V552, P110, DOI 10.1038/nature24676; Soldevila G, 2011, CURR OPIN IMMUNOL, V23, P310, DOI 10.1016/j.coi.2011.03.003; Sommermeyer D, 2016, LEUKEMIA, V30, P492, DOI 10.1038/leu.2015.247; Szoke D, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23546-6; Tombacz I, 2021, MOL THER, V29, P3293, DOI 10.1016/j.ymthe.2021.06.004; Wang LCS, 2014, CANCER IMMUNOL RES, V2, P154, DOI 10.1158/2326-6066.CIR-13-0027; Weissman D, 2015, EXPERT REV VACCINES, V14, P265, DOI 10.1586/14760584.2015.973859; Widjaja AA, 2021, FRONT MOL BIOSCI, V8, DOI 10.3389/fmolb.2021.740650; Yokota T, 2020, CELL, V182, P545, DOI 10.1016/j.cell.2020.06.030; Zhao YB, 2010, CANCER RES, V70, P9053, DOI 10.1158/0008-5472.CAN-10-2880	36	92	96	222	503	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 7	2022	375	6576					91	+	eabm0594	10.1126/science.abm0594	http://dx.doi.org/10.1126/science.abm0594			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YD3FW	34990237				2022-12-28	WOS:000740261400046
J	Schumacher, TN; Thommen, DS				Schumacher, Ton N.; Thommen, Daniela S.			Tertiary lymphoid structures in cancer	SCIENCE			English	Review							INFILTRATING B-CELLS; T-CELLS; IMMUNE CONTEXTURE; LYMPHOTOXIN-ALPHA; SOMATIC HYPERMUTATION; PROGNOSTIC RELEVANCE; RECEPTOR-ALPHA; TUMOR-CONTROL; MOUSE MODELS; PLASMA-CELLS	Ectopic lymphoid aggregates, termed tertiary lymphoid structures (TLSs), are formed in numerous cancer types, and, with few exceptions, their presence is associated with superior prognosis and response to immunotherapy. In spite of their presumed importance, the triggers that lead to TLS formation in cancer tissue and the contribution of these structures to intratumoral immune responses remain incompletely understood. Here, we discuss the present knowledge on TLSs in cancer, focusing on (i) the drivers of TLS formation, (ii) the function and contribution of TLSs to the antitumor immune response, and (iii) the potential of TLSs as therapeutic targets in human cancers.	[Schumacher, Ton N.] Netherlands Canc Inst, Oncode Inst, Div Mol Oncol & Immunol, NL-1066 CX Amsterdam, Netherlands; [Thommen, Daniela S.] Netherlands Canc Inst, Div Mol Oncol & Immunol, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute	Schumacher, TN (corresponding author), Netherlands Canc Inst, Oncode Inst, Div Mol Oncol & Immunol, NL-1066 CX Amsterdam, Netherlands.; Thommen, DS (corresponding author), Netherlands Canc Inst, Div Mol Oncol & Immunol, NL-1066 CX Amsterdam, Netherlands.	t.schumacher@nki.nl; d.thommen@nki.nl	Schumacher, Ton/Y-2432-2019	Schumacher, Ton/0000-0003-0517-8804; Thommen, Daniela/0000-0002-7431-2854	European Research Council (ERC) [742259]; Stevin Award; Jeantet-Collen Prize for Translational Medicine; Dutch Cancer Society [12046]	European Research Council (ERC)(European Research Council (ERC)European Commission); Stevin Award; Jeantet-Collen Prize for Translational Medicine; Dutch Cancer Society(KWF Kankerbestrijding)	This work was supported by European Research Council (ERC) Advanced Grant SENSIT (grant agreement no. 742259), the Stevin Award, and the Jeantet-Collen Prize for Translational Medicine (to T.N.S.) and by the Dutch Cancer Society (KWF Young Investigator Grant 12046) (to D.S.T.).	Ager A, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00045; Allen E, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aak9679; Alsughayyir J, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01639; Armengol MP, 2001, AM J PATHOL, V159, P861, DOI 10.1016/S0002-9440(10)61762-2; Azimi F, 2012, J CLIN ONCOL, V30, P2678, DOI 10.1200/JCO.2011.37.8539; Baratin M, 2017, IMMUNITY, V47, P349, DOI 10.1016/j.immuni.2017.07.019; Barone F, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00477; Bergomas Francesca, 2011, Cancers (Basel), V4, P1, DOI 10.3390/cancers4010001; Bruno TC, 2020, NATURE, V577, DOI 10.1038/d41586-019-03943-0; Buckley CD, 2015, ANNU REV IMMUNOL, V33, P715, DOI 10.1146/annurev-immunol-032713-120252; Buisseret L, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2016.1257452; Cabrita R, 2020, NATURE, V577, P561, DOI 10.1038/s41586-019-1914-8; Calabrese LH, 2018, NAT REV RHEUMATOL, V14, P569, DOI 10.1038/s41584-018-0074-9; Calderaro J, 2019, J HEPATOL, V70, P58, DOI 10.1016/j.jhep.2018.09.003; Carrega P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9280; Caushi JX, 2021, NATURE, V596, P126, DOI 10.1038/s41586-021-03752-4; Cillo AR, 2020, IMMUNITY, V52, P183, DOI 10.1016/j.immuni.2019.11.014; Cimino-Mathews A, 2016, HUM PATHOL, V47, P52, DOI 10.1016/j.humpath.2015.09.003; Cipponi A, 2012, CANCER RES, V72, P3997, DOI 10.1158/0008-5472.CAN-12-1377; Colbeck EJ, 2017, CANCER IMMUNOL RES, V5, P1005, DOI 10.1158/2326-6066.CIR-17-0131; Colbeck EJ, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01830; Coppola D, 2011, AM J PATHOL, V179, P37, DOI 10.1016/j.ajpath.2011.03.007; Coronella JA, 2002, J IMMUNOL, V169, P1829, DOI 10.4049/jimmunol.169.4.1829; Cottrell TR, 2018, ANN ONCOL, V29, P1853, DOI 10.1093/annonc/mdy218; Cupedo T, 2003, SEMIN IMMUNOL, V15, P243, DOI 10.1016/j.smim.2003.08.002; Cupedo T, 2002, IMMUNOL REV, V189, P41, DOI 10.1034/j.1600-065X.2002.18905.x; da Graca CG, 2021, J IMMUNOL, V206, P273, DOI 10.4049/jimmunol.2000873; de Chaisemartin L, 2011, CANCER RES, V71, P6391, DOI 10.1158/0008-5472.CAN-11-0952; De Silva P, 2019, EBIOMEDICINE, V39, P226, DOI 10.1016/j.ebiom.2018.11.066; Deteix C, 2010, J IMMUNOL, V184, P5344, DOI 10.4049/jimmunol.0902999; Di Caro G, 2014, CLIN CANCER RES, V20, P2147, DOI 10.1158/1078-0432.CCR-13-2590; Dieu-Nosjean MC, 2008, J CLIN ONCOL, V26, P4410, DOI 10.1200/JCO.2007.15.0284; Dieu-Nosjean MC, 2016, IMMUNOL REV, V271, P260, DOI 10.1111/imr.12405; Dieu-Nosjean MC, 2014, TRENDS IMMUNOL, V35, P571, DOI 10.1016/j.it.2014.09.006; Drayton DL, 2006, NAT IMMUNOL, V7, P344, DOI 10.1038/ni1330; Figenschau SL, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1116-1; Finkin S, 2015, NAT IMMUNOL, V16, P1235, DOI 10.1038/ni.3290; Fleige H, 2014, J EXP MED, V211, P643, DOI 10.1084/jem.20131737; Fridman WH, 2017, NAT REV CLIN ONCOL, V14, P717, DOI 10.1038/nrclinonc.2017.101; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Furtado GC, 2014, MUCOSAL IMMUNOL, V7, P602, DOI 10.1038/mi.2013.79; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Gao JJ, 2020, NAT MED, V26, DOI 10.1038/s41591-020-1086-y; GENTA RM, 1993, HUM PATHOL, V24, P577, DOI 10.1016/0046-8177(93)90235-9; Germain C, 2014, AM J RESP CRIT CARE, V189, P832, DOI 10.1164/rccm.201309-1611OC; GeurtsvanKessel CH, 2009, J EXP MED, V206, P2339, DOI 10.1084/jem.20090410; Giraldo NA, 2015, CLIN CANCER RES, V21, P3031, DOI 10.1158/1078-0432.CCR-14-2926; Goc J, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.28976; Goc J, 2014, CANCER RES, V74, P705, DOI 10.1158/0008-5472.CAN-13-1342; Goc J, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.26836; Griss J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12160-2; Gu-Trantien C, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.91487; Gu-Trantien C, 2013, J CLIN INVEST, V123, P2873, DOI 10.1172/JCI67428; Guedj K, 2019, J AUTOIMMUN, V103, DOI 10.1016/j.jaut.2019.05.009; Guedj K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116295; Guedj K, 2014, CARDIOVASC RES, V101, P434, DOI 10.1093/cvr/cvt263; Halle S, 2009, J EXP MED, V206, P2593, DOI 10.1084/jem.20091472; Helmink BA, 2020, NATURE, V577, P549, DOI 10.1038/s41586-019-1922-8; Hennequin A, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1054598; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Hindley JP, 2012, CANCER RES, V72, P5473, DOI 10.1158/0008-5472.CAN-12-1912; Hiraoka N, 2015, BRIT J CANCER, V112, P1782, DOI 10.1038/bjc.2015.145; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hollern DP, 2019, CELL, V179, P1191, DOI 10.1016/j.cell.2019.10.028; Jansen CS, 2019, NATURE, V576, P465, DOI 10.1038/s41586-019-1836-5; Jezequel P, 2019, BREAST CANCER RES, V21, DOI 10.1186/s13058-019-1148-6; Johansson-Percival A, 2017, NAT IMMUNOL, V18, P1207, DOI 10.1038/ni.3836; Joshi NS, 2015, IMMUNITY, V43, P579, DOI 10.1016/j.immuni.2015.08.006; Junt T, 2008, NAT REV IMMUNOL, V8, P764, DOI 10.1038/nri2414; Keren L, 2018, CELL, V174, P1373, DOI 10.1016/j.cell.2018.08.039; Kim A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224430; Kroeger DR, 2016, CLIN CANCER RES, V22, P3005, DOI 10.1158/1078-0432.CCR-15-2762; Kurtulus S, 2019, IMMUNITY, V50, P181, DOI 10.1016/j.immuni.2018.11.014; Lee Y, 2006, IMMUNITY, V25, P499, DOI 10.1016/j.immuni.2006.06.016; Liu X, 2017, ONCOLOGIST, V22, P1316, DOI 10.1634/theoncologist.2017-0029; Lochner M, 2011, J EXP MED, V208, P125, DOI 10.1084/jem.20100052; Luther SA, 2000, IMMUNITY, V12, P471, DOI 10.1016/S1074-7613(00)80199-5; Luther SA, 2003, J EXP MED, V197, P1191, DOI 10.1084/jem.20021294; Luther SA, 2002, J IMMUNOL, V169, P424, DOI 10.4049/jimmunol.169.1.424; Lutz ER, 2014, CANCER IMMUNOL RES, V2, P616, DOI 10.1158/2326-6066.CIR-14-0027; Maldonado L, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007323; Manzo A, 2010, IMMUNOL REV, V233, P267, DOI 10.1111/j.0105-2896.2009.00861.x; Matsubara S, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0736-4; McMahon EJ, 2005, NAT MED, V11, P335, DOI 10.1038/nm1202; McMullen TPW, 2010, CLIN EXP IMMUNOL, V161, P81, DOI 10.1111/j.1365-2249.2010.04147.x; Mebius RE, 2003, NAT REV IMMUNOL, V3, P292, DOI 10.1038/nri1054; Messina JL, 2012, SCI REP-UK, V2, DOI 10.1038/srep00765; Miller BC, 2019, NAT IMMUNOL, V20, P326, DOI 10.1038/s41590-019-0312-6; Montfort A, 2017, CLIN CANCER RES, V23, P250, DOI 10.1158/1078-0432.CCR-16-0081; Morcrette G, 2019, ONCOIMMUNOLOGY, V8, DOI 10.1080/2162402X.2019.1583547; Mounzer RH, 2010, BLOOD, V116, P2173, DOI 10.1182/blood-2009-12-256065; Moyron-Quiroz JE, 2004, NAT MED, V10, P927, DOI 10.1038/nm1091; Moyron-Quiroz JE, 2006, IMMUNITY, V25, P643, DOI 10.1016/j.immuni.2006.08.022; Munoz-Erazo L, 2020, CELL MOL IMMUNOL, V17, P570, DOI 10.1038/s41423-020-0457-0; Neyt K, 2012, TRENDS IMMUNOL, V33, P297, DOI 10.1016/j.it.2012.04.006; Nielsen JS, 2012, ONCOIMMUNOLOGY, V1, P1623, DOI 10.4161/onci.21650; Nishikawa SI, 2003, IMMUNOL REV, V195, P72, DOI 10.1034/j.1600-065X.2003.00063.x; Nzula S, 2003, CANCER RES, V63, P3275; Okabe Y, 2014, CELL, V157, P832, DOI 10.1016/j.cell.2014.04.016; Oliveira G, 2021, NATURE, V596, P119, DOI 10.1038/s41586-021-03704-y; Pages F, 2018, LANCET, V391, P2128, DOI 10.1016/S0140-6736(18)30789-X; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Peske JD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8114; Peters A, 2011, IMMUNITY, V35, P986, DOI 10.1016/j.immuni.2011.10.015; Petitprez F, 2020, NATURE, V577, P556, DOI 10.1038/s41586-019-1906-8; Pfannstiel C, 2019, CANCER IMMUNOL RES, V7, P923, DOI 10.1158/2326-6066.CIR-18-0758; Posch F, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2017.1378844; Prabhakaran S, 2017, BREAST CANCER RES, V19, DOI 10.1186/s13058-017-0864-z; Randall TD, 2008, ANNU REV IMMUNOL, V26, P627, DOI 10.1146/annurev.immunol.26.021607.090257; Randall TD, 2010, ADV IMMUNOL, V107, P187, DOI [10.1016/S0065-2776(10)07002-1, 10.1016/B978-0-12-381300-8.00007-1]; Rangel-Moreno J, 2007, P NATL ACAD SCI USA, V104, P10577, DOI 10.1073/pnas.0700591104; Rangel-Moreno J, 2011, NAT IMMUNOL, V12, P639, DOI 10.1038/ni.2053; Rehal S, 2017, AM J PATHOL, V187, P798, DOI 10.1016/j.ajpath.2016.12.007; Remark R, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1255394; Remark R, 2013, CLIN CANCER RES, V19, P4079, DOI 10.1158/1078-0432.CCR-12-3847; Rodriguez AB, 2021, CELL REP, V36, DOI 10.1016/j.celrep.2021.109422; Rosenberg SA, 2015, SCIENCE, V348, P62, DOI 10.1126/science.aaa4967; Ruddle NH, 2014, J CLIN INVEST, V124, P953, DOI 10.1172/JCI71611; Salomonsson S, 2003, ARTHRITIS RHEUM-US, V48, P3187, DOI 10.1002/art.11311; Sanchez-Alonso S, 2020, J IMMUNOTHER CANCER, V8, DOI 10.1136/jitc-2020-001187; Sautes-Fridman C, 2019, NAT REV CANCER, V19, P307, DOI 10.1038/s41568-019-0144-6; Sautes-Fridman C, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00407; Savas P, 2018, NAT MED, V24, P986, DOI 10.1038/s41591-018-0078-7; Schlosser HA, 2019, ONCOIMMUNOLOGY, V8, DOI 10.1080/2162402X.2018.1512458; Schrama D, 2001, IMMUNITY, V14, P111, DOI 10.1016/S1074-7613(01)00094-2; Schrama D, 2008, CANCER IMMUNOL IMMUN, V57, P85, DOI 10.1007/s00262-007-0352-x; Shalapour S, 2015, NATURE, V521, P94, DOI 10.1038/nature14395; Sharonov GV, 2020, NAT REV IMMUNOL, V20, P294, DOI 10.1038/s41577-019-0257-x; Siddiqui I, 2019, IMMUNITY, V50, P195, DOI 10.1016/j.immuni.2018.12.021; Silina K, 2018, CANCER RES, V78, P1308, DOI 10.1158/0008-5472.CAN-17-1987; Silina K, 2014, CANCER IMMUNOL IMMUN, V63, P643, DOI 10.1007/s00262-014-1544-9; Sims GP, 2001, J IMMUNOL, V167, P1935, DOI 10.4049/jimmunol.167.4.1935; Solinas C, 2019, CANCER LETT, V450, P88, DOI 10.1016/j.canlet.2019.02.027; Stranford S, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00350; Thaunat O, 2010, J IMMUNOL, V185, P717, DOI 10.4049/jimmunol.0903589; Thommen DS, 2018, NAT MED, V24, P994, DOI 10.1038/s41591-018-0057-z; Topalian SL, 2012, CURR OPIN IMMUNOL, V24, P207, DOI 10.1016/j.coi.2011.12.009; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; van de Pavert SA, 2010, NAT REV IMMUNOL, V10, P664, DOI 10.1038/nri2832; van Dijk N, 2020, NAT MED, V26, DOI 10.1038/s41591-020-1085-z; Voabil P, 2021, NAT MED, V27, P1250, DOI 10.1038/s41591-021-01398-3; Willis SN, 2009, J IMMUNOL, V182, P3310, DOI 10.4049/jimmunol.0803424; Workel HH, 2019, CANCER IMMUNOL RES, V7, P784, DOI 10.1158/2326-6066.CIR-18-0517; Wu SZ, 2020, EMBO J, V39, DOI 10.15252/embj.2019104063; Yang MR, 2021, J IMMUNOTHER CANCER, V9, DOI 10.1136/jitc-2020-001136; Yoshida H, 2002, IMMUNITY, V17, P823, DOI 10.1016/S1074-7613(02)00479-X; Zhang Q, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2326; Zhu W, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2015.1051922	148	36	36	51	107	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 7	2022	375	6576					39	+	eabf9419	10.1126/science.abf9419	http://dx.doi.org/10.1126/science.abf9419			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YD3FW	34990248				2022-12-28	WOS:000740261400033
J	John, LN; Beiras, CG; Houinei, W; Medappa, M; Sabok, M; Kolmau, R; Jonathan, E; Maika, E; Wangi, JK; Pospisilova, P; Smajs, D; Ouchi, D; Galvan-Femenia, I; Beale, MA; Giacani, L; Clotet, B; Mooring, EQ; Marks, M; Vall-Mayans, M; Mitja, O				John, Lucy N.; Beiras, Camila G.; Houinei, Wendy; Medappa, Monica; Sabok, Maria; Kolmau, Reman; Jonathan, Eunice; Maika, Edward; Wangi, James K.; Pospisilova, Petra; Smajs, David; Ouchi, Dan; Galvan-Femenia, Ivan; Beale, Mathew A.; Giacani, Lorenzo; Clotet, Bonaventura; Mooring, Eric Q.; Marks, Michael; Vall-Mayans, Marti; Mitja, Oriol			Trial of Three Rounds of Mass Azithromycin Administration for Yaws Eradication	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SINGLE-DOSE AZITHROMYCIN; PAPUA-NEW-GUINEA; HAEMOPHILUS-DUCREYI; SKIN ULCERS; RESISTANCE; SELECTION; CHILDREN	BACKGROUND Treponema pallidum subspecies pertenue causes yaws. Strategies to better control, eliminate, and eradicate yaws are needed. METHODS In an open-label, cluster-randomized, community-based trial conducted in a yaws-endemic area of Papua New Guinea, we randomly assigned 38 wards (i.e., clusters) to receive one round of mass administration of azithromycin followed by two rounds of target treatment of active cases (control group) or three rounds of mass administration of azithromycin (experimental group); round 1 was administered at baseline, round 2 at 6 months, and round 3 at 12 months. The coprimary end points were the prevalence of active cases of yaws, confirmed by polymerase-chain-reaction assay, in the entire trial population and the prevalence of latent yaws, confirmed by serologic testing, in a subgroup of asymptomatic children 1 to 15 years of age; prevalences were measured at 18 months, and the between-group differences were calculated. RESULTS Of the 38 wards, 19 were randomly assigned to the control group (30,438 persons) and 19 to the experimental group (26,238 persons). A total of 24,848 doses of azithromycin were administered in the control group (22,033 were given to the participants at round 1 and 207 and 2608 were given to the participants with yaws-like lesions and their contacts, respectively, at rounds 2 and 3 (combined)), and 59,852 doses were administered in the experimental group. At 18 months, the prevalence of active yaws had decreased from 0.46% (102 of 22,033 persons) at baseline to 0.16% (47 of 29,954 persons) in the control group and from 0.43% (87 of 20,331 persons) at baseline to 0.04% (10 of 25,987 persons) in the experimental group (relative risk adjusted for clustering, 4.08; 95% confidence interval (CI), 1.90 to 8.76). The prevalence of other infectious ulcers decreased to a similar extent in the two treatment groups. The prevalence of latent yaws at 18 months was 6.54% (95% CI, 5.00 to 8.08) among 994 children in the control group and 3.28% (95% CI, 2.14 to 4.42) among 945 children in the experimental group (relative risk adjusted for clustering and age, 2.03; 95% CI, 1.12 to 3.70). Three cases of yaws with resistance to macrolides were found in the experimental group. CONCLUSIONS The reduction in the community prevalence of yaws was greater with three rounds of mass administration of azithromycin at 6-month intervals than with one round of mass administration of azithromycin followed by two rounds of targeted treatment. Monitoring for the emergence and spread of antimicrobial resistance is needed.	[John, Lucy N.; Houinei, Wendy] Aopi Ctr, Natl Dept Hlth, Port Moresby, Papua N Guinea; [John, Lucy N.; Mitja, Oriol] Univ Papua New Guinea, Sch Med & Hlth Sci, Port Moresby, Papua N Guinea; [Wangi, James K.] WHO, Representat Off Papua New Guinea, Port Moresby, Papua N Guinea; [Sabok, Maria; Jonathan, Eunice; Maika, Edward] New Ireland Prov Hlth Author, Kavieng, Papua N Guinea; [Kolmau, Reman; Mitja, Oriol] Int SOS, Lihir Med Ctr, Lihir Isl, Papua N Guinea; [John, Lucy N.; Beiras, Camila G.; Ouchi, Dan; Clotet, Bonaventura; Vall-Mayans, Marti; Mitja, Oriol] Hosp Badalona Germans Trias & Pujol, Infect Dis Dept, Badalona, Spain; [John, Lucy N.; Beiras, Camila G.; Ouchi, Dan; Clotet, Bonaventura; Vall-Mayans, Marti; Mitja, Oriol] Hosp Badalona Germans Trias & Pujol, Fight AIDS & Infect Dis Fdn, Badalona, Spain; [Galvan-Femenia, Ivan] Inst Hlth Sci Res Germans Trias & Pujol, Genomes Life Genomes Catalonia Lab Grp, Badalona, Spain; [Clotet, Bonaventura] IrsiCaixa AIDS Res Inst, Badalona, Spain; [John, Lucy N.] Univ Barcelona, Fac Med, Barcelona Inst Global Hlth, Barcelona, Spain; [Galvan-Femenia, Ivan] Barcelona Inst Sci & Technol, Inst Res Biomed, Barcelona, Spain; [Clotet, Bonaventura; Mitja, Oriol] Univ Vic Univ Cent Catalunya, Vic, Spain; [Medappa, Monica; Pospisilova, Petra; Smajs, David] Masaryk Univ, Fac Med, Dept Biol, Brno, Czech Republic; [Beale, Mathew A.] Wellcome Sanger Inst, Parasites & Microbes Programme, Hinxton, England; [Marks, Michael] London Sch Hyg & Trop Med, Clin Res Dept, London, England; [Marks, Michael] Univ Coll London Hosp, Hosp Trop Dis, London, England; [Giacani, Lorenzo] Univ Washington, Dept Med, Div Allergy & Infect Dis, Seattle, WA 98195 USA; [Giacani, Lorenzo] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Mooring, Eric Q.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA	University of Papua New Guinea; World Health Organization; Hospital Germans Trias i Pujol; Hospital Germans Trias i Pujol; Fundacio Institut d'Investigacio en Ciencies de la Salut Germans Trias i Pujol (IGTP); Institut de Recerca de la Sida - IrsiCaixa; ISGlobal; University of Barcelona; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Universitat de Vic - Universitat Central de Catalunya (UVic-UCC); Masaryk University Brno; Wellcome Trust Sanger Institute; University of London; London School of Hygiene & Tropical Medicine; University College London Hospitals NHS Foundation Trust; University of London; London School of Hygiene & Tropical Medicine; University College London; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Harvard University; Harvard T.H. Chan School of Public Health	John, LN (corresponding author), Natl Dept Hlth, Div Publ Hlth, POB 807, Waigani 131, NCD, Papua N Guinea.; Mitja, O (corresponding author), Hosp Germans Trias Pujol, Sexually Transmitted Infect & Skin Neglected Trop, Dept Infect Dis, Carretera Canyet SN, Badalona 08916, Spain.; Mitja, O (corresponding author), Hosp Germans Trias Pujol, Fight AIDS & Infect Dis Fdn, Carretera Canyet SN, Badalona 08916, Spain.	lucyninmongojohn@gmail.com; oriolmitja@hotmail.com	; Mitja, Oriol/W-4181-2018	Gonzalez-Beiras, Camila/0000-0001-6617-0748; Beale, Mathew/0000-0002-4740-3187; Mitja, Oriol/0000-0003-3266-8868; Galvan Femenia, Ivan/0000-0002-6124-3730; Ouchi, Dan/0000-0002-8630-152X; Medappa, Monica/0000-0002-7486-3058; Marks, Michael/0000-0002-7585-4743	Fundacio "la Caixa," Diputacio de Barcelona; Fundacio Barbera Solidaria; Wellcome [206194]; National Institute of Allergy and Infectious Diseases [T32 AI 007535]; European Research Council [850450]	Fundacio "la Caixa," Diputacio de Barcelona; Fundacio Barbera Solidaria; Wellcome; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); European Research Council(European Research Council (ERC)European Commission)	Supported by Fundacio "la Caixa," Diputacio de Barcelona, and Fundacio Barbera Solidaria. The Papua New Guinea National Department of Health provided logistic and personnel support and disseminated information to raise awareness in communities and among local stakeholders. Dr. Beale was supported by Wellcome funding to the Sanger Institute (grant 206194), Dr. Mooring by the National Institute of Allergy and Infectious Diseases (grant T32 AI 007535), and Dr. Mitja by the European Research Council under Grant Agreement number 850450 (European Union's Horizon 2020 Research and Innovation Program, ERC-2019-STG funding scheme).	Abdulai AA, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006303; Ayove T, 2014, LANCET GLOB HEALTH, V2, pE415, DOI 10.1016/S2214-109X(14)70231-1; Beale MA, 2020, LANCET MICROBE, V1, pE263, DOI 10.1016/S2666-5247(20)30113-0; Cui J, 2007, STATA J, V7, P209, DOI 10.1177/1536867X0700700205; Dyson L, 2018, AM J EPIDEMIOL, V187, P837, DOI 10.1093/aje/kwx305; Fitzpatrick C, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003165; G-Beiras C, 2021, DERMATOL CLIN, V39, P15, DOI 10.1016/j.det.2020.08.002; Godornes C, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006113; Gonzalez-Beiras C, 2017, CLIN INFECT DIS, V65, P2085, DOI 10.1093/cid/cix723; Griesenauer B, 2021, MBIO, V12, DOI 10.1128/mBio.03162-20; Grillova L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200773; Hetzel MW, 2018, PAPUA NEW GUINEA MAL; Holmes A, 2020, EMERG INFECT DIS, V26, P2685, DOI 10.3201/eid2611.191491; Lee K, 2009, GLOB INST, P1; Marks M, 2017, EMERG INFECT DIS, V23, P22, DOI 10.3201/eid2301.160487; Marks M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004927; Marks M, 2016, CLIN INFECT DIS, V63, P627, DOI 10.1093/cid/ciw348; Mitja O, 2018, LANCET, V391, P1599, DOI 10.1016/S0140-6736(18)30204-6; Mitja O, 2015, NEW ENGL J MED, V372, P703, DOI 10.1056/NEJMoa1408586; Mitja O, 2014, LANCET GLOB HEALTH, V2, pE235, DOI 10.1016/S2214-109X(14)70019-1; Mitja O, 2013, LANCET, V381, P763, DOI 10.1016/S0140-6736(12)62130-8; Mitja O, 2012, LANCET, V379, P342, DOI 10.1016/S0140-6736(11)61624-3; Newcombe RG, 1998, STAT MED, V17, P857, DOI 10.1002/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E; Ngono JPN, 2021, PLOS NEGLECT TROP D, V15, DOI 10.1371/journal.pntd.0009180; Orle KA, 1996, J CLIN MICROBIOL, V34, P49, DOI 10.1128/JCM.34.1.49-54.1996; Smajs D, 2018, LANCET, V391, P1555, DOI 10.1016/S0140-6736(18)30205-8; WHO, 2012, SUMM REP CONS ER YAW; WHO, 2018, CROP STORAGE RES; World Health Organization, 2018, REP GLOB M YAWS ER S	29	1	1	1	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 6	2022	386	1					47	56		10.1056/NEJMoa2109449	http://dx.doi.org/10.1056/NEJMoa2109449			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YC1QX	34986286	Green Published, Green Accepted			2022-12-28	WOS:000739473800010
J	Horton, R				Horton, Richard			Offline: The origin story-towards a final resolution?	LANCET			English	Editorial Material												richard.horton@lancet.com							0	1	1	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 1	2022	399	10319					11	11						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YA3YW	34973709	Green Published, Bronze			2022-12-28	WOS:000738273800007
J	Penuelas, J; Sardans, J				Penuelas, Josep; Sardans, Jordi			The global nitrogen-phosphorus imbalance	SCIENCE			English	Editorial Material							CNP STOICHIOMETRY; RATIOS	The imbalance has grave consequences for natural ecosystems and global food security	[Penuelas, Josep; Sardans, Jordi] Univ Autonoma Barcelona, Consejo Super Invest Cient CSIC, Global Ecol Unit CREAF CSC UAB, Barcelona 08193, Catalonia, Spain; [Penuelas, Josep; Sardans, Jordi] CREAF, Barcelona 08193, Spain	Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); University of Barcelona	Penuelas, J (corresponding author), Univ Autonoma Barcelona, Consejo Super Invest Cient CSIC, Global Ecol Unit CREAF CSC UAB, Barcelona 08193, Catalonia, Spain.; Penuelas, J (corresponding author), CREAF, Barcelona 08193, Spain.	josep.penuelas@uab.cat	Sardans, Jordi/AEM-0228-2022; Penuelas, Josep/D-9704-2011	Sardans, Jordi/0000-0003-2478-0219; Penuelas, Josep/0000-0002-7215-0150	Spanish Government [PID2019-110521GB-I00, PID2020115770RB-I]; Fundacion Ramon Areces; Catalan Government [SGR 2017-1005, AGAUR2020PANDE00117]; European Research Council [ERC-SyG-2013-610028]	Spanish Government(Spanish GovernmentEuropean Commission); Fundacion Ramon Areces; Catalan Government; European Research Council(European Research Council (ERC)European Commission)	Our research is supported by the Spanish Government (grants PID2019-110521GB-I00 and PID2020115770RB-I), Fundacion Ramon Areces (grant ELEMENTAL-CLIMATE), Catalan Government (grants SGR 2017-1005 and AGAUR2020PANDE00117), and European Research Council (Synergy grant ERC-SyG-2013-610028,IMBALANCE-P).	Ekins P., 2019, GLOB SUSTAIN, V2, pe20; Elser JJ, 2009, SCIENCE, V326, P835, DOI 10.1126/science.1176199; Fujita Y, 2014, NATURE, V505, P82, DOI 10.1038/nature12733; Obersteiner M, 2013, NAT GEOSCI, V6, P897, DOI 10.1038/ngeo1990; Paseka RE, 2019, FRONT ECOL EVOL, V7, DOI 10.3389/fevo.2019.00378; Penuelas J, 2020, GLOBAL CHANGE BIOL, V26, P1962, DOI 10.1111/gcb.14981; Penuelas J, 2019, ECOLOGY, V100, DOI 10.1002/ecy.2652; Razzaque MS, 2011, CLIN SCI, V120, P91, DOI 10.1042/CS20100377; Ren CJ, 2017, BIOL FERT SOILS, V53, P457, DOI 10.1007/s00374-017-1197-x; Smil V, 1999, NATURE, V400, P415, DOI 10.1038/22672; Steffen W, 2015, SCIENCE, V347, DOI 10.1126/science.1259855; Sterner W., 2003, ECOLOGICAL STOICHIOM; Tong YD, 2020, P NATL ACAD SCI USA, V117, P11566, DOI 10.1073/pnas.1920759117; Yue K, 2017, GLOBAL CHANGE BIOL, V23, P2450, DOI 10.1111/gcb.13569	14	19	19	94	212	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2022	375	6578					266	267		10.1126/science.abl4827	http://dx.doi.org/10.1126/science.abl4827			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YK2FS	35050668				2022-12-28	WOS:000745036100015
J	Makker, V; Colombo, N; Herraez, AC; Santin, A; Colomba, E; Miller, DS; Fujiwara, K; Pignata, S; Baron, H; Ray, OQAR; Shapira, RROE; Ushijima, K; Sakata, J; Yonemori, K; Kim, YM; Guerra, E; Sanli, A; McCormack, MM; Smith, A; Keefe, S; Bird, S; Dutta, L; Orlowski, R; Lorusso, D				Makker, V; Colombo, N.; Casado Herraez, A.; Santin, A. D.; Colomba, E.; Miller, D. S.; Fujiwara, K.; Pignata, S.; Baron-Hay, S.; Ray-Coquard, I; Shapira-Frommer, R.; Ushijima, K.; Sakata, J.; Yonemori, K.; Kim, Y. M.; Guerra, E. M.; Sanli, U. A.; McCormack, M. M.; Smith, A. D.; Keefe, S.; Bird, S.; Dutta, L.; Orlowski, R. J.; Lorusso, D.		Study 309 KEYNOTE-775 Investigator	Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PHASE-II; OPEN-LABEL; COMBINATION; MULTICENTER; CARCINOMA; EFFICACY; SAFETY; TRIAL; WOMEN	BACKGROUND Standard therapy for advanced endometrial cancer after failure of platinum-based chemotherapy remains unclear. METHODS In this phase 3 trial, we randomly assigned, in a 1:1 ratio, patients with advanced endometrial cancer who had previously received at least one platinum-based chemotherapy regimen to receive either lenvatinib (20 mg, administered orally once daily) plus pembrolizumab (200 mg, administered intravenously every 3 weeks) or chemotherapy of the treating physician's choice (doxorubicin at 60 mg per square meter of body-surface area, administered intravenously every 3 weeks, or paclitaxel at 80 mg per square meter, administered intravenously weekly [with a cycle of 3 weeks on and 1 week off]). The two primary end points were progression-free survival as assessed on blinded independent central review according to the Response Evaluation Criteria in Solid Tumors, version 1.1, and overall survival. The end points were evaluated in patients with mismatch repair-proficient (pMMR) disease and in all patients. Safety was also assessed. RESULTS A total of 827 patients (697 with pMMR disease and 130 with mismatch repair-deficient disease) were randomly assigned to receive lenvatinib plus pembrolizumab (411 patients) or chemotherapy (416 patients). The median progression-free survival was longer with lenvatinib plus pembrolizumab than with chemotherapy (pMMR population: 6.6 vs. 3.8 months; hazard ratio for progression or death, 0.60; 95% confidence interval [CI], 0.50 to 0.72; P<0.001; overall: 7.2 vs. 3.8 months; hazard ratio, 0.56; 95% CI, 0.47 to 0.66; P<0.001). The median overall survival was longer with lenvatinib plus pembrolizumab than with chemotherapy (pMMR population: 17.4 vs. 12.0 months; hazard ratio for death, 0.68; 95% CI, 0.56 to 0.84; P<0.001; overall: 18.3 vs. 11.4 months; hazard ratio, 0.62; 95% CI, 0.51 to 0.75; P<0.001). Adverse events of grade 3 or higher occurred in 88.9% of the patients who received lenvatinib plus pembrolizumab and in 72.7% of those who received chemotherapy. CONCLUSIONS Lenvatinib plus pembrolizumab led to significantly longer progression-free survival and overall survival than chemotherapy among patients with advanced endometrial cancer.	[Makker, V] Mem Sloan Kettering Canc Ctr, Dept Med, Weill Cornell Med Ctr, St 5, New York, NY 10065 USA; [Colombo, N.] Univ Milano Bicocca, European Inst Oncol IRCCS, Milan, Italy; [Pignata, S.] Ist Nazl Tumori IRCCS Fdn G Pascale, Naples, Italy; [Lorusso, D.] Fdn Policlin Univ Agostino Gemelli IRCCS, Rome, Italy; [Lorusso, D.] Univ Cattolica Sacro Cuore, Rome, Italy; [Casado Herraez, A.] San Carlos Univ Teaching Hosp, Madrid, Spain; [Guerra, E. M.] Hosp Univ Ramon y Cajal, Madrid, Spain; [Santin, A. D.] Yale Univ, Sch Med, New Haven, CT USA; [Colomba, E.] Gustave Roussy Cancerol Inst, Grp Investigateurs Nationaux Etud Canc Ovariens G, Villejuif, France; [Ray-Coquard, I] Univ Claude Bernard, Ctr Leon Berard, GLNECO, Lyon, France; [Miller, D. S.] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA; [Fujiwara, K.] Saitama Med Univ, Int Med Ctr, Hidaka, Japan; [Ushijima, K.] Kurume Univ, Sch Med, Kurume, Fukuoka, Japan; [Sakata, J.] Aichi Canc Ctr Hosp, Nagoya, Aichi, Japan; [Yonemori, K.] Natl Canc Ctr, Kokuritsu Gan Kenkyu Ctr Chuo Byoin, Tokyo, Japan; [Baron-Hay, S.] Royal North Shore Hosp, St Leonards, NSW, Australia; [Shapira-Frommer, R.] Sheba Med Ctr, Ramat Gan, Israel; [Kim, Y. M.] Univ Ulsan, Asan Med Ctr, Seoul, South Korea; [Sanli, U. A.] Ege Univ, Izmir, Turkey; [McCormack, M. M.] Univ Coll London Hosp NHS Fdn Trust, London, England; [Smith, A. D.] Eisai, Hatfield, Herts, England; [Keefe, S.; Bird, S.; Orlowski, R. J.] Merck, Kenilworth, NJ USA; [Dutta, L.] Eisai, Woodcliff Lake, NJ USA	Cornell University; Memorial Sloan Kettering Cancer Center; IRCCS European Institute of Oncology (IEO); University of Milano-Bicocca; IRCCS Fondazione Pascale; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Hospital Universitario Ramon y Cajal; Yale University; UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UNICANCER; Centre Leon Berard; University of Texas System; University of Texas Southwestern Medical Center Dallas; Saitama Medical University; Kurume University; Aichi Cancer Center; National Cancer Center - Japan; Royal North Shore Hospital; Chaim Sheba Medical Center; University of Ulsan; Ege University; University College London Hospitals NHS Foundation Trust; University of London; University College London; Eisai Co Ltd; Merck & Company; Eisai Co Ltd	Makker, V (corresponding author), Mem Sloan Kettering Canc Ctr, 300 E 66th St, New York, NY 10065 USA.	makkerv@mskcc.org	Miller, David Scott/H-4604-2011; de Melo, Andreia/C-8133-2019; Tarnawski, Rafal/N-7526-2016; Altundag, Ozden/W-9219-2019	Miller, David Scott/0000-0002-8215-5887; de Melo, Andreia/0000-0002-1201-4333; Tarnawski, Rafal/0000-0001-6802-5093; Altundag, Ozden/0000-0003-0197-6622	Eisai; Merck Sharp and Dohme	Eisai(Eisai Co Ltd); Merck Sharp and Dohme(Merck & Company)	Supported by Eisai and Merck Sharp and Dohme, a subsidiary of Merck.	[Anonymous], 2021, KEYTRUDA PEMBROLIZUM; [Anonymous], 2020, LENVIMA LENVATINIB P; Bonneville R, 2017, JCO PRECIS ONCOL, V1, DOI 10.1200/PO.17.00073; Brooks RA, 2019, CA-CANCER J CLIN, V69, P258, DOI 10.3322/caac.21561; Brose MS, 2020, ANN ONCOL, V31, pS1409, DOI 10.1016/j.annonc.2020.10.418; Concin N, 2021, INT J GYNECOL CANCER, V31, P12, DOI 10.1136/ijgc-2020-002230; Emons G, 2016, GYNECOL ONCOL, V140, P450, DOI 10.1016/j.ygyno.2015.12.025; Heudel PE, 2017, BRIT J CANCER, V116, P303, DOI 10.1038/bjc.2016.430; How Jeffrey A, 2021, Gynecol Oncol, V162, P24, DOI 10.1016/j.ygyno.2021.04.034; Howlader NR, 2020, BREAST CANCER RES TR, V182, P739, DOI 10.1007/s10549-020-05738-8; Konecny GE, 2015, LANCET ONCOL, V16, P686, DOI 10.1016/S1470-2045(15)70159-2; Lorenzi M, 2020, J ONCOL, V2020, DOI 10.1155/2020/1807929; Lortet-Tieulent J, 2018, JNCI-J NATL CANCER I, V110, P354, DOI 10.1093/jnci/djx214; Makker V, 2020, J CLIN ONCOL, V38, DOI 10.1200/JCO.19.02627; Marabelle A, 2020, J CLIN ONCOL, V38, P1, DOI 10.1200/JCO.19.02105; McMeekin S, 2015, GYNECOL ONCOL, V138, P18, DOI 10.1016/j.ygyno.2015.04.026; Miller DS, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2018.36.15_suppl.5503; Motzer RJ, 2015, LANCET ONCOL, V16, P1473, DOI 10.1016/S1470-2045(15)00290-9; National Comprehensive Cancer Network, CLIN PRACTICE GUIDEL; O'Malley D, 2019, ANN ONCOL, V30; Ott PA, 2017, J CLIN ONCOL, V35, P2535, DOI 10.1200/JCO.2017.72.5952; Oza AM, 2015, J CLIN ONCOL, V33, P3576, DOI 10.1200/JCO.2014.58.8871; Pal SK., 2020, INT KIDN CANC S IKCS, V18, P34; Pautier P, 2017, INT J GYNECOL CANCER, V27, P258, DOI 10.1097/IGC.0000000000000862; Prendergast EN, 2019, GYNECOL ONCOL, V154, P461, DOI 10.1016/j.ygyno.2019.06.016; Rahib L, 2014, CANCER RES, V74, P2913, DOI 10.1158/0008-5472.CAN-14-0155; Robert C, 2015, NEW ENGL J MED, V372, P2521, DOI 10.1056/NEJMoa1503093; Schlumberger M, 2015, NEW ENGL J MED, V372, P621, DOI 10.1056/NEJMoa1406470; Soumerai TE, 2018, CLIN CANCER RES, V24, P5939, DOI 10.1158/1078-0432.CCR-18-0412; Sung H, 2021, CA-CANCER J CLIN, V71, P209, DOI 10.3322/caac.21660; Taylor M, 2016, ANN ONCOL, V27, DOI 10.1093/annonc/mdw373.4; Vale CL, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003915.pub4; Vergote I TM, 2013, J CLIN ONCOL S, V31, P5520, DOI DOI 10.1200/jco.2013.31.15_suppl.5520; Vergote I, 2020, GYNECOL ONCOL, V156, P575, DOI 10.1016/j.ygyno.2019.12.039; Zhang S, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.01440	35	78	78	14	32	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 3	2022	386	5					437	448		10.1056/NEJMoa2108330	http://dx.doi.org/10.1056/NEJMoa2108330		JAN 2022	12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YR1JU	35045221				2022-12-28	WOS:000744900700001
J	Greene, SJ; Fonarow, GC; Butler, J				Greene, Stephen J.; Fonarow, Gregg C.; Butler, Javed			Inpatient Notes: Clinical Pearls-Stopping, Starting, and Optimizing Guideline-Directed Medical Therapy in Patients Hospitalized for Heart Failure With Reduced Ejection Fraction	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Greene, Stephen J.] Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC USA; [Greene, Stephen J.] Duke Univ, Sch Med, Div Cardiol, Durham, NC USA; [Fonarow, Gregg C.] Ronald Reagan UCLA Med Ctr, Dept Med, Div Cardiol, Los Angeles, CA USA; [Butler, Javed] Univ Mississippi, Dept Med, Med Ctr, L650,2500 North State St, Jackson, MS 39216 USA	Duke University; Duke University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Ronald Reagan UCLA Medical Center; University of Mississippi; University of Mississippi Medical Center	Butler, J (corresponding author), Univ Mississippi, Dept Med, Med Ctr, L650,2500 North State St, Jackson, MS 39216 USA.	jbutler4@umc.edu	Fonarow, Gregg/D-5988-2014	Fonarow, Gregg/0000-0002-3192-8093				Bassi NS, 2020, JAMA CARDIOL, V5, P948, DOI 10.1001/jamacardio.2020.0898; Greene SJ, 2021, JAMA CARDIOL, V6, P743, DOI 10.1001/jamacardio.2021.0496; Greene SJ, 2021, J AM COLL CARDIOL, V77, P1023, DOI 10.1016/j.jacc.2020.12.026; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Vaduganathan M, 2020, LANCET, V396, P121, DOI 10.1016/S0140-6736(20)30748-0	5	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN	2022	175	1					HO2	HO3		10.7326/M21-4558	http://dx.doi.org/10.7326/M21-4558		JAN 2022	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0Y3LO	35038400				2022-12-28	WOS:000745538700001
J	Salisbury, H				Salisbury, Helen			Helen Salisbury: Health, poverty, and stigma	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												helen.salisbury@phc.ox.ac.uk						Marmot M, 2018, HLTH INEQUALITIES ME; Moscrop A, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4150	2	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 18	2022	376								o116	10.1136/bmj.o116	http://dx.doi.org/10.1136/bmj.o116			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YP6OA	35042726	Bronze			2022-12-28	WOS:000748741800003
J	Zettler, PJ; Sarpatwari, A				Zettler, Patricia J.; Sarpatwari, Ameet			State Restrictions on Mifepristone Access - The Case for Federal Preemption	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Zettler, Patricia J.] Ohio State Univ, Drug Enforcement & Policy Ctr, Moritz Coll Law, Columbus, OH 43210 USA; [Zettler, Patricia J.] Ohio State Univ, James Comprehens Canc Ctr, Columbus, OH 43210 USA; [Sarpatwari, Ameet] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Program Regulat Therapeut & Law,Div Pharmacoepide, Boston, MA 02115 USA; [Sarpatwari, Ameet] Harvard Med Sch, Boston, MA 02115 USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Zettler, PJ (corresponding author), Ohio State Univ, Drug Enforcement & Policy Ctr, Moritz Coll Law, Columbus, OH 43210 USA.; Zettler, PJ (corresponding author), Ohio State Univ, James Comprehens Canc Ctr, Columbus, OH 43210 USA.							[Anonymous], GENBIOPRO DOBBS; Brown BL, 2021, ANN INTERN MED, V174, P105, DOI 10.7326/M20-6671; Kaiser Family Foundation, 2021, AV US MED AB; Raymond EG, 2017, NEW ENGL J MED, V376, P790, DOI 10.1056/NEJMsb1612526; Zettler PJ, 2017, INDIANA LAW J, V92, P845	5	4	4	1	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 24	2022	386	8					705	707		10.1056/NEJMp2118696	http://dx.doi.org/10.1056/NEJMp2118696		JAN 2022	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ZF7PI	35020981	Bronze			2022-12-28	WOS:000741665700001
J	Condylis, C; Ghanbari, A; Manjrekar, N; Bistrong, K; Yao, SQ; Yao, ZZ; Nguyen, TN; Zeng, HK; Tasic, B; Chen, JL				Condylis, Cameron; Ghanbari, Abed; Manjrekar, Nikita; Bistrong, Karina; Yao, Shenqin; Yao, Zizhen; Nguyen, Thuc Nghi; Zeng, Hongkui; Tasic, Bosiljka; Chen, Jerry L.			Dense functional and molecular readout of a circuit hub in sensory cortex	SCIENCE			English	Article							TRANSCRIPTOMIC CELL-TYPES; GABAERGIC NEURONS; MOUSE; POPULATION; ARCHITECTURE; INTEGRATION; TAXONOMY; DRIVER; VIRUS; LINES	Although single-cell transcriptomics of the neocortex has uncovered more than 300 putative cell types, whether this molecular classification predicts distinct functional roles is unclear. We combined two-photon calcium imaging with spatial transcriptomics to functionally and molecularly investigate cortical circuits. We characterized behavior-related responses across major neuronal subclasses in layers 2 or 3 of the primary somatosensory cortex as mice performed a tactile working memory task. We identified an excitatory intratelencephalic cell type, Baz1a, that exhibits high tactile feature selectivity. Baz1a neurons homeostatically maintain stimulus responsiveness during altered experience and show persistent enrichment of subsets of immediately early genes. Functional and anatomical connectivity reveals that Baz1a neurons residing in upper portions of layers 2 or 3 preferentially innervate somatostatin-expressing inhibitory neurons. This motif defines a circuit hub that orchestrates local sensory processing in superficial layers of the neocortex.	[Condylis, Cameron; Chen, Jerry L.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Condylis, Cameron; Chen, Jerry L.] Boston Univ, Ctr Neurophoton, Boston, MA 02215 USA; [Ghanbari, Abed; Manjrekar, Nikita; Bistrong, Karina; Chen, Jerry L.] Boston Univ, Dept Biol, Boston, MA 02215 USA; [Yao, Shenqin; Yao, Zizhen; Nguyen, Thuc Nghi; Zeng, Hongkui; Tasic, Bosiljka] Allen Inst Brain Sci, Seattle, WA 98109 USA; [Chen, Jerry L.] Boston Univ, Ctr Syst Neurosci, Boston, MA 02215 USA	Boston University; Boston University; Boston University; Allen Institute for Brain Science; Boston University	Chen, JL (corresponding author), Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.; Chen, JL (corresponding author), Boston Univ, Ctr Neurophoton, Boston, MA 02215 USA.; Chen, JL (corresponding author), Boston Univ, Dept Biol, Boston, MA 02215 USA.; Chen, JL (corresponding author), Boston Univ, Ctr Syst Neurosci, Boston, MA 02215 USA.	jerry@chen-lab.org		Manjrekar, Nikita/0000-0002-4323-0135; Condylis, Cameron/0000-0003-3036-369X; Tasic, Bosiljka/0000-0002-6861-4506; Bistrong, Karina/0000-0003-0972-3339; Yao, Zizhen/0000-0002-9361-5607; Zeng, Hongkui/0000-0002-0326-5878	NARSAD Young Investigator Grant from the Brain & Behavior Research Foundation; Richard and Susan Smith Family Foundation; Elizabeth and Stuart Pratt Career Development Award; Whitehall Foundation; Harvard NeuroDiscovery Center, National Institutes of Health BRAIN Initiative Award [R01NS109965, U19MH114830]; National Institutes of Health New Innovator Award [DP2NS111134]; National Institutes of Health Ruth L. Kirschstein Predoctoral Individual National Research Service Award [F31NS111896]	NARSAD Young Investigator Grant from the Brain & Behavior Research Foundation(NARSAD); Richard and Susan Smith Family Foundation; Elizabeth and Stuart Pratt Career Development Award; Whitehall Foundation; Harvard NeuroDiscovery Center, National Institutes of Health BRAIN Initiative Award; National Institutes of Health New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Ruth L. Kirschstein Predoctoral Individual National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a NARSAD Young Investigator Grant from the Brain & Behavior Research Foundation, the Richard and Susan Smith Family Foundation, an Elizabeth and Stuart Pratt Career Development Award, the Whitehall Foundation, Harvard NeuroDiscovery Center, National Institutes of Health BRAIN Initiative Award (R01NS109965 to J.L.C. and U19MH114830 to H.Z.), National Institutes of Health New Innovator Award (DP2NS111134), and National Institutes of Health Ruth L. Kirschstein Predoctoral Individual National Research Service Award (F31NS111896) to C.C.	Abs E, 2018, NEURON, V100, P684, DOI 10.1016/j.neuron.2018.09.001; Aponte Y, 2008, J PHYSIOL-LONDON, V586, P2061, DOI 10.1113/jphysiol.2007.147298; Arganda-Carreras I, 2017, BIOINFORMATICS, V33, P2424, DOI 10.1093/bioinformatics/btx180; Axelrod S., 2021, J OPEN SOURCE SOFTW, V6, P2440; Barth AL, 2004, J NEUROSCI, V24, P6466, DOI 10.1523/JNEUROSCI.4737-03.2004; Bria A, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-316; Chan KY, 2017, NAT NEUROSCI, V20, P1172, DOI 10.1038/nn.4593; Chen JL, 2016, ELIFE, V5, DOI 10.7554/eLife.14679; Chen KH, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6090; Choi HMT, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.165753; Clack NG, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002591; Cohen MR, 2011, NAT NEUROSCI, V14, P811, DOI 10.1038/nn.2842; Condylis C., 2021, G NODE, DOI [10.12751/g-node.7q0lz0, DOI 10.12751/G-NODE.7Q0LZ0]; Condylis C, 2020, NEURON, V106, P515, DOI 10.1016/j.neuron.2020.02.004; Daigle TL, 2018, CELL, V174, P465, DOI 10.1016/j.cell.2018.06.035; Diamond ME, 2008, NAT REV NEUROSCI, V9, P601, DOI 10.1038/nrn2411; Doron G, 2020, SCIENCE, V370, P1435, DOI 10.1126/science.aaz3136; Dudai A, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000613; Friedrich J, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005423; Gainey MA, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0157; Gerashchenko D, 2008, P NATL ACAD SCI USA, V105, P10227, DOI 10.1073/pnas.0803125105; Greig LC, 2013, NAT REV NEUROSCI, V14, P755, DOI 10.1038/nrn3586; Guizar-Sicairos M, 2008, OPT LETT, V33, P156, DOI 10.1364/OL.33.000156; Harris KD, 2015, NAT NEUROSCI, V18, P170, DOI 10.1038/nn.3917; He M, 2016, NEURON, V91, P1228, DOI 10.1016/j.neuron.2016.08.021; Hill DN, 2011, NEURON, V72, P344, DOI 10.1016/j.neuron.2011.09.020; Hioki H, 2018, BRAIN RES, V1695, P18, DOI 10.1016/j.brainres.2018.05.029; Jouhanneau JS, 2014, NEURON, V84, P1065, DOI 10.1016/j.neuron.2014.10.014; Kepecs A, 2014, NATURE, V505, P318, DOI 10.1038/nature12983; Khan AG, 2018, NAT NEUROSCI, V21, P851, DOI 10.1038/s41593-018-0143-z; Klingler E, 2019, CURR BIOL, V29, P332, DOI 10.1016/j.cub.2018.11.071; Kwan AC, 2012, CURR BIOL, V22, P1459, DOI 10.1016/j.cub.2012.06.007; Lee S, 2013, NAT NEUROSCI, V16, P1662, DOI 10.1038/nn.3544; Lim L, 2018, NEURON, V100, P294, DOI 10.1016/j.neuron.2018.10.009; Loebrich S, 2009, PHYSIOL REV, V89, P1079, DOI 10.1152/physrev.00013.2009; Lou XH, 2014, STEM CELL REP, V2, P382, DOI 10.1016/j.stemcr.2014.01.010; Lubeck E, 2014, NAT METHODS, V11, P360, DOI 10.1038/nmeth.2892; Magnusson K. E. G, 2016, THESIS KTH ROYAL I T; Margolis DJ, 2012, NAT NEUROSCI, V15, P1539, DOI 10.1038/nn.3240; Minderer M, 2019, NEURON, V102, P232, DOI 10.1016/j.neuron.2019.01.029; Nathanson JL, 2009, NEUROSCIENCE, V161, P441, DOI 10.1016/j.neuroscience.2009.03.032; Nicovich P. R., 2019, MULTIMODAL CELL TYPE, DOI [10.1101/525451, DOI 10.1101/525451]; Ohkura M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039933; Park IM, 2014, NAT NEUROSCI, V17, P1395, DOI 10.1038/nn.3800; Paul A, 2017, CELL, V171, P522, DOI 10.1016/j.cell.2017.08.032; Pillow JW, 2008, NATURE, V454, P995, DOI 10.1038/nature07140; Pnevmatikakis EA, 2016, NEURON, V89, P285, DOI 10.1016/j.neuron.2015.11.037; Pronneke A, 2015, CEREB CORTEX, V25, P4854, DOI 10.1093/cercor/bhv202; Reardon TR, 2016, NEURON, V89, P711, DOI 10.1016/j.neuron.2016.01.004; Runyan CA, 2017, NATURE, V548, P92, DOI 10.1038/nature23020; Rupprecht P., 2020, BIORXIV, DOI [10.1101/2020.08.31.272450, DOI 10.1101/2020.08.31.272450]; Shah S, 2016, DEVELOPMENT, V143, P2862, DOI 10.1242/dev.138560; Sorensen SA, 2015, CEREB CORTEX, V25, P433, DOI 10.1093/cercor/bht243; Spruston N, 2008, NAT REV NEUROSCI, V9, P206, DOI 10.1038/nrn2286; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Tasic B, 2018, NATURE, V563, P72, DOI 10.1038/s41586-018-0654-5; Tasic B, 2016, NAT NEUROSCI, V19, P335, DOI 10.1038/nn.4216; Tomioka R, 2005, EUR J NEUROSCI, V21, P1587, DOI 10.1111/j.1460-9568.2005.03989.x; Tremblay R, 2016, NEURON, V91, P260, DOI 10.1016/j.neuron.2016.06.033; Treweek JB, 2015, NAT PROTOC, V10, P1860, DOI 10.1038/nprot.2015.122; Wang X., 2018, SCIENCE, V361, pAAT5691, DOI [DOI 10.1126/science.aat5691, 10.1126/science.aat5691]; Wang Y, 2004, J PHYSIOL-LONDON, V561, P65, DOI 10.1113/jphysiol.2004.073353; Williams LE, 2019, NEURON, V101, P91, DOI 10.1016/j.neuron.2018.10.049; Xu NL, 2012, NATURE, V492, P247, DOI 10.1038/nature11601; Yao ZZ, 2021, CELL, V184, P3222, DOI 10.1016/j.cell.2021.04.021; Yap EL, 2018, NEURON, V100, P330, DOI 10.1016/j.neuron.2018.10.013; Yassin L, 2010, NEURON, V68, P1043, DOI 10.1016/j.neuron.2010.11.029; Yu JN, 2019, NEURON, V104, P412, DOI 10.1016/j.neuron.2019.07.027; Zeisel A, 2018, CELL, V174, P999, DOI 10.1016/j.cell.2018.06.021	69	4	4	2	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 7	2022	375	6576					41	+	eabl5981	10.1126/science.abl5981	http://dx.doi.org/10.1126/science.abl5981			54	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YD3FW	34990233	Green Accepted, Green Submitted			2022-12-28	WOS:000740261400035
J	Chebly, KO				Chebly, Katherine Otto			Centring equity over exceptionalism in the global covid-19 response	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Chebly, Katherine Otto] NYU, Div Gen Internal Med & Clin Innovat, Langone Med Ctr, New York, NY 10003 USA	New York University; NYU Langone Medical Center	Chebly, KO (corresponding author), NYU, Div Gen Internal Med & Clin Innovat, Langone Med Ctr, New York, NY 10003 USA.	Katherine.otto@nyulangone.org						Adhikari S, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.16938; [Anonymous], 2021, COVAX VACCINE ROLL O; Lau J, 2020, HEALTH AFFAIR, V39, P1437, DOI 10.1377/hlthaff.2020.00903; Uppal A, 2020, HEALTH AFFAIR, V39, P1443, DOI 10.1377/hlthaff.2020.00901	4	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 6	2022	376								o20	10.1136/bmj.o20	http://dx.doi.org/10.1136/bmj.o20			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YG5VA	34992066	Bronze			2022-12-28	WOS:000742554700002
J	Liston, C; Roberts, A; Dzirasa, K; Geschwind, D; Ahmari, SE; Luscher, C				Liston, Conor; Roberts, Angela; Dzirasa, Kafui; Geschwind, Dan; Ahmari, Susanne E.; Luscher, Christian			Understanding the biological basis of psychiatric disease: What's next	CELL			English	Editorial Material								Psychiatric disease is one of the greatest health challenges of our time. The pipeline for conceptually novel therapeutics remains low, in part because uncovering the biological mechanisms of psychiatric disease has been difficult. We asked experts researching different aspects of psychiatric disease: what do you see as the major urgent questions that need to be addressed? Where are the next frontiers, and what are the current hurdles to understanding the biological basis of psychiatric disease?	[Liston, Conor] Weill Cornell Med, New York, NY 10065 USA; [Roberts, Angela] Univ Cambridge, Cambridge, England; [Dzirasa, Kafui] Howard Hughes Med Inst, Chevy Chase, MD USA; [Dzirasa, Kafui] Duke Univ, Dept Psychiat & Behav Sci, Med Ctr, Durham, NC 27706 USA; [Dzirasa, Kafui] Duke Univ, Dept Neurobiol, Med Ctr, Durham, NC 27706 USA; [Dzirasa, Kafui] Duke Univ, Dept Neurosurg, Med Ctr, Durham, NC 27706 USA; [Dzirasa, Kafui] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; [Geschwind, Dan] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Ahmari, Susanne E.] Wellcome Leap, Multichannel Psych, Los Angeles, CA USA; [Ahmari, Susanne E.] Univ Pittsburgh, Pittsburgh, PA 15260 USA; [Luscher, Christian] Univ Geneva, Dept Basic Neurosci, Geneva, Switzerland; [Luscher, Christian] Geneva Univ Hosp, Dept Clin Neurosci, Geneva, Switzerland	Cornell University; University of Cambridge; Howard Hughes Medical Institute; Duke University; Duke University; Duke University; Duke University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Geneva; University of Geneva	Liston, C (corresponding author), Weill Cornell Med, New York, NY 10065 USA.		, Conor Liston/GQH-8931-2022; Dzirasa, Kafui/GQB-1424-2022						0	1	1	2	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 6	2022	185	1					1	3						3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology	YL5FO	34995512				2022-12-28	WOS:000745916700001
J	Christie, B				Christie, Bryan			Covid-19: Fact check-how many patients in hospital are unvaccinated?	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2021, REUTERS 1229; Centers for Disease Control and Prevention, COV DAT TRACK; Office for National Statistics,, 2021, DEATHS INV COVID 19; UK Health Security Agency,, 2021, SARS COV 2 VAR INV E; UK Health Security Agency,, 2021, OM DAIL OV 31 DEC 20; Weaver M., 2021, GUARDIAN 1222	6	1	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 4	2022	376								o5	10.1136/bmj.o5	http://dx.doi.org/10.1136/bmj.o5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YD7MV	34983804	Bronze			2022-12-28	WOS:000740622800006
J	Maslo, C; Friedland, R; Toubkin, M; Laubscher, A; Akaloo, T; Kama, B				Maslo, Caroline; Friedland, Richard; Toubkin, Mande; Laubscher, Anchen; Akaloo, Teshlin; Kama, Boniswa			Characteristics and Outcomes of Hospitalized Patients in South Africa During the COVID-19 Omicron Wave Compared With Previous Waves	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Maslo, Caroline; Friedland, Richard; Toubkin, Mande; Laubscher, Anchen; Akaloo, Teshlin; Kama, Boniswa] Netcare Ltd South Africa, Johannesburg, South Africa		Maslo, C (corresponding author), Netcare, 76 Maude St, ZA-2196 Johannesburg, South Africa.	caroline.maslo@netcare.co.za						[Anonymous], NEW COVID 19 VARIANT; [Anonymous], LATEST VACCINE STAT; Kleynhans J, 2021, EMERG INFECT DIS, V27, P3020, DOI 10.3201/eid2712.211465; Network for Genomic Surveillance in South Africa (NGS-SA), 2021, SARS COV 2 SEQ UPD	4	144	150	6	26	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 8	2022	327	6					583	584		10.1001/jama.2021.24868	http://dx.doi.org/10.1001/jama.2021.24868		DEC 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZD5RT	34967859	Green Published, Bronze			2022-12-28	WOS:000737837900001
J	Smith, L; Mohan, R				Smith, Lade; Mohan, Rajesh			If the government is serious about tackling inequalities, the Health and Care Bill must get serious about data	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		NHS England, 2020, IMPR 2020 ADV MENT H; Royal College of Psychiatrists, EQ ACT PLAN	2	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 5	2020	376								o12	10.1136/bmj.o12	http://dx.doi.org/10.1136/bmj.o12			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	VK7CI	34987030	Bronze			2022-12-28	WOS:000744126300001
J	Zhou, HX; Holleis, L; Saito, Y; Cohen, L; Huynh, W; Patterson, CL; Yang, FY; Taniguchi, T; Watanabe, K; Young, AF				Zhou, Haoxin; Holleis, Ludwig; Saito, Yu; Cohen, Liam; Huynh, William; Patterson, Caitlin L.; Yang, Fangyuan; Taniguchi, Takashi; Watanabe, Kenji; Young, Andrea F.			Isospin magnetism and spin-polarized superconductivity in Bernal bilayer graphene	SCIENCE			English	Article							ELECTRIC-FIELD; SYMMETRY; LIMIT	In conventional superconductors, Cooper pairing occurs between electrons of opposite spin. We observe spin-polarized superconductivity in Bernal bilayer graphene when doped to a saddle-point van Hove singularity generated by a large applied perpendicular electric field. We observe a cascade of electrostatic gate-tuned transitions between electronic phases distinguished by their polarization within the isospin space defined by the combination of the spin and momentum-space valley degrees of freedom. Although all of these phases are metallic at zero magnetic field, we observe a transition to a superconducting state at finite magnetic field B-parallel to approximate to 150 milliteslas applied parallel to the two-dimensional sheet. Superconductivity occurs near a symmetry-breaking transition and exists exclusively above the B-parallel to limit expected of a paramagnetic superconductor with the observed transition critical temperature T-C approximate to 30 millikelvins, consistent with a spin-triplet order parameter.	[Zhou, Haoxin; Holleis, Ludwig; Saito, Yu; Cohen, Liam; Huynh, William; Patterson, Caitlin L.; Yang, Fangyuan; Young, Andrea F.] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; [Taniguchi, Takashi] Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton, 1-1 Namiki, Tsukuba, Ibaraki 3050044, Japan; [Watanabe, Kenji] Natl Inst Mat Sci, Res Ctr Funct Mat, 1-1 Namiki, Tsukuba, Ibaraki 3050044, Japan; [Zhou, Haoxin] CALTECH, Dept Appl Phys & Mat Sci, Pasadena, CA 91125 USA	University of California System; University of California Santa Barbara; National Institute for Materials Science; National Institute for Materials Science; California Institute of Technology	Young, AF (corresponding author), Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA.	andrea@physics.ucsb.edu	Zhou, Haoxin/GQB-0513-2022; Watanabe, Kenji/H-2825-2011	Zhou, Haoxin/0000-0003-1235-0035; Cohen, Liam/0000-0002-7257-4105; Holleis, Ludwig/0000-0001-9718-2477; Saito, Yu/0000-0001-6155-5278; Watanabe, Kenji/0000-0003-3701-8119	Department of Energy [DE-SC0020043]; Army Research Office [W911NF-17-10323]; Gordon and Betty Moore Foundation [GBMF9471]; Packard Foundation [2016-65145]; Elemental Strategy Initiative by the MEXT, Japan [JPMXP0112101001]; JSPS KAKENHI [19H05790, 20H00354, 21H05233]	Department of Energy(United States Department of Energy (DOE)); Army Research Office; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Packard Foundation(The David & Lucile Packard Foundation); Elemental Strategy Initiative by the MEXT, Japan; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This project was primarily funded by the Department of Energy under DE-SC0020043. Support to purchase the cryogen-free dilution refrigerator was provided by the Army Research Office under award W911NF-17-10323. A.F.Y. acknowledges the support of the Gordon and Betty Moore Foundation under award GBMF9471 and the Packard Foundation under award 2016-65145 for general group activities. K.W. and T.T. acknowledge support from the Elemental Strategy Initiative conducted by the MEXT, Japan (grant no. JPMXP0112101001), and JSPS KAKENHI (grant nos. 19H05790, 20H00354, and 21H05233).	Abrikosov A. A., 1960, ZH EKSPTL TEORET FIZ, V39; ANDERSON PW, 1959, J PHYS CHEM SOLIDS, V11, P26, DOI 10.1016/0022-3697(59)90036-8; Avetissian HK, 2021, PHYS REV B, V104, DOI 10.1103/PhysRevB.104.125436; Balents L, 2020, NAT PHYS, V16, P725, DOI 10.1038/s41567-020-0906-9; Cao Y, 2021, NATURE, V595, P526, DOI 10.1038/s41586-021-03685-y; Cao Y, 2018, NATURE, V556, P43, DOI 10.1038/nature26160; Castro EV, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.186803; Cea T., ARXIV210904345CONDMA; Cea T., 2021, ARXIV210904345CONDMA; Chatterjee S., 2021, ARXIV210900002CONDMA; Dong Z., 2021, ARXIV210901133CONDMA; Ghazaryan Areg, 2021, Phys Rev Lett, V127, P247001, DOI 10.1103/PhysRevLett.127.247001; Hao ZY, 2021, SCIENCE, V371, P1133, DOI 10.1126/science.abg0399; Island JO, 2019, NATURE, V571, P85, DOI 10.1038/s41586-019-1304-2; Kuemmeth F., 2015, U.S. patent, Patent No. [US20150060190 A1, 20150060190]; Levy F, 2005, SCIENCE, V309, P1343, DOI 10.1126/science.1115498; Li HY, 2018, NANO LETT, V18, P8011, DOI 10.1021/acs.nanolett.8b04166; Lu JM, 2015, SCIENCE, V350, P1353, DOI 10.1126/science.aab2277; Min H, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.165310; Novoselov KS, 2006, NAT PHYS, V2, P177, DOI 10.1038/nphys245; Park JM, 2021, NATURE, V590, DOI 10.1038/s41586-021-03192-0; Ran S, 2019, SCIENCE, V365, P684, DOI 10.1126/science.aav8645; Szabo A., 2021, ARXIV210904466CONDMA; Tinkham M., 1975, INTRO SUPERCONDUCTIV; Vavilov MG, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.035303; Wang L, 2013, SCIENCE, V342, P614, DOI 10.1126/science.1244358; Xi XX, 2016, NAT PHYS, V12, P139, DOI [10.1038/NPHYS3538, 10.1038/nphys3538]; Yankowitz M, 2018, NATURE, V557, P404, DOI 10.1038/s41586-018-0107-1; You Y.-Z., 2021, ARXIV210904669CONDMA; Zhang D, 2021, NANOTECHNOLOGY, V32, DOI 10.1088/1361-6528/ac238d; Zhang YB, 2009, NATURE, V459, P820, DOI 10.1038/nature08105; Zhou HX, 2021, NATURE, V598, P434, DOI 10.1038/s41586-021-03926-0; Zhou HX, 2021, NATURE, V598, P429, DOI 10.1038/s41586-021-03938-w	53	24	24	27	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 18	2022	375	6582					774	+		10.1126/science.abm8386	http://dx.doi.org/10.1126/science.abm8386			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZD4AQ	35025604	Green Submitted			2022-12-28	WOS:000758142600047
J	Bjornevik, K; Cortese, M; Healy, BC; Kuhle, J; Mina, MJ; Leng, YM; Elledge, SJ; Niebuhr, DW; Scher, AI; Munger, KL; Ascherio, A				Bjornevik, Kjetil; Cortese, Marianna; Healy, Brian C.; Kuhle, Jens; Mina, Michael J.; Leng, Yumei; Elledge, Stephen J.; Niebuhr, David W.; Scher, Ann, I; Munger, Kassandra L.; Ascherio, Alberto			Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis	SCIENCE			English	Article							NEUROFILAMENT LIGHT; RISK-FACTORS; INFECTION; UNIVERSITY; RESPONSES; BRAIN; CHAIN	Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system of unknown etiology. We tested the hypothesis that MS is caused by Epstein-Barr virus (EBV) in a cohort comprising more than 10 million young adults on active duty in the US military, 955 of whom were diagnosed with MS during their period of service. Risk of MS increased 32-fold after infection with EBV but was not increased after infection with other viruses, including the similarly transmitted cytomegalovirus. Serum levels of neurofilament light chain, a biomarker of neuroaxonal degeneration, increased only after EBV seroconversion. These findings cannot be explained by any known risk factor for MS and suggest EBV as the leading cause of MS.	[Bjornevik, Kjetil; Cortese, Marianna; Munger, Kassandra L.; Ascherio, Alberto] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Healy, Brian C.] Brigham & Womens Hosp, Partners Multiple Sclerosis Ctr, 75 Francis St, Boston, MA 02115 USA; [Healy, Brian C.] Harvard Med Sch, Dept Neurol, Boston, MA 02115 USA; [Healy, Brian C.] Massachusetts Gen Hosp, Biostat Ctr, Boston, MA USA; [Kuhle, Jens] Univ Basel, Univ Hosp Basel, Neurol Clin & Policlin, MS Ctr, Basel, Switzerland; [Kuhle, Jens] Univ Basel, Univ Hosp Basel, Res Ctr Clin Neuroimmunol & Neurosci Basel RC2NB, Basel, Switzerland; [Mina, Michael J.; Leng, Yumei; Elledge, Stephen J.] Harvard Med Sch, Brigham & Womens Hosp, Howard Hughes Med Inst, Div Genet,Dept Genet, Boston, MA 02115 USA; [Mina, Michael J.; Leng, Yumei; Elledge, Stephen J.] Harvard Med Sch, Program Virol, Boston, MA 02115 USA; [Mina, Michael J.] Harvard TH Chan Sch Publ Hlth, Ctr Communicable Dis Dynam, Dept Epidemiol, Boston, MA USA; [Mina, Michael J.] Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA USA; [Mina, Michael J.] Harvard Med Sch, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Niebuhr, David W.; Scher, Ann, I] Uniformed Serv Univ Hlth Sci, Dept Prevent Med & Biostat, Bethesda, MD 20814 USA; [Ascherio, Alberto] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Ascherio, Alberto] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; University of Basel; University of Basel; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Uniformed Services University of the Health Sciences - USA; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Ascherio, A (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA.; Ascherio, A (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.; Ascherio, A (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA.	aascheri@hsph.harvard.edu	Bjornevik, Kjetil/J-8888-2019; Kuhle, Jens/AGE-3474-2022	Bjornevik, Kjetil/0000-0002-2892-6986; Munger, Kassandra/0000-0001-7486-9858; Scher, Ann/0000-0003-4599-9834; Mina, Michael/0000-0002-0674-5762; Elledge, Stephen/0000-0001-7923-6283; leng, yumei/0000-0003-2512-9284	National Institute of Neurological Disorders and Stroke, National Institutes of Health (NIH) [NS046635, NS042194, NS103891]; National Multiple Sclerosis Society [PP-1912-35234]; German Research Foundation (DFG) [CO 2129/1-1]; NIH Directors Early Independence Award [DP5-OD028145]	National Institute of Neurological Disorders and Stroke, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Multiple Sclerosis Society(National Multiple Sclerosis Society); German Research Foundation (DFG)(German Research Foundation (DFG)); NIH Directors Early Independence Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants NS046635, NS042194, and NS103891 from the National Institute of Neurological Disorders and Stroke, National Institutes of Health (NIH); National Multiple Sclerosis Society award PP-1912-35234 and German Research Foundation (DFG) research fellowship CO 2129/1-1 to M.C.; and NIH Directors Early Independence Award DP5-OD028145 to M.J.M.. S.J.E is an investigator with the Howard Hughes Medical Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Ascherio A, 2016, SEMIN NEUROL, V36, P103, DOI 10.1055/s-0036-1579693; Balfour HH, 2013, J INFECT DIS, V208, P1286, DOI 10.1093/infdis/jit321; Bjornevik K., 2021, HARVARD DATAVERSE, DOI [10.7910/DVN/KYH9SF, DOI 10.7910/DVN/KYH9SF]; Bjornevik K, 2020, JAMA NEUROL, V77, P58, DOI 10.1001/jamaneurol.2019.3238; Cohen JI, 2018, ADV EXP MED BIOL, V1045, P477, DOI 10.1007/978-981-10-7230-7_22; Crawford DH, 2006, CLIN INFECT DIS, V43, P276, DOI 10.1086/505400; De Paschale Massimo, 2012, World J Virol, V1, P31, DOI 10.5501/wjv.v1.i1.31; Delcoigne B, 2020, NEUROLOGY, V94, pE1201, DOI 10.1212/WNL.0000000000009097; DeLorenze GN, 2006, ARCH NEUROL-CHICAGO, V63, P839, DOI 10.1001/archneur.63.6.noc50328; Disanto G, 2017, ANN NEUROL, V81, P857, DOI 10.1002/ana.24954; Dowd JB, 2009, EPIDEMIOL INFECT, V137, P58, DOI 10.1017/S0950268808000551; Dowd JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064921; Dunmire SK, 2018, J CLIN VIROL, V102, P84, DOI 10.1016/j.jcv.2018.03.001; Fransen NL, 2020, BRAIN, V143, P1714, DOI 10.1093/brain/awaa117; Gaiottino J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075091; Grimm JM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.48; Grut V, 2021, EUR J NEUROL, V28, P3072, DOI 10.1111/ene.14961; Hassani A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192109; Hauser SL, 2017, NEW ENGL J MED, V376, P221, DOI 10.1056/NEJMoa1601277; HENLE W, 1987, P NATL ACAD SCI USA, V84, P570, DOI 10.1073/pnas.84.2.570; Hislop AD, 2007, ANNU REV IMMUNOL, V25, P587, DOI 10.1146/annurev.immunol.25.022106.141553; Jabs WJ, 1999, CLIN EXP IMMUNOL, V116, P468; Khalil M, 2018, NAT REV NEUROL, V14, P577, DOI 10.1038/s41582-018-0058-z; Knol MJ, 2008, AM J EPIDEMIOL, V168, P1073, DOI 10.1093/aje/kwn217; Kuhle J, 2016, CLIN CHEM LAB MED, V54, P1655, DOI 10.1515/cclm-2015-1195; Kuhle J, 2013, MULT SCLER J, V19, P1597, DOI 10.1177/1352458513482374; Larman HB, 2011, NAT BIOTECHNOL, V29, P535, DOI 10.1038/nbt.1856; Lassmann H, 2011, BRAIN, V134, P2772, DOI 10.1093/brain/awr197; Levin LI, 2005, JAMA-J AM MED ASSOC, V293, P2496, DOI 10.1001/jama.293.20.2496; Levin LI, 2010, ANN NEUROL, V67, P824, DOI 10.1002/ana.21978; Lipsitch M, 2010, EPIDEMIOLOGY, V21, P383, DOI 10.1097/EDE.0b013e3181d61eeb; Messacar K, 2015, LANCET, V385, P1662, DOI 10.1016/S0140-6736(14)62457-0; Mina MJ, 2019, SCIENCE, V366, P599, DOI 10.1126/science.aay6485; Moreno MA, 2018, NEUROL-NEUROIMMUNOL, V5, DOI 10.1212/NXI.0000000000000466; Nielsen TR, 2007, ARCH NEUROL-CHICAGO, V64, P72, DOI 10.1001/archneur.64.1.72; Olsson T, 2017, NAT REV NEUROL, V13, P25, DOI 10.1038/nrneurol.2016.187; Pender MP, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.124714; Perdue CL, 2015, MIL MED, V180, P10, DOI 10.7205/MILMED-D-14-00739; Reich DS, 2018, NEW ENGL J MED, V378, P169, DOI 10.1056/NEJMra1401483; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Serafini B, 2007, J EXP MED, V204, P2899, DOI 10.1084/jem.20071030; SIBLEY WA, 1985, LANCET, V1, P1313; Thacker EL, 2006, ANN NEUROL, V59, P499, DOI 10.1002/ana.20820; Thorley-Lawson DA, 2001, NAT REV IMMUNOL, V1, P75, DOI 10.1038/35095584; Tremlett H, 2021, MULT SCLER J, V27, P6, DOI 10.1177/1352458520914844; U.S. Department of Defense, 2019, 2019 DEM PROF MIL CO; VanderWeele TJ, 2017, ANN INTERN MED, V167, P268, DOI 10.7326/M16-2607; Vita R, 2019, NUCLEIC ACIDS RES, V47, pD339, DOI 10.1093/nar/gky1006; Wijnands JMA, 2019, EUR J NEUROL, V26, P1032, DOI 10.1111/ene.13925; Xu GJ, 2015, SCIENCE, V348, DOI 10.1126/science.aaa0698; Xu Y, 2021, BRAIN, V144, P2390, DOI 10.1093/brain/awab100; Zdimerova H, 2021, EUR J IMMUNOL, V51, P64, DOI 10.1002/eji.202048655	52	259	261	41	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2022	375	6578					296	+		10.1126/science.abj8222	http://dx.doi.org/10.1126/science.abj8222			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YK2FS	35025605				2022-12-28	WOS:000745036100029
J	Geyman, EC; van Pelt, WJJ; Maloof, AC; Aas, HF; Kohler, J				Geyman, Emily C.; van Pelt, Ward J. J.; Maloof, Adam C.; Aas, Harald Faste; Kohler, Jack			Historical glacier change on Svalbard predicts doubling of mass loss by 2100	NATURE			English	Article							STRUCTURE-FROM-MOTION; SEA-LEVEL RISE; ICE CAPS; TIDEWATER GLACIERS; MOUNTAIN GLACIERS; ARCTIC GLACIERS; SNOW CONDITIONS; CLIMATE-CHANGE; VOLUME CHANGE; TIDE-GAUGE	The melting of glaciers and ice caps accounts for about one-third of current sea-level rise(1-3), exceeding the mass loss from the more voluminous Greenland or Antarctic Ice Sheets(3,4). The Arctic archipelago of Svalbard, which hosts spatial climate gradients that are larger than the expected temporal climate shifts over the next century(5,6), is a natural laboratory to constrain the climate sensitivity of glaciers and predict their response to future warming. Here we link historical and modern glacier observations to predict that twenty-first century glacier thinning rates will more than double those from 1936 to 2010. Making use of an archive of historical aerial imagery(7) from 1936 and 1938, we use structure-from-motion photogrammetry to reconstruct the three-dimensional geometry of 1,594 glaciers across Svalbard. We compare these reconstructions to modern ice elevation data to derive the spatial pattern of mass balance over a more than 70-year timespan, enabling us to see through the noise of annual and decadal variability to quantify how variables such as temperature and precipitation control ice loss. We find a robust temperature dependence of melt rates, whereby a 1 degrees C rise in mean summer temperature corresponds to a decrease in area-normalized mass balance of -0.28 m yr(-1) of water equivalent. Finally, we design a space-for-time substitution(8) to combine our historical glacier observations with climate projections and make first-order predictions of twenty-first century glacier change across Svalbard.	[Geyman, Emily C.; Aas, Harald Faste; Kohler, Jack] Norwegian Polar Res Inst, Fram Ctr, Tromso, Norway; [van Pelt, Ward J. J.] Uppsala Univ, Dept Earth Sci, Uppsala, Sweden; [Maloof, Adam C.] Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA; [Geyman, Emily C.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA	Norwegian Polar Institute; Uppsala University; Princeton University; California Institute of Technology	Geyman, EC (corresponding author), Norwegian Polar Res Inst, Fram Ctr, Tromso, Norway.; Geyman, EC (corresponding author), CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA.	egeyman@caltech.edu		van Pelt, Ward/0000-0003-4839-7900	Swedish National Space Agency [189/18]; Daniel M. Sachs Class of 1960 Global Scholarship at Princeton University; Svalbard Science Forum Arctic Field Grant; Fannie and John Hertz Foundation	Swedish National Space Agency; Daniel M. Sachs Class of 1960 Global Scholarship at Princeton University; Svalbard Science Forum Arctic Field Grant; Fannie and John Hertz Foundation	We thank F. Simons, C.-Y. Lai, P. Wennberg, P. Moore, B. Dyer, G. Moholdt, R.A. Morris, E. Isaksson, A. Schomacker, C. Nuth, E. Schytt Holmlund and B. Geyman for conversations that improved the manuscript. W.J.J.v.P. acknowledges funding from the Swedish National Space Agency (project 189/18). E.C.G. was supported by a Daniel M. Sachs Class of 1960 Global Scholarship at Princeton University, a Svalbard Science Forum Arctic Field Grant, and the Fannie and John Hertz Foundation.	Aas KS, 2016, CRYOSPHERE, V10, P1089, DOI 10.5194/tc-10-1089-2016; Amdur T, 2021, J CLIMATE, V34, P2893, DOI 10.1175/JCLI-D-20-0312.1; [Anonymous], 2014, TERR SVALB SO TERR; Beaulieu C, 2018, J CLIMATE, V31, P9519, DOI 10.1175/JCLI-D-17-0863.1; Benn DI, 2019, J GLACIOL, V65, P701, DOI 10.1017/jog.2019.62; Benn DI, 2017, J GLACIOL, V63, P691, DOI 10.1017/jog.2017.41; Bjork AA, 2012, NAT GEOSCI, V5, P427, DOI [10.1038/NGEO1481, 10.1038/ngeo1481]; Blaszczyk M, 2009, POL POLAR RES, V30, P85; Blois JL, 2013, P NATL ACAD SCI USA, V110, P9374, DOI 10.1073/pnas.1220228110; Bonan DB, 2019, J GLACIOL, V65, P580, DOI 10.1017/jog.2019.35; Box JE, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aaf2ed; Bretscher O, 2013, LINEAR ALGEBRA APPL, VFifth; Child SF, 2021, REMOTE SENS-BASEL, V13, DOI 10.3390/rs13010021; Ciraci E, 2020, GEOPHYS RES LETT, V47, DOI 10.1029/2019GL086926; Cuffey K., 2010, PHYS GLACIERS; Davis JL, 1996, NATURE, V379, P331, DOI 10.1038/379331a0; Dowdeswell JA, 1997, QUATERNARY RES, V48, P1, DOI 10.1006/qres.1997.1900; Dunse T, 2015, CRYOSPHERE, V9, P197, DOI 10.5194/tc-9-197-2015; Dyurgerov MB, 2000, P NATL ACAD SCI USA, V97, P1406, DOI 10.1073/pnas.97.4.1406; Etzelmuller B, 2011, CRYOSPHERE, V5, P67, DOI 10.5194/tc-5-67-2011; Florentine C, 2018, CRYOSPHERE, V12, P2109, DOI 10.5194/tc-12-2109-2018; Forland EJ, 2020, J HYDROMETEOROL, V21, P1279, DOI 10.1175/JHM-D-19-0252.1; Furst JJ, 2018, GEOPHYS RES LETT, V45, P11760, DOI 10.1029/2018GL079734; Furst JJ, 2017, CRYOSPHERE, V11, P2003, DOI 10.5194/tc-11-2003-2017; Fujita K, 2000, J GLACIOL, V46, P244, DOI 10.3189/172756500781832945; Gabbi J, 2014, J GLACIOL, V60, P1140, DOI 10.3189/2014JoG14J011; Gardner AS, 2013, SCIENCE, V340, P852, DOI 10.1126/science.1234532; Geyman EC, 2021, EARTH PLANET SC LETT, V560, DOI 10.1016/j.epsl.2021.116790; Girod L, 2018, GEOSCI INSTRUM METH, V7, P277, DOI 10.5194/gi-7-277-2018; Granshaw FD, 2006, J GLACIOL, V52, P251, DOI 10.3189/172756506781828782; Hagedoorn JM, 2003, J GEODYN, V35, P415, DOI 10.1016/S0264-3707(03)00004-8; Hagen JO, 2003, POLAR RES, V22, P145, DOI 10.1111/j.1751-8369.2003.tb00104.x; Hagen JO, 2003, ARCT ANTARCT ALP RES, V35, P264, DOI 10.1657/1523-0430(2003)035[0264:OTNMBO]2.0.CO;2; Hanssen-Bauer I., 2019, 2100 NORW CTR CLIM S; Hay CC, 2015, NATURE, V517, P481, DOI 10.1038/nature14093; HAYS JD, 1976, SCIENCE, V194, P1121, DOI 10.1126/science.194.4270.1121; Holmlund ES, 2021, J GLACIOL, V67, P107, DOI 10.1017/jog.2020.89; Hugonnet R, 2021, NATURE, V592, P726, DOI 10.1038/s41586-021-03436-z; Huss M, 2013, CRYOSPHERE, V7, P877, DOI 10.5194/tc-7-877-2013; Huss M, 2015, FRONT EARTH SC-SWITZ, V3, DOI 10.3389/feart.2075.00054; Huybers P, 2006, NATURE, V441, P329, DOI 10.1038/nature04745; Huybers P, 2006, SCIENCE, V313, P508, DOI 10.1126/science.1125249; Isaksen K, 2016, J GEOPHYS RES-ATMOS, V121, P11913, DOI 10.1002/2016JD025606; Jacob T, 2012, NATURE, V482, P514, DOI 10.1038/nature10847; James MR, 2017, GEOMORPHOLOGY, V280, P51, DOI 10.1016/j.geomorph.2016.11.021; Kavan J, 2020, GEOGR ANN A, V102, P57, DOI 10.1080/04353676.2020.1715124; Kb A., 2005, SCHRIFTENREIHE PHYS, V48; Kierulf HP, 2009, GEOPHYS J INT, V179, P1, DOI 10.1111/j.1365-246X.2009.04322.x; Kingslake J, 2018, NATURE, V558, P430, DOI 10.1038/s41586-018-0208-x; Kjeldsen KK, 2015, NATURE, V528, P396, DOI 10.1038/nature16183; KOENDERINK JJ, 1991, J OPT SOC AM A, V8, P377, DOI 10.1364/JOSAA.8.000377; Lang C, 2015, CRYOSPHERE, V9, P83, DOI 10.5194/tc-9-83-2015; Liu J, 2020, AGU ADV; Loop C., 1999, 1999 IEEE COMP SOC C, V1, P125, DOI [10.1109/CVPR.1999.786928, DOI 10.1109/CVPR.1999.786928]; Luckman A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9566; Luncke B., 1936, NORSK GEOGRAFISK TID, V6, P145; MACAYEAL DR, 1993, PALEOCEANOGRAPHY, V8, P775, DOI 10.1029/93PA02200; Marzeion B, 2012, CRYOSPHERE, V6, P1295, DOI 10.5194/tc-6-1295-2012; Matsuo K, 2013, TERR ATMOS OCEAN SCI, V24, P657, DOI 10.3319/TAO.2013.02.22.01(TibXS); McNabb R, 2019, CRYOSPHERE, V13, P895, DOI 10.5194/tc-13-895-2019; Meier MF, 2007, SCIENCE, V317, P1064, DOI 10.1126/science.1143906; Mertes JR, 2017, EARTH SURF PROC LAND, V42, P2350, DOI 10.1002/esp.4188; Midgley NG, 2017, GEOMORPHOLOGY, V282, P18, DOI 10.1016/j.geomorph.2017.01.008; Moller M, 2018, FRONT EARTH SC-SWITZ, V6, DOI 10.3389/feart.2018.00128; Moholdt G, 2010, REMOTE SENS ENVIRON, V114, P2756, DOI 10.1016/j.rse.2010.06.008; Morlighem M, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048659; Morris A, 2020, J GEOPHYS RES-EARTH, V125, DOI 10.1029/2019JF005357; Mott R, 2019, CRYOSPHERE, V13, P1247, DOI 10.5194/tc-13-1247-2019; Naegeli K, 2017, ANN GLACIOL, V58, P119, DOI 10.1017/aog.2017.25; Noel B, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18356-1; Nordli O, 2020, POLAR RES, V39, DOI 10.33265/polar.v39.3614; Nuth C, 2013, CRYOSPHERE, V7, P1603, DOI 10.5194/tc-7-1603-2013; Nuth C, 2011, CRYOSPHERE, V5, P271, DOI 10.5194/tc-5-271-2011; Nuth C, 2010, J GEOPHYS RES-EARTH, V115, DOI 10.1029/2008JF001223; Oerlemans J, 2005, ANN GLACIOL-SER, V42, P230, DOI 10.3189/172756405781812745; Oerlemans J, 2011, CRYOSPHERE, V5, P1, DOI 10.5194/tc-5-1-2011; OERLEMANS J, 1992, SCIENCE, V258, P115, DOI 10.1126/science.258.5079.115; Oerlemans J., 2001, GLACIERS CLIMATE CHA; Oerlemans J, 2008, MINIMAL GLACIER MODE; Ostby TI, 2017, CRYOSPHERE, V11, P191, DOI 10.5194/tc-11-191-2017; Porter C., 2018, ARCTICDEM, DOI DOI 10.7910/DVN/OHHUKH; Radic V, 2014, CLIM DYNAM, V42, P37, DOI 10.1007/s00382-013-1719-7; Radic V, 2011, NAT GEOSCI, V4, P91, DOI [10.1038/ngeo1052, 10.1038/NGEO1052]; Raper SCB, 2006, NATURE, V439, P311, DOI 10.1038/nature04448; Rasmussen CE, 2005, ADAPT COMPUT MACH LE, P1; Reistad M, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006402; Rolstad C, 2009, J GLACIOL, V55, P666, DOI 10.3189/002214309789470950; Sasgen I, 2020, COMMUN EARTH ENVIRON, V1, DOI 10.1038/s43247-020-0010-1; Sato T, 2006, GEOPHYS J INT, V165, P729, DOI 10.1111/J.1365-246X.2006.02992.X; Schuler TV, 2020, FRONT EARTH SC-SWITZ, V8, DOI 10.3389/feart.2020.00156; Serreze MC, 2011, GLOBAL PLANET CHANGE, V77, P85, DOI 10.1016/j.gloplacha.2011.03.004; Straneo F, 2011, NAT GEOSCI, V4, P322, DOI [10.1038/ngeo1109, 10.1038/NGEO1109]; Sullivan MJP, 2020, SCIENCE, V368, P869, DOI 10.1126/science.aaw7578; Uppala SM, 2005, Q J ROY METEOR SOC, V131, P2961, DOI 10.1256/qj.04.176; van Pelt WJJ, 2016, J GEOPHYS RES-EARTH, V121, P2100, DOI 10.1002/2016JF003999; van Pelt W, 2019, CRYOSPHERE, V13, P2259, DOI 10.5194/tc-13-2259-2019; Velicogna I, 2014, GEOPHYS RES LETT, V41, P8130, DOI 10.1002/2014GL061052; Westoby MJ, 2012, GEOMORPHOLOGY, V179, P300, DOI 10.1016/j.geomorph.2012.08.021; WGMS, FLUCT GLAC DAT; Wouters B, 2019, FRONT EARTH SC-SWITZ, V7, DOI 10.3389/feart.2019.00096; Zemp M, 2019, NATURE, V568, P382, DOI 10.1038/s41586-019-1071-0	102	9	9	17	30	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 20	2022	601	7893					374	+		10.1038/s41586-021-04314-4	http://dx.doi.org/10.1038/s41586-021-04314-4			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YJ6UI	35046605				2022-12-28	WOS:000744666700029
J	[Anonymous]				[Anonymous]			The 'war on cancer' isn't yet won	NATURE			English	Editorial Material						Cancer; Genomics; Health care													0	5	5	0	3	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 20	2022	601	7893					297	297		10.1038/d41586-022-00109-3	http://dx.doi.org/10.1038/d41586-022-00109-3			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YJ6UI	35046608				2022-12-28	WOS:000744666700016
J	Limb, M				Limb, Matthew			Delayed discharge: how are services and patients being affected?	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Discombe M, 2022, HSJ; Jameel F, 2021, COMMUNICATION DEC; NHS England, URG EM CAR DAIL SIT; NHS England, 2021, PREP NHS POT IMP OM; Nuffield Trust, 2021, DEL TRANSF CAR	5	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 17	2022	376								o118	10.1136/bmj.o118	http://dx.doi.org/10.1136/bmj.o118			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YP6HX	35039308	Bronze			2022-12-28	WOS:000748724000006
J	Swenor, B; Deal, JA				Swenor, Bonnielin; Deal, Jennifer A.			Disability Inclusion as a Key Component of Research Study Diversity	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Disability Inclusion and Research Study Diversity The Covid-19 pandemic has deepened commitments to enhancing the diversity of the populations participating in research studies. But people with disabilities have been left out of most of these initiatives.	[Swenor, Bonnielin] Johns Hopkins Disabil Hlth Res Ctr, Baltimore, MD 21287 USA; [Swenor, Bonnielin] Johns Hopkins Univ, Sch Nursing, Baltimore, MD 21287 USA; [Deal, Jennifer A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Swenor, B (corresponding author), Johns Hopkins Disabil Hlth Res Ctr, Baltimore, MD 21287 USA.; Swenor, B (corresponding author), Johns Hopkins Univ, Sch Nursing, Baltimore, MD 21287 USA.							[Anonymous], 2021, NEW ENGL J MED, V385, P1429, DOI 10.1056/NEJMe2114651; Krahn GL, 2015, AM J PUBLIC HEALTH, V105, pS198, DOI 10.2105/AJPH.2014.302182; Swenor BK, 2021, LANCET PUBLIC HEALTH, V6, pE359, DOI 10.1016/S2468-2667(21)00115-8; Varadaraj V, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.30358; Yee S., 2016, ROUNDT WORKSH INT HL	5	3	3	1	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 20	2022	386	3					205	207		10.1056/NEJMp2115475	http://dx.doi.org/10.1056/NEJMp2115475		JAN 2022	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YK1UG	35029848				2022-12-28	WOS:000742767700001
J	Nolan, T				Nolan, Tom			Tom Nolan's research reviews-13 January 2022	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		Desch S, 2021, NEW ENGL J MED, V385, P2544, DOI 10.1056/NEJMoa2101909; Gans JS, 2022, JAMA-J AM MED ASSOC, V327, P485, DOI 10.1001/jama.2021.24355; Hargreave M, 2022, JAMA-J AM MED ASSOC, V327, P59, DOI 10.1001/jama.2021.22482; Najafi N, 2022, JAMA INTERN MED, V182, P172, DOI 10.1001/jamainternmed.2021.7387; Ramacciotti E, 2022, LANCET, V399, P50, DOI 10.1016/S0140-6736(21)02392-8	5	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 13	2022	376								o57	10.1136/bmj.o57	http://dx.doi.org/10.1136/bmj.o57			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZE9IW	35027411	Bronze			2022-12-28	WOS:000759191400003
J	Torjesen, I				Torjesen, Ingrid			Covid-19: Peak of viral shedding is later with omicron variant, Japanese data suggest	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		He X, 2020, NAT MED, V26, DOI 10.1038/s41591-020-0869-5; National Institute of Infectious Diseases. Japan, 2022, ACT EP INV SARS COV	2	12	12	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 13	2022	376								o89	10.1136/bmj.o89	http://dx.doi.org/10.1136/bmj.o89			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZE9IW	35027360	Bronze			2022-12-28	WOS:000759191400009
J	Lin, DY; Gu, Y; Wheeler, B; Young, H; Holloway, S; Sunny, SK; Moore, Z; Zeng, DL				Lin, Dan-Yu; Gu, Yu; Wheeler, Bradford; Young, Hayley; Holloway, Shannon; Sunny, Shadia-Khan; Moore, Zack; Zeng, Donglin			Effectiveness of Covid-19 Vaccines over a 9-Month Period in North Carolina	NEW ENGLAND JOURNAL OF MEDICINE			English	Article								Covid-19 Vaccine Effectiveness in North Carolina In an analysis involving more than 10 million North Carolina residents, Covid-19 vaccines were highly effective in preventing hospitalization and death up to 9 months after vaccination. Waning protection against infection over time was due to both declining immunity and the emergence of the delta variant. Background The duration of protection afforded by coronavirus disease 2019 (Covid-19) vaccines in the United States is unclear. Whether the increase in postvaccination infections during the summer of 2021 was caused by declining immunity over time, the emergence of the B.1.617.2 (delta) variant, or both is unknown. Methods We extracted data regarding Covid-19-related vaccination and outcomes during a 9-month period (December 11, 2020, to September 8, 2021) for approximately 10.6 million North Carolina residents by linking data from the North Carolina Covid-19 Surveillance System and the Covid-19 Vaccine Management System. We used a Cox regression model to estimate the effectiveness of the BNT162b2 (Pfizer-BioNTech), mRNA-1273 (Moderna), and Ad26.COV2.S (Johnson & Johnson-Janssen) vaccines in reducing the current risks of Covid-19, hospitalization, and death, as a function of time elapsed since vaccination. Results For the two-dose regimens of messenger RNA (mRNA) vaccines BNT162b2 (30 mu g per dose) and mRNA-1273 (100 mu g per dose), vaccine effectiveness against Covid-19 was 94.5% (95% confidence interval [CI], 94.1 to 94.9) and 95.9% (95% CI, 95.5 to 96.2), respectively, at 2 months after the first dose and decreased to 66.6% (95% CI, 65.2 to 67.8) and 80.3% (95% CI, 79.3 to 81.2), respectively, at 7 months. Among early recipients of BNT162b2 and mRNA-1273, effectiveness decreased by approximately 15 and 10 percentage points, respectively, from mid-June to mid-July, when the delta variant became dominant. For the one-dose regimen of Ad26.COV2.S (5x10(10) viral particles), effectiveness against Covid-19 was 74.8% (95% CI, 72.5 to 76.9) at 1 month and decreased to 59.4% (95% CI, 57.2 to 61.5) at 5 months. All three vaccines maintained better effectiveness in preventing hospitalization and death than in preventing infection over time, although the two mRNA vaccines provided higher levels of protection than Ad26.COV2.S. Conclusions All three Covid-19 vaccines had durable effectiveness in reducing the risks of hospitalization and death. Waning protection against infection over time was due to both declining immunity and the emergence of the delta variant. (Funded by a Dennis Gillings Distinguished Professorship and the National Institutes of Health.)	[Lin, Dan-Yu; Gu, Yu; Zeng, Donglin] Univ N Carolina, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27599 USA; [Wheeler, Bradford; Young, Hayley; Moore, Zack] North Carolina Dept Hlth & Human Serv, Raleigh, NC USA; [Holloway, Shannon] North Carolina State Univ, Raleigh, NC USA; [Sunny, Shadia-Khan] North Carolina Dept Hlth & Human Serv, Cdc Fdn, Raleigh, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; North Carolina State University	Lin, DY (corresponding author), Univ N Carolina, Dept Biostat, 3101E McGavran Greenberg Hall, Chapel Hill, NC 27599 USA.	lin@bios.unc.edu		Gu, Yu/0000-0003-2353-063X	Dennis Gillings Distinguished Professorship; National Institutes of Health	Dennis Gillings Distinguished Professorship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported by a Dennis Gillings Distinguished Professorship (to Dr. Lin) and National Institutes of Health R01 grants (to Dr. Lin, Ms. Gu, Dr. Holloway, and Dr. Zeng).	Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389; Chemaitelly H, 2021, NEW ENGL J MED, V385, pE83, DOI 10.1056/NEJMoa2114114; COX DR, 1972, J R STAT SOC B, V34, P187; El Sahly HM, 2021, NEW ENGL J MED, V385, P1774, DOI 10.1056/NEJMoa2113017; Fowlkes A, 2021, MMWR-MORBID MORTAL W, V70, P1167, DOI 10.15585/mmwr.mm7034e4; Goldberg Y., 2021, WANING IMMUNITY BNT1, DOI [10.1101/2021.08.24.21262423v1, DOI 10.1101/2021.08.24.21262423, DOI 10.1101/2021.08.24.21262423V1]; Kanaan MN, 2002, J AM STAT ASSOC, V97, P389, DOI 10.1198/016214502760046943; Lin D-Y, 2021, CLIN INFECT DIS; Lin DY., 2021, J INFECT DIS, DOI [10.1101/2021.12.22.21268201v1, DOI 10.1101/2021.12.22.21268201V1]; Nanduri S, 2021, MMWR-MORBID MORTAL W, V70, P1163, DOI 10.15585/mmwr.mm7034e3; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Puranik Arjun, 2021, medRxiv, DOI 10.1101/2021.08.06.21261707; Rosenberg ES, 2021, COVID 19 VACCINE EFF, DOI 10.08.21264595v1; Rubin DB, 1987, MULTIPLE IMPUTATION; Sadoff J, 2021, NEW ENGL J MED, V384, P2187, DOI 10.1056/NEJMoa2101544; Self WH, 2021, MMWR-MORBID MORTAL W, V70, P1337, DOI 10.15585/mmwr.mm7038e1; Tartof SY, 2021, LANCET, V398, P1407, DOI 10.1016/S0140-6736(21)02183-8; Tenforde MW, 2021, MMWR-MORBID MORTAL W, V70, P1156, DOI 10.15585/mmwr.mm7034e2; Thomas SJ, 2021, NEW ENGL J MED, V385, P1761, DOI 10.1056/NEJMoa2110345	19	80	79	5	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 10	2022	386	10					933	941		10.1056/NEJMoa2117128	http://dx.doi.org/10.1056/NEJMoa2117128		JAN 2022	9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZP3BU	35020982	Green Published, Bronze			2022-12-28	WOS:000741665900001
J	Jacobsen, J; Bernacki, R; Paladino, J				Jacobsen, Juliet; Bernacki, Rachelle; Paladino, Joanna			Shifting to Serious Illness Communication	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ADULTS; CARE		[Jacobsen, Juliet; Bernacki, Rachelle] Harvard Med Sch, 55 Fruit St,Founders 600, Boston, MA 02114 USA; [Jacobsen, Juliet] Lund Univ, Inst Palliat Care, Lund, Sweden; [Bernacki, Rachelle] Brigham & Womens Hosp, Dana Farber Canc Inst, 75 Francis St, Boston, MA 02115 USA; [Paladino, Joanna] Ariadne Labs, Serious Illness Care Program, Boston, MA USA; [Paladino, Joanna] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Lund University; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Jacobsen, J (corresponding author), Harvard Med Sch, 55 Fruit St,Founders 600, Boston, MA 02114 USA.	jjacobsen@partners.org						Ahalt C, 2012, J GEN INTERN MED, V27, P568, DOI 10.1007/s11606-011-1933-0; Bernacki R, 2019, JAMA INTERN MED, V179, P751, DOI 10.1001/jamainternmed.2019.0077; Haun MW, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011129.pub2; Hoerger M, 2018, J CLIN ONCOL, V36, P1096, DOI 10.1200/JCO.2017.75.6676; Kelley AS, 2018, J PALLIAT MED, V21, pS7, DOI 10.1089/jpm.2017.0548; Lagrotteria A, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.21517; Morrison RS, 2021, JAMA-J AM MED ASSOC, V326, P1575, DOI 10.1001/jama.2021.16430; Paladino J, 2020, CANCER MED-US, V9, P4550, DOI 10.1002/cam4.3102; Sanders JJ, 2019, PALLIAT SUPPORT CARE, V17, P306, DOI 10.1017/S147895151800038X; Sudore RL, 2017, J PAIN SYMPTOM MANAG, V53, P821, DOI 10.1016/j.jpainsymman.2016.12.331	10	12	12	1	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 25	2022	327	4					321	322		10.1001/jama.2021.23695	http://dx.doi.org/10.1001/jama.2021.23695		JAN 2022	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YV9PW	34994773				2022-12-28	WOS:000739989000003
J	Farrant, O; Eisen, S; Van Tulleken, C; Ward, A; Longley, N				Farrant, Olivia; Eisen, Sarah; Van Tulleken, Chris; Ward, Allison; Longley, Nicky			Why asylum seekers deserve better healthcare, and how we can give it to them	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							COVID-19		[Farrant, Olivia; Eisen, Sarah; Van Tulleken, Chris; Ward, Allison; Longley, Nicky] Univ Coll London Hosp NHS Fdn Trust, Hosp Trop Dis, London, England; [Eisen, Sarah; Van Tulleken, Chris] UCL, London, England; [Ward, Allison] Royal Free London NHS Fdn Trust, London, England; [Ward, Allison] Cent & North West London NHS Fdn Trust, London, England; [Longley, Nicky] London Sch Hyg & Trop Med, London, England	University College London Hospitals NHS Foundation Trust; University of London; London School of Hygiene & Tropical Medicine; University College London; University of London; University College London; University of London; University College London; Royal Free London NHS Foundation Trust; University of London; London School of Hygiene & Tropical Medicine	Farrant, O (corresponding author), Univ Coll London Hosp NHS Fdn Trust, Hosp Trop Dis, London, England.	olivia.farrant1@nhs.net						Amnesty International, REFUGEES ASYLUM SEEK; Doctors of the World, 2017, CLOS GAPS HEALTHC AC; Equality and Human Rights Commission, 2018, 122 EQ HUM RIGHTS CO; Home Office, 2020, US TEMP HOT HOUS ASY; Mansfield KE, 2021, LANCET DIGIT HEALTH, V3, pE217, DOI [10.1016/S2589-7500(21)00017-0, 10.1016/S2589-7500(21)00017-0ac.uk]; McColl H., 2008, ADV PSYCHIAT TREATME, V14, P452, DOI [10.1192/apt.bp.107.005041, DOI 10.1192/APT.BP.107.005041]; Mishra V, 2021, J HEALTHC LEADERSH, V13, P19, DOI 10.2147/JHL.S270175; National Audit Office, 2020, AS ACC SUPP; Network SAN, 2021, HLTH WELLB SAF NEEDS; Refugee Health Screener-15 (RHS-15), INT REF HLTH WELLB; Right to Remain, 2021, RIGHT REM TOOLK; Sturge G., ASYLUM STAT; Worsoe H., 2021, THESIS U QUEENSLAND	13	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 6	2022	376								n3069	10.1136/bmj.n3069	http://dx.doi.org/10.1136/bmj.n3069			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YG5VA	34992052				2022-12-28	WOS:000742554700001
J	Eyre, DW; Taylor, D; Purver, M; Chapman, D; Fowler, T; Pouwels, KB; Walker, AS; Peto, TEA				Eyre, David W.; Taylor, Donald; Purver, Mark; Chapman, David; Fowler, Tom; Pouwels, Koen B.; Walker, A. Sarah; Peto, Tim E. A.			Effect of Covid-19 Vaccination on Transmission of Alpha and Delta Variants	NEW ENGLAND JOURNAL OF MEDICINE			English	Article								Background Before the emergence of the B.1.617.2 (delta) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), vaccination reduced transmission of SARS-CoV-2 from vaccinated persons who became infected, potentially by reducing viral loads. Although vaccination still lowers the risk of infection, similar viral loads in vaccinated and unvaccinated persons who are infected with the delta variant call into question the degree to which vaccination prevents transmission. Methods We used contact-testing data from England to perform a retrospective observational cohort study involving adult contacts of SARS-CoV-2-infected adult index patients. We used multivariable Poisson regression to investigate associations between transmission and the vaccination status of index patients and contacts and to determine how these associations varied with the B.1.1.7 (alpha) and delta variants and time since the second vaccination. Results Among 146,243 tested contacts of 108,498 index patients, 54,667 (37%) had positive SARS-CoV-2 polymerase-chain-reaction (PCR) tests. In vaccinated index patients who became infected with the alpha variant, two vaccinations with either BNT162b2 or ChAdOx1 nCoV-19 (also known as AZD1222), as compared with no vaccination, were independently associated with reduced PCR positivity in contacts (adjusted rate ratio with BNT162b2, 0.32; 95% confidence interval [CI], 0.21 to 0.48; and with ChAdOx1 nCoV-19, 0.48; 95% CI, 0.30 to 0.78). Vaccine-associated reductions in transmission of the delta variant were smaller than those with the alpha variant, and reductions in transmission of the delta variant after two BNT162b2 vaccinations were greater (adjusted rate ratio for the comparison with no vaccination, 0.50; 95% CI, 0.39 to 0.65) than after two ChAdOx1 vaccinations (adjusted rate ratio, 0.76; 95% CI, 0.70 to 0.82). Variation in cycle-threshold (Ct) values (indicative of viral load) in index patients explained 7 to 23% of vaccine-associated reductions in transmission of the two variants. The reductions in transmission of the delta variant declined over time after the second vaccination, reaching levels that were similar to those in unvaccinated persons by 12 weeks in index patients who had received ChAdOx1 nCoV-19 and attenuating substantially in those who had received BNT162b2. Protection in contacts also declined in the 3-month period after the second vaccination. Conclusions Vaccination was associated with a smaller reduction in transmission of the delta variant than of the alpha variant, and the effects of vaccination decreased over time. PCR Ct values at diagnosis of the index patient only partially explained decreased transmission. (Funded by the U.K. Government Department of Health and Social Care and others.) Covid-19 Vaccination and Delta Transmission In this study, 37% of 146,000 PCR-tested contacts of infected persons in England were positive for SARS-CoV-2. Transmission to vaccinated contacts was rarer than transmission to unvaccinated contacts (adjusted rate ratio, 0.32), but the protection of vaccination waned over time and was more effective against the alpha strain than against the delta strain.	[Eyre, David W.] Univ Oxford, Big Data Inst, Old Rd Campus,Old Rd, Oxford OX3 7LF, England; [Pouwels, Koen B.] Univ Oxford, Hlth Econ Res Ctr, Oxford, England; [Eyre, David W.; Pouwels, Koen B.; Walker, A. Sarah; Peto, Tim E. A.] Univ Oxford, Nuffield Dept Populat Hlth, Natl Inst Hlth Res, Protect Res Unit Healthcare Associated Infect & A, Oxford, England; [Walker, A. Sarah; Peto, Tim E. A.] Univ Oxford, Nuffield Dept Med, Oxford, England; [Taylor, Donald; Purver, Mark; Fowler, Tom] Queen Mary Univ London, Natl Hlth Serv Test & Trace, Dept Hlth & Social Care, London, England; [Chapman, David] Queen Mary Univ London, Deloitte MCS, London, England; [Fowler, Tom] Queen Mary Univ London, William & Larvey Res Inst, London, England	University of Oxford; University of Oxford; University of Oxford; University of Oxford; University of London; Queen Mary University London; Deloitte Touche Tohmatsu Limited; University of London; Queen Mary University London; University of London; Queen Mary University London	Eyre, DW (corresponding author), Univ Oxford, Big Data Inst, Old Rd Campus,Old Rd, Oxford OX3 7LF, England.	david.eyre@bdi.ox.ac.uk	Walker, Sarah/HDM-8717-2022; Fowler, Tom/AGT-1933-2022; Eyre, David/P-6887-2016	Fowler, Tom/0000-0002-7258-2279; Purver, Mark/0000-0001-5538-6076; Pouwels, Koen/0000-0001-7097-8950; Eyre, David/0000-0001-5095-6367	U.K. Government Department of Health and Social Care; National Institute for Health Research (NIHR) Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Oxford University; NIHR Biomedical Research Centre, Oxford; Public Health England [NIHR200915]	U.K. Government Department of Health and Social Care; National Institute for Health Research (NIHR) Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Oxford University; NIHR Biomedical Research Centre, Oxford(National Institute for Health Research (NIHR)); Public Health England	Supported by the U.K. Government Department of Health and Social Care; the National Institute for Health Research (NIHR) Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Oxford University, in partnership with Public Health England (NIHR200915); and the NIHR Biomedical Research Centre, Oxford. Dr. Eyre is a Robertson Foundation Fellow and an NIHR Oxford Biomedical Research Centre Senior Fellow; and Dr. Walker is an NIHR Senior Investigator.	Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389; Bar-On YM, 2021, NEW ENGL J MED, V385, P1393, DOI 10.1056/NEJMoa2114255; Bernal JL, 2021, NEW ENGL J MED, V385, P585, DOI 10.1056/NEJMoa2108891; Bernal JL, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n1088; Brown CM, 2021, MMWR-MORBID MORTAL W, V70, P1059, DOI 10.15585/mmwr.mm7031e2; Chia PY, 2022, CLIN MICROBIOL INFEC, V28, DOI 10.1016/j.cmi.2021.11.010; Dagan N, 2021, NEW ENGL J MED, V384, P1412, DOI 10.1056/NEJMoa2101765; Fukushima W, 2017, VACCINE, V35, P4796, DOI 10.1016/j.vaccine.2017.07.003; Harris RJ, 2021, NEW ENGL J MED, V385, P759, DOI 10.1056/NEJMc2107717; He X, 2020, NAT MED, V26, DOI 10.1038/s41591-020-0869-5; Layan M, 2021, MEDRV WORKING PAPER, V2021, DOI [10.1101/2021.07.12.21260377, DOI 10.1101/2021.07.12.21260377V1, 10.1101/2021.07.12.21260377v1, DOI 10.1101/2021.07.12.21260377]; Lee LYW, 2022, CLIN INFECT DIS, V74, P407, DOI 10.1093/cid/ciab421; Levine-Tiefenbrun M, 2021, NAT MED, V27, P790, DOI 10.1038/s41591-021-01316-7; Lewnard JA, 2021, EPIDEMIOLOGY, V32, P508, DOI 10.1097/EDE.0000000000001366; Marks M, 2021, LANCET INFECT DIS, V21, P629, DOI 10.1016/S1473-3099(20)30985-3; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Pouwels KB, 2021, NAT MED, V27, P2127, DOI 10.1038/s41591-021-01548-7; Pritchard E, 2021, NAT MED, V27, P1370, DOI 10.1038/s41591-021-01410-w; Prunas Ottavia, 2021, medRxiv, DOI 10.1101/2021.07.13.21260393; Public Health England, 2021, SARS COV 2 VAR VAR I; Public Health England, 2020, UND CYCL THRESH CT S; Salo J., 2021, INDIRECT EFFECT MRNA, DOI [10.1101/2021.05.27.21257896v2, DOI 10.1101/2021.05.27.21257896, 10.1101/2021.05.27.21257896]; Singanayagam A, 2022, LANCET INFECT DIS, V22, P183, DOI 10.1016/S1473-3099(21)00648-4; Vihta KD, 2022, CLIN INFECT DIS, V75, pE329, DOI 10.1093/cid/ciab945; Voysey M, 2021, LANCET, V397, P99, DOI 10.1016/S0140-6736(20)32661-1; Wei J, 2021, NAT MICROBIOL, V6, P1140, DOI 10.1038/s41564-021-00947-3	26	96	96	9	44	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 24	2022	386	8					744	756		10.1056/NEJMoa2116597	http://dx.doi.org/10.1056/NEJMoa2116597		JAN 2022	13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZF7PI	34986294	Bronze, Green Published			2022-12-28	WOS:000738962000001
J	Liang, SK; Thomas, SE; Chaplin, AK; Hardwick, SW; Chirgadze, DY; Blundell, TL				Liang, Shikang; Thomas, Sherine E.; Chaplin, Amanda K.; Hardwick, Steven W.; Chirgadze, Dimitri Y.; Blundell, Tom L.			Structural insights into inhibitor regulation of the DNA repair protein DNA-PKcs	NATURE			English	Article							DOUBLE-STRAND BREAK; CRYO-EM STRUCTURE; DAMAGE RESPONSE; KINASE; MECHANISM; DISCOVERY; POTENT; WORTMANNIN	The DNA-dependent protein kinase catalytic subunit (DNA-PKcs) has a central role in non-homologous end joining, one of the two main pathways that detect and repair DNA double-strand breaks (DSBs) in humans(1,2). DNA-PKcs is of great importance in repairing pathological DSBs, making DNA-PKcs inhibitors attractive therapeutic agents for cancer in combination with DSB-inducing radiotherapy and chemotherapy(3). Many of the selective inhibitors of DNA-PKcs that have been developed exhibit potential as treatment for various cancers(4). Here we report cryo-electron microscopy (cryo-EM) structures of human DNA-PKcs natively purified from HeLa cell nuclear extracts, in complex with adenosine-5'-(gamma-thio)-triphosphate (ATP gamma S) and four inhibitors (wortmannin, NU7441, AZD7648 and M3814), including drug candidates undergoing clinical trials. The structures reveal molecular details of ATP binding at the active site before catalysis and provide insights into the modes of action and specificities of the competitive inhibitors. Of note, binding of the ligands causes movement of the PIKK regulatory domain (PRD), revealing a connection between the p-loop and PRD conformations. Electrophoretic mobility shift assay and cryo-EM studies on the DNA-dependent protein kinase holoenzyme further show that ligand binding does not have a negative allosteric or inhibitory effect on assembly of the holoenzyme complex and that inhibitors function through direct competition with ATP. Overall, the structures described in this study should greatly assist future efforts in rational drug design targeting DNA-PKcs, demonstrating the potential of cryo-EM in structure-guided drug development for large and challenging targets.	[Liang, Shikang; Thomas, Sherine E.; Chaplin, Amanda K.; Blundell, Tom L.] Univ Cambridge, Dept Biochem, Cambridge, England; [Hardwick, Steven W.; Chirgadze, Dimitri Y.] Univ Cambridge, Dept Biochem, Cryo EM Facil, Cambridge, England; [Thomas, Sherine E.] Univ Cambridge, Dept Pathol, Cambridge, England; [Chaplin, Amanda K.] Univ Leicester, Leicester Inst Struct & Chem Biol, Dept Mol & Cell Biol, Leicester, Leics, England	University of Cambridge; University of Cambridge; University of Cambridge; University of Leicester	Liang, SK (corresponding author), Univ Cambridge, Dept Biochem, Cambridge, England.	sl744@cam.ac.uk; tlb20@cam.ac.uk		Chirgadze, Dimitri/0000-0001-9942-0993; Liang, Shikang/0000-0002-6930-7882; Blundell, Tom/0000-0002-2708-8992	Wellcome Trust [200814/Z/16/Z, 2016-]; Cystic Fibrosis Trust [RG92393]; Fondation Botnar [6063]	Wellcome Trust(Wellcome TrustEuropean Commission); Cystic Fibrosis Trust; Fondation Botnar	We thank L. Cooper and the cryo-EM facility in the Biochemistry Department, University of Cambridge, for their help with sample preparation, screening and data collection. We thank Q. Wu, T. Ochi and T.M. De Oliveira for discussion on NHEJ and DNA-PKcs. We thank B. Mao, J. He, T. Dendooven, M. Ma and B. Luisi for advice and discussion on support film and sample preparation. We are also grateful for an Investigator Award from the Wellcome Trust (200814/Z/16/Z; 2016-) for support of this research. S.E.T. has been funded by the Cystic Fibrosis Trust (RG92393) and Fondation Botnar (grant project no. 6063).	Afonine PV, 2018, ACTA CRYSTALLOGR D, V74, P531, DOI 10.1107/S2059798318006551; Bokori-Brown M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11293; Boulton S, 1996, CARCINOGENESIS, V17, P2285, DOI 10.1093/carcin/17.11.2285; Chang HHY, 2017, NAT REV MOL CELL BIO, V18, P495, DOI 10.1038/nrm.2017.48; Chaplin AK, 2021, MOL CELL, V81, P3400, DOI 10.1016/j.molcel.2021.07.005; Chaplin AK, 2021, NAT STRUCT MOL BIOL, V28, DOI 10.1038/s41594-020-00517-x; Chen SY, 2021, NATURE, V593, P294, DOI 10.1038/s41586-021-03458-7; Chen XM, 2021, MOL CELL, V81, P801, DOI 10.1016/j.molcel.2020.12.015; Davis AJ, 2014, DNA REPAIR, V17, P21, DOI 10.1016/j.dnarep.2014.02.020; Davis AJ, 2013, J BIOL CHEM, V288, P7037, DOI 10.1074/jbc.M112.434498; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fok JHL, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12836-9; Goldberg FW, 2020, J MED CHEM, V63, P3461, DOI 10.1021/acs.jmedchem.9b01684; Graham TGW, 2016, MOL CELL, V61, P850, DOI 10.1016/j.molcel.2016.02.010; Hajduk PJ, 2005, DRUG DISCOV TODAY, V10, P1675, DOI 10.1016/S1359-6446(05)03624-X; Hardcastle IR, 2005, J MED CHEM, V48, P7829, DOI 10.1021/jm050444b; Harnor SJ, 2017, CHEMMEDCHEM, V12, P895, DOI 10.1002/cmdc.201700143; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jette N, 2015, PROG BIOPHYS MOL BIO, V117, P194, DOI 10.1016/j.pbiomolbio.2014.12.003; Lai AC, 2017, NAT REV DRUG DISCOV, V16, P101, DOI 10.1038/nrd.2016.211; Liang SK, 2021, PROG BIOPHYS MOL BIO, V163, P60, DOI 10.1016/j.pbiomolbio.2020.11.008; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Menolfi D, 2020, CELL BIOSCI, V10, DOI 10.1186/s13578-020-0376-x; Mohiuddin IS, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00635; O'Connor MJ, 2015, MOL CELL, V60, P547, DOI 10.1016/j.molcel.2015.10.040; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pettersen EF, 2021, PROTEIN SCI, V30, P70, DOI 10.1002/pro.3943; Punjani A, 2017, IEEE T PATTERN ANAL, V39, P706, DOI 10.1109/TPAMI.2016.2627573; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Radoux CJ, 2016, J MED CHEM, V59, P4314, DOI 10.1021/acs.jmedchem.5b01980; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Sharif H, 2017, P NATL ACAD SCI USA, V114, P7367, DOI 10.1073/pnas.1707386114; Sibanda BL, 2017, SCIENCE, V355, P520, DOI 10.1126/science.aak9654; Sun XY, 2019, SIGNAL TRANSDUCT TAR, V4, DOI 10.1038/s41392-019-0101-6; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; van Bussel MTJ, 2021, BRIT J CANCER, V124, P728, DOI 10.1038/s41416-020-01151-6; Walker EH, 2000, MOL CELL, V6, P909, DOI 10.1016/S1097-2765(05)00089-4; Wise HC, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54796-6; Yang F, 2014, BBA-REV CANCER, V1845, P84, DOI 10.1016/j.bbcan.2013.12.002; Yang HJ, 2013, NATURE, V497, P217, DOI 10.1038/nature12122; Yin XT, 2017, CELL RES, V27, P1341, DOI 10.1038/cr.2017.110; Zenke FT, 2020, MOL CANCER THER, V19, P1091, DOI 10.1158/1535-7163.MCT-19-0734	43	13	12	18	35	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 27	2022	601	7894					643	+		10.1038/s41586-021-04274-9	http://dx.doi.org/10.1038/s41586-021-04274-9		JAN 2022	15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YQ8HX	34987222	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000739283800001
J	Pai, M; Kasaeva, T; Swaminathan, S				Pai, Madhukar; Kasaeva, Tereza; Swaminathan, Soumya			Covid-19's Devastating Effect on Tuberculosis Care - A Path to Recovery	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Pai, Madhukar] McGill Univ, McGill Int TB Ctr, Montreal, PQ, Canada; [Pai, Madhukar] McGill Univ, McGill Sch Populat & Global Hlth, Montreal, PQ, Canada; [Kasaeva, Tereza] World Hlth Org, Global TB Program, Geneva, Switzerland; [Swaminathan, Soumya] World Hlth Org, Sci Div, Geneva, Switzerland	McGill University; McGill University; World Health Organization; World Health Organization	Pai, M (corresponding author), McGill Univ, McGill Int TB Ctr, Montreal, PQ, Canada.; Pai, M (corresponding author), McGill Univ, McGill Sch Populat & Global Hlth, Montreal, PQ, Canada.							Ruhwald M, 2021, LANCET MICROBE, V2, pE169, DOI 10.1016/S2666-5247(21)00057-4; Silva S, 2021, LANCET GLOB HEALTH, V9, pE1372, DOI 10.1016/S2214-109X(21)00299-0; Sinha P, 2021, LANCET INFECT DIS, V21, pE318, DOI 10.1016/S1473-3099(20)30792-1; WHO, 2021, B WORLD HEALTH ORGAN, DOI DOI 10.2471/BLT.21.286807; Zimmer AJ, 2022, J EPIDEMIOL COMMUN H, V76, P310, DOI 10.1136/jech-2021-217529	5	39	39	2	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 21	2022	386	16					1490	1493		10.1056/NEJMp2118145	http://dx.doi.org/10.1056/NEJMp2118145		JAN 2022	4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	1F4SD	34986295	Bronze			2022-12-28	WOS:000739053200001
J	Shrank, WH; Chernew, ME; Navathe, AS				Shrank, William H.; Chernew, Michael E.; Navathe, Amol S.			Hierarchical PaymentModels-A Path for Coordinating Population- and Episode-Based Payment Models	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARE		[Shrank, William H.] Humana Inc, Louisville, KY USA; [Chernew, Michael E.] Harvard Med Sch, Dept Hlth Care Policy, Boston, MA 02115 USA; [Navathe, Amol S.] Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, 423 Guardian Dr,1108 Blockley Hall, Philadelphia, PA 19104 USA; [Navathe, Amol S.] Corporal Michael J Crescenz VA Med Ctr, Philadelphia, PA USA	Humana Inc.; Harvard University; Harvard Medical School; University of Pennsylvania; Pennsylvania Medicine	Navathe, AS (corresponding author), Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, 423 Guardian Dr,1108 Blockley Hall, Philadelphia, PA 19104 USA.	amol@wharton.upenn.edu						Agarwal R, 2020, HEALTH AFFAIR, V39, P50, DOI 10.1377/hlthaff.2019.00784; Chernew ME, 2021, JAMA-HEALTH FORUM, V2, DOI 10.1001/jamahealthforum.2021.0232; McWilliams MJ, 2021, VISION DESIGN ADV ME; Navathe AS, 2021, JAMA-HEALTH FORUM, V2, DOI 10.1001/jamahealthforum.2021.2131; Navathe AS, 2020, JAMA-J AM MED ASSOC, V324, P237, DOI 10.1001/jama.2020.4133; Shrank W, 2013, HEALTH AFFAIR, V32, P807, DOI 10.1377/hlthaff.2013.0216	6	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 1	2022	327	5					423	424		10.1001/jama.2021.23786	http://dx.doi.org/10.1001/jama.2021.23786			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YV9QB	35029652				2022-12-28	WOS:000753056200012
J	Cooper, MJ; Martin, RV; Hammer, MS; Levelt, PF; Veefkind, P; Lamsal, LN; Krotkov, NA; Brook, JR; McLinden, CA				Cooper, Matthew J.; Martin, Randall, V; Hammer, Melanie S.; Levelt, Pieternel F.; Veefkind, Pepijn; Lamsal, Lok N.; Krotkov, Nickolay A.; Brook, Jeffrey R.; McLinden, Chris A.			Global fine-scale changes in ambient NO2 during COVID-19 lockdowns	NATURE			English	Article							NITROGEN-DIOXIDE; TROPOSPHERIC NO2; AIR-QUALITY; S5P TROPOMI; TRENDS; SURFACE; POLLUTION; SATELLITE; SPACE; METEOROLOGY	Nitrogen dioxide (NO2) is an important contributor to air pollution and can adversely affect human health(1-9). A decrease in NO2 concentrations has been reported as a result of lockdown measures to reduce the spread of COVID-19(10-20). Questions remain, however, regarding the relationship of satellite-derived atmospheric column NO2 data with health-relevant ambient ground-level concentrations, and the representativeness of limited ground-based monitoring data for global assessment. Here we derive spatially resolved, global ground-level NO2 concentrations from NO2 column densities observed by the TROPOMI satellite instrument at sufficiently fine resolution (approximately one kilometre) to allow assessment of individual cities during COVID-19 lockdowns in 2020 compared to 2019. We apply these estimates to quantify NO2 changes in more than 200 cities, including 65 cities without available ground monitoring, largely in lower-income regions. Mean country-level population-weighted NO2 concentrations are 29% +/- 3% lower in countries with strict lockdown conditions than in those without. Relative to long-term trends, NO2 decreases during COVID-19 lockdowns exceed recent Ozone Monitoring Instrument (OMI)-derived year-to-year decreases from emission controls, comparable to 15 +/- 4 years of reductions globally. Our case studies indicate that the sensitivity of NO2 to lockdowns varies by country and emissions sector, demonstrating the critical need for spatially resolved observational information provided by these satellite-derived surface concentration estimates.	[Cooper, Matthew J.; Martin, Randall, V; Hammer, Melanie S.] Dalhousie Univ, Dept Phys & Atmospher Sci, Halifax, NS, Canada; [Cooper, Matthew J.; Martin, Randall, V; Hammer, Melanie S.] Washington Univ, Dept Energy Environm & Chem Engn, St Louis, MO 63110 USA; [Martin, Randall, V] Harvard Smithsonian Ctr Astrophys, 60 Garden St, Cambridge, MA 02138 USA; [Levelt, Pieternel F.; Veefkind, Pepijn] Royal Netherlands Meteorol Inst KNMI, De Bilt, Netherlands; [Levelt, Pieternel F.] Univ Technol Delft, Delft, Netherlands; [Levelt, Pieternel F.] Natl Ctr Atmospher Res, POB 3000, Boulder, CO 80307 USA; [Veefkind, Pepijn] Delft Univ Technol, Dept Geosci & Remote Sensing, Delft, Netherlands; [Lamsal, Lok N.; Krotkov, Nickolay A.] NASA, Goddard Space Flight Ctr, Greenbelt, MD USA; [Lamsal, Lok N.] Univ Space Res Assoc, Columbia, MD USA; [Brook, Jeffrey R.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Brook, Jeffrey R.] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON, Canada; [McLinden, Chris A.] Environm & Climate Change Canada, Toronto, ON, Canada	Dalhousie University; Washington University (WUSTL); Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Royal Netherlands Meteorological Institute; Delft University of Technology; National Center Atmospheric Research (NCAR) - USA; Delft University of Technology; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Universities Space Research Association (USRA); University of Toronto; University of Toronto; Environment & Climate Change Canada	Cooper, MJ (corresponding author), Dalhousie Univ, Dept Phys & Atmospher Sci, Halifax, NS, Canada.; Cooper, MJ (corresponding author), Washington Univ, Dept Energy Environm & Chem Engn, St Louis, MO 63110 USA.	cooperm2@dal.ca	Levelt, Pieternel/AAE-3835-2022; Krotkov, Nickolay A/E-1541-2012; Martin, Randall/C-1205-2014; McLinden, Chris/A-7710-2010	Krotkov, Nickolay A/0000-0001-6170-6750; Martin, Randall/0000-0003-2632-8402; McLinden, Chris/0000-0001-5054-1380; Hammer, Melanie/0000-0001-8443-7979; Cooper, Matthew/0000-0002-4145-3458	Environment and Climate Change Canada; Canadian Urban Environmental Health Research Consortium; NASA [80NSSC21K1343, 80NSSC21K0508]	Environment and Climate Change Canada; Canadian Urban Environmental Health Research Consortium; NASA(National Aeronautics & Space Administration (NASA))	This research was supported by Environment and Climate Change Canada and by the Canadian Urban Environmental Health Research Consortium. R.V.M. acknowledges support from NASA grants 80NSSC21K1343 and 80NSSC21K0508. We thank the OMI instrument team, and the OMI and TROPOMI teams for making NO<INF>2</INF> data publicly available.	Achakulwisut P, 2019, LANCET PLANET HEALTH, V3, pE166, DOI 10.1016/S2542-5196(19)30046-4; Anenberg SC, 2018, ENVIRON HEALTH PERSP, V126, DOI [10.1289/ehp3766, 10.1289/EHP3766]; Bari M, 2015, ENVIRON INT, V74, P200, DOI 10.1016/j.envint.2014.10.009; Barkley MP, 2017, ATMOS CHEM PHYS, V17, P4687, DOI 10.5194/acp-17-4687-2017; Bauwens M, 2020, GEOPHYS RES LETT, V47, DOI 10.1029/2020GL087978; Benitez-Garcia SE, 2014, ATMOSPHERE-BASEL, V5, P806, DOI 10.3390/atmos5040806; Bey I, 2001, J GEOPHYS RES-ATMOS, V106, P23073, DOI 10.1029/2001JD000807; Biswal A, 2021, ATMOS CHEM PHYS, V21, P5235, DOI 10.5194/acp-21-5235-2021; Boersma KF, 2018, ATMOS MEAS TECH, V11, P6651, DOI 10.5194/amt-11-6651-2018; Brook JR, 2007, J EXPO SCI ENV EPID, V17, pS36, DOI 10.1038/sj.jes.7500626; Chen LWA, 2020, SCI TOTAL ENVIRON, V745, DOI 10.1016/j.scitotenv.2020.141105; Chimot J, 2016, ATMOS MEAS TECH, V9, P359, DOI 10.5194/amt-9-359-2016; Cooper MJ, 2020, ENVIRON RES LETT, V15, DOI 10.1088/1748-9326/aba3a5; Cooper MJ, 2019, GEOPHYS RES LETT, V46, P8442, DOI 10.1029/2019GL083673; Crouse DL, 2015, J EXPO SCI ENV EPID, V25, P482, DOI 10.1038/jes.2014.89; Dix B, 2020, GEOPHYS RES LETT, V47, DOI 10.1029/2019GL085866; Duncan BN, 2016, J GEOPHYS RES-ATMOS, V121, P976, DOI 10.1002/2015JD024121; Field R.D., 2020, CHANGES SATELLITE RE, V2020, DOI [10.5194/acp-2020-567, DOI 10.5194/ACP-2020-567]; Fu F, 2020, ATMOSPHERE-BASEL, V11, DOI 10.3390/atmos11111189; GATZ DF, 1995, ATMOS ENVIRON, V29, P1185, DOI 10.1016/1352-2310(94)00210-C; *GBD 2019 RISK FAC, 2019, LANCET, V0396; Geddes JA, 2016, ENVIRON HEALTH PERSP, V124, P281, DOI 10.1289/ehp.1409567; Georgoulias AK, 2019, ATMOS CHEM PHYS, V19, P6269, DOI 10.5194/acp-19-6269-2019; Gkatzelis GI, 2021, ELEMENTA-SCI ANTHROP, V9, DOI 10.1525/elementa.2021.00176; Goldberg D. L., 2020, TROPOMI NO2 US DETAI, DOI [10.1002/essoar.10503422.1, DOI 10.1002/ESSOAR.10503422.1]; Goldberg DL, 2020, GEOPHYS RES LETT, V47, DOI 10.1029/2020GL089269; Goldberg DL, 2019, ENVIRON SCI TECHNOL, V53, P12594, DOI 10.1021/acs.est.9b04488; Greene CA, 2019, GEOCHEM GEOPHY GEOSY, V20, P3774, DOI 10.1029/2019GC008392; Gu JB, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9060519; Hammer MS, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abg7670; Hammer MS, 2020, ENVIRON SCI TECHNOL, V54, P7879, DOI 10.1021/acs.est.0c01764; Hamra GB, 2015, ENVIRON HEALTH PERSP, V123, P1107, DOI 10.1289/ehp.1408882; Hilboll A., 2017, NO2 POLLUTION INDIA, DOI [10.5194/acp-2017-101, DOI 10.5194/ACP-2017-101]; Judd LM, 2019, ATMOS MEAS TECH, V12, P6091, DOI 10.5194/amt-12-6091-2019; Keller CA, 2021, ATMOS CHEM PHYS, V21, P3555, DOI 10.5194/acp-21-3555-2021; Kerr GH, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2022409118; Kharol SK, 2015, ATMOS ENVIRON, V118, P236, DOI 10.1016/j.atmosenv.2015.08.011; Koukouli ME, 2021, ATMOS CHEM PHYS, V21, P1759, DOI 10.5194/acp-21-1759-2021; Krotkov NA, 2016, ATMOS CHEM PHYS, V16, P4605, DOI 10.5194/acp-16-4605-2016; Lamsal LN, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009235; Lamsal LN, 2021, ATMOS MEAS TECH, V14, P455, DOI 10.5194/amt-14-455-2021; Laughner JL, 2016, ATMOS CHEM PHYS, V16, P15247, DOI 10.5194/acp-16-15247-2016; Le TH, 2020, SCIENCE, V369, P702, DOI 10.1126/science.abb7431; Levelt PF, 2006, IEEE T GEOSCI REMOTE, V44, P1093, DOI 10.1109/TGRS.2006.872333; Levelt PF, 2018, ATMOS CHEM PHYS, V18, P5699, DOI 10.5194/acp-18-5699-2018; Levy I, 2014, ENVIRON HEALTH PERSP, V122, P65, DOI 10.1289/ehp.1306518; Lin JT, 2014, ATMOS CHEM PHYS, V14, P1441, DOI 10.5194/acp-14-1441-2014; Lin N, 2019, SCI TOTAL ENVIRON, V675, P337, DOI 10.1016/j.scitotenv.2019.04.090; Liu F, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abc2992; Liu Q, 2021, SCI TOTAL ENVIRON, V776, DOI 10.1016/j.scitotenv.2021.146027; Liu S, 2020, ATMOS MEAS TECH, V13, P755, DOI 10.5194/amt-13-755-2020; Pannullo F, 2017, ENVIRON HEALTH-GLOB, V16, DOI 10.1186/s12940-017-0237-1; Park RJ, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004473; Prunet P, 2020, CITY ENVIRON INTERAC, V8, DOI 10.1016/j.cacint.2020.100051; Rienecker MM, 2011, J CLIMATE, V24, P3624, DOI 10.1175/JCLI-D-11-00015.1; Ropkins K, 2021, SCI TOTAL ENVIRON, V754, DOI 10.1016/j.scitotenv.2020.142374; Schenkeveld VME, 2017, ATMOS MEAS TECH, V10, P1957, DOI [10.5194/amt-10-1957-2017, 10.5194/amt-2016-420]; Shi XQ, 2020, GEOPHYS RES LETT, V47, DOI 10.1029/2020GL088070; Shi ZB, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abd6696; Spurr R., 2003, AREA WEIGHTING TESSE; Tao Y, 2014, ENVIRON POLLUT, V185, P196, DOI 10.1016/j.envpol.2013.10.035; van Geffen J, 2020, ATMOS MEAS TECH, V13, P1315, DOI 10.5194/amt-13-1315-2020; Veefkind JP, 2012, REMOTE SENS ENVIRON, V120, P70, DOI 10.1016/j.rse.2011.09.027; Venter ZS, 2020, P NATL ACAD SCI USA, V117, P18984, DOI 10.1073/pnas.2006853117; Verhoelst T, 2021, ATMOS MEAS TECH, V14, P481, DOI 10.5194/amt-14-481-2021; Vohra K, 2021, ATMOS CHEM PHYS, V21, P6275, DOI 10.5194/acp-21-6275-2021; Zeng W, 2020, ENVIRON RES, V189, DOI 10.1016/j.envres.2020.109926; Zhang RX, 2018, ATMOS MEAS TECH, V11, P3955, DOI 10.5194/amt-11-3955-2018; Zheng B, 2018, ATMOS CHEM PHYS, V18, P14095, DOI 10.5194/acp-18-14095-2018; Zhu L, 2017, ENVIRON SCI TECHNOL, V51, P5650, DOI 10.1021/acs.est.7b01356	70	22	22	41	88	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 20	2022	601	7893					380	+		10.1038/s41586-021-04229-0	http://dx.doi.org/10.1038/s41586-021-04229-0			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YJ6UI	35046607	Green Published, hybrid			2022-12-28	WOS:000744666700030
J	Kuehn, BM				Kuehn, Bridget M.			COVID-19 Cuts Life Expectancy in Dozens of Countries	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 18	2022	327	3					209	209						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YV9PQ	35040879	Bronze			2022-12-28	WOS:000753055100007
J	[Anonymous]				[Anonymous]			Update to living WHO guideline on drugs for covid-19	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	7	7	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 13	2022	376								o80	10.1136/bmj.o80	http://dx.doi.org/10.1136/bmj.o80			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZE9IW	35027394				2022-12-28	WOS:000759191400008
J	Moberly, T				Moberly, Tom			THE BIG PICTURE BMJ appeal 2021-22: Help bring hope to Afghanistan	BMJ-BRITISH MEDICAL JOURNAL			English	News Item															Green Room Charitable Trust	Green Room Charitable Trust	The 2021-22 appeal is being supported by the Green Room Charitable Trust, which has made up to 50 pound 000 available to match donations received before 31 January 2022. This means that your support will go even further.		0	0	0	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 12	2022	376								o55	10.1136/bmj.o55	http://dx.doi.org/10.1136/bmj.o55			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YP6JI	35022160				2022-12-28	WOS:000748728200005
J	Iacobucci, G				Iacobucci, Gareth			Covid-19: NHS trusts declare "critical incidents" because of staff shortages	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2022, NHS CONFEDERATI 0103	1	9	9	3	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 4	2022	376								o3	10.1136/bmj.o3	http://dx.doi.org/10.1136/bmj.o3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YD7MV	34983792	Bronze			2022-12-28	WOS:000740622800001
J	Carreno, JM; Alshammary, H; Tcheou, J; Singh, G; Raskin, AJ; Kawabata, H; Sominsky, LA; Clark, JJ; Adelsberg, DC; Bielak, DA; Gonzalez-Reiche, AS; Dambrauskas, N; Vigdorovich, V; Srivastava, K; Sather, DN; Sordillo, EM; Bajic, G; van Bakel, H; Simon, V; Krammer, F				Carreno, Juan Manuel; Alshammary, Hala; Tcheou, Johnstone; Singh, Gagandeep; Raskin, Ariel J.; Kawabata, Hisaaki; Sominsky, Levy A.; Clark, Jordan J.; Adelsberg, Daniel C.; Bielak, Dominika A.; Gonzalez-Reiche, Ana Silvia; Dambrauskas, Nicholas; Vigdorovich, Vladimir; Srivastava, Komal; Sather, D. Noah; Sordillo, Emilia Mia; Bajic, Goran; van Bakel, Harm; Simon, Viviana; Krammer, Florian		PSP-PARIS Study Grp	Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron	NATURE			English	Article							ANTIBODIES; RBD	The Omicron (B.1.1.529) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was initially identified in November 2021 in South Africa and Botswana, as well as in a sample from a traveller from South Africa in Hong Kong(1,2). Since then, Omicron has been detected globally. This variant appears to be at least as infectious as Delta (B.1.617.2), has already caused superspreader events(3), and has outcompeted Delta within weeks in several countries and metropolitan areas. Omicron hosts an unprecedented number of mutations in its spike gene and early reports have provided evidence for extensive immune escape and reduced vaccine effectiveness(2,4-6). Here we investigated the virus-neutralizing and spike protein-binding activity of sera from convalescent, double mRNA-vaccinated, mRNA-boosted, convalescent double-vaccinated and convalescent boosted individuals against wild-type, Beta (B.1.351) and Omicron SARS-CoV-2 isolates and spike proteins. Neutralizing activity of sera from convalescent and double-vaccinated participants was undetectable or very low against Omicron compared with the wild-type virus, whereas neutralizing activity of sera from individuals who had been exposed to spike three or four times through infection and vaccination was maintained, although at significantly reduced levels. Binding to the receptor-binding and N-terminal domains of the Omicron spike protein was reduced compared with binding to the wild type in convalescent unvaccinated individuals, but was mostly retained in vaccinated individuals.	[Carreno, Juan Manuel; Alshammary, Hala; Tcheou, Johnstone; Singh, Gagandeep; Raskin, Ariel J.; Kawabata, Hisaaki; Sominsky, Levy A.; Clark, Jordan J.; Adelsberg, Daniel C.; Bielak, Dominika A.; Srivastava, Komal; Bajic, Goran; Simon, Viviana; Krammer, Florian] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA; [Gonzalez-Reiche, Ana Silvia; van Bakel, Harm] ISMMS, Dept Genet & Genom Sci, New York, NY 10029 USA; [van Bakel, Harm] ISMMS, Icahn Genom Inst, New York, NY 10029 USA; [Dambrauskas, Nicholas; Vigdorovich, Vladimir; Sather, D. Noah] Univ Washington, Ctr Global Infect Dis Res, Seattle Childrens Res Inst, Seattle, WA USA; [Sather, D. Noah] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Sordillo, Emilia Mia; van Bakel, Harm; Simon, Viviana; Krammer, Florian] ISMMS, Dept Pathol Mol & Cell Based Med, New York, NY 10029 USA; [Simon, Viviana] ISMMS, Dept Med, Div Infect Dis, New York, NY 10029 USA; [Simon, Viviana] ISMMS, Global Hearth & Emerging Pathogens Inst, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Bajic, G; Simon, V; Krammer, F (corresponding author), Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.; van Bakel, H (corresponding author), ISMMS, Dept Genet & Genom Sci, New York, NY 10029 USA.; van Bakel, H (corresponding author), ISMMS, Icahn Genom Inst, New York, NY 10029 USA.; Sordillo, EM; van Bakel, H; Simon, V; Krammer, F (corresponding author), ISMMS, Dept Pathol Mol & Cell Based Med, New York, NY 10029 USA.; Simon, V (corresponding author), ISMMS, Dept Med, Div Infect Dis, New York, NY 10029 USA.; Simon, V (corresponding author), ISMMS, Global Hearth & Emerging Pathogens Inst, New York, NY 10029 USA.	emilia.sordillo@mountsinai.org; goran.bajic@mssm.edu; harm.vanbakel@mssm.edu; viviana.simon@mssm.edu; florian.krammer@mssm.edu	Krammer, Florian/H-3237-2019; Singh, Gagandeep/AAH-9436-2021; Clark, Jordan/GOJ-7992-2022	Krammer, Florian/0000-0003-4121-776X; Singh, Gagandeep/0000-0001-5848-2741; Clark, Jordan/0000-0003-1790-7883; Raskin, Ariel/0000-0001-9110-8217; Sominsky, Levy/0000-0001-8084-3187; Adelsberg, Daniel/0000-0003-0591-7136; Bajic, Goran/0000-0003-0480-4324; Carreno Quiroz, Juan Manuel/0000-0002-9039-9275; Kleiner, Giulio/0000-0002-1830-3961	NIAID Collaborative Influenza Vaccine Innovation Centers (CIVIC) [75N93019C00051]; NIAID Centers of Excellence for Influenza Research and Response (CEIRR) [75N93021C00014]; institutional School of Medicine and Hospital funds	NIAID Collaborative Influenza Vaccine Innovation Centers (CIVIC); NIAID Centers of Excellence for Influenza Research and Response (CEIRR); institutional School of Medicine and Hospital funds	We thank the study participants for their generosity and willingness to participate in longitudinal COVID-19 research studies. We thank the Rapid Response Laboratories and the Molecular Microbiology Laboratory of the Mount Sinai Health System for their assistance in the expeditious transfer of SARS-CoV-2 positive diagnostic specimen; R. A. Albrecht for oversight of the conventional BSL3 biocontainment facility; J. Kimpel and D. von Laer for sharing B.1.1.529 virus isolates (even though they could not be included in this work); P. Palese, C. Cordon-Cardo, D. Charney, D. Reich and K. Davis for their leadership and support throughout the COVID-19 pandemic; and D. Caughey for expert administrative assistance. This work is part of the PARIS/SPARTA studies funded by the NIAID Collaborative Influenza Vaccine Innovation Centers (CIVIC) contract 75N93019C00051. In addition, this work was also partially funded by the NIAID Centers of Excellence for Influenza Research and Response (CEIRR) contract and 75N93021C00014 by anonymous donors. The Mount Sinai Pathogen Surveillance Program is supported by institutional School of Medicine and Hospital funds. This work is part of the NIAID SARS-CoV-2 Assessment of Viral Evolution (SAVE) program.	Amanat F, 2021, CELL, V184, P3936, DOI 10.1016/j.cell.2021.06.005; Amanat Fatima, 2020, Curr Protoc Microbiol, V58, pe108, DOI 10.1002/cpmc.108; Amanat F, 2020, NAT MED, V26, P1033, DOI [10.1038/s41591-020-0913-5, 10.1101/2020.03.17.20037713]; Amanat F, 2018, MSPHERE, V3, DOI 10.1128/mSphere.00189-18; Arunkumar GA, 2019, J VIROL, V93, DOI 10.1128/JVI.01696-18; Bernal JL, 2021, NEW ENGL J MED, V385, P585, DOI 10.1056/NEJMoa2108891; Brandal LT, 2021, EUROSURVEILLANCE, V26, DOI 10.2807/1560-7917.ES.2021.26.50.2101147; Cameroni E, 2022, NATURE, V602, P664, DOI [10.1038/s41586-021-04386-2, 10.1101/2021.12.12.472269]; Carreno JM, 2021, EBIOMEDICINE, V73, DOI 10.1016/j.ebiom.2021.103626; Cele S, 2022, NATURE, V602, P654, DOI 10.1038/s41586-021-04387-1; Cerutti G, 2021, CELL HOST MICROBE, V29, P819, DOI 10.1016/j.chom.2021.03.005; Chi XY, 2020, SCIENCE, V369, P650, DOI 10.1126/science.abc6952; DiLillo DJ, 2014, NAT MED, V20, P143, DOI 10.1038/nm.3443; Earle KA, 2021, VACCINE, V39, P4423, DOI 10.1016/j.vaccine.2021.05.063; GeurtsvanKessel CH., 2021, MEDRXIV2021220220211, DOI [10.1101/2021.12.27.21268416, DOI 10.1101/2021.12.27.21268416]; Gilbert PB, 2022, SCIENCE, V375, P43, DOI 10.1126/science.abm3425; Gonzalez-Reiche AS, 2020, SCIENCE, V369, P297, DOI 10.1126/science.abc1917; Gu HG, 2022, EMERG INFECT DIS, V28, P460, DOI 10.3201/eid2802.212422; Krammer F, 2021, NEW ENGL J MED, V384, P1372, DOI 10.1056/NEJMc2101667; Lan J, 2020, NATURE, V581, P215, DOI 10.1038/s41586-020-2180-5; Liu LH, 2022, NATURE, V602, P676, DOI 10.1038/s41586-021-04388-0; Margine I, 2013, JOVE-J VIS EXP, DOI 10.3791/51112; Ng S, 2019, NAT MED, V25, P962, DOI 10.1038/s41591-019-0463-x; Pulliam JRC., 2021, INCREASED RISK SARS, DOI [10.1101/2021.11.11.21266068, 10.1101/2021.11.11.21266068:2021.11.11.21266068, DOI 10.1101/2021.11.11.21266068:2021.11.11.21266068]; Rossler A, 2022, NEW ENGL J MED, V386, P698, DOI 10.1056/NEJMc2119236; Rosa A, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abg7607; Rosenberg ES, 2022, NEW ENGL J MED, V386, P116, DOI 10.1056/NEJMoa2116063; Stadlbauer Daniel, 2020, Curr Protoc Microbiol, V57, pe100, DOI 10.1002/cpmc.100; Turner JS, 2021, NATURE, V596, P109, DOI 10.1038/s41586-021-03738-2; Uriu K, 2021, NEW ENGL J MED, V385, DOI 10.1056/NEJMc2114706; Voss WN, 2021, SCIENCE, V372, P1108, DOI 10.1126/science.abg5268; Wilhelm A., 2021, REDUCED NEUTRALIZATI, DOI [10.1101/2021.12.07.21267432, DOI 10.15585/MMWR.MM7011A1EXTERNALICON, DOI 10.1101/2021.12.07.21267432]	32	159	161	36	53	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 24	2022	602	7898					682	+		10.1038/s41586-022-04399-5	http://dx.doi.org/10.1038/s41586-022-04399-5		DEC 2021	17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZG7GF	35016197	Bronze			2022-12-28	WOS:000756560000001
J	Cao, Y; Neytcheva, M				Cao, Yang; Neytcheva, Maya			Cell-by-cell approximate Schur complement technique in preconditioning of meshfree discretized piezoelectric equations	NUMERICAL LINEAR ALGEBRA WITH APPLICATIONS			English	Article						approximate Schur complement; meshfree discretization; piezoelectricity; preconditioning; saddle point linear systems		The radial point interpolation meshfree discretization is a very efficient numerical framework for the analysis of piezoelectricity, in which the fundamental electrostatic equations governing piezoelectric media are solved without mesh generation. Due to the mechanical-electrical coupling property and the piezoelectric constant, the discrete linear system is sparse, of generalized saddle point form and often very ill conditioned. In this work, we propose a technique for constructing a family of cell-by-cell approximate Schur complement matrices, to be used in preconditioning to accelerate the convergence of Krylov subspace iteration methods for such problems. The approximate Schur complement matrices are simply and cheaply constructed in the process of the meshfree discretization and have a sparse structure. It is proved that the so-constructed approximate Schur complement matrices are spectrally equivalent to the exact Schur complement matrix, which leads to very fast convergence when used in preconditioning. In addition, nondimensionalization of the piezoelectric equations is considered to make the computations more stable. The robustness and the efficiency of the proposed preconditioners is illustrated numerically on two test problems, arising from a piezoelectric strip shear deformation problem and a piezoelectric strip bending problem. Numerical results show that the number of iterations to achieve a given tolerance is independent of the number of degrees of freedom as well as of the various problem parameters.	[Cao, Yang] Nantong Univ, Sch Transportat & Civil Engn, Nantong, Peoples R China; [Neytcheva, Maya] Uppsala Univ, Dept Informat Technol, S-75105 Uppsala, Sweden	Nantong University; Uppsala University	Neytcheva, M (corresponding author), Uppsala Univ, Dept Informat Technol, S-75105 Uppsala, Sweden.	maya.neytcheva@it.uu.se		Jian, Fanchong/0000-0001-8703-3507; Cao, Yunlong/0000-0001-5918-1078; Huang, Weijin/0000-0002-4246-8889; Neytcheva, Maya/0000-0002-6719-4984; wang, jing/0000-0002-9084-9985	National Natural Science Foundation of China [11771225, 11572210]; Vetenskapsradet [2017-03749]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Vetenskapsradet(Swedish Research Council)	National Natural Science Foundation of China, Grant/Award Number: 11771225, 11572210; Vetenskapsradet, Grant/Award Number: 2017-03749	Axelsson O, 2006, NUMER LINEAR ALGEBR, V13, P339, DOI 10.1002/nla.469; Axelsson O, 1999, MATH COMPUT SIMULAT, V50, P11, DOI 10.1016/S0378-4754(99)00058-0; Axelsson O, 2015, NUMER LINEAR ALGEBR, V22, P233, DOI 10.1002/nla.1947; Axelsson O, 2013, NUMER LINEAR ALGEBR, V20, P723, DOI 10.1002/nla.830; Axelsson O, 2009, SIAM J MATRIX ANAL A, V31, P767, DOI 10.1137/070679673; BELYTSCHKO T, 1994, INT J NUMER METH ENG, V37, P229, DOI 10.1002/nme.1620370205; Benjeddou A, 2000, COMPUT STRUCT, V76, P347, DOI 10.1016/S0045-7949(99)00151-0; Benzi M, 2005, ACTA NUMER, V14, P1, DOI 10.1017/S0962492904000212; Cao Y, 2021, NUMER LINEAR ALGEBR, V28, DOI [10.1002/nla.2362, 10.1038/s41586-021-04385-3]; Cao Y, 2013, J COMPUT MATH, V31, P398, DOI 10.4208/jcm.1304-m4209; Cao Y, 2013, ACTA MECH SOLIDA SIN, V26, P302, DOI 10.1016/S0894-9166(13)60028-2; Chen SS, 2013, ENG ANAL BOUND ELEM, V37, P273, DOI 10.1016/j.enganabound.2012.10.002; Dolbow J, 1999, COMPUT MECH, V23, P219, DOI 10.1007/s004660050403; Dorostkar A, 2016, COMPUT METHOD APPL M, V309, P74, DOI 10.1016/j.cma.2016.05.042; Dorostkar A, 2015, PARALLEL COMPUT, V49, P164, DOI 10.1016/j.parco.2015.06.003; Fasshauer G.E., 2007, MESHFREE APPROXIMATI, V6; Flyer N, 2016, J COMPUT PHYS, V321, P21, DOI 10.1016/j.jcp.2016.05.026; Garg S, 2018, INT J COMP METH-SING, V15, DOI 10.1142/S0219876218300015; HORGAN CO, 1983, ARCH RATION MECH AN, V82, P165, DOI 10.1007/BF00250935; Igumnov LA, 2019, MATER PHYS MECH, V42, P256, DOI 10.18720/MPM.4222019_12; Kraus J, 2015, NUMER LINEAR ALGEBR, V22, P965, DOI 10.1002/nla.1959; Kraus JK, 2006, NUMER LINEAR ALGEBR, V13, P49, DOI 10.1002/nla.462; Kraus J, 2016, SIAM J SCI COMPUT, V38, pA875, DOI 10.1137/140974092; Kraus J, 2012, SIAM J SCI COMPUT, V34, pA2872, DOI 10.1137/110845082; Legner D, 2013, INT J NUMER METH ENG, V95, P901, DOI 10.1002/nme.4521; Liu G.R., 2005, INTRO MESHFREE METHO; Liu GR, 2003, SMART MATER STRUCT, V12, P171, DOI 10.1088/0964-1726/12/2/303; Liu GR, 2002, COMPUT MECH, V29, P510, DOI 10.1007/s00466-002-0360-9; Murphy MF, 2000, SIAM J SCI COMPUT, V21, P1969, DOI 10.1137/S1064827599355153; Napov A, 2012, SIAM J SCI COMPUT, V34, pA1079, DOI 10.1137/100818509; Neytcheva M, 2011, LINEAR ALGEBRA APPL, V434, P2308, DOI 10.1016/j.laa.2010.03.031; Nguyen-Van H, 2008, CMES-COMP MODEL ENG, V23, P209; Notay Y, 2012, SIAM J SCI COMPUT, V34, pA2288, DOI 10.1137/110835347; Notay Y, 2010, ELECTRON T NUMER ANA, V37, P123; Ohs RR, 2001, COMPUT MECH, V27, P23, DOI 10.1007/s004660000211; Polla DL, 1998, ANNU REV MATER SCI, V28, P563, DOI 10.1146/annurev.matsci.28.1.563; Saad Y., 2003, ITERATIVE METHODS SP, DOI [10.1137/1.9780898718003, DOI 10.1137/1.9780898718003]; Sladek J, 2006, CMC-COMPUT MATER CON, V4, P109; Bui TQ, 2011, SMART MATER STRUCT, V20, DOI 10.1088/0964-1726/20/6/065016; Wang BB, 2019, ENG ANAL BOUND ELEM, V98, P157, DOI 10.1016/j.enganabound.2018.10.020; Wang JG, 2002, INT J NUMER METH ENG, V54, P1623, DOI 10.1002/nme.489; Zienkiewicz OC, 2005, FINITE ELEMENT METHOD FOR FLUID DYNAMICS, 6TH EDITION, P1	42	289	303	63	65	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1070-5325	1099-1506		NUMER LINEAR ALGEBR	Numer. Linear Algebr. Appl.	AUG	2021	28	4								10.1002/nla.2362	http://dx.doi.org/10.1002/nla.2362		FEB 2021	30	Mathematics, Applied; Mathematics	Science Citation Index Expanded (SCI-EXPANDED)	Mathematics	TC5NM	35016194				2022-12-28	WOS:000615995000001
J	Colaianni, CA				Colaianni, C. Alessandra			Lens - On Aesthetic Distance and Empathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Colaianni, C. Alessandra] Oregon Hlth & Sci Univ, Dept Otolaryngol Head & Neck Surg, Portland, OR 97201 USA	Oregon Health & Science University	Colaianni, CA (corresponding author), Oregon Hlth & Sci Univ, Dept Otolaryngol Head & Neck Surg, Portland, OR 97201 USA.							[Anonymous], Hear from the artist: Graciela Iturbide's Mexico.; Gresh K., 2019, GRACIELA ITURBIDES M; Iturbide G., 1993, NOMBRE PADRE; Iturbide G, 2006, EYES FLY PORTRAITS S; Lanzoni S, 2018, EMPATHY HIST; Meyers W., 2019, WALL STR J; Taladrid S., 2019, NEW YORKER; Underman K, 2016, SOC SCI MED, V160, P94, DOI 10.1016/j.socscimed.2016.05.027	8	0	0	1	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 20	2022	386	3					290	293		10.1056/NEJMms2107241	http://dx.doi.org/10.1056/NEJMms2107241			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YK1UG	35045233				2022-12-28	WOS:000745006000018
J	Grayson, PC; Perugino, CA; Dinculescu, VV; Ferry, JA				Grayson, Peter C.; Perugino, Cory A.; Dinculescu, Vincent V.; Ferry, Judith A.			Case 2-2022: A 70-Year-Old Man with a Recurrent Left Pleural Effusion	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VEXAS SYNDROME	A Man with a Recurrent Left Pleural Effusion A 70-year-old man presented with a recurrent left pleural effusion. He had a history of polymyalgia rheumatica, relapsing polychondritis, scleritis, macrocytic anemia, and intermittent neutropenia, all of which had been refractory to multiple immunosuppressive agents. A diagnostic test was performed, and management decisions were made.	[Grayson, Peter C.] NIAMSD, Syst Autoimmun Branch, NIH, Bethesda, MD 20892 USA; [Perugino, Cory A.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Dinculescu, Vincent V.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA USA; [Ferry, Judith A.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Perugino, Cory A.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Dinculescu, Vincent V.] Harvard Med Sch, Dept Radiol, Boston, MA 02115 USA; [Ferry, Judith A.] Harvard Med Sch, Dept Pathol, Boston, MA 02115 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Grayson, PC (corresponding author), NIAMSD, Syst Autoimmun Branch, NIH, Bethesda, MD 20892 USA.							Balbir-Gurman A, 2006, SEMIN ARTHRITIS RHEU, V35, P368, DOI 10.1016/j.semarthrit.2006.03.002; Beck DB, 2020, NEW ENGL J MED, V383, P2628, DOI 10.1056/NEJMoa2026834; Bourbon E, 2021, BLOOD, V137, P3682, DOI 10.1182/blood.2020010177; Dion J, 2016, ARTHRITIS RHEUMATOL, V68, P2992, DOI 10.1002/art.39790; Ferrada M, 2020, ARTHRITIS RHEUMATOL, V72, P1396, DOI 10.1002/art.41270; Ferrada MA, 2021, ARTHRITIS RHEUMATOL, V73, P1886, DOI 10.1002/art.41743; Grayson PC, 2021, BLOOD, V137, P3591, DOI 10.1182/blood.2021011455; Merkel PA, 2005, ANN INTERN MED, V142, P620, DOI 10.7326/0003-4819-142-8-200505030-00011; Mustjoki Satu, 2021, N Engl J Med, V385, pe34, DOI 10.1056/NEJMc2110545; Obiorah IE, 2021, BLOOD ADV, V5, P3203, DOI 10.1182/bloodadvances.2021004976; Oganesyan A, 2021, RHEUMATOLOGY, V60, pE321, DOI 10.1093/rheumatology/keab225; Sharma A., 2021, ARTHRITIS RHEUMATOL; Weyand CM, 2014, NEW ENGL J MED, V371, P1653, DOI [10.1056/NEJMcp1214825, 10.1056/NEJMc1409206]; Zhao LP, 2021, LEUKEMIA, V35, P2731, DOI 10.1038/s41375-021-01353-8	14	0	0	6	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 20	2022	386	3					274	283		10.1056/NEJMcpc2115847	http://dx.doi.org/10.1056/NEJMcpc2115847			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YK1UG	35045230				2022-12-28	WOS:000745006000015
J	Iacobucci, G				Iacobucci, Gareth			Covid-19: Focus should be on new vaccines rather than boosters, says WHO	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		WHO, 2022, INT STAT COV 19 VACC	1	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 17	2022	376								o108	10.1136/bmj.o108	http://dx.doi.org/10.1136/bmj.o108			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YP6HX	35039317	Bronze			2022-12-28	WOS:000748724000002
J	Henderson, K				Henderson, Katherine			Recognising how big a problem we currently have in the NHS is the beginning of trying to solve it	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Henderson, Katherine] Royal Coll Emergency Med, London, England		Henderson, K (corresponding author), Royal Coll Emergency Med, London, England.							NHS England, URG EM CAR DAIL SIT; NHS England, CLIN LED REV URG EM; NHS England, AMB QUAL IND DAT 202; NHS England, STAT COMM NOV 2021; WHO, EM CAR SYST UN HLTH	5	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 14	2022	376								o103	10.1136/bmj.o103	http://dx.doi.org/10.1136/bmj.o103			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZE9IM	35031562	Bronze			2022-12-28	WOS:000759190400006
J	Herbert, M; Surani, A				Herbert, Mary; Surani, Azim			Oocytes from Stem Cells	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								From Stem Cell to Oocyte to Newborn A recent study involving murine stem cells showed a recapitulation of the entire female germline life cycle, which resulted in fertilizable mouse oocytes in culture. Among approximately 200 resultant two-cell embryos transferred into pseudopregnant dams, 5% resulted in live offspring.	[Herbert, Mary] Newcastle Univ, Newcastle Fertil Ctr, Biosci Inst, Newcastle Upon Tyne, Tyne & Wear, England; [Surani, Azim] Univ Cambridge, Gurdon Inst, Cambridge, England	Newcastle University - UK; University of Cambridge	Herbert, M (corresponding author), Newcastle Univ, Newcastle Fertil Ctr, Biosci Inst, Newcastle Upon Tyne, Tyne & Wear, England.							Cahoon CK, 2016, NAT STRUCT MOL BIOL, V23, P369, DOI 10.1038/nsmb.3208; Dokshin GA, 2013, NAT GENET, V45, P877, DOI 10.1038/ng.2672; Hikabe O, 2016, NATURE, V539, P299, DOI 10.1038/nature20104; McLaren A, 2003, DEV BIOL, V262, P1, DOI 10.1016/S0012-1606(03)00214-8; Yoshino T, 2021, SCIENCE, V373, DOI 10.1126/science.abe0237	5	0	0	1	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 13	2022	386	2					188	190		10.1056/NEJMcibr2112049	http://dx.doi.org/10.1056/NEJMcibr2112049			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YF2NZ	35020990				2022-12-28	WOS:000741651400019
J	Kadambari, S; Goldacre, R; Morris, E; Goldacre, MJ; Pollard, AJ				Kadambari, Seilesh; Goldacre, Raphael; Morris, Eva; Goldacre, Michael J.; Pollard, Andrew J.			Indirect effects of the covid-19 pandemic on childhood infection in England: population based observational study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HOME	OBJECTIVE To assess the impact of the covid-19 pandemic on hospital admission rates and mortality outcomes for childhood respiratory infections, severe invasive infections, and vaccine preventable disease in England. DESIGN Population based observational study of 19 common childhood respiratory, severe invasive, and vaccine preventable infections, comparing hospital admission rates and mortality outcomes before and after the onset of the pandemic in England. SETTING Hospital admission data from every NHS hospital in England from 1 March 2017 to 30 June 2021 with record linkage to national mortality data. POPULATION Children aged 0-14 years admitted to an NHS hospital with a selected childhood infection from 1 March 2017 to 30 June 2021. MAIN OUTCOME MEASURES For each infection, numbers of hospital admissions every month from 1 March 2017 to 30 June 2021, percentage changes in the number of hospital admissions before and after 1 March 2020, and adjusted odds ratios to compare 60 day case fatality outcomes before and after 1 March 2020. RESULTS After 1 March 2020, substantial and sustained reductions in hospital admissions were found for all but one of the 19 infective conditions studied. Among the respiratory infections, the greatest percentage reductions were for influenza (mean annual number admitted between 1 March 2017 and 29 February 2020 was 5379 and number of children admitted from 1 March 2020 to 28 February 2021 was 304, 94% reduction, 95% confidence interval 89% to 97%), and bronchiolitis (from 51 655 to 9423, 82% reduction, 95% confidence interval 79% to 84%). Among the severe invasive infections, the greatest reduction was for meningitis (50% reduction, 47% to 52%). For the vaccine preventable infections, reductions ranged from 53% (32% to 68%) for mumps to 90% (80% to 95%) for measles. Reductions were seen across all demographic subgroups and in children with underlying comorbidities. Corresponding decreases were also found for the absolute numbers of 60 day case fatalities, although the proportion of children admitted for pneumonia who died within 60 days increased (age-sex adjusted odds ratio 1.71, 95% confidence interval 1.43 to 2.05). More recent data indicate that some respiratory infections increased to higher levels than usual after May 2021. CONCLUSIONS During the covid-19 pandemic, a range of behavioural changes (adoption of non-pharmacological interventions) and societal strategies (school closures, lockdowns, and restricted travel) were used to reduce transmission of SARS-CoV-2, which also reduced admissions for common and severe childhood infections. Continued monitoring of these infections is required as social restrictions evolve.	[Kadambari, Seilesh; Pollard, Andrew J.] Univ Oxford, Dept Paediat, Oxford Vaccine Grp, Oxford, England; [Kadambari, Seilesh; Pollard, Andrew J.] NIHR Oxford Biomed Res Ctr, Oxford, England; [Goldacre, Raphael; Morris, Eva; Goldacre, Michael J.] Univ Oxford, Big Data Inst, Nuffield Dept Populat & Hlth, Unit Hlth Care Epidemiol, Oxford, England	University of Oxford; University of Oxford; University of Oxford	Kadambari, S (corresponding author), Univ Oxford, Dept Paediat, Oxford Vaccine Grp, Oxford, England.; Kadambari, S (corresponding author), NIHR Oxford Biomed Res Ctr, Oxford, England.	Seilesh.kadambari@paediatrics.ox.ac.uk		Morris, Eva/0000-0002-1075-6544; kadambari, seilesh/0000-0003-3658-7635	Office for Health Improvement and Disparities, Health Data Research UK; National Institute for Health Research Oxford Biomedical Research Centre	Office for Health Improvement and Disparities, Health Data Research UK; National Institute for Health Research Oxford Biomedical Research Centre(National Institute for Health Research (NIHR))	Office for Health Improvement and Disparities, Health Data Research UK, and the National Institute for Health Research Oxford Biomedical Research Centre. The funders had no role in study design, data collection, data analysis, data interpretation, or writing of the report.	American Academy of Pediatrics, CHILDR COVID 19 STAT; Angoulvant F, 2021, CLIN INFECT DIS, V72, P319, DOI 10.1093/cid/ciaa710; Brown J., 2021, COR HIST ENGL LOCKD; Brueggemann AB, 2021, LANCET DIGIT HEALTH, V3, pE360, DOI 10.1016/S2589-7500(21)00077-7; Brunstein JD, 2008, J CLIN MICROBIOL, V46, P97, DOI 10.1128/JCM.01117-07; Dong YY, 2020, PEDIATRICS, V145, DOI 10.1542/peds.2020-0702; Flaxman S, 2020, NATURE, V584, P257, DOI 10.1038/s41586-020-2405-7; Fricke LM, 2021, J INFECTION, V82, P1, DOI 10.1016/j.jinf.2020.11.039; Gotzinger F, 2020, LANCET CHILD ADOLESC, V4, P653, DOI 10.1016/S2352-4642(20)30177-2; Green CA, 2016, ARCH DIS CHILD, V101, P140, DOI 10.1136/archdischild-2015-308723; Hensey CC, 2017, PEDIATR INFECT DIS J, V36, P827, DOI 10.1097/INF.0000000000001605; Ibrahim LF, 2016, PEDIATR INFECT DIS J, V35, P269, DOI 10.1097/INF.0000000000000992; Isba R, 2020, ARCH DIS CHILD, V105, P704, DOI 10.1136/archdischild-2020-319385; Jackson C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097297; Kadambari S, 2020, PEDIATR INFECT DIS J, V39, pE385, DOI 10.1097/INF.0000000000002870; Krivec U, 2020, ARCH DIS CHILD, V105, P809, DOI 10.1136/archdischild-2020-319522; Kruizinga MD, 2021, EUR J PEDIATR, V180, P2271, DOI 10.1007/s00431-021-04015-0; Ladhani SN, 2021, LANCET CHILD ADOLESC, V5, P417, DOI 10.1016/S2352-4642(21)00061-4; Lazzerini M, 2020, LANCET CHILD ADOLESC, V4, pE10, DOI 10.1016/S2352-4642(20)30108-5; Lynn RM, 2021, ARCH DIS CHILD, V106, DOI 10.1136/archdischild-2020-319848; McDonald HI, 2020, EUROSURVEILLANCE, V25, P7, DOI 10.2807/1560-7917.ES.2020.25.19.2000848; McLennan D., 2019, ENGLISH INDICES DEPR; Moore DP, 2012, EXPERT REV RESP MED, V6, P451, DOI [10.1586/ers.12.32, 10.1586/ERS.12.32]; NHS Digital, 2020, CHILDH VACC COV STAT; Polcwiartek LB, 2021, EUR J PEDIATR, V180, P1955, DOI 10.1007/s00431-021-03934-2; Scanlan BT, 2019, PEDIATR INFECT DIS J, V38, pE20, DOI 10.1097/INF.0000000000002070; Stokes EK, 2020, MMWR-MORBID MORTAL W, V69, P759, DOI 10.15585/mmwr.mm6924e2; Swann OV, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3249; Todd IMF, 2021, INT J EPIDEMIOL, V50, P1435, DOI 10.1093/ije/dyab101; Vasquez-Hoyos P, 2021, ARCH DIS CHILD, V106, P808, DOI 10.1136/archdischild-2020-320469; Viner R., 2021, IMPACTS SCH CLOSURES, DOI [10.1101/2021.02.10.21251526v1, DOI 10.1101/2021.02.10.21251526]; WHO, 2020, LEAST 80 MILL CHILDR; WHO Regional Office for Europe, 2020, MIN BACK 5 YEAR PLAN; Williams TC, 2021, ARCH DIS CHILD, V106, P911, DOI 10.1136/archdischild-2020-321008; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Yeoh DK, 2021, CLIN INFECT DIS, V72, P2199, DOI 10.1093/cid/ciaa1475	36	8	9	5	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 12	2022	376								e067519	10.1136/bmj-2021-067519	http://dx.doi.org/10.1136/bmj-2021-067519			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YP6JI	35022215	hybrid, Green Published			2022-12-28	WOS:000748728200006
J	Collins-Key, SA				Collins-Key, Savannah A.			Beyond Title IX	SCIENCE			English	Editorial Material									[Collins-Key, Savannah A.] Univ Tennessee, Knoxville, TN 37996 USA	University of Tennessee System; University of Tennessee Knoxville	Collins-Key, SA (corresponding author), Univ Tennessee, Knoxville, TN 37996 USA.								0	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 7	2022	375	6576					114	114						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YD3FW	34990250				2022-12-28	WOS:000740261400050
J	Huycke, TR; Gartner, ZJ				Huycke, Tyler R.; Gartner, Zev J.			Setting boundaries for tissue patterning	SCIENCE			English	Editorial Material									[Huycke, Tyler R.] Univ Florida, Dept Microbiol & Cell Sci, Inst Food & Agr Sci, Ft Lauderdale Res & Educ Ctr, Davie, FL 33314 USA; [Gartner, Zev J.] Univ Oklahoma, Dept Microbiol & Plant Biol, Norman, OK 73019 USA	State University System of Florida; University of Florida; University of Oklahoma System; University of Oklahoma - Norman	Gartner, ZJ (corresponding author), Univ Oklahoma, Dept Microbiol & Plant Biol, Norman, OK 73019 USA.	zev.gartner@ucsf.edu						BISSELL MJ, 1982, J THEOR BIOL, V99, P31, DOI 10.1016/0022-5193(82)90388-5; Gjorevski N, 2021, SCIENCE, V375; Guiu J., 2021, CELL MOL GASTROENTER, V13, P1; Guiu J, 2019, NATURE, V570, P107, DOI 10.1038/s41586-019-1212-5; Karzbrun E, 2021, NATURE, V599, P268, DOI 10.1038/s41586-021-04026-9; Martyn L, 2021, DEV BIOL, V474, P62, DOI 10.1016/j.ydbio.2021.01.017; McCarthy N, 2020, CELL STEM CELL, V26, P391, DOI 10.1016/j.stem.2020.01.008; Nelson CM, 2006, SCIENCE, V314, P298, DOI 10.1126/science.1131000; Perez-Gonzalez C, 2021, NAT CELL BIOL, V23, P745, DOI 10.1038/s41556-021-00699-6; Serra D, 2019, NATURE, V569, P66, DOI 10.1038/s41586-019-1146-y; Shyer AE, 2015, CELL, V161, P569, DOI 10.1016/j.cell.2015.03.041; Sugimoto S., 2021, CELL MOL GASTROENTER, V13, P195; Thorne CA, 2018, DEV CELL, V44, P624, DOI 10.1016/j.devcel.2018.01.024; Yang QT, 2021, NAT CELL BIOL, V23, P733, DOI 10.1038/s41556-021-00700-2	14	1	1	2	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 7	2022	375	6576					26	27		10.1126/science.abn3054	http://dx.doi.org/10.1126/science.abn3054			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YD3FW	34990228				2022-12-28	WOS:000740261400026
J	Adashi, EY; Cohen, IG				Adashi, Eli Y.; Cohen, I. Glenn			The Pandemic Preparedness Program Reimagining Public Health	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Adashi, Eli Y.] Brown Univ, Dept Med Sci, 222 Richmond St, Providence, RI 02903 USA; [Cohen, I. Glenn] Harvard Univ, Harvard Law, Petrie Flom Ctr Hlth Law Policy Biotechnol & Bioe, Cambridge, MA USA	Brown University; Harvard University	Adashi, EY (corresponding author), Brown Univ, Dept Med Sci, 222 Richmond St, Providence, RI 02903 USA.	eli_adashi@brown.edu						Alexander L, PREPARING NEXT PANDE; Congressional Research Service, US GLOB HLTH ASS FY2; National Institute of Allergy and Infectious Diseases, ANT PROGR PAND; National Institute of Allergy and Infectious Diseases, ANT DRUG DISC AVIDD; National Institutes of Health, ACC COVID 19 THER IN; The White House, AM PAND PREP TRANSF; The White House, NAT SEC MEM US GLOB; The White House, EX ORD ORG MOB US GO	8	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 18	2022	327	3					219	220		10.1001/jama.2021.23656	http://dx.doi.org/10.1001/jama.2021.23656		JAN 2022	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YV9PQ	34989800				2022-12-28	WOS:000739988300004
J	Spanjaart, AM; van der Valk, FM; van Rooijen, G; Brouwer, MC; Kersten, MJ				Spanjaart, Anne M.; van der Valk, Fleur M.; van Rooijen, Geeske; Brouwer, Matthijs C.; Kersten, Marie J.			Confused about Confusion	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HUMAN HERPESVIRUS-6 ENCEPHALITIS; CELL	During morning rounds, the hematologist on call noticed confusion in a 49-year-old female patient. She had been admitted 5 days earlier for CD19-directed chimeric antigen receptor T-cell (CAR-T) therapy with infusion of axicabtagene ciloleucel for relapsed diffuse large B-cell lymphoma. Although the patient had been able to have a normal conversation the previous day, on this morning the hematologist found her to have bradyphrenia and to be disoriented to time and place. She had difficulty writing and counting backward. No signs of headache, vomiting, focal deficits, vision abnormalities, hallucinations, pain, changes in bowel or bladder function, cough, or shortness of breath were noticed. No trauma or seizure was observed. Vital signs, including temperature, were normal. A neurologic examination was notable only for disorientation and for slow speech with difficulty in putting words together, with no focal abnormalities. The rest of her physical examination was normal.	[Spanjaart, Anne M.; van der Valk, Fleur M.; Kersten, Marie J.] Canc Ctr Amsterdam, Dept Hematol, Amsterdam, Netherlands; [Spanjaart, Anne M.; van der Valk, Fleur M.; Kersten, Marie J.] LYMMCARE, Amsterdam, Netherlands; [van Rooijen, Geeske] Univ Amsterdam, Amsterdam Univ, Med Ctr, Dept Psychiat, Amsterdam, Netherlands; [Brouwer, Matthijs C.] Univ Amsterdam, Amsterdam Univ, Med Ctr, Dept Neurol,Amsterdam Neurosci, Amsterdam, Netherlands	University of Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam	Kersten, MJ (corresponding author), Univ Amsterdam, Dept Hematol, Amsterdam UMC, D3-321,Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	m.j.kersten@amsterdamumc.nl		Brouwer, Matthijs/0000-0001-7775-7843				Baird JH, 2021, BLOOD ADV, V5, P143, DOI 10.1182/bloodadvances.2020002732; Crump M, 2017, BLOOD, V130, P1800, DOI 10.1182/blood-2017-03-769620; Hill JA, 2019, CURR OPIN INFECT DIS, V32, P584, DOI 10.1097/QCO.0000000000000592; Locke FL, 2019, LANCET ONCOL, V20, P31, DOI 10.1016/S1470-2045(18)30864-7; Maude SL, 2018, NEW ENGL J MED, V378, P439, DOI 10.1056/NEJMoa1709866; Maus MV, 2020, J IMMUNOTHER CANCER, V8, DOI 10.1136/jitc-2020-001511; Morris EC, 2022, NAT REV IMMUNOL, V22, P85, DOI 10.1038/s41577-021-00547-6; Ogata M, 2017, BONE MARROW TRANSPL, V52, P1563, DOI 10.1038/bmt.2017.175; Ogata M, 2015, BONE MARROW TRANSPL, V50, P1030, DOI 10.1038/bmt.2015.76; Rebechi MT., 2021, OPEN FORUM INFECT DI, V8, DOI [10.1093/ofid/ofab470, DOI 10.1093/OFID/OFAB470]; Schubert ML, 2021, ANN ONCOL, V32, P34, DOI 10.1016/j.annonc.2020.10.478; Shah M, 2021, HEMASPHERE, V5, DOI 10.1097/HS9.0000000000000535; Strati P, 2020, BLOOD ADV, V4, P3943, DOI 10.1182/bloodadvances.2020002228; Ward KN, 2019, HAEMATOLOGICA, V104, P2155, DOI 10.3324/haematol.2019.223073; Westin JR, 2021, AM J HEMATOL, V96, P1295, DOI 10.1002/ajh.26301	15	0	0	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 6	2022	386	1					80	87		10.1056/NEJMcps2114818	http://dx.doi.org/10.1056/NEJMcps2114818			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YC1QX	34986289				2022-12-28	WOS:000739473800014
J	Brown, K; Donato, AA				Brown, Krysta; Donato, Anthony A.			In hypertension, a quadpill containing quarter doses of 4 BP drugs reduced BP at 12 wk vs. standard-dose monotherapy	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Brown, Krysta; Donato, Anthony A.] Tower Hlth Reading Hosp, W Reading, PA 19611 USA		Brown, K (corresponding author), Tower Hlth Reading Hosp, W Reading, PA 19611 USA.								0	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN	2022	175	1					JC3	JC3		10.7326/J21-0003	http://dx.doi.org/10.7326/J21-0003		JAN 2022	1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0Y3LO	34978861				2022-12-28	WOS:000790293700010
J	Rouyard, T; Engelen, B; Papanikitas, A; Nakamura, R				Rouyard, Thomas; Engelen, Bart; Papanikitas, Andrew; Nakamura, Ryota			Boosting healthier choices	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							BENEFITS; CANCER; NUDGES; HARMS; BOX		[Rouyard, Thomas; Nakamura, Ryota] Hitotsubashi Univ, Res Ctr Hlth Policy & Econ, Tokyo, Japan; [Engelen, Bart] Tilburg Univ, Tilburg Ctr Moral Philosophy, Epistemol & Philosophy Sci TiLPS, Tilburg, Netherlands; [Papanikitas, Andrew] Univ Oxford, Nuffield Dept Primary Care Hearth Sci, Oxford, England	Hitotsubashi University; Tilburg University; University of Oxford	Rouyard, T (corresponding author), Hitotsubashi Univ, Res Ctr Hlth Policy & Econ, Tokyo, Japan.	thomas.rouyard@r.hit-u.ac.jp	Engelen, Bart/AAS-5476-2021	Engelen, Bart/0000-0002-8915-9768	Japan Society for the Promotion of Science (KAKENHI) [20K18934]; Ministry of Health, Labour and Welfare of Japan [20FA1022]	Japan Society for the Promotion of Science (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	TR is supported by the Japan Society for the Promotion of Science (KAKENHI grant-in-aid for early-career scientists-grant No 20K18934). RN is supported by the Ministry of Health, Labour and Welfare of Japan (Health and Labour Sciences Research Grant-grant No 20FA1022).	Altmann S, 2014, EUR ECON REV, V72, P19, DOI 10.1016/j.euroecorev.2014.07.007; Bucher T, 2016, BRIT J NUTR, V115, P2252, DOI 10.1017/S0007114516001653; Chapman GB, 2010, JAMA-J AM MED ASSOC, V304, P43, DOI 10.1001/jama.2010.892; DellaVigna S., 2020, W27594 NAT BUR EC RE, DOI 10.3386/w27594; DellaVigna S, 2006, AM ECON REV, V96, P694, DOI 10.1257/aer.96.3.694; Eber MR, 2021, J RISK UNCERTAINTY, V62, P29, DOI 10.1007/s11166-021-09344-x; Engelen B, 2019, AM J BIOETHICS, V19, P48, DOI 10.1080/15265161.2019.1588411; Ford A, 2020, TOB CONTROL, V29, P282, DOI 10.1136/tobaccocontrol-2018-054831; GIGERENZER G, 1995, PSYCHOL REV, V102, P684, DOI 10.1037/0033-295X.102.4.684; Gigerenzer G, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j2460; Grune-Yanoff T, 2016, MIND MACH, V26, P149, DOI 10.1007/s11023-015-9367-9; Grune-Yanoff T, 2012, SOC CHOICE WELFARE, V38, P635, DOI 10.1007/s00355-011-0636-0; Harding Center for Risk Literacy, HPV VACC PREV CERV P; Hausman DM, 2010, J POLIT PHILOS, V18, P123, DOI 10.1111/j.1467-9760.2009.00351.x; Hertwig R, 2020, ECON J, V130, P1384, DOI 10.1093/ej/uez054; Hertwig R, 2017, PERSPECT PSYCHOL SCI, V12, P973, DOI 10.1177/1745691617702496; Hogarth RM, 2015, J APPL RES MEM COGN, V4, P221, DOI 10.1016/j.jarmac.2014.01.005; Hummel D, 2019, J BEHAV EXP ECON, V80, P47, DOI 10.1016/j.socec.2019.03.005; Johnson EJ, 2003, SCIENCE, V302, P1338, DOI 10.1126/science.1091721; Kirgios EL, 2020, ORGAN BEHAV HUM DEC, V161, P20, DOI 10.1016/j.obhdp.2020.09.003; Konig LM, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7306-z; Kurvers RHJM, 2016, P NATL ACAD SCI USA, V113, P8777, DOI 10.1073/pnas.1601827113; Leonard TC, 2008, CONST POLITICAL ECON, V19, P356, DOI 10.1007/s10602-008-9056-2; Lunn PD, 2021, PSYCHOL HEALTH, V36, P195, DOI 10.1080/08870446.2020.1849701; Marteau TM, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d228; McDowell M, 2019, MED DECIS MAKING, V39, P41, DOI 10.1177/0272989X18818166; Mollenkamp M, 2019, HEALTH POLICY, V123, P1199, DOI 10.1016/j.healthpol.2019.09.008; Naslund U, 2019, LANCET, V393, P133, DOI 10.1016/S0140-6736(18)32818-6; Oliver A, 2015, PUBLIC ADMIN, V93, P700, DOI 10.1111/padm.12165; Quigley M, 2013, MED LAW REV, V21, P588, DOI 10.1093/medlaw/fwt022; Sanders M., 2018, BEHAV PUBLIC POLICY, V2, P144, DOI DOI 10.1017/BPP.2018.17; Sarfati D, 1998, J MED SCREEN, V5, P137, DOI 10.1136/jms.5.3.137; Schwartz LM, 2009, ANN INTERN MED, V150, P516, DOI 10.7326/0003-4819-150-8-200904210-00106; Sedlmeier P, 2001, J EXP PSYCHOL GEN, V130, P380, DOI 10.1037//0096-3445.130.3.380; Sugden, 2017, INT REV EC, V64, P113, DOI [DOI 10.1007/S12232-016-0264-1, 10.1007/s12232-016-0264-1]; Sugden R., 2018, COMMUNITY ADVANTAGE, DOI [10.1093/oso/9780198825142.001.0001, DOI 10.1093/OSO/9780198825142.001.0001]; Sunstein Cass R., 2015, J MKTG BEHAV, V1, P213; Tang YY, 2013, P NATL ACAD SCI USA, V110, P13971, DOI 10.1073/pnas.1311887110; Wang Y, 2018, J RISK UNCERTAINTY, V57, P177, DOI 10.1007/s11166-018-9289-z	39	1	1	2	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 4	2022	376								e064225	10.1136/bmj-2021-064225	http://dx.doi.org/10.1136/bmj-2021-064225			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YD7MV	34983778	hybrid, Green Published			2022-12-28	WOS:000740622800005
J	Greer, DM				Greer, David M.			Determination of Brain Death	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TRANSCRANIAL DOPPLER; DIAGNOSIS; ANGIOGRAPHY; PITFALLS; UPDATE; ADULTS	Key Clinical Points Determination of Brain Death Brain death, or death as determined by neurologic criteria, accounts for approximately 2% of adult and 5% of pediatric in-hospital deaths in the United States each year. Determination of brain death is typically made clinically and requires demonstration of the permanent loss of function throughout the brain, including the brainstem, in the absence of factors that may confound the assessment, such as temperature or blood-pressure dysregulation, electrolyte or acid-base disturbances, or toxins or medications. If confounding factors cannot be eliminated, or if the examination cannot be safely or fully performed, ancillary testing is performed (typically in the form of cerebral blood-flow studies that evaluate for the complete loss of cerebral circulation). The use of therapeutic hypothermia or extracorporeal membrane oxygenation complicates but does not preclude the determination of brain death. The determination requires meticulous attention to technique, with careful avoidance of potential pitfalls that may lead to misdiagnosis. Evaluation and Assessment of Brain Death The determination of brain death is typically made on the basis of clinical assessment (shown in a video) and requires demonstration of the permanent loss of all brain function, including brainstem function, in the absence of factors that may confound the assessment. If these factors cannot be eliminated, or if the examination cannot be safely or fully performed, ancillary testing is conducted.	[Greer, David M.] Boston Univ, Sch Med, Boston, MA 02215 USA; [Greer, David M.] Boston Med Ctr, Boston, MA 02118 USA	Boston University; Boston Medical Center	Greer, DM (corresponding author), Dept Neurol, 85 East Concord St,Rm 1145, Boston, MA 02118 USA.	dgreer@bu.edu						[Anonymous], 1995, Neurology, V45, P1012; [Anonymous], 1987, PEDIATRICS, V80, P298; Arpino PA, 2008, PHARMACOTHERAPY, V28, P102, DOI 10.1592/phco.28.1.102; Braun M, 1997, NEURORADIOLOGY, V39, P400, DOI 10.1007/s002340050432; Busl KM, 2009, NEUROCRIT CARE, V11, P276, DOI 10.1007/s12028-009-9231-y; Donohoe KJ, 2012, J NUCL MED TECHNOL, V4, P198, DOI 10.2967/jnmt.112.105130; Ducrocq X, 1998, J NEUROL SCI, V160, P41, DOI 10.1016/S0022-510X(98)00188-9; Dupas B, 1998, AM J NEURORADIOL, V19, P641; Flowers WM, 1997, SOUTH MED J, V90, P1091, DOI 10.1097/00007611-199711000-00007; Greer DM, 2020, JAMA-J AM MED ASSOC, V324, P1078, DOI 10.1001/jama.2020.11586; Heckmann JG, 2003, EUR J EMERG MED, V10, P241, DOI 10.1097/00063110-200309000-00018; Ishii K, 1996, AM J NEURORADIOL, V17, P731; Lewis A, 2020, NEUROLOGY, V95, pE299, DOI 10.1212/WNL.0000000000009888; MacDougall BJ, 2014, NEUROCRIT CARE, V21, P383, DOI 10.1007/s12028-014-9975-x; Maciel CB, 2020, NEUROCRIT CARE, V33, P399, DOI 10.1007/s12028-019-00896-0; Mollaret P, 1959, REV NEUROL-FRANCE, V101, P3; Munari M, 2005, CRIT CARE MED, V33, P2068, DOI 10.1097/01.CCM.0000179143.19233.6A; Nakagawa TA, 2011, CRIT CARE MED, V39, P2139, DOI 10.1097/CCM.0b013e31821f0d4f; Neavyn MJ, 2017, J MED TOXICOL, V13, P271, DOI 10.1007/s13181-017-0606-8; Neurocritical Care Society, DIG ED BRAIN DEATH T; Olgun G, 2015, NEUROL RES, V37, P945, DOI 10.1179/1743132815Y.0000000072; Russell JA, 2019, NEUROLOGY, V92, P228, DOI 10.1212/WNL.0000000000006750; Seifi A, 2020, CLIN NEUROL NEUROSUR, V195, DOI 10.1016/j.clineuro.2020.105885; Trowbridge A, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2017-4182; Wang HH, 2017, NEUROLOGY, V88, P562, DOI 10.1212/WNL.0000000000003597; Wang K, 2008, J ZHEJIANG UNIV-SC B, V9, P916, DOI 10.1631/jzus.B0820123; Wijdicks EFM, 2013, NEUROL RES, V35, P169, DOI 10.1179/1743132812Y.0000000123; Wijdicks EFM, 2010, NEUROLOGY, V74, P1911, DOI 10.1212/WNL.0b013e3181e242a8	28	4	5	1	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 30	2021	385	27					2554	2561		10.1056/NEJMcp2025326	http://dx.doi.org/10.1056/NEJMcp2025326			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XW2YE	34965339				2022-12-28	WOS:000735490500012
J	Feuerstadt, P; Louie, TJ; Lashner, B; Wang, EEL; Diao, LY; Bryant, JA; Sims, M; Kraft, CS; Cohen, SH; Berenson, CS; Korman, LY; Ford, CB; Litcofsky, KD; Lombardo, MJ; Wortman, JR; Wu, H; Aunins, JG; McChalicher, CWJ; Winkler, JA; McGovern, BH; Trucksis, M; Henn, MR; von Moltke, L				Feuerstadt, Paul; Louie, Thomas J.; Lashner, Bret; Wang, Elaine E. L.; Diao, Liyang; Bryant, Jessica A.; Sims, Matthew; Kraft, Colleen S.; Cohen, Stuart H.; Berenson, Charles S.; Korman, Louis Y.; Ford, Christopher B.; Litcofsky, Kevin D.; Lombardo, Mary-Jane; Wortman, Jennifer R.; Wu, Henry; Aunins, John G.; McChalicher, Christopher W. J.; Winkler, Jonathan A.; McGovern, Barbara H.; Trucksis, Michele; Henn, Matthew R.; von Moltke, Lisa			SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FECAL MICROBIOTA; TRANSPLANTATION; VANCOMYCIN; FIDAXOMICIN; HEALTH	BACKGROUND Current therapies for recurrent Clostridioides difficile infection do not address the disrupted microbiome, which supports C. difficile spore germination into toxinproducing bacteria. SER-109 is an investigational microbiome therapeutic composed of purified Firmicutes spores for the treatment of recurrent C. difficile infection. METHODS We conducted a phase 3, double-blind, randomized, placebo-controlled trial in which patients who had had three or more episodes of C. difficile infection (inclusive of the qualifying acute episode) received SER-109 or placebo (four capsules daily for 3 days) after standard-of-care antibiotic treatment. The primary efficacy objective was to show superiority of SER-109 as compared with placebo in reducing the risk of C. difficile infection recurrence up to 8 weeks after treatment. Diagnosis by toxin testing was performed at trial entry, and randomization was stratified according to age and antibiotic agent received. Analyses of safety, microbiome engraftment, and metabolites were also performed. RESULTS Among the 281 patients screened, 182 were enrolled. The percentage of patients with recurrence of C. difficile infection was 12% in the SER-109 group and 40% in the placebo group (relative risk, 0.32; 95% confidence interval [CI], 0.18 to 0.58; P<0.001 for a relative risk of <1.0; P<0.001 for a relative risk of <0.833). SER-109 led to less frequent recurrence than placebo in analyses stratified according to age stratum (relative risk, 0.24 [95% CI, 0.07 to 0.78] for patients <65 years of age and 0.36 [95% CI, 0.18 to 0.72] for those >= 65 years) and antibiotic received (relative risk, 0.41 [95% CI, 0.22 to 0.79] with vancomycin and 0.09 [95% CI, 0.01 to 0.63] with fidaxomicin). Most adverse events were mild to moderate and were gastrointestinal in nature, with similar numbers in the two groups. SER-109 dose species were detected as early as week 1 and were associated with bile-acid profiles that are known to inhibit C. difficile spore germination. CONCLUSIONS In patients with symptom resolution of C. difficile infection after treatment with standard-of-care antibiotics, oral administration of SER-109 was superior to placebo in reducing the risk of recurrent infection. The observed safety profile of SER-109 was similar to that of placebo.	[Feuerstadt, Paul] Yale Univ, Sch Med, New Haven, CT USA; [Feuerstadt, Paul] PACT Gastroenterol Ctr, Hamden, CT USA; [Louie, Thomas J.] Univ Calgary, Calgary, AB, Canada; [Louie, Thomas J.] Foothills Med Ctr, Calgary, AB, Canada; [Lashner, Bret] Cleveland Clin, Cleveland, OH 44106 USA; [Wang, Elaine E. L.; Diao, Liyang; Bryant, Jessica A.; Ford, Christopher B.; Litcofsky, Kevin D.; Lombardo, Mary-Jane; Wortman, Jennifer R.; Wu, Henry; Aunins, John G.; McChalicher, Christopher W. J.; Winkler, Jonathan A.; McGovern, Barbara H.; Trucksis, Michele; Henn, Matthew R.; von Moltke, Lisa] Seres Therapeut, 200 Sidney St, Cambridge, MA 02139 USA; [Sims, Matthew] Beaumont Hosp, Royal Oak, MI USA; [Sims, Matthew] Oakland Univ, William Beaumont Sch Med, Rochester, MI 48063 USA; [Kraft, Colleen S.] Emory Univ, Atlanta, GA 30322 USA; [Cohen, Stuart H.] Univ Calif Davis, Davis, CA 95616 USA; [Berenson, Charles S.] Univ Buffalo, Buffalo, NY USA; [Berenson, Charles S.] Vet Affairs Western New York Healthcare Syst, Buffalo, NY USA; [Korman, Louis Y.] Capital Digest Care, Washington, DC USA	Yale University; University of Calgary; University of Calgary; Cleveland Clinic Foundation; Beaumont Health; Oakland University; Emory University; University of California System; University of California Davis; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	McGovern, BH (corresponding author), Seres Therapeut, 200 Sidney St, Cambridge, MA 02139 USA.	bmcgovern@serestherapeutics.com	Kraft, Colleen S/M-2347-2013	Kraft, Colleen S/0000-0003-1757-8477	Seres Therapeutics	Seres Therapeutics	Supported by Seres Therapeutics.	Abujamel T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076269; Allegretti JR, 2016, ALIMENT PHARM THER, V43, P1142, DOI 10.1111/apt.13616; BARTLETT JG, 1978, NEW ENGL J MED, V298, P531, DOI 10.1056/NEJM197803092981003; Blaser MJ, 2019, NEW ENGL J MED, V381, P2064, DOI 10.1056/NEJMe1913807; Browne HP, 2016, NATURE, V533, P543, DOI 10.1038/nature17645; Bryant JA., 2021, DIGESTIVE DIS WEEK; Carlson PE, 2020, CELL HOST MICROBE, V27, P173, DOI 10.1016/j.chom.2020.01.018; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; Crowther GS, 2015, INFECT DRUG RESIST, V8, P333, DOI 10.2147/IDR.S87224; DeFilipp Z, 2019, NEW ENGL J MED, V381, P2043, DOI 10.1056/NEJMoa1910437; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Dubberke ER, 2012, CLIN INFECT DIS, V55, pS88, DOI 10.1093/cid/cis335; Food and Drug Administration, 2020, SAF AL REG US FEC MI; Gerding DN, 2018, CLIN INFECT DIS, V67, P649, DOI 10.1093/cid/ciy171; Gilbert JA, 2018, NAT MED, V24, P392, DOI 10.1038/nm.4517; GREENLAND S, 1985, BIOMETRICS, V41, P55, DOI 10.2307/2530643; Guh AY, 2020, NEW ENGL J MED, V382, P1320, DOI 10.1056/NEJMoa1910215; Guh AY, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx171; Henn MR, 2021, GASTROENTEROLOGY, V160, P115, DOI 10.1053/j.gastro.2020.07.048; Jiang ZD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205064; Johnson S, 2014, CLIN INFECT DIS, V59, P345, DOI 10.1093/cid/ciu313; Kelly CR, 2016, ANN INTERN MED, V165, P609, DOI 10.7326/M16-0271; Khanna S, 2016, J INFECT DIS, V214, P173, DOI 10.1093/infdis/jiv766; Lopetuso LR, 2013, GUT PATHOG, V5, DOI 10.1186/1757-4749-5-23; Louie TJ, 2012, CLIN INFECT DIS, V55, pS132, DOI 10.1093/cid/cis338; Louie TJ, 2011, NEW ENGL J MED, V364, P422, DOI 10.1056/NEJMoa0910812; McGovern BH, 2021, CLIN INFECT DIS, V72, P2132, DOI 10.1093/cid/ciaa387; Patron RL, 2017, CLIN INFECT DIS, V65, P1214, DOI 10.1093/cid/cix511; Polage CR, 2015, JAMA INTERN MED, V175, P1792, DOI 10.1001/jamainternmed.2015.4114; Ridlon JM, 2016, GUT MICROBES, V7, P22, DOI 10.1080/19490976.2015.1127483; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Sethi AK, 2010, INFECT CONT HOSP EP, V31, P21, DOI 10.1086/649016; Shields K, 2015, ANAEROBE, V34, P59, DOI 10.1016/j.anaerobe.2015.04.012; Sorg JA, 2009, J BACTERIOL, V191, P1115, DOI 10.1128/JB.01260-08; Staley C, 2017, AM J GASTROENTEROL, V112, P940, DOI 10.1038/ajg.2017.6; Tariq R, 2019, CLIN INFECT DIS, V68, P1351, DOI 10.1093/cid/ciy721; Theriot CM, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00045-15; Theriot CM, 2015, ANNU REV MICROBIOL, V69, P445, DOI 10.1146/annurev-micro-091014-104115; Zilberberg MD, 2009, CRIT CARE MED, V37, P2583, DOI 10.1097/CCM.0b013e3181ab8388	39	40	40	10	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 20	2022	386	3					220	229		10.1056/NEJMoa2106516	http://dx.doi.org/10.1056/NEJMoa2106516			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YK1UG	35045228				2022-12-28	WOS:000745006000009
J	Xue, X; Russ, M; Samkharadze, N; Undseth, B; Sammak, A; Scappucci, G; Vandersypen, LMK				Xue, Xiao; Russ, Maximilian; Samkharadze, Nodar; Undseth, Brennan; Sammak, Amir; Scappucci, Giordano; Vandersypen, Lieven M. K.			Quantum logic with spin qubits crossing the surface code threshold	NATURE			English	Article							ELECTRON-SPIN; NOISE; GATE	High-fidelity control of quantum bits is paramount for the reliable execution of quantum algorithms and for achieving fault tolerance-the ability to correct errors faster than they occur(1). The central requirement for fault tolerance is expressed in terms of an error threshold. Whereas the actual threshold depends on many details, a common target is the approximately 1% error threshold of the well-known surface code(2,3). Reaching two-qubit gate fidelities above 99% has been a long-standing major goal for semiconductor spin qubits. These qubits are promising for scaling, as they can leverage advanced semiconductor technology(4). Here we report a spin-based quantum processor in silicon with single-qubit and two-qubit gate fidelities, all of which are above 99.5%, extracted from gate-set tomography. The average single-qubit gate fidelities remain above 99% when including crosstalk and idling errors on the neighbouring qubit. Using this high-fidelity gate set, we execute the demanding task of calculating molecular ground-state energies using a variational quantum eigensolver algorithm(5). Having surpassed the 99% barrier for the two-qubit gate fidelity, semiconductor qubits are well positioned on the path to fault tolerance and to possible applications in the era of noisy intermediate-scale quantum devices.	[Xue, Xiao; Russ, Maximilian; Samkharadze, Nodar; Undseth, Brennan; Sammak, Amir; Scappucci, Giordano; Vandersypen, Lieven M. K.] Delft Univ Technol, QuTech, Delft, Netherlands; [Xue, Xiao; Russ, Maximilian; Undseth, Brennan; Scappucci, Giordano; Vandersypen, Lieven M. K.] Delft Univ Technol, Kavli Inst Nanosci, Delft, Netherlands; [Samkharadze, Nodar; Sammak, Amir] Netherlands Org Appl Sci Res TNO, Delft, Netherlands	Delft University of Technology; Delft University of Technology; Netherlands Organization Applied Science Research	Vandersypen, LMK (corresponding author), Delft Univ Technol, QuTech, Delft, Netherlands.; Vandersypen, LMK (corresponding author), Delft Univ Technol, Kavli Inst Nanosci, Delft, Netherlands.	l.m.k.vandersypen@tudelft.nl		Rimbach-Russ, Maximilian/0000-0001-9775-0323; Vandersypen, Lieven/0000-0003-4346-7877	Dutch Ministry of Economic Affairs through the allowance for Top Consortia for Knowledge and Innovation (TKI); Army Research Office (ARO) [W911NF-17-1-0274]	Dutch Ministry of Economic Affairs through the allowance for Top Consortia for Knowledge and Innovation (TKI); Army Research Office (ARO)	We acknowledge discussions with P. Cerfontaine, C. Bureau-Oxton, M. T. Madzik, A. Morello, J. Helsen, B. Terhal, M. Veldhorst and all the members of the spin qubit team, and technical assistance from O. Benningshof, M. Sarsby, R. Schouten and R. Vermeulen. This research was funded by the Dutch Ministry of Economic Affairs through the allowance for Top Consortia for Knowledge and Innovation (TKI) and the Army Research Office (ARO) under grant number W911NF-17-1-0274. The views and conclusions contained in this document are those of the authors and should not be interpreted as representing the official policies, either expressed or implied, of the ARO or the US Government. The US Government is authorized to reproduce and distribute reprints for government purposes notwithstanding any copyright notation herein.	Blume-Kohout R., TAXONOMY SMALL MARKO; Elzerman JM, 2004, NATURE, V430, P431, DOI 10.1039/nature02693; Fowler AG, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.032324; Greenbaum D., 2015, INTRO QUANTUM GATE S; Hempel C, 2018, PHYS REV X, V8, DOI 10.1103/PhysRevX.8.031022; Huang W, 2019, NATURE, V569, P532, DOI 10.1038/s41586-019-1197-0; Koski JV, 2020, NAT PHYS, V16, P642, DOI 10.1038/s41567-020-0862-4; Loss D, 1998, PHYS REV A, V57, P120, DOI 10.1103/PhysRevA.57.120; Madzik MT, 2022, NATURE, V601, P348, DOI 10.1038/s41586-021-04292-7; Martins F, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.116801; McArdle S, 2020, REV MOD PHYS, V92, DOI 10.1103/RevModPhys.92.015003; Meunier T, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.121403; Nielsen E, 2021, QUANTUM-AUSTRIA, V5, DOI 10.22331/q-2021-10-05-557; Nielsen Michael A., 2002, QUANTUM COMPUTATION; Pan AR, 2020, QUANTUM SCI TECHNOL, V5, DOI 10.1088/2058-9565/ab86c9; Petta JR, 2005, SCIENCE, V309, P2180, DOI 10.1126/science.1116955; Pioro-Ladriere M, 2008, NAT PHYS, V4, P776, DOI 10.1038/nphys1053; Preskill J, 2018, QUANTUM-AUSTRIA, V2, DOI 10.22331/q-2018-08-06-79; Raussendorf R, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.190504; Russ M, 2021, B AM PHYS SOC, V66; Russ M, 2018, PHYS REV B, V97, DOI 10.1103/PhysRevB.97.085421; Schaal S, 2020, PHYS REV LETT, V124, DOI 10.1103/PhysRevLett.124.067701; Taube AG, 2006, INT J QUANTUM CHEM, V106, P3393, DOI 10.1002/qua.21198; Vandersypen LMK, 2017, NPJ QUANTUM INFORM, V3, DOI 10.1038/s41534-017-0038-y; Vandersypen LMK, 2004, REV MOD PHYS, V76, P1037, DOI 10.1103/RevModPhys.76.1037; Veldhorst M, 2015, NATURE, V526, P410, DOI 10.1038/nature15263; White GAL, 2021, PHYS REV APPL, V15, DOI 10.1103/PhysRevApplied.15.014023; Xue X, 2019, PHYS REV X, V9, DOI 10.1103/PhysRevX.9.021011; Yang CH, 2019, NAT ELECTRON, V2, P151, DOI 10.1038/s41928-019-0234-1; Yang Y, 2019, NPJ COMPUT MATER, V5, DOI 10.1038/s41524-018-0142-3; Yoneda J, 2018, NAT NANOTECHNOL, V13, P102, DOI 10.1038/s41565-017-0014-x; Zajac DM, 2018, SCIENCE, V359, P439, DOI 10.1126/science.aao5965; Zajac DM, 2016, PHYS REV APPL, V6, DOI 10.1103/PhysRevApplied.6.054013; Zheng GJ, 2019, NAT NANOTECHNOL, V14, P742, DOI 10.1038/s41565-019-0488-9; Zwerver A. M. J., 2021, ARXIV210112650	53	54	54	21	32	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 20	2022	601	7893					343	+		10.1038/s41586-021-04273-w	http://dx.doi.org/10.1038/s41586-021-04273-w			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YJ6UI	35046604	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000744666700024
J	Yee, LM; Miller, EC; Greenland, P				Yee, Lynn M.; Miller, Eliza C.; Greenland, Philip			Mitigating the Long-term Health Risks of Adverse Pregnancy Outcomes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARDIOVASCULAR-DISEASE; WOMEN; PREVENTION		[Yee, Lynn M.] Northwestern Univ, Feinberg Sch Med, Dept Obstet & Gynecol, Chicago, IL 60611 USA; [Miller, Eliza C.] Columbia Univ, Dept Neurol, Vagelos Coll Phys & Surg, New York, NY USA; [Greenland, Philip] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; [Greenland, Philip] Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Columbia University; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Greenland, P (corresponding author), 680 N Lake Shore Dr,Ste1400, Chicago, IL 60611 USA.	p-greenland@northwestern.edu	Miller, Eliza C./AAF-5332-2020	Miller, Eliza C./0000-0002-7108-8906				Arnett DK, 2019, CIRCULATION, V140, pE596, DOI [10.1161/CIR.0000000000000678, 10.1161/CIR.0000000000000677, 10.1016/j.jacc.2019.03.009, 10.1016/j.jacc.2019.03.010]; Brown HL, 2018, CIRCULATION, V137, pE843, DOI 10.1161/CIR.0000000000000582; Cho L, 2020, J AM COLL CARDIOL, V75, P2602, DOI 10.1016/j.jacc.2020.03.060; Jowell AR, 2022, JAMA CARDIOL, V7, P346, DOI 10.1001/jamacardio.2021.4391; Parikh NI, 2021, CIRCULATION, V143, pE902, DOI 10.1161/CIR.0000000000000961; Roth H, 2019, FRONT CARDIOVASC MED, V6, DOI 10.3389/fcvm.2019.00178; Stuebe A, 2018, OBSTET GYNECOL, V131, pE140, DOI 10.1097/AOG.0000000000002633	7	1	1	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 1	2022	327	5					421	422		10.1001/jama.2021.23870	http://dx.doi.org/10.1001/jama.2021.23870		JAN 2022	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YV9QB	35024771				2022-12-28	WOS:000742416300001
J	Taylor, JL; Samet, JH				Taylor, Jessica L.; Samet, Jeffrey H.			In the Clinic Opioid Use Disorder	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							EXTENDED-RELEASE NALTREXONE; INJECTION-DRUG USE; SUBSTANCE USE; PREEXPOSURE PROPHYLAXIS; PRACTICE GUIDELINE; UNITED-STATES; METHADONE; DEPENDENCE; PEOPLE; PRESCRIPTION		[Taylor, Jessica L.] Boston Univ, Sch Med, Sect Gen Internal Med, Boston, MA 02118 USA; [Taylor, Jessica L.] Boston Med Ctr, Boston, MA 02118 USA; Boston Med Ctr, Grayken Ctr Addict, Boston, MA USA	Boston University; Boston Medical Center; Boston Medical Center	Taylor, JL (corresponding author), Boston Univ, Sch Med, Sect Gen Internal Med, Boston, MA 02118 USA.; Taylor, JL (corresponding author), Boston Med Ctr, Boston, MA 02118 USA.			Samet, Jeffrey/0000-0002-0897-3400	American College of Physicians	American College of Physicians	American College of Physicians.	Abdul-Quader AS, 2013, AIDS BEHAV, V17, P2878, DOI 10.1007/s10461-013-0593-y; Ahmad FB., 2021, PROVISIONAL DRUG OVE; Alcoholics Anonymous, 2021, AA MEMB MED OTH DRUG; Alpren C, 2020, AM J PUBLIC HEALTH, V110, P37, DOI 10.2105/AJPH.2019.305366; American Psychiatric Association, 2018, APA PUBL OP POLL ANN; Anderson KE, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.4925; [Anonymous], 2019, SUBST AB MENT HLTH S; Antoine D, 2021, AM J ADDICTION, V30, P83, DOI 10.1111/ajad.13069; Barocas JA, 2018, AM J PUBLIC HEALTH, V108, P1675, DOI 10.2105/AJPH.2018.304673; Bazzi AR, 2018, AIDS PATIENT CARE ST, V32, P529, DOI 10.1089/apc.2018.0126; Benyamin R, 2008, PAIN PHYSICIAN, V11, pS105; Biello KB, 2021, AM J PUBLIC HEALTH, V111, P1045, DOI 10.2105/AJPH.2021.306208; Binswanger IA, 2007, NEW ENGL J MED, V356, P157, DOI 10.1056/NEJMsa064115; Brothers S, 2021, J SUBST ABUSE TREAT, V131, DOI 10.1016/j.jsat.2021.108449; Brown HD, 2020, DRUG ALCOHOL DEPEN, V216, DOI 10.1016/j.drugalcdep.2020.108307; Caplehorn JRM, 2002, AUST NZ J PUBL HEAL, V26, P358, DOI 10.1111/j.1467-842X.2002.tb00185.x; Centers for Disease Control and Prevention, PREEXP PROPH PREV HI; Centers for Disease Control and Prevention, 2021, UND EP; Chan B, 2020, AHRQ PUBLICATION, DOI [10.23970/AHRQEPCRAPIDMAT, DOI 10.23970/AHRQEPCRAPIDMAT]; Chou R, 2014, J PAIN, V15, P321, DOI 10.1016/j.jpain.2014.01.494; Cicero TJ, 2020, AM J PUBLIC HEALTH, V110, P244, DOI 10.2105/AJPH.2019.305412; Commonwealth of Massachusetts, 2018, ONG HEP OUTBR PERS E; *CTR DRUG EV RES, APPR PACK APPL NUMB; D'Aunno T, 2014, J SUBST ABUSE TREAT, V47, P245, DOI 10.1016/j.jsat.2014.06.001; Dowell D, 2016, MMWR RECOMM REP, V65, P1, DOI [10.15585/mmwr.rr7103a1, 10.1001/jama.2016.1464]; Edelman EJ, 2019, JAMA INTERN MED, V179, P297, DOI 10.1001/jamainternmed.2018.6101; Ferri M, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003410.pub4; Gryczynski J, 2011, J SUBST ABUSE TREAT, V41, P431, DOI 10.1016/j.jsat.2011.06.005; Hammig R, 2016, SUBST ABUSE REHABIL, V7, P99, DOI 10.2147/SAR.S109919; Jakubowski A, 2020, J ADDICT MED, V14, P95, DOI 10.1097/ADM.0000000000000555; Joudrey PJ, 2020, DRUG ALCOHOL DEPEN, V211, DOI 10.1016/j.drugalcdep.2020.107968; Kampman K, 2015, J ADDICT MED, V9, P358, DOI 10.1097/ADM.0000000000000166; Khan MR, 2013, AIDS BEHAV, V17, P1185, DOI 10.1007/s10461-012-0276-0; Klaire S, 2019, AM J ADDICTION, V28, P262, DOI 10.1111/ajad.12869; Krist AH, 2020, JAMA-J AM MED ASSOC, V323, P2301, DOI 10.1001/jama.2020.8020; Krupitsky E, 2011, LANCET, V377, P1506, DOI 10.1016/S0140-6736(11)60358-9; Lagisetty PA, 2019, JAMA PSYCHIAT, V76, P979, DOI 10.1001/jamapsychiatry.2019.0876; Larochelle MR, 2018, ANN INTERN MED, V169, P137, DOI 10.7326/M17-3107; Larochelle MR, 2016, ANN INTERN MED, V164, P1, DOI 10.7326/M15-0038; Learn to Cope, HELPFUL LINKS; Lee JD, 2015, ADDICTION, V110, P1008, DOI 10.1111/add.12894; Link HM, 2020, AM J OBST GYNEC MFM, V2, DOI 10.1016/j.ajogmf.2020.100179; Lo A, 2018, J SUBST ABUSE TREAT, V94, P41, DOI 10.1016/j.jsat.2018.08.009; Lyss SB, 2020, J INFECT DIS, V222, pS239, DOI 10.1093/infdis/jiaa112; Magidson JF, 2021, J SUBST ABUSE TREAT, V122, DOI 10.1016/j.jsat.2020.108248; Mattick RP, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002207.pub3; Merikangas KR, 1998, ARCH GEN PSYCHIAT, V55, P973, DOI 10.1001/archpsyc.55.11.973; Michna E, 2014, CURR MED RES OPIN, V30, P1589, DOI 10.1185/03007995.2014.915803; Motavalli D, 2021, J GEN INTERN MED, V36, P129, DOI 10.1007/s11606-020-06201-6; National Institute on Drug Abuse, 2021, SCI DRUG US ADD BAS; Nolan S, 2016, ADDICT SCI CLIN PRAC, V11, DOI 10.1186/s13722-016-0065-6; OBAT TTA, OBAT CLIN TOOLS FORM; OBAT TTA, UPC TRAIN; Oquendo MA, 2018, NEW ENGL J MED, V378, P1567, DOI 10.1056/NEJMp1801417; Oviedo-Joekes E, 2016, JAMA PSYCHIAT, V73, P447, DOI 10.1001/jamapsychiatry.2016.0109; Park TW, 2020, ADDICTION, V115, P924, DOI 10.1111/add.14886; Peckham AM, 2021, J SUBST ABUSE TREAT, V126, DOI 10.1016/j.jsat.2021.108316; Peiper NC, 2019, INT J DRUG POLICY, V63, P122, DOI 10.1016/j.drugpo.2018.08.007; Pellegrino JL, 2021, CUREUS, V13, DOI 10.7759/cureus.12454; Quello Susan B, 2005, Sci Pract Perspect, V3, P13; Ray GT, 2007, MED CARE, V45, P116, DOI 10.1097/01.mlr.0000241109.55054.04; Roth AM, 2021, JAIDS-J ACQ IMM DEF, V86, pE61, DOI 10.1097/QAI.0000000000002558; Samet JH, 2018, NEW ENGL J MED, V379, P7, DOI 10.1056/NEJMp1803982; SAMET JH, 1990, AM J MED, V89, P53, DOI 10.1016/0002-9343(90)90098-X; Sigmon SC, 2014, JAMA PSYCHIAT, V71, P359, DOI 10.1001/jamapsychiatry.2013.4450; Silverstein SM, 2019, INT J DRUG POLICY, V74, P76, DOI 10.1016/j.drugpo.2019.09.003; Smith PC, 2010, ARCH INTERN MED, V170, P1155, DOI 10.1001/archinternmed.2010.140; Substance Abuse and Mental Health Services Administration, 2020, PUBLICATIONS; Substance Abuse and Mental Health Services Administration, 2020, HHS PUBL NSDUH, VH-55; Substance Abuse and Mental Health Services Administration, TIP 63 MED OP US DIS; Substance Abuse and Mental Health Services Administration, RES FAM COP MENT SUB; Sullivan MA, 2019, AM J PSYCHIAT, V176, P129, DOI 10.1176/appi.ajp.2018.17070732; Takeda MY, 2016, SUBST ABUS, V37, P591, DOI 10.1080/08897077.2016.1179704; Taylor JL, 2021, J GEN INTERN MED, V36, P3810, DOI 10.1007/s11606-021-06904-4; Taylor JL, 2021, J SUBST ABUSE TREAT, V124, DOI 10.1016/j.jsat.2021.108280; Tofighi B, 2020, J ADDICT DIS, V39, P37, DOI 10.1080/10550887.2020.1811456; Tori ME, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.2361; U.S. Department of Health and Human Services, 2021, PRACTICE GUIDELINES; Wakeman SE, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2019.20622; Wakeman SE, 2015, SUBST ABUS, V36, P427, DOI 10.1080/08897077.2014.962722; Walley Alexander Y, 2013, BMJ, V346, pf174, DOI 10.1136/bmj.f174; Weinberger AH, 2017, J CLIN PSYCHIAT, V78, pE152, DOI 10.4088/JCP.15m10062; Weinstein ZM, 2017, J SUBST ABUSE TREAT, V74, P65, DOI 10.1016/j.jsat.2016.12.010; Weiss RD, 2011, ARCH GEN PSYCHIAT, V68, P1238, DOI 10.1001/archgenpsychiatry.2011.121; Wesson DR, 2003, J PSYCHOACTIVE DRUGS, V35, P253, DOI 10.1080/02791072.2003.10400007; Winstanley EL, 2019, CLIN THER, V41, P1655, DOI 10.1016/j.clinthera.2019.06.003; Zibbell JE, 2015, MMWR-MORBID MORTAL W, V64, P453	87	5	5	1	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN	2022	175	1					ITC1	U33		10.7326/AITC202201180	http://dx.doi.org/10.7326/AITC202201180		JAN 2022	17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	0Y3LO	35007147				2022-12-28	WOS:000743247900001
J	Tanne, JH				Tanne, Janice Hopkins			Covid-19: Vaccination during pregnancy is safe, finds large US study	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Lipkind HS, 2022, MMWR-MORBID MORTAL W, V7, P26, DOI 10.15585/mmwr.mm7101e1	1	2	2	5	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 7	2022	376								o27	10.1136/bmj.o27	http://dx.doi.org/10.1136/bmj.o27			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YP9GN	34996775	Bronze			2022-12-28	WOS:000748927300015
J	Kim, TH; Schnitzer, MJ				Kim, Tony Hyun; Schnitzer, Mark J.			Primer Fluorescence imaging of large-scale neural ensemble dynamics	CELL			English	Article							FIELD-OF-VIEW; ALL-OPTICAL ELECTROPHYSIOLOGY; MINIATURE 2-PHOTON MICROSCOPY; HIPPOCAMPAL PLACE CELLS; IN-VIVO; LONG-TERM; MULTIPHOTON MICROSCOPY; CELLULAR-RESOLUTION; NEURONAL-ACTIVITY; HIGH-SPEED	Recent progress in fluorescence imaging allows neuroscientists to observe the dynamics of thousands of individual neurons, identified genetically or by their connectivity, across multiple brain areas and for extended durations in awake behaving mammals. We discuss advances in fluorescent indicators of neural activity, viral and genetic methods to express these indicators, chronic animal preparations for long-term imaging studies, and microscopes to monitor and manipulate the activity of large neural ensembles. Ca2+ imaging studies of neural activity can track brain area interactions and distributed information processing at cellular resolution. Across smaller spatial scales, high-speed voltage imaging reveals the distinctive spiking patterns and coding properties of targeted neuron types. Collectively, these innovations will propel studies of brain function and dovetail with ongoing neuroscience initiatives to identify new neuron types and develop widely applicable, non-human primate models. The optical toolkit's growing sophistication also suggests that "brain observatory"facilities would be useful open resources for future brain-imaging studies.	[Kim, Tony Hyun; Schnitzer, Mark J.] Stanford Univ, James Clark Ctr Biomed Engn & Sci, Stanford, CA 94305 USA; [Kim, Tony Hyun; Schnitzer, Mark J.] Stanford Univ, CNC Program, Stanford, CA 94305 USA; [Kim, Tony Hyun; Schnitzer, Mark J.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Kim, TH; Schnitzer, MJ (corresponding author), Stanford Univ, James Clark Ctr Biomed Engn & Sci, Stanford, CA 94305 USA.; Kim, TH; Schnitzer, MJ (corresponding author), Stanford Univ, CNC Program, Stanford, CA 94305 USA.; Kim, TH; Schnitzer, MJ (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA.	kimth@stanford.edu; mschnitz@stanford.edu		Kim, Hyun/0000-0002-4311-8258	NIH BRAIN Initiative; NSF NeuroNex Program; DARPA; HHMI	NIH BRAIN Initiative; NSF NeuroNex Program; DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); HHMI(Howard Hughes Medical Institute)	Our work on brain imaging has been supported by funding from the NIH BRAIN Initiative, the NSF NeuroNex Program, DARPA, and HHMI. We thank H. Bito, R. Chrapkiewicz, S. Haziza, O. Hernandez, L. Huang, M. Inoue, M.Z. Lin, L. Luo, S. Sternson, M.J. Wagner, and Y. Zhang for helpful conversations.	Abdelfattah AS, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17322-1; Abdelfattah AS, 2019, SCIENCE, V365, P699, DOI 10.1126/science.aav6416; Akemann W, 2013, SCI REP-UK, V3, DOI 10.1038/srep02231; Akemann W, 2010, NAT METHODS, V7, P643, DOI [10.1038/nmeth.1479, 10.1038/NMETH.1479]; Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; Al-Juboori SI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067626; Alivisatos AP, 2015, NEURON, V88, P445, DOI 10.1016/j.neuron.2015.10.015; Allen WE, 2017, NEURON, V94, P891, DOI 10.1016/j.neuron.2017.04.017; Amir W, 2007, OPT LETT, V32, P1731, DOI 10.1364/OL.32.001731; Andermann ML, 2013, NEURON, V80, P900, DOI 10.1016/j.neuron.2013.07.052; Andrasfalvy BK, 2010, P NATL ACAD SCI USA, V107, P11981, DOI 10.1073/pnas.1006620107; Arieli A, 2002, J NEUROSCI METH, V114, P119, DOI 10.1016/S0165-0270(01)00507-6; Baker CA, 2016, ELIFE, V5, DOI 10.7554/eLife.14193; Barbera G, 2019, J NEUROSCI METH, V323, P56, DOI 10.1016/j.jneumeth.2019.05.008; Barnett L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043454; Barretto RPJ, 2011, NAT MED, V17, P223, DOI 10.1038/nm.2292; Barretto RPJ, 2009, NAT METHODS, V6, P511, DOI 10.1038/nmeth.1339; Barson D, 2020, NAT METHODS, V17, P107, DOI 10.1038/s41592-019-0625-2; Beaulieu DR, 2020, NAT METHODS, V17, P283, DOI 10.1038/s41592-019-0728-9; Bedbrook CN, 2018, ANNU REV NEUROSCI, V41, P323, DOI 10.1146/annurev-neuro-080317-062048; Bewersdorf J, 1998, OPT LETT, V23, P655, DOI 10.1364/OL.23.000655; Blankvoort S, 2018, CURR BIOL, V28, P2103, DOI 10.1016/j.cub.2018.05.015; Bollimunta A, 2021, CELL REP, V35, DOI 10.1016/j.celrep.2021.109239; Botcherby EJ, 2012, P NATL ACAD SCI USA, V109, P2919, DOI 10.1073/pnas.1111662109; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Brinks D, 2015, BIOPHYS J, V109, P914, DOI 10.1016/j.bpj.2015.07.038; Brondi M, 2020, CELL REP, V30, P2567, DOI 10.1016/j.celrep.2020.01.105; Broxton M, 2013, OPT EXPRESS, V21, P25418, DOI 10.1364/OE.21.025418; Cai DJ, 2016, NATURE, V534, P115, DOI 10.1038/nature17955; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Challis RC, 2019, NAT PROTOC, V14, P379, DOI 10.1038/s41596-018-0097-3; Chamberland S, 2017, ELIFE, V6, DOI 10.7554/eLife.25690; Chan KY, 2017, NAT NEUROSCI, V20, P1172, DOI 10.1038/nn.4593; Chatterjee S, 2018, NAT NEUROSCI, V21, P638, DOI 10.1038/s41593-018-0091-7; Chen LM, 2002, J NEUROSCI METH, V113, P41, DOI 10.1016/S0165-0270(01)00475-7; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chen YM, 2020, NEURON, V107, P454, DOI 10.1016/j.neuron.2020.05.005; Cheng A, 2011, NAT METHODS, V8, P139, DOI 10.1038/NMETH.1552; Choi John, 2018, Annu Int Conf IEEE Eng Med Biol Soc, V2018, P3013, DOI 10.1109/EMBC.2018.8512994; Chuong AS, 2014, NAT NEUROSCI, V17, P1123, DOI 10.1038/nn.3752; Close JL, 2021, NAT METHODS, V18, P23, DOI 10.1038/s41592-020-01040-z; Condylis C, 2020, NEURON, V106, P515, DOI 10.1016/j.neuron.2020.02.004; Cong L, 2017, ELIFE, V6, DOI 10.7554/eLife.28158; Corder G, 2019, SCIENCE, V363, P276, DOI 10.1126/science.aap8586; Cornejo VH, 2022, SCIENCE, V375, P82, DOI 10.1126/science.abg0501; da Silva JA, 2018, NATURE, V554, P244, DOI 10.1038/nature25457; Daigle TL, 2018, CELL, V174, P465, DOI 10.1016/j.cell.2018.06.035; Dana H, 2019, NAT METHODS, V16, P649, DOI 10.1038/s41592-019-0435-6; Dana H, 2016, ELIFE, V5, DOI 10.7554/eLife.12727; de Groot A, 2020, ELIFE, V9, DOI 10.7554/eLife.49987; Demas J, 2021, NAT METHODS, V18, P1103, DOI 10.1038/s41592-021-01239-8; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Dimitrov D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000440; Dombeck DA, 2010, NAT NEUROSCI, V13, P1433, DOI 10.1038/nn.2648; Dong A, 2022, NAT BIOTECHNOL, V40, P787, DOI 10.1038/s41587-021-01074-4; Donnert G, 2007, NAT METHODS, V4, P81, DOI 10.1038/NMETH986; Drew PJ, 2010, NAT METHODS, V7, P981, DOI 10.1038/NMETH.1530; Ebina T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04286-6; Emiliani V, 2015, J NEUROSCI, V35, P13917, DOI 10.1523/JNEUROSCI.2916-15.2015; Fan JT, 2019, NAT PHOTONICS, V13, P809, DOI 10.1038/s41566-019-0474-7; Fan LLZ, 2020, CELL, V180, P521, DOI 10.1016/j.cell.2020.01.001; Feldbauer K, 2009, P NATL ACAD SCI USA, V106, P12317, DOI 10.1073/pnas.0905852106; Fenno LE, 2020, NEURON, V107, P836, DOI 10.1016/j.neuron.2020.06.003; Flusberg BA, 2008, NAT METHODS, V5, P935, DOI 10.1038/nmeth.1256; Flytzanis N.C., 2020, BROAD GENE EXPRESSIO, DOI [10.1101/2020.06.16.152975, DOI 10.1101/2020.06.16.152975]; Flytzanis NC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5894; Forli A, 2018, CELL REP, V22, P3087, DOI 10.1016/j.celrep.2018.02.063; Gao PR, 2015, CURR OPIN NEUROBIOL, V32, P148, DOI 10.1016/j.conb.2015.04.003; Garg AK, 2019, SCIENCE, V364, P1275, DOI 10.1126/science.aaw5868; Gerfen CR, 2013, NEURON, V80, P1368, DOI 10.1016/j.neuron.2013.10.016; Ghosh KK, 2011, NAT METHODS, V8, P871, DOI [10.1038/NMETH.1694, 10.1038/nmeth.1694]; Gong YY, 2015, SCIENCE, V350, P1361, DOI 10.1126/science.aab0810; Gong YY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4674; Gong YY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0066959, 10.1371/journal.pone.0070340]; Gonzalez WG, 2019, SCIENCE, V365, P821, DOI 10.1126/science.aav9199; Graybuck L.T., 2019, ENHANCER VIRUSES TRA; Grewe BF, 2017, NATURE, V543, P670, DOI 10.1038/nature21682; Grewe BF, 2011, BIOMED OPT EXPRESS, V2, P2035, DOI 10.1364/BOE.2.002035; Grewe BF, 2010, NAT METHODS, V7, P399, DOI 10.1038/nmeth.1453; Grienberger C, 2012, NEURON, V73, P862, DOI 10.1016/j.neuron.2012.02.011; Griffiths VA, 2020, NAT METHODS, V17, P741, DOI 10.1038/s41592-020-0851-7; GRINVALD A, 1991, P NATL ACAD SCI USA, V88, P11559, DOI 10.1073/pnas.88.24.11559; Grundemann J, 2019, SCIENCE, V364, P254, DOI 10.1126/science.aav8736; Haery L, 2019, FRONT NEUROANAT, V13, DOI 10.3389/fnana.2019.00093; Hamel EJO, 2015, NEURON, V86, P140, DOI 10.1016/j.neuron.2015.03.055; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; Heider B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013829; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Helmchen F, 2001, NEURON, V31, P903, DOI 10.1016/S0896-6273(01)00421-4; Helmchen F, 1996, BIOPHYS J, V70, P1069, DOI 10.1016/S0006-3495(96)79653-4; Hernandez O, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11928; Hochbaum DR, 2014, NAT METHODS, V11, P825, DOI [10.1038/NMETH.3000, 10.1038/nmeth.3000]; Holtmaat A, 2009, NAT PROTOC, V4, P1128, DOI 10.1038/nprot.2009.89; Hopt A, 2001, BIOPHYS J, V80, P2029, DOI 10.1016/S0006-3495(01)76173-5; Hornung R, 2020, NEUROSCI LETT, V736, DOI 10.1016/j.neulet.2020.135287; Horton NG, 2013, NAT PHOTONICS, V7, P205, DOI [10.1038/NPHOTON.2012.336, 10.1038/nphoton.2012.336]; Huang C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02873-1; Huang L., 2020, RELATION SHIP SPIKIN, DOI [10.1101/788802, DOI 10.1101/788802]; Inan H., 2021, BIORXIV, V2003, DOI [DOI 10.1101/2021.03.24.436279, 10.1101/2021.03.24.436279]; Inoue M, 2019, CELL, V177, P1346, DOI 10.1016/j.cell.2019.04.007; Jackman SL, 2018, CELL REP, V22, P3351, DOI 10.1016/j.celrep.2018.02.081; Jarvie BC, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20100-8; Jazayeri M, 2021, CURR OPIN NEUROBIOL, V70, P113, DOI 10.1016/j.conb.2021.08.002; Jennings JH, 2019, NATURE, V565, P645, DOI 10.1038/s41586-018-0866-8; Jercog P, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a021824; Ji N, 2017, NAT METHODS, V14, P374, DOI 10.1038/nmeth.4218; Jia N, 2012, P NATL ACAD SCI USA, V109, P22, DOI 10.1073/pnas.1109202108; Jin L, 2012, NEURON, V75, P779, DOI 10.1016/j.neuron.2012.06.040; Ju NS, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14501-y; Ju NS, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005839; Jung JC, 2004, J NEUROPHYSIOL, V92, P3121, DOI 10.1152/jn.00234.2004; Jung JC, 2003, OPT LETT, V28, P902, DOI 10.1364/OL.28.000902; Kalmbach AS, 2012, J NEUROPHYSIOL, V108, P3138, DOI 10.1152/jn.00557.2012; Kannan M., DUAL POLARITY VOLTAG, DOI 10.13.463730; Kannan M, 2018, NAT METHODS, V15, P1108, DOI 10.1038/s41592-018-0188-7; Khan AG, 2018, NAT NEUROSCI, V21, P851, DOI 10.1038/s41593-018-0143-z; Kim KH, 2007, OPT EXPRESS, V15, P11658, DOI 10.1364/OE.15.011658; Kim TH, 2016, CELL REP, V17, P3385, DOI 10.1016/j.celrep.2016.12.004; Klapoetke NC, 2014, NAT METHODS, V11, P338, DOI [10.1038/NMETH.2836, 10.1038/nmeth.2836]; Klaus A, 2017, NEURON, V96, P949, DOI 10.1016/j.neuron.2017.10.031; Klioutchnikov A, 2020, NAT METHODS, V17, P509, DOI 10.1038/s41592-020-0817-9; Kobat D, 2009, OPT EXPRESS, V17, P13354, DOI 10.1364/OE.17.013354; Koch C, 2012, NATURE, V483, P397, DOI 10.1038/483397a; Kondo M, 2017, ELIFE, V6, DOI 10.7554/eLife.26839; Kondo T, 2018, CELL REP, V24, P2191, DOI 10.1016/j.celrep.2018.07.057; Kong LJ, 2015, NAT METHODS, V12, P759, DOI [10.1038/nmeth.3476, 10.1038/NMETH.3476]; Kralj JM, 2012, NAT METHODS, V9, P90, DOI [10.1038/NMETH.1782, 10.1038/nmeth.1782]; Lanyi JK, 2004, ANNU REV PHYSIOL, V66, P665, DOI 10.1146/annurev.physiol.66.032102.150049; Lecca S, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107752; Lecoq J, 2014, NAT NEUROSCI, V17, P1825, DOI 10.1038/nn.3867; Lecoq J, 2011, NAT BIOTECHNOL, V29, P715, DOI 10.1038/nbt.1941; Lee D, 2019, SCIENCE, V366, P1384, DOI 10.1126/science.aax8055; Levene MJ, 2004, J NEUROPHYSIOL, V91, P1908, DOI 10.1152/jn.01007.2003; Levoy M, 2006, ACM T GRAPHIC, V25, P924, DOI 10.1145/1141911.1141976; Li B, 2020, NAT METHODS, V17, P163, DOI 10.1038/s41592-019-0663-9; Li M, 2017, NEURON, V93, P1049, DOI 10.1016/j.neuron.2017.01.027; Li Y, 2017, CELL, V171, P1176, DOI 10.1016/j.cell.2017.10.015; LIEKE EE, 1989, ANNU REV PHYSIOL, V51, P543, DOI 10.1146/annurev.physiol.51.1.543; Lim ST, 2000, NEURON, V25, P385, DOI 10.1016/S0896-6273(00)80902-2; Lin JY, 2013, NAT NEUROSCI, V16, P1499, DOI 10.1038/nn.3502; Lin MZ, 2016, NAT NEUROSCI, V19, P1142, DOI 10.1038/nn.4359; Liu R, 2019, NAT METHODS, V16, P615, DOI 10.1038/s41592-019-0434-7; Low RJ, 2014, P NATL ACAD SCI USA, V111, P18739, DOI 10.1073/pnas.1421753111; Lu RW, 2020, NAT METHODS, V17, P291, DOI 10.1038/s41592-020-0760-9; Lu RW, 2017, NAT NEUROSCI, V20, P620, DOI 10.1038/nn.4516; Maclaurin D, 2013, P NATL ACAD SCI USA, V110, P5939, DOI 10.1073/pnas.1215595110; Madisen L, 2015, NEURON, V85, P942, DOI 10.1016/j.neuron.2015.02.022; Mardinly AR, 2018, NAT NEUROSCI, V21, P881, DOI 10.1038/s41593-018-0139-8; Mattis J, 2012, NAT METHODS, V9, P159, DOI [10.1038/nmeth.1808, 10.1038/NMETH.1808]; McCall JG, 2017, NAT PROTOC, V12, P219, DOI 10.1038/nprot.2016.155; Modi MN, 2019, OPT EXPRESS, V27, P35830, DOI 10.1364/OE.27.035830; Mohr MA, 2020, NAT METHODS, V17, P694, DOI 10.1038/s41592-020-0835-7; Nadella KMNS, 2016, NAT METHODS, V13, P1001, DOI [10.1038/NMETH.4033, 10.1038/nmeth.4033]; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Nandy A, 2019, ELIFE, V8, DOI 10.7554/eLife.35123; Nikolenko V, 2008, FRONT NEURAL CIRCUIT, V2, DOI 10.3389/neuro.04.005.2008; Okano H, 2021, ANNU REV NEUROSCI, V44, P27, DOI 10.1146/annurev-neuro-030520-101844; Oron D, 2005, OPT EXPRESS, V13, P1468, DOI 10.1364/OPEX.13.001468; Ota K, 2021, NEURON, V109, P1810, DOI 10.1016/j.neuron.2021.03.032; Otis JM, 2019, NEURON, V103, P423, DOI 10.1016/j.neuron.2019.05.018; Ouzounov DG, 2017, NAT METHODS, V14, P388, DOI 10.1038/nmeth.4183; Owen SF, 2018, CELL, V172, P683, DOI 10.1016/j.cell.2018.01.005; Packer AM, 2015, NAT METHODS, V12, P140, DOI 10.1038/nmeth.3217; Packer AM, 2012, NAT METHODS, V9, P1202, DOI [10.1038/NMETH.2249, 10.1038/nmeth.2249]; Papagiakoumou E, 2010, NAT METHODS, V7, P848, DOI [10.1038/NMETH.1505, 10.1038/nmeth.1505]; Papagiakoumou E, 2008, OPT EXPRESS, V16, P22039, DOI 10.1364/OE.16.022039; Park JE, 2016, SCI REP-UK, V6, DOI 10.1038/srep34931; Parker JG, 2018, NATURE, V557, P177, DOI 10.1038/s41586-018-0090-6; Patriarchi T, 2020, NAT METHODS, V17, P1147, DOI 10.1038/s41592-020-0936-3; Patriarchi T, 2018, SCIENCE, V360, P1420, DOI 10.1126/science.aat4422; Pegard NC, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01031-3; Piatkevich KD, 2019, NATURE, V574, P413, DOI 10.1038/s41586-019-1641-1; Piatkevich KD, 2018, NAT CHEM BIOL, V14, P352, DOI 10.1038/s41589-018-0004-9; Picot A, 2018, CELL REP, V24, P1243, DOI 10.1016/j.celrep.2018.06.119; Pinto L, 2015, NEURON, V87, P437, DOI 10.1016/j.neuron.2015.06.021; Piyawattanametha W, 2006, OPT LETT, V31, P2018, DOI 10.1364/OL.31.002018; Piyawattanametha W, 2009, OPT LETT, V34, P2309, DOI 10.1364/OL.34.002309; Podgorski K, 2016, J NEUROPHYSIOL, V116, P1012, DOI 10.1152/jn.00275.2016; Prakash R, 2012, NAT METHODS, V9, P1171, DOI 10.1038/NMETH.2215; Prevedel R, 2014, NAT METHODS, V11, P727, DOI [10.1038/NMETH.2964, 10.1038/nmeth.2964]; Qian Y, 2019, NAT METHODS, V16, P171, DOI 10.1038/s41592-018-0294-6; Raymond CS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000162; Reddy GD, 2008, NAT NEUROSCI, V11, P713, DOI 10.1038/nn.2116; Remedios R, 2017, NATURE, V550, P388, DOI 10.1038/nature23885; Rickgauer JP, 2014, NAT NEUROSCI, V17, P1816, DOI 10.1038/nn.3866; Rickgauer JP, 2009, P NATL ACAD SCI USA, V106, P15025, DOI 10.1073/pnas.0907084106; Roberts TF, 2017, NAT NEUROSCI, V20, P978, DOI 10.1038/nn.4563; Ronzitti E, 2017, J NEUROSCI, V37, P10679, DOI 10.1523/JNEUROSCI.1246-17.2017; Rose T, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00088; Rumyantsev OI, 2020, NATURE, V580, P100, DOI 10.1038/s41586-020-2130-2; Rupprecht P, 2021, NAT NEUROSCI, V24, P1324, DOI 10.1038/s41593-021-00895-5; Sabatini BL, 2020, NEURON, V108, P17, DOI 10.1016/j.neuron.2020.09.036; Sadakane O, 2015, CELL REP, V13, P1989, DOI 10.1016/j.celrep.2015.10.050; Sakai R, 2001, EUR J NEUROSCI, V13, P2314, DOI 10.1046/j.0953-816x.2001.01617.x; Sawinski J, 2009, P NATL ACAD SCI USA, V106, P19557, DOI 10.1073/pnas.0903680106; Schwertner M, 2004, OPT EXPRESS, V12, P6540, DOI 10.1364/OPEX.12.006540; Scott BB, 2018, NEURON, V100, P1045, DOI 10.1016/j.neuron.2018.09.050; Scribner JL, 2020, P NATL ACAD SCI USA, V117, P11076, DOI 10.1073/pnas.1917287117; Seidemann E, 2016, ELIFE, V5, DOI [10.7554/eLife.16178, 10.7554/elife.16178]; Sheintuch L, 2017, CELL REP, V21, P1102, DOI 10.1016/j.celrep.2017.10.013; Shemesh OA, 2020, NEURON, V107, P470, DOI 10.1016/j.neuron.2020.05.029; Shemesh OA, 2017, NAT NEUROSCI, V20, P1796, DOI 10.1038/s41593-017-0018-8; Shemetov AA, 2021, NAT BIOTECHNOL, V39, P368, DOI 10.1038/s41587-020-0710-1; Siegel MS, 1997, NEURON, V19, P735, DOI 10.1016/S0896-6273(00)80955-1; Sjulson L, 2007, PHYSIOLOGY, V22, P47, DOI 10.1152/physiol.00036.2006; Skocek O, 2018, NAT METHODS, V15, P429, DOI 10.1038/s41592-018-0008-0; Sofroniew NJ, 2016, ELIFE, V5, DOI 10.7554/eLife.14472; Song A, 2017, NAT METHODS, V14, P420, DOI 10.1038/nmeth.4226; Soudais C, 2001, FASEB J, V15, P2283, DOI 10.1096/fj.01-0321fje; Sridharan S., 2021, HIGH PERFORMANCE MIC, DOI [10.1101/202104. 01.438134, DOI 10.1101/202104.01.438134]; St-Pierre F, 2014, NAT NEUROSCI, V17, P884, DOI 10.1038/nn.3709; Stamatakis AM, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00496; Steinmetz NA, 2021, SCIENCE, V372, P258, DOI 10.1126/science.abf4588; Stirman JN, 2016, NAT BIOTECHNOL, V34, P857, DOI 10.1038/nbt.3594; Sun FM, 2020, NAT METHODS, V17, P1156, DOI 10.1038/s41592-020-00981-9; Szabo V, 2014, NEURON, V84, P1157, DOI 10.1016/j.neuron.2014.11.005; Szalay G, 2016, NEURON, V92, P723, DOI 10.1016/j.neuron.2016.10.002; Tang SM, 2018, ELIFE, V7, DOI 10.7554/eLife.33370; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Tervo DGR, 2016, NEURON, V92, P372, DOI 10.1016/j.neuron.2016.09.021; Theer P, 2003, OPT LETT, V28, P1022, DOI 10.1364/OL.28.001022; Theer P, 2006, J OPT SOC AM A, V23, P3139, DOI 10.1364/JOSAA.23.003139; Theriault G, 2013, OPT EXPRESS, V21, P10095, DOI 10.1364/OE.21.010095; Thunemann M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04457-5; Trautmann EM, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23884-5; Tsai PS, 2015, OPT EXPRESS, V23, P13833, DOI 10.1364/OE.23.013833; Unger EK, 2020, CELL, V183, P1986, DOI 10.1016/j.cell.2020.11.040; Villette V, 2019, CELL, V179, P1590, DOI 10.1016/j.cell.2019.11.004; Voigt FF, 2015, PROC SPIE, V9329, DOI 10.1117/12.2076388; Voleti V, 2019, NAT METHODS, V16, P1054, DOI 10.1038/s41592-019-0579-4; Wagner MJ, 2019, CELL, V177, P669, DOI 10.1016/j.cell.2019.02.019; Wang H, 2018, CURR OPIN NEUROBIOL, V50, P171, DOI 10.1016/j.conb.2018.03.010; Wang K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8276; Wang MR, 2018, BIOMED OPT EXPRESS, V9, DOI 10.1364/BOE.9.003534; Wang TY, 2020, OPTICA, V7, P947, DOI 10.1364/OPTICA.395825; Wang TY, 2020, ELIFE, V9, DOI 10.7554/eLife.53205; Watakabe A, 2015, NEUROSCI RES, V93, P144, DOI 10.1016/j.neures.2014.09.002; Weisenburger S, 2019, CELL, V177, P1050, DOI 10.1016/j.cell.2019.03.011; Weiss AR, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-63559-7; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; Wilt BA, 2013, BIOPHYS J, V104, P51, DOI 10.1016/j.bpj.2012.07.058; Wu JL, 2020, NAT METHODS, V17, P287, DOI 10.1038/s41592-020-0762-7; Xu HT, 2007, NAT NEUROSCI, V10, P549, DOI 10.1038/nn1883; Xu SJ, 2020, SCIENCE, V370, P313, DOI 10.1126/science.abb2494; Yamada Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep35722; Yamahachi H, 2009, NEURON, V64, P719, DOI 10.1016/j.neuron.2009.11.026; Yang G, 2010, NAT PROTOC, V5, P201, DOI 10.1038/nprot.2009.222; Yang MK, 2019, LIGHT-SCI APPL, V8, DOI 10.1038/s41377-019-0219-x; Yang WJ, 2018, ELIFE, V7, DOI 10.7554/eLife.32671; Yang WJ, 2017, NAT METHODS, V14, P349, DOI 10.1038/nmeth.4230; Yang WJ, 2016, NEURON, V89, P269, DOI 10.1016/j.neuron.2015.12.012; Yanny K, 2020, LIGHT-SCI APPL, V9, DOI 10.1038/s41377-020-00403-7; Yao SQ, 2020, NAT METHODS, V17, P422, DOI 10.1038/s41592-020-0774-3; Yildirim M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08179-6; Yuste R, 2015, NAT REV NEUROSCI, V16, P487, DOI 10.1038/nrn3962; Zeng HH, 2019, P NATL ACAD SCI USA, V116, P3239, DOI 10.1073/pnas.1816653116; Zhang F, 2011, CELL, V147, P1446, DOI 10.1016/j.cell.2011.12.004; Zhang T, 2019, NAT METHODS, V16, P1119, DOI 10.1038/s41592-019-0597-2; Zhang Y., 2021, FAST SENSITIVE GCAMP, DOI [10.1101/2021.11.08.467793, DOI 10.1101/2021.11.08.467793]; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592; Zhu GH, 2005, OPT EXPRESS, V13, P2153, DOI 10.1364/OPEX.13.002153; Zingg B, 2017, NEURON, V93, P33, DOI 10.1016/j.neuron.2016.11.045; Zipfel WR, 2003, NAT BIOTECHNOL, V21, P1368, DOI 10.1038/nbt899; Ziv Y, 2013, NAT NEUROSCI, V16, P264, DOI 10.1038/nn.3329; Zong WJ, 2021, NAT METHODS, V18, P46, DOI 10.1038/s41592-020-01024-z; Zong WJ, 2017, NAT METHODS, V14, P713, DOI 10.1038/nmeth.4305; Zou P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5625	268	7	7	14	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 6	2022	185	1					9	41		10.1016/j.cell.2021.12.007	http://dx.doi.org/10.1016/j.cell.2021.12.007			33	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	YL5FO	34995519				2022-12-28	WOS:000745916700003
J	Salisbury, H				Salisbury, Helen			Helen Salisbury: New Year's revolutions?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												helen.salisbury@phc.ox.ac.uk						Greener Practice, REDUCING WASTE HLTH; Health Foundation, INEQUALITIES; Janson C, 2020, THORAX, V75, P82, DOI 10.1136/thoraxjnl-2019-213744	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 4	2022	376								n3154	10.1136/bmj.n3154	http://dx.doi.org/10.1136/bmj.n3154			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YD7MV	34983791	Bronze			2022-12-28	WOS:000740622800002
J	Samarasekera, U				Samarasekera, Udani			Challenges ahead for new UNICEF leader	LANCET			English	Editorial Material																			0	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN	2022	399	10320					130	131						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YD7YG	34998495				2022-12-28	WOS:000740652500010
J	Lin, JX; Zhang, YH; Morissette, E; Wang, Z; Liu, S; Rhodes, D; Watanabe, K; Taniguchi, T; Hone, J; Li, JIA				Lin, Jiang-Xiazi; Zhang, Ya-Hui; Morissette, Erin; Wang, Zhi; Liu, Song; Rhodes, Daniel; Watanabe, K.; Taniguchi, T.; Hone, James; Li, J. I. A.			Spin-orbit-driven ferromagnetism at half moire filling in magic-angle twisted bilayer graphene	SCIENCE			English	Article							TOPOLOGICAL INSULATORS; CORRELATED STATES; SUPERCONDUCTIVITY	Strong electron correlation and spin-orbit coupling (SOC) can have a profound influence on the electronic properties of materials. We examined their combined influence on a two-dimensional electronic system at the atomic interface between magic-angle twisted bilayer graphene and a tungsten diselenide crystal. We found that strong electron correlation within the moire flatband stabilizes correlated insulating states at both quarter and half filling, and that SOC transforms these Mott-like insulators into ferromagnets, as evidenced by a robust anomalous Hall effect with hysteretic switching behavior. The coupling between spin and valley degrees of freedom could be demonstrated through control of the magnetic order with an in-plane magnetic field or a perpendicular electric field. Our findings establish an experimental knob to engineer topological properties of moire bands in twisted bilayer graphene and related systems.	[Lin, Jiang-Xiazi; Morissette, Erin; Wang, Zhi; Li, J. I. A.] Brown Univ, Dept Phys, Providence, RI 02912 USA; [Zhang, Ya-Hui] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Liu, Song; Rhodes, Daniel; Hone, James] Columbia Univ, Dept Mech Engn, New York, NY 10027 USA; [Watanabe, K.; Taniguchi, T.] Natl Inst Mat Sci, 1-1 Namiki, Tsukuba, Ibaraki 3050044, Japan	Brown University; Harvard University; Columbia University; National Institute for Materials Science	Li, JIA (corresponding author), Brown Univ, Dept Phys, Providence, RI 02912 USA.	jia_li@brown.edu	Liu, Song/Z-1870-2018; Watanabe, Kenji/H-2825-2011; Hone, James/E-1879-2011	Liu, Song/0000-0002-3046-3335; Lin, Jiang-Xiazi/0000-0002-7283-5619; Watanabe, Kenji/0000-0003-3701-8119; Hone, James/0000-0002-8084-3301; Li, Jia/0000-0002-8431-2567	Brown University; MRI [DMR-1827453]; NSF MRSEC program through the Center for Precision-Assembled Quantum Materials [DMR-2011738]; EMEXT Element Strategy Initiative to Form Core Research Center [JPMXP0112101001]; CREST [JPMJCR15F3]	Brown University; MRI; NSF MRSEC program through the Center for Precision-Assembled Quantum Materials; EMEXT Element Strategy Initiative to Form Core Research Center; CREST(Core Research for Evolutional Science and Technology (CREST))	This work was primarily supported by Brown University. Device fabrication was performed in the Institute for Molecular and Nanoscale Innovation at Brown University. This work was performed, in part, at the Center for Integrated Nanotechnologies, an Office of Science User Facility operated for the US Department of Energy (DOE) Office of Science. J.-X.L., E.M., and J.I.A.L. acknowledge the use of equipment funded by MRI award DMR-1827453. Synthesis of WSe2 (S.L., D.R., J.H.) at Columbia was supported by the NSF MRSEC program through the Center for Precision-Assembled Quantum Materials (DMR-2011738). K.W. and T.T. acknowledge support from the EMEXT Element Strategy Initiative to Form Core Research Center, grant JPMXP0112101001, and CREST (JPMJCR15F3), JST.	Avsar A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5875; Bultinck N, 2020, PHYS REV LETT, V124, DOI 10.1103/PhysRevLett.124.166601; Cao Y, 2020, NATURE, V583, P215, DOI 10.1038/s41586-020-2260-6; Cao Y, 2018, NATURE, V556, P80, DOI 10.1038/nature26154; Cao Y, 2018, NATURE, V556, P43, DOI 10.1038/nature26160; Chen GR, 2020, NATURE, V579, P56, DOI 10.1038/s41586-020-2049-7; Chen SW, 2021, NAT PHYS, V17, P374, DOI 10.1038/s41567-020-01062-6; Fulop B, 2021, NPJ 2D MATER APPL, V5, DOI 10.1038/s41699-021-00262-9; Gmitra M, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.146401; Gmitra M, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.155403; Hasan MZ, 2010, REV MOD PHYS, V82, P3045, DOI 10.1103/RevModPhys.82.3045; Island JO, 2019, NATURE, V571, P85, DOI 10.1038/s41586-019-1304-2; Kennes DM, 2021, NAT PHYS, V17, P155, DOI 10.1038/s41567-020-01154-3; Lin J.-X., 2021, SPIN ORBIT DRIVEN FE; Liu CC, 2018, PHYS REV LETT, V121, DOI 10.1103/PhysRevLett.121.217001; Liu XM, 2020, NATURE, V583, P221, DOI 10.1038/s41586-020-2458-7; Lu XB, 2019, NATURE, V574, P653, DOI 10.1038/s41586-019-1695-0; McGilly LJ, 2020, NAT NANOTECHNOL, V15, P580, DOI 10.1038/s41565-020-0708-3; Polshyn H, 2020, NATURE, V588, P66, DOI 10.1038/s41586-020-2963-8; Qi XL, 2011, REV MOD PHYS, V83, DOI 10.1103/RevModPhys.83.1057; Qi XL, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.184516; Repellin C, 2020, PHYS REV LETT, V124, DOI 10.1103/PhysRevLett.124.187601; Rozen A, 2021, NATURE, V592, P214, DOI 10.1038/s41586-021-03319-3; Saito Y, 2020, NAT PHYS, V16, P926, DOI 10.1038/s41567-020-0928-3; Sboychakov AO, 2019, PHYS REV B, V100, DOI 10.1103/PhysRevB.100.045111; Serlin M, 2020, SCIENCE, V367, P900, DOI 10.1126/science.aay5533; Sharpe AL, 2021, NANO LETT, V21, P4299, DOI 10.1021/acs.nanolett.1c00696; Sharpe AL, 2019, SCIENCE, V365, P605, DOI 10.1126/science.aaw3780; Uri A, 2020, NATURE, V581, P47, DOI 10.1038/s41586-020-2255-3; Wang TL, 2020, PHYS REV B, V102, DOI 10.1103/PhysRevB.102.235146; Wang Z, 2016, PHYS REV X, V6, DOI 10.1103/PhysRevX.6.041020; Wang Z, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9339; Yang BW, 2017, PHYS REV B, V96, DOI 10.1103/PhysRevB.96.041409; Yankowitz M, 2019, SCIENCE, V363, P1059, DOI 10.1126/science.aav1910; Zhang HJ, 2009, NAT PHYS, V5, P438, DOI 10.1038/NPHYS1270; Zhang YH, 2019, PHYS REV RES, V1, DOI 10.1103/PhysRevResearch.1.033126; Zhang YH, 2019, PHYS REV B, V99, DOI 10.1103/PhysRevB.99.075127; ZHU J, 2020, PHYS REV LETT, V125; Zibrov AA, 2018, NAT PHYS, V14, P930, DOI 10.1038/s41567-018-0190-0	45	14	15	29	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2022	375	6579					437	+		10.1126/science.abh2889	http://dx.doi.org/10.1126/science.abh2889			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YS8CI	34990215	Green Submitted			2022-12-28	WOS:000750899500037
J	Reardon, S				Reardon, Sara			FIRST PIG-TO-HUMAN HEART TRANSPLANT: WHAT CAN SCIENTISTS LEARN?	NATURE			English	News Item						Medical research; Physiology													0	37	37	4	51	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 20	2022	601	7893					305	306		10.1038/d41586-022-00111-9	http://dx.doi.org/10.1038/d41586-022-00111-9			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YI6PE	35031782				2022-12-28	WOS:000743967700009
J	Simon, DA; Shachar, C; Cohen, IG				Simon, David A.; Shachar, Carmel; Cohen, I. Glenn			At-home Diagnostics and Diagnostic Excellence Devices vs General Wellness Products	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Simon, David A.; Shachar, Carmel; Cohen, I. Glenn] Harvard Law Sch, Petrie Flom Ctr Hlth Law Policy Biotechnol & Bioe, Cambridge, MA USA	Harvard University	Cohen, IG (corresponding author), Harvard Univ, Harvard Law Sch, Petrie Flom Ctr Hlth Law Policy Biotechnol & Bioe, 1525 Massachusetts Ave,Griswold Hall,Room 503, Cambridge, MA 02138 USA.	igcohen@law.harvard.edu			Gordon and Betty Moore Foundation [9974]	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	All authors receive funding support from the Gordon and Betty Moore Foundation (grant No. 9974).	Babic B, 2021, NAT MACH INTELL, V3, P283, DOI 10.1038/s42256-021-00331-0; Cohen IG, 2020, JAMA-J AM MED ASSOC, V323, P477, DOI 10.1001/jama.2019.19655; Cohen IG., 2021, CONSUMER GENETIC TEC; Marchant G, 2020, J LAW MED ETHICS, V48, P11, DOI 10.1177/1073110520916994; US Food and Drug Administration, GEN WELLN POL LOW RI; US Food and Drug Administration, FACT CONS MAK BEN RI	6	1	1	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 8	2022	327	6					523	524		10.1001/jama.2022.0047	http://dx.doi.org/10.1001/jama.2022.0047		JAN 2022	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZD5RT	35050304				2022-12-28	WOS:000745103500001
J	Dyer, O				Dyer, Owen			Covid-19: Quebec to tax the unvaccinated as vaccine mandates spread in Europe	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Jena AB, 2021, NEW YORK TIMES; Tovey M., 2017, OBESITY PUBLIC PURSE; van Baal PHM, 2008, PLOS MED, V5, P242, DOI 10.1371/journal.pmed.0050029; Walt V., 2022, FORTUNE	4	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 14	2022	376								o112	10.1136/bmj.o112	http://dx.doi.org/10.1136/bmj.o112			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZE9IM	35031538	Bronze			2022-12-28	WOS:000759190400004
J	Fassl, A; Geng, Y; Sicinski, P				Fassl, Anne; Geng, Yan; Sicinski, Piotr			CDK4 and CDK6 kinases: From basic science to cancer therapy	SCIENCE			English	Review							CYCLIN-DEPENDENT KINASES; BREAST-CANCER; CELL-CYCLE; PHARMACOLOGICAL INHIBITION; TRANSCRIPTIONAL REGULATION; ACQUIRED-RESISTANCE; ANTITUMOR-ACTIVITY; ENDOCRINE THERAPY; OVARIAN-CANCER; INDUCED DEATH	Cyclin-dependent kinases 4 and 6 (CDK4 and CDK6) and their activating partners, D-type cyclins, link the extracellular environment with the core cell cycle machinery. Constitutive activation of cyclin D-CDK4/6 represents the driving force of tumorigenesis in several cancer types. Small-molecule inhibitors of CDK4/6 have been used with great success in the treatment of hormone receptor-positive breast cancers and are in clinical trials for many other tumor types. Unexpectedly, recent work indicates that inhibition of CDK4/6 affects a wide range of cellular functions such as tumor cell metabolism and antitumor immunity. We discuss how recent advances in understanding CDK4/6 biology are opening new avenues for the future use of cyclin D-CDK4/6 inhibitors in cancer treatment.	[Fassl, Anne; Geng, Yan; Sicinski, Piotr] Harvard Med Sch, Dana Farber Canc Inst, Blavatnik Inst, Dept Canc Biol,Dept Genet, Boston, MA 02215 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Sicinski, P (corresponding author), Harvard Med Sch, Dana Farber Canc Inst, Blavatnik Inst, Dept Canc Biol,Dept Genet, Boston, MA 02215 USA.	peter_sicinski@dfcl.harvard.edu	Fassl, Anne/AAA-5249-2022		Claudia Adams Barr Program for Innovative Basic Cancer Research Award; NIH [R50CA243769, R01CA202634, CA236226, P50CA168504, P01CA250959]	Claudia Adams Barr Program for Innovative Basic Cancer Research Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported by a Claudia Adams Barr Program for Innovative Basic Cancer Research Award (A.F.), NIH grant R50CA243769 (Y.G.), and NIH grants R01CA202634, CA236226, P50CA168504, and P01CA250959 (P.S.).	AbuHammad S, 2019, P NATL ACAD SCI USA, V116, P17990, DOI 10.1073/pnas.1901323116; Aggarwal P, 2010, CANCER CELL, V18, P329, DOI 10.1016/j.ccr.2010.08.012; Alt JR, 2000, GENE DEV, V14, P3102, DOI 10.1101/gad.854900; Alvarez-Fernandez M, 2020, CANCER CELL, V37, P514, DOI 10.1016/j.ccell.2020.03.010; Anders L, 2011, CANCER CELL, V20, P620, DOI 10.1016/j.ccr.2011.10.001; Arnold A, 2005, J CLIN ONCOL, V23, P4215, DOI 10.1200/JCO.2005.05.064; Bellutti F, 2018, CANCER DISCOV, V8, P884, DOI 10.1158/2159-8290.CD-17-0912; Bisi JE, 2016, MOL CANCER THER, V15, P783, DOI 10.1158/1535-7163.MCT-15-0775; Blain SW, 2008, CELL CYCLE, V7, P892, DOI 10.4161/cc.7.7.5637; Bowe DB, 2002, ONCOGENE, V21, P291, DOI 10.1038/sj/onc/1205025; Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399; Cao J, 2019, ONCOGENE, V38, P4125, DOI 10.1038/s41388-019-0708-7; Cen L, 2012, NEURO-ONCOLOGY, V14, P870, DOI 10.1093/neuonc/nos114; Chaikovsky AC, 2021, NATURE, V592, P794, DOI 10.1038/s41586-021-03474-7; Cheng MG, 1999, EMBO J, V18, P1571, DOI 10.1093/emboj/18.6.1571; Cheng MG, 1998, P NATL ACAD SCI USA, V95, P1091, DOI 10.1073/pnas.95.3.1091; Choi YJ, 2021, CANCER RES, V81; Choi YJ, 2012, CANCER CELL, V22, P438, DOI 10.1016/j.ccr.2012.09.015; Chung MY, 2019, MOL CELL, V76, P562, DOI 10.1016/j.molcel.2019.08.020; Condorelli R, 2018, ANN ONCOL, V29, P640, DOI 10.1093/annonc/mdx784; Cornell L, 2019, CELL REP, V26, P2667, DOI 10.1016/j.celrep.2019.02.023; Costa C, 2020, CANCER DISCOV, V10, P72, DOI 10.1158/2159-8290.CD-18-0830; Cristofanilli M, 2016, LANCET ONCOL, V17, P425, DOI 10.1016/S1470-2045(15)00613-0; Dall'Acqua A, 2017, EMBO MOL MED, V9, P1415, DOI 10.15252/emmm.201607012; de Leeuw R, 2018, CLIN CANCER RES, V24, P4201, DOI 10.1158/1078-0432.CCR-18-0410; Dean JL, 2010, ONCOGENE, V29, P4018, DOI 10.1038/onc.2010.154; Dean JL, 2012, J BIOL CHEM, V287, P29075, DOI 10.1074/jbc.M112.365494; Dean JL, 2012, CELL CYCLE, V11, P2756, DOI 10.4161/cc.21195; Deng JH, 2018, CANCER DISCOV, V8, P216, DOI 10.1158/2159-8290.CD-17-0915; Dickler MN, 2017, CLIN CANCER RES, V23, P5218, DOI 10.1158/1078-0432.CCR-17-0754; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Fassl A, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abb2210; Finn RS, 2020, CLIN CANCER RES, V26, P110, DOI 10.1158/1078-0432.CCR-19-0751; Finn RS, 2016, NEW ENGL J MED, V375, P1925, DOI 10.1056/NEJMoa1607303; Finn RS, 2015, LANCET ONCOL, V16, P25, DOI 10.1016/S1470-2045(14)71159-3; Finn RS, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2419; Formisano L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09068-2; Franco J, 2016, CELL REP, V14, P979, DOI 10.1016/j.celrep.2015.12.094; Freeman-Cook K, 2021, CANCER CELL, V39, P1404, DOI 10.1016/j.ccell.2021.08.009; Fry DW, 2004, MOL CANCER THER, V3, P1427; Gao H, 2015, NAT MED, V21, P1318, DOI 10.1038/nm.3954; Gao Y, 2017, CELL ONCOL, V40, P209, DOI 10.1007/s13402-017-0316-x; Geng Y, 1999, CELL, V97, P767, DOI 10.1016/S0092-8674(00)80788-6; Geng Y, 2018, P NATL ACAD SCI USA, V115, P1015, DOI 10.1073/pnas.1711477115; Goel S, 2017, NATURE, V548, P471, DOI 10.1038/nature23465; Goel S, 2016, CANCER CELL, V29, P255, DOI 10.1016/j.ccell.2016.02.006; Goetz MP, 2017, J CLIN ONCOL, V35, P3638, DOI 10.1200/JCO.2017.75.6155; Gong XQ, 2017, CANCER CELL, V32, P761, DOI 10.1016/j.ccell.2017.11.006; Gottesman SRS, 2019, MOL CANCER RES, V17, P669, DOI 10.1158/1541-7786.MCR-18-0188; Griffiths JI, 2021, CANCER RES, V81; Guiley KZ, 2019, SCIENCE, V366, P1330, DOI 10.1126/science.aaw2106; Haines Eric, 2018, Oncotarget, V9, P31572, DOI 10.18632/oncotarget.25803; Hall M, 1996, ADV CANCER RES, V68, P67, DOI 10.1016/S0065-230X(08)60352-8; Hallett ST, 2017, CELL REP, V21, P1386, DOI 10.1016/j.celrep.2017.10.042; He SH, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal3986; Herrera-Abreu MT, 2016, CANCER RES, V76, P2301, DOI 10.1158/0008-5472.CAN-15-0728; Hoffman R. L., 2021, AACR ANN M 2021 VIRT; Hortobagyi GN, 2016, NEW ENGL J MED, V375, P1738, DOI 10.1056/NEJMoa1609709; Hydbring P, 2016, NAT REV MOL CELL BIO, V17, P280, DOI 10.1038/nrm.2016.27; Im SA, 2019, NEW ENGL J MED, V381, P307, DOI 10.1056/NEJMoa1903765; James MK, 2008, MOL CELL BIOL, V28, P498, DOI 10.1128/MCB.02171-06; Jansen VM, 2017, CANCER RES, V77, P2488, DOI 10.1158/0008-5472.CAN-16-2653; Jerby-Arnon L, 2018, CELL, V175, P984, DOI 10.1016/j.cell.2018.09.006; Jin X, 2019, MOL CELL, V73, P22, DOI 10.1016/j.molcel.2018.10.034; Johnson SM, 2010, J CLIN INVEST, V120, P2528, DOI 10.1172/JCI41402; Johnston S, 2019, NPJ BREAST CANCER, V5, DOI 10.1038/s41523-018-0097-z; Johnston SRD, 2020, J CLIN ONCOL, V38, DOI 10.1200/JCO.20.02514; Kanie T, 2012, MOL CELL BIOL, V32, P590, DOI 10.1128/MCB.06570-11; Kim Sunkyu, 2018, Oncotarget, V9, P35226, DOI 10.18632/oncotarget.26215; Klein EA, 2008, J CELL SCI, V121, P3853, DOI 10.1242/jcs.039131; Klein ME, 2018, ONCOGENE, V37, P5066, DOI 10.1038/s41388-018-0332-y; Knudsen ES, 2019, ONCOGENE, V38, P3355, DOI 10.1038/s41388-018-0650-0; Kovatcheva M, 2015, ONCOTARGET, V6, P8226, DOI 10.18632/oncotarget.3364; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; Landis MW, 2006, CANCER CELL, V9, P13, DOI 10.1016/j.ccr.2005.12.019; Lavoie JN, 1996, J BIOL CHEM, V271, P20608, DOI 10.1074/jbc.271.34.20608; Li Y, 2015, CANCER DISCOV, V5, P288, DOI 10.1158/2159-8290.CD-14-0625; Li ZQ, 2018, CANCER CELL, V34, P893, DOI 10.1016/j.ccell.2018.11.006; Lin S, 2019, CANCER RES, V79, DOI 10.1158/1538-7445.AM2019-4425; Long F, 2019, CANCER SCI, V110, P1420, DOI 10.1111/cas.13957; LUKAS J, 1995, MOL CELL BIOL, V15, P2600; Lukas J, 1996, MOL CELL BIOL, V16, P6917; LUKAS J, 1995, NATURE, V375, P503, DOI 10.1038/375503a0; Luo C, 2020, CANCER RES, V80, P3215, DOI 10.1158/0008-5472.CAN-20-0106; Maiani E, 2021, NATURE, V592, P799, DOI 10.1038/s41586-021-03422-5; Malumbres M, 2004, CELL, V118, P493, DOI 10.1016/j.cell.2004.08.002; Malumbres M, 2001, NAT REV CANCER, V1, P222, DOI 10.1038/35106065; Martin CA, 2018, INT J CANCER, V142, P2139, DOI 10.1002/ijc.31220; Martinez-Carreres L, 2019, CANCER RES, V79, P5245, DOI 10.1158/0008-5472.CAN-19-0708; MATSUSHIME H, 1991, CELL, V65, P701, DOI 10.1016/0092-8674(91)90101-4; Matsuura I, 2004, NATURE, V430, P226, DOI 10.1038/nature02650; Mayer EL, 2020, ANN ONCOL, V31, pS1145, DOI 10.1016/j.annonc.2020.08.2240; MEDEMA RH, 1995, P NATL ACAD SCI USA, V92, P6289, DOI 10.1073/pnas.92.14.6289; Michaud K, 2010, CANCER RES, V70, P3228, DOI 10.1158/0008-5472.CAN-09-4559; MOTOKURA T, 1991, NATURE, V350, P512, DOI 10.1038/350512a0; Muise-Helmericks RC, 1998, J BIOL CHEM, V273, P29864, DOI 10.1074/jbc.273.45.29864; Narasimha AM, 2014, ELIFE, V3, DOI 10.7554/eLife.02872; O'Leary B, 2018, CANCER DISCOV, V8, P1390, DOI 10.1158/2159-8290.CD-18-0264; Olanich ME, 2015, CLIN CANCER RES, V21, P4947, DOI 10.1158/1078-0432.CCR-14-2955; OShaughnessy J, 2020, 2020 SAN ANT BREAST; Otto T, 2017, NAT REV CANCER, V17, P93, DOI 10.1038/nrc.2016.138; Patel P, 2015, MOL CELL BIOL, V35, P1506, DOI 10.1128/MCB.01206-14; Paternot S, 2014, CELL CYCLE, V13, P2879, DOI 10.4161/15384101.2014.946841; Pek M, 2017, ONCOGENE, V36, P4975, DOI 10.1038/onc.2017.120; Pernas S, 2018, THER ADV MED ONCOL, V10, DOI 10.1177/1758835918786451; Pikman Y, 2017, CLIN CANCER RES, V23, P1012, DOI 10.1158/1078-0432.CCR-15-2869; Polier S, 2013, NAT CHEM BIOL, V9, P307, DOI [10.1038/NCHEMBIO.1212, 10.1038/nchembio.1212]; Puyol M, 2010, CANCER CELL, V18, P63, DOI 10.1016/j.ccr.2010.05.025; Qie S, 2016, J MOL MED, V94, P1313, DOI 10.1007/s00109-016-1475-3; Rader J, 2013, CLIN CANCER RES, V19, P6173, DOI 10.1158/1078-0432.CCR-13-1675; Raspe E, 2017, EMBO MOL MED, V9, P1052, DOI 10.15252/emmm.201607084; Raub TJ, 2015, DRUG METAB DISPOS, V43, P1360, DOI 10.1124/dmd.114.062745; Ray A, 2009, MOL CELL BIOL, V29, P986, DOI 10.1128/MCB.00898-08; Reddy HKDL, 2005, CANCER RES, V65, P10174, DOI 10.1158/0008-5472.CAN-05-2639; Romano G, 2018, CANCER DISCOV, V8, P556, DOI 10.1158/2159-8290.CD-17-0745; Romero-Pozuelo J, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.03.068; Rubio C, 2019, CLIN CANCER RES, V25, P390, DOI 10.1158/1078-0432.CCR-18-0685; Saab R, 2006, MOL CANCER THER, V5, P1299, DOI 10.1158/1535-7163.MCT-05-0383; Salvador-Barbero B, 2020, CANCER CELL, V37, P340, DOI 10.1016/j.ccell.2020.01.007; Schaer DA, 2018, CELL REP, V22, P2978, DOI 10.1016/j.celrep.2018.02.053; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Simoneschi D, 2021, NATURE, V592, P789, DOI 10.1038/s41586-021-03445-y; Slamon DJ, 2020, NEW ENGL J MED, V382, P514, DOI 10.1056/NEJMoa1911149; Slamon DJ, 2018, J CLIN ONCOL, V36, P2465, DOI 10.1200/JCO.2018.78.9909; Sledge GW, 2020, JAMA ONCOL, V6, P116, DOI 10.1001/jamaoncol.2019.4782; Sledge GW, 2017, J CLIN ONCOL, V35, P2875, DOI 10.1200/JCO.2017.73.7585; Smirnov A, 2016, AGING-US, V8, P1384, DOI 10.18632/aging.100988; Tan AR, 2019, LANCET ONCOL, V20, P1587, DOI 10.1016/S1470-2045(19)30616-3; Teh JLF, 2018, CANCER DISCOV, V8, P568, DOI 10.1158/2159-8290.CD-17-0699; Tempka D, 2018, REDOX BIOL, V15, P316, DOI 10.1016/j.redox.2017.12.017; Teo ZL, 2017, CANCER RES, V77, P6340, DOI 10.1158/0008-5472.CAN-17-2210; Tetsu O, 2003, CANCER CELL, V3, P233, DOI 10.1016/S1535-6108(03)00053-9; The I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6906; Topacio BR, 2019, MOL CELL, V74, P758, DOI 10.1016/j.molcel.2019.03.020; Torres-Guzman R, 2017, ONCOTARGET, V8, P69493, DOI 10.18632/oncotarget.17778; Tripathy D, 2018, LANCET ONCOL, V19, P904, DOI 10.1016/S1470-2045(18)30292-4; Turner NC, 2018, NEW ENGL J MED, V379, P1926, DOI 10.1056/NEJMoa1810527; Turner NC, 2019, J CLIN ONCOL, V37, P1169, DOI 10.1200/JCO.18.00925; Turner NC, 2015, NEW ENGL J MED, V373, P209, DOI 10.1056/NEJMoa1505270; Uras IZ, 2016, BLOOD, V127, P2890, DOI 10.1182/blood-2015-11-683581; Vijayaraghavan S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15916; Vilgelm AE, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aav7171; Vora SR, 2014, CANCER CELL, V26, P136, DOI 10.1016/j.ccr.2014.05.020; Wander SA, 2020, CANCER DISCOV, V10, P1174, DOI 10.1158/2159-8290.CD-19-1390; Wang HZ, 2017, NATURE, V546, P426, DOI 10.1038/nature22797; Wang L, 2007, BLOOD, V110, P2075, DOI 10.1182/blood-2007-02-071266; WANG TC, 1994, NATURE, V369, P669, DOI 10.1038/369669a0; Weiss JM, 2019, ANN ONCOL, V30, P1613, DOI 10.1093/annonc/mdz278; Wiedemeyer WR, 2010, P NATL ACAD SCI USA, V107, P11501, DOI 10.1073/pnas.1001613107; WITHERS DA, 1991, MOL CELL BIOL, V11, P4846, DOI 10.1128/MCB.11.10.4846; Wood AC, 2017, CLIN CANCER RES, V23, P2856, DOI 10.1158/1078-0432.CCR-16-1114; Yadav V, 2014, MOL CANCER THER, V13, P2253, DOI 10.1158/1535-7163.MCT-14-0257; Yang C, 2017, ONCOGENE, V36, P2255, DOI 10.1038/onc.2016.379; Yi JY, 2019, EBIOMEDICINE, V43, P225, DOI 10.1016/j.ebiom.2019.03.027; Yin L, 2018, EUR J MED CHEM, V144, P1, DOI 10.1016/j.ejmech.2017.12.003; Yin QY, 2020, J CELL BIOL, V219, DOI 10.1083/jcb.201911036; Yoshida A, 2021, ONCOGENE, V40, P292, DOI 10.1038/s41388-020-01532-4; Yoshida A, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax6352; Yoshida A, 2016, CANCER RES, V76, P2990, DOI 10.1158/0008-5472.CAN-15-2931; Yu JY, 2019, CLIN CANCER RES, V25, P6511, DOI 10.1158/1078-0432.CCR-19-0475; Yu QY, 2001, NATURE, V411, P1017, DOI 10.1038/35082500; Yu QY, 2006, CANCER CELL, V9, P23, DOI 10.1016/j.ccr.2005.12.012; YUE X, 1991, CELL, V65, P691, DOI 10.1016/0092-8674(91)90100-D; Zainal NS, 2019, CANCER BIOL MED, V16, P264, DOI 10.20892/j.issn.2095-3941.2018.0257; Zhang JF, 2018, NATURE, V553, P91, DOI 10.1038/nature25015	165	20	20	24	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2022	375	6577					158	+		10.1126/science.abc1495	http://dx.doi.org/10.1126/science.abc1495			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YG3OI	35025636	Green Accepted			2022-12-28	WOS:000742401600024
J	Orecchioni, M; Kobiyama, K; Winkels, H; Ghosheh, Y; McArdle, S; Mikulski, Z; Kiosses, WB; Fan, ZC; Wen, L; Jung, YM; Roy, P; Ali, AJ; Miyamoto, Y; Mangan, M; Makings, J; Wang, ZH; Denn, A; Vallejo, J; Owens, M; Durant, CP; Braumann, S; Mader, N; Li, L; Matsunami, H; Eckmann, L; Latz, E; Wang, ZN; Hazen, SL; Ley, K				Orecchioni, Marco; Kobiyama, Kouji; Winkels, Holger; Ghosheh, Yanal; McArdle, Sara; Mikulski, Zbigniew; Kiosses, William B.; Fan, Zhichao; Wen, Lai; Jung, Yunmin; Roy, Payel; Ali, Amal J.; Miyamoto, Yukiko; Mangan, Matthew; Makings, Jeffrey; Wang, Zhihao; Denn, Angela; Vallejo, Jenifer; Owens, Michaela; Durant, Christopher P.; Braumann, Simon; Mader, Navid; Li, Lin; Matsunami, Hiroaki; Eckmann, Lars; Latz, Eicke; Wang, Zeneng; Hazen, Stanley L.; Ley, Klaus			Olfactory receptor 2 in vascular macrophages drives atherosclerosis by NLRP3-dependent IL-1 production	SCIENCE			English	Article							SMOOTH-MUSCLE-CELLS; LIPID-PEROXIDATION; ODORANT RECEPTORS; OXIDIZED LDL; MOUSE; REPERTOIRE; ALDEHYDE; EXPRESSION; FAMILY; GENE	Atherosclerosis is an inflammatory disease of the artery walls and involves immune cells such as macrophages. Olfactory receptors (OLFRs) are G protein-coupled chemoreceptors that have a central role in detecting odorants and the sense of smell. We found that mouse vascular macrophages express the olfactory receptor Olfr2 and all associated trafficking and signaling molecules. Olfr2 detects the compound octanal, which activates the NLR family pyrin domain containing 3 (NLRP3) inflammasome and induces interleukin-1b secretion in human and mouse macrophages. We found that human and mouse blood plasma contains octanal, a product of lipid peroxidation, at concentrations sufficient to activate Olfr2 and the human ortholog olfactory receptor 6A2 (OR6A2). Boosting octanal levels exacerbated atherosclerosis, whereas genetic targeting of Olfr2 in mice significantly reduced atherosclerotic plaques. Our findings suggest that inhibiting OR6A2 may provide a promising strategy to prevent and treat atherosclerosis.	[Orecchioni, Marco; Kobiyama, Kouji; Winkels, Holger; Ghosheh, Yanal; Fan, Zhichao; Wen, Lai; Jung, Yunmin; Roy, Payel; Ali, Amal J.; Makings, Jeffrey; Wang, Zhihao; Vallejo, Jenifer; Owens, Michaela; Durant, Christopher P.; Ley, Klaus] La Jolla Inst Immunol, La Jolla, CA 92037 USA; [Kobiyama, Kouji] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Vaccine Sci,Minato Ku, Tokyo 1088639, Japan; [Winkels, Holger; Braumann, Simon] Univ Hosp Cologne, Heart Ctr, Dept Internal Med 3, Div Cardiol, D-50937 Cologne, Germany; [McArdle, Sara; Mikulski, Zbigniew; Kiosses, William B.; Denn, Angela] La Jolla Inst Immunol, Histol & Microscopy Core Facil, La Jolla, CA 92037 USA; [Fan, Zhichao] Univ Connecticut, Sch Med, Dept Immunol, UConn Hlth, Farmington, CT 06030 USA; [Miyamoto, Yukiko; Eckmann, Lars] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Mangan, Matthew; Latz, Eicke] Univ Hosp Bonn, Inst Innate Immun, D-53127 Bonn, Germany; [Mader, Navid] Univ Hosp Cologne, Heart Ctr, Dept Cardiothorac Surg, D-50937 Cologne, Germany; [Li, Lin; Wang, Zeneng; Hazen, Stanley L.] Cleveland Clin, Lerner Res Inst, Cleveland, OH 44195 USA; [Matsunami, Hiroaki] Duke Univ, Mol Genet & Microbiol, Med Ctr, Durham, NC 27708 USA; [Hazen, Stanley L.] Cleveland Clin, Heart & Vasc Inst, Cleveland, OH 44195 USA; [Ley, Klaus] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA	La Jolla Institute for Immunology; University of Tokyo; University of Cologne; La Jolla Institute for Immunology; University of Connecticut; University of California System; University of California San Diego; University of Bonn; University of Cologne; Cleveland Clinic Foundation; Duke University; Cleveland Clinic Foundation; University of California System; University of California San Diego	Ley, K (corresponding author), La Jolla Inst Immunol, La Jolla, CA 92037 USA.; Ley, K (corresponding author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.	klaus@lji.org	Winkels, Holger/ADQ-0339-2022; Fan, Zhichao/A-9835-2014; Latz, Eicke/H-3951-2014	Winkels, Holger/0000-0003-1333-2031; Wen, Lai/0000-0001-9760-3403; Mikulski, Zbigniew/0000-0002-1918-9216; Fan, Zhichao/0000-0001-5385-9626; Jung, Yunmin/0000-0002-4734-5837; Mangan, Matthew/0000-0001-5990-3034; Ghosheh, Yanal/0000-0002-3733-2098; Orecchioni, Marco/0000-0002-3602-8510; Latz, Eicke/0000-0003-1488-5666; Wang, Zhihao/0000-0002-2597-4464	American Heart Association [AHA18POST34060251]; Tullie and Rickey Families SPARK Awards at La Jolla Institute; Conrad Prebys Foundation Award; Deutsche Forschungsgemeinschaft [GZ WI 4811/1-1]; Chan Zuckerberg Initiative; NIH [DK 120515, HL 130819, HL 115232, 145241, HL088093, S10OD021831]; National Institutes of Health; Office of Dietary Supplements [HL103866, HL126827, DK106000]; Kyowa Kirin; Shared Instrumentation Grant Program [RR027366]; AHA [18CDA34110426];  [R01 HL 145454]	American Heart Association(American Heart Association); Tullie and Rickey Families SPARK Awards at La Jolla Institute; Conrad Prebys Foundation Award; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Chan Zuckerberg Initiative; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Dietary Supplements(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kyowa Kirin; Shared Instrumentation Grant Program; AHA(American Heart Association); 	This work was supported by grants to M.Or. from the American Heart Association (AHA18POST34060251), the Tullie and Rickey Families SPARK Awards at La Jolla Institute, and the Conrad Prebys Foundation Award. H.W. was supported by Deutsche Forschungsgemeinschaft (GZ WI 4811/1-1). S.M. was supported by an Imaging Scientist grant from the Chan Zuckerberg Initiative. Z.F. was supported by grant R01 HL 145454 and AHA 18CDA34110426. L.E. was supported by grant NIH DK 120515. S.L.H. was supported in part by the National Institutes of Health and the Office of Dietary Supplements grants HL103866, HL126827, and DK106000. Z.W. was supported by NIH HL 130819. K.L. was supported by grants NIH HL 115232, 145241, HL088093, and a grant from Kyowa Kirin. The Aria-3 cell sorter was supported by the Shared Instrumentation Grant Program RR027366, and the Zeiss LSM 880 confocal microscope was funded by NIH S10OD021831.	Ameli S, 1996, ARTERIOSCL THROM VAS, V16, P1074, DOI 10.1161/01.ATV.16.8.1074; Antunes G, 2016, METHOD CELL BIOL, V132, P127, DOI 10.1016/bs.mcb.2015.11.003; Araneda RC, 2000, NAT NEUROSCI, V3, P1248, DOI 10.1038/81774; Araneda RC, 2004, J PHYSIOL-LONDON, V555, P743, DOI 10.1113/jphysiol.2003.058040; Bennett MR, 2016, CIRC RES, V118, P692, DOI 10.1161/CIRCRESAHA.115.306361; Bozza T, 2002, J NEUROSCI, V22, P3033, DOI 10.1523/JNEUROSCI.22-08-03033.2002; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Camarena V, 2017, ELIFE, V6, DOI 10.7554/eLife.29750; Cochain C, 2018, CIRC RES, V122, P1661, DOI 10.1161/CIRCRESAHA.117.312509; Coll RC, 2015, NAT MED, V21, P248, DOI 10.1038/nm.3806; Daugherty A, 2017, ARTERIOSCL THROM VAS, V37, pE131, DOI 10.1161/ATV.0000000000000062; ESTERBAUER H, 1993, BRIT MED BULL, V49, P566, DOI 10.1093/oxfordjournals.bmb.a072631; Feil S, 2014, CIRC RES, V115, P662, DOI 10.1161/CIRCRESAHA.115.304634; Ferrer I, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00163; Folkersen L, 2012, MOL MED, V18, P669, DOI 10.2119/molmed.2011.00479; Hu JJ, 2020, NAT IMMUNOL, V21, P736, DOI 10.1038/s41590-020-0669-6; Lee SJ, 2019, NAT REV DRUG DISCOV, V18, P116, DOI 10.1038/s41573-018-0002-3; Li F, 2013, J NEUROSCI, V33, P7975, DOI 10.1523/JNEUROSCI.5563-12.2013; Li JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080148; Li YD, 2014, ACS CHEM BIOL, V9, P2563, DOI 10.1021/cb400290u; McArdle S, 2019, CIRC RES, V125, P1038, DOI 10.1161/CIRCRESAHA.119.315175; McKenzie BA, 2018, P NATL ACAD SCI USA, V115, pE6065, DOI 10.1073/pnas.1722041115; Miller YI, 2005, FUTUR CARDIOL, V1, P785, DOI 10.2217/14796678.1.6.785; Morales MT, 1997, J AGR FOOD CHEM, V45, P2666, DOI 10.1021/jf960585+; Mukherjee P, 2018, J LIPID RES, V59, P1818, DOI 10.1194/jlr.M083527; PIOTROWSKI JJ, 1990, LIFE SCI, V46, P715, DOI 10.1016/0024-3205(90)90077-5; Rizzo WB, 2014, BBA-MOL CELL BIOL L, V1841, P377, DOI 10.1016/j.bbalip.2013.09.001; Rouquier S, 2000, P NATL ACAD SCI USA, V97, P2870, DOI 10.1073/pnas.040580197; Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021; Sharma R, 2017, ELIFE, V6, DOI 10.7554/eLife.21895; Teixeira CSS, 2016, CHEM SENSES, V41, P105, DOI 10.1093/chemse/bjv075; Swanson KV, 2019, NAT REV IMMUNOL, V19, P477, DOI 10.1038/s41577-019-0165-0; Tsuchiya K, 2021, CELL REP, V34, DOI 10.1016/j.celrep.2021.108887; Wang XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066397; Winkels H, 2018, CIRC RES, V122, P1675, DOI 10.1161/CIRCRESAHA.117.312513; Xu LR, 2018, INT J FOOD PROP, V20, pS2926, DOI 10.1080/10942912.2017.1382510; Yaron JR, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.277; Zernecke A, 2020, CIRC RES, V127, P402, DOI 10.1161/CIRCRESAHA.120.316903	38	19	19	36	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2022	375	6577					214	+		10.1126/science.abg3067	http://dx.doi.org/10.1126/science.abg3067			204	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YG3OI	35025664	Green Accepted			2022-12-28	WOS:000742401600037
J	Kuehn, BM				Kuehn, Bridget M.			PrEP Awareness Is Low Among Heterosexual People	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 11	2022	327	2					116	116						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YH8QV	35015029				2022-12-28	WOS:000743426500006
J	Siddharthan, T; Pollard, SL; Quaderi, SA; Rykiel, NA; Wosu, AC; Alupo, P; Barber, JA; Cardenas, MK; Chandyo, RK; Flores-Flores, O; Kirenga, B; Miranda, JJ; Mohan, S; Ricciardi, F; Sharma, AK; Das, S; Shrestha, L; Soares, MO; Checkley, W; Hurst, JR				Siddharthan, Trishul; Pollard, Suzanne L.; Quaderi, Shumonta A.; Rykiel, Natalie A.; Wosu, Adaeze C.; Alupo, Patricia; Barber, Julie A.; Cardenas, Maria Kathia; Chandyo, Ram K.; Flores-Flores, Oscar; Kirenga, Bruce; Miranda, J. Jaime; Mohan, Sakshi; Ricciardi, Federico; Sharma, Arun K.; Das, Santa Kumar; Shrestha, Laxman; Soares, Marta O.; Checkley, William; Hurst, John R.		GECo Study Investigators	Discriminative Accuracy of Chronic Obstructive Pulmonary Disease Screening Instruments in 3 Low- and Middle-Income Country Settings	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LUNG-FUNCTION; COPD; INTERVENTION; BURDEN; ACCESS	IMPORTANCE Most of the global morbidity and mortality in chronic obstructive pulmonary disease (COPD) occurs in low- and middle-income countries (LMICs), with significant economic effects. OBJECTIVE To assess the discriminative accuracy of 3 instruments using questionnaires and peakexpiratory flow (PEF) to screen for COPD in 3 LMIC settings. DESIGN, SETTING, AND PARTICIPANTS A cross-sectional analysis of discriminative accuracy, conducted between January 2018 and March 2020 in semiurban Bhaktapur, Nepal; urban Lima, Peru; and rural Nakaseke, Uganda, using a random age- and sex-stratified sample of the population 40 years or older. EXPOSURES Three screening tools, the COPD Assessment in Primary Care to Identify Undiagnosed Respiratory Disease and Exacerbation Risk (CAPTURE; range, 0-6; high risk indicated by a score of 5 or more or score 2-5 with low PEF [<250 L/min for females and <350 L/min for males]), the COPD in LMICs Assessment questionnaire (COLA-6; range, 0-5; high risk indicated by a score of 4 or more), and the Lung Function Questionnaire (LFQ; range, 0-25; high risk indicated by a score of 18 or less) were assessed against a reference standard diagnosis of COPD using quality-assured postbronchodilator spirometry. CAPTURE and COLA-6 include a measure of PEF. Main Outcomes and Measures The primary outcome was discriminative accuracy of the tools in identifying COPD as measured by area under receiver operating characteristic curves (AUCs) with 95% CIs. Secondary outcomes included sensitivity, specificity, positive predictive value, and negative predictive value. RESULTS Among 10 709 adults who consented to participate in the study (mean age, 56.3 years (SD, 11.7); 50% female), 35% had ever smoked, and 30% were currently exposed to biomass smoke. The unweighted prevalence of COPD at the 3 sites was 18.2% (642/3534 participants) in Nepal, 2.7% (97/3550) in Peru, and 7.4% (264/3580) in Uganda. Among 1000 COPD cases, 49.3% had clinically important disease (Global Initiative for Chronic Obstructive Lung Disease classification B-D), 16.4% had severe or very severe airflow obstruction (forced expiratory volume in 1 second <50% predicted), and 95.3% of cases were previously undiagnosed. The AUC for the screening instruments ranged from 0.717 (95% CI, 0.677-0.774) for LFQ in Peru to 0.791 (95% CI, 0.770-0.809) for COLA-6 in Nepal. The sensitivity ranged from 34.8% (95% CI, 25.3%-45.2%) for COLA-6 in Nepal to 64.2% (95% CI, 60.3%-67.9%) for CAPTURE in Nepal. The mean time to administer the instruments was 7.6 minutes (SD 1.11), and data completeness was 99.5%. CONCLUSIONS AND RELEVANCE This study demonstrated that screening instruments for COPD were feasible to administer in 3 low- and middle-income settings. Further research is needed to assess instrument performance in other low- and middle-income settings and to determine whether implementation is associated with improved clinical outcomes.	[Siddharthan, Trishul] Univ Miami, Miller Sch Med, Div Pulm & Crit Care, Miami, FL 33136 USA; [Siddharthan, Trishul; Pollard, Suzanne L.; Rykiel, Natalie A.; Wosu, Adaeze C.; Flores-Flores, Oscar; Checkley, William] Johns Hopkins Univ, Sch Med, Ctr Global NonCommun Dis Res & Training, Baltimore, MD 21205 USA; [Siddharthan, Trishul; Pollard, Suzanne L.; Rykiel, Natalie A.; Wosu, Adaeze C.; Checkley, William] Johns Hopkins Univ, Sch Med, Div Pulm & Crit Care, Baltimore, MD USA; [Pollard, Suzanne L.] NIH, Bldg 10, Bethesda, MD 20892 USA; [Quaderi, Shumonta A.; Hurst, John R.] UCL, UCL Resp, Royal Free Campus,Rowland Hill St, London NW3 2PF, England; [Alupo, Patricia; Kirenga, Bruce] Makerere Univ, Makerere Lung Inst, Kampala, Uganda; [Barber, Julie A.; Ricciardi, Federico] UCL, Dept Stat Sci, London, England; [Cardenas, Maria Kathia; Miranda, J. Jaime] Univ Peruana Cayetano Heredia, CRONICAS Ctr Excellence Chron Dis, Lima, Peru; [Chandyo, Ram K.] Kathmandu Med Coll, Dept Commun Med, Kathmandu, Nepal; [Flores-Flores, Oscar] A BPRISMA, Biomed Res Unit, Lima, Peru; [Flores-Flores, Oscar] Univ San Martin Porres, Fac Med Humana, Ctr Invest Envejecimiento CIEN, Lima, Peru; [Miranda, J. Jaime] Univ Peruana Cayetano Heredia, Sch Med, Dept Med, Lima, Peru; [Mohan, Sakshi; Soares, Marta O.] Univ York, Ctr Hlth Econ, York, N Yorkshire, England; [Sharma, Arun K.; Das, Santa Kumar; Shrestha, Laxman] Tribhuvan Univ, Inst Med, Child Hlth Res Project, Kathmandu, Nepal	University of Miami; Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA; University of London; University College London; Makerere University; University of London; University College London; Universidad Peruana Cayetano Heredia; Universidad de San Martin de Porres; Universidad Peruana Cayetano Heredia; University of York - UK; Tribhuvan University; Institute of Medicine (IoM) - Nepal	Hurst, JR (corresponding author), UCL, UCL Resp, Royal Free Campus,Rowland Hill St, London NW3 2PF, England.	j.hurst@ucl.ac.uk	Michie, Susan/A-1745-2010	Michie, Susan/0000-0003-0063-6378; Ricciardi, Federico/0000-0002-4473-7691; Flores-Flores, Oscar/0000-0002-9780-937X; Barber, Julie/0000-0001-5762-762X; Soares, Marta Ferreira Oliveira/0000-0003-1579-8513; Hurst, John/0000-0002-7246-6040; CARDENAS, MARIA KATHIA/0000-0002-3173-9284	Medical Research Council [MR/P008984/1]; National Institutes of Health [K23HL126946, D43 TW009340, 1D43TW011502-01]	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was funded by the Medical Research Council (grant MR/P008984/1) and the National Institutes of Health (grants K23HL126946 [Dr Siddharthan], D43 TW009340 [Dr Flores-Flores], and 1D43TW011502-01 [Dr Flores-Flores]).	[Anonymous], 2017, PNEUMOLOGIE, V71, P9; Bae E, 2020, BMC PULM MED, V20, DOI 10.1186/s12890-020-1116-z; Beran D, 2015, LANCET RESP MED, V3, P159, DOI 10.1016/S2213-2600(15)00004-1; Buist AS, 2007, LANCET, V370, P741, DOI 10.1016/S0140-6736(07)61377-4; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; Checkley W, 2016, LANCET RESP MED, V4, P852, DOI 10.1016/S2213-2600(16)30245-4; Checkley W, 2010, NEW ENGL J MED, V362, P1784, DOI 10.1056/NEJMoa0907441; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Guirguis-Blake JM, 2016, JAMA-J AM MED ASSOC, V315, P1378, DOI 10.1001/jama.2016.2654; Herdman M, 2011, QUAL LIFE RES, V20, P1727, DOI 10.1007/s11136-011-9903-x; Herman Cheryl, 2006, Virtual Mentor, V8, P34, DOI 10.1001/virtualmentor.2006.8.1.cprl1-0601; Hurst JR, 2021, ANN AM THORAC SOC, V18, P1269, DOI 10.1513/AnnalsATS.202103-284ST; Jithoo A, 2013, EUR RESPIR J, V41, P548, DOI 10.1183/09031936.00132011; Jones PW, 2009, EUR RESPIR J, V34, P648, DOI 10.1183/09031936.00102509; Jones R, 2017, INT J CHRONIC OBSTR, V12, P3533, DOI 10.2147/COPD.S146659; Koch M, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-8071-8; Kon SSC, 2014, LANCET RESP MED, V2, P195, DOI 10.1016/S2213-2600(14)70001-3; Lange P, 2015, NEW ENGL J MED, V373, P111, DOI 10.1056/NEJMoa1411532; Mahler Donald A, 2005, COPD, V2, P99; Martinez FJ, 2017, AM J RESP CRIT CARE, V195, P748, DOI 10.1164/rccm.201603-0622OC; Maxim LD, 2014, INHAL TOXICOL, V26, P811, DOI 10.3109/08958378.2014.955932; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Mortimer K, 2018, ANN AM THORAC SOC, V15, P539, DOI 10.1513/AnnalsATS.201710-831GH; NICE, 2020, CHRONIC OBSTRUCTIVE; Robertson NM, 2019, COPD-J COPD FDN, V6, P17, DOI 10.15326/jcopdf.6.1.2018.0143; Roth GA, 2018, LANCET, V392, P1736, DOI 10.1016/s0140-6736(18)32203-7; Sarkar BK, 2017, THORAX, V72, P167, DOI 10.1136/thoraxjnl-2016-208732; Siddharthan T, 2020, INT J CHRONIC OBSTR, V15, P2769, DOI 10.2147/COPD.S268076; Siddharthan T, 2020, AM J RESP CRIT CARE, V202, P171, DOI 10.1164/rccm.202001-0165ED; Siddharthan T, 2018, TRIALS, V19, DOI 10.1186/s13063-018-2909-8; Siddharthan T, 2018, AM J RESP CRIT CARE, V197, P611, DOI 10.1164/rccm.201709-1861OC; Sobrino E, 2017, BMC PULM MED, V17, DOI 10.1186/s12890-017-0537-9; Tabyshova A, 2021, CHEST, V159, P575, DOI 10.1016/j.chest.2020.09.260; Williams N, 2017, OCCUP MED-OXFORD, V67, P496, DOI 10.1093/occmed/kqx086; World Health Organization, 2021, WHO MODEL LIST ESSEN; Yawn Barbara P, 2010, Int J Chron Obstruct Pulmon Dis, V5, P1	36	6	6	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 11	2022	327	2					151	160		10.1001/jama.2021.23065	http://dx.doi.org/10.1001/jama.2021.23065			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YH8QV	35015039	Green Published			2022-12-28	WOS:000743426500016
J	Bartholomew, T; Colleoni, M; Schmidt, H				Bartholomew, Theodore; Colleoni, Mirela; Schmidt, Harald			Financial incentives for breast cancer screening undermine informed choice	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							BENEFITS; OVERDETECTION; PERFORMANCE; PHYSICIANS; PROGRAM; IMPACT; WOMEN	Theodore Bartholomew, Mirela Colleoni, and Harald Schmidt argue that the focus should be on decision making not uptake when the balance of benefit and harm is subjective	[Bartholomew, Theodore] Royal Surrey Cty Hosp NHS Fdn Trust, Guildford, Surrey, England; [Colleoni, Mirela] Hauts France, Pas De Calais, France; [Schmidt, Harald] Univ Penn, Dept Med Ethics & Hlth Policy, Philadelphia, PA 19104 USA	Royal Surrey County Hospital; University of Pennsylvania	Bartholomew, T (corresponding author), Royal Surrey Cty Hosp NHS Fdn Trust, Guildford, Surrey, England.	tb.public@mailbox.org						Aliabadi S, 2021, LANCET INFECT DIS, V21, P1689, DOI 10.1016/S1473-3099(21)00069-4; Baum M, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f385; Berlin L, 2010, RADIOLOGY, V255, P311, DOI 10.1148/radiol.10100056; Breast Cancer Now, 2016, WOM ATT BREAST SCREE; Burton RC, 2012, BREAST CANCER RES TR, V131, P949, DOI 10.1007/s10549-011-1794-6; Dinh CT, 2021, PREV MED, V148, DOI 10.1016/j.ypmed.2021.106534; Esmaeili M, 2021, INT J MED INFORM, V149, DOI 10.1016/j.ijmedinf.2021.104406; Eurostat, 2020, EUROSTAT; FREEDMAN JD, 1994, J GEN INTERN MED, V9, P462, DOI 10.1007/BF02599066; General Medical Council, 2020, DECISION MAKING CONS; Gigerenzer G, 2009, JNCI-J NATL CANCER I, V101, P1216, DOI 10.1093/jnci/djp237; GODLEE F., 2013, BRIT MED J, V346, pf477, DOI DOI 10.1136/BMJ.F477; Gotzsche PC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub5; Gould DJ, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005186.pub4; Gupta S, 2016, AM J GASTROENTEROL, V111, P1630, DOI 10.1038/ajg.2016.286; Health Systems and Policy Monitor, 2018, HLTH SYSTEMS TRANSIT; Hersch J, 2021, JNCI-J NATL CANCER I, V113, P1523, DOI 10.1093/jnci/djab083; Hersch J, 2015, LANCET, V385, P1642, DOI 10.1016/S0140-6736(15)60123-4; Institut national du cancer, STRAT DEC LUTT CANC; Kane RL, 2004, AM J PREV MED, V27, P327, DOI 10.1016/j.amepre.2004.07.002; Kaplan CP, 2000, J WOMEN HEALTH GEN-B, V9, P779, DOI 10.1089/15246090050147754; Kirwan CC, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f87; L'Assurance Maladie, 2016, CONV 2016 NOUV ROSP; Marmot MG, 2013, BRIT J CANCER, V108, P2205, DOI 10.1038/bjc.2013.177; Marteau TM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1415; Martins C, 2019, BREAST CANC SCREENIN; Mauro M, 2019, HEALTH POLICY, V123, P1210, DOI 10.1016/j.healthpol.2019.09.012; MAYER JA, 1989, J BEHAV MED, V12, P605, DOI 10.1007/BF00844829; Mehrotra A, 2014, AM J MANAG CARE, V20, P494; Mehta SJ, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.1156; Merrick EL, 2015, AM J MANAG CARE, V21, P771; Moyer VA, 2014, ANN INTERN MED, V160, P330, DOI 10.7326/M13-2771; National Cancer Institute, 2020, BRE CANC SCREENING; Nelson HD, 2016, ANN INTERN MED, V164, P244, DOI 10.7326/M15-0969; NHS Digital, 2021, BREAST SCREENING PRO; O'Connor AM, 2003, BMJ-BRIT MED J, V327, P736, DOI 10.1136/bmj.327.7417.736; Pace LE, 2014, JAMA-J AM MED ASSOC, V311, P1327, DOI 10.1001/jama.2014.1398; Pappadis MR, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-022138; Petrova D, 2018, MED DECIS MAKING, V38, P355, DOI 10.1177/0272989X17729359; Pharoah PDP, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2618; Richards M, 2019, REPORT INDEPENDENT R; Rosenthal MB, 2006, NEW ENGL J MED, V355, P1895, DOI 10.1056/NEJMsa063682; Sante Publique France, DEPISTAGE CANC SEIN; Schmidt H, 2015, JAMA-J AM MED ASSOC, V314, P995, DOI 10.1001/jama.2015.8852; Silvia KA, 2006, HEALTH EXPECT, V9, P255, DOI 10.1111/j.1369-7625.2006.00393.x; Spagnoli L, 2018, MEDICINE, V97, DOI [10.1097/MD.0000000000010957, 10.1097/md.0000000000010957]; Strech D, 2014, HEALTH POLICY, V115, P100, DOI 10.1016/j.healthpol.2013.11.012; Sung HH, 2022, CLIN EXP HYPERTENS, V44, P146, DOI 10.1080/10641963.2021.2007943; Sutherland K, 2008, MED CARE RES REV, V65, p36S, DOI 10.1177/1077558708324235; Valentino L, 2022, RSF-RUS SAGE J SOC S, V8, P89, DOI [10.18311/ti/2021/v28i1/24809, 10.1097/QAD.0000000000003368, 10.1016/j.vaccine.2022.07.056, 10.7758/RSF.2022.8.7.05]; Wegwarth O, 2013, JAMA INTERN MED, V173, P2086, DOI 10.1001/jamainternmed.2013.10363; Wegwarth O, 2012, ANN INTERN MED, V156, P340, DOI 10.7326/0003-4819-156-5-201203060-00005; Woloshin S, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5132	53	3	3	2	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 10	2022	376								e065726	10.1136/bmj-2021-065726	http://dx.doi.org/10.1136/bmj-2021-065726			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YP6IZ	35012959	Bronze			2022-12-28	WOS:000748727200004
J	Horn, DM; Haas, JS				Horn, Daniel M.; Haas, Jennifer S.			Expanded Lung and Colorectal Cancer Screening - Ensuring Equity and Safety under New Guidelines	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Horn, Daniel M.; Haas, Jennifer S.] Massachusetts Gen Hosp, Div Gen Internal Med, Boston, MA 02114 USA; [Horn, Daniel M.; Haas, Jennifer S.] Harvard Med Sch, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Horn, DM (corresponding author), Massachusetts Gen Hosp, Div Gen Internal Med, Boston, MA 02114 USA.; Horn, DM (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.							Basu P, 2018, INT J CANCER, V142, P44, DOI 10.1002/ijc.31043; Doubeni CA, 2021, JAMA-J AM MED ASSOC, V325, P627, DOI 10.1001/jama.2020.26188; Fedewa SA, 2019, AM J PREV MED, V57, P3, DOI 10.1016/j.amepre.2019.02.015; Glied, 2021, JAMA HLTH FORUM, V2; Henderson LM, 2021, JAMA-J AM MED ASSOC, V325, P939, DOI 10.1001/jama.2020.26422	5	2	2	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 13	2022	386	2					100	102		10.1056/NEJMp2113332	http://dx.doi.org/10.1056/NEJMp2113332		JAN 2022	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YF2NZ	34995027	Bronze			2022-12-28	WOS:000740348100001
J	Woolston, C; Francia, ME				Woolston, Chris; Francia, Maria Eugenia			Where I work	NATURE			English	Editorial Material						Health care; Infection; Parasitology			[Francia, Maria Eugenia] Pasteur Inst Montevideo, Apicomplexan Biol Lab, Montevideo, Uruguay	Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis	Francia, ME (corresponding author), Pasteur Inst Montevideo, Apicomplexan Biol Lab, Montevideo, Uruguay.								0	0	0	1	5	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 6	2022	601	7891					158	158						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YB0AX	34983990				2022-12-28	WOS:000738686800015
J	Jahangir, A				Jahangir, Arshad			In adults aged 75 to 76 y, systematic AF screening reduced morbidity and mortality at 6 y	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Jahangir, Arshad] Aurora Sinai Aurora St Lukes Med Ctr, Ctr Adv Atrial Fibrillat Therapies, Milwaukee, WI 53215 USA		Jahangir, A (corresponding author), Aurora Sinai Aurora St Lukes Med Ctr, Ctr Adv Atrial Fibrillat Therapies, Milwaukee, WI 53215 USA.								0	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN	2022	175	1					JC9	JC9		10.7326/J21-0012	http://dx.doi.org/10.7326/J21-0012		JAN 2022	1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0Y3LO	34978858				2022-12-28	WOS:000742140100002
J	Jones, H				Jones, Helen			Why I ... keep bees	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 4	2022	376								n3089	10.1136/bmj.n3089	http://dx.doi.org/10.1136/bmj.n3089			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YD7MV	34983777	Bronze			2022-12-28	WOS:000740622800008
J	MacDougall, P				MacDougall, Peter			In long-term, higher-dose opioid use, dose tapering was linked to overdose and mental health crises	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							GUIDELINE		[MacDougall, Peter] Dalhousie Univ, Halifax, NS, Canada	Dalhousie University	MacDougall, P (corresponding author), Dalhousie Univ, Halifax, NS, Canada.							Ahonle Zaccheus J, 2020, Fed Pract, V37, P420, DOI 10.12788/fp.0025; Busse JW, 2017, CAN MED ASSOC J, V189, pE659, DOI 10.1503/cmaj.170363; Dowell D, 2016, MMWR RECOMM REP, V65, P1, DOI [10.15585/mmwr.rr7103a1, 10.1001/jama.2016.1464]	3	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN	2022	175	1					JC11	JC11		10.7326/J21-0005	http://dx.doi.org/10.7326/J21-0005		JAN 2022	1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	0Y3LO	34978849				2022-12-28	WOS:000742139800001
J	Samarasekera, U				Samarasekera, Udani			Medecins Sans Frontieres: 50 years of bearing witness	LANCET			English	Editorial Material																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 1	2022	399	10319					12	15						4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YA3YW	34973710				2022-12-28	WOS:000738273800008
J	Georg, P; Astaburuaga-Garcia, R; Bonaguro, L; Brumhard, S; Michalick, L; Lippert, LJ; Kostevc, T; Gabel, C; Schneider, M; Streitz, M; Demichev, V; Gemund, I; Barone, M; Tober-Lau, P; Helbig, ET; Hillus, D; Petrov, L; Stein, J; Dey, HP; Paclik, D; Iwert, C; Mulleder, M; Aulakh, SK; Djudjaj, S; Bulow, RD; Mei, HE; Schulz, AR; Thiel, A; Hippenstiel, S; Saliba, AE; Eils, R; Lehmann, I; Mall, MA; Stricker, S; Rohmel, J; Corman, VM; Beule, D; Wyler, E; Landthaler, M; Obermayer, B; von Stillfried, S; Boor, P; Demir, M; Wesselmann, H; Suttorp, N; Uhrig, A; Muller-Redetzky, H; Nattermann, J; Kuebler, WM; Meisel, C; Ralser, M; Schultze, JL; Aschenbrenner, AC; Thibeault, C; Kurth, F; Sander, LE; Bluthgen, N; Sawitzki, B				Georg, Philipp; Astaburuaga-Garcia, Rosario; Bonaguro, Lorenzo; Brumhard, Sophia; Michalick, Laura; Lippert, Lena J.; Kostevc, Tomislav; Gaebel, Christiane; Schneider, Maria; Streitz, Mathias; Demichev, Vadim; Gemuend, Ioanna; Barone, Matthias; Tober-Lau, Pinkus; Helbig, Elisa T.; Hillus, David; Petrov, Lev; Stein, Julia; Dey, Hannah-Philine; Paclik, Daniela; Iwert, Christina; Muelleder, Michael; Aulakh, Simran Kaur; Djudjaj, Sonja; Buelow, Roman D.; Mei, Henrik E.; Schulz, Axel R.; Thiel, Andreas; Hippenstiel, Stefan; Saliba, Antoine-Emmanuel; Eils, Roland; Lehmann, Irina; Mall, Marcus A.; Stricker, Sebastian; Roehmel, Jobst; Corman, Victor M.; Beule, Dieter; Wyler, Emanuel; Landthaler, Markus; Obermayer, Benedikt; von Stillfried, Saskia; Boor, Peter; Demir, Munevver; Wesselmann, Hans; Suttorp, Norbert; Uhrig, Alexander; Mueller-Redetzky, Holger; Nattermann, Jacob; Kuebler, Wolfgang M.; Meisel, Christian; Ralser, Markus; Schultze, Joachim L.; Aschenbrenner, Anna C.; Thibeault, Charlotte; Kurth, Florian; Sander, Leif E.; Bluethgen, Nils; Sawitzki, Birgit		PA-COVID-19 Study Grp	Complement activation induces excessive T cell cytotoxicity in severe COVID-19	CELL			English	Article							R PACKAGE; NK CELLS; REVEALS; EXPRESSION; INFERENCE; INNATE	Severe COVID-19 is linked to both dysfunctional immune response and unrestrained immunopathology, and it remains unclear whether T cells contribute to disease pathology. Here, we combined single-cell transcriptomics and single-cell proteomics with mechanistic studies to assess pathogenic T cell functions and inducing signals. We identified highly activated CD16(+) T cells with increased cytotoxic functions in severe COVID-19. CD16 expression enabled immune-complex-mediated, T cell receptor-independent degranulation and cytotoxicity not found in other diseases. CD16(+) T cells from COVID-19 patients promoted microvascular endothelial cell injury and release of neutrophil and monocyte chemoattractants. CD16(+) T cell clones persisted beyond acute disease maintaining their cytotoxic phenotype. Increased generation of C3a in severe COVID-19 induced activated CD16(+) cytotoxic T cells. Proportions of activated CD16(+) T cells and plasma levels of complement proteins upstream of C3a were associated with fatal outcome of COVID-19, supporting a pathological role of exacerbated cytotoxicity and complement activation in COVID-19.	[Georg, Philipp; Brumhard, Sophia; Lippert, Lena J.; Tober-Lau, Pinkus; Helbig, Elisa T.; Hillus, David; Hippenstiel, Stefan; Wesselmann, Hans; Suttorp, Norbert; Uhrig, Alexander; Mueller-Redetzky, Holger; Thibeault, Charlotte; Kurth, Florian; Sander, Leif E.] Charite Univ Med Berlin, Dept Infect Dis & Resp Med, Berlin, Germany; [Georg, Philipp; Brumhard, Sophia; Lippert, Lena J.; Tober-Lau, Pinkus; Helbig, Elisa T.; Hillus, David; Thiel, Andreas; Hippenstiel, Stefan; Wesselmann, Hans; Suttorp, Norbert; Uhrig, Alexander; Mueller-Redetzky, Holger; Thibeault, Charlotte; Kurth, Florian; Sander, Leif E.] Free Univ Berlin, Berlin, Germany; [Georg, Philipp; Brumhard, Sophia; Lippert, Lena J.; Tober-Lau, Pinkus; Helbig, Elisa T.; Hillus, David; Thiel, Andreas; Hippenstiel, Stefan; Wesselmann, Hans; Suttorp, Norbert; Uhrig, Alexander; Mueller-Redetzky, Holger; Thibeault, Charlotte; Kurth, Florian; Sander, Leif E.] Humboldt Univ, Berlin, Germany; [Astaburuaga-Garcia, Rosario; Bluethgen, Nils] Charite Univ Med Berlin, Inst Pathol, Berlin, Germany; [Astaburuaga-Garcia, Rosario; Landthaler, Markus; Bluethgen, Nils] Humboldt Univ, IRI Life Sci, Berlin, Germany; [Bonaguro, Lorenzo; Gemuend, Ioanna; Schultze, Joachim L.; Aschenbrenner, Anna C.] Univ Bonn, Life & Med Sci LIMES Inst, Genom & Immunoregulat, Bonn, Germany; [Bonaguro, Lorenzo; Schultze, Joachim L.; Aschenbrenner, Anna C.] Deutsch Zentrum Neurodegenerativen Erkrankungen D, Syst Med, Bonn, Germany; [Michalick, Laura; Kuebler, Wolfgang M.] Charite Univ Med Berlin, Inst Physiol, Berlin, Germany; [Kostevc, Tomislav; Gaebel, Christiane; Schneider, Maria; Streitz, Mathias; Barone, Matthias; Petrov, Lev; Stein, Julia; Dey, Hannah-Philine; Paclik, Daniela; Iwert, Christina; Meisel, Christian; Sawitzki, Birgit] Charite Univ Med Berlin, Inst Med Immunol, Berlin, Germany; [Demichev, Vadim; Aulakh, Simran Kaur; Ralser, Markus] Francis Crick Inst, Mol Biol Metab Lab, London, England; [Demichev, Vadim; Ralser, Markus] Charite Univ Med Berlin, Dept Biochem, Berlin, Germany; [Demichev, Vadim] Univ Cambridge, Cambridge Ctr Prote, Dept Biochem, Cambridge, England; [Gemuend, Ioanna; Schultze, Joachim L.; Aschenbrenner, Anna C.] Univ Bonn, PRECISE Platform Genom & Epigen, DZNE, Bonn, Germany; [Gemuend, Ioanna] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic, Australia; [Muelleder, Michael] Charite Univ Med Berlin, High Throughput Mass Spectrometry, Core Facil, Berlin, Germany; [Djudjaj, Sonja; Buelow, Roman D.; von Stillfried, Saskia; Boor, Peter] Rhein Westfal TH Aachen, Inst Pathol, Univ Clin Aachen, Aachen, Germany; [Mei, Henrik E.; Schulz, Axel R.] DRFZ Berlin, Mass Cytometry Lab, Berlin, Germany; [Thiel, Andreas] Tech Univ Berlin, Si M Simulierte Mensch Sci Framework, Berlin, Germany; [Thiel, Andreas] Charite Univ Med Berlin, Berlin, Germany; [Thiel, Andreas] Berlin Inst Hlth, Berlin, Germany; [Saliba, Antoine-Emmanuel] Helmholtz Ctr Infect Res HZI, Helmholtz Inst RNA Based Infect Res HIRI, Wurzburg, Germany; [Eils, Roland; Lehmann, Irina] Charite Univ Med Berlin, Berlin Inst Hlth BIH, Ctr Digital Hlth, Berlin, Germany; [Eils, Roland; Lehmann, Irina; Mall, Marcus A.] German Ctr Lung Res DZL, Berlin, Germany; [Mall, Marcus A.; Stricker, Sebastian; Roehmel, Jobst] Charite Univ Med Berlin, Dept Pediat Resp Med Immunol & Crit Care Med, Berlin, Germany; [Mall, Marcus A.; Sawitzki, Birgit] Charite Univ Med Berlin, Berlin Inst Hlth BIH, Berlin, Germany; [Corman, Victor M.] Charite Univ Med Berlin, Inst Virol, Berlin, Germany; [Beule, Dieter; Obermayer, Benedikt] Charite Univ Med Berlin, Core Unit Bioinformat, Berlin Inst Hlth BIH, Berlin, Germany; [Wyler, Emanuel; Landthaler, Markus] Helmholtz Assoc, Berlin Inst Med Syst Biol, Max Delbruck Ctr Mol Med, Berlin, Germany; [Boor, Peter] Rhein Westfal TH Aachen, Dept Nephrol, Univ Clin Aachen, Aachen, Germany; [Boor, Peter] Rhein Westfal TH Aachen, Univ Clin Aachen, Electron Microscopy Facil, Aachen, Germany; [Demir, Munevver] Charite Univ Med Berlin, Dept Hepatol & Gastroenterol, Berlin, Germany; [Suttorp, Norbert] German Ctr Lung Res DZL, Giessen, Germany; [Nattermann, Jacob] Univ Hosp Bonn, Dept Internal Med 1, Bonn, Germany; [Meisel, Christian] Charite Vivantes, Labor Berlin, Dept Immunol, Berlin, Germany; [Aschenbrenner, Anna C.] Radboud Univ Nijmegen Med Ctr, Radboud Ctr Infect Dis, Dept Internal Med, Nijmegen, Netherlands; [Kurth, Florian] Univ Med Ctr Hamburg Eppendorf, Bernhard Nocht Inst Trop Med, Dept Trop Med, Dept Med 1, Hamburg, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humboldt University of Berlin; University of Bonn; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Francis Crick Institute; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Cambridge; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Bonn; University of Melbourne; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; RWTH Aachen University; RWTH Aachen University Hospital; Deutsches Rheuma-Forschungszentrum (DRFZ); Technical University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Berlin Institute of Health; Helmholtz Association; Helmholtz-Center for Infection Research; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Bonn; Radboud University Nijmegen; Bernhard Nocht Institut fur Tropenmedizin; University of Hamburg; University Medical Center Hamburg-Eppendorf	Sawitzki, B (corresponding author), Charite Univ Med Berlin, Inst Med Immunol, Berlin, Germany.; Sawitzki, B (corresponding author), Charite Univ Med Berlin, Berlin Inst Hlth BIH, Berlin, Germany.	birgit.sawitzki@charite.de	Stricker, Sebastian/ABD-1986-2021; Corman, Victor M/K-1319-2019; Bülow, Roman David/AGZ-8407-2022; Landthaler, Markus/A-1427-2010; Mall, Marcus A./AAA-1498-2022; Eils, Roland/B-6121-2009	Stricker, Sebastian/0000-0001-9129-8997; Corman, Victor M/0000-0002-3605-0136; Bülow, Roman David/0000-0002-8527-7353; Landthaler, Markus/0000-0002-1075-8734; Mall, Marcus A./0000-0002-4057-2199; Eils, Roland/0000-0002-0034-4036; Obermayer, Benedikt/0000-0002-9116-630X; Lehmann, Irina/0000-0001-8875-5587; Roehmel, Jobst/0000-0002-1535-8852; Meisel, Christian/0000-0003-0222-991X; Ralser, Markus/0000-0001-9535-7413; Gemund, Ioanna/0000-0003-2217-4178; Mulleder, Michael/0000-0001-9792-3861; Kostevc, Tomislav/0000-0002-8675-8335; Astaburuaga-Garcia, Rosario/0000-0003-1179-4080; Demir, Munevver/0000-0002-7050-797X; Thiel, Andreas/0000-0002-5515-4002; Barone, Matthias/0000-0002-6554-6464; Kuebler, Wolfgang/0000-0003-4100-2961; Saliba, Antoine-Emmanuel/0000-0001-8539-2784; Lippert, Lena/0000-0002-8337-1311; Brumhard, Sophia/0000-0002-1202-6684; Tober-Lau, Pinkus/0000-0002-9148-3663; Kurth, Florian/0000-0002-3807-473X; Beule, Dieter/0000-0002-3284-0632; Helbig, Elisa Theresa/0000-0003-4276-7974; Sawitzki, Birgit/0000-0001-8166-8579; Demichev, Vadim/0000-0002-2424-9412; Bonaguro, Lorenzo/0000-0001-9675-7208; Paclik, Daniela/0000-0003-2791-3136	German Research Foundation (DFG) [SA1383/3-1, SFB-TR84 114933180, INST 37/1049-1, INST 216/981-1, INST 257/605-1, INST 269/768-1, INST 217/988-1, INST 217/577-1, EXC2151-390873048, GRK 2168 -272482170, ERA CVD 00160389, SFB 1454 -432325352, SFB TR57, SPP1937, GRK2157]; Berlin University Alliance (BUA) (PreEP-Corona grant); Berlin Institute of Health (BIH); Helmholtz-Gemeinschaft Deutscher Forschungszentren, Germany; EU [733100, 260687, 305147, 860003]; European Research Council Horizon 2020 [101001791]; DZIF, Germany [TTU 04.816, 04.817]; Hector Foundation [M89]; Federal Ministry of Education and Research [FKZ 01KX2021, STOP-FSGS-01GM1901A]; German Registry of COVID19 Autopsies - Federal Ministry of Health [ZMVI1-2520COR201]; European Research Council (ERC) [101001791]; START-Program of the Faculty of Medicine of the RWTH Aachen University [125/17, 148/21]; Berlin Senate to German Rheumatism Research Centre (DRFZ); Berlin Brandenburg School for regenerative Therapies (BSRT); German Federal Ministry of Education and Research (BMBF) [01KI20337, 01KI2021, 01KX2021, 02NUK047E]; National Research Node "Mass spectrometry in Systems Medicine'' (MSCoresys) [031L0220A]; Diet-Body-Brain (DietBB) [01EA1809A]; UKRI/NIHR through the UK Coronavirus Immunology Consortium (UK-CIC); Francis Crick Institute through the Cancer Research UK [FC001134]; UK Medical Research Council [FC001134]; Wellcome Trust [FC001134, IA 200829/Z/16/Z]; Charite 3R project; Department of Genomics & Immunoregulation at the LIMES Institute; federal state of Bavaria (FOR-COVID); The German Research Foundation (DFG) [ME 3644/5-1, RTG2424, SFB-TRR219, 322900939, BO3755/13-1, 454024652]	German Research Foundation (DFG)(German Research Foundation (DFG)); Berlin University Alliance (BUA) (PreEP-Corona grant); Berlin Institute of Health (BIH); Helmholtz-Gemeinschaft Deutscher Forschungszentren, Germany(Helmholtz Association); EU(European Commission); European Research Council Horizon 2020; DZIF, Germany; Hector Foundation; Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Registry of COVID19 Autopsies - Federal Ministry of Health; European Research Council (ERC)(European Research Council (ERC)European Commission); START-Program of the Faculty of Medicine of the RWTH Aachen University; Berlin Senate to German Rheumatism Research Centre (DRFZ); Berlin Brandenburg School for regenerative Therapies (BSRT); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); National Research Node "Mass spectrometry in Systems Medicine'' (MSCoresys); Diet-Body-Brain (DietBB); UKRI/NIHR through the UK Coronavirus Immunology Consortium (UK-CIC)(UK Research & Innovation (UKRI)); Francis Crick Institute through the Cancer Research UK; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Charite 3R project; Department of Genomics & Immunoregulation at the LIMES Institute; federal state of Bavaria (FOR-COVID); The German Research Foundation (DFG)(German Research Foundation (DFG))	Department of Genomics & Immunoregulation at the LIMES Institute01KI2021 This work was supported by the German Research Foundation (DFG): SA1383/3-1 to B.S.; SFB-TR84 114933180 to L.E.S., S.B., P.G., S.H., and W.M.K. INST 37/1049-1, INST 216/981-1, INST 257/605-1, INST 269/768-1, INST 217/988-1, INST 217/577-1, and EXC2151-390873048 to J.L.S.; GRK 2168 -272482170, ERA CVD 00160389 to J.L.S.; SFB 1454 -432325352 to A.C.A. and J.L.S.; SFB TR57 and SPP1937 to J.N.; GRK2157 to A.-E.S.; ME 3644/5-1 to H.E.M.; RTG2424 to N.B.; SFB-TRR219 322900939, BO3755/13-1 Project-ID 454024652 to P.B.; the Berlin University Alliance (BUA) (PreEP-Corona grant to L.E.S. and V.M.C.); the Berlin Institute of Health (BIH) (to L.E.S., V.M.C., B.S., and W.M.K.); Helmholtz-Gemeinschaft Deutscher Forschungszentren, Germany (sparse2big to J.L.S.); EU projects SYSCID (733100 to J.L.S.); European Research Council Horizon 2020 (grant agreement no. 101001791 to P.B.); the DZIF, Germany (TTU 04.816 and 04.817 to J.N.); the Hector Foundation (M89 to J.N.); the EU projects ONE STUDY (260687), BIO-DrIM (305147) and INsTRuCT (860003) to B.S.; Federal Ministry of Education and Research FKZ 01KX2021 (COVIM to B.S., L.E.S., F.K., and V.M.C.; DEFEAT PANDEMIcs to P.B.; OrganoStrat to A.-E.S.); and STOP-FSGS-01GM1901A to P.B. and S.D.; the German Registry of COVID19 Autopsies (www.DeRegCOVID.ukaachen.de), funded by the Federal Ministry of Health (ZMVI1-2520COR201 to P.B.) and through a resolution of the German Bundestag (Charite ' Corona Cross [CCC] and Charite ' Corona Cross 2.0 [CCC 2.0] to A.T.); the German Research Foundation (DFG; Project-IDs 322900939, 454024652, and 432698239 to P.B.; 432698239 to S.D.), the European Research Council (ERC; Consolidator Grant AIM.imaging.CKD, no. 101001791 to P.B.), and by the START-Program of the Faculty of Medicine of the RWTH Aachen University (grant numbers 125/17 to S.V.S. and 148/21 to R.D.B.); the Berlin Senate to German Rheumatism Research Centre (DRFZ); the Berlin Brandenburg School for regenerative Therapies (BSRT) to C.B.; the German Federal Ministry of Education and Research (BMBF) projects RECAST (01KI20337) to B.S., V.M.C., L.E.S., and M.R.; VARIPath (01KI2021) to V.M.C.; NUM COVIM (01KX2021) to L.E.S., V.M.C., F.K., J.L.S., J.N., and B.S.; RAPID to S.H.; SYMPATH to N.S. and W.M.K.; PROVID to S.H. and W.M.K.; ZissTrans (02NUK047E) to N.B.; National Research Node ``Mass spectrometry in Systems Medicine'' (MSCoresys) (031L0220A) to M.R. and N.B.; Diet-Body-Brain (DietBB) (01EA1809A) to J.L.S.; the UKRI/NIHR through the UK Coronavirus Immunology Consortium (UK-CIC), the Francis Crick Institute through the Cancer Research UK (FC001134), the UK Medical Research Council (FC001134), and the Wellcome Trust (FC001134 and IA 200829/Z/16/Z) to M.R.; a Charite ' 3R project (to B.S., S.H., and W.M.K.); and an intramural grant from the Department of Genomics & Immunoregulation at the LIMES Institute to A.C.A. The federal state of Bavaria (FOR-COVID to A.-E.S.).	Aibar S, 2017, NAT METHODS, V14, P1083, DOI [10.1038/NMETH.4463, 10.1038/nmeth.4463]; Angerer P, 2016, BIOINFORMATICS, V32, P1241, DOI 10.1093/bioinformatics/btv715; Aran D, 2019, NAT IMMUNOL, V20, P163, DOI 10.1038/s41590-018-0276-y; Arbore G, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06706-z; Bagnato G, 2015, EUR RESPIR REV, V24, P102, DOI 10.1183/09059180.00003214; Benmansour NC, 2021, EUR J IMMUNOL, V51, P1652, DOI 10.1002/eji.202048959; Bergamaschi L, 2021, IMMUNITY, V54, P1257, DOI 10.1016/j.immuni.2021.05.010; Bjorkstrom NK, 2008, J IMMUNOL, V181, P4219, DOI 10.4049/jimmunol.181.6.4219; Boor P, 2021, PATHOLOGE, V42, P197, DOI 10.1007/s00292-021-00925-w; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Cariou B, 2020, DIABETOLOGIA, V63, P1500, DOI 10.1007/s00125-020-05180-x; Carvelli J, 2020, NATURE, V588, P146, DOI 10.1038/s41586-020-2600-6; Chen Y., 2020, MEDRXIV, DOI 10.1101/2020.03.27.20045427; Clemenceau B, 2011, J IMMUNOTHER, V34, P542, DOI 10.1097/CJI.0b013e31822801d4; Crotty S, 2014, IMMUNITY, V41, P529, DOI 10.1016/j.immuni.2014.10.004; Defendi F, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.742446; Degauque N, 2021, FASEB J, V35, DOI 10.1096/fj.202100024R; Demichev V, 2021, CELL SYST, V12, P780, DOI 10.1016/j.cels.2021.05.005; Demichev V, 2020, NAT METHODS, V17, P41, DOI 10.1038/s41592-019-0638-x; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Fenoglio D, 2021, J MED VIROL, V93, P5608, DOI 10.1002/jmv.27037; Fernandez-Arias C, 2013, J IMMUNOL, V190, P3363, DOI 10.4049/jimmunol.1103812; Ferrara C, 2011, P NATL ACAD SCI USA, V108, P12669, DOI 10.1073/pnas.1108455108; Garcia-Beltran WF, 2021, CELL, V184, P476, DOI 10.1016/j.cell.2020.12.015; Gillet LC, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.O111.016717; Goplen NP, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abc4557; Gralinski LE, 2018, MBIO, V9, DOI 10.1128/mBio.01753-18; Gu ZG, 2016, BIOINFORMATICS, V32, P2847, DOI 10.1093/bioinformatics/btw313; Gustine JN, 2021, AM J PATHOL, V191, P4, DOI 10.1016/j.ajpath.2020.08.009; Hafemeister C, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1874-1; Hess C, 2016, IMMUNITY, V45, P240, DOI 10.1016/j.immuni.2016.08.003; Hoepel W, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abf8654; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Huang XJ, 2021, BIOINFORMATICS, V37, P4569, DOI 10.1093/bioinformatics/btab358; Jacob CO, 2020, CLIN IMMUNOL, V220, DOI 10.1016/j.clim.2020.108591; Jacquemont L, 2020, J AM SOC NEPHROL, V31, P876, DOI 10.1681/ASN.2019080847; Janky R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003731; Johnson K.S, 2021, PHENOPTR INFORM HELP; Kavai M, 2008, AUTOIMMUN REV, V8, P160, DOI 10.1016/j.autrev.2008.06.002; Kiselev VY, 2019, NAT REV GENET, V20, P273, DOI 10.1038/s41576-018-0088-9; Korsunsky I, 2019, NAT METHODS, V16, P1289, DOI 10.1038/s41592-019-0619-0; Kotecha Nikesh, 2010, Curr Protoc Cytom, VChapter 10, DOI 10.1002/0471142956.cy1017s53; Kramer B, 2021, IMMUNITY, V54, P2650, DOI 10.1016/j.immuni.2021.09.002; Krovi SH, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01393; Kurth F, 2020, INFECTION, V48, P619, DOI 10.1007/s15010-020-01464-x; Kverneland AH, 2016, CYTOM PART A, V89A, P543, DOI 10.1002/cyto.a.22855; Le Bert N, 2021, J EXP MED, V218, DOI 10.1084/jem.20202617; Lee WS, 2021, CELL REP MED, V2, DOI 10.1016/j.xcrm.2021.100296; Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01; Levine JH, 2015, CELL, V162, P184, DOI 10.1016/j.cell.2015.05.047; Liao MF, 2020, NAT MED, V26, P842, DOI 10.1038/s41591-020-0901-9; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lubbers R, 2017, CLIN EXP IMMUNOL, V188, P183, DOI 10.1111/cei.12952; [Anonymous], 2021, Sci Immunol, V6, DOI [10.1101/2021.02.22.432177, 10.1126/sciimmunol.abh2259]; Maier M. J, 2014, DIRICHLETREG DIRICHL; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Mastaglio S, 2020, CLIN IMMUNOL, V215, DOI 10.1016/j.clim.2020.108450; Mastellos DC, 2020, CLIN IMMUNOL, V220, DOI 10.1016/j.clim.2020.108598; Mathew D, 2020, SCIENCE, V369, P1209, DOI 10.1126/science.abc8511; McKechnie JL, 2020, CELL HOST MICROBE, V27, P863, DOI 10.1016/j.chom.2020.05.009; Messner CB, 2020, CELL SYST, V11, P11, DOI 10.1016/j.cels.2020.05.012; Miyazawa M, 2020, INFLAMM REGEN, V40, DOI 10.1186/s41232-020-00148-1; Moderbacher CR, 2020, CELL, V183, P996, DOI 10.1016/j.cell.2020.09.038; Mogilenko DA, 2021, IMMUNITY, V54, P99, DOI 10.1016/j.immuni.2020.11.005; Moretta A, 2008, CELL DEATH DIFFER, V15, P226, DOI 10.1038/sj.cdd.4402170; Nanda A, 2020, AGING CLIN EXP RES, V32, P1199, DOI 10.1007/s40520-020-01581-5; Noris M, 2013, SEMIN NEPHROL, V33, P479, DOI 10.1016/j.semnephrol.2013.08.001; Oja AE, 2018, MUCOSAL IMMUNOL, V11, P654, DOI 10.1038/mi.2017.94; Peng YC, 2020, NAT IMMUNOL, V21, P1336, DOI [10.1038/s41590-020-0782-6, 10.1101/2020.06.05.134551]; Polycarpou A, 2020, EMBO MOL MED, V12, DOI 10.15252/emmm.202012642; Qiu P, 2011, NAT BIOTECHNOL, V29, P886, DOI 10.1038/nbt.1991; Remmelink M, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03218-5; Rendeiro AF, 2021, NATURE, V593, P564, DOI 10.1038/s41586-021-03475-6; Satyam A, 2021, CLIN IMMUNOL, V226, DOI 10.1016/j.clim.2021.108716; Sawitzki B, 2020, LANCET, V395, P1627, DOI 10.1016/S0140-6736(20)30167-7; Schlickeiser S, 2021, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.628971; Schulte-Schrepping J, 2020, CELL, V182, P1419, DOI 10.1016/j.cell.2020.08.001; Schuyler RP, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02367; Sette A, 2021, CELL, V184, P861, DOI 10.1016/j.cell.2021.01.007; Shanmugasundaram U, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.137858; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sharma M, 2016, FEBS J, V283, P1734, DOI 10.1111/febs.13699; Shuwa HA, 2021, MED-CAMBRIDGE, V2, P720, DOI 10.1016/j.medj.2021.03.013; Sinkovits G, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.663187; Spessott WA, 2017, TRAFFIC, V18, P442, DOI 10.1111/tra.12490; Stephenson E, 2021, NAT MED, V27, P904, DOI 10.1038/s41591-021-01329-2; Streitz M, 2013, TRANSPLANT RES, V2, DOI 10.1186/2047-1440-2-17; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tan AT, 2021, CELL REP, V34, DOI 10.1016/j.celrep.2021.108728; Thieme CJ, 2020, CELL REP MED, V1, DOI 10.1016/j.xcrm.2020.100092; Tiwari-Heckler S, 2021, OPEN FORUM INFECT DI, V8, DOI 10.1093/ofid/ofab019; Vabret N, 2020, IMMUNITY, V52, P910, DOI 10.1016/j.immuni.2020.05.002; Varga Z, 2020, LANCET, V395, P1417, DOI 10.1016/S0140-6736(20)30937-5; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; von Stillfried S, 2021, MICROB BIOTECHNOL, V14, P1627, DOI 10.1111/1751-7915.13828; Wauters E, 2021, CELL RES, V31, P272, DOI 10.1038/s41422-020-00455-9; West EE, 2018, ANNU REV IMMUNOL, V36, P309, DOI 10.1146/annurev-immunol-042617-053245; Wong DWL, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10081900; Yan BY, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abg0833; Youngs J, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009804; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Yu YL, 2021, SIGNAL TRANSDUCT TAR, V6, DOI 10.1038/s41392-021-00759-1; Zenarruzabeitia O, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.655934; Zhang JY, 2020, NAT IMMUNOL, V21, P1107, DOI 10.1038/s41590-020-0762-x	105	33	33	22	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 3	2022	185	3					493	+		10.1016/j.cel.2021.12.040	http://dx.doi.org/10.1016/j.cel.2021.12.040			46	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ZS1YD	35032429				2022-12-28	WOS:000768266500001
J	Park, YJ; De Marco, A; Starr, TN; Liu, ZM; Pinto, D; Walls, AC; Zatta, F; Zepeda, SK; Bowen, J; Sprouse, KS; Joshi, A; Giurdanella, M; Guarino, B; Noack, J; Abdelnabi, R; Foo, SYC; Lempp, FA; Benigni, F; Snell, G; Neyts, J; Whelan, SP; Virgin, HW; Bloom, JD; Corti, D; Pizzuto, MS; Veesler, D				Park, Young-Jun; De Marco, Anna; Starr, Tyler N.; Liu, Zhuoming; Pinto, Dora; Walls, Alexandra C.; Zatta, Fabrizia; Zepeda, Samantha K.; Bowen, John; Sprouse, Kaitlin S.; Joshi, Anshu; Giurdanella, Martina; Guarino, Barbara; Noack, Julia; Abdelnabi, Rana; Foo, Shi-Yan Caroline; Lempp, Florian A.; Benigni, Fabio; Snell, Gyorgy; Neyts, Johan; Whelan, Sean Pj; Virgin, Herbert W.; Bloom, Jesse D.; Corti, Davide; Pizzuto, Matteo Samuele; Veesler, David			Antibody-mediated broad sarbecovirus neutralization through ACE2 molecular mimicry	SCIENCE			English	Article							RECEPTOR-BINDING DOMAIN; CRYO-EM STRUCTURE; SPIKE; VALIDATION; VISUALIZATION; ELICITATION; MICROSCOPY; MUTATIONS	Understanding broadly neutralizing sarbecovirus antibody responses is key to developing countermeasures against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants and future zoonotic sarbecoviruses. We describe the isolation and characterization of a human monoclonal antibody, designated S2K146, that broadly neutralizes viruses belonging to SARS-CoV- and SARS-CoV-2-related sarbecovirus clades, which use angiotensin-converting enzyme 2 (ACE2) as an entry receptor. Structural and functional studies show that most of the virus residues that directly bind S2K146 are also involved in binding to ACE2. This allows the antibody to potently inhibit receptor attachment. S2K146 protects against SARS-CoV-2 Beta variant challenge in hamsters, and viral passaging experiments reveal a high barrier for emergence of escape mutants, making it a good candidate for clinical development. The conserved ACE2-binding residues present a site of vulnerability that might be leveraged for developing vaccines eliciting broad sarbecovirus immunity.	[Park, Young-Jun; Walls, Alexandra C.; Zepeda, Samantha K.; Bowen, John; Sprouse, Kaitlin S.; Joshi, Anshu; Veesler, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Park, Young-Jun; Walls, Alexandra C.; Bloom, Jesse D.; Veesler, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [De Marco, Anna; Pinto, Dora; Zatta, Fabrizia; Giurdanella, Martina; Guarino, Barbara; Benigni, Fabio; Corti, Davide; Pizzuto, Matteo Samuele] Humabs Biomed SA, CH-6500 Bellinzona, Switzerland; [Starr, Tyler N.; Bloom, Jesse D.] Fred Hutchinson Canc Res Ctr, Basic Sci Div, Seattle, WA 98109 USA; [Liu, Zhuoming; Whelan, Sean Pj] Washington Univ, Dept Mol Microbiol, Sch Med, St Louis, MO 63110 USA; [Noack, Julia; Lempp, Florian A.; Snell, Gyorgy; Virgin, Herbert W.] Vir Biotechnol, San Francisco, CA 94158 USA; [Abdelnabi, Rana; Foo, Shi-Yan Caroline; Neyts, Johan] Katholieke Univ Leuven, Lab Virol & Chemotherapy, Rega Inst Med Res, B-3000 Leuven, Belgium; [Virgin, Herbert W.] Washington Univ, Dept Pathol & Immunol, Sch Med, St Louis, MO 63110 USA; [Virgin, Herbert W.] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Washington University (WUSTL); KU Leuven; Washington University (WUSTL); University of Texas System; University of Texas Southwestern Medical Center Dallas	Veesler, D (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.; Veesler, D (corresponding author), Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA.; Corti, D; Pizzuto, MS (corresponding author), Humabs Biomed SA, CH-6500 Bellinzona, Switzerland.	dcorti@vir.bio; mpizzuto@vir.bio; dveesler@uw.edu	Park, Young-Jun/AAF-6249-2021; Veesler, David/HCH-3986-2022; abdelnabi, rana/D-9526-2018; NEYTS, Johan/U-8267-2017	Park, Young-Jun/0000-0003-2901-6949; De Marco, Anna/0000-0001-9641-4838; Bowen, John/0000-0003-3590-9727; Walls, Alexandra/0000-0002-9636-8330; Zepeda, Samantha/0000-0003-0005-9793; Liu, Zhuoming/0000-0001-8198-0976; Sprouse, Kaitlin/0000-0003-0007-2226; Foo, Caroline Shi-Yan/0000-0002-6380-4917; abdelnabi, rana/0000-0001-9771-7312; NEYTS, Johan/0000-0002-0033-7514	National Institute of Allergy and Infectious Diseases [DP1AI158186, HHSN272201700059C]; National Institute of General Medical Sciences [5T32GM008268]; Pew Biomedical Scholars Award; Burroughs Wellcome Fund; University of Washington Arnold and Mabel Beckman cryo-EM center; National Institutes of Health [S10OD032290]	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Pew Biomedical Scholars Award; Burroughs Wellcome Fund(Burroughs Wellcome Fund); University of Washington Arnold and Mabel Beckman cryo-EM center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by the National Institute of Allergy and Infectious Diseases (DP1AI158186 and HHSN272201700059C to D.V.), the National Institute of General Medical Sciences (5T32GM008268 to S.K.Z.), a Pew Biomedical Scholars Award (D.V.), an Investigators in the Pathogenesis of Infectious Disease Award from the Burroughs Wellcome Fund (D.V.), Fast Grants (D.V.), the University of Washington Arnold and Mabel Beckman cryo-EM center and the National Institutes of Health grant S10OD032290 (to D.V.). J.D.B. and D.V. are investigators of the Howard Hughes Medical Institute.	Abdelnabi R, 2021, EBIOMEDICINE, V68, DOI 10.1016/j.ebiom.2021.103403; Agirre J, 2015, NAT STRUCT MOL BIOL, V22, P833, DOI 10.1038/nsmb.3115; Arunachalam PS, 2021, NATURE, V594, P253, DOI 10.1038/s41586-021-03530-2; Boudewijns R, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19684-y; Case JB, 2020, CELL HOST MICROBE, V28, P475, DOI 10.1016/j.chom.2020.06.021; Case James Brett, 2020, bioRxiv, DOI 10.1101/2020.05.18.102038; Cathcart AL, 2021, DUAL FUNCTION MONOCL, DOI [10.1101/2021.03.09.434607, DOI 10.1101/2021.03.09.434607, 10.1101/2021.03.09. 434607]; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Corti D, 2021, CELL, V184, P3086, DOI [10.1016/j.cell.2021.05.005, 10.1016/j.cell.2021.07.027]; Crawford KHD, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12050513; Dejnirattisai W, 2021, CELL, V184, P2183, DOI 10.1016/j.cell.2021.02.032; Dugdale RC, 1998, NATURE, V391, P270, DOI 10.1038/34630; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Frenz B, 2019, STRUCTURE, V27, P134, DOI 10.1016/j.str.2018.09.006; Goddard TD, 2018, PROTEIN SCI, V27, P14, DOI 10.1002/pro.3235; Greaney AJ, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abi9915; Greaney AJ, 2021, CELL HOST MICROBE, V29, P44, DOI 10.1016/j.chom.2020.11.007; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Hsieh CL, 2021, CELL REP, V37, DOI 10.1016/j.celrep.2021.109929; Hsieh CL, 2020, SCIENCE, V369, P1501, DOI 10.1126/science.abd0826; Huo JD, 2020, CELL HOST MICROBE, V28, P445, DOI [10.1016/j.chom.2020.06.010, 10.1016/j.chom.2020.07.002]; Jette CA, 2021, CELL REP, V36, DOI [10.1016/j.celrep.2021.109760, 10.1101/2021.04.23.441195]; Kaname Y, 2010, J VIROL, V84, P3210, DOI 10.1128/JVI.02519-09; Lan J, 2020, NATURE, V581, P215, DOI 10.1038/s41586-020-2180-5; Lempp FA, 2021, NATURE, V598, P342, DOI 10.1038/s41586-021-03925-1; Letko M, 2020, NAT MICROBIOL, V5, P562, DOI [10.1101/2020.01.22.915660, 10.1038/s41564-020-0688-y]; Li F, 2005, SCIENCE, V309, P1864, DOI 10.1126/science.1116480; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Martinez David R, 2021, bioRxiv, DOI 10.1101/2021.04.27.441655; Martinez DR, 2021, SCIENCE, V373, P991, DOI [10.1126/science.abi4506, 10.1101/2021.03.11.434872]; McCallum M, 2021, SCIENCE, V374, P1621, DOI [10.1126/science.abl8506, 10.1101/2021.08.11.455956]; McCallum M, 2021, SCIENCE, V373, P648, DOI 10.1126/science.abi7994; Mlcochova P, 2021, NATURE, V599, P114, DOI 10.1038/s41586-021-03944-y; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Piccoli L, 2020, CELL, V183, P1024, DOI 10.1016/j.cell.2020.09.037; Pinto D, 2021, SCIENCE, V373, P1109, DOI 10.1126/science.abj3321; Pinto D, 2020, NATURE, V583, P290, DOI 10.1038/s41586-020-2349-y; Pinto D, 2019, CELL HOST MICROBE, V26, P623, DOI 10.1016/j.chom.2019.09.016; Punjani A, 2020, NAT METHODS, V17, P1214, DOI 10.1038/s41592-020-00990-8; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Rappazzo CG, 2021, SCIENCE, V371, P823, DOI 10.1126/science.abf4830; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Sanchez CA, 2022, NAT COMMUN, V13, DOI [10.1038/s41467-022-31860-w, 10.1101/2021.09.09.21263359]; Sauer MM, 2021, NAT STRUCT MOL BIOL, V28, P478, DOI [10.1101/2020.12.29.424482, 10.1038/s41594-021-00596-4]; Saunders KO, 2021, NATURE, V594, P553, DOI 10.1038/s41586-021-03594-0; Shang J, 2020, NATURE, V581, P221, DOI 10.1038/s41586-020-2179-y; Song G, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23074-3; Stamatatos L, 2021, SCIENCE, V372, P1413, DOI 10.1126/science.abg9175; Starr T. N., 2021, NATURE, V597, P97; Starr TN, 2021, NATURE, V597, P97, DOI 10.1038/s41586-021-03807-6; Starr TN, 2021, CELL REP MED, V2, DOI 10.1016/j.xcrm.2021.100255; Starr TN, 2021, SCIENCE, V371, P850, DOI 10.1126/science.abf9302; Starr Tyler N, 2020, bioRxiv, DOI [10.1126/science.abf9302, 10.1101/2020.11.30.405472]; Starr TN, 2020, CELL, V182, P1295, DOI 10.1016/j.cell.2020.08.012; Starr Tyler N, 2020, Cell, V182, P1295, DOI [10.1101/2020.06.17.157982, 10.1016/j.cell.2020.08.012]; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Tortorici MA, 2021, NATURE, V597, P103, DOI 10.1038/s41586-021-03817-4; Tortorici MA, 2020, SCIENCE, V370, P950, DOI 10.1126/science.abe3354; Tortorici MA, 2019, ADV VIRUS RES, V105, P93, DOI 10.1016/bs.aivir.2019.08.002; Walls AC, 2021, CELL, V184, P5432, DOI 10.1016/j.cell.2021.09.015; Walls Alexandra C, 2021, bioRxiv, DOI [10.1016/j.cell.2021.09.015, 10.1101/2021.03.15.435528]; Walls AC, 2020, CELL, V183, P1367, DOI 10.1016/j.cell.2020.10.043; Walls Alexandra C, 2020, Cell, V183, P1367, DOI [10.1101/2020.08.11.247395, 10.1016/j.cell.2020.10.043]; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Walls AC, 2019, CELL, V176, P1026, DOI 10.1016/j.cell.2018.12.028; Walls AC, 2017, P NATL ACAD SCI USA, V114, P11157, DOI 10.1073/pnas.1708727114; Walls AC, 2016, NATURE, V531, P114, DOI 10.1038/nature16988; Wang CY, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21968-w; Wang QH, 2020, CELL, V181, P894, DOI 10.1016/j.cell.2020.03.045; Wang RYR, 2016, ELIFE, V5, DOI 10.7554/eLife.17219; Wec AZ, 2020, SCIENCE, V369, P731, DOI 10.1126/science.abc7424; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1126/science.abb2507, 10.1101/2020.02.11.944462]; Yan RH, 2020, SCIENCE, V367, P1444, DOI 10.1126/science.abb2762; Zhou Panpan, 2022, bioRxiv, DOI 10.1101/2021.03.30.437769; Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2951-z, 10.1038/s41586-020-2012-7]; Zivanov J, 2019, IUCRJ, V6, P5, DOI 10.1107/S205225251801463X; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	82	28	28	9	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2022	375	6579					449	+		10.1126/science.abm8143	http://dx.doi.org/10.1126/science.abm8143			41	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YS8CI	34990214	Green Accepted, Green Submitted, Green Published			2022-12-28	WOS:000750899500040
J	Noiri, A; Takeda, K; Nakajima, T; Kobayashi, T; Sammak, A; Scappucci, G; Tarucha, S				Noiri, Akito; Takeda, Kenta; Nakajima, Takashi; Kobayashi, Takashi; Sammak, Amir; Scappucci, Giordano; Tarucha, Seigo			Fast universal quantum gate above the fault-tolerance threshold in silicon	NATURE			English	Article							ELECTRON-SPIN; QUBIT; LOGIC; NOISE	Fault-tolerant quantum computers that can solve hard problems rely on quantum error correction(1). One of the most promising error correction codes is the surface code(2), which requires universal gate fidelities exceeding an error correction threshold of 99 per cent(3). Among the many qubit platforms, only superconducting circuits(4), trapped ions(5) and nitrogen-vacancy centres in diamond(6) have delivered this requirement. Electron spin qubits in silicon(7-15) are particularly promising for a large-scale quantum computer owing to their nanofabrication capability, but the two-qubit gate fidelity has been limited to 98 per cent owing to the slow operation(16). Here we demonstrate a two-qubit gate fidelity of 99.5 per cent, along with single-qubit gate fidelities of 99.8 per cent, in silicon spin qubits by fast electrical control using a micromagnet-induced gradient field and a tunable two-qubit coupling. We identify the qubit rotation speed and coupling strength where we robustly achieve high-fidelity gates. We realize Deutsch-Jozsa and Grover search algorithms with high success rates using our universal gate set. Our results demonstrate universal gate fidelity beyond the fault-tolerance threshold and may enable scalable silicon quantum computers.	[Noiri, Akito; Takeda, Kenta; Nakajima, Takashi; Tarucha, Seigo] RIKEN, Ctr Emergent Matter Sci CEMS, Wako, Saitama, Japan; [Kobayashi, Takashi; Tarucha, Seigo] RIKEN, Ctr Quantum Comp RQC, Wako, Saitama, Japan; [Sammak, Amir; Scappucci, Giordano] Delft Univ Technol, QuTech, Delft, Netherlands; [Sammak, Amir] Netherlands Org Appl Sci Res TNO, Delft, Netherlands; [Scappucci, Giordano] Delft Univ Technol, Kavli Inst Nanosci, Delft, Netherlands	RIKEN; RIKEN; Delft University of Technology; Netherlands Organization Applied Science Research; Delft University of Technology	Noiri, A; Tarucha, S (corresponding author), RIKEN, Ctr Emergent Matter Sci CEMS, Wako, Saitama, Japan.; Tarucha, S (corresponding author), RIKEN, Ctr Quantum Comp RQC, Wako, Saitama, Japan.	akito.noiri@riken.jp; tarucha@riken.jp	TARUCHA, SEIGO/I-7030-2012; Takeda, Kenta/F-7440-2017; Nakajima, Takashi/G-2127-2019	Takeda, Kenta/0000-0003-1240-1103; Nakajima, Takashi/0000-0001-6759-6441; Tarucha, Seigo/0000-0001-7465-0135; Kobayashi, Takashi/0000-0003-2841-8129; Noiri, Akito/0000-0001-9145-0303	Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (JST) [JPMJCR15N2, JPMJCR1675]; MEXT Quantum Leap Flagship Program (MEXT Q-LEAP) [JPMXS0118069228]; JST Moonshot RD grant [JPMJMS2065]; JSPS KAKENHI [16H02204, 17K14078, 18H01819, 19K14640, 20H00237]; JST PRESTO [JPMJPR2017]	Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); MEXT Quantum Leap Flagship Program (MEXT Q-LEAP); JST Moonshot RD grant; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JST PRESTO(Japan Science & Technology Agency (JST))	We thank the Microwave Research Group in Caltech for technical support. This work was supported financially by Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (JST) (JPMJCR15N2 and JPMJCR1675), MEXT Quantum Leap Flagship Program (MEXT Q-LEAP) grant numbers JPMXS0118069228, JST Moonshot R&D grant number JPMJMS2065, and JSPS KAKENHI grant numbers 16H02204, 17K14078, 18H01819, 19K14640 and 20H00237. T.N. acknowledges support from JST PRESTO grant number JPMJPR2017.	Ballance CJ, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.060504; Connors EJ, 2020, PHYS REV APPL, V13, DOI 10.1103/PhysRevApplied.13.024019; DEUTSCH D, 1992, P ROY SOC LOND A MAT, V439, P553, DOI 10.1098/rspa.1992.0167; Elzerman JM, 2004, NATURE, V430, P431, DOI 10.1039/nature02693; Fowler AG, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.032324; Grover LK, 1997, PHYS REV LETT, V79, P325, DOI 10.1103/PhysRevLett.79.325; Huang W, 2019, NATURE, V569, P532, DOI 10.1038/s41586-019-1197-0; Loss D, 1998, PHYS REV A, V57, P120, DOI 10.1103/PhysRevA.57.120; Madzik M. T, PRECISION TOMOGRAPHY; Morello A, 2010, NATURE, V467, P687, DOI 10.1038/nature09392; Muhonen JT, 2015, J PHYS-CONDENS MAT, V27, DOI 10.1088/0953-8984/27/15/154205; Nakajima T, 2020, PHYS REV X, V10, DOI 10.1103/PhysRevX.10.011060; Nielsen Michael A., 2002, QUANTUM COMPUTATION; Noiri A, 2020, NANO LETT, V20, P947, DOI 10.1021/acs.nanolett.9b03847; Petit L, 2020, NATURE, V580, P355, DOI 10.1038/s41586-020-2170-7; Petta JR, 2005, SCIENCE, V309, P2180, DOI 10.1126/science.1116955; Rong X, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9748; Russ M, 2018, PHYS REV B, V97, DOI 10.1103/PhysRevB.97.085421; Shulman MD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6156; Takeda K, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600694; Vandersypen LMK, 2017, NPJ QUANTUM INFORM, V3, DOI 10.1038/s41534-017-0038-y; Veldhorst M, 2015, NATURE, V526, P410, DOI 10.1038/nature15263; Veldhorst M, 2014, NAT NANOTECHNOL, V9, P981, DOI [10.1038/nnano.2014.216, 10.1038/NNANO.2014.216]; Xue X, 2019, PHYS REV X, V9, DOI 10.1103/PhysRevX.9.021011; Xue X., COMPUTING SPIN QUBIT; Yang CH, 2019, NAT ELECTRON, V2, P151, DOI 10.1038/s41928-019-0234-1; Yoneda J, 2018, NAT NANOTECHNOL, V13, P102, DOI 10.1038/s41565-017-0014-x; Zajac DM, 2018, SCIENCE, V359, P439, DOI 10.1126/science.aao5965; Zajac DM, 2016, PHYS REV APPL, V6, DOI 10.1103/PhysRevApplied.6.054013	44	47	47	16	27	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 20	2022	601	7893					338	+		10.1038/s41586-021-04182-y	http://dx.doi.org/10.1038/s41586-021-04182-y			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YJ6UI	35046603	Green Submitted			2022-12-28	WOS:000744666700023
J	Kmietowicz, Z				Kmietowicz, Zosia			Covid-19: WHO recommends baricitinib and sotrovimab to treat patients	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Lamontagne F, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3379; Mahase E, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n2990	2	8	8	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 14	2022	376								o97	10.1136/bmj.o97	http://dx.doi.org/10.1136/bmj.o97			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZE9IM	35027362	Bronze			2022-12-28	WOS:000759190400001
J	Sidik, SM				Sidik, Saima May			WEAVING THE LORE OF THE LAND INTO THE SCIENTIFIC METHOD	NATURE			English	Editorial Material						Careers; Lab life; Research management													0	4	4	1	4	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 13	2022	601	7892					285	287		10.1038/d41586-022-00029-2	http://dx.doi.org/10.1038/d41586-022-00029-2			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YE9KY	35017707				2022-12-28	WOS:000741438200024
J	Iacobucci, G				Iacobucci, Gareth			Covid-19: Complaints must be viewed in context of huge staff shortages, say defence bodies	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 10	2022	376								o53	10.1136/bmj.o53	http://dx.doi.org/10.1136/bmj.o53			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YP6IZ	35012929	Bronze			2022-12-28	WOS:000748727200008
J	Selk, A				Selk, Amanda			Vulvar Squamous-Cell Carcinoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Selk, Amanda] Womens Coll Hosp, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Womens College Hospital	Selk, A (corresponding author), Womens Coll Hosp, Toronto, ON, Canada.	amanda.selk@utoronto.ca		Selk, Amanda/0000-0003-3744-8258					0	0	0	2	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 13	2022	386	2								10.1056/NEJMicm2112703	http://dx.doi.org/10.1056/NEJMicm2112703		JAN 2022	1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YF2NZ	34995026				2022-12-28	WOS:000740347900001
J	Aronson, JK				Aronson, Jeffrey K.			When I use a word .... Medical anniversaries in 2022	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Aronson, Jeffrey K.] Univ Oxford, Ctr Evidence Based Med, Nuffield Dept Primary Care Hlth Sci, Oxford, England	University of Oxford	Aronson, JK (corresponding author), Univ Oxford, Ctr Evidence Based Med, Nuffield Dept Primary Care Hlth Sci, Oxford, England.	jeffrey.aronson@phc.ox.ac.uk		Aronson, Jeffrey/0000-0003-1139-655X				Aronson J, 2016, BMJ OPINION; Aronson J.K., 2017, BMJ OPINION; Aronson JK., 2020, BMJ OPINION; Aronson JK, 2018, BMJ OPINION; Aronson JK, 2019, BMJ OPINION; Aronson JK., 2021, BMJ OPINION; Barney SA, 2006, ETYMOLOGIES OF ISIDORE OF SEVILLE, P3, DOI 10.1017/CBO9780511482113.002; Connor H, 2020, J ROY SOC MED, V113, P504, DOI 10.1177/0141076820962060; Ellis Harold, 2021, J Perioper Pract, V31, P163, DOI 10.1177/1750458920957248; Fleming A, 1922, P R SOC LOND B-CONTA, V93, P306, DOI 10.1098/rspb.1922.0023; Mason VR, 1922, J AMER MED ASSOC, V79, P1318, DOI 10.1001/jama.1922.02640160038012; PLESSNER M, 1954, Isis, V45, P331, DOI 10.1086/348355; Rengachary SS, 2008, NEUROSURGERY, V63, P164, DOI 10.1227/01.NEU.0000335083.93093.06	13	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 7	2022	376								o39	10.1136/bmj.o39	http://dx.doi.org/10.1136/bmj.o39			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YP9GN	34996753	Bronze			2022-12-28	WOS:000748927300004
J	Lentzos, F; Rybicki, EP; Engelhard, M; Paterson, P; Sandholtz, WA; Reeves, RG				Lentzos, Filippa; Rybicki, Edward P.; Engelhard, Margret; Paterson, Pauline; Sandholtz, Wayne Arthur; Reeves, R. Guy			Eroding norms over release of self-spreading viruses	SCIENCE			English	Editorial Material									[Lentzos, Filippa] Kings Coll London, Dept Global Hlth & Social Med, London, England; [Lentzos, Filippa] Kings Coll London, Dept War Studies, London, England; [Rybicki, Edward P.] Univ Cape Town, Dept Mol & Cell Biol, Biopharming Res Unit, Cape Town, South Africa; [Engelhard, Margret] Fed Agcy Nat Conservat BfN, Bonn, Germany; [Paterson, Pauline] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England; [Sandholtz, Wayne Arthur] Univ Southern Calif, Dept Polit Sci & Int Relat, Los Angeles, CA 90007 USA; [Reeves, R. Guy] Max Planck Inst Evolutionary Biol, Dept Evolutionary Genet, Plon, Germany	University of London; King's College London; University of London; King's College London; University of Cape Town; University of London; London School of Hygiene & Tropical Medicine; University of Southern California; Max Planck Society	Lentzos, F (corresponding author), Kings Coll London, Dept Global Hlth & Social Med, London, England.; Lentzos, F (corresponding author), Kings Coll London, Dept War Studies, London, England.	filippa.lentzos@kcl.ac.uk; reeves@evolbio.mpg.de			Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	This article stems from a panel discussion at the 2020 EuroScience Open Forum, which was partially facilitated by funding from the Max Planck Society. We thank participants for discussions as part of that panel,as well as participants in the 2019"Going viral?"meeting that ran in parallel to the Biological Weapons Convention Meeting of Experts (Geneva).	Bakker KM, 2019, NAT ECOL EVOL, V3, P1697, DOI 10.1038/s41559-019-1032-x; Barnett KM, 2020, TRENDS PARASITOL, V36, P970, DOI 10.1016/j.pt.2020.08.006; Bull JJ, 2018, TRENDS MICROBIOL, V26, P6, DOI 10.1016/j.tim.2017.09.007; Cogley M, 2020, THE TELEGRAPH UK; Conference of the Parties to the Convention on Biological Diversity,, 2007, UNEPCBDBS COP MOP4IN, P39; Gallardo C, 2019, TRANSBOUND EMERG DIS, V66, P1399, DOI 10.1111/tbed.13132; Henderson WR, 2007, WILDLIFE RES, V34, P578, DOI 10.1071/WR07062; Nuismer SL, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1903; O'Hara P, 2006, REV SCI TECH OIE, V25, P119, DOI 10.20506/rst.25.1.1650; Ortega R. P., 2020, QUANTA MAG; PREEMPT, 2021, PRED SPILL INT MASS; Smithson MW, 2019, VACCINE, V37, P1153, DOI 10.1016/j.vaccine.2019.01.018; Torres JM, 2001, VACCINE, V19, P4536, DOI 10.1016/S0264-410X(01)00184-0; Van Damme P, 2019, LANCET, V394, P148, DOI 10.1016/S0140-6736(19)31279-6; Wille M, 2021, PLOS BIOL, V19, DOI 10.1371/journal.pbio.3001135	15	2	2	3	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 7	2022	375	6576					31	33		10.1126/science.abj5593	http://dx.doi.org/10.1126/science.abj5593			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YD3FW	34990258				2022-12-28	WOS:000740261400030
J	Michaels, D; Emanuel, EJ; Bright, RA				Michaels, David; Emanuel, Ezekiel J.; Bright, Rick A.			A National Strategy for COVID-19 Testing, Surveillance, and Mitigation Strategies	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Michaels, David] George Washington Univ, Milken Inst Sch Publ Hlth, Washington, DC 20052 USA; [Emanuel, Ezekiel J.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Emanuel, Ezekiel J.] Univ Penn, Wharton Sch, Philadelphia, PA 19104 USA; [Bright, Rick A.] Rockefeller Fdn, New York, NY USA	George Washington University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Michaels, D (corresponding author), George Washington Univ, Milken Inst Sch Publ Hlth Environm & Occupat Hlth, 950 New Hampshire Ave NW, Washington, DC 20052 USA.	dmm@gwu.edu						Allen J., HILL; Brosseau LM., COMMENTARY WHAT CAN; DePillis L, HERES WHY RAPID COVI; Michaels D, 2020, JAMA-J AM MED ASSOC, V324, P1389, DOI 10.1001/jama.2020.16343; Rabin RC, NEW YORK TIMES; Wang CC, 2021, SCIENCE, V373, DOI 10.1126/science.abd9149; White House, PRES BID ANN NEW ACT	7	6	6	3	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 18	2022	327	3					213	214		10.1001/jama.2021.24168	http://dx.doi.org/10.1001/jama.2021.24168		JAN 2022	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YV9PQ	34989785				2022-12-28	WOS:000739988300003
J	Brush, JE; Sherbino, J; Norman, GR				Brush, John E., Jr.; Sherbino, Jonathan; Norman, Geoffrey R.			Diagnostic reasoning in cardiovascular medicine	BMJ-BRITISH MEDICAL JOURNAL			English	Review							COGNITIVE FORCING STRATEGIES; ACUTE MYOCARDIAL-INFARCTION; INTERNAL-MEDICINE; BIOMEDICAL KNOWLEDGE; IMPROVING DIAGNOSIS; REFLECTIVE PRACTICE; AVAILABILITY BIAS; MISSED DIAGNOSES; DECISION-MAKING; HEALTH-CARE	Research in cognitive psychology shows that expert clinicians make a medical diagnosis through a two step process of hypothesis generation and hypothesis testing. Experts generate a list of possible diagnoses quickly and intuitively, drawing on previous experience. Experts remember specific examples of various disease categories as exemplars, which enables rapid access to diagnostic possibilities and gives them an intuitive sense of the base rates of various diagnoses. After generating diagnostic hypotheses, clinicians then test the hypotheses and subjectively estimate the probability of each diagnostic possibility by using a heuristic called anchoring and adjusting. Although both novices and experts use this two step diagnostic process, experts distinguish themselves as better diagnosticians through their ability to mobilize experiential knowledge in a manner that is content specific. Experience is clearly the best teacher, but some educational strategies have been shown to modestly improve diagnostic accuracy. Increased knowledge about the cognitive psychology of the diagnostic process and the pitfalls inherent in the process may inform clinical teachers and help learners and clinicians to improve the accuracy of diagnostic reasoning. This article reviews the literature on the cognitive psychology of diagnostic reasoning in the context of cardiovascular disease.	[Brush, John E., Jr.] Sentara Hlth Res Ctr, Norfolk, VA 23507 USA; [Brush, John E., Jr.] Eastern Virginia Med Sch, Norfolk, VA 23501 USA; [Sherbino, Jonathan; Norman, Geoffrey R.] McMaster Univ, McMaster Educ Res Innovat & Theory MERIT Program, Hamilton, ON, Canada; [Sherbino, Jonathan] McMaster Univ, Dept Med, Hamilton, ON, Canada	Eastern Virginia Medical School; McMaster University; McMaster University	Brush, JE (corresponding author), Sentara Hlth Res Ctr, Norfolk, VA 23507 USA.; Brush, JE (corresponding author), Eastern Virginia Med Sch, Norfolk, VA 23501 USA.	jebrush@sentara.com						Allen S W, 1988, Res Med Educ, V27, P9; ALQahtani DA, 2016, ACAD MED, V91, P710, DOI 10.1097/ACM.0000000000001098; Balogh EP, 2015, IMPROVING DIAGNOSIS IN HEALTH CARE, P1, DOI 10.17226/21794; Bargh JA, 1999, AM PSYCHOL, V54, P462, DOI 10.1037/0003-066x.54.7.462; BARROWS HS, 1982, CLIN INVEST MED, V5, P49; Berbaum KS, 2013, ACAD RADIOL, V20, P194, DOI 10.1016/j.acra.2012.08.017; BERNER ES, 1994, NEW ENGL J MED, V330, P1792, DOI 10.1056/NEJM199406233302506; Blumenthal-Barby JS, 2015, MED DECIS MAKING, V35, P539, DOI 10.1177/0272989X14547740; BORDAGE G, 1984, MED EDUC, V18, P406, DOI 10.1111/j.1365-2923.1984.tb01295.x; BORDAGE G, 1994, ACAD MED, V69, P883, DOI 10.1097/00001888-199411000-00004; Bowen JL, 2006, NEW ENGL J MED, V355, P2217, DOI 10.1056/NEJMra054782; Bradley EH, 2009, J AM COLL CARDIOL, V54, P2423, DOI 10.1016/j.jacc.2009.11.003; BROOKS LR, 1991, J EXP PSYCHOL GEN, V120, P278, DOI 10.1037/0096-3445.120.3.278; Brush JE, 2015, SCI ART MED GUIDE ME; Brush JE, 2015, BRAUNWALDS HEART DIS, P25; Brush JE, 2020, CIRC-CARDIOVASC QUAL, V13, DOI 10.1161/CIRCOUTCOMES.119.005948; Brush John E Jr, 2020, Methodist Debakey Cardiovasc J, V16, P199, DOI 10.14797/mdcj-16-3-199; Brush JE, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.18023; Brush JE, 2017, AM J MED, V130, P629, DOI 10.1016/j.amjmed.2017.01.045; Brush JE, 2016, J AM COLL CARDIOL, V68, P2365, DOI 10.1016/j.jacc.2016.08.066; CASSCELLS W, 1978, NEW ENGL J MED, V299, P999, DOI 10.1056/NEJM197811022991808; Cook DA, 2019, ACAD MED, V94, P1310, DOI 10.1097/ACM.0000000000002768; Cook DA, 2018, JAMA-J AM MED ASSOC, V319, P2267, DOI 10.1001/jama.2018.4385; Croskerry P, 2003, ACAD MED, V78, P775, DOI 10.1097/00001888-200308000-00003; Croskerry P, 2013, NEW ENGL J MED, V368, P2445, DOI 10.1056/NEJMp1303712; Croskerry P, 2009, ACAD MED, V84, P1022, DOI 10.1097/ACM.0b013e3181ace703; Croskerry P, 2009, ADV HEALTH SCI EDUC, V14, P27, DOI 10.1007/s10459-009-9182-2; Custers EJFM, 1996, ACAD MED, V71, pS55, DOI 10.1097/00001888-199610000-00044; Custers EJFM, 2015, MED TEACH, V37, P457, DOI 10.3109/0142159X.2014.956052; Dharmarajan K, 2016, J AM GERIATR SOC, V64, P1574, DOI 10.1111/jgs.14303; DIAMOND GA, 1979, NEW ENGL J MED, V300, P1350, DOI 10.1056/NEJM197906143002402; Douglas PS, 2015, NEW ENGL J MED, V372, P1291, DOI 10.1056/NEJMoa1415516; Eddy DM, 1982, JUDGMENT UNCERTAINTY, P249; Elstein AS, 2009, ADV HEALTH SCI EDUC, V14, P7, DOI 10.1007/s10459-009-9184-0; Elstein AS, 1978, MED PROBLEM SOLVING, DOI DOI 10.4159/HARVARD.9780674189089; Ely JW, 2015, DIAGNOSIS, V2, P163, DOI 10.1515/dx-2015-0008; Ericsson KA, 2004, ACAD MED, V79, pS70, DOI 10.1097/00001888-200410001-00022; Eva KW, 2005, MED EDUC, V39, P98, DOI 10.1111/j.1365-2929.2004.01972.x; Eva KW, 1998, ACAD MED, V73, pS1, DOI 10.1097/00001888-199810000-00028; Evans JSBT, 2008, ANNU REV PSYCHOL, V59, P255, DOI 10.1146/annurev.psych.59.103006.093629; Evans JST, 2013, PERSPECT PSYCHOL SCI, V8, P223, DOI 10.1177/1745691612460685; Feltovich, 1984, TUTORIALS PROBLEM BA, P128; Friedman CP, 2005, J GEN INTERN MED, V20, P334, DOI 10.1111/j.1525-1497.2005.30145.x; Friedman CP, 1999, JAMA-J AM MED ASSOC, V282, P1851, DOI 10.1001/jama.282.19.1851; Fuster V, 2015, J AM COLL CARDIOL, V65, P1734, DOI 10.1016/j.jacc.2015.03.023; Genders TSS, 2011, EUR HEART J, V32, P1316, DOI 10.1093/eurheartj/ehr014; Gibbons RJ, 2021, JAMA INTERN MED, V181, P579, DOI 10.1001/jamainternmed.2021.0171; Gigerenzer G, 2011, ANNU REV PSYCHOL, V62, P451, DOI 10.1146/annurev-psych-120709-145346; GILOVICH THOMAS, 2002, HEURISTICS BIASES PS, DOI DOI 10.1017/CBO9780511808098; Goel V, 2003, COGNITION, V87, pB11, DOI 10.1016/S0010-0277(02)00185-3; Graber ML, 2018, DIAGNOSIS, V5, P107, DOI 10.1515/dx-2018-0033; Graber ML, 2013, BMJ QUAL SAF, V22, pii21, DOI 10.1136/bmjqs-2012-001615; Graber ML, 2012, JAMA-J AM MED ASSOC, V308, P1211, DOI 10.1001/2012.jama.11913; Graber ML, 2012, BMJ QUAL SAF, V21, P535, DOI 10.1136/bmjqs-2011-000149; Graber ML, 2005, ARCH INTERN MED, V165, P1493, DOI 10.1001/archinte.165.13.1493; Groves M, 2003, MED TEACH, V25, P621, DOI 10.1080/01421590310001605688; Gruppen LD, 1987, P ANN C RES MED ED A, P242; Gupta A, 2019, ANN INTERN MED, V170, pHO2, DOI 10.7326/M19-0829; Hartshorne C, 1931, COLLECTED PAPERS CS, V5, P189; Hatala R, 1999, J GEN INTERN MED, V14, P126, DOI 10.1046/j.1525-1497.1999.00298.x; Hatala RM, 2003, ADV HEALTH SCI EDUC, V8, P17, DOI 10.1023/A:1022687404380; Ilgen JS, 2013, ACAD MED, V88, P1545, DOI 10.1097/ACM.0b013e3182a31c1e; Ilgen JS, 2011, ACAD EMERG MED, V18, pS79, DOI 10.1111/j.1553-2712.2011.01182.x; Issenberg SB, 2002, TEACH LEARN MED, V14, P223, DOI 10.1207/S15328015TLM1404_4; Kahneman D, 2015, FORTUNE, V172, P20; KASSIRER JP, 1978, ANN INTERN MED, V89, P245, DOI 10.7326/0003-4819-89-2-245; Kohn KT, 2000, ERR IS HUMAN BUILDIN; Krumholz HM, 2008, J AM COLL CARDIOL, V52, P2046, DOI 10.1016/j.jacc.2008.10.012; Kulasegaram KM, 2013, ACAD MED, V88, P1578, DOI [10.1097/ACM.0b013e31827c9465, 10.1097/ACM.0b013e3182a45def, 10.1097/ACM.0b013e31827c953e]; Ladapo JA, 2014, ANN INTERN MED, V161, P482, DOI 10.7326/M14-0296; LOGAN GD, 1988, PSYCHOL REV, V95, P492, DOI 10.1037/0033-295X.95.4.492; LOPES LL, 1991, THEOR PSYCHOL, V1, P65, DOI 10.1177/0959354391011005; Mamede S, 2004, MED EDUC, V38, P1302, DOI 10.1111/j.1365-2929.2004.01917.x; Mamede S, 2008, MED EDUC, V42, P468, DOI 10.1111/j.1365-2923.2008.03030.x; Mamede S, 2007, MED EDUC, V41, P1185, DOI 10.1111/j.1365-2923.2007.02921.x; Mamede S, 2020, BMJ QUAL SAF, V29, P550, DOI 10.1136/bmjqs-2019-010079; Mamede S, 2020, ACAD MED, V95, P1223, DOI 10.1097/ACM.0000000000003153; Mamede S, 2014, ACAD MED, V89, P959, DOI 10.1097/ACM.0000000000000306; Mamede S, 2014, ACAD MED, V89, P114, DOI 10.1097/ACM.0000000000000077; Mamede S, 2012, BMJ QUAL SAF, V21, P295, DOI 10.1136/bmjqs-2011-000518; Mamede S, 2010, JAMA-J AM MED ASSOC, V304, P1198, DOI 10.1001/jama.2010.1276; Mamede S, 2008, ACAD MED, V83, P1210, DOI 10.1097/ACM.0b013e31818c71d7; Mangione S, 1997, JAMA-J AM MED ASSOC, V278, P717, DOI 10.1001/jama.278.9.717; Masicampo EJ, 2008, PSYCHOL SCI, V19, P255, DOI 10.1111/j.1467-9280.2008.02077.x; MEDIN DL, 1989, AM PSYCHOL, V44, P1469, DOI 10.1037/0003-066X.44.12.1469; Monteiro SD, 2015, J GEN INTERN MED, V30, P1270, DOI 10.1007/s11606-015-3369-4; Montgomery K, 2006, DOCTORS THINK CLIN J; Moulton CA, 2010, ACAD MED, V85, P1571, DOI 10.1097/ACM.0b013e3181f073dd; Moy E, 2015, DIAGNOSIS, V2, P29, DOI 10.1515/dx-2014-0053; Mylopoulos M, 2007, MED EDUC, V41, P1159, DOI 10.1111/j.1365-2923.2007.02912.x; Nallamothu BK, 2015, LANCET, V385, P1114, DOI 10.1016/S0140-6736(14)61932-2; NEUFELD VR, 1981, MED EDUC, V15, P315, DOI 10.1111/j.1365-2923.1981.tb02495.x; Norman G, 2002, BMJ-BRIT MED J, V324, P1560, DOI 10.1136/bmj.324.7353.1560; Norman G, 2007, MED EDUC, V41, P1140, DOI 10.1111/j.1365-2923.2007.02914.x; Norman G, 2014, ACAD MED, V89, P277, DOI 10.1097/ACM.0000000000000105; Norman GR, 2017, ACAD MED, V92, P23, DOI 10.1097/ACM.0000000000001421; NORMAN GR, 1992, ACAD MED, V67, pS78, DOI 10.1097/00001888-199210000-00045; NORMAN GR, 1989, ARCH DERMATOL, V125, P1063, DOI 10.1001/archderm.125.8.1063; PATEL VL, 1990, MED EDUC, V24, P129, DOI 10.1111/j.1365-2923.1990.tb02511.x; PATEL VL, 1986, COGNITIVE SCI, V10, P91, DOI 10.1016/S0364-0213(86)80010-6; Pelaccia T, 2014, ANN EMERG MED, V64, P575, DOI 10.1016/j.annemergmed.2014.05.003; Pope JH, 2000, NEW ENGL J MED, V342, P1163, DOI 10.1056/NEJM200004203421603; RANSOHOFF DF, 1978, NEW ENGL J MED, V299, P926, DOI 10.1056/NEJM197810262991705; REDELMEIER DA, 1991, MED DECIS MAKING, V11, P169, DOI 10.1177/0272989X9101100304; Redelmeier DA, 2001, CAN MED ASSOC J, V164, P358; Regehr G, 1996, ACAD MED, V71, P988, DOI 10.1097/00001888-199609000-00015; Reichlin T, 2009, NEW ENGL J MED, V361, P858, DOI 10.1056/NEJMoa0900428; ROSS BH, 1987, J EXP PSYCHOL LEARN, V13, P629, DOI 10.1037/0278-7393.13.4.629; Schmidt HG, 2007, MED EDUC, V41, P1133, DOI 10.1111/j.1365-2923.2007.02915.x; Schmidt HG, 2015, MED EDUC, V49, P961, DOI 10.1111/medu.12775; Schmidt HG, 2014, ACAD MED, V89, P285, DOI 10.1097/ACM.0000000000000107; SCHMIDT HG, 1990, ACAD MED, V65, P611, DOI 10.1097/00001888-199010000-00001; Schull MJ, 2006, ANN EMERG MED, V48, P647, DOI 10.1016/j.annemergmed.2006.03.025; Schulman KA, 1999, NEW ENGL J MED, V340, P618, DOI 10.1056/NEJM199902253400806; Sherbino J, 2014, CAN J EMERG MED, V16, P34, DOI 10.2310/8000.2013.130860; Sherbino J, 2012, ACAD MED, V87, P785, DOI 10.1097/ACM.0b013e318253acbd; Sherbino J, 2011, TEACH LEARN MED, V23, P78, DOI 10.1080/10401334.2011.536897; SHIFFRIN RM, 1984, PSYCHOL REV, V91, P269, DOI 10.1037/0033-295X.91.2.269; Shimizu T, 2013, MED TEACH, V35, pE1218, DOI 10.3109/0142159X.2012.742493; Sibbald M, 2022, BMJ QUAL SAF, V31, P426, DOI 10.1136/bmjqs-2021-013493; Sibbald M, 2017, MED EDUC, V51, P1138, DOI 10.1111/medu.13396; SIMON HA, 1990, ANNU REV PSYCHOL, V41, P1, DOI 10.1146/annurev.ps.41.020190.000245; Singh H, 2015, NEW ENGL J MED, V373, P2493, DOI 10.1056/NEJMp1512241; Smedley B.D, 2003, UNEQUAL TREATMENT CO, DOI DOI 10.17226/12875; Smith BW, 2015, DIAGNOSIS, V2, P117, DOI 10.1515/dx-2015-0007; Stone J, 2011, MED EDUC, V45, P768, DOI 10.1111/j.1365-2923.2011.04026.x; Studdert DM, 2006, NEW ENGL J MED, V354, P2024, DOI 10.1056/NEJMsa054479; Wachter RM, 2010, HEALTH AFFAIR, V29, P1605, DOI 10.1377/hlthaff.2009.0513; WEBER EU, 1993, J EXP PSYCHOL LEARN, V19, P1151, DOI 10.1037/0278-7393.19.5.1151; Woods NN, 2007, ADV HEALTH SCI EDUC, V12, P405, DOI 10.1007/s10459-006-9055-x; Woods NN, 2006, ACAD MED, V81, pS124, DOI 10.1097/00001888-200610001-00031; Zwaan L, 2020, AHRQ PAPERS DIAGNOST; Zwaan L, 2017, BMJ QUAL SAF, V26, P104, DOI 10.1136/bmjqs-2015-005014; Zwaan L, 2012, ACAD MED, V87, P149, DOI 10.1097/ACM.0b013e31823f71e6	134	4	4	3	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 5	2022	376								e064389	10.1136/bmj-2021-064389	http://dx.doi.org/10.1136/bmj-2021-064389			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YI8XS	34987062	Bronze			2022-12-28	WOS:000744126400005
J	Christie, B				Christie, Bryan			Sixty seconds on ... hangovers ...	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Roberts E, 2022, ADDICTION, V117, P2157, DOI 10.1111/add.15786	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 4	2022	376								n3156	10.1136/bmj.n3156	http://dx.doi.org/10.1136/bmj.n3156			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YD7MV	34983747				2022-12-28	WOS:000740622800004
J	Yu, M; Tang, A; Brown, K; Bouchakri, R; St-Onge, P; Wu, S; Reeder, J; Mullie, L; Chasse, M				Yu, Michael; Tang, An; Brown, Kip; Bouchakri, Rima; St-Onge, Pascal; Wu, Sheng; Reeder, John; Mullie, Louis; Chasse, Michael			Integrating artificial intelligence in bedside care for covid-19 and future pandemics	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HEALTH		[Yu, Michael; Brown, Kip; Bouchakri, Rima; St-Onge, Pascal; Mullie, Louis; Chasse, Michael] Univ Montreal, Ctr Hosp Univ Montreal, Ctr Integrat & Anal Med Data CITADEL, Dept Med,Ctr Rech, Montreal, PQ, Canada; [Tang, An] Ctr Hosp Univ Montreal CHUM, Dept Radiol, Montreal, PQ, Canada; [Wu, Sheng; Reeder, John] WHO, Geneva, Switzerland	Universite de Montreal; Universite de Montreal; World Health Organization	Chasse, M (corresponding author), Univ Montreal, Ctr Hosp Univ Montreal, Ctr Integrat & Anal Med Data CITADEL, Dept Med,Ctr Rech, Montreal, PQ, Canada.	michael.chasse.med@ssss.gouv.qc.ca		Reeder, John/0000-0003-1395-1289				Boserup B, 2020, AM J EMERG MED, V38, P1732, DOI 10.1016/j.ajem.2020.06.007; Cave S, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n364; Chassagnon G, 2021, MED IMAGE ANAL, V67, DOI 10.1016/j.media.2020.101860; Collins GS, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-048008; Drouin A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40561-2; Futoma J, 2020, LANCET DIGIT HEALTH, V2, pE489, DOI 10.1016/S2589-7500(20)30186-2; Haibe-Kains B, 2020, NATURE, V586, pE14, DOI 10.1038/s41586-020-2766-y; Health Level Seven International, HL7 FHIR; Ibrahim H, 2021, TRIALS, V22, DOI 10.1186/s13063-020-04951-6; Kaissis G, 2021, NAT MACH INTELL, V3, P473, DOI 10.1038/s42256-021-00337-8; Khanumyan A. A., 2020, Molochnaya Promyshlennost, P26; Leslie D, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n304; Markus AF, 2021, J BIOMED INFORM, V113, DOI 10.1016/j.jbi.2020.103655; Mesko B, 2020, NPJ DIGIT MED, V3, DOI 10.1038/s41746-020-00333-z; Obermeyer Z, 2019, SCIENCE, V366, P447, DOI 10.1126/science.aax2342; Price W. Nicholson, 2019, YALE J LAW TECHNOLOG, V21, P122; Robbins R., 2020, STAT NEWS; Roberts M, 2021, NAT MACH INTELL, V3, P199, DOI 10.1038/s42256-021-00307-0; Rosenbaum L, 2020, NEW ENGL J MED, V382, P2368, DOI 10.1056/NEJMms2009984; The Data Lab, OPENSAFELY; von Brozyskowski I, DAT SCI AG COVID 19; Wynants L, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1328	22	0	0	2	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 31	2021	375								e068197	10.1136/bmj-2021-068197	http://dx.doi.org/10.1136/bmj-2021-068197			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YD6KP	34972694	Green Published, hybrid			2022-12-28	WOS:000740549300001
J	Limb, M				Limb, Matthew			Covid-19: Give NHS staff working with patients higher grade masks, say medical leaders	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Harries Jenny, 2021, DAUK SEND OPEN LETT; UK Health Security Agency,, 2021, INF PREV CONTR SEAS; Wise J, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n1663	3	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 30	2021	375								n3162	10.1136/bmj.n3162	http://dx.doi.org/10.1136/bmj.n3162			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YC3TX	34969773	Bronze			2022-12-28	WOS:000739618400006
J	Acquisti, A; Brandimarte, L; Hancock, J				Acquisti, Alessandro; Brandimarte, Laura; Hancock, Jeff			How privacy's past may shape its future	SCIENCE			English	Editorial Material								An account of privacy's evolutionary roots may hold lessons for policies in the digital age	[Acquisti, Alessandro] Carnegie Mellon Univ, Heinz Coll, Pittsburgh, PA 15213 USA; [Brandimarte, Laura] Univ Arizona, Eller Coll Management, Tucson, AZ USA; [Hancock, Jeff] Stanford Univ, Dept Commun, Stanford, CA 94305 USA	Carnegie Mellon University; University of Arizona; Stanford University	Acquisti, A (corresponding author), Carnegie Mellon Univ, Heinz Coll, Pittsburgh, PA 15213 USA.	acquisti@andrew.cmu.edu		Acquisti, Alessandro/0000-0001-6582-6178	National Science Foundation [1228857, 1514192]; Alfred P.Sloan Foundation [G-2015-14111]; Carnegie Corporation of New York via anAndrew Carnegie Fellowship	National Science Foundation(National Science Foundation (NSF)); Alfred P.Sloan Foundation(Alfred P. Sloan Foundation); Carnegie Corporation of New York via anAndrew Carnegie Fellowship	The authors acknowledge support from the National Science Foundation through Awards 1228857 (Evolutionary Approaches to Privacy and Information Security, 2012) and 1514192 (Understanding and Exploiting Visceral Roots of Privacy and Security Concerns, 2015). A.A. acknowledges support from the Alfred P.Sloan Foundation through grant G-2015-14111 and from the Carnegie Corporation of New York via anAndrew Carnegie Fellowship. The authors are thankful for comments provided by the reviewers, as well as J. Bailenson, E. Carbone,D. Chang, J. Flagg, C. Hoofnagle, L. Jiang,L. John, G. Loewenstein, J. Spiegel, R. Steed, and by participants at several workshops (including PLSC 2013, SHB 2014, and WEIS 2015) and seminars.	Acquisti A, 2013, PRIV LAW SCHOL C; Acquisti A, 2020, J CONSUM PSYCHOL, V30, P736, DOI 10.1002/jcpy.1191; Acquisti A, 2015, SCIENCE, V347, P509, DOI 10.1126/science.aaa1465; ALTMAN I, 1977, J SOC ISSUES, V33, P66, DOI 10.1111/j.1540-4560.1977.tb01883.x; ARIES P, 1987, HIST PRIVATE LIFE PA, V1; Barkow J. H, 1989, DARWIN SEXAND STATUS; BAUMEISTER RF, 1995, PSYCHOL BULL, V117, P497, DOI 10.1037/0033-2909.117.3.497; KLOPFER PH, 1977, J SOC ISSUES, V33, P52, DOI 10.1111/j.1540-4560.1977.tb01882.x; Moore Jr B., 1984, PRIVACY STUDIES SOCI; Shariff A, 2021, CURR DIR PSYCHOL SCI, V30, P159, DOI 10.1177/0963721421990355; Utz C, 2019, PROCEEDINGS OF THE 2019 ACM SIGSAC CONFERENCE ON COMPUTER AND COMMUNICATIONS SECURITY (CCS'19), P973, DOI 10.1145/3319535.3354212; Varian Hal R, 1996, PRIVACY SELF REGULAT; Warofka A., 2018, INDEPENDENT ASSESSME; Westin A.F., 1967, PRIVACY FREEDOM	14	2	2	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2022	375	6578					270	272		10.1126/science.abj0826	http://dx.doi.org/10.1126/science.abj0826			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YK2FS	35050645				2022-12-28	WOS:000745036100017
J	Zhong, S; Li, L; Wang, ZJ; Ge, ZX; Li, QY; Bleckmann, A; Wang, JZ; Song, ZH; Shi, YH; Liu, TX; Li, LH; Zhou, HB; Wang, YY; Zhang, L; Wu, HM; Lai, LH; Gu, HY; Dong, J; Cheung, AY; Dresselhaus, T; Qu, LJ				Zhong, Sheng; Li, Ling; Wang, Zhijuan; Ge, Zengxiang; Li, Qiyun; Bleckmann, Andrea; Wang, Jizong; Song, Zihan; Shi, Yihao; Liu, Tianxu; Li, Luhan; Zhou, Huabin; Wang, Yanyan; Zhang, Li; Wu, Hen-Ming; Lai, Luhua; Gu, Hongya; Dong, Juan; Cheung, Alice Y.; Dresselhaus, Thomas; Qu, Li-Jia			RALF peptide signaling controls the polytubey block in Arabidopsis	SCIENCE			English	Article							POLLEN-TUBE; RNA-SEQ; FERTILIZATION; PENETRATION; RELEASE; FUSION	Fertilization of an egg by multiple sperm (polyspermy) leads to lethal genome imbalance and chromosome segregation defects. In Arabidopsis thaliana, the block to polyspermy is facilitated by a mechanism that prevents polytubey (the arrival of multiple pollen tubes to one ovule). We show here that FERONIA, ANJEA, and HERCULES RECEPTOR KINASE 1 receptor-like kinases located at the septum interact with pollen tube-specific RALF6, 7,16, 36, and 37 peptide ligands to establish this polytubey block, The same combination of RALF (rapid alkalinization factor) peptides and receptor complexes controls pollen tube reception and rupture inside the targeted ovule. Pollen tube rupture releases the polytubey block at the septum, which allows the emergence of secondary pollen tubes upon fertilization failure. Thus, orchestrated steps in the fertilization process in Arabidopsis are coordinated by the same signaling components to guarantee and optimize reproductive success.	[Zhong, Sheng; Li, Ling; Wang, Zhijuan; Ge, Zengxiang; Li, Qiyun; Wang, Jizong; Song, Zihan; Shi, Yihao; Liu, Tianxu; Li, Luhan; Zhang, Li; Gu, Hongya; Qu, Li-Jia] Peking Univ, Coll Life Sci, State Key Lab Prot & Plant Gene Res, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China; [Bleckmann, Andrea; Dresselhaus, Thomas] Univ Regensburg, Cell Biol & Plant Biochem, D-93053 Regensburg, Germany; [Zhou, Huabin; Wang, Yanyan; Lai, Luhua] Peking Univ, Coll Chem & Mol Engn, Beijing 100871, Peoples R China; [Wu, Hen-Ming; Cheung, Alice Y.] Univ Massachusetts, Dept Biochem & Mol Biol, Plant Biol Program, Mol & Cell Biol Program, Amherst, MA 01003 USA; [Gu, Hongya; Qu, Li-Jia] Natl Plant Gene Res Ctr Beijing, Beijing 100101, Peoples R China; [Dong, Juan] Rutgers State Univ, Waksman Inst Microbiol, Piscataway, NJ 08854 USA; [Ge, Zengxiang] IST Austria, A-3400 Klosterneuburg, Austria	Peking University; University of Regensburg; Peking University; University of Massachusetts System; University of Massachusetts Amherst; Rutgers State University New Brunswick; Institute of Science & Technology - Austria	Qu, LJ (corresponding author), Peking Univ, Coll Life Sci, State Key Lab Prot & Plant Gene Res, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China.; Qu, LJ (corresponding author), Natl Plant Gene Res Ctr Beijing, Beijing 100101, Peoples R China.	qulj@pku.edu.cn	Ge, Zengxiang/AIE-6727-2022	Li, Ling/0000-0002-8086-6589; Li, Qiyun/0000-0002-3321-1213; Wang, Zhijuan/0000-0002-5690-6456; Wang, Jizong/0000-0003-1085-5347; Liu, Tianxu/0000-0002-5874-6660; Zengxiang, Ge/0000-0001-9381-3577	National Natural Science Foundation of China [31991202, 31830004, 31620103903, 31621001]; Young Elite Scientists Sponsorship Program by the China Association of Science and Technology [2019QNRC001]; NSFC Young Scientists Fund [31900161]; US Natural Science Foundation [IOS-1645854, MCB-1715764, MCB-0955910]; National Institute of Health [R01GM109080]; German Research Foundation DFG [SFB924]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Young Elite Scientists Sponsorship Program by the China Association of Science and Technology; NSFC Young Scientists Fund; US Natural Science Foundation; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation DFG(German Research Foundation (DFG))	L.-J.Q. was funded by the National Natural Science Foundation of China (grant nos. 31991202, 31830004, 31620103903, and 31621001), S.Z. was supported by the Young Elite Scientists Sponsorship Program by the China Association of Science and Technology (2019QNRC001), Z.G. was supported by a NSFC Young Scientists Fund (31900161), A.Y.C. was funded by the US Natural Science Foundation (IOS-1645854, MCB1715764, andMCB-0955910), J.D. was funded by the National Institute of Health (R01GM109080), and T.D. was supported by the German Research Foundation DFG (SFB924).	Abarca A, 2021, PLANT PHYSIOL, V187, P996, DOI 10.1093/plphys/kiab308; Beale KM, 2012, CURR BIOL, V22, P1090, DOI 10.1016/j.cub.2012.04.041; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Denninger P, 2019, CURR BIOL, V29, P1854, DOI 10.1016/j.cub.2019.04.059; Denninger P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5645; Dresselhaus T, 2016, CURR BIOL, V26, pR125, DOI 10.1016/j.cub.2015.12.032; Duan QH, 2020, NATURE, V579, P561, DOI 10.1038/s41586-020-2106-2; Duan QH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4129; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Escobar-Restrepo JM, 2007, SCIENCE, V317, P656, DOI 10.1126/science.1143562; Evans JP, 2020, MOL REPROD DEV, V87, P341, DOI 10.1002/mrd.23331; Galindo-Trigo S, 2020, EMBO REP, V21, DOI 10.15252/embr.201948466; Ge ZX, 2019, TRENDS PLANT SCI, V24, P978, DOI 10.1016/j.tplants.2019.09.002; Ge ZX, 2019, CURR BIOL, V29, P3256, DOI 10.1016/j.cub.2019.08.032; Ge ZX, 2017, SCIENCE, V358, P1596, DOI 10.1126/science.aao3642; Hamamura Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5722; Hamamura Y, 2011, CURR BIOL, V21, P497, DOI 10.1016/j.cub.2011.02.013; Haruta M, 2014, SCIENCE, V343, P408, DOI 10.1126/science.1244454; Kasahara RD, 2012, CURR BIOL, V22, P1084, DOI 10.1016/j.cub.2012.03.069; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Lampropoulos A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083043; Leydon AR, 2013, CURR BIOL, V23, P1209, DOI 10.1016/j.cub.2013.05.021; Li C, 2015, ELIFE, V4, DOI [10.7554/eLife.06587, 10.1155/2015/757269]; Liang Y, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003933; Liu C, 2021, SCIENCE, V372, P171, DOI 10.1126/science.abc6107; Lu LZ, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0652-y; Maruyama D, 2015, CELL, V161, P907, DOI 10.1016/j.cell.2015.03.018; Mori T, 2006, NAT CELL BIOL, V8, P64, DOI 10.1038/ncb1345; Palanivelu R, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-7; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Schiott M, 2004, P NATL ACAD SCI USA, V101, P9502, DOI 10.1073/pnas.0401542101; Sprunck S, 2012, SCIENCE, V338, P1093, DOI 10.1126/science.1223944; Stegmann M, 2017, SCIENCE, V355, P287, DOI 10.1126/science.aal2541; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Volz R, 2013, DEV CELL, V25, P310, DOI 10.1016/j.devcel.2013.04.001; von Besser K, 2006, DEVELOPMENT, V133, P4761, DOI 10.1242/dev.02683; Wang JZ, 2019, SCIENCE, V364, P43, DOI 10.1126/science.aav5868; WILLEMSE MTM, 1995, PLANT SCI, V108, P201, DOI 10.1016/0168-9452(95)04133-F; WOLF DP, 1978, DEV BIOL, V64, P1, DOI 10.1016/0012-1606(78)90056-8; Xing HL, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0327-y; Yu X, 2021, NATURE, V594, P560, DOI 10.1038/s41586-021-03573-5; Yu XB, 2021, NATURE, V592, P433, DOI 10.1038/s41586-021-03387-5; Zhang JZ, 2017, PLANT CELL, V29, P243, DOI 10.1105/tpc.16.00771; Zhang J, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.79; Zhang LL, 2021, CURR BIOL, V31, P3004, DOI 10.1016/j.cub.2021.04.060; Zhang M, 2016, J EXP BOT, V67, P3407, DOI 10.1093/jxb/erw160; Zhong S, 2019, SCIENCE, V364, P851, DOI 10.1126/science.aau9564; Zhong S, 2019, CURR OPIN PLANT BIOL, V51, P7, DOI 10.1016/j.pbi.2019.03.004	48	15	15	45	98	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2022	375	6578					290	+		10.1126/science.ab14683	http://dx.doi.org/10.1126/science.ab14683			47	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YK2FS	35050671				2022-12-28	WOS:000745036100028
J	Ware, J; Allen, JM; Boughton, CK; Wilinska, ME; Hartnell, S; Thankamony, A; de Beaufort, C; Schierloh, U; Frohlich-Reiterer, E; Mader, JK; Kapellen, TM; Rami-Merhar, B; Tauschmann, M; Nagl, K; Hofer, SE; Campbell, FM; Yong, J; Hood, KK; Lawton, J; Roze, S; Sibayan, J; Bocchino, LE; Kollman, C; Hovorka, R				Ware, J.; Allen, J. M.; Boughton, C. K.; Wilinska, M. E.; Hartnell, S.; Thankamony, A.; de Beaufort, C.; Schierloh, U.; Froehlich-Reiterer, E.; Mader, J. K.; Kapellen, T. M.; Rami-Merhar, B.; Tauschmann, M.; Nagl, K.; Hofer, S. E.; Campbell, F. M.; Yong, J.; Hood, K. K.; Lawton, J.; Roze, S.; Sibayan, J.; Bocchino, L. E.; Kollman, C.; Hovorka, R.		KidsAP Consortium	Randomized Trial of Closed-Loop Control in Very Young Children with Type 1 Diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HYPOGLYCEMIA; MULTICENTER	BACKGROUND The possible advantage of hybrid closed-loop therapy (i.e., artificial pancreas) over sensor-augmented pump therapy in very young children with type 1 diabetes is unclear. METHODS In this multicenter, randomized, crossover trial, we recruited children 1 to 7 years of age with type 1 diabetes who were receiving insulin-pump therapy at seven centers across Austria, Germany, Luxembourg, and the United Kingdom. Participants received treatment in two 16-week periods, in random order, in which the closedloop system was compared with sensor-augmented pump therapy (control). The primary end point was the between-treatment difference in the percentage of time that the sensor glucose measurement was in the target range (70 to 180 mg per deciliter) during each 16-week period. The analysis was conducted according to the intention-to-treat principle. Key secondary end points included the percentage of time spent in a hyperglycemic state (glucose level, >180 mg per deciliter), the glycated hemoglobin level, the mean sensor glucose level, and the percentage of time spent in a hypoglycemic state (glucose level, <70 mg per deciliter). Safety was assessed. RESULTS A total of 74 participants underwent randomization. The mean (+/- SD) age of the participants was 5.6 +/- 1.6 years, and the baseline glycated hemoglobin level was 7.3 +/- 0.7%. The percentage of time with the glucose level in the target range was 8.7 percentage points (95% confidence interval [CI], 7.4 to 9.9) higher during the closed-loop period than during the control period (P<0.001). The mean adjusted difference (closed-loop minus control) in the percentage of time spent in a hyperglycemic state was -8.5 percentage points (95% CI, -9.9 to -7.1), the difference in the glycated hemoglobin level was -0.4 percentage points (95% CI, -0.5 to -0.3), and the difference in the mean sensor glucose level was -12.3 mg per deciliter (95% CI, -14.8 to -9.8) (P<0.001 for all comparisons). The time spent in a hypoglycemic state was similar with the two treatments (P =0.74). The median time spent in the closed-loop mode was 95% (interquartile range, 92 to 97) over the 16-week closed-loop period. One serious adverse event of severe hypoglycemia occurred during the closed-loop period. One serious adverse event that was deemed to be unrelated to treatment occurred. CONCLUSIONS A hybrid closed-loop system significantly improved glycemic control in very young children with type 1 diabetes, without increasing the time spent in hypoglycemia.	[Ware, J.; Allen, J. M.; Boughton, C. K.; Wilinska, M. E.; Hovorka, R.] Wellcome Trust Med Res Council MRC Inst Metab Sci, Cambridge, England; [Ware, J.; Wilinska, M. E.; Thankamony, A.; Hovorka, R.] Univ Cambridge, Dept Paediat, Cambridge, England; [Hartnell, S.] Cambridge Univ Hosp NHS Fdn Trust, Wolfson Diabet & Endocrine Clin, Cambridge, England; [Campbell, F. M.; Yong, J.] Leeds Childrens Hosp, Dept Paediat Diabet, Leeds, W Yorkshire, England; [Lawton, J.] Univ Edinburgh, Usher Inst, Edinburgh, Midlothian, Scotland; [de Beaufort, C.; Schierloh, U.] Ctr Hosp r Luxembourg, Clin Pediat, Diabet & Endocrine Care Clin Pediat, Luxembourg, Luxembourg; [de Beaufort, C.] Vrije Univ Brussel, Univ Ziekenhuis Brussel, Dept Pediat Endocrinol, Brussels, Belgium; [Froehlich-Reiterer, E.] Med Univ Graz, Dept Pediat & Adolescent Med, Graz, Austria; [Mader, J. K.] Med Univ Graz, Dept Internal Med, Div Endocrinol & Diabetol, Graz, Austria; [Rami-Merhar, B.; Tauschmann, M.; Nagl, K.] Med Univ Vienna, Dept Pediat & Adolescent Med, Vienna, Austria; [Hofer, S. E.] Med Univ Innsbruck, Dept Pediat 1, Innsbruck, Austria; [Kapellen, T. M.] Univ Leipzig, Hosp Children & Adolescents, Leipzig, Germany; [Kapellen, T. M.] Hosp Children & Adolescents Am Nicolausholz, Bad Kosen, Germany; [Hood, K. K.] Stanford Univ, Div Pediat Endocrinol, Stanford, CA 94305 USA; [Roze, S.] Vyoo Agcy, Lyon, France; [Sibayan, J.; Bocchino, L. E.; Kollman, C.] Jaeb Ctr Hlth Res, Tampa, FL USA	University of Cambridge; University of Cambridge; University of Edinburgh; University Hospital Brussels; Vrije Universiteit Brussel; Medical University of Graz; Medical University of Graz; Medical University of Vienna; Medical University of Innsbruck; Leipzig University; Stanford University; JAEB Center For Health Research	Hovorka, R (corresponding author), Univ Cambridge Metab Res Labs, Cambridge CB2 0QQ, England.; Hovorka, R (corresponding author), Wellcome Trust MRC Inst Metab Sci, NIHR Cambridge Biomed Res Ctr, Addenbrookes Hosp, Box 289,Hills Rd, Cambridge CB2 0QQ, England.	rh347@cam.ac.uk	Tauschmann, Martin/GLN-8103-2022; Hovorka, Roman/J-4123-2016	Hovorka, Roman/0000-0003-2901-461X; Mader, Julia/0000-0001-7854-4233; de Beaufort, Carine/0000-0003-4310-6799; Boughton, Charlotte/0000-0003-3272-9544; Fuchs, Julia/0000-0002-4497-0979	European Commission [731560]; NIHR Cambridge Biomedical Research Centre [BRC-1215-20014]; JDRF [22-2013-266, 2-RSC-2019-828-M-N]	European Commission(European CommissionEuropean Commission Joint Research Centre); NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); JDRF(Juvenile Diabetes Research Foundation)	Supported by the European Commission within the Horizon 2020 Framework Program (grant agreement number, 731560). The NIHR Cambridge Biomedical Research Centre (grant number, BRC-1215-20014) and JDRF (grant numbers, 22-2013-266 and 2-RSC-2019-828-M-N) provided additional support for work with the hybrid closed-loop therapy system (artificial pancreas) and all resulting analyses.	Anderzen J, 2020, PEDIATR DIABETES, V21, P621, DOI 10.1111/pedi.13014; Bergenstal RM, 2021, LANCET, V397, P208, DOI 10.1016/S0140-6736(20)32514-9; Berget C, 2020, PEDIATR DIABETES, V21, DOI 10.1111/pedi.12962; Breton MD, 2020, NEW ENGL J MED, V383, P836, DOI 10.1056/NEJMoa2004736; DiMeglio LA, 2021, DIABETES CARE, V44, P464, DOI 10.2337/dc20-1060; Dovc K, 2019, DIABETES CARE, V42, P1344, DOI 10.2337/dc18-2625; Ekhlaspour L, 2021, DIABETES TECHNOL THE, V23, P384, DOI 10.1089/dia.2020.0507; Forlenza GP, 2018, DIABETES CARE, V41, P2155, DOI 10.2337/dc18-0771; Foster NC, 2019, DIABETES TECHNOL THE, V21, P66, DOI 10.1089/dia.2018.0384; Fuchs J, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-042790; Hermann JM, 2020, DIABETIC MED, V37, P848, DOI 10.1111/dme.14148; Kimbell B, 2021, BMC PEDIATR, V21, DOI 10.1186/s12887-021-02569-4; Mauras N, 2021, DIABETES CARE, V44, P983, DOI 10.2337/dc20-2125; Musolino G, 2019, PEDIATR DIABETES, V20, P794, DOI 10.1111/pedi.12872; National Paediatric Diabetes Audit, 2021, ANN REP 2019 20 CAR; Northam EA, 2009, DIABETES CARE, V32, P445, DOI 10.2337/dc08-1657; Sherr JL, 2018, DIABETES CARE, V41, P1572, DOI 10.2337/dci18-0003; Sundberg F, 2014, PEDIATR DIABETES, V15, P34, DOI 10.1111/pedi.12057; Tauschmann M, 2020, DIABETES CARE, V43, pE40, DOI 10.2337/dc19-1358; Tauschmann M, 2019, DIABETES CARE, V42, P594, DOI 10.2337/dc18-1881; Tauschmann M, 2018, LANCET, V392, P1321, DOI 10.1016/S0140-6736(18)31947-0; van den Boom L, 2019, DIABETES CARE, V42, P2050, DOI 10.2337/dc19-0345; Van Name MA, 2018, PEDIATR DIABETES, V19, P114, DOI 10.1111/pedi.12525	23	28	28	5	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 20	2022	386	3					209	219		10.1056/NEJMoa2111673	http://dx.doi.org/10.1056/NEJMoa2111673			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YK1UG	35045227	Green Published			2022-12-28	WOS:000745006000008
J	Weidemann, S; Kremer, M; Longhi, S; Szameit, A				Weidemann, Sebastian; Kremer, Mark; Longhi, Stefano; Szameit, Alexander			Topological triple phase transition in non-Hermitian Floquet quasicrystals	NATURE			English	Article							LOCALIZATION; ELECTRONS	Phase transitions connect different states of matter and are often concomitant with the spontaneous breaking of symmetries. An important category of phase transitions is mobility transitions, among which is the well known Anderson localization(1), where increasing the randomness induces a metal-insulator transition. The introduction of topology in condensed-matter physics(2-4) lead to the discovery of topological phase transitions and materials as topological insulators(5). Phase transitions in the symmetry of non-Hermitian systems describe the transition to on-average conserved energy(6) and new topological phases(7-9). Bulk conductivity, topology and non-Hermitian symmetry breaking seemingly emerge from different physics and, thus, may appear as separable phenomena. However, in non-Hermitian quasicrystals, such transitions can be mutually interlinked by forming a triple phase transition(10). Here we report the experimental observation of a triple phase transition, where changing a single parameter simultaneously gives rise to a localization (metal-insulator), a topological and parity-time symmetry-breaking (energy) phase transition. The physics is manifested in a temporally driven (Floquet) dissipative quasicrystal. We implement our ideas via photonic quantum walks in coupled optical fibre loops(11). Our study highlights the intertwinement of topology, symmetry breaking and mobility phase transitions in non-Hermitian quasicrystalline synthetic matter. Our results may be applied in phase-change devices, in which the bulk and edge transport and the energy or particle exchange with the environment can be predicted and controlled.	[Weidemann, Sebastian; Kremer, Mark; Szameit, Alexander] Univ Rostock, Inst Phys, Rostock, Germany; [Longhi, Stefano] Politecn Milan, Dipartimento Fis, Milan, Italy; [Longhi, Stefano] IFISC UIB CSIC, Inst Fis Interdisciplinar & Sistemas Complejos Pa, Palma De Mallorca, Spain	University of Rostock; Polytechnic University of Milan; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat de les Illes Balears; CSIC-UIB - Instituto de Fisica Interdisciplinar y Sistemas Complejos (IFISC)	Szameit, A (corresponding author), Univ Rostock, Inst Phys, Rostock, Germany.	alexander.szameit@uni-rostock.de	Longhi, Stefano/AAY-7537-2021; Szameit, Alexander/AGK-5446-2022	Longhi, Stefano/0000-0002-8739-3542; Szameit, Alexander/0000-0003-0071-6941; Weidemann, Sebastian/0000-0002-0090-1760; Kremer, Mark/0000-0003-2597-7259	Deutsche Forschungsgemeinschaft [BL 574/13-1, SZ 276/9-2, SZ 276/15-1, SZ 276/20-1]; Krupp von Bohlen and Halbach foundation; Spanish State Research Agency through the Severo Ochoa and Maria de Maeztu Program for Centers and Units of Excellence in RD [MDM-2017-0711]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Krupp von Bohlen and Halbach foundation; Spanish State Research Agency through the Severo Ochoa and Maria de Maeztu Program for Centers and Units of Excellence in RD	We thank U. Peschel and M. Wimmer for discussions. S.W., M.K. and A.S. thank the Deutsche Forschungsgemeinschaft for funding their research (grants BL 574/13-1, SZ 276/9-2, SZ 276/15-1 and SZ 276/20-1) and the Krupp von Bohlen and Halbach foundation. S.L. acknowledges the Spanish State Research Agency through the Severo Ochoa and Maria de Maeztu Program for Centers and Units of Excellence in R&D (MDM-2017-0711)	ANDERSON PW, 1958, PHYS REV, V109, P1492, DOI 10.1103/PhysRev.109.1492; Aubry S., 1980, Annals of the Israel Physical Society, V3, P133; BARDEEN J, 1957, PHYS REV, V108, P1175, DOI 10.1103/PhysRev.108.1175; Bender CM, 1998, PHYS REV LETT, V80, P5243, DOI 10.1103/PhysRevLett.80.5243; Bergholtz EJ, 2021, REV MOD PHYS, V93, DOI 10.1103/RevModPhys.93.015005; Cheng BQ, 2020, NATURE, V585, P217, DOI 10.1038/s41586-020-2677-y; Choi JM, 2020, ANNU REV BIOPHYS, V49, P107, DOI 10.1146/annurev-biophys-121219-081629; Evers F, 2008, REV MOD PHYS, V80, P1355, DOI 10.1103/RevModPhys.80.1355; Gong ZP, 2018, PHYS REV X, V8, DOI 10.1103/PhysRevX.8.031079; Griffin A., 1996, BOSE EINSTEIN CONDEN; HALDANE FDM, 1988, PHYS REV LETT, V61, P2015, DOI 10.1103/PhysRevLett.61.2015; HARPER PG, 1955, P PHYS SOC LOND A, V68, P874, DOI 10.1088/0370-1298/68/10/304; Hasan MZ, 2010, REV MOD PHYS, V82, P3045, DOI 10.1103/RevModPhys.82.3045; Hatano N, 1996, PHYS REV LETT, V77, P570, DOI 10.1103/PhysRevLett.77.570; Helbig T, 2020, NAT PHYS, V16, P747, DOI 10.1038/s41567-020-0922-9; Hodaei H, 2017, NATURE, V548, P187, DOI 10.1038/nature23280; HOFSTADTER DR, 1976, PHYS REV B, V14, P2239, DOI 10.1103/PhysRevB.14.2239; Jain A, 2017, NATURE, V546, P243, DOI 10.1038/nature22386; Kawabata K, 2019, PHYS REV X, V9, DOI 10.1103/PhysRevX.9.041015; KIBBLE TWB, 1980, PHYS REP, V67, P183, DOI 10.1016/0370-1573(80)90091-5; Kosterlitz JM, 1973, J PHYS C SOLID STATE, V6, P1181, DOI 10.1088/0022-3719/6/7/010; Kraus YE, 2016, NAT PHYS, V12, P624, DOI 10.1038/nphys3784; Lahini Y, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.013901; Lin Z, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.213901; LINDE AD, 1979, REP PROG PHYS, V42, P389, DOI 10.1088/0034-4885/42/3/001; Longhi S, 2019, PHYS REV LETT, V122, DOI 10.1103/PhysRevLett.122.237601; Longhi S, 2019, PHYS REV RES, V1, DOI 10.1103/PhysRevResearch.1.023013; Mazumdar A, 2019, REP PROG PHYS, V82, DOI 10.1088/1361-6633/ab1f55; Miao P, 2016, SCIENCE, V353, P464, DOI 10.1126/science.aaf8533; Mochizuki K, 2016, PHYS REV A, V93, DOI 10.1103/PhysRevA.93.062116; Okuma N, 2020, PHYS REV LETT, V124, DOI 10.1103/PhysRevLett.124.086801; Regensburger A, 2012, NATURE, V488, P167, DOI 10.1038/nature11298; Roati G, 2008, NATURE, V453, P895, DOI 10.1038/nature07071; Sadovskii MV, 1997, PHYS REP, V282, P225, DOI 10.1016/S0370-1573(96)00036-1; Schreiber A, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.180403; Schreiber A, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.050502; THOULESS DJ, 1982, PHYS REV LETT, V49, P405, DOI 10.1103/PhysRevLett.49.405; Weidemann S., 2021, DATA SET TOPOLOGICAL, DOI [10.18453/rosdok_id00003282, DOI 10.18453/ROSDOK_ID00003282]; Weidemann S, 2020, SCIENCE, V368, P311, DOI 10.1126/science.aaz8727; Wimmer M, 2017, NAT PHYS, V13, P545, DOI [10.1038/NPHYS4050, 10.1038/nphys4050]; Yao SY, 2018, PHYS REV LETT, V121, DOI 10.1103/PhysRevLett.121.086803	41	17	17	22	44	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 20	2022	601	7893					354	+		10.1038/s41586-021-04253-0	http://dx.doi.org/10.1038/s41586-021-04253-0			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YJ6UI	35046602	Green Published, hybrid			2022-12-28	WOS:000744666700026
J	Huddleston, HG; Dokras, A				Huddleston, Heather G.; Dokras, Anuja			Diagnosis and Treatment of Polycystic Ovary Syndrome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Huddleston, Heather G.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA USA; [Dokras, Anuja] Univ Penn, Dept Obstet & Gynecol, Philadelphia, PA 19104 USA	University of California System; University of California San Francisco; University of Pennsylvania	Huddleston, HG (corresponding author), Ctr Reprod Hlth, 499 Illinois St, San Francisco, CA 94158 USA.	heather.huddleston@ucsf.edu						American College of Obstetricians and Gynecologists' Committee on Practice BulletinsGynecology, 2018, Obstet Gynecol, V131, pe157, DOI 10.1097/AOG.0000000000002656; Azziz R, 2018, OBSTET GYNECOL, V132, P321, DOI 10.1097/AOG.0000000000002698; Carmina E, 2019, J CLIN ENDOCR METAB, V104, P2875, DOI 10.1210/jc.2018-02548; Ibanez L, 2017, HORM RES PAEDIAT, V88, P371, DOI 10.1159/000479371; Lizneva D, 2016, FERTIL STERIL, V106, P6, DOI 10.1016/j.fertnstert.2016.05.003; Meczekalski B, 2020, GYNECOL ENDOCRINOL, V36, P289, DOI 10.1080/09513590.2020.1730794; Teede HJ, 2018, CLIN ENDOCRINOL, V89, P251, DOI 10.1111/cen.13795	7	3	3	10	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 18	2022	327	3					274	275						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YV9PQ	35040896				2022-12-28	WOS:000753055100021
J	Madsen, DB; Davis, LG; Rhode, D; Oviatt, CG				Madsen, David B.; Davis, Loren G.; Rhode, David; Oviatt, Charles G.			Comment on "Evidence of humans in North America during the Last Glacial Maximum"	SCIENCE			English	Editorial Material							POPULATION	Bennett et al. (Reports, 24 September 2021, p. 1528) report human footprints from Lake Otero, New Mexico, USA similar to 22,000 years ago. Critical assessment suggests that their radiocarbon chronology may be inaccurate. Reservoir effects may have caused radiocarbon ages to appear thousands of years too old. Independent verification of the ages of the footprint horizons is imperative and is possible through other means.	[Madsen, David B.] Univ Nevada, Dept Anthropol, Reno, NV 89557 USA; [Davis, Loren G.] Oregon State Univ, Dept Anthropol, Corvallis, OR 97331 USA; [Rhode, David] Desert Res Inst, Div Earth & Ecosyst Sci, Reno, NV 89512 USA; [Oviatt, Charles G.] Kansas State Univ, Dept Geol, Manhattan, KS 66506 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; Oregon State University; Nevada System of Higher Education (NSHE); Desert Research Institute NSHE; Kansas State University	Davis, LG (corresponding author), Oregon State Univ, Dept Anthropol, Corvallis, OR 97331 USA.	loren.davis@oregonstate.edu		Madsen, David/0000-0002-4477-103X; Davis, Loren/0000-0003-0283-9822				Allen B.D., 2009, N M GEOL, V31, P9; Bennett MR, 2021, SCIENCE, V373, P1528, DOI 10.1126/science.abg7586; Davis LG, 2020, QUATERNARY SCI REV, V249, DOI 10.1016/j.quascirev.2020.106605; Davis LG, 2019, SCIENCE, V365, P891, DOI 10.1126/science.aax9830; Geyh MA, 1999, QUATERNARY RES, V52, P143, DOI 10.1006/qres.1999.2060; Moreno-Mayar JV, 2018, SCIENCE, V362, DOI 10.1126/science.aav2621; Moreno-Mayar JV, 2018, NATURE, V553, P203, DOI 10.1038/nature25173; Oviatt C. G, 2018, UTAH GEOL SURV MISC, V18-1; Raghavan M, 2015, SCIENCE, V349, DOI 10.1126/science.aab3884; Sikora M, 2019, NATURE, V570, P182, DOI 10.1038/s41586-019-1279-z; Waters MR, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aat4505; Willerslev E, 2021, NATURE, V594, P356, DOI 10.1038/s41586-021-03499-y; Williams TJ, 2020, PALEOAMERICA, V6, P4, DOI 10.1080/20555563.2019.1606668; Williams TJ, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar5954; Zhou AF, 2009, RADIOCARBON, V51, P529, DOI 10.1017/S0033822200055909	15	3	3	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2022	375	6577								10.1126/science.abm4678	http://dx.doi.org/10.1126/science.abm4678			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YG3OI	35025634				2022-12-28	WOS:000742401600001
J	Shrank, WH; Chernew, ME; Navathe, AS				Shrank, William H.; Chernew, Michael E.; Navathe, Amol S.			Hierarchical Payment Models-A Path for Coordinating Population- and Episode-Based Payment Models	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material; Early Access							CARE		[Shrank, William H.] Humana Inc, Louisville, KY USA; [Chernew, Michael E.] Harvard Med Sch, Dept Hlth Care Policy, Boston, MA 02115 USA; [Navathe, Amol S.] Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, 423 Guardian Dr,1108 Blockley Hall, Philadelphia, PA 19104 USA; [Navathe, Amol S.] Corporal Michael J Crescenz VA Med Ctr, Philadelphia, PA USA	Humana Inc.; Harvard University; Harvard Medical School; University of Pennsylvania; Pennsylvania Medicine	Navathe, AS (corresponding author), Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, 423 Guardian Dr,1108 Blockley Hall, Philadelphia, PA 19104 USA.	amol@wharton.upenn.edu						Agarwal R, 2020, HEALTH AFFAIR, V39, P50, DOI 10.1377/hlthaff.2019.00784; Centers for Medicare & Medicaid Services, INN CTR STRAT REFR; Chernew ME, 2021, JAMA-HEALTH FORUM, V2, DOI 10.1001/jamahealthforum.2021.0232; McWilliams MJ, 2021, VISION DESIGN ADV ME; Navathe AS, 2020, JAMA-J AM MED ASSOC, V324, P237, DOI 10.1001/jama.2020.4133; Shrank W, 2013, HEALTH AFFAIR, V32, P807, DOI 10.1377/hlthaff.2013.0216; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1	7	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.												10.1001/jama.2021.23786	http://dx.doi.org/10.1001/jama.2021.23786		JAN 2022	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YG3UF	35029652				2022-12-28	WOS:000742417400003
J	Harrison, C				Harrison, Catherine			Sustaining high quality care in a time of transition: is risk management getting enough attention?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Harrison, Catherine] NHS Providers, London, England		Harrison, C (corresponding author), NHS Providers, London, England.								0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 12	2022	376								o72	10.1136/bmj.o72	http://dx.doi.org/10.1136/bmj.o72			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YP6JI	35022223	Bronze			2022-12-28	WOS:000748728200007
J	Rubino, DM; Greenway, FL; Khalid, U; O'Neil, PM; Rosenstock, J; Sorrig, R; Wadden, TA; Wizert, A; Garvey, WT				Rubino, Domenica M.; Greenway, Frank L.; Khalid, Usman; O'Neil, Patrick M.; Rosenstock, Julio; Sorrig, Rasmus; Wadden, Thomas A.; Wizert, Alicja; Garvey, W. Timothy		STEP 8 Investigators	Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes The STEP 8 Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							3.0 MG	IMPORTANCE Phase 3 trials have not compared semaglutide and liraglutide, glucagon-like peptide-1 analogues available for weight management. OBJECTIVE To compare the efficacy and adverse event profiles of once-weekly subcutaneous semaglutide, 2.4 mg, vs once-daily subcutaneous liraglutide, 3.0 mg (both with diet and physical activity), in people with overweight or obesity. DESIGN, SETTING, AND PARTICIPANTS Randomized, open-label, 68-week, phase 3b trial conducted at 19 US sites from September 2019 (enrollment: September 11-November 26) to May 2021 (end of follow-up: May 11) in adults with body mass index of 30 or greater or 27 or greater with 1 or more weight-related comorbidities, without diabetes (N = 338). INTERVENTIONS Participants were randomized (3:1:3:1) to receive once-weekly subcutaneous semaglutide, 2.4 mg (16-week escalation; n = 126), or matching placebo, or once-daily subcutaneous liraglutide, 3.0 mg (4-week escalation; n = 127), or matching placebo, plus diet and physical activity. Participants unable to tolerate 2.4 mg of semaglutide could receive 1.7 mg; participants unable to tolerate 3.0 mg of liraglutide discontinued treatment and could restart the 4-week titration. Placebo groups were pooled (n = 85). MAIN OUTCOMES AND MEASURES The primary end point was percentage change in body weight, and confirmatory secondary end points were achievement of 10% or more, 15% or more, and 20% or more weight loss, assessed for semaglutide vs liraglutide at week 68. Semaglutide vs liraglutide comparisons were open-label, with active treatment groups double-blinded against matched placebo groups. Comparisons of active treatments vs pooled placebo were supportive secondary end points. RESULTS Of 338 randomized participants (mean [SD] age, 49 [13] years; 265 women [78.4%]; mean [SD] body weight, 104.5 [23.8] kg; mean [SD] body mass index, 37.5 [6.8]), 319 (94.4%) completed the trial, and 271(80.2%) completed treatment. The mean weight change from baseline was -15.8% with semaglutide vs -6.4% with liraglutide (difference, -9.4 percentage points [95% CI, -12.0 to -6.8]; P < .001); weight change with pooled placebo was -1.9%. Participants had significantly greater odds of achieving 10% or more, 15% or more, and 20% or more weight loss with semaglutide vs liraglutide (70.9% of participants vs 25.6% [odds ratio, 6.3 {95% CI, 3.5 to 11.2)], 55.6% vs 12.0% [odds ratio, 7.9 {95% CI, 4.1to 15.4}], and 38.5% vs 6.0% [odds ratio, 8.2 {95% CI, 3.5 to 19.1)], respectively; all P < .001). Proportions of participants discontinuing treatment for any reason were 13.5% with semaglutide and 27.6% with liraglutide. Gastrointestinal adverse events were reported by 84.1% with semaglutide and 82.7% with liraglutide. CONCLUSIONS AND RELEVANCE Among adults with overweight or obesity without diabetes, once-weekly subcutaneous semaglutide compared with once-daily subcutaneous liraglutide, added to counseling for diet and physical activity, resulted in significantly greater weight loss at 68 weeks.	[Rubino, Domenica M.] Washington Ctr Weight Management & Res, 2800 S Shirlington Rd,Ste 505, Arlington, VA 22206 USA; [Greenway, Frank L.] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA USA; [Khalid, Usman; Sorrig, Rasmus; Wizert, Alicja] Novo Nordisk AS, Soborg, Denmark; [O'Neil, Patrick M.] Med Univ South Carolina, Weight Management Ctr, Dept Psychiat & Behav Sci, Charleston, SC 29425 USA; [Rosenstock, Julio] Dallas Diabet Res Ctr Med City, Dallas, TX USA; [Wadden, Thomas A.] Univ Penn, Dept Psychiat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Garvey, W. Timothy] Univ Alabama, Dept Nutr Sci, Birmingham, England	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Novo Nordisk; Medical University of South Carolina; Diabetes & Endocrine Center; University of Pennsylvania; Pennsylvania Medicine; Aston University	Rubino, DM (corresponding author), Washington Ctr Weight Management & Res, 2800 S Shirlington Rd,Ste 505, Arlington, VA 22206 USA.	drubino@wtmgmt.com			Novo Nordisk A/S	Novo Nordisk A/S(Novo Nordisk)	This trial was funded by Novo Nordisk A/S	American Diabetes Association, 2017, Diabetes Care, V40, pS11, DOI 10.2337/dc15-S005; Astrup A, 2012, INT J OBESITY, V36, P843, DOI 10.1038/ijo.2011.158; Blackman A, 2016, INT J OBESITY, V40, P1310, DOI 10.1038/ijo.2016.52; Capehorn MS, 2020, DIABETES METAB, V46, P100, DOI 10.1016/j.diabet.2019.101117; Cawley J, 2015, PHARMACOECONOMICS, V33, P707, DOI 10.1007/s40273-014-0230-2; Chao AM, 2019, OBESITY, V27, P2005, DOI 10.1002/oby.22653; Davies M, 2021, LANCET, V397, P971, DOI 10.1016/S0140-6736(21)00213-0; Davies MJ, 2015, JAMA-J AM MED ASSOC, V314, P687, DOI 10.1001/jama.2015.9676; Divino V, 2021, J MANAG CARE SPEC PH, V27, P210, DOI 10.18553/jmcp.2020.20272; Friedrichsen M, 2021, DIABETES OBES METAB, V23, P754, DOI 10.1111/dom.14280; Gabery S, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.133429; Garvey WT, 2016, ENDOCR PRACT, V22, P1, DOI 10.4158/EP161365.GL; Hauber AB, 2016, CURR MED RES OPIN, V32, P251, DOI 10.1185/03007995.2015.1117433; International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use, EFF GUID E9 STAT PRI; Knudsen LB, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00155; Lau J, 2015, J MED CHEM, V58, P7370, DOI 10.1021/acs.jmedchem.5b00726; Little R. J. A., 1987, STAT ANAL MISSING DA; McEvoy BW, 2016, J BIOPHARM STAT, V26, P30, DOI 10.1080/10543406.2015.1094814; O'Neil PM, 2018, LANCET, V392, P637, DOI 10.1016/S0140-6736(18)31773-2; O'Neil PM, 2017, DIABETES OBES METAB, V19, P1529, DOI 10.1111/dom.12963; Pedersen SD., CANADIAN ADULT OBES; Pi-Sunyer X, 2015, NEW ENGL J MED, V373, P11, DOI 10.1056/NEJMoa1411892; Rubino D, 2021, JAMA-J AM MED ASSOC, V325, P1414, DOI 10.1001/jama.2021.3224; Ryan DH, 2020, AM HEART J, V229, P61, DOI 10.1016/j.ahj.2020.07.008; US Food and Drug Administration, GUID DOC DEV PROD WE; US Food and Drug Administration, 2021, E9 R1 STAT PRINCIPL; US Food and Drug Administration, SAX PRESCR INF; US Food and Drug Administration, WEG PRESCR INF; van Can J, 2014, INT J OBESITY, V38, P784, DOI 10.1038/ijo.2013.162; Wadden TA, 2013, INT J OBESITY, V37, P1443, DOI 10.1038/ijo.2013.120; Wadden TA, 2021, JAMA-J AM MED ASSOC, V325, P1403, DOI 10.1001/jama.2021.1831; Wharton S, 2021, INT J OBESITY, V45, P923, DOI 10.1038/s41366-020-00733-x; Wharton S, 2020, CAN MED ASSOC J, V192, pE875, DOI 10.1503/cmaj.191707; Wilding JPH, 2021, NEW ENGL J MED, V384, P989, DOI 10.1056/NEJMoa2032183; Yadav K, 2017, JAMA-J AM MED ASSOC, V318, P1385, DOI 10.1001/jama.2017.13276; Yumuk V, 2015, OBESITY FACTS, V8, P402, DOI 10.1159/000442721	36	44	45	11	22	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 11	2022	327	2					138	150		10.1001/jama.2021.23619	http://dx.doi.org/10.1001/jama.2021.23619			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YH8QV	35015037	Green Published			2022-12-28	WOS:000743426500015
J	Jones, H				Jones, Helen			Role Model: Cheng-Hock Toh	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material								Cheng-Hock Toh talks to Helen Jones about his passion for his specialty and for nurturing the next generation of haematologists				awaters@bmj.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 10	2022	376								o17	10.1136/bmj.o17	http://dx.doi.org/10.1136/bmj.o17			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YP6IZ	35012928	Bronze			2022-12-28	WOS:000748727200002
J	Limb, M				Limb, Matthew			Doctors' leader calls for support for overseas doctors left stranded after exams are cancelled	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 7	2022	376								o36	10.1136/bmj.o36	http://dx.doi.org/10.1136/bmj.o36			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YP9GN	34996752				2022-12-28	WOS:000748927300007
J	Ralph, R; Abul Faiz, M; Sharma, SK; Ribeiro, I; Chappuis, F				Ralph, Ravikar; Abul Faiz, Mohammad; Sharma, Sanjib Kumar; Ribeiro, Isabela; Chappuis, Francois			Managing snakebite	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ACUTE KIDNEY INJURY; RANDOMIZED COMPARATIVE TRIAL; BLOOD CLOTTING TEST; RUSSELLS VIPER; SRI-LANKA; RATTLESNAKE ENVENOMATION; ADVERSE-REACTIONS; DABOIA-SIAMENSIS; BITE; VENOM		[Ralph, Ravikar] Christian Med Coll & Hosp, Dept Internal Med, Vellore 632004, Tamil Nadu, India; [Abul Faiz, Mohammad] Dev Care Fdn, Dhaka 1209, Bangladesh; [Sharma, Sanjib Kumar] BP Koirala Inst Hlth Sci, Dept Internal Med, Dharan 76500, Nepal; [Ribeiro, Isabela] Drugs Neglected Dis DND, Dynam Portfolio, 15 Chemin Louis Dunant, CH-1202 Geneva, Switzerland; [Chappuis, Francois] Geneva Univ Hosp, Div Trop & Humanitarian Med, Rue Gabrielle Perret Gentil 6, CH-1211 Geneva, Switzerland	Christian Medical College & Hospital (CMCH) Vellore; B.P. Koirala Institute of Health Sciences; University of Geneva	Ralph, R (corresponding author), Christian Med Coll & Hosp, Dept Internal Med, Vellore 632004, Tamil Nadu, India.	ravikar_ralph@yahoo.com		Chappuis, Francois/0000-0003-0442-7610				Abubakar SB, 2010, TROP DOCT, V40, P114, DOI 10.1258/td.2009.090266; Abubakar SB, 2010, TOXICON, V55, P719, DOI 10.1016/j.toxicon.2009.10.024; Alfred S, 2019, KIDNEY INT REP, V4, P1337, DOI 10.1016/j.ekir.2019.05.017; Alirol E, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000603; Allen GE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053188; Alves EC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202361; Amaral CFS, 1998, TOXICON, V36, P805, DOI 10.1016/S0041-0101(97)00132-3; Ameade EPK, 2021, PLOS NEGLECT TROP D, V15, DOI 10.1371/journal.pntd.0008756; ANKER RL, 1982, MED J AUSTRALIA, V1, P212, DOI 10.5694/j.1326-5377.1982.tb132272.x; Antonypillai CN, 2011, QJM-INT J MED, V104, P97, DOI 10.1093/qjmed/hcq214; Ariaratnam CA, 2009, AM J TROP MED HYG, V81, P725, DOI 10.4269/ajtmh.2009.09-0225; Ascoet S, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21103565; Avau B, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005079; Aye KP, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-017-0510-0; Bawaskar HS, 2015, J MAHATMA GANDHI I M, V20, P5, DOI DOI 10.4103/0971-9903.151717; Blaylock RS, 2005, S AFR FAM PRACT, V47, P48, DOI 10.1080/20786204.2005.10873288; Bucaretchi F, 2016, CLIN TOXICOL, V54, P222, DOI 10.3109/15563650.2015.1135337; Bush SP, 2004, ANN EMERG MED, V44, P599, DOI 10.1016/j.annemergmed.2004.06.007; Calvete JJ, 2016, TOXICON, V119, P280, DOI 10.1016/j.toxicon.2016.06.022; Camargo ACM, 2012, TOXICON, V59, P516, DOI 10.1016/j.toxicon.2011.07.013; CARDOSO JLC, 1993, Q J MED, V86, P315; Chalmers J, 1999, J HYPERTENS, V17, P151; Chippaux JP, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005662; Chippaux JP, 2011, TOXICON, V57, P586, DOI 10.1016/j.toxicon.2010.12.022; Chippaux JP, 1998, B WORLD HEALTH ORGAN, V76, P515; Chu ER, 2010, TOXICON, V56, P259, DOI 10.1016/j.toxicon.2010.02.023; Cruz LS, 2009, ETHNIC DIS, V19, P42; Darracq MA, 2015, TOXICON, V101, P23, DOI 10.1016/j.toxicon.2015.04.014; Dart RC, 2001, ANN EMERG MED, V37, P181, DOI 10.1067/mem.2001.113372; de Silva HA, 2016, BRIT J CLIN PHARMACO, V81, P446, DOI 10.1111/bcp.12739; GARFIN SR, 1984, TOXICON, V22, P177, DOI 10.1016/0041-0101(84)90018-7; George Mathew, 2011, Indian J Med Ethics, V8, P161; Golay V, 2012, SAUDI J KIDNEY DIS T, V23, P1262, DOI 10.4103/1319-2442.103573; Gold BS, 2003, J EMERG MED, V24, P285, DOI 10.1016/S0736-4679(02)00762-X; Gulati A, 2013, TOXICON, V61, P94, DOI 10.1016/j.toxicon.2012.11.001; Gutierrez JM, 1998, TOXICON, V36, P1529, DOI 10.1016/S0041-0101(98)00145-7; Gutierrez JM, 2017, NAT REV DIS PRIMERS, V3, DOI [10.1038/nrdp.2017.63, 10.1038/nrdp.2017.79]; Gutierrez JM, 2016, TOXINS, V8, DOI 10.3390/toxins8040093; Habib AG, 2003, ACTA TROP, V85, P87, DOI 10.1016/S0001-706X(02)00234-6; Habib ZG, 2021, INT J PSYCHIAT MED, V56, P97, DOI 10.1177/0091217420913400; Harris JB, 2010, T ROY SOC TROP MED H, V104, P320, DOI 10.1016/j.trstmh.2009.12.006; Harrison RA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005969; Harrison RA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000569; Herath HMNJ, 2012, POSTGRAD MED J, V88, P138, DOI 10.1136/postgradmedj-2011-130225; Hsiang AY, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0358-5; Hung DZ, 2002, TOXICON, V40, P1291, DOI 10.1016/S0041-0101(02)00137-X; Iliyasu G, 2015, RURAL REMOTE HEALTH, V15; Isbister GK, 2013, QJM-INT J MED, V106, P925, DOI 10.1093/qjmed/hct102; Isbister GK, 2010, J THROMB HAEMOST, V8, P2504, DOI 10.1111/j.1538-7836.2010.04050.x; Isbister GK, 2009, QJM-INT J MED, V102, P563, DOI 10.1093/qjmed/hcp081; Isbister GK, 2013, MED J AUSTRALIA, V199, P763, DOI 10.5694/mja12.11172; Isbister GK, 2012, MED J AUSTRALIA, V197, P173, DOI 10.5694/mja11.11300; Jain R, 2019, PRIM HEALTH CARE RES, V20, DOI 10.1017/S1463423619000537; Jayawardana S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005103; Jeevagan V, 2013, TOXICON, V63, P78, DOI 10.1016/j.toxicon.2012.11.012; Johnston CI, 2017, MED J AUSTRALIA, V207, P119, DOI 10.5694/mja17.00094; Kanjanabuch T, 2008, SEMIN NEPHROL, V28, P363, DOI 10.1016/j.semnephrol.2008.04.005; Kasturiratne A, 2008, PLOS MED, V5, P1591, DOI 10.1371/journal.pmed.0050218; Kasturiratne A, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005647; Kerkkamp HMI, 2017, TOXINOLOGY, P303, DOI 10.1007/978-94-007-6458-3_11; Kularatne S A M, 2003, Southeast Asian J Trop Med Public Health, V34, P855; Kularatne SAM, 2002, POSTGRAD MED J, V78, P276, DOI 10.1136/pmj.78.919.276; LALLOO DG, 1995, AM J TROP MED HYG, V52, P525, DOI 10.4269/ajtmh.1995.52.525; Lamb T, 2021, PLOS NEGLECT TROP D, V15, DOI 10.1371/journal.pntd.0009657; Laohawiriyakamol S, 2011, WORLD J PEDIATR, V7, P361, DOI 10.1007/s12519-011-0282-8; Leon G, 2013, TOXICON, V76, P63, DOI 10.1016/j.toxicon.2013.09.010; Mallik Subhendu, 2016, J Family Med Prim Care, V5, P474; Gutierrez JM, 2014, J VENOM ANIM TOXINS, V20, DOI 10.1186/1678-9199-20-7; Means Russel, 2017, Clin Pract Cases Emerg Med, V1, P47, DOI 10.5811/cpcem.2016.11.31220; Michael GC, 2018, T ROY SOC TROP MED H, V112, P47, DOI 10.1093/trstmh/try028; Michael GC, 2011, T ROY SOC TROP MED H, V105, P95, DOI 10.1016/j.trstmh.2010.09.005; MYINTLWIN, 1985, LANCET, V2, P1259; Naik BN, 2018, NEUROL INDIA, V66, P1351, DOI 10.4103/0028-3886.241378; Ochoa-Aviles Angelica, 2020, Toxicon X, V7, P100051, DOI 10.1016/j.toxcx.2020.100051; Parker-Cote J, 2018, TROP MED INFECT DIS, V3, DOI 10.3390/tropicalmed3020045; Peterfi O, 2019, MOLECULES, V24, DOI 10.3390/molecules24152778; Pinho FMO, 2005, KIDNEY INT, V67, P659, DOI 10.1111/j.1523-1755.2005.67122.x; Pochanugool C, 1998, MIL MED, V163, P318, DOI 10.1093/milmed/163.5.318; Premawardhena AP, 1999, BRIT MED J, V318, P1041, DOI 10.1136/bmj.318.7190.1041; Priyamvada PS, 2020, CLIN KIDNEY J, V13, P564, DOI 10.1093/ckj/sfz055; Pucca MB, 2020, TOXINS, V12, DOI 10.3390/toxins12110668; Pulimaddi R, 2017, INDIAN J MED RES, V146, P754, DOI 10.4103/ijmr.IJMR_1581_16; Pyron RA, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-93; Ralph R, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.k5317; Ramanayake R P J C, 2014, J Family Med Prim Care, V3, P305, DOI 10.4103/2249-4863.148089; Ranawaka UK, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002302; REID HA, 1956, BRIT MED J, V2, P73, DOI 10.1136/bmj.2.4984.73; Rucavado A, 2005, THROMB HAEMOSTASIS, V94, P123; Saini R K, 1986, J Assoc Physicians India, V34, P415; SANOMARTINS IS, 1994, TOXICON, V32, P1045, DOI 10.1016/0041-0101(94)90388-3; Sapkota S, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008793; Seifert SA, 2011, J MED TOXICOL, V7, P324, DOI 10.1007/s13181-011-0188-9; Sharma SK, 2013, AM J TROP MED HYG, V89, P145, DOI 10.4269/ajtmh.12-0750; Sharma SK, 2019, J TROP MED-US, V2019, DOI 10.1155/2019/2689171; Shivaprasad C, 2019, PITUITARY, V22, P4, DOI 10.1007/s11102-018-0915-1; Silva A, 2017, TOXINS, V9, DOI 10.3390/toxins9040143; Silva Anjana, 2012, BMC Res Notes, V5, P500, DOI 10.1186/1756-0500-5-500; Sitprija V, 2006, NEPHROLOGY, V11, P442, DOI 10.1111/j.1440-1797.2006.00599.x; Slagboom J, 2017, BRIT J HAEMATOL, V177, P947, DOI 10.1111/bjh.14591; Smalligan R, 2004, BMJ-BRIT MED J, V329, P1129, DOI 10.1136/bmj.329.7475.1129; Srinivasan KG, 2010, NEURORADIOL J, V23, P38, DOI 10.1177/197140091002300106; Stone SF, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002326; SUTHERLAND SK, 1979, LANCET, V1, P183, DOI 10.1016/S0140-6736(79)90580-4; Taieb F, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006716; Tanos PP, 2008, TOXICON, V52, P769, DOI 10.1016/j.toxicon.2008.08.013; Theakston RDG, 2014, TOXINS, V6, P1667, DOI 10.3390/toxins6051667; Tongpoo A, 2018, THER CLIN RISK MANAG, V14, P1711, DOI 10.2147/TCRM.S169581; TUNPE, 1995, T ROY SOC TROP MED H, V89, P293, DOI 10.1016/0035-9203(95)90547-2; TUNPE, 1987, LANCET, V2, P763; van Heiden DF, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45022-4; Waiddyanatha S, 2019, TOXINS, V11, DOI 10.3390/toxins11040193; Waikhom R, 2012, RENAL FAILURE, V34, P271, DOI 10.3109/0886022X.2011.647297; WARRELL DA, 1977, Q J MED, V46, P33; WARRELL DA, 1986, AM J TROP MED HYG, V35, P1235, DOI 10.4269/ajtmh.1986.35.1235; Warrell DA, 2010, LANCET, V375, P77, DOI 10.1016/S0140-6736(09)61754-2; Watson JA, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008109; WATT G, 1988, AM J TROP MED HYG, V39, P306, DOI 10.4269/ajtmh.1988.39.306; Wedasingha S, 2020, TOXINS, V12, DOI 10.3390/toxins12090583; Westhoff G, 2005, J COMP PHYSIOL A, V191, P873, DOI 10.1007/s00359-005-0010-8; WHO, 2019, SNAK ENV STRAT PREV; Williams DJ, 2018, TOXICON, V150, P1, DOI 10.1016/j.toxicon.2018.05.001; Williams HF, 2019, TOXINS, V11, DOI 10.3390/toxins11060363; Williams SS, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001255; World Health Organization, 2018, WHO TECH REP SER; Young BA, 2004, J EXP BIOL, V207, P3483, DOI 10.1242/jeb.01170	125	1	1	2	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 7	2022	376								e057926	10.1136/bmj-2020-057926	http://dx.doi.org/10.1136/bmj-2020-057926			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YP9GN	34996773	Green Published			2022-12-28	WOS:000748927300003
J	Zhang, ZW; Li, YZ; Xu, R; Zhou, WJ; Li, YB; Oyakhire, ST; Wu, YC; Xu, JW; Wang, HS; Yu, ZA; Boyle, DT; Huang, W; Ye, YS; Chen, H; Wan, JY; Bao, ZN; Chiu, W; Cui, Y				Zhang, Zewen; Li, Yuzhang; Xu, Rong; Zhou, Weijiang; Li, Yanbin; Oyakhire, Solomon T.; Wu, Yecun; Xu, Jinwei; Wang, Hansen; Yu, Zhiao; Boyle, David T.; Huang, William; Ye, Yusheng; Chen, Hao; Wan, Jiayu; Bao, Zhenan; Chiu, Wah; Cui, Yi			Capturing the swelling of solid-electrolyte interphase in lithium metal batteries	SCIENCE			English	Article							ION BATTERIES; INTERFACES; MORPHOLOGY; SPECIMENS; ANODE	Although liquid-solid interfaces are foundational in broad areas of science, characterizing this delicate interface remains inherently difficult because of shortcomings in existing tools to access liquid and solid phases simultaneously at the nanoscale. This leads to substantial gaps in our understanding of the structure and chemistry of key interfaces in battery systems. We adopt and modify a thin film vitrification method to preserve the sensitive yet critical interfaces in batteries at native liquid electrolyte environments to enable cryo-electron microscopy and spectroscopy. We report substantial swelling of the solid-electrolyte interphase (SEI) on lithium metal anode in various electrolytes. The swelling behavior is dependent on electrolyte chemistry and is highly correlated to battery performance. Higher degrees of SEI swelling tend to exhibit poor electrochemical cycling.	[Zhang, Zewen; Li, Yuzhang; Xu, Rong; Li, Yanbin; Xu, Jinwei; Wang, Hansen; Huang, William; Ye, Yusheng; Chen, Hao; Wan, Jiayu; Cui, Yi] Stanford Univ, Dept Mat Sci & Engn, Stanford, CA 94305 USA; [Li, Yuzhang] Univ Calif Los Angeles, Dept Chem & Biomol Engn, Los Angeles, CA 90095 USA; [Zhou, Weijiang; Chiu, Wah] Stanford Univ, Sch Med, Biophys Program, Stanford, CA 94305 USA; [Oyakhire, Solomon T.; Yu, Zhiao; Bao, Zhenan] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; [Wu, Yecun] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA; [Yu, Zhiao; Boyle, David T.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Chiu, Wah] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Chiu, Wah] SLAC Natl Accelerator Lab, Div CryoEM & Bioimaging, SSRL, Menlo Pk, CA 94025 USA; [Cui, Yi] SLAC Natl Accelerator Lab, Stanford Inst Mat & Energy Sci, Menlo Pk, CA 94025 USA	Stanford University; University of California System; University of California Los Angeles; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	Cui, Y (corresponding author), Stanford Univ, Dept Mat Sci & Engn, Stanford, CA 94305 USA.; Chiu, W (corresponding author), Stanford Univ, Sch Med, Biophys Program, Stanford, CA 94305 USA.; Chiu, W (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.; Chiu, W (corresponding author), SLAC Natl Accelerator Lab, Div CryoEM & Bioimaging, SSRL, Menlo Pk, CA 94025 USA.; Cui, Y (corresponding author), SLAC Natl Accelerator Lab, Stanford Inst Mat & Energy Sci, Menlo Pk, CA 94025 USA.	wahc@stanford.edu; yicui@stanford.edu	Ye, Yusheng/ABE-2770-2020; Yu, Zhiao/R-6736-2017; wan, jiayu/AHB-6091-2022; Xu, Rong/W-1112-2018	Ye, Yusheng/0000-0001-9832-2478; Yu, Zhiao/0000-0001-8746-1640; wan, jiayu/0000-0003-4603-3265; Xu, Rong/0000-0002-3694-595X; Wu, Yecun/0000-0001-6011-4489; Wang, Hansen/0000-0002-6738-1659; Bao, Zhenan/0000-0002-0972-1715; Oyakhire, Solomon/0000-0002-3189-5949	Office of Basic Energy Sciences, Division of Materials Science and Engineering, Department of Energy [DE-AC02-76SF00515]; Stanford Interdisciplinary Graduate Fellowship; Stanford University Knight Hennessy scholarship; National Science Foundation [ECCS-2026822]	Office of Basic Energy Sciences, Division of Materials Science and Engineering, Department of Energy(United States Department of Energy (DOE)); Stanford Interdisciplinary Graduate Fellowship; Stanford University Knight Hennessy scholarship; National Science Foundation(National Science Foundation (NSF))	This study received funding from the Office of Basic Energy Sciences, Division of Materials Science and Engineering, Department of Energy, DE-AC02-76SF00515 (to Y.C. and W.C.); the Stanford Interdisciplinary Graduate Fellowship (to Z.Z. and W.Z.); the Stanford University Knight Hennessy scholarship (to S.T.O.); and National Science Foundation award ECCS-2026822.	Adams BD, 2018, ADV ENERGY MATER, V8, DOI 10.1002/aenm.201702097; BARD AJ, 1993, J PHYS CHEM-US, V97, P7147, DOI 10.1021/j100130a007; Cao X, 2019, NAT ENERGY, V4, P796, DOI 10.1038/s41560-019-0464-5; Cheng XB, 2017, CHEM REV, V117, P10403, DOI 10.1021/acs.chemrev.7b00115; Cheng XB, 2016, ADV SCI, V3, DOI 10.1002/advs.201500213; Choi JW, 2016, NAT REV MATER, V1, DOI 10.1038/natrevmats.2016.13; Colby R.H., 2003, POLYM PHYS; Danino D, 2002, J COLLOID INTERF SCI, V249, P180, DOI 10.1006/jcis.2002.8229; Egerton RF, 2019, MICRON, V119, P72, DOI 10.1016/j.micron.2019.01.005; GARREAU M, 1987, J POWER SOURCES, V20, P9, DOI 10.1016/0378-7753(87)80085-X; Gauthier M, 2015, J PHYS CHEM LETT, V6, P4653, DOI 10.1021/acs.jpclett.5b01727; GEJVALL T, 1975, RADIAT EFF DEFECT S, V25, P187, DOI 10.1080/00337577508235388; Guan PJ, 2015, J ELECTROCHEM SOC, V162, pA1798, DOI 10.1149/2.0521509jes; Huang W, 2020, ACS ENERGY LETT, V5, P1128, DOI 10.1021/acsenergylett.0c00194; Huang W, 2019, MATTER-US, V1, P1232, DOI 10.1016/j.matt.2019.09.020; Huang W, 2019, NANO LETT, V19, P5140, DOI 10.1021/acs.nanolett.9b01515; Kranz S, 2019, J POWER SOURCES, V418, P138, DOI 10.1016/j.jpowsour.2019.01.060; LEAPMAN RD, 1995, ULTRAMICROSCOPY, V59, P71, DOI 10.1016/0304-3991(95)00019-W; Li YZ, 2017, SCIENCE, V358, P506, DOI 10.1126/science.aam6014; Nojabaee M, 2020, SMALL, V16, DOI 10.1002/smll.202000756; Peled E, 2017, J ELECTROCHEM SOC, V164, pA1703, DOI 10.1149/2.1441707jes; Pinson MB, 2013, J ELECTROCHEM SOC, V160, pA243, DOI 10.1149/2.044302jes; Popovic J, 2021, ENERGY TECHNOL-GER, V9, DOI 10.1002/ente.202001056; Qian JF, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7362; Ren XD, 2020, P NATL ACAD SCI USA, V117, P28603, DOI 10.1073/pnas.2010852117; Single F, 2016, PHYS CHEM CHEM PHYS, V18, P17810, DOI 10.1039/c6cp02816k; Stamenkovic VR, 2017, NAT MATER, V16, P57, DOI [10.1038/nmat4738, 10.1038/NMAT4738]; Subramani R, 2020, FRONT MATER, V7, DOI 10.3389/fmats.2020.00212; TAYLOR KA, 1974, SCIENCE, V186, P1036, DOI 10.1126/science.186.4168.1036; Wang LN, 2019, NAT CHEM, V11, P789, DOI 10.1038/s41557-019-0304-z; Wang XF, 2017, NANO LETT, V17, P7606, DOI 10.1021/acs.nanolett.7b03606; Weber R, 2019, NAT ENERGY, V4, P683, DOI 10.1038/s41560-019-0428-9; Xu K, 2014, CHEM REV, V114, P11503, DOI 10.1021/cr500003w; Xu YB, 2020, ACS NANO, V14, P8766, DOI 10.1021/acsnano.0c03344; Yu XW, 2018, ENERG ENVIRON SCI, V11, P527, DOI 10.1039/c7ee02555f; Yu Z, 2020, NAT ENERGY, V5, P526, DOI 10.1038/s41560-020-0634-5; Zachman MJ, 2018, NATURE, V560, P345, DOI 10.1038/s41586-018-0397-3; Zhang ZW, 2021, MATTER-US, V4, DOI 10.1016/j.matt.2020.10.021	38	44	45	191	403	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 7	2022	375	6576					66	+	eabi8703	10.1126/science.abi8703	http://dx.doi.org/10.1126/science.abi8703			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YD3FW	34990230				2022-12-28	WOS:000740261400041
J	Mahase, E				Mahase, Elisabeth			Address staffing crisis to tackle waiting list backlog, say MPs	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		House of Commons Health and Social Care Committee, 2022, CLEAR BACKL CAUS PAN; Mahase E, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n2637; Wise J, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n2980	3	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 6	2022	376								o13	10.1136/bmj.o13	http://dx.doi.org/10.1136/bmj.o13			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YG5VA	34992081	Bronze			2022-12-28	WOS:000742554700003
J	Hargreave, M; Morch, LS; Winther, JF; Schmiegelow, K; Kjaer, SK				Hargreave, Marie; Morch, Lina S.; Winther, Jeanette F.; Schmiegelow, Kjeld; Kjaer, Susanne K.			Association Between Maternal Hormonal Contraception Use and Central Nervous System Tumors in Children	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BRAIN-TUMORS; RISK-FACTORS; CHILDHOOD-CANCER; GLIOMA; WOMEN	IMPORTANCE The incidence of central nervous system (CNS) tumors in children appears to be increasing, yet few risk factors are established. There is limited information regarding whether maternal hormonal contraception use increases this risk. OBJECTIVE To examine the association between maternal hormonal contraception use and CNS tumors in children (<20 years). DESIGN, SETTING, AND PARTICIPANTS In this nationwide cohort study based on population-based registry data, 1 185 063 children born in Denmark between January 1, 1996, and December 31, 2014, were followed up for a diagnosis of a CNS tumor (final follow-up on December 31, 2018). EXPOSURES Maternal hormonal contraception use was analyzed according to any use, regimen (combined/progestin only), and route of administration (oral/nonoral), categorized as recent use (<= 3 months before start and during pregnancy), previous use (>3 months before start of pregnancy), and no use. For injections, implants, and intrauterine devices that are used for a different time period, the categorization was appropriately altered. MAIN OUTCOMES AND MEASURES Hazard ratio (HR) and incidence rate difference (IRD) of CNS tumors diagnosed at younger than 20 years. RESULTS After 15 335 990 person-years of follow-up (mean follow-up, 12.9 years), 725 children were diagnosed with a CNS tumor. The mean age at diagnosis was 7 years, and 342 (47.2%) of the diagnosed children were female. The adjusted incidence rate of CNS tumors per 100 000 person-years was 5.0 for children born to mothers with recent hormonal contraception use (n = 136 022), 4.5 for children born to mothers with previous use (n = 778 843), and 5.3 for children born to mothers with no use (n = 270 198). The corresponding HRs were 0.95 ([95% CI, 0.74-1.23]; 84 children with CNS tumors; IRD, -0.3 [95% CI, -1.6 to 1.0]) for recent use and 0.86 ([95% CI, 0.72-1.02]; 421 children with CNS tumors; IRD, -0.8 [95% CI, -1.7 to 0.0]) for previous use, compared with no use. No statistically significant associations were found for recent or previous use of oral combined, nonoral combined, oral progestin only, or nonoral products compared with no use of hormonal contraception. CONCLUSIONS AND RELEVANCE Among Danish children, there was no statistically significant association between any maternal hormonal contraception use and CNS tumor risk.	[Hargreave, Marie; Morch, Lina S.; Kjaer, Susanne K.] Danish Canc Soc, Virus Lifestyle & Genes, Res Ctr, Strandblvd 49, DK-2100 Copenhagen, Denmark; [Morch, Lina S.] Danish Canc Soc, Canc Surveillance & Pharmacoepidemiol, Res Ctr, Copenhagen, Denmark; [Winther, Jeanette F.] Danish Canc Soc, Childhood Canc Res Grp, Res Ctr, Copenhagen, Denmark; [Winther, Jeanette F.] Aarhus Univ, Fac Hlth, Dept Clin Med, Aarhus, Denmark; [Winther, Jeanette F.] Univ Hosp, Aarhus, Denmark; [Schmiegelow, Kjeld] Rigshosp, Juliane Marie Ctr, Pediat & Adolescent Med, Copenhagen, Denmark; [Schmiegelow, Kjeld] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark; [Schmiegelow, Kjeld] Rigshosp, Juliane Marie Ctr, Pediat Clin, Copenhagen, Denmark; [Kjaer, Susanne K.] Rigshosp, Dept Gynecol, Copenhagen, Denmark	Danish Cancer Society; Danish Cancer Society; Danish Cancer Society; Aarhus University; Aarhus University; Rigshospitalet; University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen	Hargreave, M (corresponding author), Danish Canc Soc, Virus Lifestyle & Genes, Res Ctr, Strandblvd 49, DK-2100 Copenhagen, Denmark.	mariehar@cancer.dk		Morch, Lina/0000-0001-6506-2569; Schmiegelow, Kjeld/0000-0002-0829-4993	Danish Cancer Research Foundation; Arvid Nilssons Foundation; Gangsted Foundation; Harboe Foundation; Johannes Clemmesens Foundation	Danish Cancer Research Foundation; Arvid Nilssons Foundation; Gangsted Foundation; Harboe Foundation; Johannes Clemmesens Foundation	The study was supported by the Danish Cancer Research Foundation, the Arvid Nilssons Foundation, the Gangsted Foundation, the Harboe Foundation, and the Johannes Clemmesens Foundation.	Andersen L, 2015, BRIT J CLIN PHARMACO, V79, P677, DOI 10.1111/bcp.12535; [Anonymous], 2019, LANCET CHILD ADOLESC, V3, P585, DOI 10.1016/S2352-4642(19)30238-X; [Anonymous], 1979, IARC Monogr Eval Carcinog Risk Chem Hum, V21, P173; [Anonymous], DANISH HEALTHCARE DA; [Anonymous], 1979, SEX HORMONES 2 IARC, V21; Bartlett JW, 2015, STAT METHODS MED RES, V24, P462, DOI 10.1177/0962280214521348; BIRCH J M, 1990, British Journal of Neurosurgery, V4, P17, DOI 10.3109/02688699009000677; Brinton RD, 2008, FRONT NEUROENDOCRIN, V29, P313, DOI 10.1016/j.yfrne.2008.02.001; BUNIN GR, 1994, CANCER EPIDEM BIOMAR, V3, P197; Diaz NF, 2009, J NEUROENDOCRINOL, V21, P730, DOI 10.1111/j.1365-2826.2009.01891.x; Ellis L, 2009, MOL CANCER THER, V8, P1409, DOI 10.1158/1535-7163.MCT-08-0860; GOLD E, 1979, AM J EPIDEMIOL, V109, P309, DOI 10.1093/oxfordjournals.aje.a112684; Grabas MR, 2020, ACTA ONCOL, V59, P588, DOI 10.1080/0284186X.2020.1725239; Hargreave M, 2018, LANCET ONCOL, V19, P1307, DOI 10.1016/S1470-2045(18)30479-0; Hargreave M, 2013, FERTIL STERIL, V100, P150, DOI 10.1016/j.fertnstert.2013.03.017; Harris RM, 2012, MATURITAS, V72, P108, DOI 10.1016/j.maturitas.2012.03.002; Johnson KJ, 2014, CANCER EPIDEM BIOMAR, V23, P2716, DOI 10.1158/1055-9965.EPI-14-0207; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Kristensen J, 1996, J CLIN EPIDEMIOL, V49, P893, DOI 10.1016/0895-4356(96)00018-2; Linet MS, 1996, CANCER CAUSE CONTROL, V7, P437, DOI 10.1007/BF00052670; MCCREDIE M, 1994, INT J CANCER, V56, P6; PARDTHAISONG T, 1988, TERATOLOGY, V38, P51, DOI 10.1002/tera.1420380108; Patel S, 2014, CHILD NERV SYST, V30, P147, DOI 10.1007/s00381-013-2307-1; Servais L, 2002, J INTELL DISABIL RES, V46, P108, DOI 10.1046/j.1365-2788.2002.00360.x; Steliarova-Foucher E, 2005, CANCER-AM CANCER SOC, V103, P1457, DOI 10.1002/cncr.20910; Steliarova-Foucher E, 2018, LANCET ONCOL, V19, P1159, DOI 10.1016/S1470-2045(18)30423-6; Steliarova-Foucher E, 2017, LANCET ONCOL, V18, P719, DOI 10.1016/S1470-2045(17)30186-9; Storm HH, 1997, DAN MED BULL, V44, P535; Sundh KJ, 2014, HUM REPROD, V29, P2050, DOI 10.1093/humrep/deu143; Williams RL, 2000, BIOMETRICS, V56, P645, DOI 10.1111/j.0006-341X.2000.00645.x	30	3	3	2	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 4	2022	327	1					59	66		10.1001/jama.2021.22482	http://dx.doi.org/10.1001/jama.2021.22482			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YF7YT	34982120	Green Published			2022-12-28	WOS:000742019000019
J	Arnold-Forster, A; Moses, JD; Schotland, SV				Arnold-Forster, Agnes; Moses, Jacob D.; Schotland, Samuel, V			Obstacles to Physicians' Emotional Health - Lessons from History	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							BURNOUT		[Arnold-Forster, Agnes] London Sch Hyg & Trop Med, Ctr Hist Publ Hlth, London, England; [Moses, Jacob D.] Johns Hopkins Univ, Ctr Med Humanities & Social Med, Baltimore, MD USA; [Schotland, Samuel, V] Yale Univ, Program Hist Sci & Med, New Haven, CT USA; [Schotland, Samuel, V] Univ Michigan, Sch Med, Ann Arbor, MI USA	University of London; London School of Hygiene & Tropical Medicine; Johns Hopkins University; Yale University; University of Michigan System; University of Michigan	Arnold-Forster, A (corresponding author), London Sch Hyg & Trop Med, Ctr Hist Publ Hlth, London, England.			Moses, Jacob/0000-0001-8089-3870				Eisenstein L, 2018, NEW ENGL J MED, V379, P509, DOI 10.1056/NEJMp1803771; Hoffarth MJ, 2017, HIST HUM SCI, V30, P30, DOI 10.1177/0952695117724929; Legha RK, 2012, J MED HUMANIT, V33, P219, DOI 10.1007/s10912-012-9182-8; Rotenstein LS, 2018, JAMA-J AM MED ASSOC, V320, P1131, DOI 10.1001/jama.2018.12777; Travis J.W, 1977, WELLNESS WORKBOOK GU	5	8	8	3	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 6	2022	386	1					4	7		10.1056/NEJMp2112095	http://dx.doi.org/10.1056/NEJMp2112095		JAN 2022	4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YC1QX	34979069	Green Published			2022-12-28	WOS:000736921400001
J	McCall, C				McCall, Chris			Disrupted care in Papua New Guinea: the harms of COVID-19	LANCET			English	Editorial Material																			0	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN	2022	399	10321					226	227						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YL7AZ	35033215	Green Published, Bronze			2022-12-28	WOS:000746041700009
J	Mahase, E				Mahase, Elisabeth			Covid-19: Is it safe to reduce the self-isolation period?	BMJ-BRITISH MEDICAL JOURNAL			English	News Item								Two years after the covid-19 outbreak began and a year since vaccinations started, many governments are now reducing the length of time people with covid have to isolate. Elisabeth Mahase looks at the evidence behind the different strategies										Centers for Disease Control and Prevention, 2021, CDC UPD SHORT REC IS; Dathan M, 2021, TIMES 1229; Limb M, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n3137; Office of National Statistics, 2021, COR SELF IS TEST POS; Tanne JH, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n3161	5	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 30	2021	375								n3164	10.1136/bmj.n3164	http://dx.doi.org/10.1136/bmj.n3164			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YC3TX	34969702	Bronze			2022-12-28	WOS:000739618400005
J	Sahtoe, DD; Praetorius, F; Courbet, A; Hsia, Y; Wicky, BIM; Edman, NI; Miller, LM; Timmerman, BJR; Decarreau, J; Morris, HM; Kan, A; Bera, AK; Baker, D				Sahtoe, Danny D.; Praetorius, Florian; Courbet, Alexis; Hsia, Yang; Wicky, Basile I. M.; Edman, Natasha, I; Miller, Lauren M.; Timmerman, Bart J. R.; Decarreau, Justin; Morris, Hana M.; Kan, Alex; Bera, Asim K.; Baker, David			Reconfigurable asymmetric protein assemblies through implicit negative design	SCIENCE			English	Article							DE-NOVO DESIGN; COMPUTATIONAL DESIGN; ALGORITHMS; MECHANISM; SHAPE	Asymmetric multiprotein complexes that undergo subunit exchange play central roles in biology but present a challenge for design because the components must not only contain interfaces that enable reversible association but also be stable and well behaved in isolation. We use implicit negative design to generate p sheet-mediated heterodimers that can be assembled into a wide variety of complexes. The designs are stable, folded, and soluble in isolation and rapidly assemble upon mixing, and crystal structures are close to the computational models. We construct linearly arranged hetero-oligomers with up to six different components, branched hetero-oligomers, closed C4-symmetric two-component rings, and hetero-oligomers assembled on a cyclic homo-oligomeric central hub and demonstrate that such complexes can readily reconfigure through subunit exchange. Our approach provides a general route to designing asymmetric reconfigurable protein systems.	[Sahtoe, Danny D.; Praetorius, Florian; Courbet, Alexis; Hsia, Yang; Wicky, Basile I. M.; Edman, Natasha, I; Miller, Lauren M.; Timmerman, Bart J. R.; Decarreau, Justin; Morris, Hana M.; Kan, Alex; Bera, Asim K.; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Sahtoe, Danny D.; Praetorius, Florian; Courbet, Alexis; Hsia, Yang; Wicky, Basile I. M.; Edman, Natasha, I; Miller, Lauren M.; Timmerman, Bart J. R.; Decarreau, Justin; Morris, Hana M.; Kan, Alex; Bera, Asim K.; Baker, David] Univ Washington, Inst Prot Design, Seattle, WA 98195 USA; [Sahtoe, Danny D.; Courbet, Alexis; Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Edman, Natasha, I] Univ Washington, Mol & Cellular Biol Grad Program, Seattle, WA 98195 USA; [Edman, Natasha, I] Univ Washington, Med Scientist Training Program, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Baker, D (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.; Baker, D (corresponding author), Univ Washington, Inst Prot Design, Seattle, WA 98195 USA.; Baker, D (corresponding author), Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA.	dabaker@uw.edu	Timmermans, Bart/HIR-7358-2022	Timmermans, Bart/0000-0002-4837-0372; , Lauren/0000-0001-5935-4549; Wicky, Basile I. M./0000-0002-2501-7875; Hsia, Yang/0000-0001-7467-8373; Courbet, Alexis/0000-0003-0539-7011; Decarreau, Justin/0000-0001-8996-7741; Edman, Natasha/0000-0002-7315-7127; Praetorius, Florian/0000-0002-0806-8101	EMBO long term fellowship [ALTF 1295-2015, ALTF 139-2018]; Washington Research Foundation Innovation Fellowship; Human Frontiers Science Program long term fellowship; DARPA Biostasis [HR001118S0034]; Open Philanthropy Project Improving Protein Design Fund; Audacious Project at the Institute for Protein Design; Howard Hughes Medical Research Institute; NIH Resource for Native Mass Spectrometry Guided Structural Biology [P41 GM128577]	EMBO long term fellowship(European Molecular Biology Organization (EMBO)); Washington Research Foundation Innovation Fellowship; Human Frontiers Science Program long term fellowship; DARPA Biostasis; Open Philanthropy Project Improving Protein Design Fund; Audacious Project at the Institute for Protein Design; Howard Hughes Medical Research Institute(Howard Hughes Medical Institute); NIH Resource for Native Mass Spectrometry Guided Structural Biology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by EMBO long term fellowship ALTF 1295-2015 and ALTF 139-2018 (D.D.S. and B.I.M.W.); Washington Research Foundation Innovation Fellowship (D.D.S.); Human Frontiers Science Program long term fellowship (F.P. and A.C.); DARPA Biostasis HR001118S0034 (Y.H. and D.B.); Open Philanthropy Project Improving Protein Design Fund (D.B., F.P., A.K.B., and A.K.); The Audacious Project at the Institute for Protein Design (L.M.M., H.M.M., B.J.R.T., and N.I.E.); Eric and Wendy Schmidt by recommendation of the Schmidt Futures (D.B. and Y.H.); The Howard Hughes Medical Research Institute (D.B. and A.C.); and NIH Resource for Native Mass Spectrometry Guided Structural Biology P41 GM128577 (V. Wysocki, Ohio State University).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alford RF, 2017, J CHEM THEORY COMPUT, V13, P3031, DOI 10.1021/acs.jctc.7b00125; Ben-Sasson AJ, 2021, NATURE, V589, P468, DOI 10.1038/s41586-020-03120-8; Bhardwaj G, 2016, NATURE, V538, P329, DOI 10.1038/nature19791; Boyken SE, 2016, SCIENCE, V352, P680, DOI 10.1126/science.aad8865; Broz P, 2016, NAT REV IMMUNOL, V16, P407, DOI 10.1038/nri.2016.58; Brunette TJ, 2020, P NATL ACAD SCI USA, V117, P8870, DOI 10.1073/pnas.1908768117; Brunette TJ, 2015, NATURE, V528, P580, DOI 10.1038/nature16162; Burgers PMJ, 2017, ANNU REV BIOCHEM, V86, P417, DOI 10.1146/annurev-biochem-061516-044709; Chen ZB, 2020, SCIENCE, V368, P78, DOI 10.1126/science.aay2790; Chen ZB, 2019, NATURE, V565, P106, DOI 10.1038/s41586-018-0802-y; Chevalier A, 2017, NATURE, V550, P74, DOI 10.1038/nature23912; Coventry B, 2021, PLOS COMPUT BIOL, V17, DOI 10.1371/journal.pcbi.1008061; Dang B, 2019, NAT METHODS, V16, P319, DOI 10.1038/s41592-019-0357-3; Dang BB, 2017, P NATL ACAD SCI USA, V114, P10852, DOI 10.1073/pnas.1710695114; Divine Robby, 2021, Science, V372, DOI [10.1101/2020.12.01.406611, 10.1126/science.abd9994]; Doyle L, 2015, NATURE, V528, P585, DOI 10.1038/nature16191; Edgell CL, 2020, ACS SYNTH BIOL, V9, P427, DOI 10.1021/acssynbio.9b00453; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engel C, 2018, ANNU REV BIOPHYS, V47, P425, DOI 10.1146/annurev-biophys-070317-033058; Fleishman SJ, 2012, CELL, V149, P262, DOI 10.1016/j.cell.2012.03.016; Fleishman SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020161; Gonen S, 2015, SCIENCE, V348, P1365, DOI 10.1126/science.aaa9897; Gradisar H, 2011, J PEPT SCI, V17, P100, DOI 10.1002/psc.1331; Havranek JJ, 2003, NAT STRUCT BIOL, V10, P45, DOI 10.1038/nsb877; Hosseinzadeh P, 2017, SCIENCE, V358, P1461, DOI 10.1126/science.aap7577; Hsia Y, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22276-z; Hsia Y, 2016, NATURE, V535, P136, DOI 10.1038/nature18010; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; King NP, 2014, NATURE, V510, P103, DOI 10.1038/nature13404; Koepnick B, 2019, NATURE, V570, P390, DOI 10.1038/s41586-019-1274-4; Koga N, 2012, NATURE, V491, P222, DOI 10.1038/nature11600; Langeberg LK, 2015, NAT REV MOL CELL BIO, V16, P232, DOI 10.1038/nrm3966; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Leaver-Fay A, 2016, STRUCTURE, V24, P641, DOI 10.1016/j.str.2016.02.013; Leaver-Fay A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020937; Leman JK, 2020, NAT METHODS, V17, P665, DOI 10.1038/s41592-020-0848-2; Lin YR, 2015, P NATL ACAD SCI USA, V112, pE5478, DOI 10.1073/pnas.1509508112; Lydeard JR, 2013, EMBO REP, V14, P1050, DOI 10.1038/embor.2013.173; Mariani V, 2013, BIOINFORMATICS, V29, P2722, DOI 10.1093/bioinformatics/btt473; Marty MT, 2015, ANAL CHEM, V87, P4370, DOI 10.1021/acs.analchem.5b00140; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nannenga Brent L, 2013, Curr Protoc Protein Sci, VChapter 17, DOI 10.1002/0471140864.ps1715s72; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Remaut H, 2006, TRENDS BIOCHEM SCI, V31, P436, DOI 10.1016/j.tibs.2006.06.007; Sahtoe D. D., 2021, ZENODO, DOI [10.5281/zenodo.5717329, DOI 10.5281/ZENODO.5717329]; Sahtoe DD, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2021569118; Schroeder HW, 2010, J ALLERGY CLIN IMMUN, V125, pS41, DOI 10.1016/j.jaci.2009.09.046; Stranges PB, 2011, P NATL ACAD SCI USA, V108, P20562, DOI 10.1073/pnas.1115124108; Tusk SE, 2018, J MOL BIOL, V430, P4557, DOI 10.1016/j.jmb.2018.06.039; Tyka MD, 2011, J MOL BIOL, V405, P607, DOI 10.1016/j.jmb.2010.11.008; VanAernum ZL, 2020, NAT PROTOC, V15, P1132, DOI 10.1038/s41596-019-0281-0; Vulovic I, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2015037118; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	60	3	3	14	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2022	375	6578					283	+	eabj7662	10.1126/science.abj7662	http://dx.doi.org/10.1126/science.abj7662			50	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YK2FS	35050655	Green Submitted			2022-12-28	WOS:000745036100025
J	Chawla, N; Anothaisintawee, T; Charoenrungrueangchai, K; Thaipisuttikul, P; McKay, GJ; Attia, J; Thakkinstian, A				Chawla, Natasha; Anothaisintawee, Thunyarat; Charoenrungrueangchai, Kridsada; Thaipisuttikul, Papan; McKay, Gareth J.; Attia, John; Thakkinstian, Ammarin			Drug treatment for panic disorder with or without agoraphobia: systematic review and network meta-analysis of randomised controlled trials	BMJ-BRITISH MEDICAL JOURNAL			English	Review							ANXIETY DISORDERS; SCALE; DEPRESSION; EPIDEMIOLOGY; ESCITALOPRAM; RELIABILITY; STATEMENT; VALIDITY; RISK	OBJECTIVE To identify drug classes and individual selective serotonin reuptake inhibitors (SSRIs) with high rates of remission and low risk of adverse events in the treatment of panic disorder with or without agoraphobia. DESIGN Systematic review and network meta-analysis. DATA SOURCES Embase, Medline, and ClinicalTrials.gov from inception to 17 June 2021. ELIGIBILITY CRITERIA FOR STUDY SELECTION Randomised controlled trials that included adults aged >= 18 years with a diagnosis of panic disorder, compared drugs used to treat the panic disorder, and measured the outcomes of interest, including remissions, dropouts, and adverse events. METHODS Risk of bias in the included studies was assessed using the revised Cochrane risk of bias tool for randomised trials. Direct meta-analyses were performed using random effects models. A two stage network meta-analysis with surface under the cumulative ranking curve (SUCRA) was used to estimate the comparative efficacy of drug classes and individual SSRIs. RESULTS 87 studies including a total of 12 800 participants and 12 drug classes were eligible for inclusion. Almost all the studies (86/87) had some concern or were at high risk of bias. Network meta-analysis of remission with consistent results indicated that tricyclic antidepressants, benzodiazepines, monoamine oxidase inhibitors, SSRIs, and serotonin-noradrenaline reuptake inhibitors (SNRIs) were associated with significantly higher remission rates than placebo, with risk ratios of 1.39 (95% confidence interval 1.26 to 1.54), 1.47 (1.36 to 1.60), 1.30 (1.00 to 1.69), 1.38 (1.26 to 1.50), and 1.27 (1.12 to 1.45), respectively. SUCRAs identified benzodiazepines (84.5%, mean rank=2.4), tricyclic antidepressants (68.7%, 3.8), and SSRIs (66.4%, 4.0) as the top three best treatments for remission. However, tricyclic antidepressants, benzodiazepines, and SSRIs were also significantly associated with increased risk of adverse events compared with placebo, with risk ratios of 1.79 (1.47 to 2.19), 1.76 (1.50 to 2.06), and 1.19 (1.01 to 1.41), respectively. Consistency assumption of adverse events was upheld but could still be present on removal of studies with high percentages of women participants and those with agoraphobia. A SUCRA cluster ranking plot considering both remission and adverse events among all drug classes indicated that SSRIs were associated with high remission and low risk of adverse events. Among individual SSRIs, sertraline and escitalopram provided high remission with an acceptable risk of adverse events. CONCLUSION The findings suggest that SSRIs provide high rates of remission with low risk of adverse events for the treatment of panic disorder. Among SSRIs, sertraline and escitalopram were associated with high remission and low risk of adverse events. The findings were, however, based on studies of moderate to very low certainty levels of evidence, mostly as a result of within study bias, inconsistency, and imprecision of the findings reported. SYSTEMATIC REVIEW REGISTRATION PROSPERO CRD42020180638.	[Chawla, Natasha; Anothaisintawee, Thunyarat; Charoenrungrueangchai, Kridsada] Mahidol Univ, Ramathibodi Hosp, Dept Family Med, Fac Med, Bangkok, Thailand; [Anothaisintawee, Thunyarat; Thakkinstian, Ammarin] Mahidol Univ, Ramathibodi Hosp, Dept Clin Epidemiol & Biostat, Fac Med, Bangkok, Thailand; [Thaipisuttikul, Papan] Mahidol Univ, Ramathibodi Hosp, Dept Psychiat, Fac Med, Bangkok, Thailand; [McKay, Gareth J.] Queens Univ Belfast, Sch Med Dent & Biomed Sci, Ctr Publ Hlth, Belfast, Antrim, North Ireland; [Attia, John] Univ Newcastle, Sch Med & Publ Hlth, Callaghan, NSW, Australia	Mahidol University; Mahidol University; Mahidol University; Queens University Belfast; University of Newcastle	Anothaisintawee, T (corresponding author), Mahidol Univ, Ramathibodi Hosp, Dept Family Med, Fac Med, Bangkok, Thailand.; Anothaisintawee, T (corresponding author), Mahidol Univ, Ramathibodi Hosp, Dept Clin Epidemiol & Biostat, Fac Med, Bangkok, Thailand.	thunyarat.ano@mahidol.ac.th	McKay, Gareth/AAZ-2601-2020	McKay, Gareth/0000-0001-8197-6280				Amer Psychiat Assoc, 1998, AM J PSYCHIAT, V155, P1; American Psychiatric Association, 2010, PRACT GUID TREATM PA; Baldwin DS, 2014, J PSYCHOPHARMACOL, V28, P403, DOI 10.1177/0269881114525674; Ballenger JC, 1998, J CLIN PSYCHIAT, V59, P47; Bandelow B, 2015, DIALOGUES CLIN NEURO, V17, P327; Bighelli I, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010676.pub2; Bighelli I, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011567.pub2; Breilmann J, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010677.pub2; Bruce SE, 2003, AM J PSYCHIAT, V160, P1432, DOI 10.1176/appi.ajp.160.8.1432; Chaimani A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076654; Chen YH, 2010, CAN J PSYCHIAT, V55, P43, DOI 10.1177/070674371005500107; da Costa BR, 2014, EUR HEART J, V35, P3336, DOI 10.1093/eurheartj/ehu424; de Jonge P, 2016, DEPRESS ANXIETY, V33, P1155, DOI 10.1002/da.22572; FEIGHNER JP, 1972, ARCH GEN PSYCHIAT, V26, P57, DOI 10.1001/archpsyc.1972.01750190059011; Gomez-Caminero A, 2005, PSYCHOSOM MED, V67, P688, DOI 10.1097/01.psy.0000174169.14227.1f; Hasnain M, 2013, J PSYCHIATR NEUROSCI, V38, pE11, DOI 10.1503/jpn.130055; Higgins JPT, 2012, RES SYNTH METHODS, V3, P98, DOI 10.1002/jrsm.1044; Hutton B, 2015, ANN INTERN MED, V162, P777, DOI 10.7326/M14-2385; Jackson D, 2016, RES SYNTH METHODS, V7, P329, DOI 10.1002/jrsm.1188; Lam RW, 2013, J PSYCHIATR NEUROSCI, V38, pE5, DOI 10.1503/jpn.120256; Liu Y, 2016, LARYNGOSCOPE, V126, P951, DOI 10.1002/lary.25688; MAIER W, 1988, J AFFECT DISORDERS, V14, P61, DOI 10.1016/0165-0327(88)90072-9; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Muller MJ, 2003, J AFFECT DISORDERS, V77, P255, DOI 10.1016/S0165-0327(02)00120-9; National Institute for Health and Care Excellence, 2011, CG113 NICE; Nikolakopoulou A, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003082; Reynolds WM, 1995, PSYCHOL ASSESSMENT, V7, P472; Ribeiro L, 2001, BRAZ J MED BIOL RES, V34, P1303, DOI 10.1590/S0100-879X2001001000010; Sherbourne CD, 2010, PSYCHOL MED, V40, P2059, DOI 10.1017/S0033291710000176; Stahl SM, 2003, J CLIN PSYCHIAT, V64, P1322, DOI 10.4088/JCP.v64n1107; Sterne JAC, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l4898; Sub Laban T., 2020, MONOAMINE OXIDASE IN; Turner RM, 2012, INT J EPIDEMIOL, V41, P818, DOI 10.1093/ije/dys041; West SL., 2010, COMP EFFECTIVENESS R; WESTHUIS D, 1989, EDUC PSYCHOL MEAS, V49, P153, DOI 10.1177/0013164489491016; Xu C, 2021, J CLIN EPIDEMIOL, V135, P70, DOI 10.1016/j.jclinepi.2021.02.012	36	4	4	3	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 19	2022	376								e066084	10.1136/bmj-2021-066084	http://dx.doi.org/10.1136/bmj-2021-066084			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YL6WC	35045991	hybrid, Green Published			2022-12-28	WOS:000746028500005
J	Berger, JS; Kornblith, LZ; Gong, MN; Reynolds, HR; Cushman, M; Cheng, Y; McVerry, BJ; Kim, KS; Lopes, RD; Atassi, B; Berry, S; Bochicchio, G; Antunes, MD; Farkouh, ME; Greenstein, Y; Hade, EM; Hudock, K; Hyzy, R; Khatri, P; Kindzelski, A; Kirwan, BA; Kreuziger, LB; Lawler, PR; Leifer, E; Moreno, JLS; Lopez-Sendon, J; Luther, JF; Maia, LN; Quigley, J; Sherwin, R; Wahid, L; Wilson, J; Hochman, JS; Neal, MD				Berger, Jeffrey S.; Kornblith, Lucy Z.; Gong, Michelle N.; Reynolds, Harmony R.; Cushman, Mary; Cheng, Yu; McVerry, Bryan J.; Kim, Keri S.; Lopes, Renato D.; Atassi, Bassel; Berry, Scott; Bochicchio, Grant; Antunes, Murillo de Oliveira; Farkouh, Michael E.; Greenstein, Yonatan; Hade, Erinn M.; Hudock, Kristin; Hyzy, Robert; Khatri, Pooja; Kindzelski, Andrei; Kirwan, Bridget-Anne; Kreuziger, Lisa Baumann; Lawler, Patrick R.; Leifer, Eric; Moreno, Jose Lopez-Sendon; Lopez-Sendon, Jose; Luther, James F.; Maia, Lilia Nigro; Quigley, John; Sherwin, Robert; Wahid, Lana; Wilson, Jennifer; Hochman, Judith S.; Neal, Matthew D.		ACTIV-4a Investigators	Effect of P2Y12 Inhibitors on Survival Free of Organ Support Among Non-Critically Ill Hospitalized Patients With COVID-19 A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								IMPORTANCE Platelets represent a potential therapeutic target for improved clinical outcomes in patients with COVID-19. OBJECTIVE To evaluate the benefits and risks of adding a P2Y12 inhibitor to anticoagulant therapy among non-critically ill patients hospitalized for COVID-19. DESIGN, SETTING, AND PARTICIPANTS An open-label, bayesian, adaptive randomized clinical trial including 562 non-critically ill patients hospitalized for COVID-19 was conducted between February 2021 and June 2021 at 60 hospitals in Brazil, Italy, Spain, and the US. The date of final 90-day follow-up was September 15, 2021. INTERVENTIONS Patients were randomized to a therapeutic dose of heparin plus a P2Y12 inhibitor (n = 293) or a therapeutic dose of heparin only (usual care) (n = 269) in a 1:1 ratio for 14 days or until hospital discharge, whichever was sooner. Ticagrelor was the preferred P2Y12 inhibitor. MAIN OUTCOMES AND MEASURES The composite primary outcome was organ support-free days evaluated on an ordinal scale that combined in-hospital death (assigned a value of -1) and, for those who survived to hospital discharge, the number of days free of respiratory or cardiovascular organ support up to day 21 of the index hospitalization (range, -1 to 21 days; higher scores indicate less organ support and better outcomes). The primary safety outcome was major bleeding by 28 days as defined by the International Society on Thrombosis and Hemostasis. RESULTS Enrollment of non-critically ill patients was discontinued when the prespecified criterion for futility was met. All 562 patients who were randomized (mean age, 523 [SD, 13.5] years; 41.5% women) completed the trial and 87% received a therapeutic dose of heparin by the end of study day 1. In the P2Y12 inhibitor group, ticagrelor was used in 63% of patients and clopidogrel in 37%. The median number of organ support-free days was 21 days (IQR, 20-21days) among patients in the P2Y12 inhibitor group and was 21 days (IQR, 21-21 days) in the usual care group (adjusted odds ratio, 0.83 [95% credible interval, 0.55-1.25]; posterior probability of futility [defined as an odds ratio <1.2], 96%). Major bleeding occurred in 6 patients (2.0%) in the P2Y12 inhibitor group and in 2 patients (0.7%) in the usual care group (adjusted odds ratio, 3.31 [95% CI, 0.64-17.2]; P = .15). CONCLUSIONS AND RELEVANCE Among non-critically ill patients hospitalized for COVID-19, the use of a P2Y12 inhibitor in addition to a therapeutic dose of heparin, compared with a therapeutic dose of heparin only, did not result in an increased odds of improvement in organ support-free days within 21days during hospitalization.	[Berger, Jeffrey S.; Reynolds, Harmony R.; Hade, Erinn M.; Hochman, Judith S.] NYU Grossman Sch Med, 530 First Ave,Skirball 9R, New York, NY 10016 USA; [Kornblith, Lucy Z.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Gong, Michelle N.] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Cushman, Mary] Univ Vermont, Coll Med, Burlington, VT USA; [Cheng, Yu; McVerry, Bryan J.; Luther, James F.; Neal, Matthew D.] Univ Pittsburgh, Pittsburgh, PA USA; [Kim, Keri S.; Quigley, John] Univ Illinois, Chicago, IL USA; [Lopes, Renato D.] Duke Univ, Med Ctr, Durham, NC USA; [Atassi, Bassel] OSF Little Co Mary Med Ctr, Evergreen Pk, IL USA; [Berry, Scott] Berry Consultants LLC, Austin, TX USA; [Bochicchio, Grant] Washington Univ, Sch Med, St Louis, MO USA; [Antunes, Murillo de Oliveira] Hosp Univ Sao Francisco Assis, Sao Paulo, Brazil; [Farkouh, Michael E.; Lawler, Patrick R.] Peter Munk Cardiac Ctr, Toronto, ON, Canada; [Greenstein, Yonatan] Rutgers State Univ, New Jersey Med Sch, Newark, NJ USA; [Hudock, Kristin; Khatri, Pooja] Univ Cincinnati, Med Ctr, Cincinnati, OH 45267 USA; [Hyzy, Robert] Univ Michigan, Ann Arbor, MI USA; [Kindzelski, Andrei; Leifer, Eric] NHLBI, Bldg 10, Bethesda, MD 20892 USA; [Kirwan, Bridget-Anne] Socar Res SA, Nyon, Switzerland; [Kreuziger, Lisa Baumann] Vers Blood Res Inst, Milwaukee, WI USA; [Moreno, Jose Lopez-Sendon] Hosp Univ Ramon Y Cajal, Madrid, Spain; [Lopez-Sendon, Jose] Hosp Univ La Paz, Madrid, Spain; [Maia, Lilia Nigro] Fundacao Fac Reg Med Sao Jose Rio Do Preto, Sao Jose Do Rio Preto, Brazil; [Sherwin, Robert] Wayne State Univ, Detroit, MI USA; [Wahid, Lana] Duke Univ Hosp, Durham, NC USA; [Wilson, Jennifer] Stanford Univ, Med Ctr, Stanford, CA 94305 USA	University of California System; University of California San Francisco; Yeshiva University; Albert Einstein College of Medicine; University of Vermont; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Duke University; Washington University (WUSTL); University of Toronto; Peter Munk Cardiac Centre; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; University System of Ohio; University of Cincinnati; University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Hospital Universitario Ramon y Cajal; Hospital Universitario La Paz; Wayne State University; Duke University; Stanford University	Berger, JS (corresponding author), NYU Grossman Sch Med, 530 First Ave,Skirball 9R, New York, NY 10016 USA.	jeffrey.berger@nyulangone.org	Neal, Matthew/GMW-5601-2022; Vallurupalli, Srikanth/H-9413-2019	Neal, Matthew/0000-0001-8931-6236; Vallurupalli, Srikanth/0000-0002-2404-1152; Jimenez, Jose Victor/0000-0002-9209-0327; Gonzalez Juanatey, Jose Ramon/0000-0001-9681-3388; Kim, Keri S./0000-0002-8480-4801; Morin, Haley/0000-0003-1967-7890; Wahid, Lana/0000-0002-2160-3287	National Institutes of Health [1OT2HL156812-01];  [OTA-20-011]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 	This research was funded by agreement 1OT2HL156812-01 with the National Institutes of Health. The ACTIV-4a platform was sponsored by the National Heart, Lung, and Blood Institute and administered through an other transactions authority (OTA-20-011).	Abdulnour REE, 2018, AM J RESP CRIT CARE, V197, P1575, DOI 10.1164/rccm.201712-2530OC; Barnes GD, 2020, HEMATOL-AM SOC HEMAT, P642, DOI 10.1182/hematology.2020000151; Barrett TJ, 2021, J THROMB HAEMOST, V19, P3139, DOI 10.1111/jth.15534; Barrett TJ, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abh2434; Barrett TJ, 2020, CIRC RES, V127, P945, DOI 10.1161/CIRCRESAHA.120.317803; Bilaloglu S, 2020, JAMA-J AM MED ASSOC, V324, P799, DOI 10.1001/jama.2020.13372; Challen R, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n579; Hottz ED, 2020, BLOOD, V136, P1330, DOI 10.1182/blood.2020007252; Kamran H, 2021, JAMA-J AM MED ASSOC, V325, P1545, DOI 10.1001/jama.2021.0716; Koupenova M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09607-x; Lancellotti P, 2019, JAMA CARDIOL, V4, P596, DOI 10.1001/jamacardio.2019.1189; Lawler PR, 2021, NEW ENGL J MED, V385, P790, DOI 10.1056/NEJMoa2105911; Lowenstein CJ, 2020, CIRCULATION, V142, P1609, DOI 10.1161/CIRCULATIONAHA.120.050354; Manne BK, 2020, BLOOD, V136, P1317, DOI 10.1182/blood.2020007214; Newman JD, 2018, J AM COLL CARDIOL, V72, P1856, DOI 10.1016/j.jacc.2018.07.071; Nguyen NT, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.0417; Rapkiewicz AV, 2020, ECLINICALMEDICINE, V24, DOI 10.1016/j.eclinm.2020.100434; RECOVERY Collaborative Group, 2022, Lancet, V399, P143, DOI 10.1016/S0140-6736(21)01825-0; Rodriguez F, 2021, NEW ENGL J MED, V384, P452, DOI 10.1056/NEJMra1607714; Taus F, 2020, ARTERIOSCL THROM VAS, V40, P2975, DOI 10.1161/ATVBAHA.120.315175; Thomas MR, 2015, THROMB HAEMOSTASIS, V114, P490, DOI 10.1160/TH14-12-1068	21	36	37	1	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 18	2022	327	3					227	236		10.1001/jama.2021.23605	http://dx.doi.org/10.1001/jama.2021.23605			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YV9PQ	35040887	Bronze, Green Published			2022-12-28	WOS:000753055100017
J	Bryan, CS; Deshazo, RD; Balch, MW				Bryan, Charles S.; deshazo, Richard D.; Balch, Margaret W.			A Legacy of Scientific Racism: William Osler's "An Alabama Student"	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							JOHN LOCKE; HISTORY	William Osler's essay "An Alabama Student" made John Young Bassett (1804-1851) a widely admired avatar of idealism in medicine. However, Bassett fiercely attacked the idea that all humans are members of the same species (known as monogenesis) and asserted that Black inferiority was a justification for slavery. Antebellum physician-anthropologists bequeathed a legacy of scientific racism that in subtler forms still runs deep in American society, including in the field of medicine.	[Bryan, Charles S.] Univ South Carolina, Sch Med, Dept Med, Columbia, SC 29208 USA; [deshazo, Richard D.] Univ Alabama Birmingham, Sch Med, Dept Med Educ, Birmingham, AL USA; [deshazo, Richard D.] Univ Mississippi, Med Ctr, Dept Med, Jackson, MS 39216 USA; [deshazo, Richard D.] Univ Mississippi, Med Ctr, Dept Pediat, Jackson, MS 39216 USA; [Balch, Margaret W.] Univ Alabama Birmingham, Reynolds Finley Hist Lib, Birmingham, AL USA	University of South Carolina System; University of South Carolina Columbia; University of Alabama System; University of Alabama Birmingham; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; University of Alabama System; University of Alabama Birmingham	Bryan, CS (corresponding author), 6222 Westshore Rd, Columbia, SC 29206 USA.	cboslerian@gmail.com		Balch, Margaret/0000-0002-5592-5575				Anstey PR, 2011, EARLY SCI MED, V16, P379, DOI 10.1163/157338211X594759; Armitage D, 2004, POLIT THEORY, V32, P602, DOI 10.1177/0090591704267122; Bassett John Y, 1851, SO ADVOCATE 1105; Bassett John Y, 1851, DEMOCRAT 1113; Bassett JY., 1848, SCRAPBOOK SLAVERY; Bassett JY, 1848, SCRAPBOOK SLAVERY; Bassett JY], 1847, DEMOCRAT 1215; Bassett JY., 1849, COMMUNICATION 1215; Brewer H, 2017, AM HIST REV, V122, P1038, DOI 10.1093/ahr/122.4.1038; Bryan C S, 1999, Pharos Alpha Omega Alpha Honor Med Soc, V62, P27; Bryan Charles S, 2020, Proc (Bayl Univ Med Cent), V34, P194, DOI 10.1080/08998280.2020.1843380; Bryan Charles S, 2020, Trans Am Clin Climatol Assoc, V131, P335; Bryan CS, 2019, NEW ENGL J MED, V381, P2194, DOI 10.1056/NEJMp1911601; Bryan CS, 2020, W OSLER ENCY, P175; Bryan CS., 2020, W OSLER ENCY, P669; Cerdena JP, 2021, AM J BIOETHICS, V21, P48, DOI 10.1080/15265161.2020.1861383; Coates T.-N., 2015, WORLD ME; DiAngelo R., 2018, WHITE FRAGILITY; Dorr Gregory Michael, 2008, SEGREGATIONS SCI EUG; Eberhardt JenniferL., 2019, BIASED UNCOVERING HI; Elkins DC., 1941, MED REPORTS JY BASSE; Emerson CP, 1926, B INT ASS MED MUSEUM, P294; Gillborn D, 2015, QUAL INQ, V21, P277, DOI 10.1177/1077800414557827; Green A, 2010, B HIST MED, V84, P193, DOI 10.1353/bhm.0.0341; Grzanka PR, 2017, AM J BIOETHICS, V17, P65, DOI 10.1080/15265161.2017.1353179; Henze Brent, 2004, RHETOR REV, V23, P311, DOI DOI 10.1207/s15327981rr2304_2; Hester N, 2020, PSYCHOL SCI, V31, P1013, DOI 10.1177/0956797620929979; Hinshelwood B, 2013, POLIT THEORY, V41, P562, DOI 10.1177/0090591713485446; Horsman R., 1987, J NOTT MOBILE SO PHY; Inskeep S., 2015, JACKSONLAND A JACKSO; Isenberg N., 2016, WHITE TRASH 400 YEAR, P43; John G., 1850, HUNTSVILLE MADISON A; JYB [Bassett JY., 1851, SO Q REV, V4, P206; Mastin CH, 1941, MED REPORTS JY BASSE, P57; Mohsen H, 2020, YALE J BIOL MED, V93, P215; Moss SP, 1969, POES LIT QUARRELS CR; Nott J, 1854, TYPES MANKIND ETHNOL; Nott Josiah, 1851, ESSAY NATURAL HIST M; Osler W, 1932, OW AEQWUANIMITAS OTH, V3rd, P161; Osler W, 1932, OW AEQUANIMITAS OTHE, V3rd, P347; Osler W., 1908, ALABAMA STUDENT OTHE, P159; Osler W., 1908, ALABAMA STUDENT OTHE, P68; Osler W, 1906, COMMUNICATION 0825; Osler W, 1908, ALABAMA STUDENT OTHE, P189; Osler W, 1908, CLARENDON PR, P1; Payne BK, 2021, TRENDS COGN SCI, V25, P927, DOI 10.1016/j.tics.2021.08.001; Persaud N, 2020, CAN MED ASSOC J, V192, pE1414, DOI 10.1503/cmaj.201567; Pettigrew William A., 2013, FREEDOMS DEBT ROYAL; Poe EA., MARGARET; Pritlove C, 2019, LANCET, V393, P502, DOI 10.1016/S0140-6736(18)32267-0; Saini A., 2019, SUPERIOR RETURN RACE; Statistics Canada, 2015, HIST STAT OR POP; Teigen P M, 1986, Bull Can Hist Med, V3, P31; Turner J, 2021, AM SURGEON, V87, P1727, DOI 10.1177/00031348211023418; Wallis F, 1997, CAN MED ASSOC J, V156, P1549; Warner J.H., 1986, THERAPEUTIC PERSPECT; Warner John Harley, 1998, SPIRIT SYSTEM FRENCH; Wilkerson Isabel, 2020, CASTE ORIGINS OUR DI; Wilson Y, 2019, AM J BIOETHICS, V19, P8, DOI 10.1080/15265161.2018.1557275; Young B, JY BASSETT SKETCH WR; Zaidi Z, 2021, ACAD MED, V96, pI, DOI 10.1097/ACM.0000000000004373	61	1	1	2	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN	2022	175	1					114	+		10.7326/M21-3474	http://dx.doi.org/10.7326/M21-3474		JAN 2022	6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	0Y3LO	35038401				2022-12-28	WOS:000745507100001
J	Kuehn, BM				Kuehn, Bridget M.			Vaccine Passports Help Boost Lagging Vaccination Rates	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 18	2022	327	3					209	209						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YV9PQ	35040880	Bronze			2022-12-28	WOS:000753055100003
J	See, I; Lale, A; Marquez, P; Streiff, MB; Wheeler, AP; Tepper, NK; Woo, EJ; Broder, KR; Edwards, KM; Gallego, R; Geller, AI; Jackson, KA; Sharma, S; Talaat, KR; Walter, EB; Akpan, IJ; Ortel, TL; Urrutia, VC; Walker, SC; Yui, JC; Shimabukuro, TT; Mba-Jonas, A; Su, JR; Shay, DK				See, Isaac; Lale, Allison; Marquez, Paige; Streiff, Michael B.; Wheeler, Allison P.; Tepper, Naomi K.; Woo, Emily Jane; Broder, Karen R.; Edwards, Kathryn M.; Gallego, Ruth; Geller, Andrew, I; Jackson, Kelly A.; Sharma, Shashi; Talaat, Kawsar R.; Walter, Emmanuel B.; Akpan, Imo J.; Ortel, Thomas L.; Urrutia, Victor C.; Walker, Shannon C.; Yui, Jennifer C.; Shimabukuro, Tom T.; Mba-Jonas, Adamma; Su, John R.; Shay, David K.			Case Series of Thrombosis With Thrombocytopenia Syndrome After COVID-19 Vaccination-United States, December 2020 to August 2021	ANNALS OF INTERNAL MEDICINE			English	Article							JANSSEN JOHNSON; RISK-FACTORS; DIAGNOSIS	Background: Thrombosis with thrombocytopenia syndrome (TTS) is a potentially life-threatening condition associated with adenoviral-vectored COVID-19 vaccination. It presents similarly to spontaneous heparin-induced thrombocytopenia. Twelve cases of cerebral venous sinus thrombosis after vaccination with the Ad26.COV2.S COVID-19 vaccine (Janssen/Johnson & Johnson) have previously been described. Objective: To describe surveillance data and reporting rates of all reported TTS cases after COVID-19 vaccination in the United States. Design: Case series. Setting: United States. Patients: Case patients receiving a COVID-19 vaccine from 14 December 2020 through 31 August 2021 with thrombocytopenia and thrombosis (excluding isolated ischemic stroke or myocardial infarction) reported to the Vaccine Adverse Event Reporting System. If thrombosis was only in an extremity vein or pulmonary embolism, a positive enzyme-linked immunosorbent assay for antiplatelet factor 4 antibodies or functional heparin-induced thrombocytopenia platelet test result was required. Measurements: Reporting rates (cases per million vaccine doses) and descriptive epidemiology. Results: A total of 57 TTS cases were confirmed after vaccination with Ad26.COV2.S (n = 54) or a messenger RNA (mRNA)- based COVID-19 vaccine (n = 3). Reporting rates for TTS were 3.83 per million vaccine doses (Ad26.COV2.S) and 0.00855 per million vaccine doses (mRNA-based COVID-19 vaccines). The median age of patients with TTS after Ad26.COV2.S vaccination was 44.5 years (range, 18 to 70 years), and 69% of patients were women. Of the TTS cases after mRNA-based COVID-19 vaccination, 2 occurred in men older than 50 years and 1 in a woman aged 50 to 59 years. All cases after Ad26.COV2.S vaccination involved hospitalization, including 36 (67%) with intensive care unit admission. Outcomes of hospitalizations after Ad26.COV2.S vaccination included death (15%), discharge to postacute care (17%), and discharge home (68%). Limitations: Underreporting and incomplete case follow-up. Conclusion: Thrombosis with thrombocytopenia syndrome is a rare but serious adverse event associated with Ad26.COV2.S vaccination. The different demographic characteristics of the 3 cases reported after mRNA-based COVID-19 vaccines and the much lower reporting rate suggest that these cases represent a background rate.	[See, Isaac; Lale, Allison; Marquez, Paige; Tepper, Naomi K.; Broder, Karen R.; Gallego, Ruth; Geller, Andrew, I; Jackson, Kelly A.; Sharma, Shashi; Shimabukuro, Tom T.; Su, John R.; Shay, David K.] Ctr Dis Control & Prevent, COVID 19 Response Team, Atlanta, GA USA; [Streiff, Michael B.; Talaat, Kawsar R.; Urrutia, Victor C.; Yui, Jennifer C.] Johns Hopkins Univ, Baltimore, MD USA; [Wheeler, Allison P.; Edwards, Kathryn M.; Walker, Shannon C.] Vanderbilt Univ, Med Ctr, Nashville, TN USA; [Woo, Emily Jane; Mba-Jonas, Adamma] US FDA, Ctr Biol Evaluat & Res, Silver Spring, MD USA; [Walter, Emmanuel B.; Ortel, Thomas L.] Duke Univ, Sch Med, Durham, NC USA; [Akpan, Imo J.] Columbia Univ, Irving Med Ctr, New York, NY USA	Centers for Disease Control & Prevention - USA; Johns Hopkins University; Vanderbilt University; US Food & Drug Administration (FDA); Duke University; Columbia University; NewYork-Presbyterian Hospital	See, I (corresponding author), 1600 Clifton Rd,HT16-3, Atlanta, GA 30329 USA.	isee@cdc.gov		Sharma, Shashi/0000-0002-3017-0575; Wheeler, Allison/0000-0003-3967-4873; Akpan, Imo/0000-0002-6793-599X; Walker, Shannon/0000-0003-4390-3931	CDC CISA Project [200-201253664-0005, 200-2012-50430-0005, 200-2012-53663-0011, 200-2012-53665-0005]	CDC CISA Project	By CDC CISA Project contracts 200-201253664-0005 to Johns Hopkins University, 200-2012-50430-0005 to Vanderbilt UniversityMedical Center, 200-2012-53663-0011 to Duke University, and 200-2012-53665-0005 to Columbia University.	American Society of Hematology, THROMB THROMB SYNDR; Australian Government Department of Health Therapeutic Goods Administration, 02092021 AUSTR GOV D; Bourguignon A, 2021, NEW ENGL J MED, V385, P720, DOI 10.1056/NEJMoa2107051; Brighton Collaboration, BRIGHT COLL IS COMM; Centers for Disease Control and Prevention, COVID 19 VACC US; Crous-Bou M, 2016, SEMIN THROMB HEMOST, V42, P808, DOI 10.1055/s-0036-1592333; Custers J, 2021, VACCINE, V39, P3081, DOI 10.1016/j.vaccine.2020.09.018; Favaloro EJ, 2022, CLIN CHEM LAB MED, V60, P7, DOI 10.1515/cclm-2021-1039; Greinacher A, RES SQUARE; Greinacher A, 2021, NEW ENGL J MED, V384, P2092, DOI 10.1056/NEJMoa2104840; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Huynh A, 2021, NATURE, V596, P565, DOI 10.1038/s41586-021-03744-4; Klok FA, 2022, LANCET HAEMATOL, V9, pE73, DOI 10.1016/S2352-3026(21)00306-9; Kowarz E, RES SQUARE; Lijfering WM, 2010, BRIT J HAEMATOL, V149, P824, DOI 10.1111/j.1365-2141.2010.08206.x; MacNeil JR, 2021, MMWR-MORBID MORTAL W, V70, P651, DOI 10.15585/mmwr.mm7017e4; Medical Dictionary for Regulatory Activities, WELC MEDDRA; Miller Z, 2021, ASS PRESS; Pavord S, 2021, NEW ENGL J MED, V385, P1680, DOI 10.1056/NEJMoa2109908; Pinkerton JV, 2018, CLIN OBSTET GYNECOL, V61, P260, DOI 10.1097/GRF.0000000000000358; Platton S, 2021, J THROMB HAEMOST, V19, P2007, DOI 10.1111/jth.15362; Public Health Agency of Canada, ADV COMM STAT ACS NA; Rosenblum HG, 2021, MMWR-MORBID MORTAL W, V70, P1094, DOI 10.15585/mmwr.mm7032e4; Sahu KK, 2020, J BLOOD MED, V11, P267, DOI 10.2147/JBM.S232648; Salih F, 2021, NEW ENGL J MED, V385, P2103, DOI 10.1056/NEJMc2112974; Sangli S, 2021, ANN INTERN MED, V174, P1480, DOI 10.7326/L21-0244; Schultz NH, 2021, NEW ENGL J MED, V384, P2124, DOI 10.1056/NEJMoa2104882; Scully M, 2021, NEW ENGL J MED, V384, P2202, DOI 10.1056/NEJMoa2105385; See I, 2021, JAMA-J AM MED ASSOC, V325, P2448, DOI 10.1001/jama.2021.7517; Shay DK, 2021, MMWR-MORBID MORTAL W, V70, P680, DOI 10.15585/mmwr.mm7018e2; Shimabukuro TT, 2015, VACCINE, V33, P4398, DOI 10.1016/j.vaccine.2015.07.035; Solsvik T, 2021, REUTERS 0512; Tiede Andreas, 2021, Blood, DOI 10.1182/blood.2021011958; U.S. Food and Drug Administration, FACT SHEET HEALTHC P; United Kingdom Medicines & Healthcare products Regulatory Agency, RES AN COR VACC WEEK; Vayne C, 2021, NEW ENGL J MED, V385, P376, DOI 10.1056/NEJMc2106383; WALTER U, NEUROLOGY, V2021; Warkentin TE, 2014, BLOOD, V123, P3651, DOI 10.1182/blood-2014-01-549741	38	39	39	1	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR	2022	175	4					513	+		10.7326/M21-4502	http://dx.doi.org/10.7326/M21-4502		JAN 2022	16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	1D1PG	35038274	Green Published, Green Submitted			2022-12-28	WOS:000745532600001
J	Lin, RX; Xu, J; Wei, MY; Wang, YR; Qin, ZY; Liu, Z; Wu, JL; Xiao, K; Chen, B; Park, SM; Chen, G; Atapattu, HR; Graham, KR; Xu, J; Zhu, J; Li, LD; Zhang, CF; Sargent, EH; Tan, HR				Lin, Renxing; Xu, Jian; Wei, Mingyang; Wang, Yurui; Qin, Zhengyuan; Liu, Zhou; Wu, Jinlong; Xiao, Ke; Chen, Bin; Park, So Min; Chen, Gang; Atapattu, Harindi R.; Graham, Kenneth R.; Xu, Jun; Zhu, Jia; Li, Ludong; Zhang, Chunfeng; Sargent, Edward H.; Tan, Hairen			All-perovskite tandem solar cells with improved grain surface passivation	NATURE			English	Article							EFFICIENCY; METHYLAMMONIUM; LIFETIMES	All-perovskite tandem solar cells hold the promise of surpassing the efficiency limits of single-junction solar cells(1-3); however, until now, the best-performing all-perovskite tandem solar cells have exhibited lower certified efficiency than have single-junction perovskite solar cells(4,5). A thick mixed Pb-Sn narrow-bandgap subcell is needed to achieve high photocurrent density in tandem solar cells(6), yet this is challenging owing to the short carrier diffusion length within Pb-Sn perovskites. Here we develop ammonium-cation-passivated Pb-Sn perovskites with long diffusion lengths, enabling subcells that have an absorber thickness of approximately 1.2 mu m. Molecular dynamics simulations indicate that widely used phenethylammonium cations are only partially adsorbed on the surface defective sites at perovskite crystallization temperatures. The passivator adsorption is predicted to be enhanced using 4-trifluoromethyl-phenylammonium (CF3-PA), which exhibits a stronger perovskite surface-passivator interaction than does phenethylammonium. By adding a small amount of CF3-PA into the precursor solution, we increase the carrier diffusion length within Pb-Sn perovskites twofold, to over 5 mu m, and increase the efficiency of Pb-Sn perovskite solar cells to over 22%. We report a certified efficiency of 26.4% in all-perovskite tandem solar cells, which exceeds that of the best-performing single-junction perovskite solar cells. Encapsulated tandem devices retain more than 90% of their initial performance after 600 h of operation at the maximum power point under 1 Sun illumination in ambient conditions. A certified efficiency of 26.4% in all-perovskite tandem solar cells, exceeding that of the best-performing single-junction perovskite solar cells, is achieved by control over surface defects in the Pb-Sn subcell.	[Lin, Renxing; Wang, Yurui; Liu, Zhou; Wu, Jinlong; Xiao, Ke; Zhu, Jia; Li, Ludong; Tan, Hairen] Nanjing Univ, Coll Engn & Appl Sci, Jiangsu Key Lab Artificial Funct Mat, Collaborat Innovat Ctr Adv Microstruct,Natl Lab S, Nanjing, Peoples R China; [Xu, Jian; Wei, Mingyang; Chen, Bin; Park, So Min; Sargent, Edward H.] Univ Toronto, Dept Elect & Comp Engn, Toronto, ON, Canada; [Qin, Zhengyuan; Zhang, Chunfeng] Nanjing Univ, Sch Phys, Nanjing, Peoples R China; [Xiao, Ke] Nanjing Univ, Sch Elect Sci & Engn, Nanjing, Peoples R China; [Chen, Gang] Shanghai Tech Univ, Sch Phys Sci & Technol, Shanghai, Peoples R China; [Atapattu, Harindi R.; Graham, Kenneth R.] Univ Kentucky, Dept Chem, Lexington, KY USA; [Tan, Hairen] Nanjing Univ, Frontiers Sci Ctr Crit Earth Mat Cycling, Nanjing, Peoples R China	Nanjing University; University of Toronto; Nanjing University; Nanjing University; ShanghaiTech University; University of Kentucky; Nanjing University	Tan, HR (corresponding author), Nanjing Univ, Coll Engn & Appl Sci, Jiangsu Key Lab Artificial Funct Mat, Collaborat Innovat Ctr Adv Microstruct,Natl Lab S, Nanjing, Peoples R China.; Sargent, EH (corresponding author), Univ Toronto, Dept Elect & Comp Engn, Toronto, ON, Canada.; Tan, HR (corresponding author), Nanjing Univ, Frontiers Sci Ctr Crit Earth Mat Cycling, Nanjing, Peoples R China.	ted.sargent@utoronto.ca; hairentan@nju.edu.cn	Wei, Mingyang/AAC-1337-2022	Wei, Mingyang/0000-0003-4820-2210	National Key R&D Program of China [2018YFB1500102]; National Natural Science Foundation of China [61974063, 61921005]; Natural Science Foundation of Jiangsu Province [BK20202008, BK20190315]; Technology Innovation Fund of Nanjing University, Fundamental Research Funds for the Central Universities [0213/14380206, 0205/14380252]; Frontiers Science Center for Critical Earth Material Cycling Fund [DLTD2109]; Program A for Outstanding PhD Candidate of Nanjing University; Program for Innovative Talents and Entrepreneur in Jiangsu; US Department of the Navy, Office of Naval Research [N00014-20-1-2572]; Canada Foundation for Innovation under the Compute Canada; US Department of Energy, Office of Basic Energy Sciences [DE-SC0018208]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Technology Innovation Fund of Nanjing University, Fundamental Research Funds for the Central Universities; Frontiers Science Center for Critical Earth Material Cycling Fund; Program A for Outstanding PhD Candidate of Nanjing University; Program for Innovative Talents and Entrepreneur in Jiangsu; US Department of the Navy, Office of Naval Research(Office of Naval Research); Canada Foundation for Innovation under the Compute Canada; US Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE))	This work was financially supported by the National Key R&D Program of China (grant no. 2018YFB1500102), the National Natural Science Foundation of China (grant nos. 61974063 and 61921005), the Natural Science Foundation of Jiangsu Province (grant nos. BK20202008 and BK20190315), the Technology Innovation Fund of Nanjing University, Fundamental Research Funds for the Central Universities (grant nos. 0213/14380206 and 0205/14380252), the Frontiers Science Center for Critical Earth Material Cycling Fund (grant no. DLTD2109), the Program A for Outstanding PhD Candidate of Nanjing University, and the Program for Innovative Talents and Entrepreneur in Jiangsu. The work at the University of Toronto was supported by the US Department of the Navy, Office of Naval Research (grant no. N00014-20-1-2572). SciNet is funded by the Canada Foundation for Innovation under the auspices of Compute Canada. K.R.G., S.M.P. and H.R.A. acknowledge the US Department of Energy, Office of Basic Energy Sciences under grant no. DE-SC0018208 for supporting the photoelectron spectroscopy measurements.	Abate A, 2014, NANO LETT, V14, P3247, DOI 10.1021/nl500627x; Al-Ashouri A, 2020, SCIENCE, V370, P1300, DOI 10.1126/science.abd4016; Albrecht S, 2017, NAT ENERGY, V2, DOI 10.1038/nenergy.2016.196; Aydin E, 2019, ADV MATER, V31, DOI 10.1002/adma.201900428; Chen B, 2019, CHEM SOC REV, V48, P3842, DOI 10.1039/c8cs00853a; Chen JZ, 2020, ACS ENERGY LETT, V5, P2742, DOI 10.1021/acsenergylett.0c01240; Eperon GE, 2016, SCIENCE, V354, P861, DOI 10.1126/science.aaf9717; Gao F, 2020, ADV ENERGY MATER, V10, DOI 10.1002/aenm.201902650; Gao H, 2021, SOL RRL, V5, DOI 10.1002/solr.202100814; Goedecker S, 1996, PHYS REV B, V54, P1703, DOI 10.1103/PhysRevB.54.1703; Green MA, 2015, PROG PHOTOVOLTAICS, V23, P1, DOI 10.1002/pip.2573; Han QL, 2019, SCI BULL, V64, P1399, DOI 10.1016/j.scib.2019.08.002; Hempel H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32695-6; Jiang Q, 2019, NAT PHOTONICS, V13, P460, DOI 10.1038/s41566-019-0398-2; Jost M, 2020, ADV ENERGY MATER, V10, DOI 10.1002/aenm.201904102; Kapil G, 2021, ADV ENERGY MATER, V11, DOI 10.1002/aenm.202101069; Kirchartz T, 2018, ADV ENERGY MATER, V8, DOI 10.1002/aenm.201703385; Kirchartz T, 2015, PHYS CHEM CHEM PHYS, V17, P4007, DOI 10.1039/c4cp05174b; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Kuhne TD, 2020, J CHEM PHYS, V152, DOI 10.1063/5.0007045; Lee K, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.081101; Li CH, 2020, ACS ENERGY LETT, V5, P1386, DOI 10.1021/acsenergylett.0c00634; Li CW, 2020, NAT ENERGY, V5, P768, DOI 10.1038/s41560-020-00692-7; Li ZQ, 2018, JOULE, V2, P1559, DOI 10.1016/j.joule.2018.05.001; Lin RX, 2019, NAT ENERGY, V4, P864, DOI 10.1038/s41560-019-0466-3; Liu H, 2021, ACS ENERGY LETT, V6, P2907, DOI 10.1021/acsenergylett.1c01217; Lu T, 2012, J COMPUT CHEM, V33, P580, DOI 10.1002/jcc.22885; Luo DY, 2020, NAT REV MATER, V5, P44, DOI 10.1038/s41578-019-0151-y; Min H, 2021, NATURE, V598, P444, DOI 10.1038/s41586-021-03964-8; Ni ZY, 2020, SCIENCE, V367, P1352, DOI 10.1126/science.aba0893; NOSE S, 1984, J CHEM PHYS, V81, P511, DOI 10.1063/1.447334; Palmstrom AF, 2019, JOULE, V3, P2193, DOI 10.1016/j.joule.2019.05.009; Park SM, 2020, ACS ENERGY LETT, V5, P799, DOI 10.1021/acsenergylett.0c00054; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Ricciarelli D, 2020, ACS ENERGY LETT, V5, P2787, DOI 10.1021/acsenergylett.0c01174; Santbergen R, 2017, IEEE J PHOTOVOLT, V7, P919, DOI 10.1109/JPHOTOV.2017.2669640; Savill KJ, 2021, ACS ENERGY LETT, V6, P2413, DOI 10.1021/acsenergylett.1c00776; Tong JH, 2019, SCIENCE, V364, P475, DOI 10.1126/science.aav7911; VandeVondele J, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2770708; Walsh A, 2015, ANGEW CHEM INT EDIT, V54, P1791, DOI 10.1002/anie.201409740; Wang R, 2021, NAT PHOTONICS, V15, P411, DOI 10.1038/s41566-021-00809-8; Wang R, 2019, SCIENCE, V366, P1509, DOI 10.1126/science.aay9698; Wehrenfennig C, 2014, ADV MATER, V26, P1584, DOI 10.1002/adma.201305172; Wei MY, 2020, ADV MATER, V32, DOI 10.1002/adma.201907058; Xiao K, 2020, NAT ENERGY, V5, P870, DOI 10.1038/s41560-020-00705-5; Yang Y, 2017, NAT ENERGY, V2, DOI 10.1038/nenergy.2016.207; Yang ZB, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12513-x; Yu ZH, 2020, NAT ENERGY, V5, P657, DOI 10.1038/s41560-020-0657-y; Zong YX, 2018, ADV ENERGY MATER, V8, DOI 10.1002/aenm.201800997	49	147	147	502	841	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 3	2022	603	7899					73	+		10.1038/s41586-021-04372-8	http://dx.doi.org/10.1038/s41586-021-04372-8		JAN 2022	19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZL3UV	35038717				2022-12-28	WOS:000760256700001
J	Steele, A; Benning, LG; Wirth, R; Schreiber, A; Araki, T; McCubbin, FM; Fries, MD; Nittler, LR; Wang, J; Hallis, LJ; Conrad, PG; Conley, C; Vitale, S; O'Brien, AC; Riggi, V; Rogers, K				Steele, A.; Benning, L. G.; Wirth, R.; Schreiber, A.; Araki, T.; McCubbin, F. M.; Fries, M. D.; Nittler, L. R.; Wang, J.; Hallis, L. J.; Conrad, P. G.; Conley, C.; Vitale, S.; O'Brien, A. C.; Riggi, V; Rogers, K.			Organic synthesis associated with serpentinization and carbonation on early Mars	SCIENCE			English	Article							MARTIAN METEORITE ALH84001; ION-BEAM FIB; HYDROGEN GENERATION; RAMAN-SPECTROSCOPY; OPHIOLITE; OXIDES; CRUST; AGE	Water-rock interactions are relevant to planetary habitability, influencing mineralogical diversity and the production of organic molecules. We examine carbonates and silicates in the martian meteorite Allan Hills 84001 (ALH 84001), using colocated nanoscale analyses, to characterize the nature of water-rock reactions on early Mars. We find complex refractory organic material associated with mineral assemblages that formed by mineral carbonation and serpentinization reactions. The organic molecules are colocated with nanophase magnetite; both formed in situ during water-rock interactions on Mars. Two potentially distinct mechanisms of abiotic organic synthesis operated on early Mars during the late Noachian period (3.9 to 4.1 billion years ago).	[Steele, A.; Nittler, L. R.; Wang, J.; Conrad, P. G.; Vitale, S.; Riggi, V] Carnegie Inst Sci, Earth & Planets Lab, Washington, DC 20015 USA; [Benning, L. G.; Wirth, R.; Schreiber, A.] Deutsch GeoForschungsZentrum, D-14473 Potsdam, Germany; [Benning, L. G.] Free Univ Berlin, Dept Earth Sci, D-12249 Berlin, Germany; [Araki, T.] Diamond Light Source, Harwell Sci & Innovat Campus, Didcot OX11 0DE, Oxon, England; [McCubbin, F. M.; Fries, M. D.] NASA Johnson Space Ctr, Houston, TX 77058 USA; [Hallis, L. J.; O'Brien, A. C.] Univ Glasgow, Sch Geog & Earth Sci, Glasgow G12 8QQ, Lanark, Scotland; [Conley, C.] NASA Ames Res Ctr, Mountain View, CA 94035 USA; [Rogers, K.] Rensselaer Polytech Inst, Earth & Environm Sci, Troy, NY 12180 USA	Carnegie Institution for Science; Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences; Free University of Berlin; Diamond Light Source; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; University of Glasgow; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Rensselaer Polytechnic Institute	Steele, A (corresponding author), Carnegie Inst Sci, Earth & Planets Lab, Washington, DC 20015 USA.	asteele@carnegiescience.edu	Vitale, Suzy M/ABC-8870-2021; Wang, Jianhua/D-6500-2011; Benning, Liane G/E-7071-2011; Araki, Tohru/K-9301-2015	Vitale, Suzy M/0000-0002-4036-6619; Wang, Jianhua/0000-0002-7671-2413; Benning, Liane G/0000-0001-9972-5578; Araki, Tohru/0000-0002-2689-4642; O'Brien, Aine Clare/0000-0002-2591-7902; Nittler, Larry/0000-0002-5292-6089; McCubbin, Francis/0000-0002-2101-4431	NASA [17-NAI8_2-0020]; Helmholtz Recruiting Initiative program; NASA's Planetary Science Research Program	NASA(National Aeronautics & Space Administration (NASA)); Helmholtz Recruiting Initiative program; NASA's Planetary Science Research Program	A.St. acknowledges NASA grant 17-NAI8_2-0020 (principal investigator K.R.) and M. Walter (EPL) for travel funding. L.G.B., R.W., and A.St. acknowledge financial support for the TEM work through the Helmholtz Recruiting Initiative program awarded to L.G.B. F.M.M. acknowledges support from NASA's Planetary Science Research Program.	Barnes JJ, 2020, NAT GEOSCI, V13, P260, DOI 10.1038/s41561-020-0552-y; Bjerga A, 2015, LITHOS, V227, P21, DOI 10.1016/j.lithos.2015.03.016; Borg LE, 1999, SCIENCE, V286, P90, DOI 10.1126/science.286.5437.90; Boschi C, 2009, CHEM GEOL, V265, P209, DOI 10.1016/j.chemgeo.2009.03.016; Cody GD, 2011, P NATL ACAD SCI USA, V108, P19171, DOI 10.1073/pnas.1015913108; Cooney TF, 1999, AM MINERAL, V84, P1569; Corrigan CM, 2004, METEORIT PLANET SCI, V39, P17, DOI 10.1111/j.1945-5100.2004.tb00047.x; Daval D, 2010, GEOCHIM COSMOCHIM AC, V74, P2615, DOI 10.1016/j.gca.2010.02.003; de Obeso JC, 2020, PHILOS T R SOC A, V378, DOI 10.1098/rsta.2018.0433; Ehlmann BL, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL042596; Eigenbrode JL, 2018, SCIENCE, V360, P1096, DOI 10.1126/science.aas9185; Eiler JM, 2002, GEOCHIM COSMOCHIM AC, V66, P1285, DOI 10.1016/S0016-7037(01)00847-X; Evans BW, 2008, J PETROL, V49, P1873, DOI 10.1093/petrology/egn050; Frost BR, 2007, J PETROL, V48, P1351, DOI 10.1093/petrology/egm021; FROST BR, 1985, J PETROL, V26, P31, DOI 10.1093/petrology/26.1.31; Grozeva NG, 2020, PHILOS T R SOC A, V378, DOI 10.1098/rsta.2018.0431; Halevy I, 2011, P NATL ACAD SCI USA, V108, P16895, DOI 10.1073/pnas.1109444108; Hauri EH, 2011, SCIENCE, V333, P213, DOI 10.1126/science.1204626; Hitchcock A. P., 2000, AXIS 2000 ANAL XRAY; Holm NG, 2009, GEOCHEM T, V10, DOI 10.1186/1467-4866-10-9; Huang RF, 2019, MINERALS-BASEL, V9, DOI 10.3390/min9110661; Jacobsen C, 2000, J MICROSC-OXFORD, V197, P173, DOI 10.1046/j.1365-2818.2000.00640.x; Klein F, 2013, LITHOS, V178, P55, DOI 10.1016/j.lithos.2013.03.008; Klein F, 2011, LITHOS, V126, P147, DOI 10.1016/j.lithos.2011.07.020; Koike M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15931-4; Lafuente B., 2015, HIGHLIGHTS MINERALOG, P1, DOI DOI 10.1515/9783110417104-003; Lapen TJ, 2010, SCIENCE, V328, P347, DOI 10.1126/science.1185395; Lerotic M, 2014, J SYNCHROTRON RADIAT, V21, P1206, DOI 10.1107/S1600577514013964; Lollar BS, 2002, NATURE, V416, P522, DOI 10.1038/416522a; Lyons JR, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL022161; Mayhew LE, 2013, NAT GEOSCI, V6, P478, DOI [10.1038/ngeo1825, 10.1038/NGEO1825]; McCollom TM, 2007, CHEM REV, V107, P382, DOI 10.1021/cr0503660; McKay DS, 1996, SCIENCE, V273, P924, DOI 10.1126/science.273.5277.924; MITTLEFEHLDT DW, 1994, METEORITICS, V29, P214, DOI 10.1111/j.1945-5100.1994.tb00673.x; NAHON DB, 1982, AM J SCI, V282, P1232, DOI 10.2475/ajs.282.8.1232; Nittler L., IMAGE LARRYS IMAGE P; Paukert AN, 2012, CHEM GEOL, V330, P86, DOI 10.1016/j.chemgeo.2012.08.013; Phillips-Lander CM, 2017, AM MINERAL, V102, P1915, DOI 10.2138/am-2017-6155; Schulte M, 2004, METEORIT PLANET SCI, V39, P1577, DOI 10.1111/j.1945-5100.2004.tb00128.x; Socrates G, 2001, INFRARED RAMAN CHARA; Steele A, 2007, METEORIT PLANET SCI, V42, P1549, DOI 10.1111/j.1945-5100.2007.tb00590.x; Steele A, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aat5118; Steele A, 2012, SCIENCE, V337, P212, DOI 10.1126/science.1220715; Steele A, 2000, METEORIT PLANET SCI, V35, P237, DOI 10.1111/j.1945-5100.2000.tb01772.x; Steele A., 2021, DRYAD, DOI DOI 10.5061/DRYAD.C2FQZ6198; Stephan T, 2003, METEORIT PLANET SCI, V38, P109, DOI 10.1111/j.1945-5100.2003.tb01049.x; Streit E, 2012, CONTRIB MINERAL PETR, V164, P821, DOI 10.1007/s00410-012-0775-z; Thomas-Keprta KL, 2009, GEOCHIM COSMOCHIM AC, V73, P6631, DOI 10.1016/j.gca.2009.05.064; Tomkinson T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3662; Treiman AH, 2003, ASTROBIOLOGY, V3, P369, DOI 10.1089/153110703769016451; TREIMAN AH, 1995, METEORITICS, V30, P294, DOI 10.1111/j.1945-5100.1995.tb01127.x; Treiman AH, 2021, ASTROBIOLOGY, V21, P940, DOI 10.1089/ast.2020.2306; Tsikouras B, 2006, EUR J MINERAL, V18, P243, DOI 10.1127/0935-1221/2006/0018-0243; Viviano CE, 2013, J GEOPHYS RES-PLANET, V118, P1858, DOI 10.1002/jgre.20141; Wang A, 2004, J RAMAN SPECTROSC, V35, P504, DOI 10.1002/jrs.1175; Wang A, 2004, AM MINERAL, V89, P665; Whittaker EJW., 1956, MINERAL MAG, V31, P107, DOI [10.1180/minmag.1956.031.233.01, DOI 10.1180/MINMAG.1956.031.233.01]; Wirth R, 2004, EUR J MINERAL, V16, P863, DOI 10.1127/0935-1221/2004/0016-0863; Wirth R, 2009, CHEM GEOL, V261, P217, DOI 10.1016/j.chemgeo.2008.05.019	59	8	8	20	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2022	375	6577					172	+		10.1126/science.abg7905	http://dx.doi.org/10.1126/science.abg7905			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YG3OI	35025630				2022-12-28	WOS:000742401600029
J	Haase, CB; Brodersen, JB; Billow, J				Haase, Christoffer Bjerre; Brodersen, John Brandt; Billow, Jacob			Sarcopenia: early prevention or overdiagnosis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CONSENSUS; DEFINITION; FRAILTY; ICD-10; HEALTH; BODY		[Haase, Christoffer Bjerre; Brodersen, John Brandt] Univ Copenhagen, Dept Publ Hlth, Ctr Gen Practice, Copenhagen, Denmark; [Brodersen, John Brandt] Primary Hlth Care Res Unit, Copenhagen, Region Zealand, Denmark; [Billow, Jacob] Bispebjerg Hosp, Inst Sports Med, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; Bispebjerg Hospital	Billow, J (corresponding author), Bispebjerg Hosp, Inst Sports Med, Copenhagen, Denmark.	jacob.buelow.02@regionh.dk		Brodersen, John Brandt/0000-0001-9369-3376; Haase, Christoffer Bjerre/0000-0003-3895-518X				ALDERMAN MH, 1990, J CLIN EPIDEMIOL, V43, P195, DOI 10.1016/0895-4356(90)90185-R; Anker SD, 2016, J CACHEXIA SARCOPENI, V7, P512, DOI 10.1002/jcsm.12147; Bahat G, 2018, J NUTR HEALTH AGING, V22, P898, DOI 10.1007/s12603-018-1067-8; Bahat G, 2018, EUR GERIATR MED, V9, P23, DOI 10.1007/s41999-017-0003-5; Barger SD, 2006, J HUM HYPERTENS, V20, P117, DOI 10.1038/sj.jhh.1001950; Bell KJL, 2018, JAMA INTERN MED, V178, P755, DOI 10.1001/jamainternmed.2018.0310; Bloom I, 2018, NUTRIENTS, V10, DOI 10.3390/nu10030308; Brodersen J, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k3494; Brodersen J, 2018, BMJ EVID-BASED MED, V23, P1, DOI 10.1136/ebmed-2017-110886; Campbell WW, 2002, J PHYSIOL-LONDON, V542, P631, DOI 10.1113/jphysiol.2002.020685; Cao L, 2016, J AM MED DIR ASSOC, V17, P675, DOI 10.1016/j.jamda.2016.06.001; Cederholm T, 2015, NESTLE NUTR WORKS SE, V83, P65, DOI 10.1159/000382063; Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025; Cruz-Jentoft AJ, 2019, AGE AGEING, V48, P16, DOI 10.1093/ageing/afy169; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Dent E, 2018, J NUTR HEALTH AGING, V22, P1148, DOI 10.1007/s12603-018-1139-9; Dodds Richard, 2015, Clin Med (Lond), V15 Suppl 6, ps88, DOI 10.7861/clinmedicine.15-6-s88; Doust J, 2017, JAMA INTERN MED, V177, P1020, DOI 10.1001/jamainternmed.2017.1302; Ethgen O, 2017, CALCIFIED TISSUE INT, V100, P229, DOI 10.1007/s00223-016-0220-9; Fielding RA, 2011, J AM MED DIR ASSOC, V12, P249, DOI 10.1016/j.jamda.2011.01.003; Guyatt G., 2015, CUREUS J MED SCIENCE, V3rd ed., DOI DOI 10.7759/CUR; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Gyuricza JV, 2019, J PATIENT-REP OUTCOM, V4, DOI 10.1186/s41687-019-0168-4; Ida S, 2018, J AM MED DIR ASSOC, V19, P685, DOI 10.1016/j.jamda.2018.04.001; Jarvinen TLN, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2088; Larsson L, 2019, PHYSIOL REV, V99, P427, DOI 10.1152/physrev.00061.2017; Lloyd N, 2016, AIM COALITION ANNOUN; Martin Stephen A, 2014, BMJ, V349, pg5432, DOI 10.1136/bmj.g5432; Morley JE, 2015, J CACHEXIA SARCOPENI, V6, P312, DOI 10.1002/jcsm.12079; Morley JE, 2011, J AM MED DIR ASSOC, V12, P403, DOI 10.1016/j.jamda.2011.04.014; Moynihan R, 2019, BMJ EVID-BASED MED, V24, P170, DOI 10.1136/bmjebm-2018-111148; Muscaritoli M, 2010, CLIN NUTR, V29, P154, DOI 10.1016/j.clnu.2009.12.004; Reventlow SD, 2006, SOC SCI MED, V62, P2720, DOI 10.1016/j.socscimed.2005.11.009; Rolland Y, 2011, CLIN GERIATR MED, V27, P423, DOI 10.1016/j.cger.2011.03.008; ROSENBERG IH, 1989, AM J CLIN NUTR, V50, P1231, DOI 10.1093/ajcn/50.5.1231; Rosenberg IH, 1997, J NUTR, V127, pS990, DOI 10.1093/jn/127.5.990S; Steffl M, 2017, CLIN INTERV AGING, V12, P835, DOI 10.2147/CIA.S132940; Studenski SA, 2014, J GERONTOL A-BIOL, V69, P547, DOI 10.1093/gerona/glu010; Vellas B, 2018, J FRALITY AGING, V7, P2, DOI 10.14283/jfa.2017.30; WHO, 2007, WHO TECH REP SER, V935, P1; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1; WILSON JMG, 1968, B OFIC SANIT PANAM, V65, P281	42	3	4	6	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 13	2022	376								e052592	10.1136/bmj-2019-052592	http://dx.doi.org/10.1136/bmj-2019-052592			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZE9IW	35027442	Bronze			2022-12-28	WOS:000759191400001
J	Jbaily, A; Zhou, XD; Liu, J; Lee, TH; Kamareddine, L; Verguet, S; Dominici, F				Jbaily, Abdulrahman; Zhou, Xiaodan; Liu, Jie; Lee, Ting-Hwan; Kamareddine, Leila; Verguet, Stephane; Dominici, Francesca			Air pollution exposure disparities across US population and income groups	NATURE			English	Article							FINE PARTICULATE MATTER; SHORT-TERM EXPOSURE; ENVIRONMENTAL JUSTICE; HOSPITAL ADMISSIONS; MORTALITY; INEQUALITY; PM2.5; HEALTH; TRENDS; ASSOCIATION	Air pollution contributes to the global burden of disease, with ambient exposure to fine particulate matter of diameters smaller than 2.5 mu m (PM2.5) being identified as the fifth-ranking risk factor for mortality globally(1). Racial/ethnic minorities and lower-income groups in the USA are at a higher risk of death from exposure to PM2.5 than are other population/income groups(2-5). Moreover, disparities in exposure to air pollution among population and income groups are known to exist(6-17). Here we develop a data platform that links demographic data (from the US Census Bureau and American Community Survey) and PM2.5 data(18) across the USA. We analyse the data at the tabulation area level of US zip codes (N is approximately 32,000) between 2000 and 2016. We show that areas with higher-than-average white and Native American populations have been consistently exposed to average PM2.5 levels that are lower than areas with higher-than-average Black, Asian and Hispanic or Latino populations. Moreover, areas with low-income populations have been consistently exposed to higher average PM2.5 levels than areas with high-income groups for the years 2004-2016. Furthermore, disparities in exposure relative to safety standards set by the US Environmental Protection Agency(19) and the World Health Organization(20) have been increasing over time. Our findings suggest that more-targeted PM2.5 reductions are necessary to provide all people with a similar degree of protection from environmental hazards. Our study is observational and cannot provide insight into the drivers of the identified disparities.	[Jbaily, Abdulrahman; Verguet, Stephane] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Zhou, Xiaodan; Liu, Jie; Lee, Ting-Hwan] Environm Syst Res Inst, Redlands, CA USA; [Kamareddine, Leila; Dominici, Francesca] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Dominici, Francesca] Harvard Data Sci Initiat, Cambridge, MA 02138 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Jbaily, A (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA.; Dominici, F (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA.; Dominici, F (corresponding author), Harvard Data Sci Initiat, Cambridge, MA 02138 USA.	ajbaily@hsph.harvard.edu; fdominic@hsph.harvard.edu		Dominici, Francesca/0000-0002-9382-0141; Jbaily, Abdulrahman/0000-0001-9378-1819; Kamareddine, Leila/0000-0002-5903-3910	Health Effects Institute [4953- RFA14-3/16-4]; National Institutes of Health [DP2MD012722, P50MD010428]; National Institutes of Health; Yale University [R01MD012769]; National Institute of Environmental Health Sciences [R01 ES028033, R01ES026217, R01AG066793-01, R01ES029950, R01ES028033-S1]; Columbia University [1R01ES030616]; Environmental Protection Agency [83587201-0]; The Climate Change Solutions Fund; Harvard Star Friedman Award	Health Effects Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yale University; National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Columbia University; Environmental Protection Agency(United States Environmental Protection Agency); The Climate Change Solutions Fund; Harvard Star Friedman Award	We thank R. Martin and J. D. Schwartz for providing the air-pollution data; B. Sabbath for cleaning and preparing the data sets; and L. Bennett for comments and discussions. We also thank J. Kodros for his comments on an earlier draft. This work was supported financially by grants from the Health Effects Institute (4953- RFA14-3/16-4), the National Institutes of Health (DP2MD012722, P50MD010428), the National Institutes of Health and Yale University (R01MD012769), the National Institutes of Health and National Institute of Environmental Health Sciences (R01 ES028033, R01ES026217, R01AG066793-01, R01ES029950, R01ES028033-S1), the National Institutes of Health and Columbia University (1R01ES030616), the Environmental Protection Agency (83587201-0), The Climate Change Solutions Fund, and a Harvard Star Friedman Award.	Agyeman J, 2016, ANNU REV ENV RESOUR, V41, P321, DOI 10.1146/annurev-environ-110615-090052; American Psychological Association, RAC ETHN ID; [Anonymous], EPA PROPOSES RETAIN; Auffhammer M, 2009, J ENVIRON ECON MANAG, V58, P15, DOI 10.1016/j.jeem.2008.12.004; Banzhaf S, 2019, J ECON PERSPECT, V33, P185, DOI 10.1257/jep.33.1.185; Beelen R, 2014, LANCET, V383, P785, DOI 10.1016/S0140-6736(13)62158-3; Bell ML, 2013, AM J EPIDEMIOL, V178, P865, DOI 10.1093/aje/kwt090; Bell ML, 2012, ENVIRON HEALTH PERSP, V120, P1699, DOI 10.1289/ehp.1205201; Bell ML, 2008, AM J EPIDEMIOL, V168, P1301, DOI 10.1093/aje/kwn252; Bravo MA, 2017, ENVIRON HEALTH PERSP, V125, P594, DOI 10.1289/EHP257; Clark LP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094431; Cohen AJ, 2017, LANCET, V389, P1907, DOI [10.1016/S0140-6736(17)30505-6, 10.1016/s0140-6736(17)30505-6]; Colmer J, 2020, SCIENCE, V369, P575, DOI 10.1126/science.aaz9353; Crouse DL, 2015, ENVIRON HEALTH PERSP, V123, P1180, DOI 10.1289/ehp.1409276; Currie J., 2020, WHAT CAUSED RACIAL D; Di Q, 2019, ENVIRON INT, V130, DOI 10.1016/j.envint.2019.104909; Di Q, 2017, JAMA-J AM MED ASSOC, V318, P2446, DOI 10.1001/jama.2017.17923; Di Q, 2017, NEW ENGL J MED, V376, P2513, DOI 10.1056/NEJMoa1702747; Di Q, 2016, ENVIRON SCI TECHNOL, V50, P4712, DOI 10.1021/acs.est.5b06121; Dominici F, 2006, JAMA-J AM MED ASSOC, V295, P1127, DOI 10.1001/jama.295.10.1127; Dominici F, 2003, ENVIRON HEALTH PERSP, V111, P39, DOI 10.1289/ehp.5181; Fann N, 2018, ENVIRON RES, V167, P506, DOI 10.1016/j.envres.2018.08.018; Grainger CA, 2012, J PUBLIC ECON, V96, P840, DOI 10.1016/j.jpubeco.2012.06.006; Harper S, 2013, INT J ENV RES PUB HE, V10, P4039, DOI 10.3390/ijerph10094039; Kelly JT, 2021, ENVIRON RES, V196, DOI 10.1016/j.envres.2020.110432; Kioumourtzoglou MA, 2016, EPIDEMIOLOGY, V27, P221, DOI 10.1097/EDE.0000000000000422; Kloog I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088578; Lambert PJ, 2003, J PUBLIC ECON, V87, P1061, DOI 10.1016/S0047-2727(00)00171-7; Levy Jonathan I, 2006, Int J Equity Health, V5, P2, DOI 10.1186/1475-9276-5-2; Liu C, 2019, NEW ENGL J MED, V381, P705, DOI 10.1056/NEJMoa1817364; Makar M, 2017, EPIDEMIOLOGY, V28, P627, DOI 10.1097/EDE.0000000000000690; Meng J, 2019, ENVIRON SCI TECHNOL, V53, P5071, DOI 10.1021/acs.est.8b06875; Mikati I, 2018, AM J PUBLIC HEALTH, V108, P480, DOI [10.2105/AJPH.2017.304297, 10.2105/ajph.2017.304297]; Miranda ML, 2011, INT J ENV RES PUB HE, V8, P1755, DOI 10.3390/ijerph8061755; Mohai P, 2009, ANNU REV ENV RESOUR, V34, P405, DOI 10.1146/annurev.environ.082508-094348; Rosofsky A, 2018, ENVIRON RES, V161, P76, DOI 10.1016/j.envres.2017.10.028; Samet JM, 2000, NEW ENGL J MED, V343, P1742, DOI 10.1056/NEJM200012143432401; Samoli E, 2005, ENVIRON HEALTH PERSP, V113, P88, DOI 10.1289/ehp.7387; Shah ASV, 2013, LANCET, V382, P1039, DOI 10.1016/S0140-6736(13)60898-3; Tessum CW, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abf4491; US Environmental Protection Agency, PROC REV NAT AMB AIR; Wang Y, 2017, EPIDEMIOLOGY, V28, P207, DOI 10.1097/EDE.0000000000000614; World Health Organization, 2005, AIR QUAL GUID GLOB U; Wu X, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aba5692	44	30	30	54	103	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 13	2022	601	7892					228	+		10.1038/s41586-021-04190-y	http://dx.doi.org/10.1038/s41586-021-04190-y			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YF9MG	35022594				2022-12-28	WOS:000742123100014
J	Spitzer, A; Angel, Y; Marudi, O; Zeltser, D; Saiag, E; Goldshmidt, H; Goldiner, I; Stark, M; Halutz, O; Gamzu, R; Slobodkin, M; Amrami, N; Feigin, E; Elbaz, M; Furman, M; Bronstein, Y; Chikly, A; Eshkol, A; Furer, V; Mayer, T; Meijer, S; Melloul, A; Mizrahi, M; Yakubovsky, M; Rosenberg, D; Safir, A; Spitzer, L; Taleb, E; Elkayam, O; Silberman, A; Eviatar, T; Elalouf, O; Levinson, T; Pozyuchenko, K; Itzhaki-Alfia, A; Sprecher, E; Ben-Ami, R; Henig, O				Spitzer, Avishay; Angel, Yoel; Marudi, Or; Zeltser, David; Saiag, Esther; Goldshmidt, Hanoch; Goldiner, Ilana; Stark, Moshe; Halutz, Ora; Gamzu, Ronni; Slobodkin, Marina; Amrami, Nadav; Feigin, Eugene; Elbaz, Meital; Furman, Moran; Bronstein, Yotam; Chikly, Amanda; Eshkol, Anna; Furer, Victoria; Mayer, Talia; Meijer, Suzy; Melloul, Ariel; Mizrahi, Michal; Yakubovsky, Michal; Rosenberg, Dana; Safir, Ari; Spitzer, Liron; Taleb, Eyal; Elkayam, Ori; Silberman, Adi; Eviatar, Tali; Elalouf, Ofir; Levinson, Tal; Pozyuchenko, Katia; Itzhaki-Alfia, Ayelet; Sprecher, Eli; Ben-Ami, Ronen; Henig, Oryan			Association of a Third Dose of BNT162b2 Vaccine With Incidence of SARS-CoV-2 Infection Among Health Care Workers in Israel	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							B.1.617.2	IMPORTANCE Administration of a BNT162b2 booster dose (Pfizer-BioNTech) to fully vaccinated individuals aged 60 years and older was significantly associated with lower risk of SARS-CoV-2 infection and severe illness. Data are lacking on the effectiveness of booster doses for younger individuals and health care workers. OBJECTIVE To estimate the association of a BNT162b2 booster dose with SARS-CoV-2 infections among health care workers who were previously vaccinated with a 2-dose series of BNT162b2. DESIGN, SETTING, AND PARTICIPANTS This was a prospective cohort study conducted at a tertiary medical center in Tel Aviv, Israel. The study cohort included 1928 immunocompetent health care workers who were previously vaccinated with a 2-dose series of BNT162b2, and had enrolled between August 8 and 19, 2021, with final follow-up reported through September 20, 2021. Screening for SARS-CoV-2 infection was performed every 14 days. Anti-spike protein receptor binding domain IgG titers were determined at baseline and 1 month after enrollment. Cox regression with time-dependent analysis was used to estimate hazard ratios of SARS-CoV-2 infection between booster-immunized status and 2-dose vaccinated (booster-nonimmunized) status. EXPOSURES Vaccination with a booster dose of BNT162b2 vaccine. MAIN OUTCOMES AND MEASURES The primary outcome was SARS-CoV-2 infection, as confirmed by reverse transcriptase-polymerase chain reaction. RESULTS Among 1928 participants, the median age was 44 years (IQR, 36-52 years) and 1381 were women (71.6%). Participants completed the 2-dose vaccination series a median of 210 days (IQR, 205-213 days) before study enrollment. A total of 1650 participants (85.6%) received the booster dose. During a median follow-up of 39 days (IQR, 35-41 days), SARS-CoV-2 infection occurred in 44 participants (incidence rate, 60.2 per 100 000 person-days); 31(70.5%) were symptomatic. Five SARS-CoV-2 infections occurred in booster-immunized participants and 39 in booster-nonimmunized participants (incidence rate, 12.8 vs 116 per 100 000 person-days, respectively). In a time-dependent Cox regression analysis, the adjusted hazard ratio of SARS-CoV-2 infection for booster-immunized vs booster-nonimmunized participants was 0.07 (95% CI, 0.02-0.20). CONCLUSIONS AND RELEVANCE Among health care workers at a single center in Israel who were previously vaccinated with a 2-dose series of BNT162b2, administration of a booster dose compared with not receiving one was associated with a significantly lower rate of SARS-CoV-2 infection over a median of 39 days of follow-up. Ongoing surveillance is required to assess durability of the findings.	[Elbaz, Meital; Chikly, Amanda; Meijer, Suzy; Yakubovsky, Michal; Levinson, Tal; Ben-Ami, Ronen; Henig, Oryan] Tel Aviv Sourasky Med Ctr, Dept Infect Dis & Infect Control, Weizmann 6, IL-6423906 Tel Aviv, Israel; [Spitzer, Avishay] Tel Aviv Sourasky Med Ctr, Dept Oncol, Tel Aviv, Israel; [Spitzer, Avishay; Angel, Yoel; Marudi, Or; Zeltser, David; Saiag, Esther; Goldshmidt, Hanoch; Goldiner, Ilana; Stark, Moshe; Halutz, Ora; Gamzu, Ronni; Slobodkin, Marina; Amrami, Nadav; Feigin, Eugene; Elbaz, Meital; Furman, Moran; Bronstein, Yotam; Chikly, Amanda; Eshkol, Anna; Furer, Victoria; Mayer, Talia; Meijer, Suzy; Melloul, Ariel; Mizrahi, Michal; Yakubovsky, Michal; Rosenberg, Dana; Safir, Ari; Spitzer, Liron; Taleb, Eyal; Elkayam, Ori; Silberman, Adi; Eviatar, Tali; Elalouf, Ofir; Levinson, Tal; Itzhaki-Alfia, Ayelet; Sprecher, Eli; Ben-Ami, Ronen; Henig, Oryan] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel; [Spitzer, Avishay] Weizmann Inst Sci, Dept Mol Cell Biol, Rehovot, Israel; [Angel, Yoel] Tel Aviv Sourasky Med Ctr, Dept Anesthesia Pain Management & Intens Care, Tel Aviv, Israel; [Angel, Yoel] Tel Aviv Sourasky Med Ctr, Dept Phys Affairs, Tel Aviv, Israel; [Zeltser, David] Tel Aviv Sourasky Med Ctr, Dept Emergency Med, Tel Aviv, Israel; [Saiag, Esther] Tel Aviv Sourasky Med Ctr, Dept Informat Syst & Operat, Tel Aviv, Israel; [Goldshmidt, Hanoch; Goldiner, Ilana; Stark, Moshe; Halutz, Ora] Tel Aviv Sourasky Med Ctr, Dept Clin Labs, Tel Aviv, Israel; [Gamzu, Ronni] Tel Aviv Sourasky Med Ctr, Tel Aviv, Israel; [Slobodkin, Marina; Amrami, Nadav; Feigin, Eugene; Bronstein, Yotam; Melloul, Ariel; Mizrahi, Michal] Tel Aviv Sourasky Med Ctr, Dept Internal Med D, Tel Aviv, Israel; [Furman, Moran; Eshkol, Anna; Mayer, Talia; Safir, Ari; Spitzer, Liron; Taleb, Eyal; Sprecher, Eli] Tel Aviv Sourasky Med Ctr, Dept Dermatol, Tel Aviv, Israel; [Furer, Victoria; Rosenberg, Dana; Elkayam, Ori; Silberman, Adi; Eviatar, Tali; Elalouf, Ofir] Tel Aviv Sourasky Med Ctr, Dept Rheumatol, Tel Aviv, Israel; [Pozyuchenko, Katia; Itzhaki-Alfia, Ayelet] Tel Aviv Sourasky Med Ctr, Dept Pathol, Tel Aviv, Israel; [Sprecher, Eli] Tel Aviv Sourasky Med Ctr, Dept Res & Dev, Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Weizmann Institute of Science; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center	Henig, O (corresponding author), Tel Aviv Sourasky Med Ctr, Dept Infect Dis & Infect Control, Weizmann 6, IL-6423906 Tel Aviv, Israel.	oryanh@tlvmc.gov.il	Eviatar, Tali/AAT-3616-2021	Eviatar, Tali/0000-0002-2894-4033; Bronstein, Yotam/0000-0002-3026-8724; yakubovsky, michal/0000-0002-1587-7310; Feigin, Eugene/0000-0002-0936-7453	Tel Aviv Sourasky Medical Center; Siemens; Israeli Council for Higher Education via theWeizmann Data Science Research Center; estate of Tully and Michele Plesser	Tel Aviv Sourasky Medical Center; Siemens(Siemens AG); Israeli Council for Higher Education via theWeizmann Data Science Research Center; estate of Tully and Michele Plesser	The study was funded by the Tel Aviv Sourasky Medical Center. Anti-S1-RBD serology laboratory assays were funded and provided by Siemens. Dr A. Spitzer is partially supported by the Israeli Council for Higher Education via theWeizmann Data Science Research Center, and by a research grant from the estate of Tully and Michele Plesser.	Angel Y, 2021, JAMA-J AM MED ASSOC, V325, P2457, DOI 10.1001/jama.2021.7152; Bar-On YM, 2021, NEW ENGL J MED, V385, P1393, DOI 10.1056/NEJMoa2114255; Barda N, 2021, LANCET, V398, P2093, DOI 10.1016/S0140-6736(21)02249-2; Benotmane I, 2021, JAMA-J AM MED ASSOC, V326, P1063, DOI 10.1001/jama.2021.12339; Bergwerk M, 2021, NEW ENGL J MED, V385, P1474, DOI 10.1056/NEJMoa2109072; Brochot E, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.584251; Dagan N, 2021, NEW ENGL J MED, V384, P1412, DOI 10.1056/NEJMoa2101765; Eliakim-Raz N, 2021, JAMA-J AM MED ASSOC, V326, P2203, DOI 10.1001/jama.2021.19885; Fowlkes A, 2021, MMWR-MORBID MORTAL W, V70, P1167, DOI 10.15585/mmwr.mm7034e4; Goldberg Y, 2021, NEW ENGL J MED, V385, pE85, DOI 10.1056/NEJMoa2114228; Haas EJ, 2021, LANCET, V397, P1819, DOI 10.1016/S0140-6736(21)00947-8; Hall VG, 2021, NEW ENGL J MED, V385, P1244, DOI 10.1056/NEJMc2111462; Irsara C, 2021, CLIN CHEM LAB MED, V59, P1453, DOI 10.1515/cclm-2021-0214; Israeli Ministry of Health, IND 3 DOS SARS COV 2; Khoury DS, 2021, NAT MED, V27, P1205, DOI 10.1038/s41591-021-01377-8; Lustig Y, 2021, LANCET RESP MED, V9, P999, DOI 10.1016/S2213-2600(21)00220-4; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; R Project for Statistical Computing, R SOFTW VERS 4 0 3; Ritchie H., 2020, CORONAVIRUS COVID 19; Rosen B, 2021, ISR J HEALTH POLICY, V10, DOI 10.1186/s13584-021-00440-6; Self WH, 2021, MMWR-MORBID MORTAL W, V70, P1337, DOI 10.15585/mmwr.mm7038e1; Siemens Healthineers, UND SARS COV 2 IGG I; Wall EC, 2021, LANCET, V397, P2331, DOI 10.1016/S0140-6736(21)01290-3; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053	24	38	39	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 25	2022	327	4					341	349		10.1001/jama.2021.23641	http://dx.doi.org/10.1001/jama.2021.23641		JAN 2022	9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YV9PW	35006256	Green Published, Bronze			2022-12-28	WOS:000742416500001
J	Croskerry, P				Croskerry, Pat			The Rational Diagnostician and Achieving Diagnostic Excellence	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Croskerry, Pat] Dalhousie Univ, Continuing Profess Dev & Med Educ, Crit Thinking Program, Halifax, NS, Canada	Dalhousie University	Croskerry, P (corresponding author), Halifax Infirm, Continuing Profess Dev & Med Educ, Crit Thinking Program, Fac Med, Ste 355,1796 Summer St, Halifax, NS B3H 3A7, Canada.	pgcxkerry@gmail.com						Abrami PC, 2015, REV EDUC RES, V85, P275, DOI 10.3102/0034654314551063; Croskerry P., 2020, COGNITIVE AUTOPSY RO, DOI [10.1093/med/9780190088743.001.0001, DOI 10.1093/MED/9780190088743.001.0001]; Croskerry P, 2018, MED TEACH, V40, P803, DOI 10.1080/0142159X.2018.1484898; Ely JW, 2014, DIAGNOSIS, V1, P131, DOI 10.1515/dx-2013-0008; Kahneman D., 2021, NOISE FLAW HUMAN JUD; Pinker S., 2021, RATIONALITY WHAT IT; Stanovich KE, 2016, RATIONALITY QUOTIENT: TOWARD A TEST OF RATIONAL THINKING, P1, DOI 10.7551/mitpress/9780262034845.001.0001; Stark M, 2014, CAMB Q HEALTHC ETHIC, V23, P386, DOI 10.1017/S0963180114000061	8	4	4	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 25	2022	327	4					317	318		10.1001/jama.2021.24988	http://dx.doi.org/10.1001/jama.2021.24988		JAN 2022	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YV9PW	34994774				2022-12-28	WOS:000739989000002
J	Drain, PK				Drain, Paul K.			Rapid Diagnostic Testing for SARS-CoV-2	NEW ENGLAND JOURNAL OF MEDICINE			English	Article								Key Clinical Points Rapid Diagnostic Testing for SARS-CoV-2 Rapid diagnostic tests (RDTs) that are authorized by the Food and Drug Administration to diagnose severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection are either nucleic acid amplification tests to detect genes or antigen-based immunoassays to detect proteins of SARS-CoV-2. RDTs are approved for use in persons with symptoms of coronavirus disease 2019 (Covid-19) and in asymptomatic persons who are close contacts of a person with Covid-19 or who have been in a potential high-risk transmission setting. Symptomatic persons should undergo testing as soon as possible, quarantine while awaiting test results, and consider retesting if they have a negative RDT, particularly if they have a high pretest probability of infection. Asymptomatic persons with a known exposure to SARS-CoV-2 should undergo testing 5 to 7 days after exposure, and if the RDT is negative, they should undergo testing again 2 days later. Persons with a known exposure to SARS-CoV-2 who are not fully vaccinated should quarantine while awaiting test results, and persons who test positive should isolate, contact a health care provider or public health department, and inform close contacts about the infection. Rapid Diagnostic Testing for SARS-CoV-2 RDTs for SARS-CoV-2 - either molecular nucleic acid amplification tests or antigen-based immunoassays to detect proteins - are approved for persons with Covid-19 symptoms and asymptomatic persons with known exposure to SARS-CoV-2 or those in a high-transmission setting. Antigen-based tests have lower sensitivity than PCR tests, but they may correlate better with replication-competent virus.	[Drain, Paul K.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Drain, Paul K.] Univ Washington, Dept Med, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Drain, PK (corresponding author), Harborview Med Ctr, Int Clin Res Ctr, 325 9th Ave,Box 359927, Seattle, WA 98104 USA.	pkdrain@uw.edu		Drain, Paul/0000-0002-9569-4097				[Anonymous], 2021, FACT SHEET PRES BID; Arbel R, 2021, NEW ENGL J MED, V385, P2413, DOI 10.1056/NEJMoa2115624; Bar-On YM, 2021, NEW ENGL J MED, V385, P2421, DOI 10.1056/NEJMoa2115926; Bekliz M, 2021, LANCET MICROBE, V2, pE351, DOI 10.1016/S2666-5247(21)00147-6; Brummer LE, 2021, PLOS MED, V18, DOI 10.1371/journal.pmed.1003735; Buitrago-Garcia D, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003346; Bullard J, 2020, CLIN INFECT DIS, V71, P2663, DOI 10.1093/cid/ciaa638; Byambasuren Oyungerel, 2020, J Assoc Med Microbiol Infect Dis Can, V5, P223, DOI 10.3138/jammi-2020-0030; Centers for Disease Control and Prevention, 2021, SYMPT COVID 19; Centers for Disease Control and Prevention, 2021, TEST COVID 19; Corman VM, 2021, LANCET MICROBE, V2, pE311, DOI 10.1016/S2666-5247(21)00056-2; Dinnes J, 2020, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD013705.pub2, 10.1002/14651858.CD013705]; Drain Paul, 2022, Am J Clin Pathol, V157, P602, DOI 10.1093/ajcp/aqab173; Drain PK, 2021, INFECT DIS THER, V10, P753, DOI 10.1007/s40121-021-00413-x; Drain PK, 2020, ECLINICALMEDICINE, V22, DOI 10.1016/j.eclinm.2020.100342; Drain PK, 2014, LANCET INFECT DIS, V14, P239, DOI 10.1016/S1473-3099(13)70250-0; European Centre for Disease Prevention and Control,, 2021, OPT US RAP ANT TESTS; European Commission Directorate-General for Health and Food Safety, 2021, EU HLTH PREP COMM LI; European Commission Joint Research Center, COVID 19 INV DIAGN M; Fajnzylber J, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19057-5; Food and Drug Administration, 2021, EM US AUTH MED DEV; Food and Drug Administration, 2021, SARS COV 2 VIR MUT I; Foundation for Innovative New Diagnostics, TEST DIR; Frediani JK, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-94055-1; Hanson KE., 2021, IDSA GUID DIAGN COVI; He X, 2020, NAT MED, V26, DOI 10.1038/s41591-020-0869-5; Jaaskelainen AE, 2021, J CLIN VIROL, V137, DOI 10.1016/j.jcv.2021.104785; Jones TC, 2021, SCIENCE, V373, P180, DOI 10.1126/science.abi5273; Kissler SM, 2021, NEW ENGL J MED, V385, P2489, DOI 10.1056/NEJMc2102507; Larremore DB, 2021, SCI ADV, V7, DOI [10.1126/sciadv.abd5393, 10.1101/2020.06.22.20136309]; Lee J, 2021, J CLIN VIROL, V144, DOI 10.1016/j.jcv.2021.104985; Lee S, 2020, JAMA INTERN MED, V180, P1447, DOI 10.1001/jamainternmed.2020.3862; Levin EG, 2021, NEW ENGL J MED, V385, pE84, DOI 10.1056/NEJMoa2114583; Lindner AK., 2021, SARS COV 2 VARIANT B, DOI [10.1101/2021.06.15.21258502v1, DOI 10.1101/2021.06.15.21258502V1]; Lindner AK, 2021, EUR RESPIR J, V57, DOI 10.1183/13993003.03961-2020; Love N., 2021, ACCEPTABILITY TESTIN, DOI [10.1101/2021.03.23.21254168v1, DOI 10.1101/2021.03.23.21254168V1]; Martin-Sanchez V, 2021, J CLIN MED, V10, DOI 10.3390/jcm10173854; Mina MJ, 2021, SCIENCE, V371, P126, DOI 10.1126/science.abe9187; Mina MJ, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMp2025631; Pavelka M, 2021, SCIENCE, V372, P635, DOI 10.1126/science.abf9648; Peeling RW, 2021, LANCET INFECT DIS, V21, pE290, DOI 10.1016/S1473-3099(21)00048-7; Pekosz A, 2021, CLIN INFECT DIS, V73, pE2861, DOI 10.1093/cid/ciaa1706; Pray IW, 2021, MMWR-MORBID MORTAL W, V69, P1642, DOI 10.15585/mmwr.mm695152a3; Prince-Guerra JL, 2021, MMWR-MORBID MORTAL W, V70, P100, DOI 10.15585/mmwr.mm7003e3; Qiu XT, 2021, CLIN MICROBIOL INFEC, V27, P511, DOI 10.1016/j.cmi.2021.01.011; Ricks S, 2021, BMC MED, V19, DOI 10.1186/s12916-021-01948-z; Ritchie H, CORONAVIRUS PANDEMIC; WHO, 2021, INT GUID; Wolfel R, 2020, NATURE, V588, pE35, DOI 10.1038/s41586-020-2984-3; World Health Organization, WHO COR COVID 19 DAS; World Health Organization, COR DIS COVID 19 SYM; World Health Organization, 2020, EM US LIST PROC INV; Wu SL, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18272-4; Yadav H, 2021, LANCET GLOB HEALTH, V9, pE1553, DOI 10.1016/S2214-109X(21)00442-3; Young BC, 2021, LANCET, V398, P1217, DOI 10.1016/S0140-6736(21)01908-5	56	32	34	35	51	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 20	2022	386	3					264	272		10.1056/NEJMcp2117115	http://dx.doi.org/10.1056/NEJMcp2117115		JAN 2022	9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YK1UG	34995029	Green Published, Bronze			2022-12-28	WOS:000740009300001
J	Gans, JS; Goldfarb, A; Agrawal, AK; Sennik, S; Stein, J; Rosella, L				Gans, Joshua S.; Goldfarb, Avi; Agrawal, Ajay K.; Sennik, Sonia; Stein, Janice; Rosella, Laura			False-Positive Results in Rapid Antigen Tests for SARS-CoV-2	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Gans, Joshua S.; Goldfarb, Avi; Agrawal, Ajay K.; Stein, Janice; Rosella, Laura] Univ Toronto, Toronto, ON, Canada; [Sennik, Sonia] Creat Destruct Lab, Toronto, ON, Canada	University of Toronto	Gans, JS (corresponding author), Univ Toronto, Rotman Sch Management, 105 St George St, Toronto, ON M5S3E6, Canada.	joshua.gans@utoronto.ca						Kanji JN, 2021, J CLIN MICROBIOL, V59, DOI 10.1128/JCM.01411-21; Kretschmer A, 2022, J INFECTION, V84, P276, DOI 10.1016/j.jinf.2021.08.020; Ogawa T, 2020, J CLIN VIROL, V131, DOI 10.1016/j.jcv.2020.104612	3	17	18	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 1	2022	327	5					485	486		10.1001/jama.2021.24355	http://dx.doi.org/10.1001/jama.2021.24355		JAN 2022	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YV9QB	34994775	Green Published, Bronze			2022-12-28	WOS:000739989000001
J	Turkova, A; White, E; Mujuru, HA; Kekitiinwa, AR; Kityo, CM; Violari, A; Lugemwa, A; Cressey, TR; Musoke, P; Variava, E; Cotton, MF; Archary, M; Puthanakit, T; Behuhuma, O; Kobbe, R; Welch, SB; Bwakura-Dangarembizi, M; Amuge, P; Kaudha, E; Barlow-Mosha, L; Makumbi, S; Ramsagar, N; Ngampiyaskul, C; Musoro, G; Atwine, L; Liberty, A; Musiime, V; Bbuye, D; Ahimbisibwe, GM; Chalermpantmetagul, S; Ali, S; Sarfati, T; Wynne, B; Shakeshaft, C; Colbers, A; Klein, N; Bernays, S; Saidi, Y; Coelho, A; Grossele, T; Compagnucci, A; Giaquinto, C; Rojo, P; DFord; Gibb, DM				Turkova, A.; White, E.; Mujuru, H. A.; Kekitiinwa, A. R.; Kityo, C. M.; Violari, A.; Lugemwa, A.; Cressey, T. R.; Musoke, P.; Variava, E.; Cotton, M. F.; Archary, M.; Puthanakit, T.; Behuhuma, O.; Kobbe, R.; Welch, S. B.; Bwakura-Dangarembizi, M.; Amuge, P.; Kaudha, E.; Barlow-Mosha, L.; Makumbi, S.; Ramsagar, N.; Ngampiyaskul, C.; Musoro, G.; Atwine, L.; Liberty, A.; Musiime, V; Bbuye, D.; Ahimbisibwe, G. M.; Chalermpantmetagul, S.; Ali, S.; Sarfati, T.; Wynne, B.; Shakeshaft, C.; Colbers, A.; Klein, N.; Bernays, S.; Saidi, Y.; Coelho, A.; Grossele, T.; Compagnucci, A.; Giaquinto, C.; Rojo, P.; DFord; Gibb, D. M.		ODYSSEY Trial Team	Dolutegravir as First- or Second-Line Treatment for HIV-1 Infection in Children	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INITIAL TREATMENT; MULTICENTER; EFAVIRENZ; PHASE-3; SAFETY	BACKGROUND Children with human immunodeficiency virus type 1 (HIV-1) infection have limited options for effective antiretroviral treatment (ART). METHODS We conducted an open-label, randomized, noninferiority trial comparing three-drug ART based on the HIV integrase inhibitor dolutegravir with standard care (non-dolutegravir-based ART) in children and adolescents starting first- or second-line ART. The primary end point was the proportion of participants with virologic or clinical treatment failure by 96 weeks, as estimated by the Kaplan-Meier method. Safety was assessed. RESULTS From September 2016 through June 2018, a total of 707 children and adolescents who weighed at least 14 kg were randomly assigned to receive dolutegravir-based ART (350 participants) or standard care (357). The median age was 12.2 years (range, 2.9 to 18.0), the median weight was 30.7 kg (range, 14.0 to 85.0), and 49% of the participants were girls. By design, 311 participants (44%) started first-line ART (with 92% of those in the standard-care group receiving efavirenz-based ART), and 396 (56%) started second-line ART (with 98% of those in the standard-care group receiving boosted protease inhibitor-based ART). The median follow-up was 142 weeks. By 96 weeks, 47 participants in the dolutegravir group and 75 in the standard-care group had treatment failure (estimated probability, 0.14 vs. 0.22; difference, -0.08; 95% confidence interval, -0.14 to -0.03; P = 0.004). Treatment effects were similar with first- and second-line therapies (P = 0.16 for heterogeneity). A total of 35 participants in the dolutegravir group and 40 in the standard-care group had at least one serious adverse event (P = 0.53), and 73 and 86, respectively, had at least one adverse event of grade 3 or higher (P = 0.24). At least one ART-modifying adverse event occurred in 5 participants in the dolutegravir group and in 17 in the standard-care group (P = 0.01). CONCLUSIONS In this trial involving children and adolescents with HIV-1 infection who were starting first- or second-line treatment, dolutegravir-based ART was superior to standard care.	[Turkova, A.; White, E.; Ali, S.; Sarfati, T.; Wynne, B.; Shakeshaft, C.; DFord; Gibb, D. M.] UCL, Inst Clin Trials & Methodol, Clin Trials Unit, MRC, London, England; [Klein, N.] UCL, Great Ormond St Inst Child Hlth, London, England; [Bernays, S.] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London, England; [Welch, S. B.] Univ Hosp Birmingham NHS Fdn Trust, Heartlands Hosp, Birmingham, W Midlands, England; [Mujuru, H. A.; Bwakura-Dangarembizi, M.; Musoro, G.] Univ Zimbabwe, Harare, Zimbabwe; [Kekitiinwa, A. R.; Amuge, P.; Bbuye, D.] Baylor Coll Med, Ft Portal, Uganda; [Lugemwa, A.; Makumbi, S.; Atwine, L.] Joint Clin Res Ctr, Mbarara, Uganda; [Kityo, C. M.; Kaudha, E.; Musiime, V] Joint Clin Res Ctr, Kampala, Uganda; [Musoke, P.; Barlow-Mosha, L.; Ahimbisibwe, G. M.] Makerere Univ, Johns Hopkins Univ Res Collaborat, Kampala, Uganda; [Musiime, V] Makerere Univ, Kampala, Uganda; [Violari, A.; Variava, E.; Ramsagar, N.; Liberty, A.] Univ Witwatersrand, Perinatal HIV Res Unit, Johannesburg, South Africa; [Cotton, M. F.] Stellenbosch Univ, Dept Paediat & Child Hlth, Family Ctr Res Ubuntu, Tygerberg, South Africa; [Archary, M.] Univ KwaZulu Natal, King Edward VIII Hosp, Dept Paediat & Children Hlth, Durban, South Africa; [Behuhuma, O.; Klein, N.] Africa Hlth Res Inst, Durban, South Africa; [Cressey, T. R.; Chalermpantmetagul, S.] Chiang Mai Univ, Fac Associated Med Sci, Inst Rech Dev Res Unit, Program HIV Prevent & Treatment, Chiang Mai, Thailand; [Puthanakit, T.] Chulalongkorn Univ, Fac Med, Bangkok, Thailand; [Puthanakit, T.] Thai Red Cross AIDS Res Ctr, HIV NAT Netherlands Australia Thailand Res Collab, Bangkok, Thailand; [Ngampiyaskul, C.] Prapokklao Hosp, Chanthaburi, Thailand; [Kobbe, R.] Univ Med Ctr Hamburg Eppendorf, Div Infect Dis, Dept Med 1, Hamburg, Germany; [Colbers, A.] Radboud Univ Nijmegen Med Ctr, Radboud Inst Hlth Sci, Dept Pharm, Nijmegen, Netherlands; [Bernays, S.] Univ Sydney, Sch Publ Hlth, Sydney, NSW, Australia; [Saidi, Y.; Coelho, A.; Compagnucci, A.] INSERM, ANRS SC10 US019, Essais Therapeut & Malad Infect, Villejuif, France; [Grossele, T.; Giaquinto, C.] Univ Padua, Penta Fdn, Padua, Italy; [Giaquinto, C.] Univ Padua, Dept Women & Child Hlth, Padua, Italy; [Rojo, P.] Hosp Univ 12 Octubre, Pediat Infect Dis Unit, Madrid, Spain	Medical Research Council Clinical Trials Unit; University of London; University College London; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; Heart of England NHS Foundation Trust; University of Birmingham; University of Zimbabwe; Baylor College of Medicine; Joint Clinic Research Center - United Arab Emirates; Makerere University; Makerere University; University of Witwatersrand; Stellenbosch University; University of Kwazulu Natal; Africa Health Research Institute; Chiang Mai University; Chulalongkorn University; Thai Red Cross Society; University of Hamburg; University Medical Center Hamburg-Eppendorf; Radboud University Nijmegen; University of Sydney; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Padua; University of Padua; Hospital Universitario 12 de Octubre	Turkova, A (corresponding author), UCL, Clin Trials Unit, MRC, London WC1V 6LJ, England.	a.turkova@ucl.ac.uk	Bernays, Sarah/AFT-0369-2022; Colbers, Angela/L-4248-2015; Turkova, Anna/AEQ-9099-2022; Turkova, Anna/AAH-1760-2022; Jourdain, Gonzague/F-9117-2017	Bernays, Sarah/0000-0001-7628-8408; Turkova, Anna/0000-0002-7008-4145; Turkova, Anna/0000-0002-7008-4145; Rau, Cornelius/0000-0002-8173-1096; Archary, Moherndran/0000-0003-3082-9234; Cressey, Tim R./0000-0002-8106-0974; Jourdain, Gonzague/0000-0002-3365-7020; Klein, Nigel/0000-0003-3925-9258; GIAQUINTO, CARLO/0000-0001-9365-0413; Gibb, Diana/0000-0002-9738-5490; Serunjogi, Robert/0000-0002-8694-1359; Munoz-Fernandez/0000-0002-0813-4500				Aboud M, 2019, LANCET INFECT DIS, V19, P253, DOI 10.1016/S1473-3099(19)30036-2; Bollen PDJ, 2020, LANCET HIV, V7, pE533, DOI 10.1016/S2352-3018(20)30189-2; Bourgi K, 2020, J INT AIDS SOC, V23, DOI 10.1002/jia2.25484; Burki T, 2020, LANCET, V396, P1873, DOI 10.1016/S0140-6736(20)32665-9; Calmy A, 2020, LANCET HIV, V7, pE677, DOI 10.1016/S2352-3018(20)30238-1; Committee for Medicinal Products for Human Use (CHMP), 2020, TIV ASS REP; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2020, PROGR START FREE STA; Kanters S, 2020, ECLINICALMEDICINE, V28, DOI 10.1016/j.eclinm.2020.100573; Lee K, 2009, GLOB INST, P1; Moore CL, 2021, BMC INFECT DIS, V21, DOI 10.1186/s12879-020-05672-6; Musaazi J., 2021, VIRT C RETR OPP INF; Nickel K, 2021, BMC INFECT DIS, V21, DOI 10.1186/s12879-021-05850-0; Penazzato M, 2019, LANCET HIV, V6, pE623, DOI 10.1016/S2352-3018(19)30193-6; Sax PE, 2020, CLIN INFECT DIS, V71, P1379, DOI 10.1093/cid/ciz999; Turner B., 2019, 40 ANN C INT SOC CLI; Venter WDF, 2020, LANCET HIV, V7, pE666, DOI 10.1016/S2352-3018(20)30241-1; Venter WDF, 2019, NEW ENGL J MED, V381, P803, DOI 10.1056/NEJMoa1902824; Waalewijn H, 2019, J INT AIDS SOC, V22, P101; Waalewijn H., 2020, C RETR OPP INF CROI; Wensing Annemarie M, 2019, Top Antivir Med, V27, P111; WHO, 2013, CONSOLIDATED GUIDELI; World Health Organization, 2020, JOINT STAT CALL URG; World Health Organization, 2018, UPD REC 1 LIN 2 LIN	23	13	13	1	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 30	2021	385	27					2531	2543		10.1056/NEJMoa2108793	http://dx.doi.org/10.1056/NEJMoa2108793			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XW2YE	34965338	Bronze, Green Published			2022-12-28	WOS:000735490500010
J	Robinson, WH; Steinman, L				Robinson, William H.; Steinman, Lawrence			Epstein-Barr virus and multiple sclerosis	SCIENCE			English	Editorial Material								Infection with Epstein-Barr virus is the trigger for the development of multiple sclerosis	[Robinson, William H.] Stanford Univ, Dept Med, Div Immunol & Rheumatol, Stanford, CA 94305 USA; [Robinson, William H.] VA Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA; [Steinman, Lawrence] Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University	Robinson, WH (corresponding author), Stanford Univ, Dept Med, Div Immunol & Rheumatol, Stanford, CA 94305 USA.; Robinson, WH (corresponding author), VA Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA.	w.robinson@stanford.edu; steinman@stanford.edu		Robinson, William/0000-0003-4385-704X; Steinman, Lawrence/0000-0002-2437-2250				Ascherio A, 2007, ANN NEUROL, V61, P288, DOI 10.1002/ana.21117; Bar-Or A, 2020, TRENDS MOL MED, V26, P296, DOI 10.1016/j.molmed.2019.11.003; Bjornevik K, 2022, SCIENCE, V375, P296, DOI 10.1126/science.abj8222; FUJINAMI RS, 1985, SCIENCE, V230, P1043, DOI 10.1126/science.2414848; Hauser SL, 2017, NEW ENGL J MED, V376, P221, DOI 10.1056/NEJMoa1601277; Jog NR, 2020, J AUTOIMMUN, V106, DOI 10.1016/j.jaut.2019.102332; Kang MS, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2014.84; Lanz T.V., 2022, RES SQUARE, DOI [10.21203/rs.3.rs-1239863/v1, DOI 10.21203/RS.3.RS-1239863/V1]; Lindsey JW, 2017, J NEUROIMMUNOL, V310, P131, DOI 10.1016/j.jneuroim.2017.07.013; McClain MT, 2005, NAT MED, V11, P85, DOI 10.1038/nm1167; Moreno MA, 2018, NEUROL-NEUROIMMUNOL, V5, DOI 10.1212/NXI.0000000000000466; Munroe ME, 2021, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.606936; SABBATINI A, 1993, EUR J IMMUNOL, V23, P1146, DOI 10.1002/eji.1830230525; Serafini B, 2019, J VIROL, V93, DOI 10.1128/JVI.00980-19; Tengvall K, 2019, P NATL ACAD SCI USA, V116, P16955, DOI 10.1073/pnas.1902623116	15	21	21	5	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2022	375	6578					264	265		10.1126/science.abm7930	http://dx.doi.org/10.1126/science.abm7930			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YK2FS	35025606				2022-12-28	WOS:000745036100014
J	Anyfantakis, D; Kastanakis, S				Anyfantakis, Dimitrios; Kastanakis, Serafim			Hemiparesis and facial droop in an older woman	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Anyfantakis, Dimitrios] Primary Hlth Care Ctr Kissamos, Khania, Crete, Greece; [Kastanakis, Serafim] Agios Georgios Gen Hosp Chania, Emergency Care Dept, Iraklion, Greece		Anyfantakis, D (corresponding author), Primary Hlth Care Ctr Kissamos, Khania, Crete, Greece.	fantakis@yahoo.gr						Amiel SA, 2017, DIABETES CARE, V40, P155, DOI 10.2337/dc16-2215; Fernandes Peter M, 2013, Pract Neurol, V13, P21, DOI 10.1136/practneurol-2012-000465; Ioannidis I, 2014, WORLD J DIABETES, V5, P651, DOI 10.4239/wjd.v5.i5.651; Kirresh Othman, 2013, BMJ Case Rep, V2013, DOI 10.1136/bcr-2013-008893; Kwah LK, 2014, J PHYSIOTHER, V60, P61, DOI 10.1016/j.jphys.2013.12.012; Morales J, 2014, AM J MED, V127, pS17, DOI 10.1016/j.amjmed.2014.07.004; Moulin S, 2019, CURR OPIN NEUROL, V32, P54, DOI 10.1097/WCO.0000000000000620; Nannapaneni N, 2014, AM J MED, V127, pE13, DOI 10.1016/j.amjmed.2014.06.001; RATCHESON RA, 1981, J NEUROCHEM, V36, P1952, DOI 10.1111/j.1471-4159.1981.tb10820.x; Yoshino T, 2012, UPSALA J MED SCI, V117, P347, DOI 10.3109/03009734.2011.652748	10	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 13	2022	376								e067134	10.1136/bmj-2021-067134	http://dx.doi.org/10.1136/bmj-2021-067134			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZE9IW	35027361				2022-12-28	WOS:000759191400002
J	Palmer, J				Palmer, Jane			THE ONE-TWO PUNCH OF FIRES AND MUDSLIDES	NATURE			English	News Item								Regions that never used to burn are now suffering from forest fires - and that raises the risks of devastating mudslides that are hard to forecast.										Mataix-Solera J, 2013, CATENA, V108, P6, DOI 10.1016/j.catena.2011.12.006; Montgomery DR, 2000, GEOLOGY, V28, P311, DOI 10.1130/0091-7613(2000)028<0311:FCARL>2.3.CO;2; Tabari H, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70816-2	3	2	2	4	7	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 13	2022	601	7892					184	186						3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YF9MG	35022598				2022-12-28	WOS:000742123100006
J	Dyer, O				Dyer, Owen			"Shkreli Awards" highlight profiteering and price gouging in US health industry	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Feuerstein A., 2021, STAT-US; Kliff, 2021, NEW YORK TIMES; Lown Institute, 2022, 2021 SHKREL AW; Mulvihill G., 2021, ASS PRESS 1216; The Centers for Medicare and Medicaid (CMS), 2022, MONOCLONAL ANTIBODIE	5	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 12	2022	376								o82	10.1136/bmj.o82	http://dx.doi.org/10.1136/bmj.o82			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YP6JI	35022228				2022-12-28	WOS:000748728200001
J	Morgan, AS; Mendonca, M; Thiele, N; David, AL				Morgan, Andrei S.; Mendonca, Marina; Thiele, Nicole; David, Anna L.			Management and outcomes of extreme preterm birth	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CHILDREN BORN; GESTATION; METAANALYSIS; ASSOCIATION; CESSATION; SURVIVAL; DELIVERY; INFANTS; CARE		[Morgan, Andrei S.] Univ Paris, Epidemiol & Stat Res Ctr CRESS, INSERM EPOPe U1153, INRA, Paris, France; [Morgan, Andrei S.; David, Anna L.] UCL, Elizabeth Garrett Anderson Inst Womens Hlth Londo, London, England; [Morgan, Andrei S.] Assoc Publ Hop Paris APHP, Dept Neonatal Med, Maternite Port Royal, Paris, France; [Mendonca, Marina] Univ Warwick, Dept Psychol, Coventry, W Midlands, England; [Mendonca, Marina] Univ Leicester, Dept Neurosci Psychol & Behav, Leicester, Leics, England; [Thiele, Nicole] European Fdn Care Newborn Infant, Munich, Germany; [David, Anna L.] UCL, Natl Inst Hlth Res, Hosp Biomed Res Ctr, London, England	INRAE; UDICE-French Research Universities; Universite Paris Cite; University of London; University College London; University of Warwick; University of Leicester; University of London; University College London	Morgan, AS (corresponding author), Univ Paris, Epidemiol & Stat Res Ctr CRESS, INSERM EPOPe U1153, INRA, Paris, France.; Morgan, AS (corresponding author), UCL, Elizabeth Garrett Anderson Inst Womens Hlth Londo, London, England.; Morgan, AS (corresponding author), Assoc Publ Hop Paris APHP, Dept Neonatal Med, Maternite Port Royal, Paris, France.	andrei.morgan@inserm.fr		David, Anna/0000-0002-0199-6140; Mendonca, Marina/0000-0002-9224-4891; Morgan, Andrei/0000-0003-4143-1977	European Union's Horizon 2020 Research and Innovation Program RECAP Preterm Project [733280]; National Institute for Health Research University College London Hospitals Biomedical Research Centre	European Union's Horizon 2020 Research and Innovation Program RECAP Preterm Project; National Institute for Health Research University College London Hospitals Biomedical Research Centre(General Electric)	ASM, MM, and NT are supported by funding from the European Union's Horizon 2020 Research and Innovation Program RECAP Preterm Project (grant no. 733280). ALD is supported by the National Institute for Health Research University College London Hospitals Biomedical Research Centre.	Alenius S, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-1354; Alfirevic Z, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000078.pub3; Allotey J, 2018, BJOG-INT J OBSTET GY, V125, P16, DOI 10.1111/1471-0528.14832; AlS HDS, 2011, CURR WOMENS HEALTH R, V7, P288, DOI 10.2174/157340411796355216; Ancel PY, 2015, JAMA PEDIATR, V169, P230, DOI 10.1001/jamapediatrics.2014.3351; [Anonymous], 2020, Obstet Gynecol, V136, P1238, DOI 10.1097/AOG.0000000000004168; Barthel D, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.575429; Bickerstaff M, 2012, AUST NZ J OBSTET GYN, V52, P54, DOI 10.1111/j.1479-828X.2011.01387.x; Bilgin A, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2017-3625; Chawanpaiboon S, 2019, LANCET GLOB HEALTH, V7, pE37, DOI 10.1016/S2214-109X(18)30451-0; Chen HN, 2010, COMMUN STAT-SIMUL C, V39, P860, DOI 10.1080/03610911003650383; Cheong JLY, 2018, LANCET CHILD ADOLESC, V2, P872, DOI 10.1016/S2352-4642(18)30287-6; Cheong JLY, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-4086; Day KL, 2015, CLIN PEDIATR, V54, P1339, DOI 10.1177/0009922815580770; DeMauro SB, 2021, EVOLVING RESP CARE P, V175, P1004; Doyle LW, 2021, ARCH DIS CHILD, V106, P834, DOI 10.1136/archdischild-2021-321668; Draper ES, 2021, INFANT MORTALITY MOR; Duley L, 2018, ARCH DIS CHILD-FETAL, V103, pF6, DOI 10.1136/archdischild-2016-312567; Faber T, 2017, LANCET PUBLIC HEALTH, V2, pE420, DOI 10.1016/S2468-2667(17)30144-5; Franz AP, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-1645; Gallagher K, 2014, ARCH DIS CHILD-FETAL, V99, pF245, DOI 10.1136/archdischild-2013-305191; Gao R, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.33413; Hafstrom M, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-1433; He Y, 2017, LANCET, V390, pS52, DOI 10.1016/S0140-6736(17)33190-2; Hoffman MK, 2020, LANCET, V395, P285, DOI 10.1016/S0140-6736(19)32973-3; Hurst JR, 2020, AM J RESP CRIT CARE, V202, P422, DOI 10.1164/rccm.202001-0016OC; Jayaram PM, 2019, J PERINAT MED, V47, P262, DOI 10.1515/jpm-2018-0174; Johnson S, 2019, J AM ACAD CHILD PSY, V58, P820, DOI 10.1016/j.jaac.2019.02.020; Johnson S, 2011, PEDIATR RES, V69, p11R, DOI 10.1203/PDR.0b013e318212faa0; Johnson S, 2010, J PEDIATR-US, V156, P525, DOI 10.1016/j.jpeds.2009.10.041; Katheria A, 2019, JAMA-J AM MED ASSOC, V322, P1877, DOI 10.1001/jama.2019.16004; Katheria AC, 2018, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00100; Koliouli F, 2016, NEWBORN INFANT NURS, V16, P110, DOI 10.1053/j.nainr.2016.08.003; Kwok TC, 2019, SEMIN PERINATOL, V43, DOI 10.1053/j.semperi.2019.06.007; Linsell L, 2018, ARCH DIS CHILD, V103, P363, DOI 10.1136/archdischild-2017-313414; Lykke JA, 2009, OBSTET GYNECOL, V113, P1217, DOI 10.1097/AOG.0b013e3181a66f2d; Mactier H, 2020, ARCH DIS CHILD-FETAL, V105, pF232, DOI 10.1136/fetalneonatal-2019-318402; Marlow N, 2021, ARCH DIS CHILD-FETAL, V106, P418, DOI 10.1136/archdischild-2020-320650; Mathewson KJ, 2017, PSYCHOL BULL, V143, P347, DOI 10.1037/bul0000091; Mendonca M, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.6961; Meyer MP, 2019, FRONT PEDIATR, V7, DOI 10.3389/fped.2019.00046; Morgan AS, 2022, ACTA PAEDIATR, V111, P59, DOI 10.1111/apa.16084; Morgan AS, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-020-79445-1; Morgan AS, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1206-4; Myrhaug HT, 2019, PEDIATRICS, V143, DOI 10.1542/peds.2018-0933; National Institute for Clinical Excellence, 2020, NG25 NICE; National Institute for Health and Care Excellence, 2019, NG25 NICE; National Institute for Health and Care Excellence, 2021, ANT CAR NICE GUID NG; Ni YY, 2021, ARCH DIS CHILD-FETAL, V106, pF149, DOI 10.1136/archdischild-2020-319328; Norman M, 2019, JAMA-J AM MED ASSOC, V321, P1188, DOI 10.1001/jama.2019.2021; Nusinovici S, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017845; O'Reilly H, 2021, MOL AUTISM, V12, DOI 10.1186/s13229-021-00414-0; Oehmke F, 2019, FRONT PEDIATR, V7, DOI 10.3389/fped.2019.00175; Patnode CD, 2021, JAMA-J AM MED ASSOC, V325, P280, DOI 10.1001/jama.2020.23541; Pierrat V, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n741; Pittara T, 2021, BJOG-INT J OBSTET GY, V128, P1421, DOI 10.1111/1471-0528.16683; Rackham O, 2019, PARENT LED WARD ROUN; Reddy UM, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.06.064; Reid SM, 2016, DEV MED CHILD NEUROL, V58, P25, DOI 10.1111/dmcn.13001; Ritchie K, 2018, J PEDIATR-US, V201, P238, DOI 10.1016/j.jpeds.2018.05.034; Rysavy MA, 2015, NEW ENGL J MED, V372, P1801, DOI 10.1056/NEJMoa1410689; Schmolzer GM, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5980; Sentenac M, INT J EPIDEMIOL, V2021, DOI [10.1093/ije/dyab17, DOI 10.1093/IJE/DYAB17]; Serenius F, 2015, PEDIATRICS, V135, pE1163, DOI 10.1542/peds.2014-2988; Smith LK, 2020, BJOG-INT J OBSTET GY, V127, P314, DOI 10.1111/1471-0528.15971; Smith LK, 2018, LANCET, V392, P1639, DOI [10.1016/s0140-6736(18)31651-9, 10.1016/S0140-6736(18)31651-9]; Sneider K, 2016, ACTA OBSTET GYN SCAN, V95, P1383, DOI 10.1111/aogs.13027; Soni R, 2022, ARCH DIS CHILD-FETAL, V107, P242, DOI 10.1136/archdischild-2020-319450; Spittle A, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005495.pub3; Spittle AJ, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-3410; Stephenson J, 2018, LANCET, V391, P1830, DOI [10.1016/S0140-6736(18)30311-8, 10.1016/s0140-6736(18)30311-8]; Stewart LA, 2021, LANCET, V397, P1183, DOI 10.1016/S0140-6736(21)00217-8; Story Lisa, 2019, Eur J Obstet Gynecol Reprod Biol X, V3, P100018, DOI 10.1016/j.eurox.2019.100018; Tarnow-Mordi W, 2017, NEW ENGL J MED, V377, P2445, DOI 10.1056/NEJMoa1711281; Thomson K, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-042753; Torchin H, 2020, SEMIN FETAL NEONAT M, V25, DOI 10.1016/j.siny.2020.101109; Twilhaar ES, 2018, JAMA PEDIATR, V172, P361, DOI 10.1001/jamapediatrics.2017.5323; Wang Q, 2018, ENVIRON INT, V121, P317, DOI 10.1016/j.envint.2018.09.021; Weeks A D, 2015, BMJ Innov, V1, P53; Wingert A, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2017-021347; Wolke D, 2019, ANN REV DEV PSYCHOL, V1, P69, DOI [10.1146/annurev-devpsych-121318-084804, DOI 10.1146/ANNUREV-DEVPSYCH-121318-084804]; Wolke D, 2015, J PEDIATR-US, V166, P1417, DOI 10.1016/j.jpeds.2015.02.055; World Health Organization, 2018, PRET BIRTH FACTSH	83	6	6	4	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 10	2022	376								e055924	10.1136/bmj-2021-055924	http://dx.doi.org/10.1136/bmj-2021-055924			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YP6IZ	35012942	Green Published, hybrid			2022-12-28	WOS:000748727200003
J	Dyer, O				Dyer, Owen			Tigray's hospitals lack necessities as relief supplies are blocked, say doctors	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Houreld K., 2022, DOCTORS SAY LIVES AR	1	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 7	2022	376								o34	10.1136/bmj.o34	http://dx.doi.org/10.1136/bmj.o34			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YP9GN	34996759				2022-12-28	WOS:000748927300013
J	Joshi, V; Osborne, T; Tzias, D				Joshi, Vanya; Osborne, Thomas; Tzias, Demitrios			A case of non-traumatic shoulder pain	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CALCIFYING TENDINITIS		[Joshi, Vanya; Osborne, Thomas; Tzias, Demitrios] Dept Radiol, Ashford & St Peters Hosp NHS Fdn Tnist, Chertsey, Surrey, England		Joshi, V (corresponding author), Dept Radiol, Ashford & St Peters Hosp NHS Fdn Tnist, Chertsey, Surrey, England.	Vanya.joshi@nhs.net						Ioppolo F, 2013, ARCH PHYS MED REHAB, V94, P1699, DOI 10.1016/j.apmr.2013.01.030; Lam F, 2006, CURR ORTHOPAED, V20, P446, DOI 10.1016/j.cuor.2006.09.005; National Institute for Health and Care Excellence, 2017, SHOULDER PAIN; Rotini R, 2005, Chir Organi Mov, V90, P105; Sansone V, 2018, ORTHOP RES REV, V10, P63, DOI 10.2147/ORR.S138225; Speed CA, 1999, NEW ENGL J MED, V340, P1582, DOI 10.1056/NEJM199905203402011; UHTHOFF HK, 1976, CLIN ORTHOP RELAT R, P164	7	0	0	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 5	2022	376								e052278	10.1136/bmj-2019-052278	http://dx.doi.org/10.1136/bmj-2019-052278			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YI8XS	34987027				2022-12-28	WOS:000744126400003
J	Tanne, JH				Tanne, Janice Hopkins			Covid-19: Military medics are sent to hardest hit hospitals as US records a million cases a day	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Centers for Disease Control and Prevention,, 2022, CDC REC PFIZ BOOST 5; Coronavirus in the US, 2022, NEW YORK TIMES; Farrow M., 2022, WASHINGTON POST 0131; Johns Hopkins Coronavirus Resource Center, 2022, TRACK HOM; Nirappil F., 2022, WASH POST; The White House, 2022, COMMUNICATION	6	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 5	2022	376								o10	10.1136/bmj.o10	http://dx.doi.org/10.1136/bmj.o10			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YI8XS	34987031	Bronze			2022-12-28	WOS:000744126400004
J	Slomski, A				Slomski, Anita			Novel Study Tests n-of-1 Trials for Atrial Fibrillation Triggers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 4	2022	327	1					26	26		10.1001/jama.2021.23319	http://dx.doi.org/10.1001/jama.2021.23319			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YF7YT	34982128				2022-12-28	WOS:000742019000007
J	Devi, S				Devi, Sharmila			Humanitarian need in 2022	LANCET			English	Editorial Material																			0	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN	2022	399	10320					132	133						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YD7YG	34998496	Bronze			2022-12-28	WOS:000740652500011
J	Suran, M				Suran, Melissa			Preparing Hospitals' Medical Oxygen Delivery Systems for a Respiratory "Twindemic"	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	2	2	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 1	2022	327	5					411	413						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YV9QB	35019960	Bronze			2022-12-28	WOS:000753056200001
J	Schraivogel, D; Kuhn, TM; Rauscher, B; Rodriguez-Martinez, M; Paulsen, M; Owsley, K; Middlebrook, A; Tischer, C; Ramasz, B; Ordonez-Rueda, D; Dees, M; Cuylen-Haering, S; Diebold, E; Steinmetz, LM				Schraivogel, Daniel; Kuhn, Terra M.; Rauscher, Benedikt; Rodriguez-Martinez, Marta; Paulsen, Malte; Owsley, Keegan; Middlebrook, Aaron; Tischer, Christian; Ramasz, Beata; Ordonez-Rueda, Diana; Dees, Martina; Cuylen-Haering, Sara; Diebold, Eric; Steinmetz, Lars M.			High-speed fluorescence image-enabled cell sorting	SCIENCE			English	Article							KAPPA-B ACTIVATION; FLOW-CYTOMETRY; POOLED SCREENS; R PACKAGE; DESIGN; CANCER; SPECIFICITY; SENSITIZES; EXPRESSION; DATABASE	Fast and selective isolation of single cells with unique spatial and morphological traits remains a technical challenge. Here, we address this by establishing high-speed image-enabled cell sorting (ICS), which records multicolor fluorescence images and sorts cells based on measurements from image data at speeds up to 15,000 events per second. We show that ICS quantifies cell morphology and localization of labeled proteins and increases the resolution of cell cycle analyses by separating mitotic stages. We combine ICS with CRISPR-pooled screens to identify regulators of the nuclear factor kappa B (NF-kappa B) pathway, enabling the completion of genome-wide image-based screens in about 9 hours of run time. By assessing complex cellular phenotypes, ICS substantially expands the phenotypic space accessible to cell-sorting applications and pooled genetic screening.	[Schraivogel, Daniel; Rauscher, Benedikt; Rodriguez-Martinez, Marta; Steinmetz, Lars M.] European Mol Biol Lab EMBL, Genome Biol Unit, Heidelberg, Germany; [Kuhn, Terra M.; Dees, Martina; Cuylen-Haering, Sara] EMBL, Cell Biol & Biophys Unit, Heidelberg, Germany; [Paulsen, Malte; Ramasz, Beata; Ordonez-Rueda, Diana] EMBL, Flow Cytometry Core Facil, Heidelberg, Germany; [Owsley, Keegan; Middlebrook, Aaron; Diebold, Eric] BD Biosci, San Jose, CA 95131 USA; [Tischer, Christian] EMBL, Adv Light Microscopy Core Facil, Heidelberg, Germany; [Steinmetz, Lars M.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Steinmetz, Lars M.] Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA; [Paulsen, Malte] Novo Nordisk Fdn, reNEW, Ctr Stem Cell Med, Copenhagen, Denmark	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); Stanford University; Stanford University; Novo Nordisk Foundation	Steinmetz, LM (corresponding author), European Mol Biol Lab EMBL, Genome Biol Unit, Heidelberg, Germany.; Cuylen-Haering, S (corresponding author), EMBL, Cell Biol & Biophys Unit, Heidelberg, Germany.; Diebold, E (corresponding author), BD Biosci, San Jose, CA 95131 USA.; Steinmetz, LM (corresponding author), Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA.; Steinmetz, LM (corresponding author), Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA.	sara.cuylen-haering@embl.de; eric.diebold@bd.com; lars.steinmetz@embl.de		Kuhn, Terra/0000-0001-6709-1179; Schraivogel, Daniel/0000-0002-5734-6980; Rodriguez-Martinez, Marta/0000-0001-9728-166X; Ordonez-Rueda, Diana/0000-0002-8387-6707	European Research Council [AdG-294542, AdG-742804]; German Research Foundation (DFG) [402723784]; Human Frontier Science Program [CDA00045/2019]; EMBL Interdisciplinary Postdoc (EIPOD) program (Marie Sklodowska-Curie Actions COFUND grant) [664726]; European Molecular Biology Organization [EMBO ALTF 1154-2020]; Chan Zuckerberg Initiative DAF, an advised fund of the Silicon Valley Community Foundation [2020-225265]; Novo Nordisk Foundation [NNF17CC0027852, NNF21CC0073729]	European Research Council(European Research Council (ERC)European Commission); German Research Foundation (DFG)(German Research Foundation (DFG)); Human Frontier Science Program(Human Frontier Science Program); EMBL Interdisciplinary Postdoc (EIPOD) program (Marie Sklodowska-Curie Actions COFUND grant); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Chan Zuckerberg Initiative DAF, an advised fund of the Silicon Valley Community Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	This work was supported by grants from the European Research Council (Advanced Investigator Grants AdG-294542 and AdG-742804 to L.M.S.), the German Research Foundation (DFG project number 402723784 to S.C.-H.), and the Human Frontier Science Program (CDA00045/2019 to S.C.-H.). D.S. was supported by a fellowship from the EMBL Interdisciplinary Postdoc (EIPOD) program (Marie Sklodowska-Curie Actions COFUND grant agreement 664726). T.M.K. was supported by a postdoctoral fellowship from the European Molecular Biology Organization (EMBO ALTF 1154-2020). C.T. was supported by the Chan Zuckerberg Initiative DAF, an advised fund of the Silicon Valley Community Foundation (grant 2020-225265). M.P. was supported by the Novo Nordisk Foundation (grants NNF17CC0027852 and NNF21CC0073729).	An JB, 2005, ONCOGENE, V24, P1563, DOI 10.1038/sj.onc.1208348; BD Biosciences, 2012, BD FACSARIA 3 US GUI; BD Biosciences, 2017, BD FACSMELODY CELL S; Beckwith SL, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007216; Benaglia T, 2009, J STAT SOFTW, V32, P1; Boutros M, 2015, CELL, V163, P1314, DOI 10.1016/j.cell.2015.11.007; Carbon S, 2019, NUCLEIC ACIDS RES, V47, pD330, DOI 10.1093/nar/gky1055; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Chen L, 2011, J BIOL CHEM, V286, P11283, DOI 10.1074/jbc.M111.222505; Clute P, 1999, NAT CELL BIOL, V1, P82, DOI 10.1038/10049; Corre I, 2017, ONCOTARGET, V8, P55684, DOI 10.18632/oncotarget.18264; Cossarizza A, 2019, EUR J IMMUNOL, V49, P1457, DOI 10.1002/eji.201970107; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Cuylen S, 2016, NATURE, V535, P308, DOI 10.1038/nature18610; Datlinger P, 2017, NAT METHODS, V14, P297, DOI [10.1038/NMETH.4177, 10.1038/nmeth.4177]; de Boer CG, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-02046-8; Dempster J.M.R.J., 2019, BIORXIV, P720243, DOI [10.1101/720243, DOI 10.1101/720243]; Diebold ED, 2013, NAT PHOTONICS, V7, P806, DOI [10.1038/NPHOTON.2013.245, 10.1038/nphoton.2013.245]; Dixit A, 2016, CELL, V167, P1853, DOI 10.1016/j.cell.2016.11.038; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Ellis B., 2021, FLOWCORE BASIC STRUC; Espina V, 2006, NAT PROTOC, V1, P586, DOI 10.1038/nprot.2006.85; Feldman D, 2019, CELL, V179, P787, DOI 10.1016/j.cell.2019.09.016; Feng Y, 2009, NAT REV DRUG DISCOV, V8, P567, DOI 10.1038/nrd2876; Finak G., 2014, FLOWWORKSPACE PACKAG; George TC, 2004, CYTOM PART A, V59A, P237, DOI 10.1002/cyto.a.20048; Ghandi M, 2019, NATURE, V569, P503, DOI 10.1038/s41586-019-1186-3; Gil-Araujo B, 2014, MOL ONCOL, V8, P27, DOI 10.1016/j.molonc.2013.08.012; Goda K, 2012, P NATL ACAD SCI USA, V109, P11630, DOI 10.1073/pnas.1204718109; Gong ZH, 2009, J BIOL CHEM, V284, P7284, DOI 10.1074/jbc.M809158200; Harris CR, 2020, NATURE, V585, P357, DOI 10.1038/s41586-020-2649-2; Hart T, 2017, G3-GENES GENOM GENET, V7, P2719, DOI 10.1534/g3.117.041277; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; Helmlinger D, 2017, TRENDS BIOCHEM SCI, V42, P850, DOI 10.1016/j.tibs.2017.09.001; Henkel L, 2020, BMC BIOL, V18, DOI 10.1186/s12915-020-00905-1; Holzner G, 2021, CELL REP, V34, DOI 10.1016/j.celrep.2021.108824; Isozaki A, 2020, LAB CHIP, V20, P2263, DOI 10.1039/d0lc00080a; Jaattela M, 1996, J IMMUNOL, V156, P1166; Jackman J, 2001, Curr Protoc Cell Biol, VChapter 8, DOI 10.1002/0471143030.cb0803s00; Jaitin DA, 2016, CELL, V167, P1883, DOI 10.1016/j.cell.2016.11.039; Joung J, 2017, NAT PROTOC, V12, P828, DOI 10.1038/nprot.2017.016; Kanfer G, 2021, J CELL BIOL, V220, DOI 10.1083/jcb.202006180; Kim JH, 2017, P NATL ACAD SCI USA, V114, P11739, DOI 10.1073/pnas.1712616114; Korotkevich G., 2016, BIORXIV, DOI [10.1101/060012v3, DOI 10.1101/060012, 10.1101/060012]; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Lafon A, 2015, MOL CELL, V60, P784, DOI 10.1016/j.molcel.2015.10.028; Lara-Pezzi E, 2004, J BIOL CHEM, V279, P6553, DOI 10.1074/jbc.M307663200; Li W, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0554-4; Li YP, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66789-x; Mao XC, 2009, GENE DEV, V23, P849, DOI 10.1101/gad.1748409; Marshall WF, 2001, CURR BIOL, V11, pR487, DOI 10.1016/S0960-9822(01)00289-5; Meyers RM, 2017, NAT GENET, V49, P1779, DOI 10.1038/ng.3984; Mikami H, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14929-2; Miura T, 2018, BIOMED OPT EXPRESS, V9, P3424, DOI 10.1364/BOE.9.003424; Munoz HE, 2018, ANAL CHEM, V90, P11280, DOI 10.1021/acs.analchem.8b01794; Nitta N, 2018, CELL, V175, P266, DOI 10.1016/j.cell.2018.08.028; Ota S, 2018, SCIENCE, V360, P1246, DOI 10.1126/science.aan0096; Perlman ZE, 2004, SCIENCE, V306, P1194, DOI 10.1126/science.1100709; Piyasena ME, 2014, LAB CHIP, V14, P1044, DOI 10.1039/c3lc51152a; Prigent C, 2003, J CELL SCI, V116, P3677, DOI 10.1242/jcs.00735; Pujar S, 2018, NUCLEIC ACIDS RES, V46, pD221, DOI 10.1093/nar/gkx1031; Qi H, 2003, CANCER RES, V63, P7076; Rane AS, 2017, CHEM-US, V3, P588, DOI 10.1016/j.chempr.2017.08.005; Rauscher B., 2021, ZENODO; Ray JP, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15022-4; Rottger S, 1998, J CELL SCI, V111, P45; Samwer M, 2017, CELL, V170, P956, DOI 10.1016/j.cell.2017.07.038; Sarkans U, 2018, NUCLEIC ACIDS RES, V46, pD1266, DOI 10.1093/nar/gkx965; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schmitz MHA, 2010, NAT CELL BIOL, V12, P886, DOI 10.1038/ncb2092; Schraivogel D, 2020, NAT METHODS, V17, P629, DOI 10.1038/s41592-020-0837-5; Schwartz A, 1996, CYTOMETRY, V26, P22, DOI 10.1002/(SICI)1097-0320(19960315)26:1<22::AID-CYTO4>3.0.CO;2-I; Sekine Y, 2012, MOL CELL, V48, P692, DOI 10.1016/j.molcel.2012.09.018; Shahi P, 2017, SCI REP-UK, V7, DOI 10.1038/srep44447; Shembade N, 2012, CELL MOL IMMUNOL, V9, P123, DOI 10.1038/cmi.2011.59; Shirane M, 1999, J BIOL CHEM, V274, P28169, DOI 10.1074/jbc.274.40.28169; Simeonov DR, 2017, NATURE, V549, P111, DOI 10.1038/nature23875; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Spencer E, 1999, GENE DEV, V13, P284, DOI 10.1101/gad.13.3.284; Spidlen J, 2012, CYTOM PART A, V81A, P727, DOI 10.1002/cyto.a.22106; Spidlen J, 2010, CYTOM PART A, V77A, P97, DOI 10.1002/cyto.a.20825; Stoeckius M, 2017, NAT METHODS, V14, P865, DOI [10.1038/nmeth.4380, 10.1038/NMETH.4380]; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Tada K, 2001, J BIOL CHEM, V276, P36530, DOI 10.1074/jbc.M104837200; Taminiau A, 2016, NUCLEIC ACIDS RES, V44, P7331, DOI 10.1093/nar/gkw606; Tang Y, 2018, J IMMUNOL, V200, P4117, DOI 10.4049/jimmunol.1800172; Thul PJ, 2017, SCIENCE, V356, DOI 10.1126/science.aal3321; Tian Y, 2007, J BIOL CHEM, V282, P16776, DOI 10.1074/jbc.M701913200; Virtanen P, 2020, NAT METHODS, V17, P261, DOI 10.1038/s41592-019-0686-2; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wang C, 2019, P NATL ACAD SCI USA, V116, P10842, DOI 10.1073/pnas.1903808116; Wei PF, 2015, RELIAB ENG SYST SAFE, V142, P399, DOI 10.1016/j.ress.2015.05.018; Wen AY, 2010, J IMMUNOL, V185, P6413, DOI 10.4049/jimmunol.1001829; Wheeler EC, 2020, NAT METHODS, V17, P636, DOI 10.1038/s41592-020-0826-8; Yan XW, 2021, J CELL BIOL, V220, DOI 10.1083/jcb.202008158; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zambrano S, 2016, ELIFE, V5, DOI 10.7554/eLife.09100; ZHENG GX, 2017, NATURE, V0008; ZIEVE GW, 1980, EXP CELL RES, V126, P397, DOI 10.1016/0014-4827(80)90279-7; Zotti T, 2011, J BIOL CHEM, V286, P22924, DOI 10.1074/jbc.M110.215426	102	34	33	52	118	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2022	375	6578					315	+		10.1126/science.abj3013	http://dx.doi.org/10.1126/science.abj3013			81	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YK2FS	35050652	Green Accepted			2022-12-28	WOS:000745036100033
J	Lee, MJ; Han, J; Lee, K; Lee, YJ; Kim, BG; Jung, KN; Kim, BJ; Lee, SW				Lee, Michael J.; Han, Junghun; Lee, Kyungbin; Lee, Young Jun; Kim, Byoung Gak; Jung, Kyu-Nam; Kim, Bumjoon J.; Lee, Seung Woo			Elastomeric electrolytes for high-energy solid-state lithium batteries	NATURE			English	Article							POLYMER ELECTROLYTES; TRANSFERENCE NUMBER; ELECTROCHEMICAL STABILITY; CONDUCTIVITY; PHASE; SUCCINONITRILE; TRANSPORT; THIN	The use of lithium metal anodes in solid-state batteries has emerged as one of the most promising technologies for replacing conventional lithium-ion batteries(1,2). Solid-state electrolytes are a key enabling technology for the safe operation of lithium metal batteries as they suppress the uncontrolled growth of lithium dendrites. However, the mechanical properties and electrochemical performance of current solid-state electrolytes do not meet the requirements for practical applications of lithium metal batteries. Here we report a class of elastomeric solid-state electrolytes with a three-dimensional interconnected plastic crystal phase. The elastomeric electrolytes show a combination of mechanical robustness, high ionic conductivity, low interfacial resistance and high lithium-ion transference number. The in situ-formed elastomer electrolyte on copper foils accommodates volume changes for prolonged lithium plating and stripping processes with a Coulombic efficiency of 100.0 per cent. Moreover, the elastomer electrolytes enable stable operation of the full cells under constrained conditions of a limited lithium source, a thin electrolyte and a high-loading LiNi0.83Mn0.06Co0.11O2 cathode at a high voltage of 4.5 volts at ambient temperature, delivering a high specific energy exceeding 410 watt-hours per kilogram of electrode plus electrolyte. The elastomeric electrolyte system presents a powerful strategy for enabling stable operation of high-energy, solid-state lithium batteries.	[Lee, Michael J.; Lee, Kyungbin; Lee, Seung Woo] Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA; [Han, Junghun; Lee, Young Jun; Kim, Bumjoon J.] Korea Adv Inst Sci & Technol KAIST, Dept Chem & Biomol Engn, Daejeon, South Korea; [Kim, Byoung Gak] Korea Res Inst Chem Technol, Div Adv Mat, Daejeon, South Korea; [Jung, Kyu-Nam] Korea Inst Energy Res, Renewable Energy Inst, Daejeon, South Korea	University System of Georgia; Georgia Institute of Technology; Korea Advanced Institute of Science & Technology (KAIST); Korea Research Institute of Chemical Technology (KRICT); Korea Institute of Energy Research (KIER)	Lee, SW (corresponding author), Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.; Kim, BJ (corresponding author), Korea Adv Inst Sci & Technol KAIST, Dept Chem & Biomol Engn, Daejeon, South Korea.	bumjoonkim@kaist.ac.kr; seung.lee@me.gatech.edu	Kim, Bumjoon J./C-1714-2011; Lee, Kyungbin/AAA-7814-2020	Lee, Kyungbin/0000-0003-1046-7811; Lee, Seung Woo/0000-0002-2695-7105; Han, Junghun/0000-0003-3064-0511; Lee, Michael/0000-0001-5087-3991; Lee, Young Jun/0000-0001-6406-890X	National Science Foundation [ECCS-2025462]; KRICT core project [BSF20-242]; National Research Foundation of Korea [NRF-2019R1A2B5B03101123, 2017M3D1A1039553, 2020RlA4A1018516]	National Science Foundation(National Science Foundation (NSF)); KRICT core project; National Research Foundation of Korea(National Research Foundation of Korea)	This work was performed in part at the Georgia Tech Institute for Electronics and Nanotechnology, a member of the National Nanotechnology Coordinated Infrastructure (NNCI), which is supported by the National Science Foundation (ECCS-2025462). This work was partially supported by KRICT core project (BSF20-242). J.H., Y.J.L. and B.J.K. acknowledge the support from the National Research Foundation of Korea (NRF-2019R1A2B5B03101123, 2017M3D1A1039553 and 2020RlA4A1018516).	Alarco PJ, 2004, NAT MATER, V3, P476, DOI 10.1038/nmat1158; Albertus P, 2018, NAT ENERGY, V3, P16, DOI 10.1038/s41560-017-0047-2; Armand M, 2008, NATURE, V451, P652, DOI 10.1038/451652a; Bai P, 2016, ENERG ENVIRON SCI, V9, P3221, DOI 10.1039/c6ee01674j; Bouchet R, 2013, NAT MATER, V12, P452, DOI [10.1038/NMAT3602, 10.1038/nmat3602]; BRUCE PG, 1988, SOLID STATE IONICS, V28, P918, DOI 10.1016/0167-2738(88)90304-9; Chen L, 2018, NANO ENERGY, V46, P176, DOI 10.1016/j.nanoen.2017.12.037; Chen RJ, 2017, ACS APPL MATER INTER, V9, P9654, DOI 10.1021/acsami.6b16304; Chen T, 2018, NANO ENERGY, V54, P17, DOI 10.1016/j.nanoen.2018.09.059; Choi JW, 2016, NAT REV MATER, V1, DOI 10.1038/natrevmats.2016.13; Choi KH, 2014, ADV FUNCT MATER, V24, P44, DOI 10.1002/adfm.201301345; Diederichsen KM, 2017, ACS ENERGY LETT, V2, P2563, DOI 10.1021/acsenergylett.7b00792; Dong TT, 2018, ENERG ENVIRON SCI, V11, P1197, DOI 10.1039/c7ee03365f; Duan H, 2019, ADV MATER, V31, DOI 10.1002/adma.201807789; Fu CY, 2020, NAT MATER, V19, P758, DOI 10.1038/s41563-020-0655-2; Fu CK, 2020, J MATER CHEM A, V8, P2066, DOI 10.1039/c9ta11341j; He MN, 2015, J ELECTROCHEM SOC, V162, pA1725, DOI 10.1149/2.0231509jes; Jiang TL, 2020, ADV ENERGY MATER, V10, DOI 10.1002/aenm.201903376; Kim HJ, 2020, SCIENCE, V367, P773, DOI 10.1126/science.aay8467; Lee W, 2019, ADV FUNCT MATER, V29, DOI 10.1002/adfm.201807872; Lee YG, 2020, NAT ENERGY, V5, P299, DOI 10.1038/s41560-020-0575-z; Lin DC, 2017, NAT NANOTECHNOL, V12, P194, DOI [10.1038/nnano.2017.16, 10.1038/NNANO.2017.16]; Liu W, 2017, NAT ENERGY, V2, DOI 10.1038/nenergy.2017.35; Lopez J, 2018, ADV MATER, V30, DOI 10.1002/adma.201804142; Lu QW, 2017, ADV MATER, V29, DOI 10.1002/adma.201604460; Mackanic DG, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13362-4; Markvicka EJ, 2018, NAT MATER, V17, P618, DOI 10.1038/s41563-018-0084-7; Meng JW, 2019, ADV FUNCT MATER, V29, DOI 10.1002/adfm.201902220; Pan CF, 2019, ADV MATER, V31, DOI 10.1002/adma.201900663; Park M, 2012, NAT NANOTECHNOL, V7, P803, DOI [10.1038/nnano.2012.206, 10.1038/NNANO.2012.206]; Phillip WA, 2009, ACS APPL MATER INTER, V1, P472, DOI 10.1021/am8001428; Randau S, 2020, NAT ENERGY, V5, P259, DOI 10.1038/s41560-020-0565-1; Saier MH, 2007, WATER AIR SOIL POLL, V181, P1, DOI 10.1007/s11270-007-9372-6; Schulze MW, 2014, NANO LETT, V14, P122, DOI 10.1021/nl4034818; Seo M, 2012, SCIENCE, V336, P1422, DOI 10.1126/science.1221383; Serbutoviez C, 1996, MACROMOLECULES, V29, P7690, DOI 10.1021/ma960293+; Sun JQ, 2021, ADV FUNCT MATER, V31, DOI 10.1002/adfm.202006381; Timachova K, 2015, MACROMOLECULES, V48, P7882, DOI 10.1021/acs.macromol.5b01724; Wan JY, 2019, NAT NANOTECHNOL, V14, P705, DOI 10.1038/s41565-019-0465-3; Wang CH, 2019, ADV FUNCT MATER, V29, DOI 10.1002/adfm.201900392; Wang F, 2019, ADV MATER, V31, DOI 10.1002/adma.201806733; Watson BL, 2017, ENERG ENVIRON SCI, V10, P2500, DOI 10.1039/c7ee02185b; White TJ, 2007, MACROMOLECULES, V40, P1112, DOI 10.1021/ma061828u; Xia SX, 2019, ADV SCI, V6, DOI 10.1002/advs.201802353; Yang XF, 2020, ENERG ENVIRON SCI, V13, P1318, DOI 10.1039/d0ee00342e; Yao PC, 2018, NANO LETT, V18, P6113, DOI 10.1021/acs.nanolett.8b01421; Yu XR, 2020, ADV ENERGY MATER, V10, DOI 10.1002/aenm.201903939; Zhang WQ, 2018, NANO ENERGY, V45, P413, DOI 10.1016/j.nanoen.2018.01.028; Zhang XY, 2020, NANO LETT, V20, P2871, DOI 10.1021/acs.nanolett.0c00693; Zhao Q, 2019, NAT ENERGY, V4, P365, DOI 10.1038/s41560-019-0349-7; Zhou D, 2015, ADV ENERGY MATER, V5, DOI 10.1002/aenm.201500353; Zhu YH, 2019, J MATER CHEM A, V7, P6832, DOI 10.1039/c9ta00560a	52	60	62	362	687	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 13	2022	601	7892					217	+		10.1038/s41586-021-04209-4	http://dx.doi.org/10.1038/s41586-021-04209-4			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YF9MG	35022589				2022-12-28	WOS:000742123100012
J	Iacobucci, G				Iacobucci, Gareth			Covid-19: Fourth vaccine doses-who needs them and why?	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2021, UK RES INNOVATIO DEC; [Anonymous], 2021, REUTERS DEC; [Anonymous], 2021, NEW STUDY TESTS 3 JA; [Anonymous], 2021, SARS COV 2 VARIANTS; [Anonymous], 2022, CNET JAN; Centers for Disease Control and Prevention, INT CLIN CONS US COV; Department of Health and Social Care, 2021, ALL AD BE OFF COV 19; Mahase E, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n2860; Munro C, 2021, BMJ-BRIT MED J, V374, DOI 10.1136/bmj.n2098; Prime Minister's Office, 2022, PM BENN ANN ISR 60 M; Rayner G, 2022, TELEGRAPH 0103	11	9	9	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 7	2022	376								o30	10.1136/bmj.o30	http://dx.doi.org/10.1136/bmj.o30			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YP9GN	34996757	Bronze			2022-12-28	WOS:000748927300012
J	Mahase, E				Mahase, Elisabeth			Covid-19: Shorten isolation periods to relieve NHS pressures, say leaders	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		[Anonymous], 2022, GUARDIAN 0104; [Anonymous], 2021, COVID 19 MANAGEMENT; Iacobucci G, 2022, BMJ-BRIT MED J, V376, DOI 10.1136/bmj.o3; Mahase E, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n2534; Mahase E, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1156	5	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 7	2022	376								o38	10.1136/bmj.o38	http://dx.doi.org/10.1136/bmj.o38			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YP9GN	34996760	Bronze			2022-12-28	WOS:000748927300001
J	Viana, R; Moyo, S; Amoako, DG; Tegally, H; Scheepers, C; Althaus, CL; Anyaneji, UJ; Bester, PA; Boni, MF; Chand, M; Choga, WT; Colquhoun, R; Davids, M; Deforche, K; Doolabh, D; du Plessis, L; Engelbrecht, S; Everatt, J; Giandhari, J; Giovanetti, M; Hardie, D; Hill, V; Hsiao, NY; Iranzadeh, A; Ismail, A; Joseph, C; Joseph, R; Koopile, L; Pond, SKL; Kraemer, MUG; Kuate-Lere, L; Laguda-Akingba, O; Lesetedi-Mafoko, O; Lessells, RJ; Lockman, S; Lucaci, AG; Maharaj, A; Mahlangu, B; Maponga, T; Mahlakwane, K; Makatini, Z; Marais, G; Maruapula, D; Masupu, K; Matshaba, M; Mayaphi, S; Mbhele, N; Mbulawa, MB; Mendes, A; Mlisana, K; Mnguni, A; Mohale, T; Moir, M; Moruisi, K; Mosepele, M; Motsatsi, G; Motswaledi, MS; Mphoyakgosi, T; Msomi, N; Mwangi, PN; Naidoo, Y; Ntuli, N; Nyaga, M; Olubayo, L; Pillay, S; Radibe, B; Ramphal, Y; Ramphal, U; San, JME; Scott, L; Shapiro, R; Singh, L; Smith-Lawrence, P; Stevens, W; Strydom, A; Subramoney, K; Tebeila, N; Tshiabuila, D; Tsui, JS; van Wyk, S; Weaver, S; Wibmer, CK; Wilkinson, E; Wolter, N; Zarebski, AE; Zuze, B; Goedhals, D; Preiser, W; Treurnicht, F; Venter, M; Williamson, C; Pybus, OG; Bhiman, J; Glass, A; Martin, DP; Rambaut, A; Gaseitsiwe, S; von Gottberg, A; de Oliveira, T				Viana, Raquel; Moyo, Sikhulile; Amoako, Daniel G.; Tegally, Houriiyah; Scheepers, Cathrine; Althaus, Christian L.; Anyaneji, Ugochukwu J.; Bester, Phillip A.; Boni, Maciej F.; Chand, Mohammed; Choga, Wonderful T.; Colquhoun, Rachel; Davids, Michaela; Deforche, Koen; Doolabh, Deelan; du Plessis, Louis; Engelbrecht, Susan; Everatt, Josie; Giandhari, Jennifer; Giovanetti, Marta; Hardie, Diana; Hill, Verity; Hsiao, Nei-Yuan; Iranzadeh, Arash; Ismail, Arshad; Joseph, Charity; Joseph, Rageema; Koopile, Legodile; Kosakovsky Pond, Sergei L.; Kraemer, Moritz U. G.; Kuate-Lere, Lesego; Laguda-Akingba, Oluwakemi; Lesetedi-Mafoko, Onalethatha; Lessells, Richard J.; Lockman; Lucaci, Alexander G.; Maharaj, Arisha; Mahlangu, Boitshoko; Maponga, Tongai; Mahlakwane, Kamela; Makatini, Zinhle; Marais, Gert; Maruapula, Dorcas; Masupu, Kereng; Matshaba, Mogomotsi; Mayaphi, Simnikiwe; Mbhele, Nokuzola; Mbulawa, Mpaphi B.; Mendes, Adriano; Mlisana, Koleka; Mnguni, Anele; Mohale, Thabo; Moir, Monika; Moruisi, Kgomotso; Mosepele, Mosepele; Motsatsi, Gerald; Motswaledi, Modisa S.; Mphoyakgosi, Thongbotho; Msomi, Nokukhanya; Mwangi, Peter N.; Naidoo, Yeshnee; Ntuli, Noxolo; Nyaga, Martin; Olubayo, Lucier; Pillay, Sureshnee; Radibe, Botshelo; Ramphal, Yajna; Ramphal, Upasana; San, James E.; Scott, Lesley; Shapiro, Roger; Singh, Lavanya; Smith-Lawrence, Pamela; Stevens, Wendy; Strydom, Amy; Subramoney, Kathleen; Tebeila, Naume; Tshiabuila, Derek; Tsui, Joseph; van Wyk, Stephanie; Weaver, Steven; Wibmer, Constantinos K.; Wilkinson, Eduan; Wolter, Nicole; Zarebski, Alexander E.; Zuze, Boitumelo; Goedhals, Dominique; Preiser, Wolfgang; Treurnicht, Florette; Venter, Marietje; Williamson, Carolyn; Pybus, Oliver G.; Bhiman, Jinal; Glass, Allison; Martin, Darren P.; Rambaut, Andrew; Gaseitsiwe, Simani; von Gottberg, Anne; de Oliveira, Tulio			Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa	NATURE			English	Article							RECEPTOR-BINDING DOMAIN; MUTATIONS; RECOMBINATION; EVOLUTION; SEQUENCES; TOOL	Y The SARS-CoV-2 epidemic in southern Africa has been characterized by three distinct waves. The first was associated with a mix of SARS-CoV-2 lineages, while the second and third waves were driven by the Beta (B.1.351) and Delta (B.1.617.2) variants, respectively1-3. In November 2021, genomic surveillance teams in South Africa and Botswana detected a new SARS-CoV-2 variant associated with a rapid resurgence of infections in Gauteng province, South Africa. Within three days of the first genome being uploaded, it was designated a variant of concern (Omicron, B.1.1.529) by the World Health Organization and, within three weeks, had been identified in 87 countries. The Omicron variant is exceptional for carrying over 30 mutations in the spike glycoprotein, which are predicted to influence antibody neutralization and spike function4. Here we describe the genomic profile and early transmission dynamics of Omicron, highlighting the rapid spread in regions with high levels of population immunity.	[Viana, Raquel; Glass, Allison] Lancet Labs, Johannesburg, South Africa; [Moyo, Sikhulile; Koopile, Legodile; Lockman; Maruapula, Dorcas; Radibe, Botshelo; Shapiro, Roger; Zuze, Boitumelo; Gaseitsiwe, Simani] Botswana Harvard HIV Reference Lab, Botswana Harvard AIDS Inst Partnership, Gaborone, Botswana; [Moyo, Sikhulile; Choga, Wonderful T.; Gaseitsiwe, Simani] Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [Moyo, Sikhulile; Masupu, Kereng; Matshaba, Mogomotsi; Mosepele, Mosepele; Motswaledi, Modisa S.] Botswana Presidential COVID 19 Taskforce, Gaborone, Botswana; [Amoako, Daniel G.; Scheepers, Cathrine; Everatt, Josie; Ismail, Arshad; Mahlangu, Boitshoko; Mnguni, Anele; Mohale, Thabo; Motsatsi, Gerald; Ntuli, Noxolo; Tebeila, Naume; Wibmer, Constantinos K.; Wolter, Nicole; Bhiman, Jinal; von Gottberg, Anne] Natl Hlth Lab Serv NHLS, Natl Inst Communicable Dis NICD, Johannesburg, South Africa; [Tegally, Houriiyah; Anyaneji, Ugochukwu J.; Giandhari, Jennifer; Lessells, Richard J.; Maharaj, Arisha; Naidoo, Yeshnee; Pillay, Sureshnee; Ramphal, Yajna; Ramphal, Upasana; San, James E.; Singh, Lavanya; Tshiabuila, Derek; de Oliveira, Tulio] Univ KwaZulu Natal, Nelson R Mandela Sch Med, KwaZulu Natal Res Innovat & Sequencing Platform K, Durban, South Africa; [Scheepers, Cathrine; Bhiman, Jinal] Univ Witwatersrand, South African Med Res Council, Antibody Immun Res Unit, Fac Hlth Sci,Sch Pathol, Johannesburg, South Africa; [Althaus, Christian L.] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Bester, Phillip A.] Natl Hlth Lab Serv, Div Virol, Bloemfontein, South Africa; [Bester, Phillip A.; Mwangi, Peter N.; Nyaga, Martin; Goedhals, Dominique] Univ Free State, Div Virol, Bloemfontein, South Africa; [Boni, Maciej F.] Penn State Univ, Dept Biol, Ctr Infect Dis Dynam, University Pk, PA 16802 USA; [Chand, Mohammed; Joseph, Charity] Diagnofirm Med Labs, Gaborone, Botswana; [Colquhoun, Rachel; Hill, Verity; Rambaut, Andrew] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland; [Davids, Michaela; Mendes, Adriano; Strydom, Amy; Venter, Marietje] Univ Pretoria, Ctr Viral Zoonoses, Dept Med Virol, Zoonot Arbo & Resp Virus Program, Pretoria, South Africa; [Deforche, Koen] Emweb, Herent, Belgium; [Doolabh, Deelan; Hardie, Diana; Hsiao, Nei-Yuan; Joseph, Rageema; Marais, Gert; Mbhele, Nokuzola; Williamson, Carolyn] Univ Cape Town, Fac Hlth Sci, Div Med Virol, Cape Town, South Africa; [du Plessis, Louis; Kraemer, Moritz U. G.; Tsui, Joseph; Zarebski, Alexander E.; Pybus, Oliver G.] Univ Oxford, Dept Zool, Oxford, England; [du Plessis, Louis] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Zurich, Switzerland; [Engelbrecht, Susan; Maponga, Tongai; Mahlakwane, Kamela; Preiser, Wolfgang] Stellenbosch Univ, Fac Med & Hlth Sci, Div Med Virol, Cape Town, South Africa; [Giovanetti, Marta] Fundacao Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil; [Giovanetti, Marta] Univ Fed Minas Gerais, Lab Genet Celular & Mol, Belo Horizonte, MG, Brazil; [Hardie, Diana; Hsiao, Nei-Yuan; Marais, Gert; Williamson, Carolyn] NHLS Groote Schuur Lab, Div Virol, Cape Town, South Africa; [Hsiao, Nei-Yuan; Olubayo, Lucier; Williamson, Carolyn; Martin, Darren P.] Wellcome Ctr Infect Dis Res Africa CIDRI Africa, Cape Town, South Africa; [Iranzadeh, Arash; Olubayo, Lucier] Univ Cape Town, Fac Hlth Sci, Div Computat Biol, Cape Town, South Africa; [Kosakovsky Pond, Sergei L.; Lucaci, Alexander G.; Weaver, Steven] Temple Univ, Dept Biol, Inst Genom & Evolutionary Med, Philadelphia, PA 19122 USA; [Kuate-Lere, Lesego; Moruisi, Kgomotso; Smith-Lawrence, Pamela] Minist Hlth & Wellness, Hlth Serv Management, Gaborone, Botswana; [Laguda-Akingba, Oluwakemi] NHLS Port Elizabeth Lab, Port Elizabeth, South Africa; [Laguda-Akingba, Oluwakemi] Walter Sisulu Univ, Fac Hlth Sci, Mthatha, South Africa; [Lesetedi-Mafoko, Onalethatha] Minist Hlth & Wellness, Integrated Dis Surveillance & Response, Publ Hlth Dept, Gaborone, Botswana; [Lockman; Shapiro, Roger] Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA USA; [Mahlakwane, Kamela; Preiser, Wolfgang] Tygerberg Hosp, NHLS Tygerberg Lab, Cape Town, South Africa; [Makatini, Zinhle; Subramoney, Kathleen; Treurnicht, Florette] Charlotte Maxeke Johannesburg Acad Hosp, Dept Virol, Johannesburg, South Africa; [Matshaba, Mogomotsi] Botswana Baylor Childrens Clin Ctr Excellence, Gaborone, Botswana; [Matshaba, Mogomotsi] Baylor Coll Med, Houston, TX 77030 USA; [Mayaphi, Simnikiwe] Univ Pretoria, Dept Med Virol, Pretoria, South Africa; [Mbulawa, Mpaphi B.; Mphoyakgosi, Thongbotho] Minist Hlth & Wellness, Hlth Serv Management, Natl Hlth Lab, Gaborone, Botswana; [Mlisana, Koleka] Natl Hlth Lab Serv NHLS, Johannesburg, South Africa; [Mlisana, Koleka] Ctr AIDS Programme Res South Africa CAPRISA, Durban, South Africa; [Moir, Monika; van Wyk, Stephanie; Wilkinson, Eduan; de Oliveira, Tulio] Stellenbosch Univ, Sch Data Sci & Computat Thinking, Ctr Epidem Response & Innovat CERI, Stellenbosch, South Africa; [Mosepele, Mosepele] Univ Botswana, Fac Med, Dept Med, Gaborone, Botswana; [Motswaledi, Modisa S.] Univ Botswana, Sch Allied Hlth Profess, Fac Hlth Sci, Dept Med Lab Sci, Gaborone, Botswana; [Msomi, Nokukhanya] Univ KwaZulu Natal, Discipline Virol, Sch Lab Med & Med Sci, Durban, South Africa; [Msomi, Nokukhanya] Univ KwaZulu Natal, Natl Hlth Lab Serv NHLS, Durban, South Africa; [Mwangi, Peter N.; Nyaga, Martin] Univ Free State, Next Generat Sequencing Unit, Div Virol, Fac Hlth Sci, Bloemfontein, South Africa; [Scott, Lesley; Stevens, Wendy] Univ Witwatersrand, Dept Mol Med & Haematol, Johannesburg, South Africa; [Wolter, Nicole; von Gottberg, Anne] Univ Witwatersrand, Fac Hlth Sci, Sch Pathol, Johannesburg, South Africa; [Goedhals, Dominique] PathCare Vermaak, Pretoria, South Africa; [Williamson, Carolyn; Martin, Darren P.] Univ Cape Town, Inst Infect Dis & Mol Med, Cape Town, South Africa; [Glass, Allison] Univ Witwatersrand, Fac Hlth Sci, Sch Pathol, Dept Mol Pathol, Johannesburg, South Africa; [de Oliveira, Tulio] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA	Botswana-Harvard AIDS Institute Partnership; Harvard University; Harvard T.H. Chan School of Public Health; National Health Laboratory Service; National Institute for Communicable Diseases (NICD); University of Kwazulu Natal; South African Medical Research Council; University of Witwatersrand; University of Bern; University of the Free State; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Edinburgh; University of Pretoria; University of Cape Town; University of Oxford; Swiss Federal Institutes of Technology Domain; ETH Zurich; Stellenbosch University; Fundacao Oswaldo Cruz; Universidade Federal de Minas Gerais; University of Cape Town; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Walter Sisulu University; Harvard University; Harvard T.H. Chan School of Public Health; Tygerberg Hospital; University of Witwatersrand; Baylor College of Medicine; Baylor College of Medicine; University of Pretoria; National Health Laboratory Service; Stellenbosch University; University of Botswana; University of Botswana; University of Kwazulu Natal; University of Kwazulu Natal; University of the Free State; University of Witwatersrand; University of Witwatersrand; University of Cape Town; University of Witwatersrand; University of Washington; University of Washington Seattle	de Oliveira, T (corresponding author), Univ KwaZulu Natal, Nelson R Mandela Sch Med, KwaZulu Natal Res Innovat & Sequencing Platform K, Durban, South Africa.; de Oliveira, T (corresponding author), Stellenbosch Univ, Sch Data Sci & Computat Thinking, Ctr Epidem Response & Innovat CERI, Stellenbosch, South Africa.; de Oliveira, T (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.	tulio@sun.ac.za	Ismail, Arshad/B-8552-2019; Moyo, Sikhulile/E-1464-2015; Mahlakwane, Kamela/GMW-7195-2022; Scheepers, Cathrine/ABC-9229-2021; CHOGA, Wonderful T./ABB-4787-2021; Preiser, Wolfgang/J-4875-2016; Mwangi, Peter Nthiga/AHE-0033-2022; Venter, Marietjie/P-9604-2016; Althaus, Christian/F-6008-2015	Ismail, Arshad/0000-0003-4672-5915; Moyo, Sikhulile/0000-0003-3821-4592; CHOGA, Wonderful T./0000-0001-7606-0569; Preiser, Wolfgang/0000-0002-0254-7910; Everatt, Josie/0000-0002-0373-2093; Venter, Marietjie/0000-0003-2696-824X; de Oliveira, Tulio/0000-0002-3027-5254; Olubayo, Luicer Anne Ingasia/0000-0002-7370-7272; Scott, Lesley/0000-0001-6573-9525; von Gottberg, Anne/0000-0002-0243-7455; Ramphal, Upasana/0000-0002-2441-3868; Maponga, Tongai/0000-0002-6876-3712; Wibmer, Constantinos Kurt/0000-0003-2329-2280; Nyaga, Martin Munene/0000-0002-5017-5584; Althaus, Christian/0000-0002-5230-6760	Strategic Health Innovation Partnerships Unit of the South African Medical Research Council; South African Department of Science and Innovation; WHO; National Institutes of Health (NIH) [U01 AI151698]; Rockefeller Foundation [2021 HTH 017, 2020 HTH 062]; European Union's Horizon 2020 research and innovation programme, project EpiPose [101003688]; Wellcome Trust [222574/Z/21/Z, 206298/Z/17/Z, 203135/Z/16/Z, 222754]; European Research Council [725422]; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/M010996/1]; Oxford Martin School; Rockefeller Foundation; Google; European Horizon 2020 programme MOOD [874850]; ANDEMIA G7 Global Health; South African Medical Research Council; Department of Science and Innovation; Wellcome Centre for Infectious Diseases Research in Africa (CIDRI-Africa); National Institute for Communicable Diseases of the National Health Laboratory Service; United States Centers for Disease Control and Prevention [5U01IP001048-05-00]; African Society of Laboratory Medicine (ASLM); Africa Centers for Disease Control and Prevention through Bill and Melinda Gates Foundation [INV-018978]; UK Foreign, Commonwealth and Development Office and Wellcome [221003/Z/20/Z]; South African Medical Research Council [SHIPNCD 76756]; UK Department of Health and Social Care; Foundation for Innovative New Diagnostics and Fogarty International Center [5D43TW009610]; NIH [5K24AI131924-04, 5K24AI131928-05]; Botswana government through the Ministry of Health & Wellness and Presidential COVID-19 Task Force; Bill & Melinda Gates Foundation [036530]	Strategic Health Innovation Partnerships Unit of the South African Medical Research Council; South African Department of Science and Innovation; WHO(World Health Organization); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rockefeller Foundation; European Union's Horizon 2020 research and innovation programme, project EpiPose; Wellcome Trust(Wellcome Trust); European Research Council(European Research Council (ERC)European Commission); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Oxford Martin School; Rockefeller Foundation; Google(Google Incorporated); European Horizon 2020 programme MOOD; ANDEMIA G7 Global Health; South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Science and Innovation; Wellcome Centre for Infectious Diseases Research in Africa (CIDRI-Africa); National Institute for Communicable Diseases of the National Health Laboratory Service; United States Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); African Society of Laboratory Medicine (ASLM); Africa Centers for Disease Control and Prevention through Bill and Melinda Gates Foundation; UK Foreign, Commonwealth and Development Office and Wellcome; South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Department of Health and Social Care; Foundation for Innovative New Diagnostics and Fogarty International Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Botswana government through the Ministry of Health & Wellness and Presidential COVID-19 Task Force; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	We thank L. de Gouveia, A. Buys, C. Fourie, N. Duma, M. Ndlovu and other members of the NICD Centre for Respiratory Diseases and Meningitis and Sequencing Core Facility; N. Govender, G. Ntshoe, A. Moipone Shonhiwa, D. Muganhiri, I. Matiea, E. Mathatha, F. Gavhi, T. Mashudu Lamola, M. Makhubele, M. Matjokotja, S. Mdleleni, M. Makhubela from the national SARS-CoV-2 NICD surveillance team for NMCSS case data; F. Mckenna, T. Graham Bell, N. Munava, S. Kwenda, M. Raza Bano and J. Khosa from NICD IT for NMCSS case and test data (in particular, SGTF data); and the following people from the diagnostic laboratories for their assistance: K. Reddy, L. Gounder and C. Naicker from NHLS Inkosi Albert Luthuli Central Hospital Laboratory, S. Korsman from the NHLS Groote Schuur Laboratory, and A. Enoch at NHLS Green Point Laboratory; the staff at the global laboratories who generated and made public the SARS-CoV-2 sequences (through GISAID) used as reference dataset in this study (a complete list of individual contributors of sequences is provided in Supplementary Table 1). The research reported in this publication was supported by the Strategic Health Innovation Partnerships Unit of the South African Medical Research Council, with funds received from the South African Department of Science and Innovation. Sequencing activities at KRISP and CERI were supported in part by the WHO, the National Institutes of Health (NIH) (U01 AI151698) for the United World Antivirus Research Network (UWARN), and the Rockefeller Foundation (grants 2021 HTH 017 and 2020 HTH 062). C.L.A. received funding from the European Union's Horizon 2020 research and innovation programme, project EpiPose (no. 101003688). D.P.M. was funded by the Wellcome Trust (222574/Z/21/Z). R.C. and A.R. acknowledge support from the Wellcome Trust (Collaborators Award 206298/Z/17/Z, ARTIC network) and A.R. from the European Research Council (no. 725422, ReservoirDOCS). V.H. was supported by the Biotechnology and Biological Sciences Research Council (BBSRC) (grant no. BB/M010996/1). A.E.Z., J.T., M.U.G.K. and O.G.P. acknowledge support from the Oxford Martin School. M.U.G.K. acknowledges support from the Rockefeller Foundation, Google.org, and the European Horizon 2020 programme MOOD (no. 874850). M.V. and the members of the Zoonotic Arbo and Respiratory Virus Program, UP was funded through the ANDEMIA G7 Global Health Concept: contributions to improvement of International Health, COVID-19 funds through the Robert Koch Institute. The genomic sequencing at UCT/NHLS is funded from the South African Medical Research Council and Department of Science and Innovation; and by the Wellcome Centre for Infectious Diseases Research in Africa (CIDRI-Africa), which is supported by core funding from the Wellcome Trust (203135/Z/16/Z and 222754). C.W. and J.B. are funded by the EDCTP (RADIATES Consortium; RIA2020EF-3030). Sequencing activities at the NICD were supported by a conditional grant from the South African National Department of Health as part of the emergency COVID-19 response; a cooperative agreement between the National Institute for Communicable Diseases of the National Health Laboratory Service and the United States Centers for Disease Control and Prevention (no. 5U01IP001048-05-00); the African Society of Laboratory Medicine (ASLM) and Africa Centers for Disease Control and Prevention through a subaward from the Bill and Melinda Gates Foundation grant no. INV-018978; the UK Foreign, Commonwealth and Development Office and Wellcome (no.; 221003/Z/20/Z); the South African Medical Research Council (SHIPNCD 76756); the UK Department of Health and Social Care, managed by the Fleming Fund and performed under the auspices of the SEQAFRICA project. The genomic sequencing in Botswana was supported by the Foundation for Innovative New Diagnostics and Fogarty International Center (5D43TW009610), NIH (5K24AI131924-04; 5K24AI131928-05) and support from the Botswana government through the Ministry of Health & Wellness and Presidential COVID-19 Task Force. S. Moyo. was supported in part by the Bill & Melinda Gates Foundation (036530). Under the grant conditions of the Foundation, a Creative Commons Attribution 4.0 Generic License has already been assigned to the Author Accepted Manuscript version that might arise from this submission.	Aksamentov I, 2021, J OPEN SOURCE SOFTW, V6, P3773, DOI [DOI 10.21105/JOSS.03773, 10.21105/joss.03773]; Ali A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-67685-0; Althaus CL, TALE 2 VARIANTS SPRE, DOI [10.1101/2021.06.10.21258468, DOI 10.1101/2021.06.10.21258468]; [Anonymous], NEW A Y LINEAGES PAN; Benton DJ, 2020, NATURE, V588, DOI 10.1038/s41586-020-2772-0; Benvenuto D, 2020, PATHOG GLOB HEALTH, V114, P64, DOI 10.1080/20477724.2020.1725339; Boni M., 2021, COVID19 OMICRON ORIG; Boni MF, 2007, GENETICS, V176, P1035, DOI 10.1534/genetics.106.068874; Boni MF, 2020, NAT MICROBIOL, V5, P1408, DOI 10.1038/s41564-020-0771-4; Bouckaert R, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006650; Bragg LM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003031; Brown JC., 2021, INCREASED TRANSMISSI, DOI [10.1101/2021.02.24.432576, DOI 10.1101/2021.02.24.432576]; Byrne AW, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-039856; Campbell F, 2021, EUROSURVEILLANCE, V26, DOI 10.2807/1560-7917.ES.2021.26.24.2100509; Cao YL, 2022, NATURE, V602, P657, DOI 10.1038/s41586-021-04385-3; Cele S, 2022, NATURE, V602, P54; Cleemput S, 2020, BIOINFORMATICS, V36, P3552, DOI 10.1093/bioinformatics/btaa145; Davies NG, 2021, SCIENCE, V372, P149, DOI 10.1126/science.abg3055; Dellicour S, 2016, BIOINFORMATICS, V32, P3204, DOI 10.1093/bioinformatics/btw384; Dhar MS, 2021, SCIENCE, V374, P995, DOI 10.1126/science.abj9932; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Eales O., 2021, SARS COV 2 LINEAGE D, DOI [10.1101/2021.12.17.21267925, DOI 10.1101/2021.12.17.21267925]; Elbe S, 2017, GLOB CHALL, V1, P33, DOI 10.1002/gch2.1018; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Freed N., 2021, SARS COV2 GENOME SEQ, DOI [10.17504/protocols.io.bwyppfvn, DOI 10.17504/PROTOCOLS.IO.BWYPPFVN]; Ganyani T, 2020, EUROSURVEILLANCE, V25, P12, DOI 10.2807/1560-7917.ES.2020.25.17.2000257; Greaney AJ, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-24435-8; Greaney AJ, 2021, CELL HOST MICROBE, V29, P463, DOI 10.1016/j.chom.2021.02.003; Greaney AJ, 2021, CELL HOST MICROBE, V29, P44, DOI 10.1016/j.chom.2020.11.007; Lam HM, 2018, MOL BIOL EVOL, V35, P247, DOI 10.1093/molbev/msx263; Hatcher EL, 2017, NUCLEIC ACIDS RES, V45, pD482, DOI 10.1093/nar/gkw1065; Huisman J.S., 2020, ELIFE, DOI [10.1101/2020.11.26.20239368, DOI 10.1101/2020.11.26.20239368]; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Keeton R, 2022, NATURE, V603, P488, DOI 10.1038/s41586-022-04460-3; Kleynhans J, 2021, EMERG INFECT DIS, V27, P3020, DOI 10.3201/eid2712.211465; Madhi SA, 2022, NEW ENGL J MED, V386, P1314, DOI 10.1056/NEJMoa2119658; Marivate V., 2020, DATA SCI J, V19, P19, DOI DOI 10.5334/DSJ-2020-019; Marivate V., 2020, **DATA OBJECT**, DOI 10.5281/zenodo.3819126; Martin Darren P, 2022, bioRxiv, DOI 10.1101/2022.01.14.476382; Martin DP, 2021, CELL, V184, P5189, DOI 10.1016/j.cell.2021.09.003; Martin DP, 2021, VIRUS EVOL, V7, DOI 10.1093/ve/veaa087; McCallum M, 2021, CELL, V184, P2332, DOI [10.1016/j.cell.2021.03.028, 10.1101/2021.01.14.426475]; Mlcochova P, 2021, NATURE, V599, P114, DOI 10.1038/s41586-021-03944-y; Msomi N, 2020, LANCET MICROBE, V1, pE229, DOI 10.1016/S2666-5247(20)30116-6; Murrell B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002764; National Library of Medicine, NCBI VIR SARS COV 2; NICD, WEEKL TEST SUMM; Planas D, 2022, NATURE, V602, P671, DOI 10.1038/s41586-021-04389-z; Pond SLK, 2008, MOL BIOL EVOL, V25, P1809, DOI 10.1093/molbev/msn123; Pond SLK, 2020, MOL BIOL EVOL, V37, P295, DOI 10.1093/molbev/msz197; Pond SLK, 2006, BIOINFORMATICS, V22, P3096, DOI 10.1093/bioinformatics/btl474; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Pulliam JRC., 2021, INCREASED RISK SARS, DOI [10.1101/2021.11.11.21266068, 10.1101/2021.11.11.21266068:2021.11.11.21266068, DOI 10.1101/2021.11.11.21266068:2021.11.11.21266068]; Rambaut A, 2020, NAT MICROBIOL, V5, P1403, DOI 10.1038/s41564-020-0770-5; Rambaut A, 2018, SYST BIOL, V67, P901, DOI 10.1093/sysbio/syy032; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rossler A, 2022, NEW ENGL J MED, V386, P698, DOI 10.1056/NEJMc2119236; Sagulenko P, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vex042; Saito A, 2022, NATURE, V602, P300, DOI 10.1038/s41586-021-04266-9; Scheepers C., 2021, CONTINUOUS EVOLUTION, DOI [10.1101/2021.08.20.21262342, DOI 10.1101/2021.08.20.21262342]; Shu YL, 2017, EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.13.30494; Smith MD, 2015, MOL BIOL EVOL, V32, P1342, DOI 10.1093/molbev/msv022; Stadler T, 2013, P NATL ACAD SCI USA, V110, P228, DOI 10.1073/pnas.1207965110; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Starr TN, 2021, CELL REP MED, V2, DOI 10.1016/j.xcrm.2021.100255; Starr TN, 2021, SCIENCE, V371, P850, DOI 10.1126/science.abf9302; Starr TN, 2020, CELL, V182, P1295, DOI 10.1016/j.cell.2020.08.012; Suchard MA, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey016; Tegally H., 2021, RAPID REPLACEMENT BE, p2021.09.23.21264018, DOI [10.1101/2021.09.23.21264018, DOI 10.1101/2021.09.23.21264018]; Tegally H, 2021, NATURE, V592, P438, DOI 10.1038/s41586-021-03402-9; Tegally H, 2021, NAT MED, V27, P440, DOI 10.1038/s41591-021-01255-3; van der Walt E, 2009, J GEN VIROL, V90, P734, DOI 10.1099/vir.0.007724-0; Vermeulen M., 2021, PREVALENCE ANTISARS, DOI [10.21203/rs.3.rs-690372/v1, DOI 10.21203/RS.3.RS-690372/V1]; Volz E, 2021, NATURE, V593, P266, DOI 10.1038/s41586-021-03470-x; Wertheim JO, 2015, MOL BIOL EVOL, V32, P820, DOI 10.1093/molbev/msu400; WHO, 2021, CLASSIFICATION OMICR; Wickham H, 2011, WIRES COMPUT STAT, V3, P180, DOI 10.1002/wics.147; Wilkinson Eduan, 2021, Science, V374, P423, DOI 10.1126/science.abj4336; Wisotsky SR, 2020, MOL BIOL EVOL, V37, P2430, DOI 10.1093/molbev/msaa037; Wright C., 2021, EPI2ME LABS WF ARTIC; Wu HB, 2021, CELL HOST MICROBE, V29, P1788, DOI 10.1016/j.chom.2021.11.005; Yu Guangchuang, 2020, Curr Protoc Bioinformatics, V69, pe96, DOI 10.1002/cpbi.96	83	394	402	77	133	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 24	2022	603	7902					679	+		10.1038/s41586-022-04411-y	http://dx.doi.org/10.1038/s41586-022-04411-y		JAN 2022	27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZY5YD	35042229	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000769826100001
J	Emanuel, EJ; Osterholm, M; Gounder, CR				Emanuel, Ezekiel J.; Osterholm, Michael; Gounder, Celine R.			A National Strategy for the "New Normal" of Life With COVID	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Emanuel, Ezekiel J.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Emanuel, Ezekiel J.] Univ Penn, Wharton Sch, Philadelphia, PA 19104 USA; [Osterholm, Michael] Univ Minnesota, Ctr Infect Dis Res & Policy, Minneapolis, MN USA; [Gounder, Celine R.] NYU, Grossman Sch Med, New York, NY USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Minnesota System; University of Minnesota Twin Cities; New York University	Emanuel, EJ (corresponding author), Univ Penn, Med Eth & Hlth Policy, Perelman Sch Med, 423 Guardian Dr,Blockley Hall, Philadelphia, PA 19104 USA.	zemanuel@upenn.edu						[Anonymous], 2021, COVID DATA TRACKER W; CDC Health Action Network, 2021, INCR INT RESP SYNC V; Gounder C, 1998, HEALTH POLICY PLANN, V13, P212, DOI 10.1093/heapol/13.3.212; JHU Coronavirus Resource Center, WEEKLY HOSP TRENDS; Makridis CA, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0245135; National Center for Immunization and Respiratory Diseases, 2021, EST FLU REL ILLN MED; Swagel P., 2020, COMMUNICATION MAY	7	27	27	4	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 18	2022	327	3					211	212		10.1001/jama.2021.24282	http://dx.doi.org/10.1001/jama.2021.24282		JAN 2022	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YV9PQ	34989789				2022-12-28	WOS:000739988300001
J	Fernandes, RM; Coldea, AI; Ding, H; Fisher, IR; Hirschfeld, PJ; Kotliar, G				Fernandes, Rafael M.; Coldea, Amalia I.; Ding, Hong; Fisher, Ian R.; Hirschfeld, P. J.; Kotliar, Gabriel			Iron pnictides and chalcogenides: a new paradigm for superconductivity	NATURE			English	Article							NEMATIC QUANTUM CRITICALITY; SPIN DYNAMICS; T-C; TEMPERATURE; ORDER; STATE; FRUSTRATION; DEPENDENCE; INTEGER; ORIGIN	Superconductivity is a remarkably widespread phenomenon that is observed in most metals cooled to very low temperatures. The ubiquity of such conventional superconductors, and the wide range of associated critical temperatures, is readily understood in terms of the well-known Bardeen-Cooper-Schrieffer theory. Occasionally, however, unconventional superconductors are found, such as the iron-based materials, which extend and defy this understanding in unexpected ways. In the case of the iron-based superconductors, this includes the different ways in which the presence of multiple atomic orbitals can manifest in unconventional superconductivity, giving rise to a rich landscape of gap structures that share the same dominant pairing mechanism. In addition, these materials have also led to insights into the unusual metallic state governed by the Hund's interaction, the control and mechanisms of electronic nematicity, the impact of magnetic fluctuations and quantum criticality, and the importance of topology in correlated states. Over the fourteen years since their discovery, iron-based superconductors have proven to be a testing ground for the development of novel experimental tools and theoretical approaches, both of which have extensively influenced the wider field of quantum materials.	[Fernandes, Rafael M.] Univ Minnesota, Sch Phys & Astron, Minneapolis, MN 55455 USA; [Coldea, Amalia I.] Univ Oxford, Dept Phys, Clarendon Lab, Oxford, England; [Ding, Hong] Chinese Acad Sci, Beijing Natl Lab Condensed Matter Phys, Beijing, Peoples R China; [Ding, Hong] Chinese Acad Sci, Inst Phys, Beijing, Peoples R China; [Ding, Hong] Univ Chinese Acad Sci, CAS Ctr Excellence Topol Quantum Computat, Beijing, Peoples R China; [Fisher, Ian R.] Stanford Univ, Geballe Lab Adv Mat, Stanford, CA USA; [Fisher, Ian R.] Stanford Univ, Dept Appl Phys, Stanford, CA USA; [Fisher, Ian R.] Stanford Inst Mat & Energy Sci, SLAC Natl Accelerator Lab, Menlo Pk, CA USA; [Hirschfeld, P. J.] Univ Florida, Dept Phys, Gainesville, FL USA; [Kotliar, Gabriel] Rutgers State Univ, Phys & Astron Dept, Piscataway, NJ USA; [Kotliar, Gabriel] Brookhaven Natl Lab, Condensed Matter Phys & Mat Sci Dept, Upton, NY USA	University of Minnesota System; University of Minnesota Twin Cities; University of Oxford; Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Physics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Stanford University; Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; State University System of Florida; University of Florida; Rutgers State University New Brunswick; United States Department of Energy (DOE); Brookhaven National Laboratory	Fernandes, RM (corresponding author), Univ Minnesota, Sch Phys & Astron, Minneapolis, MN 55455 USA.	rfernand@umn.edu	Fernandes, Rafael/E-9273-2010; Coldea, Amalia/C-1106-2013	Fernandes, Rafael/0000-0002-3584-5180; Coldea, Amalia/0000-0002-6732-5964; Fisher, Ian/0000-0002-1278-7862	US Department of Energy, Office of Science, Basic Energy Sciences, Materials Science and Engineering Division [DE-SC0020045]; EPSRC Career Acceleration Fellowship [EP/I004475/1]; Oxford Centre for Applied Superconductivity (CFAS); National Science Foundation [NSF PHY-1748958]; National Natural Science Foundation of China [11888101, 11674371]; Strategic Priority Research Program of the Chinese Academy of Sciences, China [XDB28000000, XDB07000000]; Beijing Municipal Science and Technology Commission, China [Z191100007219012]; US Department of Energy, Office of Basic Energy Sciences [DE-AC02-76SF00515]; US Department of Energy, Office of Basic Sciences [DE-FG02-05ER46236]; NSF [DMR-1733071]	US Department of Energy, Office of Science, Basic Energy Sciences, Materials Science and Engineering Division(United States Department of Energy (DOE)); EPSRC Career Acceleration Fellowship(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Oxford Centre for Applied Superconductivity (CFAS); National Science Foundation(National Science Foundation (NSF)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of the Chinese Academy of Sciences, China; Beijing Municipal Science and Technology Commission, China(Beijing Municipal Science & Technology Commission); US Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); US Department of Energy, Office of Basic Sciences(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF))	We thank all our co-authors and collaborators with whom we have had many discussions since the discovery of the iron-based superconductors. In particular, we thank H. Miao and T. H. Lee (Figs. 2 and 5), M. Christensen (Fig. 4) and L.-Y. Kong (Fig. 6) for their assistance in making some of the figures panels. R.M.F. was supported by the US Department of Energy, Office of Science, Basic Energy Sciences, Materials Science and Engineering Division, under award number DE-SC0020045. A.I.C. acknowledges an EPSRC Career Acceleration Fellowship (EP/I004475/1) and the Oxford Centre for Applied Superconductivity (CFAS) for financial support. A.I.C. is grateful to the KITP programme `correlated20', which was supported in part by the National Science Foundation under grant number NSF PHY-1748958. H.D. is supported by the National Natural Science Foundation of China (grant numbers 11888101 and 11674371), the Strategic Priority Research Program of the Chinese Academy of Sciences, China (grant numbers XDB28000000 and XDB07000000) and the Beijing Municipal Science and Technology Commission, China (grant number Z191100007219012). I.R.F. was supported by the US Department of Energy, Office of Basic Energy Sciences, under contract DE-AC02-76SF00515. P.J.H. was supported by the US Department of Energy, Office of Basic Sciences under grant number DE-FG02-05ER46236. G.K. was supported by NSF DMR-1733071.	Abrahams E, 2011, J PHYS-CONDENS MAT, V23, DOI 10.1088/0953-8984/23/22/223201; Aichhorn M, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.064504; Allred JM, 2016, NAT PHYS, V12, P493, DOI [10.1038/nphys3629, 10.1038/NPHYS3629]; Baek SH, 2015, NAT MATER, V14, P210, DOI [10.1038/NMAT4138, 10.1038/nmat4138]; Bascones E, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.174508; Bohmer AE, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.047001; Boeri L, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.026403; Bohmer AE, 2019, PHYS REV B, V100, DOI 10.1103/PhysRevB.100.064515; Borisenko SV, 2016, NAT PHYS, V12, P311, DOI 10.1038/NPHYS3594; Borisenko SV, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.067002; Carrington A, 2011, REP PROG PHYS, V74, DOI 10.1088/0034-4885/74/12/124507; Chen CT, 2010, NAT PHYS, V6, P260, DOI 10.1038/NPHYS1531; Chen C, 2020, NAT PHYS, V16, P536, DOI 10.1038/s41567-020-0813-0; Cho K, 2018, SUPERCOND SCI TECH, V31, DOI 10.1088/1361-6668/aabfa8; Chowdhury D, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.157004; Christensen MH, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.214509; Chu JH, 2010, SCIENCE, V329, P824, DOI 10.1126/science.1190482; Chubukov A, 2012, ANNU REV CONDEN MA P, V3, P57, DOI 10.1146/annurev-conmatphys-020911-125055; Coldea AI, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.216402; Coldea AI, 2021, FRONT PHYS-LAUSANNE, V8, DOI 10.3389/fphy.2020.594500; Cvetkovic V, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.134510; Dagotto E, 2013, REV MOD PHYS, V85, P849, DOI 10.1103/RevModPhys.85.849; Dai PC, 2015, REV MOD PHYS, V87, P855, DOI 10.1103/RevModPhys.87.855; Dai PC, 2012, NAT PHYS, V8, P709, DOI 10.1038/NPHYS2438; de Medici L, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.126401; de' Medici L, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.177001; Dioguardi AP, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.165116; Eremin I, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.024511; Eschrig H, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.104503; Fanfarillo L, 2020, PHYS REV LETT, V125, DOI 10.1103/PhysRevLett.125.177001; Fanfarillo L, 2016, PHYS REV B, V94, DOI 10.1103/PhysRevB.94.155138; Fang C, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.224509; Ferber J, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.094505; Fernandes RM, 2016, PHYS REV B, V93, DOI 10.1103/PhysRevB.93.014511; Fernandes RM, 2014, NAT PHYS, V10, P97, DOI 10.1038/nphys2877; Fernandes RM, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.024534; Fernandes RM, 2017, REP PROG PHYS, V80, DOI 10.1088/1361-6633/80/1/014503; Fernandes RM, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.137001; Fradkin E, 2010, ANNU REV CONDEN MA P, V1, P153, DOI 10.1146/annurev-conmatphys-070909-103925; Frandsen BA, 2019, PHYS REV B, V100, DOI 10.1103/PhysRevB.100.020504; Gallais Y, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.267001; Gallais Y, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.017001; Gastiasoro MN, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.067002; Gati E, 2019, PHYS REV B, V100, DOI 10.1103/PhysRevB.100.064512; Georges A, 2013, ANNU REV CONDEN MA P, V4, P137, DOI 10.1146/annurev-conmatphys-020911-125045; Glasbrenner JK, 2015, NAT PHYS, V11, P953, DOI [10.1038/nphys3434, 10.1038/NPHYS3434]; Grinenko V, 2020, NAT PHYS, V16, P789, DOI 10.1038/s41567-020-0886-9; Hanaguri T, 2010, SCIENCE, V328, P474, DOI 10.1126/science.1187399; Hardy F, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.027002; Haule K, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.226402; Haule K, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/2/025021; Hayes IM, 2016, NAT PHYS, V12, P916, DOI [10.1038/NPHYS3773, 10.1038/nphys3773]; Hirayama M, 2015, J PHYS SOC JPN, V84, DOI 10.7566/JPSJ.84.093703; Hirschfeld PJ, 2011, REP PROG PHYS, V74, DOI 10.1088/0034-4885/74/12/124508; Hosono H, 2018, MATER TODAY, V21, P278, DOI 10.1016/j.mattod.2017.09.006; Huang D, 2017, ANNU REV CONDEN MA P, V8, P311, DOI 10.1146/annurev-conmatphys-031016-025242; Inosov DS, 2010, NAT PHYS, V6, P178, DOI 10.1038/NPHYS1483; Kamihara Y, 2008, J AM CHEM SOC, V130, P3296, DOI 10.1021/ja800073m; Karahasanovic U, 2016, PHYS REV B, V93, DOI 10.1103/PhysRevB.93.064520; Katayama N, 2013, J PHYS SOC JPN, V82, DOI 10.7566/JPSJ.82.123702; Keimer B, 2015, NATURE, V518, P179, DOI 10.1038/nature14165; Klein A, 2018, PHYS REV B, V98, DOI 10.1103/PhysRevB.98.220501; Konig EJ, 2019, PHYS REV LETT, V122, DOI 10.1103/PhysRevLett.122.207001; Kong LY, 2020, ACTA PHYS SIN-CH ED, V69, DOI 10.7498/aps.69.20200717; Kong LY, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-24372-6; Kong LY, 2019, NAT PHYS, V15, P1181, DOI 10.1038/s41567-019-0630-5; Kontani H, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.157001; Kreisel A, 2020, SYMMETRY-BASEL, V12, DOI 10.3390/sym12091402; Kretzschmar F, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.187002; Kuo HH, 2016, SCIENCE, V352, P958, DOI 10.1126/science.aab0103; Kuroki K, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.224511; Lederer S, 2017, P NATL ACAD SCI USA, V114, P4905, DOI 10.1073/pnas.1620651114; Lee CC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.267001; Lee G, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.177001; Lee JJ, 2014, NATURE, V515, P245, DOI 10.1038/nature13894; Lee TH, 2018, PHYS REV LETT, V121, DOI 10.1103/PhysRevLett.121.187003; Levchenko A, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.177003; Liang SH, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.047004; Liu DF, 2018, PHYS REV X, V8, DOI 10.1103/PhysRevX.8.031033; Lohani H, 2020, PHYS REV B, V101, DOI 10.1103/PhysRevB.101.245146; Lorenzana J, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.186402; Lu XY, 2014, SCIENCE, V345, P657, DOI 10.1126/science.1251853; Lumsden MD, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/20/203203; Lumsden MD, 2010, NAT PHYS, V6, P182, DOI 10.1038/NPHYS1512; Lv W, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.045125; Machida T, 2019, NAT MATER, V18, P811, DOI 10.1038/s41563-019-0397-1; Mandal S, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.220502; Mazin II, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.057003; Meier WR, 2018, NPJ QUANTUM MATER, V3, DOI 10.1038/s41535-017-0076-x; Mirri C, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.107001; Misawa T, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.177007; Miyake T, 2010, J PHYS SOC JPN, V79, DOI 10.1143/JPSJ.79.044705; Momma K, 2011, J APPL CRYSTALLOGR, V44, P1272, DOI 10.1107/S0021889811038970; Okazaki K, 2012, SCIENCE, V337, P1314, DOI 10.1126/science.1222793; Ortenzi L, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.046404; Paul I, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.227601; Pelliciari J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07286-6; Pratt DK, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.257001; Qazilbash MM, 2009, NAT PHYS, V5, P647, DOI 10.1038/NPHYS1343; Qureshi N, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.117001; Reiss P, 2020, NAT PHYS, V16, P89, DOI 10.1038/s41567-019-0694-2; Rhodes LC, 2018, PHYS REV B, V98, DOI 10.1103/PhysRevB.98.180503; Richard P, 2015, J PHYS-CONDENS MAT, V27, DOI 10.1088/0953-8984/27/29/293203; Rinott S, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602372; Scalapino DJ, 2012, REV MOD PHYS, V84, P1383, DOI 10.1103/RevModPhys.84.1383; Seo KJ, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.206404; Shibauchi T, 2014, ANNU REV CONDEN MA P, V5, P113, DOI 10.1146/annurev-conmatphys-031113-133921; Shibauchi T, 2020, J PHYS SOC JPN, V89, DOI 10.7566/JPSJ.89.102002; Si QM, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.076401; Singh DJ, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.237003; Skornyakov SL, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.092501; Sprau PO, 2017, SCIENCE, V357, P76, DOI 10.1126/science.aal1575; Stadler KM, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.136401; Stanev V, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.134522; Suzuki Y, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.205117; Tafti FF, 2013, NAT PHYS, V9, P349, DOI [10.1038/nphys2617, 10.1038/NPHYS2617]; Thomale R, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.117001; Thorsmolle VK, 2016, PHYS REV B, V93, DOI 10.1103/PhysRevB.93.054515; Tomczak JM, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.237010; Vafek O, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.087003; VANDERMAREL D, 1988, PHYS REV B, V37, P10674, DOI 10.1103/PhysRevB.37.10674; Wang DF, 2018, SCIENCE, V362, P333, DOI 10.1126/science.aao1797; Wang F, 2015, NAT PHYS, V11, P959, DOI [10.1038/nphys3456, 10.1038/NPHYS3456]; Wang F, 2011, SCIENCE, V332, P200, DOI 10.1126/science.1200182; Wang M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3874; Wang QS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12182; Wang ZY, 2020, SCIENCE, V367, P104, DOI 10.1126/science.aaw8419; Wang ZJ, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.115119; Werner P, 2012, NAT PHYS, V8, P331, DOI [10.1038/NPHYS2250, 10.1038/nphys2250]; Worasaran T, 2021, SCIENCE, V372, P973, DOI 10.1126/science.abb9280; Wu S, 2020, J SUPERCOND NOV MAGN, V33, P143, DOI 10.1007/s10948-019-05304-4; Xu C, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.020501; Yang H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3749; Yang WL, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.014508; Yi M, 2017, NPJ QUANTUM MATER, V2, DOI 10.1038/s41535-017-0059-y; Yildirim T, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.057010; Yin JX, 2015, NAT PHYS, V11, P543, DOI 10.1038/NPHYS3371; Yin ZP, 2014, NAT PHYS, V10, P845, DOI 10.1038/NPHYS3116; Yin ZP, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.195141; Yin ZP, 2011, NAT MATER, V10, P932, DOI [10.1038/NMAT3120, 10.1038/nmat3120]; Yu R, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.024509; Yu R, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.146402; Zaki N, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2007241118; Zantout K, 2019, PHYS REV LETT, V123, DOI 10.1103/PhysRevLett.123.256401; Zhang P, 2019, NAT PHYS, V15, P41, DOI 10.1038/s41567-018-0280-z; Zhang P, 2018, SCIENCE, V360, P182, DOI 10.1126/science.aan4596; Zhang RX, 2019, PHYS REV LETT, V122, DOI 10.1103/PhysRevLett.122.187001	152	16	16	41	68	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 6	2022	601	7891								10.1038/s41586-021-04073-2	http://dx.doi.org/10.1038/s41586-021-04073-2			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6O4IA	34987212	Green Submitted			2022-12-28	WOS:000890204900001
J	Tawbi, HA; Schadendorf, D; Lipson, EJ; Ascierto, PA; Matamala, L; Gutierrez, EC; Rutkowski, P; Gogas, HJ; Lao, CD; De Menezes, JJ; Dalle, S; Arance, A; Grob, JJ; Srivastava, S; Abaskharoun, M; Hamilton, M; Keidel, S; Simonsen, KL; Sobiesk, AM; Li, B; Hodi, FS; Long, GV				Tawbi, Hussein A.; Schadendorf, Dirk; Lipson, Evan J.; Ascierto, Paolo A.; Matamala, Luis; Gutierrez, Erika Castillo; Rutkowski, Piotr; Gogas, Helen J.; Lao, Christopher D.; De Menezes, Juliana Janoski; Dalle, Stephane; Arance, Ana; Grob, Jean-Jacques; Srivastava, Shivani; Abaskharoun, Mena; Hamilton, Melissa; Keidel, Sarah; Simonsen, Katy L.; Sobiesk, Anne Marie; Li, Bin; Hodi, F. Stephen; Long, Georgina, V		RELATIVITY-047 Investigators	Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IPILIMUMAB; LAG-3; THERAPY	BACKGROUND Lymphocyte-activation gene 3 (LAG-3) and programmed death 1 (PD-1) are distinct inhibitory immune checkpoints that contribute to T-cell exhaustion. The combination of relatlimab, a LAG-3-blocking antibody, and nivolumab, a PD-1-blocking antibody, has been shown to be safe and to have antitumor activity in patients with previously treated melanoma, but the safety and activity in patients with previously untreated melanoma need investigation. METHODS In this phase 2-3, global, double-blind, randomized trial, we evaluated relatlimab and nivolumab as a fixed-dose combination as compared with nivolumab alone when administered intravenously every 4 weeks to patients with previously untreated metastatic or unresectable melanoma. The primary end point was progression-free survival as assessed by blinded independent central review. RESULTS The median progression-free survival was 10.1 months (95% confidence interval [CI], 6.4 to 15.7) with relatlimab-nivolumab as compared with 4.6 months (95% CI, 3.4 to 5.6) with nivolumab (hazard ratio for progression or death, 0.75 [95% CI, 0.62 to 0.92]; P=0.006 by the log-rank test). Progression-free survival at 12 months was 47.7% (95% CI, 41.8 to 53.2) with relatlimab-nivolumab as compared with 36.0% (95% CI, 30.5 to 41.6) with nivolumab. Progression-free survival across key subgroups favored relatlimab-nivolumab over nivolumab. Grade 3 or 4 treatment-related adverse events occurred in 18.9% of patients in the relatlimab-nivolumab group and in 9.7% of patients in the nivolumab group. CONCLUSIONS The inhibition of two immune checkpoints, LAG-3 and PD-1, provided a greater benefit with regard to progression-free survival than inhibition of PD-1 alone in patients with previously untreated metastatic or unresectable melanoma. Relatlimab and nivolumab in combination showed no new safety signals.	[Tawbi, Hussein A.] Univ Texas MD Anderson Canc Ctr, Dept Melanoma Med Oncol, Div Canc Med, Houston, TX 77030 USA; [Schadendorf, Dirk] Univ Hosp Essen, Dept Dermatol, Essen, Germany; [Schadendorf, Dirk] German Canc Consortium, Essen, Germany; [Lipson, Evan J.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Bloomberg Kimmel Inst Canc Immunotherapy, Baltimore, MD USA; [Ascierto, Paolo A.] Ist Nazl Tumori IRCCS Fdn G Pascale, Naples, Italy; [Matamala, Luis] Inst Oncol Fdn Arturo Lopez Perez, Dept Oncol, Santiago, Chile; [Gutierrez, Erika Castillo] FAICIC Clin Res, Veracruz, Veracruz, Mexico; [Rutkowski, Piotr] Maria Sklodowska Curie Natl Res Inst Oncol, Warsaw, Poland; [Gogas, Helen J.] Natl & Kapodistrian Univ Athens, Dept Med, Athens, Greece; [Lao, Christopher D.] Univ Michigan, Rogel Canc Ctr, Michigan Med, Ann Arbor, MI 48109 USA; [De Menezes, Juliana Janoski] Hosp Nossa Senhora da Conceicao, Porto Alegre, RS, Brazil; [Dalle, Stephane] Hosp Civils Lyon, Canc Res Ctr Lyon, Unit Dermatol, Pierre Benite, France; [Grob, Jean-Jacques] Aix Marseille Univ, CHU Timone, Marseille, France; [Arance, Ana] Hosp Clin Barcelona, Dept Med Oncol, Barcelona, Spain; [Arance, Ana] IDIBAPS, Barcelona, Spain; [Srivastava, Shivani; Abaskharoun, Mena; Hamilton, Melissa; Keidel, Sarah; Simonsen, Katy L.; Sobiesk, Anne Marie; Li, Bin] Bristol Myers Squibb, Princeton, NJ USA; [Hodi, F. Stephen] Dana Farber Canc Inst, Boston, MA 02115 USA; [Long, Georgina, V] Univ Sydney, Melanoma Inst Australia, Royal North Shore & Mater Hosp, Sydney, NSW, Australia	University of Texas System; UTMD Anderson Cancer Center; University of Duisburg Essen; Helmholtz Association; German Cancer Research Center (DKFZ); Johns Hopkins University; Johns Hopkins Medicine; IRCCS Fondazione Pascale; National & Kapodistrian University of Athens; University of Michigan System; University of Michigan; CHU Lyon; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Bristol-Myers Squibb; Harvard University; Dana-Farber Cancer Institute; Melanoma Institute Australia; Royal North Shore Hospital; University of Sydney	Tawbi, HA (corresponding author), Univ Texas MD Anderson Canc Ctr, Div Canc Med, 1400 Holcombe Blvd, Houston, TX 77030 USA.	htawbi@mdanderson.org	de Melo, Andreia/C-8133-2019; Pigozzo, Jacopo/AAD-5994-2021; Rutkowski, Piotr/B-3907-2013; Long, Georgina/C-1771-2013	de Melo, Andreia/0000-0002-1201-4333; Pigozzo, Jacopo/0000-0003-2427-8915; Rutkowski, Piotr/0000-0002-8920-5429; Long, Georgina/0000-0001-8894-3545; Kruse, Vibeke/0000-0002-8840-3298; Neyns, Bart/0000-0003-0658-5903; Svane, Inge Marie/0000-0002-9451-6037; Schadendorf, Dirk/0000-0003-3524-7858				American Joint Committee on Cancer, 2018, AJCC CANC STAGING MA; Anderson AC, 2016, IMMUNITY, V44, P989, DOI 10.1016/j.immuni.2016.05.001; Ascierto PA, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.35.15_suppl.9520; Askew RL, 2009, VALUE HEALTH, V12, P1144, DOI 10.1111/j.1524-4733.2009.00570.x; Cormier JN, 2008, CANCER-AM CANCER SOC, V112, P2249, DOI 10.1002/cncr.23424; Dillon LM., CANCER RES, V81, P1625; Durham NM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109080; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Hemon P, 2011, J IMMUNOL, V186, P5173, DOI 10.4049/jimmunol.1002050; Hodi FS, 2018, LANCET ONCOL, V19, P1480, DOI 10.1016/S1470-2045(18)30700-9; Larkin J, 2019, NEW ENGL J MED, V381, P1535, DOI 10.1056/NEJMoa1910836; Larkin J, 2015, NEW ENGL J MED, V373, P23, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Lipson E., 2016, J IMMUNOTHER CANCER, V4, P232; Long GV, 2019, LANCET ONCOL, V20, P1083, DOI 10.1016/S1470-2045(19)30274-8; Michielin O, 2019, ANN ONCOL, V30, P1884, DOI 10.1093/annonc/mdz411; Phillips T, 2018, APPL IMMUNOHISTO M M, V26, P6, DOI [10.1097/PAI.0000000000000380, 10.1097/PAI.0000000000000605]; Pickard AS, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-70; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; Robert C, 2015, NEW ENGL J MED, V372, P2521, DOI 10.1056/NEJMoa1503093; Robert C, 2015, NEW ENGL J MED, V372, P320, DOI 10.1056/NEJMoa1412082; Seth R, 2020, J CLIN ONCOL, V38, DOI 10.1200/JCO.20.00198; Wolchok JD, 2017, NEW ENGL J MED, V377, P1345, DOI 10.1056/NEJMoa1709684; Wolchok JD, 2021, J CLIN ONCOL, V39, DOI 10.1200/JCO.2021.39.15_suppl.9506; Woo SR, 2012, CANCER RES, V72, P917, DOI 10.1158/0008-5472.CAN-11-1620; Workman CJ, 2004, J IMMUNOL, V172, P5450, DOI 10.4049/jimmunol.172.9.5450	25	180	181	22	54	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 6	2022	386	1					24	34		10.1056/NEJMoa2109970	http://dx.doi.org/10.1056/NEJMoa2109970			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YC1QX	34986285				2022-12-28	WOS:000739473800008
J	Greenhalgh, T; Griffin, S; Gurdasani, D; Hamdy, A; Katzourakis, A; McKee, M; Michie, S; Pagel, C; Roberts, A; Yates, K; Alwan, N; Agius, R; Ahmed, H; Ashworth, S; Augst, C; Bacon, SL; Bergholtz, EJ; Blanchflower, D; Bosman, A; Ben Alaya, NBE; Brown, K; Butler, M; Byrne, M; Cacciola, R; Cane, DJ; Cascini, F; Chahed, M; Cheng, KK; Costello, A; Morris, AC; Davies, R; Davis, C; Delaney, B; Dewald, D; Drew, D; Ewing, A; Drury, J; Fisman, D; Friel, S; Gasperowicz, M; Grimes, DR; Haque, Z; Haseltine, WA; Hegarty, O; Hodes, S; Hughes, E; Hyde, Z; Iannattone, L; Jadad, AR; Jha, N; Jimenez, JL; Jimenez, JL; Johnson, J; Karan, A; Khunti, K; Khuri-Bulos, N; Kim, WJ; Knight, MJ; Lavoie, KL; Lawton, T; Lazarus, JV; Leonardi, AJ; Leshem, E; Lightstone, L; Markov, PV; Martin-Moreno, JM; Meier, P; Mesiano-Crookston, J; Mishra, AK; Moore, M; Moschos, SA; Naylor, CD; Nichols, T; Nicholl, D; Norheim, OF; Oliver, M; Peters, C; Pillay, D; Pimenta, D; Pirzada, K; Pope, C; Prather, KA; Preest, G; Quereshi, Z; Rabiei, K; Ray, J; Reddy, KS; Ricciardi, W; Rice, K; Robertson, E; Roberts, K; Ryan, T; Salisbury, H; Scally, G; Schooley, RT; Shah, V; Silver, J; Silvey, N; Sivan, M; Souza, LE; Staines, A; Tomlinson, D; Tukuitonga, C; Vincent, C; Vipond, J; West, R; Weyand, AC; Ziauddeen, H				Greenhalgh, Trisha; Griffin, Stephen; Gurdasani, Deepti; Hamdy, Adam; Katzourakis, Aris; McKee, Martin; Michie, Susan; Pagel, Christina; Roberts, Alice; Yates, Kit; Alwan, Nisreen; Agius, Raymond; Ahmed, Haitham; Ashworth, Simon; Augst, Charlotte; Bacon, Simon L.; Bergholtz, Emil J.; Blanchflower, David; Bosman, Arnold; Ben Alaya, Nissaf Bouafif Ep; Brown, Katherine; Butler, Matthew; Byrne, Molly; Cacciola, Roberto; Cane, Danielle J.; Cascini, Fidelia; Chahed, Mohamed; Cheng, K. K.; Costello, Anthony; Morris, Andrew Conway; Davies, Roz; Davis, Colin; Delaney, Brendan; Dewald, Denise; Drew, David; Ewing, Andrew; Drury, John; Fisman, David; Friel, Sharon; Gasperowicz, Malgorzata; Grimes, David Robert; Haque, Zubaida; Haseltine, William A.; Hegarty, Orla; Hodes, Simon; Hughes, Eilir; Hyde, Zoe; Iannattone, Lisa; Jadad, Alejandro R.; Jha, Neena; Jimenez, Jose Luis; Jimenez, Jose Luis; Johnson, John; Karan, Abraar; Khunti, Kamlesh; Khuri-Bulos, Najwa; Kim, Woo Joo; Knight, Matthew J.; Lavoie, Kim L.; Lawton, Tom; Lazarus, Jeffrey V.; Leonardi, Anthony Joseph; Leshem, Eyal; Lightstone, Liz; Markov, Peter V.; Martin-Moreno, Jose M.; Meier, Petra; Mesiano-Crookston, Jonathan; Mishra, Asit Kumar; Moore, Michael; Moschos, Sterghios A.; Naylor, C. David; Nichols, Taylor; Nicholl, David; Norheim, Ole F.; Oliver, Matthew; Peters, Christine; Pillay, Deenan; Pimenta, Dominic; Pirzada, Kashif; Pope, Catherine; Prather, Kimberly A.; Preest, Geraint; Quereshi, Zeshan; Rabiei, Katrin; Ray, James; Reddy, K. Srinath; Ricciardi, Walter; Rice, Ken; Robertson, Eleanor; Roberts, Kim; Ryan, Tomas; Salisbury, Helen; Scally, Gabriel; Schooley, Robert T.; Shah, Vipul; Silver, Joshua; Silvey, Natalie; Sivan, Manoj; Souza, Luis Eugenio; Staines, Anthony; Tomlinson, David; Tukuitonga, Collin; Vincent, Charles; Vipond, Joe; West, Robert; Weyand, Angela C.; Ziauddeen, Hisham		World Federation Public Hlth Assoc	Covid-19: An urgent call for global "vaccines-plus" action	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Greenhalgh, Trisha; Salisbury, Helen] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England; [Griffin, Stephen] Univ Leeds, Sch Med, Leeds Inst Med Res, Leeds, W Yorkshire, England; [Gurdasani, Deepti] Queen Mary Univ London, London, England; [Katzourakis, Aris] Univ Oxford, Dept Zool, Oxford, England; [McKee, Martin; Cane, Danielle J.; Markov, Peter V.] London Sch Hyg & Trop Med, London, England; [Michie, Susan] UCL, Dept Clin Hlth & Educ Psychol, London, England; [Pagel, Christina; Brown, Katherine] UCL, London, England; [Roberts, Alice] Univ Birmingham, Publ Engagement Sci, Birmingham, W Midlands, England; [Yates, Kit] Univ Bath, Dept Math Sci, Ctr Math Biol, Bath, Avon, England; [Alwan, Nisreen] Univ Southampton, Southampton, Hants, England; [Agius, Raymond] Univ Manchester, Manchester, Lancs, England; [Ahmed, Haitham] AdvantageCare Phys, New York, NY USA; [Ashworth, Simon; Lightstone, Liz] Imperial Coll Healthcare NHS Trust, London, England; [Augst, Charlotte] Natl Voices, London, England; [Bacon, Simon L.] Concordia Univ, Dept Hlth Kinesiol & Appl Physiol HKAP, Montreal, PQ, Canada; [Bergholtz, Emil J.] Stockholm Univ, Dept Phys, Stockholm, Sweden; [Blanchflower, David] Dartmouth Coll, Hanover, NH 03755 USA; [Blanchflower, David; Meier, Petra] Univ Glasgow, Glasgow, Lanark, Scotland; [Bosman, Arnold] Transmissible BV, Tiendeveen, Netherlands; [Ben Alaya, Nissaf Bouafif Ep] Minist Hlth, Natl Observ New & Emerging Dis, Tunis, Tunisia; [Ben Alaya, Nissaf Bouafif Ep] Univ Tunis El Manar, Fac Med Tunis, Dept Prevent Med, Tunis, Tunisia; [Brown, Katherine] Great Ormond St Hosp Sick Children, London, England; [Butler, Matthew] Cambridge Univ Hosp, Cambridge, England; [Byrne, Molly] Natl Univ Ireland, Sch Psychol, Hlth Behav Change Res Grp, Galway, Ireland; [Cacciola, Roberto] Univ Tor Vergata, Dept Surg Sci, Rome, Italy; [Cascini, Fidelia] Univ Cattolica Sacro Cuore, Dipartimento Sci Vita & Sanita Pubbl, Rome, Italy; [Chahed, Mohamed] Univ Tunis El Manar, Fac Med Tunis, Tunis, Tunisia; [Cheng, K. K.] Univ Birmingham, Inst Appl Hlth Res, Birmingham, W Midlands, England; [Costello, Anthony] UCL, Inst Global Hlth, London, England; [Morris, Andrew Conway; Quereshi, Zeshan] Univ Cambridge, Cambridge, England; [Morris, Andrew Conway] European Soc Intens Care Med, Cambridge, England; [Davies, Roz] Thrive By Design, Leeds, W Yorkshire, England; [Davis, Colin] Univ Bristol, Sch Psychol Sci, Bristol, Avon, England; [Delaney, Brendan] Imperial Coll, London, England; [Dewald, Denise] Case Western Reserve Univ, Sch Med, Cleveland, OH USA; [Drury, John] Univ Sussex, Sch Psychol, Brighton, E Sussex, England; [Ewing, Andrew] Univ Gothenburg, Dept Chem & Mol Biol, Gothenburg, Sweden; [Ewing, Andrew] Swedish Acad Sci, Stockholm, Sweden; [Fisman, David] Univ Toronto, Dalla Lana Sch Publ Hlth, Epidemiol, Toronto, ON, Canada; [Friel, Sharon] Australian Natl Univ, Canberra, ACT, Australia; [Gasperowicz, Malgorzata] Univ Calgary, Fac Nursing, Calgary, AB, Canada; [Grimes, David Robert] Dublin City Univ, Dublin, Ireland; [Grimes, David Robert; Vincent, Charles] Univ Oxford, Oxford, England; [Haseltine, William A.] ACCESS Hlth Int, New York, NY USA; [Hegarty, Orla] Univ Coll Dublin, Sch Architecture Planning & Environm Policy, Dublin, Ireland; [Hodes, Simon] Bridgewater Surgeries, London, England; [Hodes, Simon] Cleveland Clin London, London, England; [Hughes, Eilir] West Wales, Cardiff, Wales; [Hyde, Zoe] Univ Western Australia, Western Australian Ctr Hlth & Ageing, Nedlands, WA, Australia; [Iannattone, Lisa] Univ Montreal, Montreal, PQ, Canada; [Jadad, Alejandro R.] Ctr Global eHlth Innovat, Toronto, ON, Canada; [Jimenez, Jose Luis] Univ Colorado, Dept Chem, Boulder, CO 80309 USA; [Jimenez, Jose Luis] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; [Johnson, John] Eastern Hlth, Melbourne, Vic, Australia; [Karan, Abraar] Stanford Univ, Div Infect Dis & Geog Med, Stanford, CA 94305 USA; [Khunti, Kamlesh] Univ Leicester, Leicester, Leics, England; [Khuri-Bulos, Najwa] Univ Jordan, Amman, Jordan; [Khuri-Bulos, Najwa] Vanderbilt Univ, Paediat Infect Dis, 221 Kirkland Hall, Nashville, TN 37235 USA; [Kim, Woo Joo] Guro Hosp, Div Infect Dis, Seoul, South Korea; [Kim, Woo Joo] Korea Univ, Coll Med, Chung Mong Koo Vaccine Innovat Ctr, Seoul, South Korea; [Knight, Matthew J.] West Hertfordshire Hosp NHS Trust, Watford, England; [Lavoie, Kim L.] Univ Quebec Montreal, Dept Psychol, Montreal, PQ, Canada; [Lawton, Tom] Bradford Inst Hlth Res, Bradford, W Yorkshire, England; [Lawton, Tom] Bradford Teaching Hosp NHS Fdn Trust, Bradford, W Yorkshire, England; [Lazarus, Jeffrey V.] Univ Barcelona, Hosp Clin, Barcelona Inst Global Hlth ISGlobal, Barcelona, Spain; [Leonardi, Anthony Joseph] Johns Hopkins Univ Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Leshem, Eyal] Tel Aviv Univ, Sch Med, Tel Aviv, Israel; [Martin-Moreno, Jose M.] Univ Valencia, Dept Prevent Med & Publ Hlth, Valencia, Spain; [Martin-Moreno, Jose M.] Univ Valencia, INCLIVA, Valencia, Spain; [Mesiano-Crookston, Jonathan] Partner Goldman Hine LLP, Toronto, ON, Canada; [Mishra, Asit Kumar] NUI Galway, Galway, Ireland; [Moore, Michael] George Inst Global Hlth, Oxford, England; [Moschos, Sterghios A.] Northumbria Univ, Cellular & Mol Sci, Newcastle Upon Tyne, Tyne & Wear, England; [Naylor, C. David] Univ Toronto, Toronto, ON, Canada; [Nicholl, David] Sandwell & West Birmingham NHS Trust, Birmingham, W Midlands, England; [Norheim, Ole F.] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway; [Oliver, Matthew] Assoc Profess Engn & Geoscientists Alberta, Edmonton, AB, Canada; [Peters, Christine] QEUH NHS Greater Glasgow & Clyde, Glasgow, Lanark, Scotland; [Pimenta, Dominic] Richmond Res Inst, London, England; [Pirzada, Kashif] McMaster Univ, Hamilton, ON, Canada; [Pope, Catherine] Univ Oxford, Med Sociol, Oxford, England; [Prather, Kimberly A.] Univ Calif San Diego, La Jolla, CA 92093 USA; [Rabiei, Katrin] Gothenburg Univ, Sahlgrenska Acad, Inst Neurosci & Physiol, Gothenburg, Sweden; [Ray, James] NHS England, London, England; [Reddy, K. Srinath] Publ Hlth Fdn India, Gurugram, India; [Ricciardi, Walter] Univ Cattolica Sacro Cuore, Rome, Italy; [Rice, Ken] Univ Edinburgh, Sch Phys & Astron, Edinburgh, Midlothian, Scotland; [Robertson, Eleanor] NHS Greater Glasgow & Clyde, Glasgow, Lanark, Scotland; [Roberts, Kim] Trinity Coll Dublin, Dept Microbiol, Dublin, Ireland; [Ryan, Tomas] Trinity Coll Dublin, Dublin, Ireland; [Scally, Gabriel] Univ Bristol, Populat Sci, Bristol, Avon, England; [Schooley, Robert T.] Univ Calif San Diego, La Jolla, CA 92093 USA; [Shah, Vipul] RP Shah Mem Trust, Lucknow, Uttar Pradesh, India; [Silver, Joshua] Univ Oxford, Dept Phys, Oxford, England; [Sivan, Manoj] Univ Leeds, Leeds, W Yorkshire, England; [Sivan, Manoj] Leeds Teaching Hosp NHS Trust, Leeds, W Yorkshire, England; [Souza, Luis Eugenio] Univ Fed Bahia, Salvador, BA, Brazil; [Souza, Luis Eugenio] World Federat Publ Hlth Associat, Rio De Janeiro, Brazil; [Staines, Anthony] Dublin City Univ, Sch Nursing Psychotherapy & Community Hlth, Dublin, Ireland; [Tomlinson, David] Univ Hosp Plymouth NHS Trust, Plymouth, Devon, England; [Tomlinson, David] Fresh Air NHS, Poole, Dorset, England; [Tukuitonga, Collin] Univ Auckland, Fac Med & Hlth Sci, Auckland, New Zealand; [Vipond, Joe] Univ Calgary, Calgary, AB, Canada; [West, Robert] UCL, Inst Epidemiol & Healthcare, London, England; [Weyand, Angela C.] Univ Michigan, Sch Med, Ann Arbor, MI USA; [Ziauddeen, Hisham] Univ Cambridge, Dept Psychiat, Cambridge, England	University of Oxford; University of Leeds; University of London; Queen Mary University London; University of Oxford; University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; University of London; University College London; University of Birmingham; University of Bath; University of Southampton; University of Manchester; Imperial College London; Concordia University - Canada; Stockholm University; Dartmouth College; University of Glasgow; Universite de Tunis-El-Manar; Faculte de Medecine de Tunis (FMT); University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Cambridge; Ollscoil na Gaillimhe-University of Galway; University of Rome Tor Vergata; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Universite de Tunis-El-Manar; Faculte de Medecine de Tunis (FMT); University of Birmingham; University of London; University College London; University of Cambridge; University of Bristol; Imperial College London; Case Western Reserve University; University of Sussex; University of Gothenburg; Royal Swedish Academy of Sciences; University of Toronto; Australian National University; University of Calgary; Dublin City University; University of Oxford; University College Dublin; Cleveland Clinic Foundation; University of Western Australia; Universite de Montreal; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Stanford University; University of Leicester; University of Jordan; Vanderbilt University; Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); University of Quebec; University of Quebec Montreal; ISGlobal; University of Barcelona; Hospital Clinic de Barcelona; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Tel Aviv University; University of Valencia; University of Valencia; Northumbria University; University of Toronto; University of Bergen; McMaster University; University of Oxford; University of California System; University of California San Diego; University of Gothenburg; Public Health Foundation of India; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Edinburgh; Trinity College Dublin; Trinity College Dublin; University of Bristol; University of California System; University of California San Diego; University of Oxford; University of Leeds; University of Leeds; Universidade Federal da Bahia; Dublin City University; University of Auckland; University of Calgary; University of London; University College London; University of Michigan System; University of Michigan; University of Cambridge	Greenhalgh, T (corresponding author), Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England.		Lazarus, Jeffrey V./R-6248-2018; Jimenez, Jose L/A-5294-2008; Ricciardi, Walter/AAB-2056-2019; Karan, Abraar/AAD-7967-2022; Hyde, Zoë/B-6411-2009; Grimes, David Robert/J-7384-2013; Moschos, Sterghios/AAD-8848-2022; Cacciola, Roberto/ABA-6116-2020; Alwan, Nisreen A./AFP-0662-2022; Bergholtz, Emil J./C-3820-2008; Greenhalgh, Trisha/B-1825-2015; Staines, Anthony/AFQ-7565-2022; Norheim, Ole Frithjof/AAC-8771-2020; Michie, Susan/A-1745-2010; West, Robert/B-5414-2009; Yates, Christian/A-8863-2014	Lazarus, Jeffrey V./0000-0001-9618-2299; Jimenez, Jose L/0000-0001-6203-1847; Ricciardi, Walter/0000-0002-5655-688X; Hyde, Zoë/0000-0002-5985-1729; Grimes, David Robert/0000-0003-3140-3278; Moschos, Sterghios/0000-0001-6038-3785; Cacciola, Roberto/0000-0001-8363-1358; Alwan, Nisreen A./0000-0002-4134-8463; Bergholtz, Emil J./0000-0002-9739-2930; Greenhalgh, Trisha/0000-0003-2369-8088; Staines, Anthony/0000-0001-9161-1357; Norheim, Ole Frithjof/0000-0002-5748-5956; Michie, Susan/0000-0003-0063-6378; Hamdy, Adam/0000-0001-8565-0835; West, Robert/0000-0001-6398-0921; Yates, Christian/0000-0003-0461-7297				[Anonymous], 2021, WHORECOMMENDATIONS M; [Anonymous], 2021, COVID 19 INF PREV CO; Bagheri G, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2110117118; Berry G, 2022, ENVIRON RES, V203, DOI 10.1016/j.envres.2021.111765; Cevik M, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n224; Engzell P, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2022376118; Ferris M, FFP3 RESPIRATORS PRO; Fisman D, 2021, PROGR INCREASE VIRUL; Gettings J, 2021, MMWR-MORBID MORTAL W, V70, P779, DOI 10.15585/mmwr.mm7021e1; Giattino C., 2021, EXCESS MORTALITY COR; Greenhalgh Trisha, 2021, Wellcome Open Res, V6, P126, DOI 10.12688/wellcomeopenres.16855.1; Jazieh AR, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00429; Katz IT, 2021, NEW ENGL J MED, V384, P1281, DOI 10.1056/NEJMp2103614; Kochanczyk M, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-81869-2; Kung S, 2021, LANCET, V397, P25, DOI 10.1016/S0140-6736(20)32647-7; Ledford H, 2021, NATURE, V599, P546, DOI 10.1038/d41586-021-03495-2; McCann P, 2022, REG STUD, V56, P1142, DOI 10.1080/00343404.2021.1983164; McKee M, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n3128; Morawska L, 2021, SCIENCE, V372, P689, DOI 10.1126/science.abg2025; Morawska L, 2020, CLIN INFECT DIS, V71, P2311, DOI 10.1093/cid/ciaa939; Oliu-Barton M, 2021, LANCET, V397, P2234, DOI 10.1016/S0140-6736(21)00978-8; Patel J, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n625; Planas D., CONSIDERABLE ESCAPE, DOI [10.1101/2021.12.14.472630, DOI 10.1101/2021.12.14.472630]; Randolph HE, 2020, IMMUNITY, V52, P737, DOI 10.1016/j.immuni.2020.04.012; Sudre CH, 2021, NAT MED, V27, DOI 10.1038/s41591-021-01292-y; UK Health Security Agency, 2021, OM DAIL OV; US) CfDCaP, SCI BRIEF COMM US MA, P2021; Wu SS, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj-2021-067508	28	9	9	2	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 3	2022	376								o1	10.1136/bmj.o1	http://dx.doi.org/10.1136/bmj.o1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YD5XT	34980603	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000740515600001
J	Harman, S				Harman, Sophie			The wall	LANCET			English	Editorial Material									[Harman, Sophie] Queen Mary Univ London, Sch Polit & Int Relat, London E1 4NS, England	University of London; Queen Mary University London	Harman, S (corresponding author), Queen Mary Univ London, Sch Polit & Int Relat, London E1 4NS, England.	s.harman@qmul.ac.uk							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN	2022	399	10320					136	137						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YD7YG	34998498				2022-12-28	WOS:000740652500014
J	Valaiyapathi, R; Wu, MS; McGregor, A				Valaiyapathi, Rajalakshmi; Wu, Meng-San; McGregor, Alastair			Ground glass opacities are not always COVID-19: a case of acute eosinophilic pneumonitis caused by daptomycin	LANCET			English	Editorial Material									[Valaiyapathi, Rajalakshmi; Wu, Meng-San; McGregor, Alastair] London North West Univ Healthcare NHS Trust, Northwick Pk Hosp, Dept Infect Dis, Harrow HA1 3UJ, Middx, England	Imperial College London	Valaiyapathi, R (corresponding author), London North West Univ Healthcare NHS Trust, Northwick Pk Hosp, Dept Infect Dis, Harrow HA1 3UJ, Middx, England.	r.valaiyapathi@nhs.net							0	1	1	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN	2022	399	10321					270	270						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YL7AZ	35033220	Green Published, Bronze			2022-12-28	WOS:000746041700022
J	Drossart, G				Drossart, Gaetan			Afghanistan is in crisis-urgent health and humanitarian aid must be facilitated	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Drossart, Gaetan] MSF, Kabul, Afghanistan	Doctors Without Borders	Drossart, G (corresponding author), MSF, Kabul, Afghanistan.							[Anonymous], 2021, 97 PERCENT AFGHANS C; Lawder D., 2021, REUTERS 0824	2	1	1	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 30	2021	375								n3160	10.1136/bmj.n3160	http://dx.doi.org/10.1136/bmj.n3160			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YE7WR	34969674				2022-12-28	WOS:000741331900001
J	Whittaker, HR; Gulea, C; Koteci, A; Kallis, C; Morgan, AD; Iwundu, C; Weeks, M; Gupta, R; Quint, JK				Whittaker, Hannah R.; Gulea, Claudia; Koteci, Ardita; Kallis, Constantinos; Morgan, Ann D.; Iwundu, Chukwuma; Weeks, Mark; Gupta, Rikisha; Quint, Jennifer K.			GP consultation rates for sequelae after acute covid-19 in patients managed in the community or hospital in the UK: population based study	BMJ-BRITISH MEDICAL JOURNAL			English	Article								OBJECTIVES To describe the rates for consulting a general practitioner (GP) for sequelae after acute covid-19 in patients admitted to hospital with covid-19 and those managed in the community, and to determine how the rates change over time for patients in the community and after vaccination for covid-19. DESIGN Population based study. SETTING 1392 general practices in England contributing to the Clinical Practice Research Datalink Aurum database. PARTICIPANTS 456 002 patients with a diagnosis of covid-19 between 1 August 2020 and 14 February 2021 (44.7% men; median age 61 years), admitted to hospital within two weeks of diagnosis or managed in the community, and followed-up for a maximum of 9.2 months. A negative control group included individuals without covid-19 (n=38 511) and patients with influenza before the pandemic (n=21 803). MAIN OUTCOME MEASURES Comparison of rates for consulting a GP for new symptoms, diseases, prescriptions, and healthcare use in individuals admitted to hospital and those managed in the community, separately, before and after covid-19 infection, using Cox regression and negative binomial regression for healthcare use. The analysis was repeated for the negative control and influenza cohorts. In individuals in the community, outcomes were also described over time after a diagnosis of covid-19, and compared before and after vaccination for individuals who were symptomatic after covid-19 infection, using negative binomial regression. RESULTS Relative to the negative control and influenza cohorts, patients in the community (n=437 943) had significantly higher GP consultation rates for multiple sequelae, and the most common were loss of smell or taste, or both (adjusted hazard ratio 5.28, 95% confidence interval 3.89 to 7.17, P<0.001); venous thromboembolism (3.35, 2.87 to 3.91, P<0.001); lung fibrosis (2.41, 1.37 to 4.25, P=0.002), and muscle pain (1.89, 1.63 to 2.20, P<0.001); and also for healthcare use after a diagnosis of covid-19 compared with 12 months before infection. For absolute proportions, the most common outcomes >= 4 weeks after a covid-19 diagnosis in patients in the community were joint pain (2.5%), anxiety (1.2%), and prescriptions for non-steroidal anti-inflammatory drugs (1.2%). Patients admitted to hospital (n=18 059) also had significantly higher GP consultation rates for multiple sequelae, most commonly for venous thromboembolism (16.21, 11.28 to 23.31, P<0.001), nausea (4.64, 2.24 to 9.21, P<0.001), prescriptions for paracetamol (3.68, 2.86 to 4.74, P<0.001), renal failure (3.42, 2.67 to 4.38, P<0.001), and healthcare use after a covid-19 diagnosis compared with 12 months before infection. For absolute proportions, the most common outcomes >= 4 weeks after a covid-19 diagnosis in patients admitted to hospital were venous thromboembolism (3.5%), joint pain (2.7%), and breathlessness (2.8%). In patients in the community, anxiety and depression, abdominal pain, diarrhoea, general pain, nausea, chest tightness, and tinnitus persisted throughout follow-up. GP consultation rates were reduced for all symptoms, prescriptions, and healthcare use, except for neuropathic pain, cognitive impairment, strong opiates, and paracetamol use in patients in the community after the first vaccination dose for covid-19 relative to before vaccination. GP consultation rates were also reduced for ischaemic heart disease, asthma, and gastro-oesophageal disease. CONCLUSIONS GP consultation rates for sequelae after acute covid-19 infection differed between patients with covid-19 who were admitted to hospital and those managed in the community. For individuals in the community, rates of some sequelae decreased over time but those for others, such as anxiety and depression, persisted. Rates of some outcomes decreased after vaccination in this group.	[Whittaker, Hannah R.; Gulea, Claudia; Koteci, Ardita; Kallis, Constantinos; Morgan, Ann D.; Iwundu, Chukwuma; Weeks, Mark; Gupta, Rikisha; Quint, Jennifer K.] Imperial Coll London, Natl Heart & Lung Inst, London, England; [Whittaker, Hannah R.; Gulea, Claudia; Koteci, Ardita; Kallis, Constantinos; Morgan, Ann D.; Iwundu, Chukwuma; Weeks, Mark; Gupta, Rikisha; Quint, Jennifer K.] NIHR Imperial Biomed Res Ctr, London, England	Imperial College London	Quint, JK (corresponding author), Imperial Coll London, Natl Heart & Lung Inst, London, England.; Quint, JK (corresponding author), NIHR Imperial Biomed Res Ctr, London, England.	j.quint@imperial.ac.uk	weeks, Mark/AAT-7258-2021; quint, jennifer/ABE-3384-2020	Whittaker, Hannah/0000-0002-7705-0300; Kallis, Constantinos/0000-0003-0866-5421; Quint, Jennifer/0000-0003-0149-4869; Gulea, Claudia/0000-0001-9607-5901; Gupta, Rikisha/0000-0001-9784-416X; Koteci, Ardita/0000-0002-6074-7099; Iwundu, Chukwuma/0000-0002-3066-1999	BREATHE-The Health Data Research Hub for Respiratory Health [MC_PC_19004]; UK Research and Innovation Industrial Strategy Challenge Fund	BREATHE-The Health Data Research Hub for Respiratory Health; UK Research and Innovation Industrial Strategy Challenge Fund(UK Research & Innovation (UKRI))	This work is supported by BREATHE-The Health Data Research Hub for Respiratory Health (MC_PC_19004). BREATHE is funded through the UK Research and Innovation Industrial Strategy Challenge Fund and delivered through Health Data Research UK. The funder had no role in study design, data collection, analysis or interpretation, or manuscript writing. All authors had full access to all the data in the study and had final responsibility for the decision to submit for publication.	Al-Aly Z, 2021, NATURE, V594, P259, DOI 10.1038/s41586-021-03553-9; Alwan NA, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3565; Antonelli M, 2022, LANCET INFECT DIS, V22, P43, DOI 10.1016/S1473-3099(21)00460-6; Arnold DT., 2021, MEDRXIV, DOI [10.1101/2021.03.11.21253225, DOI 10.1101/2021.03.11.21253225]; Augustin M, 2021, LANCET REG HEALTH-EU, V6, DOI 10.1016/j.lanepe.2021.100122; Ayoubkhani D., 2021, PREVALENCE ONGOING S; Ayoubkhani D, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n693; Daugherty SE, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n1098; Di Minno A, 2020, SEMIN THROMB HEMOST, V46, P763, DOI 10.1055/s-0040-1715456; Doe G, 2021, NPJ PRIM CARE RESP M, V31, DOI 10.1038/s41533-021-00232-0; Fraser E, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3001; Goertz YMJ, 2020, ERJ OPEN RES, V6, DOI 10.1183/23120541.00542-2020; Hernandez-Romieu AC, 2021, MMWR-MORBID MORTAL W, V70, P644, DOI 10.15585/mmwr.mm7017e3; Knock ES, 2020, 41 IMP COLL LOND, DOI [10.25561/85146, DOI 10.25561/85146]; Ladds E, 2020, BMC HEALTH SERV RES, V20, DOI 10.1186/s12913-020-06001-y; Lopez-Leon S, 2021, SCI REP-UK, V11, DOI [10.1038/s41598-021-95565-8, 10.1101/2021.01.27.21250617]; Lund LC, 2021, LANCET INFECT DIS, V21, P1373, DOI 10.1016/S1473-3099(21)00211-5; Medicines and Healthcare products Regulatory Agency, 2021, REL NOT CPRD AUR; Metcalfe D, 2019, BMC MED RES METHODOL, V19, DOI 10.1186/s12874-019-0753-5; Moynihan R, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-045343; National Institute for Health Care Excellence, 2021, COVID 19 RAP GUID MA; O'Dowc A, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n1626; Paterson RW, 2020, BRAIN, V143, P3104, DOI 10.1093/brain/awaa240; Piroth L, 2021, LANCET RESP MED, V9, P251, DOI 10.1016/S2213-2600(20)30527-0; Puntmann VO, 2020, JAMA CARDIOL, V5, P1265, DOI 10.1001/jamacardio.2020.3557; Rogers W, 1994, STATA TECHNICAL B, V3, P1; Rubino F, 2020, NEW ENGL J MED, V383, P789, DOI [10.1056/NEJMc2018688, 10.1056/NEJMc2021832]; Salamanna F, 2021, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.653516; Skyrud KD., 2021, MEDRXIV, DOI [10.1101/2021.02.16.21251807, DOI 10.1101/2021.02.16.21251807]; Strain WD, 2021, IMPACT COVID VACCINA; Taquet M, 2021, LANCET PSYCHIAT, V8, P130, DOI 10.1016/S2215-0366(20)30462-4; UK government, COR COV 19 DASHB; Wolf A, 2019, INT J EPIDEMIOL, V48, P1740, DOI 10.1093/ije/dyz034; World Health Organization, 2021, CLIN CAS DEF POST CO	34	11	11	3	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 29	2021	375								e065834	10.1136/bmj-2021-065834	http://dx.doi.org/10.1136/bmj-2021-065834			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YH4NO	34965929	Green Published, hybrid			2022-12-28	WOS:000743145900005
J	Israeli, E				Israeli, Eitan			Effectiveness of BNT162b2 vaccine against critical COVID-19 in adolescents	ISRAEL MEDICAL ASSOCIATION JOURNAL			English	Editorial Material													Bhumbra, Samina/AAX-8266-2020	Bhumbra, Samina/0000-0002-4036-0479; Olson, Samantha/0000-0003-0589-5766; Schwartz, Stephanie/0000-0003-4314-6117; Randolph, Adrienne/0000-0002-3084-3071; Hume, Janet/0000-0002-8891-6800; Hobbs, Charlotte/0000-0003-4829-0791					0	45	45	7	7	ISRAEL MEDICAL ASSOC JOURNAL	RAMAT GAN	2 TWIN TOWERS, 11TH FL, 35 JABOTINSKY ST, PO BOX 3604, RAMAT GAN 52136, ISRAEL	1565-1088			ISR MED ASSOC J	Isr. Med. Assoc. J.	APR	2022	24	4					257	257		10.1056/NEJMoa2117995	http://dx.doi.org/10.1056/NEJMoa2117995			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	1V4MH	35021004	Bronze, Green Published			2022-12-28	WOS:000806065400032
J	Ganapathi, AM; Daniels, CJ				Ganapathi, Asvin M.; Daniels, Curt J.			Pulmonary-Artery Aneurysm with Acute Dissection	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ganapathi, Asvin M.; Daniels, Curt J.] Ohio State Univ, Wexner Med Ctr, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Ganapathi, AM (corresponding author), Ohio State Univ, Wexner Med Ctr, Columbus, OH 43210 USA.	asvin.ganapathi@osumc.edu		Ganapathi, Asvin/0000-0003-2765-3733					0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 20	2022	386	3					273	273		10.1056/NEJMicm2104225	http://dx.doi.org/10.1056/NEJMicm2104225			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YK1UG	35045229				2022-12-28	WOS:000745006000014
J	Wang, L; Davis, PB; Kaelber, DC; Volkow, ND; Xu, R				Wang, Lindsey; Davis, Pamela B.; Kaelber, David C.; Volkow, Nora D.; Xu, Rong			Comparison of mRNA-1273 and BNT162b2 Vaccines on Breakthrough SARS-CoV-2 Infections, Hospitalizations, and Death During the Delta-Predominant Period	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Wang, Lindsey; Xu, Rong] Case Western Reserve Univ, Sch Med, Ctr Artificial Intelligence Drug Discovery, Cleveland, OH USA; [Davis, Pamela B.] Case Western Reserve Univ, Ctr Community Hlth Integrat, Sch Med, Cleveland, OH USA; [Kaelber, David C.] MetroHealth Syst, Ctr Clin Informat Res & Educ, Cleveland, OH USA; [Volkow, Nora D.] NIDA, NIH, Bethesda, MD 20892 USA	Case Western Reserve University; Case Western Reserve University; MetroHealth System; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Xu, R (corresponding author), Ctr Artificial Intelligence Drug Discovery, 2103 Cornell Rd, Cleveland, OH 44106 USA.	rxx@case.edu			National Institute on Alcohol Abuse and Alcoholism [R01AA029831]; National Institute on Aging [AG057557, AG061388, AG062272]; National Institute on Drug Abuse [UG1DA049435]; National Cancer Institute [R25CA221718]; Clinical and Translational Science Collaborative of Cleveland [1UL1TR002548-01]	National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Clinical and Translational Science Collaborative of Cleveland(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The study was supported by the National Institute on Alcohol Abuse and Alcoholism (grant R01AA029831), the National Institute on Aging (grants AG057557, AG061388, and AG062272), the National Institute on Drug Abuse (grant UG1DA049435), the National Cancer Institute (grant R25CA221718), and the Clinical and Translational Science Collaborative of Cleveland (grant 1UL1TR002548-01).	Centers for Disease Control and Prevention, COVID DAT TRACK VAR; Centers for Disease Control and Prevention, INF CLIN INV THER PA; Centers for Disease Control and Prevention, COVID 19 PEOPL CERT; Collier AY, 2021, NEW ENGL J MED, V385, P2010, DOI 10.1056/NEJMc2115596; Self WH, 2021, MMWR-MORBID MORTAL W, V70, P1337, DOI 10.15585/mmwr.mm7038e1; Steensels D, 2021, JAMA-J AM MED ASSOC, V326, P1533, DOI 10.1001/jama.2021.15125	6	19	18	2	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 15	2022	327	7					678	680		10.1001/jama.2022.0210	http://dx.doi.org/10.1001/jama.2022.0210		JAN 2022	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZD5SM	35050314	Bronze, Green Published			2022-12-28	WOS:000745103500002
J	Bell, EF; Hintz, SR; Hansen, NI; Bann, CM; Wyckoff, MH; DeMauro, SB; Walsh, MC; Vohr, BR; Stoll, BJ; Carlo, WA; Van Meurs, KP; Rysavy, MA; Patel, RM; Merhar, SL; Sanchez, PJ; Laptook, AR; Hibbs, AM; Cotten, CM; D'Angio, CT; Winter, S; Fuller, J; Das, A				Bell, Edward F.; Hintz, Susan R.; Hansen, Nellie, I; Bann, Carla M.; Wyckoff, Myra H.; DeMauro, Sara B.; Walsh, Michele C.; Vohr, Betty R.; Stoll, Barbara J.; Carlo, Waldemar A.; Van Meurs, Krisa P.; Rysavy, Matthew A.; Patel, Ravi M.; Merhar, Stephanie L.; Sanchez, Pablo J.; Laptook, Abbot R.; Hibbs, Anna Maria; Cotten, C. Michael; D'Angio, Carl T.; Winter, Sarah; Fuller, Janell; Das, Abhik		Eunice Kennedy Shriver Natl Inst C	Mortality, In-Hospital Morbidity, Care Practices, and 2-Year Outcomes for Extremely Preterm Infants in the US, 2013-2018	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NEURODEVELOPMENTAL IMPAIRMENT; NECROTIZING ENTEROCOLITIS; WEEKS GESTATION; SURVIVAL; BIRTH; BORN; AGE	IMPORTANCE Despite improvement during recent decades, extremely preterm infants continue to contribute disproportionately to neonatal mortality and childhood morbidity. OBJECTIVE To review survival, in-hospital morbidities, care practices, and neurodevelopmental and functional outcomes at 22-26 months' corrected age for extremely preterm infants. DESIGN, SETTING, AND PARTICEPANTS Prospective registry for extremely preterm infants born at 19 US academic centers that are part of the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. The study included 10 877 infants born at 22-28 weeks' gestational age between January 1, 2013, and December 31, 2018, including 2566 infants born before 27 weeks between January 1, 2013. and December 31, 2016, who completed follow-up assessments at 22-26 months' corrected age. The last assessment was completed on August 13, 2019. Outcomes were compared with a similar cohort of infants born in 2008-2012 adjusting for gestational age. EXPOSURES Extremely preterm birth. MAIN OUTCOMES AND MEASURES Survival and 12 in-hospital morbidities were assessed, including necrotizing enterocolitis, infection, intracranial hemorrhage, retinopathy of prematurity, and bronchopulmonary dysplasia. Infants were assessed at 22-26 months' corrected age for 12 health and functional outcomes, including neurodevelopment, cerebral palsy, vision, hearing, rehospitalizations, and need for assistive devices. RESULTS The 10 877 infants were 49.0% female and 51.0% male; 78.3% (8495/10848) survived to discharge, an increase from 76.0% in 2008-2012 (adjusted difference, 2.0%; 95% CI, 1.0%-2.9%). Survival to discharge was 10.9% (60/549)for live-born infants at 22 weeks and 94.0% (2267/2412) at 28 weeks. Survival among actively treated infants was 30.0% (60/200) at 22 weeks and 55.8% (535/958) at 23 weeks. All in-hospital morbidities were more likely among infants born at earlier gestational ages. Overall, 8.9% (890/9956) of infants had necrotizing enterocolitis, 2.4% (238/9957) had early-onset infection, 19.9% (1911/9610) had late-onset infection. 14.3% (1386/9705) had severe intracranial hemorrhage. 12.8% (1099/8585) had severe retinopathy of prematurity, and 8.0% (666/8305) had severe bronchopulmonary dysplasia. Among 2930 surviving infants with gestational ages of 22-26 weeks eligible for follow-up, 2566 (87.6%) were examined. By 2-year follow-up, 8.4% (214/2555) of children had moderate to severe cerebral palsy, 1.5% (38/2555) had bilateral blindness, 2.5% (64/2527) required hearing aids or cochlear implants, 49.9% (1277/2561) had been rehospitalized, and 15.4% (393/2560) required mobility aids or other supportive devices. Among 2458 fully evaluated infants, 48/% (1198/2458) had no or mild neurodevelopmental impairment at follow-up, 29.3% (709/2419) had moderate neurodevelopmental impairment, and 21.2% (512/2419) had severe neurodevelopmental impairment. CONCLUSIONS AND RELEVANCE Among extremely preterm infants born in 2013-2018 and treated at 19 US academic medical centers, 78.3% survived to discharge, a significantly higher rate than for infants born in 2008-2012. Among infants born at less than 27 weeks' gestational age, rehospitalization and neurodevelopmental impairment were common at 2 years of age.	[Bell, Edward F.] Univ Iowa, Dept Pediat, 200 Hawkins Dr, Iowa City, IA 52242 USA; [Hintz, Susan R.; Van Meurs, Krisa P.] Stanford Univ, Dept Pediat, Palo Alto, CA USA; [Hansen, Nellie, I; Bann, Carla M.] RTI Int, Social Stat & Environm Sci Unit, Res Triangle Pk, NC USA; [Wyckoff, Myra H.] Univ Texas Southwestern, Dept Pediat, Dallas, TX USA; [DeMauro, Sara B.] Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA; [Walsh, Michele C.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Bethesda, MD USA; [Vohr, Betty R.; Laptook, Abbot R.] Brown Univ, Dept Pediat, Providence, RI 02912 USA; [Stoll, Barbara J.; Patel, Ravi M.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA; [Stoll, Barbara J.; Patel, Ravi M.] Childrens Healthcare Atlanta, Atlanta, GA USA; [Carlo, Waldemar A.] Univ Alabama Birmingham, Dept Pediat, Birmingham, AL USA; [Rysavy, Matthew A.] Univ Texas Houston, Dept Pediat, Houston, TX USA; [Merhar, Stephanie L.] Univ Cincinnati, Dept Pediat, Cincinnati, OH USA; [Sanchez, Pablo J.] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Sanchez, Pablo J.] Nationwide Childrens Hosp, Columbus, OH USA; [Hibbs, Anna Maria] Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA; [Cotten, C. Michael] Duke Univ, Dept Pediat, Durham, NC USA; [D'Angio, Carl T.] Univ Rochester, Dept Pediat, Rochester, NY USA; [Winter, Sarah] Univ Utah, Dept Pediat, Salt Lake City, UT USA; [Fuller, Janell] Univ New Mexico, Dept Pediat, Albuquerque, NM 87131 USA; [Das, Abhik] RTI Int, Social Stat & Environm Sci Unit, Rockville, MD USA	University of Iowa; Stanford University; Research Triangle Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Pennsylvania; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Brown University; Emory University; Children's Healthcare of Atlanta (CHOA); University of Alabama System; University of Alabama Birmingham; University of Texas System; University of Texas Health Science Center Houston; University System of Ohio; University of Cincinnati; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Case Western Reserve University; Duke University; University of Rochester; Utah System of Higher Education; University of Utah; University of New Mexico; Research Triangle Institute	Bell, EF (corresponding author), Univ Iowa, Dept Pediat, 200 Hawkins Dr, Iowa City, IA 52242 USA.	edward-bell@uiowa.edu	Patel, Ravi/B-7218-2011; Das, Abhik/AAF-1883-2020	Patel, Ravi/0000-0002-7444-5550; Das, Abhik/0000-0003-2722-0479; Bann, Carla/0000-0001-9305-8305; Hintz, Susan/0000-0001-7023-4433; Rysavy, Matthew/0000-0002-1209-6607; Hansen, Nellie/0000-0003-4794-9646	NIH; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Center for Research Resources; National Center for Advancing Translational Sciences [U10 HD021373, UG1 HD021364, UG1 HD021385, UG1 HD027851, UG1 HD027853, UG1 HD027856, UG1 HD027880, UG1 HD027904, UG1 HD034216, UG1 HD036790, UG1 HD040492, UG1 HD040689, UG1 HD053089, UG1 HD053109, UG1 HD068244, UG1 HD068263, UG1 HD068270, UG1 HD068278, UG1 HD068284];  [UG1 HD087226];  [UG1 HD087229];  [UL1 TR000006];  [UL1 TR000041];  [UL1 TR000042];  [UL1 TR000077];  [UL1 TR000093];  [UL1 TR000105];  [UL1 TR000442];  [UL1 TR000454];  [UL1 TR001117]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); ; ; ; ; ; ; ; ; ; ; 	The NIH, the Eunice Kennedy Shriver National Institute of Child Health and Human Development, the National Center for Research Resources, and the National Center for Advancing Translational Sciences provided grant support for the Neonatal Research Network Generic Database and Follow-up studies to maintain high-risk preterm infant registries through the following cooperative agreements: U10 HD021373, UG1 HD021364, UG1 HD021385, UG1 HD027851, UG1 HD027853, UG1 HD027856, UG1 HD027880, UG1 HD027904, UG1 HD034216, UG1 HD036790, UG1 HD040492, UG1 HD040689, UG1 HD053089, UG1 HD053109, UG1 HD068244, UG1 HD068263, UG1 HD068270, UG1 HD068278, UG1 HD068284, UG1 HD087226, UG1 HD087229, UL1 TR000006, UL1 TR000041, UL1 TR000042, UL1 TR000077, UL1 TR000093, UL1 TR000105, UL1 TR000442, UL1 TR000454, and UL1 TR001117.	Adams-Chapman I, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-3091; Albers CA, 2007, J PSYCHOEDUC ASSESS, V25, P180, DOI 10.1177/0734282906297199; Alexander GR, 1996, OBSTET GYNECOL, V87, P163, DOI 10.1016/0029-7844(95)00386-X; Bangma JT, 2018, J PEDIATR-US, V202, P44, DOI 10.1016/j.jpeds.2018.06.037; BELL MJ, 1978, ANN SURG, V187, P1, DOI 10.1097/00000658-197801000-00001; Blackmon LR, 2004, PEDIATRICS, V114, P1362, DOI 10.1542/peds.2004-1915; Cheong JLY, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-4086; Daly M, 2019, BMJ PAEDIATR OPEN, V3, DOI 10.1136/bmjpo-2018-000404; DeMauro SB, 2019, PEDIATRICS, V143, DOI 10.1542/peds.2018-2956; Ehret DEY, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.3235; Haslam MD, 2018, J PEDIATR-US, V197, P75, DOI 10.1016/j.jpeds.2017.12.020; Horbar JD, 2017, JAMA PEDIATR, V171, DOI 10.1001/jamapediatrics.2016.4396; Janvier A, 2016, SEMIN PERINATOL, V40, P571, DOI 10.1053/j.semperi.2016.09.009; Jaworski M, 2018, J PEDIATR-US, V200, P58, DOI 10.1016/j.jpeds.2018.03.006; Jensen EA, 2019, AM J RESP CRIT CARE, V200, P751, DOI 10.1164/rccm.201812-2348OC; Kono Y, 2018, BMJ PAEDIATR OPEN, V2, DOI 10.1136/bmjpo-2017-000211; Lamarche-Vadel A, 2004, ACTA PAEDIATR, V93, P1340, DOI 10.1080/08035250410032926; Lee SK, 2020, CAN MED ASSOC J, V192, pE81, DOI 10.1503/cmaj.190940; Marlow N, 2019, PEDIATR RES, V86, P567, DOI 10.1038/s41390-019-0526-1; Marlow N, 2015, ARCH DIS CHILD-FETAL, V100, pF82, DOI 10.1136/archdischild-2014-306191; McAndrew S, 2019, J PEDIATR-US, V213, P38, DOI 10.1016/j.jpeds.2019.05.067; Moore T, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7961; Newman JE, 2012, J PEDIATR-US, V161, P1041, DOI 10.1016/j.jpeds.2012.05.048; Norman M, 2019, JAMA-J AM MED ASSOC, V321, P1188, DOI 10.1001/jama.2019.2021; Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x; PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0; Rysavy MA, 2021, J PERINATOL, V41, P2270, DOI 10.1038/s41372-021-00999-7; Rysavy MA, 2015, NEW ENGL J MED, V372, P1801, DOI 10.1056/NEJMoa1410689; Saigal S, 2016, J PEDIATR-US, V179, P68, DOI 10.1016/j.jpeds.2016.08.018; Serenius F, 2013, JAMA-J AM MED ASSOC, V309, P1810, DOI 10.1001/jama.2013.3786; Spiegelman D, 2005, AM J EPIDEMIOL, V162, P199, DOI 10.1093/aje/kwi188; Stoll BJ, 2015, JAMA-J AM MED ASSOC, V314, P1039, DOI 10.1001/jama.2015.10244; Synnes A, 2017, ARCH DIS CHILD-FETAL, V102, pF235, DOI 10.1136/archdischild-2016-311228; Taylor GL, 2021, PEDIATRICS, V147, DOI 10.1542/peds.2020-001040; Travers CP, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.6757; WALSH MC, 1986, PEDIATR CLIN N AM, V33, P179, DOI 10.1016/s0031-3955(16)34975-6; Younge N, 2017, NEW ENGL J MED, V376, P617, DOI 10.1056/NEJMoa1605566	37	47	48	14	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 18	2022	327	3					248	263		10.1001/jama.2021.23580	http://dx.doi.org/10.1001/jama.2021.23580			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YV9PQ	35040888	Green Published			2022-12-28	WOS:000753055100019
J	Mazzone, PJ; Lam, L				Mazzone, Peter J.; Lam, Louis			Evaluating the Patient With a Pulmonary Nodule A Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							LUNG-CANCER; SOCIETY GUIDELINES; FOLLOW-UP; MANAGEMENT; CT; PROBABILITY; VETERANS; ADHERENCE; CARE; BRONCHOSCOPY	IMPORTANCE Pulmonary nodules are identified in approximately 1.6 million patients per year in the US and are detected on approximately 30% of computed tomographic (CT) images of the chest. Optimal treatment of an individual with a pulmonary nodule can lead to early detection of cancer while minimizing testing for a benign nodule. OBSERVATIONS At least 95% of all pulmonary nodules identified are benign, most often granulomas or intrapulmonary lymph nodes. Smaller nodules are more likely to be benign. Pulmonary nodules are categorized as small solid (<8 mm), larger solid (>= 8 mm), and subsolid. Subsolid nodules are divided into ground-glass nodules (no solid component) and part-solid (both ground-glass and solid components). The probability of malignancy is less than 1% for all nodules smaller than 6 mm and 1% to 2% for nodules 6 mm to 8 mm. Nodules that are 6 mm to 8 mm can be followed with a repeat chest CT in 6 to 12 months, depending on the presence of patient risk factors and imaging characteristics associated with lung malignancy, clinical judgment about the probability of malignancy, and patient preferences. The treatment of an individual with a solid pulmonary nodule 8 mm or larger is based on the estimated probability of malignancy; the presence of patient comorbidities, such as chronic obstructive pulmonary disease and coronary artery disease; and patient preferences. Management options include surveillance imaging, defined as monitoring for nodule growth with chest CT imaging, positron emission tomography-CT imaging, nonsurgical biopsy with bronchoscopy or transthoracic needle biopsy, and surgical resection. Part-solid pulmonary nodules are managed according to the size of the solid component. Larger solid components are associated with a higher risk of malignancy. Ground-glass pulmonary nodules have a probability of malignancy of 10% to 50% when they persist beyond 3 months and are larger than 10 mm in diameter. A malignant nodule that is entirely ground glass in appearance is typically slow growing. Current bronchoscopy and transthoracic needle biopsy methods yield a sensitivity of 70% to 90% for a diagnosis of lung cancer. CONCLUSIONS AND RELEVANCE Pulmonary nodules are identified in approximately 1.6 million people per year in the US and approximately 30% of chest CT images. The treatment of an individual with a pulmonary nodule should be guided by the probability that the nodule is malignant, safety of testing, the likelihood that additional testing will be informative, and patient preferences.	[Mazzone, Peter J.; Lam, Louis] Cleveland Clin, Resp Inst, 9500 Euclid Ave,A90, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Mazzone, PJ (corresponding author), Cleveland Clin, Resp Inst, 9500 Euclid Ave,A90, Cleveland, OH 44195 USA.	mazzonp@ccf.org						Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; American College of Radiology Committee on Lung-RADS, 2019, LUNG RADS ASS CAT VE; Bai CX, 2016, CHEST, V150, P877, DOI 10.1016/j.chest.2016.02.650; Balekian AA, 2016, ANN AM THORAC SOC, V13, P1568, DOI 10.1513/AnnalsATS.201602-091OC; Balekian Alex A, 2013, Ann Am Thorac Soc, V10, P629, DOI 10.1513/AnnalsATS.201305-107OC; Bankier AA, 2017, RADIOLOGY, V285, P584, DOI 10.1148/radiol.2017162894; Blagev DP, 2014, J AM COLL RADIOL, V11, P378, DOI 10.1016/j.jacr.2013.08.003; Brunelli A, 2013, CHEST, V143, pE166, DOI 10.1378/chest.12-2395; Callister MEJ, 2015, THORAX, V70, P1, DOI 10.1136/thoraxjnl-2015-207168; Chen AC, 2021, CHEST, V159, P845, DOI 10.1016/j.chest.2020.08.2047; Church TR, 2013, NEW ENGL J MED, V368, P1980, DOI 10.1056/NEJMoa1209120; de Koning HJ, 2020, NEW ENGL J MED, V382, P503, DOI 10.1056/NEJMoa1911793; Deppen SA, 2014, JAMA-J AM MED ASSOC, V312, P1227, DOI 10.1001/jama.2014.11488; Farjah F, 2021, JAMA INTERN MED, V181, P480, DOI 10.1001/jamainternmed.2020.8250; Folch EE, 2020, CHEST, V158, P1753, DOI 10.1016/j.chest.2020.05.534; Folch EE, 2019, J THORAC ONCOL, V14, P445, DOI 10.1016/j.jtho.2018.11.013; Gould MK, 2007, CHEST, V131, P383, DOI 10.1378/chest.06-1261; Gould MK, 2015, AM J RESP CRIT CARE, V192, P1208, DOI 10.1164/rccm.201505-0990OC; Gould MK, 2013, CHEST, V143, pE93, DOI 10.1378/chest.12-2351; Han DW, 2020, J THORAC ONCOL, V15, P125, DOI 10.1016/j.jtho.2019.09.193; Han Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191590; Hanamiya M, 2012, EUR J RADIOL, V81, P152, DOI 10.1016/j.ejrad.2010.08.013; Herder GJ, 2005, CHEST, V128, P2490, DOI 10.1378/chest.128.4.2490; Heyneman LE, 2002, LUNG CANCER-J IASLC, V38, P261, DOI 10.1016/S0169-5002(02)00221-0; Iaccarino JM, 2017, ANN AM THORAC SOC, V14, P968, DOI 10.1513/AnnalsATS.201609-727OC; Jonas DE, 2021, JAMA-J AM MED ASSOC, V325, P971, DOI 10.1001/jama.2021.0377; Kakinuma R, 2015, RADIOLOGY, V276, P873, DOI 10.1148/radiol.2015141071; Kinsinger LS, 2017, JAMA INTERN MED, V177, P399, DOI 10.1001/jamainternmed.2016.9022; Lam S, 2020, CAN J RESP CRIT CARE, V4, P236, DOI 10.1080/24745332.2020.1819175; Lee HJ, 2021, CHEST, V159, P401, DOI 10.1016/j.chest.2020.07.067; Lu MT, 2016, J AM COLL RADIOL, V13, P156, DOI 10.1016/j.jacr.2015.09.029; MacMahon H, 2019, CHEST, V156, P112, DOI 10.1016/j.chest.2019.04.002; MacMahon H, 2017, RADIOLOGY, V284, P228, DOI 10.1148/radiol.2017161659; Massion PP, 2020, AM J RESP CRIT CARE, V202, P241, DOI 10.1164/rccm.201903-0505OC; McDonald JS, 2017, ACAD RADIOL, V24, P337, DOI 10.1016/j.acra.2016.08.026; McWilliams A, 2013, NEW ENGL J MED, V369, P910, DOI 10.1056/NEJMoa1214726; Moseson EM, 2016, ANN AM THORAC SOC, V13, P651, DOI 10.1513/AnnalsATS.201511-745OC; Oken MM, 2005, JNCI-J NATL CANCER I, V97, P1832, DOI 10.1093/jnci/dji430; Oki M, 2015, AM J RESP CRIT CARE, V192, P468, DOI 10.1164/rccm.201502-0205OC; Pinsky PF, 2017, AM J ROENTGENOL, V209, P1009, DOI 10.2214/AJR.17.18252; Reid M, 2019, CHEST, V156, P367, DOI 10.1016/j.chest.2019.01.038; Sawada S, 2017, CHEST, V151, P308, DOI 10.1016/j.chest.2016.07.007; Shimizu K, 2006, LUNG CANCER-J IASLC, V51, P173, DOI 10.1016/j.lungcan.2005.10.019; Silvestri GA, 2018, CHEST, V154, P491, DOI 10.1016/j.chest.2018.02.012; Slatore CG, 2016, ANN AM THORAC SOC, V13, P1983, DOI 10.1513/AnnalsATS.201607-555OC; Slatore CG, 2015, ANN AM THORAC SOC, V12, P184, DOI 10.1513/AnnalsATS.201406-283OC; Swensen SJ, 1997, ARCH INTERN MED, V157, P849, DOI 10.1001/archinte.157.8.849; Verdial FC, 2020, CHEST, V157, P985, DOI 10.1016/j.chest.2019.11.032; Wiener RS, 2014, JAMA INTERN MED, V174, P871, DOI 10.1001/jamainternmed.2014.561; Yip R, 2016, LUNG CANCER, V97, P35, DOI 10.1016/j.lungcan.2016.04.005; Zygmont ME, 2016, J AM COLL RADIOL, V13, P1494, DOI 10.1016/j.jacr.2016.07.032	51	15	17	18	41	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 18	2022	327	3					264	273		10.1001/jama.2021.24287	http://dx.doi.org/10.1001/jama.2021.24287			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YV9PQ	35040882				2022-12-28	WOS:000753055100020
J	Jung, S; Lee, H; Myung, S; Kim, H; Yoon, SK; Kwon, SW; Ju, Y; Kim, M; Yi, W; Han, S; Kwon, B; Seo, B; Lee, K; Koh, GH; Lee, K; Song, Y; Choi, C; Ham, D; Kim, SJ				Jung, Seungchul; Lee, Hyungwoo; Myung, Sungmeen; Kim, Hyunsoo; Yoon, Seung Keun; Kwon, Soon-Wan; Ju, Yongmin; Kim, Minje; Yi, Wooseok; Han, Shinhee; Kwon, Baeseong; Seo, Boyoung; Lee, Kilho; Koh, Gwan-Hyeob; Lee, Kangho; Song, Yoonjong; Choi, Changkyu; Ham, Donhee; Kim, Sang Joon			A crossbar array of magnetoresistive memory devices for in-memory computing	NATURE			English	Article							NEURAL-NETWORKS; FLASH	Implementations of artificial neural networks that borrow analogue techniques could potentially offer low-power alternatives to fully digital approaches(1-3). One notable example is in-memory computing based on crossbar arrays of non-volatile memories(4-7) that execute, in an analogue manner, multiply-accumulate operations prevalent in artificial neural networks. Various non-volatile memories-including resistive memory(8-13), phase-change memory(14,15) and flash memory(16-19)-have been used for such approaches. However, it remains challenging to develop a crossbar array of spin-transfer-torque magnetoresistive random-access memory (MRAM)(20-22), despite the technology's practical advantages such as endurance and large-scale commercialization(5). The difficulty stems from the low resistance of MRAM, which would result in large power consumption in a conventional crossbar array that uses current summation for analogue multiply-accumulate operations. Here we report a 64 x 64 crossbar array based on MRAM cells that overcomes the low-resistance issue with an architecture that uses resistance summation for analogue multiply-accumulate operations. The array is integrated with readout electronics in 28-nanometre complementary metal-oxide-semiconductor technology. Using this array, a two-layer perceptron is implemented to classify 10,000 Modified National Institute of Standards and Technology digits with an accuracy of 93.23 per cent (software baseline: 95.24 per cent). In an emulation of a deeper, eight-layer Visual Geometry Group-8 neural network with measured errors, the classification accuracy improves to 98.86 per cent (software baseline: 99.28 per cent). We also use the array to implement a single layer in a ten-layer neural network to realize face detection with an accuracy of 93.4 per cent.	[Jung, Seungchul; Lee, Hyungwoo; Myung, Sungmeen; Kim, Hyunsoo; Yoon, Seung Keun; Kwon, Soon-Wan; Ju, Yongmin; Kim, Minje; Yi, Wooseok; Choi, Changkyu; Ham, Donhee; Kim, Sang Joon] Samsung Elect, Samsung Adv Inst Technol, Suwon, South Korea; [Han, Shinhee; Kwon, Baeseong; Seo, Boyoung; Lee, Kangho] Samsung Elect, Foundry Business, Yongin, South Korea; [Lee, Kilho; Koh, Gwan-Hyeob; Song, Yoonjong] Samsung Elect, Semicond R&D Ctr, Hwaseong Si, South Korea; [Ham, Donhee] Harvard Univ, John A Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Samsung; Samsung Electronics; Samsung; Samsung Electronics; Samsung; Samsung Electronics; Harvard University	Ju, Y; Ham, D; Kim, SJ (corresponding author), Samsung Elect, Samsung Adv Inst Technol, Suwon, South Korea.; Ham, D (corresponding author), Harvard Univ, John A Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA.	donhee@seas.harvard.edu; sangjoon0919.kim@samsung.com		Myung, Sungmeen/0000-0002-2899-5092; Ham, Donhee/0000-0001-6925-2466; Jung, Seungchul/0000-0003-2727-0791				Ambrogio S, 2018, NATURE, V558, P60, DOI 10.1038/s41586-018-0180-5; Chen WH, 2019, NAT ELECTRON, V2, P420, DOI 10.1038/s41928-019-0288-0; Ham D, 2021, NAT ELECTRON, V4, P635, DOI 10.1038/s41928-021-00646-1; Horowitz M, 2014, ISSCC DIG TECH PAP I, V57, P10, DOI 10.1109/ISSCC.2014.6757323; Hubara I, 2016, ADV NEUR IN, V29; Hung JM, 2020, IEEE T ELECTRON DEV, V67, P1444, DOI 10.1109/TED.2020.2976115; Ielmini D, 2018, NAT ELECTRON, V1, P333, DOI 10.1038/s41928-018-0092-2; Jiang ZW, 2020, IEEE J SOLID-ST CIRC, V55, P1888, DOI 10.1109/JSSC.2020.2992886; Kang SH, 2014, S VLSI TECH; Keckler SW, 2011, IEEE MICRO, V31, P7, DOI 10.1109/MM.2011.89; Kim H, US patent, Patent No. [17/085,300, 17085300]; Le Gallo M, 2018, NAT ELECTRON, V1, P246, DOI 10.1038/s41928-018-0054-8; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Lee YK, 2018, 2018 IEEE SYMPOSIUM ON VLSI TECHNOLOGY, P181; Li C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04484-2; Lin Xiaofan, 2017, NEURIPS, V1, P2; Lin YY, 2018, INT EL DEVICES MEET; Liu BY, 2013, DES AUT CON; Merrikh-Bayat F, 2018, IEEE T NEUR NET LEAR, V29, P4782, DOI 10.1109/TNNLS.2017.2778940; Patil AD, 2019, IEEE INT SYMP CIRC S; Rastegari M, 2016, LECT NOTES COMPUT SC, V9908, P525, DOI 10.1007/978-3-319-46493-0_32; Sebastian A, 2020, NAT NANOTECHNOL, V15, P529, DOI 10.1038/s41565-020-0655-z; Shafiee A, 2016, CONF PROC INT SYMP C, P14, DOI 10.1109/ISCA.2016.12; Song J, 2019, ISSCC DIG TECH PAP I, V62, P130, DOI 10.1109/ISSCC.2019.8662476; Song YJ, 2018, INT EL DEVICES MEET; Verma Naveen, 2019, IEEE Solid-State Circuits Magazine, V11, P43, DOI 10.1109/MSSC.2019.2922889; Wang PN, 2019, IEEE T VLSI SYST, V27, P988, DOI 10.1109/TVLSI.2018.2882194; Wang PS, 2018, PROC CVPR IEEE, P4376, DOI 10.1109/CVPR.2018.00460; Wang ZR, 2020, NAT REV MATER, V5, P173, DOI 10.1038/s41578-019-0159-3; Wei LQ, 2019, ISSCC DIG TECH PAP I, V62, P214, DOI 10.1109/ISSCC.2019.8662444; Woo J, 2016, IEEE ELECTR DEVICE L, V37, P994, DOI 10.1109/LED.2016.2582859; Wu BC, 2017, IEEE COMPUT SOC CONF, P446, DOI 10.1109/CVPRW.2017.60; Wu HQ, 2017, INT EL DEVICES MEET; Xiang YC, 2020, IEEE T ELECTRON DEV, V67, P2329, DOI 10.1109/TED.2020.2987439; Yao P, 2020, NATURE, V577, P641, DOI 10.1038/s41586-020-1942-4; Yao P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15199; Yu SM, 2018, P IEEE, V106, P260, DOI 10.1109/JPROC.2018.2790840; Zabihi M, 2019, IEEE T COMPUT, V68, P1159, DOI 10.1109/TC.2018.2858251; Zeng ZM, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3556615; Zhuang BH, 2019, PROC CVPR IEEE, P413, DOI 10.1109/CVPR.2019.00050	40	43	42	54	113	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 13	2022	601	7892					211	+		10.1038/s41586-021-04196-6	http://dx.doi.org/10.1038/s41586-021-04196-6			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YF9MG	35022590				2022-12-28	WOS:000742123100011
J	Hopkinson, NS; Vestbo, J; Bush, A; Grigg, J				Hopkinson, Nicholas S.; Vestbo, Jorgen; Bush, Andrew; Grigg, Jonathan			Should e-cigarettes be licensed as medicines?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Hopkinson, Nicholas S.; Bush, Andrew] Imperial Coll London, Natl Heart & Lung Inst, London, England; [Vestbo, Jorgen] Univ Manchester, Manchester, Lancs, England; [Grigg, Jonathan] Queen Mary Univ, London, England	Imperial College London; University of Manchester; University of London; Queen Mary University London	Hopkinson, NS (corresponding author), Imperial Coll London, Natl Heart & Lung Inst, London, England.	n.hopkinson@ic.ac.uk; Jorgen.Vestbo@manchester.ac.uk						Action on Smoking and Health, 2021, US E CIG VAP AD GREA; Action on Smoking and Health, 2021, US EL CIG YOUNG PEOP; Aladeokin A, 2019, TOB PREV CESS, V5, DOI 10.18332/tpc/108553; All Party Parliamentary Group on Smoking and Health, 2021, DEL SMOK 2030 ALL PA; Barufaldi LA, 2021, TOB PREV CESS, V7, DOI 10.18332/tpc/132964; Britton J, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1745; Committee on Toxicity of Chemicals in Food Consumer Products and the Environment (COT), 2020, STAT POT TOX RISKS E; *GBD 2019 RISK FAC, 2019, LANCET, V0396; Gornall J, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5826; Hajek P, 2019, NEW ENGL J MED, V380, P629, DOI 10.1056/NEJMoa1808779; Hartmann-Boyce J, 2016, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD010216.pub3, 10.1002/14651858.CD010216.pub4]; Hedman L, 2021, TOB PREV CESS, V7, DOI 10.18332/tpc/142320; Kaufman J., 2021, THESIS U IOWA; Medicines and Healthcare Products Regulatory Agency, GUID LIC EL CIG INH; Miyashita L, 2020, J PHYSIOL-LONDON, V598, P5027, DOI 10.1113/JP279526; National Institute for Health and Care Excellence, 2021, TOB PREV UPT PROM QU; Pisinger C, 2019, EUR RESPIR J, V54, DOI 10.1183/13993003.02009-2019; Shahab L, 2017, ANN INTERN MED, V166, P390, DOI 10.7326/M16-1107; Smoking in England, DISC MAJ FIND REL SM; Zafeiridou M, 2018, ENVIRON SCI TECHNOL, V52, P8087, DOI 10.1021/acs.est.8b01533	20	2	2	2	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 12	2022	376								n2912	10.1136/bmj.n2912	http://dx.doi.org/10.1136/bmj.n2912			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YP6JI	35022214	Bronze			2022-12-28	WOS:000748728200004
J	Niknam, BA; Zubizarreta, JR				Niknam, Bijan A.; Zubizarreta, Jose R.			Using Cardinality Matching to Design Balanced and Representative Samples for Observational Studies	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Niknam, Bijan A.; Zubizarreta, Jose R.] Harvard Med Sch, Dept Hlth Care Policy, Boston, MA 02115 USA; [Niknam, Bijan A.; Zubizarreta, Jose R.] Harvard Sch Publ Hlth, CAUSA Lab, Boston, MA USA; [Zubizarreta, Jose R.] Harvard Univ, Dept Stat, Boston, MA 02115 USA; [Zubizarreta, Jose R.] Harvard Sch Publ Hlth, Dept Biostat, Boston, MA USA	Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard University; Harvard T.H. Chan School of Public Health	Zubizarreta, JR (corresponding author), Harvard Univ, 180A Longwood Ave,Off 307-D, Boston, MA 02115 USA.	zubizarreta@hcp.med.harvard.edu			PCORI project program award [ME-2019C1-16172]	PCORI project program award(Patient-Centered Outcomes Research Institute - PCORI)	Supported through a PCORI project program award (ME-2019C1-16172).	Benjet C, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.19848; Bennett M, 2020, J COMPUT GRAPH STAT, V29, P744, DOI 10.1080/10618600.2020.1753532; Haukoos JS, 2015, JAMA-J AM MED ASSOC, V314, P1637, DOI 10.1001/jama.2015.13480; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; ROSENBAUM PR, 1985, AM STAT, V39, P33, DOI 10.2307/2683903; Rubin DB, 2007, STAT MED, V26, P20, DOI 10.1002/sim.2739; Thomas L, 2020, JAMA-J AM MED ASSOC, V323, P466, DOI 10.1001/jama.2019.21558; Thomas LE, 2020, JAMA-J AM MED ASSOC, V323, P2417, DOI 10.1001/jama.2020.7819; Zubizarreta JR, 2014, ANN APPL STAT, V8, P204, DOI 10.1214/13-AOAS713	9	3	3	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 11	2022	327	2					173	174						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YH8QV	35015049	Green Submitted			2022-12-28	WOS:000743426500018
J	Viner, R; Bonell, C; Blakemore, SJ; Hargreaves, J; Panovska-Griffiths, J				Viner, Russell; Bonell, Chris; Blakemore, Sarah-Jayne; Hargreaves, James; Panovska-Griffiths, Jasmina			Schools should still be the last to close and first to open if there were any future lockdown	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Viner, Russell] UCL Great Ormond St Inst Child Hlth, London, England; [Bonell, Chris; Hargreaves, James] London Sch Hyg & Trop Med, London, England; [Blakemore, Sarah-Jayne] Univ Cambridge, Cambridge, England; [Panovska-Griffiths, Jasmina] Univ Oxford, Oxford, England	University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; University of Cambridge; University of Oxford	Viner, R (corresponding author), UCL Great Ormond St Inst Child Hlth, London, England.		; Viner, Russell/A-1441-2009	Hargreaves, James/0000-0002-3509-3572; Viner, Russell/0000-0003-3047-2247; Panovska-Griffiths, Jasmina/0000-0002-7720-1121				[Anonymous], 2021, SURVEY NATL ED RESPO; [Anonymous], 2021, COVID 19 SCH INFECT; Behnood SA., 2021, J INFECT, DOI [10.2139/ssrn.3940260, DOI 10.2139/SSRN.3940260]; Bhopal S, 2021, ARCH DIS CHILD, V106, DOI 10.1136/archdischild-2020-319783; Di Gilio A, 2021, ENVIRON RES, V202, DOI 10.1016/j.envres.2021.111560; Ertem Z, 2021, NAT MED, V27, P2120, DOI 10.1038/s41591-021-01563-8; Fukumoto K, 2021, NAT MED, V27, P2111, DOI 10.1038/s41591-021-01571-8; House T, 2021, INFERRING RISKS CORO; Krishnaratne S, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013812; National Child Measurement Programme, 2021, ENGL 2020 21 SCH YEA; Panovska-Griffiths J, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-88075-0; Panovska-Griffiths J, 2020, LANCET CHILD ADOLESC, V4, P817, DOI 10.1016/S2352-4642(20)30250-9; Smith C, 2022, NAT MED, V28, P185, DOI 10.1038/s41591-021-01578-1; Sundaram N, 2021, HEALTH EDUC RES, V36, P272, DOI 10.1093/her/cyab016; Viner R, 2022, JAMA PEDIATR, DOI [10.1001/damapediatrics.2021.3221, DOI 10.1001/DAMAPEDIATRICS.2021.3221]; Viner RM, 2022, J INFECT, DOI DOI 10.1016/J.JINF.2021.12.026; Vizard T., 2020, MENTAL HLTH CHILDREN; Walsh S, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2021-053371	18	4	4	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 7	2022	376								o21	10.1136/bmj.o21	http://dx.doi.org/10.1136/bmj.o21			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YP9GN	34996758	Green Submitted, Bronze			2022-12-28	WOS:000748927300005
J	Cowper, A				Cowper, Andy			Omicron: Who needs action when you've got Plan B?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Cowper, Andy] Hlth Policy Insight, London, England		Cowper, A (corresponding author), Hlth Policy Insight, London, England.							GOV, UK COR UK; Iacobucci Gareth, 2022, BMJ, V376, po4, DOI 10.1136/bmj.o4; Iacobucci G, 2022, BMJ-BRIT MED J, V376, DOI 10.1136/bmj.o3; Office of National Statistics, COR COVID 19 INF SUR; Statista, NUMB COVID 19 VACC D	5	0	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 6	2022	376								015	10.1136/bmj.015	http://dx.doi.org/10.1136/bmj.015			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YG5VA	34992065				2022-12-28	WOS:000742554700008
J	Niu, SH; Li, J; Bo, WH; Yang, WF; Zuccolo, A; Giacomello, S; Chen, X; Han, FX; Yang, JH; Song, YT; Nie, YM; Zhou, B; Wang, PY; Zuo, Q; Zhang, H; Ma, JJ; Wang, J; Wang, LJ; Zhu, QY; Zhao, HH; Liu, ZM; Zhang, XM; Liu, T; Pei, SR; Li, ZM; Hu, Y; Yang, YH; Li, WZ; Zan, YJ; Zhou, LH; Lin, JX; Yuan, TQ; Li, W; Li, Y; Wei, HR; Wu, HX				Niu, Shihui; Li, Jiang; Bo, Wenhao; Yang, Weifei; Zuccolo, Andrea; Giacomello, Stefania; Chen, Xi; Han, Fangxu; Yang, Junhe; Song, Yitong; Nie, Yumeng; Zhou, Biao; Wang, Peiyi; Zuo, Quan; Zhang, Hui; Ma, Jingjing; Wang, Jun; Wang, Lvji; Zhu, Qianya; Zhao, Huanhuan; Liu, Zhanmin; Zhang, Xuemei; Liu, Tao; Pei, Surui; Li, Zhimin; Hu, Yao; Yang, Yehui; Li, Wenzhao; Zan, Yanjun; Zhou, Linghua; Lin, Jinxing; Yuan, Tongqi; Li, Wei; Li, Yue; Wei, Hairong; Wu, Harry X.			The Chinese pine genome and methylome unveil key features of conifer evolution	CELL			English	Article							TRANSCRIPTION FACTORS; DNA METHYLATION; READ ALIGNMENT; GENES; ANNOTATION; SEQUENCE; ANGIOSPERMS; ASSEMBLIES; REVEALS; LIGHT	Conifers dominate the world's forest ecosystems and are the most widely planted tree species. Their giant and complex genomes present great challenges for assembling a complete reference genome for evolutionary and genomic studies. We present a 25.4-Gb chromosome-level assembly of Chinese pine (Pinus tabuliformis) and revealed that its genome size is mostly attributable to huge intergenic regions and long introns with high transposable element (TE) content. Large genes with long introns exhibited higher expressions levels. Despite a lack of recent whole-genome duplication, 91.2% of genes were duplicated through dispersed duplication, and expanded gene families are mainly related to stress responses, which may underpin conifers' adaptation, particularly in cold and/or arid conditions. The reproductive regulation network is distinct compared with angiosperms. Slow removal of TEs with high-level methylation may have contributed to genomic expansion. This study provides insights into conifer evolution and resources for advancing research on conifer adaptation and development.	[Niu, Shihui; Li, Jiang; Bo, Wenhao; Chen, Xi; Han, Fangxu; Yang, Junhe; Song, Yitong; Nie, Yumeng; Zhou, Biao; Wang, Peiyi; Zuo, Quan; Zhang, Hui; Ma, Jingjing; Wang, Jun; Wang, Lvji; Zhu, Qianya; Zhao, Huanhuan; Lin, Jinxing; Yuan, Tongqi; Li, Wei; Li, Yue; Wu, Harry X.] Beijing Forestry Univ, Coll Biol Sci & Technol,Tree & Ornamental Plant B, Minist Educ,Beijing Adv Innovat Ctr Tree Breeding, Natl Engn Lab Tree Breeding,Key Lab Genet & Breed, Beijing 100083, Peoples R China; [Yang, Weifei; Zhang, Xuemei; Liu, Tao; Pei, Surui; Li, Zhimin] Annord Gene Technol Beijing Co Ltd, Beijing 100180, Peoples R China; [Zuccolo, Andrea] King Abdullah Univ Sci & Technol, Ctr Desert Agr, Biol & Environm Sci & Engn Div BESE, Thuwal 239556900, Saudi Arabia; [Zuccolo, Andrea] Scuola Super Sant Anna, Inst Life Sci, I-56127 Pisa, Italy; [Giacomello, Stefania] KTH Royal Inst Technol, SciLife Lab, Tomtebodavagen 23, SE-17165 Stockholm, Sweden; [Liu, Zhanmin] Qigou State Owned Forest Farm, Pingquan 067509, Hebei, Peoples R China; [Hu, Yao; Yang, Yehui; Li, Wenzhao] Alibaba Grp, Hangzhou 311121, Peoples R China; [Zan, Yanjun; Zhou, Linghua; Wu, Harry X.] Swedish Univ Agr Sci, Umea Plant Sci Ctr, Dept Forest Genet & Plant Physiol, Linnaeus Vag 6, S-90183 Umea, Sweden; [Yuan, Tongqi] Beijing Forestry Univ, Coll Mat Sci & Technol, Beijing 100083, Peoples R China; [Wei, Hairong] Michigan Technol Univ, Coll Forest Resources & Environm Sci, Houghton, MI 49931 USA; [Wu, Harry X.] CSIRO Natl Res Collect Australia, Black Mt Lab, Canberra, ACT 2601, Australia	Beijing Forestry University; King Abdullah University of Science & Technology; Scuola Superiore Sant'Anna; Royal Institute of Technology; SciLifeLab; Alibaba Group; Swedish University of Agricultural Sciences; Umea University; Beijing Forestry University; Michigan Technological University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Niu, SH; Wu, HX (corresponding author), Beijing Forestry Univ, Coll Biol Sci & Technol,Tree & Ornamental Plant B, Minist Educ,Beijing Adv Innovat Ctr Tree Breeding, Natl Engn Lab Tree Breeding,Key Lab Genet & Breed, Beijing 100083, Peoples R China.; Wu, HX (corresponding author), Swedish Univ Agr Sci, Umea Plant Sci Ctr, Dept Forest Genet & Plant Physiol, Linnaeus Vag 6, S-90183 Umea, Sweden.; Wei, HR (corresponding author), Michigan Technol Univ, Coll Forest Resources & Environm Sci, Houghton, MI 49931 USA.; Wu, HX (corresponding author), CSIRO Natl Res Collect Australia, Black Mt Lab, Canberra, ACT 2601, Australia.	arrennew@bjfu.edu.cn; hairong@mtu.edu; harry.wu@slu.se	yang, yang/HGT-7999-2022; Lang, Ming/HIK-0758-2022; Yang, Ye/GZM-4812-2022; Niu, Shihui/HCH-9336-2022; wei, hairong/GNM-7061-2022	Niu, Shihui/0000-0002-6296-9373; wei, hairong/0000-0002-3551-4998; Zuccolo, Andrea/0000-0001-7574-0714; Yang, Junhe/0000-0001-8060-5648; Giacomello, Stefania/0000-0003-0738-1574; Wu, Harry/0000-0002-7072-4704	National Natural Science Foundation of China [31870651, 31600535]; Program of Introducing Talents of Discipline to Universities [B13007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of Introducing Talents of Discipline to Universities(Ministry of Education, China - 111 Project)	This work was supported by The National Natural Science Foundation of China (no. 31870651 and 31600535) and The Program of Introducing Talents of Discipline to Universities (111 project, B13007) . We would like to thank Dong-mei Hu for her help in drawing some diagrams and English editing by Dr. Peter Stevens and Dr. Jennifer Sanders.	Albert VA, 2013, SCIENCE, V342, P1467, DOI 10.1126/science.1241089; Ausin I, 2016, P NATL ACAD SCI USA, V113, pE8106, DOI 10.1073/pnas.1618019113; Blumel M, 2015, CURR OPIN BIOTECH, V32, P121, DOI 10.1016/j.copbio.2014.11.023; Bouche F, 2016, NUCLEIC ACIDS RES, V44, pD1167, DOI 10.1093/nar/gkv1054; Burton JN, 2013, NAT BIOTECHNOL, V31, P1119, DOI 10.1038/nbt.2727; Cantarel BL, 2008, GENOME RES, V18, P188, DOI 10.1101/gr.6743907; Celedon JM, 2019, NEW PHYTOL, V224, P1444, DOI 10.1111/nph.15984; Chan PP, 2019, METHODS MOL BIOL, V1962, P1, DOI 10.1007/978-1-4939-9173-0_1; Chen CJ., 1990, INTEGRATED MANAGEMEN; Chen X., 2021, FORESTRY RES, V1, P12; Chen XL, 2016, P NATL ACAD SCI USA, V113, P12132, DOI 10.1073/pnas.1610379113; Cheng CY, 2017, PLANT J, V89, P789, DOI 10.1111/tpj.13415; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; Cossu RM, 2017, GENOME BIOL EVOL, V9, P3449, DOI 10.1093/gbe/evx260; De Bie T, 2006, BIOINFORMATICS, V22, P1269, DOI 10.1093/bioinformatics/btl097; Dodsworth S, 2015, CURR OPIN GENET DEV, V35, P73, DOI 10.1016/j.gde.2015.10.006; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eilbeck K, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-67; El Baidouri M, 2013, GENOME BIOL EVOL, V5, P954, DOI 10.1093/gbe/evt025; Emms DM, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0721-2; Fedoroff NV, 2012, SCIENCE, V338, P758, DOI 10.1126/science.338.6108.758; Gramzow L, 2014, ANN BOT-LONDON, V114, P1407, DOI 10.1093/aob/mcu066; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Ji XJ, 2020, NUCLEIC ACIDS RES, V48, P8320, DOI 10.1093/nar/gkaa638; Jin WT, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2022302118; Joyner KL, 2001, CAN J BOT, V79, P192, DOI 10.1139/cjb-79-2-192; Kelly LJ, 2015, NEW PHYTOL, V208, P596, DOI 10.1111/nph.13471; Kendig KI, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00736; Kim D, 2019, NAT BIOTECHNOL, V37, P907, DOI 10.1038/s41587-019-0201-4; Kim EY, 2021, NAT PLANTS, V7, P303, DOI 10.1038/s41477-021-00867-4; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Koren S, 2017, GENOME RES, V27, P722, DOI 10.1101/gr.215087.116; Kovaka S, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1910-1; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lawrence M, 2009, BIOINFORMATICS, V25, P1841, DOI 10.1093/bioinformatics/btp328; Leebens-Mack JH, 2019, NATURE, V574, P679, DOI 10.1038/s41586-019-1693-2; Leslie AB, 2021, SCIENCE, V373, P1368, DOI 10.1126/science.abi6984; Letunic I, 2021, NUCLEIC ACIDS RES, V49, pD458, DOI 10.1093/nar/gkaa937; Letunic I, 2019, NUCLEIC ACIDS RES, V47, pW256, DOI 10.1093/nar/gkz239; Li H, 2018, BIOINFORMATICS, V34, P3094, DOI 10.1093/bioinformatics/bty191; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li W, 2020, PLANT PHYSIOL, V182, P658, DOI 10.1104/pp.19.00954; Li Z, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1501084; Lim JQ, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-r82, 10.1186/gb-2012-13-10-R82]; Liu B., 2013, ARXIV, V35, P62; Liu B, 2021, PLANT CELL ENVIRON, V44, P257, DOI 10.1111/pce.13873; Liu HL, 2021, NAT PLANTS, V7, P748, DOI 10.1038/s41477-021-00933-x; Liu YY, 2016, NEW PHYTOL, V212, P730, DOI 10.1111/nph.14066; Loh WY, 2002, STAT SINICA, V12, P361; Ma JJ, 2021, PLANT PHYSIOL, V187, P247, DOI 10.1093/plphys/kiab250; Ma L, 2015, GENOME BIOL EVOL, V7, P2648, DOI 10.1093/gbe/evv171; Maor GL, 2015, TRENDS GENET, V31, P274, DOI 10.1016/j.tig.2015.03.002; Marcais G, 2011, BIOINFORMATICS, V27, P764, DOI 10.1093/bioinformatics/btr011; Meyer A, 2021, NATURE, V590, DOI 10.1038/s41586-021-03198-8; Mizutani M, 2010, ANNU REV PLANT BIOL, V61, P291, DOI 10.1146/annurev-arplant-042809-112305; Mosca E, 2019, G3-GENES GENOM GENET, V9, P2039, DOI 10.1534/g3.119.400083; Murray BG, 1998, ANN BOT-LONDON, V82, P3, DOI 10.1006/anbo.1998.0764; Nawrocki EP, 2013, BIOINFORMATICS, V29, P2933, DOI 10.1093/bioinformatics/btt509; Niu SH, 2019, TREE PHYSIOL, V39, P1173, DOI 10.1093/treephys/tpz023; Niu SH, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1885-6; Niu SH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-263; Niu SH, 2016, NEW PHYTOL, V209, P1278, DOI 10.1111/nph.13680; Nowoshilow S, 2018, NATURE, V554, P50, DOI 10.1038/nature25458; Nystedt B, 2013, NATURE, V497, P579, DOI 10.1038/nature12211; Ou SJ, 2019, MOBILE DNA-UK, V10, DOI 10.1186/s13100-019-0193-0; Ou SJ, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1905-y; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pervaiz T, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22179604; Qiao X, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1650-2; Roach MJ, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2485-7; Rosso MG, 2003, PLANT MOL BIOL, V53, P247, DOI 10.1023/B:PLAN.0000009297.37235.4a; Sander H, 2009, ALLG FORST JAGDZTG, V180, P158; Schneider H, 2004, NATURE, V428, P553, DOI 10.1038/nature02361; Scott AD, 2020, G3-GENES GENOM GENET, V10, P3907, DOI 10.1534/g3.120.401612; Sederoff R, 2013, NATURE, V497, P569, DOI 10.1038/nature12250; Sena JS, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-95; Seppey M, 2019, METHODS MOL BIOL, V1962, P227, DOI 10.1007/978-1-4939-9173-0_14; Servant N, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0831-x; Shao MF, 2017, NAT BIOTECHNOL, V35, P1167, DOI 10.1038/nbt.4020; Sharma V, 2021, PLANT REPROD, V34, P353, DOI 10.1007/s00497-021-00414-3; Shi YT, 2018, TRENDS PLANT SCI, V23, P623, DOI 10.1016/j.tplants.2018.04.002; Smith SA, 2010, P NATL ACAD SCI USA, V107, P5897, DOI 10.1073/pnas.1001225107; Song L, 2016, SCIENCE, V354, DOI 10.1126/science.aag1550; Song XM, 2020, PLANT BIOTECHNOL J, V18, P1444, DOI 10.1111/pbi.13310; Stanke M, 2008, BIOINFORMATICS, V24, P637, DOI 10.1093/bioinformatics/btn013; Stull GW, 2021, NAT PLANTS, V7, P1015, DOI 10.1038/s41477-021-00964-4; Sun YQ, 2022, TRENDS PLANT SCI, V27, P391, DOI 10.1016/j.tplants.2021.10.006; Tang HB, 2008, SCIENCE, V320, P486, DOI 10.1126/science.1153917; Tholl Dorothea, 2011, Arabidopsis Book, V9, pe0143, DOI 10.1199/tab.0143; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Van Bel M, 2018, NUCLEIC ACIDS RES, V46, pD1190, DOI 10.1093/nar/gkx1002; Van de Peer Y, 2009, NAT REV GENET, V10, P725, DOI 10.1038/nrg2600; Walker BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112963; Wan T, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-24528-4; Wan T, 2018, NAT PLANTS, V4, P82, DOI 10.1038/s41477-017-0097-2; Wang CM, 2015, GENOME RES, V25, P246, DOI 10.1101/gr.170332.113; Wang DD, 2021, ECOL EVOL, V11, P2660, DOI 10.1002/ece3.7222; Wang K, 2021, CELL, V184, P1362, DOI 10.1016/j.cell.2021.01.047; Wang L, 2019, PLANT BIOTECHNOL J, V17, P826, DOI 10.1111/pbi.13018; Wang YL, 2012, NUCLEIC ACIDS RES, V40, pD400, DOI [10.1093/nar/gkr1293, 10.1093/nar/gkr1132]; Warren RL, 2015, PLANT J, V83, P189, DOI 10.1111/tpj.12886; Wegrzyn Jill L, 2008, Int J Plant Genomics, V2008, P412875, DOI 10.1155/2008/412875; Wellmer F, 2010, TRENDS GENET, V26, P519, DOI 10.1016/j.tig.2010.09.001; Wickland DP, 2015, MOL PLANT, V8, P983, DOI 10.1016/j.molp.2015.01.007; Wu SD, 2020, MOL PLANT, V13, P59, DOI 10.1016/j.molp.2019.10.012; Xu J, 2021, TREE PHYSIOL, V41, P1247, DOI 10.1093/treephys/tpaa180; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang LS, 2020, PLANT CELL ENVIRON, V43, P2847, DOI 10.1111/pce.13898; Zhang SD, 2020, NUCLEIC ACIDS RES, V48, P7700, DOI 10.1093/nar/gkaa588; Zhang Z, 2012, BIOCHEM BIOPH RES CO, V419, P779, DOI 10.1016/j.bbrc.2012.02.101; Zhao CZ, 2016, PLANT PHYSIOL, V171, P2744, DOI 10.1104/pp.16.00533; Zhao SY, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.01459; Zhao YP, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12133-5; Zheng Y, 2016, MOL PLANT, V9, P1667, DOI 10.1016/j.molp.2016.09.014; Zhou WD, 2020, P NATL ACAD SCI USA, V117, P19359, DOI 10.1073/pnas.1921719117	120	36	38	78	158	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 6	2022	185	1					204	+		10.1016/j.cell.2021.12.006	http://dx.doi.org/10.1016/j.cell.2021.12.006			29	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	YN0XD	34965378	hybrid, Green Published			2022-12-28	WOS:000746989500002
J	Jaffe, S				Jaffe, Susan			Holmes verdicts prompt questions over justice for patients	LANCET			English	Editorial Material																			0	0	0	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN	2022	399	10321					224	225						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YL7AZ	35033214				2022-12-28	WOS:000746041700008
J	Einkauf, KB; Osborn, MR; Gao, C; Sun, WW; Sun, XM; Lian, XD; Parsons, EM; Gladkov, GT; Seiger, KW; Blackmer, JE; Jiang, CY; Yukl, SA; Rosenberg, ES; Yu, XG; Lichterfeld, M				Einkauf, Kevin B.; Osborn, Matthew R.; Gao, Ce; Sun, Weiwei; Sun, Xiaoming; Lian, Xiaodong; Parsons, Elizabeth M.; Gladkov, Gregory T.; Seiger, Kyra W.; Blackmer, Jane E.; Jiang, Chenyang; Yukl, Steven A.; Rosenberg, Eric S.; Yu, Xu G.; Lichterfeld, Mathias			Parallel analysis of transcription, integration, and sequence of single HIV-1 proviruses	CELL			English	Article							CD4(+) T-CELLS; CHROMATIN ACCESSIBILITY; ANTIRETROVIRAL THERAPY; GENE-EXPRESSION; READ ALIGNMENT; INTACT HIV-1; LATENT; RESERVOIR; SEQ; IDENTIFICATION	HIV-1-infected cells that persist despite antiretroviral therapy (ART) are frequently considered "transcriptionally silent,"but active viral gene expression may occur in some cells, challenging the concept of viral latency. Applying an assay for profiling the transcriptional activity and the chromosomal locations of individual proviruses, we describe a global genomic and epigenetic map of transcriptionally active and silent proviral species and evaluate their longitudinal evolution in persons receiving suppressive ART. Using genome-wide epigenetic reference data, we show that proviral transcriptional activity is associated with activating epigenetic chromatin features in linear proximity of integration sites and in their inter-and intrachromosomal contact regions. Transcriptionally active proviruses were actively selected against during prolonged ART; however, this pattern was violated by large clones of virally infected cells that may outcompete negative selection forces through elevated intrinsic proliferative activity. Our results suggest that transcriptionally active proviruses are dynamically evolving under selection pressure by host factors.	[Einkauf, Kevin B.; Osborn, Matthew R.; Lian, Xiaodong; Parsons, Elizabeth M.; Seiger, Kyra W.; Blackmer, Jane E.; Jiang, Chenyang; Yu, Xu G.; Lichterfeld, Mathias] Brigham & Womens Hosp, Infect Dis Div, Boston, MA 02115 USA; [Einkauf, Kevin B.; Osborn, Matthew R.; Gao, Ce; Sun, Weiwei; Sun, Xiaoming; Lian, Xiaodong; Parsons, Elizabeth M.; Gladkov, Gregory T.; Seiger, Kyra W.; Blackmer, Jane E.; Jiang, Chenyang; Yu, Xu G.; Lichterfeld, Mathias] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA; [Yukl, Steven A.] Univ Calif San Francisco, San Francisco VA Med Ctr, San Francisco, CA 94121 USA; [Rosenberg, Eric S.] Massachusetts Gen Hosp, Infect Dis Div, Boston, MA 02114 USA; [Sun, Xiaoming] Hangzhou Normal Univ, Dept Immunol & Microbiol, Hangzhou, Zhejiang, Peoples R China	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; Harvard University; Massachusetts General Hospital; Hangzhou Normal University	Lichterfeld, M (corresponding author), Brigham & Womens Hosp, Infect Dis Div, Boston, MA 02115 USA.; Lichterfeld, M (corresponding author), Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA.	mlichterfeld@partners.org		Gao, Ce/0000-0002-3775-790X; Einkauf, Kevin/0000-0001-7123-1293; Lian, Xiaodong/0000-0002-6163-9452; Parsons, Elizabeth/0000-0002-5962-3283; Osborn, Matthew/0000-0002-5979-3311; Gladkov, Gregory/0000-0003-0206-6575	NIH [AI117841, AI120008, AI130005, DK120387, AI152979, AI155233, AI155171, AI116228, AI078799, HL134539, DA047034]; American Foundation for AIDS Research [110181-69-RGCV]; Bill and Melinda Gates Foundation [INV-002703];  [UM1 AI164560];  [AI164562];  [AI164570]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Foundation for AIDS Research; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); ; ; 	M.L. is supported by NIH grants AI117841, AI120008, AI130005, DK120387, AI152979, and AI155233 and by the American Foundation for AIDS Research (#110181-69-RGCV). X.G.Y. is supported by NIH grants AI155171, AI116228, AI078799, HL134539, and DA047034 and the Bill and Melinda Gates Foundation (INV-002703). M.L. and X.G.Y. are members of the DARE, ERASE, and BEAT-HIV Martin Delaney Collaboratories (UM1 AI164560, AI164562, and AI164570).	Aamer HA, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008791; Achuthan V, 2018, CELL HOST MICROBE, V24, P392, DOI 10.1016/j.chom.2018.08.002; Agarwal N, 2016, CANCER RES, V76, P5175, DOI 10.1158/0008-5472.CAN-16-1099; Anderson EL, 2008, P NATL ACAD SCI USA, V105, P14976, DOI [10.1073/pnas.0807297105, 10.1038/s41598-019-45839-z]; Antar AAR, 2020, J CLIN INVEST, V130, P3543, DOI 10.1172/JCI135953; Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286; Ay F, 2014, GENOME RES, V24, P999, DOI 10.1101/gr.160374.113; Battivelli E, 2018, ELIFE, V7, DOI 10.7554/eLife.34655; Beagan JA, 2020, NAT GENET, V52, P8, DOI 10.1038/s41588-019-0561-1; Bronner I.F, 1979, METHODS MOL BIOL, P319; Bruner KM, 2019, NATURE, V566, P120, DOI 10.1038/s41586-019-0898-8; Bui JK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006283; Burtt N.P., 2011, COLD SPRING HARB PRO, V2011; Cesana D, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00609-1; Chen HC, 2017, NAT STRUCT MOL BIOL, V24, P47, DOI 10.1038/nsmb.3328; Chen JY, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.71; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Ciuffi A, 2005, NAT MED, V11, P1287, DOI 10.1038/nm1329; Cohn LB, 2018, NAT MED, V24, P604, DOI 10.1038/s41591-018-0017-7; Cohn LB, 2015, CELL, V160, P420, DOI 10.1016/j.cell.2015.01.020; Cole B, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-24080-1; Corces MR, 2017, NAT METHODS, V14, P959, DOI [10.1038/NMETH.4396, 10.1038/nmeth.4396]; Corces MR, 2016, NAT GENET, V48, P1193, DOI 10.1038/ng.3646; Crowley C, 2021, COMPUT STRUCT BIOTEC, V19, P355, DOI 10.1016/j.csbj.2020.12.026; Diaz N, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06961-0; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Edelman LB, 2012, CURR OPIN GENET DEV, V22, P110, DOI 10.1016/j.gde.2012.01.010; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Einkauf KB, 2019, J CLIN INVEST, V129, P988, DOI 10.1172/JCI124291; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Fraietta JA, 2018, NATURE, V558, P307, DOI 10.1038/s41586-018-0178-z; Halvas EK, 2020, J CLIN INVEST, V130, P5847, DOI 10.1172/JCI138099; Han YF, 2008, CELL HOST MICROBE, V4, P134, DOI 10.1016/j.chom.2008.06.008; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hiener B, 2017, CELL REP, V21, P813, DOI 10.1016/j.celrep.2017.09.081; Ho YC, 2013, CELL, V155, P540, DOI 10.1016/j.cell.2013.09.020; Hosmane NN, 2017, J EXP MED, V214, P959, DOI 10.1084/jem.20170193; Jiang CY, 2020, NATURE, V585, P261, DOI 10.1038/s41586-020-2651-8; Jordan A, 2003, EMBO J, V22, P1868, DOI 10.1093/emboj/cdg188; Josefsson L, 2011, P NATL ACAD SCI USA, V108, P11199, DOI 10.1073/pnas.1107729108; Kaul A, 2020, NAT PROTOC, V15, P991, DOI 10.1038/s41596-019-0273-0; Knight PA, 2013, IMA J NUMER ANAL, V33, P1029, DOI 10.1093/imanum/drs019; Komaki S, 2018, HUM GENOME VAR, V5, DOI 10.1038/hgv.2018.8; Kumar A, 2014, P NATL ACAD SCI USA, V111, P18249, DOI 10.1073/pnas.1415120112; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Kuo HH, 2018, IMMUNITY, V48, P1183, DOI 10.1016/j.immuni.2018.04.004; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee GQ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10659-2; Lee GQ, 2017, J CLIN INVEST, V127, P2689, DOI 10.1172/JCI93289; Lenasi T, 2008, CELL HOST MICROBE, V4, P123, DOI 10.1016/j.chom.2008.05.016; Lewinski MK, 2005, J VIROL, V79, P6610, DOI 10.1128/JVI.79.11.6610-6619.2005; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Lian X., 2021, SCI TRANSL MED, V13, P1; Liu RX, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aaz0802; Lorenzi JCC, 2016, P NATL ACAD SCI USA, V113, pE7908, DOI 10.1073/pnas.1617789113; Maass PG, 2019, J CELL BIOL, V218, P27, DOI 10.1083/jcb.201806052; Macaulay IC, 2016, NAT PROTOC, V11, P36, DOI 10.1038/nprot.2016.138; Macaulay IC, 2015, NAT METHODS, V12, P519, DOI 10.1038/nmeth.3370; Maldarelli F, 2014, SCIENCE, V345, P179, DOI 10.1126/science.1254194; Mendoza P, 2020, J EXP MED, V217, DOI 10.1084/jem.20200051; Patro SC, 2019, P NATL ACAD SCI USA, V116, P25891, DOI 10.1073/pnas.1910334116; Pedregosa F., 2011, J MACH LEARN RES, V12, P2825; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Pinzone MR, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08431-7; Pollack RA, 2017, CELL HOST MICROBE, V21, P494, DOI 10.1016/j.chom.2017.03.008; R Core Team, 2019, R FDN STAT COMP, DOI DOI 10.1007/978-3-540-74686-7; Rasmussen TA, 2014, LANCET HIV, V1, pE13, DOI 10.1016/S2352-3018(14)70014-1; Ren YQ, 2020, J CLIN INVEST, V130, P2542, DOI 10.1172/JCI132374; Rose PP, 2000, BIOINFORMATICS, V16, P400, DOI 10.1093/bioinformatics/16.4.400; Rouzine IM, 2015, CELL, V160, P1002, DOI 10.1016/j.cell.2015.02.017; Schmitt AD, 2016, CELL REP, V17, P2042, DOI 10.1016/j.celrep.2016.10.061; Schoenfelder S, 2010, CURR OPIN GENET DEV, V20, P127, DOI 10.1016/j.gde.2010.02.002; Scholtysik R, 2015, INT J CANCER, V136, P1033, DOI 10.1002/ijc.29072; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Shao W, 2020, AIDS RES HUM RETROV, V36, P942, DOI [10.1089/aid.2020.0109, 10.1089/AID.2020.0109]; Shukla A, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12050555; Simonetti FR, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI145254; Simonetti FR, 2016, P NATL ACAD SCI USA, V113, P1883, DOI 10.1073/pnas.1522675113; Singh A, 2010, BIOPHYS J, V98, pL32, DOI 10.1016/j.bpj.2010.03.001; Skupsky R, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000952; Smurova K, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00674; Trombetta John J, 2014, Curr Protoc Mol Biol, V107, DOI 10.1002/0471142727.mb0422s107; Vansant G, 2020, NUCLEIC ACIDS RES, V48, P7801, DOI 10.1093/nar/gkaa536; Wagner TA, 2014, SCIENCE, V345, P570, DOI 10.1126/science.1256304; Wang WL, 2020, P NATL ACAD SCI USA, V117, P5442, DOI 10.1073/pnas.1919259117; Wiegand A, 2017, P NATL ACAD SCI USA, V114, pE3659, DOI 10.1073/pnas.1617961114; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Yukl SA, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aap9927	89	29	29	13	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 20	2022	185	2					266	+		10.1016/j.cell.2021.12.011	http://dx.doi.org/10.1016/j.cell.2021.12.011			33	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	YL8YE	35026153	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000746172100008
J	O'Brien, MP; Forleo-Neto, E; Sarkar, N; Isa, F; Hou, PJ; Chan, KC; Musser, BJ; Bar, KJ; Barnabas, RV; Barouch, DH; Cohen, MS; Hurt, CB; Burwen, DR; Marovich, MA; Brown, ER; Heirman, I; Davis, JD; Turner, KC; Ramesh, D; Mahmood, A; Hooper, AT; Hamilton, JD; Kim, Y; Purcell, LA; Baum, A; Kyratsous, CA; Krainson, J; Perez-Perez, R; Mohseni, R; Kowal, B; DiCioccio, AT; Geba, GP; Stahl, N; Lipsich, L; Braunstein, N; Herman, G; Yancopoulos, GD; Weinreich, DM				O'Brien, Meagan P.; Forleo-Neto, Eduardo; Sarkar, Neena; Isa, Flonza; Hou, Peijie; Chan, Kuo-Chen; Musser, Bret J.; Bar, Katharine J.; Barnabas, Ruanne, V; Barouch, Dan H.; Cohen, Myron S.; Hurt, Christopher B.; Burwen, Dale R.; Marovich, Mary A.; Brown, Elizabeth R.; Heirman, Ingeborg; Davis, John D.; Turner, Kenneth C.; Ramesh, Divya; Mahmood, Adnan; Hooper, Andrea T.; Hamilton, Jennifer D.; Kim, Yunji; Purcell, Lisa A.; Baum, Alina; Kyratsous, Christos A.; Krainson, James; Perez-Perez, Richard; Mohseni, Rizwana; Kowal, Bari; DiCioccio, A. Thomas; Geba, Gregory P.; Stahl, Neil; Lipsich, Leah; Braunstein, Ned; Herman, Gary; Yancopoulos, George D.; Weinreich, David M.		COVID-19 Phase 3 Prevention Trial	Effect of Subcutaneous Casirivimab and Imdevimab Antibody Combination vs Placebo on Development of Symptomatic COVID-19 in Early Asymptomatic SARS-CoV-2 Infection A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								IMPORTANCE Easy-to-administer anti-SARS-CoV-2 treatments may be used to prevent progression from asymptomatic infection to symptomatic disease and to reduce viral carriage. OBJECTIVE To evaluate the effect of combination subcutaneous casirivimab and imdevimab on progression from early asymptomatic SARS-CoV-2 infection to symptomatic COVID-19. DESIGN, SETTING, AND PARTICIPANTS Randomized, double-blind, placebo-controlled, phase 3 trial of close household contacts of a SARS-CoV-2-infected index case at 112 sites in the US, Romania, and Moldova enrolled July 13, 2020-January 28, 2021; follow-up ended March 11, 2021. Asymptomatic individuals (aged >= 12 years) were eligible if identified within 96 hours of index case positive test collection. Results from 314 individuals positive on SARS-CoV-2 reverse transcriptase-quantitative polymerase chain reaction (RT-qPCR) testing are reported. INTERVENTIONS Individuals were randomized 1:1 to receive 1 dose of subcutaneous casirivimab and imdevimab, 1200 mg (600 mg of each; n = 158), or placebo (n = 156). MAIN OUTCOMES AND MEASURES The primary end point was the proportion of seronegative participants who developed symptomatic COVID-19 during the 28-day efficacy assessment period. The key secondary efficacy end points were the number of weeks of symptomatic SARS-CoV-2 infection and the number of weeks of high viral load (>4 log(10) copies/mL). RESULTS Among 314 randomized participants (mean age, 41.0 years; 51.6% women), 310 (99.7%) completed the efficacy assessment period; 204 were asymptomatic and seronegative at baseline and included in the primary efficacy analysis. Subcutaneous casirivimab and imdevimab, 1200 mg, significantly prevented progression to symptomatic disease (29/100 [29.0%] vs 44/104 [42.3%] with placebo; odds ratio, 0.54 [95% CI, 0.30-0.97]; P = .04; absolute risk difference, -13.3% [95% CI, -26.3% to -0.3%]). Casirivimab and imdevimab reduced the number of symptomatic weeks per 1000 participants (895.7 weeks vs 1637.4 weeks with placebo; P = .03), an approximately 5.6-day reduction in symptom duration per symptomatic participant. Treatment with casirivimab and imdevimab also reduced the number of high viral load weeks per 1000 participants (489.8 weeks vs 811.9 weeks with placebo; P = .001). The proportion of participants receiving casirivimab and imdevimab who had 1 or more treatment-emergent adverse event was 33.5% vs 48.1% for placebo, including events related (25.8% vs 39.7%) or not related (11.0% vs 16.0%) to COVID-19. CONCLUSIONS AND RELEVANCE Among asymptomatic SARS-CoV-2 RT-qPCR-positive individuals living with an infected household contact, treatment with subcutaneous casirivimab and imdevimab antibody combination vs placebo significantly reduced the incidence of symptomatic COVID-19 over 28 days.	[O'Brien, Meagan P.; Forleo-Neto, Eduardo; Sarkar, Neena; Isa, Flonza; Hou, Peijie; Chan, Kuo-Chen; Musser, Bret J.; Heirman, Ingeborg; Davis, John D.; Turner, Kenneth C.; Ramesh, Divya; Mahmood, Adnan; Hooper, Andrea T.; Hamilton, Jennifer D.; Kim, Yunji; Purcell, Lisa A.; Baum, Alina; Kyratsous, Christos A.; Kowal, Bari; DiCioccio, A. Thomas; Geba, Gregory P.; Stahl, Neil; Lipsich, Leah; Braunstein, Ned; Herman, Gary; Yancopoulos, George D.; Weinreich, David M.] Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA; [Bar, Katharine J.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Bar, Katharine J.] Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA; [Barnabas, Ruanne, V] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Barnabas, Ruanne, V] Univ Washington, Div Allergy & Infect Dis, Seattle, WA 98195 USA; [Barnabas, Ruanne, V] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Barnabas, Ruanne, V; Brown, Elizabeth R.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA; [Barouch, Dan H.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02115 USA; [Cohen, Myron S.; Hurt, Christopher B.] Univ N Carolina, Inst Global Hlth & Infect Dis, Chapel Hill, NC 27515 USA; [Burwen, Dale R.; Marovich, Mary A.] NIAID, NIH, Rockville, MD USA; [Brown, Elizabeth R.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Krainson, James] Clin Trials Florida LLC, Miami, FL USA; [Perez-Perez, Richard] Med Res Westchester, Miami, FL USA; [Mohseni, Rizwana] Catalina Res Inst LLC, Montclair, CA USA	Regeneron; University of Pennsylvania; University of Pennsylvania; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Washington; University of Washington Seattle	O'Brien, MP (corresponding author), Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA.	meagan.obrien@regeneron.com	Narayanan, Shivakumar/AGO-6664-2022; Streinu-Cercel, Adrian/M-5835-2017	Narayanan, Shivakumar/0000-0003-3440-0259; Streinu-Cercel, Adrian/0000-0001-6382-5067; Andrews, Jason/0000-0002-5967-251X; Hooper, Andrea/0000-0003-1131-1229; Stankiewicz Karita, Helen C./0000-0002-9458-286X; Huaman, Moises/0000-0002-6839-5809; OBrien, Meagan/0000-0003-4476-8057	Regeneron Pharmaceuticals Inc; F. Hoffmann-La Roche Ltd.; NIAID, NIH;  [UM1AI068619];  [UM1AI148684]	Regeneron Pharmaceuticals Inc(Regeneron); F. Hoffmann-La Roche Ltd.(Hoffmann-La Roche); NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ; 	This study was supported by Regeneron Pharmaceuticals Inc and F. Hoffmann-La Roche Ltd. This trial was conducted jointly with the NIAID, NIH. The CoVPN is supported by cooperative agreement awards from the NIAID, NIH. The work on this study was supported by awards UM1AI068619 and UM1AI148684.	Baum A, 2020, SCIENCE, V370, P1110, DOI 10.1126/science.abe2402; Baum A, 2020, SCIENCE, V369, P1014, DOI 10.1126/science.abd0831; Boutron I., 2020, COCHRANE DB SYST REV, pCD013769, DOI [10.1002/14651858.CD013769, DOI 10.1002/14651858.CD013769]; Boyarsky BJ, 2021, JAMA-J AM MED ASSOC, V325, P2204, DOI 10.1001/jama.2021.7489; Buitrago-Garcia D, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003346; Centers for Disease Control and Prevention, CLIN QUEST COVID 19; Centers for Disease Control and Prevention, COVID 19 PEOPL CERT; Copin R, 2021, CELL, V184, P3949, DOI 10.1016/j.cell.2021.06.002; Garcia-Beltran WF, 2021, CELL, V184, P2372, DOI [10.1016/j.cell.2021.03.013, 10.1101/2021.02.14.21251704, 10.1016/j.cell.2021.04.006]; GISAID, HCOV19 VAR; Hansen J, 2020, SCIENCE, V369, P1010, DOI 10.1126/science.abd0827; Higdon MM, PREPRINT, V2021, DOI [10.1101/2021.09.17.21263549, DOI 10.1101/2021.09.17.21263549]; Kreuzberger N, 2021, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD013825.pub2, 10.1002/14651858.CD013825]; Magesh S, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.34147; O'Brien MP, 2021, NEW ENGL J MED, V385, P1184, DOI 10.1056/NEJMoa2109682; Portal-Celhay C., 2021, 31 EUR C CLIN MICR I; U.S. Food and Drug Administration, FACT SHEET HLTH CAR; US Food and Drug Administration, 2021, LETT AUTH EM US REGE; Weinreich DM, 2021, NEW ENGL J MED, V385, DOI 10.1056/NEJMoa2108163; Weinreich DM, 2021, NEW ENGL J MED, V384, P238, DOI 10.1056/NEJMoa2035002; World Health Organization (WHO), COR COVID 19 DASHB; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053	22	32	34	2	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 1	2022	327	5					432	441		10.1001/jama.2021.24939	http://dx.doi.org/10.1001/jama.2021.24939		JAN 2022	10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YV9QB	35029629	Green Published, Bronze			2022-12-28	WOS:000742417400004
J	Torjesen, I				Torjesen, Ingrid			Covid-19: Omicron variant is linked to steep rise in hospital admissions of very young children	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		McNiff S., 2022, US NEWS; Scientific Advisory Group for Emergencies, 2022, CO CIN CHILD ADM SEV	2	9	11	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 14	2022	376								o110	10.1136/bmj.o110	http://dx.doi.org/10.1136/bmj.o110			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZE9IM	35031537	Bronze			2022-12-28	WOS:000759190400019
J	Gal-Yam, A; Bruch, R; Schulze, S; Yang, Y; Perley, DA; Irani, I; Sollerman, J; Kool, EC; Soumagnac, MT; Yaron, O; Strotjohann, NL; Zimmerman, E; Barbarino, C; Kulkarni, SR; Kasliwal, MM; De, K; Yao, Y; Fremling, C; Yan, L; Ofek, EO; Fransson, C; Filippenko, AV; Zheng, W; Brink, TG; Copperwheat, CM; Foley, RJ; Brown, J; Siebert, M; Leloudas, G; Cabrera-Lavers, AL; Garcia-Alvarez, D; Marante-Barreto, A; Frederick, S; Hung, T; Wheeler, JC; Vinko, J; Thomas, BP; Graham, MJ; Duev, DA; Drake, AJ; Dekany, R; Bellm, EC; Rusholme, B; Shupe, DL; Andreoni, I; Sharma, Y; Riddle, R; van Roestel, J; Knezevic, N				Gal-Yam, A.; Bruch, R.; Schulze, S.; Yang, Y.; Perley, D. A.; Irani, I.; Sollerman, J.; Kool, E. C.; Soumagnac, M. T.; Yaron, O.; Strotjohann, N. L.; Zimmerman, E.; Barbarino, C.; Kulkarni, S. R.; Kasliwal, M. M.; De, K.; Yao, Y.; Fremling, C.; Yan, L.; Ofek, E. O.; Fransson, C.; Filippenko, A. V.; Zheng, W.; Brink, T. G.; Copperwheat, C. M.; Foley, R. J.; Brown, J.; Siebert, M.; Leloudas, G.; Cabrera-Lavers, A. L.; Garcia-Alvarez, D.; Marante-Barreto, A.; Frederick, S.; Hung, T.; Wheeler, J. C.; Vinko, J.; Thomas, B. P.; Graham, M. J.; Duev, D. A.; Drake, A. J.; Dekany, R.; Bellm, E. C.; Rusholme, B.; Shupe, D. L.; Andreoni, I.; Sharma, Y.; Riddle, R.; van Roestel, J.; Knezevic, N.			A WC/WO star exploding within an expanding carbon-oxygen-neon nebula	NATURE			English	Article							RICH CIRCUMSTELLAR MEDIUM; DIGITAL SKY SURVEY; GAMMA-RAY BURST; IC SN 2007GR; CORE-COLLAPSE; PHYSICAL-PROPERTIES; LOW-RESOLUTION; DATA RELEASE; MASS-LOSS; SUPERNOVA	The final fate of massive stars, and the nature of the compact remnants they leave behind (black holes and neutron stars), are open questions in astrophysics. Many massive stars are stripped of their outer hydrogen envelopes as they evolve. Such Wolf-Rayet stars(1) emit strong and rapidly expanding winds with speeds greater than 1,000 kilometres per second. A fraction of this population is also helium-depleted, with spectra dominated by highly ionized emission lines of carbon and oxygen (types WC/WO). Evidence indicates that the most commonly observed supernova explosions that lack hydrogen and helium (types Ib/Ic) cannot result from massive WC/WO stars(2,3), leading some to suggest that most such stars collapse directly into black holes without a visible supernova explosion(4). Here we report observations of SN 2019hgp, beginning about a day after the explosion. Its short rise time and rapid decline place it among an emerging population of rapidly evolving transients(5-8). Spectroscopy reveals a rich set of emission lines indicating that the explosion occurred within a nebula composed of carbon, oxygen and neon. Narrow absorption features show that this material is expanding at high velocities (greater than 1,500 kilometres per second), requiring a compact progenitor. Our observations are consistent with an explosion of a massive WC/WO star, and suggest that massive Wolf-Rayet stars may be the progenitors of some rapidly evolving transients.	[Gal-Yam, A.; Bruch, R.; Schulze, S.; Yang, Y.; Irani, I.; Soumagnac, M. T.; Yaron, O.; Strotjohann, N. L.; Zimmerman, E.; Ofek, E. O.] Weizmann Inst Sci, Dept Particle Phys & Astrophys, Rehovot, Israel; [Schulze, S.; Sollerman, J.; Kool, E. C.; Barbarino, C.; Fransson, C.] Stockholm Univ, Oskar Klein Ctr, Dept Astron, Stockholm, Sweden; [Schulze, S.; Sollerman, J.; Kool, E. C.; Barbarino, C.; Fransson, C.] Stockholm Univ, AlbaNova, Dept Phys, Stockholm, Sweden; [Yang, Y.; Filippenko, A. V.; Zheng, W.; Brink, T. G.] Univ Calif Berkeley, Dept Astron, 601 Campbell Hall, Berkeley, CA 94720 USA; [Perley, D. A.; Copperwheat, C. M.] Liverpool John Moores Univ, Astrophys Res Inst, Liverpool, Merseyside, England; [Sollerman, J.] Lawrence Berkeley Natl Lab, Berkeley, CA USA; [Kulkarni, S. R.; Kasliwal, M. M.; De, K.; Yao, Y.; Fremling, C.; Yan, L.; Graham, M. J.; Duev, D. A.; Drake, A. J.; Dekany, R.; Andreoni, I.; Sharma, Y.; Riddle, R.; van Roestel, J.] CALTECH, Div Phys Math & Astron, Pasadena, CA 91125 USA; [Filippenko, A. V.] Univ Calif Berkeley, Miller Inst Basic Res Sci, Berkeley, CA USA; [Foley, R. J.; Brown, J.; Siebert, M.; Hung, T.] Univ Calif Santa Cruz, Dept Astron & Astrophys, Santa Cruz, CA 95064 USA; [Leloudas, G.] Tech Univ Denmark, Natl Space Inst, DTU Space, Kongens Lyngby, Denmark; [Cabrera-Lavers, A. L.; Garcia-Alvarez, D.; Marante-Barreto, A.] Grantecan, Ctr Astrofis La Palma, La Palma, Spain; [Frederick, S.] Univ Maryland, Dept Astron, College Pk, MD 20742 USA; [Wheeler, J. C.; Vinko, J.; Thomas, B. P.] Univ Texas Austin, Dept Astron, RLM 15308, Austin, TX 78712 USA; [Vinko, J.] Konkoly Observ Budapest, ELKH CSFK, Budapest, Hungary; [Vinko, J.] Univ Szeged, Dept Opt & Quantum Elect, Szeged, Hungary; [Vinko, J.] Eotvos Lorand Univ, ELTE Inst Phys, Budapest, Hungary; [Bellm, E. C.] Univ Washington, Dept Astron, DIRAC Inst, Seattle, WA 98195 USA; [Rusholme, B.; Shupe, D. L.] CALTECH, IPAC, Pasadena, CA 91125 USA; [Knezevic, N.] Univ Belgrade, Fac Math, Dept Astron, Belgrade, Serbia	Weizmann Institute of Science; Oskar Klein Centre; Stockholm University; Stockholm University; University of California System; University of California Berkeley; Liverpool John Moores University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; California Institute of Technology; University of California System; University of California Berkeley; University of California System; University of California Santa Cruz; Technical University of Denmark; University System of Maryland; University of Maryland College Park; University of Texas System; University of Texas Austin; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Astronomy & Earth Sciences; Szeged University; Eotvos Lorand University; University of Washington; University of Washington Seattle; California Institute of Technology; University of Belgrade	Gal-Yam, A (corresponding author), Weizmann Inst Sci, Dept Particle Phys & Astrophys, Rehovot, Israel.	avishay.gal-yam@weizmann.ac.il	Strotjohann, Nora Linn/GPX-7122-2022; Van roestel, Joannes/AGP-5214-2022; Leloudas, Giorgos/E-4470-2015	Leloudas, Giorgos/0000-0002-8597-0756; Sollerman, Jesper/0000-0003-1546-6615; Sharma, Yashvi/0000-0003-4531-1745; Gal-Yam, Avishay/0000-0002-3653-5598; Schulze, Steve/0000-0001-6797-1889; Soumagnac, Maayane/0000-0001-6753-1488; Foley, Ryan/0000-0002-2445-5275; Thomas, Benjamin Peter/0000-0002-0977-1974; Copperwheat, Christopher/0000-0001-7983-8698	US National Science Foundation (NSF) [AST-1440341]; Caltech; IPAC; Weizmann Institute for Science; Oskar Klein Center at Stockholm University; University of Maryland; University of Washington; Deutsches Elektronen-Synchrotron; Humboldt University; Los Alamos National Laboratories; TANGO Consortium of Taiwan; University of Wisconsin at Milwaukee; Lawrence Berkeley National Laboratories; UK Science and Technology Facilities Council; European Union [730890]; EU via ERC [725161]; ISF GW excellence centre; IMOS space infrastructure grant; BSF/Transformative; GIF grants; Benoziyo Endowment Fund for the Advancement of Science; Deloro Institute for Advanced Research in Space and Optics; The Veronika A. Rabl Physics Discretionary Fund; Minerva; Schwartz/Reisman Collaborative Science Program; David and Lucile Packard Foundation; NSF [AST-1813825, AST-1545949]; G.R.E.A.T. research environment - Vetenskapsradet, the Swedish Research Council [2016-06012]; The Wenner-Gren Foundations; VILLUM FONDEN [19054]; TABASGo Foundation; Christopher R. Redlich Fund; Miller Institute for Basic Research in Science; W. M. Keck Foundation; Yeda-Sela	US National Science Foundation (NSF)(National Science Foundation (NSF)); Caltech; IPAC; Weizmann Institute for Science; Oskar Klein Center at Stockholm University; University of Maryland; University of Washington(University of Washington); Deutsches Elektronen-Synchrotron; Humboldt University; Los Alamos National Laboratories(United States Department of Energy (DOE)Los Alamos National Laboratory); TANGO Consortium of Taiwan; University of Wisconsin at Milwaukee; Lawrence Berkeley National Laboratories(United States Department of Energy (DOE)); UK Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); European Union(European Commission); EU via ERC; ISF GW excellence centre; IMOS space infrastructure grant; BSF/Transformative; GIF grants; Benoziyo Endowment Fund for the Advancement of Science; Deloro Institute for Advanced Research in Space and Optics; The Veronika A. Rabl Physics Discretionary Fund; Minerva; Schwartz/Reisman Collaborative Science Program; David and Lucile Packard Foundation(The David & Lucile Packard Foundation); NSF(National Science Foundation (NSF)); G.R.E.A.T. research environment - Vetenskapsradet, the Swedish Research Council; The Wenner-Gren Foundations; VILLUM FONDEN(Villum Fonden); TABASGo Foundation; Christopher R. Redlich Fund; Miller Institute for Basic Research in Science; W. M. Keck Foundation(W.M. Keck Foundation); Yeda-Sela	This work is based on observations obtained with the Samuel Oschin 48-inch Telescope and the 60-inch Telescope at Palomar Observatory as part of the Zwicky Transient Facility project. ZTF is supported by the US National Science Foundation (NSF) under grant AST-1440341 and a collaboration including Caltech, IPAC, the Weizmann Institute for Science, the Oskar Klein Center at Stockholm University, the University of Maryland, the University of Washington, Deutsches Elektronen-Synchrotron and Humboldt University, Los Alamos National Laboratories, the TANGO Consortium of Taiwan, the University of Wisconsin at Milwaukee, and Lawrence Berkeley National Laboratories. Operations are conducted by COO, IPAC, and UW. This work includes observations made with the Nordic Optical Telescope (NOT), owned in collaboration by the University of Turku and Aarhus University, and operated jointly by Aarhus University, the University of Turku and the University of Oslo (representing Denmark, Finland and Norway, respectively), the University of Iceland and Stockholm University, at the Observatorio del Roque de los Muchachos, La Palma, Spain, of the Instituto de Astrofisica de Canarias. These data were obtained with ALFOSC, which is provided by the Instituto de Astrofisica de Andalucia (IAA) under a joint agreement with the University of Copenhagen and NOT. This work includes observations made with the GTC telescope, in the Spanish Observatorio del Roque de los Muchachos of the Instituto de Astrofisica de Canarias, under Director's Discretionary Time. Some of the data presented herein were obtained at the W. M. Keck Observatory, which is operated as a scientific partnership among the California Institute of Technology, the University of California, and the National Aeronautics and Space Administration (NASA); the Observatory was made possible by the generous financial support of the W. M. Keck Foundation. This work includes observations obtained at the international Gemini Observatory, a programme of NSF's NOIRLab, which is managed by the Association of Universities for Research in Astronomy (AURA) under a cooperative agreement with the NSF on behalf of the Gemini Observatory partnership: the NSF (USA), National Research Council (Canada), Agencia Nacional de Investigacion y Desarrollo (Chile), Ministerio de Ciencia, Tecnologia e Innovacion (Argentina), Ministerio da Ciencia, Tecnologia, Inovacoes e Comunicacoes (Brazil), and Korea Astronomy and Space Science Institute (Republic of Korea). We wish to recognize and acknowledge the very significant cultural role and reverence that the summit of Maunakea has always had within the Indigenous Hawaiian community. We are most fortunate to have the opportunity to conduct observations from this mountain. This work includes observations obtained at the Liverpool Telescope, which is operated on the island of La Palma by Liverpool John Moores University in the Spanish Observatorio del Roque de los Muchachos of the Instituto de Astrofisica de Canarias with financial support from the UK Science and Technology Facilities Council. Research at Lick Observatory is partially supported by a generous gift from Google. This work includes observations obtained with the HobbyEberly Telescope, which is a joint project of the University of Texas at Austin, the Pennsylvania State University, Ludwig-Maximilians-Universitat Munchen, and Georg-August-Universitat Gottingen. These results made use of the Lowell Discovery Telescope (LDT) at Lowell Observatory.; Lowell is a private, non-profit institution dedicated to astrophysical research and public appreciation of astronomy and operates the LDT in partnership with Boston University, the University of Maryland, the University of Toledo, Northern Arizona University and Yale University. This work benefited from the OPTICON telescope access programme (https://www.astro-opticon.org/index.html), funded from the European Union's Horizon 2020 research and innovation programme under grant agreement 730890. We made use of IRAF, which is distributed by the NSF NOIRLab. A.G.-Y. is supported by the EU via ERC grant no. 725161, the ISF GW excellence centre, an IMOS space infrastructure grant, BSF/Transformative and GIF grants, as well as by the Benoziyo Endowment Fund for the Advancement of Science, the Deloro Institute for Advanced Research in Space and Optics, The Veronika A. Rabl Physics Discretionary Fund, Minerva, Yeda-Sela and the Schwartz/Reisman Collaborative Science Program; A.G.-Y. is the incumbent of the The Arlyn Imberman Professorial Chair. M.M.K. acknowledges generous support from the David and Lucile Packard Foundation; the GROWTH project was funded by the NSF under grant AST-1545949. E.C.K., J.S. and S.S. acknowledge support from the G.R.E.A.T. research environment funded by Vetenskapsra det, the Swedish Research Council, under project number 2016-06012; E.C.K. also received support from The Wenner-Gren Foundations. The Oskar Klein Center's participation in ZTF was made available by the K.A.W. Foundation. G.L. is supported by a research grant (19054) from VILLUM FONDEN. J.C.W. and B.P.T. are supported by NSF grant AST-1813825. A.V.F.'s supernova group at UC Berkeley is supported by the TABASGo Foundation, the Christopher R. Redlich Fund, and the Miller Institute for Basic Research in Science (A.V.F. is a Senior Miller Fellow).	Ahn CP, 2012, ASTROPHYS J SUPPL S, V203, DOI 10.1088/0067-0049/203/2/21; Aihara H, 2011, ASTROPHYS J SUPPL S, V193, DOI 10.1088/0067-0049/193/2/29; Arcavi I, 2016, ASTROPHYS J, V819, DOI 10.3847/0004-637X/819/1/35; ARNETT WD, 1982, ASTROPHYS J, V253, P785, DOI 10.1086/159681; Asplund M, 2009, ANNU REV ASTRON ASTR, V47, P481, DOI 10.1146/annurev.astro.46.060407.145222; Barbarino C., 2020, TYPE IC SUPERNOVAE I; Bellm E. C., 2016, PYRAF DBSP REDUCTION; Bellm EC, 2019, PUBL ASTRON SOC PAC, V131, DOI 10.1088/1538-3873/aaecbe; Ben Bekhti N, 2016, ASTRON ASTROPHYS, V594, DOI 10.1051/0004-6361/201629178; Ben-Ami S, 2014, ASTROPHYS J, V785, DOI 10.1088/0004-637X/785/1/37; Ben-Ami S, 2012, PROC SPIE, V8446, DOI 10.1117/12.926317; Ben-Ami S, 2012, ASTROPHYS J LETT, V760, DOI 10.1088/2041-8205/760/2/L33; Benn C, 2008, PROC SPIE, V7014, DOI 10.1117/12.788694; Bianco FB, 2014, ASTROPHYS J SUPPL S, V213, DOI 10.1088/0067-0049/213/2/19; Blagorodnova N, 2018, PUBL ASTRON SOC PAC, V130, DOI 10.1088/1538-3873/aaa53f; Branch D, 2005, PUBL ASTRON SOC PAC, V117, P545, DOI 10.1086/430135; Bruch R., 2019, 20190610 TRANS NAM S; Bruch RJ, 2021, ASTROPHYS J, V912, DOI 10.3847/1538-4357/abef05; Burrows DN, 2005, SPACE SCI REV, V120, P165, DOI 10.1007/s11214-005-5097-2; Byler N, 2017, ASTROPHYS J, V840, DOI 10.3847/1538-4357/aa6c66; Calzetti D, 2000, ASTROPHYS J, V533, P682, DOI 10.1086/308692; Campana S, 2006, NATURE, V442, P1008, DOI 10.1038/natureO4892; Cao Y, 2013, ASTROPHYS J LETT, V775, DOI 10.1088/2041-8205/775/1/L7; Cenko SB, 2006, PUBL ASTRON SOC PAC, V118, P1396, DOI 10.1086/508366; Chabrier G, 2003, PUBL ASTRON SOC PAC, V115, P763, DOI 10.1086/376392; Chandra P, 2015, ASTROPHYS J, V810, DOI 10.1088/0004-637X/810/1/32; Chatzopoulos E, 2012, ASTROPHYS J, V746, DOI 10.1088/0004-637X/746/2/121; Chonis TS, 2016, PROC SPIE, V9908, DOI 10.1117/12.2232209; Conroy C, 2009, ASTROPHYS J, V699, P486, DOI 10.1088/0004-637X/699/1/486; Coppejans DL, 2020, ASTROPHYS J LETT, V895, DOI 10.3847/2041-8213/ab8cc7; Crowther PA, 2007, ANNU REV ASTRON ASTR, V45, P177, DOI 10.1146/annurev.astro.45.051806.110615; De K, 2018, SCIENCE, V362, P201, DOI 10.1126/science.aas8693; Dekany R, 2020, PUBL ASTRON SOC PAC, V132, DOI 10.1088/1538-3873/ab4ca2; Dessart L, 2011, MON NOT R ASTRON SOC, V414, P2985, DOI 10.1111/j.1365-2966.2011.18598.x; Drout MR, 2014, ASTROPHYS J, V794, DOI 10.1088/0004-637X/794/1/23; Drout MR, 2011, ASTROPHYS J, V741, DOI 10.1088/0004-637X/741/2/97; Evans PA, 2007, ASTRON ASTROPHYS, V469, P379, DOI 10.1051/0004-6361:20077530; Evans PA, 2009, MON NOT R ASTRON SOC, V397, P1177, DOI 10.1111/j.1365-2966.2009.14913.x; Filippenko AV, 1997, ANNU REV ASTRON ASTR, V35, P309, DOI 10.1146/annurev.astro.35.1.309; Foley RJ, 2007, ASTROPHYS J, V657, pL105, DOI 10.1086/513145; Foreman-Mackey D., 2014, PYTHON FSPS PYTHON B, DOI [10.5281/zenodo.12157, DOI 10.5281/ZENODO.12157]; Fremling C, 2020, ASTROPHYS J, V895, DOI 10.3847/1538-4357/ab8943; Fremling C, 2016, ASTRON ASTROPHYS, V593, DOI 10.1051/0004-6361/201628275; Gal-Yam A, 2002, MON NOT R ASTRON SOC, V332, pL73, DOI 10.1046/j.1365-8711.2002.05535.x; Gal-Yam A., 2017, HDB SUPERNOVAE, P195; Gal-Yam A., 2021, 202176 TRANS NAM SER; Gal-Yam A., 2019, 233 AM ASTR SOC M; Gal-Yam A, 2019, ASTROPHYS J, V882, DOI 10.3847/1538-4357/ab2f79; Gal-Yam A, 2019, ANNU REV ASTRON ASTR, V57, P305, DOI 10.1146/annurev-astro-081817-051819; Gal-Yam A, 2014, NATURE, V509, P471, DOI 10.1038/nature13304; Gal-Yam A, 2011, ASTROPHYS J, V736, DOI 10.1088/0004-637X/736/2/159; Galama TJ, 1998, NATURE, V395, P670, DOI 10.1038/27150; Ganot N, 2016, ASTROPHYS J, V820, DOI 10.3847/0004-637X/820/1/57; Ho AYQ, 2020, ASTROPHYS J, V895, DOI 10.3847/1538-4357/ab8bcf; Ho AYQ, 2019, ASTROPHYS J, V887, DOI 10.3847/1538-4357/ab55ec; Hook IM, 2004, PUBL ASTRON SOC PAC, V116, P425, DOI 10.1086/383624; Hosseinzadeh G, 2017, ASTROPHYS J, V836, DOI 10.3847/1538-4357/836/2/158; Immler S, 2008, ASTROPHYS J LETT, V674, pL85, DOI 10.1086/529373; Janka HT, 2012, ANNU REV NUCL PART S, V62, P407, DOI 10.1146/annurev-nucl-102711-094901; Karamehmetoglu E, 2021, ASTRON ASTROPHYS, V649, DOI 10.1051/0004-6361/201936308; Karamehmetoglu E, 2017, ASTRON ASTROPHYS, V602, DOI 10.1051/0004-6361/201629619; Kasliwal MM, 2019, PUBL ASTRON SOC PAC, V131, DOI 10.1088/1538-3873/aafbc2; Khazov D, 2016, ASTROPHYS J, V818, DOI 10.3847/0004-637X/818/1/3; Kiewe M, 2012, ASTROPHYS J, V744, DOI 10.1088/0004-637X/744/1/10; Komatsu E, 2011, ASTROPHYS J SUPPL S, V192, DOI 10.1088/0067-0049/192/2/18; Kool EC, 2021, ASTRON ASTROPHYS, V652, DOI 10.1051/0004-6361/202039137; Lang D, 2014, ASTRON J, V147, DOI 10.1088/0004-6256/147/5/108; Leja J, 2017, ASTROPHYS J, V837, DOI 10.3847/1538-4357/aa5ffe; Leloudas G, 2015, MON NOT R ASTRON SOC, V449, P917, DOI 10.1093/mnras/stv320; Levine SE, 2016, PROC SPIE, V9906, DOI 10.1117/12.2232732; Levine SE, 2012, PROC SPIE, V8444, DOI 10.1117/12.926415; Lunnan R, 2014, ASTROPHYS J, V787, DOI 10.1088/0004-637X/787/2/138; Mainzer A, 2014, ASTROPHYS J, V792, DOI 10.1088/0004-637X/792/1/30; Margutti R, 2019, ASTROPHYS J, V872, DOI 10.3847/1538-4357/aafa01; Marino RA, 2013, ASTRON ASTROPHYS, V559, DOI 10.1051/0004-6361/201321956; Martin C, 2005, IAU SYMP, P221; Masci FJ, 2019, PUBL ASTRON SOC PAC, V131, DOI 10.1088/1538-3873/aae8ac; Mazzali PA, 2002, ASTROPHYS J, V572, pL61, DOI 10.1086/341504; Mazzali PA, 2008, SCIENCE, V321, P1185, DOI 10.1126/science.1158088; Mazzali PA, 2010, MON NOT R ASTRON SOC, V408, P87, DOI 10.1111/j.1365-2966.2010.17133.x; Meisner AM, 2017, ASTRON J, V154, DOI 10.3847/1538-3881/aa894e; Miller AA, 2020, ASTROPHYS J, V902, DOI 10.3847/1538-4357/abb13b; Ofek EO, 2013, NATURE, V494, P65, DOI 10.1038/nature11877; Ofek EO, 2010, ASTROPHYS J, V724, P1396, DOI 10.1088/0004-637X/724/2/1396; Ofek EO, 2014, ASTROPHYS J, V789, DOI 10.1088/0004-637X/789/2/104; Ofek EO, 2014, ASTROPHYS J, V781, DOI 10.1088/0004-637X/781/1/42; OKE JB, 1982, PUBL ASTRON SOC PAC, V94, P586, DOI 10.1086/131027; OKE JB, 1995, PUBL ASTRON SOC PAC, V107, P375, DOI 10.1086/133562; Pastorello A, 2007, NATURE, V447, P829, DOI 10.1038/nature05825; Pastorello A, 2016, MON NOT R ASTRON SOC, V456, P853, DOI 10.1093/mnras/stv2634; Pastorello A, 2008, MON NOT R ASTRON SOC, V389, P113, DOI 10.1111/j.1365-2966.2008.13602.x; Pastorello A., 2021, 202171 TRANS NAM SER; Perley D., 2021, 202162 TRANS NAM SER; Perley DA, 2016, ASTROPHYS J, V830, DOI 10.3847/0004-637X/830/1/13; Perley DA, 2021, MON NOT R ASTRON SOC, V508, P5138, DOI 10.1093/mnras/stab2785; Perley DA, 2019, PUBL ASTRON SOC PAC, V131, DOI 10.1088/1538-3873/ab215d; Perley DA, 2019, MON NOT R ASTRON SOC, V484, P1031, DOI 10.1093/mnras/sty3420; Prentice SJ, 2019, MON NOT R ASTRON SOC, V485, P1559, DOI 10.1093/mnras/sty3399; Prentice SJ, 2018, ASTROPHYS J LETT, V865, DOI 10.3847/2041-8213/aadd90; Pursiainen M, 2018, MON NOT R ASTRON SOC, V481, P894, DOI 10.1093/mnras/sty2309; Rabinak I, 2011, ASTROPHYS J, V728, DOI 10.1088/0004-637X/728/1/63; Ramsey LW, 1998, P SOC PHOTO-OPT INS, V3352, P34, DOI 10.1117/12.319287; Rest A, 2018, NAT ASTRON, V2, P307, DOI 10.1038/s41550-018-0423-2; Richmond MW, 1996, ASTRON J, V111, P327, DOI 10.1086/117785; Roming PWA, 2005, SPACE SCI REV, V120, P95, DOI 10.1007/s11214-005-5095-4; Rubin A, 2016, ASTROPHYS J, V820, DOI 10.3847/0004-637X/820/1/33; Sander A, 2012, ASTRON ASTROPHYS, V540, DOI 10.1051/0004-6361/201117830; Sauer DN, 2006, MON NOT R ASTRON SOC, V369, P1939, DOI 10.1111/j.1365-2966.2006.10438.x; Schlafly EF, 2011, ASTROPHYS J, V737, DOI 10.1088/0004-637X/737/2/103; Schulze S, 2018, MON NOT R ASTRON SOC, V473, P1258, DOI 10.1093/mnras/stx2352; Schulze S, 2021, ASTROPHYS J SUPPL S, V255, DOI 10.3847/1538-4365/abff5e; Sharon A, 2020, MON NOT R ASTRON SOC, V496, P4517, DOI 10.1093/mnras/staa1745; Smith N, 2015, MON NOT R ASTRON SOC, V449, P1876, DOI 10.1093/mnras/stv354; Smith N, 2011, MON NOT R ASTRON SOC, V418, P1959, DOI 10.1111/j.1365-2966.2011.19614.x; Smith N, 2011, MON NOT R ASTRON SOC, V412, P1522, DOI 10.1111/j.1365-2966.2011.17229.x; Soderberg AM, 2008, NATURE, V453, P469, DOI 10.1038/nature06997; Soumagnac MT, 2020, ASTROPHYS J, V902, DOI 10.3847/1538-4357/abb247; Soumagnac MT, 2019, ASTROPHYS J, V872, DOI 10.3847/1538-4357/aafe84; Speagle JS, 2020, MON NOT R ASTRON SOC, V493, P3132, DOI 10.1093/mnras/staa278; Stritzinger M, 2002, ASTRON J, V124, P2100, DOI 10.1086/342544; Strotjohann NL, 2021, ASTROPHYS J, V907, DOI 10.3847/1538-4357/abd032; Taddia F, 2019, ASTRON ASTROPHYS, V621, DOI 10.1051/0004-6361/201834429; Taddia F, 2018, ASTRON ASTROPHYS, V609, DOI 10.1051/0004-6361/201730844; Valenti S, 2008, ASTROPHYS J LETT, V673, pL155, DOI 10.1086/527672; Valenti S, 2011, MON NOT R ASTRON SOC, V416, P3138, DOI 10.1111/j.1365-2966.2011.19262.x; Waxman E., 2017, HDB SUPERNOVAE, P967, DOI DOI 10.1007/978-3-319-21846-5_33; Whitesides L, 2017, ASTROPHYS J, V851, DOI 10.3847/1538-4357/aa99de; Wright AH, 2016, MON NOT R ASTRON SOC, V460, P765, DOI 10.1093/mnras/stw832; Wright EL, 2010, ASTRON J, V140, P1868, DOI 10.1088/0004-6256/140/6/1868; Yao YH, 2020, ASTROPHYS J, V900, DOI 10.3847/1538-4357/abaa3d; Yao YH, 2019, ASTROPHYS J, V886, DOI 10.3847/1538-4357/ab4cf5; Yaron O, 2017, NAT PHYS, V13, P510, DOI [10.1038/NPHYS4025, 10.1038/nphys4025]; Yaron O., 2019, 201937 TRANS NAM SER; Yaron O, 2012, PUBL ASTRON SOC PAC, V124, P668, DOI 10.1086/666656	142	17	17	1	6	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 13	2022	601	7892					201	+		10.1038/s41586-021-04155-1	http://dx.doi.org/10.1038/s41586-021-04155-1			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YF9MG	35022591	Green Accepted, Green Submitted			2022-12-28	WOS:000742123100009
J	Openshaw, PJM				Openshaw, Peter J. M.			Using correlates to accelerate vaccinology	SCIENCE			English	Editorial Material									[Openshaw, Peter J. M.] Imperial Coll London, Natl Heart & Lung Inst, London, England	Imperial College London	Openshaw, PJM (corresponding author), Imperial Coll London, Natl Heart & Lung Inst, London, England.	p.openshaw@imperial.ac.uk						Cromer D, LANCET MICROBE, DOI [10.1016/S2666-5247(21)00267-6(2021), DOI 10.1016/S2666-5247(21)00267-6(2021), 10.1016/S2666- 5247(21)00267-6 (2021)]; Dan JM, 2021, SCIENCE, V371, P587, DOI 10.1126/science.abf4063; Dunning J, 2020, MUCOSAL IMMUNOL, V13, P566, DOI 10.1038/s41385-020-0287-5; Faber D. L, 2021, NATURE, V593, P506; Gilbert P. B, SCIENCE, V375, P43; Guvenel A, 2020, J CLIN INVEST, V130, P523, DOI 10.1172/JCI131696; Khoury DS, 2021, NAT MED, V27, P1205, DOI 10.1038/s41591-021-01377-8; Levin EG, 2021, NEW ENGL J MED, V385, pE84, DOI 10.1056/NEJMoa2114583; Ma S, 2017, SCI REP-UK, V7, DOI 10.1038/srep43399; Peng Y, 2020, NAT IMMUNOL, P1, DOI DOI 10.1038/s41590-020-0782-6; Ritchie AI, 2018, AM J RESP CELL MOL, V58, P128, DOI 10.1165/rcmb.2017-0315LE; US Food Drug Administration, 2021, TABL SURR ENDP WER B; WHO, 2021, CLASSIFICATION OMICR	13	2	2	1	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 7	2022	375	6576					22	23		10.1126/science.abn0007	http://dx.doi.org/10.1126/science.abn0007			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YD3FW	34990231				2022-12-28	WOS:000740261400023
J	Seifert, SA; Armitage, JO; Sanchez, EE				Seifert, Steven A.; Armitage, James O.; Sanchez, Elda E.			Snake Envenomation	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							FAB ANTIVENOM; VENOM METALLOPROTEINASE; PHOSPHOLIPASES A2; RATTLESNAKE; COAGULOPATHY; MANAGEMENT; BITES; INHIBITORS; SYSTEM; DAMAGE	Snakebites Snake envenomation is a global health problem. The range of clinical sequelae includes thromboses and neuromuscular paralysis. Antivenoms made in horses and sheep are the treatments of choice but require accurate identification of the bite source and can cause anaphylaxis and serum sickness.	[Seifert, Steven A.] Univ New Mexico, Hlth Sci Ctr, Dept Emergency Med, Albuquerque, NM 87131 USA; [Seifert, Steven A.] Univ New Mexico, Hlth Sci Ctr, New Mexico Poison & Drug Informat Ctr, Albuquerque, NM 87131 USA; [Armitage, James O.] Univ Nebraska Med Ctr, Dept Internal Med, Omaha, NE 68198 USA; [Sanchez, Elda E.] Texas A&M Univ Kingsville, Natl Nat Toxins Res Ctr, Kingsville, TX USA; [Sanchez, Elda E.] Texas A&M Univ Kingsville, Dept Chem, Kingsville, TX USA; [Sanchez, Elda E.] Texas A&M Univ Kingsville, Natl Nat Toxins Res Ctr, Dept Chem, Kingsville, TX 78363 USA	University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center; University of Nebraska System; University of Nebraska Medical Center; Texas A&M University System; Texas A&M University Kingsville; Texas A&M University System; Texas A&M University Kingsville; Texas A&M University System; Texas A&M University Kingsville	Seifert, SA (corresponding author), Univ New Mexico, Hlth Sci Ctr, Dept Emergency Med, Albuquerque, NM 87131 USA.; Seifert, SA (corresponding author), Univ New Mexico, Hlth Sci Ctr, New Mexico Poison & Drug Informat Ctr, Albuquerque, NM 87131 USA.	sseifert@salud.unm.edu; joarmita@unmc.edu; elda.sanchez@tamuk.edu		Seifert, Steven/0000-0002-3347-2050; Sanchez, Elda E./0000-0001-5222-8873				Al-Sadawi M., 2019, INT J CLIN RES TRIAL, V4, P133; Ali AJ, 2015, ANN EMERG MED, V65, P404, DOI 10.1016/j.annemergmed.2014.08.006; Anderson VE, 2019, CLIN TOXICOL, V57, P25, DOI 10.1080/15563650.2018.1491982; Association of Zoos and Aquariums, ANT IND; Bhaumik S, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008727; Bolon I, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229989; Bush SP, 2015, CLIN TOXICOL, V53, P37, DOI 10.3109/15563650.2014.974263; Bush SP, 2013, TOXICON, V69, P29, DOI 10.1016/j.toxicon.2013.02.008; Casewell NR, 2020, TRENDS PHARMACOL SCI, V41, P570, DOI 10.1016/j.tips.2020.05.006; Chippaux JP, 2017, J VENOM ANIM TOXINS, V23, DOI 10.1186/s40409-017-0127-6; Chippaux JP, 1998, B WORLD HEALTH ORGAN, V76, P515; Chuang PC, 2021, AM J TROP MED HYG, V104, P323, DOI 10.4269/ajtmh.20-0659; Chuang PC, 2020, ACTA TROP, V203, DOI 10.1016/j.actatropica.2019.105293; Clemetson KJ, 2010, TOXICON, V56, P1236, DOI 10.1016/j.toxicon.2010.03.011; Cumpston KL, 2011, CLIN TOXICOL, V49, P351, DOI 10.3109/15563650.2011.597032; Dart RC, 2001, ANN EMERG MED, V37, P181, DOI 10.1067/mem.2001.113372; de Haro L, 2012, TOXICON, V60, P712, DOI 10.1016/j.toxicon.2012.03.013; Di Nicola MR, 2021, TOXICOLOGY, V453, DOI 10.1016/j.tox.2021.152724; Escalante T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028017; Fernandes CM, 2007, BRIT J PHARMACOL, V151, P1254, DOI 10.1038/sj.bjp.0707351; Freiermuth CE, 2019, WEST J EMERG MED, V20, P497, DOI 10.5811/westjem.2019.3.42693; Habib AG, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008374; Habib AG, 2011, DRUG SAFETY, V34, P869, DOI 10.2165/11592050-000000000-00000; Harris JB, 2013, TOXINS, V5, P2533, DOI 10.3390/toxins5122533; Hernandez R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019834; Hughes Andrew, 2003, Emerg Med (Fremantle), V15, P511, DOI 10.1046/j.1442-2026.2003.00510.x; Hung DZ, 2006, T ROY SOC TROP MED H, V100, P489, DOI 10.1016/j.trstmh.2005.07.020; Isbister GK, 2010, SEMIN THROMB HEMOST, V36, P444, DOI 10.1055/s-0030-1254053; Jimenez N, 2008, J INVEST DERMATOL, V128, P2421, DOI 10.1038/jid.2008.118; Johnston CI, 2017, MED J AUSTRALIA, V207, P119, DOI 10.5694/mja17.00094; Kariyanna Pramod Theetha, 2018, Scifed J Cardiol, V2; Keyler DE, 2020, WILD ENVIRON MED, V31, P220, DOI 10.1016/j.wem.2019.12.007; Komives CF, 2017, BIOTECHNOL PROGR, V33, P81, DOI 10.1002/btpr.2386; Lauridsen LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041702; Laustsen AH, 2018, NEW BIOTECHNOL, V45, P19, DOI 10.1016/j.nbt.2017.05.005; Lavonas EJ, 2011, BMC EMERG MED, V11, DOI 10.1186/1471-227X-11-2; Le Geyt J, 2021, ARCH DIS CHILD, V106, P14, DOI 10.1136/archdischild-2020-319428; Leffers P, 2018, BLOOD COAGUL FIBRIN, V29, P656, DOI 10.1097/MBC.0000000000000771; Lomonte B, 2014, J PROTEOMICS, V105, P323, DOI 10.1016/j.jprot.2014.02.020; Longbottom J, 2018, LANCET, V392, P673, DOI 10.1016/S0140-6736(18)31224-8; Braga JRM, 2020, TOXICON, V181, P45, DOI 10.1016/j.toxicon.2020.04.095; Maduwage K, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003220; Marinho AD, 2021, TOXICON, V190, P31, DOI 10.1016/j.toxicon.2020.12.004; Massey DJ, 2012, J PROTEOMICS, V75, P2576, DOI 10.1016/j.jprot.2012.02.035; Noutsos T, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008936; Paniagua D, 2019, CLIN TOXICOL, V57, P727, DOI 10.1080/15563650.2018.1550199; Peterfi O, 2019, MOLECULES, V24, DOI 10.3390/molecules24152778; Pla Davinia, 2020, Toxicon X, V6, P100035, DOI 10.1016/j.toxcx.2020.100035; Pucca MB, 2020, TOXINS, V12, DOI 10.3390/toxins12110668; Ramirez-Cruz MP, 2020, TOXICON, V186, P78, DOI 10.1016/j.toxicon.2020.07.029; Ratnayake I, 2017, THROMB HAEMOSTASIS, V117, P500, DOI [10.1160/TH16-10-0769, 10.1160/th16-10-0769]; Reis LDG, 2021, CARDIOVASC TOXICOL, V21, P462, DOI 10.1007/s12012-021-09640-7; Ren MH, 2019, LANCET GLOB HEALTH, V7, pE837, DOI 10.1016/S2214-109X(19)30225-6; Roth GA, 2018, LANCET, V392, P1736, DOI 10.1016/s0140-6736(18)32203-7; Oliveira SS, 2020, TOXINS, V12, DOI 10.3390/toxins12090554; Sanchez EE, 2008, IMMUNOPHARM IMMUNOT, V30, P647, DOI 10.1080/08923970802279019 ; Seifert SA, 2020, TOXICON, V184, P55, DOI 10.1016/j.toxicon.2020.05.026; Seifert SA, 2001, ANN EMERG MED, V37, P189, DOI 10.1067/mem.2001.113135; Seifert S, 2011, CLIN TOXICOL, V49, P883, DOI 10.3109/15563650.2011.626424; Seifert SA, 2011, CLIN TOXICOL, V49, P324, DOI 10.3109/15563650.2011.566883; Senthilkumaran Subramanian, 2013, Int J Crit Illn Inj Sci, V3, P214, DOI 10.4103/2229-5151.119202; Silva A, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004368; Arias AS, 2017, TOXICON, V132, P40, DOI 10.1016/j.toxicon.2017.04.001; Tsai TH, 2020, J CHIN MED ASSOC, V83, P77, DOI 10.1097/JCMA.0000000000000223; Turner D, 2019, EMERG MED AUSTRALAS, V31, P542, DOI 10.1111/1742-6723.13327; University of Adelaide, 2018, CLIN TOX RES; Vergara I, 2016, TOXINS, V8, DOI 10.3390/toxins8040085; Warrell DA, 2002, NEW ENGL J MED, V347, P1804; Warrick BJ, 2014, TOXINS, V6, P2899, DOI 10.3390/toxins6102899; Welton RE, 2017, TOXICON, V131, P11, DOI 10.1016/j.toxicon.2017.03.008; Wood D, 2016, EMERG MED J, V33, P477, DOI 10.1136/emermed-2015-205279; World Health Organization, SNAK; Yeh H, 2021, TOXINS, V13, DOI 10.3390/toxins13030183; Zeng XX, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000015684	74	14	14	8	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 6	2022	386	1					68	78		10.1056/NEJMra2105228	http://dx.doi.org/10.1056/NEJMra2105228			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YC1QX	34986287				2022-12-28	WOS:000739473800012
J	Wallace, M; Sharfstein, JM				Wallace, Megan; Sharfstein, Joshua M.			The Patchwork US Public Health System	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Wallace, Megan] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Sharfstein, Joshua M.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Wallace, M (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.							Alfonso YN, 2021, HEALTH AFFAIR, V40, P664, DOI 10.1377/hlthaff.2020.01084; [Anonymous], 2019, NATL PROFILE LOCAL H; Ivory D., 2021, NEW YORK TIMES; NORC at the University of Chicago, 2012, STAT PUBL HLTH AG CL; Wood P., 2014, BALTIMORE SUN	5	3	3	3	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 6	2022	386	1					1	4		10.1056/NEJMp2104881	http://dx.doi.org/10.1056/NEJMp2104881		JAN 2022	4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YC1QX	34979071				2022-12-28	WOS:000736921300001
J	Cameroni, E; Bowen, JE; Rosen, LE; Saliba, C; Zepeda, SK; Culap, K; Pinto, D; VanBlargan, LA; De Marco, A; di Iulio, J; Zatta, F; Kaiser, H; Noack, J; Farhat, N; Czudnochowski, N; Havenar-Daughton, C; Sprouse, KR; Dillen, JR; Powell, AE; Chen, A; Maher, C; Yin, L; Sun, D; Soriaga, L; Bassi, J; Silacci-Fregni, C; Gustafsson, C; Franko, NM; Logue, J; Iqbal, NT; Mazzitelli, I; Geffner, J; Grifantini, R; Chu, H; Gori, A; Riva, A; Giannini, O; Ceschi, A; Ferrari, P; Cippa, PE; Franzetti-Pellanda, A; Garzoni, C; Halfmann, PJ; Kawaoka, Y; Hebner, C; Purcell, LA; Piccoli, L; Pizzuto, MS; Walls, AC; Diamond, MS; Telenti, A; Virgin, HW; Lanzavecchia, A; Snell, G; Veesler, D; Corti, D				Cameroni, Elisabetta; Bowen, John E.; Rosen, Laura E.; Saliba, Christian; Zepeda, Samantha K.; Culap, Katja; Pinto, Dora; VanBlargan, Laura A.; De Marco, Anna; di Iulio, Julia; Zatta, Fabrizia; Kaiser, Hannah; Noack, Julia; Farhat, Nisar; Czudnochowski, Nadine; Havenar-Daughton, Colin; Sprouse, Kaitlin R.; Dillen, Josh R.; Powell, Abigail E.; Chen, Alex; Maher, Cyrus; Yin, Li; Sun, David; Soriaga, Leah; Bassi, Jessica; Silacci-Fregni, Chiara; Gustafsson, Claes; Franko, Nicholas M.; Logue, Jenni; Iqbal, Najeeha Talat; Mazzitelli, Ignacio; Geffner, Jorge; Grifantini, Renata; Chu, Helen; Gori, Andrea; Riva, Agostino; Giannini, Olivier; Ceschi, Alessandro; Ferrari, Paolo; Cippa, Pietro E.; Franzetti-Pellanda, Alessandra; Garzoni, Christian; Halfmann, Peter J.; Kawaoka, Yoshihiro; Hebner, Christy; Purcell, Lisa A.; Piccoli, Luca; Pizzuto, Matteo Samuele; Walls, Alexandra C.; Diamond, Michael S.; Telenti, Amalio; Virgin, Herbert W.; Lanzavecchia, Antonio; Snell, Gyorgy; Veesler, David; Corti, Davide			Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift	NATURE			English	Article							RECEPTOR-BINDING DOMAIN; VARIANTS; INFECTION	The recently emerged SARS-CoV-2 Omicron variant encodes 37 amino acid substitutions in the spike protein, 15 of which are in the receptor-binding domain (RBD), thereby raising concerns about the effectiveness of available vaccines and antibody-based therapeutics. Here we show that the Omicron RBD binds to human ACE2 with enhanced affinity, relative to the Wuhan-Hu-1 RBD, and binds to mouse ACE2. Marked reductions in neutralizing activity were observed against Omicron compared to the ancestral pseudovirus in plasma from convalescent individuals and from individuals who had been vaccinated against SARS-CoV-2, but this loss was less pronounced after a third dose of vaccine. Most monoclonal antibodies that are directed against the receptor-binding motif lost in vitro neutralizing activity against Omicron, with only 3 out of 29 monoclonal antibodies retaining unaltered potency, including the ACE2-mimicking S2K146 antibody(1). Furthermore, a fraction of broadly neutralizing sarbecovirus monoclonal antibodies neutralized Omicron through recognition of antigenic sites outside the receptor-binding motif, including sotrovimab(2), S2X259(3) and S2H97(4). The magnitude of Omicron-mediated immune evasion marks a major antigenic shift in SARS-CoV-2. Broadly neutralizing monoclonal antibodies that recognize RBD epitopes that are conserved among SARS-CoV-2 variants and other sarbecoviruses may prove key to controlling the ongoing pandemic and future zoonotic spillovers.	[Cameroni, Elisabetta; Saliba, Christian; Culap, Katja; Pinto, Dora; De Marco, Anna; Zatta, Fabrizia; Bassi, Jessica; Silacci-Fregni, Chiara; Piccoli, Luca; Pizzuto, Matteo Samuele; Lanzavecchia, Antonio; Corti, Davide] Humabs Biomed SA, Subsidiary Vir Biotechnol, Bellinzona, Switzerland; [Bowen, John E.; Zepeda, Samantha K.; Sprouse, Kaitlin R.; Walls, Alexandra C.; Veesler, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Rosen, Laura E.; di Iulio, Julia; Kaiser, Hannah; Noack, Julia; Farhat, Nisar; Czudnochowski, Nadine; Havenar-Daughton, Colin; Dillen, Josh R.; Powell, Abigail E.; Chen, Alex; Maher, Cyrus; Yin, Li; Sun, David; Soriaga, Leah; Hebner, Christy; Purcell, Lisa A.; Telenti, Amalio; Virgin, Herbert W.; Snell, Gyorgy] Vir Biotechnol, San Francisco, CA 94158 USA; [VanBlargan, Laura A.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Gustafsson, Claes] ATUM, Newark, CA USA; [Franko, Nicholas M.; Logue, Jenni; Chu, Helen] Univ Washington, Div Allergy & Infect Dis, Seattle, WA 98195 USA; [Iqbal, Najeeha Talat] Aga Khan Univ, Dept Paediat & Child Hlth, Karachi, Pakistan; [Mazzitelli, Ignacio; Geffner, Jorge] Univ Buenos Aires, Fac Med, Inst Invest Biomed Retrovirus & SIDA INBIRS, Buenos Aires, DF, Argentina; [Grifantini, Renata; Lanzavecchia, Antonio] Natl Inst Mol Genet, Milan, Italy; [Gori, Andrea] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Infect Dis Unit, Milan, Italy; [Riva, Agostino] Univ Milan, Dept Biomed & Clin Sci L Sacco DIBIC, Milan, Italy; [Giannini, Olivier; Ceschi, Alessandro; Ferrari, Paolo] Univ Svizzera Italiana, Fac Biomed Sci, Lugano, Switzerland; [Giannini, Olivier; Cippa, Pietro E.] Ente Osped Cantonale, Dept Med, Bellinzona, Switzerland; [Ceschi, Alessandro] Ente Osped Cantonale, Clin Trial Unit, Lugano, Switzerland; [Ceschi, Alessandro] Ente Osped Cantonale, Inst Pharmacol Sci Southern Switzerland, Div Clin Pharmacol & Toxicol, Lugano, Switzerland; [Ceschi, Alessandro] Univ Hosp Zurich, Dept Clin Pharmacol & Toxicol, Zurich, Switzerland; [Ferrari, Paolo; Cippa, Pietro E.] Ente Osped Cantonale, Div Nephrol, Lugano, Switzerland; [Ferrari, Paolo] Univ New South Wales, Clin Sch, Sydney, NSW, Australia; [Cippa, Pietro E.] Univ Zurich, Fac Med, Zurich, Switzerland; [Franzetti-Pellanda, Alessandra] Clin Luganese Moncucco, Clin Res Unit, Lugano, Switzerland; [Garzoni, Christian] Clin Luganese Moncucco, Clin Internal Med & Infect Dis, Lugano, Switzerland; [Halfmann, Peter J.; Kawaoka, Yoshihiro] Univ Wisconsin, Sch Vet Med, Influenza Res Inst, Dept Pathobiol Sci, Madison, WI 53706 USA; [Kawaoka, Yoshihiro] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Virol, Tokyo, Japan; [Kawaoka, Yoshihiro] Natl Ctr Global Hlth & Med Res Inst, Res Ctr Global Viral Dis, Tokyo, Japan; [Walls, Alexandra C.; Veesler, David] Howard Hughes Med Inst, Seattle, WA 98195 USA; [Diamond, Michael S.; Virgin, Herbert W.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Virgin, Herbert W.] UT Southwestern Med Ctr, Dept Internal Med, Dallas, TX USA	University of Washington; University of Washington Seattle; Washington University (WUSTL); University of Washington; University of Washington Seattle; Aga Khan University; University of Buenos Aires; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; Universita della Svizzera Italiana; University of Zurich; University Zurich Hospital; University of New South Wales Sydney; University of Geneva; University of Zurich; University of Wisconsin System; University of Wisconsin Madison; University of Tokyo; Howard Hughes Medical Institute; Washington University (WUSTL); Washington University (WUSTL); University of Texas System; University of Texas Southwestern Medical Center Dallas	Corti, D (corresponding author), Humabs Biomed SA, Subsidiary Vir Biotechnol, Bellinzona, Switzerland.; Veesler, D (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.; Snell, G (corresponding author), Vir Biotechnol, San Francisco, CA 94158 USA.; Veesler, D (corresponding author), Howard Hughes Med Inst, Seattle, WA 98195 USA.	gsnell@vir.bio; dveesler@uw.edu; dcorti@vir.bio	Logue, Jennifer K/GLS-7202-2022; Franko, Nicholas Macklin/GNP-3646-2022; Veesler, David/HCH-3986-2022; Logue, Jennifer K/GLS-1307-2022	Logue, Jennifer K/0000-0002-7889-8960; Franko, Nicholas Macklin/0000-0001-8165-6332; Logue, Jennifer K/0000-0002-7889-8960; Soriaga, Leah/0000-0001-5852-741X; Rosen, Laura/0000-0002-8030-0219; Culap, Katja/0000-0002-0956-0018; Pinto, Dora/0000-0001-5737-8467; Zepeda, Samantha/0000-0003-0005-9793; Ferrari, Paolo/0000-0002-9619-3104; VanBlargan, Laura/0000-0002-8922-8946; Grifantini, Renata/0000-0003-0024-3355; Bowen, John/0000-0003-3590-9727; De Marco, Anna/0000-0001-9641-4838; DI IULIO, JULIA/0000-0001-9343-127X	National Institute of Allergy and Infectious Diseases [DP1AI158186, HHSN272201700059C]; Pew Biomedical Scholars Award; Burroughs Wellcome Fund; National Institute of General Medical Sciences [5T32GM008268-32]; Fast Grants; Swiss Kidney Foundation; National Institutes of Allergy and Infectious Diseases Center for Research on Influenza Pathogenesis [HHSN272201400008C]; Center for Research on Influenza Pathogenesis and Transmission (CRIPT) [75N93021C00014]; Japan Program for Infectious Diseases Research and Infrastructure from the Japan Agency for Medical Research and Development (AMED) [JP21wm0125002]; National Institutes of Health USA grant [U01 AI151698]	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Pew Biomedical Scholars Award; Burroughs Wellcome Fund(Burroughs Wellcome Fund); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Fast Grants; Swiss Kidney Foundation; National Institutes of Allergy and Infectious Diseases Center for Research on Influenza Pathogenesis; Center for Research on Influenza Pathogenesis and Transmission (CRIPT); Japan Program for Infectious Diseases Research and Infrastructure from the Japan Agency for Medical Research and Development (AMED); National Institutes of Health USA grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank H. Tani for providing the reagents necessary for preparing VSV pseudotyped viruses. This study was supported by the National Institute of Allergy and Infectious Diseases (DP1AI158186 and HHSN272201700059C to D.V.), a Pew Biomedical Scholars Award (D.V.), an Investigators in the Pathogenesis of Infectious Disease Awards from the Burroughs Wellcome Fund (D.V.), Fast Grants (D.V.) and the National Institute of General Medical Sciences (5T32GM008268-32 to S.K.Z.). D.V. is an Investigator of the Howard Hughes Medical Institute. O.G. is funded by the Swiss Kidney Foundation. This work was supported, in part, by the National Institutes of Allergy and Infectious Diseases Center for Research on Influenza Pathogenesis (HHSN272201400008C), the Center for Research on Influenza Pathogenesis and Transmission (CRIPT) (75N93021C00014) and the Japan Program for Infectious Diseases Research and Infrastructure (JP21wm0125002) from the Japan Agency for Medical Research and Development (AMED). This work was supported in part through National Institutes of Health USA grant U01 AI151698 for the United World Antivirus Research Network (UWARN).	ACTIV-3 TICO LY-CoV555 Study Grp, 2021, NEW ENGL J MED, V384, P905, DOI 10.1056/NEJMoa2033130; Aggarwal A., SARS COV 2 OMICRON E, DOI [10.1101/2021.12.14.21267772(2021, DOI 10.1101/2021.12.14.21267772(2021]; Bassi J., POOR NEUTRALIZATION, DOI 10.05.21264054 (2021; Baum A, 2020, SCIENCE, V370, P1110, DOI 10.1126/science.abe2402; Baum A, 2020, SCIENCE, V369, P1014, DOI 10.1126/science.abd0831; Belk J., PCT application., Patent No. [WO/2021/207597, 2021207597]; Bergstrom JJE, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00238; Bernal JL, 2021, NEW ENGL J MED, V385, P585, DOI 10.1056/NEJMoa2108891; Cao Y, NATURE, DOI [10.1038/s41586-021-04385-3(2021, DOI 10.1038/S41586-021-04385-3(2021]; Cathcart AL, 2021, DUAL FUNCTION MONOCL, DOI [10.1101/2021.03.09.434607, DOI 10.1101/2021.03.09.434607, 10.1101/2021.03.09. 434607]; Cele S, 2022, NATURE, V602, P654, DOI 10.1038/s41586-021-04387-1; Chen P, 2021, NEW ENGL J MED, V384, P229, DOI 10.1056/NEJMoa2029849; Chen RTE, 2021, NAT MED, V27, DOI 10.1038/s41591-021-01294-w; Collier DA, 2021, NATURE, V593, P136, DOI 10.1038/s41586-021-03412-7; Copin R, 2021, CELL, V184, P3949, DOI 10.1016/j.cell.2021.06.002; Corey L, 2021, NEW ENGL J MED, V385, P562, DOI 10.1056/NEJMsb2104756; Corti D, 2021, CELL, V184, P3086, DOI [10.1016/j.cell.2021.05.005, 10.1016/j.cell.2021.07.027]; Dinnon KH, 2020, NATURE, V586, P560, DOI 10.1038/s41586-020-2708-8; Dong JH, 2021, NAT MICROBIOL, V6, P1233, DOI 10.1038/s41564-021-00972-2; Fischer W, 2021, CELL HOST MICROBE, V29, P1093, DOI 10.1016/j.chom.2021.05.012; Giroglou T, 2004, J VIROL, V78, P9007, DOI 10.1128/JVI.78.17.9007-9015.2004; Gottlieb RL, 2021, JAMA-J AM MED ASSOC, V325, P632, DOI 10.1001/jama.2021.0202; Greaney AJ, 2021, CELL HOST MICROBE, V29, P463, DOI 10.1016/j.chom.2021.02.003; Hansen J, 2020, SCIENCE, V369, P1010, DOI 10.1126/science.abd0827; Harvey WT, 2021, NAT REV MICROBIOL, V19, P409, DOI 10.1038/s41579-021-00573-0; Hoffmann M., CELL, DOI [10.1016/j.cell.2021.12.032(2021, DOI 10.1016/J.CELL.2021.12.032(2021]; Imai M, 2020, P NATL ACAD SCI USA, V117, P16587, DOI 10.1073/pnas.2009799117; Jones BE, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abf1906; Kaname Y, 2010, J VIROL, V84, P3210, DOI 10.1128/JVI.02519-09; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Khoury DS, 2021, NAT MED, V27, P1205, DOI 10.1038/s41591-021-01377-8; Kim C, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20602-5; Kupferschmidt K, 2021, SCIENCE, V374, P1179, DOI 10.1126/science.acx9738; Leist SR, 2020, CELL, V183, P1070, DOI 10.1016/j.cell.2020.09.050; Lempp FA, 2021, NATURE, V598, P342, DOI 10.1038/s41586-021-03925-1; Liu ZM, 2021, CELL HOST MICROBE, V29, P477, DOI 10.1016/j.chom.2021.01.014; Maziarz RT, 2010, BIOL BLOOD MARROW TR, V16, pS166, DOI 10.1016/j.bbmt.2009.09.014; McCallum M, 2021, SCIENCE, V374, P1621, DOI [10.1126/science.abl8506, 10.1101/2021.08.11.455956]; McCallum M, 2021, SCIENCE, V373, P648, DOI 10.1126/science.abi7994; McCallum M, 2021, CELL, V184, P2332, DOI [10.1016/j.cell.2021.03.028, 10.1101/2021.01.14.426475]; Mlcochova P, 2021, NATURE, V599, P114, DOI 10.1038/s41586-021-03944-y; Munnink BBO, 2021, SCIENCE, V371, P172, DOI 10.1126/science.abe5901; Nicholls J, 2021, HKUMED FINDS OMICRON; Pan T, 2021, SIGNAL TRANSDUCT TAR, V6, DOI 10.1038/s41392-021-00848-1; Park YJ, 2022, SCIENCE, V375, P449, DOI 10.1126/science.abm8143; Piccoli L, 2020, CELL, V183, P1024, DOI 10.1016/j.cell.2020.09.037; Pinto D, 2020, NATURE, V583, P290, DOI 10.1038/s41586-020-2349-y; Plante JA, 2021, NATURE, V592, P116, DOI 10.1038/s41586-020-2895-3; Ryu DK, 2021, BIOCHEM BIOPH RES CO, V566, P135, DOI 10.1016/j.bbrc.2021.06.016; Sheikh A, 2021, LANCET, V397, P2461, DOI 10.1016/S0140-6736(21)01358-1; Shi R, 2020, NATURE, V584, P120, DOI 10.1038/s41586-020-2381-y; Shuai HP, 2021, EBIOMEDICINE, V73, DOI 10.1016/j.ebiom.2021.103643; Stamatatos L, 2021, SCIENCE, V372, P1413, DOI 10.1126/science.abg9175; Starr T. N., ACE2 BINDING IS ANCE, DOI [10.1101/2021.07.17.452804(2021, DOI 10.1101/2021.07.17.452804(2021]; Starr TN, 2021, NATURE, V597, P97, DOI 10.1038/s41586-021-03807-6; Starr TN, 2020, CELL, V182, P1295, DOI 10.1016/j.cell.2020.08.012; Telenti A, 2021, NATURE, V596, P495, DOI 10.1038/s41586-021-03792-w; Thomson EC, 2021, CELL, V184, P1171, DOI 10.1016/j.cell.2021.01.037; Tortorici MA, 2021, NATURE, V597, P103, DOI 10.1038/s41586-021-03817-4; Tortorici MA, 2020, SCIENCE, V370, P950, DOI 10.1126/science.abe3354; VanBlargan L. A., NAT MED, DOI [10.1038/s41591-021-01678-y(2022, DOI 10.1038/S41591-021-01678-Y(2022]; VanBlargan LA, 2021, IMMUNITY, V54, P2399, DOI 10.1016/j.immuni.2021.08.016; Walls AC, 2021, CELL, V184, P5432, DOI 10.1016/j.cell.2021.09.015; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Wang PF, 2021, NATURE, V593, P130, DOI 10.1038/s41586-021-03398-2; Weinreich DM, 2021, NEW ENGL J MED, V384, P238, DOI 10.1056/NEJMoa2035002; Wilhelm A, REDUCED NEUTRALIZATI, DOI [10.1101/2021.12.07.21267432(2021, DOI 10.1101/2021.12.07.21267432(2021]; Yamin R, 2021, NATURE, V599, P465, DOI 10.1038/s41586-021-04017-w; Zang RC, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abc3582; Zost SJ, 2020, NATURE, V584, P443, DOI 10.1038/s41586-020-2548-6	70	395	399	34	113	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 24	2022	602	7898					664	+		10.1038/s41586-021-04386-2	http://dx.doi.org/10.1038/s41586-021-04386-2		DEC 2021	24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZG7GF	34931194	Green Submitted, Bronze			2022-12-28	WOS:000756560800002
J	Garcia-Beltran, WF; St Denis, KJ; Hoelzemer, A; Lam, EC; Nitido, AD; Sheehan, ML; Berrios, C; Ofoman, O; Chang, CC; Hauser, BM; Feldman, J; Roederer, AL; Gregory, DJ; Poznansky, MC; Schmidt, AG; Iafrate, AJ; Naranbhai, V; Balazs, AB				Garcia-Beltran, Wilfredo F.; St Denis, Kerri J.; Hoelzemer, Angelique; Lam, Evan C.; Nitido, Adam D.; Sheehan, Maegan L.; Berrios, Cristhian; Ofoman, Onosereme; Chang, Christina C.; Hauser, Blake M.; Feldman, Jared; Roederer, Alex L.; Gregory, David J.; Poznansky, Mark C.; Schmidt, Aaron G.; Iafrate, A. John; Naranbhai, Vivek; Balazs, Alejandro B.			mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant	CELL			English	Article							ANTIBODY	Recent surveillance has revealed the emergence of the SARS-CoV-2 Omicron variant (BA.1/B.1.1.529) harboring up to 36 mutations in spike protein, the target of neutralizing antibodies. Given its potential to escape vaccine-induced humoral immunity, we measured the neutralization potency of sera from 88 mRNA-1273, 111 BNT162b, and 40 Ad26.COV2.S vaccine recipients against wild-type, Delta, and Omicron SARS-CoV-2 pseudoviruses. We included individuals that received their primary series recently (<3 months), distantly (6-12 months), or an additional "booster"dose, while accounting for prior SARS-CoV-2 infection. Remarkably, neutralization of Omicron was undetectable in most vaccinees. However, individuals boosted with mRNA vaccines exhibited potent neutralization of Omicron, only 4-6-fold lower than wild type, suggesting enhanced cross-reactivity of neutralizing antibody responses. In addition, we find that Omicron pseudo virus infects more efficiently than other variants tested. Overall, this study highlights the importance of additional mRNA doses to broaden neutralizing antibody responses against highly divergent SARS-CoV-2 variants.	[Garcia-Beltran, Wilfredo F.; Berrios, Cristhian; Ofoman, Onosereme; Iafrate, A. John] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Garcia-Beltran, Wilfredo F.; St Denis, Kerri J.; Lam, Evan C.; Nitido, Adam D.; Sheehan, Maegan L.; Hauser, Blake M.; Feldman, Jared; Roederer, Alex L.; Schmidt, Aaron G.; Balazs, Alejandro B.] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA; [Hoelzemer, Angelique] Univ Med Ctr Eppendorf, Dept Internal Med 1, Div Infect Dis, Hamburg, Germany; [Hoelzemer, Angelique] German Ctr Infect Res DZIF, Site Hamburg Lubeck Borstel Riems, Braunschweig, Germany; [Hoelzemer, Angelique] Leibniz Inst Expt Virol, Res Dept Virus Immunol, Hamburg, Germany; [Nitido, Adam D.; Feldman, Jared; Roederer, Alex L.] Harvard Med Sch, Div Med Sci, PhD Program Virol, Boston, MA 02115 USA; [Chang, Christina C.] Monash Univ, Alfred Hosp, Cent Clin Sch, Prahran, Vic 3181, Australia; [Chang, Christina C.; Naranbhai, Vivek] Ctr AIDS Programme Res South Africa, ZA-4001 Durban, South Africa; [Gregory, David J.; Poznansky, Mark C.] Massachusetts Gen Hosp, Vaccine & Immunotherapy Ctr, Boston, MA 02129 USA; [Gregory, David J.] Massachusetts Gen Hosp Children, Pediat Infect Dis, Boston, MA 02114 USA; [Poznansky, Mark C.; Naranbhai, Vivek] Massachusetts Gen Hosp Canc Ctr, Boston, MA 02114 USA; [Naranbhai, Vivek] Dana Farber Canc Inst, Boston, MA 02215 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; University of Hamburg; University Medical Center Hamburg-Eppendorf; German Center for Infection Research; Heinrich Pette Institute; Harvard University; Harvard Medical School; Florey Institute of Neuroscience & Mental Health; Monash University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute	Garcia-Beltran, WF (corresponding author), Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA.; Garcia-Beltran, WF; Balazs, AB (corresponding author), Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA.	wgarciabeltran@mgh.harvard.edu; abalazs@mgh.harvard.edu		Chang, Christina Catherine/0000-0003-0109-0725; Lam, Evan/0000-0002-5556-2559; Balazs, Alejandro/0000-0002-1767-3944; Hauser, Blake/0000-0002-0100-1684	DZIF (German Center for Infection Research) [TTU 01.709, 8009701709]; National Institute of General Medical Sciences [T32GM007753]; National Institute of Allergy and Infectious Diseases [F30 AI160908]; VIC Innovation Fund; NIH [R01 AI146779]; Massachusetts Consortium on Pathogenesis Readiness (MassCPR) grant; Peter and Ann Lambertus Family Foundation; Medscape Young Investigators Lung Cancer Award; National Institute on Drug Abuse (NIDA) Avenir New Innovator Award [DP2DA040254]; MGH Transformative Scholars Program;  [T32AI007245]	DZIF (German Center for Infection Research); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); VIC Innovation Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Massachusetts Consortium on Pathogenesis Readiness (MassCPR) grant; Peter and Ann Lambertus Family Foundation; Medscape Young Investigators Lung Cancer Award; National Institute on Drug Abuse (NIDA) Avenir New Innovator Award; MGH Transformative Scholars Program; 	We thank Anand Dighe, MD; Andrea Nixon, BS; and the MGH Core Laboratory for excellent assistance with clinical SARS-CoV-2 serology testing. We wish to thank Michael Farzan, PhD, for providing ACE2-expressing 293T cells. A.H. is supported by the DZIF (German Center for Infection Research, TTU 01.709; 8009701709). B.M.H. is supported by award number T32GM007753 from the National Institute of General Medical Sciences and F30 AI160908 from the National Institute of Allergy and Infectious Diseases. J.F. is supported by T32AI007245. D.J.G. and M.C.P. were supported by the VIC Innovation Fund. A.G.S. was supported by NIH R01 AI146779 and a Massachusetts Consortium on Pathogenesis Readiness (MassCPR) grant. A.H. is supported by the DZIF (German Center for Infection Research, TTU 01.709). This work was supported by the Peter and Ann Lambertus Family Foundation. V.N. received support from a Medscape Young Investigators Lung Cancer Award. A.B.B. was supported by the National Institute on Drug Abuse (NIDA) Avenir New Innovator Award DP2DA040254, the MGH Transformative Scholars Program, and a Massachusetts Consortium on Pathogenesis Readiness (MassCPR) grant.	Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389; Bajema KL, 2021, MMWR-MORBID MORTAL W, V70, P1700, DOI 10.15585/mmwr.mm7049a2; Bar-On YM, 2021, NEW ENGL J MED, V385, P1393, DOI 10.1056/NEJMoa2114255; Barnes CO, 2020, NATURE, V588, P682, DOI 10.1038/s41586-020-2852-1; BBC, 2021, BBC; Bernal JL, 2021, NEW ENGL J MED, V385, P585, DOI 10.1056/NEJMoa2108891; Cele Sandile, 2021, medRxiv, DOI 10.1101/2021.12.08.21267417; Cele S, 2021, NATURE, V593, P142, DOI 10.1038/s41586-021-03471-w; Corbett KS, 2021, SCIENCE, V374, P1343, DOI 10.1126/science.abl8912; Crawford KHD, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12050513; Cromer D, 2022, LANCET MICROBE, V3, pE52, DOI 10.1016/S2666-5247(21)00267-6; Dong JH, 2021, NAT MICROBIOL, V6, P1233, DOI 10.1038/s41564-021-00972-2; Doria-Rose N, 2021, NEW ENGL J MED, V384, P2259, DOI 10.1056/NEJMc2103916; Earle KA, 2021, VACCINE, V39, P4423, DOI 10.1016/j.vaccine.2021.05.063; Garcia-Beltran WF, 2021, CELL, V184, P2372, DOI [10.1016/j.cell.2021.03.013, 10.1101/2021.02.14.21251704, 10.1016/j.cell.2021.04.006]; Garcia-Beltran Wilfredo F, 2020, medRxiv, DOI [10.1016/j.cell.2020.12.015, 10.1101/2020.10.15.20213512]; Greaney AJ, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-24435-8; Greaney AJ, 2021, CELL HOST MICROBE, V29, P463, DOI 10.1016/j.chom.2021.02.003; Ju B, 2020, NATURE, V584, P115, DOI 10.1038/s41586-020-2380-z; Khoury DS, 2021, NAT MED, V27, P1205, DOI 10.1038/s41591-021-01377-8; Knezevic I, 2022, LANCET MICROBE, V3, pE235, DOI 10.1016/S2666-5247(21)00266-4; Levin EG, 2021, NEW ENGL J MED, V385, pE84, DOI 10.1056/NEJMoa2114583; Mlcochova P, 2021, NATURE, V599, P114, DOI 10.1038/s41586-021-03944-y; Moore MJ, 2004, J VIROL, V78, P10628, DOI 10.1128/JVI.78.19.10628-10635.2004; Naranbhai V., 2021, J INFECT DIS, pJiab593; Naranbhai V., 2021, CANCER CELL; Naranbhai V, 2022, J CLIN ONCOL, V40, P12, DOI 10.1200/JCO.21.01891; Pinto Dora, 2020, bioRxiv, DOI 10.1101/2020.04.07.023903; Planas D, 2021, NATURE, V596, P276, DOI 10.1038/s41586-021-03777-9; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Rambaut A, 2020, NAT MICROBIOL, V5, P1403, DOI 10.1038/s41564-020-0770-5; Riepler L, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9010013; Sadoff J, 2021, NEW ENGL J MED, V384, P2187, DOI 10.1056/NEJMoa2101544; Schmidt F, 2021, NATURE, V600, P512, DOI 10.1038/s41586-021-04005-0; Tian F, 2021, ELIFE, V10, DOI 10.7554/eLife.69091; Tregoning JS, 2021, NAT REV IMMUNOL, V21, P626, DOI 10.1038/s41577-021-00592-1; Wang CY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16256-y; Zhang J, 2021, SCIENCE, V374, P1353, DOI [10.1126/science.abl9463, 10.1101/2021.08.17.456689]; Zhou DM, 2021, CELL, V184, P2348, DOI 10.1016/j.cell.2021.02.037	41	404	408	86	173	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 3	2022	185	3					457	+		10.1016/j.cell.2021.12.033	http://dx.doi.org/10.1016/j.cell.2021.12.033			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	YW7SP	34931201	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000753615000008
J	Castellucci, GA; Kovach, CK; Howard, MA; Greenlee, JDW; Long, MA				Castellucci, Gregg A.; Kovach, Christopher K.; Howard, Matthew A., III; Greenlee, Jeremy D. W.; Long, Michael A.			A speech planning network for interactive language use	NATURE			English	Article							HUMAN CEREBRAL-CORTEX; TURN-TAKING; BROCAS AREA; REGIONS; ORGANIZATION; APRAXIA	During conversation, people take turns speaking by rapidly responding to their partners while simultaneously avoiding interruption(1,2). Such interactions display a remarkable degree of coordination, as gaps between turns are typically about 200 milliseconds(3)-approximately the duration of an eyeblink(4). These latencies are considerably shorter than those observed in simple word-production tasks, which indicates that speakers often plan their responses while listening to their partners(2). Although a distributed network of brain regions has been implicated in speech planning(5-9), the neural dynamics underlying the specific preparatory processes that enable rapid turn-taking are poorly understood. Here we use intracranial electrocorticography to precisely measure neural activity as participants perform interactive tasks, and we observe a functionally and anatomically distinct class of planning-related cortical dynamics. We localize these responses to a frontotemporal circuit centred on the language-critical caudal inferior frontal cortex(10) (Broca's region) and the caudal middle frontal gyrus-a region not normally implicated in speech planning(11-13). Using a series of motor tasks, we then show that this planning network is more active when preparing speech as opposed to non-linguistic actions. Finally, we delineate planning-related circuitry during natural conversation that is nearly identical to the network mapped with our interactive tasks, and we find this circuit to be most active before participant speech during unconstrained turn-taking. Therefore, we have identified a speech planning network that is central to natural language generation during social interaction.During conversation, people take turns speaking by rapidly responding to their partners while simultaneously avoiding interruption(1,2). Such interactions display a remarkable degree of coordination, as gaps between turns are typically about 200 milliseconds(3)-approximately the duration of an eyeblink(4). These latencies are considerably shorter than those observed in simple word-production tasks, which indicates that speakers often plan their responses while listening to their partners(2). Although a distributed network of brain regions has been implicated in speech planning(5-9), the neural dynamics underlying the specific preparatory processes that enable rapid turn-taking are poorly understood. Here we use intracranial electrocorticography to precisely measure neural activity as participants perform interactive tasks, and we observe a functionally and anatomically distinct class of planning-related cortical dynamics. We localize these responses to a frontotemporal circuit centred on the language-critical caudal inferior frontal cortex(10) (Broca's region) and the caudal middle frontal gyrus-a region not normally implicated in speech planning(11-13). Using a series of motor tasks, we then show that this planning network is more active when preparing speech as opposed to non-linguistic actions. Finally, we delineate planning-related circuitry during natural conversation that is nearly identical to the network mapped with our interactive tasks, and we find this circuit to be most active before participant speech during unconstrained turn-taking. Therefore, we have identified a speech planning network that is central to natural language generation during social interaction. During conversation, people take turns speaking by rapidly responding to their partners while simultaneously avoiding interruption(1,2). Such interactions display a remarkable degree of coordination, as gaps between turns are typically about 200 milliseconds(3)-approximately the duration of an eyeblink(4). These latencies are considerably shorter than those observed in simple word-production tasks, which indicates that speakers often plan their responses while listening to their partners(2). Although a distributed network of brain regions has been implicated in speech planning(5-9), the neural dynamics underlying the specific preparatory processes that enable rapid turn-taking are poorly understood. Here we use intracranial electrocorticography to precisely measure neural activity as participants perform interactive tasks, and we observe a functionally and anatomically distinct class of planning-related cortical dynamics. We localize these responses to a frontotemporal circuit centred on the language-critical caudal inferior frontal cortex(10) (Broca's region) and the caudal middle frontal gyrus-a region not normally implicated in speech planning(11-13). Using a series of motor tasks, we then show that this planning network is more active when preparing speech as opposed to non-linguistic actions. Finally, we delineate planning-related circuitry during natural conversation that is nearly identical to the network mapped with our interactive tasks, and we find this circuit to be most active before participant speech during unconstrained turn-taking. Therefore, we have identified a speech planning network that is central to natural language generation during social interaction.During conversation, people take turns speaking by rapidly responding to their partners while simultaneously avoiding interruption(1,2). Such interactions display a remarkable degree of coordination, as gaps between turns are typically about 200 milliseconds(3)-approximately the duration of an eyeblink(4). These latencies are considerably shorter than those observed in simple word-production tasks, which indicates that speakers often plan their responses while listening to their partners(2). Although a distributed network of brain regions has been implicated in speech planning(5-9), the neural dynamics underlying the specific preparatory processes that enable rapid turn-taking are poorly understood. Here we use intracranial electrocorticography to precisely measure neural activity as participants perform interactive tasks, and we observe a functionally and anatomically distinct class of planning-related cortical dynamics. We localize these responses to a frontotemporal circuit centred on the language-critical caudal inferior frontal cortex(10) (Broca's region) and the caudal middle frontal gyrus-a region not normally implicated in speech planning(11-13). Using a series of motor tasks, we then show that this planning network is more active when preparing speech as opposed to non-linguistic actions. Finally, we delineate planning-related circuitry during natural conversation that is nearly identical to the network mapped with our interactive tasks, and we find this circuit to be most active before participant speech during unconstrained turn-taking. Therefore, we have identified a speech planning network that is central to natural language generation during social interaction. During conversation, people take turns speaking by rapidly responding to their partners while simultaneously avoiding interruption(1,2). Such interactions display a remarkable degree of coordination, as gaps between turns are typically about 200 milliseconds(3)-approximately the duration of an eyeblink(4). These latencies are considerably shorter than those observed in simple word-production tasks, which indicates that speakers often plan their responses while listening to their partners(2). Although a distributed network of brain regions has been implicated in speech planning(5-9), the neural dynamics underlying the specific preparatory processes that enable rapid turn-taking are poorly understood. Here we use intracranial electrocorticography to precisely measure neural activity as participants perform interactive tasks, and we observe a functionally and anatomically distinct class of planning-related cortical dynamics. We localize these responses to a frontotemporal circuit centred on the language-critical caudal inferior frontal cortex(10) (Broca's region) and the caudal middle frontal gyrus-a region not normally implicated in speech planning(11-13). Using a series of motor tasks, we then show that this planning network is more active when preparing speech as opposed to non-linguistic actions. Finally, we delineate planning-related circuitry during natural conversation that is nearly identical to the network mapped with our interactive tasks, and we find this circuit to be most active before participant speech during unconstrained turn-taking. Therefore, we have identified a speech planning network that is central to natural language generation during social interaction.	[Castellucci, Gregg A.; Long, Michael A.] NYU, Langone Med Ctr, Neurosci Inst, New York, NY 10016 USA; [Castellucci, Gregg A.; Long, Michael A.] NYU, Langone Med Ctr, Dept Otolaryngol, New York, NY 10016 USA; [Castellucci, Gregg A.; Long, Michael A.] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Kovach, Christopher K.; Howard, Matthew A., III; Greenlee, Jeremy D. W.] Univ Iowa, Dept Neurosurg, Iowa City, IA USA	New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; New York University; University of Iowa	Long, MA (corresponding author), NYU, Langone Med Ctr, Neurosci Inst, New York, NY 10016 USA.; Long, MA (corresponding author), NYU, Langone Med Ctr, Dept Otolaryngol, New York, NY 10016 USA.; Long, MA (corresponding author), NYU, Ctr Neural Sci, New York, NY 10003 USA.	mlong@med.nyu.edu	Garcia-Beltran, Olimpo/O-1846-2017; Areche, Carlos/I-2461-2013; Kovach, Christopher/N-7254-2016	Garcia-Beltran, Olimpo/0000-0003-3312-1776; Castaneta Condori, Grover/0000-0002-7134-8229; Areche, Carlos/0000-0001-5246-1368; Kovach, Christopher/0000-0002-0117-151X; Castellucci, Gregg/0000-0001-7311-2829; Long, Michael/0000-0002-9283-3741; Greenlee, Jeremy/0000-0002-8481-8517	Simons Collaboration on the Global Brain [R01 DC019354, R01 DC015260]	Simons Collaboration on the Global Brain	We thank A. Flinker, E. Jackson, J. Krivokapic, D. Schneider, N. Tritsch and members of the Long laboratory for comments on earlier versions of this manuscript; A. Ramirez-Cardenas, H. Chen, K. Ibayashi, H. Kawasaki, K. Nourski, H. Oya, A. Rhone and B. Snoad for help with data collection; and F. Guenther and N. Majaj for helpful conversations. This research was supported by R01 DC019354 (M.A.L.), R01 DC015260 (J.D.W.G.) and Simons Collaboration on the Global Brain (M.A.L.).	Alario FX, 2006, BRAIN RES, V1076, P129, DOI 10.1016/j.brainres.2005.11.104; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Basilakos A, 2018, CEREB CORTEX, V28, P1816, DOI 10.1093/cercor/bhx100; Bogels S, 2018, NEUROPSYCHOLOGIA, V109, P295, DOI 10.1016/j.neuropsychologia.2017.12.028; Bogels S, 2015, SCI REP-UK, V5, DOI 10.1038/srep12881; Bouchard KE, 2013, NATURE, V495, P327, DOI 10.1038/nature11911; Brass M, 2002, CEREB CORTEX, V12, P908, DOI 10.1093/cercor/12.9.908; Broca P., 1861, B SOC ANAT PARIS, V6, P330, DOI DOI 10.1093/ACPROF:OSO/9780195177640.003.0018; Catani M, 2012, CORTEX, V48, P273, DOI 10.1016/j.cortex.2011.12.001; Chang EF, 2020, NEUROSURGERY, V87, pE383, DOI 10.1093/neuros/nyaa002; Cheung C, 2016, ELIFE, V5, DOI [10.7554/eLife.12577, 10.7554/eLife.17181]; Cisek P, 2010, ANNU REV NEUROSCI, V33, P269, DOI 10.1146/annurev.neuro.051508.135409; Cogan GB, 2014, NATURE, V507, P94, DOI 10.1038/nature12935; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Deger K, 2002, J PHONETICS, V30, P321, DOI 10.1006/jpho.2001.0163; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dubey A, 2019, J NEUROSCI, V39, P4299, DOI 10.1523/JNEUROSCI.2917-18.2019; Fadiga L, 2006, CORTEX, V42, P486, DOI 10.1016/S0010-9452(08)70383-6; Ferpozzi V, 2018, FRONT HUM NEUROSCI, V12, DOI 10.3389/fnhum.2018.00064; Ferreira F, 2002, J MEM LANG, V46, P57, DOI 10.1006/jmla.2001.2797; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Flinker A, 2011, BRAIN LANG, V117, P103, DOI 10.1016/j.bandl.2010.09.009; Flinker A, 2015, P NATL ACAD SCI USA, V112, P2871, DOI 10.1073/pnas.1414491112; Friston K., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Glanz Iljina O., 2018, SCI REP-UK, V8; Glasser MF, 2016, NATURE, V536, P171, DOI 10.1038/nature18933; Guenther FH, 2016, NEURAL CONTROL OF SPEECH, P1, DOI 10.7551/mitpress/10471.001.0001; Hosman T, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-020-77616-8; Indefrey P, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00255; Jackson ES, 2019, NEUROSCIENCE, V406, P73, DOI 10.1016/j.neuroscience.2019.02.032; Klein A, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00171; Knudsen B, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.593671; Kotz SA, 2010, BRAIN LANG, V112, P3, DOI 10.1016/j.bandl.2009.07.008; Kovach CK, 2016, J NEUROSCI METH, V261, P135, DOI 10.1016/j.jneumeth.2015.12.004; Levinson SC, 2016, TRENDS COGN SCI, V20, P6, DOI 10.1016/j.tics.2015.10.010; Levinson SC, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00731; Liu Y, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/5/056008; Long MA, 2008, NATURE, V456, P189, DOI 10.1038/nature07448; Long MA, 2016, NEURON, V89, P1187, DOI 10.1016/j.neuron.2016.01.032; Mathis A, 2018, NAT NEUROSCI, V21, P1281, DOI 10.1038/s41593-018-0209-y; Mirman D, 2019, COGN AFFECT BEHAV NE, V19, P1286, DOI 10.3758/s13415-019-00729-9; Okobi DE, 2019, SCIENCE, V363, P983, DOI 10.1126/science.aau9480; Qian T., ANN INT C IEEE ENG M, P2347; Ramanarayanan V, 2013, J ACOUST SOC AM, V134, P510, DOI 10.1121/1.4807639; Ray S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000610; SACKS H, 1974, LANGUAGE, V50, P696, DOI 10.2307/412243; Sahin NT, 2009, SCIENCE, V326, P445, DOI 10.1126/science.1174481; Schuhmann T, 2009, CORTEX, V45, P1111, DOI 10.1016/j.cortex.2008.10.013; Sierpowska J, 2018, CORTEX, V99, P78, DOI 10.1016/j.cortex.2017.10.017; Stivers T, 2009, P NATL ACAD SCI USA, V106, P10587, DOI 10.1073/pnas.0903616106; Taschenbuch H., 2001, SENSATION PERCEPTION; Tate MC, 2014, BRAIN, V137, P2773, DOI 10.1093/brain/awu168; Tilsen S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146813; Tremblay P, 2016, BRAIN LANG, V162, P60, DOI 10.1016/j.bandl.2016.08.004; Tyszka JM, 2016, HUM BRAIN MAPP, V37, P3979, DOI 10.1002/hbm.23289; Wagner V, 2010, J EXP PSYCHOL LEARN, V36, P423, DOI 10.1037/a0018619	56	7	7	19	31	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 3	2022	602	7895					117	+		10.1038/s41586-021-04270-z	http://dx.doi.org/10.1038/s41586-021-04270-z		JAN 2022	24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YS1FH	34987226				2022-12-28	WOS:000739283800004
J	Castaneta, G; Sepulveda, B; Vargas, R; Garcia-Beltran, O; Simirgiotis, M; Areche, C				Castaneta, Grover; Sepulveda, Beatriz; Vargas, Reinaldo; Garcia-Beltran, Olimpo; Simirgiotis, Mario; Areche, Carlos			A sustainable application for the extraction of lichen metabolites from Usnea cornuta: nontargeted metabolomics and antioxidant activity	NATURAL PRODUCT RESEARCH			English	Article; Early Access						Alternative solvents; antioxidants; green chemistry; Usnea; LC; MS; lichens	ACID	In this study, isolation and purification of lichen substances from Usnea cornuta were performed using conventional solvents, green solvents and green technologies. In addition, several lichen compounds were tentatively identified by UHPLC/ESI/MS/MS and usnic acid, diffractaic and galbinic acids were quantified as well. Limonene, ethyl lactate and methanol, were compared regarding their extraction properties and antioxidant capacities, determined by DPPH, ORAC, and FRAP assays. In the ethyl lactate, methanol and limonene extracts, 28 compounds in all, were detected for the first time by high resolution UHPLC-MS/MS fingerprinting. Untargeted metabolomics tentatively identified 14 compounds from the methanolic extract, 4 from limonene extract, and 20 metabolites from ethyl lactate extract. The green extract of ethyl lactate showed a similar antioxidant capacity to toxic methanol extract, except at ORAC assay where it was higher. Therefore, ethyl lactate can replace methanol, to provide more sustainable green chemistry methods.	[Castaneta, Grover; Areche, Carlos] Univ Chile, Fac Ciencias, Dept Quim, Santiago, Chile; [Sepulveda, Beatriz] Univ Andres Bello, Dept Ciencias Quim, Quillota, Chile; [Vargas, Reinaldo] Univ Metropolitana Ciencias Educ, Dept Biol, Santiago, Chile; [Garcia-Beltran, Olimpo] Univ Ibague, Fac Ciencias Nat & Matemat, Ibague, Colombia; [Simirgiotis, Mario] Univ Austral Chile, Fac Ciencias, Inst Farm, Valdivia, Chile	Universidad de Chile; Universidad Andres Bello; Universidad Metropolitana de Ciencias de la Educacion (UMCE); Universidad Austral de Chile	Areche, C (corresponding author), Univ Chile, Fac Ciencias, Dept Quim, Santiago, Chile.; Sepulveda, B (corresponding author), Univ Andres Bello, Dept Ciencias Quim, Quillota, Chile.	bsepulveda@uc.cl; areche@uchile.cl	Garcia-Beltran, Olimpo/O-1846-2017; Areche, Carlos/I-2461-2013; Kovach, Christopher/N-7254-2016	Garcia-Beltran, Olimpo/0000-0003-3312-1776; Castaneta Condori, Grover/0000-0002-7134-8229; Areche, Carlos/0000-0001-5246-1368; Kovach, Christopher/0000-0002-0117-151X; Castellucci, Gregg/0000-0001-7311-2829; Long, Michael/0000-0002-9283-3741; Greenlee, Jeremy/0000-0002-8481-8517	Fondecyt Regular (ANID) [1190314]; Ministry of Science, Technology and Innovation; Ministry of Education; Ministry of Industry, Commerce and Tourism; Francisco Jose de Caldas Fund [FP44842212-2018]	Fondecyt Regular (ANID); Ministry of Science, Technology and Innovation(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia); Ministry of Education; Ministry of Industry, Commerce and Tourism; Francisco Jose de Caldas Fund	This work was supported by the Fondecyt Regular (ANID) under Grant No. 1190314. O.G.-B. acknowledges funding from the Ministry of Science, Technology and Innovation, the Ministry of Education, the Ministry of Industry, Commerce and Tourism, and ICETEX, Programme Ecosistema Cientifico-Colombia Cientifica, from the Francisco Jose de Caldas Fund, Grant RC-FP44842212-2018.	Behera BC, 2005, BIOTECHNOL LETT, V27, P991, DOI 10.1007/s10529-005-7847-3; Calla-Quispe E, 2020, FRONT CHEM, V8, DOI 10.3389/fchem.2020.00450; Canadas R, 2020, FOOD RES INT, V136, DOI 10.1016/j.foodres.2020.109558; Chae HJ, 2021, MOLECULES, V26, DOI 10.3390/molecules26133937; Chemat F, 2019, TRAC-TREND ANAL CHEM, V118, P248, DOI 10.1016/j.trac.2019.05.037; Doble M., 2007, GREEN CHEM ENG, pxi, DOI [10.1016/B978-0-12-372532-5.X5000-7, DOI 10.1016/B978-0-12-372532-5.X5000-7]; ELIX JA, 1975, AUST J CHEM, V28, P1793, DOI 10.1071/CH9751793; Fernandez-Moriano C, 2016, PHARM BIOL, V54, P1, DOI 10.3109/13880209.2014.1003354; OKUYAMA E, 1995, PLANTA MED, V61, P113, DOI 10.1055/s-2006-958027; Pathak A., 2016, MEDICINES, V3, P24, DOI DOI 10.3390/MEDICINES3030024; Pavithra G. M., 2013, Journal of Applied Pharmaceutical Science, V3, P154; Pereira CSM, 2011, GREEN CHEM, V13, P2658, DOI 10.1039/c1gc15523g; Popovici V, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10081171; Popovici V, 2021, PLANTS-BASEL, V10, DOI 10.3390/plants10050909; Prateeksha, 2016, RSC ADV, V6, P21672, DOI 10.1039/c5ra24205c; Reddy SD, 2019, MOLECULES, V24, DOI 10.3390/molecules24122270; Salgado F, 2020, NAT PROD RES, V34, P646, DOI 10.1080/14786419.2018.1492576; Sepulveda B, 2021, NAT PROD RES, DOI 10.1080/14786419.2021.1956922; Soquetta MB, 2018, CYTA-J FOOD, V16, P400, DOI 10.1080/19476337.2017.1411978; Tang JY, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9080694; Verma N, 2008, APPL BIOCHEM BIOTECH, V151, P167, DOI 10.1007/s12010-008-8164-9; Zugic A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146342	22	7	7	19	31	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1478-6419	1478-6427		NAT PROD RES	Nat. Prod. Res.												10.1080/14786419.2022.2116703	http://dx.doi.org/10.1080/14786419.2022.2116703		AUG 2022	7	Chemistry, Applied; Chemistry, Medicinal	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Pharmacology & Pharmacy	3Z9KJ	34987226	Green Submitted			2022-12-28	WOS:000844732800001
J	Husereau, D; Drummond, M; Augustovski, F; De Bekker-Grob, E; Briggs, AH; Carswell, C; Caulley, L; Chaiyakunapruk, N; Greenberg, D; Loder, E; Mauskopf, J; Mullins, CD; Petrou, S; Pwu, RF; Staniszewska, S				Husereau, Don; Drummond, Michael; Augustovski, Federico; De Bekker-Grob, Esther; Briggs, Andrew H.; Carswell, Chris; Caulley, Lisa; Chaiyakunapruk, Nathorn; Greenberg, Dan; Loder, Elizabeth; Mauskopf, Josephine; Mullins, C. Daniel; Petrou, Stavros; Pwu, Raoh-Fang; Staniszewska, Sophie		CHEERS 2022 ISPOR Good Res Practic	Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations	VALUE IN HEALTH			English	Article							COST-EFFECTIVENESS ANALYSIS; CLINICAL-TRIALS; GUIDELINES; RECOMMENDATIONS; IMPACT; DESIGN	Health economic evaluations are comparative analyses of alternative courses of action in terms of their costs and consequences. The Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement, published in 2013, was created to ensure health economic evaluations are identifiable, interpretable, and useful for decision making. It was intended as guidance to help authors report accurately which health interventions were being compared and in what context, how the evaluation was undertaken, what the findings were, and other details that may aid readers and reviewers in interpretation and use of the study. The new CHEERS 2022 statement replaces previous CHEERS reporting guidance. It reflects the need for guidance that can be more easily applied to all types of health economic evaluation, new methods and developments in the field, as well as the increased role of stakeholder involvement including patients and the public. It is also broadly applicable to any form of intervention intended to improve the health of individuals or the population, whether simple or complex, and without regard to context (such as health care, public health, education, social care, etc). This summary article presents the new CHEERS 2022 28-item checklist and recommendations for each item. The CHEERS 2022 statement is primarily intended for researchers reporting economic evaluations for peer reviewed journals as well as the peer reviewers and editors assessing them for publication. However, we anticipate familiarity with reporting requirements will be useful for analysts when planning studies. It may also be useful for health technology assessment bodies seeking guidance on reporting, as there is an increasing emphasis on transparency in decision making.	[Husereau, Don] Univ Ottawa, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada; [Husereau, Don] Inst Hlth Econ, Edmonton, AB, Canada; [Drummond, Michael] Univ York, Ctr Hlth Econ, York, N Yorkshire, England; [Augustovski, Federico] Inst Clin Effectiveness & Hlth Policy, Hlth Technol Assessment & Hlth Econ, Buenos Aires, DF, Argentina; [Augustovski, Federico] Natl Sci & Tech Res Council Buenos Aires, Buenos Aires, DF, Argentina; [Briggs, Andrew H.] London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London, England; [Carswell, Chris] Springer Nat, Auckland, New Zealand; [Caulley, Lisa] Ottawa Hosp, Ottawa, ON, Canada; [Chaiyakunapruk, Nathorn] Univ Utah, Dept Pharmacotherapy, Salt Lake City, UT USA; [De Bekker-Grob, Esther] Erasmus Univ, Sch Hlth Policy & Management, Rotterdam, Netherlands; [Greenberg, Dan] Ben Gurion Univ Negev, Dept Hlth Syst Management, Beer Sheva, Israel; [Loder, Elizabeth] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Mauskopf, Josephine] RTI Int, Res Triangle Pk, NC USA; [Mullins, C. Daniel] Univ Maryland, Pharmaceut Hlth Serv Res Dept, Baltimore, MD USA; [Petrou, Stavros] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, Oxon, England; [Pwu, Raoh-Fang] Taiwan Minist Hlth & Welf, Taipei, Taiwan; [Staniszewska, Sophie] Univ Warwick, Warwick Med Sch, Coventry, W Midlands, England	University of Ottawa; University of York - UK; University of London; London School of Hygiene & Tropical Medicine; University of Ottawa; Ottawa Hospital Research Institute; Utah System of Higher Education; University of Utah; Erasmus University Rotterdam; Ben Gurion University; Harvard University; Brigham & Women's Hospital; Research Triangle Institute; University System of Maryland; University of Maryland Baltimore; University of Oxford; University of Warwick	Husereau, D (corresponding author), 879 Winnington Ave, Ottawa, ON K2B 5C4, Canada.	donh@donhusereau.com	Kostyuk, Alexander/HGA-2381-2022; Kostyuk, Alex/E-7579-2011; Pwu, Raoh Fang/AFK-8020-2022; Petrou, Stavros/ABD-8323-2021; Hughes, Dyfrig/H-5252-2012	Kostyuk, Alexander/0000-0001-6538-1324; Kostyuk, Alex/0000-0001-6538-1324; Pwu, Raoh Fang/0000-0002-0113-6917; Husereau, Don/0000-0002-4416-6876; Caulley, Lisa/0000-0002-9661-4634; Petrou, Stavros/0000-0003-3121-6050; Powell, John/0000-0002-1456-4857; Chaiyakunapruk, Nathorn/0000-0003-4572-8794; Mauskopf, Josephine/0000-0002-6098-5548; Briggs, Andrew/0000-0002-0777-1997; Hughes, Dyfrig/0000-0001-8247-7459	ISPOR-The Professional Society for Health Economics and Outcomes Research; NIHR Applied Research Collaboration (ARC) West Midlands; NIHR Health Protection Research Unit (HPRU) Gastrointestinal Infections; NIHR HPRU Genomics and Enabling data; Canada Inc. [9363980]	ISPOR-The Professional Society for Health Economics and Outcomes Research; NIHR Applied Research Collaboration (ARC) West Midlands; NIHR Health Protection Research Unit (HPRU) Gastrointestinal Infections; NIHR HPRU Genomics and Enabling data; Canada Inc.	Funding to support ongoing meetings was provided by ISPOR-The Professional Society for Health Economics and Outcomes Research. The funders had no role in considering the study design or in the collec-tion, analysis, interpretation of data, or writing of the report. Funding for DH and the Delphi Panel exercise was provided by 9363980 Canada Inc. SS is part funded by the NIHR Applied Research Collaboration (ARC) West Midlands, the NIHR Health Protection Research Unit (HPRU) Gastrointes-tinal Infections, and the NIHR HPRU Genomics and Enabling data.	Altman DG, 2016, J ROY SOC MED, V109, P67, DOI 10.1177/0141076815625599; [Anonymous], CONS HLTH EC EV REP; Bond K, 2020, INT J TECHNOL ASSESS, V36, P445, DOI 10.1017/S0266462320000550; CADTH.ca, 2015, GUID EC EV HLTH TECH; Catala-Lopez F, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-034463; Caulley L, 2020, J CLIN EPIDEMIOL, V122, P87, DOI 10.1016/j.jclinepi.2020.03.006; Cohen JT, 2017, ANN INTERN MED, V167, P432, DOI 10.7326/M17-1153; Cookson R, 2021, VALUE HEALTH, V24, P118, DOI 10.1016/j.jval.2020.10.001; Cookson R, 2009, HEALTH ECON POLICY L, V4, P231, DOI 10.1017/S1744133109004903; Crown W, 2017, VALUE HEALTH, V20, P310, DOI 10.1016/j.jval.2017.01.013; Davis JC, 2011, OSTEOPOROSIS INT, V22, P2449, DOI 10.1007/s00198-010-1482-0; Drummond M, 2005, INT J TECHNOL ASSESS, V21, P165, DOI 10.1017/S0266462305050221; Drummond MF, 1996, BRIT MED J, V313, P275, DOI 10.1136/bmj.313.7052.275; Drummond MF, 2015, METHODS EC EVALUATIO; Dunlop WCN, 2017, PHARMACOECONOMICS, V35, P125, DOI 10.1007/s40273-016-0479-8; Emerson J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0205633; EUnetHTA European Network for Health Technology Assessment, 2021, GUID DOC; Goetghebeur MM, 2008, VALUE HEALTH, V11, pA183, DOI 10.1186/1472-6963-8-270; Gold MR, 1996, COST EFFECTIVENESS H; Hawton A, 2021, PATIENT, V14, P429, DOI 10.1007/s40271-020-00461-4; HILLMAN AL, 1995, ANN INTERN MED, V123, P61; Husereau D, 2022, VALUE HEALTH, V25, P10, DOI 10.1016/j.jval.2021.10.008; Husereau D, 2013, VALUE HEALTH, V16, P231, DOI 10.1016/j.jval.2013.02.002; ISPOR, OP SOURC MOD; Jansen JP, 2019, PHARMACOECONOMICS, V37, P1313, DOI 10.1007/s40273-019-00827-z; Juni P, 1999, JAMA-J AM MED ASSOC, V282, P1054, DOI 10.1001/jama.282.11.1054; Lorgelly PK, 2021, PATIENT, V14, P379, DOI 10.1007/s40271-021-00505-3; Malone DC, 2020, VALUE HEALTH, V23, P409, DOI 10.1016/j.jval.2020.03.001; Mauskopf J, 2018, VALUE HEALTH, V21, P1133, DOI 10.1016/j.jval.2018.08.005; Moher D., 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000217, 10.1371/journal.pmed.1000097]; Neumann PJ, 2015, VALUE HEALTH, V18, P271, DOI 10.1016/j.jval.2014.12.002; Nuijten MJC, 1998, PHARMACOECONOMICS, V14, P259; Panzer AD, 2020, HEALTH ECON, V29, P945, DOI 10.1002/hec.4029; Petrou S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1766; Petrou S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1548; Pitt C, 2016, HEALTH ECON, V25, P9, DOI 10.1002/hec.3305; Ramsey SD, 2015, VALUE HEALTH, V18, P161, DOI 10.1016/j.jval.2015.02.001; Ryan M, 2017, INT J TECHNOL ASSESS, V33, P424, DOI 10.1017/S026646231700085X; Sanders GD, 2016, JAMA-J AM MED ASSOC, V316, P1093, DOI 10.1001/jama.2016.12195; Sanghera S, 2015, PHARMACOECONOMICS, V33, P533, DOI 10.1007/s40273-015-0265-z; Siegel JE, 1996, JAMA-J AM MED ASSOC, V276, P1339, DOI 10.1001/jama.276.16.1339; Smith Robert, 2020, Wellcome Open Res, V5, P69, DOI 10.12688/wellcomeopenres.15807.1; Sperber AD, 2004, GASTROENTEROLOGY, V126, pS124, DOI 10.1053/j.gastro.2003.10.016; Staniszewska S, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3453; Sullivan SD, 2014, VALUE HEALTH, V17, P5, DOI 10.1016/j.jval.2013.08.2291; Thorn JC, 2016, VALUE HEALTH, V19, pA397, DOI 10.1016/j.jval.2016.09.291; Vintzileos AM, 2004, AM J OBSTET GYNECOL, V191, P1070, DOI 10.1016/j.ajog.2004.05.021; Walker DG, 2012, BEST PRACTICES CONDU; Wilkinson T, 2016, VALUE HEALTH, V19, P921, DOI 10.1016/j.jval.2016.04.015; World Health Organization (WHO), WHO GUID STAND EC EV, V2	50	78	78	30	42	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1098-3015	1524-4733		VALUE HEALTH	Value Health	JAN	2022	25	1					3	9		10.1016/j.jval.2021.11.1351	http://dx.doi.org/10.1016/j.jval.2021.11.1351			7	Economics; Health Care Sciences & Services; Health Policy & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Business & Economics; Health Care Sciences & Services	YI5XX	35098747	Green Published, hybrid			2022-12-28	WOS:000743921800002
J	Husereau, D; Drummond, M; Augustovski, F; de Bekker-Grob, E; Briggs, AH; Carswell, C; Caulley, L; Chaiyakunapruk, N; Greenberg, D; Loder, E; Mauskopf, J; Mullins, CD; Petrou, S; Pwu, RF; Staniszewska, S				Husereau, Don; Drummond, Michael; Augustovski, Federico; de Bekker-Grob, Esther; Briggs, Andrew H.; Carswell, Chris; Caulley, Lisa; Chaiyakunapruk, Nathorn; Greenberg, Dan; Loder, Elizabeth; Mauskopf, Josephine; Mullins, C. Daniel; Petrou, Stavros; Pwu, Raoh-Fang; Staniszewska, Sophie		CHEERS 2022 ISPOR Good Res Practic	Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations	BMC HEALTH SERVICES RESEARCH			English	Article							COST-EFFECTIVENESS ANALYSIS; TASK-FORCE; CLINICAL-TRIALS; GUIDELINES; RECOMMENDATIONS; IMPACT; TECHNOLOGY; PRINCIPLES; DESIGN	Health economic evaluations are comparative analyses of alternative courses of action in terms of their costs and consequences. The Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement, published in 2013, was created to ensure health economic evaluations are identifiable, interpretable, and useful for decision making. It was intended as guidance to help authors report accurately which health interventions were being compared and in what context, how the evaluation was undertaken, what the findings were, and other details that may aid readers and reviewers in interpretation and use of the study. The new CHEERS 2022 statement replaces previous CHEERS reporting guidance. It reflects the need for guidance that can be more easily applied to all types of health economic evaluation, new methods and developments in the field, as well as the increased role of stakeholder involvement including patients and the public. It is also broadly applicable to any form of intervention intended to improve the health of individuals or the population, whether simple or complex, and without regard to context (such as health care, public health, education, social care, etc). This summary article presents the new CHEERS 2022 28-item checklist and recommendations for each item. The CHEERS 2022 statement is primarily intended for researchers reporting economic evaluations for peer reviewed journals as well as the peer reviewers and editors assessing them for publication. However, we anticipate familiarity with reporting requirements will be useful for analysts when planning studies. It may also be useful for health technology assessment bodies seeking guidance on reporting, as there is an increasing emphasis on transparency in decision making.	[Husereau, Don] Univ Ottawa, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada; [Husereau, Don] Inst Hlth Econ, Edmonton, AB, Canada; [Drummond, Michael] Univ York, Ctr Hlth Econ, York, N Yorkshire, England; [Augustovski, Federico] Inst Clin Effectiveness & Hlth Policy IECS CONICE, Hlth Technol Assessment & Hlth Econ Dept, Buenos Aires, DF, Argentina; [Augustovski, Federico] Univ Buenos Aires, Buenos Aires, DF, Argentina; [Augustovski, Federico] CONICET Natl Sci & Tech Res Council, Buenos Aires, DF, Argentina; [de Bekker-Grob, Esther] Erasmus Univ, Erasmus Sch Hlth Policy & Management, Rotterdam, Netherlands; [Briggs, Andrew H.] London Sch Hyg & Trop Med, London, England; [Carswell, Chris] Springer Nat, Adis Journals, Auckland, New Zealand; [Caulley, Lisa] Univ Ottawa, Dept Otolaryngol Head & Neck Surg, Ottawa, ON, Canada; [Caulley, Lisa] Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Caulley, Lisa] Ottawa Hosp Res Inst, Ctr Journalol, Ottawa, ON, Canada; [Caulley, Lisa] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Chaiyakunapruk, Nathorn] Univ Utah, Coll Pharm, Dept Pharmacotherapy, Salt Lake City, UT 84112 USA; [Greenberg, Dan] Ben Gurion Univ Negev, Fac Hlth Sci, Sch Publ Hlth, Dept Hlth Policy & Management, Beer Sheva, Israel; [Loder, Elizabeth] Harvard Med Sch, Boston, MA 02115 USA; [Loder, Elizabeth] The BMJ, London, England; [Mauskopf, Josephine] RTI Int, RII Hlth Solut, Res Triangle Pk, NC USA; [Mullins, C. Daniel] Univ Maryland, Sch Pharm, Baltimore, MD 21201 USA; [Petrou, Stavros] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England; [Pwu, Raoh-Fang] Minist Hlth & Welf, Natl Hepatitis C Program Off, Taipei, Taiwan; [Staniszewska, Sophie] Univ Warwick, Warwick Med Sch, Watwick Res Nursing, Warwick, England	University of Ottawa; University of York - UK; University of Buenos Aires; Erasmus University Rotterdam; University of London; London School of Hygiene & Tropical Medicine; Adis International; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; Erasmus University Rotterdam; Erasmus MC; Utah System of Higher Education; University of Utah; Ben Gurion University; Harvard University; Harvard Medical School; Research Triangle Institute; University System of Maryland; University of Maryland Baltimore; University of Oxford; University of Warwick	Husereau, D (corresponding author), Univ Ottawa, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada.; Husereau, D (corresponding author), Inst Hlth Econ, Edmonton, AB, Canada.	donh@donhusereau.com	Kostyuk, Alexander/HGA-2381-2022; Kostyuk, Alex/E-7579-2011; Pwu, Raoh Fang/AFK-8020-2022; Petrou, Stavros/ABD-8323-2021; Hughes, Dyfrig/H-5252-2012	Kostyuk, Alexander/0000-0001-6538-1324; Kostyuk, Alex/0000-0001-6538-1324; Pwu, Raoh Fang/0000-0002-0113-6917; Husereau, Don/0000-0002-4416-6876; Caulley, Lisa/0000-0002-9661-4634; Petrou, Stavros/0000-0003-3121-6050; Powell, John/0000-0002-1456-4857; Chaiyakunapruk, Nathorn/0000-0003-4572-8794; Mauskopf, Josephine/0000-0002-6098-5548; Briggs, Andrew/0000-0002-0777-1997; Hughes, Dyfrig/0000-0001-8247-7459	Canada Inc. [9363980]; NIHR Applied Research Collaboration (ARC) West Midlands; NIHR Health Protection Research Unit (HPRU) Gastrointestinal Infections; NIHR HPRU Genomics and Enabling data; ISPOR - The Professional Society for Health Economics and Outcomes Research	Canada Inc.; NIHR Applied Research Collaboration (ARC) West Midlands; NIHR Health Protection Research Unit (HPRU) Gastrointestinal Infections; NIHR HPRU Genomics and Enabling data; ISPOR - The Professional Society for Health Economics and Outcomes Research	Funding to support ongoing meetings was provided by ISPOR - The Professional Society for Health Economics and Outcomes Research. The funders had no role in considering the study design or in the collection, analysis, interpretation of data, or writing of the report. Funding for DH and the Delphi Panel exercise was provided by 9363980 Canada Inc. SS is part funded by the NIHR Applied Research Collaboration (ARC) West Midlands, the NIHR Health Protection Research Unit (HPRU) Gastrointestinal Infections, and the NIHR HPRU Genomics and Enabling data.	Altman DG, 2016, J ROY SOC MED, V109, P67, DOI 10.1177/0141076815625599; [Anonymous], CONS HLTH EC EV REP; Bond K, 2020, INT J TECHNOL ASSESS, V36, P445, DOI 10.1017/S0266462320000550; CADTH.ca, 2015, GUID EC EV HLTH TECH; Catala-Lopez F, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-034463; Caulley L, 2020, J CLIN EPIDEMIOL, V122, P87, DOI 10.1016/j.jclinepi.2020.03.006; Cohen JT, 2017, ANN INTERN MED, V167, P432, DOI 10.7326/M17-1153; Cookson R, 2021, VALUE HEALTH, V24, P118, DOI 10.1016/j.jval.2020.10.001; Cookson R, 2009, HEALTH ECON POLICY L, V4, P231, DOI 10.1017/S1744133109004903; Crown W, 2017, VALUE HEALTH, V20, P310, DOI 10.1016/j.jval.2017.01.013; Davis JC, 2011, OSTEOPOROSIS INT, V22, P2449, DOI 10.1007/s00198-010-1482-0; Drummond M, 2005, INT J TECHNOL ASSESS, V21, P165, DOI 10.1017/S0266462305050221; Drummond MF, 1996, BRIT MED J, V313, P275, DOI 10.1136/bmj.313.7052.275; Drummond MF, 2015, METHODS EC EVALUATIO; Dunlop WCN, 2017, PHARMACOECONOMICS, V35, P125, DOI 10.1007/s40273-016-0479-8; Emerson J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0205633; Goetghebeur MM, 2008, VALUE HEALTH, V11, pA183, DOI 10.1186/1472-6963-8-270; Hawton A, 2021, PATIENT, V14, P429, DOI 10.1007/s40271-020-00461-4; HILLMAN AL, 1995, ANN INTERN MED, V123, P61; Husereau D, 2022, VALUE HEALTH, V25, P10, DOI 10.1016/j.jval.2021.10.008; Husereau D, 2013, VALUE HEALTH, V16, P231, DOI 10.1016/j.jval.2013.02.002; ISPOR, OP SOURC MOD; Jansen JP, 2019, PHARMACOECONOMICS, V37, P1313, DOI 10.1007/s40273-019-00827-z; Juni P, 1999, JAMA-J AM MED ASSOC, V282, P1054, DOI 10.1001/jama.282.11.1054; Lorgelly PK, 2021, PATIENT, V14, P379, DOI 10.1007/s40271-021-00505-3; Malone DC, 2020, VALUE HEALTH, V23, P409, DOI 10.1016/j.jval.2020.03.001; Mauskopf J, 2018, VALUE HEALTH, V21, P1133, DOI 10.1016/j.jval.2018.08.005; Moher D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000217; Neumann PJ, 2015, VALUE HEALTH, V18, P271, DOI 10.1016/j.jval.2014.12.002; Neyt M, 2020, PRACTICAL CONSIDERAT, P153; Nuijten MJC, 1998, PHARMACOECONOMICS, V14, P259; Panzer AD, 2020, HEALTH ECON, V29, P945, DOI 10.1002/hec.4029; Petrou S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1766; Petrou S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1548; Pitt C, 2016, HEALTH ECON, V25, P9, DOI 10.1002/hec.3305; Ramsey SD, 2015, VALUE HEALTH, V18, P161, DOI 10.1016/j.jval.2015.02.001; Ryan M, 2017, INT J TECHNOL ASSESS, V33, P424, DOI 10.1017/S026646231700085X; Sanders GD, 2016, JAMA-J AM MED ASSOC, V316, P1093, DOI 10.1001/jama.2016.12195; Sanghera S, 2015, PHARMACOECONOMICS, V33, P533, DOI 10.1007/s40273-015-0265-z; Siegel JE, 1996, JAMA-J AM MED ASSOC, V276, P1339, DOI 10.1001/jama.276.16.1339; Smith Robert, 2020, Wellcome Open Res, V5, P69, DOI 10.12688/wellcomeopenres.15807.1; Sperber AD, 2004, GASTROENTEROLOGY, V126, pS124, DOI 10.1053/j.gastro.2003.10.016; Staniszewska S, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3453; Sullivan SD, 2014, VALUE HEALTH, V17, P5, DOI 10.1016/j.jval.2013.08.2291; Thorn JC, 2016, VALUE HEALTH, V19, pA397, DOI 10.1016/j.jval.2016.09.291; Vintzileos AM, 2004, AM J OBSTET GYNECOL, V191, P1070, DOI 10.1016/j.ajog.2004.05.021; Walker DG, 2012, AGENCY HEALTHC RES Q; Wilkinson T, 2016, VALUE HEALTH, V19, P921, DOI 10.1016/j.jval.2016.04.015; World Health Organization (WHO), WHO GUID STAND EC EV, V2	49	78	78	30	42	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1472-6963		BMC HEALTH SERV RES	BMC Health Serv. Res.	JAN 27	2022	22	1							114	10.1186/s12913-021-07460-7	http://dx.doi.org/10.1186/s12913-021-07460-7			8	Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services	YN3DP	35098747	Green Published, gold			2022-12-28	WOS:000747142100001
J	Husereau, D; Drummond, M; Augustovski, F; de Bekker-Grob, E; Briggs, AH; Carswell, C; Caulley, L; Chaiyakunapruk, N; Greenberg, D; Loder, E; Mauskopf, J; Mullins, CD; Petrou, S; Pwu, RF; Staniszewska, S				Husereau, Don; Drummond, Michael; Augustovski, Federico; de Bekker-Grob, Esther; Briggs, Andrew H.; Carswell, Chris; Caulley, Lisa; Chaiyakunapruk, Nathorn; Greenberg, Dan; Loder, Elizabeth; Mauskopf, Josephine; Mullins, C. Daniel; Petrou, Stavros; Pwu, Raoh-Fang; Staniszewska, Sophie		CHEERS 2022 ISPOR Good Res Practic	Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations	BMC PUBLIC HEALTH			English	Article							COST-EFFECTIVENESS ANALYSIS; TASK-FORCE; CLINICAL-TRIALS; GUIDELINES; RECOMMENDATIONS; IMPACT; TECHNOLOGY; PRINCIPLES; DESIGN	Health economic evaluations are comparative analyses of alternative courses of action in terms of their costs and consequences. The Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement, published in 2013, was created to ensure health economic evaluations are identifiable, interpretable, and useful for decision making. It was intended as guidance to help authors report accurately which health interventions were being compared and in what context, how the evaluation was undertaken, what the findings were, and other details that may aid readers and reviewers in interpretation and use of the study. The new CHEERS 2022 statement replaces previous CHEERS reporting guidance. It reflects the need for guidance that can be more easily applied to all types of health economic evaluation, new methods and developments in the field, as well as the increased role of stakeholder involvement including patients and the public. It is also broadly applicable to any form of intervention intended to improve the health of individuals or the population, whether simple or complex, and without regard to context (such as health care, public health, education, social care, etc). This summary article presents the new CHEERS 2022 28-item checklist and recommendations for each item. The CHEERS 2022 statement is primarily intended for researchers reporting economic evaluations for peer reviewed journals as well as the peer reviewers and editors assessing them for publication. However, we anticipate familiarity with reporting requirements will be useful for analysts when planning studies. It may also be useful for health technology assessment bodies seeking guidance on reporting, as there is an increasing emphasis on transparency in decision making.	[Husereau, Don] Univ Ottawa, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada; [Husereau, Don] Inst Hlth Econ, Edmonton, AB, Canada; [Drummond, Michael] Univ York, Ctr Hlth Econ, York, N Yorkshire, England; [Augustovski, Federico] Inst Clin Effectiveness & Hlth Policy IECS CONICE, Hlth Technol Assessment & Hlth Econ Dept, Buenos Aires, DF, Argentina; [Augustovski, Federico] Univ Buenos Aires, Buenos Aires, DF, Argentina; [Augustovski, Federico] CONICET Natl Sci & Tech Res Council, Buenos Aires, DF, Argentina; [de Bekker-Grob, Esther] Erasmus Univ, Erasmus Sch Hlth Policy & Management, Rotterdam, Netherlands; [Briggs, Andrew H.] London Sch Hyg & Trop Med, London, England; [Carswell, Chris] Springer Nat, Adis Journals, Auckland, New Zealand; [Caulley, Lisa] Univ Ottawa, Dept Otolaryngol Head & Neck Surg, Ottawa, ON, Canada; [Caulley, Lisa] Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Caulley, Lisa] Ottawa Hosp Res Inst, Ctr Journalol, Ottawa, ON, Canada; [Caulley, Lisa] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Chaiyakunapruk, Nathorn] Univ Utah, Coll Pharm, Dept Pharmacotherapy, Salt Lake City, UT 84112 USA; [Greenberg, Dan] Ben Gurion Univ Negev, Fac Hlth Sci, Sch Publ Hlth, Dept Hlth Policy & Management, Beer Sheva, Israel; [Loder, Elizabeth] Harvard Med Sch, Boston, MA 02115 USA; [Loder, Elizabeth] The BMJ, London, England; [Mauskopf, Josephine] RTI Int, RTI Hlth Solut, Res Triangle Pk, NC USA; [Mullins, C. Daniel] Univ Maryland, Sch Pharm, Baltimore, MD 21201 USA; [Petrou, Stavros] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England; [Pwu, Raoh-Fang] Minist Hlth & Welf, Natl Hepatitis C Program Off, Taipei, Taiwan; [Staniszewska, Sophie] Univ Warwick, Warwick Med Sch, Warwick Res Nursing, Warwick, England	University of Ottawa; University of York - UK; University of Buenos Aires; Erasmus University Rotterdam; University of London; London School of Hygiene & Tropical Medicine; Adis International; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; Erasmus University Rotterdam; Erasmus MC; Utah System of Higher Education; University of Utah; Ben Gurion University; Harvard University; Harvard Medical School; Research Triangle Institute; University System of Maryland; University of Maryland Baltimore; University of Oxford; University of Warwick	Husereau, D (corresponding author), Univ Ottawa, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada.; Husereau, D (corresponding author), Inst Hlth Econ, Edmonton, AB, Canada.	donh@donhusereau.com	Kostyuk, Alexander/HGA-2381-2022; Kostyuk, Alex/E-7579-2011; Pwu, Raoh Fang/AFK-8020-2022; Petrou, Stavros/ABD-8323-2021; Hughes, Dyfrig/H-5252-2012	Kostyuk, Alexander/0000-0001-6538-1324; Kostyuk, Alex/0000-0001-6538-1324; Pwu, Raoh Fang/0000-0002-0113-6917; Husereau, Don/0000-0002-4416-6876; Caulley, Lisa/0000-0002-9661-4634; Petrou, Stavros/0000-0003-3121-6050; Powell, John/0000-0002-1456-4857; Chaiyakunapruk, Nathorn/0000-0003-4572-8794; Mauskopf, Josephine/0000-0002-6098-5548; Briggs, Andrew/0000-0002-0777-1997; Hughes, Dyfrig/0000-0001-8247-7459	ISPOR -The Professional Society for Health Economics and Outcomes Research; Canada Inc. [9363980]; NIHR Applied Research Collaboration (ARC) West Midlands; NIHR Health Protection Research Unit (HPRU) Gastrointestinal Infections; NIHR HPRU Genomics and Enabling data	ISPOR -The Professional Society for Health Economics and Outcomes Research; Canada Inc.; NIHR Applied Research Collaboration (ARC) West Midlands; NIHR Health Protection Research Unit (HPRU) Gastrointestinal Infections; NIHR HPRU Genomics and Enabling data	Funding to support ongoing meetings was provided by ISPOR -The Professional Society for Health Economics and Outcomes Research. The funders had no role in considering the study design or in the collection, analysis, interpretation of data, or writing of the report. Funding for DH and the Delphi Panel exercise was provided by 9363980 Canada Inc. SS is part funded by the NIHR Applied Research Collaboration (ARC) West Midlands, the NIHR Health Protection Research Unit (HPRU) Gastrointestinal Infections, and the NIHR HPRU Genomics and Enabling data.	Altman DG, 2016, J ROY SOC MED, V109, P67, DOI 10.1177/0141076815625599; [Anonymous], CONS HLTH EC EV REP; Bond K, 2020, INT J TECHNOL ASSESS, V36, P445, DOI 10.1017/S0266462320000550; CADTH.ca, 2015, GUID EC EV HLTH TECH; Catala-Lopez F, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-034463; Caulley L, 2020, J CLIN EPIDEMIOL, V122, P87, DOI 10.1016/j.jclinepi.2020.03.006; Cohen JT, 2017, ANN INTERN MED, V167, P432, DOI 10.7326/M17-1153; Cookson R, 2021, VALUE HEALTH, V24, P118, DOI 10.1016/j.jval.2020.10.001; Cookson R, 2009, HEALTH ECON POLICY L, V4, P231, DOI 10.1017/S1744133109004903; Crown W, 2017, VALUE HEALTH, V20, P310, DOI 10.1016/j.jval.2017.01.013; Davis JC, 2011, OSTEOPOROSIS INT, V22, P2449, DOI 10.1007/s00198-010-1482-0; Drummond M, 2005, INT J TECHNOL ASSESS, V21, P165, DOI 10.1017/S0266462305050221; Drummond MF, 1996, BRIT MED J, V313, P275, DOI 10.1136/bmj.313.7052.275; Drummond MF, 2015, METHODS EC EVALUATIO; Dunlop WCN, 2017, PHARMACOECONOMICS, V35, P125, DOI 10.1007/s40273-016-0479-8; Emerson J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0205633; Goetghebeur MM, 2008, VALUE HEALTH, V11, pA183, DOI 10.1186/1472-6963-8-270; Hawton A, 2021, PATIENT, V14, P429, DOI 10.1007/s40271-020-00461-4; HILLMAN AL, 1995, ANN INTERN MED, V123, P61; Husereau D, 2022, VALUE HEALTH, V25, P10, DOI 10.1016/j.jval.2021.10.008; Husereau D, 2013, VALUE HEALTH, V16, P231, DOI 10.1016/j.jval.2013.02.002; ISPOR, OP SOURC MOD; Jansen JP, 2019, PHARMACOECONOMICS, V37, P1313, DOI 10.1007/s40273-019-00827-z; Juni P, 1999, JAMA-J AM MED ASSOC, V282, P1054, DOI 10.1001/jama.282.11.1054; Lorgelly PK, 2021, PATIENT, V14, P379, DOI 10.1007/s40271-021-00505-3; Malone DC, 2020, VALUE HEALTH, V23, P409, DOI 10.1016/j.jval.2020.03.001; Mauskopf J, 2018, VALUE HEALTH, V21, P1133, DOI 10.1016/j.jval.2018.08.005; Moher D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000217; Neumann PJ, 2015, VALUE HEALTH, V18, P271, DOI 10.1016/j.jval.2014.12.002; Neyt M, 2020, PRACTICAL CONSIDERAT, P153; Nuijten MJC, 1998, PHARMACOECONOMICS, V14, P259; Panzer AD, 2020, HEALTH ECON, V29, P945, DOI 10.1002/hec.4029; Petrou S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1766; Petrou S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1548; Pitt C, 2016, HEALTH ECON, V25, P9, DOI 10.1002/hec.3305; Ramsey SD, 2015, VALUE HEALTH, V18, P161, DOI 10.1016/j.jval.2015.02.001; Ryan M, 2017, INT J TECHNOL ASSESS, V33, P424, DOI 10.1017/S026646231700085X; Sanders GD, 2016, JAMA-J AM MED ASSOC, V316, P1093, DOI 10.1001/jama.2016.12195; Sanghera S, 2015, PHARMACOECONOMICS, V33, P533, DOI 10.1007/s40273-015-0265-z; Siegel JE, 1996, JAMA-J AM MED ASSOC, V276, P1339, DOI 10.1001/jama.276.16.1339; Smith Robert, 2020, Wellcome Open Res, V5, P69, DOI 10.12688/wellcomeopenres.15807.1; Sperber AD, 2004, GASTROENTEROLOGY, V126, pS124, DOI 10.1053/j.gastro.2003.10.016; Staniszewska S, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3453; Sullivan SD, 2014, VALUE HEALTH, V17, P5, DOI 10.1016/j.jval.2013.08.2291; Thorn JC, 2016, VALUE HEALTH, V19, pA397, DOI 10.1016/j.jval.2016.09.291; Vintzileos AM, 2004, AM J OBSTET GYNECOL, V191, P1070, DOI 10.1016/j.ajog.2004.05.021; Walker DG, 2012, AGENCY HEALTHC RES Q; Wilkinson T, 2016, VALUE HEALTH, V19, P921, DOI 10.1016/j.jval.2016.04.015; World Health Organization (WHO), WHO GUID STAND EC EV, V2	49	78	78	30	42	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2458		BMC PUBLIC HEALTH	BMC Public Health	JAN 27	2022	22	1							179	10.1186/s12889-021-12491-0	http://dx.doi.org/10.1186/s12889-021-12491-0			8	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health	YN3EZ	35098747	gold, Green Published, Green Accepted			2022-12-28	WOS:000747145700001
J	Husereau, D; Drummond, M; Augustovski, F; De Bekker-Grob, E; Briggs, AH; Carswell, C; Caulley, L; Chaiyakunapruk, N; Greenberg, D; Loder, E; Mauskopf, J; Mullins, CD; Petrou, S; Pwu, RF; Staniszewska, S				Husereau, Don; Drummond, Michael; Augustovski, Federico; De Bekker-Grob, Esther; Briggs, Andrew H.; Carswell, Chris; Caulley, Lisa; Chaiyakunapruk, Nathorn; Greenberg, Dan; Loder, Elizabeth; Mauskopf, Josephine; Mullins, C. Daniel; Petrou, Stavros; Pwu, Raoh-Fang; Staniszewska, Sophie			Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations	APPLIED HEALTH ECONOMICS AND HEALTH POLICY			English	Article							COST-EFFECTIVENESS ANALYSIS; TASK-FORCE; CLINICAL-TRIALS; GUIDELINES; RECOMMENDATIONS; IMPACT; TECHNOLOGY; PRINCIPLES; DESIGN	Health economic evaluations are comparative analyses of alternative courses of action in terms of their costs and consequences. The Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement, published in 2013, was created to ensure health economic evaluations are identifiable, interpretable, and useful for decision making. It was intended as guidance to help authors report accurately which health interventions were being compared and in what context, how the evaluation was undertaken, what the findings were, and other details that may aid readers and reviewers in interpretation and use of the study. The new CHEERS 2022 statement replaces previous CHEERS reporting guidance. It reflects the need for guidance that can be more easily applied to all types of health economic evaluation, new methods and developments in the field, as well as the increased role of stakeholder involvement including patients and the public. It is also broadly applicable to any form of intervention intended to improve the health of individuals or the population, whether simple or complex, and without regard to context (such as health care, public health, education, social care, etc). This summary article presents the new CHEERS 2022 28-item checklist and recommendations for each item. The CHEERS 2022 statement is primarily intended for researchers reporting economic evaluations for peer reviewed journals as well as the peer reviewers and editors assessing them for publication. However, we anticipate familiarity with reporting requirements will be useful for analysts when planning studies. It may also be useful for health technology assessment bodies seeking guidance on reporting, as there is an increasing emphasis on transparency in decision making.	[Husereau, Don] Univ Ottawa, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada; [Husereau, Don] Inst Hlth Econ, Edmonton, AB, Canada; [Drummond, Michael] Univ York, Ctr Hlth Econ, York, N Yorkshire, England; [Augustovski, Federico] Inst Clin Effectiveness & Hlth Policy IECS CONICE, Hlth Technol Assessment & Hlth Econ Dept, Buenos Aires, DF, Argentina; [Augustovski, Federico] Univ Buenos Aires, Buenos Aires, DF, Argentina; [Augustovski, Federico] CONICET Natl Sci & Tech Res Council, Buenos Aires, DF, Argentina; [De Bekker-Grob, Esther] Erasmus Univ, Erasmus Sch Hlth Policy & Management, Rotterdam, Netherlands; [Briggs, Andrew H.] London Sch Hyg & Trop Med, London, England; [Carswell, Chris] Springer Nat, Adis Journals, Auckland, New Zealand; [Caulley, Lisa] Univ Ottawa, Dept Otolaryngol Head & Neck Surg, Ottawa, ON, Canada; [Caulley, Lisa] Ottawa Hosp, Clin Epidemiol Program, Res Inst, Ottawa, ON, Canada; [Caulley, Lisa] Ottawa Hosp, Ctr Journalol, Res Inst, Ottawa, ON, Canada; [Caulley, Lisa] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Chaiyakunapruk, Nathorn] Univ Utah, Coll Pharm, Dept Pharmacotherapy, Salt Lake City, UT 84112 USA; [Greenberg, Dan] Ben Gurion Univ Negev, Fac Hlth Sci, Sch Publ Hlth, Dept Hlth Policy & Management, Beer Sheva, Israel; [Loder, Elizabeth] Harvard Med Sch, Boston, MA 02115 USA; [Loder, Elizabeth] BMJ, London, England; [Mauskopf, Josephine] RTI Int, RTI Hlth Solut, Res Triangle Pk, NC USA; [Mullins, C. Daniel] Univ Maryland, Sch Pharm, Baltimore, MD 21201 USA; [Petrou, Stavros] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England; [Pwu, Raoh-Fang] Minist Hlth & Welf, Natl Hepatitis C Program Off, Taipei, Taiwan; [Staniszewska, Sophie] Univ Warwick, Warwick Res Nursing, Warwick Med Sch, Warwick, England	University of Ottawa; University of York - UK; University of Buenos Aires; Erasmus University Rotterdam; University of London; London School of Hygiene & Tropical Medicine; Adis International; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; Erasmus University Rotterdam; Erasmus MC; Utah System of Higher Education; University of Utah; Ben Gurion University; Harvard University; Harvard Medical School; Research Triangle Institute; University System of Maryland; University of Maryland Baltimore; University of Oxford; University of Warwick	Husereau, D (corresponding author), Univ Ottawa, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada.; Husereau, D (corresponding author), Inst Hlth Econ, Edmonton, AB, Canada.	donh@donhusereau.com	Kostyuk, Alexander/HGA-2381-2022; Kostyuk, Alex/E-7579-2011; Pwu, Raoh Fang/AFK-8020-2022; Petrou, Stavros/ABD-8323-2021; Hughes, Dyfrig/H-5252-2012	Kostyuk, Alexander/0000-0001-6538-1324; Kostyuk, Alex/0000-0001-6538-1324; Pwu, Raoh Fang/0000-0002-0113-6917; Husereau, Don/0000-0002-4416-6876; Caulley, Lisa/0000-0002-9661-4634; Petrou, Stavros/0000-0003-3121-6050; Powell, John/0000-0002-1456-4857; Chaiyakunapruk, Nathorn/0000-0003-4572-8794; Mauskopf, Josephine/0000-0002-6098-5548; Briggs, Andrew/0000-0002-0777-1997; Hughes, Dyfrig/0000-0001-8247-7459	ISPOR; Canada Inc.; NIHR Applied Research Collaboration (ARC) West Midlands; NIHR Health Protection Research Unit (HPRU) Gastrointestinal Infections; NIHR HPRU Genomics and Enabling data	ISPOR; Canada Inc.; NIHR Applied Research Collaboration (ARC) West Midlands; NIHR Health Protection Research Unit (HPRU) Gastrointestinal Infections; NIHR HPRU Genomics and Enabling data	Funding to support ongoing meetings was provided by ISPOR. The funders had no role in considering the study design or in the collection, analysis, interpretation of data, or writing of the report. Funding for DH and the Delphi panel exercise was provided by 9363980 Canada Inc. SS is part funded by the NIHR Applied Research Collaboration (ARC) West Midlands, the NIHR Health Protection Research Unit (HPRU) Gastrointestinal Infections, and the NIHR HPRU Genomics and Enabling data.	Altman DG, 2016, J ROY SOC MED, V109, P67, DOI 10.1177/0141076815625599; [Anonymous], CONS HLTH EC EV REP; BOND K, 2020, INT J TECHNOL ASSESS; Catala-Lopez F, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-034463; Caulley L, 2020, J CLIN EPIDEMIOL, V122, P87, DOI 10.1016/j.jclinepi.2020.03.006; Cohen JT, 2017, ANN INTERN MED, V167, P432, DOI 10.7326/M17-1153; Common Market of the Southern Cone (MERCOSUR), 2015, GUID EC EV HLTH TECH; Cookson R, 2021, VALUE HEALTH, V24, P118, DOI 10.1016/j.jval.2020.10.001; Cookson R, 2009, HEALTH ECON POLICY L, V4, P231, DOI 10.1017/S1744133109004903; Crown W, 2017, VALUE HEALTH, V20, P310, DOI 10.1016/j.jval.2017.01.013; Davis JC, 2011, OSTEOPOROSIS INT, V22, P2449, DOI 10.1007/s00198-010-1482-0; Drummond M, 2005, INT J TECHNOL ASSESS, V21, P165, DOI 10.1017/S0266462305050221; Drummond MF, 1996, BRIT MED J, V313, P275, DOI 10.1136/bmj.313.7052.275; Drummond MF, 2015, METHODS EC EVALUATIO; Dunlop WCN, 2017, PHARMACOECONOMICS, V35, P125, DOI 10.1007/s40273-016-0479-8; Emerson J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0205633; EUnetHTA European Network for Health Technology Assessment, 2021, GUID DOC; Goetghebeur MM, 2008, VALUE HEALTH, V11, pA183, DOI 10.1186/1472-6963-8-270; Hawton A, 2021, PATIENT, V14, P429, DOI 10.1007/s40271-020-00461-4; HILLMAN AL, 1995, ANN INTERN MED, V123, P61; Husereau D, 2022, VALUE HEALTH, V25, P10, DOI 10.1016/j.jval.2021.10.008; Husereau D, 2013, VALUE HEALTH, V16, pE1, DOI 10.1016/j.jval.2013.02.010; ISPOR, OP SOURC MOD; Jansen JP, 2019, PHARMACOECONOMICS, V37, P1313, DOI 10.1007/s40273-019-00827-z; Juni P, 1999, JAMA-J AM MED ASSOC, V282, P1054, DOI 10.1001/jama.282.11.1054; Lorgelly PK, 2021, PATIENT, V14, P379, DOI 10.1007/s40271-021-00505-3; Malone DC, 2020, VALUE HEALTH, V23, P409, DOI 10.1016/j.jval.2020.03.001; Mauskopf J, 2018, VALUE HEALTH, V21, P1133, DOI 10.1016/j.jval.2018.08.005; Moher D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000217; Neumann PJ, 2015, VALUE HEALTH, V18, P271, DOI 10.1016/j.jval.2014.12.002; Nuijten MJC, 1998, PHARMACOECONOMICS, V14, P259; Panzer AD, 2020, HEALTH ECON, V29, P945, DOI 10.1002/hec.4029; Petrou S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1766; Petrou Stavros, 2011, BMJ, V342, pd1548, DOI 10.1136/bmj.d1548; Pitt C, 2016, HEALTH ECON, V25, P9, DOI 10.1002/hec.3305; Ramsey SD, 2015, VALUE HEALTH, V18, P161, DOI 10.1016/j.jval.2015.02.001; Ryan M, 2017, INT J TECHNOL ASSESS, V33, P424, DOI 10.1017/S026646231700085X; Sanders GD, 2016, JAMA-J AM MED ASSOC, V316, P1093, DOI 10.1001/jama.2016.12195; Sanghera S, 2015, PHARMACOECONOMICS, V33, P533, DOI 10.1007/s40273-015-0265-z; Siegel JE, 1996, JAMA-J AM MED ASSOC, V276, P1339, DOI 10.1001/jama.276.16.1339; Smith Robert, 2020, Wellcome Open Res, V5, P69, DOI 10.12688/wellcomeopenres.15807.1; Sperber AD, 2004, GASTROENTEROLOGY, V126, pS124, DOI 10.1053/j.gastro.2003.10.016; Staniszewska S, 2017, Res Involv Engagem, V3, P13, DOI 10.1186/s40900-017-0062-2; Sullivan SD, 2014, VALUE HEALTH, V17, P5, DOI 10.1016/j.jval.2013.08.2291; Thorn JC, 2016, VALUE HEALTH, V19, pA397, DOI 10.1016/j.jval.2016.09.291; Vintzileos AM, 2004, AM J OBSTET GYNECOL, V191, P1070, DOI 10.1016/j.ajog.2004.05.021; Walker DG, 2012, BEST PRACTICES CONDU; Wilkinson T, 2016, VALUE HEALTH, V19, P921, DOI 10.1016/j.jval.2016.04.015; World Health Organization (WHO), WHO GUID STAND EC EV, V2	49	78	78	30	42	SPRINGER INT PUBL AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND	1175-5652	1179-1896		APPL HEALTH ECON HEA	Appl. Health Econ. Health Policy	MAR	2022	20	2					213	221		10.1007/s40258-021-00704-x	http://dx.doi.org/10.1007/s40258-021-00704-x		JAN 2022	9	Economics; Health Care Sciences & Services; Health Policy & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Business & Economics; Health Care Sciences & Services	ZA0TW	35098747	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000741209600001
J	Husereau, D; Drummond, M; Augustovski, F; De Bekker-Grob, E; Briggs, AH; Carswell, C; Caulley, L; Chaiyakunapruk, N; Greenberg, D; Loder, E; Mauskopf, J; Mullins, CD; Petrou, S; Pwu, RF; Staniszewska, S				Husereau, Don; Drummond, Michael; Augustovski, Federico; De Bekker-Grob, Esther; Briggs, Andrew H.; Carswell, Chris; Caulley, Lisa; Chaiyakunapruk, Nathorn; Greenberg, Dan; Loder, Elizabeth; Mauskopf, Josephine; Mullins, C. Daniel; Petrou, Stavros; Pwu, Raoh-Fang; Staniszewska, Sophie		CHEERS 2022 ISPOR Good Res Practic	Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations	CLINICAL THERAPEUTICS			English	Article						economic evaluation; cost-benefit analysis; reporting; guidelines	COST-EFFECTIVENESS ANALYSIS; TASK-FORCE; CLINICAL-TRIALS; GUIDELINES; RECOMMENDATIONS; IMPACT; TECHNOLOGY; PRINCIPLES; DESIGN	Health economic evaluations are comparative analyses of alternative courses of action in terms of their costs and consequences. The Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement, published in 2013, was created to ensure health economic evaluations are identifiable, interpretable, and useful for decision making. It was intended as guidance to help authors report accurately which health interventions were being compared and in what context, how the evaluation was undertaken, what the findings were, and other details that may aid readers and reviewers in interpretation and use of the study. The new CHEERS 2022 statement replaces previous CHEERS reporting guidance. It reflects the need for guidance that can be more easily applied to all types of health economic evaluation, new methods and developments in the field, as well as the increased role of stakeholder involvement including patients and the public. It is also broadly applicable to any form of intervention intended to improve the health of individuals or the population, whether simple or complex, and without regard to context (such as health care, public health, education, social care, etc). This summary article presents the new CHEERS 2022 28-item checklist and recommendations for each item. The CHEERS 2022 statement is primarily intended for researchers reporting economic evaluations for peer reviewed journals as well as the peer reviewers and editors assessing them for publication. However, we anticipate familiarity with reporting requirements will be useful for analysts when planning studies. It may also be useful for health technology assessment bodies seeking guidance on reporting, as there is an increasing emphasis on transparency in decision making.	[Husereau, Don] Univ Ottawa, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada; [Husereau, Don] Inst Hlth Econ, Edmonton, AB, Canada; [Drummond, Michael] Univ York, Ctr Hlth Econ, York, N Yorkshire, England; [Augustovski, Federico] Univ Buenos Aires, Hlth Technol Assessment & Hlth Econ Dept, Inst Clin Effectiveness & Hlth Policy, CONICET,IECS,Natl Sci & Tech Res Council, Buenos Aires, DF, Argentina; [De Bekker-Grob, Esther] Erasmus Univ, Erasmus Sch Hlth Policy & Management, Rotterdam, Netherlands; [Briggs, Andrew H.] London Sch Hyg & Trop Med, London, England; [Carswell, Chris] Springer Nat, Adis Journals, Auckland, New Zealand; [Caulley, Lisa] Univ Ottawa, Dept Otolaryngol Head & Neck Surg, Ottawa, ON, Canada; [Caulley, Lisa] Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Caulley, Lisa] Ottawa Hosp Res Inst, Ctr Journalol, Ottawa, ON, Canada; [Caulley, Lisa] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Chaiyakunapruk, Nathorn] Univ Utah, Coll Pharm, Dept Pharmacotherapy, Salt Lake City, UT 84112 USA; [Greenberg, Dan] Ben Gurion Univ Negev, Fac Hlth Sci, Sch Publ Hlth, Dept Hlth Policy & Management, Beer Sheva, Israel; [Loder, Elizabeth] Harvard Med Sch, Boston, MA 02115 USA; [Loder, Elizabeth] BMJ, London, England; [Mauskopf, Josephine] RTI Int, RTI Hlth Solut, Res Triangle Pk, NC USA; [Mullins, C. Daniel] Univ Maryland, Sch Pharm, Baltimore, MD 21201 USA; [Petrou, Stavros] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Stavros Petros, Oxford, England; [Pwu, Raoh-Fang] Minist Hlth & Welf, Natl Hepatitis C Program Off, Taipei, Taiwan; [Staniszewska, Sophie] Univ Warwick, Warwick Med Sch, Warwick Res Nursing, Warwick, England	University of Ottawa; University of York - UK; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Erasmus University Rotterdam; University of London; London School of Hygiene & Tropical Medicine; Adis International; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; Erasmus University Rotterdam; Erasmus MC; Utah System of Higher Education; University of Utah; Ben Gurion University; Harvard University; Harvard Medical School; Research Triangle Institute; University System of Maryland; University of Maryland Baltimore; University of Oxford; University of Warwick	Husereau, D (corresponding author), 879 Winnington Ave, Ottawa, ON K28 5C4, Canada.	donh@donhusereau.com	Kostyuk, Alexander/HGA-2381-2022; Kostyuk, Alex/E-7579-2011; Pwu, Raoh Fang/AFK-8020-2022; Petrou, Stavros/ABD-8323-2021; Hughes, Dyfrig/H-5252-2012	Kostyuk, Alexander/0000-0001-6538-1324; Kostyuk, Alex/0000-0001-6538-1324; Pwu, Raoh Fang/0000-0002-0113-6917; Husereau, Don/0000-0002-4416-6876; Caulley, Lisa/0000-0002-9661-4634; Petrou, Stavros/0000-0003-3121-6050; Powell, John/0000-0002-1456-4857; Chaiyakunapruk, Nathorn/0000-0003-4572-8794; Mauskopf, Josephine/0000-0002-6098-5548; Briggs, Andrew/0000-0002-0777-1997; Hughes, Dyfrig/0000-0001-8247-7459	ISPOR - The Professional Society for Health Economics and Outcomes Research; NIHR Applied Research Collaboration (ARC) West Midlands; NIHR Health Protection Research Unit (HPRU) Gastrointestinal Infections; NIHR HPRU Genomics and Enabling data; Canada Inc. [9363980]	ISPOR - The Professional Society for Health Economics and Outcomes Research; NIHR Applied Research Collaboration (ARC) West Midlands; NIHR Health Protection Research Unit (HPRU) Gastrointestinal Infections; NIHR HPRU Genomics and Enabling data; Canada Inc.	Funding to support ongoing meetings was provided by ISPOR - The Professional Society for Health Economics and Outcomes Research. The funders had no role in considering the study design or in the collection, analysis, interpretation of data, or writing of the report. Funding for DH and the Delphi Panel exercise was provided by 9363980 Canada Inc. SS is part funded by the NIHR Applied Research Collaboration (ARC) West Midlands, the NIHR Health Protection Research Unit (HPRU) Gastrointestinal Infections, and the NIHR HPRU Genomics and Enabling data.	Altman DG, 2016, J ROY SOC MED, V109, P67, DOI 10.1177/0141076815625599; [Anonymous], CONS HLTH EC EV REP; Bond K, 2020, INT J TECHNOL ASSESS, V36, P445, DOI 10.1017/S0266462320000550; Catala-Lopez F, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-034463; Caulley L, 2020, J CLIN EPIDEMIOL, V122, P87, DOI 10.1016/j.jclinepi.2020.03.006; Cohen JT, 2017, ANN INTERN MED, V167, P432, DOI 10.7326/M17-1153; Common Market of the Southern Cone (MERCOSUR), 2015, GUID EC EV HLTH TECH; Cookson R, 2021, VALUE HEALTH, V24, P118, DOI 10.1016/j.jval.2020.10.001; Cookson R, 2009, HEALTH ECON POLICY L, V4, P231, DOI 10.1017/S1744133109004903; Crown W, 2017, VALUE HEALTH, V20, P310, DOI 10.1016/j.jval.2017.01.013; Davis JC, 2011, OSTEOPOROSIS INT, V22, P2449, DOI 10.1007/s00198-010-1482-0; Drummond M, 2005, INT J TECHNOL ASSESS, V21, P165, DOI 10.1017/S0266462305050221; Drummond MF, 1996, BRIT MED J, V313, P275, DOI 10.1136/bmj.313.7052.275; Drummond MF, 2015, METHODS EC EVALUATIO; Dunlop WCN, 2017, PHARMACOECONOMICS, V35, P125, DOI 10.1007/s40273-016-0479-8; Emerson J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0205633; EUnetHTA European Network for Health Technology Assessment, 2021, GUID DOC; Goetghebeur MM, 2008, VALUE HEALTH, V11, pA183, DOI 10.1186/1472-6963-8-270; Hawton A, 2021, PATIENT, V14, P429, DOI 10.1007/s40271-020-00461-4; HILLMAN AL, 1995, ANN INTERN MED, V123, P61; Husereau D, 2013, VALUE HEALTH, V16, P231, DOI 10.1016/j.jval.2013.02.002; Husereau D, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1049; ISPOR, OP SOURC MOD; Jansen JP, 2019, PHARMACOECONOMICS, V37, P1313, DOI 10.1007/s40273-019-00827-z; Juni P, 1999, JAMA-J AM MED ASSOC, V282, P1054, DOI 10.1001/jama.282.11.1054; Lorgelly PK, 2021, PATIENT, V14, P379, DOI 10.1007/s40271-021-00505-3; Malone DC, 2020, VALUE HEALTH, V23, P409, DOI 10.1016/j.jval.2020.03.001; Mauskopf J, 2018, VALUE HEALTH, V21, P1133, DOI 10.1016/j.jval.2018.08.005; Moher D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000217; Neumann PJ, 2015, VALUE HEALTH, V18, P271, DOI 10.1016/j.jval.2014.12.002; Nuijten MJC, 1998, PHARMACOECONOMICS, V14, P259; Panzer AD, 2020, HEALTH ECON, V29, P945, DOI 10.1002/hec.4029; Petrou S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1766; Petrou S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1548; Pitt C, 2016, HEALTH ECON, V25, P9, DOI 10.1002/hec.3305; Ramsey SD, 2015, VALUE HEALTH, V18, P161, DOI 10.1016/j.jval.2015.02.001; Ryan M, 2017, INT J TECHNOL ASSESS, V33, P424, DOI 10.1017/S026646231700085X; Sanders GD, 2016, JAMA-J AM MED ASSOC, V316, P1093, DOI 10.1001/jama.2016.12195; Sanghera S, 2015, PHARMACOECONOMICS, V33, P533, DOI 10.1007/s40273-015-0265-z; Siegel JE, 1996, JAMA-J AM MED ASSOC, V276, P1339, DOI 10.1001/jama.276.16.1339; Smith Robert, 2020, Wellcome Open Res, V5, P69, DOI 10.12688/wellcomeopenres.15807.1; Sperber AD, 2004, GASTROENTEROLOGY, V126, pS124, DOI 10.1053/j.gastro.2003.10.016; Staniszewska S, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3453; Sullivan SD, 2014, VALUE HEALTH, V17, P5, DOI 10.1016/j.jval.2013.08.2291; Thorn JC, 2016, VALUE HEALTH, V19, pA397, DOI 10.1016/j.jval.2016.09.291; Vintzileos AM, 2004, AM J OBSTET GYNECOL, V191, P1070, DOI 10.1016/j.ajog.2004.05.021; Walker DG, 2012, BEST PRACTICES CONDU; Wilkinson T, 2016, VALUE HEALTH, V19, P921, DOI 10.1016/j.jval.2016.04.015; World Health Organization (WHO), WHO GUID STAND EC EV, V2	49	78	78	30	42	ELSEVIER	BRIDGEWATER	685 ROUTE 202-206, BRIDGEWATER, NJ 08807 USA	0149-2918	1879-114X		CLIN THER	Clin. Ther.	FEB	2022	44	2					158	168		10.1016/j.clinthera.2022.01.011	http://dx.doi.org/10.1016/j.clinthera.2022.01.011			11	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	2Q8XD	35098747				2022-12-28	WOS:000820700000003
J	Husereau, D; Drummond, M; Augustovski, F; de Bekker-Grob, E; Briggs, AH; Carswell, C; Caulley, L; Chaiyakunapruk, N; Greenberg, D; Loder, E; Mauskopf, J; Mullins, CD; Petrou, S; Pwu, RF; Staniszewska, S				Husereau, Don; Drummond, Michael; Augustovski, Federico; de Bekker-Grob, Esther; Briggs, Andrew H.; Carswell, Chris; Caulley, Lisa; Chaiyakunapruk, Nathorn; Greenberg, Dan; Loder, Elizabeth; Mauskopf, Josephine; Mullins, C. Daniel; Petrou, Stavros; Pwu, Raoh-Fang; Staniszewska, Sophie			Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations	PHARMACOECONOMICS			English	Article							COST-EFFECTIVENESS ANALYSIS; TASK-FORCE; CLINICAL-TRIALS; GUIDELINES; RECOMMENDATIONS; IMPACT; TECHNOLOGY; PRINCIPLES; DESIGN	Health economic evaluations are comparative analyses of alternative courses of action in terms of their costs and consequences. The Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement, published in 2013, was created to ensure health economic evaluations are identifiable, interpretable, and useful for decision making. It was intended as guidance to help authors report accurately which health interventions were being compared and in what context, how the evaluation was undertaken, what the findings were, and other details that may aid readers and reviewers in interpretation and use of the study. The new CHEERS 2022 statement replaces previous CHEERS reporting guidance. It reflects the need for guidance that can be more easily applied to all types of health economic evaluation, new methods and developments in the field, as well as the increased role of stakeholder involvement including patients and the public. It is also broadly applicable to any form of intervention intended to improve the health of individuals or the population, whether simple or complex, and without regard to context (such as health care, public health, education, social care, etc). This summary article presents the new CHEERS 2022 28-item checklist and recommendations for each item. The CHEERS 2022 statement is primarily intended for researchers reporting economic evaluations for peer reviewed journals as well as the peer reviewers and editors assessing them for publication. However, we anticipate familiarity with reporting requirements will be useful for analysts when planning studies. It may also be useful for health technology assessment bodies seeking guidance on reporting, as there is an increasing emphasis on transparency in decision making.	[Husereau, Don] Univ Ottawa, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada; [Husereau, Don] Inst Hlth Econ, Edmonton, AB, Canada; [Drummond, Michael] Univ York, Ctr Hlth Econ, York, N Yorkshire, England; [Augustovski, Federico] Inst Clin Effectiveness & Hlth Policy IECS CONICE, Hlth Technol Assessment & Hlth Econ Dept, Buenos Aires, DF, Argentina; [Augustovski, Federico] Univ Buenos Aires, Buenos Aires, DF, Argentina; [Augustovski, Federico] CONICET Natl Sci & Tech Res Council, Buenos Aires, DF, Argentina; [de Bekker-Grob, Esther] Erasmus Univ, Erasmus Sch Hlth Policy & Management, Rotterdam, Netherlands; [Briggs, Andrew H.] London Sch Hyg & Trop Med, London, England; [Carswell, Chris] Springer Nat, Adis Journals, Auckland, New Zealand; [Caulley, Lisa] Univ Ottawa, Dept Otolaryngol Head & Neck Surg, Ottawa, ON, Canada; [Caulley, Lisa] Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Caulley, Lisa] Ottawa Hosp Res Inst, Ctr Journalol, Ottawa, ON, Canada; [Caulley, Lisa] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Chaiyakunapruk, Nathorn] Univ Utah, Coll Pharm, Dept Pharmacotherapy, Salt Lake City, UT 84112 USA; [Greenberg, Dan] Ben Gurion Univ Negev, Fac Hlth Sci, Sch Publ Hlth, Dept Hlth Policy & Management, Beer Sheva, Israel; [Loder, Elizabeth] Harvard Med Sch, Boston, MA USA; [Loder, Elizabeth] BMJ, London, England; [Mauskopf, Josephine] RTI Int, RTI Hlth Solut, Res Triangle Pk, NC USA; [Mullins, C. Daniel] Univ Maryland, Sch Pharm, Baltimore, MD 21201 USA; [Petrou, Stavros] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England; [Pwu, Raoh-Fang] Minist Hlth & Welf, Natl Hepatitis C Program Off, Taipei, Taiwan; [Staniszewska, Sophie] Univ Warwick, Med Sch, Warwick Res Nursing, Warwick, England	University of Ottawa; University of York - UK; University of Buenos Aires; Erasmus University Rotterdam; University of London; London School of Hygiene & Tropical Medicine; Adis International; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; Erasmus University Rotterdam; Erasmus MC; Utah System of Higher Education; University of Utah; Ben Gurion University; Harvard University; Harvard Medical School; Research Triangle Institute; University System of Maryland; University of Maryland Baltimore; University of Oxford; University of Warwick	Husereau, D (corresponding author), Univ Ottawa, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada.; Husereau, D (corresponding author), Inst Hlth Econ, Edmonton, AB, Canada.	donh@donhusereau.com	Kostyuk, Alexander/HGA-2381-2022; Kostyuk, Alex/E-7579-2011; Pwu, Raoh Fang/AFK-8020-2022; Petrou, Stavros/ABD-8323-2021; Hughes, Dyfrig/H-5252-2012	Kostyuk, Alexander/0000-0001-6538-1324; Kostyuk, Alex/0000-0001-6538-1324; Pwu, Raoh Fang/0000-0002-0113-6917; Husereau, Don/0000-0002-4416-6876; Caulley, Lisa/0000-0002-9661-4634; Petrou, Stavros/0000-0003-3121-6050; Powell, John/0000-0002-1456-4857; Chaiyakunapruk, Nathorn/0000-0003-4572-8794; Mauskopf, Josephine/0000-0002-6098-5548; Briggs, Andrew/0000-0002-0777-1997; Hughes, Dyfrig/0000-0001-8247-7459	Canada Inc. [9363980]; NIHR Applied Research Collaboration (ARC) West Midlands; NIHR Health Protection Research Unit (HPRU) Gastrointestinal Infections; NIHR HPRU Genomics and Enabling data	Canada Inc.; NIHR Applied Research Collaboration (ARC) West Midlands; NIHR Health Protection Research Unit (HPRU) Gastrointestinal Infections; NIHR HPRU Genomics and Enabling data	Funding to support ongoing meetings was provided by ISPOR. The funders had no role in considering the study design or in the collection, analysis, interpretation of data, or writing of the report. Funding for DH and the Delphi panel exercise was provided by 9363980 Canada Inc. SS is part funded by the NIHR Applied Research Collaboration (ARC) West Midlands, the NIHR Health Protection Research Unit (HPRU) Gastrointestinal Infections, and the NIHR HPRU Genomics and Enabling data.	Altman DG, 2016, J ROY SOC MED, V109, P67, DOI 10.1177/0141076815625599; BOND K, 2020, INT J TECHNOL ASSESS; CADTH.ca, 2015, GUIDELINES EC EVALUA; Catala-Lopez F, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-034463; Caulley L, 2020, J CLIN EPIDEMIOL, V122, P87, DOI 10.1016/j.jclinepi.2020.03.006; Cohen JT, 2017, ANN INTERN MED, V167, P432, DOI 10.7326/M17-1153; Cookson R, 2021, VALUE HEALTH, V24, P118, DOI 10.1016/j.jval.2020.10.001; Cookson R, 2009, HEALTH ECON POLICY L, V4, P231, DOI 10.1017/S1744133109004903; Crown W, 2017, VALUE HEALTH, V20, P310, DOI 10.1016/j.jval.2017.01.013; Davis JC, 2011, OSTEOPOROSIS INT, V22, P2449, DOI 10.1007/s00198-010-1482-0; Drummond M, 2005, INT J TECHNOL ASSESS, V21, P165, DOI 10.1017/S0266462305050221; Drummond MF, 1996, BRIT MED J, V313, P275, DOI 10.1136/bmj.313.7052.275; Drummond MF, 2015, METHODS EC EVALUATIO; Dunlop WCN, 2017, PHARMACOECONOMICS, V35, P125, DOI 10.1007/s40273-016-0479-8; Emerson J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0205633; EUnetHTA European Network for Health Technology Assessment, 2021, PRACTICAL CONSIDERAT; Goetghebeur MM, 2008, VALUE HEALTH, V11, pA183, DOI 10.1186/1472-6963-8-270; Hawton A, 2021, PATIENT, V14, P429, DOI 10.1007/s40271-020-00461-4; HILLMAN AL, 1995, ANN INTERN MED, V123, P61; Husereau D, 2022, VALUE HEALTH, V25, P10, DOI 10.1016/j.jval.2021.10.008; Husereau D, 2013, VALUE HEALTH, V16, pE1, DOI 10.1016/j.jval.2013.02.010; ISPOR, CONSOLIDATED HLTH EC; Jansen JP, 2019, PHARMACOECONOMICS, V37, P1313, DOI 10.1007/s40273-019-00827-z; Juni P, 1999, JAMA-J AM MED ASSOC, V282, P1054, DOI 10.1001/jama.282.11.1054; Lorgelly PK, 2021, PATIENT, V14, P379, DOI 10.1007/s40271-021-00505-3; Malone DC, 2020, VALUE HEALTH, V23, P409, DOI 10.1016/j.jval.2020.03.001; Mauskopf J, 2018, VALUE HEALTH, V21, P1133, DOI 10.1016/j.jval.2018.08.005; Moher D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000217; Neumann PJ, 2015, VALUE HEALTH, V18, P271, DOI 10.1016/j.jval.2014.12.002; Nuijten MJC, 1998, PHARMACOECONOMICS, V14, P259; Panzer AD, 2020, HEALTH ECON, V29, P945, DOI 10.1002/hec.4029; Petrou S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1766; Petrou Stavros, 2011, BMJ, V342, pd1548, DOI 10.1136/bmj.d1548; Pitt C, 2016, HEALTH ECON, V25, P9, DOI 10.1002/hec.3305; Ramsey SD, 2015, VALUE HEALTH, V18, P161, DOI 10.1016/j.jval.2015.02.001; Ryan M, 2017, INT J TECHNOL ASSESS, V33, P424, DOI 10.1017/S026646231700085X; Sanders GD, 2016, JAMA-J AM MED ASSOC, V316, P1093, DOI 10.1001/jama.2016.12195; Sanghera S, 2015, PHARMACOECONOMICS, V33, P533, DOI 10.1007/s40273-015-0265-z; Siegel JE, 1996, JAMA-J AM MED ASSOC, V276, P1339, DOI 10.1001/jama.276.16.1339; Smith Robert, 2020, Wellcome Open Res, V5, P69, DOI 10.12688/wellcomeopenres.15807.1; Sperber AD, 2004, GASTROENTEROLOGY, V126, pS124, DOI 10.1053/j.gastro.2003.10.016; Staniszewska S, 2017, Res Involv Engagem, V3, P13, DOI 10.1186/s40900-017-0062-2; Sullivan SD, 2014, VALUE HEALTH, V17, P5, DOI 10.1016/j.jval.2013.08.2291; Thorn JC, 2016, VALUE HEALTH, V19, pA397, DOI 10.1016/j.jval.2016.09.291; Vintzileos AM, 2004, AM J OBSTET GYNECOL, V191, P1070, DOI 10.1016/j.ajog.2004.05.021; Walker DG, 2012, BEST PRACTICES CONDU; Wilkinson T, 2016, VALUE HEALTH, V19, P921, DOI 10.1016/j.jval.2016.04.015	47	78	78	30	42	ADIS INT LTD	NORTHCOTE	5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND	1170-7690	1179-2027		PHARMACOECONOMICS	Pharmacoeconomics	JUN	2022	40	6					601	609		10.1007/s40273-021-01112-8	http://dx.doi.org/10.1007/s40273-021-01112-8		JAN 2022	9	Economics; Health Care Sciences & Services; Health Policy & Services; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Business & Economics; Health Care Sciences & Services; Pharmacology & Pharmacy	1O1XA	35098747	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000741236100001
J	Husereau, D; Drummond, M; Augustovski, F; De Bekker-Grob, E; Briggs, AH; Carswell, C; Caulley, L; Chaiyakunapruk, N; Greenberg, D; Loder, E; Mauskopf, J; Mullins, CD; Petrou, S; Pwu, RF; Staniszewska, S				Husereau, Don; Drummond, Michael; Augustovski, Federico; De Bekker-Grob, Esther; Briggs, Andrew H.; Carswell, Chris; Caulley, Lisa; Chaiyakunapruk, Nathorn; Greenberg, Dan; Loder, Elizabeth; Mauskopf, Josephine; Mullins, C. Daniel; Petrou, Stavros; Pwu, Raoh-Fang; Staniszewska, Sophie		Cheers 2022 ISPOR Good Res Practic	Consolidated health economic evaluation reporting standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations	INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE			English	Article						Economic evaluation; Reporting; Guidance; Cost-benefit analysis; Methods	COST-EFFECTIVENESS ANALYSIS; TASK-FORCE; CLINICAL-TRIALS; GUIDELINES; RECOMMENDATIONS; IMPACT; TECHNOLOGY; PRINCIPLES; DESIGN	Health economic evaluations are comparative analyses of alternative courses of action in terms of their costs and consequences. The Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement, published in 2013, was created to ensure health economic evaluations are identifiable, interpretable, and useful for decision making. It was intended as guidance to help authors report accurately which health interventions were being compared and in what context, how the evaluation was undertaken, what the findings were, and other details that may aid readers and reviewers in interpretation and use of the study. The new CHEERS 2022 statement replaces previous CHEERS reporting guidance. It reflects the need for guidance that can be more easily applied to all types of health economic evaluation, new methods and developments in the field, as well as the increased role of stakeholder involvement including patients and the public. It is also broadly applicable to any form of intervention intended to improve the health of individuals or the population, whether simple or complex, and without regard to context (such as health care, public health, education, social care, etc.). This summary article presents the new CHEERS 2022 28-item checklist and recommendations for each item. The CHEERS 2022 statement is primarily intended for researchers reporting economic evaluations for peer-reviewed journals, as well as the peer reviewers and editors assessing them for publication. However, we anticipate familiarity with reporting requirements will be useful for analysts when planning studies. It may also be useful for health technology assessment bodies seeking guidance on reporting, as there is an increasing emphasis on transparency in decision making.	[Husereau, Don] Univ Ottawa, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada; [Husereau, Don] Inst Hlth Econ, Edmonton, AB, Canada; [Drummond, Michael] Univ York, Ctr Hlth Econ, York, N Yorkshire, England; [Augustovski, Federico] Inst Clin Effectiveness & Hlth Policy IECS CONICE, Hlth Technol Assessment & Hlth Econ Dept, Buenos Aires, DF, Argentina; [Augustovski, Federico] Univ Buenos Aires, Buenos Aires, DF, Argentina; [Augustovski, Federico] Consejo Nacl Invest Cient & Tecn, Natl Sci & Tech Res Council, Buenos Aires, DF, Argentina; [De Bekker-Grob, Esther] Erasmus Univ, Erasmus Sch Hlth Policy & Management, Rotterdam, Netherlands; [Briggs, Andrew H.] London Sch Hyg & Trop Med, London, England; [Carswell, Chris] Springer Nat, Adis Journals, Auckland, New Zealand; [Caulley, Lisa] Univ Ottawa, Dept Otolaryngol Head & Neck Surg, Ottawa, ON, Canada; [Caulley, Lisa] Ottawa Hosp, Clin Epidemiol Program, Res Inst, Ottawa, ON, Canada; [Caulley, Lisa] Ottawa Hosp, Ctr Journal, Res Inst, Ottawa, ON, Canada; [Caulley, Lisa] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Chaiyakunapruk, Nathorn] Univ Utah, Coll Pharm, Dept Pharmacotherapy, Salt Lake City, UT 84112 USA; [Greenberg, Dan] Ben Gurion Univ Negev, Fac Hlth Sci, Sch Publ Hlth, Dept Hlth Policy & Management, Beer Sheva, Israel; [Loder, Elizabeth] Harvard Med Sch, Boston, MA 02115 USA; [Loder, Elizabeth] BMJ, London, England; [Mauskopf, Josephine] RTI Int, RTI Hlth Solut, Res Triangle Pk, NC USA; [Mullins, C. Daniel] Univ Maryland, Sch Pharm, Baltimore, MD 21201 USA; [Petrou, Stavros] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England; [Pwu, Raoh-Fang] Minist Hlth & Welf, Natl Hepatitis Program Off C, Taipei, Taiwan; [Staniszewska, Sophie] Univ Warwick, Warwick Res Nursing, Med Sch, Warwick, England	University of Ottawa; University of York - UK; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Erasmus University Rotterdam; University of London; London School of Hygiene & Tropical Medicine; Adis International; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; Erasmus University Rotterdam; Erasmus MC; Utah System of Higher Education; University of Utah; Ben Gurion University; Harvard University; Harvard Medical School; Research Triangle Institute; University System of Maryland; University of Maryland Baltimore; University of Oxford; University of Warwick	Husereau, D (corresponding author), Univ Ottawa, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada.; Husereau, D (corresponding author), Inst Hlth Econ, Edmonton, AB, Canada.	donh@donhusereau.com	Kostyuk, Alexander/HGA-2381-2022; Kostyuk, Alex/E-7579-2011; Pwu, Raoh Fang/AFK-8020-2022; Petrou, Stavros/ABD-8323-2021; Hughes, Dyfrig/H-5252-2012	Kostyuk, Alexander/0000-0001-6538-1324; Kostyuk, Alex/0000-0001-6538-1324; Pwu, Raoh Fang/0000-0002-0113-6917; Husereau, Don/0000-0002-4416-6876; Caulley, Lisa/0000-0002-9661-4634; Petrou, Stavros/0000-0003-3121-6050; Powell, John/0000-0002-1456-4857; Chaiyakunapruk, Nathorn/0000-0003-4572-8794; Mauskopf, Josephine/0000-0002-6098-5548; Briggs, Andrew/0000-0002-0777-1997; Hughes, Dyfrig/0000-0001-8247-7459	ISPORThe Professional Society for Health Economics and Outcomes Research; Canada Inc. [9363980]; NIHR Applied Research Collaboration (ARC) West Midlands; NIHR Health Protection Research Unit (HPRU) Gastrointestinal Infections; NIHR HPRU Genomics and Enabling data	ISPORThe Professional Society for Health Economics and Outcomes Research; Canada Inc.; NIHR Applied Research Collaboration (ARC) West Midlands; NIHR Health Protection Research Unit (HPRU) Gastrointestinal Infections; NIHR HPRU Genomics and Enabling data	Funding to support ongoing meetings was provided by ISPORThe Professional Society for Health Economics and Outcomes Research. The funders had no role in considering the study design or in the collection, analysis, interpretation of data, or writing of the report. Funding for DH and the Delphi Panel exercise was provided by 9363980 Canada Inc. .SS is partly funded by the NIHR Applied Research Collaboration (ARC) West Midlands, the NIHR Health Protection Research Unit (HPRU) Gastrointestinal Infections, and the NIHR HPRU Genomics and Enabling data.	Altman DG, 2016, J ROY SOC MED, V109, P67, DOI 10.1177/0141076815625599; [Anonymous], CONS HLTH EC EV REP; Bond K, 2020, INT J TECHNOL ASSESS, V36, P445, DOI 10.1017/S0266462320000550; CADTH.ca, 2015, GUID EC EV HLTH TECH; Catala-Lopez F, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-034463; Caulley L, 2020, J CLIN EPIDEMIOL, V122, P87, DOI 10.1016/j.jclinepi.2020.03.006; Cohen JT, 2017, ANN INTERN MED, V167, P432, DOI 10.7326/M17-1153; Cookson R, 2021, VALUE HEALTH, V24, P118, DOI 10.1016/j.jval.2020.10.001; Cookson R, 2009, HEALTH ECON POLICY L, V4, P231, DOI 10.1017/S1744133109004903; Crown W, 2017, VALUE HEALTH, V20, P310, DOI 10.1016/j.jval.2017.01.013; Davis JC, 2011, OSTEOPOROSIS INT, V22, P2449, DOI 10.1007/s00198-010-1482-0; Drummond M, 2005, INT J TECHNOL ASSESS, V21, P165, DOI 10.1017/S0266462305050221; Drummond MF, 1996, BRIT MED J, V313, P275, DOI 10.1136/bmj.313.7052.275; Drummond MF, 2015, METHODS EC EVALUATIO; Dunlop WCN, 2017, PHARMACOECONOMICS, V35, P125, DOI 10.1007/s40273-016-0479-8; Emerson J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0205633; EUnetHTA European Network for Health Technology Assessment, 2021, PRACTICAL CONSIDERAT; Goetghebeur MM, 2008, VALUE HEALTH, V11, pA183, DOI 10.1186/1472-6963-8-270; Gold MR, 1996, COST EFFECTIVENESS H; Hawton A, 2021, PATIENT, V14, P429, DOI 10.1007/s40271-020-00461-4; HILLMAN AL, 1995, ANN INTERN MED, V123, P61; Husereau D, 2022, VALUE HEALTH, V25, P10, DOI 10.1016/j.jval.2021.10.008; Husereau D, 2013, VALUE HEALTH, V16, P231, DOI 10.1016/j.jval.2013.02.002; ISPOR, OP SOURC MOD; Jansen JP, 2019, PHARMACOECONOMICS, V37, P1313, DOI 10.1007/s40273-019-00827-z; Juni P, 1999, JAMA-J AM MED ASSOC, V282, P1054, DOI 10.1001/jama.282.11.1054; Lorgelly PK, 2021, PATIENT, V14, P379, DOI 10.1007/s40271-021-00505-3; Malone DC, 2020, VALUE HEALTH, V23, P409, DOI 10.1016/j.jval.2020.03.001; Mauskopf J, 2018, VALUE HEALTH, V21, P1133, DOI 10.1016/j.jval.2018.08.005; Moher D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000217; Neumann PJ, 2015, VALUE HEALTH, V18, P271, DOI 10.1016/j.jval.2014.12.002; Nuijten MJC, 1998, PHARMACOECONOMICS, V14, P259; Panzer AD, 2020, HEALTH ECON, V29, P945, DOI 10.1002/hec.4029; Petrou S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1766; Petrou S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1548; Pitt C, 2016, HEALTH ECON, V25, P9, DOI 10.1002/hec.3305; Ramsey SD, 2015, VALUE HEALTH, V18, P161, DOI 10.1016/j.jval.2015.02.001; Ryan M, 2017, INT J TECHNOL ASSESS, V33, P424, DOI 10.1017/S026646231700085X; Sanders GD, 2016, JAMA-J AM MED ASSOC, V316, P1093, DOI 10.1001/jama.2016.12195; Sanghera S, 2015, PHARMACOECONOMICS, V33, P533, DOI 10.1007/s40273-015-0265-z; Siegel JE, 1996, JAMA-J AM MED ASSOC, V276, P1339, DOI 10.1001/jama.276.16.1339; Smith Robert, 2020, Wellcome Open Res, V5, P69, DOI 10.12688/wellcomeopenres.15807.1; Sperber AD, 2004, GASTROENTEROLOGY, V126, pS124, DOI 10.1053/j.gastro.2003.10.016; Staniszewska S, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3453; Sullivan SD, 2014, VALUE HEALTH, V17, P5, DOI 10.1016/j.jval.2013.08.2291; Thorn JC, 2016, VALUE HEALTH, V19, pA397, DOI 10.1016/j.jval.2016.09.291; Vintzileos AM, 2004, AM J OBSTET GYNECOL, V191, P1070, DOI 10.1016/j.ajog.2004.05.021; Walker DG., 2012, AGENCY HEALTHCARE RE; Wilkinson T, 2016, VALUE HEALTH, V19, P921, DOI 10.1016/j.jval.2016.04.015; World Health Organization (WHO), WHO GUID STAND EC EV, V2	50	78	78	30	42	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0266-4623	1471-6348		INT J TECHNOL ASSESS	Int. J. Technol. Assess. Health Care	JAN 11	2022	38	1							e13	10.1017/S0266462321001732	http://dx.doi.org/10.1017/S0266462321001732			7	Health Care Sciences & Services; Public, Environmental & Occupational Health; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services; Public, Environmental & Occupational Health; Medical Informatics	YE0GZ	35098747	hybrid, Green Published			2022-12-28	WOS:000740812400001
J	Husereau, D; Drummond, M; Augustovski, F; Briggs, AH; Carswell, C; Caulley, L; Chaiyakunapruk, N; Bekker-Grob, E; Greenberg, D; Loder, E; Mauskopf, J; Mullins, CD; Petrou, S; Pwu, RF; Staniszewska, S				Husereau, D.; Drummond, M.; Augustovski, F.; Briggs, A. H.; Carswell, C.; Caulley, L.; Chaiyakunapruk, N.; Bekker-Grob, E.; Greenberg, D.; Loder, E.; Mauskopf, J.; Mullins, C. D.; Petrou, S.; Pwu, R-F; Staniszewska, S.		CHEERS 2022 ISPOR Good Res Practic	Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations	BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY			English	Article							COST-EFFECTIVENESS ANALYSIS; TASK-FORCE; CLINICAL-TRIALS; GUIDELINES; RECOMMENDATIONS; IMPACT; TECHNOLOGY; PRINCIPLES; DESIGN	Health economic evaluations are comparative analyses of alternative courses of action in terms of their costs and consequences. The Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement, published in 2013, was created to ensure health economic evaluations are identifiable, interpretable, and useful for decision making. It was intended as guidance to help authors report accurately which health interventions were being compared and in what context, how the evaluation was undertaken, what the findings were, and other details that may aid readers and reviewers in interpretation and use of the study. The new CHEERS 2022 statement replaces previous CHEERS reporting guidance. It reflects the need for guidance that can be more easily applied to all types of health economic evaluation, new methods and developments in the field, as well as the increased role of stakeholder involvement including patients and the public. It is also broadly applicable to any form of intervention intended to improve the health of individuals or the population, whether simple or complex, and without regard to context (such as health care, public health, education, social care, etc). This summary article presents the new CHEERS 2022 28-item checklist and recommendations for each item. The CHEERS 2022 statement is primarily intended for researchers reporting economic evaluations for peer reviewed journals as well as the peer reviewers and editors assessing them for publication. However, we anticipate familiarity with reporting requirements will be useful for analysts when planning studies. It may also be useful for health technology assessment bodies seeking guidance on reporting, as there is an increasing emphasis on transparency in decision making.	[Husereau, D.] Univ Ottawa, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada; [Husereau, D.] Inst Hlth Econ, Edmonton, AB, Canada; [Drummond, M.] Univ York, Ctr Hlth Econ, York, N Yorkshire, England; [Augustovski, F.] Inst Clin Effectiveness & Hlth Policy IECS CONICE, Hlth Technol Assessment & Hlth Econ Dept, Buenos Aires, DF, Argentina; [Augustovski, F.] Univ Buenos Aires, Buenos Aires, DF, Argentina; [Augustovski, F.] CONICET Natl Sci & Tech Res Council, Buenos Aires, DF, Argentina; [Briggs, A. H.] London Sch Hyg & Trop Med, London, England; [Carswell, C.] Springer Nat, Adis Journals, Auckland, New Zealand; [Caulley, L.] Univ Ottawa, Dept Otolaryngol Head & Neck Surg, Ottawa, ON, Canada; [Caulley, L.] Ottawa Hosp, Clin Epidemiol Program, Res Inst, Ottawa, ON, Canada; [Caulley, L.] Ottawa Hosp, Ctr Journalol, Res Inst, Ottawa, ON, Canada; [Caulley, L.] Erasmus Univ, Dept Epidemiol, Med Ctr Rotterdam, Rotterdam, Netherlands; [Chaiyakunapruk, N.] Univ Utah, Coll Pharm, Dept Pharmacotherapy, Salt Lake City, UT 84112 USA; [Bekker-Grob, E.] Erasmus Univ, Erasmus Sch Hlth Policy & Management, Rotterdam, Netherlands; [Greenberg, D.] Ben Gurion Univ Negev, Fac Hlth Sci, Sch Publ Hlth, Dept Hlth Policy & Management, Beer Sheva, Israel; [Loder, E.] Harvard Med Sch, Boston, MA 02115 USA; [Loder, E.] BMJ, London, England; [Mauskopf, J.] RTI Int, RTI Hlth Solut, Res Triangle Pk, NC USA; [Mullins, C. D.] Univ Maryland, Sch Pharm, Baltimore, MD 21201 USA; [Petrou, S.] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England; [Pwu, R-F] Minist Hlth & Welf, Natl Hepatitis C Program Off, Taipei, Taiwan; [Staniszewska, S.] Univ Warwick, Warwick Res Nursing, Warwick Med Sch, Warwick, England	University of Ottawa; University of York - UK; University of Buenos Aires; University of London; London School of Hygiene & Tropical Medicine; Adis International; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; Erasmus University Rotterdam; Erasmus MC; Utah System of Higher Education; University of Utah; Erasmus University Rotterdam; Ben Gurion University; Harvard University; Harvard Medical School; Research Triangle Institute; University System of Maryland; University of Maryland Baltimore; University of Oxford; University of Warwick	Husereau, D (corresponding author), Univ Ottawa, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada.; Husereau, D (corresponding author), Inst Hlth Econ, Edmonton, AB, Canada.	donh@donhusereau.com	Kostyuk, Alexander/HGA-2381-2022; Kostyuk, Alex/E-7579-2011; Pwu, Raoh Fang/AFK-8020-2022; Petrou, Stavros/ABD-8323-2021; Hughes, Dyfrig/H-5252-2012	Kostyuk, Alexander/0000-0001-6538-1324; Kostyuk, Alex/0000-0001-6538-1324; Pwu, Raoh Fang/0000-0002-0113-6917; Husereau, Don/0000-0002-4416-6876; Caulley, Lisa/0000-0002-9661-4634; Petrou, Stavros/0000-0003-3121-6050; Powell, John/0000-0002-1456-4857; Chaiyakunapruk, Nathorn/0000-0003-4572-8794; Mauskopf, Josephine/0000-0002-6098-5548; Briggs, Andrew/0000-0002-0777-1997; Hughes, Dyfrig/0000-0001-8247-7459	ISPOR - The Professional Society for Health Economics and Outcomes Research; Canada Inc. [9363980]; NIHR Applied Research Collaboration (ARC) West Midlands; NIHR Health Protection Research Unit (HPRU) Gastrointestinal Infections; NIHR HPRU Genomics and Enabling data	ISPOR - The Professional Society for Health Economics and Outcomes Research; Canada Inc.; NIHR Applied Research Collaboration (ARC) West Midlands; NIHR Health Protection Research Unit (HPRU) Gastrointestinal Infections; NIHR HPRU Genomics and Enabling data	Funding to support ongoing meetings was provided by ISPOR - The Professional Society for Health Economics and Outcomes Research. The funders had no role in considering the study design or in the collection, analysis, interpretation of data, or writing of the report. Funding for DH and the Delphi Panel exercise was provided by 9363980 Canada Inc. SS is part funded by the NIHR Applied Research Collaboration (ARC) West Midlands, the NIHR Health Protection Research Unit (HPRU) Gastrointestinal Infections, and the NIHR HPRU Genomics and Enabling data.	Altman DG, 2016, J ROY SOC MED, V109, P67, DOI 10.1177/0141076815625599; [Anonymous], 2020, ISPOR CONSOLIDATED H; [Anonymous], 2015, GUID EC EV HLTH TECH; Bond K, 2020, INT J TECHNOL ASSESS, V36, P445, DOI 10.1017/S0266462320000550; Catala-Lopez F, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-034463; Caulley L, 2020, J CLIN EPIDEMIOL, V122, P87, DOI 10.1016/j.jclinepi.2020.03.006; Cohen JT, 2017, ANN INTERN MED, V167, P432, DOI 10.7326/M17-1153; Cookson R, 2021, VALUE HEALTH, V24, P118, DOI 10.1016/j.jval.2020.10.001; Cookson R, 2009, HEALTH ECON POLICY L, V4, P231, DOI 10.1017/S1744133109004903; Crown W, 2017, VALUE HEALTH, V20, P310, DOI 10.1016/j.jval.2017.01.013; Davis JC, 2011, OSTEOPOROSIS INT, V22, P2449, DOI 10.1007/s00198-010-1482-0; Drummond M, 2005, INT J TECHNOL ASSESS, V21, P165, DOI 10.1017/S0266462305050221; Drummond MF, 1996, BRIT MED J, V313, P275, DOI 10.1136/bmj.313.7052.275; Drummond MF, 2015, METHODS EC EVALUATIO, P445; Dunlop WCN, 2017, PHARMACOECONOMICS, V35, P125, DOI 10.1007/s40273-016-0479-8; Emerson J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0205633; EUnetHTA JA3WP6B2-5 Authoring Team, 2020, JA3WP7 EUNETHTA; Goetghebeur MM, 2008, VALUE HEALTH, V11, pA183, DOI 10.1186/1472-6963-8-270; Gold MR, 1996, COST EFFECTIVENESS H, P462; Hawton A, 2021, PATIENT, V14, P429, DOI 10.1007/s40271-020-00461-4; HILLMAN AL, 1995, ANN INTERN MED, V123, P61; Husereau D., 2022, VALUE HEALTH, V25; Husereau D, 2013, VALUE HEALTH, V16, P231, DOI 10.1016/j.jval.2013.02.002; Jansen JP, 2019, PHARMACOECONOMICS, V37, P1313, DOI 10.1007/s40273-019-00827-z; Juni P, 1999, JAMA-J AM MED ASSOC, V282, P1054, DOI 10.1001/jama.282.11.1054; Lorgelly PK, 2021, PATIENT, V14, P379, DOI 10.1007/s40271-021-00505-3; Malone DC, 2020, VALUE HEALTH, V23, P409, DOI 10.1016/j.jval.2020.03.001; Mauskopf J, 2018, VALUE HEALTH, V21, P1133, DOI 10.1016/j.jval.2018.08.005; Moher D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000217; Neumann PJ, 2015, VALUE HEALTH, V18, P271, DOI 10.1016/j.jval.2014.12.002; Nuijten MJC, 1998, PHARMACOECONOMICS, V14, P259; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Panzer AD, 2020, HEALTH ECON, V29, P945, DOI 10.1002/hec.4029; Petrou S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1766; Petrou S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1548; Pitt C, 2016, HEALTH ECON, V25, P9, DOI 10.1002/hec.3305; Ramsey SD, 2015, VALUE HEALTH, V18, P161, DOI 10.1016/j.jval.2015.02.001; Ryan M, 2017, INT J TECHNOL ASSESS, V33, P424, DOI 10.1017/S026646231700085X; Sanders GD, 2016, JAMA-J AM MED ASSOC, V316, P1093, DOI 10.1001/jama.2016.12195; Sanghera S, 2015, PHARMACOECONOMICS, V33, P533, DOI 10.1007/s40273-015-0265-z; Siegel JE, 1996, JAMA-J AM MED ASSOC, V276, P1339, DOI 10.1001/jama.276.16.1339; Smith Robert, 2020, Wellcome Open Res, V5, P69, DOI 10.12688/wellcomeopenres.15807.1; Sperber AD, 2004, GASTROENTEROLOGY, V126, pS124, DOI 10.1053/j.gastro.2003.10.016; Staniszewska S, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3453; Sullivan SD, 2014, VALUE HEALTH, V17, P5, DOI 10.1016/j.jval.2013.08.2291; Thorn JC, 2016, VALUE HEALTH, V19, pA397, DOI 10.1016/j.jval.2016.09.291; Vintzileos AM, 2004, AM J OBSTET GYNECOL, V191, P1070, DOI 10.1016/j.ajog.2004.05.021; Wilkinson T, 2016, VALUE HEALTH, V19, P921, DOI 10.1016/j.jval.2016.04.015	48	78	78	30	42	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1470-0328	1471-0528		BJOG-INT J OBSTET GY	BJOG	FEB	2022	129	3					336	344		10.1111/1471-0528.17012	http://dx.doi.org/10.1111/1471-0528.17012			9	Obstetrics & Gynecology	Science Citation Index Expanded (SCI-EXPANDED)	Obstetrics & Gynecology	YE1SJ	35098747	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000740909800004
J	Husereau, D; Drummond, M; Augustovski, F; de Bekker-Grob, E; Briggs, AH; Carswell, C; Caulley, L; Chaiyakunapruk, N; Greenberg, D; Loder, E; Mauskopf, J; Mullins, CD; Petrou, S; Pwu, RF; Staniszewska, S				Husereau, Don; Drummond, Michael; Augustovski, Federico; de Bekker-Grob, Esther; Briggs, Andrew H.; Carswell, Chris; Caulley, Lisa; Chaiyakunapruk, Nathorn; Greenberg, Dan; Loder, Elizabeth; Mauskopf, Josephine; Mullins, C. Daniel; Petrou, Stavros; Pwu, Raoh-Fang; Staniszewska, Sophie		CHEERS 2022 ISPOR Good Res Practic	Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations	BMC MEDICINE			English	Article							COST-EFFECTIVENESS ANALYSIS; TASK-FORCE; CLINICAL-TRIALS; GUIDELINES; RECOMMENDATIONS; IMPACT; TECHNOLOGY; PRINCIPLES; DESIGN	Health economic evaluations are comparative analyses of alternative courses of action in terms of their costs and consequences. The Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement, published in 2013, was created to ensure health economic evaluations are identifiable, interpretable, and useful for decision making. It was intended as guidance to help authors report accurately which health interventions were being compared and in what context, how the evaluation was undertaken, what the findings were, and other details that may aid readers and reviewers in interpretation and use of the study. The new CHEERS 2022 statement replaces previous CHEERS reporting guidance. It reflects the need for guidance that can be more easily applied to all types of health economic evaluation, new methods and developments in the field, as well as the increased role of stakeholder involvement including patients and the public. It is also broadly applicable to any form of intervention intended to improve the health of individuals or the population, whether simple or complex, and without regard to context (such as health care, public health, education, social care, etc). This summary article presents the new CHEERS 2022 28-item checklist and recommendations for each item. The CHEERS 2022 statement is primarily intended for researchers reporting economic evaluations for peer reviewed journals as well as the peer reviewers and editors assessing them for publication. However, we anticipate familiarity with reporting requirements will be useful for analysts when planning studies. It may also be useful for health technology assessment bodies seeking guidance on reporting, as there is an increasing emphasis on transparency in decision making.	[Husereau, Don] Univ Ottawa, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada; [Husereau, Don] Inst Hlth Econ, Edmonton, AB, Canada; [Drummond, Michael] Univ York, Ctr Hlth Econ, York, N Yorkshire, England; [Augustovski, Federico] Inst Clin Effectiveness & Hlth Policy IECS CONICE, Hlth Technol Assessment & Hlth Econ Dept, Buenos Aires, DF, Argentina; [Augustovski, Federico] Univ Buenos Aires, Buenos Aires, DF, Argentina; [Augustovski, Federico] CONICET Natl Sci & Tech Res Council, Buenos Aires, DF, Argentina; [de Bekker-Grob, Esther] Erasmus Univ, Erasmus Sch Hlth Policy & Management, Rotterdam, Netherlands; [Briggs, Andrew H.] London Sch Hyg & Trop Med, London, England; [Carswell, Chris] Springer Nat, Adis Journals, Auckland, New Zealand; [Caulley, Lisa] Univ Ottawa, Dept Otolaryngol Head & Neck Surg, Ottawa, ON, Canada; [Caulley, Lisa] Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Caulley, Lisa] Ottawa Hosp Res Inst, Ctr Journalol, Ottawa, ON, Canada; [Caulley, Lisa] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Chaiyakunapruk, Nathorn] Univ Utah, Coll Pharm, Dept Pharmacotherapy, Salt Lake City, UT 84112 USA; [Greenberg, Dan] Ben Gurion Univ Negev, Fac Hlth Sci, Sch Publ Hlth, Dept Hlth Policy & Management, Beer Sheva, Israel; [Loder, Elizabeth] Harvard Med Sch, Boston, MA 02115 USA; [Loder, Elizabeth] BMJ, London, England; [Mauskopf, Josephine] RTI Int, RI Hlth Solut, Res Triangle Pk, NC USA; [Mullins, C. Daniel] Univ Maryland, Sch Pharm, Baltimore, MD 21201 USA; [Petrou, Stavros] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England; [Pwu, Raoh-Fang] Minist Hlth & Welf, Natl Hepatitis C Program Off, Taipei, Taiwan; [Staniszewska, Sophie] Univ Warwick, Warwick Med Sch, Waiwick Res Nursing, Warwick, England	University of Ottawa; University of York - UK; University of Buenos Aires; Erasmus University Rotterdam; University of London; London School of Hygiene & Tropical Medicine; Adis International; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; Erasmus University Rotterdam; Erasmus MC; Utah System of Higher Education; University of Utah; Ben Gurion University; Harvard University; Harvard Medical School; Research Triangle Institute; University System of Maryland; University of Maryland Baltimore; University of Oxford; University of Warwick	Husereau, D (corresponding author), Univ Ottawa, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada.; Husereau, D (corresponding author), Inst Hlth Econ, Edmonton, AB, Canada.	donh@donhusereau.com	Kostyuk, Alexander/HGA-2381-2022; Kostyuk, Alex/E-7579-2011; Pwu, Raoh Fang/AFK-8020-2022; Petrou, Stavros/ABD-8323-2021; Hughes, Dyfrig/H-5252-2012	Kostyuk, Alexander/0000-0001-6538-1324; Kostyuk, Alex/0000-0001-6538-1324; Pwu, Raoh Fang/0000-0002-0113-6917; Husereau, Don/0000-0002-4416-6876; Caulley, Lisa/0000-0002-9661-4634; Petrou, Stavros/0000-0003-3121-6050; Powell, John/0000-0002-1456-4857; Chaiyakunapruk, Nathorn/0000-0003-4572-8794; Mauskopf, Josephine/0000-0002-6098-5548; Briggs, Andrew/0000-0002-0777-1997; Hughes, Dyfrig/0000-0001-8247-7459	ISPOR -The Professional Society for Health Economics and Outcomes Research; NIHR Applied Research Collaboration (ARC) West Midlands; NIHR Health Protection Research Unit (HPRU) Gastrointestinal Infections; NIHR HPRU Genomics and Enabling data; Canada Inc. [9363980]	ISPOR -The Professional Society for Health Economics and Outcomes Research; NIHR Applied Research Collaboration (ARC) West Midlands; NIHR Health Protection Research Unit (HPRU) Gastrointestinal Infections; NIHR HPRU Genomics and Enabling data; Canada Inc.	Funding to support ongoing meetings was provided by ISPOR -The Professional Society for Health Economics and Outcomes Research. The funders had no role in considering the study design or in the collection, analysis, interpretation of data, or writing of the report. Funding for DH and the Delphi Panel exercise was provided by 9363980 Canada Inc. SS is part funded by the NIHR Applied Research Collaboration (ARC) West Midlands, the NIHR Health Protection Research Unit (HPRU) Gastrointestinal Infections, and the NIHR HPRU Genomics and Enabling data.	Altman DG, 2016, J ROY SOC MED, V109, P67, DOI 10.1177/0141076815625599; Bond K, 2020, INT J TECHNOL ASSESS, V36, P445, DOI 10.1017/S0266462320000550; CADTH.ca, 2015, GUID EC EV HLTH TECH; Catala-Lopez F, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-034463; Caulley L, 2020, J CLIN EPIDEMIOL, V122, P87, DOI 10.1016/j.jclinepi.2020.03.006; Cohen JT, 2017, ANN INTERN MED, V167, P432, DOI 10.7326/M17-1153; Cookson R, 2021, VALUE HEALTH, V24, P118, DOI 10.1016/j.jval.2020.10.001; Cookson R, 2009, HEALTH ECON POLICY L, V4, P231, DOI 10.1017/S1744133109004903; Crown W, 2017, VALUE HEALTH, V20, P310, DOI 10.1016/j.jval.2017.01.013; Davis JC, 2011, OSTEOPOROSIS INT, V22, P2449, DOI 10.1007/s00198-010-1482-0; Drummond M, 2005, INT J TECHNOL ASSESS, V21, P165, DOI 10.1017/S0266462305050221; Drummond MF, 1996, BRIT MED J, V313, P275, DOI 10.1136/bmj.313.7052.275; Drummond MF, 2015, METHODS EC EVALUATIO; Dunlop WCN, 2017, PHARMACOECONOMICS, V35, P125, DOI 10.1007/s40273-016-0479-8; Emerson J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0205633; Goetghebeur MM, 2008, VALUE HEALTH, V11, pA183, DOI 10.1186/1472-6963-8-270; Gold MR, 1996, COST EFFECTIVENESS H; Hawton A, 2021, PATIENT, V14, P429, DOI 10.1007/s40271-020-00461-4; HILLMAN AL, 1995, ANN INTERN MED, V123, P61; Husereau D, 2022, VALUE HEALTH, V25, P10, DOI 10.1016/j.jval.2021.10.008; Husereau D, 2013, VALUE HEALTH, V16, P231, DOI 10.1016/j.jval.2013.02.002; ISPOR, OP SOURC MOD; Jansen JP, 2019, PHARMACOECONOMICS, V37, P1313, DOI 10.1007/s40273-019-00827-z; Juni P, 1999, JAMA-J AM MED ASSOC, V282, P1054, DOI 10.1001/jama.282.11.1054; Lorgelly PK, 2021, PATIENT, V14, P379, DOI 10.1007/s40271-021-00505-3; Malone DC, 2020, VALUE HEALTH, V23, P409, DOI 10.1016/j.jval.2020.03.001; Mauskopf J, 2018, VALUE HEALTH, V21, P1133, DOI 10.1016/j.jval.2018.08.005; Moher D., 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000217, 10.1371/journal.pmed.1000097]; Neumann PJ, 2015, VALUE HEALTH, V18, P271, DOI 10.1016/j.jval.2014.12.002; Neyt M, 2020, PRACTICAL CONSIDERAT, P153; Nuijten MJC, 1998, PHARMACOECONOMICS, V14, P259; Panzer AD, 2020, HEALTH ECON, V29, P945, DOI 10.1002/hec.4029; Petrou S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1766; Petrou S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1548; Pitt C, 2016, HEALTH ECON, V25, P9, DOI 10.1002/hec.3305; Ramsey SD, 2015, VALUE HEALTH, V18, P161, DOI 10.1016/j.jval.2015.02.001; Ryan M, 2017, INT J TECHNOL ASSESS, V33, P424, DOI 10.1017/S026646231700085X; Sanders GD, 2016, JAMA-J AM MED ASSOC, V316, P1093, DOI 10.1001/jama.2016.12195; Sanghera S, 2015, PHARMACOECONOMICS, V33, P533, DOI 10.1007/s40273-015-0265-z; Siegel JE, 1996, JAMA-J AM MED ASSOC, V276, P1339, DOI 10.1001/jama.276.16.1339; Smith Robert, 2020, Wellcome Open Res, V5, P69, DOI 10.12688/wellcomeopenres.15807.1; Sperber AD, 2004, GASTROENTEROLOGY, V126, pS124, DOI 10.1053/j.gastro.2003.10.016; Staniszewska S, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3453; Sullivan SD, 2014, VALUE HEALTH, V17, P5, DOI 10.1016/j.jval.2013.08.2291; Thorn JC, 2016, VALUE HEALTH, V19, pA397, DOI 10.1016/j.jval.2016.09.291; Vintzileos AM, 2004, AM J OBSTET GYNECOL, V191, P1070, DOI 10.1016/j.ajog.2004.05.021; Walker DG, 2012, BEST PRACTICES CONDU; Wilkinson T, 2016, VALUE HEALTH, V19, P921, DOI 10.1016/j.jval.2016.04.015; World Health Organization (WHO), WHO GUID STAND EC EV, V2	49	78	78	30	42	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1741-7015			BMC MED	BMC Med.	JAN 12	2022	20	1							23	10.1186/s12916-021-02204-0	http://dx.doi.org/10.1186/s12916-021-02204-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YF7YX	35098747	Green Published, Green Accepted, gold			2022-12-28	WOS:000742019400001
J	Husereau, D; Drummond, M; Augustovski, F; de Bekker-Grob, E; Briggs, AH; Carswell, C; Caulley, L; Chaiyakunapruk, N; Greenberg, D; Loder, E; Mauskopf, J; Mullins, CD; Petrou, S; Pwu, RF; Staniszewska, S				Husereau, Don; Drummond, Michael; Augustovski, Federico; de Bekker-Grob, Esther; Briggs, Andrew H.; Carswell, Chris; Caulley, Lisa; Chaiyakunapruk, Nathorn; Greenberg, Dan; Loder, Elizabeth; Mauskopf, Josephine; Mullins, C. Daniel; Petrou, Stavros; Pwu, Raoh-Fang; Staniszewska, Sophie		CHEERS 2022 ISPOR Good Res Practic	Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations	BMJ-BRITISH MEDICAL JOURNAL			English	Article							COST-EFFECTIVENESS ANALYSIS; TASK-FORCE; CLINICAL-TRIALS; GUIDELINES; RECOMMENDATIONS; IMPACT; TECHNOLOGY; PRINCIPLES; DESIGN		[Husereau, Don] Univ Ottawa, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada; [Husereau, Don] Inst Hlth Econ, Ottawa, ON, Canada; [Drummond, Michael] Univ York, Ctr Hlth Econ, York, N Yorkshire, England; [Augustovski, Federico] Inst Clin Effectiveness & Hlth Policy IECS CON IC, Hlth Technol Assessment & Hlth Econ Dept, Buenos Aires, DF, Argentina; [Augustovski, Federico] Univ Buenos Aires, Buenos Aires, DF, Argentina; [Augustovski, Federico] CONICET Natl Sci & Tech Res Council, Buenos Aires, DF, Argentina; [de Bekker-Grob, Esther] Erasmus Univ, Erasmus Sch Hlth Policy & Management, Rotterdam, Netherlands; [Briggs, Andrew H.] London Sch Hyg & Trop Med, London, England; [Carswell, Chris] Springer Nat, Adis Journals, Auckland, New Zealand; [Caulley, Lisa] Univ Ottawa, Dept Otolaryngol Head & Neck Surg, Ottawa, ON, Canada; [Caulley, Lisa] Ottawa Hosp, Clin Epidemiol Program, Res Inst, Ottawa, ON, Canada; [Caulley, Lisa] Ottawa Hosp, Ctr Journalol, Res Inst, Ottawa, ON, Canada; [Caulley, Lisa] Erasmus Univ, Dept Epidemiol, Med Ctr Rotterdam, Rotterdam, Netherlands; [Chaiyakunapruk, Nathorn] Univ Utah, Coll Pharm, Dept Pharmacotherapy, Salt Lake City, UT 84112 USA; [Greenberg, Dan] Ben Gurion Univ Negev, Fac Hlth Sci, Sch Publ Hlth, Dept Hlth Policy & Management, Beer Sheva, Israel; [Loder, Elizabeth] Harvard Med Sch, Boston, MA 02115 USA; [Loder, Elizabeth] BMJ, London, England; [Mauskopf, Josephine] RTI Int, RTI Hlth Solut, Res Triangle Pk, NC USA; [Mullins, C. Daniel] Univ Maryland, Sch Pharm, Baltimore, MD 21201 USA; [Petrou, Stavros] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England; [Pwu, Raoh-Fang] Minist Hlth & Welf, Natl Hepatitis C Program Off, Taipei, Taiwan; [Staniszewska, Sophie] Univ Warwick, Warwick Med Sch, Warwick Res Nursing, Warwick, England	University of Ottawa; University of York - UK; University of Buenos Aires; Erasmus University Rotterdam; University of London; London School of Hygiene & Tropical Medicine; Adis International; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; Erasmus University Rotterdam; Erasmus MC; Utah System of Higher Education; University of Utah; Ben Gurion University; Harvard University; Harvard Medical School; Research Triangle Institute; University System of Maryland; University of Maryland Baltimore; University of Oxford; University of Warwick	Husereau, D (corresponding author), Univ Ottawa, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada.; Husereau, D (corresponding author), Inst Hlth Econ, Ottawa, ON, Canada.	donh@donhusereau.com	Kostyuk, Alexander/HGA-2381-2022; Kostyuk, Alex/E-7579-2011; Pwu, Raoh Fang/AFK-8020-2022; Petrou, Stavros/ABD-8323-2021; Hughes, Dyfrig/H-5252-2012	Kostyuk, Alexander/0000-0001-6538-1324; Kostyuk, Alex/0000-0001-6538-1324; Pwu, Raoh Fang/0000-0002-0113-6917; Husereau, Don/0000-0002-4416-6876; Caulley, Lisa/0000-0002-9661-4634; Petrou, Stavros/0000-0003-3121-6050; Powell, John/0000-0002-1456-4857; Chaiyakunapruk, Nathorn/0000-0003-4572-8794; Mauskopf, Josephine/0000-0002-6098-5548; Briggs, Andrew/0000-0002-0777-1997; Hughes, Dyfrig/0000-0001-8247-7459	ISPOR - The Professional Society for Health Economics and Outcomes Research; Canada Inc. [9363980]; NIHR Applied Research Collaboration (ARC) West Midlands; NIHR Health Protection Research Unit (HPRU) Gastrointestinal Infections; NIHR HPRU Genomics and Enabling data	ISPOR - The Professional Society for Health Economics and Outcomes Research; Canada Inc.; NIHR Applied Research Collaboration (ARC) West Midlands; NIHR Health Protection Research Unit (HPRU) Gastrointestinal Infections; NIHR HPRU Genomics and Enabling data	Funding to support ongoing meetings was provided by ISPOR - The Professional Society for Health Economics and Outcomes Research. The funders had no role in considering the study design or in the collection, analysis, interpretation of data, or writing of the report. Funding for DH and the Delphi Panel exercise was provided by 9363980 Canada Inc. SS is part funded by the NIHR Applied Research Collaboration (ARC) West Midlands, the NIHR Health Protection Research Unit (HPRU) Gastrointestinal Infections, and the NIHR HPRU Genomics and Enabling data.	Altman DG, 2016, J ROY SOC MED, V109, P67, DOI 10.1177/0141076815625599; [Anonymous], CONS HLTH EC EV REP; Bond K, 2020, INT J TECHNOL ASSESS, V36, P445, DOI 10.1017/S0266462320000550; Catala-Lopez F, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-034463; Caulley L, 2020, J CLIN EPIDEMIOL, V122, P87, DOI 10.1016/j.jclinepi.2020.03.006; Cohen JT, 2017, ANN INTERN MED, V167, P432, DOI 10.7326/M17-1153; Common Market of the Southern Cone (MERCOSUR), 2015, GUID EC EV HLTH TECH; Cookson R, 2021, VALUE HEALTH, V24, P118, DOI 10.1016/j.jval.2020.10.001; Cookson R, 2009, HEALTH ECON POLICY L, V4, P231, DOI 10.1017/S1744133109004903; Crown W, 2017, VALUE HEALTH, V20, P310, DOI 10.1016/j.jval.2017.01.013; Davis JC, 2011, OSTEOPOROSIS INT, V22, P2449, DOI 10.1007/s00198-010-1482-0; Drummond M, 2005, INT J TECHNOL ASSESS, V21, P165, DOI 10.1017/S0266462305050221; Drummond MF, 1996, BRIT MED J, V313, P275, DOI 10.1136/bmj.313.7052.275; Drummond MF, 2015, METHODS EC EVALUATIO; Dunlop WCN, 2017, PHARMACOECONOMICS, V35, P125, DOI 10.1007/s40273-016-0479-8; Emerson J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0205633; EUnetHTA European Network for Health Technology Assessment, 2021, GUID DOC; Goetghebeur MM, 2008, VALUE HEALTH, V11, pA183, DOI 10.1186/1472-6963-8-270; Hawton A, 2021, PATIENT, V14, P429, DOI 10.1007/s40271-020-00461-4; HILLMAN AL, 1995, ANN INTERN MED, V123, P61; Husereau D, 2022, VALUE HEALTH, V25, P10, DOI 10.1016/j.jval.2021.10.008; Husereau D, 2013, VALUE HEALTH, V16, pE1, DOI 10.1016/j.jval.2013.02.010; ISPOR, OP SOURC MOD; Jansen JP, 2019, PHARMACOECONOMICS, V37, P1313, DOI 10.1007/s40273-019-00827-z; Juni P, 1999, JAMA-J AM MED ASSOC, V282, P1054, DOI 10.1001/jama.282.11.1054; Lorgelly PK, 2021, PATIENT, V14, P379, DOI 10.1007/s40271-021-00505-3; Malone DC, 2020, VALUE HEALTH, V23, P409, DOI 10.1016/j.jval.2020.03.001; Mauskopf J, 2018, VALUE HEALTH, V21, P1133, DOI 10.1016/j.jval.2018.08.005; Moher D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000217; Neumann PJ, 2015, VALUE HEALTH, V18, P271, DOI 10.1016/j.jval.2014.12.002; Nuijten MJC, 1998, PHARMACOECONOMICS, V14, P259; Panzer AD, 2020, HEALTH ECON, V29, P945, DOI 10.1002/hec.4029; Petrou S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1766; Petrou Stavros, 2011, BMJ, V342, pd1548, DOI 10.1136/bmj.d1548; Pitt C, 2016, HEALTH ECON, V25, P9, DOI 10.1002/hec.3305; Ramsey SD, 2015, VALUE HEALTH, V18, P161, DOI 10.1016/j.jval.2015.02.001; Ryan M, 2017, INT J TECHNOL ASSESS, V33, P424, DOI 10.1017/S026646231700085X; Sanders GD, 2016, JAMA-J AM MED ASSOC, V316, P1093, DOI 10.1001/jama.2016.12195; Sanghera S, 2015, PHARMACOECONOMICS, V33, P533, DOI 10.1007/s40273-015-0265-z; Siegel JE, 1996, JAMA-J AM MED ASSOC, V276, P1339, DOI 10.1001/jama.276.16.1339; Smith Robert, 2020, Wellcome Open Res, V5, P69, DOI 10.12688/wellcomeopenres.15807.1; Sperber AD, 2004, GASTROENTEROLOGY, V126, pS124, DOI 10.1053/j.gastro.2003.10.016; Staniszewska S, 2017, Res Involv Engagem, V3, P13, DOI 10.1186/s40900-017-0062-2; Sullivan SD, 2014, VALUE HEALTH, V17, P5, DOI 10.1016/j.jval.2013.08.2291; Thorn JC, 2016, VALUE HEALTH, V19, pA397, DOI 10.1016/j.jval.2016.09.291; Vintzileos AM, 2004, AM J OBSTET GYNECOL, V191, P1070, DOI 10.1016/j.ajog.2004.05.021; Walker DG, 2012, BEST PRACTICES CONDU; Wilkinson T, 2016, VALUE HEALTH, V19, P921, DOI 10.1016/j.jval.2016.04.015; World Health Organization (WHO), WHO GUID STAND EC EV, V2	49	78	78	30	42	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 11	2022	376								e067975	10.1136/bmj-2021-067975	http://dx.doi.org/10.1136/bmj-2021-067975			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YI8HV	35098747	Green Published, hybrid			2022-12-28	WOS:000744084600001
J	Husereau, D; Drummond, M; Augustovski, F; de Bekker-Grob, E; Briggs, AH; Carswell, C; Caulley, L; Chaiyakunapruk, N; Greenberg, D; Loder, E; Mauskopf, J; Mullins, CD; Petrou, S; Pwu, RF; Staniszewska, S				Husereau, Don; Drummond, Michael; Augustovski, Federico; de Bekker-Grob, Esther; Briggs, Andrew H.; Carswell, Chris; Caulley, Lisa; Chaiyakunapruk, Nathorn; Greenberg, Dan; Loder, Elizabeth; Mauskopf, Josephine; Mullins, C. Daniel; Petrou, Stavros; Pwu, Raoh-Fang; Staniszewska, Sophie		CHEERS 2022 ISPOR Good Res Practic	Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations	JOURNAL OF MEDICAL ECONOMICS			English	Review						Health economics; reporting; guidelines; economic evaluation	COST-EFFECTIVENESS ANALYSIS; TASK-FORCE; CLINICAL-TRIALS; GUIDELINES; RECOMMENDATIONS; IMPACT; TECHNOLOGY; PRINCIPLES; DESIGN	Health economic evaluations are comparative analyses of alternative courses of action in terms of their costs and consequences. The Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement, published in 2013, was created to ensure health economic evaluations are identifiable, interpretable, and useful for decision making. It was intended as guidance to help authors report accurately which health interventions were being compared and in what context, how the evaluation was undertaken, what the findings were, and other details that may aid readers and reviewers in interpretation and use of the study. The new CHEERS 2022 statement replaces previous CHEERS reporting guidance. It reflects the need for guidance that can be more easily applied to all types of health economic evaluation, new methods and developments in the field, as well as the increased role of stakeholder involvement including patients and the public. It is also broadly applicable to any form of intervention intended to improve the health of individuals or the population, whether simple or complex, and without regard to context (such as health care, public health, education, social care, etc). This summary article presents the new CHEERS 2022 28-item checklist and recommendations for each item. The CHEERS 2022 statement is primarily intended for researchers reporting economic evaluations for peer reviewed journals as well as the peer reviewers and editors assessing them for publication. However, we anticipate familiarity with reporting requirements will be useful for analysts when planning studies. It may also be useful for health technology assessment bodies seeking guidance on reporting, as there is an increasing emphasis on transparency in decision making.	[Husereau, Don] Univ Ottawa, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada; [Husereau, Don] Inst Hlth Econ, Edmonton, AB, Canada; [Drummond, Michael] Univ York, Ctr Hlth Econ, York, N Yorkshire, England; [Augustovski, Federico] Inst Clin Effectiveness & Hlth Policy IECS CONICE, Hlth Technol Assessment & Hlth Econ Dept, Buenos Aires, DF, Argentina; [Augustovski, Federico] Univ Buenos Aires, Buenos Aires, DF, Argentina; [Augustovski, Federico] CONICET Natl Sci & Tech Res Council, Buenos Aires, DF, Argentina; [de Bekker-Grob, Esther] Erasmus Univ, Erasmus Sch Hlth Policy & Management, Rotterdam, Netherlands; [Briggs, Andrew H.] London Sch Hyg & Trop Med, London, England; [Carswell, Chris] Springer Nat, Adis Journals, Auckland, New Zealand; [Caulley, Lisa] Univ Ottawa, Dept Otolaryngol Head & Neck Surg, Ottawa, ON, Canada; [Caulley, Lisa] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Chaiyakunapruk, Nathorn] Univ Utah, Coll Pharm, Dept Pharmacotherapy, Salt Lake City, UT 84112 USA; [Greenberg, Dan] Ben Gurion Univ Negev, Fac Hlth Sci, Sch Publ Hlth, Dept Hlth Policy & Management, Beer Sheva, Israel; [Loder, Elizabeth] Harvard Med Sch, Boston, MA 02115 USA; [Loder, Elizabeth] BMJ, London, England; [Mauskopf, Josephine] RTI Int, RTI Hlth Solut, Res Triangle Pk, NC USA; [Mullins, C. Daniel] Univ Maryland, Sch Pharm, Baltimore, MD 21201 USA; [Petrou, Stavros] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Stavros Petros, Oxford, England; [Pwu, Raoh-Fang] Minist Hlth & Welf, Natl Hepatitis C Program Off, Taipei, Taiwan; [Staniszewska, Sophie] Univ Warwick, Med Sch, Warwick Res Nursing, Warwick, England	University of Ottawa; University of York - UK; University of Buenos Aires; Erasmus University Rotterdam; University of London; London School of Hygiene & Tropical Medicine; Adis International; University of Ottawa; Erasmus University Rotterdam; Erasmus MC; Utah System of Higher Education; University of Utah; Ben Gurion University; Harvard University; Harvard Medical School; Research Triangle Institute; University System of Maryland; University of Maryland Baltimore; University of Oxford; University of Warwick	Husereau, D (corresponding author), Univ Ottawa, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada.; Husereau, D (corresponding author), Inst Hlth Econ, Edmonton, AB, Canada.	donh@donhusereau.com	Kostyuk, Alexander/HGA-2381-2022; Kostyuk, Alex/E-7579-2011; Pwu, Raoh Fang/AFK-8020-2022; Petrou, Stavros/ABD-8323-2021; Hughes, Dyfrig/H-5252-2012	Kostyuk, Alexander/0000-0001-6538-1324; Kostyuk, Alex/0000-0001-6538-1324; Pwu, Raoh Fang/0000-0002-0113-6917; Husereau, Don/0000-0002-4416-6876; Caulley, Lisa/0000-0002-9661-4634; Petrou, Stavros/0000-0003-3121-6050; Powell, John/0000-0002-1456-4857; Chaiyakunapruk, Nathorn/0000-0003-4572-8794; Mauskopf, Josephine/0000-0002-6098-5548; Briggs, Andrew/0000-0002-0777-1997; Hughes, Dyfrig/0000-0001-8247-7459	ISPOR -The Professional Society for Health Economics and Outcomes Research; Canada Inc. [9363980]; NIHR Applied Research Collaboration (ARC) West Midlands; NIHR Health Protection Research Unit (HPRU) Gastrointestinal Infections; NIHR HPRU Genomics and Enabling data	ISPOR -The Professional Society for Health Economics and Outcomes Research; Canada Inc.; NIHR Applied Research Collaboration (ARC) West Midlands; NIHR Health Protection Research Unit (HPRU) Gastrointestinal Infections; NIHR HPRU Genomics and Enabling data	Funding to support ongoing meetings was provided by ISPOR -The Professional Society for Health Economics and Outcomes Research. The funders had no role in considering the study design or in the collection, analysis, interpretation of data, or writing of the report. Funding for DH and the Delphi Panel exercise was provided by 9363980 Canada Inc. SS is part funded by the NIHR Applied Research Collaboration (ARC) West Midlands, the NIHR Health Protection Research Unit (HPRU) Gastrointestinal Infections, and the NIHR HPRU Genomics and Enabling data.	Altman DG, 2016, J ROY SOC MED, V109, P67, DOI 10.1177/0141076815625599; [Anonymous], CONS HLTH EC EV REP; Bond K, 2020, INT J TECHNOL ASSESS, V36, P445, DOI 10.1017/S0266462320000550; CADTH.ca, 2015, GUID EC EV HLTH TECH; Catala-Lopez F, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-034463; Caulley L, 2020, J CLIN EPIDEMIOL, V122, P87, DOI 10.1016/j.jclinepi.2020.03.006; Cohen JT, 2017, ANN INTERN MED, V167, P432, DOI 10.7326/M17-1153; Cookson R, 2021, VALUE HEALTH, V24, P118, DOI 10.1016/j.jval.2020.10.001; Cookson R, 2009, HEALTH ECON POLICY L, V4, P231, DOI 10.1017/S1744133109004903; Crown W, 2017, VALUE HEALTH, V20, P310, DOI 10.1016/j.jval.2017.01.013; Davis JC, 2011, OSTEOPOROSIS INT, V22, P2449, DOI 10.1007/s00198-010-1482-0; Drummond M, 2005, INT J TECHNOL ASSESS, V21, P165, DOI 10.1017/S0266462305050221; Drummond MF, 1996, BRIT MED J, V313, P275, DOI 10.1136/bmj.313.7052.275; Drummond MF, 2015, METHODS EC EVALUATIO; Dunlop WCN, 2017, PHARMACOECONOMICS, V35, P125, DOI 10.1007/s40273-016-0479-8; Emerson J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0205633; EUnetHTA European Network for Health Technology Assessment, 2021, GUID DOC; Goetghebeur MM, 2008, VALUE HEALTH, V11, pA183, DOI 10.1186/1472-6963-8-270; Gold MR, 1996, COST EFFECTIVENESS H; Hawton A, 2021, PATIENT, V14, P429, DOI 10.1007/s40271-020-00461-4; HILLMAN AL, 1995, ANN INTERN MED, V123, P61; Husereau D, 2022, VALUE HEALTH, V25, P10, DOI 10.1016/j.jval.2021.10.008; Husereau D, 2013, VALUE HEALTH, V16, P231, DOI 10.1016/j.jval.2013.02.002; ISPOR, OP SOURC MOD; Jansen JP, 2019, PHARMACOECONOMICS, V37, P1313, DOI 10.1007/s40273-019-00827-z; Juni P, 1999, JAMA-J AM MED ASSOC, V282, P1054, DOI 10.1001/jama.282.11.1054; Lorgelly PK, 2021, PATIENT, V14, P379, DOI 10.1007/s40271-021-00505-3; Malone DC, 2020, VALUE HEALTH, V23, P409, DOI 10.1016/j.jval.2020.03.001; Mauskopf J, 2018, VALUE HEALTH, V21, P1133, DOI 10.1016/j.jval.2018.08.005; Moher D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000217; Neumann PJ, 2015, VALUE HEALTH, V18, P271, DOI 10.1016/j.jval.2014.12.002; Nuijten MJC, 1998, PHARMACOECONOMICS, V14, P259; Panzer AD, 2020, HEALTH ECON, V29, P945, DOI 10.1002/hec.4029; Petrou S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1766; Petrou S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1548; Pitt C, 2016, HEALTH ECON, V25, P9, DOI 10.1002/hec.3305; Ramsey SD, 2015, VALUE HEALTH, V18, P161, DOI 10.1016/j.jval.2015.02.001; Ryan M, 2017, INT J TECHNOL ASSESS, V33, P424, DOI 10.1017/S026646231700085X; Sanders GD, 2016, JAMA-J AM MED ASSOC, V316, P1093, DOI 10.1001/jama.2016.12195; Sanghera S, 2015, PHARMACOECONOMICS, V33, P533, DOI 10.1007/s40273-015-0265-z; Siegel JE, 1996, JAMA-J AM MED ASSOC, V276, P1339, DOI 10.1001/jama.276.16.1339; Smith Robert, 2020, Wellcome Open Res, V5, P69, DOI 10.12688/wellcomeopenres.15807.1; Sperber AD, 2004, GASTROENTEROLOGY, V126, pS124, DOI 10.1053/j.gastro.2003.10.016; Staniszewska S, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3453; Sullivan SD, 2014, VALUE HEALTH, V17, P5, DOI 10.1016/j.jval.2013.08.2291; Thorn JC, 2016, VALUE HEALTH, V19, pA397, DOI 10.1016/j.jval.2016.09.291; Vintzileos AM, 2004, AM J OBSTET GYNECOL, V191, P1070, DOI 10.1016/j.ajog.2004.05.021; Walker DG, 2012, BEST PRACTICES CONDU; Wilkinson T, 2016, VALUE HEALTH, V19, P921, DOI 10.1016/j.jval.2016.04.015; World Health Organization (WHO), WHO GUID STAND EC EV, V2	50	78	78	30	42	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1369-6998	1941-837X		J MED ECON	J. Med. Econ.	JAN 11	2022	25			1	SI		1	7		10.1080/13696998.2021.2014721	http://dx.doi.org/10.1080/13696998.2021.2014721			7	Health Care Sciences & Services; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services; General & Internal Medicine	YG0NQ	35098747	gold, Green Accepted			2022-12-28	WOS:000742195300001
J	Husereau, D; Drummond, M; Augustovski, F; De Bekker-Grob, E; Briggs, AH; Carswell, C; Caulley, L; Chaiyakunapruk, N; Greenberg, D; Loder, E; Mauskopf, J; Mullins, CD; Petrou, S; Pwu, RF; Staniszewska, S				Husereau, Don; Drummond, Michael; Augustovski, Federico; De Bekker-Grob, Esther; Briggs, Andrew H.; Carswell, Chris; Caulley, Lisa; Chaiyakunapruk, Nathorn; Greenberg, Dan; Loder, Elizabeth; Mauskopf, Josephine; Mullins, C. Daniel; Petrou, Stavros; Pwu, Raoh-Fang; Staniszewska, Sophie			Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations	JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY			English	Article							COST-EFFECTIVENESS ANALYSIS; CLINICAL-TRIALS; GUIDELINES; RECOMMENDATIONS; IMPACT; DESIGN	Health economic evaluations are comparative analyses of alternative courses of action in terms of their costs and consequences. The Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement, published in 2013, was created to ensure health economic evaluations are identifiable, interpretable, and useful for decision making. It was intended as guidance to help authors report accurately which health interventions were being compared and in what context, how the evaluation was undertaken, what the findings were, and other details that may aid readers and reviewers in interpretation and use of the study. The new CHEERS 2022 statement replaces previous CHEERS reporting guidance. It reflects the need for guidance that can be more easily applied to all types of health economic evaluation, new methods and developments in the field, as well as the increased rote of stakeholder involvement including patients and the public. It is also broadly applicable to any form of intervention intended to improve the health of individuals or the population, whether simple or complex, and without regard to context (such as health care, public health, education, social care, etc). This summary article presents the new CHEERS 2022 28-item checklist and recommendations for each item. The CHEERS 2022 statement is primarily intended for researchers reporting economic evaluations for peer reviewed journals as welt as the peer reviewers and editors assessing them for publication. However, we anticipate familiarity with reporting requirements wilt be useful for analysts when planning studies. It may also be useful for health technology assessment bodies seeking guidance on reporting, as there is an increasing emphasis on transparency in decision making.	[Husereau, Don] Univ Ottawa, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada; [Husereau, Don] Inst Hlth Econ, Edmonton, AB, Canada; [Drummond, Michael] Univ York, Ctr Hlth Econ, York, N Yorkshire, England; [Augustovski, Federico] Inst Clin Effectiveness & Hlth Policy IECS CONICE, Hlth Technol Assessment & Hlth Econ Dept, Buenos Aires, DF, Argentina; [Augustovski, Federico] Univ Buenos Aires, Buenos Aires, DF, Argentina; [Augustovski, Federico] CONICET Natl Sci & Tech Res Council, Buenos Aires, DF, Argentina; [De Bekker-Grob, Esther] Erasmus Univ, Erasmus Sch Hlth Policy & Management, Hlth Econ & Hlth Preferences, Rotterdam, Netherlands; [Briggs, Andrew H.] London Sch Hyg & Trop Med, Hlth Econ, London, England; [Carswell, Chris] Springer Nat, Adis Journals, Auckland, New Zealand; [Caulley, Lisa] Univ Ottawa, Dept Otolaryngol Head & Neck Surg, Ottawa, ON, Canada; [Caulley, Lisa] Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Caulley, Lisa] Ottawa Hosp Res Inst, Ctr Journatol, Ottawa, ON, Canada; [Caulley, Lisa] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Chaiyakunapruk, Nathorn] Univ Utah, Coll Pharm, Dept Pharmacotherapy, Salt Lake City, UT 84112 USA; [Greenberg, Dan] Ben Gurion Univ Negev, Fac Hlth Sci, Sch Publ Hlth, Dept Hlth Policy & Management, Beer Sheva, Israel; [Loder, Elizabeth] Harvard Med Sch, Res, Boston, MA 02115 USA; [Loder, Elizabeth] BMJ, London, England; [Mauskopf, Josephine] RTI Int, RTI Hlth Solut, Res Triangle Pk, NC USA; [Mullins, C. Daniel] Univ Maryland, Sch Pharm, Baltimore, MD 21201 USA; [Petrou, Stavros] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Hlth Econ, Oxford, England; [Pwu, Raoh-Fang] Minist Hlth & Welf, Natl Hepatitis C Program Off, Taipei, Taiwan; [Staniszewska, Sophie] Univ Warwick, Warwick Res Nursing, Warwick Med Sch, Res,Cheers 2022 ISPOR Good Res Practices Task For, Coventry, Warwick, England	University of Ottawa; University of York - UK; University of Buenos Aires; Erasmus University Rotterdam; University of London; London School of Hygiene & Tropical Medicine; Adis International; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; Erasmus University Rotterdam; Erasmus MC; Utah System of Higher Education; University of Utah; Ben Gurion University; Harvard University; Harvard Medical School; Research Triangle Institute; University System of Maryland; University of Maryland Baltimore; University of Oxford; University of Warwick	Husereau, D (corresponding author), Univ Ottawa, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada.; Husereau, D (corresponding author), Inst Hlth Econ, Edmonton, AB, Canada.	donh@donhusereau.com	Kostyuk, Alexander/HGA-2381-2022; Kostyuk, Alex/E-7579-2011; Pwu, Raoh Fang/AFK-8020-2022; Petrou, Stavros/ABD-8323-2021; Hughes, Dyfrig/H-5252-2012	Kostyuk, Alexander/0000-0001-6538-1324; Kostyuk, Alex/0000-0001-6538-1324; Pwu, Raoh Fang/0000-0002-0113-6917; Husereau, Don/0000-0002-4416-6876; Caulley, Lisa/0000-0002-9661-4634; Petrou, Stavros/0000-0003-3121-6050; Powell, John/0000-0002-1456-4857; Chaiyakunapruk, Nathorn/0000-0003-4572-8794; Mauskopf, Josephine/0000-0002-6098-5548; Briggs, Andrew/0000-0002-0777-1997; Hughes, Dyfrig/0000-0001-8247-7459	ISPOR-The Profes-sional Society for Health Economics and Outcomes Research; Canada Inc. [9363980]; NIHR Applied Research Col-laboration (ARC) West Midlands; NIHR Health Protection Research Unit (HPRU) Gastrointestinal Infections; NIHR HPRU Genomics and Enabling data	ISPOR-The Profes-sional Society for Health Economics and Outcomes Research; Canada Inc.; NIHR Applied Research Col-laboration (ARC) West Midlands; NIHR Health Protection Research Unit (HPRU) Gastrointestinal Infections; NIHR HPRU Genomics and Enabling data	Funding to support ongoing meetings was provided by ISPOR-The Profes-sional Society for Health Economics and Outcomes Research. The funders had no role in considering the study design or in the collection, analysis, interpretation of data, or writing of the report. Funding for DH and the Delphi Panel exercise was provided by 9363980 Canada Inc. SS is part funded by the NIHR Applied Research Col-laboration (ARC) West Midlands, the NIHR Health Protection Research Unit (HPRU) Gastrointestinal Infections, and the NIHR HPRU Genomics and Enabling data.	Altman DG, 2016, J ROY SOC MED, V109, P67, DOI 10.1177/0141076815625599; [Anonymous], CONS HLTH EC EV REP; Bond K, 2020, INT J TECHNOL ASSESS, V36, P445, DOI 10.1017/S0266462320000550; CADTH.ca, 2015, GUID EC EV HLTH TECH; Catala-Lopez F, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-034463; Caulley L, 2020, J CLIN EPIDEMIOL, V122, P87, DOI 10.1016/j.jclinepi.2020.03.006; Cohen JT, 2017, ANN INTERN MED, V167, P432, DOI 10.7326/M17-1153; Cookson R, 2021, VALUE HEALTH, V24, P118, DOI 10.1016/j.jval.2020.10.001; Cookson R, 2009, HEALTH ECON POLICY L, V4, P231, DOI 10.1017/S1744133109004903; Crown W, 2017, VALUE HEALTH, V20, P310, DOI 10.1016/j.jval.2017.01.013; Davis JC, 2011, OSTEOPOROSIS INT, V22, P2449, DOI 10.1007/s00198-010-1482-0; Drummond M, 2005, INT J TECHNOL ASSESS, V21, P165, DOI 10.1017/S0266462305050221; Drummond MF, 1996, BRIT MED J, V313, P275, DOI 10.1136/bmj.313.7052.275; Drummond MF, 2015, METHODS EC EVALUATIO; Dunlop WCN, 2017, PHARMACOECONOMICS, V35, P125, DOI 10.1007/s40273-016-0479-8; Emerson J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0205633; EUnetHTA European Network for Health Technology Assessment, 2021, GUID DOC; Goetghebeur MM, 2008, VALUE HEALTH, V11, pA183, DOI 10.1186/1472-6963-8-270; Gold MR, 1996, COST EFFECTIVENESS H; Hawton A, 2021, PATIENT, V14, P429, DOI 10.1007/s40271-020-00461-4; HILLMAN AL, 1995, ANN INTERN MED, V123, P61; Husereau D, 2022, VALUE HEALTH, V25, P10, DOI 10.1016/j.jval.2021.10.008; Husereau D, 2013, VALUE HEALTH, V16, P231, DOI 10.1016/j.jval.2013.02.002; ISPOR, OP SOURC MOD; Jansen JP, 2019, PHARMACOECONOMICS, V37, P1313, DOI 10.1007/s40273-019-00827-z; Juni P, 1999, JAMA-J AM MED ASSOC, V282, P1054, DOI 10.1001/jama.282.11.1054; Lorgelly PK, 2021, PATIENT, V14, P379, DOI 10.1007/s40271-021-00505-3; Malone DC, 2020, VALUE HEALTH, V23, P409, DOI 10.1016/j.jval.2020.03.001; Mauskopf J, 2018, VALUE HEALTH, V21, P1133, DOI 10.1016/j.jval.2018.08.005; Moher D., 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000217, 10.1371/journal.pmed.1000097]; Neumann PJ, 2015, VALUE HEALTH, V18, P271, DOI 10.1016/j.jval.2014.12.002; Nuijten MJC, 1998, PHARMACOECONOMICS, V14, P259; Panzer AD, 2020, HEALTH ECON, V29, P945, DOI 10.1002/hec.4029; Petrou S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1766; Petrou S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1548; Pitt C, 2016, HEALTH ECON, V25, P9, DOI 10.1002/hec.3305; Ramsey SD, 2015, VALUE HEALTH, V18, P161, DOI 10.1016/j.jval.2015.02.001; Ryan M, 2017, INT J TECHNOL ASSESS, V33, P424, DOI 10.1017/S026646231700085X; Sanders GD, 2016, JAMA-J AM MED ASSOC, V316, P1093, DOI 10.1001/jama.2016.12195; Sanghera S, 2015, PHARMACOECONOMICS, V33, P533, DOI 10.1007/s40273-015-0265-z; Siegel JE, 1996, JAMA-J AM MED ASSOC, V276, P1339, DOI 10.1001/jama.276.16.1339; Smith Robert, 2020, Wellcome Open Res, V5, P69, DOI 10.12688/wellcomeopenres.15807.1; Sperber AD, 2004, GASTROENTEROLOGY, V126, pS124, DOI 10.1053/j.gastro.2003.10.016; Staniszewska S, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3453; Sullivan SD, 2014, VALUE HEALTH, V17, P5, DOI 10.1016/j.jval.2013.08.2291; Thorn JC, 2016, VALUE HEALTH, V19, pA397, DOI 10.1016/j.jval.2016.09.291; Vintzileos AM, 2004, AM J OBSTET GYNECOL, V191, P1070, DOI 10.1016/j.ajog.2004.05.021; Walker DG, 2012, BEST PRACTICES CONDU; Wilkinson T, 2016, VALUE HEALTH, V19, P921, DOI 10.1016/j.jval.2016.04.015; World Health Organization (WHO), WHO GUID STAND EC EV, V2	50	78	78	30	42	ACAD MANAGED CARE PHARMACY	ALEXANDRIA	100 N PITT ST, 400, ALEXANDRIA, VA 22314-3134 USA	2376-0540	2376-1032		J MANAG CARE SPEC PH	J. Manag. Care Spec. Pharm.	FEB	2022	28	2					146	155						10	Health Care Sciences & Services; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services; Pharmacology & Pharmacy	YS6VL	35098747				2022-12-28	WOS:000750811900002
J	Husereau, D; Drummond, M; Augustovski, F; de Bekker-Grob, E; Briggs, AH; Carswell, C; Caulley, L; Chaiyakunapruk, N; Greenberg, D; Loder, E; Mauskopf, J; Mullins, CD; Petrou, S; Pwu, RF; Staniszewska, S				Husereau, Don; Drummond, Michael; Augustovski, Federico; de Bekker-Grob, Esther; Briggs, Andrew H.; Carswell, Chris; Caulley, Lisa; Chaiyakunapruk, Nathorn; Greenberg, Dan; Loder, Elizabeth; Mauskopf, Josephine; Mullins, C. Daniel; Petrou, Stavros; Pwu, Raoh-Fang; Staniszewska, Sophie		CHEERS 2022 ISPOR Good Res Practic	Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations	EUROPEAN JOURNAL OF HEALTH ECONOMICS			English	Article; Early Access						Cost-benefit analysis; Economic evaluation; Reporting; Guidelines	COST-EFFECTIVENESS ANALYSIS; TASK-FORCE; CLINICAL-TRIALS; GUIDELINES; RECOMMENDATIONS; IMPACT; TECHNOLOGY; PRINCIPLES; DESIGN	Health economic evaluations are comparative analyses of alternative courses of action in terms of their costs and consequences. The Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement, published in 2013, was created to ensure health economic evaluations are identifiable, interpretable, and useful for decision making. It was intended as guidance to help authors report accurately which health interventions were being compared and in what context, how the evaluation was undertaken, what the findings were, and other details that may aid readers and reviewers in interpretation and use of the study. The new CHEERS 2022 statement replaces previous CHEERS reporting guidance. It reflects the need for guidance that can be more easily applied to all types of health economic evaluation, new methods and developments in the field, as well as the increased role of stakeholder involvement including patients and the public. It is also broadly applicable to any form of intervention intended to improve the health of individuals or the population, whether simple or complex, and without regard to context (such as health care, public health, education, social care, etc.). This summary article presents the new CHEERS 2022 28-item checklist and recommendations for each item. The CHEERS 2022 statement is primarily intended for researchers reporting economic evaluations for peer reviewed journals as well as the peer reviewers and editors assessing them for publication. However, we anticipate familiarity with reporting requirements will be useful for analysts when planning studies. It may also be useful for health technology assessment bodies seeking guidance on reporting, as there is an increasing emphasis on transparency in decision making.	[Husereau, Don] Univ Ottawa, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada; [Drummond, Michael] Univ York, Ctr Hlth Econ, York, N Yorkshire, England; [Augustovski, Federico] Inst Clin Effectiveness & Hlth Policy IECS CONICE, Hlth Technol Assessment & Hlth Econ Dept, Buenos Aires, DF, Argentina; [de Bekker-Grob, Esther] Erasmus Univ, Erasmus Sch Hlth Policy & Management, Rotterdam, Netherlands; [Briggs, Andrew H.] London Sch Hyg & Trop Med, London, England; [Carswell, Chris] Springer Nat, Adis Journals, Auckland, New Zealand; [Caulley, Lisa] Univ Ottawa, Dept Otolaryngol Head & Neck Surg, Ottawa, ON, Canada; [Chaiyakunapruk, Nathorn] Univ Utah, Coll Pharm, Dept Pharmacotherapy, Salt Lake City, UT 84112 USA; [Greenberg, Dan] Ben Gurion Univ Negev, Fac Hlth Sci, Sch Publ Hlth, Dept Hlth Policy & Management, Beer Sheva, Israel; [Loder, Elizabeth] Harvard Med Sch, Boston, MA 02115 USA; [Mauskopf, Josephine] RTI Int, RTI Hlth Solut, Res Triangle Pk, NC USA; [Mullins, C. Daniel] Univ Maryland, Sch Pharm, Baltimore, MD 21201 USA; [Petrou, Stavros] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England; [Pwu, Raoh-Fang] Minist Hlth & Welf, Natl Hepatitis C Program Off, Taipei, Taiwan; [Staniszewska, Sophie] Univ Warwick, Warwick Res Nursing, Warwick Med Sch, Warwick, England; [Husereau, Don] Inst Hlth Econ, 879 Winnington Ave, Ottawa, ON K2B 5C4, Canada; [Augustovski, Federico] Univ Buenos Aires, Buenos Aires, DF, Argentina; [Augustovski, Federico] CONICET Natl Sci & Tech Res Council, Buenos Aires, DF, Argentina; [Caulley, Lisa] Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Caulley, Lisa] Ottawa Hosp Res Inst, Ctr Journalol, Ottawa, ON, Canada; [Caulley, Lisa] Erasmus Univ, Dept Epidemiol, Med Ctr Rotterdam, Rotterdam, Netherlands; [Loder, Elizabeth] The BMJ, London, England	University of Ottawa; University of York - UK; Erasmus University Rotterdam; University of London; London School of Hygiene & Tropical Medicine; Adis International; University of Ottawa; Utah System of Higher Education; University of Utah; Ben Gurion University; Harvard University; Harvard Medical School; Research Triangle Institute; University System of Maryland; University of Maryland Baltimore; University of Oxford; University of Warwick; University of Buenos Aires; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; Erasmus University Rotterdam; Erasmus MC	Husereau, D (corresponding author), Univ Ottawa, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada.; Husereau, D (corresponding author), Inst Hlth Econ, 879 Winnington Ave, Ottawa, ON K2B 5C4, Canada.	donh@donhusereau.com	Kostyuk, Alexander/HGA-2381-2022; Kostyuk, Alex/E-7579-2011; Pwu, Raoh Fang/AFK-8020-2022; Petrou, Stavros/ABD-8323-2021; Hughes, Dyfrig/H-5252-2012	Kostyuk, Alexander/0000-0001-6538-1324; Kostyuk, Alex/0000-0001-6538-1324; Pwu, Raoh Fang/0000-0002-0113-6917; Husereau, Don/0000-0002-4416-6876; Caulley, Lisa/0000-0002-9661-4634; Petrou, Stavros/0000-0003-3121-6050; Powell, John/0000-0002-1456-4857; Chaiyakunapruk, Nathorn/0000-0003-4572-8794; Mauskopf, Josephine/0000-0002-6098-5548; Briggs, Andrew/0000-0002-0777-1997; Hughes, Dyfrig/0000-0001-8247-7459	ISPOR-The Professional Society for Health Economics and Outcomes Research; NIHR Applied Research Collaboration (ARC) West Midlands; NIHR Health Protection Research Unit (HPRU) Gastrointestinal Infections; NIHR HPRU Genomics and Enabling data; Canada Inc. [9363980]	ISPOR-The Professional Society for Health Economics and Outcomes Research; NIHR Applied Research Collaboration (ARC) West Midlands; NIHR Health Protection Research Unit (HPRU) Gastrointestinal Infections; NIHR HPRU Genomics and Enabling data; Canada Inc.	Funding to support ongoing meetings was provided by ISPOR-The Professional Society for Health Economics and Outcomes Research. The funders had no role in considering the study design or in the collection, analysis, interpretation of data, or writing of the report. Funding for DH and the Delphi Panel exercise was provided by 9363980 Canada Inc. SS is part funded by the NIHR Applied Research Collaboration (ARC) West Midlands, the NIHR Health Protection Research Unit (HPRU) Gastrointestinal Infections, and the NIHR HPRU Genomics and Enabling data.	Altman DG, 2016, J ROY SOC MED, V109, P67, DOI 10.1177/0141076815625599; [Anonymous], CONS HLTH EC EV REP; Bond K, 2020, INT J TECHNOL ASSESS, V36, P445, DOI 10.1017/S0266462320000550; CADTH.ca, 2015, GUID EC EV HLTH TECH; Catala-Lopez F, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-034463; Caulley L, 2020, J CLIN EPIDEMIOL, V122, P87, DOI 10.1016/j.jclinepi.2020.03.006; Cohen JT, 2017, ANN INTERN MED, V167, P432, DOI 10.7326/M17-1153; Cookson R, 2021, VALUE HEALTH, V24, P118, DOI 10.1016/j.jval.2020.10.001; Cookson R, 2009, HEALTH ECON POLICY L, V4, P231, DOI 10.1017/S1744133109004903; Crown W, 2017, VALUE HEALTH, V20, P310, DOI 10.1016/j.jval.2017.01.013; Davis JC, 2011, OSTEOPOROSIS INT, V22, P2449, DOI 10.1007/s00198-010-1482-0; Drummond M, 2005, INT J TECHNOL ASSESS, V21, P165, DOI 10.1017/S0266462305050221; Drummond MF, 1996, BRIT MED J, V313, P275, DOI 10.1136/bmj.313.7052.275; Drummond MF, 2015, METHODS EC EVALUATIO; Dunlop WCN, 2017, PHARMACOECONOMICS, V35, P125, DOI 10.1007/s40273-016-0479-8; Emerson J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0205633; EUnetHTA European Network for Health Technology Assessment, 2021, GUID DOC; Goetghebeur MM, 2008, VALUE HEALTH, V11, pA183, DOI 10.1186/1472-6963-8-270; Gold MR, 1996, COST EFFECTIVENESS H; Hawton A, 2021, PATIENT, V14, P429, DOI 10.1007/s40271-020-00461-4; HILLMAN AL, 1995, ANN INTERN MED, V123, P61; Husereau D, 2022, VALUE HEALTH, V25, P10, DOI 10.1016/j.jval.2021.10.008; Husereau D, 2013, VALUE HEALTH, V16, P231, DOI 10.1016/j.jval.2013.02.002; ISPOR, OP SOURC MOD; Jansen JP, 2019, PHARMACOECONOMICS, V37, P1313, DOI 10.1007/s40273-019-00827-z; Juni P, 1999, JAMA-J AM MED ASSOC, V282, P1054, DOI 10.1001/jama.282.11.1054; Lorgelly PK, 2021, PATIENT, V14, P379, DOI 10.1007/s40271-021-00505-3; Malone DC, 2020, VALUE HEALTH, V23, P409, DOI 10.1016/j.jval.2020.03.001; Mauskopf J, 2018, VALUE HEALTH, V21, P1133, DOI 10.1016/j.jval.2018.08.005; Moher D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000217; Neumann PJ, 2015, VALUE HEALTH, V18, P271, DOI 10.1016/j.jval.2014.12.002; Nuijten MJC, 1998, PHARMACOECONOMICS, V14, P259; Panzer AD, 2020, HEALTH ECON, V29, P945, DOI 10.1002/hec.4029; Petrou S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1766; Petrou S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1548; Pitt C, 2016, HEALTH ECON, V25, P9, DOI 10.1002/hec.3305; Ramsey SD, 2015, VALUE HEALTH, V18, P161, DOI 10.1016/j.jval.2015.02.001; Ryan M, 2017, INT J TECHNOL ASSESS, V33, P424, DOI 10.1017/S026646231700085X; Sanders GD, 2016, JAMA-J AM MED ASSOC, V316, P1093, DOI 10.1001/jama.2016.12195; Sanghera S, 2015, PHARMACOECONOMICS, V33, P533, DOI 10.1007/s40273-015-0265-z; Siegel JE, 1996, JAMA-J AM MED ASSOC, V276, P1339, DOI 10.1001/jama.276.16.1339; Smith Robert, 2020, Wellcome Open Res, V5, P69, DOI 10.12688/wellcomeopenres.15807.1; Sperber AD, 2004, GASTROENTEROLOGY, V126, pS124, DOI 10.1053/j.gastro.2003.10.016; Staniszewska S, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3453; Sullivan SD, 2014, VALUE HEALTH, V17, P5, DOI 10.1016/j.jval.2013.08.2291; Thorn JC, 2016, VALUE HEALTH, V19, pA397, DOI 10.1016/j.jval.2016.09.291; Vintzileos AM, 2004, AM J OBSTET GYNECOL, V191, P1070, DOI 10.1016/j.ajog.2004.05.021; Walker DG, 2012, BEST PRACTICES CONDU; Wilkinson T, 2016, VALUE HEALTH, V19, P921, DOI 10.1016/j.jval.2016.04.015; World Health Organization (WHO), WHO GUID STAND EC EV, V2	50	78	78	30	42	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1618-7598	1618-7601		EUR J HEALTH ECON	Eur. J. Health Econ.												10.1007/s10198-021-01426-6	http://dx.doi.org/10.1007/s10198-021-01426-6		JAN 2022	9	Economics; Health Policy & Services	Social Science Citation Index (SSCI)	Business & Economics; Health Care Sciences & Services	YQ1FQ	35098747	hybrid, Green Accepted, Green Published			2022-12-28	WOS:000749063400001
